PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Singh, S; Narayanan, SP; Biswas, K; Gupta, A; Ahuja, N; Yadav, S; Panday, RK; Samaiya, A; Sharan, SK; Shukla, S				Singh, Smriti; Narayanan, Sathiya Pandi; Biswas, Kajal; Gupta, Amit; Ahuja, Neha; Yadav, Sandhya; Panday, Rajendra Kumar; Samaiya, Atul; Sharan, Shyam K.; Shukla, Sanjeev			Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						alternative splicing; BORIS; DNA methylation; cancer; Warburg effect	DE-NOVO METHYLATION; PYRUVATE-KINASE; METABOLIC REQUIREMENTS; CELL-PROLIFERATION; HNRNP PROTEINS; TRANSCRIPTION; ISOFORM; GENE; CTCF; M2	Aberrant alternative splicing and epigenetic changes are both associated with various cancers, but epigenetic regulation of alternative splicing in cancer is largely unknown. Here we report that the intragenic DNA methylation-mediated binding of Brother of Regulator of Imprinted Sites (BORIS) at the alternative exon of Pyruvate Kinase (PKM) is associated with cancer-specific splicing that promotes the Warburg effect and breast cancer progression. Interestingly, the inhibition of DNA methylation, BORIS depletion, or CRISPR/Cas9-mediated deletion of the BORIS binding site leads to a splicing switch from cancer-specific PKM2 to normal PKM1 isoform. This results in the reversal of the Warburg effect and the inhibition of breast cancer cell growth, which may serve as a useful approach to inhibit the growth of breast cancer cells. Importantly, our results show that in addition to PKM splicing, BORIS also regulates the alternative splicing of several genes in a DNA methylation-dependent manner. Our findings highlight the role of intragenic DNA methylation and DNA binding protein BORIS in cancer-specific splicing and its role in tumorigenesis.	[Singh, Smriti; Narayanan, Sathiya Pandi; Gupta, Amit; Ahuja, Neha; Shukla, Sanjeev] Indian Inst Sci Educ & Res, Dept Biol Sci, Bhopal 462066, Madhya Pradesh, India; [Biswas, Kajal; Sharan, Shyam K.] NCI, Ctr Canc Res, Frederick, MD 21702 USA; [Panday, Rajendra Kumar] Navodaya Canc Hosp, Unit Radiotherapy, Bhopal 462022, Madhya Pradesh, India; [Panday, Rajendra Kumar] Bansal Hosp, Dept Radiotherapy, Bhopal 462016, Madhya Pradesh, India; [Samaiya, Atul] NCH, Unit Surg Oncol, Bhopal 462022, Madhya Pradesh, India; [Samaiya, Atul] BH, Dept Surg Oncol, Bhopal 462016, Madhya Pradesh, India; [Narayanan, Sathiya Pandi] Univ Michigan, Dept Pathol, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA	Shukla, S (reprint author), Indian Inst Sci Educ & Res, Dept Biol Sci, Bhopal 462066, Madhya Pradesh, India.	sanjeevs@iiserb.ac.in			Science and Engineering Research Board (SERB) [EMR/2014/000716]; Wellcome Trust/Department of Biotechnology (DBT) India [IA/I/16/2/502719]; Indian Institute of Science Education and Research Bhopal; Council of Scientific and Industrial Research; SERB [PDF/2015/000560]	We thank N. Kalra for critical reading of this manuscript. This work is supported by Science and Engineering Research Board (SERB) Grant EMR/2014/000716 and Wellcome Trust/Department of Biotechnology (DBT) India Alliance Fellowship Grant IA/I/16/2/502719 (to S. Shukla). S. Singh and A.G. were supported by an Indian Institute of Science Education and Research Bhopal fellowship. N.A. and S.Y. were supported by a Council of Scientific and Industrial Research fellowship. S.P.N. was supported by SERB-National Postdoctoral Fellowship PDF/2015/000560.	Chen M, 2012, NAT STRUCT MOL BIOL, V19, P346, DOI 10.1038/nsmb.2219; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Desai S, 2014, ONCOTARGET, V5, P8202, DOI 10.18632/oncotarget.1159                                                        ; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Girault I, 2003, CLIN CANCER RES, V9, P4415; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Link Petra A, 2013, Cancer Immun, V13, P6; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002; Martin-Kleiner I, 2012, EUR J CANCER, V48, P929, DOI 10.1016/j.ejca.2011.09.009; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Menafra R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099603; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pugacheva EM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0736-8; Roll JD, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-15; Ruckenstuhl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004592; Shukla S, 2012, BBA-GENE REGUL MECH, V1819, P673, DOI 10.1016/j.bbagrm.2012.01.014; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Sleutels F, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-8; van Hoesel AQ, 2013, BRIT J CANCER, V108, P2033, DOI 10.1038/bjc.2013.136; Wang ZX, 2012, J MOL CELL BIOL, V4, P79, DOI 10.1093/jmcb/mjr030; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Yearim A, 2015, CELL REP, V10, P1122, DOI 10.1016/j.celrep.2015.01.038; Zhang YM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40786	40	0	0	3	3	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 24	2017	114	43					11440	11445		10.1073/pnas.1708447114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FK5EN	WOS:000413520700063	29073069	green_published			2018-01-05	
J	Yu, B; Wang, XL; Wei, S; Fu, T; Dzakah, EE; Waqas, A; Walthall, WW; Shan, G				Yu, Bin; Wang, Xiaolin; Wei, Shuai; Fu, Tao; Dzakah, Emmanuel Enoch; Waqas, Ahmed; Walthall, Walter W.; Shan, Ge			Convergent Transcriptional Programs Regulate cAMP Levels in C-elegans GABAergic Motor Neurons	DEVELOPMENTAL CELL			English	Article							AXON REGENERATION REQUIRES; NUCLEAR HORMONE-RECEPTOR; MAP KINASE PATHWAY; CAENORHABDITIS-ELEGANS; HOMEODOMAIN PROTEIN; NERVOUS-SYSTEM; DLK-1 KINASE; IDENTITY; GENOME; CELLS	Both transcriptional regulation and signaling pathways play crucial roles in neuronal differentiation and plasticity. Caenorhabditis elegans possesses 19 GABAergic motor neurons (MNs) called D MNs, which are divided into two subgroups: DD and VD. DD, but not VD, MNs reverse their cellular polarity in a developmental process called respecification. UNC-30 and UNC-55 are two critical transcription factors in D MNs. By using chromatin immunoprecipitation with CRISPR/Cas9 knockin of GFP fusion, we uncovered the global targets of UNC-30 and UNC-55. UNC-30 and UNC-55 are largely converged to regulate over 1,300 noncoding and coding genes, and genes in multiple biological processes, including cAMP metabolism, are co-regulated. Increase in cAMP levels may serve as a timing signal for respecification, whereas UNC-55 regulates genes such as pde-4 to keep the cAMP levels low in VD. Other genes modulating DD respecification such as lin-14, irx-1, and oig-1 are also found to affect cAMP levels.	[Yu, Bin; Wang, Xiaolin; Wei, Shuai; Fu, Tao; Dzakah, Emmanuel Enoch; Waqas, Ahmed; Shan, Ge] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, CAS Ctr Excellence Mol Cell Sci, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Walthall, Walter W.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	Shan, G (reprint author), Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, CAS Ctr Excellence Mol Cell Sci, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	shange@ustc.edu.cn			National Basic Research Program of China [2015CB943000]; National Natural Science Foundation of China [31471225]; Open Project of the CAS Key Laboratory of Innate Immunity and Chronic Disease; Pilot Project of Hefei Center of Materials Science and Technology [2016FXCX006]; Fundamental Research Funds for the Central Universities [WK2070000034]	The authors thank Guoqiang Bi, Qingfa Wu, Shouhong Guang, and Zheng-xing Wu for providing experimental facilities. Thanks to Dr. Abby Dernburg for the Degron constructs and Dr. Kees Jalink for the cAMP FRET constructs. Thanks to CGC, Japan NBRP-C. elegans, Yingchuan B. Qi, Min Han, Mei Zhen, Mike Francis, David Miller, III, Haijun Tu, and Yishi Jin for providing worm strains. We thank the Bioinformatics Center of the USTC, School of Life Sciences, for providing supercomputing resources. This work was supported by the National Basic Research Program of China (2015CB943000 to G.S.), the National Natural Science Foundation of China (31471225 to G.S.), the Open Project of the CAS Key Laboratory of Innate Immunity and Chronic Disease (to G.S.), the Pilot Project of Hefei Center of Materials Science and Technology (2016FXCX006 to G.S.), and the Fundamental Research Funds for the Central Universities (WK2070000034 to G.S.).	Araya CL, 2014, NATURE, V512, P400, DOI 10.1038/nature13497; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; BRENNER S, 1974, GENETICS, V77, P71; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI [10.1038/nmeth.2641, 10.1038/NMETH.2641]; Doitsidou M, 2013, GENE DEV, V27, P1391, DOI 10.1101/gad.217224.113; Eastman C, 1999, J NEUROSCI, V19, P6225; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; He SW, 2015, CURR BIOL, V25, P2541, DOI 10.1016/j.cub.2015.08.022; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hobert O, 2016, CURR TOP DEV BIOL, V116, P455, DOI 10.1016/bs.ctdb.2015.12.007; Howell K, 2015, NATURE, V523, P83, DOI 10.1038/nature14545; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0                                                                ; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kerk SY, 2017, NEURON, V93, P80, DOI 10.1016/j.neuron.2016.11.036; Kim KW, 2015, FEBS LETT, V589, P1644, DOI 10.1016/j.febslet.2015.05.005; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurup N, 2015, CURR BIOL, V25, P1594, DOI 10.1016/j.cub.2015.04.061; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Li C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005603; Li C, 2012, NAT NEUROSCI, V15, P551, DOI 10.1038/nn.3052; Liu HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2071; Melkman T, 2005, DEVELOPMENT, V132, P1935, DOI 10.1242/dev.01788; MELLO CC, 1991, EMBO J, V10, P3959; Meng LF, 2015, CELL REP, V11, P1737, DOI 10.1016/j.celrep.2015.05.031; Miller-Fleming TW, 2016, ELIFE, V5, DOI 10.7554/eLife.14599; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Pastuhov SI, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2136; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Shafer OT, 2008, NEURON, V58, P223, DOI 10.1016/j.neuron.2008.02.018; Shan G, 2005, DEV BIOL, V280, P494, DOI 10.1016/j.ydbio.2005.01.032; Shan G, 2008, DEV BIOL, V322, P11, DOI 10.1016/j.ydbio.2008.06.034; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; Tang K, 2015, BBA-GENE REGUL MECH, V1849, P201, DOI 10.1016/j.bbagrm.2014.05.022; Thompson-Peer KL, 2012, NEURON, V73, P453, DOI 10.1016/j.neuron.2011.11.025; Tsuyama T, 2013, ANAL CHEM, V85, P7889, DOI 10.1021/ac4015325; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0                                                                ; WHITE JG, 1986, PHILOS T ROY SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yan D, 2009, CELL, V138, P1005, DOI 10.1016/j.cell.2009.06.023; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848; Zhou HM, 1998, J NEUROSCI, V18, P10438	61	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1534-5807	1878-1551		DEV CELL	Dev. Cell	OCT 23	2017	43	2					212	+		10.1016/j.devcel.2017.09.013				22	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	FK4EZ	WOS:000413443700012	29033363				2018-01-05	
J	Howe, FS; Russell, A; Lamstaes, AR; EI-Sagheer, A; Nair, A; Brown, T; Mellor, J				Howe, Francoise S.; Russell, Andrew; Lamstaes, Anna R.; EI-Sagheer, Afaf; Nair, Anitha; Brown, Tom; Mellor, Jane			CRISPRi is not strand-specific at all loci and redefines the transcriptional landscape	ELIFE			English	Article							ANTISENSE TRANSCRIPTION; GENOME; ARCHITECTURES; PLATFORM; GENES; SENSE; DNA	CRISPRi, an adapted CRISPR-Cas9 system, is proposed to act as a strand-specific roadblock to repress transcription in eukaryotic cells using guide RNAs (sgRNAs) to target catalytically inactive Cas9 (dCas9) and offers an alternative to genetic interventions for studying pervasive antisense transcription. Here, we successfully use click chemistry to construct DNA templates for sgRNA expression and show, rather than acting simply as a roadblock, sgRNA/dCas9 binding creates an environment that is permissive for transcription initiation/termination, thus generating novel sense and antisense transcripts. At HMS2 in Saccharomyces cerevisiae, sgRNA/dCas9 targeting to the non-template strand for antisense transcription results in antisense transcription termination, premature termination of a proportion of sense transcripts and initiation of a novel antisense transcript downstream of the sgRNA/dCas9-binding site. This redefinition of the transcriptional landscape by CRISPRi demonstrates that it is not strand-specific and highlights the controls and locus understanding required to properly interpret results from CRISPRi interventions.	[Howe, Francoise S.; Russell, Andrew; Lamstaes, Anna R.; Nair, Anitha; Mellor, Jane] Univ Oxford, Dept Biochem, Oxford, England; [EI-Sagheer, Afaf; Brown, Tom] Univ Oxford, Chem Res Lab, Dept Chem, Oxford, England; [EI-Sagheer, Afaf] Suez Univ, Fac Petr & Min Engn, Chem Branch, Suez, Egypt	Mellor, J (reprint author), Univ Oxford, Dept Biochem, Oxford, England.	jane.mellor@bioch.ox.ac.uk		Mellor, Jane/0000-0002-5196-3734; El-Sagheer, Afaf/0000-0001-8706-1292; Brown, Tom/0000-0002-6538-3036	Biotechnology and Biological Sciences Research Council [BB/J001694/2]; Wellcome [209897/Z/17/Z]	Funder Grant reference number Author; Biotechnology and Biological Sciences Research Council BB/J001694/2 Tom Brown Jane Mellor; Wellcome 209897/Z/17/Z Anna R Lamstaes; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Birts CN, 2014, ANGEW CHEM INT EDIT, V53, P2362, DOI 10.1002/anie.201308691; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; El-Sagheer AH, 2011, CHEM COMMUN, V47, P12057, DOI 10.1039/c1cc14316f; El-Sagheer AH, 2011, P NATL ACAD SCI USA, V108, P11338, DOI 10.1073/pnas.1101519108; El-Sagheer AH, 2010, CHEM SOC REV, V39, P1388, DOI 10.1039/b901971p; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Horlbeck M. A., 2016, ELIFE, V5; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Knight B, 2014, GENE DEV, V28, P1695, DOI 10.1101/gad.244434.114; Lavender CA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006224; Lenstra TL, 2015, MOL CELL, V60, P597, DOI 10.1016/j.molcel.2015.09.028; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mellor J, 2016, TRENDS GENET, V32, P57, DOI 10.1016/j.tig.2015.10.006; Murray SC, 2015, NUCLEIC ACIDS RES, V43, P7823, DOI 10.1093/nar/gkv666; Murray SC, 2012, NUCLEIC ACIDS RES, V40, P2432, DOI 10.1093/nar/gkr1121; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Nguyen T, 2014, ELIFE, V3, DOI 10.7554/eLife.03635	24	0	0	6	6	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	OCT 23	2017	6								e29878	10.7554/eLife.29878				15	Biology	Life Sciences & Biomedicine - Other Topics	FL3QI	WOS:000414137600001		gold			2018-01-05	
J	Wang, AD; Wang, JB; Liu, Y; Zhou, Y				Wang, Andi; Wang, Junbao; Liu, Ying; Zhou, Yan			Mechanisms of Long Non-Coding RNAs in the Assembly and Plasticity of Neural Circuitry	FRONTIERS IN NEURAL CIRCUITS			English	Review						long non-coding RNA; neural circuit; cell fates; synaptogenesis; synaptic plasticity; CRISPR-Cas9	SINGLE-CELL TRANSCRIPTOMICS; SPINAL MUSCULAR-ATROPHY; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; GENOME-WIDE ANALYSIS; DENDRITIC BC1 RNA; GENE-EXPRESSION; MESSENGER-RNA; CIRCULAR RNAS; HUMAN BRAIN	The mechanisms underlying development processes and functional dynamics of neural circuits are far from understood. Long non-coding RNAs (lncRNAs) have emerged as essential players in defining identities of neural cells, and in modulating neural activities. In this review, we summarized latest advances concerning roles and mechanisms of lncRNAs in assembly, maintenance and plasticity of neural circuitry, as well as lncRNAs' implications in neurological disorders. We also discussed technical advances and challenges in studying functions and mechanisms of lncRNAs in neural circuitry. Finally, we proposed that lncRNA studies would advance our understanding on how neural circuits develop and function in physiology and disease conditions.	[Wang, Andi; Wang, Junbao; Zhou, Yan] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Hubei, Peoples R China; [Liu, Ying; Zhou, Yan] Wuhan Univ, Med Res Inst, Wuhan, Hubei, Peoples R China	Zhou, Y (reprint author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan, Hubei, Peoples R China.; Liu, Y; Zhou, Y (reprint author), Wuhan Univ, Med Res Inst, Wuhan, Hubei, Peoples R China.	y.liu@whu.edu.cn; yan.zhou@whu.edu.cn			National Natural Science Foundation of China [31671418, 31471361]; Fundamental Research Funds for the Central Universities [2042017kf0205, 2042017kf0242]	We thank all Zhou lab members for critical reading. This work was supported by grants from National Natural Science Foundation of China (No. 31671418 and No. 31471361), and Fundamental Research Funds for the Central Universities (2042017kf0205 and 2042017kf0242) to YZ.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Aliperti V, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00015; Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702; Aprea J, 2013, EMBO J, V32, P3145, DOI 10.1038/emboj.2013.245; Barry G, 2014, MOL PSYCHIATR, V19, P486, DOI 10.1038/mp.2013.45; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Berghoff EG, 2013, DEVELOPMENT, V140, P4407, DOI 10.1242/dev.099390; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chalei V, 2014, ELIFE, V3, DOI 10.7554/eLife.04530; Chen KY, 2011, MOL CELL NEUROSCI, V48, P171, DOI 10.1016/j.mcn.2011.07.009; Chen L, 2016, J CELL MOL MED, V20, P2102, DOI 10.1111/jcmm.12904; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; d'Ydewalle C, 2017, NEURON, V93, P66, DOI 10.1016/j.neuron.2016.11.033; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Desai AR, 2000, DEVELOPMENT, V127, P2863; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dong XM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005669; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Ghosh S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw063; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gummalla M, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fnce1.2014.00096, 10.3389/fncel.2014.00096]; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hadley D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r105; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He DY, 2017, NEURON, V93, P362, DOI 10.1016/j.neuron.2016.11.044; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang X, 2017, PROG NEURO-PSYCHOPH, V73, P73, DOI 10.1016/j.pnpbp.2016.06.004; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Keppetipola N, 2012, CRIT REV BIOCHEM MOL, V47, P360, DOI 10.3109/10409238.2012.691456; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Lewejohann L, 2004, BEHAV BRAIN RES, V154, P273, DOI 10.1016/j.bbr.2004.02.015; Li LJ, 2014, TRENDS CELL BIOL, V24, P594, DOI 10.1016/j.tcb.2014.06.003; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li MX, 2012, NUCLEIC ACIDS RES, V40, P11714, DOI 10.1093/nar/gks943; Lin NW, 2014, MOL CELL, V53, P1067, DOI 10.1016/j.molcel.2014.03.013; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Liu T, 2014, MOL MED REP, V10, P1275, DOI 10.3892/mmr.2014.2351; Liu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093388; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Martin JR, 1996, EMBO J, V15, P1865; Matsumoto A, 2017, NATURE, V541, P228, DOI 10.1038/nature21034; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X                                                    ; McHugh CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4152; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Molinie B, 2016, NAT METHODS, V13, P692, DOI 10.1038/nmeth.3898; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Muslimov IA, 1998, J CELL BIOL, V141, P1601, DOI 10.1083/jcb.141.7.1601; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Ng SY, 2013, MOL CELL, V51, P349, DOI 10.1016/j.molcel.2013.07.017; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; NIH, 2014, BRAIN 2025 SCI VIS; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Onoguchi M, 2012, P NATL ACAD SCI USA, V109, P16939, DOI 10.1073/pnas.1202956109; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Peng Y, 2014, DEVELOPMENT, V141, P4042, DOI 10.1242/dev.102186; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Polymenidou M, 2012, BRAIN RES, V1462, P3, DOI 10.1016/j.brainres.2012.02.059; Poo MM, 2016, NEURON, V92, P591, DOI 10.1016/j.neuron.2016.10.050; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Puthanveettil SV, 2013, P NATL ACAD SCI USA, V110, P7464, DOI 10.1073/pnas.1304422110; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qin PW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14725; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramos AD, 2015, CELL STEM CELL, V16, P439, DOI 10.1016/j.stem.2015.02.007; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Rani N, 2016, NEURON, V90, P1174, DOI 10.1016/j.neuron.2016.05.005; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schlackow M, 2017, MOL CELL, V65, P25, DOI 10.1016/j.molcel.2016.11.029; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shi CH, 2017, BRAIN RES BULL, V132, P160, DOI 10.1016/j.brainresbull.2017.03.010; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Slawson JB, 2011, GENETICS, V187, P171, DOI 10.1534/genetics.110.123406; Soshnev AA, 2011, GENETICS, V189, P455, DOI 10.1534/genetics.111.131706; Spadaro PA, 2015, BIOL PSYCHIAT, V78, P848, DOI 10.1016/j.biopsych.2015.02.004; Su YJ, 2017, NAT NEUROSCI, V20, P476, DOI 10.1038/nn.4494; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Telley L, 2016, SCIENCE, V351, P1443, DOI 10.1126/science.aad8361; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Uhde CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008641; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vance KW, 2014, EMBO J, V33, P296, DOI 10.1002/embj.201386225; Wang HD, 2002, J NEUROSCI, V22, P10232; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wang Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.144; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Wu TQ, 2015, BIOMED PHARMACOTHER, V70, P239, DOI 10.1016/j.biopha.2015.01.023; Xing YH, 2016, IUBMB LIFE, V68, P887, DOI 10.1002/iub.1564; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang LQ, 2015, HUM MOL GENET, V24, P5174, DOI 10.1093/hmg/ddv239; Yang YW, 2014, ELIFE, V3, DOI 10.7554/eLife.02046; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5                                                   ; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhao XL, 2013, NAT NEUROSCI, V16, P1024, DOI 10.1038/nn.3438; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252; Zhong J, 2009, J NEUROSCI, V29, P9977, DOI 10.1523/JNEUROSCI.3893-08.2009; Zhou Yan, 2012, [Frontiers in Biology, 生物学前沿], V7, P297; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	159	0	0	5	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5110			FRONT NEURAL CIRCUIT	Front. Neural Circuits	OCT 23	2017	11								76	10.3389/fncir.2017.00076				14	Neurosciences	Neurosciences & Neurology	FK4DP	WOS:000413440000001	29109677	gold			2018-01-05	
J	Liu, S; Liu, YW; Zhang, Q; Wu, JY; Liang, JB; Yu, S; Wei, GH; White, KP; Wang, XY				Liu, Song; Liu, Yuwen; Zhang, Qin; Wu, Jiayu; Liang, Junbo; Yu, Shan; Wei, Gong-Hong; White, Kevin P.; Wang, Xiaoyue			Systematic identification of regulatory variants associated with cancer risk	GENOME BIOLOGY			English	Article						GWAS; STARR-seq; Regulatory variants; Cancer susceptibility; CRISPR interference	HISTONE METHYLTRANSFERASE SETDB1; NONCODING GENETIC-VARIATION; B-CELL LYMPHOMA; HUMAN GENOME; FUNCTIONAL DISSECTION; ENHANCER ACTIVITY; ANALYSES REVEAL; REPORTER ASSAY; TRANSCRIPTION; EXPRESSION	Background: Most cancer risk-associated single nucleotide polymorphisms (SNPs) identified by genome-wide association studies (GWAS) are noncoding and it is challenging to assess their functional impacts. To systematically identify the SNPs that affect gene expression by modulating activities of distal regulatory elements, we adapt the self-transcribing active regulatory region sequencing (STARR-seq) strategy, a high-throughput technique to functionally quantify enhancer activities. Results: From 10,673 SNPs linked with 996 cancer risk-associated SNPs identified in previous GWAS studies, we identify 575 SNPs in the fragments that positively regulate gene expression, and 758 SNPs in the fragments with negative regulatory activities. Among them, 70 variants are regulatory variants for which the two alleles confer different regulatory activities. We analyze in depth two regulatory variants-breast cancer risk SNP rs11055880 and leukemia risk-associated SNP rs12142375-and demonstrate their endogenous regulatory activities on expression of ATF7IP and PDE4B genes, respectively, using a CRISPR-Cas9 approach. Conclusions: By identifying regulatory variants associated with cancer susceptibility and studying their molecular functions, we hope to help the interpretation of GWAS results and provide improved information for cancer risk assessment.	[Liu, Song; Wu, Jiayu; Liang, Junbo; Wang, Xiaoyue] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, State Key Lab Med Mol Biol,Dept Biochem, Beijing 100005, Peoples R China; [Liu, Song; Wu, Jiayu; Liang, Junbo; Wang, Xiaoyue] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Ctr Bioinformat,Inst Basic Med Sci, Beijing 100005, Peoples R China; [Liu, Yuwen; Yu, Shan; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Liu, Yuwen; Yu, Shan; White, Kevin P.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Zhang, Qin; Wei, Gong-Hong] Univ Oulu, Fac Biochem & Mol Med, Bioctr Oulu, FIN-90014 Oulu, Finland; [White, Kevin P.] Tempus Labs Inc, Chicago, IL 60654, Finland	Wang, XY (reprint author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, State Key Lab Med Mol Biol,Dept Biochem, Beijing 100005, Peoples R China.; Wang, XY (reprint author), Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Ctr Bioinformat,Inst Basic Med Sci, Beijing 100005, Peoples R China.; White, KP (reprint author), Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA.; White, KP (reprint author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	kpwhite@uchicago.edu; wangxiaoyue@ibms.cams.cn		Wang, Xiaoyue/0000-0002-0208-5322	National Natural Science Foundation of China [31470069]; CAMS [2016-I2M-1-005]; National Laboratory Special Fund [2060204]; Institute of Basic Medical Sciences [20151225009]; Thousand Young Talents Program of China	This work was supported by the National Natural Science Foundation of China (31470069), CAMS Innovation Fund for Medical Sciences (CAMS-I2M, 2016-I2M-1-005), National Laboratory Special Fund (2060204), the Institute of Basic Medical Sciences start-up fund (20151225009) and the Thousand Young Talents Program of China (to XW).	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Barrera LA, 2016, SCIENCE, V351, P1450, DOI 10.1126/science.aad2257; Becker JS, 2016, TRENDS GENET, V32, P29, DOI 10.1016/j.tig.2015.11.001; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fei Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9651; Gao P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061239; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Joehanes R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1142-6; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kulakovskiy IV, 2016, NUCLEIC ACIDS RES, V44, pD116, DOI 10.1093/nar/gkv1249; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QY, 2014, HUM MOL GENET, V23, P5294, DOI 10.1093/hmg/ddu228; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Liu Y., 2014, THESIS; Low SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076463; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Nagy ZS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057326; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Oldridge DA, 2015, NATURE, V528, P418, DOI 10.1038/nature15540; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Suhasini AN, 2016, LEUKEMIA, V30, P617, DOI 10.1038/leu.2015.302; Sun QY, 2015, J PATHOL, V235, P559, DOI 10.1002/path.4482; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Timms RT, 2016, CELL REP, V17, P653, DOI 10.1016/j.celrep.2016.09.050; Ulirsch JC, 2016, CELL, V165, P1530, DOI 10.1016/j.cell.2016.04.048; Vanhille L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7905; Vockley CM, 2015, GENOME RES, V25, P1206, DOI 10.1101/gr.190090.115; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Whitington T, 2016, NAT GENET, V48, P387, DOI 10.1038/ng.3523; Yang JJ, 2012, BLOOD, V120, P4197, DOI 10.1182/blood-2012-07-440107; Yao LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6114; Zhou J, 2014, THESIS	58	0	0	4	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	OCT 23	2017	18								194	10.1186/s13059-017-1322-z				14	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FK5XX	WOS:000413577600001	29061142	gold			2018-01-05	
J	Muzumdar, MD; Chen, PY; Dorans, KJ; Chung, KM; Bhutkar, A; Hong, E; Noll, EM; Sprick, MR; Trumpp, A; Jacks, T				Muzumdar, Mandar Deepak; Chen, Pan-Yu; Dorans, Kimberly Judith; Chung, Katherine Minjee; Bhutkar, Arjun; Hong, Erin; Noll, Elisa M.; Sprick, Martin R.; Trumpp, Andreas; Jacks, Tyler			Survival of pancreatic cancer cells lacking KRAS function	NATURE COMMUNICATIONS			English	Article							ANABOLIC GLUCOSE-METABOLISM; DUCTAL ADENOCARCINOMA; K-RAS; GENOMIC ANALYSES; PI3K INHIBITORS; GENE-EXPRESSION; SMALL MOLECULES; ACTIVATION; TUMOR; RESISTANCE	Activating mutations in the proto-oncogene KRAS are a hallmark of pancreatic ductal adenocarcinoma (PDAC), an aggressive malignancy with few effective therapeutic options. Despite efforts to develop KRAS-targeted drugs, the absolute dependence of PDAC cells on KRAS remains incompletely understood. Here we model complete KRAS inhibition using CRISPR/Cas-mediated genome editing and demonstrate that KRAS is dispensable in a subset of human and mouse PDAC cells. Remarkably, nearly all KRAS deficient cells exhibit phosphoinositide 3-kinase (PI3K)-dependent mitogen-activated protein kinase (MAPK) signaling and induced sensitivity to PI3K inhibitors. Furthermore, comparison of gene expression profiles of PDAC cells retaining or lacking KRAS reveal a role of KRAS in the suppression of metastasis-related genes. Collectively, these data underscore the potential for PDAC resistance to even the very best KRAS inhibitors and provide insights into mechanisms of response and resistance to KRAS inhibition.	[Muzumdar, Mandar Deepak; Chen, Pan-Yu; Dorans, Kimberly Judith; Chung, Katherine Minjee; Bhutkar, Arjun; Hong, Erin; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Muzumdar, Mandar Deepak] Dana Farber Canc Inst, Boston, MA 02215 USA; [Muzumdar, Mandar Deepak] Harvard Med Sch, Boston, MA 02215 USA; [Chen, Pan-Yu; Jacks, Tyler] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Noll, Elisa M.; Sprick, Martin R.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Noll, Elisa M.; Sprick, Martin R.; Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Jacks, T (reprint author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Jacks, T (reprint author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Jacks, T (reprint author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	tjacks@mit.edu		Muzumdar, Mandar/0000-0001-7424-7223; Trumpp, Andreas/0000-0002-6212-3466	NIH; Howard Hughes Medical Institute; Lustgarten Foundation; Blum-Kovler Pancreatic Cancer Action Network-AACR; Department of Defense Congressionally-Directed Medical Research Program [W81XWH-12-043]; Cancer Center Support (core) from the National Cancer Institute (NCI) [P30-CA14051]; NCI [K08-CA2080016-01]; Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences); National Institutes of Health [KL2 TR001100]; Conquer Cancer Foundation-American Society for Clinical Oncology (CCF-ASCO)	We thank Jeffrey Settleman for critical reading of the manuscript; V. Gocheva, N. Dimitrova, F. Sanchez-Rivera, C. Li, K. Chung, C. Ellis, B. Wagner, A. Aguirre, and O. Shalem for technical assistance and reagents; J. Cheah and C. Soule from the Koch Institute (KI) Genomics Core/HTS Facility for screening assistance; K. Cormier and C. Condon from the Hope Babette Tang (1983) Histology Facility for histology assistance; M. Jennings, M. Griffin, G. Paradis and S. Malstrom from the Swanson Biotechnology Center for technical support; S. Levine and A. Perez from the MIT BioMicro Center for RNA-Seq support; and W. Hahn, M. Herold, S. Lowe, W. Sellers, R. Weinberg and F. Zhang for constructs. We acknowledge that all experimental and analytical work done in the KI Genomics Core/HTS Facility was funded by the NIH and must be made available through the NIH's public access policy when published (https://publicaccess.nih.gov/). This work was supported by the Howard Hughes Medical Institute, Lustgarten Foundation Consortium Grant and Research Investigator Award, Blum-Kovler Pancreatic Cancer Action Network-AACR Innovative grant, Department of Defense Congressionally-Directed Medical Research Program grant (W81XWH-12-043), and in part by the Cancer Center Support (core) Grant P30-CA14051 from the National Cancer Institute (NCI). M.D.M. is supported by an NCI Mentored Clinical Scientist Research Career Development Award (K08-CA2080016-01) and was supported by a KL2/Catalyst Medical Research Investigator Training award (an appointed KL2 award) from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences), National Institutes of Health Award KL2 TR001100), and a Conquer Cancer Foundation-American Society for Clinical Oncology (CCF-ASCO) Young Investigator Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health. T.J. is a Howard Hughes Medical Institute Investigator, the David H. Koch Professor of Biology, and a Daniel K. Ludwig Scholar.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Akama-garren E. H., 2015, SCI REP, V6, P16836; Akutagawa J, 2016, LEUKEMIA, V30, P1335, DOI 10.1038/leu.2016.14; Alagesan B, 2015, CLIN CANCER RES, V21, P396, DOI 10.1158/1078-0432.CCR-14-1591; American Cancer Society, 2017, CANC FACTS FIG; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8                                                   ; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Diaz-Flores E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004125; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X                                                   ; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hofmann I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044146; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Junttila MR, 2015, MOL CANCER THER, V14, P40, DOI 10.1158/1535-7163.MCT-14-0030; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Ledford H, 2015, NATURE, V520, P278, DOI 10.1038/520278a; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Martineau Y, 2014, ONCOGENE, V33, P1367, DOI 10.1038/onc.2013.100; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Modrek B, 2009, MOL CANCER RES, V7, P1244, DOI 10.1158/1541-7786.MCR-08-0532; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Noll EM, 2016, NAT MED, V22, P278, DOI 10.1038/nm.4038; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Payne SN, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.28; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rutledge DN, 2013, TRAC-TREND ANAL CHEM, V50, P22, DOI 10.1016/j.trac.2013.03.013; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sampaio C, 2008, MOL CELL BIOL, V28, P587, DOI 10.1128/MCB.01318-07; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; She Q., 2012, CANCER CELL, V18, P39; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Ting DT, 2014, CELL REP, V8, P1905, DOI 10.1016/j.celrep.2014.08.029; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wells V, 2007, ONCOGENE, V26, P7709, DOI 10.1038/sj.onc.1210580; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Whittle MC, 2015, CELL, V161, P1345, DOI 10.1016/j.cell.2015.04.048; Will M, 2014, CANCER DISCOV, V4, P334, DOI 10.1158/2159-8290.CD-13-0611; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhao MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082138; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	70	0	0	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	OCT 23	2017	8								1090	10.1038/s41467-017-00942-5				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FK3RW	WOS:000413404800001	29061961	gold			2018-01-05	
J	Hanada, Y; Nakamura, Y; Ishida, Y; Takimoto, Y; Taniguchi, M; Ozono, Y; Koyama, Y; Morihana, T; Imai, T; Ota, Y; Sato, T; Inohara, H; Shimada, S				Hanada, Yukiko; Nakamura, Yukiko; Ishida, Yusuke; Takimoto, Yasumitsu; Taniguchi, Manabu; Ozono, Yoshiyuki; Koyama, Yoshihisa; Morihana, Tetsuo; Imai, Takao; Ota, Yumi; Sato, Takashi; Inohara, Hidenori; Shimada, Shoichi			Epiphycan is specifically expressed in cochlear supporting cells and is necessary for normal hearing	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Epiphycan; SLRP; Cochlear supporting cells	DEFICIENCY; DEAFNESS; MICE	The study of inner ear specific transcripts has revealed novel information about hereditary hearing loss and a mechanism of normal hearing. In this study, by analyzing a published cDNA library, we focused on Epiphycan (Epyc), a member of the small leucine-rich repeat proteoglycan family, whose transcript is enriched in the inner ear. Epyc mRNA was expressed abundantly and specifically in adult mice cochleae and was localized in supporting cells within the organ of Corti of both neonatal and adult mice. To examine the function of Epyc, we generated Epyc knockout (KO) mice using the CRISPR/Cas9 system. Epyc KO mice cochleae exhibited normal morphology. However, measurement of the auditory brain-stem response in Epyc KO mice revealed an elevated hearing threshold above 16 kHz frequency. This study suggests that Epyc is necessary for normal auditory function. (C) 2017 Elsevier Inc. All rights reserved.	[Hanada, Yukiko; Nakamura, Yukiko; Ishida, Yusuke; Takimoto, Yasumitsu; Koyama, Yoshihisa; Shimada, Shoichi] Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Hanada, Yukiko; Takimoto, Yasumitsu; Ozono, Yoshiyuki; Morihana, Tetsuo; Imai, Takao; Ota, Yumi; Sato, Takashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Takimoto, Yasumitsu] Osaka Police Hosp, Dept Otorhinolaryngol, Tennouji Ku, 10-31 Kitayamacho, Osaka 5430035, Japan; [Taniguchi, Manabu] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Morihana, Tetsuo] Natl Hosp Org, Osaka Natl Hosp, Dept Otorhinolaryngol, Chuo Ku, 2-1-14 Hoenzaka, Osaka, Osaka 5400006, Japan	Nakamura, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Neurosci & Cell Biol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ynakamura@anat1.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15K20207, 17K16911]	We thank NPO Biotechnology Research and Development for technical assistance. This study was supported by a Grant-in-Aid for Young Scientists (B) (15K20207) (17K16911) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We disclose no conflict of interest.	Asamura K, 2005, NEUROSCIENCE, V132, P493, DOI 10.1016/j.neuroscience.2005.01.013; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Buniello A, 2016, EMBO MOL MED, V8, P191, DOI 10.15252/emmm.201505523; Cazals Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9780; Chen J, 2014, BIOCHEM BIOPH RES CO, V448, P28, DOI 10.1016/j.bbrc.2014.04.016; Dong W, 2009, BIOPHYS J, V97, P1233, DOI 10.1016/j.bpj.2009.05.057; Hildebrand M.S., 2007, HEAR RES, V225; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; Kamiya K, 2014, P NATL ACAD SCI USA, V111, P9307, DOI 10.1073/pnas.1405322111; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kikuchi Toshihiko, 2000, Medical Electron Microscopy, V33, P51, DOI 10.1007/s007950070001; Kono M, 2007, J BIOL CHEM, V282, P10690, DOI 10.1074/jbc.M700370200; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Lu MH, 2012, J PHYSIOL-LONDON, V590, P4029, DOI 10.1113/jphysiol.2012.235846; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Monzack EL, 2013, HEARING RES, V303, P20, DOI 10.1016/j.heares.2013.01.008; Muramatsu R, 2015, J BIOL CHEM, V290, P11515, DOI 10.1074/jbc.M114.587253; Nuka S, 2010, OSTEOARTHR CARTILAGE, V18, P88, DOI 10.1016/j.joca.2009.11.006; Tatara Y, 2015, GLYCOBIOLOGY, V25, P557, DOI 10.1093/glycob/cwu186; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Wan GQ, 2013, SEMIN CELL DEV BIOL, V24, P448, DOI 10.1016/j.semcdb.2013.03.009; Whitlon DS, 2001, BRAIN RES PROTOC, V6, P159, DOI 10.1016/S1385-299X(00)00048-9; Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009	24	0	0	12	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 21	2017	492	3					379	385		10.1016/j.bbrc.2017.08.092				7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FH8EJ	WOS:000411424300016	28864419				2018-01-05	
J	Han, N; Hu, GY; Shi, L; Long, GX; Yang, L; Xi, QS; Guo, QY; Wang, JH; Dong, Z; Zhang, MX				Han, Na; Hu, Guangyuan; Shi, Lei; Long, Guoxian; Yang, Lin; Xi, Qingsong; Guo, Qiuyun; Wang, Jianhua; Dong, Zhen; Zhang, Mengxian			Notch1 ablation radiosensitizes glioblastoma cells	ONCOTARGET			English	Article						glioblastoma; Notch1; CRISPR/Cas9; radiosensitivity; angiogenesis	TUMOR-INITIATING CELLS; SELF-RENEWAL; STEM-CELLS; SURVIVAL; CANCER; HYPOXIA; PATHWAY; PROLIFERATION; ANGIOGENESIS; RADIOTHERAPY	Broad specific Notch1 inhibitors suppress glioblastoma multiforme (GBM) growth but have significant gastrointestinal toxicities. Here, we examined Notch1 expression in GBM tissue specimens and its correlation with the overall survival (OS) of GBM patients. Furthermore, using the CRISPR/Cas9 system, we investigated the effects of Notch1 downregulation on clonogenic growth and angiogenesis of GBM cells and xenografts. Immunohistochemistry showed positive Notch1 expression in 71% (49/69) of GBM tissues. Our multivariate Cox regression analysis further revealed that Notch1 expression was an independent adverse prognostic factor for OS. Notch1 downregulation suppressed the growth of GBM cells U87MG and U251. The mean duration to reach 6 x the starting volume was 18.3 days for xenografts with Notch1 downregulation and 13.4 days for the control xenografts. Immunofluorescent staining further disclosed that Notch1 downregulation markedly increased the number of gamma H2AX foci and radiosensitized GBM cells. Notch1 downregulation also impaired angiogenesis and attenuated VEGF and hypoxic response to irradiation in xenografts. In conclusion, Notch1 ablation inhibited GBM cell proliferation and neovascularization and radiosensitized GBM cells and xenografts, suggesting a pivotal role of Notch1 in tumor growth, angiogenesis, and radioresistance in GBM.	[Han, Na; Hu, Guangyuan; Shi, Lei; Long, Guoxian; Yang, Lin; Xi, Qingsong; Guo, Qiuyun; Wang, Jianhua; Dong, Zhen; Zhang, Mengxian] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Zhang, MX (reprint author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	zhangmx0904@163.com			National Natural Science Foundation of China [81272780, 81502209]	This work was supported in part by grants from National Natural Science Foundation of China (No. 81272780, No. 81502209).	Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cui D, 2015, CLIN CANCER RES, V21, P4619, DOI 10.1158/1078-0432.CCR-15-0242; Doan NB, 2017, ONCOTARGET, V8, P24753, DOI 10.18632/oncotarget.15800; Giachino C, 2015, CANCER CELL, V28, P730, DOI 10.1016/j.ccell.2015.10.008; Jiang LG, 2011, J CLIN NEUROSCI, V18, P387, DOI 10.1016/j.jocn.2010.07.131; Kalkan R, 2015, CRIT REV EUKAR GENE, V25, P363; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kim BS, 2017, CANCER RES TREAT, V49, P193, DOI 10.4143/crt.2015.473; Li DW, 2014, ANN OTO RHINOL LARYN, V123, P705, DOI 10.1177/0003489414532784; Li J, 2011, J SURG ONCOL, V103, P813, DOI 10.1002/jso.21851; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Saito N, 2014, STEM CELLS, V32, P301, DOI 10.1002/stem.1528; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330                                                            ; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wu WR, 2014, ONCOL REP, V31, P2515, DOI 10.3892/or.2014.3123; Xing ZY, 2015, CLIN NEUROL NEUROSUR, V131, P54, DOI 10.1016/j.clineuro.2015.01.018; Xu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053654; Yahyanejad S, 2016, ONCOTARGET, V7, P41251, DOI 10.18632/oncotarget.9275; Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212; Zhu TS, 2011, CANCER RES, V71, P6061, DOI 10.1158/0008-5472.CAN-10-4269; Zinn PO, 2013, INT J ONCOL, V42, P929, DOI 10.3892/ijo.2013.1770	32	0	0	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	OCT 20	2017	8	50					88059	88068		10.18632/oncotarget.21409				10	Oncology; Cell Biology	Oncology; Cell Biology	FK2VP	WOS:000413341400085	29152141				2018-01-05	
J	Zabinyakov, N; Bullivant, G; Cao, F; Ojeda, MF; Jia, ZP; Wen, XY; Dowling, JJ; Salomons, GS; Mercimek-Andrews, S				Zabinyakov, Nikita; Bullivant, Garrett; Cao, Feng; Ojeda, Matilde Fernandez; Jia, Zheng Ping; Wen, Xiao-Yan; Dowling, James J.; Salomons, Gajja S.; Mercimek-Andrews, Saadet			Characterization of the first knock-out aldh7a1 zebrafish model for pyridoxine-dependent epilepsy using CRISPR-Cas9 technology	PLOS ONE			English	Article							LYSINE-RESTRICTED DIET; ARGININE SUPPLEMENTATION; PIPECOLIC ACID; MUTATIONS; THERAPY; ANTIQUITIN; SEIZURES	Pyridoxine dependent epilepsy (PDE) is caused by likely pathogenic variants in ALDH7A1 (PDE-ALDH7A1) and inherited autosomal recessively. Neurotoxic alpha-amino adipic semialdehyde (alpha-AASA), piperideine 6-carboxylate and pipecolic acid accumulate in body fluids. Neonatal or infantile onset seizures refractory to anti-epileptic medications are clinical features. Treatment with pyridoxine, arginine and lysine-restricted diet does not normalize neurodevelopmental outcome or accumulation of neurotoxic metabolites. There is no animal model for high throughput drug screening. For this reason, we developed and characterized the first knock-out aldh7a1 zebrafish model using CRISPR-Cas9 technology. Zebrafish aldh7a1 mutants were generated by using a vector free method of CRISPR-Cas9 mutagenesis. Genotype analysis of aldh7a1 knock-out zebrafish was performed by high resolution melt analysis, direct sequencing and QIAxcel system. Electroencephalogram was performed. Alpha-AASA, piperideine 6-carboxylate and pipecolic acid, were measured by liquid chromatography-tandem mass spectrometry. Our knock-out aldh7a1 zebrafish has homozygous 5 base pair (bp) mutation in ALDH7A1. Knock-out aldh7a1 embryos have spontaneous rapid increase in locomotion and a rapid circling swim behavior earliest 8-day post fertilization (dpf). Electroencephalogram revealed large amplitude spike discharges compared to wild type. Knock-out aldh7a1 embryos have elevated alpha-AASA, piperideine 6-carboxylate and pipecolic acid compared to wild type embryos at 3 dpf. Knock-out aldh7a1 embryos showed no aldh7a1 protein by western blot compared to wild type. Our knock-out aldh7a1 zebrafish is a well characterized model for large-scale drug screening using behavioral and biochemical features and accurately recapitulates the human PDE-ALDH7A1 disease.	[Zabinyakov, Nikita; Dowling, James J.; Mercimek-Andrews, Saadet] Hosp Sick Children, Res Inst, Genet & Genome Biol Program, Toronto, ON, Canada; [Bullivant, Garrett; Mercimek-Andrews, Saadet] Univ Toronto, Div Clin & Metab Genet, Dept Pediat, Toronto, ON, Canada; [Cao, Feng; Jia, Zheng Ping] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Program, Toronto, ON, Canada; [Cao, Feng; Jia, Zheng Ping] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ojeda, Matilde Fernandez; Salomons, Gajja S.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Lab,Neurosci Amsterdam, Amsterdam, Netherlands; [Wen, Xiao-Yan] St Michaels Hosp, Zebrafish Ctr Adv Drug Discovery, Toronto, ON, Canada; [Wen, Xiao-Yan] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Dowling, James J.] Univ Toronto, Div Neurol, Dept Pediat, Toronto, ON, Canada; [Dowling, James J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Salomons, Gajja S.] Neurosci Campus, Amsterdam, Netherlands; [Mercimek-Andrews, Saadet] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	Mercimek-Andrews, S (reprint author), Hosp Sick Children, Res Inst, Genet & Genome Biol Program, Toronto, ON, Canada.; Mercimek-Andrews, S (reprint author), Univ Toronto, Div Clin & Metab Genet, Dept Pediat, Toronto, ON, Canada.; Mercimek-Andrews, S (reprint author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	saadet.andrews@sickkids.ca			Department of Pediatrics, University of Toronto	Dr. Saadet Mercimek-Andrews is funded through the Department of Pediatrics, University of Toronto for this study (New Investigator Start-Up Funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As principal author of this study, I, Saadet Mercimek-Andrews, would like to thank Dr. Berge Minassian for his tremendous support by providing laboratory space for the molecular genetic studies and encouragement for the development of my research program and his ongoing and excellent guidance and mentorship. We would like to thank Sarah Hutchinson at the Institutional Zebrafish Genetics and Disease Models Core Facility for generation of aldh7al knockout zebrafish using CRISPR-Cas9 technology. The authors would like to thank Michael Lead ley and Denis Reynaud for LC-MS-MS alpha-AASA, P6C, PA measurements and Analytical Facility for Bioactive Molecules (AFBM) of the Centre for the Study of Complex Childhood Diseases (CSCCD) at The Hospital for Sick Children, Toronto, Ontario. CSCCD was supported by the Canadian Foundation for Innovation (CFI). We would like to thank Dr. Eduard Struys for his help for the development of methods for alpha-AASA, P6C, PA measurements in our Institution. We would like to thank Ann Davidson, Jonathan Volpatti and Ramil Noche for their help with our technical questions regarding zebrafish. We would like to thank CaroLyne DesRoches for breeding and maintaining heterozygous knock-out aldh7al zebrafish. We would like to thank Theodora Bruun and Yannay Khaikin for their help in contributing high resolution melt analysis for genotyping. Dr. Saadet Mercimek-Andrews is funded through the Department of Pediatrics, University of Toronto for this study (New Investigator Start-Up Funding) and we would like to them thank for this funding support. We would like to thank Peter (Peixiang) Wang for his guidance in molecular genetic methods.	Al Teneiji A, 2017, MOL GENET METAB, V120, P235, DOI 10.1016/j.ymgme.2016.12.014; Babcock HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101782; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2013, J VIS EXP, V71; Coughlin CR, 2015, MOL GENET METAB, V116, P35, DOI 10.1016/j.ymgme.2015.05.011; Dinday MT, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0068-15.2015; Elango R, 2007, AM J CLIN NUTR, V86, P360; Gospe Jr SM, 1993, PYRIDOXINE DEPENDENT; HUNT AD, 1954, PEDIATRICS, V13, P140; Mahajnah M, 2016, PEDIATR NEUROL, V60, P60, DOI 10.1016/j.pediatrneurol.2016.03.008; Mercimek-Mahmutoglu S, 2014, EUR J PAEDIATR NEURO, V18, P741, DOI 10.1016/j.ejpn.2014.07.001; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Plecko B, 2005, NEUROPEDIATRICS, V36, P200, DOI 10.1055/s-2005-865727; Sadilkova K, 2009, J NEUROSCI METH, V184, P136, DOI 10.1016/j.jneumeth.2009.07.019; Schubert J, 2014, NAT GENET, V46, P1327, DOI 10.1038/ng.3130; Stockler S, 2011, MOL GENET METAB, V104, P48, DOI 10.1016/j.ymgme.2011.05.014; van Karnebeek CDM, 2015, JIMD REP, V15, P47, DOI 10.1007/8904_2014_296; van Karnebeek CDM, 2012, MOL GENET METAB, V107, P335, DOI 10.1016/j.ymgme.2012.09.006; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Winter Matthew J., 2008, Journal of Pharmacological and Toxicological Methods, V57, P176, DOI 10.1016/j.vascn.2008.01.004	20	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2017	12	10							e0186645	10.1371/journal.pone.0186645				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FK2MA	WOS:000413315100030	29053735	gold			2018-01-05	
J	Zhang, Y; Kitajima, M; Whittle, AJ; Liu, WT				Zhang, Ya; Kitajima, Masaaki; Whittle, Andrew J.; Liu, Wen-Tso			Benefits of Genomic Insights and CRISPR-Cas Signatures to Monitor Potential Pathogens across Drinking Water Production and Distribution Systems	FRONTIERS IN MICROBIOLOGY			English	Article						virulence; genomic analysis; drinking water distribution systems; Legionella; Mycobacterium; Parachlamydia; Leptospira; CRISPR	SEQUENCE-BASED SCHEME; IV SECRETION SYSTEMS; LEGIONELLA-PNEUMOPHILA; VIRULENCE FACTORS; TREATMENT-PLANT; TAP WATER; PARACHLAMYDIA-ACANTHAMOEBAE; MYCOBACTERIUM-TUBERCULOSIS; HETEROTROPHIC BACTERIA; METAGENOMIC DATASETS	The occurrence of pathogenic bacteria in drinking water distribution systems (DWDSs) is a major health concern, and our current understanding is mostly related to pathogenic species such as Legionella pneumophila and Mycobacterium avium but not to bacterial species closely related to them. In this study, genomic-based approaches were used to characterize pathogen-related species in relation to their abundance, diversity, potential pathogenicity, genetic exchange, and distribution across an urban drinking water system. Nine draft genomes recovered from 10 metagenomes were identified as Legionella (4 draft genomes), Mycobacterium (3 draft genomes), Parachlamydia (1 draft genome), and Leptospira (1 draft genome). The pathogenicity potential of these genomes was examined by the presence/ absence of virulence machinery, including genes belonging to Type III, IV, and VII secretion systems and their effectors. Several virulence factors known to pathogenic species were detected with these retrieved draft genomes except the Leptospira-related genome. Identical clustered regularly interspaced short palindromic repeats-CRISPR-associated proteins (CRISPR-Cas) genetic signatures were observed in two draft genomes recovered at different stages of the studied system, suggesting that the spacers in CRISPR-Cas could potentially be used as a biomarker in the monitoring of Legionella related strains at an evolutionary scale of several years across different drinking water production and distribution systems. Overall, metagenomics approach was an effective and complementary tool of culturing techniques to gain insights into the pathogenic characteristics and the CRISPR-Cas signatures of pathogen-related species in DWDSs.	[Zhang, Ya; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL USA; [Kitajima, Masaaki] Hokkaido Univ, Fac Engn, Div Environm Engn, Sapporo, Hokkaido, Japan; [Whittle, Andrew J.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Liu, WT (reprint author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL USA.	wtliu@illinois.edu					Ainsa JA, 1997, MOL MICROBIOL, V24, P431, DOI 10.1046/j.1365-2958.1997.3471717.x                                              ; Ashbolt Nicholas J, 2015, Curr Environ Health Rep, V2, P95, DOI 10.1007/s40572-014-0037-5; Barret M, 2013, ENV MICROBIOL REP, V5, P117, DOI 10.1111/j.1758-2229.2012.00394.x; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bobay LM, 2014, P NATL ACAD SCI USA, V111, P12127, DOI 10.1073/pnas.1405336111; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; BREIMAN RF, 1990, JAMA-J AM MED ASSOC, V263, P2924, DOI 10.1001/jama.263.21.2924; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; Chapman TA, 2006, APPL ENVIRON MICROB, V72, P4782, DOI 10.1128/AEM.02885-05; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Croxatto A, 2013, PATHOG DIS, V69, P159, DOI 10.1111/2049-632X.12065; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dupuy M, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw022; Edberg SC, 1996, MICROB ECOL HEALTH D, V9, P67, DOI 10.1002/(SICI)1234-987X(199603)9:2<67::AID-MEH412>3.3.CO;2-A; Edwards David J, 2013, Microb Inform Exp, V3, P2, DOI 10.1186/2042-5783-3-2; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicrol163; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI [10.2217/fmb.10.102, 10.2217/FMB.10.102]; Falkinham JO, 2001, APPL ENVIRON MICROB, V67, P1225, DOI 10.1128/AEM.67.3.1225-1231.2001; Fan XY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-243; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136; Foley SL, 2013, MICROBIOL MOL BIOL R, V77, P582, DOI 10.1128/MMBR.00015-13; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403; Fry NK, 2000, EUR J CLIN MICROBIOL, V19, P773, DOI 10.1007/s100960000359; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Gimenez G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-542; Ginevra C, 2012, J CLIN MICROBIOL, V50, P696, DOI 10.1128/JCM.06180-11; Gomez-Valero L, 2009, INFECT GENET EVOL, V9, P727, DOI 10.1016/j.meegid.2009.05.004; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Gomez-Alvarez V., 2016, GENOME ANNOUNC, V4, DOI [10.1128/genomeA.01539-15, DOI 10.1128/GENOMEA.01539-15]; Gomez-Alvarez V., 2016, GENOME ANNOUNC, V4, DOI [10.1128/genomeA.01538-15, DOI 10.1128/GENOMEA.01538-15]; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guidi L, 2016, NATURE, V532, P465, DOI 10.1038/nature16942; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; HAVELAAR AH, 1992, J APPL BACTERIOL, V72, P435, DOI 10.1111/j.1365-2672.1992.tb01857.x; Hilbi H, 2001, MOL MICROBIOL, V42, P603, DOI 10.1046/j.1365-2958.2001.02645.x                                                ; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; HSU SC, 1984, APPL ENVIRON MICROB, V48, P830; Huang KL, 2014, ECOTOX ENVIRON SAFE, V109, P15, DOI 10.1016/j.ecoenv.2014.07.029; Hwang CC, 2012, MICROBES ENVIRON, V27, P9, DOI 10.1264/jsme2.ME11132; Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165; Kao PM, 2014, SCI TOTAL ENVIRON, V490, P416, DOI 10.1016/j.scitotenv.2014.04.103; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Lagkouvardos I, 2014, ISME J, V8, P115, DOI 10.1038/ismej.2013.142; Lalande V, 2001, J HOSP INFECT, V48, P76, DOI 10.1053/jhin.2000.0929; Lamoth F, 2011, CLIN INFECT DIS, V53, P500, DOI 10.1093/cid/cir420; Lehtola MJ, 2004, WATER RES, V38, P3769, DOI 10.1016/j.watres.2004.06.024; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Ling FQ, 2016, ISME J, V10, P582, DOI 10.1038/ismej.2015.136; Liu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14217; LOWRY PW, 1990, J INFECT DIS, V161, P85, DOI 10.1093/infdis/161.1.85                                                         ; Luck C, 2015, INT J MED MICROBIOL, V305, P828, DOI 10.1016/j.ijmm.2015.08.001; Lye DJ, 2007, CURR MICROBIOL, V54, P195, DOI 10.1007/s00284-006-0381-2; LYE DJ, 1993, ENVIRON TOXIC WATER, V8, P13, DOI 10.1002/tox.2530080103; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; MARANGER R, 1995, MAR ECOL PROG SER, V121, P217, DOI 10.3354/meps121217; Miller CS, 2013, METHOD ENZYMOL, V531, P333, DOI 10.1016/B978-0-12-407863-5.00017-4; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; More RP, 2014, BIORESOURCE TECHNOL, V153, P137, DOI 10.1016/j.biortech.2013.11.065; Nagarajan N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-242; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rao CT, 2016, CELL MICROBIOL, V18, P1319, DOI 10.1111/cmi.12586; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rodriguez-Martinez S, 2015, WATER RES, V77, P119, DOI 10.1016/j.watres.2015.03.010; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sangwan N, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0154-5; Schmidt T. M., 2012, TOPICS ECOLOGICAL EN; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Soderberg MA, 2008, APPL ENVIRON MICROB, V74, P5583, DOI 10.1128/AEM.00067-08; Stelma GN, 2004, INT J FOOD MICROBIOL, V92, P249, DOI 10.1016/j.ijfoodmicro.2003.08.011; Sun CL, 2016, ISME J, V10, P858, DOI 10.1038/ismej.2015.162; Tamaki H, 2012, ENVIRON MICROBIOL, V14, P441, DOI 10.1111/j.1462-2920.2011.02630.x; Tennessen K, 2016, ISME J, V10, P269, DOI 10.1038/ismej.2015.100; Thomas V, 2008, ENVIRON MICROBIOL, V10, P2728, DOI 10.1111/j.1462-2920.2008.01693.x; Tilney LG, 2001, J CELL SCI, V114, P4637; Tortora G. J., 2013, MICROBIOLOGY INTRO; Vaerewijck MJM, 2005, FEMS MICROBIOL REV, V29, P911, DOI 10.1016/j.femsre.2005.02.001; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/FMB.11.150, 10.2217/fmb.11.150]; WADOWSKY RM, 1988, APPL ENVIRON MICROB, V54, P2677; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wilson JW, 2002, POSTGRAD MED J, V78, P216, DOI 10.1136/pmj.78.918.216                                                          ; Wilson RW, 2001, INT J SYST EVOL MICR, V51, P1751, DOI 10.1099/00207713-51-5-1751                                                      ; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Wu YW, 2016, BIOINFORMATICS, V32, P605, DOI 10.1093/bioinformatics/btv638; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087                                                                  ; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang Y, 2017, ENVIRON MICROBIOL, V19, P3163, DOI 10.1111/1462-2920.13800; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	115	0	0	8	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	OCT 19	2017	8								2036	10.3389/fmicb.2017.02036				15	Microbiology	Microbiology	FK0PO	WOS:000413182200001	29097994	gold			2018-01-05	
J	Chen, JS; Dagdas, YS; Kleinstiver, BP; Welch, MM; Sousa, AA; Harrington, LB; Sternberg, SH; Joung, JK; Yildiz, A; Doudna, JA				Chen, Janice S.; Dagdas, Yavuz S.; Kleinstiver, Benjamin P.; Welch, Moira M.; Sousa, Alexander A.; Harrington, Lucas B. .; Sternberg, Samuel H.; Joung, J. Keith; Yildiz, Ahmet; Doudna, Jennifer A.			Enhanced proofreading governs CRISPR-Cas9 targeting accuracy	NATURE			English	Article							MOLECULAR SIMULATIONS; DNA RECOGNITION; CAS NUCLEASES; RNA; CLEAVAGE; COMPLEX; ENDONUCLEASE; SPECIFICITY	The RNA-guided CRISPR-Cas9 nuclease from Streptococcus pyogenes (SpCas9) has been widely repurposed for genome editing1-4. High-fidelity (SpCas9-HF1) and enhanced specificity (eSpCas9(1.1)) variants exhibit substantially reduced off-target cleavage in human cells, but the mechanism of target discrimination and the potential to further improve fidelity are unknown5-9. Here, using single-molecule Frster resonance energy transfer experiments, we show that both SpCas9-HF1 and eSpCas9(1.1) are trapped in an inactive state10 when bound to mismatched targets. We find that a non-catalytic domain within Cas9, REC3, recognizes target complementarity and governs the HNH nuclease to regulate overall catalytic competence. Exploiting this observation, we design a new hyper-accurate Cas9 variant (HypaCas9) that demonstrates high genome-wide specificity without compromising on-target activity in human cells. These results offer a more comprehensive model to rationalize and modify the balance between target recognition and nuclease activation for precision genome editing.	[Chen, Janice S.; Harrington, Lucas B. .; Yildiz, Ahmet; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dagdas, Yavuz S.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Kleinstiver, Benjamin P.; Welch, Moira M.; Sousa, Alexander A.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Welch, Moira M.; Sousa, Alexander A.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Kleinstiver, Benjamin P.; Joung, J. Keith] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Sternberg, Samuel H.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Yildiz, Ahmet] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Sternberg, Samuel H.] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA	Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu			National Science Foundation Graduate Research Fellowships; Banting (Natural Sciences and Engineering Research Council of Canada); Charles A. King Trust Postdoctoral Fellowships; National Institutes of Health [GM094522, GM118773, R35 GM118158]; National Science Foundation [MCB-1617028, MCB-1244557]; Desmond and Ann Heathwood MGH Research Scholar Award	We thank A.V. Wright, S.N. Floor, J.C. Cofsky, D. Burstein, C. Fellman, B.L. Oakes and O. Mavrothalassitis for discussions and reading the manuscript, M.S. Prew for technical assistance, and J.M. Lopez for assistance with GUIDE-seq data processing. J.S.C. and L.B.H. are supported by National Science Foundation Graduate Research Fellowships, and B.P.K. from Banting (Natural Sciences and Engineering Research Council of Canada) and Charles A. King Trust Postdoctoral Fellowships. J.A.D. is an Investigator of the Howard Hughes Medical Institute. This work was supported by the National Institutes of Health (GM094522 and GM118773 (A.Y.), R35 GM118158 (J.K.J.)), National Science Foundation (MCB-1617028 (A.Y.) and MCB-1244557 (J.A.D.)), and the Desmond and Ann Heathwood MGH Research Scholar Award (J.K.J.).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Bisaria N, 2017, CELL SYST, V4, P21, DOI 10.1016/j.cels.2016.12.010; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Dagdas YS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao0027; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Majumdar ZK, 2005, J MOL BIOL, V351, P1123, DOI 10.1016/j.jmb.2005.06.027; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Palermo G, 2017, P NATL ACAD SCI USA, V114, P7260, DOI 10.1073/pnas.1707645114; Palermo G, 2016, ACS CENTRAL SCI, V2, P756, DOI 10.1021/acscentsci.6b00218; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117	22	5	5	18	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2017	550	7676					407	+		10.1038/nature24268				16	Multidisciplinary Sciences	Science & Technology - Other Topics	FK1NF	WOS:000413247900063	28931002				2018-01-05	
J	Hoff, JL; Decker, JE; Schnabel, RD; Taylor, JF				Hoff, Jesse L.; Decker, Jared E.; Schnabel, Robert D.; Taylor, Jeremy F.			Candidate lethal haplotypes and causal mutations in Angus cattle	BMC GENOMICS			English	Article						Inbreeding; Autosomal recessives; Lethal Haplotypes; Phasing; Imputation	FERTILITY; VIABILITY; VARIANTS; TRAITS; GENE; IV	Background: If unmanaged, high rates of inbreeding in livestock populations adversely impact their reproductive fitness. In beef cattle, historical selection strategies have increased the frequency of several segregating fatal autosomal recessive polymorphisms. Selective breeding has also decreased the extent of haplotypic diversity genome-wide. By identifying haplotypes for which homozygotes are not observed but would be expected based on their frequency, candidates for developmentally lethal recessive loci can be localized. This analysis comes without the need for observation of the lossassociated phenotype (e.g., failure to implant, first trimester abortion, deformity at birth). In this study, haplotypes were estimated for 3961 registered Angus individuals using 52,545 SNP loci using findhap v2, which exploited the complex pedigree among the individuals in this population. Results: Seven loci were detected to possess haplotypes that were not observed in homozygous form despite a sufficiently high frequency and pedigree-based expectation of homozygote occurrence. These haplotypes were identified as candidates for harboring autosomal recessive lethal alleles. Of the genotyped individuals, 109 were resequenced to an average 27X depth of coverage to identify putative loss-of-function alleles genome-wide and had variants called using a custom in-house developed pipeline. For the candidate lethal-harboring haplotypes present in these bulls, sequence-called genotypes were used to identify concordant variants. In addition, wholegenome sequence imputation of variants was performed into the set of 3961 genotyped animals using the 109 resequenced animals to identify candidate lethal recessive variants at the seven loci. Following the imputation, no variants were identified that were fully concordant with the marker-based diplotypes. Conclusions: Selective breeding programs could utilize the predicted lethal haplotypes associated with SNP genotypes. Sequencing and other methods for identifying the causal variants underlying these haplotypes can allow for more efficient methods of management such as gene editing. These two methods in total will reduce the negative impacts of inbreeding on fertility and maximize overall genetic gains.	[Hoff, Jesse L.; Decker, Jared E.; Schnabel, Robert D.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Decker, Jared E.; Schnabel, Robert D.] Univ Missouri, Informat Inst, Columbia, MO 65211 USA	Taylor, JF (reprint author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	taylorjerr@missouri.edu			National Research Initiative [2008-35205-04687, 2009-65205-05635]; USDA Cooperative State Research, Education and Extension Service [2008-35205-18864]; USDA National Institute of Food and Agriculture [2013-68004-20364]	This project was supported by National Research Initiative grants number 2008-35205-04687 and 2008-35205-18864 from the USDA Cooperative State Research, Education and Extension Service and National Research Initiative grants number 2009-65205-05635 and 2013-68004-20364 from the USDA National Institute of Food and Agriculture. The funding agency had no role in in the design of the study or collection, analysis, or interpretation of data or in writing the manuscript.	Akman HO, 2011, HUM MOL GENET, V20, P4430, DOI 10.1093/hmg/ddr371; Andrews S, 2010, QUAL CONTROL TOOL HI; Bjelland DW, 2015, J DAIRY SCI, V98, P4934, DOI 10.3168/jds.2014-9014; Cao S, 2003, MOL CELL BIOL, V23, P5301, DOI 10.1128/MCB.23.15.2301-5307.2003; CHARLESWORTH D, 1992, GENET RES, V59, P49, DOI 10.1017/S0016672300030160                                                       ; Cole JB, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0174-9; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Decker JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005621; Decker JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-606; Eenennaam AL, 2014, 10 WORLD C GEN APPL; FALCONER DS, 1996, INTRO QUANTITATIVE G; Flisikowski K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015116; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Gao ZY, 2015, GENETICS, V199, P1243, DOI 10.1534/genetics.114.173351; Helgason A, 2008, SCIENCE, V319, P813, DOI 10.1126/science.1150232; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Jenko J, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0135-3; Kadri NK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004049; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li X, 2016, BIORXIV, DOI [10.1101/074443, DOI 10.1101/074443]; Marcais G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130821; Marsden CD, 2016, P NATL ACAD SCI USA, V113, P152, DOI 10.1073/pnas.1512501113; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Rolf MM, 2014, LIVEST SCI, V166, P84, DOI 10.1016/j.livsci.2014.06.005; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Taylor JF, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0237-6; Teseling CF, 2013, P ASS ADV ANIM BREED, V20, P558; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; Wagner ML, 2006, J VET INTERN MED, V20, P1207, DOI 10.1892/0891-6640(2006)20[1207:AFALIO]2.0.CO;2; Ward TL, 2004, MAMM GENOME, V15, P570, DOI 10.1007/s00335-004-2369-1; Whitlock BK, 2010, APPL REPROD STRATEGI, P146	37	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	OCT 18	2017	18								799	10.1186/s12864-017-4196-2				11	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FK4MB	WOS:000413467300001	29047335	gold			2018-01-05	
J	Wallet, MA; Santostefano, KE; Terada, N; Brusko, TM				Wallet, Mark A.; Santostefano, Katherine E.; Terada, Naohiro; Brusko, Todd M.			Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes	FRONTIERS IN ENDOCRINOLOGY			English	Review						type 1 diabetes; autoimmunity; induced pluripotent stem cells; gene editing; genome-wide association studies; expression quantitative trait loci	ANTIBODY STANDARDIZATION PROGRAM; INSULIN-PRODUCING CELLS; GENOME-WIDE ASSOCIATION; PLURIPOTENT STEM-CELLS; PRESERVES C-PEPTIDE; REGULATORY T-CELLS; BETA-LIKE CELLS; HUMAN IPS CELLS; RECENT-ONSET; IN-VITRO	At least 57 independent loci within the human genome confer varying degrees of risk for the development of type 1 diabetes (T1D). The majority of these variants are thought to contribute to overall genetic risk by modulating host innate and adaptive immune responses, ultimately resulting in a loss of immunological tolerance to beta cell antigens. Early efforts to link specific risk variants with functional alterations in host immune responses have employed animal models or genotype-selected individuals from clinical bioresource banks. While some notable genotype: phenotype associations have been described, there remains an urgent need to accelerate the discovery of causal variants and elucidate the molecular mechanisms by which susceptible alleles alter immune functions. One significant limitation has been the inability to study human T1D risk loci on an isogenic background. The advent of induced pluripotent stem cells (iPSCs) and genome-editing technologies have made it possible to address a number of these outstanding questions. Specifically, the ability to drive multiple cell fates from iPSC under isogenic conditions now facilitates the analysis of causal variants in multiple cellular lineages. Bioinformatic analyses have revealed that T1D risk genes cluster within a limited number of immune signaling pathways, yet the relevant immune cell subsets and cellular activation states in which candidate risk genes impact cellular activities remain largely unknown. In this review, we summarize the functional impact of several candidate risk variants on host immunity in T1D and present an isogenic disease-in-a-dish model system for interrogating risk variants, with the goal of expediting precision therapeutics	[Wallet, Mark A.; Santostefano, Katherine E.; Terada, Naohiro; Brusko, Todd M.] Univ Florida, Coll Med, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA	Brusko, TM (reprint author), Univ Florida, Coll Med, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	tbrusko@ufl.edu			JDRF [CDA 2-2012-280]; ADA [ADA-1-17-JDF-048]; Helmsley Charitable Trust; National Institutes of Health [NIAID P01 AI42288, NIDDK HIRN 1UC4 DK104194-01, R01 DK106191]	The content of this article is derived from research grants and support from the JDRF (CDA 2-2012-280 to TB) and ADA (ADA-1-17-JDF-048 to MW) and the Helmsley Charitable Trust. Content reviewed is supported by grants from the National Institutes of Health NIAID P01 AI42288, NIDDK HIRN 1UC4 DK104194-01, and R01 DK106191.	Achenbach P, 2008, CURR DIABETES REP, V8, P87, DOI 10.1007/s11892-008-0017-y                                                       ; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bell CJM, 2015, J AUTOIMMUN, V56, P66, DOI 10.1016/j.jaut.2014.10.002; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284                                                              ; Bersenev A, 2010, J CLIN INVEST, V120, P2058, DOI 10.1172/JCI42032; Bhattacharjee T, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500655; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bose B, 2012, CELL BIOL INT, V36, P1013, DOI 10.1042/CBI20120210; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Brehm MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007757; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Brusko TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011726; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Chang CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097335; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Daifotis AG, 2013, CLIN IMMUNOL, V149, P268, DOI 10.1016/j.clim.2013.05.001; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Eisenbarth GS, 2010, DIABETES, V59, P759, DOI 10.2337/db09-1855; Eisenbarth GS, 2003, ANN NY ACAD SCI, V1005, P109, DOI 10.1196/annals.1288.012; Esensten JH, 2017, ANNU REV PATHOL-MECH, V12, P305, DOI 10.1146/annurev-pathol-052016-100304; Evangelou M, 2014, GENET EPIDEMIOL, V38, P661, DOI 10.1002/gepi.21853; Ferreira RC, 2014, DIABETES, V63, P2538, DOI 10.2337/db13-1777; Fontenot JD, 2004, SEMIN IMMUNOL, V16, P73, DOI 10.1016/j.smim.2003.12.002; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; GAMBLE DR, 1969, BRIT MED J, V3, P631, DOI 10.1136/bmj.3.5671.631                                                          ; GAMBLE DR, 1969, BRIT MED J, V3, P627, DOI 10.1136/bmj.3.5671.627                                                          ; Gery S, 2009, J LEUKOCYTE BIOL, V85, P957, DOI 10.1189/jlb.0908575; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Gitelman SE, 2016, DIABETOLOGIA, V59, P1153, DOI 10.1007/s00125-016-3917-4; Gonzales AJ, 2014, J VET PHARMACOL THER, V37, P317, DOI 10.1111/jvp.12101; Goudy KS, 2003, J IMMUNOL, V171, P2270, DOI 10.4049/jimmunol.171.5.2270                                                     ; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Hagopian W, 2013, DIABETES, V62, P3901, DOI 10.2337/db13-0236; Haller MJ, 2016, DIABETES, V65, P3765, DOI 10.2337/db16-0823; Haller MJ, 2015, J CLIN INVEST, V125, P448, DOI 10.1172/JCI78492; Herold KC, 2013, DIABETES, V62, P3766, DOI 10.2337/db13-0345; Hulme MA, 2012, DIABETES, V61, P14, DOI 10.2337/db11-1213; Hummel S, 2017, DIABETES CARE, V40, P398, DOI 10.2337/dc16-1624; Husebye ES, 2010, IMMUNITY, V32, P479, DOI 10.1016/j.immuni.2010.03.016; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kaneko S, 2016, METHODS MOL BIOL, V1393, P67, DOI 10.1007/978-1-4939-3338-9_6; Kieback E, 2016, IMMUNITY, V44, P1114, DOI 10.1016/j.immuni.2016.04.018; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Koizumi K, 1998, EXP HEMATOL, V26, P1140; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Kurokawa YK, 2017, TISSUE ENG PART C-ME, V23, P474, DOI [10.1089/ten.TEC.2017.0133, 10.1089/ten.tec.2017.0133]; Laitinen OH, 2014, DIABETES, V63, P446, DOI 10.2337/db13-0619; Lampasona V, 2011, CLIN CHEM, V57, P1693, DOI 10.1373/clinchem.2011.170662; Laugesen E, 2015, DIABETIC MED, V32, P843, DOI 10.1111/dme.12700; Long SA, 2012, DIABETES, V61, P2340, DOI 10.2337/db12-0049; Maeda T, 2016, CANCER RES, V76, P6839, DOI 10.1158/0008-5472.CAN-16-1149; Mannering SI, 2005, J EXP MED, V202, P1191, DOI 10.1084/jem.20051251; Marro BS, 2017, P NATL ACAD SCI USA, V114, P3708, DOI 10.1073/pnas.1700878114; Marselli L, 2001, J CLIN ENDOCR METAB, V86, P4974, DOI 10.1210/jc.86.10.4974; Marson A, 2015, J CLIN INVEST, V125, P2234, DOI 10.1172/JCI78086; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Michels AW, 2017, DIABETES, V66, P722, DOI 10.2337/db16-1025; Nakanishi M, 2012, CURR GENE THER, V12, P410, DOI 10.2174/156652312802762518                                                      ; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nepom GT, 2002, ARTHRITIS RHEUM, V46, P5, DOI 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S; Newby BN, 2017, DIABETES, V66, P3061, DOI 10.2337/db17-0106; Nishimura K, 2007, J BIOL CHEM, V282, P27383, DOI 10.1074/jbc.M702028200; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Okabe M, 2015, CELL REPROGRAM, V17, P368, DOI 10.1089/cell.2015.0006; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Orban T, 2014, DIABETES CARE, V37, P1069, DOI 10.2337/dc13-0604; Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0; Pane JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29697; PENNLINE KJ, 1994, CLIN IMMUNOL IMMUNOP, V71, P169, DOI 10.1006/clin.1994.1068; Pescovitz MD, 2014, DIABETES CARE, V37, P453, DOI 10.2337/dc13-0626; Peters EB., 2017, TISSUE ENG PART B-RE, DOI DOI 10.1089/TEN.TEB.2017.0127; Pipeleers D, 2016, STEM CELL TRANSL MED, V5, P1338, DOI 10.5966/sctm.2015-0187; Pop SM, 2007, DIABETES, V56, P1395, DOI 10.2337/db06-0543; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Pugliese A, 2016, DIABETES, V65, P1109, DOI 10.2337/db15-1105; Ram Ramesh, 2016, J Immunol, V196, P3043, DOI 10.4049/jimmunol.1502056; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Richardson SJ, 2016, DIABETOLOGIA, V59, P2448, DOI 10.1007/s00125-016-4067-4; Rigby MR, 2015, J CLIN INVEST, V125, P3285, DOI 10.1172/JCI81722; Rodriguez-Calvo T, 2015, J HISTOCHEM CYTOCHEM, V63, P626, DOI 10.1369/0022155415576543; Rowe PA, 2011, SEMIN IMMUNOPATHOL, V33, P29, DOI 10.1007/s00281-010-0208-x; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Schlosser M, 2011, DIABETES CARE, V34, P2410, DOI 10.2337/dc11-1161; Schulte BM, 2010, VIRAL IMMUNOL, V23, P99, DOI 10.1089/vim.2009.0072; Seay HR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88242; Shahjalal HM, 2014, J MOL CELL BIOL, V6, P394, DOI 10.1093/jmcb/mju029; Shi Y, 2010, METHODS MOL BIOL, V636, P79, DOI 10.1007/978-1-60761-691-7_5; Sosenko JM, 2011, DIABETES CARE, V34, P1785, DOI 10.2337/dc11-0641; Sosinowski T, 2013, IMMUNOL RES, V55, P270, DOI 10.1007/s12026-012-8367-6; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Storling J, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020072; Szot GL, 2015, CELL STEM CELL, V16, P148, DOI 10.1016/j.stem.2014.12.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Thatava T, 2011, GENE THER, V18, P283, DOI 10.1038/gt.2010.145; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tooley JE, 2016, EUR J IMMUNOL, V46, P230, DOI 10.1002/eji.201545708; Torn C, 2008, DIABETOLOGIA, V51, P846, DOI 10.1007/s00125-008-0967-2; Toyoda T, 2015, STEM CELL RES, V14, P185, DOI 10.1016/j.scr.2015.01.007; van Lummel M, 2012, J BIOL CHEM, V287, P9514, DOI 10.1074/jbc.M111.313940; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Vudattu NK, 2014, EXPERT OPIN BIOL TH, V14, P377, DOI 10.1517/14712598.2014.881797; Wang YY, 2015, ARTHRITIS RHEUMATOL, V67, P2403, DOI 10.1002/art.39211; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Wasserfall C, 2016, CLIN EXP IMMUNOL, V185, P33, DOI 10.1111/cei.12797; Waters MJ, 2015, BIOCHEM J, V466, P1, DOI 10.1042/BJ20141293; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; WICKER LS, 1987, J EXP MED, V165, P1639, DOI 10.1084/jem.165.6.1639; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wong WT, 2012, CIRC RES, V111, P1363, DOI 10.1161/CIRCRESAHA.111.247213; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Yeh WI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01313; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z; Yoshida K, 2013, NAT GENET, V45, P1293, DOI 10.1038/ng.2759; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhu SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10080; Ziegler AG, 2012, PEDIATR DIABETES, V13, P438, DOI 10.1111/j.1399-5448.2011.00763.x; Zschaler J, 2014, CRIT REV IMMUNOL, V34, P433	133	0	0	10	10	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	OCT 18	2017	8								276	10.3389/fendo.2017.00276				17	Endocrinology & Metabolism	Endocrinology & Metabolism	FK0AV	WOS:000413143500001	29093700	gold			2018-01-05	
J	Odipio, J; Alicai, T; Ingelbrecht, I; Nusinow, DA; Bart, R; Taylor, NJ				Odipio, John; Alicai, Titus; Ingelbrecht, Ivan; Nusinow, Dmitri A.; Bart, Rebecca; Taylor, Nigel J.			Efficient CRISPR/Cas9 Genome Editing of Phytoene desaturase in Cassava	FRONTIERS IN PLANT SCIENCE			English	Article						cassava; genome editing; CRISPR/Cas9; Phytoene desaturase (PDS); albino; mutation; homozygous; heterozygous	RNA-GUIDED ENDONUCLEASE; TARGETED MUTAGENESIS; HOMOLOGOUS RECOMBINATION; 1ST GENERATION; CAS SYSTEM; PLANTS; ARABIDOPSIS; REPAIR; CROPS; RICE	CRISPR/Cas9 has become a powerful genome-editing tool for introducing genetic changes into crop species. In order to develop capacity for CRISPR/Cas9 technology in the tropical staple cassava (Manihot esculenta), the Phytoene desaturase (MePDS) gene was targeted in two cultivars using constructs carrying gRNAs targeting two sequences within MePDS exon 13. After Agrobacterium-mediated delivery of CRISPR/Cas9 reagents into cassava cells, both constructs induced visible albino phenotypes within cotyledon-stage somatic embryos regenerating on selection medium and the plants regenerated therefrom. A total of 58 (cv. 60444) and 25 (cv. TME 204) plant lines were recovered, of which 38 plant lines (19 from each cultivar) were analyzed for mutagenesis. The frequency of plant lines showing albino phenotype was high, ranging from 90 to 100% in cv. TME 204. Observed albino phenotypes were comprised of full albinos devoid of green tissue and chimeras containing a mixture of white and green tissues. Sequence analysis revealed that 38/38 (100%) of the plant lines examined carried mutations at the targeted MePDS site, with insertions, deletions, and substitutions recorded. One putatively mono-allelic homozygous line (1/19) was found from cv. 60444, while 1 (1/19) and 4 (4/19) putatively bi-allelic homozygous lines were found in 60444 and TME204, respectively. The remaining plant lines, comprised mostly of the chimeras, were found to be putatively heterozygous. We observed minor (1 bp) nucleotide substitutions and or deletions upstream of the 5 0 and or downstream of the 3 0 targeted MePDS region. The data reported demonstrates that CRISPR/Cas9-mediated genome editing of cassava is highly efficient and relatively simple, generating multi-allelic mutations in both cultivars studied. Modification of MePDS described here generates visually detectable mutated events in a relatively short time frame of 6-8 weeks, and does not require sequencing to confirm editing at the target. It therefore provides a valuable platform to facilitate rapid assessment and optimization of CRISPR/Cas9 and other genome-editing technologies in cassava.	[Odipio, John; Nusinow, Dmitri A.; Bart, Rebecca; Taylor, Nigel J.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Odipio, John; Alicai, Titus] Natl Crops Resources Res Inst, Kampala, Uganda; [Odipio, John; Ingelbrecht, Ivan] Univ Ghent, Vlaams Inst Biotechnol, Dept Plant Biotechnol & Bioinformat, Fac Sci, Ghent, Belgium; [Ingelbrecht, Ivan] IAEA, FAO IAEA Div Nucl Tech Food & Agr, Dept Nucl Sci & Applicat, Vienna, Austria	Taylor, NJ (reprint author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	ntaylor@danforthcenter.org		Nusinow, Dmitri/0000-0002-0497-1723	Bill and Melinda Gates Foundation	This work was supported by funds from the Bill and Melinda Gates Foundation.	Bart RS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006287; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Ceballos H, 2015, THEOR APPL GENET, V128, P1647, DOI 10.1007/s00122-015-2555-4; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Chauhan RD, 2015, PLANT CELL TISS ORG, V121, P591, DOI 10.1007/s11240-015-0729-z; Curtin SJ, 2012, PLANT GENOME-US, V5, P42, DOI 10.3835/plantgenome2012.06.0008; Ding YD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00703; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.1313/1-92559-287-7:141; Fan D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12217; Gao W, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01364; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Li C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43902; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Qin GJ, 2007, CELL RES, V17, P471, DOI 10.1038/cr.2007.40; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Taylor N, 2012, TROP PLANT BIOL, V5, P127, DOI 10.1007/s12042-012-9099-4; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00177	34	0	0	23	23	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	OCT 18	2017	8								1780	10.3389/fpls.2017.01780				11	Plant Sciences	Plant Sciences	FJ9YV	WOS:000413138300001	29093724	gold			2018-01-05	
J	Kumagai, H; Nakanishi, T; Matsuura, T; Kato, Y; Watanabe, H				Kumagai, Hitoshi; Nakanishi, Takashi; Matsuura, Tomoaki; Kato, Yasuhiko; Watanabe, Hajime			CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna	PLOS ONE			English	Article							TARGETED INTEGRATION; HETERODIMERIC TALENS; HUMAN-CELLS; GENOME; RNA; CAS9; DNA; DROSOPHILA; ZEBRAFISH; NUCLEASE	The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system (Cas) is widely used for mediating the knock-in of foreign DNA into the genomes of various organisms. Here, we report a process of CRISPR/Cas-mediated knockin via non-homologous end joining by the direct injection of Cas9/gRNA ribonucleoproteins (RNPs) in the crustacean Daphnia magna, which is a model organism for studies on toxicology, ecology, and evolution. First, we confirmed the cleavage activity of Cas9 RNPs comprising purified Cas9 proteins and gRNAs in D. magna. We used a gRNA that targets exon 10 of the eyeless gene. Cas9 proteins were incubated with the gRNAs and the resulting Cas9 RNPs were injected into D. magna eggs, which led to a typical phenotype of the eyeless mutant, i. e., eye deformity. The somatic and heritable mutagenesis efficiencies were up to 96% and 40%, respectively. Second, we tested the CRISPR/Cas-mediated knock-in of a plasmid by the injection of Cas9 RNPs. The donor DNA plasmid harboring the fluorescent reporter gene was designed to contain the gRNA recognition site. The co-injection of Cas9 RNPs together with the donor DNAs resulted in generation of one founder animal that produced fluorescent progenies. This transgenic Daphnia had donor DNA at the targeted genomic site, which suggested the concurrent cleavage of the injected plasmid DNA and genomic DNA. Owing to its simplicity and ease of experimental design, we suggest that the CRISPR/Cas-mediated knock-in method represents a promising tool for studying functional genomics in D. magna.	[Kumagai, Hitoshi; Nakanishi, Takashi; Matsuura, Tomoaki; Kato, Yasuhiko; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka, Japan; [Kato, Yasuhiko] Osaka Univ, Grad Sch Engn, Frontier Res Base Global Young Researchers, 2-1 Yamadaoka, Suita, Osaka, Japan	Watanabe, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka, Japan.	watanabe@bio.eng.osaka-u.ac.jp			JSPS KAKENHI Grant [15H01472, 26281027]; Frontier Research Base for Global Young Researchers, Osaka University;  [15J005870];  [14J04949]	This work was supported by JSPS KAKENHI Grant Number (15H01472, 26281027) to Y.K. and H.W. This work was also supported by Grant-in-Aid for JSPS Fellows (15J005870, 14J04949) to T.N. and H.K.	Alfred J, 2015, ELIFE, V4, DOI 10.7554/eLife.06956; ASSAAD FF, 1993, PLANT MOL BIOL, V22, P1067, DOI 10.1007/BF00028978; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cristea S, 2013, BIOTECHNOL BIOENG, V110, P871, DOI 10.1002/bit.24733; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; EADS BD, 2007, BMC GENOMICS, V8, P38211; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Goldstein B, 2016, TRENDS CELL BIOL, V26, P818, DOI 10.1016/j.tcb.2016.08.005; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; Honda Y, 2017, J CELL SCI, V130, P1652, DOI 10.1242/jcs.200923; Huang YP, 2016, J GENET GENOMICS, V43, P263, DOI 10.1016/j.jgg.2016.04.007; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kato Y, 2008, GENOMICS, V91, P94, DOI 10.1016/j.ygeno.2007.09.002; Kato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045318; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Lampert W., 2011, DAPHNIA DEV MODEL OR; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Miner BE, 2012, P ROY SOC B-BIOL SCI, V279, P1873, DOI 10.1098/rspb.2011.2404; Naitou A, 2015, BIOL OPEN, V4, P364, DOI 10.1242/bio.20149738; Nakanishi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36252; Nakanishi T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18312; Nakanishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098363; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Orsini L, 2011, BIOL LETTERS, V7, P2, DOI 10.1098/rsbl.2010.0629; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Pan YZ, 2013, MOL BIOTECHNOL, V55, P54, DOI 10.1007/s12033-012-9613-9; Rahdar M, 2015, P NATL ACAD SCI USA, V112, pE7110, DOI 10.1073/pnas.1520883112; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; STROSS RG, 1965, SCIENCE, V150, P1462, DOI 10.1126/science.150.3702.1462; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Torner K, 2014, MOL GENET GENOMICS, V289, P707, DOI 10.1007/s00438-014-0830-8; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Watanabe H, 2007, ENVIRON TOXICOL CHEM, V26, P669, DOI 10.1897/06-075R.1	42	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2017	12	10							e0186112	10.1371/journal.pone.0186112				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FK0KG	WOS:000413168100036	29045453	gold			2018-01-05	
J	Novellasdemunt, L; Foglizzo, V; Cuadrado, L; Antas, P; Kucharska, A; Encheva, V; Snijders, AP; Li, VSW				Novellasdemunt, Laura; Foglizzo, Valentina; Cuadrado, Laura; Antas, Pedro; Kucharska, Anna; Encheva, Vesela; Snijders, Ambrosius P.; Li, Vivian S. W.			USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating beta-Catenin Deubiquitination	CELL REPORTS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; UBIQUITIN LIGASE; STEM-CELLS; COLI GENE; E3 LIGASE; MUTATIONS; DEGRADATION; PATHWAY; IDENTIFICATION; COMPLEX	The tumor suppressor gene adenomatous polyposis coli (APC) is mutated in most colorectal cancers (CRCs), resulting in constitutive Wnt activation. To understand the Wnt-activating mechanism of the APC mutation, we applied CRISPR/Cas9 technology to engineer various APC-truncated isogenic lines. We find that the beta-catenin inhibitory domain (CID) in APC represents the threshold for pathological levels of Wnt activation and tumor transformation. Mechanistically, CID-deleted APC truncation promotes beta-catenin deubiquitination through reverse binding of beta-TrCP and USP7 to the destruction complex. USP7 depletion in APC-mutated CRC inhibits Wnt activation by restoring beta-catenin ubiquitination, drives differentiation, and suppresses xenograft tumor growth. Finally, the Wnt-activating role of USP7 is specific to APC mutations; thus, it can be used as a tumor-specific therapeutic target for most CRCs.	[Novellasdemunt, Laura; Foglizzo, Valentina; Cuadrado, Laura; Antas, Pedro; Kucharska, Anna; Li, Vivian S. W.] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Encheva, Vesela; Snijders, Ambrosius P.] Francis Crick Inst, Mass Spectrometry Sci Technol Platform, 1 Midland Rd, London NW1 1AT, England	Li, VSW (reprint author), Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England.	vivian.li@crick.ac.uk			Francis Crick Institute from Cancer Research UK [FC001105]; UK Medical Research Council [FC001105]; Wellcome Trust [FC001105]	We thank Hans Clevers for providing AXIN1-specific antibody and Christina Christopoulou for technical assistance. We also thank the Peptide Chemistry and the Biological Research Facility and the Experimental Histopathology Laboratory at the Francis Crick Institute for providing reagent and processing of samples. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001105), the UK Medical Research Council (FC001105), and the Wellcome Trust (FC001105).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choi SH, 2013, GENE DEV, V27, P2473, DOI 10.1101/gad.229062.113; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dihlmann S, 1999, CANCER RES, V59, P1857; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Fan YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.400; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737                                                               ; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madan B, 2016, P NATL ACAD SCI USA, V113, pE2945, DOI 10.1073/pnas.1605691113; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Novellasdemunt L, 2015, AM J PHYSIOL-CELL PH, V309, pC511, DOI 10.1152/ajpcell.00117.2015; Polakis Paul, 1995, Current Opinion in Genetics and Development, V5, P66, DOI 10.1016/S0959-437X(95)90055-1; Pronobis MI, 2015, ELIFE, V4, DOI 10.7554/eLife.08022; Reverdy C, 2012, CHEM BIOL, V19, P467, DOI 10.1016/j.chembiol.2012.02.007; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shi JD, 2015, MOL CELL BIOL, V35, P3301, DOI 10.1128/MCB.00373-15; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884                                                                   ; Tominaga J, 2008, GENES CELLS, V13, P67, DOI 10.1111/j.1365-2443.2007.01149.x; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	47	0	0	12	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	OCT 17	2017	21	3					612	627		10.1016/j.celrep.2017.09.072				16	Cell Biology	Cell Biology	FJ9IX	WOS:000413090600006	29045831	gold			2018-01-05	
J	Liu, Y; Liu, Y; Wang, M				Liu, Yang; Liu, Ye; Wang, Meng			Design, Optimization and Application of Small Molecule Biosensor in Metabolic Engineering	FRONTIERS IN MICROBIOLOGY			English	Review						metabolic engineering; synthetic biology; small molecule biosensor; transcription factor; optimization strategy; industrial application	INDUCED GENE-EXPRESSION; FRET-BASED NANOSENSOR; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; STRUCTURAL INSIGHTS; LYSINE RIBOSWITCH; REGULATOR SYSTEM; FREE GUANIDINE; FATTY-ACIDS; SENSORS	The development of synthetic biology and metabolic engineering has painted a great future for the bio-based economy, including fuels, chemicals, and drugs produced from renewable feedstocks. With the rapid advance of genome-scale modeling, pathway assembling and genome engineering/editing, our ability to design and generate microbial cell factories with various phenotype becomes almost limitless. However, our lack of ability to measure and exert precise control over metabolite concentration related phenotypes becomes a bottleneck in metabolic engineering. Genetically encoded small molecule biosensors, which provide the means to couple metabolite concentration to measurable or actionable outputs, are highly promising solutions to the bottleneck. Here we review recent advances in the design, optimization and application of small molecule biosensor in metabolic engineering, with particular focus on optimization strategies for transcription factor (TF) based biosensors.	[Liu, Yang; Liu, Ye; Wang, Meng] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	Wang, M (reprint author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China.	wangmeng@tib.cas.cn			Chinese Academy of Sciences [QYZDB-SSW-SMC012]; Chinese Academy of Sciences	This work was supported by key project of Chinese Academy of Sciences (QYZDB-SSW-SMC012) and 100 Talents Program of Chinese Academy of Sciences.	AMANN RI, 1995, MICROBIOL REV, V59, P143; Ameen S, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0204-y; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Becker J, 2012, CURR OPIN BIOTECH, V23, P718, DOI 10.1016/j.copbio.2011.12.025; Becker K, 2015, MOL MICROBIOL, V96, P1002, DOI 10.1111/mmi.12987; Bermejo C, 2011, NAT PROTOC, V6, P1806, DOI 10.1038/nprot.2011.391; Binder S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r40; Breaker RR, 2017, BIOCHEMISTRY-US, V56, P345, DOI 10.1021/acs.biochem.6b01269; BRENT R, 1984, NATURE, V312, P612, DOI 10.1038/312612a0; Chen W, 2015, METAB ENG, V30, P149, DOI 10.1016/j.ymben.2015.05.004; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; de los Santos ELC, 2016, ACS SYNTH BIOL, V5, P287, DOI 10.1021/acssynbio.5b00090; De Michele R, 2013, ELIFE, V2, DOI 10.7554/eLife.00800; Dietrich JA, 2013, ACS SYNTH BIOL, V2, P47, DOI 10.1021/sb300091d; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Ferrer M, 2009, J MOL MICROB BIOTECH, V16, P109, DOI 10.1159/000142898; Frei CS, 2016, PROTEIN SCI, V25, P804, DOI 10.1002/pro.2873; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Grkovic S, 2003, BIOCHEMISTRY-US, V42, P15226, DOI 10.1021/bi035447+; Ho CH, 2014, ELIFE, V3, DOI 10.7554/eLife.01917; Kaper T, 2007, PLOS BIOL, V5, P2201, DOI 10.1371/journal.pbio.0050257; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kim H, 2015, ANALYST, V140, P3384, DOI 10.1039/c4an02195a; Klauser B, 2015, ACS SYNTH BIOL, V4, P516, DOI 10.1021/sb500062p; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Knudsen JD, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0081-4; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; Li SJ, 2015, ACS SYNTH BIOL, V4, P1308, DOI 10.1021/acssynbio.5b00069; Liu D, 2015, METAB ENG, V31, P35, DOI 10.1016/j.ymben.2015.06.008; Liu YN, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0311-8; Liu YF, 2017, ACS SYNTH BIOL, V6, P837, DOI 10.1021/acssynbio.6b00328; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829                                                         ; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Marin AM, 2013, MICROBIOL-SGM, V159, P167, DOI 10.1099/mic.0.061135-0; Mohsin M, 2014, BIOSENS BIOELECTRON, V59, P358, DOI 10.1016/j.bios.2014.03.066; Mohsin M, 2013, BIOSENS BIOELECTRON, V50, P72, DOI 10.1016/j.bios.2013.06.028; Mustafi N, 2012, METAB ENG, V14, P449, DOI 10.1016/j.ymben.2012.02.002; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nelson JW, 2017, MOL CELL, V65, P220, DOI 10.1016/j.molcel.2016.11.019; Ng CY, 2015, CURR OPIN CHEM BIOL, V28, P105, DOI 10.1016/j.cbpa.2015.06.026; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Peroza EA, 2015, ANAL BIOCHEM, V474, P1, DOI 10.1016/j.ab.2014.12.019; Raman S, 2014, P NATL ACAD SCI USA, V111, P17803, DOI 10.1073/pnas.1409523111; Rogers JK, 2016, P NATL ACAD SCI USA, V113, P2388, DOI 10.1073/pnas.1600375113; Rogers JK, 2015, NUCLEIC ACIDS RES, V43, P7648, DOI 10.1093/nar/gkv616; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2009, NATURE, V458, P233, DOI 10.1038/nature07642; Siedler S, 2017, ACS SYNTH BIOL, V6, P1860, DOI 10.1021/acssynbio.7b00009; Siedler S, 2014, ACS SYNTH BIOL, V3, P41, DOI 10.1021/sb400110j; Stanton BC, 2014, ACS SYNTH BIOL, V3, P880, DOI 10.1021/sb5002856; Tang JL, 2014, CHEM COMMUN, V50, P15411, DOI 10.1039/c4cc08044k; Tang SY, 2008, J AM CHEM SOC, V130, P5267, DOI 10.1021/ja7109053; Tang SY, 2013, J AM CHEM SOC, V135, P10099, DOI 10.1021/ja402654z; Tang SY, 2011, ANGEW CHEM INT EDIT, V50, P1084, DOI 10.1002/anie.201006083; Tao RK, 2017, NAT METHODS, V14, P720, DOI 10.1038/nmeth.4306; Teran W, 2003, ANTIMICROB AGENTS CH, V47, P3067, DOI 10.1128/AAC.47.10.3067-3072.2003; Uchiyama T, 2005, NAT BIOTECHNOL, V23, P88, DOI 10.1038/nbt1048; Uchiyama T, 2010, APPL ENVIRON MICROB, V76, P7029, DOI 10.1128/AEM.00464-10; Umeyama T, 2013, ACS SYNTH BIOL, V2, P425, DOI 10.1021/sb300115n; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Wang M, 2016, BIOTECHNOL BIOENG, V113, P206, DOI 10.1002/bit.25676; Wu JY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45994; Xiu Y, 2017, BIOTECHNOL BIOENG, V114, P2235, DOI 10.1002/bit.26340; Xu P, 2014, P NATL ACAD SCI USA, V111, P11299, DOI 10.1073/pnas.1406401111; Xu P, 2014, ACS CHEM BIOL, V9, P451, DOI 10.1021/cb400623m; Yang P, 2017, METAB ENG, V43, P21, DOI 10.1016/j.ymben.2017.08.001; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang J, 2015, CURR OPIN CHEM BIOL, V28, P1, DOI 10.1016/j.cbpa.2015.05.013; Zhang JW, 2017, ACS SYNTH BIOL, V6, P439, DOI 10.1021/acssynbio.6b00136; Zhou LB, 2015, ACS SYNTH BIOL, V4, P1335, DOI 10.1021/acssynbio.5b00075; Zhou LB, 2015, ACS SYNTH BIOL, V4, P729, DOI 10.1021/sb500332c; Eggeling L, 2016, U. S. Patent No, Patent No. [US20160289776 A1, 20160289776]	79	0	0	15	15	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	OCT 17	2017	8								2012	10.3389/fmicb.2017.02012				10	Microbiology	Microbiology	FJ9NZ	WOS:000413106000001	29089935	gold			2018-01-05	
J	Peng, WX; Huang, JG; Yang, L; Gong, AH; Mo, YY				Peng, Wan-xin; Huang, Jian-guo; Yang, Liu; Gong, Ai-hua; Mo, Yin-Yuan			Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer	MOLECULAR CANCER			English	Article						Breast cancer; Estrogen-independent growth; Linc-RoR; ERK; DUSP7	NONCODING RNA-ROR; TAMOXIFEN-RESISTANCE; RECEPTOR-ALPHA; SERINE 118; PHOSPHORYLATION; PATHWAY; ACTIVATION; MECHANISMS; EXPRESSION; CELLS	Background: The conversion from estrogen-dependent to estrogen-independent state of ER+ breast cancer cells is the key step to promote resistance to endocrine therapies. Although the crucial role of MAPK/ERK signaling pathway in estrogen-independent breast cancer cell growth is well established, the underlying mechanism is not fully understood. Methods: In this study, we profiled lncRNA expression against a focused group of lncRNAs selected from lncRNA database. CRISPR/Cas9 was employed to knockout (KO) linc-RoR in MCF-7 cells, while rescue experiments were carried out to re-express linc-RoR in KO cells. Colony formation and MTT assays were used to examine the role of linc-RoR in estrogen-independent growth and tamoxifen resistance. Western blot and qRT-PCR were used to determine the change of protein and lncRNA levels, respectively. The expression of DUSP7 in clinical specimens was downloaded from Oncomine (www.oncomine.org) and the dataset from Kaplan-Meier Plotter (http://kmplot.com) was used to analyze the clinical outcomes in relation to DUSP7. Results: We identified that linc-RoR functions as an onco-lncRNA to promote estrogen-independent growth of ER+ breast cancer. Under estrogen deprivation, linc-RoR causes the upregulation of phosphorylated MAPK/ERK pathway which in turn activates ER signaling. Knockout of linc-RoR abrogates estrogen deprivation-induced ERK activation as well as ER phosphorylation, whereas re-expression of linc-RoR restores all above phenotypes. Moreover, we show that the ERK-specific phosphatase Dual Specificity Phosphatase 7 (DUSP7), also known as MKP-X, is involved in linc-RoR KO induced repression of MAPK/ERK signaling. Interestingly, linc-RoR KO increases the protein stability of DUSP7, resulting in repression of ERK phosphorylation. Clinical data analysis reveal that DUSP7 expression is lower in ER+ breast cancer samples than that in ER-breast cancer. Moreover, downregulation of DUSP7 expression is associated with poor patient survival. Conclusion: Taken together, these results suggest that linc-RoR promotes estrogen-independent growth and activation of MAPK/ERK pathway of breast cancer cells by regulating the ERK-specific phosphatase DUSP7. Thus, this study might help not only in establishing a role for linc-RoR in estrogen-independent and tamoxifen resistance of ER+ breast cancer, but also suggesting a link between linc-RoR and MAPK/ERK pathway.	[Peng, Wan-xin; Gong, Ai-hua] Jiangsu Univ, Sch Med, Dept Cell Biol, Zhenjiang, Peoples R China; [Peng, Wan-xin; Huang, Jian-guo; Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Canc Inst, Jackson, MS 39216 USA; [Huang, Jian-guo] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Yang, Liu] Zhejiang Prov Peoples Hosp, Dept Sci & Res, Hangzhou, Zhejiang, Peoples R China; [Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Dept Pharmacol Toxicol, Jackson, MS 39216 USA	Gong, AH (reprint author), Jiangsu Univ, Sch Med, Dept Cell Biol, Zhenjiang, Peoples R China.; Mo, YY (reprint author), Univ Mississippi, Med Ctr, Canc Inst, Jackson, MS 39216 USA.	ahg5@ujs.edu.cn; ymo@umc.edu			Jiangsu key laboratory of Medical Science and Laboratory Medicine [JSKLM-2014-007]; NIH grant [R01 CA154989]; Jiangsu Government Scholarship for Overseas Studies (Jiangsu provincial department of education) [JS-2014-269]	This research was in part supported by grant from the Jiangsu key laboratory of Medical Science and Laboratory Medicine (JSKLM-2014-007 to WP) and NIH grant R01 CA154989 (YM). WP is supported by a fellowship from the Jiangsu Government Scholarship for Overseas Studies (Jiangsu provincial department of education, JS-2014-269).	Anbalagan M, 2015, MOL CELL ENDOCRINOL, V418, P264, DOI 10.1016/j.mce.2015.01.016; Angus L, 2017, CANCER TREAT REV, V52, P33, DOI 10.1016/j.ctrv.2016.11.001; Bartholomeusz C, 2012, ONCOLOGIST, V17, P766, DOI 10.1634/theoncologist.2011-0377; Bunone G, 1996, EMBO J, V15, P2174; Carlos AR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3697; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Chen M, 2013, ONCOL LETT, V6, P118, DOI 10.3892/ol.2013.1324; Chen WC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155660; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Coleman KM, 2001, FRONT BIOSCI, V6, pD1379, DOI 10.2741/Coleman                                                                 ; Daurio NA, 2016, CANCER RES, V76, P3295, DOI 10.1158/0008-5472.CAN-15-2197; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Eades G, 2015, MOL CANCER RES, V13, P330, DOI 10.1158/1541-7786.MCR-14-0251; Giltnane JM, 2014, DISCOV MED, V17, P275; Gu GW, 2016, CURR OPIN PHARMACOL, V31, P97, DOI 10.1016/j.coph.2016.11.005; Hayes EL, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0542-y; Herrero A, 2015, CANCER CELL, V28, P170, DOI 10.1016/j.ccell.2015.07.001; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Huang JG, 2016, NUCLEIC ACIDS RES, V44, P3059, DOI 10.1093/nar/gkv1353; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jain AK, 2016, MOL CELL, V64, P967, DOI 10.1016/j.molcel.2016.10.039; Kok M, 2009, J NATL CANCER I, V101, P1725, DOI 10.1093/jnci/djp412; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743                                                                 ; Kumler I, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000062; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Li P, 2016, AM J TRANSL RES, V8, P3522; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Low HB, 2016, IMMUNE NETW, V16, P85, DOI 10.4110/in.2016.16.2.85; Mancuso MR, 2016, CURR PROBL CANC; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mohseni M, 2014, P NATL ACAD SCI USA, V111, P17606, DOI 10.1073/pnas.1408650111; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Peng WX, 2016, EXP CELL RES, V340, P62, DOI 10.1016/j.yexcr.2015.12.006; Pritchard KI, 2013, J INTERN MED, V274, P144, DOI 10.1111/joim.12065; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sachdeva M, 2011, ONCOGENE, V30, P822, DOI 10.1038/onc.2010.463; Shou J, 2004, J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2                                                    ; Tang JY, 2013, SCI WORLD J, V2013, DOI DOI 10.1155/2013/943539; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wu CH, 2016, MED SCI MONITOR, V22, P3860, DOI 10.12659/MSM.900689; Wu FT, 2007, MOL CANCER THER, V6, P1823, DOI 10.1158/1535-7163.MCT-06-0771; Wu XS, 2014, CANCER BIOL THER, V15, P806, DOI 10.4161/cbt.28584; Xue X, 2016, ONCOGENE, V35, P2746, DOI 10.1038/onc.2015.340; Yamashita H, 2008, ENDOCR-RELAT CANCER, V15, P755, DOI 10.1677/ERC-08-0078; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164; Zhang Y, 2009, INT J CANCER, V125, P2021, DOI 10.1002/ijc.24540	51	0	0	4	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-4598			MOL CANCER	Mol. Cancer	OCT 17	2017	16								161	10.1186/s12943-017-0727-3				11	Biochemistry & Molecular Biology; Oncology	Biochemistry & Molecular Biology; Oncology	FJ9MD	WOS:000413100500001	29041978	gold			2018-01-05	
J	Luo, XM; Li, CM; Tan, R; Xu, XH; Wu, WKK; Satoh, A; Wang, TL; Yu, S				Luo, Xiaomin; Li, Chunman; Tan, Ran; Xu, Xiaohui; Wu, William K. K.; Satoh, Ayano; Wang, Tuanlao; Yu, Sidney			A RasGAP, DAB2IP, regulates lipid droplet homeostasis by serving as GAP toward RAB40C	ONCOTARGET			English	Article						lipid droplets; RAB40C; GTPase activating protein; DAB2IP	GTPASE-ACTIVATING PROTEINS; INDUCED HEPATIC STEATOSIS; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; HEPG2 CELLS; LIVER-CELLS; RAB18; ACCUMULATION; STIMULATION; TRANSPORT	Lipid droplet (LD) homeostasis involves activities of various RAB small GTPases. Recently, we found RAB40C was one of the RAB proteins regulating LD homeostasis. RAB40C contains a unique SOCS domain that is required for clustering of LDs. However, its precise functional role in LD homeostasis and mechanism of regulation remain largely unknown. In this study, we observed over-accumulation of LDs in cells with RAB40C deleted by Crispr-Cas9 editing. RAB40C appeared to reduce LD accumulation after long term incubation of cells with oleic acid (24 hours). Unexpectedly, we found that Ras GTPase activating protein (GAP), DAB2IP, bound to RAB40C mainly via its GAP domain and could serve as RAB40C GAP. Studies involving overexpression of DAB2IP and its GAP defective mutant and siRNA depletion of DAB2IP all confirmed that DAB2IP negatively regulated the effect of RAB40C on LD homeostasis. These results provide a novel perspective on the regulation of RAB40C and implicate various signalling pathways regulated by DAB2IP, which may play a role in LD homeostasis via RAB40C.	[Luo, Xiaomin] Peking Univ, Shenzhen Hosp, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Inst Urol,Shenzhen PKU HKUST Med Ctr, Shenzhen, Peoples R China; [Luo, Xiaomin; Li, Chunman; Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Tan, Ran; Xu, Xiaohui; Wang, Tuanlao] Chinese Univ Hong Kong, Dept Anesthesia, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wu, William K. K.] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China; [Satoh, Ayano] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China	Yu, S (reprint author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.; Wang, TL (reprint author), Chinese Univ Hong Kong, Dept Anesthesia, Fac Med, Hong Kong, Hong Kong, Peoples R China.; Yu, S (reprint author), Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China.	xmuibrwtl@xmu.edu.cn; Sidney.yu@cuhk.edu.hk	Wu, William K.K./A-3277-2009	Wu, William K.K./0000-0002-5662-5240	one-line budget of CUHK; National Natural Science Foundation of China [31371353]	We thank the Genome Centre of University of Hong Kong for mass spectrometry identification of RAB40C co-purified proteins. We thank Professor Michael G. Roth (University of Texas Southwestern Medical Center at Dallas) for editing this manuscript. The study was supported by the one-line budget of CUHK to S.Y. and the National Natural Science Foundation of China (no. 31371353) to T.W.	Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Dansako H, 2014, VIROLOGY, V462, P166, DOI 10.1016/j.virol.2014.05.017; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Khan SA, 2015, J LIPID RES, V56, P2260, DOI 10.1194/jlr.M056812; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003                                                    ; Kupzig S, 2006, J BIOL CHEM, V281, P9891, DOI 10.1074/jbc.M512802200; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Li CM, 2017, EMBO J, V36, P441, DOI 10.15252/embj.201694866; Li CM, 2016, CELL BIOL INT, V40, P1026, DOI 10.1002/cbin.10650; Maertens Ophelia, 2014, Advances in Biological Regulation, V55, P1, DOI 10.1016/j.jbior.2014.04.002; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Mishra Ashwini K, 2015, Methods Mol Biol, V1298, P47, DOI 10.1007/978-1-4939-2569-8_4; O'Mahony F, 2015, HEPATOLOGY, V62, P615, DOI 10.1002/hep.27645; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Park EJ, 2014, TOXICOL LETT, V224, P114, DOI 10.1016/j.toxlet.2013.09.018; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez-Gabin AG, 2004, J NEUROSCI RES, V76, P758, DOI 10.1002/jnr.20121; Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9                                                   ; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Tan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063213; Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14; Vidyashankar S, 2013, TOXICOL IN VITRO, V27, P945, DOI 10.1016/j.tiv.2013.01.014; Wan T, 2010, J BIOL CHEM, V285, P3750, DOI 10.1074/jbc.M109.069385; Wang BG, 2016, J FOOD SCI, V81, pH794, DOI 10.1111/1750-3841.13210; Wang WY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12070; Xie CF, 2016, LIFE SCI, V157, P131, DOI 10.1016/j.lfs.2016.06.001; Yatsu A, 2015, BIOL OPEN, V4, P267, DOI 10.1242/bio.201411114	33	0	0	2	2	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	OCT 17	2017	8	49					85415	85427		10.18632/oncotarget.19960				13	Oncology; Cell Biology	Oncology; Cell Biology	FJ9FN	WOS:000413077800074	29156729				2018-01-05	
J	Wu, Y; Bian, CX; Zhen, CL; Liu, L; Lin, ZH; Nisar, MF; Wang, M; Bartsch, JW; Huang, EY; Ji, P; Yang, L; Yu, YH; Yang, JF; Jiang, XM; Zhong, JLL				Wu, Yan; Bian, Chunxiang; Zhen, Chunlin; Liu, Liu; Lin, Zhenghong; Nisar, Muhammad Farrukh; Wang, Mei; Bartsch, Joerg W.; Huang, Enyi; Ji, Ping; Yang, Li; Yu, Yanhong; Yang, Junfeng; Jiang, Xuemei; Zhong, Julia Li			Telomerase reverse transcriptase mediates EMT through NF-kappa B signaling in tongue squamous cell carcinoma	ONCOTARGET			English	Article						OTSCC; hTERT; EMT; NF-kappa B; CRISPR/Cas9	TO-MESENCHYMAL TRANSITION; HTERT EXPRESSION; GASTRIC-CANCER; BREAST-CANCER; C-MYC; INVASION; PROLIFERATION; PROGRESSION; METASTASIS; INHIBITION	Locoregional lymph nodes metastasis in oral tongue squamous cell carcinoma represents one of important and common prognostic factors for poor clinical outcome. The human Telomerase Reverse Transcriptase (hTERT) is one of key players in cancer metastasis and stemness, but its exact function in tongue squamous cell carcinoma remains unknown. Here, we aim to understand the role of hTERT by utilizing the CRISPR/Cas9 gene editing system to deplete hTERT in the SCC-15 cell line. Functional comparison of SCC-15 control and knockout cells (hTERT(-/-)) showed that loss of hTERT suppressed cell proliferation and migration/invasion. Furthermore, hTERT depletion significantly decreased tumorigenesis, including alterations in cellular morphology that areindicative for epithelial-mesenchymal transition (EMT). Mechanistically we demonstrated that the hTERT knockout attenuates NF-kappa B signaling via a negative feedback regulation in tumorprogression. From these results we propose a novel molecular mechanism of hTERT to promote SCC-15 invasion and metastasis via NF-kappa B activation. We conclude that targeting hTERT may represent a new therapeutic strategy to improve therapy and survival of tongue squamous cell carcinoma patients.	[Wu, Yan; Bian, Chunxiang; Zhen, Chunlin; Huang, Enyi; Ji, Ping] Chongqing Med Univ, Stomatol Hosp, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing 401147, Peoples R China; [Wu, Yan; Bian, Chunxiang; Zhen, Chunlin; Liu, Liu; Lin, Zhenghong; Nisar, Muhammad Farrukh; Wang, Mei; Yang, Li; Jiang, Xuemei; Zhong, Julia Li] Chongqing Univ, Key Lab Biorheol Sci & Technol, Base Project Biomech & Tissue Repair Engn 111, Minist Educ,Bioengn Coll,Life Sci Coll, Chongqing 400044, Peoples R China; [Bartsch, Joerg W.] Phillips Univ Marburg, Dept Neurosurg, Baldingerstr, D-35033 Marburg, Germany; [Yu, Yanhong; Yang, Junfeng] First Peoples Hosp Yunnan Prov, Dept Urol, Kunming 650032, Yunnan, Peoples R China	Jiang, XM; Zhong, JLL (reprint author), Chongqing Univ, Key Lab Biorheol Sci & Technol, Base Project Biomech & Tissue Repair Engn 111, Minist Educ,Bioengn Coll,Life Sci Coll, Chongqing 400044, Peoples R China.	jiangxuemei@cqu.edu.cn; jlzhong@cqu.edu.cn			Chongqing Laboratory of Oral Biomedical Engineering of Higher Education [ODBS-2014-004]; National Natural Science Foundation of China [81271776, 81260375, 81573073, 31400805]; Fundamental Research Funds for the Central Universities [106112017CDJQJ298833/238815, 106112017CDJQJ]	This work was supported by the Chongqing Laboratory of Oral Biomedical Engineering of Higher Education (ODBS-2014-004), the National Natural Science Foundation of China (81271776, 81260375, 81573073, 31400805) and Fundamental Research Funds for the Central Universities (No. 106112017CDJQJ298833/238815, 106112017CDJQJ). Both projects are not in a financial or personal relationship to this study.	Arvelo F, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.617; Bello IO, 2010, ORAL ONCOL, V46, P636, DOI 10.1016/j.oraloncology.2010.06.008; Bello IO, 2010, ORAL ONCOL, V46, P630, DOI 10.1016/j.oraloncology.2010.06.006; Choi BJ, 2015, WORLD J GASTROENTERO, V21, P9328, DOI 10.3748/wjg.v21.i31.9328; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Etemad-Moghadam S, 2015, APPL IMMUNOHISTO M M, V23, pE12, DOI 10.1097/PAI.0000000000000184; Feng H, 2017, CELL ADHES MIGR, V1, P1, DOI 10.1080/19336918.2016.1259058; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Goto H, 2017, DEVELOPMENT; Guan GG, 2015, ONCOL LETT, V9, P1567, DOI 10.3892/ol.2015.2926; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276                                                        ; Hu WX, 2016, ONCOTARGET, V7, P52870, DOI 10.18632/oncotarget.9141; Islam SS, 2016, MOL CARCINOGEN, V55, P537, DOI 10.1002/mc.22300; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Kirkpatrick KL, 2003, BREAST CANCER RES TR, V77, P277, DOI 10.1023/A:1021849217054; Kong WM, 2015, J CANCER, V6, P1337, DOI 10.7150/jca.13054; Lu MH, 2012, ONCOL REP, V28, P1945, DOI 10.3892/or.2012.2036; Lyons JG, 2008, CLIN EXP METASTAS, V25, P665, DOI 10.1007/s10585-007-9134-2; Maggisano V, 2017, MOL CELL ENDOCRINOL, V448, P34, DOI 10.1016/j.mce.2017.03.007; Pal D, 2017, UROL ONCOL-SEMIN ORI, V35, P401, DOI 10.1016/j.urolonc.2017.01.019; Ruden M, 2013, CANCER TREAT REV, V39, P444, DOI 10.1016/j.ctrv.2012.06.007; Shi Y, 2015, TARGET ONCOL, V10, P565, DOI 10.1007/s11523-015-0364-y; Shrihari TG, 2017, ECANCERMEDICALSCIENC, V11, DOI 10.3332/ecancer.2017.721; Tan WJ, 2012, ORL J OTO-RHINO-LARY, V74, P264, DOI 10.1159/000343796; Tang B, 2016, ONCOTARGET, V7, P11364, DOI 10.18632/oncotarget.6575; Tang QM, 2017, CANCER RES, V77, P532, DOI 10.1158/0008-5472.CAN-16-1322; Tseng JC, 2015, HISTOL HISTOPATHOL, V30, P1283, DOI 10.14670/HH-11-638; Tsubaki M, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-62; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wu Y, 2017, EXP DERMATOL, V26, P116, DOI 10.1111/exd.13164; Yu CC, 2016, ONCOTARGET, V7, P20180, DOI 10.18632/oncotarget.7745; Zhang BG, 2015, CANCER BIOL THER, V16, P898, DOI 10.1080/15384047.2015.1028702; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388                                                          ; Zvereva MI, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1563, DOI 10.1134/S0006297910130055	34	0	0	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	OCT 17	2017	8	49					85492	85503		10.18632/oncotarget.20888				12	Oncology; Cell Biology	Oncology; Cell Biology	FJ9FN	WOS:000413077800080	29156735				2018-01-05	
J	Cao, SN; Du, NL; Chen, HM; Pang, Y; Zhang, ZX; Zheng, J; Jia, HL				Cao, Shinuo; Du, Nali; Chen, Heming; Pang, Yu; Zhang, Zhaoxia; Zheng, Jun; Jia, Honglin			Toxoplasma gondii Clp family protein: TgClpB1 plays a crucial role in thermotolerance	ONCOTARGET			English	Article						ClpB; caseinolytic proteases and chaperones; AAA plus ATPases; thermotolerance; toxoplasma gondii	HEAT-SHOCK-PROTEIN; PLASMODIUM-FALCIPARUM; LEISHMANIA-DONOVANI; HSP100 CHAPERONES; ESCHERICHIA-COLI; PROTEASES; STRESS; DISAGGREGATION; AGGREGATION; DESTRUCTION	Caseinolytic peptidase B (ClpB) plays a pivotal role in suppressing and reversing protein aggregation. Toxoplasma gondii is an intracellular parasitic protozoan that infects a wide variety of mammals and birds and therefore is exposed to a broad range of living condition. We screened ToxoDB (http://ToxoDB.org) and identified 10 putative T. gondii genes encoding members of the Clp superfamily of caseinolytic proteases and chaperones. Of these, we focused on characterizing the Class I ATP-dependent molecular chaperones TgClpB1, TgClpB2, and TgClpB3. We found that TgClpB1, the most divergent of the five T. gondii Class I Clp ATPases, is cytoplasmic, TgClpB2 is found in the mitochondria of the parasites, and TgClpB3 is a ClpB with novel apicoplast localization. Knockout strains of TgClpB1 and TgClpB2 were established by CRISPR/Cas9 mutagenesis, and their complementing strains were constructed with FLAG-tag. Although knockout of TgClpB1 or TgClpB2 did not affect growth under normal circumstances, TgClpB1 was required for T. gondii thermotolerance. The growth, replication, and invasion capabilities of TgClpB1-deficient mutants were significantly inhibited after extracellular parasites were pretreated at 45 degrees C. Moreover, TgClpB1 were observed at the poles of the Delta TgClpB1 FLAG-tagged strain treated at 42 degrees C.	[Cao, Shinuo; Du, Nali; Chen, Heming; Pang, Yu; Zhang, Zhaoxia; Zheng, Jun; Jia, Honglin] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China	Jia, HL (reprint author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China.	jiahonglin@caas.cn			National Key Research and Development program of China [2017YFD0500404]	The plasmid pCD-TgClpB1, pCD-TgClpB2 and pCD-TgClpB3 are modified from pSAG1::CAS9-U6::sgUPRT (Addgene, #54467). We thank Dr. David Sibley for providing this plasmid. This work was supported by a grant from National Key Research and Development program of China (No. 2017YFD0500404).	AhYoung AP, 2015, PROTEIN SCI, V24, P1508, DOI 10.1002/pro.2739; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Cilingir G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036598; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Eriksson MJ, 1996, J BACTERIOL, V178, P4839, DOI 10.1128/jb.178.16.4839-4846.1996                                                ; FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846; Fellows JD, 2017, MBIO, V8, DOI 10.1128/mBio.00950-17; Franco M, 2016, MBIO, V7, DOI 10.1128/mBio.02231-15; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gur E, 2013, MACHINES DESTRUCTION, P3; Hombach A, 2014, J CELL SCI, V127, P4762, DOI 10.1242/jcs.157297; Imai J, 2003, CELL CYCLE, V2, P585, DOI 10.4161/cc.2.6.586; Jain S, 2013, CELL MICROBIOL, V15, P1660, DOI 10.1111/cmi.12142; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Krobitsch S, 1999, CELL STRESS CHAPERON, V4, P191; Krobitsch S, 1998, J BIOL CHEM, V273, P6488, DOI 10.1074/jbc.273.11.6488; LEVINE ND, 1988, J PROTOZOOL, V35, P518, DOI 10.1111/j.1550-7408.1988.tb04141.x                                              ; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Ngansop F, 2013, BIOCHEM BIOPH RES CO, V439, P191, DOI 10.1016/j.bbrc.2013.08.064; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Ramasamy G, 2007, MOL BIOCHEM PARASIT, V152, P139, DOI 10.1016/j.molbiopara.2007.01.002; Riezman H, 2004, CELL CYCLE, V3, P61; SANCHEZ Y, 1992, EMBO J, V11, P2357; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/S0968-0004(96)10038-4; Schulz-Raffelt M, 2007, PLANT J, V52, P286, DOI 10.1111/j.1365-313X.2007.03228.x; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Zheng J, 2015, INT J PARASITOL, V45, P141, DOI 10.1016/j.ijpara.2014.09.003; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	39	0	0	6	6	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	OCT 17	2017	8	49					86117	86129		10.18632/oncotarget.20989				13	Oncology; Cell Biology	Oncology; Cell Biology	FJ9FN	WOS:000413077800126	29156781				2018-01-05	
J	Larsen, ISB; Narimatsu, Y; Joshi, HJ; Siukstaite, L; Harrison, OJ; Brasch, J; Goodman, KM; Hansen, L; Shapiro, L; Honig, B; Vakhrushev, SY; Clausen, H; Halim, A				Larsen, Ida Signe Bohse; Narimatsu, Yoshiki; Joshi, Hiren Jitendra; Siukstaite, Lina; Harrison, Oliver J.; Brasch, Julia; Goodman, Kerry M.; Hansen, Lars; Shapiro, Lawrence; Honig, Barry; Vakhrushev, Sergey Y.; Clausen, Henrik; Halim, Adnan			Discovery of an O-mannosylation pathway selectively serving cadherins and protocadherins	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						glycoproteomics; O-glycosylation; glycosyltransferase; mass spectrometry; gene editing	MUSCULAR-DYSTROPHY; MOLECULAR-BASIS; BAKERS-YEAST; PROTEIN; MANNOSYLTRANSFERASES; GLYCOPROTEOME; GLYCOSYLATION; TRANSFERASE; DISEASE; POMT1	The cadherin (cdh) superfamily of adhesion molecules carry O-linked mannose (O-Man) glycans at highly conserved sites localized to specific beta-strands of their extracellular cdh (EC) domains. These O-Man glycans do not appear to be elongated like O-Man glycans found on alpha-dystroglycan (alpha-DG), and we recently demonstrated that initiation of cdh/protocadherin (pcdh) O-Man glycosylation is not dependent on the evolutionary conserved POMT1/POMT2 enzymes that initiate O-Man glycosylation on alpha-DG. Here, we used a CRISPR/Cas9 genetic dissection strategy combined with sensitive and quantitative O-Man glycoproteomics to identify a homologous family of four putative protein O-mannosyltransferases encoded by the TMTC1-4 genes, which were found to be imperative for cdh and pcdh O-Man glycosylation. KO of all four TMTC genes in HEK293 cells resulted in specific loss of cdh and pcdh O-Man glycosylation, whereas combined KO of TMTC1 and TMTC3 resulted in selective loss of O-Man glycans on specific beta-strands of EC domains, suggesting that each isoenzyme serves a different function. In addition, O-Man glycosylation of IPT/TIG domains of plexins and hepatocyte growth factor receptor was not affected in TMTC KO cells, suggesting the existence of yet another O-Man glycosylation machinery. Our study demonstrates that regulation of O-mannosylation in higher eukaryotes is more complex than envisioned, and the discovery of the functions of TMTCs provide insight into cobblestone lissencephaly caused by deficiency in TMTC3.	[Larsen, Ida Signe Bohse; Narimatsu, Yoshiki; Joshi, Hiren Jitendra; Siukstaite, Lina; Hansen, Lars; Vakhrushev, Sergey Y.; Clausen, Henrik; Halim, Adnan] Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Harrison, Oliver J.; Brasch, Julia; Goodman, Kerry M.; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA; [Shapiro, Lawrence; Honig, Barry] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Halim, Adnan] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA	Halim, A (reprint author), Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark.; Halim, A (reprint author), Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA.	halim@sund.ku.dk		Halim, Adnan/0000-0003-1629-187X	A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal; Kirsten og Freddy Johansen Fonden; Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat; Lundbeck Foundation; Carlsberg Foundation; Novo Nordisk Foundation; European Union [704228]; Danish Research Councils; National Science Foundation [MCB-1412472]; National Institutes of Health [R01-GM107571, R01GM118584]; University of Copenhagen Program of Excellence; Danish National Research Foundation [DNRF107]	This work was supported by A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal, Kirsten og Freddy Johansen Fonden, Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat, The Lundbeck Foundation, The Carlsberg Foundation, The Novo Nordisk Foundation, The European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Grant 704228, The Danish Research Councils, National Science Foundation Grant MCB-1412472 (to B.H.), National Institutes of Health Grants R01-GM107571 and R01GM118584 (to L. Shapiro), the University of Copenhagen Program of Excellence, and Danish National Research Foundation Grant DNRF107.	Akasaka-Manya K, 2011, BIOCHEM BIOPH RES CO, V411, P721, DOI 10.1016/j.bbrc.2011.07.012; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bartels MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166119; Bausewein D, 2016, J BIOL CHEM, V291, P18006, DOI 10.1074/jbc.M116.739128; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Carvalho S, 2016, ONCOTARGET, V7, P65231, DOI 10.18632/oncotarget.11245; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Farhan SMK, 2017, HUM MOL GENET, V26, P4278, DOI 10.1093/hmg/ddx316; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Halim A, 2017, CURR OPIN STRUC BIOL, V44, P143, DOI 10.1016/j.sbi.2017.03.005; Halim A, 2015, P NATL ACAD SCI USA, V112, P15648, DOI 10.1073/pnas.1511743112; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hutzler J, 2007, P NATL ACAD SCI USA, V104, P7827, DOI 10.1073/pnas.0700374104; Jerber J, 2016, AM J HUM GENET, V99, P1181, DOI 10.1016/j.ajhg.2016.09.007; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Larsen ISB, 2017, J BIOL CHEM, V292, P11586, DOI 10.1074/jbc.M117.794487; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lonowski LA, 2017, NAT PROTOC, V12, P581, DOI 10.1038/nprot.2016.165; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Neubert P, 2016, MOL CELL PROTEOMICS, V15, P1323, DOI 10.1074/mcp.M115.057505; Petrou VI, 2016, SCIENCE, V351, P608, DOI 10.1126/science.aad1172; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; Racape M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019321; Radmanesh F, 2013, AM J HUM GENET, V92, P468, DOI 10.1016/j.ajhg.2013.02.005; Runge CL, 2016, JAMA OTOLARYNGOL, V142, P866, DOI 10.1001/jamaoto.2016.1444; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Sunryd JC, 2014, J BIOL CHEM, V289, P16085, DOI 10.1074/jbc.M114.554071; Tavares-Carreon F, 2016, GLYCOBIOLOGY, V26, P286, DOI 10.1093/glycob/cwv095; vanderKnaap MS, 1997, ANN NEUROL, V42, P50, DOI 10.1002/ana.410420110                                                           ; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Wells L, 2013, J BIOL CHEM, V288, P6930, DOI 10.1074/jbc.R112.438978; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yun EJ, 2012, ANAT REC, V295, P167, DOI 10.1002/ar.21475; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	45	0	0	1	1	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 17	2017	114	42					11163	11168		10.1073/pnas.1708319114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FK1JW	WOS:000413237900053	28973932				2018-01-05	
J	Jain, A; Zode, G; Kasetti, RB; Ran, FA; Yan, W; Sharma, TP; Bugge, K; Searby, CC; Fingert, JH; Zhang, F; Clark, AF; Sheffield, VC				Jain, Ankur; Zode, Gulab; Kasetti, Ramesh B.; Ran, Fei A.; Yan, Winston; Sharma, Tasneem P.; Bugge, Kevin; Searby, Charles C.; Fingert, John H.; Zhang, Feng; Clark, Abbot F.; Sheffield, Val C.			CRISPR-Cas9-based treatment of myocilin-associated glaucoma	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						myocilin; CRISPR; glaucoma; trabecular meshwork; genome editing	OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; ER STRESS; CHEMICAL CHAPERONE; JUVENILE GLAUCOMA; GENETIC-LINKAGE; AQUEOUS-HUMOR; NON-SECRETION; MOUSE MODEL; EXPRESSION	Primary open-angle glaucoma (POAG) is a leading cause of irreversible vision loss worldwide, with elevated intraocular pressure (IOP) a major risk factor. Myocilin (MYOC) dominant gain-of-function mutations have been reported in similar to 4% of POAG cases. MYOC mutations result in protein misfolding, leading to endoplasmic reticulum (ER) stress in the trabecular meshwork (TM), the tissue that regulates IOP. We use CRISPR-Cas9-mediated genome editing in cultured human TM cells and in a MYOC mouse model of POAG to knock down expression of mutant MYOC, resulting in relief of ER stress. In vivo genome editing results in lower IOP and prevents further glaucomatous damage. Importantly, using an ex vivo human organ culture system, we demonstrate the feasibility of human genome editing in the eye for this important disease.	[Jain, Ankur; Bugge, Kevin; Searby, Charles C.; Sheffield, Val C.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Zode, Gulab; Kasetti, Ramesh B.; Clark, Abbot F.] Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, Ft Worth, TX 76107 USA; [Ran, Fei A.; Yan, Winston; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02142 USA; [Sharma, Tasneem P.; Fingert, John H.; Sheffield, Val C.] Univ Iowa, Dept Ophthalmol, Carver Coll Med, Stephen A Wynn Inst Vis Res, Iowa City, IA 52242 USA	Sheffield, VC (reprint author), Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA.; Zode, G (reprint author), Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, Ft Worth, TX 76107 USA.; Sheffield, VC (reprint author), Univ Iowa, Dept Ophthalmol, Carver Coll Med, Stephen A Wynn Inst Vis Res, Iowa City, IA 52242 USA.	gulab.zode@unthsc.edu; val-sheffield@uiowa.edu		Fingert, John/0000-0002-0377-0479	National Institutes of Health [R01 EY024259, R01 EY026177, R00 EY022077]; Howard Hughes Medical Institute; Roy J. Carver Charitable Trust	This project was supported by National Institutes of Health Grants R01 EY024259, R01 EY026177, and R00 EY022077, funding from the Howard Hughes Medical Institute, and from the Roy J. Carver Charitable Trust. Adenoviral vectors were obtained from the Gene Transfer Vector Core at the University of Iowa.	Abderrahim H, 1998, MAMM GENOME, V9, P673, DOI 10.1007/s003359900844                                                           ; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503                                                     ; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Bickenbach Jackie R, 2005, Methods Mol Biol, V289, P97; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Carbone MA, 2009, PLOS ONE, V4, P4216; Chou TH, 2014, INVEST OPHTH VIS SCI, V55, P2469, DOI 10.1167/iovs.14-13943; Clark AF, 2001, INVEST OPHTH VIS SCI, V42, P1769; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Fingert JH, 2002, SURV OPHTHALMOL, V47, P547, DOI 10.1016/S0039-6257(02)00353-3; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Grinnell KL, 2007, CELL PROLIFERAT, V40, P685, DOI 10.1111/j.1365-2184.2007.00464.x; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Karali A, 2000, INVEST OPHTH VIS SCI, V41, P729; Kasetti RB, 2016, INVEST OPHTH VIS SCI, V57, P6058, DOI 10.1167/iovs.16-19610; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001                                                ; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682                                                          ; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; MEYER A, 1994, CR ACAD SCI III-VIE, V317, P565; Millar JC, 2008, MOL VIS, V14, P10; Millar JC, 2011, INVEST OPHTH VIS SCI, V52, P685, DOI 10.1167/iovs.10-6069; Morissette J, 1998, NAT GENET, V19, P319; Pang CP, 2002, INVEST OPHTH VIS SCI, V43, P3231; Pang IH, 2000, J GLAUCOMA, V9, P468; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398                                                       ; Pang IH, 2015, EXP EYE RES, V141, P33, DOI 10.1016/j.exer.2015.04.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shepard AR, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-5; Stamer WD, 2017, EXP EYE RES, V158, P112, DOI 10.1016/j.exer.2016.07.009; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Swiderski RE, 1999, MOL BRAIN RES, V68, P64, DOI 10.1016/S0169-328X(99)00085-6; Takahashi H, 1998, BIOCHEM BIOPH RES CO, V248, P104, DOI 10.1006/bbrc.1998.8917; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Ueyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108071; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269; Wiggs JL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1674; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yuan C, 2007, MOL VIS, V13, P2083; Zode GS, 2012, INVEST OPHTH VIS SCI, V53, P1557, DOI 10.1167/iovs.11-8837; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	52	0	0	3	3	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 17	2017	114	42					11199	11204		10.1073/pnas.1706193114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FK1JW	WOS:000413237900059	28973933	green_published			2018-01-05	
J	Isobe, K; Jung, HJ; Yang, CR; Claxton, J; Sandoval, P; Burg, MB; Raghuram, V; Knepper, MA				Isobe, Kiyoshi; Jung, Hyun Jun; Yang, Chin-Rang; Claxton, J'Neka; Sandoval, Pablo; Burg, Maurice B.; Raghuram, Viswanathan; Knepper, Mark A.			Systems-level identification of PKA-dependent signaling in epithelial cells	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						CRISPR-Cas9; phosphoproteomics; vasopressin; protein mass; spectrometry; next-generation sequencing	RENAL COLLECTING DUCT; AQP2 GENE-EXPRESSION; PROTEIN-KINASE; PRINCIPAL CELLS; AQUAPORIN-2 PHOSPHORYLATION; PLASMA-MEMBRANE; VASOPRESSIN; KIDNEY; CAMP; TRANSLOCATION	G protein stimulatory a-subunit (Gas)-coupled heptahelical receptors regulate cell processes largely through activation of protein kinase A (PKA). To identify signaling processes downstream of PKA, we deleted both PKA catalytic subunits using CRISPR-Cas9, followed by a "multiomic" analysis in mouse kidney epithelial cells expressing the Gas-coupled V2 vasopressin receptor. RNA-seq (sequencing)-based transcriptomics and SILAC (stable isotope labeling of amino acids in cell culture)-based quantitative proteomics revealed a complete loss of expression of the water-channel gene Aqp2 in PKA knockout cells. SILAC-based quantitative phosphoproteomics identified 229 PKA phosphorylation sites. Most of these PKA targets are thus far unannotated in public databases. Surprisingly, 1,915 phosphorylation sites with the motif x-(S/T)-P showed increased phosphooccupancy, pointing to increased activity of one or moreMAP kinases in PKA knockout cells. Indeed, phosphorylation changes associated with activation of ERK2 were seen in PKA knockout cells. The ERK2 site is downstream of a direct PKA site in the Rap1GAP, Sipa1l1, that indirectly inhibits Raf1. In addition, a direct PKA site that inhibits theMAP kinase kinase kinase Map3k5 (ASK1) is upstream of JNK1 activation. The datasets were integrated to identify a causal network describing PKA signaling that explains vasopressin-mediated regulation of membrane trafficking and gene transcription. The model predicts that, through PKA activation, vasopressin stimulates AQP2 exocytosis by inhibiting MAP kinase signaling. The model also predicts that, through PKA activation, vasopressin stimulates Aqp2 transcription through induction of nuclear translocation of the acetyltransferase EP300, which increases histone H3K27 acetylation of vasopressin-responsive genes (confirmed by ChIP-seq).	[Isobe, Kiyoshi; Jung, Hyun Jun; Yang, Chin-Rang; Claxton, J'Neka; Sandoval, Pablo; Burg, Maurice B.; Raghuram, Viswanathan; Knepper, Mark A.] NHLBI, Epithelial Syst Biol Lab, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	Knepper, MA (reprint author), NHLBI, Epithelial Syst Biol Lab, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	knepperm@nhlbi.nih.gov			Division of Intramural Research, National Heart, Lung, and Blood Institute (NHLBI) [ZIA-HL001285, ZIA-HL006129]; Japan Society for the Promotion of Science Research Fellowship	This work was primarily funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute (NHLBI) (Projects ZIA-HL001285 and ZIA-HL006129; to M.A.K.). The NHLBI Proteomics Core Facility (M. Gucek, Director), NHLBI DNA Sequencing Core Facility (Y. Li, Director), NHLBI Light Microscopy Core Facility (C. Combs, Director), and NHLBI Flow Cytometry Core Facility (P. McCoy, Director) were used. K.I. was supported by a Japan Society for the Promotion of Science Research Fellowship.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bradford D, 2014, AM J PHYSIOL-CELL PH, V307, pC123, DOI 10.1152/ajpcell.00377.2012; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Chou CL, 2004, J BIOL CHEM, V279, P49026, DOI 10.1074/jbc.M408565200; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; Gilbert ML, 2015, AM J PHYSIOL-RENAL, V308, pF627, DOI 10.1152/ajprenal.00222.2014; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Gonin S, 2001, MOL BIOL CELL, V12, P255, DOI 10.1091/mbc.12.2.255                                                            ; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317                                                          ; Henriksson E, 2015, J CELL SCI, V128, P472, DOI 10.1242/jcs.153932; Henriksson E, 2012, BIOCHEM J, V444, P503, DOI 10.1042/BJ20111932; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Khositseth S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004036; Klussmann E, 2001, KIDNEY INT, V60, P446, DOI 10.1046/j.1523-1755.2001.060002446.x; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Luo C, 1996, MOL CELL BIOL, V16, P3955; Manning Brendan D, 2002, Sci STKE, V2002, ppe49, DOI 10.1126/stke.2002.162.pe49; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001                                                      ; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Sandoval PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34863; Sandoval PC, 2013, J AM SOC NEPHROL, V24, P1793, DOI 10.1681/ASN.2013030279; SIMON H, 1993, AM J PHYSIOL, V265, pC757; Soulsby MD, 2005, BIOCHEM J, V392, P493, DOI 10.1042/BJ20051325; SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; Van Huyen JPD, 1998, J MEMBRANE BIOL, V164, P79; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Xie LK, 2010, AM J PHYSIOL-RENAL, V298, pF1018, DOI 10.1152/ajprenal.00580.2009; Yang CR, 2015, AM J PHYSIOL-CELL PH, V309, pC799, DOI 10.1152/ajpcell.00214.2015; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zhao Y, 2016, AM J PHYSIOL-RENAL, V311, pF787, DOI 10.1152/ajprenal.00249.2016	47	0	0	2	2	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 17	2017	114	42					E8875	E8884		10.1073/pnas.1709123114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FK1JW	WOS:000413237900014	28973931				2018-01-05	
J	Oldfield, LM; Grzesik, P; Voorhies, AA; Alperovich, N; MacMath, D; Najera, CD; Chandra, DS; Prasad, S; Noskov, VN; Montague, MG; Friedman, RM; Desai, PJ; Vashee, S				Oldfield, Lauren M.; Grzesik, Peter; Voorhies, Alexander A.; Alperovich, Nina; MacMath, Derek; Najera, Claudia D.; Chandra, Diya Sabrina; Prasad, Sanjana; Noskov, Vladimir N.; Montague, Michael G.; Friedman, Robert M.; Desai, Prashant J.; Vashee, Sanjay			Genome-wide engineering of an infectious clone of herpes simplex virus type 1 using synthetic genomics assembly methods	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						herpesvirus; herpes simplex virus type 1; synthetic genomics; genome-wide engineering; tegument genes	MYCOPLASMA-GENITALIUM GENOME; FLUORESCENT PROTEIN; TEGUMENT PROTEIN; GENE-PRODUCTS; CELL-CULTURE; SACCHAROMYCES-CEREVISIAE; CHEMICAL-SYNTHESIS; CAPSID TRANSPORT; STRAIN MCKRAE; DNA	Here, we present a transformational approach to genome engineering of herpes simplex virus type 1 (HSV-1), which has a large DNA genome, using synthetic genomics tools. We believe this method will enable more rapid and complex modifications of HSV-1 and other large DNA viruses than previous technologies, facilitating many useful applications. Yeast transformation-associated recombination was used to clone 11 fragments comprising the HSV-1 strain KOS 152 kb genome. Using overlapping sequences between the adjacent pieces, we assembled the fragments into a complete virus genome in yeast, transferred it into an Escherichia coli host, and reconstituted infectious virus following transfection into mammalian cells. The virus derived from this yeast-assembled genome, KOSYA, replicated with kinetics similar to wild-type virus. We demonstrated the utility of this modular assembly technology by making numerous modifications to a single gene, making changes to two genes at the same time and, finally, generating individual and combinatorial deletions to a set of five conserved genes that encode virion structural proteins. While the ability to perform genome-wide editing through assembly methods in large DNA virus genomes raises dual-use concerns, we believe the incremental risks are outweighed by potential benefits. These include enhanced functional studies, generation of oncolytic virus vectors, development of delivery platforms of genes for vaccines or therapy, as well as more rapid development of countermeasures against potential biothreats.	[Oldfield, Lauren M.; Alperovich, Nina; Najera, Claudia D.; Noskov, Vladimir N.; Montague, Michael G.; Vashee, Sanjay] J Craig Venter Inst, Dept Synthet Biol & Bioenergy, Rockville, MD 20850 USA; [Grzesik, Peter; MacMath, Derek; Chandra, Diya Sabrina; Prasad, Sanjana; Desai, Prashant J.] Johns Hopkins Univ, Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Voorhies, Alexander A.] J Craig Venter Inst, Dept Infect Dis, Rockville, MD 20850 USA; [Friedman, Robert M.] J Craig Venter Inst, Policy Ctr, La Jolla, CA 92037 USA; [Montague, Michael G.] Applicat Vital Knowledge, Ft Detrick, MD 21702 USA	Vashee, S (reprint author), J Craig Venter Inst, Dept Synthet Biol & Bioenergy, Rockville, MD 20850 USA.; Desai, PJ (reprint author), Johns Hopkins Univ, Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA.	pdesai@jhmi.edu; svashee@jcvi.org			NIH [R21AI109418, R21AI109338, R21AI107537, R33CA186790]	We thank the following colleagues for their assistance and support: David Leib (Dartmouth Geisel School of Medicine) for the gift of KOS-37 BAC; Robert Sebra (Mount Sinai) for performing PacBio sequencing; Klaus Fruh and his group at Oregon Health and Science University for stimulating discussions and their collaboration on human cytomegalovirus; Reed Shabman, Granger Sutton, and Derrick Fouts (the J. Craig Venter Institute, JCVI) for their assistance with sequencing analysis; Chuck Merryman (JCVI) for assistance with in vitro CRISPR-Cas9 editing; Erin Pryce (The Johns Hopkins University Integrated Imaging Center) for assistance with confocal analysis; Leslie Mitchel and Jef Boeke (New York University, Langone Medical Center) for help with yeast DNA protocols; Prof. Tony Minson (University of Cambridge) for providing the LP1 antibodies; and Suchismita Chandran and Nacrya Assad-Garcia (JCVI) for helpful discussions. These studies were supported by NIH Grants R21AI109418 (to S.V.), R21AI109338 (to P.J.D. and S.V.), R21AI107537 (to P.J.D.), and R33CA186790 (to P.J.D.).	Abaitua F, 2008, J VIROL, V82, P5234, DOI 10.1128/JVI.02497-07; Albecka A, 2017, J VIROL, V91, DOI 10.1128/JVI.02196-16; Ando H, 2015, CELL SYST, V1, P187, DOI 10.1016/j.cels.2015.08.013; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; BAINES JD, 1991, J VIROL, V65, P938; BAINES JD, 1992, J VIROL, V66, P5168; BAINES JD, 1994, J VIROL, V68, P2929; Baird NL, 2010, VIROLOGY, V397, P80, DOI 10.1016/j.virol.2009.10.046; Baric RS, 2007, WORKING PAPERS SYNTH, P35; BATTERSON W, 1983, J VIROL, V45, P397; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boeke JD, 2016, SCIENCE, V353, P126, DOI 10.1126/science.aaf6850; Brown DM, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1252; Carter SR, 2015, DNA SYNTHESIS BIOSEC; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Cohen JI, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002878; Colgrove RC, 2016, VIROLOGY, V487, P215, DOI 10.1016/j.virol.2015.09.026; Collett MS, 2007, WORKING PAPERS SYNTH, P83; Danaher RJ, 2017, J NEUROVIROL, V23, P171, DOI 10.1007/s13365-016-0485-9; DESAI P, 1993, J VIROL, V67, P1357; DESAI P, 1994, J VIROL, V68, P5365; Desai P, 2003, J VIROL, V77, P391, DOI 10.1128/JVI.77.1.391-404.2003; Desai P, 1998, J VIROL, V72, P7563; Desai P, 1998, VIROLOGY, V247, P115, DOI 10.1006/viro.1998.9230; Desai PJ, 2000, J VIROL, V74, P11608, DOI 10.1128/JVI.74.24.11608-11618.2000; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7                                                   ; Garfinkel MS, 2007, BIOSECUR BIOTERROR, V5, P359, DOI 10.1089/bsp.2007.0923; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Gierasch WW, 2006, J VIROL METHODS, V135, P197, DOI 10.1016/j.jviromet.2006.03.014; Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284; Hall RN, 2012, VIRUSES-BASEL, V4, P211, DOI 10.3390/v4020211; Han J, 2012, P NATL ACAD SCI USA, V109, P19798, DOI 10.1073/pnas.1212900109; HAYWARD GS, 1975, P NATL ACAD SCI USA, V72, P4243, DOI 10.1073/pnas.72.11.4243                                                         ; US Department of Health and Human Services, 2010, FED REGISTER, V75, P62820; Hogue IB, 2015, VIRUSES-BASEL, V7, P5933, DOI 10.3390/v7112915; Jaschke PR, 2012, VIROLOGY, V434, P278, DOI 10.1016/j.virol.2012.09.020; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kanda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027758; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kupferschmidt K, 2017, SCIENCE, V357, P115, DOI 10.1126/science.357.6347.115; La Boissiere S, 2004, J VIROL, V78, P8002, DOI 10.1128/JVI.78.15.8002-8014.2004; Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140765; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Luxton GWG, 2006, J VIROL, V80, P201, DOI 10.1128/JVI.80.1.201-209.2006; Luxton GWG, 2005, P NATL ACAD SCI USA, V102, P5832, DOI 10.1073/pnas.0500803102; Macdonald SJ, 2012, J VIROL, V86, P9540, DOI 10.1128/JVI.01469-12; Macdonald SJ, 2012, J VIROL, V86, P6371, DOI 10.1128/JVI.00646-12; Mbong EF, 2012, J VIROL, V86, P7003, DOI 10.1128/JVI.00411-12; Mercy G, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4597; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Mitchell LA, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4831; Montague MG, 2012, CURR OPIN BIOTECH, V23, P659, DOI 10.1016/j.copbio.2012.01.014; Muto Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00394; Nishiyama Y, 2004, REV MED VIROL, V14, P33, DOI 10.1002/rmv.409; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; Noskov V, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e8; Owen DJ, 2015, VIRUSES-BASEL, V7, P5084, DOI 10.3390/v7092861; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; POST LE, 1980, P NATL ACAD SCI-BIOL, V77, P4201, DOI 10.1073/pnas.77.7.4201; Rastrojo A., 2017, GENOME ANNOUNC, V5; Richardson SM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4557; Roller RJ, 2015, J VIROL, V89, P3112, DOI 10.1128/JVI.02799-14; Roller RJ, 2014, J VIROL, V88, P4058, DOI 10.1128/JVI.03707-13; Sacks SL, 2004, ANTIVIR RES, V63, pS27, DOI 10.1016/j.antiviral.2004.06.005; Shanda SK, 2008, J VIROL, V82, P7388, DOI 10.1128/JVI.00225-08; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Starkey JL, 2014, J VIROL, V88, P110, DOI 10.1128/JVI.02555-13; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Tanaka M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-125; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; TRUS BL, 1995, J VIROL, V69, P7362; Vashee S, 2017, MSPHERE IN PRESS; Wagner M, 1999, J VIROL, V73, P7056; Warden C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/124595; Watson G, 2012, VIROLOGY, V433, P528, DOI 10.1016/j.virol.2012.08.043; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; World Health Organization, 2017, WHO ADV COMM VAR VIR; World Health Organization, 2015, IND ADV GROUP PUBL H; WILDY P, 1960, VIROLOGY, V12, P204, DOI 10.1016/0042-6822(60)90195-1; Wu Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4706; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Yakushko Y, 2011, J VIROL, V85, P4612, DOI 10.1128/JVI.02068-10; Zhang WM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf3981; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026	94	2	2	3	3	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 17	2017	114	42					E8885	E8894		10.1073/pnas.1700534114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FK1JW	WOS:000413237900015	28928148				2018-01-05	
J	Pujantell, M; Riveira-Munoz, E; Badia, R; Castellvi, M; Garcia-Vidal, E; Sirera, G; Puig, T; Ramirez, C; Clotet, B; Este, JA; Ballana, E				Pujantell, Maria; Riveira-Munoz, Eva; Badia, Roger; Castellvi, Marc; Garcia-Vidal, Edurne; Sirera, Guillem; Puig, Teresa; Ramirez, Cristina; Clotet, Bonaventura; Este, Jose A.; Ballana, Ester			RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages	SCIENTIFIC REPORTS			English	Article							AICARDI-GOUTIERES SYNDROME; DEAMINASE ADAR1; HIV-1 INFECTION; VIRUS-INFECTION; RECOGNITION; REPLICATION; SAMHD1; TRANSCRIPTION; CELLS; GENE	ADAR1-dependent A-to-I editing has recently been recognized as a key process for marking dsRNA as self, therefore, preventing innate immune activation and affecting the development and resolution of immune-mediated diseases and infections. Here, we have determined the role of ADAR1 as a regulator of innate immune activation and modifier of viral susceptibility in primary myeloid and lymphoid cells. We show that ADAR1 knockdown significantly enhanced interferon, cytokine and chemokine production in primary macrophages that function as antiviral paracrine factors, rendering them resistant to HIV-1 infection. ADAR1 knockdown induced deregulation of the RLRs-MAVS signaling pathway, by increasing MDA5, RIG-I, IRF7 and phospho-STAT1 expression, an effect that was partially rescued by pharmacological blockade of the pathway. In summary, our results demonstrate a role of ADAR1 in regulating innate immune function in primary macrophages, suggesting that macrophages may play an essential role in disease associated to ADAR1 dysfunction. We also show that viral inhibition is exclusively dependent on innate immune activation consequence of ADAR1 knockdown, pointing towards ADAR1 as a potential target to boost antiviral immune response.	[Pujantell, Maria; Riveira-Munoz, Eva; Badia, Roger; Castellvi, Marc; Garcia-Vidal, Edurne; Puig, Teresa; Ramirez, Cristina; Clotet, Bonaventura; Este, Jose A.; Ballana, Ester] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain; [Pujantell, Maria; Riveira-Munoz, Eva; Badia, Roger; Castellvi, Marc; Garcia-Vidal, Edurne; Puig, Teresa; Ramirez, Cristina; Clotet, Bonaventura; Este, Jose A.; Ballana, Ester] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Hlth Res Inst Germans Trias & Pujol IGTP, Badalona, Spain; [Sirera, Guillem] Univ Autonoma Barcelona, Univ Hosp Germans Trias & Pujol, HIV Clin Unit, Badalona, Spain	Este, JA; Ballana, E (reprint author), Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain.; Este, JA; Ballana, E (reprint author), Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Hlth Res Inst Germans Trias & Pujol IGTP, Badalona, Spain.	jaeste@irsicaixa.es; eballana@irsicaixa.es			Spanish Ministerio de Economia y Competitividad (MINECO) [BFU2015-63800-R]; Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (FIS) - FEDER [PI16/00103, PI15/00492, CP14/00016]	We thank the National Institutes of Health (AIDS Research and Reference Reagent Program) for reagents. This work was supported in part by the Spanish Ministerio de Economia y Competitividad (MINECO) project BFU2015-63800-R, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) PI16/00103, PI15/00492 and CP14/00016 cofinanced by FEDER and Gala Sida. EB is a research fellow from FIS. RB is a PERIS research fellow. MP and EGV are research fellows from AGAUR.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Badia R, 2017, ANTIVIR RES, V142, P123, DOI 10.1016/j.antiviral.2017.03.019; Badia R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005829; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Ballana E, 2009, BLOOD, V113, P1278, DOI 10.1182/blood-2008-06-161869; Briggs SD, 2001, J BIOL CHEM, V276, P25605, DOI 10.1074/jbc.M103244200                                                          ; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cachat A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0093-9; Ciuffi A, 2004, J VIROL, V78, P10747, DOI 10.1128/JVI.78.19.10747-10754.2004; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Clerzius G, 2011, REV MED VIROL, V21, P42, DOI 10.1002/rmv.674; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Cuadrado E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143613; Cuadrado E, 2015, J IMMUNOL, V194, P3623, DOI 10.4049/jimmunol.1401334; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Erickson AK, 2008, CELL RES, V18, P433, DOI 10.1038/cr.2008.46; George CX, 2014, J INTERF CYTOK RES, V34, P437, DOI 10.1089/jir.2014.0001; Hartmann G, 2017, Adv Immunol, V133, P121, DOI 10.1016/bs.ai.2016.11.001; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Iizasa H, 2010, J BIOL CHEM, V285, P33358, DOI 10.1074/jbc.M110.138362; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Orecchini E, 2017, NUCLEIC ACIDS RES, V45, P155, DOI 10.1093/nar/gkw834; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pujantell M, 2016, ANTIVIR RES, V133, P145, DOI 10.1016/j.antiviral.2016.08.004; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Ruiz A, 2015, CELL CYCLE, V14, P1657, DOI 10.1080/15384101.2015.1030558; Ruiz A, 2014, J BIOL CHEM, V289, P27665, DOI 10.1074/jbc.M114.570341; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Song C, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120129; Takanohashi A, 2013, NEUROLOGY, V80, P997, DOI 10.1212/WNL.0b013e3182872694; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Wang QD, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010041; Wong SK, 2002, P NATL ACAD SCI USA, V99, P15118, DOI 10.1073/pnas.232416799; Yeo JC, 2010, P NATL ACAD SCI USA, V107, P20715, DOI 10.1073/pnas.1009231107	46	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 17	2017	7								13339	10.1038/s41598-017-13580-0				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ9HM	WOS:000413084800036	29042669	gold			2018-01-05	
J	Deptula, P; Laine, PK; Roberts, RJ; Smolander, OP; Vihinen, H; Piironen, V; Paulin, L; Jokitalo, E; Savijoki, K; Auvinen, P; Varmanen, P				Deptula, Paulina; Laine, Pia K.; Roberts, Richard J.; Smolander, Olli-Pekka; Vihinen, Helena; Piironen, Vieno; Paulin, Lars; Jokitalo, Eija; Savijoki, Kirsi; Auvinen, Petri; Varmanen, Pekka			De novo assembly of genomes from long sequence reads reveals uncharted territories of Propionibacterium freudenreichii	BMC GENOMICS			English	Article						Propionibacterium freudenreichii; Comparative genomics; Bacteriophage; Pilus; Vitamin B12; PacBio; Complete genome; Mobile elements; Restriction and modification; CRISPR-Cas; Gras	CHAIN FATTY-ACIDS; SSP SHERMANII JS; ANTIINFLAMMATORY PROPERTIES; PROKARYOTIC GENOMES; ADAPTIVE IMMUNITY; INTESTINAL MUCUS; BACTERIA; TOOL; METABOLISM; INSIGHTS	Background: Propionibacterium freudenreichii is an industrially important bacterium granted the Generally Recognized as Safe (the GRAS) status, due to its long safe use in food bioprocesses. Despite the recognized role in the food industry and in the production of vitamin B12, as well as its documented health-promoting potential, P. freudenreichii remained poorly characterised at the genomic level. At present, only three complete genome sequences are available for the species. Results: We used the PacBio RS II sequencing platform to generate complete genomes of 20 P. freudenreichii strains and compared them in detail. Comparative analyses revealed both sequence conservation and genome organisational diversity among the strains. Assembly from long reads resulted in the discovery of additional circular elements: two putative conjugative plasmids and three active, lysogenic bacteriophages. It also permitted characterisation of the CRISPR-Cas systems. The use of the PacBio sequencing platform allowed identification of DNA modifications, which in turn allowed characterisation of the restriction-modification systems together with their recognition motifs. The observed genomic differences suggested strain variation in surface piliation and specific mucus binding, which were validated by experimental studies. The phenotypic characterisation displayed large diversity between the strains in ability to utilise a range of carbohydrates, to grow at unfavourable conditions and to form a biofilm. Conclusion: The complete genome sequencing allowed detailed characterisation of the industrially important species, P. freudenreichii by facilitating the discovery of previously unknown features. The results presented here lay a solid foundation for future genetic and functional genomic investigations of this actinobacterial species.	[Deptula, Paulina; Piironen, Vieno; Savijoki, Kirsi; Varmanen, Pekka] Univ Helsinki, Dept Food & Environm Sci, Helsinki 00014, Finland; [Laine, Pia K.; Smolander, Olli-Pekka; Vihinen, Helena; Paulin, Lars; Jokitalo, Eija; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA 01938 USA	Deptula, P; Varmanen, P (reprint author), Univ Helsinki, Dept Food & Environm Sci, Helsinki 00014, Finland.	paulina.deptula@helsinki.fi; pekka.varmanen@helsinki.fi	Auvinen, Petri/D-5044-2009	Auvinen, Petri/0000-0002-3947-4778	Academy of Finland [257,333, 272,363, 267,755]	The study was funded by the Academy of Finland (grant numbers 257,333, 272,363 and 267,755).	Aburjaile FF, 2016, J APPL MICROBIOL, V120, P432, DOI 10.1111/jam.13000; Altieri C, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2118-0; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bhatia S, 2013, ACS SYNTH BIOL, V2, P348, DOI 10.1021/sb400024s; Brown TL, 2017, RES MICROBIOL, V168, P103, DOI 10.1016/j.resmic.2016.09.004; Burgess CM, 2009, INT J FOOD MICROBIOL, V133, P1, DOI 10.1016/j.ijfoodmicro.2009.04.012; Cardoso FS, 2007, MICROBIOL-SGM, V153, P270, DOI 10.1099/mic.0.29262-0; Perez Chaia A, 1983, M A N MICROBIOL ALIM, V6, P171; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chamlagain B, 2016, LWT-FOOD SCI TECHNOL, V72, P117, DOI 10.1016/j.lwt.2016.04.023; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Chopin MC, 2002, J BACTERIOL, V184, P2030, DOI 10.1128/JB.184.7.2030-2033.2002; Collado MC, 2007, J DAIRY SCI, V90, P2710, DOI 10.3168/jds.2006-456; Cousin FJ, 2016, ONCOTARGET, V7, P7161, DOI 10.18632/oncotarget.6881; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; Dasen GH, 1998, THESIS; de Freitas R, 2015, DAIRY SCI TECHNOL, V95, P465, DOI 10.1007/s13594-015-0229-2; Delavat F, 2016, P NATL ACAD SCI USA, V113, pE3375, DOI 10.1073/pnas.1604479113; Deptula P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00368; Deutsch SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep46409; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Falentin H, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-015-0120-z; Falentin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011748; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801                                                             ; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; GAUTIER M, 1992, LAIT, V72, P431; GAUTIER M, 1995, APPL ENVIRON MICROB, V61, P2572; Gautier M, 1999, LAIT, V79, P93, DOI 10.1051/lait:199917; Ghinet MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027846; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hadfield J, 2017, BIORXIV; Hojo K, 2007, J DAIRY SCI, V90, P4078, DOI 10.3168/jds.2006-892; Jore JPM, 2001, APPL ENVIRON MICROB, V67, P499, DOI 10.1128/AEM.67.2.499-503.2001; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kasimatis G, 2013, BIOMED RES INT, DOI 10.1155/2013/918320; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Kiatpapan P, 2000, APPL ENVIRON MICROB, V66, P4688, DOI 10.1128/AEM.66.11.4688-4695.2000                                                ; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Koskinen P, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0082-1; Le Marechal C, 2015, J PROTEOMICS, V113, P447, DOI 10.1016/j.jprot.2014.07.018; LeBlanc JG, 2006, NUTRITION, V22, P645, DOI 10.1016/j.nut.2006.01.002; Terraf MCL, 2014, J APPL MICROBIOL, V117, P1761, DOI 10.1111/jam.12642; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Loux V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1467-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; MALIK AC, 1968, CAN J MICROBIOL, V14, P1185, DOI 10.1139/m68-199                                                                 ; Marchler-Bauer A, 2016, NUCLEIC ACIDS RES, V45, P1129; Modlin RL, 2016, PROPIONIBACTERIUM PH; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; MURAKAMI K, 1993, APPL ENVIRON MICROB, V59, P347; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nastasi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16148; Nordmark EL, 2005, BIOMACROMOLECULES, V6, P521, DOI 10.1021/bm0496716; Ojala T, 2017, INT J FOOD MICROBIOL, V241, P39, DOI 10.1016/j.ijfoodmicro.2016.09.022; Ouwehand AC, 2002, LAIT, V82, P123, DOI 10.1051/lait:2001011; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Plyusnin I, 2009, BIOINFORMATICS, V25, P1187, DOI 10.1093/bioinformatics/btp127; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; REHBERGER TG, 1990, APPL ENVIRON MICROB, V56, P864; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roessner CA, 2002, MICROBIOL-SGM, V148, P1845, DOI 10.1099/00221287-148-6-1845                                                     ; SATTLER I, 1995, J BACTERIOL, V177, P1564, DOI 10.1128/jb.177.6.1564-1569.1995                                                 ; Savitskaya EE, 2016, BIOCHEMISTRY-MOSCOW+, V81, P653, DOI 10.1134/S0006297916070026; Scholz CFP, 2016, INT J SYST EVOL MICR, V66, P4422, DOI 10.1099/ijsem.0.001367; Scholz CFP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20662; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stierli MP, 2002, THESIS; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Thierry A, 2011, INT J FOOD MICROBIOL, V149, P19, DOI 10.1016/j.ijfoodmicro.2011.04.026; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Vorobjeva L., 1999, PROPIONIBACTERIA, P209; Wang LM, 2007, FOOD CHEM, V103, P313, DOI 10.1016/j.foodchem.2006.07.065; Wood HG, 1981, CYCLES CURR TOP CELL; Zarate G, 2012, PROBIOTIC IN ANIMALS, P153, DOI 10.5772/50320	85	0	0	9	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	OCT 16	2017	18								790	10.1186/s12864-017-4165-9				24	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FK4LX	WOS:000413466800005	29037147	gold			2018-01-05	
J	Mao, AP; Ishizuka, IE; Kasal, DN; Mandal, M; Bendelac, A				Mao, Ai-Ping; Ishizuka, Isabel E.; Kasal, Darshan N.; Mandal, Malay; Bendelac, Albert			A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development	NATURE COMMUNICATIONS			English	Article							NKT CELL LINEAGE; TRANSCRIPTIONAL REGULATION; T-CELLS; RUNX PROTEINS; PLZF; DIFFERENTIATION; PRECURSORS; DIVERSITY; SELECTION; PROGRAM	Zbtb16-encoded PLZF is a signature transcription factor (TF) that directs the acquisition of T-helper effector programs during the development of multiple innate lymphocyte lineages, including natural killer T cell, innate lymphoid cell, mucosal-associated invariant T cell and gamma delta lineages. PLZF is also essential in osteoblast and spermatogonial development. How Zbtb16 itself is regulated in different lineages is incompletely understood. Here, by systematic CRISPR/Cas9-assisted deletions of chromatin accessible regions within the Zbtb16 locus in mouse, we identify a critical enhancer controlling PLZF expression exclusively in innate lymphoid lineages. Multiple sites within this enhancer express canonical motifs for the TF Runx1, which is essential for the development of these lineages. Notably, some regulatory sites control the kinetic rather than the overall level of PLZF expression. Thus, our comprehensive, unbiased analysis of regulatory elements in vivo reveals critical mechanisms of Zbtb16 regulation shared between innate and innate-like lymphoid lineages.	[Mao, Ai-Ping; Ishizuka, Isabel E.; Kasal, Darshan N.; Mandal, Malay; Bendelac, Albert] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Mao, Ai-Ping; Ishizuka, Isabel E.; Kasal, Darshan N.; Bendelac, Albert] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Mandal, Malay] Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Mandal, Malay] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA	Bendelac, A (reprint author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.; Bendelac, A (reprint author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu		Mandal, Malay/0000-0002-0451-3896	NIH [R01 AI038339, AI108643]; University of Chicago Digestive Diseases Research Core Center [P30DK042086]	We thank F. Gounari (University of Chicago) and A.O. Emmanuel (University of Chicago) for help with Runx1 ChIP-seq; Dr Linda Degenstein and the University of Chicago Transgenic Facility for generation of CRISPR/Cas9-mediated enhancer-deletion mice; Grants NIH R01 AI038339 and AI108643 (A.B.) and the University of Chicago Digestive Diseases Research Core Center P30DK042086.	Barna M, 2000, NAT GENET, V25, P166; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Beyaz S, 2017, NAT IMMUNOL, V18, P184, DOI 10.1038/ni.3644; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hu TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019890; Ishizuka IE, 2016, ANNU REV IMMUNOL, V34, P299, DOI 10.1146/annurev-immunol-041015-055549; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Mao AP, 2016, P NATL ACAD SCI USA, V113, P7602, DOI 10.1073/pnas.1601504113; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Zhang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12113	34	1	1	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	OCT 16	2017	8								863	10.1038/s41467-017-00882-0				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ8FO	WOS:000412998700001	29038474	gold			2018-01-05	
J	Khan, AA; El-Sayed, A; Akbar, A; Mangravita-Novo, A; Bibi, S; Afzal, Z; Norman, DJ; Ali, GS				Khan, Aftab A.; El-Sayed, Ashraf; Akbar, Asma; Mangravita-Novo, Arianna; Bibi, Shaheen; Afzal, Zunaira; Norman, David J.; Ali, Gul Shad			A highly efficient ligation-independent cloning system for CRISPR/Cas9 based genome editing in plants	PLANT METHODS			English	Article							RNA-GUIDED ENDONUCLEASE; DOUBLE-STRAND BREAKS; HUMAN-CELLS; STAPHYLOCOCCUS-AUREUS; TARGETED MUTAGENESIS; TAL EFFECTORS; CAS9; GENE; DNA; ARABIDOPSIS	Background: Most current methods for constructing guide RNAs (gRNA) for the CRISPR/Cas9 genome editing system, depend on traditional cloning using specific type IIS restriction enzymes and DNA ligation. These methods consist of multiple steps of cloning, and are time consuming, resource intensive and not flexible. These issues are particularly exacerbated when multiple guide RNAs need to be assembled in one plasmid such as for multiplexing or for the paired nickases approach. Furthermore, identification of functional gRNA clones usually requires expensive in vitro screening. Addressing these issues will greatly facilitate usage and accessibility of CRISPR/Cas9 genome editing system to resource-limited laboratories. Results: To improve efficiency of cloning multiple guide RNAs for the CRISPR/Cas9 system, we developed a restriction enzyme-and ligation-independent strategy for cloning gRNAs directly in plant expression vectors in one step. Our method relies on a negative selection marker and seamless cloning for combining multiple gRNAs directly in a plant expression vector in one reaction. In addition, using the Agrobacterium-mediated transient assays, this method provides a simple in planta procedure for assaying the effectiveness of multiple gRNAs very rapidly. Conclusions: For a fraction of resources used in the type IIS restriction enzyme-based cloning method and in vitro screening assays, the system reported here allows efficient construction and testing several ready-to-transfect gRNA constructs in < 3 days. In addition, this system is highly versatile and flexible, and by designing only two additional target-specific primers, multiple gRNAs can be easily assembled in any plasmid in a single reaction.	[Khan, Aftab A.; El-Sayed, Ashraf; Akbar, Asma; Mangravita-Novo, Arianna; Bibi, Shaheen; Afzal, Zunaira; Norman, David J.; Ali, Gul Shad] Univ Florida, Inst Food & Agr Sci, Dept Plant Pathol, Midflorida Res & Educ Ctr, 2725 S Binion Rd, Apopka, FL 32703 USA; [El-Sayed, Ashraf] Zagazig Univ, Enzymol & Fungal Biotechnol Lab, Fac Sci, Zagazig 44519, Egypt	Ali, GS (reprint author), Univ Florida, Inst Food & Agr Sci, Dept Plant Pathol, Midflorida Res & Educ Ctr, 2725 S Binion Rd, Apopka, FL 32703 USA.	gsali@ufl.edu			Institute of Food and Agriculture Sciences, University of Florida; University of Florida	This work was supported by a grant to GSA by the Institute of Food and Agriculture Sciences, University of Florida. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1994, GENE, V148, P71, DOI 10.1016/0378-1119(94)90235-6                                                    ; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jankele R, 2014, BRIEF FUNCT GENOMICS, V13, P409, DOI 10.1093/bfgp/elu013; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Osakabe Y, 2015, PLANT CELL PHYSIOL, V56, P389, DOI 10.1093/pcp/pcu170; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Raman M, 2014, NAT METHODS, V11, pIII; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536; Zhu Lihua Julie, 2015, [Frontiers in Biology, 生物学前沿], V10, P289	55	0	0	15	15	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1746-4811			PLANT METHODS	Plant Methods	OCT 16	2017	13								86	10.1186/s13007-017-0236-9				13	Biochemical Research Methods; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	FK2SY	WOS:000413333900002	29075312	gold			2018-01-05	
J	Londino, JD; Gulick, DL; Lear, TB; Suber, TL; Weathington, NM; Masa, LS; Chen, BB; Mallampalli, RK				Londino, James D.; Gulick, Dexter L.; Lear, Travis B.; Suber, Tomeka L.; Weathington, Nathaniel M.; Masa, Luke S.; Chen, Bill B.; Mallampalli, Rama K.			Post-translational modification of the interferon-gamma receptor alters its stability and signaling	BIOCHEMICAL JOURNAL			English	Article							IFN-GAMMA; DOWN-REGULATION; PROTEASOMAL DEGRADATION; UBIQUITIN-PROTEASOME; NUCLEAR-LOCALIZATION; EPITHELIAL-CELLS; TYROSINE KINASE; PATHWAY; GLYCOSYLATION; EXPRESSION	The IFN gamma receptor 1 (IFNGR1) binds IFN-gamma and activates gene transcription pathways crucial for controlling bacterial and viral infections. Although decreases in IFNGR1 surface levels have been demonstrated to inhibit IFN-gamma signaling, little is known regarding the molecular mechanisms controlling receptor stability. Here, we show in epithelial and monocytic cell lines that IFNGR1 displays K48 polyubiquitination, is proteasomally degraded, and harbors three ubiquitin acceptor sites at K277, K279, and K285. Inhibition of glycogen synthase kinase 3 beta (GSK3 beta) destabilized IFNGR1 while overexpression of GSK3 beta increased receptor stability. We identified critical serine and threonine residues juxtaposed to ubiquitin acceptor sites that impacted IFNGR1 stability. In CRISPR-Cas9 IFNGR1 generated knockout cell lines, cellular expression of IFNGR1 plasmids encoding ubiquitin acceptor site mutations demonstrated significantly impaired STAT1 phosphorylation and decreased STAT1-dependent gene induction. Thus, IFNGR1 undergoes rapid site-specific polyubiquitination, a process modulated by GSK3 beta. Ubiquitination appears to be necessary for efficient IFNGR1-dependent gamma gene induction and represents a relatively uncharacterized regulatory mechanism for this receptor.	[Londino, James D.; Gulick, Dexter L.; Lear, Travis B.; Suber, Tomeka L.; Weathington, Nathaniel M.; Masa, Luke S.; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol & Bioengn, Pittsburgh, PA 15260 USA	Mallampalli, RK (reprint author), Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.; Mallampalli, RK (reprint author), Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv, Pittsburgh, PA 15213 USA.; Mallampalli, RK (reprint author), Univ Pittsburgh, Dept Cell Biol & Physiol & Bioengn, Pittsburgh, PA 15260 USA.	mallampallirk@upmc.edu			National Institutes of Health [HL096376, HL097376, HL098174, HL081784, P01 HL114453, 4T32HL007563-29, HL116472, HL132862]; American Heart Grant [17POST33410945]; United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs	This work was supported, in part, by National Institutes of Health Grants HL096376, HL097376, HL098174, HL081784, P01 HL114453, and 4T32HL007563-29 to R.K.M., National Institutes of Health Grants HL116472 and HL132862 to B.B.C., and American Heart Grant 17POST33410945 to J.D.L. This work was also supported in part by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, and a Merit Review Award from the United States Department of Veterans Affairs (R.K.M.).	Ahmed CMI, 2006, J IMMUNOL, V177, P315, DOI 10.4049/jimmunol.177.1.315                                                      ; Ahmed CML, 2003, J CELL SCI, V116, P3089, DOI 10.1242/jcs.00528; BADER T, 1994, CYTOKINE, V6, P70, DOI 10.1016/1043-4666(94)90010-8                                                    ; Bednash JS, 2016, CELL MOL IMMUNOL, V13, P722, DOI 10.1038/cmi.2016.15; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Chen W, 2015, MOL CELL BIOL, V35, P1001, DOI 10.1128/MCB.01185-14; Curry H, 2004, J INTERF CYTOK RES, V24, P699, DOI 10.1089/1079990042722873; de Vor IC, 2016, J CLIN IMMUNOL, V36, P195, DOI 10.1007/s10875-016-0244-y; FISCHER DG, 1988, J BIOL CHEM, V263, P2632; Fuchs SY, 2012, GROWTH FACTORS, V30, P141, DOI 10.3109/08977194.2012.669382; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Haverkamp MH, 2006, MICROBES INFECT, V8, P1157, DOI 10.1016/j.micinf.2005.10.029; HERSHEY GKK, 1989, J BIOL CHEM, V264, P11981; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799                                                            ; Kaplan DH, 1996, J BIOL CHEM, V271, P9, DOI 10.1074/jbc.271.1.9                                                             ; Kearney SJ, 2013, J IMMUNOL, V191, P3384, DOI 10.4049/jimmunol.1203510; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Larkin J, 2000, J INTERF CYTOK RES, V20, P565, DOI 10.1089/10799900050044769; Le Bras S, 2011, TRAFFIC, V12, P149, DOI 10.1111/j.1600-0854.2010.01126.x; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557                                                ; Londino JD, 2015, J BIOL CHEM, V290, P31113, DOI 10.1074/jbc.M115.682914; Londino JD, 2015, FASEB J, V29, P2712, DOI 10.1096/fj.14-268755; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; McKelvey AC, 2016, ELIFE, V5, DOI 10.7554/eLife.18496; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Pawliczak R, 2005, PHYSIOL GENOMICS, V23, P28, DOI 10.1152/physiolgenomics.00011.2005; Pollard KM, 2013, DISCOV MED, V16, P123; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shah KM, 2009, ONCOGENE, V28, P3903, DOI 10.1038/onc.2009.249; Skrenta H, 2000, J IMMUNOL, V164, P3506, DOI 10.4049/jimmunol.164.7.3506                                                     ; Tsai CC, 2009, J IMMUNOL, V183, P856, DOI 10.4049/jimmunol.0804033; Uetani K, 2008, EUR J IMMUNOL, V38, P1559, DOI 10.1002/eji.200737045; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Weathington NM, 2014, J BIOL CHEM, V289, P17610, DOI 10.1074/jbc.M114.551747; Weathington NM, 2013, AM J RESP CRIT CARE, V188, P530, DOI 10.1164/rccm.201304-0754PP; Weathington NM, 2013, CELL SIGNAL, V25, P1792, DOI 10.1016/j.cellsig.2013.05.003; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111	43	0	0	3	3	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0264-6021	1470-8728		BIOCHEM J	Biochem. J.	OCT 15	2017	474		20				3543	3557		10.1042/BCJ20170548				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FJ9QZ	WOS:000413116500012	28883123				2018-01-05	
J	Davies, B; Brown, LA; Cais, O; Watson, J; Clayton, AJ; Chang, VT; Biggs, D; Preece, C; Hernandez-Pliego, P; Krohn, J; Bhomra, A; Twigg, SRF; Rimmer, A; Kanapin, A; Sen, A; Zaiwalla, Z; McVean, G; Foster, R; Donnelly, P; Taylor, JC; Blair, E; Nutt, D; Aricescu, AR; Greger, IH; Peirson, SN; Flint, J; Martin, HC				Davies, Benjamin; Brown, Laurence A.; Cais, Ondrej; Watson, Jake; Clayton, Amber J.; Chang, Veronica T.; Biggs, Daniel; Preece, Christopher; Hernandez-Pliego, Polinka; Krohn, Jon; Bhomra, Amarjit; Twigg, Stephen R. F.; Rimmer, Andrew; Kanapin, Alexander; Sen, Arjune; Zaiwalla, Zenobia; McVean, Gil; Foster, Russell; Donnelly, Peter; Taylor, Jenny C.; Blair, Edward; Nutt, David; Aricescu, A. Radu; Greger, Ingo H.; Peirson, Stuart N.; Flint, Jonathan; Martin, Hilary C.		WGS500 Consortium	A point mutation in the ion conduction pore of AMPA receptor GRIA3 causes dramatically perturbed sleep patterns as well as intellectual disability	HUMAN MOLECULAR GENETICS			English	Article							GLUTAMATE RECEPTORS; SUPRACHIASMATIC NUCLEUS; SYNAPTIC POTENTIATION; PHOTIC REGULATION; CIRCADIAN CLOCK; PHASE SYNDROME; SUBUNIT; MICE; GLUR3; GENE	The discovery of genetic variants influencing sleep patterns can shed light on the physiological processes underlying sleep. As part of a large clinical sequencing project, WGS500, we sequenced a family in which the two male children had severe developmental delay and a dramatically disturbed sleep-wake cycle, with very long wake and sleep durations, reaching up to 106-h awake and 48-h asleep. The most likely causal variant identified was a novel missense variant in the X-linked GRIA3 gene, which has been implicated in intellectual disability. GRIA3 encodes GluA3, a subunit of AMPA-type ionotropic glutamate receptors (AMPARs). Themutation (A653T) falls within the highly conserved transmembrane domain of the ion channel gate, immediately adjacent to the analogous residue in the Grid2 (glutamate receptor) gene, which ismutated in the mouse neurobehavioral mutant, Lurcher. In vitro, the GRIA3(A653T) mutation stabilizes the channel in a closed conformation, in contrast to Lurcher. We introduced the orthologousmutation into amouse strain by CRISPR-Cas9mutagenesis and found that hemizygousmutants displayed significant differences in the structure of their activity and sleep compared to wild-type littermates. Typically, mice are polyphasic, exhibiting multiple sleep bouts of sleep several minutes long within a 24-h period. The Gria3(A653T) mouse showed significantly fewer brief bouts of activity and sleep than the wild-types. Furthermore, Gria3(A653T) mice showed enhanced period lengthening under constant light compared to wild-typemice, suggesting an increased sensitivity to light. Our results suggest a role for GluA3 channel activity in the regulation of sleep behavior in both mice and humans.	[Davies, Benjamin; Clayton, Amber J.; Biggs, Daniel; Preece, Christopher; Hernandez-Pliego, Polinka; Krohn, Jon; Bhomra, Amarjit; Kanapin, Alexander; McVean, Gil; Donnelly, Peter; Taylor, Jenny C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, Oxon, England; [Brown, Laurence A.; Foster, Russell; Peirson, Stuart N.] Univ Oxford, Sleep & Circadian Neurosci Inst, Nuffield Dept Clin Neurosci, Oxford OX39DU, Oxon, England; [Cais, Ondrej; Watson, Jake; Chang, Veronica T.; Aricescu, A. Radu; Greger, Ingo H.] MRC, Lab Mol Biol, Neurobiol Div, Cambridge CB2 0QH, Cambs, England; [Twigg, Stephen R. F.] Univ Oxford, Weatherall Inst Mol Med, Clin Genet Grp, Oxford OX3 9DS, Oxon, England; [Rimmer, Andrew] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Kanapin, Alexander] Univ Oxford, Dept Oncol, Oxford OX3 7DQ, Oxon, England; [Sen, Arjune] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, NIHR Biomed Res Ctr, Oxford Epilepsy Res Grp, Oxford OX3 9DU, England; [Zaiwalla, Zenobia] John Radcliffe Hosp, Dept Neurosci, Oxford OX3 9DU, Oxon, England; [McVean, Gil] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford OX3 7FZ, Oxon, England; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3LB, Oxon, England; [Taylor, Jenny C.] Natl Inst Hlth Res Oxford Biomed Res Ctr, Oxford OX3 7LE, Oxon, England; [Blair, Edward] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford OX3 7HE, Oxon, England; [Nutt, David] Imperial Coll London, Ctr Neuropsychopharmacol, Dept Med, Div Brain Sci, London W12 0NN, England; [Flint, Jonathan] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Martin, Hilary C.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England	Martin, HC (reprint author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	hcm@sanger.ac.uk		Watson, Jake/0000-0002-8698-3823; Kanapin, Alexander/0000-0001-9802-5297; Twigg, Stephen/0000-0001-5024-049X	Wellcome Trust Core Award [090532/Z/09/Z]; Medical Research Council Hub grant [G0900747 91070]; Medical Research Council [MC_UP_1201/15, L009609, MC_U105174197]; UK Department of Health's NIHR Biomedical Research Centres funding scheme; Illumina; Wellcome Trust [093329, 098461]	Funding was provided by Wellcome Trust Core Award (090532/Z/09/Z) and the Medical Research Council Hub grant (G0900747 91070) to P.D., Medical Research Council (MC_UP_1201/15 and L009609 to A.R.A.; MC_U105174197 to J.F.W., O.C. and I.H.G.), UK Department of Health's NIHR Biomedical Research Centres funding scheme and by Illumina. S.R.F.T. was supported by Wellcome Trust grant 093329. L.A.B., S.N.P. and R.G.F. were supported by the Wellcome Trust (098461). Funding to pay the Open Access publication charges for this article was provided by the Wellcome Trust.	Adamczyk A, 2012, BEHAV BRAIN RES, V229, P265, DOI 10.1016/j.bbr.2012.01.007; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Borbely A A, 1982, Hum Neurobiol, V1, P195; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Brown L. A., 2017, WELLCOME OPEN RES, V1, P2; Brown L. A., 2016, WELLCOME OPEN RES, V1, P2, DOI 10.12688/wellcomeopenres.9892.2; Canto CB, 2017, TRENDS NEUROSCI, V40, P309, DOI 10.1016/j.tins.2017.03.001; Cebrian-Serrano A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169887; Chiyonobu T, 2007, AM J MED GENET A, V143A, P1448, DOI 10.1002/ajmg.a.31798; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Colavito V, 2015, NEUROSCI BIOBEHAV R, V54, P3, DOI 10.1016/j.neubiorev.2014.11.021; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Diessler S, 2017, ELIFE, V6, DOI 10.7554/eLife.23292; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; Fisher SP, 2013, HDB EXP PHARM, V217, P157; Funato H, 2016, NATURE, V539, P378, DOI 10.1038/nature20142; Gecz J, 1999, GENOMICS, V62, P356, DOI 10.1006/geno.1999.6032; Gehrman PR, 2015, PSYCHIAT CLIN N AM, V38, P667, DOI 10.1016/j.psc.2015.07.004; GINSBERG SD, 1995, NEUROSCIENCE, V65, P563, DOI 10.1016/0306-4522(94)00513-5; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Gutierrez-Castellanos N, 2017, NEURON, V93, P409, DOI 10.1016/j.neuron.2016.11.046; Hiyoshi H, 2014, EXP ANIM TOKYO, V63, P205, DOI 10.1538/expanim.63.205                                                          ; Hughes S, 2015, METHOD ENZYMOL, V552, P125, DOI 10.1016/bs.mie.2014.10.018; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jones RS, 2014, J NEUROSCI, V34, P656, DOI 10.1523/JNEUROSCI.1140-13.2014; Kaur C, 2005, J PINEAL RES, V39, P294, DOI 10.1111/j.1600-079X.2005.00245.x; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Lane JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10889; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3                                                   ; Lopez-Rodriguez F, 2007, ARCH MED RES, V38, P52, DOI 10.1016/j.arcmed.2006.07.004; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4                                                   ; Miki A, 2006, JPN J OPHTHALMOL, V50, P217, DOI 10.1007/s10384-005-0316-7; Mizoro Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010951; Moriya T, 2003, J NEUROCHEM, V85, P978, DOI 10.1046/j.1471-4159.2003.01758.x; PHILLIPS RITA J. S., 1960, JOUR GENET, V57, P35, DOI 10.1007/BF02985337; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Sanchis-Segura C, 2006, J NEUROSCI, V26, P1231, DOI 10.1523/JNEUROSCI.4327-05.2006; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Sivakumar V, 2013, EXP EYE RES, V109, P83, DOI 10.1016/j.exer.2013.01.004; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sprengel R, 2001, TRENDS PHARMACOL SCI, V22, P7, DOI 10.1016/S0165-6147(00)01588-1; Steenland HW, 2008, EUR J NEUROSCI, V27, P1166, DOI 10.1111/j.1460-9568.2008.06078.x; Suzuki E, 2008, MOL CELL NEUROSCI, V38, P117, DOI 10.1016/j.mcn.2008.01.018; Tafti Mehdi, 2007, Dialogues Clin Neurosci, V9, P273; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499                                                         ; Vogel MW, 2007, BRAIN RES, V1140, P4, DOI 10.1016/j.brainres.2005.11.086; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wang H, 2011, J NEUROSCI, V31, P16675, DOI 10.1523/JNEUROSCI.4569-11.2011; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watson JF, 2017, ELIFE, V6, DOI 10.7554/eLife.23024; Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Zhang LY, 2016, P NATL ACAD SCI USA, V113, pE1536, DOI 10.1073/pnas.1600039113; Zheng BH, 1999, NATURE, V400, P169; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009                                                                   	66	0	0	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	OCT 15	2017	26	20					3869	3882		10.1093/hmg/ddx270				14	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FJ0UY	WOS:000412427100001	29016847				2018-01-05	
J	Bartsch, K; Knittler, K; Borowski, C; Rudnik, S; Damme, M; Aden, K; Spehlmann, ME; Frey, N; Saftig, P; Chalaris, A; Rabe, B				Bartsch, Kareen; Knittler, Katharina; Borowski, Christopher; Rudnik, Soenke; Damme, Markus; Aden, Konrad; Spehlmann, Martina E.; Frey, Norbert; Saftig, Paul; Chalaris, Athena; Rabe, Bjoern			Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy	HUMAN MOLECULAR GENETICS			English	Article							AICARDI-GOUTIERES-SYNDROME; DNA-DAMAGE; AUTOIMMUNE-DISEASE; RIBONUCLEASE H2; TUBERCULOSIS DNA; SENSING PATHWAY; RNADNA HYBRIDS; TREX1; MUTATIONS; SAMHD1	Hypomorphic mutations in the DNA repair enzyme RNase H2 cause the neuroinflammatory autoimmune disorder AicardiGoutie` res syndrome (AGS). Endogenous nucleic acids are believed to accumulate in patient cells and instigate pathogenic type I interferon expression. However, the underlying nucleic acid species amassing in the absence of RNase H2 has not been established yet. Here, we report that murine RNase H2 knockout cells accumulated cytosolic DNA aggregates virtually indistinguishable from micronuclei. RNase H2-dependent micronuclei were surrounded by nuclear lamina and most of them contained damaged DNA. Importantly, they induced expression of interferon-stimulated genes (ISGs) and co-localized with the nucleic acid sensor cGAS. Moreover, micronuclei associated with RNase H2 deficiency were cleared by autophagy. Consequently, induction of autophagy by pharmacological mTOR inhibition resulted in a significant reduction of cytosolic DNA and the accompanied interferon signature. Autophagy induction might therefore represent a viable therapeutic option for RNase H2-dependent disease. Endogenous retroelements have previously been proposed as a source of self-nucleic acids triggering inappropriate activation of the immune system in AGS. We used human RNase H2-knockout cells generated by CRISPR/Cas9 to investigate the impact of RNase H2 on retroelement propagation. Surprisingly, replication of LINE-1 and Alu elements was blunted in cells lacking RNase H2, establishing RNase H2 as essential host factor for the mobilisation of endogenous retrotransposons.	[Bartsch, Kareen; Knittler, Katharina; Borowski, Christopher; Rudnik, Soenke; Damme, Markus; Saftig, Paul; Chalaris, Athena; Rabe, Bjoern] Christian Albrechts Univ Kiel, Inst Biochem, Med Fac, D-24118 Kiel, Germany; [Aden, Konrad] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Campus Kiel, D-24105 Kiel, Germany; [Spehlmann, Martina E.; Frey, Norbert] Univ Hosp Schleswig Holstein, Clin Internal Med Cardiol & Angiol 3, Campus Kiel, D-24105 Kiel, Germany	Rabe, B (reprint author), Christian Albrechts Univ Kiel, Inst Biochem, Med Fac, D-24118 Kiel, Germany.	brabe@biochem.uni-kiel.de	Frey, Norbert/A-9695-2010		Deutsche Forschungsgemeinschaft, Bonn, Germany [RA 2404/1-1]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft, Bonn, Germany (Project grant RA 2404/1-1) and the Cluster of Excellence "Inflammation at Interfaces".	Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6166; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Blanz J, 2008, HUM MOL GENET, V17, P3437, DOI 10.1093/hmg/ddn237; Brooks PJ, 2008, DNA REPAIR, V7, P834, DOI 10.1016/j.dnarep.2008.01.017; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gunther C, 2015, J CLIN INVEST, V125, P413, DOI 10.1172/JCI78001; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451                                                               ; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mackenzie KJ, 2016, EMBO J, V35, P831, DOI 10.15252/embj.201593339; Mankan AK, 2014, EMBO J, V33, P2937, DOI 10.15252/embj.201488726; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Pizzi S, 2015, HUM MOL GENET, V24, P649, DOI 10.1093/hmg/ddu485; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Rabe B, 2013, J MOL MED, V91, P1235, DOI 10.1007/s00109-013-1061-x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reijns MAM, 2014, BIOCHEM SOC T, V42, P717, DOI 10.1042/BST20140079; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Rigby RE, 2014, EMBO J, V33, P542, DOI 10.1002/embj.201386117; Shen YJ, 2015, CELL REP, V11, P460, DOI 10.1016/j.celrep.2015.03.041; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Xie Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1076; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019	52	0	0	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	OCT 15	2017	26	20					3960	3972		10.1093/hmg/ddx283				13	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FJ0UY	WOS:000412427100008	29016854				2018-01-05	
J	Abiusi, E; D'Alessandro, M; Dieterich, K; Quevarec, L; Turczynski, S; Valfort, AC; Mezin, P; Jouk, PS; Gut, M; Gut, I; Bessereau, JL; Melki, J				Abiusi, Emanuela; D'Alessandro, Manuela; Dieterich, Klaus; Quevarec, Loic; Turczynski, Sandrina; Valfort, Aurore-Cecile; Mezin, Paulette; Jouk, Pierre Simon; Gut, Marta; Gut, Ivo; Bessereau, Jean Louis; Melki, Judith			Biallelic mutation of UNC50, encoding a protein involved in AChR trafficking, is responsible for arthrogryposis	HUMAN MOLECULAR GENETICS			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; GENETICS; GOLGI; RECEPTOR; GEA2P	Arthrogryposis multiplex congenita (AMC) is a developmental condition characterized by multiple joint contractures resulting from reduced or absent fetal movements. Homozygosity mapping of disease loci combined with whole exome sequencing in a consanguineous family presenting with lethal AMC allowed the identification of a homozygous frameshift deletion in UNC50 gene (c. 750_751del: p. Cys251Phefs*4) in the index case. To assess the effect of the mutation, an equivalent mutation in the Caenorhabditis elegans orthologous gene was created using CRISPR/Cas9. We demonstrated that unc-50(kr331) modification caused the loss of acetylcholine receptor (AChR) expression in C. elegans muscle. unc-50(kr331) animals were as resistant to the cholinergic agonist levamisole as unc-50 null mutants suggesting that AChRs were no longer expressed in this animal model. This was confirmed by using a knock-in strain in which a red fluorescent protein was inserted into the AChR locus: no signal was detected in unc-50(kr331) background, suggesting that UNC-50, a protein known to be involved in AChR trafficking, was no longer functional. These data indicate that biallelic mutation in the UNC50 gene underlies AMC through a probable loss of AChR expression at the neuromuscular junction which is essential for the cholinergic transmission during human muscle development.	[Abiusi, Emanuela; Quevarec, Loic; Turczynski, Sandrina; Melki, Judith] Univ Paris Sud, UMR 1169, INSERM, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France; [D'Alessandro, Manuela; Valfort, Aurore-Cecile; Bessereau, Jean Louis] Univ Claude Bernard Lyon 1, UMR 5310, Inst NeuroMyoGene, INSERM,U1217,CNRS, F-69622 Villeurbanne, France; [Dieterich, Klaus; Jouk, Pierre Simon] CHU Grenoble, Dept Genet & Procreat, Unite Genet Clin, F-38043 Grenoble, France; [Mezin, Paulette] CHU Grenoble, Dept Anat & Cytol Pathol, F-38043 Grenoble, France; [Gut, Marta; Gut, Ivo] Univ Pompeu Fabra, Barcelona Inst Sci & Technol, Ctr Genom Regulat, CNAG CRG, Barcelona 08028, Spain; [Bessereau, Jean Louis] Hosp Civils Lyon, F-69500 Lyon, France	Melki, J (reprint author), Univ Paris Sud, UMR 1169, INSERM, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.; Bessereau, JL (reprint author), Univ Claude Bernard Lyon 1, INSERM, U1217, CNRS,UMR 5310,Inst NeuroMyoGene,Hosp Civils Lyon, 16 Rue Raphael Dubois, F-69622 Villeurbanne, France.	jean-louis.bessereau@univ-lyon1.fr; judith.melki@inserm.fr			French Ministry of Health (PHRC) [AOM10181]; Association Francaise contre les Myopathies (AFM) [DAJ1891]; Institut de la Sante et de la Recherche Medicale (Inserm); AFM [AFM 16451, 19590]	This study was supported by a grant from the French Ministry of Health (PHRC 2010, AOM10181), the Association Francaise contre les Myopathies (AFM, DAJ1891) and the Institut de la Sante et de la Recherche Medicale (Inserm) to J.Me. MDA and JLB were supported by the AFM (AFM 16451 and 19590).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; BRENNER S, 1974, GENETICS, V77, P71; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Eimer S, 2007, EMBO J, V26, P4313, DOI 10.1038/sj.emboj.7601858; El Mouridi S, 2017, G3-GENES GENOM GENET, V7, P1429, DOI 10.1534/g3.117.040824; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; FAHY M J, 1990, Genetic Counseling, V1, P3; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HALL JG, 1985, CLIN ORTHOP RELAT R, P44; Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008; LEWIS JA, 1980, GENETICS, V95, P905; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Pinan-Lucarre B, 2014, NATURE, V511, P466, DOI 10.1038/nature13313; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; Radman I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076019; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhou J, 2012, AM J HUM GENET, V91, P5, DOI 10.1016/j.ajhg.2012.05.001	25	0	0	19	19	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	OCT 15	2017	26	20					3989	3994		10.1093/hmg/ddx288				6	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FJ0UY	WOS:000412427100010	29016857				2018-01-05	
J	Bekier, ME; Wang, LB; Li, J; Huang, HR; Tang, DM; Zhang, XY; Wang, YZ				Bekier, Michael E., II; Wang, Leibin; Li, Jie; Huang, Haoran; Tang, Danming; Zhang, Xiaoyan; Wang, Yanzhuang			Knockout of the Golgi stacking proteins GRASP55 and GRASP65 impairs Golgi structure and function	MOLECULAR BIOLOGY OF THE CELL			English	Article							CELL-FREE SYSTEM; MATRIX PROTEIN; UNCONVENTIONAL SECRETION; MITOTIC PHOSPHORYLATION; CISTERNAL STACKING; CHOLERA-TOXIN; HELA-CELLS; GM130; FRAGMENTATION; CYCLE	Golgi reassembly stacking protein of 65 kDa (GRASP65) and Golgi reassembly stacking protein of 55 kDa (GRASP55) were originally identified as Golgi stacking proteins; however, subsequent GRASP knockdown experiments yielded inconsistent results with respect to the Golgi structure, indicating a limitation of RNAi-based depletion. In this study, we have applied the recently developed clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology to knock out GRASP55 and GRASP65, individually or in combination, in HeLa and HEK293 cells. We show that double knockout of GRASP proteins disperses the Golgi stack into single cisternae and tubulovesicular structures, accelerates protein trafficking, and impairs accurate glycosylation of proteins and lipids. These results demonstrate a critical role for GRASPs in maintaining the stacked structure of the Golgi, which is required for accurate posttranslational modifications in the Golgi. Additionally, the GRASP knockout cell lines developed in this study will be useful tools for studying the role of GRASP proteins in other important cellular processes.	[Bekier, Michael E., II; Wang, Leibin; Li, Jie; Huang, Haoran; Tang, Danming; Zhang, Xiaoyan; Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Wang, Yanzhuang] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA	Wang, YZ (reprint author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.; Wang, YZ (reprint author), Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA.	yzwang@umich.edu			National Institutes of Health [GM112786]; MCubed; Fast Forward Protein Folding Disease Initiative of the University of Michigan	We thank Kamlesh Bisht and Jayakrishnan (J.K.) Nandakumar (University of Michigan) for technical support on the CRISPR technique, Joachim Seemann for antibodies, and David Sheff and Heike Folsch for VSV-G ts045-GFP adenovirus. We thank other members of the Wang lab for suggestions, reagents, and technical support. This work was supported in part by National Institutes of Health Grant GM112786, MCubed, and the Fast Forward Protein Folding Disease Initiative of the University of Michigan to Y.W.	Barr FA, 2005, METHOD ENZYMOL, V403, P391, DOI 10.1016/S0076-6879(05)03034-X; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9                                                   ; Pokrovskaya I, 2016, FRONT CELL DEV BIOL, V4, P23, DOI [10.3389/fcell.2016.00023, DOI 10.3389/FCELL.2016.00023]; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; CAPASSO JM, 1989, J BIOL CHEM, V264, P5233; Cheeseman LP, 2012, COMMUN INTEGR BIOL, V4, P409; Cheng JPX, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.59; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Feng YB, 2013, J BIOL CHEM, V288, P28418, DOI 10.1074/jbc.M113.478024; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Giuliani F, 2011, CURR OPIN CELL BIOL, V23, P498, DOI 10.1016/j.ceb.2011.04.005; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; HOLMGREN J, 1975, P NATL ACAD SCI USA, V72, P2520, DOI 10.1073/pnas.72.7.2520; Huff J, 2015, NAT METH, V12; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811                                                           ; Joshi G, 2014, P NATL ACAD SCI USA, V111, pE1230, DOI 10.1073/pnas.1320192111; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.bi.54.070185.003215; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135                                                          ; Lee I, 2014, P NATL ACAD SCI USA, V111, P1849, DOI 10.1073/pnas.1323895111; Li T, 2016, MOL NEUROBIOL, V53, P1377, DOI 10.1007/s12035-014-9083-0; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n                                                               ; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1                                                   ; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Petrosyan A, 2015, BIOCH MOL BIOL J, V1, P16; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949                                                        ; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Tang DM, 2016, MOL BIOL CELL, V27, P137, DOI 10.1091/mbc.E15-09-0650; Tang DM, 2013, TRENDS CELL BIOL, V23, P296, DOI 10.1016/j.tcb.2013.01.008; Tang DM, 2012, BIOL OPEN, V1, P1204, DOI 10.1242/bio.20122659; Tang DM, 2010, TRAFFIC, V11, P827, DOI 10.1111/j.1600-0854.2010.01055.x; Tang DM, 2010, NAT PROTOC, V5, P758, DOI 10.1038/nprot.2010.38; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; Veenendaal T, 2014, BIOL OPEN, V3, P431, DOI 10.1242/bio.20147757; Vielemeyer O, 2009, J BIOL CHEM, V284, P20791, DOI 10.1074/jbc.M109.008730; Wang Y, 2005, CELL BIOL LAB HDB, P33; Wang YZ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005330; Wang YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001647; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; White DT, 2010, MOL BIOL CELL, V21, P562, DOI 10.1091/mbc.E09-03-0217; Willett Rose A, 2013, Methods Mol Biol, V1022, P61, DOI 10.1007/978-1-62703-465-4_6; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Xiang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2669; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Zhang XY, 2016, J MOL BIOL, V428, P3183, DOI 10.1016/j.jmb.2016.02.030; Zhang Xiaoyan, 2015, Front Cell Dev Biol, V3, P84, DOI 10.3389/fcell.2015.00084; Zhou ZG, 2013, J VIROL, V87, P11721, DOI 10.1128/JVI.01355-13	63	1	1	3	3	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	OCT 15	2017	28	21					2833	2842		10.1091/mbc.E17-02-0112				10	Cell Biology	Cell Biology	FL9DI	WOS:000414550500008	28814501				2018-01-05	
J	Roberts, B; Haupt, A; Tucker, A; Grancharova, T; Arakaki, J; Fuqua, MA; Nelson, A; Hookway, C; Ludmann, SA; Mueller, IA; Yang, R; Horwitz, R; Rafelski, SM; Gunawardane, RN				Roberts, Brock; Haupt, Amanda; Tucker, Andrew; Grancharova, Tanya; Arakaki, Joy; Fuqua, Margaret A.; Nelson, Angelique; Hookway, Caroline; Ludmann, Susan A.; Mueller, Irina A.; Yang, Ruian; Horwitz, Rick; Rafelski, Susanne M.; Gunawardane, Ruwanthi N.			Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization	MOLECULAR BIOLOGY OF THE CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; GAMMA-TUBULIN COMPLEXES; MICROTUBULE NUCLEATION; MAMMALIAN-CELLS; LIVING CELLS; GENOME; PROTEIN; CAS9; DYNAMICS; GENERATION	We present a CRISPR/Cas9 genome-editing strategy to systematically tag endogenous proteins with fluorescent tags in human induced pluripotent stem cells (hiPSC). To date, we have generated multiple hiPSC lines with monoallelic green fluorescent protein tags labeling 10 proteins representing major cellular structures. The tagged proteins include alpha tubulin, beta actin, desmoplakin, fibrillarin, nuclear lamin B1, nonmuscle myosin heavy chain IIB, paxillin, Sec61 beta, tight junction protein ZO1, and Tom20. Our genome-editing methodology using Cas9/crRNA ribonuclear protein and donor plasmid coelectroporation, followed by fluorescence-based enrichment of edited cells, typically resulted in <0.1-4% homology-directed repair (HDR). Twenty-five percent of clones generated from each edited population were precisely edited. Furthermore, 92% (36/39) of expanded clonal lines displayed robust morphology, genomic stability, expression and localization of the tagged protein to the appropriate subcellular structure, pluripotency-marker expression, and multi-lineage differentiation. It is our conclusion that, if cell lines are confirmed to harbor an appropriate gene edit, pluripotency, differentiation potential, and genomic stability are typically maintained during the clonal line-generation process. The data described here reveal general trends that emerged from this systematic gene-tagging approach. Final clonal lines corresponding to each of the 10 cellular structures are now available to the research community.	[Roberts, Brock; Haupt, Amanda; Tucker, Andrew; Grancharova, Tanya; Arakaki, Joy; Fuqua, Margaret A.; Nelson, Angelique; Hookway, Caroline; Ludmann, Susan A.; Mueller, Irina A.; Yang, Ruian; Horwitz, Rick; Rafelski, Susanne M.; Gunawardane, Ruwanthi N.] Allen Inst Cell Sci, Seattle, WA 98109 USA	Roberts, B; Gunawardane, RN (reprint author), Allen Inst Cell Sci, Seattle, WA 98109 USA.	brockr@alleninstitute.org; rug@alleninstitute.org					Ai-Jassar C, 2013, J MOL BIOL, V425, P4006, DOI 10.1016/j.jmb.2013.07.035; Allen Institute for Cell Science, 2017, ALL CELL EXPL; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Baghbaderani BA, 2015, STEM CELL REP, V5, P647, DOI 10.1016/j.stemcr.2015.08.015; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buta C, 2013, STEM CELL RES, V11, P552, DOI 10.1016/j.scr.2013.03.001; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen Q, 2013, EXP THER MED, V6, P1145, DOI 10.3892/etm.2013.1279; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Cho WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35949; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dambournet D, 2014, METHOD ENZYMOL, V546, P139, DOI 10.1016/B978-0-12-801185-0.00007-6; Dean KM, 2014, NAT CHEM BIOL, V10, P512, DOI [10.1038/NCHEMBIO.1556, 10.1038/nchembio.1556]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93                                                             ; Findlay SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153901; Fu BXH, 2016, NUCLEIC ACIDS RES, V44, P5365, DOI 10.1093/nar/gkw417; Gan Z, 2016, CELL SYST, V3, P500, DOI 10.1016/j.cels.2016.11.011; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a                                                                 ; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; Graham DB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0823-x; Grassart A, 2014, J CELL BIOL, V205, P721, DOI 10.1083/jcb.201403041; Gunawardane RN, 2000, CURR TOP DEV BIOL, V49, P55; Hendriks WT, 2016, CELL STEM CELL, V18, P53, DOI 10.1016/j.stem.2015.12.002; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Horwitz R, 2017, SCIENCE, V356, P806, DOI 10.1126/science.aan5955; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Lian XJ, 2015, NAT METHODS, V12, P595, DOI 10.1038/nmeth.3448; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martin M., 2017, EMBNET J, V17, P10; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Oceguera-Yanez F, 2016, METHODS, V101, P43, DOI 10.1016/j.ymeth.2015.12.012; Palpant NJ, 2015, DEVELOPMENT, V142, P3198, DOI 10.1242/dev.117010; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Riesen FK, 2002, HISTOCHEM CELL BIOL, V117, P307, DOI 10.1007/s00418-002-0398-y; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Samuelov L, 2015, CELL TISSUE RES, V360, P457, DOI 10.1007/s00441-014-2062-y; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435                                                ; Soares FAC, 2014, STEM CELL REP, V3, P931, DOI 10.1016/j.stemcr.2014.11.006; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toya M, 2016, CELL STRUCT FUNCT, V41; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Viotti M, 2014, NAT CELL BIOL, V16, P1146, DOI 10.1038/ncb3070; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617                                                          ; Weissbein U, 2014, J CELL BIOL, V204, P153, DOI 10.1083/jcb.201310135; WHITE CW, 2017, SCI REP, V7; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018; Yang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21264; Young JE, 2012, HUM MOL GENET, V21, pR82, DOI 10.1093/hmg/dds319; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017	73	0	0	2	2	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	OCT 15	2017	28	21					2854	2874		10.1091/mbc.E17-03-0209				21	Cell Biology	Cell Biology	FL9DI	WOS:000414550500010	28814507				2018-01-05	
J	Chen, T; Li, MS; He, Q; Zou, L; Li, YH; Chang, C; Zhao, DY; Zhu, YP				Chen, Tao; Li, Mansheng; He, Qiang; Zou, Lei; Li, Youhuan; Chang, Cheng; Zhao, Dongyan; Zhu, Yunping			LiverWiki: a wiki-based database for human liver	BMC BIOINFORMATICS			English	Article						Wiki-based database; Human liver; Community-driven sharing	KNOWLEDGE	Background: Recent advances in omics technology have produced a large amount of liver-related data. A comprehensive and up-to-date source of liver-related data is needed to allow biologists to access the latest data. However, current liver-related data sources each cover only a specific part of the liver. It is difficult for them to keep pace with the rapid increase of liver-related data available at those data resources. Integrating diverse liver-related data is a critical yet formidable challenge, as it requires sustained human effort. Results: We present LiverWiki, a first wiki-based database that integrates liver-related genes, homolog genes, gene expressions in microarray datasets and RNA-Seq datasets, proteins, protein interactions, post-translational modifications, associated pathways, diseases, metabolites identified in the metabolomics datasets, and literatures into an easily accessible and searchable resource for community-driven sharing. LiverWiki houses information in a total of 141,897 content pages, including 19,787 liver-related gene pages, 17,077 homolog gene pages, 50,251 liver-related protein pages, 36,122 gene expression pages, 2067 metabolites identified in the metabolomics datasets, 16,366 disease-related molecules, and 227 liver disease pages. Other than assisting users in searching, browsing, reviewing, refining the contents on LiverWiki, the most important contribution of LiverWiki is to allow the community to create and update biological data of liver in visible and editable tables. This integrates newly produced data with existing knowledge. Implemented in mediawiki, LiverWiki provides powerful extensions to support community contributions. Conclusions: The main goal of LiverWiki is to provide the research community with comprehensive liver-related data, as well as to allow the research community to share their liver-related data flexibly and efficiently. It also enables rapid sharing new discoveries by allowing the discoveries to be integrated and shared immediately, rather than relying on expert curators. The database is available online at http://liverwiki.hupo.org.cn/.	[Chen, Tao; Li, Mansheng; Chang, Cheng; Zhu, Yunping] Beijing Inst Radiat Med, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, Beijing Inst Life Om,State Key Lab Prote, 33 Life Sci Pk Rd, Beijing 102206, Peoples R China; [He, Qiang] Swinburne Univ Technol, Sch Software & Elect Engn, Melbourne, Australia; [Zou, Lei; Li, Youhuan; Zhao, Dongyan] Peking Univ, Inst Comp Sci & Technol, 5 Yiheyuan Rd, Beijing 100871, Peoples R China	Zhu, YP (reprint author), Beijing Inst Radiat Med, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, Beijing Inst Life Om,State Key Lab Prote, 33 Life Sci Pk Rd, Beijing 102206, Peoples R China.	zhuyunping@gmail.com			Ministry of Science and Technology of China [2015AA020108]; Innovation Program [16CXZ027]; National Key Research and Development Program of China [2017YFC0906602, 2017YFA0505002]; National Basic Research Program of China (973 Program) [2013CB910801]	The work is funded by the Ministry of Science and Technology of China (Grant No. 2015AA020108), Innovation Program (16CXZ027), National Key Research and Development Program of China (2017YFC0906602, 2017YFA0505002), and National Basic Research Program of China (973 Program) (2013CB910801). They did not have any role in the design or conclusions of this study.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Olivier B., 2004, NUCLEIC ACIDS RES, V32, P267; Bolser DM, 2012, NUCLEIC ACIDS RES, V40, pD1250, DOI 10.1093/nar/gkr1099; Cariaso M, 2012, NUCLEIC ACIDS RES, V40, pD1308, DOI 10.1093/nar/gkr798; Chen J., 2009, BMC BIOINFORMATICS, V10, P1; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Good BM, 2012, NUCLEIC ACIDS RES, V40, pD1255, DOI 10.1093/nar/gkr925; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huss JW, 2010, NUCLEIC ACIDS RES, V38, pD633, DOI 10.1093/nar/gkp760; Jewison T, 2014, NUCLEIC ACIDS RES, V42, pD478, DOI 10.1093/nar/gkt1067; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kumar S, 2012, NUCLEIC ACIDS RES, V40, pD1295, DOI 10.1093/nar/gkr826; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li JW, 2012, NUCLEIC ACIDS RES, V40, pD1313, DOI 10.1093/nar/gkr1058; Ma LN, 2015, NUCLEIC ACIDS RES, V43, pD187, DOI 10.1093/nar/gku1167; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; McIntosh BK, 2012, NUCLEIC ACIDS RES, V40, pD1270, DOI 10.1093/nar/gkr880; Michna RH, 2016, NUCLEIC ACIDS RES, V44, pD654, DOI 10.1093/nar/gkv1006; Gallart AP, 2016, NUCLEIC ACIDS RES, V44, pD1161, DOI 10.1093/nar/gkv1215; Perez-Riverol Y, 2017, NAT BIOTECHNOL, V35, P406, DOI 10.1038/nbt.3790; Pratt-Szeliga PC, 2012, NUCLEIC ACIDS RES, V40, pD1288, DOI 10.1093/nar/gkr1054; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Renfro DP, 2012, NUCLEIC ACIDS RES, V40, pD1262, DOI 10.1093/nar/gkr907; Salek RM, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat029; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Sud M, 2016, NUCLEIC ACIDS RES, V44, pD463, DOI 10.1093/nar/gkv1042; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang K, 2006, NATURE, V439, P534, DOI 10.1038/439534a; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zhang YQ, 2013, LIVER INT, V33, P1239, DOI 10.1111/liv.12173; Zhang Z, 2014, NUCLEIC ACIDS RES, V42, pD1222, DOI 10.1093/nar/gkt926; Zheng JJ, 2006, PROTEOMICS, V6, P1716, DOI 10.1002/pmic.200500877	40	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	OCT 13	2017	18								452	10.1186/s12859-017-1852-0				11	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	FJ6QL	WOS:000412882800002	29029599	gold			2018-01-05	
J	Wang, QX; Zhao, H; Jiang, JP; Xu, JY; Xie, WB; Fu, XK; Liu, C; He, YQ; Wang, GW				Wang, Quanxiu; Zhao, Hu; Jiang, Junpeng; Xu, Jiuyue; Xie, Weibo; Fu, Xiangkui; Liu, Chang; He, Yuqing; Wang, Gongwei			Genetic Architecture of Natural Variation in Rice Nonphotochemical Quenching Capacity Revealed by Genome-Wide Association Study	FRONTIERS IN PLANT SCIENCE			English	Article						rice; nonphotochemical quenching; genome-wide association study; QTLs; OsPsbS1	XANTHOPHYLL CYCLE; EXCESS LIGHT; ARABIDOPSIS; PHOTOPROTECTION; PHOTOSYNTHESIS; FLUORESCENCE; ENERGY; MANIPULATION; DISSIPATION; IMPROVEMENT	The photoprotective processes conferred by nonphotochemical quenching (NPQ) serve fundamental roles in maintaining plant fitness and sustainable yield. So far, few loci have been reported to be involved in natural variation of NPQ capacity in rice (Oryza sativa), and the extents of variation explored are very limited. Here we conducted a genome-wide association study (GWAS) for NPQ capacity using a diverse worldwide collection of 529 O. sativa accessions. A total of 33 significant association loci were identified. To check the validity of the GWAS signals, three F2 mapping populations with parents selected from the association panel were constructed and assayed. All QTLs detected in mapping populations could correspond to at least one GWAS signal, indicating the GWAS results were quite reliable. OsPsbS1 was repeatedly detected and explained more than 40% of the variation in the whole association population in two years, and demonstrated to be a common major QTL in all three mapping populations derived from inter-group crosses. We revealed 43 single nucleotide polymorphisms (SNPs) and 7 insertions and deletions (InDels) within a 6,997-bp DNA fragment of OsPsbS1, but found no non-synonymous SNPs or InDels in the coding region, indicating the PsbS1 protein sequence is highly conserved. Haplotypes with the 2,674-bp insertion in the promoter region exhibited significantly higher NPQ values and higher expression levels of OsPsbS1. The OsPsbS1 RNAi plants and CRISPR/Cas9 mutants exhibited drastically decreased NPQ values. OsPsbS1 had specific and high-level expression in green tissues of rice. However, we didn't find significant function for OsPsbS2, the other rice PsbS homologue. Manipulation of the significant loci or candidate genes identified may enhance photoprotection and improve photosynthesis and yield in rice.	[Wang, Quanxiu; Zhao, Hu; Jiang, Junpeng; Xu, Jiuyue; Xie, Weibo; Fu, Xiangkui; Liu, Chang; He, Yuqing; Wang, Gongwei] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res Wuhan, Wuhan, Hubei, Peoples R China	Wang, GW (reprint author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res Wuhan, Wuhan, Hubei, Peoples R China.	gwwang@mail.hzau.edu.cn			Ministry of Agriculture of China [2016ZX08009001]; National 863 Project [2014AA10A600]	This work was supported by grants from the Ministry of Agriculture of China (2016ZX08009001) and National 863 Project (No. 2014AA10A600).	BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; de Bianchi S, 2010, BIOCHEM SOC T, V38, P651, DOI 10.1042/BST0380651; DEMMIGADAMS B, 1994, AUST J PLANT PHYSIOL, V21, P575, DOI 10.1071/PP9940575                                                               ; Du HY, 2011, NEW PHYTOL, V191, P275, DOI 10.1111/j.1469-8137.2011.03691.x; Horton P, 2000, J EXP BOT, V51, P475, DOI 10.1093/jexbot/51.suppl_1.475; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jung HS, 2009, PLANT PHYSIOL, V150, P977, DOI 10.1104/pp.109.137828; Kasajima I, 2011, P NATL ACAD SCI USA, V108, P13835, DOI 10.1073/pnas.1104809108; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; Nuruzzaman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102742; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang QX, 2015, MOL PLANT, V8, P946, DOI 10.1016/j.molp.2015.02.014; Xie WB, 2015, P NATL ACAD SCI USA, V112, pE5411, DOI 10.1073/pnas.1515919112; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	30	2	2	19	19	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	OCT 13	2017	8								1773	10.3389/fpls.2017.01773				13	Plant Sciences	Plant Sciences	FJ6HX	WOS:000412859200002	29081789	gold			2018-01-05	
J	Qi, LH; Song, YY; Chan, THM; Yang, H; Lin, CH; Tay, DJT; Hong, HQ; Tang, SJ; Tan, KT; Huang, XX; Lin, JS; Ng, VHE; Maury, JJP; Tenen, DG; Chen, LL				Qi, Lihua; Song, Yangyang; Chan, Tim Hon Man; Yang, Henry; Lin, Chi Ho; Tay, Daryl Jin Tai; Hong, HuiQi; Tang, Sze Jing; Tan, Kar Tong; Huang, Xi Xiao; Lin, Jaymie Siqi; Ng, Vanessa Hui En; Maury, Julien Jean Pierre; Tenen, Daniel G.; Chen, Leilei			An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer	NUCLEIC ACIDS RESEARCH			English	Article							DOUBLE-STRANDED-RNA; HEPATOCELLULAR-CARCINOMA; ADENOSINE-DEAMINASE; HUMAN TRANSCRIPTOME; UNWINDING ACTIVITY; MESSENGER-RNAS; HUMAN BRAIN; EXPRESSION; PROMOTES; ENZYME	Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by Adenosine DeAminases acting on doublestranded RNA(dsRNA) (ADAR), occurs predominantly in the 3' untranslated regions (3' UTRs) of spliced mRNA. Here we uncover an unanticipated link between ADARs (ADAR1 and ADAR2) and the expression of target genes undergoing extensive 3' UTR editing. Using METTL7A (Methyltransferase Like 7A), a novel tumor suppressor gene with multiple editing sites at its 3' UTR, we demonstrate that its expression could be repressed by ADARs beyond their RNA editing and double-stranded RNA (dsRNA) binding functions. ADARs interact with Dicer to augment the processing of pre-miR-27a to mature miR-27a. Consequently, mature miR-27a targets the METTL7A 3' UTR to repress its expression level. In sum, our study unveils that the extensive 3' UTR editing of METTL7A is merely a footprint of ADAR binding, and there are a subset of target genes that are equivalently regulated by ADAR1 and ADAR2 through their non-canonical RNA editing and dsRNA binding-independent functions, albeit maybe less common. The functional significance of ADARs is much more diverse than previously appreciated and this gene regulatory function of ADARs is most likely to be of high biological importance beyond the best-studied editing function. This non-editing side of ADARs opens another door to target cancer.	[Qi, Lihua; Song, Yangyang; Chan, Tim Hon Man; Yang, Henry; Tay, Daryl Jin Tai; Hong, HuiQi; Tang, Sze Jing; Tan, Kar Tong; Huang, Xi Xiao; Lin, Jaymie Siqi; Ng, Vanessa Hui En; Tenen, Daniel G.; Chen, Leilei] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Qi, Lihua] Natl Univ Singapore, Duke NUS Med Sch, Singapore, Singapore; [Lin, Chi Ho] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Maury, Julien Jean Pierre] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Tenen, Daniel G.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA USA; [Chen, Leilei] Natl Univ Singapore, Dept Anat, Singapore, Singapore	Tenen, DG; Chen, LL (reprint author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore.; Tenen, DG (reprint author), Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA USA.; Chen, LL (reprint author), Natl Univ Singapore, Dept Anat, Singapore, Singapore.	csidgt@nus.edu.sg; csicl@nus.edu.sg			National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiative; NMRC Clinician Scientist-Individual Research Grant New Investigator Grant (CS-IRG NIG) [NMRC/CNIG/1117/2014]; NMRC Clinician Scientist-Individual Research Grant (CS-IRG) [NMRC/CIRG/1412/2014]; NUS Young Investigator Award (NUS YIA) [NUSYIA FY14 P22]; Yong Siew Yoon Research Grant (Tier 2) (National University Cancer Institute, Singapore); NUS Start- up fund [NUHSRO/2015/095/SU/01]; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; RNA Biology Center at the Cancer Science Institute of Singapore, NUS, as part of funding under the Singapore Ministry of Education's Tier 3 grants [MOE2014-T3-1-006]; SingaporeMinistry of Education's Tier 3 grant [MOE2014-T3-1-006]	National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiative; NMRC Clinician Scientist-Individual Research Grant New Investigator Grant (CS-IRG NIG) [NMRC/CNIG/1117/2014]; NMRC Clinician Scientist-Individual Research Grant (CS-IRG) [NMRC/CIRG/1412/2014]; NUS Young Investigator Award (NUS YIA) [NUSYIA FY14 P22]; Yong Siew Yoon Research Grant (Tier 2; National University Cancer Institute, Singapore), NUS Start- up fund [NUHSRO/2015/095/SU/01]; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; RNA Biology Center at the Cancer Science Institute of Singapore, NUS, as part of funding under the Singapore Ministry of Education's Tier 3 grants [MOE2014-T3-1-006]. Funding for open access charge: SingaporeMinistry of Education's Tier 3 grant [MOE2014-T3-1-006] and NMRC Clinician Scientist-Individual Research Grant New Investigator Grant (CS-IRG NIG) [NMRC/CNIG/1117/2014].	An J, 2013, J CELL BIOCHEM, V114, P2160, DOI 10.1002/jcb.24565; Anantharaman A, 2017, NUCLEIC ACIDS RES, V45, P4189, DOI 10.1093/nar/gkw1304; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170                                                       ; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chilibeck KA, 2006, J BIOL CHEM, V281, P16530, DOI 10.1074/jbc.M511831200; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Deng Y, 2015, BIOCHEM BIOPH RES CO, V458, P321, DOI 10.1016/j.bbrc.2015.01.109; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; He XX, 2015, MOL BIOSYST, V11, P532, DOI 10.1039/c4mb00563e; Heale BSE, 2009, EMBO J, V28, P3145, DOI [10.1038/sj.emboj.2009.244, 10.1038/emboj.2009.244]; Higuchi M, 2000, NATURE, V406, P78; Hundley HA, 2008, RNA, V14, P2050, DOI 10.1261/rna.1165008; Iizasa H, 2010, J BIOL CHEM, V285, P33358, DOI 10.1074/jbc.M110.138362; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098                                                        ; Li XR, 2010, ENDOCRINOLOGY, V151, P2462, DOI 10.1210/en.2009-1150; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Martinez HD, 2008, J BIOL CHEM, V283, P29938, DOI 10.1074/jbc.M800534200; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795                                                        ; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrn2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Poulsen H, 2006, RNA, V12, P1350, DOI 10.1261/rna.2314406; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Qi LH, 2014, CANCER RES, V74, P1301, DOI 10.1158/0008-5472.CAN-13-3485; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; Soundararajan R, 2015, ONCOTARGET, V6, P35726, DOI 10.18632/oncotarget.6132; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Villa E, 2016, GUT, V65, P861, DOI 10.1136/gutjnl-2014-308483; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Washburn MC, 2014, CELL REP, V6, P599, DOI 10.1016/j.celrep.2014.01.011; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu F, 2017, AM J CANCER RES, V7, P405; Xu Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41307; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	64	1	1	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	OCT 13	2017	45	18					10436	10451		10.1093/nar/gkx667				16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FJ9OK	WOS:000413107400014	28985428	gold			2018-01-05	
J	Feng, YL; Xiang, JF; Liu, SC; Guo, T; Yan, GF; Feng, Y; Kong, N; Li, HD; Huang, Y; Lin, H; Cai, XJ; Xie, AY				Feng, Yi-Li; Xiang, Ji-Feng; Liu, Si-Cheng; Guo, Tao; Yan, Guo-Fang; Feng, Ye; Kong, Na; Li, Hao-Dan; Huang, Yang; Lin, Hui; Cai, Xiu-Jun; Xie, An-Yong			H2AX facilitates classical non-homologous end joining at the expense of limited nucleotide loss at repair junctions	NUCLEIC ACIDS RESEARCH			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; REMODELER P400 ATPASE; HISTONE H2AX; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; IN-VIVO	Phosphorylated histone H2AX, termed 'gamma H2AX', mediates the chromatin response to DNA double strand breaks (DSBs) in mammalian cells. H2AX deficiency increases the numbers of unrepaired DSBs and translocations, which are partly associated with defects in non-homologous end joining (NHEJ) and contributing to genomic instability in cancer. However, the role of gamma H2AX in NHEJ of general DSBs has yet to be clearly defined. Here, we showed that despite little effect on overall NHEJ efficiency, H2AX deficiency causes a surprising bias towards accurate NHEJ and shorter deletions in NHEJ products. By analyzing CRISPR/Cas9-induced NHEJ and by using a new reporter for mutagenic NHEJ, we found that gamma H2AX, along with its interacting protein MDC1, is required for efficient classical NHEJ (C-NHEJ) but with short deletions and insertions. Epistasis analysis revealed that ataxia telangiectasia mutated (ATM) and the chromatin remodeling complex Tip60/TRRAP/P400 are essential for this H2AX function. Taken together, these data suggest that a subset of DSBs may require gamma H2AX-mediated short-range nucleosome repositioning around the breaks to facilitate C-NHEJ with loss of a few extra nucleotides at NHEJ junctions. This may prevent outcomes such as non-repair and translocations, which are generally more destabilizing to genomes than short deletions and insertions from local NHEJ.	[Feng, Yi-Li; Xiang, Ji-Feng; Liu, Si-Cheng; Guo, Tao; Yan, Guo-Fang; Feng, Ye; Kong, Na; Lin, Hui; Cai, Xiu-Jun; Xie, An-Yong] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou 310019, Zhejiang, Peoples R China; [Feng, Yi-Li; Xiang, Ji-Feng; Liu, Si-Cheng; Guo, Tao; Yan, Guo-Fang; Feng, Ye; Kong, Na; Xie, An-Yong] Zhejiang Univ, Inst Translat Med, Hangzhou 310029, Zhejiang, Peoples R China; [Li, Hao-Dan; Huang, Yang] Shurui Tech Ltd, Hangzhou 310005, Zhejiang, Peoples R China	Cai, XJ; Xie, AY (reprint author), Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou 310019, Zhejiang, Peoples R China.; Xie, AY (reprint author), Zhejiang Univ, Inst Translat Med, Hangzhou 310029, Zhejiang, Peoples R China.	cxjzu@hotmail.com; anyongxie@zju.edu.cn			National Natural Science Foundation of China [81472755, 31671385, 81661128008, 31401189]; Natural Science Foundation of Zhejiang Province [LZ17C060001]; Department of Science and Technology of Zhejiang Province [2015C03047]; National Natural Science Foundation of China	National Natural Science Foundation of China [81472755, 31671385, 81661128008 to A-Y.X.,. 31401189 to Y.-L.F.]; Natural Science Foundation of Zhejiang Province [LZ17C060001 to A.-Y.X.]; Department of Science and Technology of Zhejiang Province [2015C03047 to A.-Y.X.]. Funding for open access charge: National Natural Science Foundation of China.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Biehs R, 2017, MOL CELL, V65, P671, DOI 10.1016/j.molcel.2016.12.016; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1                                                   ; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courilleau C, 2012, J CELL BIOL, V199, P1067, DOI 10.1083/jcb.201205059; Daniel JA, 2013, MOL CELL, V50, P309, DOI [10.1016/j.molce1.2013.04.017, 10.1016/j.molcel.2013.04.017]; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Feng YL, 2016, ACTA BIOCH BIOPH SIN, V48, P594, DOI 10.1093/abbs/gmw033; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Frit P, 2014, DNA REPAIR, V17, P81, DOI 10.1016/j.dnarep.2014.02.007; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Guirouilh-Barbat J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006230; Gursoy-Yuzugullu O, 2016, J MOL BIOL, V428, P1846, DOI 10.1016/j.jmb.2015.11.021; Helmink BA, 2011, NATURE, V469, P245, DOI 10.1038/nature09585; Iliakis G, 2015, MUTAT RES-GEN TOX EN, V793, P166, DOI 10.1016/j.mrgentox.2015.07.001; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Ochi T, 2012, STRUCTURE, V20, P1212, DOI 10.1016/j.str.2012.04.012; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Robert F, 2006, MOL CELL BIOL, V26, P402, DOI 10.1128/MCB.26.2.402-412.2006; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5                                                    ; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207                                                   ; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Taty-Taty GC, 2016, NUCLEIC ACIDS RES, V44, P1657, DOI 10.1093/nar/gkv1202; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/bjc.C100569200; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908                                                          ; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xie AY, 2010, CELL CYCLE, V9, P3602, DOI 10.4161/cc.9.17.12884; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	72	0	0	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	OCT 13	2017	45	18					10614	10633		10.1093/nar/gkx715				20	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FJ9OK	WOS:000413107400026	28977657	gold			2018-01-05	
J	Banerjee, A; Vest, KE; Pavlath, GK; Corbett, AH				Banerjee, Ayan; Vest, Katherine E.; Pavlath, Grace K.; Corbett, Anita H.			Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing	NUCLEIC ACIDS RESEARCH			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; LONG NONCODING RNA; AMYOTROPHIC-LATERAL-SCLEROSIS; LARGE-SCALE ANALYSIS; PRE-MESSENGER-RNA; POLY(A)-BINDING PROTEIN; SKELETAL-MUSCLE; PUR-ALPHA; HNRNP-C; GENE-EXPRESSION	The polyadenylate binding protein 1 (PABPN1) is a ubiquitously expressed RNA binding protein vital for multiple steps in RNA metabolism. Although PABPN1 plays a critical role in the regulation of RNA processing, mutation of the gene encoding this ubiquitously expressed RNA binding protein causes a specific form of muscular dystrophy termed oculopharyngeal muscular dystrophy (OPMD). Despite the tissue-specific pathology that occurs in this disease, only recently have studies of PABPN1 begun to explore the role of this protein in skeletal muscle. We have used co-immunoprecipitation and mass spectrometry to identify proteins that interact with PABPN1 in mouse skeletal muscles. Among the interacting proteins we identified Matrin 3 (MATR3) as a novel protein interactor of PABPN1. The MATR3 gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (ALS). We demonstrate, that like PABPN1, MATR3 is critical for myogenesis. Furthermore, MATR3 controls critical aspects of RNA processing including alternative polyadenylation and intron retention. We provide evidence that MATR3 also binds and regulates the levels of long non-coding RNA (lncRNA) Neat1 and together with PABPN1 is required for normal paraspeckle function. We demonstrate that PABPN1 and MATR3 are required for paraspeckles, as well as for adenosine to inosine (A to I) RNA editing of Ctn RNA in muscle cells. We provide a functional link between PABPN1 and MATR3 through regulation of a common lncRNA target with downstream impact on paraspeckle morphology and function. We extend our analysis to a mouse model of OPMD and demonstrate altered paraspeckle morphology in the presence of endoge-nous levels of alanine-expanded PABPN1. In this study, we report protein-binding partners of PABPN1, which could provide insight into novel functions of PABPN1 in skeletal muscle and identify proteins that could be sequestered with alanine-expanded PABPN1 in the nuclear aggregates found in OPMD.	[Banerjee, Ayan; Corbett, Anita H.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Vest, Katherine E.; Pavlath, Grace K.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Corbett, AH (reprint author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.; Pavlath, GK (reprint author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.	gpavlat@emory.edu; acorbe2@emory.edu			National Institutes of Health [5RO1AR06198705, 5F32AR06827]; Muscular Dystrophy Association [255856, 422006]; National Institutes of Health	National Institutes of Health [5RO1AR06198705 to A.H.C. and G.K.P., 5F32AR06827 to K.E.V.]; Muscular Dystrophy Association [255856 to A.B. and 422006 to A.H.C.]. Funding for open access charge: National Institutes of Health.	Aad G, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.191803; Abbassi-Daloii T, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0007-x; Afonina E, 1998, J BIOL CHEM, V273, P13015, DOI 10.1074/jbc.273.21.13015; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Apponi LH, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-23; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Bao YP, 2002, J BIOL CHEM, V277, P12263, DOI 10.1071/jbc.M109633200; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bhattacharjee RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053036; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; Brais B, 1999, SEMIN NEUROL, V19, P59, DOI 10.1055/s-2008-1040826                                                          ; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164                                                              ; Bresson SM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005610; Bresson SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003893; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924                                              ; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chang SH, 2014, NUCLEIC ACIDS RES, V42, P13788, DOI 10.1093/nar/gku1159; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chou CK, 2015, BIOMED RES INT, DOI 10.1155/2015/675714; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Coelho MB, 2015, EMBO J, V34, P653, DOI 10.15252/embj.201489852; Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019; Costelli P, 2007, BBA-GEN SUBJECTS, V1770, P1028, DOI 10.1016/j.bbagen.2007.03.003; Cutler AA, 2017, AGING CELL, V16, P738, DOI 10.1111/acel.12604; Darbinian N, 2008, J ALZHEIMERS DIS, V15, P71; Davies JE, 2008, HUM MOL GENET, V17, P1097, DOI 10.1093/hmg/ddm382; Davies JE, 2011, HUM MOL GENET, V20, P1154, DOI 10.1093/hmg/ddq559; Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242; de Klerk E., 2012, NUCL ACIDS RES; Depreux FF, 2015, HUM MOL GENET, V24, P4284, DOI 10.1093/hmg/ddv160; Di Salvio M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.295; Nguyen D, 2015, CELL REP, V13, P2244, DOI 10.1016/j.celrep.2015.11.003; Ekhterae D, 1999, CIRC RES, V85, pE70; Fan XP, 2003, CAN J NEUROL SCI, V30, P244, DOI 10.1017/S0317167100002675                                                       ; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7                                                   ; Gautheret D, 1998, GENOME RES, V8, P524, DOI 10.1101/gr.8.5.524                                                              ; Gorgoni Barbara, 2004, Briefings in Functional Genomics & Proteomics, V3, P125, DOI 10.1093/bfgp/3.2.125; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Heikaus S, 2008, APOPTOSIS, V13, P938, DOI 10.1007/s10495-008-0225-6; Hosoda N, 2006, MOL CELL BIOL, V26, P3085, DOI 10.1128/MCB.26.8.3085-3097.2006; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kini HK, 2014, MOL CELL BIOL, V34, P1300, DOI 10.1128/MCB.01683-13; Klein P, 2016, NUCLEIC ACIDS RES, V44, P10929, DOI 10.1093/nar/gkw703; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156                                                          ; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kula A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-60; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; Li WC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005166; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125                                                         ; Meola N, 2016, MOL CELL, V64, P520, DOI 10.1016/j.molcel.2016.09.025; Mitchell AS, 2015, APOPTOSIS, V20, P310, DOI 10.1007/s10495-014-1078-9; Moloney C, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0393-5; Muller TJ, 2014, ANN NEUROL, V76, P669, DOI 10.1002/ana.24255; Muniz L, 2015, MOL CELL BIOL, V35, P2218, DOI 10.1128/MCB.00123-15; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Nasrin F, 2014, SCI REP-UK, V4, DOI 10.1038/srep06841; Pak C, 2011, P NATL ACAD SCI USA, V108, P12390, DOI 10.1073/pnas.1107103108; Pichavant C, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-9; Pilaz LJ, 2015, WIRES RNA, V6, P501, DOI 10.1002/wrna.1289; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Riaz M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006031; Salton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023882; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Shetty S, 2005, MOL CELL BIOCHEM, V272, P107, DOI 10.1007/s11010-005-7644-2; Tavanez JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006418; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Uyama E, 2000, MUSCLE NERVE, V23, P1549, DOI 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0                       ; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H                                                    ; Vest K.E., 2017, HUM MOL GENET; VICTOR M, 1962, NEW ENGL J MED, V267, P1267, DOI 10.1056/NEJM196212202672501; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; White MK, 2009, CELL CYCLE, V8, P414, DOI 10.4161/cc.8.3.7585                                                             ; Williams RW, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00192; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yamashita S, 2015, NEUROPATH APPL NEURO, V41, P391, DOI 10.1111/nan.12179; Yedavalli VSRK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-61; Yoon JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6248; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zeitz MJ, 2009, J CELL BIOCHEM, V108, P125, DOI 10.1002/jcb.22234; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	107	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	OCT 13	2017	45	18					10706	10725		10.1093/nar/gkx786				20	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FJ9OK	WOS:000413107400031	28977530				2018-01-05	
J	Han, WY; Pan, SF; Lopez-Mendez, B; Montoya, G; She, QX				Han, Wenyuan; Pan, Saifu; Lopez-Mendez, Blanca; Montoya, Guillermo; She, Qunxin			Allosteric regulation of Csx1, a type IIIB-associated CARF domain ribonuclease by RNAs carrying a tetraadenylate tail	NUCLEIC ACIDS RESEARCH			English	Article							CRISPR-CAS IMMUNITY; TRANSCRIPTION TERMINATION; PYROCOCCUS-FURIOSUS; STRUCTURAL BASIS; DNA CLEAVAGE; PROTEIN; SYSTEM; RECOGNITION; INTERFERENCE; SULFOLOBUS	CRISPR-Cas systems protect prokaryotes against invading viruses and plasmids. The system is associated with a large number of Cas accessory proteins among which many contain a CARF (CRISPRassociated Rossmann fold) domain implicated in ligand binding and a HEPN (higher eukaryotes and prokaryotes nucleotide-binding) nuclease domain. Here, such a dual domain protein, i.e. the Sulfolobus islandicus Csx1 (SisCsx1) was characterized. The enzyme exhibited metal-independent single-strand specific ribonuclease activity. In fact, SisCsx1 showed a basal RNase activity in the absence of ligand; upon the binding of an RNA ligand carrying four continuous adenosines at the 3' end (3'-tetra-rA), the activated SisCsx1 degraded RNA substrate with a much higher turnover rate. Amino acid substitution mutants of SisCsx1 were obtained, and characterization of these mutant proteins showed that the CARF domain of the enzyme is responsible for binding to 3'-tetra-rA and the ligand binding strongly activates RNA cleavage by theHEPN domain. Since RNA polyadenylation is an important step in RNA decay in prokaryotes, and poly(A) RNAs can activate CARF domain proteins, the poly(A) RNA may function as an important signal in the cellular responses to viral infection and environmental stimuli, leading to degradation of both viral and host transcripts and eventually to cell dormancy or cell death.	[Han, Wenyuan; She, Qunxin] Univ Copenhagen, Dept Biol, Archaea Ctr, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Pan, Saifu; She, Qunxin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Pan, Saifu; She, Qunxin] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Lopez-Mendez, Blanca] Univ Copenhagen, Prot Struct & Funct Programme, Prot Prod & Characterizat Platform, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Montoya, Guillermo] Univ Copenhagen, Macromol Crystallog Grp, Novo Nordisk Fdn, Ctr Prot Res,Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	She, QX (reprint author), Univ Copenhagen, Dept Biol, Archaea Ctr, Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.; She, QX (reprint author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.; She, QX (reprint author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China.	qunxin@bio.ku.dk			Danish Council for Independent Research [DFF-060202196, DFF-1323-00330]; Augustinus Foundation [153934]; Brodrene Hartmanns Foundation [A29992]; Natural Science Foundation of China [31128011]; Scientific and Technological Self-Innovation Foundation of Huazhong Agricultural University [2014RC011]; Novo Nordisk Foundation [NNF14CC0001]; Danish Cancer Society; University of Copenhagen	Danish Council for Independent Research [DFF-060202196, DFF-1323-00330]; The Augustinus Foundation [153934]; Brodrene Hartmanns Foundation [A29992]; Natural Science Foundation of China [31128011]; Scientific and Technological Self-Innovation Foundation of Huazhong Agricultural University [2014RC011 to Q.S.]. The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation [NNF14CC0001]; Danish Cancer Society (to G.M.). Funding for open access charge: University of Copenhagen.	Dar D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.143, 10.1038/nmicrobiol.2016.143]; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6                                                   ; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Han WY, 2017, NUCLEIC ACIDS RES, V45, P1983, DOI 10.1093/nar/gkw1274; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Hou LL, 2014, NUCLEIC ACIDS RES, V42, P12691, DOI 10.1093/nar/gku969; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Kim YK, 2013, PROTEINS, V81, P261, DOI 10.1002/prot.24183; Koonin Eugene V, 2017, Bioessays, V39, P1, DOI 10.1002/bies.201600186; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Martens B, 2017, NUCLEIC ACIDS RES, V45, P7938, DOI 10.1093/nar/gkx437; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Portnoy V, 2005, EMBO REP, V6, P1188, DOI 10.1038/sj.embor.7400571; Ray-Soni A, 2016, ANNU REV BIOCHEM, V85, P319, DOI 10.1146/annurev-biochem-060815-014844; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; She QX, 2009, BIOCHEM SOC T, V37, P92, DOI 10.1042/BST0370092; Sheppard NF, 2016, RNA, V22, P216, DOI 10.1261/rna.039842.113; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Tanaka N, 2004, EMBO J, V23, P3929, DOI 10.1038/sj.emboj.7600420; Topuzlu E, 2016, RNA BIOL, V13, P254, DOI 10.1080/15476286.2015.1130209; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Yan XF, 2015, RNA BIOL, V12, P749, DOI 10.1080/15476286.2015.1051300	41	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	OCT 13	2017	45	18					10740	10750		10.1093/nar/gkx726				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FJ9OK	WOS:000413107400033	28977519	gold			2018-01-05	
J	Zhao, WX; Siegel, D; Biton, A; Le Tonqueze, O; Zaitlen, N; Ahituv, N; Erle, DJ				Zhao, Wenxue; Siegel, David; Biton, Anne; Le Tonqueze, Olivier; Zaitlen, Noah; Ahituv, Nadav; Erle, David J.			CRISPR-Cas9-mediated functional dissection of 3 '-UTRs	NUCLEIC ACIDS RESEARCH			English	Article							MESSENGER-RNA DECAY; MAMMALIAN-CELLS; GENETIC SCREENS; ENHANCER; GENOME; CRISPR; TRANSCRIPTION; ELEMENTS; POLYADENYLATION; TRISTETRAPROLIN	Many studies using reporter assays have demonstrated that 3' untranslated regions (3'-UTRs) regulate gene expression by controlling mRNA stability and translation. Due to intrinsic limitations of heterologous reporter assays, we sought to develop a gene editing approach to investigate the regulatory activity of 3'-UTRs in their native context. We initially used dual-CRISPR (clustered, regularly interspaced, short palindromic repeats)-Cas9 targeting to delete DNA regions corresponding to nine chemokine 3' UTRs that destabilized mRNAin a reporter assay. Targeting six chemokine 3'-UTRs increased chemokine mRNAlevels as expected. However, targetingCXCL1, CXCL6 and CXCL8 3'-UTRs unexpectedly led to substantial mRNA decreases. Metabolic labeling assays showed that targeting these three 3'-UTRs increased mRNA stability, as predicted by the reporter assay, while also markedly decreasing transcription, demonstrating an unexpected role for 3'-UTR sequences in transcriptional regulation. We further show that CRISPR-Cas9 targeting of specific ' UTR elements can be used for modulating gene expression and for highly parallel localization of active 3'-UTR elements in the native context. Our work demonstrates the duality and complexity of 3'-UTR sequences in regulation of gene expression and provides a useful approach for modulating gene expression and for functional annotation of 3'-UTRs in the native context.	[Zhao, Wenxue; Siegel, David; Biton, Anne; Le Tonqueze, Olivier; Zaitlen, Noah; Erle, David J.] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, 4th St, San Francisco, CA 94158 USA; [Biton, Anne] Inst Pasteur, C3BI, USR 3756, 25-28 Rue Dr Roux, F-75015 Paris, France; [Biton, Anne] CNRS, 25-28 Rue Dr Roux, F-75015 Paris, France; [Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, Dept Bioengn & Therapeut Sci, 4th St, San Francisco, CA 94158 USA	Zhao, WX; Erle, DJ (reprint author), Univ Calif San Francisco, Dept Med, Lung Biol Ctr, 4th St, San Francisco, CA 94158 USA.	wenxue.zhao@ucsf.edu; david.erle@ucsf.edu			National Institutes of Health (NIH) [R01HL124285, R01GM110251, K25HL121295, R01CA197139, R01MH109907, P01HD084387, UM1HG009408]; NIH [R01HL124285, R01GM110251, K25HL121295, R01CA197139, R01MH109907, P01HD084387, UM1HG009408]	National Institutes of Health (NIH) [R01HL124285, R01GM110251 to D.J.E., K25HL121295 to N.Z., R01CA197139, R01MH109907, P01HD084387, UM1HG009408 to N.A.]. Funding for open access: NIH R01HL124285, R01GM110251 to D.J.E., K25HL121295 to N.Z., R01CA197139, R01MH109907, P01HD084387, UM1HG009408 to N.A.].	Ahmed Firoz, 2009, In Silico Biology, V9, P135, DOI 10.3233/ISB-2009-0395; Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Diao YR, 2017, NAT METHODS, V14, P629, DOI [10.1038/nmeth.4264, 10.1038/NMETH.4264]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Inoue F, 2017, GENOME RES, V27, P38, DOI 10.1101/gr.212092.116; Jin Yi, 2013, Methods Mol Biol, V936, P117; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kramer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077224; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shemshedini L, 2009, METHODS MOL BIOL, V590, P195, DOI 10.1007/978-1-60327-378-7_12; Swamynathan SK, 2002, J BIOL CHEM, V277, P49700, DOI 10.1074/jbc.M209700200; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhao WX, 2014, NAT BIOTECHNOL, V32, P387, DOI 10.1038/nbt.2851; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	42	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	OCT 13	2017	45	18					10800	10810		10.1093/nar/gkx675				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FJ9OK	WOS:000413107400038	28985357	gold			2018-01-05	
J	Ayars, M; O'Sullivan, E; Macgregor-Das, A; Shindo, K; Kim, H; Borges, M; Yu, J; Hruban, RH; Goggins, M				Ayars, Michael; O'Sullivan, Eileen; Macgregor-Das, Anne; Shindo, Koji; Kim, Haeryoung; Borges, Michael; Yu, Jun; Hruban, Ralph H.; Goggins, Michael			IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth	ONCOTARGET			English	Article						pancreatic cancer; PanIN; RNA-seq; IL2RG; JAK3	GAMMA-CHAIN; DUCTAL ADENOCARCINOMA; PRECURSOR LESIONS; EXPRESSION; CELLS; BETA; REGULATOR; THERAPY; TP53	Pancreatic ductal adenocarcinoma evolves from precursor lesions, the most common of which is pancreatic intraepithelial neoplasia (PanIN). We performed RNA-sequencing analysis of laser capture microdissected PanINs and normal pancreatic duct cells to identify differentially expressed genes between PanINs and normal pancreatic duct, and between low-grade and high-grade PanINs. One of the most highly overexpressed transcripts identified in PanIN is interleukin-2 receptor subunit gamma (IL2RG) encoding the common gamma chain, IL2R gamma. CRISPR-mediated knockout of IL2RG in orthotopically implanted pancreatic cancer cells resulted in attenuated tumor growth in mice and reduced JAK3 expression in orthotopic tumors. These results indicate that IL2R gamma/JAK3 signaling contributes to pancreatic cancer cell growth in vivo.	[Ayars, Michael; O'Sullivan, Eileen; Macgregor-Das, Anne; Shindo, Koji; Kim, Haeryoung; Borges, Michael; Yu, Jun; Hruban, Ralph H.; Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Hruban, Ralph H.; Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Goggins, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA	Goggins, M (reprint author), Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA.; Goggins, M (reprint author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA.; Goggins, M (reprint author), Johns Hopkins Univ, Sch Med, Dept Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA.	mgoggins@jhmi.edu			NIH [U01CA210170, CA62924, CA176828]; Rolfe Pancreatic Cancer Foundation	This work was supported by NIH grants U01CA210170, CA62924 and CA176828, Susan Wojcicki, Dennis Troper and the Rolfe Pancreatic Cancer Foundation. MG is the Sol Goldman Professor of Pancreatic Cancer Research.	Basturk O, 2015, AM J SURG PATHOL, V39, P1730, DOI 10.1097/PAS.0000000000000533; Bonder CS, 1998, J IMMUNOL, V160, P4048; Brune K, 2006, AM J SURG PATHOL, V30, P1067; Canto MI, 2012, GASTROENTEROLOGY, V142, P796, DOI 10.1053/j.gastro.2012.01.005; Crnogorac-Jurcevic T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054830; Giron-Michel J, 2003, J EXP MED, V197, P763, DOI 10.1084/jem.20020150; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Hong SM, 2008, MODERN PATHOL, V21, P1499, DOI 10.1038/modpathol.2008.157; Hosoda W, 2017, J PATHOL, V242, P16, DOI 10.1002/path.4884; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Huang TH, 2015, INT J MOL SCI, V16, P2956, DOI 10.3390/ijms16022956; Karanjawala ZE, 2008, AM J SURG PATHOL, V32, P188, DOI 10.1097/PAS.0b013e31815701f3; Kayed H, 2006, INT J CANCER, V118, P43, DOI 10.1002/ijc.21257; Keliher EJ, 2013, NEOPLASIA, V15, P684, DOI 10.1593/neo.13276; Kim H, 2014, CLIN CANCER RES, V20, P1865, DOI 10.1158/1078-0432.CCR-13-1239; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Krosting J, 2005, RNASE ACTIVITY MOUSE; Li LS, 2011, CLIN CANCER RES, V17, P275, DOI 10.1158/1078-0432.CCR-10-1983; Maleth J, 2015, GASTROENTEROLOGY, V148, P427, DOI 10.1053/j.gastro.2014.11.002; Matsuda Y, 2017, PANCREAS, V46, P658, DOI 10.1097/MPA.0000000000000786; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Raines AN, 2012, J BIOL CHEM, V287, P24873, DOI 10.1074/jbc.M112.369173; Sato N, 2006, GASTROENTEROLOGY, V130, P548, DOI 10.1053/j.gastro.2005.11.008; Sato N, 2005, CLIN CANCER RES, V11, P4681, DOI 10.1158/1078-0432.CCR-04-2471                                                   ; Sato N, 2005, ONCOGENE, V24, P850, DOI 10.1038/sj.onc.1208050; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Strand V, 2016, RHEUMATOLOGY, V55, P1031, DOI 10.1093/rheumatology/kev442; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Terhune PG, 1998, CANCER EPIDEM BIOMAR, V7, P515; Waghray M, 2016, CANCER DISCOV, V6, P886, DOI 10.1158/2159-8290.CD-15-0947; Waickman AT, 2016, CELL MOL LIFE SCI, V73, P253, DOI 10.1007/s00018-015-2062-4; Yu J, 2017, GUT, V66, P1677, DOI 10.1136/gutjnl-2015-311166; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347	36	0	0	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	OCT 13	2017	8	48					83370	83383		10.18632/oncotarget.19848				14	Oncology; Cell Biology	Oncology; Cell Biology	FJ8PK	WOS:000413030900002	29137350				2018-01-05	
J	Tomida, J; Morita, Y; Shibayama, K; Kikuchi, K; Sawa, T; Akaike, T; Kawamura, Y				Tomida, Junko; Morita, Yuji; Shibayama, Keigo; Kikuchi, Ken; Sawa, Tomohiro; Akaike, Takaaki; Kawamura, Yoshiaki			Diversity and microevolution of CRISPR loci in Helicobacter cinaedi	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; HORIZONTAL GENE-TRANSFER; IMMUNOCOMPROMISED PATIENTS; CAS SYSTEMS; IDENTIFICATION; INFECTIONS; BACTEREMIA; REPEATS; STREPTOCOCCUS; PROKARYOTES	Helicobacter cinaedi is associated with nosocomial infections. The CRISPR-Cas system provides adaptive immunity against foreign genetic elements. We investigated the CRISPR-Cas system in H. cinaedi to assess the potential of the CRISPR-based microevolution of H. cinaedi strains. A genotyping method based on CRISPR spacer organization was carried out using 42 H. cinaedi strains. The results of sequence analysis showed that the H. cinaedi strains used in this study had two CRISPR loci (CRISPR1 and CRISPR2). The lengths of the consensus direct repeat sequences in CRISPR1 and CRISPR2 were both 36 bp-long, and 224 spacers were found in the 42 H. cinaedi strains. Analysis of the organization and sequence similarity of the spacers of the H. cinaedi strains showed that CRISPR arrays could be divided into 7 different genotypes. Each genotype had a different ancestral spacer, and spacer acquisition/deletion events occurred while isolates were spreading. Spacer polymorphisms of conserved arrays across the strains were instrumental for differentiating closely-related strains collected from the same hospital. MLST had little variability, while the CRISPR sequences showed remarkable diversity. Our data revealed the structural features of H. cinaedi CRISPR loci for the first time. CRISPR sequences constitute a valuable basis for genotyping, provide insights into the divergence and relatedness between closelyrelated strains, and reflect the microevolutionary process of H. cinaedi.	[Tomida, Junko; Morita, Yuji; Kawamura, Yoshiaki] Aichi Gakuin Univ, Sch Pharm, Dept Microbiol, Nagoya, Aichi, Japan; [Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Kikuchi, Ken] Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan; [Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto, Japan; [Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Sendai, Miyagi, Japan	Tomida, J (reprint author), Aichi Gakuin Univ, Sch Pharm, Dept Microbiol, Nagoya, Aichi, Japan.	jtomida@dpc.agu.ac.jp			JSPS KAKENHI [16K18923]	This study was supported by JSPS KAKENHI Grant Number 16K18923 (to JT).	Andersen JM, 2016, GENOME BIOL EVOL, V8, P2841, DOI 10.1093/gbe/evw203; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barros MPS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108353; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Briner AE, 2015, PLOS ONE, V31; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; D'Elios MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40515; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Dewhirst FE, 2005, J BACTERIOL, V187, P6106, DOI 10.1128/JB.187.17.6106-6118.2005; FENNELL CL, 1984, J INFECT DIS, V149, P58, DOI 10.1093/infdis/149.1.58                                                         ; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203                                           ; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goto T, 2012, J BACTERIOL, V194, P3744, DOI 10.1128/JB.00645-12; Gouy M, BIOCHIMIE; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hooton SPT, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00744; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Iwashita H, 2008, CLIN VACCINE IMMUNOL, V15, P513, DOI 10.1128/CVI.00439-07; Kawamura Y, 1999, MICROBIOL-UK, V145, P2605, DOI 10.1099/00221287-145-9-2605                                                     ; Kawamura Y, 2014, J INFECT CHEMOTHER, V20, P517, DOI 10.1016/j.jiac.2014.06.007; Khan S, 2014, SCI REP, V15, P4680; Khan S, 2012, MICROBIOL IMMUNOL, V56, P145, DOI 10.1111/j.1348-0421.2012.00421.x; KIEHLBAUCH JA, 1994, ANN INTERN MED, V121, P90, DOI 10.7326/0003-4819-121-2-199407150-00002; Kitamura T, 2007, J CLIN MICROBIOL, V45, P31, DOI 10.1128/JCM.01507-06; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Liang JG, 2013, J CLIN MICROBIOL, V51, P920, DOI 10.1128/JCM.02399-12; Mahony J, 2015, CURR OPIN BIOTECH, V32, P8, DOI [10.1016/j.copbio.2014.09.006, 10.1016/j.copbio.2014.09.00]; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Menard A, 2016, SYST APPL MICROBIOL, V39, P77, DOI 10.1016/j.syapm.2015.09.008; Minauchi K, 2010, INTERNAL MED, V49, P1733, DOI 10.2169/internalmedicine.49.3649; Miyoshi-Akiyama T, 2012, J BACTERIOL, V194, P5692, DOI 10.1128/JB.01347-12; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murakami Hinako, 2003, Journal of Infection and Chemotherapy, V9, P344, DOI 10.1007/s10156-003-0265-3; Oyama K, 2012, J CLIN MICROBIOL, V50, P3893, DOI 10.1128/JCM.01622-12; Pettengill JB, 2014, PEERJ, V2, DOI 10.7717/peerj.340; Rimbara E, 2012, J CLIN MICROBIOL, V50, P2553, DOI 10.1128/JCM.06810-11; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Shimizu S, 2013, ACTA DERM-VENEREOL, V93, P165, DOI 10.2340/00015555-1396; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Belkum A, 2015, MBIO, V6, DOI 10.1128/mBio.01796-15; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Zhu DK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3040-4	49	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2017	12	10							e0186241	10.1371/journal.pone.0186241				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ7ZQ	WOS:000412980300024	29028814	gold			2018-01-05	
J	Drost, J; van Boxtel, R; Blokzijl, F; Mizutani, T; Sasaki, N; Sasselli, V; de Ligt, J; Behjati, S; Grolleman, JE; van Wezel, T; Nik-Zainal, S; Kuiper, RP; Cuppen, E; Clevers, H				Drost, Jarno; van Boxtel, Ruben; Blokzijl, Francis; Mizutani, Tomohiro; Sasaki, Nobuo; Sasselli, Valentina; de Ligt, Joep; Behjati, Sam; Grolleman, Judith E.; van Wezel, Tom; Nik-Zainal, Serena; Kuiper, Roland P.; Cuppen, Edwin; Clevers, Hans			Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer	SCIENCE			English	Article							BASE-EXCISION-REPAIR; DNA MISMATCH REPAIR; COLORECTAL-CANCER; SOMATIC MUTATIONS; LIFE-SPAN; GENOME; TUMORS; RATES	Mutational processes underlie cancer initiation and progression. Signatures of these processes in cancer genomes may explain cancer etiology and could hold diagnostic and prognostic value. We developed a strategy that can be used to explore the origin of cancer-associated mutational signatures. We used CRISPR-Cas9 technology to delete key DNA repair genes in human colon organoids, followed by delayed subcloning and whole-genome sequencing. We found that mutation accumulation in organoids deficient in the mismatch repair gene MLH1 is driven by replication errors and accurately models the mutation profiles observed in mismatch repair-deficient colorectal cancers. Application of this strategy to the cancer predisposition gene NTHL1, which encodes a base excision repair protein, revealed a mutational footprint (signature 30) previously observed in a breast cancer cohort. We show that signature 30 can arise from germline NTHL1 mutations.	[Drost, Jarno; Mizutani, Tomohiro; Sasaki, Nobuo; Sasselli, Valentina; Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Drost, Jarno; Mizutani, Tomohiro; Sasaki, Nobuo; Sasselli, Valentina; Clevers, Hans] Univ Med Ctr UMC Utrecht, NL-3584 CT Utrecht, Netherlands; [Drost, Jarno; van Boxtel, Ruben; Blokzijl, Francis; Mizutani, Tomohiro; Sasaki, Nobuo; Sasselli, Valentina; de Ligt, Joep; Cuppen, Edwin; Clevers, Hans] UMC Utrecht, Canc Genom Netherlands, NL-3584 CX Utrecht, Netherlands; [van Boxtel, Ruben; Blokzijl, Francis; de Ligt, Joep; Cuppen, Edwin] UMC Utrecht, Dept Genet, Ctr Mol Med, NL-3584 CX Utrecht, Netherlands; [Behjati, Sam; Nik-Zainal, Serena] Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England; [Behjati, Sam] Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England; [Grolleman, Judith E.; Kuiper, Roland P.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [van Wezel, Tom] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Nik-Zainal, Serena] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, East Anglian Med Genet Serv, Cambridge, England; [Drost, Jarno; van Boxtel, Ruben; Kuiper, Roland P.; Clevers, Hans] Princess Maxima Ctr Pediat Oncol, NL-3584 CT Utrecht, Netherlands	Clevers, H (reprint author), Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.; Clevers, H (reprint author), Univ Med Ctr UMC Utrecht, NL-3584 CT Utrecht, Netherlands.; Cuppen, E; Clevers, H (reprint author), UMC Utrecht, Canc Genom Netherlands, NL-3584 CX Utrecht, Netherlands.; Cuppen, E (reprint author), UMC Utrecht, Dept Genet, Ctr Mol Med, NL-3584 CX Utrecht, Netherlands.; Clevers, H (reprint author), Princess Maxima Ctr Pediat Oncol, NL-3584 CT Utrecht, Netherlands.	ecuppen@umcutrecht.nl; h.clevers@hubrecht.eu	Drost, Jarno/J-9758-2012	Drost, Jarno/0000-0002-2941-6179	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)-ZonMw Veni grant [91614138]; Worldwide Cancer Research [16-0193]; Wellcome Trust; St. Baldrick's Foundation; "Sta op tegen Kanker" International Translational Cancer Research grant; CancerGenomics.nl (NWO Gravitation) program	We thank M. R. Stratton for scientific discussion and for reading the manuscript. We also thank the members of the contributing labs for helpful suggestions and discussions. This work was supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)-ZonMw Veni grant to J.D. (91614138), a grant from Worldwide Cancer Research to R.v.B. (16-0193), funding from the Wellcome Trust and St. Baldrick's Foundation to S.B., "Sta op tegen Kanker" International Translational Cancer Research grant to T.M. and H.C., and funding from the CancerGenomics.nl (NWO Gravitation) program to E.C. and H.C. S.N.-Z. has a paid consulting relationship with Artios Pharma. S.N.-Z. is an inventor on patent applications (1607629.1, 1607628.3, 1607630.9, and 1607635.8) submitted by the Wellcome Trust Sanger Institute that cover the applications of mutational signatures as a biomarker in clinical contexts. The sequencing data have been deposited to the European Genome-Phenome Archive (www.ebi.ac.uk/ega/) under accession numbers EGAS00001001969, EGAS00001001682, and EGAS00001000881.	Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Behjati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12605; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Davies H, 2017, NAT MED, V23, P517, DOI 10.1038/nm.4292; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Li JF, 2013, ANTIOXID REDOX SIGN, V18, P2429, DOI 10.1089/ars.2012.5107; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242                                                            ; MacRae SL, 2015, AGING-US, V7, P1171, DOI 10.18632/aging.100866                                                           ; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Rivera B, 2015, NEW ENGL J MED, V373, P1985, DOI 10.1056/NEJMc1506878; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; Viel A, 2017, EBIOMEDICINE, V20, P39, DOI 10.1016/j.ebiom.2017.04.022; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287; Zheng CL, 2014, CELL REP, V9, P1228, DOI 10.1016/j.celrep.2014.10.031	29	1	1	20	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2017	358	6360					234	+		10.1126/science.aao3130				5	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ6CO	WOS:000412841500051	28912133				2018-01-05	
J	Kong, XJ; Kuilman, T; Shahrabi, A; Oshuizen, JB; Kemper, K; Song, JY; Niessen, HWM; Rozeman, EA; Foppen, MHG; Lank, CUB; Peeper, DS				Kong, Xiangjun; Kuilman, Thomas; Shahrabi, Aida; Oshuizen, Julia B.; Kemper, Kristel; Song, Ji-Ying; Niessen, Hans W. M.; Rozeman, Elisa A.; Foppen, Marnix H. Geukes; Lank, Christian U. B.; Peeper, Daniel S.			Cancer drug addiction is relayed by an ERK2-dependent phenotype switch	NATURE			English	Article							BRAF V600E-MUTANT MELANOMA; MALIGNANT-MELANOMA; VEMURAFENIB; INHIBITION; RESISTANCE; PATIENT; CELLS; XENOGRAFTS; ACTIVATION; EFFICACY	Observations from cultured cells(1-3), animal models(4) and patients(5-7) raise the possibility that the dependency of tumours on the therapeutic drugs to which they have acquired resistance represents a vulnerability with potential applications in cancer treatment. However, for this drug addiction trait to become of clinical interest, we must first define the mechanism that underlies it. We performed an unbiased CRISPR-Cas9 knockout screen on melanoma cells that were both resistant and addicted to inhibition of the serine/ threonine-protein kinase BRAF, in order to functionally mine their genome for 'addiction genes. Here we describe a signalling pathway comprising ERK2 kinase and JUNB and FRA1 transcription factors, disruption of which allowed addicted tumour cells to survive on treatment discontinuation. This occurred in both cultured cells and mice and was irrespective of the acquired drug resistance mechanism. In melanoma and lung cancer cells, death induced by drug withdrawal was preceded by a specific ERK2-dependent phenotype switch, alongside transcriptional reprogramming reminiscent of the epithelial-mesenchymal transition. In melanoma cells, this reprogramming caused the shutdown of microphthalmia-associated transcription factor (MITF), a lineage survival oncoprotein; restoring this protein reversed phenotype switching and prevented the lethality associated with drug addiction. In patients with melanoma that had progressed during treatment with a BRAF inhibitor, treatment cessation was followed by increased expression of the receptor tyrosine kinase AXL, which is associated with the phenotype switch. Drug discontinuation synergized with the melanoma chemotherapeutic agent dacarbazine by further suppressing MITF and its prosurvival target, B-cell lymphoma 2 (BCL-2), and by inducing DNA damage in cancer cells. Our results uncover a pathway that underpins drug addiction in cancer cells, which may help to guide the use of alternating therapeutic strategies for enhanced clinical responses in drug-resistant cancers.	[Kong, Xiangjun; Kuilman, Thomas; Shahrabi, Aida; Oshuizen, Julia B.; Kemper, Kristel; Rozeman, Elisa A.; Foppen, Marnix H. Geukes; Lank, Christian U. B.; Peeper, Daniel S.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Div Expt Anim Pathol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Niessen, Hans W. M.] Vrije Univ Amsterdam, Dept Pathol & Cardiac Surg, ACS, Med Ctr, NL-1007 MB Amsterdam, Netherlands	Peeper, DS (reprint author), Netherlands Canc Inst, Div Mol Oncol & Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.peeper@nki.nl			European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC synergy grant [319661 COMBATCANCER]; Queen Wilhelmina Award; Dutch Cancer Society/Koningin Wilhelmina Fonds [10304]	We are grateful to K. Suda and T Mitsudomi for HCC827 and HCC827GIR cells, J. Villanueva for 451Lu cells, I. de Krijger for technical advice on FISH, A. Broeks and the NKI Biobank for help with patient samples, R. Beijersbergen for providing the GeCKO library and A. Huitema for providing DTIC. We thank all members of the Peeper and Blank labs for advice. This work was financially supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC synergy grant agreement number 319661 COMBATCANCER (X.K., D.S.P.), and a Fellowship (T.K.), a Queen Wilhelmina Award (D.S.P.) and a research grant (nr. 10304; X.K., D.S.P.), all by the Dutch Cancer Society/Koningin Wilhelmina Fonds.	Abdel-Wahab O, 2014, CANCER DISCOV, V4, P538, DOI 10.1158/2159-8290.CD-13-1038; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Dietrich S, 2013, J CLIN ONCOL, V31, pE300, DOI 10.1200/JCO.2012.45.9495; Dooley AJ, 2016, TARGET ONCOL, V11, P557, DOI 10.1007/s11523-015-0410-9; Dooley AJ, 2014, THER ADV MED ONCOL, V6, P262, DOI 10.1177/1758834014548187; Fontana MF, 2015, J IMMUNOL, V194, P177, DOI 10.4049/jimmunol.1401595; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Harries M, 2016, EUR J CANCER, V60, P179, DOI 10.1016/j.ejca.2016.01.011; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Jain Tania, 2015, Cureus, V7, pe410, DOI 10.7759/cureus.410; Kemper K, 2016, CELL REP, V16, P263, DOI 10.1016/j.celrep.2016.05.064; Kemper K, 2015, EMBO MOL MED, V7, P1104, DOI 10.15252/emmm.201404914; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Moriceau G, 2015, CANCER CELL, V27, P240, DOI 10.1016/j.ccell.2014.11.018; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Schreuer M, 2017, LANCET ONCOL, V18, P464, DOI 10.1016/S1470-2045(17)30171-7; Seghers AC, 2012, MELANOMA RES, V22, P466, DOI 10.1097/CMR.0b013e3283541541; Seifert H, 2016, MELANOMA RES, V26, P138, DOI 10.1097/CMR.0000000000000218; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suda K, 2012, LUNG CANCER, V76, P292, DOI 10.1016/j.lungcan.2011.11.007; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370	30	1	1	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2017	550	7675					270	+		10.1038/nature24037				16	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ5YG	WOS:000412829500051	28976960				2018-01-05	
J	Tan, MH; Li, Q; Shanmugam, R; Piskol, R; Kohler, J; Young, AN; Liu, KI; Zhang, R; Amaswami, GR; Ariyoshi, K; Gupte, A; Keegan, LP; George, CX; Amu, AR; Huang, N; Pollina, EA; Leeman, DS; Ustighi, AR; Goh, YPS; Hawla, AC; Del Sal, G; Peltz, G; Runet, AB; Onrad, DFC; Samuel, CE; O'Connell, MA; Walkley, CR; Nishikura, K; Li, JB				Tan, Meng How; Li, Qin; Shanmugam, Raghuvaran; Piskol, Robert; Kohler, Jennefer; Young, Amy N.; Liu, Kaiwen Ivy; Zhang, Rui; Amaswami, Gokul R.; Ariyoshi, Kentaro; Gupte, Ankita; Keegan, Liam P.; George, Cyril X.; Amu, Avinash R.; Huang, Ni; Pollina, Elizabeth A.; Leeman, Dena S.; Ustighi, Alessandra R.; Goh, Y. P. Sharon; Hawla, Ajay C.; Del Sal, Giannino; Peltz, Gary; Runet, Anne B.; Onrad, Donald F. C.; Samuel, Charles E. .; O'Connell, Mary A.; Walkley, Carl R. .; Nishikura, Kazuko; Li, Jin Billy		Gtex Consortium	Dynamic landscape and regulation of RNA editing in mammals	NATURE			English	Article							SEQUENCING DATA; ACCURATE IDENTIFICATION; CELL-DIFFERENTIATION; BRAIN-DEVELOPMENT; SITES; GENE; TRANSCRIPTOME; GENOME; ADAR1; DEAMINASE	Aden osine-to-inosine (A-to-I) RNA editing is a conserved post transcriptional mechanism mediated by ADAR enzymes that diversities the transcriptome by altering selected nucleotides in RNA molecules(1). Although many editing sites have recently been discovered(2-7), the extent to which most sites are edited and how the editing is regulated in different biological contexts are not fully understood(8-10). Here we report dynamic spatiotemporal patterns and new regulators of RNA editing, discovered through an extensive profiling of A-to-I RNA editing in 8,551 human samples (representing 53 body sites from 552 individuals) from the Genotype-Tissue Expression (GTEx) project and in hundreds of other primate and mouse samples. We show that editing levels in non-repetitive coding regions vary more between tissues than editing levels in repetitive regions. Globally, ADAR1 is the primary editor of repetitive sites and ADAR2 is the primary editor of non repetitive coding sites, whereas the catalytically inactive ADAR3 predominantly acts as an inhibitor of editing. Cross-species analysis of RNA editing in several tissues revealed that species, rather than tissue type, is the primary determinant of editing levels, suggesting stronger cis-directed regulation of RNA editing for most sites, although the small set of conserved coding sites is under stronger trans-regulation. In addition, we curated an extensive set of ADAR1 and ADAR2 targets and showed that many editing sites display distinct tissue-specific regulation by the ADAR enzymes in vivo. Further analysis of the GTEx data revealed several potential regulators of editing, such as AIMP2, which reduces editing in muscles by enhancing the degradation of the ADAR proteins. Collectively, our work provides insights into the complex cis- and trans-regulation of A-to-I editing.	[Tan, Meng How; Li, Qin; Piskol, Robert; Kohler, Jennefer; Young, Amy N.; Zhang, Rui; Amaswami, Gokul R.; Pollina, Elizabeth A.; Leeman, Dena S.; Runet, Anne B.; Li, Jin Billy] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Tan, Meng How; Shanmugam, Raghuvaran] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore; [Tan, Meng How; Shanmugam, Raghuvaran; Liu, Kaiwen Ivy] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Ariyoshi, Kentaro; Nishikura, Kazuko] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Gupte, Ankita; Walkley, Carl R. .] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Keegan, Liam P.; O'Connell, Mary A.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Keegan, Liam P.; O'Connell, Mary A.] Masaryk Univ, Cent European Inst Technol, Brno 62500, Czech Republic; [George, Cyril X.; Samuel, Charles E. .] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Amu, Avinash R.; Huang, Ni; Onrad, Donald F. C.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Amu, Avinash R.; Huang, Ni; Onrad, Donald F. C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Ustighi, Alessandra R.; Del Sal, Giannino] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy; [Ustighi, Alessandra R.; Del Sal, Giannino] Natl Lab CIB LNCIB, Area Sci Pk, I-34149 Trieste, Italy; [Goh, Y. P. Sharon; Hawla, Ajay C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Peltz, Gary] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA; [Walkley, Carl R. .] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	Tan, MH; Li, JB (reprint author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Tan, MH (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637459, Singapore.; Tan, MH (reprint author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore.	mh.tan@ntu.edu.sg; jin.billy.li@stanford.edu	OConnell, Mary Anne/G-4740-2015	OConnell, Mary Anne/0000-0003-3844-6174; Basha, Omer/0000-0002-5764-1066; Yeger-Lotem, Esti/0000-0002-8279-7898; Garrido-Martin, Diego/0000-0002-4131-4458; Hansen, Kasper/0000-0003-0086-0687; Gamazon, Eric/0000-0003-4204-8734; Walkley, Carl/0000-0002-4784-9031	National Institutes of Health (NIH) [R01GM102484, R01GM124215, U01HG007593, R01GM040536, R01CA175058, R01A1012520]; Ellison Medical Foundation; Stanford University Department of Genetics; Genome Institute of Singapore; Nanyang Technological University School of Chemical and Biomedical Engineering; National Medical Research Council [OFIRG15nov151]; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; MRC; European Union's Seventh Framework Programme for research, technological development and demonstration [621368]; NHMRC [1102006]; Italian Health Ministry [RF-2011-02346976]; Italian Association for Cancer Research (AIRC) Special Program Molecular Clinical Oncology '5 per mille' [10016]; AIRC IG [17659]; Cariplo Foundation [2014-0812]; Stanford Graduate Fellowship; German Academic Exchange Service research fellowship; Stanford University School of Medicine Dean's Fellowship; Common Fund of the Office of the Director of the NIH; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NCI\SAIC-Frederick, Inc. (SAIC-F) [10XS170, 10XS171, X10S172]; Broad Institute, Inc. [HHSN268201000029C]; SAIC-F subcontract [10ST1035]; University of Miami [DA006227, DA033684];  [NO1MH000028];  [MH090941];  [MH101814];  [MH090951];  [MH090937];  [MH101320];  [MH101825];  [MH090936];  [MH101819];  [MH090948];  [MH101782];  [MH101810];  [MH101822]	We thank C. Mason and L. Pipes for help with nonhuman primate RNA-seq data, Y. Hu, P Sahbaie, A. Chang, K. McGowan and R. Hannibal for technical assistance, and J. Baker and H. H. Ng for use of laboratory resources. We also thank A. Fire, Y. Wan, K. W. K. Sung, W. Zhai, S. Prabhakar,and members of the Li and Tan laboratories for discussions and critical reading of the manuscript. This work is supported by National Institutes of Health (NIH) grants R01GM102484, R01GM124215 and U01HG007593 (J.B.L.), R01GM040536 (K.N.), R01CA175058 (K.N.), and R01A1012520 (C.E.S.), Ellison Medical Foundation (J.B.L. and K. N.), Stanford University Department of Genetics (J.B.L.), Genome Institute of Singapore (M.H.T.), Nanyang Technological University School of Chemical and Biomedical Engineering (M.H.T), National Medical Research Council OFIRG15nov151 (M.H.T), the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (K.N.), MRC and European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No 621368 (M.A.O'C.), NHMRC project grant 1102006 (C.W. and J.B.L.), Italian Health Ministry (RF-2011-02346976) and the Italian Association for Cancer Research (AIRC) Special Program Molecular Clinical Oncology '5 per mille' (grant no. 10016), AIRC IG (grant no. 17659) (G.D.S.), the Cariplo Foundation (grant no. 2014-0812) (G.D.S.), Stanford Graduate Fellowship (G.R.), German Academic Exchange Service research fellowship (R. P.) and Stanford University School of Medicine Dean's Fellowship (Q.L., R.P. and R.Z.). The Genotype-Tissue Expression (GTEx) project was supported by the Common Fund of the Office of the Director of the NIH. Additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH and NINDS. Donors were enrolled at Biospecimen Source Sites funded by NCI\SAIC-Frederick, Inc. (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171), and Science Care, Inc. (X10S172). The Laboratory, Data Analysis, and Coordinating Center (LDACC) was funded through a contract (HHSN268201000029C) to The Broad Institute, Inc. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by a supplement to University of Miami grants DA006227 and DA033684 and to contract NO1MH000028. Statistical Methods development grants were made to the University of Geneva (MH090941 and MH101814), the University of Chicago (MH090951, MH090937, MH101320 and MH101825), the University of North Carolina-Chapel Hill (MH090936 and MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University St Louis (MH101810), and the University of Pennsylvania (MH101822).	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Behm M, 2016, TRENDS GENET, V32, P165, DOI 10.1016/j.tig.2015.12.005; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Daniel C, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r28; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Higuchi M, 2000, NATURE, V406, P78; Hsieh CL, 2014, CELL DEATH DIFFER, V21, P707, DOI 10.1038/cdd.2013.197; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Kadota K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-294; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Oakes E, 2017, J BIOL CHEM, V292, P4326, DOI 10.1074/jbc.M117.779868; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14941; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Pipes L, 2013, NUCLEIC ACIDS RES, V41, pD906, DOI 10.1093/nar/gks1268; Ramaswami G, 2016, METHODS, V107, P42, DOI 10.1016/j.ymeth.2016.05.011; Ramaswami G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9194; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Sapiro AL, 2015, CELL REP, V11, P697, DOI 10.1016/j.celrep.2015.04.005; Sato K, 2011, BIOINFORMATICS, V27, pI85, DOI 10.1093/bioinformatics/btr215; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Stulic M, 2013, RNA BIOL, V10, P1611, DOI 10.4161/rna.26216; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Tariq A, 2013, NUCLEIC ACIDS RES, V41, P2581, DOI 10.1093/nar/gks1353; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Zhang Q, 2015, NAT METHODS, V12, P347, DOI [10.1038/NMETH.3314, 10.1038/nmeth.3314]; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736	54	5	5	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2017	550	7675					249	+		10.1038/nature24041				24	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ5YG	WOS:000412829500047	29022589				2018-01-05	
J	Abudayyeh, OO; Gootenberg, JS; Essletzbichler, P; Han, S; Joung, J; Belanto, JJ; Verdine, V; Cox, DBT; Kellner, MJ; Regev, A; Lander, ES; Voytas, DF; Ting, AY; Zhang, F				Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Essletzbichler, Patrick; Han, Shuo; Joung, Julia; Belanto, Joseph J.; Verdine, Vanessa; Cox, David B. T.; Kellner, Max J.; Regev, Aviv; Lander, Eric S.; Voytas, Daniel F.; Ting, Alice Y.; Zhang, Feng			RNA targeting with CRISPR-Cas13	NATURE			English	Article							CAS SYSTEMS; EXPRESSION; CELLS; INTERFERENCE; ACTIVATION; KNOCKOUT	RNA has important and diverse roles in biology, but molecular tools to manipulate and measure it are limited. For example, RNA interference(1-3) can efficiently knockdown RNAs, but it is prone to off-target effects(4), and visualizing RNAs typically relies on the introduction of exogenous tags(5). Here we demonstrate that the class 2 type VI6,7 RNA-guided RNA-targeting CRISPR-Cas effector Ca.s13a(8) (previously known as C2c2) can be engineered for mammalian cell RNA knockdown and binding. After initial screening of 15 orthologues, we identified Cas13a from Leptotrichia wadei (LwaCasl3a) as the most effective in an interference assay in Escherichia coli. LwaCasl3a can be heterologously expressed in mammalian and plant cells for targeted knockdown of either reporter or endogenous transcripts with comparable levels of knockdown as RNA interference and improved specificity. Catalytically inactive LwaCasl3a maintains targeted RNA binding activity, which we leveraged for programmable tracking of transcripts in live cells. Our results establish CRISPR-Cas13a as a flexible platform for studying RNA in mammalian cells and therapeutic development.	[Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Essletzbichler, Patrick; Joung, Julia; Verdine, Vanessa; Cox, David B. T.; Kellner, Max J.; Regev, Aviv; Lander, Eric S.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Essletzbichler, Patrick; Joung, Julia; Verdine, Vanessa; Cox, David B. T.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Essletzbichler, Patrick; Joung, Julia; Verdine, Vanessa; Cox, David B. T.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.; Gootenberg, Jonathan S.; Essletzbichler, Patrick; Joung, Julia; Verdine, Vanessa; Cox, David B. T.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Abudayyeh, Omar O.] MIT, Dept Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gootenberg, Jonathan S.; Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Han, Shuo] Stanford Univ, Dept Genet Biol, Stanford, CA 94305 USA; [Han, Shuo] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Belanto, Joseph J.; Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Belanto, Joseph J.; Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Cox, David B. T.; Regev, Aviv; Lander, Eric S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Zhang, F (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Zhang, F (reprint author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org			Paul and Daisy Soros Fellowship and a National Defense Science and Engineering Fellowship; D.G.E. Computational Science Graduate Fellowship; Howard Hughes Medical Institute; National Institutes of Health through the National Institute of Mental Health [5DP1-MH100706, 1R01-MH110049]; New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation	We thank M. Alimova, D. Feldman, F. Chen, J. G. Doench, J. M. Engreitz, N. Habib, D. Tenen, A. Allen, R. Macrae, and R. Belliveau for discussions and support. G.A.A. is supported by a Paul and Daisy Soros Fellowship and a National Defense Science and Engineering Fellowship. J.S.G. is supported by a D.G.E. Computational Science Graduate Fellowship. A.R. is supported by the Howard Hughes Medical Institute. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the National Institutes of Health through the National Institute of Mental Health (5DP1-MH100706 and 1R01-MH110049), the Howard Hughes Medical Institute, the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and James and Patricia Poitras, Robert Metmlfe, and David Cheng.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107                                                                ; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Gross GG, 2013, NEURON, V78, P971, DOI 10.1016/j.neuron.2013.04.017; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mann DGJ, 2012, PLANT BIOTECHNOL J, V10, P226, DOI 10.1111/j.1467-7652.2011.00658.x; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Rath S, 2015, P NATL ACAD SCI USA, V112, P15916, DOI 10.1073/pnas.1513034112; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; Unsworth H, 2010, FASEB J, V24, P3370, DOI 10.1096/fj.09-151142; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	27	2	2	48	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 12	2017	550	7675					280	+		10.1038/nature24049				18	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ5YG	WOS:000412829500053	28976959				2018-01-05	
J	Zhang, Y; Liu, LL; Guo, SJ; Song, JH; Zhu, CX; Yue, ZW; Wei, WS; Yi, CQ				Zhang, Yuan; Liu, Lulu; Guo, Shengjie; Song, Jinghui; Zhu, Chenxu; Yue, Zongwei; Wei, Wensheng; Yi, Chengqi			Deciphering TAL effectors for 5-methylcytosine and 5-hydroxymethylcytosine recognition	NATURE COMMUNICATIONS			English	Article							III EFFECTORS; TET PROTEINS; TRANSCRIPTION FACTORS; DNA DEMETHYLATION; BASE-RESOLUTION; MAMMALIAN DNA; HOST-PLANT; GENOME; 5-CARBOXYLCYTOSINE; XANTHOMONAS	DNA recognition by transcription activator-like effector ( TALE) proteins is mediated by tandem repeats that specify nucleotides through repeat-variable diresidues. These repeat-variable diresidues form direct and sequence-specific contacts to DNA bases; hence, TALE-DNA interaction is sensitive to DNA chemical modifications. Here we conduct a thorough investigation, covering all theoretical repeat-variable diresidue combinations, for their recognition capabilities for 5-methylcytosine and 5-hydroxymethylcytosine, two important epigenetic markers in higher eukaryotes. We identify both specific and degenerate repeat-variable diresidues for 5-methylcytosine and 5-hydroxymethylcytosine. Utilizing these novel repeat-variable diresidues, we achieve methylation-dependent gene activation and genome editing in vivo; we also report base-resolution detection of 5hmC in an in vitro assay. Our work deciphers repeat-variable diresidues for 5-methylcytosine and 5-hydroxymethylcytosine, and provides tools for TALE-dependent epigenome recognition.	[Zhang, Yuan; Liu, Lulu; Guo, Shengjie; Song, Jinghui; Zhu, Chenxu; Yue, Zongwei; Wei, Wensheng; Yi, Chengqi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Zhang, Yuan; Guo, Shengjie; Wei, Wensheng] Peking Univ, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Guo, Shengjie; Wei, Wensheng] Peking Univ, Beijing Adv Innovat Ctr Genom, Beijing 100871, Peoples R China; [Wei, Wensheng; Yi, Chengqi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Yi, Chengqi] Peking Univ, Synthet & Funct Biomol Ctr, Dept Biol Chem, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	Wei, WS; Yi, CQ (reprint author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Wei, WS (reprint author), Peking Univ, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.; Wei, WS (reprint author), Peking Univ, Beijing Adv Innovat Ctr Genom, Beijing 100871, Peoples R China.; Wei, WS; Yi, CQ (reprint author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Yi, CQ (reprint author), Peking Univ, Synthet & Funct Biomol Ctr, Dept Biol Chem, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	wswei@pku.edu.cn; chengqi.yi@pku.edu.cn			National Basic Research Program of China [MOST2016YFC0900301]; National Natural Science Foundation of China [21522201, 91519325, 31430025, 81471909]; Beijing Advanced Innovation Center for Genomics at Peking University; Peking-Tsinghua Center for Life Sciences	We thank Zhonglin Fu for technical assistance. This work was supported by grants from the National Basic Research Program of China (MOST2016YFC0900301) to C.Y. and the National Natural Science Foundation of China (21522201 and 91519325 to C.Y., 31430025 and 81471909 to W.W.). This work was also supported by Beijing Advanced Innovation Center for Genomics at Peking University (to W.W.), and the Peking-Tsinghua Center for Life Sciences (to W.W. and C.Y.).	Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Dupuy A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078678; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Gurlebeck D, 2006, J PLANT PHYSIOL, V163, P233, DOI 10.1016/j.jplph.2005.11.011; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kubik G, 2015, J AM CHEM SOC, V137, P2, DOI 10.1021/ja506022t; Kubik G, 2015, CHEMBIOCHEM, V16, P228, DOI 10.1002/cbic.201402408; Kubik G, 2014, ANGEW CHEM INT EDIT, V53, P6002, DOI 10.1002/anie.201400436; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Maurer S, 2016, ACS CHEM BIOL, V11, P3294, DOI 10.1021/acschembio.6b00627; Miller JC, 2015, NAT METHODS, V12, P465, DOI 10.1038/nmeth.3330; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rathi P, 2016, J AM CHEM SOC, V138, P9910, DOI 10.1021/jacs.6b04807; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Wu H, 2015, NAT STRUCT MOL BIOL, V22, P1, DOI 10.1038/nsmb.3071; Yang JJ, 2016, METHODS MOL BIOL, V1338, P49, DOI 10.1007/978-1-4939-2932-0_5; Yang JJ, 2014, CELL RES, V24, P628, DOI 10.1038/cr.2014.19; Yang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075649; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	42	0	0	20	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	OCT 12	2017	8								901	10.1038/s41467-017-00860-6				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ6IG	WOS:000412860100001	29026078	gold			2018-01-05	
J	Jensen, HM; Eng, T; Chubukov, V; Herbert, RA; Mukhopadhyay, A				Jensen, Heather M.; Eng, Thomas; Chubukov, Victor; Herbert, Robin A.; Mukhopadhyay, Aindrila			Improving membrane protein expression and function using genomic edits	SCIENTIFIC REPORTS			English	Article							ESCHERICHIA-COLI; TOPOLOGY; OVEREXPRESSION; TOLERANCE; PATHWAYS; BACTERIA; STRESS	Expression of membrane proteins often leads to growth inhibition and perturbs central metabolism and this burden varies with the protein being overexpressed. There are also known strain backgrounds that allow greater expression of membrane proteins but that differ in efficacy across proteins. We hypothesized that for any membrane protein, it may be possible to identify a modified strain background where its expression can be accommodated with less burden. To directly test this hypothesis, we used a bar-coded transposon insertion library in tandem with cell sorting to assess genome-wide impact of gene deletions on membrane protein expression. The expression of five membrane proteins (CyoB, CydB, MdlB, YidC, and LepI) and one soluble protein (GST), each fused to GFP, was examined. We identified Escherichia coli mutants that demonstrated increased membrane protein expression relative to that in wild type. For two of the proteins (CyoB and CydB), we conducted functional assays to confirm that the increase in protein expression also led to phenotypic improvement in function. This study represents a systematic approach to broadly identify genetic loci that can be used to improve membrane protein expression, and our method can be used to improve expression of any protein that poses a cellular burden.	[Jensen, Heather M.; Eng, Thomas; Chubukov, Victor; Herbert, Robin A.; Mukhopadhyay, Aindrila] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Jensen, Heather M.; Eng, Thomas; Chubukov, Victor; Herbert, Robin A.; Mukhopadhyay, Aindrila] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA	Mukhopadhyay, A (reprint author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.; Mukhopadhyay, A (reprint author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.	amukhopadhyay@lbl.gov			U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory	We thank Sarah Richardson, Daniel Arlow, Kelly Wetmore, Morgan Price, Mitchel Thompson, Michelle Scott, and Adam Deutschbauer for sharing the E. coli transposon library, valuable discussions and technical assistance. This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Apel AR, 2016, SCI REP-UK, V6, DOI 10.1038/srep19512; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Backlund E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-35; Baumgarten T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45089; Bird LE, 2015, JOVE-J VIS EXP, DOI 10.3791/52357; Boyarskiy S, 2016, METAB ENG, V33, P130, DOI 10.1016/j.ymben.2015.11.005; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Fisher MA, 2014, ACS SYNTH BIOL, V3, P30, DOI 10.1021/sb400065q; Foo JL, 2014, MBIO, V5, DOI 10.1128/mBio.01932-14; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gialama D., 2016, ACSYNTHETIC BIOL; Goldbeck CP, 2013, ACS SYNTH BIOL, V2, P150, DOI 10.1021/sb300119v; Gubellini F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007930; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Jensen HM, 2016, ACS SYNTH BIOL, V5, P679, DOI 10.1021/acssynbio.5b00279; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Kwon SK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16076; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379; Massey-Gendel E, 2009, PROTEIN SCI, V18, P372, DOI 10.1002/pro.39; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mukhopadhyay A, 2015, TRENDS MICROBIOL, V23, P498, DOI 10.1016/j.tim.2015.04.008; Nannenga BL, 2011, PROTEIN SCI, V20, P1411, DOI 10.1002/pro.669; Neidhardt FC, 1996, ESCHERICHIA COLI SAL; Papanastasiou M, 2016, PROTEOMICS, V16, P85, DOI 10.1002/pmic.201500304; Price M. N., 2016, BIORXIV; Rapp M, 2004, PROTEIN SCI, V13, P937, DOI 10.1110/ps.03553804; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Schlegel S, 2015, CELL REP, V10, P1758, DOI 10.1016/j.celrep.2015.02.029; Skretas G, 2010, APPL ENVIRON MICROB, V76, P5852, DOI 10.1128/AEM.00963-10; Skretas G, 2009, BIOTECHNOL BIOENG, V102, P357, DOI 10.1002/bit.22097; TerAvest MA, 2014, CHEMELECTROCHEM, V1, P1874, DOI 10.1002/celc.201402194; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0                                                                ; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; WALL D, 1992, J BACTERIOL, V174, P6554; Wetmore KM, 2015, MBIO, V6, DOI 10.1128/mBio.00306-15; Zweers JC, 2009, APPL ENVIRON MICROB, V75, P7356, DOI 10.1128/AEM.01560-09	47	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 12	2017	7								13030	10.1038/s41598-017-12901-7				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ7PG	WOS:000412950600021	29026162	gold			2018-01-05	
J	Beauruelle, C; Pastuszka, A; Horvath, P; Perrotin, F; Mereghetti, L; Lanotte, P				Beauruelle, Clemence; Pastuszka, Adeline; Horvath, Philippe; Perrotin, Franck; Mereghetti, Laurent; Lanotte, Philippe			CRISPR: A Useful Genetic Feature to Follow Vaginal Carriage of Group B Streptococcus	FRONTIERS IN MICROBIOLOGY			English	Article						CRISPR; Streptococcus agalactiae; carriage; genotyping; diversity	ACQUIRED-RESISTANCE; NATURAL-HISTORY; CAS SYSTEMS; AGALACTIAE; DIVERSITY; PREGNANCY; DISEASE; COLONIZATION; THERMOPHILUS; BACTERIOPHAGES	Clustered regularly interspaced short palindromic repeats (CRISPR) and Cas (CRISPR-associated proteins) play a critical role in adaptive immunity against mobile genetic elements, especially phages, through their ability to acquire novel spacer sequences. Polarized spacer acquisition results in spacer polymorphism and temporal organization of CRISPR loci, making them attractive epidemiological markers. Group B Streptococcus (GBS), a genital commensal for 10 to 30% of healthy women and a major neonatal pathogen, possesses a ubiquitous and functional CRISPR1 locus. Our aim was to assess the CRISPR1 locus as an epidemiological marker to follow vaginal carriage of GBS in women. This study also allowed us to observe the evolution of the CRISPR1 locus in response to probable phage infection occurring in vivo. We followed carriage of GBS among 100 women over an 11-year period, with a median duration of approximately 2 years. The CRISPR1 locus was highly conserved over time. The isolates that show the same CRISPR1 genotype were collected from 83% of women. There was an agreement between CRISPR genotyping and other typing methods [MLVA (multilocus variable number of tandem repeat Analysis) and MLST (multilocus sequence typing)] for 94% of the cases. The CRISPR1 locus of the isolates from 18 women showed modifications, four of which acquired polarized spacer, highlighting the in vivo functionality of the system. The novel spacer of one isolate had sequence similarity with phage, suggesting that phage infection occurred during carriage. These findings improve our understanding of CRISPR-Cas evolution in GBS and provide a glimpse of host-phage dynamics in vivo.	[Beauruelle, Clemence; Pastuszka, Adeline; Mereghetti, Laurent; Lanotte, Philippe] Univ Francois Rabelais Tours, Infectiol & Sante Publ UMR1282, Tours, France; [Beauruelle, Clemence; Pastuszka, Adeline; Mereghetti, Laurent; Lanotte, Philippe] INRA, Infectiol & Sante Publ UMR1282, Nouzilly, France; [Beauruelle, Clemence; Pastuszka, Adeline; Mereghetti, Laurent; Lanotte, Philippe] CHU Tours, Serv Bacteriol Virol, Tours, France; [Horvath, Philippe] DuPont Nutr & Hlth, Dange St Romain, France; [Perrotin, Franck] Univ Francois Rabelais Tours, Inserm U930, Tours, France; [Perrotin, Franck] CHU Tours, Dept Obstet Gynecol & Med Foetale, Tours, France	Lanotte, P (reprint author), Univ Francois Rabelais Tours, Infectiol & Sante Publ UMR1282, Tours, France.; Lanotte, P (reprint author), INRA, Infectiol & Sante Publ UMR1282, Nouzilly, France.; Lanotte, P (reprint author), CHU Tours, Serv Bacteriol Virol, Tours, France.	philippe.lanotte@univ-tours.fr					ANAES, 2001, J GYNECOL OBST BIO R, V32, P68; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; ANTHONY BF, 1978, J INFECT DIS, V137, P524, DOI 10.1093/infdis/137.5.524                                                        ; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2013, BIOCHEM SOC T, V41, P1383, DOI 10.1042/BST20130160; Berardi A, 2013, PEDIATRICS, V131, pE361, DOI 10.1542/peds.2012-1231; Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Brzychczy-Wloch M, 2014, NEW MICROBIOL, V37, P307; Colbourn T, 2007, EARLY HUM DEV, V83, P149, DOI 10.1016/j.earlhumdev.2007.01.004; Davies MR, 2007, J BACTERIOL, V189, P2646, DOI 10.1128/JB.01590-06; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Di Renzo GC, 2015, J MATERN-FETAL NEO M, V28, P766, DOI 10.3109/14767058.2014.934804; DILLON HC, 1982, J INFECT DIS, V145, P794, DOI 10.1093/infdis/145.6.794                                                        ; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Haguenoer E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-171; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lanotte P., 2012, EUROPEAN MANUAL CLIN, P241; LEWIN EB, 1981, AM J OBSTET GYNECOL, V139, P512, DOI 10.1016/0002-9378(81)90509-3                                                    ; Lier C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00214; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Nozawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019543; Perez-Ruiz M, 2004, EPIDEMIOL INFECT, V132, P375, DOI 10.1017/S0950268803001845; Pride DT, 2011, GENOME RES, V21, P126, DOI 10.1101/gr.111732.110; REGAN JA, 1991, OBSTET GYNECOL, V77, P604; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Slotved HC, 2007, J CLIN MICROBIOL, V45, P2929, DOI 10.1128/JCM.00117-07; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; YANCEY MK, 1994, OBSTET GYNECOL, V84, P816; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	43	0	0	10	10	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	OCT 11	2017	8								1981	10.3389/fmicb.2017.01981				10	Microbiology	Microbiology	FJ4OX	WOS:000412721100001	29075246	gold			2018-01-05	
J	Zhang, DB; Zhang, HW; Li, TD; Chen, KL; Qiu, JL; Gao, CX				Zhang, Dingbo; Zhang, Huawei; Li, Tingdong; Chen, Kunling; Qiu, Jin-Long; Gao, Caixia			Perfectly matched 20-nucleotide guide RNA sequences enable robust genome editing using high-fidelity SpCas9 nucleases	GENOME BIOLOGY			English	Article							CRISPR-CAS NUCLEASES; HUMAN-CELLS; SPECIFICITY; SYSTEM; WHEAT; ENDONUCLEASES; VERSATILE; CLEAVAGE; PLANTS; RICE	High-fidelity SpCas9 variants (eSpCas9 and SpCas9-HF1) have been engineered to reduce off-target effects. We found that changes in guide RNA length induced significant reductions in the editing activities of SpCas9 variants in plant cells. Single guide RNAs harboring precise, perfectly matched 20-nucleotide guide sequences are necessary for high on-target editing activities of eSpCas9 and SpCas9-HF1. Precise 20-nucleotide guide sequences derived from tRNA sgRNA precursors enable robust on-target editing by these variants with enhanced specificity. Our work reveals an effective way of enhancing the use of the high-fidelity SpCas9 nucleases for efficient and precise genome engineering.	[Zhang, Dingbo; Zhang, Huawei; Li, Tingdong; Chen, Kunling; Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Zhang, Dingbo; Zhang, Huawei; Li, Tingdong; Chen, Kunling; Gao, Caixia] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Genome Editing, Beijing, Peoples R China; [Zhang, Dingbo; Li, Tingdong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Qiu, Jin-Long] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China	Gao, CX (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.; Gao, CX (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Genome Editing, Beijing, Peoples R China.	cxgao@genetics.ac.cn			National Transgenic Science and Technology Program [2016ZX08010-002]; National Key Research and Development Program of China [2016YFD0101804]; Chinese Academy of Sciences [QYZDY-SSW-SMC030, GJHZ1602]; National Natural Science Foundation of China [31420103912, 31501376, 31570369]	This work was supported by grants from the National Transgenic Science and Technology Program (2016ZX08010-002), the National Key Research and Development Program of China (2016YFD0101804), the Chinese Academy of Sciences (QYZDY-SSW-SMC030 and GJHZ1602), and the National Natural Science Foundation of China (31420103912, 31501376, and 31570369).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cameron P, 2017, NAT METHODS, V14, P600, DOI [10.1038/NMETH.4284, 10.1038/nmeth.4284]; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nowak CM, 2016, NUCLEIC ACIDS RES, V44, P9555, DOI 10.1093/nar/gkw908; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rees Holly A, 2017, Nat Commun, V8, P15790, DOI 10.1038/ncomms15790; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yan WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15058; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	42	0	0	27	27	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	OCT 11	2017	18								191	10.1186/s13059-017-1325-9				7	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FJ5EX	WOS:000412771300001	29020979	gold			2018-01-05	
J	Seo, J; Kritskiy, O; Watson, LA; Barker, SJ; Dey, D; Raja, WK; Lin, YT; Ko, T; Cho, S; Penney, J; Silva, XC; Sheridan, SD; Lucente, D; Gusella, JF; Dickerson, BC; Haggarty, SJ; Tsai, LH				Seo, Jinsoo; Kritskiy, Oleg; Watson, L. Ashley; Barker, Scarlett J.; Dey, Dilip; Raja, Waseem K.; Lin, Yuan-Ta; Ko, Tak; Cho, Sukhee; Penney, Jay; Silva, M. Catarina; Sheridan, Steven D.; Lucente, Diane; Gusella, James F.; Dickerson, Bradford C.; Haggarty, Stephen J.; Tsai, Li-Huei			Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia	JOURNAL OF NEUROSCIENCE			English	Article						Alzheimer's disease; cerebral organoids; cyclin-dependent kinase 5; iPSCs; isogenic; tauopathy	PLURIPOTENT STEM-CELLS; CDK5 ACTIVATOR P35; ALZHEIMERS-DISEASE; TAU HYPERPHOSPHORYLATION; NEUROFIBRILLARY TANGLES; IN-VIVO; P25; PHOSPHORYLATION; CALPAIN; MICE	Increased p25, a proteolytic fragment of the regulatory subunit p35, is known to induce aberrant activity of cyclin-dependent kinase 5 (Cdk5), which is associated with neurodegenerative disorders, including Alzheimer's disease. Previously, we showed that replacing endogenous p35 with the noncleavable mutant p35 (Delta p35) attenuated amyloidosis and improved cognitive function in a familial Alzheimer's disease mouse model. Here, to address the role of p25/Cdk5 in tauopathy, we generated double-transgenic mice by crossing mice overexpressing mutant human tau (P301S) with Delta p35KI mice. We observed significant reduction of phosphorylated tau and its seeding activity in the brain of double transgenic mice compared with the P301S mice. Furthermore, synaptic loss and impaired LTP at hippocampal CA3 region of P301S mice were attenuated by blocking p25 generation. To further validate the role of p25/Cdk5 in tauopathy, we used frontotemporal dementia patient-derived induced pluripotent stem cells (iPSCs) carrying the Tau P301L mutation and generated P301L: Delta p35KI isogenic iPSC lines using CRISPR/Cas9 genome editing. We created cerebral organoids from the isogenic iPSCs and found that blockade of p25 generation reduced levels of phosphorylated tau and increased expression of synaptophysin. Together, these data demonstrate a crucial role for p25/Cdk5 in mediating tau-associated pathology and suggest that inhibition of this kinase can remedy neurodegenerative processes in the presence of pathogenic tau mutation.	[Seo, Jinsoo; Kritskiy, Oleg; Watson, L. Ashley; Barker, Scarlett J.; Dey, Dilip; Raja, Waseem K.; Lin, Yuan-Ta; Ko, Tak; Cho, Sukhee; Penney, Jay; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Seo, Jinsoo; Watson, L. Ashley; Barker, Scarlett J.; Raja, Waseem K.; Lin, Yuan-Ta; Penney, Jay; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Silva, M. Catarina; Sheridan, Steven D.; Haggarty, Stephen J.] Massachusetts Gen Hosp, Dept Neurol & Psychiat, Ctr Genom Med, Boston, MA 02114 USA; [Silva, M. Catarina; Sheridan, Steven D.; Lucente, Diane; Gusella, James F.; Haggarty, Stephen J.] Harvard Med Sch, Boston, MA 02114 USA; [Lucente, Diane; Gusella, James F.] Massachusetts Gen Hosp, Ctr Genom Med, Mol Neurogenet Unit, Boston, MA 02114 USA; [Dickerson, Bradford C.] Massachusetts Gen Hosp, Frontotemporal Disorders Unit, Gerontol Res Unit, Charlestown, MA 02129 USA; [Dickerson, Bradford C.] Massachusetts Gen Hosp, Alzheimers Dis Res Ctr, Dept Neurol, Charlestown, MA 02129 USA; [Dickerson, Bradford C.] Harvard Med Sch, Charlestown, MA 02129 USA; [Tsai, Li-Huei] Broad Inst Harvard, Cambridge, MA 02142 USA; [Tsai, Li-Huei] MIT, Cambridge, MA 02142 USA	Tsai, LH (reprint author), MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA.	lhtsai@mit.edu			National Institutes of Health [R37NS051874]; Robert A. and Renee E. Belfer Family Foundation; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R21NS085487]; Belfer Neurodegeneration Consortium; Association for Frontotemporal Degeneration; Tau Consortium	This work was supported by National Institutes of Health Grant R37NS051874, Robert A. and Renee E. Belfer Family Foundation, and Belfer Neurodegeneration Consortium to L.-H.T., National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant R21NS085487 to S.J.H. and B.C.D., Association for Frontotemporal Degeneration to M.C.S., and Tau Consortium to S.J.H. We thank all members of L.-H.T. laboratory for advice and discussion; and Ting Fu for technical assistance with iPSC reprogramming.	Adams SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010810; Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kimura T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00065; Kolarova M, 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/731526; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kondadi AK, 2014, EMBO J, V33, P1011, DOI 10.1002/embj.201387009; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199                                                          ; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636                                                                ; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Miller N, 2015, J NEUROSCI, V35, P6038, DOI 10.1523/JNEUROSCI.3716-14.2015; Mou XN, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt105; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9                                                   ; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159                                                                   ; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao MV, 2014, J NEUROSCI, V34, P9222, DOI 10.1523/JNEUROSCI.1132-14.2014; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Seo J, 2014, CELL, V157, P486, DOI 10.1016/j.cell.2014.01.065; Siegert S, 2015, NAT NEUROSCI, V18, P1008, DOI 10.1038/nn.4023; Silva MC, 2016, STEM CELL REP, V7, P325, DOI 10.1016/j.stemcr.2016.08.001; Van den Haute C, 2001, NEUROBIOL DIS, V8, P32, DOI 10.1006/nbdi.2000.0333; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang XM, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.436402; Zhang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076055	37	0	0	9	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 11	2017	37	41					9917	9924		10.1523/JNEUROSCI.0621-17.2017				8	Neurosciences	Neurosciences & Neurology	FJ5NY	WOS:000412800500011	28912154				2018-01-05	
J	Guo, WT; Naujock, M; Fumagalli, L; Vandoorne, T; Baatsen, P; Boon, R; Ordovas, L; Patel, A; Welters, M; Vanwelden, T; Geens, N; Tricot, T; Benoy, V; Steyaert, J; Lefebvre-Omar, C; Boesmans, W; Jarpe, M; Sterneckert, J; Wegner, F; Petri, S; Bohl, D; Vanden Berghe, P; Robberecht, W; Van Damme, P; Verfaillie, C; Van den Bosch, L				Guo, Wenting; Naujock, Maximilian; Fumagalli, Laura; Vandoorne, Tijs; Baatsen, Pieter; Boon, Ruben; Ordovas, Laura; Patel, Abdulsamie; Welters, Marc; Vanwelden, Thomas; Geens, Natasja; Tricot, Tine; Benoy, Veronick; Steyaert, Jolien; Lefebvre-Omar, Cynthia; Boesmans, Werend; Jarpe, Matthew; Sterneckert, Jared; Wegner, Florian; Petri, Susanne; Bohl, Delphine; Vanden Berghe, Pieter; Robberecht, Wim; Van Damme, Philip; Verfaillie, Catherine; Van den Bosch, Ludo			HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients	NATURE COMMUNICATIONS			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PLURIPOTENT STEM-CELLS; ENDOPLASMIC-RETICULUM; MUTANT SOD1; MUTATIONS; MITOCHONDRIA; PROTEIN; DEACETYLASE; REVEALS; DISEASE	Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder due to selective loss of motor neurons (MNs). Mutations in the fused in sarcoma (FUS) gene can cause both juvenile and late onset ALS. We generated and characterized induced pluripotent stem cells (iPSCs) from ALS patients with different FUS mutations, as well as from healthy controls. Patient-derived MNs show typical cytoplasmic FUS pathology, hypoexcitability, as well as progressive axonal transport defects. Axonal transport defects are rescued by CRISPR/Cas9-mediated genetic correction of the FUS mutation in patient-derived iPSCs. Moreover, these defects are reproduced by expressing mutant FUS in human embryonic stem cells (hESCs), whereas knockdown of endogenous FUS has no effect, confirming that these pathological changes are mutant FUS dependent. Pharmacological inhibition as well as genetic silencing of histone deacetylase 6 (HDAC6) increase a-tubulin acetylation, endoplasmic reticulum (ER)-mitochondrial overlay, and restore the axonal transport defects in patient-derived MNs.	[Guo, Wenting; Fumagalli, Laura; Vandoorne, Tijs; Geens, Natasja; Benoy, Veronick; Steyaert, Jolien; Robberecht, Wim; Van Damme, Philip; Van den Bosch, Ludo] Katholieke Univ Leuven, Dept Neurosci Expt Neurol, B-3000 Leuven, Belgium; [Guo, Wenting; Fumagalli, Laura; Vandoorne, Tijs; Geens, Natasja; Benoy, Veronick; Steyaert, Jolien; Robberecht, Wim; Van Damme, Philip; Van den Bosch, Ludo] Katholieke Univ Leuven, LIND, B-3000 Leuven, Belgium; [Guo, Wenting; Fumagalli, Laura; Vandoorne, Tijs; Geens, Natasja; Benoy, Veronick; Steyaert, Jolien; Van Damme, Philip; Van den Bosch, Ludo] VIB, Ctr Brain & Dis Res, Lab Neurobiol, B-3000 Leuven, Belgium; [Naujock, Maximilian; Wegner, Florian; Petri, Susanne] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany; [Naujock, Maximilian] CNS, Res Dept, Boehringer Ingelheim Pharma GmbH & Co KG, D-88400 Biberach, Germany; [Baatsen, Pieter] VIB Bio Imaging Core, B-3000 Leuven, Belgium; [Baatsen, Pieter] VIB, KU Leuven, Ctr Brain & Dis Res, B-3000 Leuven, Belgium; [Boon, Ruben; Ordovas, Laura; Patel, Abdulsamie; Welters, Marc; Vanwelden, Thomas; Tricot, Tine; Verfaillie, Catherine] Katholieke Univ Leuven, Stem Cell Inst SCIL, B-3000 Leuven, Belgium; [Ordovas, Laura] Aragon ID Fdn ARAID, Zaragoza 50018, Spain; [Ordovas, Laura] Univ Zaragoza, Aragon Inst Engn Res, Biomed Signal Interpretat & Computat Simulat BSIC, IIS Aragon, Zaragoza 50018, Spain; [Lefebvre-Omar, Cynthia; Bohl, Delphine] Univ Paris 06, Sorbonne Univ, UPMC,Inst Cerveau & Moelle Epiniere ICM, INSERM,CNRS,UMR 7225,U 1127,Hop Pitie Salpetriere, F-75013 Paris, France; [Boesmans, Werend; Vanden Berghe, Pieter] Katholieke Univ Leuven, TARGID, Lab Enter NeuroSci, B-3000 Leuven, Belgium; [Jarpe, Matthew] Acetylon Pharmaceut Inc, Boston, MA 02210 USA; [Sterneckert, Jared] Tech Univ Dresden, CRTD, D-01069 Dresden, Germany; [Robberecht, Wim; Van Damme, Philip] Univ Hosp Leuven, Dept Neurol, B-3000 Leuven, Belgium	Van den Bosch, L (reprint author), Katholieke Univ Leuven, Dept Neurosci Expt Neurol, B-3000 Leuven, Belgium.; Van den Bosch, L (reprint author), Katholieke Univ Leuven, LIND, B-3000 Leuven, Belgium.; Van den Bosch, L (reprint author), VIB, Ctr Brain & Dis Res, Lab Neurobiol, B-3000 Leuven, Belgium.; Verfaillie, C (reprint author), Katholieke Univ Leuven, Stem Cell Inst SCIL, B-3000 Leuven, Belgium.	Catherine.Verfaillie@med.kuleuven.be; Ludo.Vandenbosch@kuleuven.vib.be	Van Damme, Philip/A-6464-2009	Van Damme, Philip/0000-0001-6384-0611; Ordovas, Laura/0000-0003-3982-1263; Verfaillie, Catherine/0000-0001-7564-4079; Van Damme, Philip/0000-0002-4010-2357; Boon, Ruben/0000-0002-9355-674X; Van Den Bosch, Ludo/0000-0003-0104-4067	KU Leuven; Fund for Scientific Research Flanders (FWO-Vlaanderen); Agency for Innovation by Science and Technology (IWT); Belgian Government (Interuniversity Attraction Poles Programme) [P7/16]; Thierry Latran Foundation; "Association Belge contre les Maladies neuro-Musculaires" (ABMM); FWO-Vlaanderen under E-RARE-2; ERA-Net for Research on Rare Diseases (PYRAMID); EU Joint Programme - Neurodegenerative Disease Research (JPND) project (STRENGTH); ALS Liga Belgie; Flemish government-initiated Flanders Impulse Program on Networks for Dementia Research (VIND); China Scholarship Council (CSC); E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders; European Research Council under the European's Seventh Framework Programme [340429]; Deutsche Gesellschaft fur Muskelkranke; Initiative Therapieforschung ALS; ANR (LabEx Revive, Investissement d'Avenir) [ANR-10-LABX-73]; Association Francaise contre les Myopathies (AFM) [16465]; Agency for Innovation by Science and Technology (SBO-iPSCAF); EU Joint Programme - Neurodegenerative Disease Research (JPND) project (RiMod-FTD); Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.)	We thank Sarah Debray and Joni Vanneste for their help with iPSC culturing. We thank Balazs Toth for the initial guidance with the patch clamp experiments. We thank Franziska Bursch for helping with the patch clamp experiments. We thank Steven Boeynaems, Elke Bogaert and Benjamin Gille for guidance with the data analysis. We thank Dr Haibo Wang and Prof Muralidhar L. Hegde for warm help and nice discussions. This work was supported by the KU Leuven (C1 and "Opening the Future" Fund), the "Fund for Scientific Research Flanders" (FWO-Vlaanderen), the Agency for Innovation by Science and Technology (IWT; SBO-iPSCAF), the Belgian Government (Interuniversity Attraction Poles Programme P7/16 initiated by the Belgian Federal Science Policy Office), the Thierry Latran Foundation, the "Association Belge contre les Maladies neuro-Musculaires" (ABMM), the FWO-Vlaanderen under the frame of E-RARE-2, the ERA-Net for Research on Rare Diseases (PYRAMID), the EU Joint Programme - Neurodegenerative Disease Research (JPND) projects (STRENGTH and RiMod-FTD), the ALS Liga Belgie (A Cure for ALS) and the Flemish government-initiated Flanders Impulse Program on Networks for Dementia Research (VIND). W.G. is supported by the China Scholarship Council (CSC). W.R. is supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.) and the European Research Council under the European's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement No. 340429. W.B. is a postdoctoral fellow of FWO. P.V.D holds a senior clinical investigatorship of FWO-Vlaanderen. F.W. and S.P. are supported in part by the Deutsche Gesellschaft fur Muskelkranke and the Initiative Therapieforschung ALS e.V. including the contribution of Elmar Siger in memory of his wife Ingrid. D.B. thanks ANR (LabEx Revive, Investissement d'Avenir, ANR-10-LABX-73) and the Association Francaise contre les Myopathies (AFM grant 16465) for their financial support. C.L. is a PhD fellow supported by ANR-10-LABX-73.	Arbab M, 2014, TRENDS NEUROSCI, V37, P642, DOI 10.1016/j.tins.2014.07.008; Baumer D, 2010, NEUROLOGY, V75, P611, DOI 10.1212/WNL.0b013e3181ed9cde; Baldwin KR, 2016, HUM MOL GENET, V25, P2378, DOI 10.1093/hmg/ddw105; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; De Vos KJ, 2017, NEUROBIOL DIS, V105, P283, DOI 10.1016/j.nbd.2017.02.004; Devlin A.-C., 2014, NAT COMMUN, V6, P1; Dormann D, 2013, MOL CELL NEUROSCI, V56, P475, DOI 10.1016/j.mcn.2013.03.006; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Godena VK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6245; Groen EJN, 2013, HUM MOL GENET, V22, P3690, DOI 10.1093/hmg/ddt222; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ichiyanagi N, 2016, STEM CELL REP, V6, P496, DOI 10.1016/j.stemcr.2016.02.011; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Lanson NA, 2012, BRAIN RES, V1462, P44, DOI 10.1016/j.brainres.2012.01.039; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Liu ML, 2016, CELL REP, V14, P115, DOI 10.1016/j.celrep.2015.12.018; Liu XX, 2015, NEUROGENETICS, V16, P223, DOI 10.1007/s10048-015-0448-y; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Majid T., 2015, ALZHEIMERS DEMENT, V1, P170; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Miskiewicz K, 2014, CELL REP, V8, P94, DOI 10.1016/j.celrep.2014.05.051; Naujock M, 2016, STEM CELLS, V34, P1563, DOI 10.1002/stem.2354; Ordovas L., 2016, JOVE-J VIS EXP, V117; Ordovas L, 2015, STEM CELL REP, V5, P918, DOI 10.1016/j.stemcr.2015.09.004; Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008; Poppe L, 2014, EXP NEUROL, V262, P138, DOI 10.1016/j.expneurol.2014.07.001; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Sainath R, 2015, DEV NEUROBIOL, V75, P757, DOI 10.1002/dneu.22246; Sharma A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10465; Shelkovnikova TA, 2013, BIOCHEM SOC T, V41, P1613, DOI 10.1042/BST20130212; Stoica R, 2016, EMBO REP, V17, P1326, DOI 10.15252/embr.201541726; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Taes I, 2013, HUM MOL GENET, V22, P1783, DOI 10.1093/hmg/ddt028; Urwyler O, 2015, DEVELOPMENT, V142, P394, DOI 10.1242/dev.115071; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vanden Berghe P, 2004, AM J PHYSIOL-GASTR L, V286, pG671, DOI 10.1152/ajpgi.00283.2003; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Wang WZ, 2017, MOL THER, V25, P127, DOI 10.1016/j.ymthe.2016.10.013; Williamson TL, 1999, NAT NEUROSCI, V2, P50; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	55	1	1	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	OCT 11	2017	8								861	10.1038/s41467-017-00911-y				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ5GA	WOS:000412775700001	29021520	gold			2018-01-05	
J	Oppikofer, M; Sagolla, M; Haley, B; Zhang, HM; Kummerfeld, SK; Sudhamsu, J; Flynn, EM; Bai, TY; Zhang, J; Ciferri, C; Cochran, AG				Oppikofer, Mariano; Sagolla, Meredith; Haley, Benjamin; Zhang, Hui-Min; Kummerfeld, Sarah K.; Sudhamsu, Jawahar; Flynn, E. Megan; Bai, Tianyi; Zhang, Jennifer; Ciferri, Claudio; Cochran, Andrea G.			Non-canonical reader modules of BAZ1A promote recovery from DNA damage	NATURE COMMUNICATIONS			English	Article							DOUBLE-STRAND BREAK; NUCLEOTIDE EXCISION-REPAIR; RESONANCE MASS-SPECTROMETRY; HOMOLOGOUS RECOMBINATION; PHD FINGER; CHROMATIN-REMODELERS; HUMAN-CELLS; HISTONE H4; ISWI; RECOGNITION	Members of the ISWI family of chromatin remodelers mobilize nucleosomes to control DNA accessibility and, in some cases, are required for recovery from DNA damage. However, it remains poorly understood how the non-catalytic ISWI subunits BAZ1A and BAZ1B might contact chromatin to direct the ATPase SMARCA5. Here, we find that the plant homeodomain of BAZ1A, but not that of BAZ1B, has the unusual function of binding DNA. Furthermore, the BAZ1A bromodomain has a non-canonical gatekeeper residue and binds relatively weakly to acetylated histone peptides. Using CRISPR-Cas9-mediated genome editing we find that BAZ1A and BAZ1B each recruit SMARCA5 to sites of damaged chromatin and promote survival. Genetic engineering of structure-designed bromodomain and plant homeodomain mutants reveals that reader modules of BAZ1A and BAZ1B, even when nonstandard, are critical for DNA damage recovery in part by regulating ISWI factors loading at DNA lesions and supporting transcriptional programs required for survival.	[Oppikofer, Mariano; Flynn, E. Megan; Cochran, Andrea G.] Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA; [Sagolla, Meredith] Genentech Inc, Ctr Adv Light Microscopy, 1 DNA Way, San Francisco, CA 94080 USA; [Haley, Benjamin] Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA; [Zhang, Hui-Min; Zhang, Jennifer] Genentech Inc, Prot Analyt Chem, 1 DNA Way, San Francisco, CA 94080 USA; [Kummerfeld, Sarah K.] Genentech Inc, Dept Bioinformat & Computat Biol, 1 DNA Way, San Francisco, CA 94080 USA; [Sudhamsu, Jawahar; Bai, Tianyi; Ciferri, Claudio] Genentech Inc, Dept Struct Biol, 1 DNA Way, San Francisco, CA 94080 USA; [Oppikofer, Mariano] Pfizer Worldwide Res & Dev, 558 Eastern Point Rd, Groton, CT 06340 USA; [Bai, Tianyi] STEMCELL Technol Inc, 1618 Stn St, Vancouver, BC V6A 1B6, Canada	Oppikofer, M; Cochran, AG (reprint author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	mariano.oppikofer@pfizer.com; cochran.andrea@gene.com					Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alekseev S, 2015, CELL MOL LIFE SCI, V72, P2177, DOI 10.1007/s00018-015-1859-5; Aydin OZ, 2014, CELL CYCLE, V13, P3016, DOI 10.4161/15384101.2014.956551; Aydin OZ, 2014, NUCLEIC ACIDS RES, V42, P8473, DOI 10.1093/nar/gku565; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dowdle JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003945; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Erdel F, 2011, NUCLEUS-AUSTIN, V2, P105, DOI 10.4161/nucl.2.2.15209; Erdel F, 2011, FEBS J, V278, P3608, DOI 10.1111/j.1742-4658.2011.08282.x; Ewing AK, 2007, MOL ENDOCRINOL, V21, P1791, DOI 10.1210/me.2007-0095; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Flynn EM, 2015, STRUCTURE, V23, P1801, DOI 10.1016/j.str.2015.08.004; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gong FD, 2015, GENE DEV, V29, P197, DOI 10.1101/gad.252189.114; HUANG CH, 1981, BIOCHEMISTRY-US, V20, P233, DOI 10.1021/bi00505a001; Hwang WL, 2014, NATURE, V512, P213, DOI 10.1038/nature13380; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kan ZY, 2011, J AM SOC MASS SPECTR, V22, P1906, DOI 10.1007/s13361-011-0236-3; Klement K, 2014, J CELL BIOL, V207, P717, DOI 10.1083/jcb.201405077; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lan L, 2010, MOL CELL, V40, P976, DOI 10.1016/j.molcel.2010.12.003; Lans H, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-4; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Ligtenberg W., 2017, REACTOME DB SET ANNO; Liu L, 2012, J STRUCT BIOL, V180, P165, DOI 10.1016/j.jsb.2012.06.014; Liu YI, 2008, DEV BIOL, V323, P41, DOI 10.1016/j.ydbio.2008.08.011; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251; Ma L, 2013, J BIOL CHEM, V288, P10154, DOI 10.1074/jbc.M112.445866; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansfield RE, 2011, J BIOL CHEM, V286, P11779, DOI 10.1074/jbc.M110.208207; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Oliveira DV, 2014, J CELL SCI, V127, P763, DOI 10.1242/jcs.135855; Otwinowski Z., 1997, METHODS ENZYMOLOGY; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Sanchez-Molina S, 2011, NUCLEIC ACIDS RES, V39, P8445, DOI 10.1093/nar/gkr435; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Singh N, 2012, P NATL ACAD SCI USA, V109, P14381, DOI 10.1073/pnas.1212366109; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Smeenk G, 2013, J CELL SCI, V126, P889, DOI 10.1242/jcs.109413; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Spivak G, 2015, DNA REPAIR, V36, P13, DOI 10.1016/j.dnarep.2015.09.003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki K, 2011, NAT PROTOC, V6, P134, DOI 10.1038/nprot.2010.183; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Vidi PA, 2014, NUCLEIC ACIDS RES, V42, P6365, DOI 10.1093/nar/gku296; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; Zhang Q, 2011, ANAL CHEM, V83, P7129, DOI 10.1021/ac201501z; Zhang XS, 1997, FREE RADICAL BIO MED, V23, P980, DOI 10.1016/S0891-5849(97)00126-3	76	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	OCT 11	2017	8								862	10.1038/s41467-017-00866-0				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ5GA	WOS:000412775700002	29021563	gold			2018-01-05	
J	Meyer, KA; Davis, TW; Watson, SB; Denef, VJ; Berry, MA; Dick, GJ				Meyer, Kevin Anthony; Davis, Timothy W.; Watson, Susan B.; Denef, Vincent J.; Berry, Michelle A.; Dick, Gregory J.			Genome sequences of lower Great Lakes Microcystis sp reveal strain-specific genes that are present and expressed in western Lake Erie blooms	PLOS ONE			English	Article							FORMING CYANOBACTERIUM MICROCYSTIS; HARMFUL ALGAL BLOOMS; RIBOSOMAL-RNA GENE; BLUE-GREEN-ALGAE; PROCHLOROCOCCUS ECOTYPES; TOXIC CYANOBACTERIUM; MARINE BACTERIOPLANKTON; POPULATION-STRUCTURE; NONTOXIC STRAINS; SPACER SEQUENCE	Blooms of the potentially toxic cyanobacterium Microcystis are increasing worldwide. In the Laurentian Great Lakes they pose major socioeconomic, ecological, and human health threats, particularly in western Lake Erie. However, the interpretation of "omics" data is constrained by the highly variable genome of Microcystis and the small number of reference genome sequences from strains isolated from the Great Lakes. To address this, we sequenced two Microcystis isolates from Lake Erie (Microcystis aeruginosa LE3 and M. wesenbergii LE013-01) and one from upstream Lake St. Clair (M. cf aeruginosa LSC13-02), and compared these data to the genomes of seventeen Microcystis spp. from across the globe as well as one metagenome and seven metatranscriptomes from a 2014 Lake Erie Microcystis bloom. For the publically available strains analyzed, the core genome is similar to 1900 genes, representing similar to 11% of total genes in the pan-genome and similar to 45% of each strain's genome. The flexible genome content was related to Microcystis subclades defined by phylogenetic analysis of both housekeeping genes and total core genes. To our knowledge this is the first evidence that the flexible genome is linked to the core genome of the Microcystis species complex. The majority of strain-specific genes were present and expressed in bloom communities in Lake Erie. Roughly 8% of these genes from the lower Great Lakes are involved in genome plasticity (rapid gain, loss, or rearrangement of genes) and resistance to foreign genetic elements (such as CRISPR-Cas systems). Intriguingly, strain-specific genes from Microcystis cultured from around the world were also present and expressed in the Lake Erie blooms, suggesting that the Microcystis pangenome is truly global. The presence and expression of flexible genes, including strain-specific genes, suggests that strain-level genomic diversity may be important in maintaining Microcystis abundance during bloom events.	[Meyer, Kevin Anthony] Univ Michigan, CIGLR, Ann Arbor, MI USA; [Meyer, Kevin Anthony; Dick, Gregory J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Davis, Timothy W.] NOAA, Great Lakes Environm Res Lab, Ann Arbor, MI USA; [Watson, Susan B.] Environm & Climate Change Canada, Burlington, ON, Canada; [Denef, Vincent J.; Berry, Michelle A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI USA	Dick, GJ (reprint author), Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA.	gdick@umich.edu			Erb Family Foundation through University of Michigan Water Center [N017871]; Environmental Protection Agency Great Lakes Restoration Initiative [2015-062a]; National Oceanic and Atmospheric Administration; University of Michigan [NA120AR4320071]; University of Michigan Office for Research MCubed program; Erb Family Foundation through University of Michigan Water Center	This work was supported by a grant from the Erb Family Foundation made through the University of Michigan Water Center (Grant N017871) and by an Environmental Protection Agency Great Lakes Restoration Initiative Grant (2015-062a). Funding was awarded to the Cooperative Institute for Limnology and Ecosystems Research through the National Oceanic and Atmospheric Administration Cooperative Agreement with the University of Michigan (NA120AR4320071). This project was supported by grants from the University of Michigan Office for Research MCubed program and the Erb Family Foundation made through the University of Michigan Water Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank NOAA-GLERL, specifically Duane Gossiaux and the Captains and crew of NOAA-GLERL R/V R4105 and to CIGLR, specifically Tom Johengen and Dack Stuart, for their assistance with field collection of samples. Thanks also to Paul Den Uyl and Sunit Jain of the University of Michigan for assistance with fieldwork and bioinformatics, respectively. This project was supported by grants from the University of Michigan Office for Research MCubed program and the Erb Family Foundation made through the University of Michigan Water Center. This manuscript is CIGLR publication number 1118 and NOAA GLERL publication number 1868.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Berry MA, 2017, ENVIRON MICROBIOL, V19, P1149, DOI 10.1111/1462-2920.13640; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Bridgeman TB, 2013, J GREAT LAKES RES, V39, P83, DOI 10.1016/j.jglr.2012.11.004; Brittain SM, 2000, J GREAT LAKES RES, V26, P241, DOI 10.1016/S0380-1330(00)70690-3                                                   ; Buffalo V., 2014, SCYTHE BAYESIAN ADAP; Bullerjahn GS, 2016, HARMFUL ALGAE, V54, P223, DOI 10.1016/j.hal.2016.01.003; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954                                                       ; Chaffin JD, 2011, J GREAT LAKES RES, V37, P92, DOI 10.1016/j.jglr.2010.11.016; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; Childs LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101710; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Crosbie ND, 2003, APPL ENVIRON MICROB, V69, P5716, DOI 10.1128/AEM.69.9.5716-5721.2003; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Davis TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106093; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ejnohova S A L, 2007, LIMNOL OCEANOGR, V52, P609; Felsenstein J., 2005, PHYLOGENY INFERENCE; FERGUSON RL, 1984, APPL ENVIRON MICROB, V47, P49; Fiore MF, 2013, GENOME ANNOUNC, V1; Fischer S, 2011, CURR PROTOC BIOINFOR, V12, P1, DOI DOI 10.1002/0471250953.BI0612S35; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fristachi A, 2008, CYANOBACTERIAL HARMF, P45; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gobler CJ, 2016, HARMFUL ALGAE, V54, P87, DOI 10.1016/j.hal.2016.01.010; Harke MJ, 2016, HARMFUL ALGAE, V54, P4, DOI 10.1016/j.hal.2015.12.007; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Harke MJ, 2012, MICROB ECOL, V63, P188, DOI 10.1007/s00248-011-9894-8; Horst GP, 2014, WATER RES, V54, P188, DOI 10.1016/j.watres.2014.01.063; Humbert JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070747; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Joshi NA, SLIDING WINDOW ADAPT; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kuno S, 2014, MICROBIOL-SGM, V160, P903, DOI 10.1099/mic.0.073494-0; Kurmayer R, 2015, ISME J, V9, P909, DOI 10.1038/ismej.2014.189; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin S, 2011, GENE, V473, P139, DOI 10.1016/j.gene.2010.11.011; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Massana R, 2001, LIMNOL OCEANOGR, V46, P1181, DOI 10.4319/lo.2001.46.5.1181                                                       ; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Meyer KA, 2013, THESIS, V15, P5353; Mlouka A, 2004, J BACTERIOL, V186, P2355, DOI 10.1128/JB.186.8.2355-2365.2004; Moore LR, 1998, NATURE, V393, P464; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Okano K, 2015, GENOME ANNOUNCE, V3; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Otten TG, 2012, ENVIRON SCI TECHNOL, V46, P3480, DOI 10.1021/es2041288; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Sandrini G, 2014, ISME J, V8, P589, DOI 10.1038/ismej.2013.179; Sant'Anna CL, 2011, NEUROTOX RES, V19, P389, DOI 10.1007/s12640-010-9177-z; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Shalapyonok A, 2001, DEEP-SEA RES PT II, V48, P1231, DOI 10.1016/S0967-0645(00)00137-5                                                   ; Simm S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00219; Sohm JA, 2015, ISME J, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STANIER RY, 1971, BACTERIOL REV, V35, P171; Steffen MM, 2015, APPL ENV MICROBIOL; Steffen MM, 2017, ENV SCI TECHNOL; Steffen MM, 2014, ISME J, P1; Steffen MM, 2014, J GREAT LAKES RES, V40, P215, DOI [10.1016/j.jg1r.2013.12.012, 10.1016/j.jglr.2013.12.012]; Stumpf RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042444; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tanabe Y, 2011, PLOS ONE, V6; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tillett D, 2001, APPL ENVIRON MICROB, V67, P2810, DOI 10.1128/AEM.67.6.2810-2818.2001; van Gremberghe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019561; Van Wichelen J, 2016, HARMFUL ALGAE, V55, P97, DOI 10.1016/j.hal.2016.02.009; Vinuesa P, 2015, METHODS MOL BIOL, V1231, P203, DOI 10.1007/978-1-4939-1720-4_14; Visser PM, 2016, HARMFUL ALGAE, V54, P145, DOI 10.1016/j.hal.2015.12.006; Watson SB, 2016, HARMFUL ALGAE, V56, P44, DOI 10.1016/j.hal.2016.04.010; Welker M, 2003, ARCH HYDROBIOL, V157, P227, DOI 10.1127/0003-9136/2003/0157-0227; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Yang C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00394; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zurawell RW, 2005, J TOXICOL ENV HEAL B, V8, P1, DOI 10.1080/10937400590889412; [Anonymous], 2002, GENOME RES, V12, P1080	101	0	0	14	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183859	10.1371/journal.pone.0183859				21	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ4ZX	WOS:000412754400008	29020009	gold			2018-01-05	
J	Schiroli, G; Ferrari, S; Conway, A; Jacob, A; Capo, V; Albano, L; Plati, T; Castiello, MC; Sanvito, F; Gennery, AR; Bovolenta, C; Palchaudhuri, R; Scadden, DT; Holmes, MC; Villa, A; Sitia, G; Lombardo, A; Genovese, P; Naldini, L				Schiroli, Giulia; Ferrari, Samuele; Conway, Anthony; Jacob, Aurelien; Capo, Valentina; Albano, Luisa; Plati, Tiziana; Castiello, Maria C.; Sanvito, Francesca; Gennery, Andrew R.; Bovolenta, Chiara; Palchaudhuri, Rahul; Scadden, David T.; Holmes, Michael C.; Villa, Anna; Sitia, Giovanni; Lombardo, Angelo; Genovese, Pietro; Naldini, Luigi			Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1	SCIENCE TRANSLATIONAL MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; ZINC-FINGER NUCLEASES; RECEPTOR-GAMMA CHAIN; LYMPHOID DEVELOPMENT; LENTIVIRAL VECTOR; PROGENITOR CELLS; MICE; TRANSPLANTATION; MURINE; CRISPR/CAS9	Targeted genome editing in hematopoietic stem/progenitor cells (HSPCs) is an attractive strategy for treating immunohematological diseases. However, the limited efficiency of homology-directed editing in primitive HSPCs constrains the yield of corrected cells and might affect the feasibility and safety of clinical translation. These concerns need to be addressed in stringent preclinical models and overcome by developing more efficient editing methods. We generated a humanized X-linked severe combined immunodeficiency (SCID-X1) mouse model and evaluated the efficacy and safety of hematopoietic reconstitution from limited input of functional HSPCs, establishing thresholds for full correction upon different types of conditioning. Unexpectedly, conditioning before HSPC infusion was required to protect the mice from lymphoma developing when transplanting small numbers of progenitors. We then designed a one-size-fits-all IL2RG (interleukin-2 receptor common g-chain) gene correction strategy and, using the same reagents suitable for correction of human HSPC, validated the edited human gene in the disease model in vivo, providing evidence of targeted gene editing in mouse HSPCs and demonstrating the functionality of the IL2RG-edited lymphoid progeny. Finally, we optimized editing reagents and protocol for human HSPCs and attained the threshold of IL2RG editing in long-term repopulating cells predicted to safely rescue the disease, using clinically relevant HSPC sources and highly specific zinc finger nucleases or CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9). Overall, our work establishes the rationale and guiding principles for clinical translation of SCID-X1 gene editing and provides a framework for developing gene correction for other diseases.	[Schiroli, Giulia; Ferrari, Samuele; Jacob, Aurelien; Capo, Valentina; Albano, Luisa; Plati, Tiziana; Castiello, Maria C.; Villa, Anna; Lombardo, Angelo; Genovese, Pietro; Naldini, Luigi] San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; [Schiroli, Giulia; Ferrari, Samuele; Lombardo, Angelo; Naldini, Luigi] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Conway, Anthony; Holmes, Michael C.] Sangamo Therapeut, Richmond, CA 94804 USA; [Sanvito, Francesca] Ist Sci San Raffaele, Dept Oncol, Pathol Unit, I-20132 Milan, Italy; [Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bovolenta, Chiara] MolMed SpA, I-20132 Milan, Italy; [Palchaudhuri, Rahul] Magenta Therapeut, Cambridge, MA 02139 USA; [Palchaudhuri, Rahul; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Villa, Anna] CNR, Inst Genet & Biomed, Res Milan Unit, I-20138 Milan, Italy; [Sitia, Giovanni] Ist Sci San Raffaele, I-20132 Milan, Italy	Genovese, P; Naldini, L (reprint author), San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy.; Naldini, L (reprint author), Univ Vita Salute San Raffaele, I-20132 Milan, Italy.	genovese.pietro@hsr.it; naldini.luigi@hsr.it		AURELIEN, JACOB/0000-0002-4799-3711	Telethon (TIGET) [D2 2011-15, E1 2016, E3 2016]; European Union [601958 SUPERSIST]; Italian Ministry of Health [NET-2011-02350069, GR-2013-02358956]	This work was supported by grants to L.N. from Telethon (TIGET grant D2 2011-15, TIGET grant E1 2016), the European Union (FP7 601958 SUPERSIST), and the Italian Ministry of Health (NET-2011-02350069) and to P.G. from Telethon (TIGET grant E3 2016) and the Italian Ministry of Health (GR-2013-02358956).	Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Bosticardo M, 2011, J ALLERGY CLIN IMMUN, V127, P1376, DOI 10.1016/j.jaci.2011.03.030; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Capotondo A, 2012, P NATL ACAD SCI USA, V109, P15018, DOI 10.1073/pnas.1205858109; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Ravin SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8856; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Ginn SL, 2017, MOL THER-NUCL ACIDS, V6, P1, DOI 10.1016/j.omtn.2016.11.011; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616                                                            ; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kumar R, 2008, J IMMUNOL, V181, P7507, DOI 10.4049/jimmunol.181.11.7507                                                    ; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lo M, 1999, BLOOD, V94, P3027; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; Moehrle BM, 2015, CELL REP, V13, P2412, DOI 10.1016/j.celrep.2015.11.030; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Oakes BL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10194; Ohbo K, 1996, BLOOD, V87, P956; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Palchaudhuri R, 2016, NAT BIOTECHNOL, V34, P738, DOI 10.1038/nbt.3584; Peterson CW, 2016, BLOOD, V127, P2416, DOI 10.1182/blood-2015-09-672337; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Puck JM, 1997, BLOOD, V89, P1968; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Zhang SL, 2014, BLOOD, V124, P296, DOI 10.1182/blood-2014-01-552794; Zhou S, 2010, BLOOD, V116, P900, DOI 10.1182/blood-2009-10-250209	43	1	1	6	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	OCT 11	2017	9	411							eaan0820	10.1126/scitranslmed.aan0820				11	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	FJ5OF	WOS:000412801300003					2018-01-05	
J	Xu, ZH; Puranik, R; Hu, JX; Xu, H; Han, DM				Xu, Zhaohui; Puranik, Rutika; Hu, Junxi; Xu, Hui; Han, Dongmei			Complete genome sequence of Thermotoga sp strain RQ7	STANDARDS IN GENOMIC SCIENCES			English	Article						Thermotoga; T. sp strain RQ7; Natural competence; CRISPR; Restriction-modification system; TneDI; CP007633	COMPETENT BACILLUS-SUBTILIS; PSEUDOMONAS-AERUGINOSA; NEISSERIA-GONORRHOEAE; HAEMOPHILUS-INFLUENZAE; DNA-UPTAKE; SP-NOV; GENETIC-TRANSFORMATION; NATURAL TRANSFORMATION; GENUS THERMOTOGA; VIBRIO-CHOLERAE	Thermotoga sp. strain RQ7 is a member of the family Thermotogaceae in the order Thermotogales. It is a Gram negative, hyperthermophilic, and strictly anaerobic bacterium. It grows on diverse simple and complex carbohydrates and can use protons as the final electron acceptor. Its complete genome is composed of a chromosome of 1,851,618 bp and a plasmid of 846 bp. The chromosome contains 1906 putative genes, including 1853 protein coding genes and 53 RNA genes. The genetic features pertaining to various lateral gene transfer mechanisms are analyzed. The genome carries a complete set of putative competence genes, 8 loci of CRISPRs, and a deletion of a well-conserved Type II R-M system.	[Xu, Zhaohui; Puranik, Rutika; Hu, Junxi; Xu, Hui; Han, Dongmei] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Hu, Junxi] Minnan Normal Univ, Sch Life Sci, 36 Xianqianzhi St, Zhangzhou 363000, Fujian, Peoples R China	Xu, ZH (reprint author), Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA.	zxu@bgsu.edu			BGSU Commercialization Catalyst Award; BGSU Building Strength Award	This work was supported by the BGSU Commercialization Catalyst Award and the BGSU Building Strength Award to ZX. BGSU plays no role in designing or conducting the study, collecting or analysing the data, or writing the manuscript.	Alm RA, 1996, J BACTERIOL, V178, P46, DOI 10.1128/jb.178.1.46-53.1996                                                     ; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556                                                                   ; Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; Bakaletz LO, 2005, INFECT IMMUN, V73, P1635, DOI 10.1128/IAI.73.3.1635-1643.2005; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bhandari V, 2014, ANTON LEEUW INT J G, V105, P143, DOI 10.1007/s10482-013-0062-7; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Chen I, 2001, J BACTERIOL, V183, P3160, DOI 10.1128/JB.183.10.3160-3168.2001; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001                                                ; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DeBoy RT, 2006, J BACTERIOL, V188, P2364, DOI 10.1128/JB.188.7.2364-2374.2006; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; EHRLICH M, 1985, NUCLEIC ACIDS RES, V13, P1399, DOI 10.1093/nar/13.4.1399; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; FREITAG NE, 1995, MOL MICROBIOL, V16, P575, DOI 10.1111/j.1365-2958.1995.tb02420.x; Frock AD, 2010, ENVIRON TECHNOL, V31, P1169, DOI 10.1080/09593330.2010.484076; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Graupner S, 2000, J BACTERIOL, V182, P2184, DOI 10.1128/JB.182.8.2184-2190.2000; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gwinn ML, 1998, J BACTERIOL, V180, P746; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; HAHN J, 1993, MOL MICROBIOL, V10, P99, DOI 10.1111/j.1365-2958.1993.tb00907.x; Han DM, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-39; Han DM, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-2; HARRIOTT OT, 1994, J BACTERIOL, V176, P2759; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; HUNTEMANN M, 2015, STAND GENOMIC SCI, V10; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995                                                ; JANNASCH HW, 1988, ARCH MICROBIOL, V150, P103, DOI 10.1007/BF00409725; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; KARUDAPURAM S, 1995, J BACTERIOL, V177, P3235, DOI 10.1128/jb.177.11.3235-3240.1995                                                ; Kline KA, 2007, J BACTERIOL, V189, P3462, DOI 10.1128/JB.01911-06; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; LARSON TG, 1991, J BACTERIOL, V173, P4683, DOI 10.1128/jb.173.15.4683-4691.1991                                                ; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mongodin EF, 2005, J BACTERIOL, V187, P4935, DOI 10.1128/JB.187.14.4935-4944.2005; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Nesbo CL, 2006, GENETICS, V172, P759, DOI 10.1534/genetics.105.049312; NUNN D, 1990, J BACTERIOL, V172, P2911, DOI 10.1128/jb.172.6.2911-2919.1990                                                 ; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281                                                          ; Paranjpye RN, 1998, INFECT IMMUN, V66, P5659; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; Puranik R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S3-S7; RACHEL R, 1990, FEBS LETT, V262, P64, DOI 10.1016/0014-5793(90)80155-C                                                    ; Reysenbach A-L, 2001, BERGEYS MANUAL SYSTE, V1, P370; Reysenbach A-L, 2001, BERGEYS MANUAL SYSTE, V1, P369; Reysenbach A-L, 2001, BERGEYS MANUAL SYSTE, V1, P369; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986                                                         ; RUSSELL MA, 1994, MOL MICROBIOL, V13, P973, DOI 10.1111/j.1365-2958.1994.tb00489.x; Sambrook J., 2006, CONDENSED PROTOCOLS; SCHRODER C, 1994, ARCH MICROBIOL, V161, P460, DOI 10.1007/BF00307766; Seitz P, 2013, P NATL ACAD SCI USA, V110, P17987, DOI 10.1073/pnas.1315647110; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Swithers KS, 2011, J BACTERIOL, V193, P5869, DOI 10.1128/JB.05923-11; Takahata Y, 2001, INT J SYST EVOL MICR, V51, P1901, DOI 10.1099/00207713-51-5-1901                                                      ; Takeno M, 2012, J BIOSCI BIOENG, V113, P689, DOI 10.1016/j.jbiosc.2012.02.004; Van Ooteghem SA, 2002, APPL BIOCHEM BIOTECH, V98, P177, DOI 10.1385/ABAB:98-100:1-9:177; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; WINDBERGER E, 1989, ARCH MICROBIOL, V151, P506, DOI 10.1007/BF00454866; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Xu H, 2015, BIOMED RES INT, DOI 10.1155/2015/304523; Xu H, 2014, BIOTECHNOL LETT, V36, P1853, DOI 10.1007/s10529-014-1552-z; Xu ZH, 2011, EXTREMOPHILES, V15, P665, DOI 10.1007/s00792-011-0397-9; Yu JS, 1997, J BACTERIOL, V179, P7161, DOI 10.1128/jb.179.22.7161-7164.1997                                                ; Yu X, 2011, BIOL ENG T, V4, P101; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106; [Anonymous], 1989, INT J SYST BACTERIOL, V39, P93, DOI 10.1099/00207713-39-1-93; [Anonymous], 1986, INT J SYST BACTERIOL, V36, P573, DOI 10.1099/00207713-36-4-573; [Anonymous], 2002, INT J SYST BACTERIOL, V52, P685	78	0	0	6	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1944-3277			STAND GENOMIC SCI	Stand. Genomic Sci.	OCT 11	2017	12								62	10.1186/s40793-017-0271-1				11	Genetics & Heredity; Microbiology	Genetics & Heredity; Microbiology	FJ5SF	WOS:000412812300001	29046741	gold			2018-01-05	
J	Gressel, S; Schwalb, B; Decker, TM; Qin, W; Leonhardt, H; Eick, D; Cramer, P				Gressel, Saskia; Schwalb, Bjorn; Decker, Tim Michael; Qin, Weihua; Leonhardt, Heinrich; Eick, Dirk; Cramer, Patrick			CDK9-dependent RNA polymerase II pausing controls transcription initiation	ELIFE			English	Article							GENOME-WIDE; ELONGATION COMPLEX; IN-VIVO; POL II; DROSOPHILA; MAPS; CRISPR-CAS9; INHIBITORS; RESOLUTION; PROMOTERS	Gene transcription can be activated by decreasing the duration of RNA polymerase II pausing in the promoter-proximal region, but how this is achieved remains unclear. Here we use a 'multi-omics' approach to demonstrate that the duration of polymerase pausing generally limits the productive frequency of transcription initiation in human cells ('pause-initiation limit'). We further engineer a human cell line to allow for specific and rapid inhibition of the P-TEFb kinase CDK9, which is implicated in polymerase pause release. CDK9 activity decreases the pause duration but also increases the productive initiation frequency. This shows that CDK9 stimulates release of paused polymerase and activates transcription by increasing the number of transcribing polymerases and thus the amount of mRNA synthesized per time. CDK9 activity is also associated with long-range chromatin interactions, suggesting that enhancers can influence the pause-initiation limit to regulate transcription.	[Gressel, Saskia; Schwalb, Bjorn; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany; [Decker, Tim Michael; Eick, Dirk] Helmholtz Ctr Munich, Dept Mol Epigenet, Ctr Integrated Prot Sci, Munich, Germany; [Qin, Weihua; Leonhardt, Heinrich] Ludwig Maximilians Univ Munchen, Dept Biol 2, Ctr Integrated Prot Sci, Martinsried, Germany	Schwalb, B; Cramer, P (reprint author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.; Eick, D (reprint author), Helmholtz Ctr Munich, Dept Mol Epigenet, Ctr Integrated Prot Sci, Munich, Germany.	bjoern.schwalb@mpibpc.mpg.de; eick@helmhollz-muenchen.de; patrick.cramer@mpibpc.mpg.de	Leonhardt, Heinrich/B-2791-2014	Schwalb, Bjorn/0000-0003-2987-2622; Gressel, Saskia/0000-0003-0261-675X	European Research Council; Volkswagen Foundation; Deutsche Forschungsgemeinschaft [SFB 1064 TP A17, SFB 1064]; Max Planck Institute for Bio-physical Chemistry	European Research Council TRANSREGULON Patrick Cramer; Volkswagen Foundation Patrick Cramer; Deutsche Forschungsgemeinschaft SFB 1064 TP A17 Heinrich Leonhardt; Deutsche Forschungsgemeinschaft SFB 1064 Dirk Eick; Max Planck Institute for Bio-physical Chemistry Open-access funding Patrick Cramer; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Buckley MS, 2014, GENE DEV, V28, P14, DOI 10.1101/gad.231886.113; Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Conrad T, 2017, METHODS MOL BIOL, V1468, P1, DOI 10.1007/978-1-4939-4035-6_1; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Day DS, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0984-2; Descostes N, 2014, ELIFE, V3, DOI 10.7554/eLife.02105; Dobin A, 2015, CURR PROTOC BIOINFOR, V51, P11; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Fuchs G, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r69; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Henriques T, 2013, MOL CELL, V52, P517, DOI 10.1016/j.molcel.2013.10.001; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Laitem C, 2015, NAT STRUCT MOL BIOL, V22, P396, DOI 10.1038/nsmb.3000; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Lopez MS, 2014, METHOD ENZYMOL, V548, P189, DOI 10.1016/B978-0-12-397918-6.00008-2; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/NMETH.3205, 10.1038/nmeth.3205]; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078                                                           ; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Morales F, 2016, CELL CYCLE, V15, P519, DOI 10.1080/15384101.2016.1138186; Mulholland CB, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv550; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nojima T, 2016, NAT PROTOC, V11, P413, DOI 10.1038/nprot.2016.012; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Saponaro M, 2014, CELL, V157, P1037, DOI 10.1016/j.cell.2014.03.048; Schlackow M, 2017, MOL CELL, V65, P25, DOI 10.1016/j.molcel.2016.11.029; Schwalb B, 2016, SCIENCE, V352, P1225, DOI 10.1126/science.aad9841; Shao WQ, 2017, NAT GENET, V49, P1045, DOI 10.1038/ng.3867; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STROBL LJ, 1992, EMBO J, V11, P3307; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029                                                             ; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113	55	0	0	4	4	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	OCT 10	2017	6								e29736	10.7554/eLife.29736				24	Biology	Life Sciences & Biomedicine - Other Topics	FL7DX	WOS:000414407800001		gold			2018-01-05	
J	Deng, HX; Gao, RJ; Liao, XR; Cai, YJ				Deng, Huaxiang; Gao, Ruijie; Liao, Xiangru; Cai, Yujie			Genome editing in Shiraia bambusicola using CRISPR-Cas9 system	JOURNAL OF BIOTECHNOLOGY			English	Article						CRISPR/Cas9 system; Polyketide synthase; Hypocrellin; Shiraia bambusicola; Virulence	CERCOSPORA-NICOTIANAE; ELSINOCHROME PHYTOTOXIN; ASPERGILLUS-FUMIGATUS; POLYKETIDE SYNTHASE; ELSINOE-FAWCETTII; SP SUPER-H168; GENE; CRISPR/CAS9; HYPOCRELLIN; BIOSYNTHESIS	Shiraia bambusicola can produce a type of hypocrellin, which is applied in antibacterial, antitumoral, and antiviral areas. Studies on the hypocrellin pathway have not been confirmed due to the deficiency of suitable genetic methods. We constructed a clustered regularly interspaced short palindromic repeat sequences (CRISPR)/Cas9 system in Shiraia sp. SUPER-H168 and targeted a polyketide synthase (SbaPKS). No hypocrellin production was detected in the ASbaPKS mutant. Relative expression levels of SbaPKS and its adjacent genes were extremely down-regulated in the dSbaPKS mutant compared to those in the wild strain. Subsequent pathogenicity assays showed that deletion of SbaPKS attenuated virulence on bamboo leaves. In contrast, restored hypocrellin in a SbaPKS overexpression strain generated necrotic lesions on bamboo leaves. These results suggest that SbaPKS is involved in hypocrellin biosynthesis and hypocrellin has an essential role in the virulence of S. bambusicola on bamboo leaves. The CRISPR/Cas9 system in Shiraia sp. will open an avenue for decoding the hypocrellin pathway and genome editing of other filamentous fungi. Strategies that disrupt hypocrellin biosynthesis may reduce the detriment of S. bambusicola.	[Deng, Huaxiang; Gao, Ruijie; Liao, Xiangru; Cai, Yujie] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China	Liao, XR; Cai, YJ (reprint author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China.	xrliao@jiangnan.edu.cn; yjcai@jiangnan.edu.cn			National Science Foundation of China [21275066]; Six talent peak program [SWYY-126]; Fundamental Research of Doctor of Philosophy [2050205, 205020502]	This study was financially supported by the National Science Foundation of China (Grant No. 21275066), the Six talent peak program at 2016 (Grant No. SWYY-126), the Fundamental Research of Doctor of Philosophy at 2014 (Grant No. 2050205), and the Fundamental Research of Doctor of Philosophy at 2015 (Grant No. 205020502).	Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; Cai YJ, 2011, NEW BIOTECHNOL, V28, P588, DOI 10.1016/j.nbt.2011.02.001; Cai YJ, 2010, APPL BIOCHEM BIOTECH, V160, P2275, DOI 10.1007/s12010-009-8728-3; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; [常魁敏 Chang Kuimin], 2014, [生物技术, Biotechnology], V24, P1; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; CHEN WS, 1981, LIEBIGS ANN CHEM, P1880; Cheng TF, 2004, J BASIC MICROB, V44, P339, DOI 10.1002/jobm.200410434; Chooi YH, 2012, J ORG CHEM, V77, P9933, DOI 10.1021/jo301592k; Choquer M, 2005, MOL PLANT MICROBE IN, V18, P468, DOI 10.1094/MPMI-18-0468; Chung KR, 2008, MICROBIOL-SGM, V154, P3556, DOI 10.1099/mic.0.2008/019414-0; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crawford JM, 2009, NATURE, V461, P1139, DOI 10.1038/nature08475; Daub ME, 2013, ANTIOXID REDOX SIGN, V19, P970, DOI 10.1089/ars.2012.5080; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Deng HX, 2016, PROCESS BIOCHEM, V51, P1357, DOI 10.1016/j.procbio.2016.07.013; Deng HX, 2016, GENE, V580, P67, DOI 10.1016/j.gene.2016.01.019; Fang YF, 2016, MOL PLANT PATHOL, V17, P127, DOI 10.1111/mpp.12318; Fujii I, 2004, J BIOL CHEM, V279, P44613, DOI 10.1074/jbc.M406758200; Fujii I, 2000, BIOCHEMISTRY-US, V39, P8853, DOI 10.1021/bi000644j; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gao L, 2012, ACS NANO, V6, P8030, DOI 10.1021/nn302634m; Hino I., 1961, ICONES FUNGORUM BAMB; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Li YR, 2010, J BIOL CHEM, V285, P22762, DOI 10.1074/jbc.M110.128504; Liao HL, 2008, MOL PLANT MICROBE IN, V21, P469, DOI 10.1094/MPMI-21-4-0469; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; LU SW, 1994, P NATL ACAD SCI USA, V91, P12649, DOI 10.1073/pnas.91.26.12649; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Newman AG, 2016, J AM CHEM SOC, V138, P4219, DOI 10.1021/jacs.6b00633; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Walther A, 2008, NAT PROTOC, V3, P1414, DOI 10.1038/nprot.2008.137; Weber J, 2017, ACS SYNTH BIOL, V6, P62, DOI 10.1021/acssynbio.6b00203; Yang H., 2014, GENOME ANNOUNC, V2; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; ZHAO N, 2016, INT J MOL SCI, V17; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105; Zhou H, 2010, NAT PROD REP, V27, P839, DOI 10.1039/b911518h	47	0	0	20	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1656	1873-4863		J BIOTECHNOL	J. Biotechnol.	OCT 10	2017	259						228	234		10.1016/j.jbiotec.2017.06.1204				7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FI5OZ	WOS:000412035000033	28690135				2018-01-05	
J	Zhou, WJ; Wan, YJ; Guo, RH; Deng, MT; Deng, KP; Wang, Z; Zhang, YL; Wang, F				Zhou, Wenjun; Wan, Yongjie; Guo, Rihong; Deng, Mingtian; Deng, Kaiping; Wang, Zhen; Zhang, Yanli; Wang, Feng			Generation of beta-lactoglobulin knock-out goats using CRISPR/Cas9	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; OFF-TARGET SITES; COWS MILK; HOMOLOGOUS RECOMBINATION; TRANSGENIC GOATS; IGE BINDING; GENE; SPECIFICITY; MICE; DNA	Goat's milk, considered a substitute for cow's milk, has a high nutritional value. However, goat's milk contains various allergens, predominantly beta-lactoglobulin (BLG). In this study, we employed the CRISPR/Cas9 system to target the BLG locus in goat fibroblasts for sgRNA optimization and generate BLG knock-out goats through co-injection of Cas9 mRNA and small guide RNAs (sgRNAs) into goat embryos at the one-cell stage. We firstly tested sgRNA editing efficiencies in goat fibroblast cells, and approximately 8.00% - 9.09% of the cells were modified in single sgRNA-guided targeting experiment. Among the kids, the genome-targeting efficiencies of single sgRNA were 12.5% (10 ng/mu L sg1) and 0% (10 ng/mu L sg2) and efficiencies of dual sgRNAs were 25.0% (25 ng/mu L sg2+sg3 group) and 28.6% (50 ng/mu L sg2+sg3 group). Relative expression of BLG in BLG knock-out goat mammary glands significantly (p < 0.01) decreased as well as other milk protein coding genes, such as CSN1S1, CSN1S2, CSN2, CSN3 and LALBA (p < 0.05). As expected, BLG protein had been abolished in the milk of the BLG knock-out goat. In addition, most of the targeted kids were chimeric (3/4), and their various body tissues were edited simultaneously. Our study thus provides a basis for optimizing the quality of goat milk, which can be applied to biomedical and agricultural research.	[Zhou, Wenjun; Wan, Yongjie; Guo, Rihong; Deng, Mingtian; Deng, Kaiping; Wang, Zhen; Zhang, Yanli; Wang, Feng] Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China	Wang, F (reprint author), Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China.	caeet@njau.edu.cn			China National Program for Transgenic Animal [2014ZX08008-004]; National Nature Science Foundation of China [31272443]	This work is financially supported by the China National Program for Transgenic Animal (2014ZX08008-004) and the National Nature Science Foundation of China (No. 31272443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bibikova M, 2002, GENETICS, V161, P1169; Cammuso C, 2000, ANIM BIOTECHNOL, V11, P1, DOI 10.1080/10495390009525943                                                       ; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creamer LK, 2002, ENCY DAIRY SCI, P1932; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Davis PJ, 1998, ALLERGY, V53, P102, DOI 10.1111/j.1398-9995.1998.tb04975.x                                              ; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Ehn BM, 2005, J AGR FOOD CHEM, V53, P3743, DOI 10.1021/jf048121w; Ehn BM, 2004, J AGR FOOD CHEM, V52, P1398, DOI 10.1021/jf0304371; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gall H, 1996, J ALLERGY CLIN IMMUN, V97, P1304, DOI 10.1016/S0091-6749(96)70199-9; Gao F, 2016, NAT BIOTECHNOL; Gong L, 2015, GENOME ENG USING CRI, P197; Guo RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29855; Haenlein GFW, 2004, SMALL RUMINANT RES, V51, P155, DOI 10.1016/j.smallrumres.2003.08.010; Hallen E., 2008, J ANIMAL BREEDING GE, V107, P458; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; KUMAR S, 1994, P NATL ACAD SCI USA, V91, P6138, DOI 10.1073/pnas.91.13.6138; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Liu JY, 2014, METHODS, V69, P22, DOI 10.1016/j.ymeth.2014.04.010; Lv QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25029; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2                                               ; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi J, 2016, CELL RES; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; Selo I, 1998, INT ARCH ALLERGY IMM, V117, P20, DOI 10.1159/000023986                                                               ; Sharma S, 2001, J CHROMATOGR B, V756, P183, DOI 10.1016/S0378-4347(01)00107-4; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Tsiplakou E, 2015, J DAIRY RES, V82, P257, DOI 10.1017/S0022029915000333; Wal JM, 1998, ALLERGY, V53, P1013, DOI 10.1111/j.1398-9995.1998.tb03811.x; Wan YJ, 2016, CELL BIOL INT, V40, P74, DOI 10.1002/cbin.10540; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; WANG Y, 2015, SCI REP UK, V5; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024	44	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186056	10.1371/journal.pone.0186056				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ3JE	WOS:000412627400052	29016691	gold			2018-01-05	
J	Chen, YY; Spitzer, S; Agathou, S; Karadottir, RT; Smith, A				Chen, Yaoyao; Spitzer, Sonia; Agathou, Sylvia; Karadottir, Ragnhildur Thora; Smith, Austin			Gene Editing in Rat Embryonic Stem Cells to Produce In Vitro Models and In Vivo Reporters	STEM CELL REPORTS			English	Article							TRANSCRIPTION FACTOR SOX10; GERMLINE TRANSMISSION; CRISPR-CAS; NEURAL CREST; SELF-RENEWAL; HOMOLOGOUS RECOMBINATION; CONDITIONAL ALLELES; ETHIDIUM-BROMIDE; GROUND-STATE; STRAND DNA	Rat embryonic stem cells (ESCs) offer the potential for sophisticated genome engineering in this valuable biomedical model species. However, germline transmission has been rare following conventional homologous recombination and clonal selection. Here, we used the CRISPR/Cas9 system to target genomic mutations and insertions. We first evaluated utility for directed mutagenesis and recovered clones with biallelic deletions in Lef1. Mutant cells exhibited reduced sensitivity to glycogen synthase kinase 3 inhibition during self-renewal. We then generated a non-disruptive knockin of dsRed at the Sox10 locus. Two clones produced germline chimeras. Comparative expression of dsRed and SOX10 validated the fidelity of the reporter. To illustrate utility, live imaging of dsRed in neonatal brain slices was employed to visualize oligodendrocyte lineage cells for patch-clamp recording. Overall, these results show that CRISPR/Cas9 gene editing technology in germline-competent rat ESCs is enabling for in vitro studies and for generating genetically modified rats.	[Chen, Yaoyao; Spitzer, Sonia; Agathou, Sylvia; Karadottir, Ragnhildur Thora; Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Tennis Court Rd, Cambridge CB2 1QR, England; [Spitzer, Sonia; Agathou, Sylvia; Karadottir, Ragnhildur Thora] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England; [Smith, Austin] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England	Smith, A (reprint author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Tennis Court Rd, Cambridge CB2 1QR, England.; Smith, A (reprint author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	austin.smith@cscr.cam.ac.uk			European Community project EURATRANS [HEALTH-F4-2010-241504]; Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/H012737/1]; Swiss National Science Foundation Sinergia Program; Louis-Jeantet Foundation; Isaac Newton Trust; Wellcome Trust Research Career Development Fellowship [091543/Z/10/Z]; Lister Institute Research Prize; Medical Research Council [G1100526/1]	We are grateful to William Mansfield and Charles-Etienne Dumeau for generation of chimeras, Sam Jameson and staff for expert husbandry, Rosalind Drummond for help with qRT-PCR, Yasmin Paterson for help with cell culture, Peter Humphreys for imaging support, Andy Riddell for flow cytometry support, and Marko Hyvonen for recombinant LIF. This research was funded by the European Community project EURATRANS (grant no. HEALTH-F4-2010-241504), the Biotechnology and Biological Sciences Research Council of the United Kingdom (grant no. BB/H012737/1), the Swiss National Science Foundation Sinergia Program, the Louis-Jeantet Foundation, and the Isaac Newton Trust. R.T.K. was supported by a Wellcome Trust Research Career Development Fellowship (grant no. 091543/Z/10/Z) and a Lister Institute Research Prize. A.S. is a Medical Research Council Professor (grant no. G1100526/1).	Blair K, 2012, BIOL OPEN, V1, P58, DOI 10.1242/bio.2011029; Blair K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002019; Breuskin I, 2010, J NEUROCHEM, V114, P1827, DOI 10.1111/j.1471-4159.2010.06897.x; Breuskin I, 2009, DEV BIOL, V335, P327, DOI 10.1016/j.ydbio.2009.09.007; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601                                                              ; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chapman KM, 2015, CELL REP, V10, P1828, DOI 10.1016/j.celrep.2015.02.040; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen YY, 2013, STEM CELL REP, V1, P209, DOI 10.1016/j.stemcr.2013.07.003; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Goudarzvand M, 2016, BASIC CLIN NEUROSCI, V7, P63; Hirabayashi M, 2014, J REPROD DEVELOP, V60, P78, DOI 10.1262/jrd.2013-109; Hirabayashi M, 2013, TRANSGENIC RES, V22, P411, DOI 10.1007/s11248-012-9638-7; Hirabayashi M, 2010, MOL REPROD DEV, V77, P474, DOI 10.1002/mrd.21181; Hirabayashi M, 2010, MOL REPROD DEV, V77, P94, DOI 10.1002/mrd.21123; Hirst WD, 2003, MOL PHARMACOL, V64, P1295, DOI 10.1124/mol.64.6.1295; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Meek S, 2013, STEM CELLS, V31, P2104, DOI 10.1002/stem.1466; Meek S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014225; Men H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056518; Men HS, 2012, STEM CELLS DEV, V21, P2606, DOI 10.1089/scd.2012.0040; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Preziosa P, 2014, RADIOLOGY, V271, P822, DOI 10.1148/radiol.13132142; Rajendran G, 2013, J BIOL CHEM, V288, P24351, DOI 10.1074/jbc.M113.455725; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shibata S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-31; Simon C, 2012, GENESIS, V50, P506, DOI 10.1002/dvg.22003; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Verkhratsky A, 2000, BRAIN RES REV, V32, P380, DOI 10.1016/S0165-0173(99)00093-4                                                   ; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431	61	0	0	17	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	OCT 10	2017	9	4					1262	1274		10.1016/j.stemcr.2017.09.005				13	Cell & Tissue Engineering; Cell Biology	Cell Biology	FJ3VH	WOS:000412660000021	29020614	gold			2018-01-05	
J	Hazelbaker, DZ; Beccard, A; Bara, AM; Dabkowski, N; Messana, A; Mazzucato, P; Lam, D; Manning, D; Eggan, K; Barrett, LE				Hazelbaker, Dane Z.; Beccard, Amanda; Bara, Anne M.; Dabkowski, Nicole; Messana, Angelica; Mazzucato, Patrizia; Lam, Daisy; Manning, Danielle; Eggan, Kevin; Barrett, Lindy E.			A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease	STEM CELL REPORTS			English	Article							AUTISM SPECTRUM DISORDERS; GENOME-WIDE ANALYSIS; HETEROZYGOUS KNOCKOUT; MAMMALIAN-CELLS; HUMAN ES; LINES; CAS9; MUTATIONS; SPECIFICITY; GENERATION	Scaling of CRISPR-Cas9 technology in human pluripotent stem cells (hPSCs) represents an important step for modeling complex disease and developing drug screens in human cells. However, variables affecting the scaling efficiency of gene editing in hPSCs remain poorly understood. Here, we report a standardized CRISPR-Cas9 approach, with robust benchmarking at each step, to successfully target and genotype a set of psychiatric disease-implicated genes in hPSCs and provide a resource of edited hPSC lines for six of these genes. We found that transcriptional state and nucleosome positioning around targeted loci was not correlated with editing efficiency. However, editing frequencies varied between different hPSC lines and correlated with genomic stability, underscoring the need for careful cell line selection and unbiased assessments of genomic integrity. Together, our step-by-step quantification and in-depth analyses provide an experimental roadmap for scaling Cas9-mediated editing in hPSCs to study psychiatric disease, with broader applicability for other polygenic diseases.	[Hazelbaker, Dane Z.; Beccard, Amanda; Bara, Anne M.; Dabkowski, Nicole; Messana, Angelica; Mazzucato, Patrizia; Lam, Daisy; Eggan, Kevin; Barrett, Lindy E.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Eggan, Kevin; Barrett, Lindy E.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Manning, Danielle] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Eggan, K; Barrett, LE (reprint author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Eggan, K; Barrett, LE (reprint author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu; lbarrett@broadinstitute.org			Stanley Center for Psychiatric Research at the Broad Institute; Genomics Platform at the Broad Institute; Bauer Flow Cytometry Core Facility at Harvard University	This project was funded by the Stanley Center for Psychiatric Research at the Broad Institute. We thank Yaoyu Wang and Alex Holman of the Center for Cancer Computational Biology, DanaFarber Cancer Institute, Boston, MA, for assistance in developing the BaySnpper indel analysis pipeline. We also thank Kiki Lilliehook and members of the Barrett and Eggan labs for insightful discussions and critical reading of the manuscript, Sara Kosmaczewski and Kevin Smith for assistance with neuron generation, Feng Zhang for Cas9 plasmids, Tim Poterba and Sulagna Ghosh of the Broad Institute for assistance with SNP genotyping data, Luis Soares of Harvard Medical School for assistance with nucleosome analyses, and Florian Merkle of the University of Cambridge for technical advice and support. We also appreciate support from the Genomics Platform at the Broad Institute and the Bauer Flow Cytometry Core Facility at Harvard University.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Baker D, 2016, STEM CELL REP, V7, P998, DOI 10.1016/j.stemcr.2016.10.003; Bara AM, 2016, STEM CELL RES, V17, P441, DOI 10.1016/j.scr.2016.09.008; Basak A, 2015, J CLIN INVEST, V125, P2363, DOI 10.1172/JCI81163; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daer RM, 2017, ACS SYNTH BIOL, V6, P428, DOI 10.1021/acssynbio.5b00299; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Flannick J, 2016, NAT REV GENET, V17, P535, DOI 10.1038/nrg.2016.56; Garrison E, 2012, ARXIV12073907; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hasan MS, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0042-2; Hendriks WT, 2016, CELL STEM CELL, V18, P53, DOI 10.1016/j.stem.2015.12.002; Herring A, 2016, STEM CELL RES, V17, P430, DOI 10.1016/j.scr.2016.09.009; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Kessler T, 2016, EMBO MOL MED, V8, P688, DOI 10.15252/emmm.201506174; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Leha A, 2016, METHODS, V96, P85, DOI 10.1016/j.ymeth.2015.11.012; Liu JC, 2014, TRENDS CELL BIOL, V24, P268, DOI 10.1016/j.tcb.2014.03.002; Lu JF, 2016, NAT BIOTECHNOL, V34, P89, DOI 10.1038/nbt.3435; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McKernan R, 2013, NAT BIOTECHNOL, V31, P875, DOI 10.1038/nbt.2710; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Nguyen HT, 2013, HUM REPROD UPDATE, V19, P187, DOI 10.1093/humupd/dms048; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017; Paull D, 2015, NAT METHODS, V12, P885, DOI [10.1038/NMETH.3507, 10.1038/nmeth.3507]; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Peterson SE, 2014, J BIOL CHEM, V289, P4578, DOI 10.1074/jbc.R113.516419; Pickard BS, 2005, PSYCHIAT GENET, V15, P37, DOI 10.1097/00041444-200503000-00007                                                ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Santos D. P., 2016, CURR PROTOC STEM CEL, V38; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Srikanth P, 2015, CELL REP, V12, P1414, DOI 10.1016/j.celrep.2015.07.061; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Too LK, 2016, BEHAV BRAIN RES, V312, P102, DOI 10.1016/j.bbr.2016.06.018; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yazdi PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136314; Yi F, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2669; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	66	0	0	10	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	OCT 10	2017	9	4					1315	1327		10.1016/j.stemcr.2017.09.006				13	Cell & Tissue Engineering; Cell Biology	Cell Biology	FJ3VH	WOS:000412660000025	29020615	gold			2018-01-05	
J	Yeow, I; Howard, G; Chadwick, J; Mendoza-Topaz, C; Hansen, CG; Nichols, BJ; Shvets, E				Yeow, Ivana; Howard, Gillian; Chadwick, Jessica; Mendoza-Topaz, Carolina; Hansen, Carsten G.; Nichols, Benjamin J.; Shvets, Elena			EHD Proteins Cooperate to Generate Caveolar Clusters and to Maintain Caveolae during Repeated Mechanical Stress	CURRENT BIOLOGY			English	Article							EARLY ENDOSOMAL TRANSPORT; PLASMA-MEMBRANE REPAIR; SKELETAL-MUSCLE; POLYMERASE-I; COMPLEX; TRANSCRIPTION; ENDOTHELIUM; INSIGHTS; DYNAMICS; SURFACE	Caveolae introduce flask-shaped convolutions into the plasma membrane and help to protect the plasma membrane from damage under stretch forces. The protein components that form the bulb of caveolae are increasingly well characterized, but less is known about the contribution of proteins that localize to the constricted neck. Here we make extensive use of multiple CRISPR/Cas9-generated gene knockout and knockin cell lines to investigate the role of Eps15 Homology Domain (EHD) proteins at the neck of caveolae. We show that EHD1, EHD2, and EHD4 are recruited to caveolae. Recruitment of the other EHDs increases markedly when EHD2, which has been previously detected at caveolae, is absent. Construction of knockout cell lines lacking EHDs 1, 2, and 4 confirms this apparent functional redundancy. Two striking sets of phenotypes are observed in EHD1,2,4 knockout cells: (1) the characteristic clustering of caveolae into higher-order assemblies is absent; and (2) when the EHD1,2,4 knockout cells are subjected to prolonged cycles of stretch forces, caveolae are destabilized and the plasma membrane is prone to rupture. Our data identify the first molecular components that act to cluster caveolae into a membrane ultrastructure with the potential to extend stretch-buffering capacity and support a revised model for the function of EHDs at the caveolar neck.	[Yeow, Ivana; Howard, Gillian; Chadwick, Jessica; Mendoza-Topaz, Carolina; Hansen, Carsten G.; Nichols, Benjamin J.; Shvets, Elena] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 2QH, England; [Hansen, Carsten G.] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Shvets, Elena] Sphere Fluid Ltd, Jonas Webb Bldg,Babraham Res Campus, Cambridge CB22 3AT, England	Nichols, BJ; Shvets, E (reprint author), MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 2QH, England.; Shvets, E (reprint author), Sphere Fluid Ltd, Jonas Webb Bldg,Babraham Res Campus, Cambridge CB22 3AT, England.	ben@mrc-lmb.cam.ac.uk; elena.shvets@spherefluidics.com			BHF project grant; MRC grant [MC_U105178778]; Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund	C.M.-T. was funded by a BHF project grant. Work in B.J.N.'s laboratory is supported by MRC grant MC_U105178778. C.G.H. is supported by the Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Ariotti N, 2014, J CELL BIOL, V204, P777, DOI 10.1083/jcb.201307055; Bahl K, 2016, J BIOL CHEM, V291, P13465, DOI 10.1074/jbc.M116.716407; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bhattacharyya S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20727; Bitsikas V, 2014, ELIFE, V3, DOI 10.7554/eLife.03970; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Cheng JPX, 2015, J CELL BIOL, V211, P53, DOI 10.1083/jcb.201504042; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; Corrotte M, 2013, ELIFE, V2, DOI 10.7554/eLife.00926; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068                                                  ; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Gambin Y., 2013, ELIFE, V3, DOI DOI 10.7554/ELIFE.01434; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hoernke M, 2017, P NATL ACAD SCI USA, V114, pE4360, DOI 10.1073/pnas.1614066114; Jansa P, 1999, MOL GEN GENET, V262, P508, DOI 10.1007/s004380051112                                                           ; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Lo HP, 2015, J CELL BIOL, V210, P833, DOI 10.1083/jcb.201501046; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Ludwig A, 2016, J CELL SCI, V129, P3077, DOI 10.1242/jcs.191262; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Melo AA, 2017, P NATL ACAD SCI USA, V114, P5629, DOI 10.1073/pnas.1614075114; MILICI AJ, 1987, J CELL BIOL, V105, P2603, DOI 10.1083/jcb.105.6.2603; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Naslavsky N, 2006, MOL BIOL CELL, V17, P163; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pekar O, 2012, BIOCHEM J, V444, P383, DOI 10.1042/BJ20111268; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Razani B, 2001, J BIOL CHEM, V276, P38121; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Shvets E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7867; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Stan RV, 2002, MICROSC RES TECHNIQ, V57, P350, DOI 10.1002/jemt.10089; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; SWANSON JA, 1987, SCIENCE, V238, P548, DOI 10.1126/science.2443981                                                         ; Tse D, 2010, SEMIN THROMB HEMOST, V36, P236, DOI 10.1055/s-0030-1253447; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100	56	1	1	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	OCT 9	2017	27	19					2951	+		10.1016/j.cub.2017.07.047				17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FJ2MF	WOS:000412561400024	28943089	gold			2018-01-05	
J	Boroviak, K; Fu, BY; Yang, FT; Doe, B; Bradley, A				Boroviak, Katharina; Fu, Beiyuan; Yang, Fengtang; Doe, Brendan; Bradley, Allan			Revealing hidden complexities of genomic rearrangements generated with Cas9	SCIENTIFIC REPORTS			English	Article							CHROMOSOMAL REARRANGEMENTS; IMMUNE-SYSTEM; MOUSE MODEL; MICE; CRISPR/CAS; DNA; RECOMBINATION; DISORDERS; EFFICIENT; AUTISM	Modelling human diseases caused by large genomic rearrangements has become more accessible since the utilization of CRISPR/Cas9 in mammalian systems. In a previous study, we showed that genomic rearrangements of up to one million base pairs can be generated by direct injection of CRISPR/Cas9 reagents into mouse zygotes. Although these rearrangements are ascertained by junction PCR, we describe here a variety of anticipated structural changes often involving reintegration of the region demarcated by the gRNAs in the vicinity of the edited locus. We illustrate here some of this diversity detected by high-resolution fibre-FISH and conclude that extensive molecular analysis is required to fully understand the structure of engineered chromosomes generated by Cas9.	[Boroviak, Katharina; Fu, Beiyuan; Yang, Fengtang; Doe, Brendan; Bradley, Allan] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England	Bradley, A (reprint author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.	abradley@sanger.ac.uk			Wellcome Trust [WT206194]; NIH [U42OD011174]	We would like to thank Daniel Gitterman and Matthew Pickering for allowing us to mention their unpublished data. We would like to thank Sebastian Gerety who generated the T7/gRNA vector that was used for generation of all the gRNAs in this study and the Wellcome Trust Sanger Mouse Genetics Project (MGP) microinjection team for performing the microinjections and embryo transfers. We gratefully acknowledge Ed Ryder for his support with the manuscript as well as James Bussell and the RSF team for the excellent animal husbandry. This work was supported by the Wellcome Trust (grant number WT206194)) and by the NIH (grant number U42OD011174).	Balmus G, 2016, GENE DEV, V30, P2152, DOI 10.1101/gad.290510.116; Behringer R, 2014, MANIPULATING MOUSE E; Birling MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep43331; Boroviak K., 2016, CHROMOSOME ENG ZYGOT; Cader M.Z., 2016, NATURE IMMUNOLOGY, V31, P1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43903; Louzada Sandra, 2017, SPRINGER PROTOCOLS H, P275; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1                                                   ; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564                                                                ; Zhang L., 2015, PLOS ONE, V10	30	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 9	2017	7								12867	10.1038/s41598-017-12740-6				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ3VS	WOS:000412661100002	28993641	gold			2018-01-05	
J	Chiu, TY; Jiang, JHR				Chiu, Tai-Yin; Jiang, Jie-Hong R.			Logic Synthesis of Recombinase-Based Genetic Circuits	SCIENTIFIC REPORTS			English	Article							SITE-SPECIFIC RECOMBINATION; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; LIVING CELLS; INTEGRATION; EXPRESSION; CRISPR; CONSTRUCTION; OSCILLATOR; BIOLOGY	A synthetic approach to biology is a promising technique for various applications. Recent advancements have demonstrated the feasibility of constructing synthetic two-input logic gates in Escherichia coli cells with long-term memory based on DNA inversion induced by recombinases. Moreover, recent evidences indicate that DNA inversion mediated by genome editing tools is possible. Powerful genome editing technologies, such as CRISPR-Cas9 systems, have great potential to be exploited to implement large-scale recombinase-based circuits. What remains unclear is how to construct arbitrary Boolean functions based on these emerging technologies. In this paper, we lay the theoretical foundation formalizing the connection between recombinase-based genetic circuits and Boolean functions. It enables systematic construction of any given Boolean function using recombinase-based logic gates. We further develop a methodology leveraging existing electronic design automation (EDA) tools to automate the synthesis of complex recombinase-based genetic circuits with respect to area and delay optimization. In silico experimental results demonstrate the applicability of our proposed methods as a useful tool for recombinase-based genetic circuit synthesis and optimization.	[Chiu, Tai-Yin; Jiang, Jie-Hong R.] Natl Taiwan Univ, Grad Inst Elect Engn, Taipei 10617, Taiwan; [Jiang, Jie-Hong R.] Natl Taiwan Univ, Dept Elect Engn, Taipei 10617, Taiwan; [Jiang, Jie-Hong R.] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10617, Taiwan	Jiang, JHR (reprint author), Natl Taiwan Univ, Grad Inst Elect Engn, Taipei 10617, Taiwan.; Jiang, JHR (reprint author), Natl Taiwan Univ, Dept Elect Engn, Taipei 10617, Taiwan.; Jiang, JHR (reprint author), Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10617, Taiwan.	jhjiang@ntu.edu.tw			Ministry of Science and Technology of Taiwan [MOST 106-2923-E-002-002-MY3]	This work was supported in part by the Ministry of Science and Technology of Taiwan under grant MOST 106-2923-E-002-002-MY3.	Bibb LA, 2005, MOL MICROBIOL, V55, P1896, DOI 10.1111/j.1365-2958.2005.04517.x; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Brayton R, 2010, LECT NOTES COMPUT SC, V6174, P24, DOI 10.1007/978-3-642-14295-6_5; Breuner A, 2001, MICROBIOL-SGM, V147, P2051, DOI 10.1099/00221287-147-8-2051                                                     ; Brown WRA, 2011, METHODS, V53, P372, DOI 10.1016/j.ymeth.2010.12.031; Canchaya C, 2002, VIROLOGY, V302, P245, DOI 10.1006/viro.2002.1570; Ceroni F, 2015, NAT METHODS, V12, P415, DOI [10.1038/NMETH.3339, 10.1038/nmeth.3339]; Chen Y, 2015, SCIENCE, V349, P986, DOI 10.1126/science.aaa3794; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courbet A, 2015, SCI TRANSL MED, V7; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131                                                                ; Ghosh P, 2003, MOL CELL, V12, P1101, DOI 10.1016/S1097-2765(03)00444-1; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Gorochowski TE, 2016, ACS SYNTH BIOL, V5, P710, DOI 10.1021/acssynbio.6b00040; Gorochowski TE, 2014, ACS SYNTH BIOL, V3, P129, DOI 10.1021/sb4001245; Gyorgy A, 2015, BIOPHYS J, V109, P639, DOI 10.1016/j.bpj.2015.06.034; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Jusiak B., 2014, REV CELL BIOL MOL ME; Keravala A, 2006, MOL GENET GENOMICS, V276, P135, DOI 10.1007/s00438-006-0129-5; Kopniczky MB, 2015, IEEE T BIOMED CIRC S, V9, P485, DOI 10.1109/TBCAS.2015.2451707; Lazarevic V, 1999, MICROBIOL-UK, V145, P1055, DOI 10.1099/13500872-145-5-1055                                                     ; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Morita K, 2009, MOL GENET GENOMICS, V282, P607, DOI 10.1007/s00438-009-0490-2; Olivares EC, 2001, GENE, V278, P167, DOI 10.1016/S0378-1119(01)00711-9; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rashel M, 2008, BIOCHEM BIOPH RES CO, V368, P192, DOI 10.1016/j.bbrc.2008.01.045; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rivest R. L., 1987, Machine Learning, V2, P229, DOI 10.1007/BF00058680; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Silva-Rocha R, 2014, ACS SYNTH BIOL, V3, P204, DOI 10.1021/sb400064y; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Torella JP, 2014, NAT PROTOC, V9, P2075, DOI 10.1038/nprot.2014.145; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Weinberg B. H., 2017, NATURE BIOTECHNOLOGY; Xu Z, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1123; Yang HY, 2002, J BACTERIOL, V184, P1859, DOI 10.1128/JB.184.7.1859-1864.2002	46	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 9	2017	7								12873	10.1038/s41598-017-07386-3				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ3VS	WOS:000412661100008	28993615	gold			2018-01-05	
J	Kulcsar, PI; Talas, A; Huszar, K; Ligeti, Z; Toth, E; Weinhardt, N; Fodor, E; Welker, E				Kulcsar, Peter Istvan; Talas, Andras; Huszar, Krisztina; Ligeti, Zoltan; Toth, Eszter; Weinhardt, Nora; Fodor, Elfrieda; Welker, Ervin			Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage	GENOME BIOLOGY			English	Article						CRISPR; Cas9; eSpCas9; SpCas9-HF1; HeFSpCas9; HeFm2SpCas9; High fidelity nuclease; sgRNA; Disruption assay; Off-target; Truncated sgRNA; Extended sgRNA	OFF-TARGET CLEAVAGE; GENOME-EDITING SPECIFICITY; CRISPR-CAS NUCLEASES; TRANSCRIPTION FACTORS; DNA RECOGNITION; HUMAN-CELLS; GUIDE RNAS; IN-VITRO; ACTIVATION; GENE	Background: The propensity for off-target activity of Streptococcus pyogenes Cas9 (SpCas9) has been considerably decreased by rationally engineered variants with increased fidelity (eSpCas9; SpCas9-HF1). However, a subset of targets still generate considerable off-target effects. To deal specifically with these targets, we generated new "Highly enhanced Fidelity" nuclease variants (HeFSpCas9s) containing mutations from both eSpCas9 and SpCas9-HF1 and examined these improved nuclease variants side by side to decipher the factors that affect their specificities and to determine the optimal nuclease for applications sensitive to off-target effects. Results: These three increased-fidelity nucleases can routinely be used only with perfectly matching 20-nucleotide-long spacers, a matching 5' G extension being more detrimental to their activities than a mismatching one. HeFSpCas9 exhibit substantially improved specificity for those targets for which eSpCas9 and SpCas9-HF1 have higher off-target propensity. The targets can also be ranked by their cleavability and off-target effects manifested by the increased fidelity nucleases. Furthermore, we show that the mutations in these variants may diminish the cleavage, but not the DNA-binding, of SpCas9s. Conclusions: No single nuclease variant shows generally superior fidelity; instead, for highest specificity cleavage, each target needs to be matched with an appropriate high-fidelity nuclease. We provide here a framework for generating new nuclease variants for targets that currently have no matching optimal nuclease, and offer a simple means for identifying the optimal nuclease for targets in the absence of accurate target-ranking prediction tools.	[Kulcsar, Peter Istvan; Talas, Andras; Huszar, Krisztina; Ligeti, Zoltan; Toth, Eszter; Weinhardt, Nora; Welker, Ervin] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Kulcsar, Peter Istvan; Huszar, Krisztina; Toth, Eszter; Weinhardt, Nora; Fodor, Elfrieda; Welker, Ervin] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary; [Kulcsar, Peter Istvan; Weinhardt, Nora] Univ Szeged, Szeged, Hungary; [Talas, Andras] Semmelweis Univ, Sch PhD Studies, Budapest, Hungary; [Huszar, Krisztina; Ligeti, Zoltan] Gene Design Kft, Szeged, Hungary	Welker, E (reprint author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.; Welker, E (reprint author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Szeged, Hungary.	welker.ervin@ttk.mta.hu		Kulcsar, Peter Istvan/0000-0002-7783-5108	National Research, Development and Innovation Office [KFI_16-1-2016-0240]	This work was supported by the National Research, Development and Innovation Office (KFI_16-1-2016-0240).	Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; GOOMER RS, 1992, NUCLEIC ACIDS RES, V20, P4903, DOI 10.1093/nar/20.18.4903                                                          ; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kostylev M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137466; Lee RTH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166020; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Palermo G, 2016, ACS CENTRAL SCI, V2, P756, DOI 10.1021/acscentsci.6b00218; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Talas A, 2017, DNA RES; Toth E, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0147-0; Toth E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090896; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	67	0	0	11	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	OCT 6	2017	18								190	10.1186/s13059-017-1318-8				17	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FJ4BK	WOS:000412678500003	28985763	gold			2018-01-05	
J	Ren, Y; Sekine-Kondo, E; Shibata, R; Kato-Itoh, M; Umino, A; Yanagida, A; Satoh, M; Inoue, K; Yamaguchi, T; Mochida, K; Nakae, S; Van Kaer, L; Iwabuchi, K; Nakauchi, H; Watarai, H				Ren, Yue; Sekine-Kondo, Etsuko; Shibata, Risa; Kato-Itoh, Megumi; Umino, Ayumi; Yanagida, Ayaka; Satoh, Masashi; Inoue, Komaki; Yamaguchi, Tomoyuki; Mochida, Keiichi; Nakae, Susumu; Van Kaer, Luc; Iwabuchi, Kazuya; Nakauchi, Hiromitsu; Watarai, Hiroshi			A Novel Mouse Model of iNKT Cell-deficiency Generated by CRISPR/Cas9 Reveals a Pathogenic Role of iNKT Cells in Metabolic Disease	SCIENTIFIC REPORTS			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; MICE; OBESITY; INNATE	iNKT cells play important roles in immune regulation by bridging the innate and acquired immune systems. The functions of iNKT cells have been investigated in mice lacking the Traj18 gene segment that were generated by traditional embryonic stem cell technology, but these animals contain a biased T cell receptor (TCR) repertoire that might affect immune responses. To circumvent this confounding factor, we have generated a new strain of iNKT cell-deficient mice by deleting the Traj18 locus using CRISPR/Cas9 technology, and these animals contain an unbiased TCR repertoire. We employed these mice to investigate the contribution of iNKT cells to metabolic disease and found a pathogenic role of these cells in obesity-associated insulin-resistance. The new Traj18-deficient mouse strain will assist in studies of iNKT cell biology.	[Ren, Yue; Sekine-Kondo, Etsuko; Shibata, Risa; Watarai, Hiroshi] Univ Tokyo, Inst Med Sci, Div Stem Cell Cell, Ctr Stem Cell Biol & Regenerat Med,Minato Ku, Tokyo, Japan; [Ren, Yue] Jiangxi Prov Peoples Hosp, Neurol Inst Jiangxi Prov, Dept Neurol, Nanchang, Jiangxi, Peoples R China; [Shibata, Risa; Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Kato-Itoh, Megumi; Umino, Ayumi; Yanagida, Ayaka; Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Tokyo, Japan; [Satoh, Masashi; Iwabuchi, Kazuya] Kitasato Univ, Dept Immunol, Sch Med, Sagamihara, Kanagawa, Japan; [Inoue, Komaki; Mochida, Keiichi] RIKEN, Cellulose Prod Res Team, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Nakauchi, Hiromitsu] Stanford Univ, Dept Genet, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Yanagida, Ayaka] Univ Cambridge, Wellcome Trust Med Res Council, Cambridge Stem Cell Inst, Cambridge CB2 1QR, England	Watarai, H (reprint author), Univ Tokyo, Inst Med Sci, Div Stem Cell Cell, Ctr Stem Cell Biol & Regenerat Med,Minato Ku, Tokyo, Japan.	hwatarai@ims.u-tokyo.ac.jp			Japan Society for the Promotion of Science [16K14591]; ImPACT program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	This work was supported mainly by a Grant-in-Aid for challenging Exploratory Research (16K14591) by the Japan Society for the Promotion of Science and in part by the ImPACT program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). We thank Ms. Yumiko Ishii and Mr. Takanori Maeno for supporting flow cytometry analysis and Ms. Kazuko Okunuki for secretarial assistant.	Bedel R, 2012, NAT IMMUNOL, V13, P705, DOI 10.1038/ni.2347; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Carolan E, 2015, J IMMUNOL, V194, P5775, DOI 10.4049/jimmunol.1402945; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Chandra S, 2015, NAT IMMUNOL, V16, P799, DOI 10.1038/ni.3203; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623                                                   ; Dashtsoodol N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153347; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Satoh M, 2016, ADIPOCYTE, V5, P389, DOI 10.1080/21623945.2016.1241913; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Shimizuhira C, 2014, J INVEST DERMATOL, V134, P2709, DOI 10.1038/jid.2014.200; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.ummunol.21.120601.141057; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Uldrich AP, 2011, NAT IMMUNOL, V12, P616, DOI 10.1038/ni.2051; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Wei B, 2010, J IMMUNOL, V184, P1218, DOI 10.4049/jimmunol.0902620; Wingender G, 2012, GASTROENTEROLOGY, V143, P418, DOI 10.1053/j.gastro.2012.04.017; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; ZHANG J, 2016, SCI REP UK, V6	29	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 6	2017	7								12765	10.1038/s41598-017-12475-4				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ1QH	WOS:000412492000009	28986544	gold			2018-01-05	
J	Uno, N; Hiramatsu, K; Uno, K; Komoto, S; Kazuki, Y; Oshimura, M				Uno, Narumi; Hiramatsu, Kei; Uno, Katsuhiro; Komoto, Shinya; Kazuki, Yasuhiro; Oshimura, Mitsuo			CRISPR/Cas9-induced transgene insertion and telomere-associated truncation of a single human chromosome for chromosome engineering in CHO and A9 cells	SCIENTIFIC REPORTS			English	Article							HUMAN ARTIFICIAL CHROMOSOMES; CRISPR CAS9; MICE; GENE; HUMAN-CHROMOSOME-21; DELIVERY	Chromosome engineering techniques including gene insertion, telomere-associated truncation and microcell-mediated chromosome transfer (MMCT) are powerful tools for generation of humanised model animal, containing megabase-sized genomic fragments. However, these techniques require two cell lines: homologous recombination (HR)-proficient DT40 cells for chromosome modification, and CHO cells for transfer to recipient cells. Here we show an improved technique using a combination of CRISPR/Cas9-induced HR in CHO and mouse A9 cells without DT40 cells following MMCT to recipient cells. Transgene insertion was performed in CHO cells with the insertion of enhanced green fluorescence protein (EGFP) using CRISPR/Cas9 and a circular targeting vector containing two 3 kb HR arms. Telomere-associated truncation was performed in CHO cells using CRISPR/Cas9 and a linearised truncation vector containing a single 7 kb HR arm at the 5' end, a 1 kb artificial telomere at the 3' end. At least 11% and 6% of the targeting efficiency were achieved for transgene insertion and telomereassociated truncation, respectively. The transgene insertion was also confirmed in A9 cells (29%). The modified chromosomes were transferrable to other cells. Thus, this CHO and A9 cell-mediated chromosome engineering using the CRISPR/Cas9 for direct transfer of the modified chromosome is a rapid technique that will facilitate chromosome manipulation.	[Uno, Narumi; Hiramatsu, Kei; Uno, Katsuhiro; Komoto, Shinya; Kazuki, Yasuhiro] Tottori Univ, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Dept Biomed Sci, 86 Nishi Cho, Yonago, Tottori 6838503, Japan; [Uno, Narumi; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, 86 Nishi Cho, Yonago, Tottori 6838503, Japan; [Kazuki, Yasuhiro] Tottori Univ, Fac Med, Dept Mol & Cellular Biol, 86 Nishi Cho, Yonago, Tottori 6838503, Japan	Oshimura, M (reprint author), Tottori Univ, Chromosome Engn Res Ctr, 86 Nishi Cho, Yonago, Tottori 6838503, Japan.	oshimura@med.tottori-u.ac.jp			JSPS KAKENHI Grant [15K19615, 25221308]; Regional Innovation Strategy Support Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by JSPS KAKENHI Grant Number 15K19615 (N. U.) and 25221308 (M. O.), and supported in part by the Regional Innovation Strategy Support Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (M. O. and Y. K.).	Abe Satoshi, 2010, Genome Integr, V1, P6, DOI 10.1186/2041-9414-1-6; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Hansen K, 2012, JOVE-J VIS EXP, DOI 10.3791/3304; Hiratsuka M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0142-z; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; IKENO M, 1994, HUM MOL GENET, V3, P1245, DOI 10.1093/hmg/3.8.1245                                                            ; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kazuki K, 2013, BIOCHEM BIOPH RES CO, V442, P44, DOI 10.1016/j.bbrc.2013.10.171; Kazuki Y, 2011, GENE THER, V18, P384, DOI 10.1038/gt.2010.147; Kazuki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06136; Kazuki Y, 2013, HUM MOL GENET, V22, P578, DOI 10.1093/hmg/dds468; Kazuki Y, 2011, MOL THER, V19, P1591, DOI 10.1038/mt.2011.136; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kugoh H, 1999, DNA Res, V6, P165, DOI 10.1093/dnares/6.3.165; Kuroiwa Y, 1998, NUCLEIC ACIDS RES, V26, P3447, DOI 10.1093/nar/26.14.3447                                                          ; Lee JS, 2015, BIOTECHNOL J, V10, P979, DOI 10.1002/biot.201500082; Lee JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08572; Liskovykh Mikhail, 2016, Mol Ther Methods Clin Dev, V3, P16043, DOI 10.1038/mtm.2016.43; Lombardo A, 2008, BLOOD CELL MOL DIS, V40, P278, DOI 10.1016/j.bcmd.2007.10.064; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Oshimura M., 2014, CHROMOSOME RES; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ronda C, 2014, BIOTECHNOL BIOENG, V111, P1604, DOI 10.1002/bit.25233; Shin J, 2015, BIOTECHNOL BIOPROC E, V20, P825, DOI 10.1007/s12257-015-0233-7; Shinohara T, 2001, HUM MOL GENET, V10, P1163, DOI 10.1093/hmg/10.11.1163                                                          ; Suzuki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110404; Takiguchi M, 2014, ACS SYNTH BIOL, V3, P903, DOI 10.1021/sb3000723; Uno N, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.45; Uno N, 2013, CYTOTECHNOLOGY, V65, P803, DOI 10.1007/s10616-013-9548-4; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735	33	0	0	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 6	2017	7								12739	10.1038/s41598-017-10418-7				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FJ1QC	WOS:000412491500011	28986519	gold			2018-01-05	
J	Ghosh, R; Tabrizi, SJ				Ghosh, Rhia; Tabrizi, Sarah J.			Gene suppression approaches to neurodegeneration	ALZHEIMERS RESEARCH & THERAPY			English	Review						Gene suppression; RNA interference; Anti-sense oligonucleotides; Zinc-finger proteins; CRISPR/Cas9; Therapeutics; Huntington's disease; Dementia	ANTISENSE OLIGONUCLEOTIDE THERAPY; MUTANT HUNTINGTIN EXPRESSION; ALLELE-SELECTIVE INHIBITION; SPINAL MUSCULAR-ATROPHY; SINGLE-NUCLEOTIDE POLYMORPHISMS; SMALL INTERFERING RNA; EXPANDED CAG REPEAT; YAC128 MOUSE MODEL; IN-VIVO; SPINOCEREBELLAR ATAXIA	Gene suppression approaches have emerged over the last 20 years as a novel therapeutic approach for the treatment of neurodegenerative diseases. These include RNA interference and anti-sense oligonucleotides, both of which act at the post-transcriptional level, and genome-editing techniques, which aim to repair the responsible mutant gene. All serve to inhibit the expression of disease-causing proteins, leading to the potential prevention or even reversal of the disease phenotype. In this review we summarise the main developments in gene suppression strategies, using examples from Huntington's disease and other inherited causes of neurodegeneration, and explore how these might illuminate a path to tackle other proteinopathy-associated dementias in the future.	[Ghosh, Rhia; Tabrizi, Sarah J.] UCL Inst Neurol, Dept Neurodegenerat Dis, UCL Huntingtons Dis Ctr, London WC1N 3BG, England	Ghosh, R; Tabrizi, SJ (reprint author), UCL Inst Neurol, Dept Neurodegenerat Dis, UCL Huntingtons Dis Ctr, London WC1N 3BG, England.	rhia.ghosh@ucl.ac.uk; s.tabrizi@ucl.ac.uk			Medical Research Council UK Clinical Research Fellowship; EU; Medical Research Council UK; CHDI Foundation; Huntington Disease Association of the UK; European Huntington's Disease Network; Wellcome Trust; Rosetrees Trust; Takeda Pharmaceuticals	RG is funded entirely by a Medical Research Council UK Clinical Research Fellowship. SJT receives grant funding for her research from the EU FP7 health call, Medical Research Council UK, CHDI Foundation, Huntington Disease Association of the UK, the European Huntington's Disease Network, the Wellcome Trust, the Rosetrees Trust and Takeda Pharmaceuticals.	Barik S, 2006, NAT BIOTECHNOL, V24, P796, DOI 10.1038/nbt0706-796                                                             ; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; April MC, 2012, INT J ALZHEIMERS DIS, V2012; Borel Florie, 2011, J RNAi Gene Silencing, V7, P434; Boudreau RL, 2011, MOL THER, V19, P2169, DOI 10.1038/mt.2011.185; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Chen ZYJ, 2005, BIOCHEM BIOPH RES CO, V329, P646, DOI 10.1016/j.bbrc.2005.02.024; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Cole T, 2016, AAN ANN M POST SESS; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Datson NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171127; De Fougerolles AR, 2008, HUM GENE THER, V19, P125, DOI 10.1089/hum.2008.928; Denovan-Wright EM, 2008, NEUROBIOL DIS, V29, P446, DOI 10.1016/j.nbd.2007.11.003; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Dragatsis I, 2000, NAT GENET, V26, P300; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Dufour BD, 2014, MOL THER, V22, P797, DOI 10.1038/mt.2013.289; Finkel R, 2016, AM AC NEUR 2016 ANN; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garriga-Canut M, 2012, P NATL ACAD SCI USA, V109, pE3136, DOI 10.1073/pnas.1206506109; Godinho BMDC, 2015, DRUG DISCOV TODAY, V20, P50, DOI 10.1016/j.drudis.2014.09.011; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grondin R, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.20; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hall B, 2017, AGEING RES REV, V36, P50, DOI 10.1016/j.arr.2017.03.002; Hammond SM, 2016, P NATL ACAD SCI USA, V113, P10962, DOI 10.1073/pnas.1605731113; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hayashita-Kinoh H, 2006, BIOCHEM BIOPH RES CO, V341, P1088, DOI 10.1016/j.bbrc.2006.01.057; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hu JX, 2009, ANN NY ACAD SCI, V1175, P24, DOI 10.1111/j.1749-6632.2009.04975.x; Hua JX, 2009, BIOORG MED CHEM LETT, V19, P6181, DOI 10.1016/j.bmcl.2009.09.004; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jeune VL, 2013, HUM GENE THER METHOD, V24, P59, DOI 10.1089/hgtb.2012.243; Kantor B, 2014, ADV GENET, V87, P71, DOI 10.1016/B978-0-12-800149-3.00002-0; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545                                                    ; Keiser MS, 2016, HUM MOL GENET, V25, pR53, DOI 10.1093/hmg/ddv442; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lecaros RLG, 2016, MOL THER, V24, P106, DOI 10.1038/mt.2015.169; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lleo A, 2015, NAT REV NEUROL, V11, P41, DOI 10.1038/nrneurol.2014.232; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Lu XH, 2012, NEURON, V74, P964, DOI 10.1016/j.neuron.2012.06.001; Machida Y, 2006, BIOCHEM BIOPH RES CO, V343, P190, DOI 10.1016/j.bbrc.2006.02.141; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin JN, 2011, GENE THER, V18, P666, DOI 10.1038/gt.2011.10; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.080177S105; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; Miller JRC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46740; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Murlidharan G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00076; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; O'Kelly F, 2012, NAT REV UROL, V9, P397, DOI 10.1038/nrurol.2012.104; Ostergaard ME, 2013, NUCLEIC ACIDS RES, V41, P9634, DOI 10.1093/nar/gkt725; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rue L, 2016, J CLIN INVEST, V126, P4319, DOI 10.1172/JCI83185; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Scoles DR, 2017, NATURE, V544, P362, DOI 10.1038/nature22044; Shin JW, 2016, HUM MOL GENET, V25, P4566, DOI 10.1093/hmg/ddw286; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Skotte NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107434; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI.25424; Southwell AL, 2014, MOL THER, V22, P2093, DOI 10.1038/mt.2014.153; Stanek LM, 2014, HUM GENE THER, V25, P461, DOI 10.1089/hum.2013.200; Stanek LM, 2013, J HUNTINGTONS DIS, V2, P217, DOI 10.3233/JHD-130057; Stiles DK, 2012, EXP NEUROL, V233, P463, DOI 10.1016/j.expneurol.2011.11.020; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Wang GH, 2016, P NATL ACAD SCI USA, V113, P3359, DOI 10.1073/pnas.1524575113; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743; Wild EJ, 2014, MOVEMENT DISORD, V29, P1434, DOI 10.1002/mds.26007; Winer L, 2013, JAMA NEUROL, V70, P201, DOI 10.1001/jamaneurol.2013.593; Wolf DA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85311; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Yen LS, 1999, ANN NEUROL, V46, P366, DOI 10.1002/1531-8249(199909)46:3<366::AID-ANA12>3.0.CO;2-D; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zhao H, 2016, AAN ANN M INS DAT BL	95	0	0	14	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1758-9193			ALZHEIMERS RES THER	Alzheimers Res. Ther.	OCT 5	2017	9									10.1186/s13195-017-0307-1				13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FI8UK	WOS:000412277400001		gold			2018-01-05	
J	Stankiewicz, P; Khan, TN; Szafranski, P; Slattery, L; Streff, H; Vetrini, F; Bernstein, JA; Brown, CW; Rosenfeld, JA; Rednam, S; Scollon, S; Bergstrom, KL; Parsons, DW; Plon, SE; Vieira, MW; Quaio, CRDC; Baratela, WAR; Guio, JCA; Armstrong, R; Mehta, SG; Rump, P; Pfundt, R; Lewandowski, R; Fernandes, EM; Shinde, DN; Tang, S; Hoyer, J; Zweier, C; Reis, A; Bacino, CA; Xiao, R; Breman, AM; Smith, JL; Katsanis, N; Bostwick, B; Popp, B; Davis, EE; Yang, YP				Stankiewicz, Pawel; Khan, Tahir N.; Szafranski, Przemyslaw; Slattery, Leah; Streff, Haley; Vetrini, Francesco; Bernstein, Jonathan A.; Brown, Chester W.; Rosenfeld, Jill A.; Rednam, Surya; Scollon, Sarah; Bergstrom, Katie L.; Parsons, Donald W.; Plon, Sharon E.; Vieira, Marta W.; Quaio, Caio R. D. C.; Baratela, Wagner A. R.; Acosta Guio, Johanna C.; Armstrong, Ruth; Mehta, Sarju G.; Rump, Patrick; Pfundt, Rolph; Lewandowski, Raymond; Fernandes, Erica M.; Shinde, Deepali N.; Tang, Sha; Hoyer, Juliane; Zweier, Christiane; Reis, Andre; Bacino, Carlos A.; Xiao, Rui; Breman, Amy M.; Smith, Janice L.; Katsanis, Nicholas; Bostwick, Bret; Popp, Bernt; Davis, Erica E.; Yang, Yaping		Deciphering Dev Disorders Study	Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIANT; TRANSCRIPTION FACTOR; INTELLECTUAL DISABILITY; COMPLEX NURF; PHD FINGER; ARRAY CGH; IN-VIVO; MUTATIONS; GENE; PROTEIN	Bromodomain PHD finger transcription factor (BPTF) is the largest subunit of nucleosome remodeling factor (NURF), a member of the ISWI chromatin-remodeling complex. However, the clinical consequences of disruption of this complex remain largely uncharacterized. BPTF is required for anterior-posterior axis formation of the mouse embryo and was shown to promote posterior neuroectodermal fate by enhancing Smad2-activated wnt8 expression in zebrafish. Here, we report eight loss-of-function and two missense variants (eight de novo and two of unknown origin) in BPTF on 17q24.2. The BPTF variants were found in unrelated individuals aged between 2.1 and 13 years, who manifest variable degrees of developmental delay/intellectual disability (10/10), speech delay (10/10), postnatal microcephaly (7/9), and dysmorphic features (9/10). Using CRISPR-Cas9 genome editing of bptf in zebrafish to induce a loss of gene function, we observed a significant reduction in head size of F0 mutants compared to control larvae. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and phospho-histone H3 (PH3) staining to assess apoptosis and cell proliferation, respectively, showed a significant increase in cell death in F0 mutants compared to controls. Additionally, we observed a substantial increase of the ceratohyal angle of the craniofacial skeleton in bptf F0 mutants, indicating abnormal craniofacial patterning. Taken together, our data demonstrate the pathogenic role of BPTF haploinsufficiency in syndromic neurodevelopmental anomalies and extend the clinical spectrum of human disorders caused by ablation of chromatin remodeling complexes.	[Stankiewicz, Pawel; Szafranski, Przemyslaw; Streff, Haley; Rosenfeld, Jill A.; Parsons, Donald W.; Plon, Sharon E.; Bacino, Carlos A.; Xiao, Rui; Breman, Amy M.; Smith, Janice L.; Bostwick, Bret; Yang, Yaping] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stankiewicz, Pawel; Vetrini, Francesco; Rosenfeld, Jill A.; Bacino, Carlos A.; Xiao, Rui; Breman, Amy M.; Smith, Janice L.; Yang, Yaping] Baylor Genet, Houston, TX 77021 USA; [Khan, Tahir N.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Slattery, Leah; Bernstein, Jonathan A.] Stanford Univ, Div Med Genet, Dept Pediat, Stanford, CA 94305 USA; [Brown, Chester W.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA; [Brown, Chester W.] Le Bonheur Childrens Hosp, Memphis, TN 38105 USA; [Rednam, Surya; Scollon, Sarah; Bergstrom, Katie L.; Parsons, Donald W.; Plon, Sharon E.] Texas Childrens Hosp, Houston, TX 77030 USA; [Rednam, Surya; Scollon, Sarah; Bergstrom, Katie L.; Parsons, Donald W.; Plon, Sharon E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Rednam, Surya; Scollon, Sarah; Bergstrom, Katie L.; Parsons, Donald W.; Plon, Sharon E.] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Vieira, Marta W.] PUCSP, Fac Ciencias Med & Saude, BR-01221020 Sao Paulo, Brazil; [Quaio, Caio R. D. C.; Baratela, Wagner A. R.] Fleury Med & Saude, BR-04344070 Sao Paulo, Brazil; [Acosta Guio, Johanna C.] Inst Ortoped Infantil Roosevelt, Genet Med, 17-50 Bogota, Cundinamarca, Colombia; [Armstrong, Ruth; Mehta, Sarju G.] Addenbrookes Hosp, Addenbrookes Treatment Ctr, Clin Genet, East Anglian Med Genet Serv, Cambridge CB2 0QQ, England; [Rump, Patrick] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 AB Groningen, Netherlands; [Pfundt, Rolph] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Lewandowski, Raymond; Fernandes, Erica M.] Virginia Commonwealth Univ, Richmond, VA 23298 USA; [Shinde, Deepali N.; Tang, Sha] Ambry Genet, Dept Clin Gen, Aliso Viejo, CA 92656 USA; [Hoyer, Juliane; Zweier, Christiane; Reis, Andre; Popp, Bernt] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Human Genet, D-91054 Erlangen, Germany	Stankiewicz, P; Yang, YP (reprint author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Stankiewicz, P; Yang, YP (reprint author), Baylor Genet, Houston, TX 77021 USA.	pawels@bcm.edu; yapingy@bcm.edu	Reis, Andre/D-2309-2009	Reis, Andre/0000-0002-6301-6363	Health Innovation Challenge Fund [HICF-1009-003]; Wellcome Trust; Department of Health; Wellcome Trust Sanger Institute [WT098051]; National Institute for Health Research, through the Comprehensive Clinical Research Network; US NIH grant [R01 MH106826]; National Institute for Health Research, through the Comprehen-sive Clinical Research Network; CHROMATIN-Net - German Federal Ministry of Education and Research (BMBF) [01GM1520A]; Rescindo Therapeutics, Inc.;  [U01HG006485]	We thank all families for participating in this study. We thank Mr. Z. Kupchinsky for zebrafish husbandry and automated imaging support. Evaluation of subject 3 was through support from U01HG006485 to S.E.P. The DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant number HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (grant number WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the Department of Health. The research team acknowledges the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network. This study makes use of data generated by the DECIPHER community. A full list of centers who contributed to the generation of the data is available from https://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. E.E.D. is supported by US NIH grant R01 MH106826. The research team acknowledges the support of the National Institute for Health Research, through the Comprehen-sive Clinical Research Network. S.E.P. is a member of the Scientific Advisory Board (SAB) of Baylor Genetics Laboratories. A.R. is supported by CHROMATIN-Net funded by German Federal Ministry of Education and Research (BMBF, grant number 01GM1520A). N.K. is a paid consultant for and holds significant stock of Rescindo Therapeutics, Inc. Y.Y. is a member of the Scientific Advisory Board (SAB) of Veritas Genetics China. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the chromosomal microarray analysis and clinical exome sequencing offered by Baylor Genetics.	Alkhatib SG, 2011, FEBS LETT, V585, P3197, DOI 10.1016/j.febslet.2011.09.003; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Bai X, 2007, GENETICS, V176, P1491, DOI 10.1534/genetics.107.071571; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Bartnik M, 2014, J APPL GENET, V55, P125, DOI 10.1007/s13353-013-0181-x; Blyth M, 2008, EUR J MED GENET, V51, P672, DOI 10.1016/j.ejmg.2008.09.002; Bohnsack BL, 2012, INVEST OPHTH VIS SCI, V53, P7, DOI 10.1167/iovs.11-8494; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Buganim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009657; Dai M, 2015, ONCOTARGET, V6, P33878, DOI 10.18632/oncotarget.5302; Dauber A, 2013, AM J HUM GENET, V93, P798, DOI 10.1016/j.ajhg.2013.09.010; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Erter CE, 2001, DEVELOPMENT, V128, P3571; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; French CA, 2003, CANCER RES, V63, P304; Frey WD, 2017, STEM CELL REP, V9, P23, DOI 10.1016/j.stemcr.2017.04.031; Frosk P, 2017, J MED GENET, V54, P490, DOI 10.1136/jmedgenet-2016-104296; Fujisawa T, 2017, NAT REV MOL CELL BIO, V18, P246, DOI 10.1038/nrm.2016.143; Goller T, 2008, MOL CELL BIOL, V28, P6819, DOI 10.1128/MCB.01058-08; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gong YC, 2017, EUR REV MED PHARMACO, V21, P102; Gordon CT, 2015, AM J HUM GENET, V96, P519, DOI 10.1016/j.ajhg.2015.01.015; Hagman KDF, 2017, GENET MED, V19, P224, DOI 10.1038/gim.2016.95; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5                                                   ; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Isrie M, 2015, AM J HUM GENET, V97, P790, DOI 10.1016/j.ajhg.2015.10.014; Jones MH, 2000, GENOMICS, V63, P35, DOI 10.1006/geno.1999.6070; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kim HT, 2011, BIOCHEM BIOPH RES CO, V409, P640, DOI 10.1016/j.bbrc.2011.05.056; Kim HG, 2010, AM J HUM GENET, V87, P465, DOI 10.1016/j.ajhg.2010.08.018; Kury S, 2017, AM J HUM GENET, V100, P352, DOI 10.1016/j.ajhg.2017.01.003; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Lee JH, 2016, APMIS, V124, P425, DOI 10.1111/apm.12512; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li JL, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-4; Ma YQ, 2015, J NEUROSCI, V35, P8493, DOI 10.1523/JNEUROSCI.0377-15.2015; Mayes K, 2017, ONCOTARGET, V8, P64344, DOI 10.18632/oncotarget.17834; Mayes K, 2016, CANCER RES, V76, P6183, DOI 10.1158/0008-5472.CAN-15-3125; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nakayama T, 2015, AM J HUM GENET, V96, P709, DOI 10.1016/j.ajhg.2015.03.003; Naud M. E., 2017, CASE REP GENET, V2017; Parsons DW, 2016, JAMA ONCOL, V2, P616, DOI 10.1001/jamaoncol.2015.5699; Richart L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10153; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130                                                                  ; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stewart DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098686; Ta-Shma A, 2017, AM J HUM GENET, V100, P666, DOI 10.1016/j.ajhg.2017.02.007; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Vergult S, 2012, EUR J HUM GENET, V20, P534, DOI 10.1038/ejhg.2011.239; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Wang CY, 2015, TRENDS BIOCHEM SCI, V40, P468, DOI 10.1016/j.tibs.2015.06.002; Wiszniewska J, 2014, EUR J HUM GENET, V22, P79, DOI 10.1038/ejhg.2013.77; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Wu B, 2016, J IMMUNOL, V197, P4325, DOI 10.4049/jimmunol.1600642; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xiao S, 2015, DIGEST DIS SCI, V60, P910, DOI 10.1007/s10620-014-3411-0; Yan KZ, 2017, AM J HUM GENET, V100, P91, DOI 10.1016/j.ajhg.2016.11.011; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	72	0	0	10	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					503	515		10.1016/j.ajhg.2017.08.014				13	Genetics & Heredity	Genetics & Heredity	FI8UJ	WOS:000412277300002	28942966				2018-01-05	
J	Karmakar, A; Goswami, R; Saha, T; Maitra, S; Roychowdhury, A; Panda, CK; Sinha, S; Ray, A; Mohanakumar, KP; Rajamma, U; Mukhopadhyay, K				Karmakar, Arijit; Goswami, Rishov; Saha, Tanusree; Maitra, Subhamita; Roychowdhury, Anirban; Panda, Chinmay Kumar; Sinha, Swagata; Ray, Anirban; Mohanakumar, Kochupurackal P.; Rajamma, Usha; Mukhopadhyay, Kanchan			Pilot study indicate role of preferentially transmitted monoamine oxidase gene variants in behavioral problems of male ADHD probands	BMC MEDICAL GENETICS			English	Article						ADHD; MAOA; MAOB; Genotyping; Maternal transmission; Behavioral trait; Maternal age; Linkage disequilibrium; Indo-Caucasoid population	DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ASSOCIATION ANALYSIS; B GENES; PROMOTER POLYMORPHISM; CANDIDATE GENES; POINT MUTATION; A GENE; MAO-A; CHILDREN	Background: Attention deficit hyperactivity disorder (ADHD) is an etiologically complex childhood onset neurobehavioral disorder characterized by age-inappropriate inattention, hyperactivity, and impulsivity. Symptom severity varies widely and boys are diagnosed more frequently than girls. ADHD probands were reported to have abnormal transmissions of dopamine, serotonin, and/or noradrenaline. Monoamine oxidase A (MAOA) and B (MAOB), mitochondrial outer membrane bound two isoenzymes, mediate degradation of these neurotransmitters and thus regulating their circulating levels. Case-control analyses in different populations, including Indians, suggested involvement of MAOA and MAOB genes in the etiology of ADHD. Due to high heritability rate of ADHD, we tested familial transmission of MAOA and MAOB variants to ADHD probands in 190 nuclear families having ADHD probands from Indo-Caucasoid ethnicity. Methods: Subjects were recruited following the Diagnostic and Statistical Manual of Mental Disorders-4th edition (DSM-IV). Appropriate scales were used for measuring the behavioral traits in probands. Genotyping was performed through PCR-based amplification of target sites followed by DNA-sequencing and/or gel-electrophoresis. Data obtained were analyzed by family based statistical methods. Results: Out of 58 variants present in the analyzed sites only 15 were found to be polymorphic (30 bp-uVNTR, rs5906883, rs1465107, rs1465108, rs5905809, rs5906957, rs6323, rs1137070 from MAOA and rs4824562, rs56220155, rs2283728, rs2283727, rs3027441, rs6324, rs3027440 from MAOB). Statistically significant maternal transmission of alleles to male probands was observed for MAOA rs5905809 'G' (p = 0.04), rs5906957 'A' (p = 0.04), rs6323 'G' (p = 0. 0001) and MAOB rs56220155 'A' (p = 0.002), rs2283728 'C' (p = 0.0008), rs2283727 'C' (p = 0.0008), rs3027441 'T' (p = 0.003), rs6324 'C' (p = 0.003), rs3027440 'T' (p = 0.0002). Significantly preferential maternal transmissions of different haplotype combinations to male probands were also noticed (p < 0.05), while female probands did not reveal such transmission bias. Behavioral traits of male probands exhibited significant association with gene variants. Age of the mother at pregnancy also revealed association with risk variants of male probands. Conclusions: It may be inferred that the MAOA and MAOB variants may contribute to the etiology of ADHD in the Indo-Caucasoid population and could be responsible for higher occurrence of ADHD in the boys.	[Karmakar, Arijit; Goswami, Rishov; Saha, Tanusree; Maitra, Subhamita; Sinha, Swagata; Rajamma, Usha; Mukhopadhyay, Kanchan] Manovikas Kendra, Manovikas Biomed Res & Diagnost Ctr, 482 Madudah,Plot 1-24,Sect J, Kolkata 700107, India; [Roychowdhury, Anirban; Panda, Chinmay Kumar] Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, 37 SP Mukherjee Rd, Kolkata 700026, India; [Ray, Anirban] Inst Post Grad Med Educ & Res, Dept Psychiat, Kolkata 700020, India; [Mohanakumar, Kochupurackal P.] Indian Inst Chem Biol, CSIR, Lab Clin & Expt Neurosci, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Mohanakumar, Kochupurackal P.; Rajamma, Usha] Inter Univ Ctr Biomed Res, Mahatma Gandhi Univ Campus Thalappady, Kottayam 686009, Kerala, India; [Mohanakumar, Kochupurackal P.; Rajamma, Usha] Super Specialty Hosp, Mahatma Gandhi Univ Campus Thalappady, Kottayam 686009, Kerala, India	Mukhopadhyay, K (reprint author), Manovikas Kendra, Manovikas Biomed Res & Diagnost Ctr, 482 Madudah,Plot 1-24,Sect J, Kolkata 700107, India.	kanchanmvk@yahoo.com			Department of Biotechnology, Government of India [BT/PR14637/MED/30/561/2010]	This work was sponsored by grant # BT/PR14637/MED/30/561/2010 of the Department of Biotechnology, Government of India.	Ajinkya S, 2013, INDIAN J PEDIATR, V80, P207, DOI 10.1007/s12098-012-0854-1; Alia-Klein N, 2008, J NEUROSCI, V28, P5099, DOI 10.1523/JNEUROSCI.0925-08.2008; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; Banaschewski T, 2010, EUR CHILD ADOLES PSY, V19, P237, DOI 10.1007/s00787-010-0090-z; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bharat RJ, 1971, J ALL INDIA I SPEECH, V2, P34; Biederman J, 2008, AM J MED GENET B, V147B, P1511, DOI 10.1002/ajmg.b.30874; Booster GD, 2012, J ATTEN DISORD, V16, P179, DOI 10.1177/1087054710383239; Brookes K, MOL PSYCHIAT; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186                                                         ; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chen K, 2004, J BIOL CHEM, V279, P39645, DOI 10.1074/jbc.M405550200; Classi Peter, 2012, Child Adolesc Psychiatry Ment Health, V6, P33, DOI 10.1186/1753-2000-6-33; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621                                                         ; Cortese S, 2012, EUR J PAEDIATR NEURO, V16, P422, DOI 10.1016/j.ejpn.2012.01.009; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Daley D, 2010, CHILD CARE HLTH DEV, V36, P455, DOI 10.1111/j.1365-2214.2009.01046.x; Das Bhowmik A, 2017, J ATTEN DISORD, V21, P200, DOI 10.1177/1087054713494004; Das M, 2006, AM J MED GENET B, V141B, P637, DOI 10.1002/ajmg.b.30385; Das M, 2011, PROG NEURO-PSYCHOPH, V35, P577, DOI 10.1016/j.pnpbp.2010.12.027; Davies W, 2014, FRONT NEUROENDOCRIN, V35, P331, DOI 10.1016/j.yfrne.2014.03.003; Dlugos AM, 2009, J NEURAL TRANSM, V116, P1323, DOI 10.1007/s00702-009-0281-2; Domschke K, 2005, AM J MED GENET B, V134B, P110, DOI 10.1002/ajmg.b.30158; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784                                                        ; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; Faraone SV, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0497-1; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fonseca DJ, 2015, ANN NEUROSCI, V22, P217, DOI 10.5214/ans.0972.7531.220405; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; Hawi Z, 2013, PSYCHOPHARMACOLOGY, V225, P895, DOI 10.1007/s00213-012-2875-x; Johansen EB, 2002, BEHAV BRAIN RES, V130, P37, DOI 10.1016/S0166-4328(01)00434-X                                                   ; Karmakar A, 2014, NEUROCHEM RES, V39, P843, DOI 10.1007/s11064-014-1276-4; Karmakar A, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0401-6; Lawson DC, 2003, AM J MED GENET B, V116B, P84, DOI 10.1002/ajmg.b.10002; Lenders JWM, 1996, J CLIN INVEST, V97, P1010, DOI 10.1172/JCI118492; Li J, 2008, AM J MED GENET B, V147B, P370, DOI 10.1002/ajmg.b.30606; Li Z, 2014, PSYCHIAT RES, V219, P10, DOI 10.1016/j.psychres.2014.05.005; Liu L, 2011, AM J MED GENET B, V156B, P737, DOI 10.1002/ajmg.b.31217; Malhi P, 2000, Indian Pediatr, V37, P1256; Malmberg K, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-28; Manor I, 2002, MOL PSYCHIATR, V7, P626, DOI 10.1038/sj.mp.4001037; Martin J, 2014, BIOL PSYCHIAT, V76, P664, DOI 10.1016/j.biopsych.2014.02.013; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mueller KL, 2012, TOP LANG DISORD, V32, P207, DOI 10.1097/TLD.0b013e318261ffdd; Oades RD, 2008, PROG BRAIN RES, V172, P543, DOI 10.1016/S0079-6123(08)00926-6; Oades RD, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-48; Oreland Lars, 2002, Neurotox Res, V4, P421, DOI 10.1080/10298420290031405; Payton A, 2001, AM J MED GENET, V105, P464, DOI 10.1002/ajmg.1407; Reinhardt MC, 2013, J PEDIAT-BRAZIL, V89, P124, DOI 10.1016/j.jped.2013.03.015; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816                                                           ; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schachar R., 2014, CURR DEV DISORD REP, V1, P41, DOI DOI 10.1007/S40474-013-0004-0; Seo DJ, 2008, AGGRESS VIOLENT BEH, V13, P383, DOI 10.1016/j.avb.2008.06.003; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Shiraishi H, 2006, PSYCHIAT GENET, V16, P55, DOI 10.1097/01.ypg.0000199447.62044.ef                                              ; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Staif R, 2006, ARCH MED SCI, V2, P235; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Tipton KF, 2004, CURR MED CHEM, V11, P1965, DOI 10.2174/0929867043364810                                                        ; Trent S, 2012, BIOL PSYCHOL, V89, P1, DOI 10.1016/j.biopsycho.2011.09.011; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Venkata JA, 2013, INDIAN J PSYCHIAT, V55, P338, DOI 10.4103/0019-5545.120544; Volkow ND, 2003, INT J EAT DISORDER, V33, P136, DOI 10.1002/eat.10118; Wechsler D., 1991, WECHSLER INTELLIGENC; Whitfield JB, 2000, PSYCHOL MED, V30, P443, DOI 10.1017/S0033291799001798                                                       ; Xu XH, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-10; ZHU QS, 1992, J NEUROSCI, V12, P4437	73	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2350			BMC MED GENET	BMC Med. Genet.	OCT 5	2017	18								109	10.1186/s12881-017-0469-5				12	Genetics & Heredity	Genetics & Heredity	FJ5UK	WOS:000412818300002	28982350	gold			2018-01-05	
J	Tu, CF; Wu, MY; Lin, YC; Kannagi, R; Yang, RB				Tu, Cheng-Fen; Wu, Meng-Ying; Lin, Yuh-Charn; Kannagi, Reiji; Yang, Ruey-Bing			FUT8 promotes breast cancer cell invasiveness by remodeling TGF-beta receptor core fucosylation	BREAST CANCER RESEARCH			English	Article						Breast cancer; Core fucosylation; EMT; FUT8; Metastasis; TGF-beta receptor	EPITHELIAL-MESENCHYMAL TRANSITIONS; N-LINKED OLIGOSACCHARIDE; FC-GAMMA-RIII; TRANSCRIPTION FACTORS; BIOLOGICAL FUNCTION; TRANSFERASE 8; GLYCOSYLATION; BINDING; EMT; FUCOSE	Background: Core fucosylation (addition of fucose in a-1,6-linkage to core N-acetylglucosamine of N-glycans) catalyzed by fucosyltransferase 8 (FUT8) is critical for signaling receptors involved in many physiological and pathological processes such as cell growth, adhesion, and tumor metastasis. Transforming growth factor-beta (TGF-beta)induced epithelial-mesenchymal transition (EMT) regulates the invasion and metastasis of breast tumors. However, whether receptor core fucosylation affects TGF-beta signaling during breast cancer progression remains largely unknown. Method: In this study, gene expression profiling and western blot were used to validate the EMT-associated expression of FUT8. Lentivirus-mediated gain-of-function study, short hairpin RNA (shRNA) or CRISPR/Cas9-mediated loss-of-function studies and pharmacological inhibition of FUT8 were used to elucidate the molecular function of FUT8 during TGF-beta-induced EMT in breast carcinoma cells. In addition, lectin blot, luciferase assay, and in vitro ligand binding assay were employed to demonstrate the involvement of FUT8 in the TGF-beta 1 signaling pathway. The role of FUT8 in breast cancer migration, invasion, and metastasis was confirmed using an in vitro transwell assay and mammary fat pad xenograft in vivo tumor model. Results: Gene expression profiling analysis revealed that FUT8 is upregulated in TGF-beta-induced EMT; the process was associated with the migratory and invasive abilities of several breast carcinoma cell lines. Gain-of-function and loss-of-function studies demonstrated that FUT8 overexpression stimulated the EMT process, whereas FUT8 knockdown suppressed the invasiveness of highly aggressive breast carcinoma cells. Furthermore, TGF-beta receptor complexes might be core fucosylated by FUT8 to facilitate TGF-beta binding and enhance downstream signaling. Importantly, FUT8 inhibition suppressed the invasive ability of highly metastatic breast cancer cells and impaired their lung metastasis. Conclusions: Our results reveal a positive feedback mechanism of FUT8-mediated receptor core fucosylation that promotes TGF-beta signaling and EMT, thus stimulating breast cancer cell invasion and metastasis.	[Tu, Cheng-Fen; Wu, Meng-Ying; Lin, Yuh-Charn; Kannagi, Reiji; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Inst Pharmacol, Taipei 11221, Taiwan; [Yang, Ruey-Bing] Taipei Med Univ, Coll Pharm, PhD Program Biotechnol Res & Dev, Taipei 11031, Taiwan	Yang, RB (reprint author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.; Yang, RB (reprint author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 11221, Taiwan.; Yang, RB (reprint author), Taipei Med Univ, Coll Pharm, PhD Program Biotechnol Res & Dev, Taipei 11031, Taiwan.	rbyang@ibms.sinica.edu.tw			MOST [VTA 106-T-6-2, MOST 106-0210-01-15-02, MOST 105-0210-01-13-01, MOST 104-0210-01-09-02, MOST 104-2320-B-001-011-MY3]; Academia Sinica	This work was supported by grants from Academia Sinica and MOST (VTA 106-T-6-2, MOST 106-0210-01-15-02, MOST 105-0210-01-13-01, MOST 104-0210-01-09-02, MOST 104-2320-B-001-011-MY3).	ALBINI A, 1987, CANCER RES, V47, P3239; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013                                                         ; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Holst S, 2015, ADV CANCER RES, V126, P203, DOI 10.1016/bs.acr.2014.11.004; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mehta A, 2015, ADV CANCER RES, V126, P257, DOI 10.1016/bs.acr.2014.11.005; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miyoshi E, 1999, BBA-GEN SUBJECTS, V1473, P9, DOI 10.1016/S0304-4165(99)00166-X; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Shibata-Koyama M, 2009, GLYCOBIOLOGY, V19, P126, DOI 10.1093/glycob/cwn110; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332; Takahashi S, 2016, GLYCOCONJUGATE J, V33, P471, DOI 10.1007/s10719-016-9653-7; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang YH, 2015, INT C NETWB INFO, P6, DOI 10.1109/NBiS.2015.5; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yue LL, 2016, HISTOL HISTOPATHOL, V31, P547, DOI 10.14670/HH-11-693; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	40	0	0	5	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1465-542X	1465-5411		BREAST CANCER RES	Breast Cancer Res.	OCT 5	2017	19								111	10.1186/s13058-017-0904-8				15	Oncology	Oncology	FI9ZS	WOS:000412368900001	28982386	green_published			2018-01-05	
J	Guo, TW; Bartesaghi, A; Yang, H; Falconieri, V; Rao, P; Merk, A; Eng, ET; Raczkowski, AM; Fox, T; Earl, LA; Patel, DJ; Subramaniam, S				Guo, Tai Wei; Bartesaghi, Alberto; Yang, Hui; Falconieri, Veronica; Rao, Prashant; Merk, Alan; Eng, Edward T.; Raczkowski, Ashleigh M.; Fox, Tara; Earl, Lesley A.; Patel, Dinshaw J.; Subramaniam, Sriram			Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex	CELL			English	Article							R-LOOP FORMATION; BACTERIAL IMMUNE-SYSTEM; BEAM-INDUCED MOTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CRYOELECTRON MICROSCOPY; PSEUDOMONAS-AERUGINOSA; VIRAL SUPPRESSORS; RNA; RECOGNITION	Prokaryotic cells possess CRISPR-mediated adaptive immune systems that protect them from foreign genetic elements, such as invading viruses. A central element of this immune system is an RNA-guided surveillance complex capable of targeting non-self DNA or RNA for degradation in a sequence-and site-specific manner analogous to RNA interference. Although the complexes display considerable diversity in their composition and architecture, many basic mechanisms underlying target recognition and cleavage are highly conserved. Using cryoelectron microscopy (cryo-EM), we show that the binding of target double-stranded DNA (dsDNA) to a type I-F CRISPR system yersinia (Csy) surveillance complex leads to large quaternary and tertiary structural changes in the complex that are likely necessary in the pathway leading to target dsDNA degradation by a trans-acting helicase-nuclease. Comparison of the structure of the surveillance complex before and after dsDNA binding, or in complex with three virally encoded anti-CRISPR suppressors that inhibit dsDNA binding, reveals mechanistic details underlying target recognition and inhibition.	[Guo, Tai Wei; Bartesaghi, Alberto; Falconieri, Veronica; Rao, Prashant; Merk, Alan; Earl, Lesley A.; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA; [Yang, Hui; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Eng, Edward T.; Raczkowski, Ashleigh M.] New York Struct Biol Ctr, Simons Electron Microscopy Ctr, New York, NY 10027 USA; [Fox, Tara; Subramaniam, Sriram] NCI, Ctr Mol Microscopy, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fox, Tara] Frederick Natl Lab Canc Res, Canc Res Technol Program, Frederick, MD 21701 USA	Subramaniam, S (reprint author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.; Subramaniam, S (reprint author), NCI, Ctr Mol Microscopy, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	subramas@mail.nih.gov			Simons Foundation [349247]; NYSTAR; NIH National Institute of General Medical Sciences [GM103310]; Agouron Institute [F00316]; NIH [S10 Od019994-01, GM104962]; Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD; Geoffrey Beene Cancer Research Center; Memorial Sloan Kettering Cancer Center [P30CA008748]; Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]	We thank K. Podolsky for initial evaluation of Csy<SUP>crRNA</SUP> by negative stain electron microscopy. We also thank Drs. Bridget Carragher and Clint Potter for access to the facilities at the New York Structural Biology Center for high-throughput electron microscopy data collection. The structural work with the Csy<SUP>crRNA</SUP>. AcrF2 was performed at the Simons Electron Microscopy Center and National Resource for Automated Molecular Microscopy located at the New York Structural Biology Center, supported by grants from the Simons Foundation (349247), NYSTAR, and the NIH National Institute of General Medical Sciences (GM103310) with additional support from the Agouron Institute (F00316) and NIH S10 Od019994-01. This research was supported by funds from the Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD (to S.S.), by NIH grant GM104962 and a Geoffrey Beene Cancer Research Center grant to D.J.P., by Memorial Sloan Kettering Cancer Center Core Grant (P30CA008748), and by federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E. The computational analyses utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH, Bethesda, MD (https://hpc.nih.gov/).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Case D. A., 2017, AMBER 2017; Cass SDB, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150043; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; Haurwitz RE, 2012, EMBO J, V31, P2824, DOI 10.1038/emboj.2012.107; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Johnson GT, 2011, STRUCTURE, V19, P293, DOI 10.1016/j.str.2010.12.023; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pausch P, 2017, MOL CELL, V67, P622, DOI 10.1016/j.molcel.2017.06.036; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Peng RC, 2017, CELL RES, V27, P853, DOI 10.1038/cr.2017.79; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rollins MF, 2017, P NATL ACAD SCI USA, V114, pE5113, DOI 10.1073/pnas.1616395114; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger, 2015, PYMOL MOL GRAPH SYST; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Xiao YB, 2017, CELL, V170, P48, DOI 10.1016/j.cell.2017.06.012; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	51	1	1	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2017	171	2					414	+		10.1016/j.cell.2017.09.006				25	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9RK	WOS:000412346100017	28985564				2018-01-05	
J	Rodriguez-Leal, D; Lemmon, ZH; Man, J; Bartlett, ME; Lippman, ZB				Rodriguez-Leal, Daniel; Lemmon, Zachary H.; Man, Jarrett; Bartlett, Madelaine E.; Lippman, Zachary B.			Engineering Quantitative Trait Variation for Crop Improvement by Genome Editing	CELL			English	Article							CIS-REGULATORY MODULES; STEM-CELL HOMEOSTASIS; SHOOT MERISTEM; GUIDE RNA; TOMATO; GENE; WUSCHEL; DOMESTICATION; SYSTEM; GENERATION	Major advances in crop yields are needed in the coming decades. However, plant breeding is currently limited by incremental improvements in quantitative traits that often rely on laborious selection of rare naturally occurring mutations in gene-regulatory regions. Here, we demonstrate that CRISPR/Cas9 genome editing of promoters generates diverse cis-regulatory alleles that provide beneficial quantitative variation for breeding. We devised a simple genetic scheme, which exploits trans-generational heritability of Cas9 activity in heterozygous loss-of-function mutant backgrounds, to rapidly evaluate the phenotypic impact of numerous promoter variants for genes regulating three major productivity traits in tomato: fruit size, inflorescence branching, and plant architecture. Our approach allows immediate selection and fixation of novel alleles in transgene-free plants and fine manipulation of yield components. Beyond a platform to enhance variation for diverse agricultural traits, our findings provide a foundation for dissecting complex relationships between gene-regulatory changes and control of quantitative traits.	[Rodriguez-Leal, Daniel; Lemmon, Zachary H.; Lippman, Zachary B.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Man, Jarrett; Bartlett, Madelaine E.] Univ Massachusetts Amherst, Biol Dept, Amherst, MA 01003 USA	Lippman, ZB (reprint author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lippman@cshl.edu			PEW [29661]; National Science Foundation [IOS-1732253, IOS-1546837, IOS-1523423]	We thank members of the Lippman lab and D. Jackson, Z. Nimchuck, and E. Vollbrecht for discussions and comments on the manuscript. We thank C. Brooks, A. Krainer, and J. Dalrymple for technical support, Y. Eshed for assistance with screening, E. van der Knaap for providing S. pim. fas and lc NILs, and M. Tjahjadi and J. Van Eck for tomato transformation. We thank T. Mulligan, S. Vermylen, S. Qiao, N. Springsteen, E. Schoenfeld, and B. Berube for assistance with plant care and data collection. This research was supported by a PEW Latin American Fellowship (29661) to D.R.-L., a National Science Foundation Postdoctoral Research Fellowship in Biology grant (IOS-1523423) to Z.H.L., a National Science Foundation Plant Genome Research Program grant (IOS-1732253) to Z.B.L., and a National Science Foundation Plant Genome Research Program grant (IOS-1546837) to M. E. B. and Z.B.L. D.R.-L. and Z.B.L. have filed a PCT patent application based in part on this work with the US Patent and Trademark Office.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Baxter L, 2012, PLANT CELL, V24, P3949, DOI 10.1105/tpc.112.103010; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Birchler JA, 2016, PLANT SCI, V245, P128, DOI 10.1016/j.plantsci.2016.02.002; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cameron RA, 2009, DEV BIOL, V336, P122, DOI 10.1016/j.ydbio.2009.09.018; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Council for Agricultural Science and Technology (CAST), 2017, PLANT BREED GEN PAP; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta S, 2016, PLANT CELL TISS ORG, V127, P417, DOI 10.1007/s11240-016-1063-9; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang ZJ, 2011, THEOR APPL GENET, V123, P465, DOI 10.1007/s00122-011-1599-3; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00465; Lippman Z, 2001, GENETICS, V158, P413; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Liu XG, 2011, PLANT CELL, V23, P3654, DOI 10.1105/tpc.111.091538; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Shu QY, 2012, PLANT MUTATION BREEDING AND BIOTECHNOLOGY, P1, DOI 10.1079/9781780640853.0000; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; Narzisi G, 2014, NAT METHODS, V11, P1033, DOI [10.1038/NMETH.3069, 10.1038/nmeth.3069]; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Olsen KM, 2013, ANNU REV PLANT BIOL, V64, P47, DOI 10.1146/annurev-arplant-050312-120048; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Perales M, 2016, P NATL ACAD SCI USA, V113, pE6298, DOI 10.1073/pnas.1607669113; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Priest HD, 2009, CURR OPIN PLANT BIOL, V12, P643, DOI 10.1016/j.pbi.2009.07.016; Qiu ZK, 2016, MOL PLANT, V9, P1168, DOI 10.1016/j.molp.2016.05.013; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Rodriguez K, 2016, P NATL ACAD SCI USA, V113, pE6307, DOI 10.1073/pnas.1607673113; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schwarzer W, 2014, CURR OPIN GENET DEV, V27, P74, DOI 10.1016/j.gde.2014.03.014; Shen L., 2016, J INTEGR PLANT BIOL, V22, P1; Somssich M, 2016, DEVELOPMENT, V143, P3238, DOI 10.1242/dev.133645; Soyk S, 2017, CELL, V169, P1142, DOI 10.1016/j.cell.2017.04.032; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Swinnen G, 2016, TRENDS PLANT SCI, V21, P506, DOI 10.1016/j.tplants.2016.01.014; van der Knaap E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00227; Van Eenennaam AL, 2017, CURR OPIN BIOTECH, V44, P27, DOI 10.1016/j.copbio.2016.10.007; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang CL, 2017, TRENDS PLANT SCI, V22, P624, DOI 10.1016/j.tplants.2017.04.002; Wang GD, 2014, ANNU REV ANIM BIOSCI, V2, P65, DOI 10.1146/annurev-animal-022513-114129; Weber B, 2016, TRENDS PLANT SCI, V21, P974, DOI 10.1016/j.tplants.2016.07.013; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Xu C, 2015, NAT GENET, V47, P784, DOI 10.1038/ng.3309; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200	65	2	2	39	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2017	171	2					470	+		10.1016/j.cell.2017.08.030				19	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9RK	WOS:000412346100021	28919077				2018-01-05	
J	Reddy, A; Zhang, J; Davis, NS; Moffitt, AB; Love, CL; Waldrop, A; Leppa, S; Pasanen, A; Meriranta, L; Karjalainen-Lindsberg, ML; Norgaard, P; Pedersen, M; Gang, AO; Hogdall, E; Heavican, TB; Lone, W; Iqbal, J; Qin, Q; Li, GJ; Kim, SY; Healy, J; Richards, KL; Fedoriw, Y; Bernal-Mizrachi, L; Koff, JL; Staton, AD; Flowers, CR; Paltiel, O; Goldschmidt, N; Calaminici, M; Clear, A; Gribben, J; Nguyen, E; Czader, MB; Ondrejka, SL; Collie, A; Hsi, ED; Tse, E; Au-Yeung, RKH; Kwong, YL; Srivastava, G; Choi, WWL; Evens, AM; Pilichowska, M; Sengar, M; Reddy, N; Li, SY; Chadburn, A; Gordon, LI; Jaffe, ES; Levy, S; Rempel, R; Tzeng, T; Happ, LE; Dave, T; Rajagopalan, D; Datta, J; Dunson, DB; Dave, SS				Reddy, Anupama; Zhang, Jenny; Davis, Nicholas S.; Moffitt, Andrea B.; Love, Cassandra L.; Waldrop, Alexander; Leppa, Sirpa; Pasanen, Annika; Meriranta, Leo; Karjalainen-Lindsberg, Marja-Liisa; Norgaard, Peter; Pedersen, Mette; Gang, Anne O.; Hogdall, Estrid; Heavican, Tayla B.; Lone, Waseem; Iqbal, Javeed; Qin, Qiu; Li, Guojie; Kim, So Young; Healy, Jane; Richards, Kristy L.; Fedoriw, Yuri; Bernal-Mizrachi, Leon; Koff, Jean L.; Staton, Ashley D.; Flowers, Christopher R.; Paltiel, Ora; Goldschmidt, Neta; Calaminici, Maria; Clear, Andrew; Gribben, John; Nguyen, Evelyn; Czader, Magdalena B.; Ondrejka, Sarah L.; Collie, Angela; Hsi, Eric D.; Tse, Eric; Au-Yeung, Rex K. H.; Kwong, Yok-Lam; Srivastava, Gopesh; Choi, William W. L.; Evens, Andrew M.; Pilichowska, Monika; Sengar, Manju; Reddy, Nishitha; Li, Shaoying; Chadburn, Amy; Gordon, Leo I.; Jaffe, Elaine S.; Levy, Shawn; Rempel, Rachel; Tzeng, Tiffany; Happ, Lanie E.; Dave, Tushar; Rajagopalan, Deepthi; Datta, Jyotishka; Dunson, David B.; Dave, Sandeep S.			Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma	CELL			English	Article							RITUXIMAB PLUS CYCLOPHOSPHAMIDE; SEQUENCING DATA; RNA-SEQ; SOMATIC MUTATIONS; EXPRESSION; CANCER; GENOME; DISCOVERY; PRIORITIZATION; CLASSIFICATION	Diffuse large B cell lymphoma (DLBCL) is the most common form of blood cancer and is characterized by a striking degree of genetic and clinical heterogeneity. This heterogeneity poses a major barrier to understanding the genetic basis of the disease and its response to therapy. Here, we performed an integrative analysis of whole-exome sequencing and transcriptome sequencing in a cohort of 1,001 DLBCL patients to comprehensively define the landscape of 150 genetic drivers of the disease. We characterized the functional impact of these genes using an unbiased CRISPR screen of DLBCL cell lines to define oncogenes that promote cell growth. A prognostic model comprising these genetic alterations outperformed current established methods: cell of origin, the International Prognostic Index comprising clinical variables, and dual MYC and BCL2 expression. These results comprehensively define the genetic drivers and their functional roles in DLBCL to identify new therapeutic opportunities in the disease.	[Reddy, Anupama; Zhang, Jenny; Davis, Nicholas S.; Moffitt, Andrea B.; Love, Cassandra L.; Waldrop, Alexander; Qin, Qiu; Li, Guojie; Kim, So Young; Healy, Jane; Rempel, Rachel; Tzeng, Tiffany; Happ, Lanie E.; Dave, Tushar; Rajagopalan, Deepthi; Datta, Jyotishka; Dave, Sandeep S.] Duke Univ, Duke Canc Inst, Durham, NC 27708 USA; [Reddy, Anupama; Zhang, Jenny; Davis, Nicholas S.; Moffitt, Andrea B.; Love, Cassandra L.; Waldrop, Alexander; Qin, Qiu; Li, Guojie; Kim, So Young; Healy, Jane; Rempel, Rachel; Tzeng, Tiffany; Happ, Lanie E.; Dave, Tushar; Rajagopalan, Deepthi; Datta, Jyotishka; Dave, Sandeep S.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Reddy, Anupama; Zhang, Jenny; Dave, Sandeep S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Leppa, Sirpa; Pasanen, Annika; Meriranta, Leo; Karjalainen-Lindsberg, Marja-Liisa] Univ Helsinki, Hosp Canc Ctr, Helsinki, Finland; [Leppa, Sirpa; Pasanen, Annika; Meriranta, Leo; Karjalainen-Lindsberg, Marja-Liisa] Univ Helsinki, Helsinki, Finland; [Norgaard, Peter; Pedersen, Mette; Gang, Anne O.; Hogdall, Estrid] Univ Copenhagen, Herlev & Gentofte Hosp, Herlev, Denmark; [Heavican, Tayla B.; Lone, Waseem; Iqbal, Javeed] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Richards, Kristy L.; Fedoriw, Yuri] Univ N Carolina, Pathol & Lab Med, Chapel Hill, NC USA; [Bernal-Mizrachi, Leon; Koff, Jean L.; Staton, Ashley D.; Flowers, Christopher R.] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA; [Paltiel, Ora; Goldschmidt, Neta] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel; [Calaminici, Maria; Clear, Andrew; Gribben, John] Queen Mary Univ London, Barts Canc Inst, London, England; [Nguyen, Evelyn; Czader, Magdalena B.] Indiana Univ, Pathol, Indianapolis, IN 46204 USA; [Ondrejka, Sarah L.; Collie, Angela; Hsi, Eric D.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Tse, Eric; Au-Yeung, Rex K. H.; Kwong, Yok-Lam; Srivastava, Gopesh; Choi, William W. L.] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Evens, Andrew M.; Pilichowska, Monika] Tufts Univ, Med Ctr, Boston, MA 02111 USA; [Sengar, Manju] Tata Mem Hosp, Mumbai, Maharashtra, India; [Reddy, Nishitha] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Li, Shaoying] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Chadburn, Amy] Columbia Presbyterian Med Ctr, New York, NY USA; [Gordon, Leo I.] Northwestern Univ, Sch Med, Chicago, IL USA; [Jaffe, Elaine S.] NCI, Bethesda, MD 20892 USA; [Levy, Shawn] Hudson Alpha Inst Biotechnol, Huntsville, AL USA; [Dunson, David B.] Duke Univ, Dept Stat Sci, Durham, NC USA	Dave, SS (reprint author), Duke Univ, Duke Canc Inst, Durham, NC 27708 USA.; Dave, SS (reprint author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.; Dave, SS (reprint author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.			Evens, Andrew/0000-0002-6900-1824; Moffitt, Andrea/0000-0001-5964-7851; Leppa, Sirpa/0000-0002-8265-511X	National Institutes of Health; Leukemia Lymphoma Society, Department of Defense	This work was partly funded through the Leukemia Lymphoma Society, Department of Defense, and the National Institutes of Health. We gratefully acknowledge the generous support of C. Stiefel and D. Stiefel.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andrews S., 2010, FASTQC QUALITY CONTR; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hart T., 2017, BIORXIV; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2016, BIOINFORMATICS, V32, P736, DOI 10.1093/bioinformatics/btw462; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Martin M, 2011, EMBNET J, V17, P1, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M., 2010, COLD SPRING HARB PRO, V6, DOI 10.1101/pdb.prot5448.; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004.07.2947; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x                                                ; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Zhang J, 2014, BLOOD, V123, P2988, DOI 10.1182/blood-2013-07-517177; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zou H, 2005, J ROY STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x                                                	51	1	1	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2017	171	2					481	+		10.1016/j.cell.2017.09.027				29	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9RK	WOS:000412346100022	28985567				2018-01-05	
J	Pulecio, J; Verma, N; Mejia-Ramirez, E; Huangfu, D; Raya, A				Pulecio, Julian; Verma, Nipun; Mejia-Ramirez, Eva; Huangfu, Danwei; Raya, Angel			CRISPR/Cas9-Based Engineering of the Epigenome	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; TARGETED DNA METHYLATION; SINGLE GENOMIC LOCUS; CRISPR-CAS SYSTEMS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; REGULATORY ELEMENTS; SATURATING MUTAGENESIS; EPIGENETIC INHERITANCE; FUNCTIONAL GENOMICS	Determining causal relationships between distinct chromatin features and gene expression, and ultimately cell behavior, remains a major challenge. Recent developments in targetable epigenome-editing tools enable us to assign direct transcriptional and functional consequences to locus-specific chromatin modifications. This Protocol Review discusses the unprecedented opportunity that CRISPR/Cas9 technology offers for investigating and manipulating the epigenome to facilitate further understanding of stem cell biology and engineering of stem cells for therapeutic applications. We also provide technical considerations for standardization and further improvement of the CRISPR/Cas9-based tools to engineer the epigenome.	[Pulecio, Julian; Mejia-Ramirez, Eva; Raya, Angel] Hosp Duran & Reynals, CMRB, 3rd Floor,Ave Gran Via 199-203, Barcelona 08908, Spain; [Pulecio, Julian; Raya, Angel] Ctr Networked Biomed Res Bioengn Biomat & Nanomed, Madrid 28029, Spain; [Pulecio, Julian; Verma, Nipun; Huangfu, Danwei] Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA; [Verma, Nipun] Rockefeller Univ, Cornell Univ, Sloan Kettering Inst Triinst MD PhD Program, Weill Grad Sch Med Sci, 1300 York Ave, New York, NY 10065 USA; [Raya, Angel] ICREA, Barcelona 08010, Spain	Raya, A (reprint author), Hosp Duran & Reynals, CMRB, 3rd Floor,Ave Gran Via 199-203, Barcelona 08908, Spain.; Raya, A (reprint author), Ctr Networked Biomed Res Bioengn Biomat & Nanomed, Madrid 28029, Spain.; Huangfu, D (reprint author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.; Raya, A (reprint author), ICREA, Barcelona 08010, Spain.	huangfud@mskcc.org; araya@cmrb.eu		Mejia-Ramirez, EVA/0000-0003-1251-5223; Huangfu, Danwei/0000-0002-1145-6199	Spanish Ministry of Economy and Competitiveness-MINECO [SAF2015-69706-R]; Instituto de Salud Carlos III-ISCIII/FEDER [FIS PI14/01682, Red de Terapia Celular - TerCel RD16/0011/0024]; Generalitat de Catalunya-AGAUR [2014-SGR-1460]; Fundacio 'La Marato de TV3 [201534-30]; CERCA Programme / Generalitat de Catalunya; NIH/NIDDK [R01DK096239]; New York State Stem Cell Science [NYSTEM C029567, C029156]; Tri-Institutional Stem Cell Initiative [2016-004, 2016-032]; MSKCC Cancer Center Support Grant [P30 CA008748]; Juan de la Cierva program (MINECO)	The work in the Raya laboratory is supported by the Spanish Ministry of Economy and Competitiveness-MINECO (SAF2015-69706-R), Instituto de Salud Carlos III-ISCIII/FEDER (FIS PI14/01682; Red de Terapia Celular - TerCel RD16/0011/0024), Generalitat de Catalunya-AGAUR (2014-SGR-1460), Fundacio 'La Marato de TV3 (201534-30), and CERCA Programme / Generalitat de Catalunya. The work in the Huangfu laboratory is supported by NIH/NIDDK (R01DK096239), New York State Stem Cell Science (NYSTEM C029567 and C029156), Tri-Institutional Stem Cell Initiative (#2016-004, 2016-032), and the MSKCC Cancer Center Support Grant (P30 CA008748). J.P. was partially supported by the Juan de la Cierva program (MINECO). Wenjing Wu assisted with the graphics.	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Allis C. D., 2006, EPIGENETICS; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Anton T, 2016, METHODS MOL BIOL, V1411, P407, DOI 10.1007/978-1-4939-3530-7_25; Anton T, 2014, NUCLEUS-AUSTIN, V5, P163, DOI [10.4161/nucl.2848, 10.4161/nucl.28488]; Atala A, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P1; Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395                                                           ; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Braun CJ, 2016, P NATL ACAD SCI USA, V113, pE3892, DOI 10.1073/pnas.1600582113; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002; Cano-Rodriguez D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12284; Canver MC, 2017, NAT GENET, V49, P625, DOI 10.1038/ng.3793; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Capellera-Garcia S, 2016, CELL REP, V15, P2550, DOI 10.1016/j.celrep.2016.05.027; Cassidy SB, 1998, MEDICINE, V77, P140, DOI 10.1097/00005792-199803000-00005                                                ; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2                                                   ; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; CHEN BH, 2016, NUCL ACIDS RES, V44; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng AW, 2016, CELL RES, V26, P254, DOI 10.1038/cr.2016.3; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Du D, 2017, NAT METHODS, V14, P577, DOI [10.1038/NMETH.4286, 10.1038/nmeth.4286]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Essers J, 2005, MOL BIOL CELL, V16, P769; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Fidalgo M, 2016, CELL STEM CELL, V19, P355, DOI 10.1016/j.stem.2016.05.025; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fujita T, 2015, METHODS MOL BIOL, V1288, P43, DOI 10.1007/978-1-4939-2474-5_4; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gao RT, 2013, MOL CELL BIOCHEM, V379, P115, DOI 10.1007/s11010-013-1633-7; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Garcia-Bloj B, 2016, ONCOTARGET, V7, P60535, DOI 10.18632/oncotarget.11142; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Genga RM, 2016, METHODS, V101, P36, DOI 10.1016/j.ymeth.2015.10.014; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Goodman RH, 2000, GENE DEV, V14, P1553; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hellwig D, 2008, J BIOPHOTONICS, V1, P245, DOI 10.1002/jbio.200810014; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Himeda CL, 2016, MOL THER, V24, P527, DOI 10.1038/mt.2015.200; Ho SM, 2017, STEM CELL REP, V9, P615, DOI 10.1016/j.stemcr.2017.06.012; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Horlbeck M. A., 2016, ELIFE; Horlbeck M. A., 2016, ELIFE, V5; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu H, 2016, J BIOL CHEM, V291, P26722, DOI 10.1074/jbc.M116.757625; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Huang HL, 2009, GENOME RES, V19, P674, DOI 10.1101/gr.083402.108; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127                                                         ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Keung AJ, 2015, NAT REV GENET, V16, P159, DOI 10.1038/nrg3900; Kim JM, 2015, NUCLEIC ACIDS RES, V43, P8868, DOI 10.1093/nar/gkv874; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Klosin A, 2017, SCIENCE, V356, P316, DOI 10.1126/science.aah6412; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kwon DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15315; Lane AB, 2015, DEV CELL, V34, P373, DOI 10.1016/j.devcel.2015.06.003; Lei Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16026; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Lindhout BI, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm618; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma HH, 2013, P NATL ACAD SCI USA, V110, P21048, DOI 10.1073/pnas.1319097110; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milite C, 2015, J MED CHEM, V58, P2779, DOI 10.1021/jm5019687; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Misteli T, 2013, CELL, V152, P1209, DOI 10.1016/j.cell.2013.02.048; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Nashun B, 2015, EMBO J, V34, P1296, DOI 10.15252/embj.201490649; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Nishizawa M, 2016, CELL STEM CELL, V19, P341, DOI 10.1016/j.stem.2016.06.019; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Oldridge DA, 2015, NATURE, V528, P418, DOI 10.1038/nature15540; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pengue G, 1996, P NATL ACAD SCI USA, V93, P1015, DOI 10.1073/pnas.93.3.1015                                                          ; Pennisi E, 2013, SCIENCE, V340, P910, DOI [10.1126/science.340.6135.910-b, 10.1126/science.340.6135.910-a]; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2012, CURR OPIN CHEM BIOL, V16, P268, DOI 10.1016/j.cbpa.2012.06.007; Polstein LR, 2015, GENOME RES, V25, P1158, DOI 10.1101/gr.179044.114; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Pradeepa MM, 2016, NAT GENET, V48, P681, DOI 10.1038/ng.3550; Pulecio J, 2016, CELL REP, V17, P671, DOI 10.1016/j.celrep.2016.09.036; Pulecio J, 2014, STEM CELLS, V32, P2923, DOI 10.1002/stem.1800; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Radzisheuskaya Aliaksandra, 2016, Nucleic Acids Res, V44, pe141; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Ramos-Mejia V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035824; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI [10.1101/gad.276568.115, 10.1101/gad.276568]; Riethoven JJM, 2010, METHODS MOL BIOL, V674, P33, DOI 10.1007/978-1-60761-854-6_3; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Rodriguez ML, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0453-x; Rodriguez-Campos A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001182; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Scacheri CA, 2015, CURR OPIN PEDIATR, V27, P659, DOI 10.1097/MOP.0000000000000283; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SHAO SP, 2016, NUCL ACIDS RES, V44; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stepper P, 2017, NUCLEIC ACIDS RES, V45, P1703, DOI 10.1093/nar/gkw1112; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thanisch K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1348; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Vitaloni M, 2014, J BIOL CHEM, V289, P2084, DOI 10.1074/jbc.M113.538702; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Waldrip ZJ, 2014, EPIGENETICS-US, V9, P1207, DOI 10.4161/epi.29919; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Weinberger L, 2016, NAT REV MOL CELL BIO, V17, P155, DOI 10.1038/nrm.2015.28; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Xiong K, 2016, STEM CELL RES, V17, P665, DOI 10.1016/j.scr.2016.10.011; XIONG TN, 2017, SCI REP, V7; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341; Yuan K, 2014, CURR BIOL, V24, pR144, DOI 10.1016/j.cub.2014.01.023; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang H, 2016, CELL STEM CELL, V18, P481, DOI 10.1016/j.stem.2016.02.004; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	194	0	0	71	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2017	21	4					431	447		10.1016/j.stem.2017.09.006				17	Cell & Tissue Engineering; Cell Biology	Cell Biology	FI9RA	WOS:000412344700008	28985525				2018-01-05	
J	Jacob, A; Morley, M; Hawkins, F; McCauley, KB; Jean, JC; Heins, H; Na, CL; Weaver, TE; Vedaie, M; Hurley, K; Hinds, A; Russo, SJ; Kook, S; Zacharias, W; Ochs, M; Traber, K; Quinton, LJ; Crane, A; Davis, BR; White, FV; Wambach, J; Whitsett, JA; Cole, FS; Morrisey, EE; Guttentag, SH; Beers, MF; Kotton, DN				Jacob, Anjali; Morley, Michael; Hawkins, Finn; McCauley, Katherine B.; Jean, J. C.; Heins, Hillary; Na, Cheng-Lun; Weaver, Timothy E.; Vedaie, Marall; Hurley, Killian; Hinds, Anne; Russo, Scott J.; Kook, Seunghyi; Zacharias, William; Ochs, Matthias; Traber, Katrina; Quinton, Lee J.; Crane, Ana; Davis, Brian R.; White, Frances V.; Wambach, Jennifer; Whitsett, Jeffrey A.; Cole, F. Sessions; Morrisey, Edward E.; Guttentag, Susan H.; Beers, Michael F.; Kotton, Darrell N.			Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells	CELL STEM CELL			English	Article							SURFACTANT PROTEIN-B; II CELLS; IN-VITRO; RAT LUNG; SP-C; RESPIRATORY EPITHELIUM; GENE; FETAL; LOCALIZATION; EXPRESSION	Lung alveoli, which are unique to air-breathing organisms, have been challenging to generate from pluripotent stem cells (PSCs) in part because there are limited model systems available to provide the necessary developmental roadmaps for in vitro differentiation. Here we report the generation of alveolar epithelial type 2 cells (AEC2s), the facultative progenitors of lung alveoli, from human PSCs. Using multicolored fluorescent reporter lines, we track and purify human SFTPC+ alveolar progenitors as they emerge from endodermal precursors in response to stimulation of Wnt and FGF signaling. Purified PSCderived SFTPC+ cells form monolayered epithelial "alveolospheres'' in 3D cultures without the need for mesenchymal support, exhibit self-renewal capacity, and display additional AEC2 functional capacities. Footprint-free CRISPR-based gene correction of PSCs derived from patients carrying a homozygous surfactant mutation (SFTPB121ins2) restores surfactant processing in AEC2s. Thus, PSC-derived AEC2s provide a platform for disease modeling and future functional regeneration of the distal lung.	[Jacob, Anjali; Hawkins, Finn; McCauley, Katherine B.; Jean, J. C.; Vedaie, Marall; Hurley, Killian; Kotton, Darrell N.] Boston Univ, Ctr Regenerat Med, Boston, MA 02118 USA; [Jacob, Anjali; Hawkins, Finn; McCauley, Katherine B.; Jean, J. C.; Vedaie, Marall; Hurley, Killian; Kotton, Darrell N.] Boston Med Ctr, Boston, MA 02118 USA; [Jacob, Anjali; Hawkins, Finn; McCauley, Katherine B.; Jean, J. C.; Vedaie, Marall; Hurley, Killian; Hinds, Anne; Traber, Katrina; Quinton, Lee J.; Kotton, Darrell N.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Jacob, Anjali; Hawkins, Finn; McCauley, Katherine B.; Jean, J. C.; Vedaie, Marall; Hurley, Killian; Hinds, Anne; Traber, Katrina; Quinton, Lee J.; Kotton, Darrell N.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Morley, Michael; Russo, Scott J.; Zacharias, William; Morrisey, Edward E.; Beers, Michael F.] Univ Penn, Penn Ctr Pulm Biol, Philadelphia, PA 19104 USA; [Heins, Hillary; White, Frances V.; Wambach, Jennifer; Cole, F. Sessions] Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, St Louis, MO 63110 USA; [Kook, Seunghyi; Guttentag, Susan H.] Vanderbilt Univ, Dept Pediat, Monroe Carell Jr Childrens Hosp, Nashville, TN 37232 USA; [Na, Cheng-Lun; Weaver, Timothy E.; Whitsett, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Ochs, Matthias] Hannover Med Sch, Biomed Res Endstage & Obstruct Lung Dis Hannover, REBIRTH Cluster Excellence, Inst Funct & Appl Anat,German Ctr Lung Res DZL, D-30625 Hannover, Germany; [Crane, Ana; Davis, Brian R.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, Ctr Stem Cell & Regenerat Med, Houston, TX 77030 USA	Kotton, DN (reprint author), Boston Univ, Ctr Regenerat Med, Boston, MA 02118 USA.; Kotton, DN (reprint author), Boston Med Ctr, Boston, MA 02118 USA.; Kotton, DN (reprint author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.; Kotton, DN (reprint author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	dkotton@bu.edu			NIH [1UL1TR001430, TL1TR001410, F31HL134274, F31HL129777, HL059959, DAVIS15XX1, R33HL120760, R01 HL119436, U01HL099997, U01HL134745, R01HL095993, R01HL122442, R01HL128172, U01HL134766]; Cystic Fibrosis Foundation [HAWKIN15XX0]; DAVISGO;  [R24HL123828];  [U01TR001810]	We dedicate this manuscript to our mentor, teacher, and friend, Dr. Mary C. Williams of Boston University School of Medicine (BUSM), whose work deciphering alveolar epithelial cell biology paved the way for the current project. We wish to thank all members of the Kotton lab for insightful discussions and Drs. Robin Deterding, Larry Nogee, and Aaron Hamvas for guidance and encouragement to pursue our shared mission of advancing research related to pediatric lung disease. We are grateful to Brian R. Tilton of the BUSM Flow Cytometry Core for technical assistance, supported by NIH Grant 1UL1TR001430, and Drs. Greg Miller, Amulya Iyer, and Marianne James of the CReM, supported by grants R24HL123828 and U01TR001810. We thank Adam Gower and Avrum Spira for RNA sequencing. We thank Don Gantz and Lars Knudsen for assistance with electron microscopy. This work was supported by Cystic Fibrosis Foundation grants HAWKIN15XX0 (to F.H.) and DAVISGO (to B.R.D.) and NIH grants TL1TR001410 and F31HL134274 (to A.J.); F31HL129777 (to K.B.M.); HL059959 (to S.H.G.); DAVIS15XX1 (to B.R.D.); R33HL120760 (to F.S.C., J.A.W., and H.H.); R01 HL119436 (to M.F.B.); U01HL099997 and U01HL134745 (to E.E.M., J.A.W., and D.N.K.); and R01HL095993, R01HL122442, R01HL128172, and U01HL134766 (to D.N.K.).	Ballard PL, 2010, AM J PHYSIOL-LUNG C, V299, pL36, DOI 10.1152/ajplung.00427.2009; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Beers MF, 2000, AM J RESP CELL MOL, V22, P380, DOI 10.1165/ajrcmb.22.3.3645                                                        ; BEERS MF, 1992, AM J PHYSIOL, V262, pL773; BEERS MF, 1994, J BIOL CHEM, V269, P20318; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Borok Z, 1998, AM J PHYSIOL-LUNG C, V275, pL155; Brasch F, 2004, AM J RESP CELL MOL, V30, P449, DOI 10.1165/rcmb.2003-0262OC; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; DOBBS LG, 1988, BIOCHIM BIOPHYS ACTA, V970, P146, DOI 10.1016/0167-4889(88)90173-5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Foster CD, 2007, PEDIATR RES, V61, P404, DOI 10.1203/pdr.0b013e3180332c6d; Frank DB, 2016, CELL REP, V17, P2312, DOI 10.1016/j.celrep.2016.11.001; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Gotoh S, 2014, STEM CELL REP, V3, P394, DOI 10.1016/j.stemcr.2014.07.005; Guttentag SH, 1998, AM J PHYSIOL-LUNG C, V275, pL559; Hawkins F, 2017, J CLIN INVEST, V127, P2277, DOI 10.1172/JCI89950; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; KALINA M, 1992, AM J RESP CELL MOL, V6, P594, DOI 10.1165/ajrcmb/6.6.594                                                          ; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126                                                            ; KIKKAWA Y, 1975, LAB INVEST, V32, P295; Korimilli A, 2000, J BIOL CHEM, V275, P8672, DOI 10.1074/jbc.275.12.8672                                                         ; Kurmann AA, 2015, CELL STEM CELL, V17, P527, DOI 10.1016/j.stem.2015.09.004; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689                                                        ; Liu Yuru, 2002, Gene Expression Patterns, V2, P229, DOI 10.1016/S1567-133X(02)00057-1; MASON RJ, 1980, BIOCHIM BIOPHYS ACTA, V617, P36, DOI 10.1016/0005-2760(80)90222-2; Mayhew TM, 2011, J EXP BOT, V62, P4101, DOI 10.1093/jxb/err176; McCauley KB, 2017, CELL STEM CELL, V20, P844, DOI 10.1016/j.stem.2017.03.001; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896                                                     ; Rankin SA, 2016, CELL REP, V16, P66, DOI 10.1016/j.celrep.2016.05.060; Ridsdale R, 2004, AM J PHYSIOL-LUNG C, V287, pL743, DOI 10.1152/ajplung.00146.2004; Ridsdale R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016482; Ross GF, 1999, AM J PHYSIOL-LUNG C, V277, pL1104; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Wade KC, 2006, AM J RESP CELL MOL, V34, P727, DOI 10.1165/rcmb.2004-0389OC; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Whitsett JA, 2015, ANNU REV PATHOL-MECH, V10, P371, DOI 10.1146/annurev-pathol-012513-104644; WILLIAMS MC, 1977, AM REV RESPIR DIS, V115, P37	46	0	0	14	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2017	21	4					472	+		10.1016/j.stem.2017.08.014				27	Cell & Tissue Engineering; Cell Biology	Cell Biology	FI9RA	WOS:000412344700011	28965766				2018-01-05	
J	Tothova, Z; Krill-Burger, JM; Popova, KD; Landers, CC; Sievers, QL; Yudovich, D; Belizaire, R; Aster, JC; Morgan, EA; Tsherniak, A; Ebert, BL				Tothova, Zuzana; Krill-Burger, John M.; Popova, Katerina D.; Landers, Catherine C.; Sievers, Quinlan L.; Yudovich, David; Belizaire, Roger; Aster, Jon C.; Morgan, Elizabeth A.; Tsherniak, Aviad; Ebert, Benjamin L.			Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia	CELL STEM CELL			English	Article							MYELODYSPLASTIC SYNDROMES; GENETIC LESIONS; COHESIN COMPLEX; LEUKEMIA; MUTATIONS; CANCER; GENERATION; MOUSE; MICE	Hematologic malignancies are driven by combinations of genetic lesions that have been difficult to model in human cells. We used CRISPR/Cas9 genome engineering of primary adult and umbilical cord blood CD34(+) human hematopoietic stem and progenitor cells (HSPCs), the cells of origin for myeloid pre-malignant and malignant diseases, followed by transplantation into immunodeficient mice to generate genetic models of clonal hematopoiesis and neoplasia. Human hematopoietic cells bearing mutations in combinations of genes, including cohesin complex genes, observed in myeloid malignancies generated immunophenotypically defined neoplastic clones capable of longterm,multi- lineage reconstitution and serial transplantation. Employing these models to investigate therapeutic efficacy, we found that TET2 and cohesin- mutated hematopoietic cells were sensitive to azacitidine treatment. These findings demonstrate the potential for generating genetically defined models of human myeloid diseases, and they are suitable for examining the biological consequences of somatic mutations and the testing of therapeutic agents.	[Tothova, Zuzana; Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Tothova, Zuzana; Popova, Katerina D.; Landers, Catherine C.; Sievers, Quinlan L.; Yudovich, David; Belizaire, Roger; Ebert, Benjamin L.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Tothova, Zuzana; Krill-Burger, John M.; Popova, Katerina D.; Landers, Catherine C.; Sievers, Quinlan L.; Yudovich, David; Belizaire, Roger; Tsherniak, Aviad; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sievers, Quinlan L.] Harvard Med Sch, Boston, MA 02115 USA; [Belizaire, Roger; Aster, Jon C.; Morgan, Elizabeth A.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Ebert, BL (reprint author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Ebert, BL (reprint author), Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA.; Ebert, BL (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	bebert@partners.org			NIH [R01HL082945, P01CA108631, 5K12CA087723-12, T32GM007753]; Edward P. Evans Foundation; Gabrielle's Angel Foundation; LLS; Broad Institute of MIT and Harvard; LLS [3363-13]; ASCO; ASH/EHA Translational Research in Hematology; NIDDK [DK106829]	We thank P.K. Mandal and D.J. Rossi for sharing reagents and technical advice; Dr. D. Neuberg for help with statistical analysis; S. Lazo for flow cytometry assistance; E. Haydu and M. Donahue for technical assistance; D. Heckl for sharing reagents; U. Ben-David, J. Doench, and M. Hegde for valuable discussion; and P. Bandopadhayay and N. Greenwald for assistance with exome data analysis. This work was supported by the NIH (R01HL082945 and P01CA108631), the Edward P. Evans Foundation, the Gabrielle's Angel Foundation, LLS Scholar Award, and a Broad Ignite early career grant to B.L.E. from the Broad Institute of MIT and Harvard; the NIH (5K12CA087723-12), LLS Special Fellow Award (3363-13), ASCO Young Investigator Award, and ASH/EHA Translational Research in Hematology Award to Z.T.; the NIH (T32GM007753) to Q.L.S.; and NIDDK (DK106829) to S. Heimfeld of the SCCA Cellular Therapy Laboratory.	Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Buechele C, 2015, BLOOD, V126, P1683, DOI 10.1182/blood-2015-05-646398; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; Mullenders J, 2015, J EXP MED, V212, P1833, DOI 10.1084/jem.20151323; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schuback HL, 2013, SEMIN HEMATOL, V50, P325, DOI 10.1053/j.seminhematol.2013.09.003; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Welch JS, 2016, NEW ENGL J MED, V375, P2023, DOI 10.1056/NEJMoa1605949; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733	31	1	1	15	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 5	2017	21	4					547	+		10.1016/j.stem.2017.07.015				16	Cell & Tissue Engineering; Cell Biology	Cell Biology	FI9RA	WOS:000412344700016	28985529				2018-01-05	
J	He, ZS; Zeng, J; Ren, Y; Chen, D; Li, WJ; Gao, FY; Cao, Y; Luo, T; Yuan, GQ; Wu, XH; Liang, YY; Deng, QM; Wang, SQ; Zheng, AP; Zhu, J; Liu, HN; Wang, LX; Li, P; Li, SC				He, Zhongshan; Zeng, Jing; Ren, Yun; Chen, Dan; Li, Wenjie; Gao, Fengyan; Cao, Ye; Luo, Tao; Yuan, Guoqiang; Wu, Xianghong; Liang, Yueyang; Deng, Qiming; Wang, Shiquan; Zheng, Aiping; Zhu, Jun; Liu, Huainian; Wang, Lingxia; Li, Ping; Li, Shuangcheng			OsGIF1 Positively Regulates the Sizes of Stems, Leaves, and Grains in Rice	FRONTIERS IN PLANT SCIENCE			English	Article						rice; OsGIF1; organ size; cell size; knock-out	SYNOVIAL SARCOMA TRANSLOCATION; ARABIDOPSIS-THALIANA; ORGAN SIZE; CELL-PROLIFERATION; GENE FAMILY; TRANSCRIPTIONAL ACTIVATOR; ASYMMETRIC-LEAVES2 GENE; LEAF DEVELOPMENT; MICRORNA MIR396; GROWTH	Growth-regulating factor (GRF) interacting factors (GIFs) are involved in several developmental processes in Arabidopsis. We previously showed that upregulation of OsGIF1 expression improves rice grain size. However, whether OsGIF1 is involved in other developmental processes remains unclear. Here, we report pleiotropic effects of OsGIF1 on rice organ size regulation. Overexpression and functional knock-out via a CRISPR/Cas9 strategy revealed that OsGIF1 not only positively regulates the sizes of rice leaf, stem, and grain but also influences rice reproduction. Expression profiles based on both qRT-PCR and GUS (beta-glucuronidase) histochemical staining suggested that OsGIF1 is differentially expressed across various rice tissues, consistent with its roles in regulating the development of multiple rice organs. Additionally, we found that OsGIF1-GFP localized preferentially in the nucleus, which supports its proposed role as a transcriptional cofactor. Further histological analysis suggested that OsGIF1 affected rice organ size possibly by regulating cell size. Our results suggest that OsGIF1 plays important roles in vegetative and reproductive developmental processes, with important implications for rice breeding.	[He, Zhongshan; Zeng, Jing; Ren, Yun; Chen, Dan; Li, Wenjie; Gao, Fengyan; Cao, Ye; Luo, Tao; Yuan, Guoqiang; Wu, Xianghong; Liang, Yueyang; Deng, Qiming; Wang, Shiquan; Zheng, Aiping; Zhu, Jun; Liu, Huainian; Wang, Lingxia; Li, Ping; Li, Shuangcheng] Sichuan Agr Univ, State Key Lab Hybrid Rice, Chengdu, Sichuan, Peoples R China; [He, Zhongshan; Zeng, Jing; Ren, Yun; Chen, Dan; Li, Wenjie; Gao, Fengyan; Cao, Ye; Luo, Tao; Yuan, Guoqiang; Wu, Xianghong; Liang, Yueyang; Deng, Qiming; Wang, Shiquan; Zheng, Aiping; Zhu, Jun; Liu, Huainian; Wang, Lingxia; Li, Ping; Li, Shuangcheng] Sichuan Agr Univ, Rice Res Inst, Wenjiang, Peoples R China; [Li, Ping] Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China	Li, P; Li, SC (reprint author), Sichuan Agr Univ, State Key Lab Hybrid Rice, Chengdu, Sichuan, Peoples R China.; Li, P; Li, SC (reprint author), Sichuan Agr Univ, Rice Res Inst, Wenjiang, Peoples R China.; Li, P (reprint author), Hunan Hybrid Rice Res Ctr, State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China.	liping6575@163.com; lisc926105@163.com			National Natural Science Foundation of China [91435102, 31570004, 31471474]; Sichuan Provincial Funding for Distinguished Young Scholars [2015JQ0048]; Open Research Fund of the State Key Laboratory of Hybrid Rice (Hunan Hybrid Rice Research Center) [2016KF10]	This work was supported by the National Natural Science Foundation of China (91435102, 31570004, and 31471474), The Sichuan Provincial Funding for Distinguished Young Scholars (2015JQ0048), and the Open Research Fund of the State Key Laboratory of Hybrid Rice (Hunan Hybrid Rice Research Center, 2016KF10).	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; CHE RH, 2016, NAT PLANTS, V2; Choi D, 2004, PLANT CELL PHYSIOL, V45, P897, DOI 10.1093/pcp/pch098; de Bruijn DRH, 2006, CYTOGENET GENOME RES, V112, P222, DOI 10.1159/000089874; Debernardi JM, 2014, PLANT J, V79, P413, DOI 10.1111/tpj.12567; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; Duan PG, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.203, 10.1038/NPLANTS.2015.203]; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Fang WJ, 2012, PLANT J, V70, P929, DOI 10.1111/j.1365-313X.2012.04907.x; Gingras AC, 2001, GENE DEV, V15, P2852; Halliday KJ, 2004, CURR BIOL, V14, pR1008, DOI 10.1016/j.cub.2004.11.025; Hiei Y, 1997, PLANT MOL BIOL, V35, P205, DOI 10.1023/A:1005847615493; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Horiguchi G, 2011, PLANT CELL PHYSIOL, V52, P112, DOI 10.1093/pcp/pcq178; Hu J, 2015, MOL PLANT, V8, P1455, DOI 10.1016/j.molp.2015.07.002; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Iwakawa H, 2002, PLANT CELL PHYSIOL, V43, P467, DOI 10.1093/pcp/pcf077; Iwakawa H, 2007, PLANT J, V51, P173, DOI 10.1111/j.1365-313X.2007.03132.x; Kanei M, 2012, DEVELOPMENT, V139, P2436, DOI 10.1242/dev.081547; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Kawade K, 2013, CURR BIOL, V23, P788, DOI 10.1016/j.cub.2013.03.044; Kawade K, 2010, DEVELOPMENT, V137, P4221, DOI 10.1242/dev.057117; Kim JH, 2015, J EXP BOT, V66, P6093, DOI 10.1093/jxb/erv349; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Lee BH, 2014, DEV BIOL, V386, P12, DOI 10.1016/j.ydbio.2013.12.009; Li SC, 2016, PLANT BIOTECHNOL J, V14, P2134, DOI 10.1111/pbi.12569; Li SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3793; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; Liang G, 2014, PLANT PHYSIOL, V164, P249, DOI 10.1104/pp.113.225144; Liu HH, 2014, PLANT PHYSIOL, V165, P160, DOI 10.1104/pp.114.235564; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Meng LS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01728; Meng LS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01645; Meng LS, 2015, PLANT BIOTECHNOL J, V13, P893, DOI 10.1111/pbi.12324; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nelissen H, 2015, PLANT CELL, V27, P1605, DOI 10.1105/tpc.15.00269; Omidbakhshfard MA, 2015, MOL PLANT, V8, P998, DOI 10.1016/j.molp.2015.01.013; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Silverstone AL, 2001, PLANT CELL, V13, P1555, DOI 10.1105/tpc.13.7.1555; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585                                                             ; van der Knaap E, 2000, PLANT PHYSIOL, V122, P695, DOI 10.1104/pp.122.3.695; Vercruyssen L, 2014, PLANT CELL, V26, P210, DOI 10.1105/tpc.113.115907; Xiang JJ, 2012, PLANT PHYSIOL, V159, P1488, DOI 10.1104/pp.112.199968; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622	50	0	0	12	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	OCT 5	2017	8								1730	10.3389/fpls.2017.01730				11	Plant Sciences	Plant Sciences	FI9YK	WOS:000412365500001	29051769	gold			2018-01-05	
J	Maxwell, KL				Maxwell, Karen L.			The Anti-CRISPR Story: A Battle for Survival	MOLECULAR CELL			English	Article							IMMUNE-SYSTEM; CAS SYSTEMS; INHIBITION; PROTEINS; REPEATS; RNA; DNA; EVOLUTIONARY; SURVEILLANCE; ADAPTATION	The last decade has seen the fields of molecular biology and genetics transformed by the development of CRISPR-based gene editing technologies. These technologies were derived from bacterial defense systems that protect against viral invasion. Elegant studies focused on the evolutionary battle between CRISPR-encoding bacteria and the viruses that infect and kill them revealed the next step in this arms race, the anti-CRISPR proteins. Investigation of these proteins has provided important new insight into how CRISPR-Cas systems work and how bacterial genomes evolve. They have also led to the development of important biotechnological tools that can be used for genetic engineering, including off switches for CRISPR-Cas9 genome editing in human cells.	[Maxwell, Karen L.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	Maxwell, KL (reprint author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	karen.maxwell@utoronto.ca		Maxwell, Karen/0000-0002-0211-5480			Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Harrington LB, 2017, CELL, V170, P1224, DOI 10.1016/j.cell.2017.07.037; Hynes A. P., 2017, NAT MICROBIOL; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729                                                          ; Kala S, 2014, P NATL ACAD SCI USA, V111, P6022, DOI 10.1073/pnas.1320952111; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Pausch P, 2017, MOL CELL, V67, P622, DOI 10.1016/j.molcel.2017.06.036; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Seed KD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004847; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shin J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701620; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Yang H, 2017, MOL CELL, V67, P117, DOI 10.1016/j.molcel.2017.05.024	30	0	0	26	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	OCT 5	2017	68	1					8	14		10.1016/j.molcel.2017.09.002				7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9UT	WOS:000412355500004	28985512				2018-01-05	
J	Murugan, K; Babu, K; Sundaresan, R; Rajan, R; Sashital, DG				Murugan, Karthik; Babu, Kesavan; Sundaresan, Ramya; Rajan, Rakhi; Sashital, Dipali G.			The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit	MOLECULAR CELL			English	Review							TARGET DNA RECOGNITION; GENOME-WIDE SPECIFICITIES; RNA-GUIDED ENDONUCLEASE; R-LOOP COMPLEX; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; PAM RECOGNITION; CPF1	CRISPR-Cas systems defend prokaryotes against bacteriophages and mobile genetic elements and serve as the basis for revolutionary tools for genetic engineering. Class 2 CRISPR-Cas systems use single Cas endonucleases paired with guide RNAs to cleave complementary nucleic acid targets, enabling programmable sequence-specific targeting with minimal machinery. Recent discoveries of previously unidentified CRISPR-Cas systems have uncovered a deep reservoir of potential biotechnological tools beyond the well-characterized Type II Cas9 systems. Here we review the current mechanistic understanding of newly discovered single-protein Cas endonucleases. Comparison of these Cas effectors reveals substantial mechanistic diversity, underscoring the phylogenetic divergence of related CRISPR-Cas systems. This diversity has enabled further expansion of CRISPR-Cas biotechnological toolkits, with wide-ranging applications from genome editing to diagnostic tools based on various Cas endonuclease activities. These advances highlight the exciting prospects for future tools based on the continually expanding set of CRISPR-Cas systems.	[Murugan, Karthik; Sashital, Dipali G.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 2437 Pammel Dr, Ames, IA 50011 USA; [Babu, Kesavan; Sundaresan, Ramya; Rajan, Rakhi] Univ Oklahoma, Stephenson Life Sci Res Ctr, Dept Chem & Biochem, 101 Stephenson Pkwy, Norman, OK 73019 USA	Sashital, DG (reprint author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 2437 Pammel Dr, Ames, IA 50011 USA.	sashital@iastate.edu			NIH [R01 GM115874]; NSF CAREER [1652661]; USDA NIFA [2016-06247]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH [P20GM103640]	We thank members of the Sashital and Rajan labs for helpful discussions and Yanli Wang for sharing the Cas13a ternary complex manuscript and structure prior to their publication. D.G.S. acknowledges the support of NIH R01 GM115874, NSF CAREER 1652661, and USDA NIFA 2016-06247. R.R. acknowledges support from the Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH under grant number P20GM103640.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Borges A. L., 2017, ANN REV VIROL; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chen J.S., 2017, BIORXIV; Dagdas Y. S., 2017, SCI ADV, V3; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gogleva AA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-202; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hille F., 2016, PHILOS T R SOC LON B, V371; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Liu L, 2017, CELL, V170, P714, DOI 10.1016/j.cell.2017.06.050; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; SHAO SP, 2016, NUCL ACIDS RES, V44; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Stella S, 2017, NATURE, V546, P559, DOI 10.1038/nature22398; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wu D, 2017, CELL RES, V27, P705, DOI 10.1038/cr.2017.46; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.18; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733; Zhong GC, 2017, NAT CHEM BIOL, V13, P839, DOI 10.1038/nchembio.2410	74	0	0	50	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	OCT 5	2017	68	1					15	25		10.1016/j.molcel.2017.09.007				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9UT	WOS:000412355500005	28985502				2018-01-05	
J	Hess, GT; Tycko, J; Yao, D; Bassik, MC				Hess, Gaelen T.; Tycko, Josh; Yao, David; Bassik, Michael C.			Methods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes	MOLECULAR CELL			English	Review							APOBEC3 CYTIDINE DEAMINASES; STAPHYLOCOCCUS-AUREUS CAS9; MAMMALIAN-CELLS; IN-VIVO; DIRECTED EVOLUTION; SYNTHETIC BIOLOGY; DNA-REPAIR; GUIDE-RNA; SOMATIC HYPERMUTATION; TRANSCRIPTIONAL ACTIVATION	The past several years have seen an explosion in development of applications for the CRISPR-Cas9 system, from efficient genome editing, to high-throughput screening, to recruitment of a range of DNA and chromatinmodifying enzymes. While homology-directed repair (HDR) coupled with Cas9 nuclease cleavage has been used with great success to repair and re-write genomes, recently developed base-editing systems present a useful orthogonal strategy to engineer nucleotide substitutions. Base editing relies on recruitment of cytidine deaminases to introduce changes (rather than double-stranded breaks and donor templates) and offers potential improvements in efficiency while limiting damage and simplifying the delivery of editing machinery. At the same time, these systems enable novel mutagenesis strategies to introduce sequence diversity for engineering and discovery. Here, we review the different base-editing platforms, including their deaminase recruitment strategies and editing outcomes, and compare them to other CRISPR genome-editing technologies. Additionally, we discuss how these systems have been applied in therapeutic, engineering, and research settings. Lastly, we explore future directions of this emerging technology.	[Hess, Gaelen T.; Tycko, Josh; Yao, David; Bassik, Michael C.] Dept Genet, Stanford, CA 94305 USA; [Hess, Gaelen T.; Tycko, Josh; Yao, David; Bassik, Michael C.] Stanford Univ, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA	Bassik, MC (reprint author), Dept Genet, Stanford, CA 94305 USA.; Bassik, MC (reprint author), Stanford Univ, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA.	bassik@stanford.edu			NIH Director's New Innovator Award Program [1DP2HD084069-01]; NIH [T32HG000044]; National Science Foundation (NSF) Graduate Research Fellowship [DGE-1656518]	We thank Laure Fresard, Stephen Montgomery, Karlene Cimprich, Billy Li, Andy Fire, members of the Boyd lab, and members of the Bassik lab for helpful discussions. This work was funded by the NIH Director's New Innovator Award Program (project no. 1DP2HD084069-01), NIH T32HG000044 (G.T.H., J.T., and D.Y.), and a National Science Foundation (NSF) Graduate Research Fellowship (grant DGE-1656518) to J.T. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF. Stanford University has filed a patent application based on the CRISPR-X system (U.S. provisional patent application no. 62/376,681).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Alseth I, 2014, CURR OPIN GENET DEV, V26, P116, DOI 10.1016/j.gde.2014.07.008; Arakawa H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm616; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Bak RO, 2017, CELL REP, V20, P750, DOI 10.1016/j.celrep.2017.06.064; Baltes NJ, 2017, PROG MOL BIOL TRANSL, V149, P1, DOI 10.1016/bs.pmbts.2017.03.011; Barrangou R., 2013, REV RNA, V4, P267; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Billon P, 2017, MOL CELL, V67, P1068, DOI 10.1016/j.molcel.2017.08.008; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Canver MC, 2017, NAT GENET, V49, P625, DOI 10.1038/ng.3793; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Chadwick AC, 2017, ARTERIOSCL THROM VAS, V37, P1741, DOI 10.1161/ATVBAHA.117.309881; CHAN L, 1992, J BIOL CHEM, V267, P25621; Charton K, 2016, HUM MOL GENET, V25, P4518, DOI 10.1093/hmg/ddw280; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chen YY, 2017, SCI CHINA LIFE SCI, V60, P520, DOI 10.1007/s11427-017-9021-5; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Cobb RE, 2013, METHODS, V60, P81, DOI 10.1016/j.ymeth.2012.03.009; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; di Fagagna FD, 2003, EMBO REP, V4, P47, DOI 10.1038/embor709; Diao YR, 2017, NAT METHODS, V14, P629, DOI [10.1038/nmeth.4264, 10.1038/NMETH.4264]; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dingal P. D. P., 2017, BIORXIV; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Donovan KF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170445; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elhanati Y., 2015, PHILOS T R SOC LON B, V370, P370; Ernst J, 2016, NAT BIOTECHNOL, V34, P1180, DOI 10.1038/nbt.3678; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garst AD, 2017, NAT BIOTECHNOL, V35, P48, DOI 10.1038/nbt.3718; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gasperini M, 2017, AM J HUM GENET, V101, P192, DOI 10.1016/j.ajhg.2017.06.010; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Greiff V, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0169-8; Hamilton CE, 2010, RNA BIOL, V7, P220, DOI 10.4161/rna.7.2.11344                                                           ; Hanswillemenke A, 2015, J AM CHEM SOC, V137, P15875, DOI 10.1021/jacs.5b10216; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9                                                   ; Hein R, 1996, CURR BIOL, V6, P178; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hershfield MS, 1998, SEMIN HEMATOL, V35, P291; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hirsch ML, 2016, METHODS MOL BIOL, V1382, P21, DOI 10.1007/978-1-4939-3271-9_2; HIRSCHHORN R, 1990, Immunodeficiency Reviews, V2, P175; Hoehn KB, 2016, MOL BIOL EVOL, V33, P1147, DOI 10.1093/molbev/msw015; HOOYKAAS PJJ, 1992, PLANT MOL BIOL, V19, P15, DOI 10.1007/BF00015604; Hsieh CL, 2014, CELL DEATH DIFFER, V21, P707, DOI 10.1038/cdd.2013.197; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ipsaro JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172177; ISHINO M, 1987, VIROLOGY, V156, P414, DOI 10.1016/0042-6822(87)90421-1; Jakociunas T, 2017, CURR OPIN BIOTECH, V46, P134, DOI 10.1016/j.copbio.2017.03.014; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kapahnke M., 2016, CELLS, V5, pE45; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584                                                                ; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koito A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00028; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Kuscu C, 2017, NAT METHODS, V14, P710, DOI 10.1038/nmeth.4327; Lackner DH, 2015, NAT COMMUN, V6; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Larson ED, 2005, MOL CELL, V20, P367, DOI 10.1016/j.molcel.2005.09.018; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Liang PP, 2017, PROTEIN CELL, V8, P601, DOI 10.1007/s13238-017-0418-2; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Lievens S, 2014, MOL CELL PROTEOMICS, V13, P3332, DOI 10.1074/mcp.M114.041087; Lim AWY, 2016, PROTEIN ENG DES SEL, V29, P39, DOI 10.1093/protein/gzv058; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mathur M, 2017, J CELL BIOL, V216, P73, DOI 10.1083/jcb.201611002; McMahon AC, 2016, CELL, V165, P742, DOI 10.1016/j.cell.2016.03.007; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Montiel-Gonzalez MF, 2013, P NATL ACAD SCI USA, V110, P18285, DOI 10.1073/pnas.1306243110; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Mou HW, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1237-8; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Nam J, 1997, PLANT CELL, V9, P317, DOI 10.1105/tpc.9.3.317; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Perez AR, 2017, NAT BIOTECHNOL, V35, P347, DOI 10.1038/nbt.3804; Petersen B, 2017, REPROD DOMEST ANIM, V52, P4, DOI 10.1111/rda.13012; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rees Holly A, 2017, Nat Commun, V8, P15790, DOI 10.1038/ncomms15790; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9                                                   ; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631                                                              ; Richardson CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12463; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; ROY JE, 1967, CAN J BIOCHEM CELL B, V45, P1263, DOI 10.1139/o67-147                                                                 ; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Sakoparnig T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004027; Samuel CE, 2012, CURR TOP MICROBIOL, V353, P163, DOI 10.1007/82_2011_148; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; SANFORD JC, 1988, TRENDS BIOTECHNOL, V6, P299, DOI 10.1016/0167-7799(88)90023-6; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Schneider MF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku272; Scott DA, 2017, NAT MED, V23, P1095, DOI 10.1038/nm.4377; Senturk S, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14370; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Strande NT, 2017, AM J HUM GENET, V100, P895, DOI 10.1016/j.ajhg.2017.04.015; Tang WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15939; Tieman D, 2017, SCIENCE, V355, P391, DOI 10.1126/science.aal1556; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Valdmanis PN, 2017, HUM GENE THER, V28, P361, DOI 10.1089/hum.2016.171; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Vieira VC, 2013, BIOMED RES INT, DOI 10.1155/2013/683095; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang CH, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-263; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Wang HX, 2017, CHEM REV, V117, P9874, DOI 10.1021/acs.chemrev.6b00799; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Way JC, 2014, CELL, V157, P151, DOI 10.1016/j.cell.2014.02.039; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xie SQ, 2017, MOL CELL, V66, P285, DOI 10.1016/j.molcel.2017.03.007; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yu XF, 2006, CURR OPIN HIV AIDS, V1, P187, DOI 10.1097/01.COH.0000221590.03670.32; Yuan G, 1999, J BIOL CHEM, V274, P8175, DOI 10.1074/jbc.274.12.8175; Yuen CM, 2006, J AM CHEM SOC, V128, P8939, DOI 10.1021/ja062980e; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang JH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-271; Zhang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00175-6; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	193	0	0	74	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	OCT 5	2017	68	1					26	43		10.1016/j.molcel.2017.09.029				18	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9UT	WOS:000412355500006	28985508				2018-01-05	
J	Montalbano, A; Canver, MC; Sanjana, NE				Montalbano, Antonino; Canver, Matthew C.; Sanjana, Neville E.			High-Throughput Approaches to Pinpoint Function within the Noncoding Genome	MOLECULAR CELL			English	Review							SCALE CRISPR-CAS9 KNOCKOUT; ALTERED PAM SPECIFICITIES; GENETIC INTERACTIONS; REGULATORY ELEMENTS; MAMMALIAN-CELLS; CAS9 NUCLEASES; TRANSCRIPTIONAL ACTIVATION; CHROMATIN ACCESSIBILITY; SATURATING MUTAGENESIS; CRISPR/CAS9 SCREENS	The clustered regularly interspaced short palindromic repeats (CRISPR)-Cas nuclease system is a powerful tool for genome editing, and its simple programmability has enabled high-throughput genetic and epigenetic studies. These high-throughput approaches offer investigators a toolkit for functional interrogation of not only protein-coding genes but also noncoding DNA. Historically, noncoding DNA has lacked the detailed characterization that has been applied to protein-coding genes in large part because there has not been a robust set of methodologies for perturbing these regions. Although the majority of high-throughput CRISPR screens have focused on the coding genome to date, an increasing number of CRISPR screens targeting noncoding genomic regions continue to emerge. Here, we review high-throughput CRISPR-based approaches to uncover and understand functional elements within the noncoding genome and discuss practical aspects of noncoding library design and screen analysis.	[Montalbano, Antonino; Sanjana, Neville E.] New York Genome Ctr, New York, NY 10013 USA; [Montalbano, Antonino; Sanjana, Neville E.] NYU, Dept Biol, New York, NY 10003 USA; [Canver, Matthew C.] Harvard Med Sch, Boston, MA USA	Sanjana, NE (reprint author), New York Genome Ctr, New York, NY 10013 USA.; Sanjana, NE (reprint author), NYU, Dept Biol, New York, NY 10003 USA.	neville@sanjanalab.org			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Award [F30-DK103359]; National Institutes of Health through National Human Genome Research Institute [R00-HG008171]; Kimmel Foundation; Melanoma Research Alliance	M.C.C. is supported by a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Award (F30-DK103359). N.E.S. is supported by the National Institutes of Health through the National Human Genome Research Institute (R00-HG008171), by the Kimmel Foundation, and by the Melanoma Research Alliance. N.E.S. is listed as an inventor on patent applications related to this work.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2017, MOL CELL, V65, P582, DOI 10.1016/j.molcel.2017.02.002; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Canver MC, 2017, NAT GENET, V49, P625, DOI 10.1038/ng.3793; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver M.C., 2017, BIORXIV; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen FQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14958; Chen J.S., 2017, BIORXIV; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen YR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182528; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chow R.D., 2017, NAT NEUROSCI; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cross BCS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31782; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Cuykendall TN, 2017, CURR OPIN SYST BIOL, V1, P9; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Diao YR, 2017, NAT METHODS, V14, P629, DOI [10.1038/nmeth.4264, 10.1038/NMETH.4264]; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Donovan KF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170445; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Gasperini M, 2017, AM J HUM GENET, V101, P192, DOI 10.1016/j.ajhg.2017.06.010; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Graur D, 2017, GENOME BIOL EVOL, V9, P1880, DOI 10.1093/gbe/evx121; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hart T, 2017, G3-GENES GENOM GENET, V7, P2719, DOI 10.1534/g3.117.041277; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jeong H.-H., 2017, BIOINFORMATICS; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Karvelis T, 2017, CURR OPIN MICROBIOL, V37, P88, DOI 10.1016/j.mib.2017.05.009; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; KIM E, 2017, NAT COMMUN, V8; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Koirala P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14422; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kuscu C, 2017, NAT METHODS, V14, P710, DOI 10.1038/nmeth.4327; Kwon DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15315; Lei Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16026; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; List M, 2016, NUCLEIC ACIDS RES, V44, P6639, DOI 10.1093/nar/gkw554; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu X, 2017, CELL, V170, P1028, DOI 10.1016/j.cell.2017.08.003; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meier JA, 2017, NAT METHODS, V14, P831, DOI 10.1038/nmeth.4423; Meyers R.M., 2017, BIORXIV; Morgan SL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15993; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Mou HW, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1237-8; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Myers SA, 2017, BIORXIV; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; OHNO S, 1972, J HUM EVOL, V1, P651, DOI 10.1016/0047-2484(72)90011-5; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pott S, 2017, ELIFE, V6, DOI 10.7554/eLife.23203; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Radzisheuskaya Aliaksandra, 2016, Nucleic Acids Res, V44, pe141; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Ramani V, 2017, NAT METHODS, V14, P263, DOI [10.1038/NMETH.4155, 10.1038/nmeth.4155]; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rands CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004525; Rauscher B., 2017, BIORXIV; Rauscher B, 2017, NUCLEIC ACIDS RES, V45, pD679, DOI 10.1093/nar/gkw997; Rosenbluh J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15403; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Sanjana NE, 2017, ANAL BIOCHEM, V532, P95, DOI 10.1016/j.ab.2016.05.014; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen JP, 2017, NAT METHODS, V14, P573, DOI [10.1036/NMETH.4225, 10.1038/nmeth.4225]; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Vitak SA, 2017, NAT METHODS, V14, P302, DOI [10.1038/NMETH.4154, 10.1038/nmeth.4154]; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wallace J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153689; Wang G., 2017, BIORXIV; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang T., 2016, COLD SPRING HARB PRO, V2016; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Winter J, 2016, BIOINFORMATICS, V32, P632, DOI 10.1093/bioinformatics/btv617; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Xiao Y., 2017, CELL, V170; Xie S., 2017, MOL CELL, V66; Xu CL, 2017, P NATL ACAD SCI USA, V114, P722, DOI 10.1073/pnas.1615735114; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	146	0	0	25	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	OCT 5	2017	68	1					44	59		10.1016/j.molcel.2017.09.017				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9UT	WOS:000412355500007	28985510				2018-01-05	
J	Cinghu, S; Yang, PY; Kosak, JP; Conway, AE; Kumar, D; Oldfield, AJ; Adelman, K; Jothi, R				Cinghu, Senthilkumar; Yang, Pengyi; Kosak, Justin P.; Conway, Amanda E.; Kumar, Dhirendra; Oldfield, Andrew J.; Adelman, Karen; Jothi, Raja			Intragenic Enhancers Attenuate Host Gene Expression	MOLECULAR CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; MASTER TRANSCRIPTION FACTORS; GENOME-WIDE; REGULATORY CIRCUITRY; SIGNALING PATHWAYS; HUMAN PROMOTERS; IDENTITY GENES; MESSENGER-RNA; CHROMATIN	Eukaryotic gene transcription is regulated at many steps, including RNA polymerase II (Pol II) recruitment, transcription initiation, promoter-proximal Pol II pause release, and transcription termination; however, mechanisms regulating transcription during productive elongation remain poorly understood. Enhancers, which activate gene transcription, themselves undergo Pol II-mediated transcription, but our understanding of enhancer transcription and enhancer RNAs (eRNAs) remains incomplete. Here we show that transcription at intragenic enhancers interferes with and attenuates host gene transcription during productive elongation. While the extent of attenuation correlates positively with nascent eRNA expression, the act of intragenic enhancer transcription alone, but not eRNAs, explains the attenuation. Through CRISPR/Cas9-mediated deletions, we demonstrate a physiological role for intragenic enhancer-mediated transcription attenuation in cell fate determination. We propose that intragenic enhancers not only enhance transcription of one or more genes from a distance but also fine-tune transcription of their host gene through transcription interference, facilitating differential utilization of the same regulatory element for disparate functions.	[Cinghu, Senthilkumar; Yang, Pengyi; Kosak, Justin P.; Conway, Amanda E.; Kumar, Dhirendra; Oldfield, Andrew J.; Adelman, Karen; Jothi, Raja] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Yang, Pengyi] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Yang, Pengyi] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Adelman, Karen] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Jothi, R (reprint author), NIEHS, Epigenet & Stem Cell Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	jothi@nih.gov		Adelman, Karen/0000-0001-5364-334X; Yang, Pengyi/0000-0003-1098-3138	NIH, National Institute of Environmental Health Sciences [1ZIAES102625]	We thank T.K. Archer, T. Henriques, L. Ho, G. Hu, D. Fargo, T.A. Kunkel, S. Peddada, and P.A. Wade for useful discussions and comments on the manuscript. This work was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (1ZIAES102625 to R.J.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bintu L, 2012, CELL, V151, P738, DOI 10.1016/j.cell.2012.10.009; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Chen PB, 2015, NAT STRUCT MOL BIOL, V22, P999, DOI 10.1038/nsmb.3122; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen Y, 2016, NAT GENET, V48, P984, DOI 10.1038/ng.3616; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; Cinghu S, 2014, P NATL ACAD SCI USA, V111, pE1581, DOI 10.1073/pnas.1318598111; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hobson DJ, 2012, MOL CELL, V48, P365, DOI [10.1016/j.molcel.2012.08.027, 10.1016/j.molce1.2012.08.027]; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027                                                    ; Knuckles P, 2017, NAT STRUCT MOL BIOL, V24, P561, DOI 10.1038/nsmb.3419; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kurimoto K, 2015, CELL STEM CELL, V16, P517, DOI 10.1016/j.stem.2015.03.002; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lavender CA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006224; Lemay JF, 2014, NAT STRUCT MOL BIOL, V21, P919, DOI 10.1038/nsmb.2893; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martin RM, 2013, CELL REP, V4, P1144, DOI 10.1016/j.celrep.2013.08.013; Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108                                                              ; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Porrua O, 2015, NAT REV MOL CELL BIO, V16, P190, DOI 10.1038/nrm3943; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Proudfoot NJ, 2016, SCIENCE, V352, DOI 10.1126/science.aad9926; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V347, P141, DOI 10.1016/j.bbrc.2006.06.060; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Nguyen T, 2014, ELIFE, V3, DOI 10.7554/eLife.03635; Teves SS, 2014, TRENDS BIOCHEM SCI, V39, P577, DOI 10.1016/j.tibs.2014.10.004; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Tippmann SC, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.23; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	80	0	0	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	OCT 5	2017	68	1					104	+		10.1016/j.molcel.2017.09.010				20	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9UT	WOS:000412355500011	28985501				2018-01-05	
J	Jost, M; Chen, YW; Gilbert, LA; Horlbeck, MA; Krenning, L; Menchon, G; Rai, A; Cho, MY; Stern, JJ; Prota, AE; Kampmann, M; Akhmanova, A; Steinmetz, MO; Tanenbaum, ME; Weissman, JS				Jost, Marco; Chen, Yuwen; Gilbert, Luke A.; Horlbeck, Max A.; Krenning, Lenno; Menchon, Gregory; Rai, Ankit; Cho, Min Y.; Stern, Jacob J.; Prota, Andrea E.; Kampmann, Martin; Akhmanova, Anna; Steinmetz, Michel O.; Tanenbaum, Marvin E.; Weissman, Jonathan S.			Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent	MOLECULAR CELL			English	Article							RISK MYELODYSPLASTIC SYNDROMES; SMALL MOLECULES; BINDING AGENTS; GENOMIC ASSAYS; TUBULIN; PROTEIN; INHIBITOR; COLCHICINE; MECHANISM; TARGETS	Chemical libraries paired with phenotypic screens can now readily identify compounds with therapeutic potential. A central limitation to exploiting these compounds, however, has been in identifying their relevant cellular targets. Here, we present a two-tiered CRISPR-mediated chemical-genetic strategy for target identification: combined genome-wide knockdown and overexpression screening as well as focused, comparative chemical-genetic profiling. Application of these strategies to rigosertib, a drug in phase 3 clinical trials for high-risk myelodysplastic syndrome whose molecular target had remained controversial, pointed singularly to microtubules as rigosertib's target. We showed that rigosertib indeed directly binds to and destabilizes microtubules using cell biological, in vitro, and structural approaches. Finally, expression of tubulin with a structure-guided mutation in the rigosertib-binding pocket conferred resistance to rigosertib, establishing that rigosertib kills cancer cells by destabilizing microtubules. These results demonstrate the power of our chemical-genetic screening strategies for pinpointing the physiologically relevant targets of chemical agents.	[Jost, Marco; Chen, Yuwen; Gilbert, Luke A.; Horlbeck, Max A.; Cho, Min Y.; Stern, Jacob J.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jost, Marco; Chen, Yuwen; Gilbert, Luke A.; Horlbeck, Max A.; Cho, Min Y.; Stern, Jacob J.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Jost, Marco; Chen, Yuwen; Gilbert, Luke A.; Horlbeck, Max A.; Cho, Min Y.; Stern, Jacob J.; Kampmann, Martin; Weissman, Jonathan S.] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA; [Jost, Marco] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gilbert, Luke A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Kampmann, Martin] Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kampmann, Martin] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Krenning, Lenno; Tanenbaum, Marvin E.] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Krenning, Lenno; Tanenbaum, Marvin E.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Menchon, Gregory; Prota, Andrea E.; Steinmetz, Michel O.] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Rai, Ankit; Akhmanova, Anna] Univ Utrecht, Fac Sci, Dept Biol, Cell Biol, NL-3548 CH Utrecht, Netherlands; [Steinmetz, Michel O.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Weissman, JS (reprint author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.; Weissman, JS (reprint author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.; Weissman, JS (reprint author), Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA.; Tanenbaum, ME (reprint author), Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands.; Tanenbaum, ME (reprint author), Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands.	m.tanenbaum@hubrecht.eu; jonathan.weissman@ucsf.edu			NIH [P50 GM102706, U01 CA168370, R01 DA036858]; post-doctoral fellowship [F32 GM116331]; Swiss National Science Foundation [31003A_166608]; European Research Council [ERC-STG 677936-RNAREG]; Dutch Cancer Society (KWF); NWO CW ECHO [711.015.005]; NIH/NCI [K99 CA204602, K99 CA181494]; Stand Up To Cancer Innovative Research Grant	We thank Eric Chow, Derek Bogdanoff (UCSF Center for Advanced Technology), Vincent Olieric, and Meitian Wang (Swiss Light Source) for technical assistance; Jeffrey Hussmann for help with data analysis; Marco Hein for sharing constructs; Kevan Shokat for pointing out rigosertib as a promising drug with a poorly characterized molecular target; Lynn McGregor (Shokat lab) for sharing ARS-853 and the H358 cell line; and Carol Gross and members of the Weissman lab for helpful discussions. This work was funded by the NIH (grants P50 GM102706, U01 CA168370, and R01 DA036858 to J.S.W. and post-doctoral fellowship F32 GM116331 to M.J.), the Swiss National Science Foundation (grant 31003A_166608 to M.O.S.), the European Research Council (starting grant ERC-STG 677936-RNAREG to M.E.T.), a fellowship from the Dutch Cancer Society (KWF) to M.E.T., NWO CW ECHO grant 711.015.005 to A. A., NIH/NCI Pathway to Independence Award K99 CA204602 to L.A.G., and an NIH/NCI Pathway to Independence Award (K99 CA181494) and Stand Up To Cancer Innovative Research Grant to M.K.J.S.W. is a Howard Hughes Medical Institute Investigator. M.A.H., L.A.G., M.K., and J.S.W. have filed a patent application related to CRISPRi and CRISPRa screening (PCT/US15/40449). M.E.T., L.A.G., and J.S.W. have filed a patent application for the SunTag technology (PCT/US2015/040439). J.S.W. is a founder of KSQ Therapeutics, a CRISPR functional genomics company. Oligonucleotide pools were provided courtesy of the Innovative Genomics Institute.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Ashley EA, 2016, NAT REV GENET, V17, P507, DOI 10.1038/nrg.2016.86; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Brouhard GJ, 2014, J CELL BIOL, V207, P323, DOI 10.1083/jcb.201407095; Carter HE, 2013, PEST MANAG SCI, V69, P1040, DOI 10.1002/ps.3585; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Doodhi H, 2016, CURR BIOL, V26, P1713, DOI 10.1016/j.cub.2016.04.053; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Edelstein AD, 2014, J BIOL METHODS, V1, pe10, DOI [10.14440/jbm.2014.36, DOI 10.14440/JBM.2014.36]; Garcia-Manero G, 2016, LANCET ONCOL, V17, P496, DOI 10.1016/S1470-2045(16)00009-7; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Ho CH, 2011, CURR OPIN CHEM BIOL, V15, P66, DOI 10.1016/j.cbpa.2010.10.023; Hood Fiona E, 2011, Bioarchitecture, V1, P105; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang H, 2011, NAT CHEM BIOL, V7, P92, DOI 10.1038/NCHEMBIO.503; Kampmann M, 2017, CHEM COMMUN, V53, P7162, DOI 10.1039/c7cc02349a; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Lu TG, 2015, MOL PHARMACOL, V87, P18, DOI 10.1124/mol.114.093245; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; Mohan R, 2013, P NATL ACAD SCI USA, V110, P8900, DOI 10.1073/pnas.1300395110; Munoz L, 2017, NAT REV DRUG DISCOV, V16, P424, DOI 10.1038/nrd.2016.266; Nijman SMB, 2015, NAT CHEM BIOL, V11, P942, DOI [10.1038/NCHEM.BIO.1963, 10.1038/nchembio.1963]; Oussenko IA, 2011, CANCER RES, V71, P4968, DOI 10.1158/0008-5472.CAN-10-1603; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Prasad A, 2009, ONCOGENE, V28, P1518, DOI 10.1038/onc.2008.502; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Reddy MVR, 2011, J MED CHEM, V54, P6254, DOI 10.1021/jm200570p; Ritt DA, 2016, MOL CELL, V64, P875, DOI 10.1016/j.molcel.2016.10.029; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Silverman LR, 2015, HEMATOL ONCOL, V33, P57, DOI 10.1002/hon.2137; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Stepanova T, 2003, J NEUROSCI, V23, P2655; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tanenbaum M. E., 2011, BIOARCHITECTURE, V1, P80, DOI DOI 10.4161/BIOA.1.2.15807; Twarog NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149439; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	50	1	1	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	OCT 5	2017	68	1					210	+		10.1016/j.molcel.2017.09.012				20	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9UT	WOS:000412355500019	28985505	gold			2018-01-05	
J	Chen, YC; Farzadfard, F; Gharaei, N; Chen, WCW; Cao, JC; Lu, TK				Chen, Ying-Chou; Farzadfard, Fahim; Gharaei, Nava; Chen, William C. W.; Cao, Jicong; Lu, Timothy K.			Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity	MOLECULAR CELL			English	Article							LENTIVIRAL RNAI LIBRARY; GENOME-WIDE ANALYSIS; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; PARKINSONS-DISEASE; MOLECULAR PATHWAYS; OXIDATIVE STRESS; YEAST; PROTEIN; EXPRESSION	The genome-wide perturbation of transcriptional networks with CRISPR-Cas technology has primarily involved systematic and targeted gene modulation. Here, we developed PRISM (Perturbing Regulatory Interactions by Synthetic Modulators), a screening platform that uses randomized CRISPR-Cas transcription factors (crisprTFs) to globally perturb transcriptional networks. By applying PRISM to a yeast model of Parkinson's disease (PD), we identified guide RNAs (gRNAs) that modulate transcriptional networks and protect cells from alpha-synuclein (alpha Syn) toxicity. One gRNA identified in this screen outperformed the most protective suppressors of aSyn toxicity reported previously, highlighting PRISM's ability to identify modulators of important phenotypes. Gene expression profiling revealed genes differentially modulated by this strong protective gRNA that rescued yeast from aSyn toxicity when overexpressed. Human homologs of top-ranked hits protected against alpha Syn-induced cell death in a human neuronal PD model. Thus, high-throughput and unbiased perturbation of transcriptional networks via randomized crisprTFs can reveal complex biological phenotypes and effective disease modulators.	[Chen, Ying-Chou; Farzadfard, Fahim; Chen, William C. W.; Cao, Jicong; Lu, Timothy K.] MIT, Synthet Biol Ctr, Synthet Biol Grp, Cambridge, MA 02139 USA; [Chen, Ying-Chou; Farzadfard, Fahim; Chen, William C. W.; Cao, Jicong; Lu, Timothy K.] MIT, Res Lab Elect, Cambridge, MA 02139 USA; [Farzadfard, Fahim; Lu, Timothy K.] MIT, Microbiol Program, Cambridge, MA 02139 USA; [Gharaei, Nava] Harvard Univ, Dept Mol & Cellular Biol, MCO Grad Program, Cambridge, MA 02138 USA; [Farzadfard, Fahim; Lu, Timothy K.] MIT, Dept Biol Engn & Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Lu, TK (reprint author), MIT, Synthet Biol Ctr, Synthet Biol Grp, Cambridge, MA 02139 USA.; Lu, TK (reprint author), MIT, Res Lab Elect, Cambridge, MA 02139 USA.; Lu, TK (reprint author), MIT, Microbiol Program, Cambridge, MA 02139 USA.; Lu, TK (reprint author), MIT, Dept Biol Engn & Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	timlu@mit.edu			Ellison Medical Foundation [AG-NS-0948-12]; National Institutes of Health [1P50GM098792]	The ITox2C yeast strain was a generous gift from Susan Lindquist (Whitehead Institute, Cambridge, MA). We thank Leonidas Stefanis (Biomedical Research Foundation Academy of Athens, Athens, Greece) for SH-SY5Y cell lines. This work was supported by The Ellison Medical Foundation (AG-NS-0948-12) and the National Institutes of Health (1P50GM098792).	BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chandran J, 2007, MOL NEUROBIOL, V36, P224, DOI 10.1007/s12035-007-0034-x; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen YC, 2013, GENETICS, V194, P389, DOI 10.1534/genetics.113.149740; Chen YC, 2010, J BIOL CHEM, V285, P41244, DOI 10.1074/jbc.M110.155242; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Demir Kubilay, 2012, Methods Mol Biol, V910, P1, DOI 10.1007/978-1-61779-965-5_1; Dietz GPH, 2008, J NEUROCHEM, V104, P757, DOI 10.1111/j.1471-4159.2007.05028.x; Durigon R, 2012, EMBO REP, V13, P916, DOI 10.1038/embor.2012.116; Escusa S, 2007, J BIOL CHEM, V282, P20097, DOI 10.1074/jbc.M702425200; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500                                                                ; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Gouarne C, 2015, BRIT J PHARMACOL, V172, P235, DOI 10.1111/bph.12939; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Horlbeck M. A., 2016, ELIFE, V5; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Khurana V, 2017, CELL SYST, V4, P147, DOI 10.1016/j.cels.2017.02.007; Khurana V, 2017, CELL SYST, V4, P157, DOI 10.1016/j.cels.2016.12.011; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kosicek M, 2014, BIOCHEM BIOPH RES CO, V450, P160, DOI 10.1016/j.bbrc.2014.05.083; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Mark KG, 2014, MOL CELL, V53, P148, DOI 10.1016/j.molcel.2013.12.003; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Santos CNS, 2008, CURR OPIN CHEM BIOL, V12, P168, DOI 10.1016/j.cbpa.2008.01.017; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen JP, 2017, NAT METHODS, V14, P573, DOI [10.1036/NMETH.4225, 10.1038/nmeth.4225]; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655                                                          ; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tardiff DF, 2014, MOVEMENT DISORD, V29, P1231, DOI 10.1002/mds.25989; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tenreiro S, 2016, HUM MOL GENET, V25, P275, DOI 10.1093/hmg/ddv470; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Tsai CJ, 2015, J BIOL CHEM, V290, P24816, DOI 10.1074/jbc.M115.678367; Vekrellis K, 2009, J NEUROCHEM, V109, P1348, DOI 10.1111/j.1471-4159.2009.06054.x; von Einem B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129047; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Wong ASL, 2015, NAT BIOTECHNOL, V33, P952, DOI 10.1038/nbt.3326; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5; Zondler L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.307	86	0	0	16	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	OCT 5	2017	68	1					247	+		10.1016/j.molcel.2017.09.014				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FI9UT	WOS:000412355500022	28985507				2018-01-05	
J	Fogarty, NME; McCarthy, A; Snijders, KE; Powell, BE; Kubikova, N; Lakeley, PB; Lea, R; Lder, KE; Wamaitha, SE; Kim, D; Maciulyte, V; Kleinjung, J; Kim, JS; Wells, D; Vallier, L; Ertero, AB; Urner, JMAT; Niakan, KK				Fogarty, Norah M. E.; McCarthy, Afshan; Snijders, Kirsten E.; Powell, Benjamin E.; Kubikova, Nada; Lakeley, Paul B.; Lea, Rebecca; Lder, Kay E.; Wamaitha, Sissy E.; Kim, Daesik; Maciulyte, Valdone; Kleinjung, Jens; Kim, Jin-Soo; Wells, Dagan; Vallier, Ludovic; Ertero, Alessandro B.; Urner, James M. A. T.; Niakan, Kathy K.			Genome editing reveals a role for OCT4 in human embryogenesis	NATURE			English	Article							EMBRYONIC STEM-CELLS; RNA-SEQ DATA; MOUSE BLASTOCYST; HUMAN ZYGOTES; DIGENOME-SEQ; POU DOMAIN; CAS9; RIBONUCLEOPROTEINS; TRANSCRIPTOMES; NORMALIZATION	Despite their fundamental biological and clinical importance, the molecular mechanisms that regulate the first cell fate decisions in the human embryo are not well understood. Here we use CRISPR-Cas9-mediated genome editing to investigate the function of the pluripotency transcription factor OCT4 during human embryogenesis. We identified an efficient OCT4-targeting guide RNA using an inducible human embryonic stem cell-based system and microinjection of mouse zygotes. Using these refined methods, we efficiently and specifically targeted the gene encoding OCT4 (POU5F1) in diploid human zygotes and found that blastocyst development was compromised. Transcriptomics analysis revealed that, in POU5F1-null cells, gene expression was downregulated not only for extra-embryonic trophectoderm genes, such as CDX2, but also for regulators of the pluripotent epiblast, including NANOG. By contrast, Pou5f1-null mouse embryos maintained the expression of orthologous genes, and blastocyst development was established, but maintenance was compromised. We conclude that CRISPR-Cas9-mediated genome editing is a powerful method for investigating gene function in the context of human development.	[Fogarty, Norah M. E.; McCarthy, Afshan; Lakeley, Paul B.; Lea, Rebecca; Wamaitha, Sissy E.; Niakan, Kathy K.] Francis Crick Inst, Human Embryo & Stem Cell Lab, 1 Midland Rd, London NW1 1AT, England; [Snijders, Kirsten E.; Vallier, Ludovic] Univ Cambridge, Dept Surg, HIPSC Core Facil, NIHR Cambridge Biomed Res Ctr, Cambridge Biomed Campus, Cambridge CB2 0SZ, England; [Powell, Benjamin E.; Maciulyte, Valdone; Urner, James M. A. T.] Francis Crick Inst, Sex Chromosome Biol Lab, London NW1 1AT, England; [Kubikova, Nada; Wells, Dagan] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Lder, Kay E.] Bourn Hall Clin, Cambridge CB23 2TN, England; [Kim, Daesik; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Kleinjung, Jens] Francis Crick Inst, Bioinformat Facil, London NW1 1AT, England; [Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Daejeon 34047, South Korea; [Vallier, Ludovic] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Vallier, Ludovic; Ertero, Alessandro B.] Univ Cambridge, Wellcome Trust & MRC Cambridge Stem Cell Inst, Cambridge CB2 0SZ, England; [Vallier, Ludovic; Ertero, Alessandro B.] Univ Cambridge, Dept Surg, Anne McLaren Lab, Biomed Res Ctr, Cambridge CB2 0SZ, England; [Ertero, Alessandro B.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA	Niakan, KK (reprint author), Francis Crick Inst, Human Embryo & Stem Cell Lab, 1 Midland Rd, London NW1 1AT, England.	kathy.niakan@crick.ac.uk			National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; University of Oxford Clarendon Fund; Brasenose College Joint Scholarship; British Heart Foundation PhD Studentship [FS/11/77/39327]; NIHR Cambridge BRC; Wellcome Trust; Medical Research Council [PSAG028]; Institute for Basic Science [IBS-R021-D1]; Francis Crick Institute - Cancer Research UK; UK Medical Research Council; Wellcome Trust [FC001120, FC001193]; Rosa Beddington Fund	We thank the generous donors whose contributions have enabled this research; M. Macnamee, P. Snell and L. Christie at Bourn Hall Clinic for their support and assistance with the donation of embryos; T. Hiroda, P. Singh and J. Schimenti for the DMC1 sgRNA sequence and product; R. Lovell-Badge, I. Henderson, J. Haber, J. Rossant and A. Handyside for discussions and advice; the Wellcome Trust policy advisers, especially K. Littler and S. Rappaport, as well as J. Lawford-Davies and M. Chatfield for advice and support; and the Francis Crick Institute's Biological Resources, Advanced Light Microscopy, High Throughput Sequencing, Research Illustration (Fig. 2a) and Bioinformatics facilities. D.W. was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme. N.K. was supported by the University of Oxford Clarendon Fund and Brasenose College Joint Scholarship. A.B. was supported by a British Heart Foundation PhD Studentship (FS/11/77/39327). K.E.S. was supported by the NIHR Cambridge BRC. L.V. was supported by core grant funding from the Wellcome Trust and Medical Research Council (PSAG028). J.-S.K. was supported by the Institute for Basic Science (IBS-R021-D1). Work in the K.K.N. and J.M.A.T. labs was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust (FC001120 and FC001193). Work in the K.K.N. laboratory was also supported by the Rosa Beddington Fund.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bacher R, 2017, NAT METHODS, V14, P584, DOI 10.1038/nmeth.4263; BALAKIER H, 1993, FERTIL STERIL, V59, P359; Bertero A, 2016, DEVELOPMENT, V143, P4405, DOI 10.1242/dev.138081; Blakeley P, 2015, DEVELOPMENT, V142, P3613, DOI 10.1242/dev.131235; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Capmany G, 1996, Mol Hum Reprod, V2, P299, DOI 10.1093/molehr/2.5.299; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Egli D., 2017, INTERHOMOLOGUE REPAI; Fragouli E, 2017, HUM GENET, V136, P805, DOI 10.1007/s00439-017-1797-4; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Guell M, 2014, BIOINFORMATICS, V30, P2968, DOI 10.1093/bioinformatics/btu427; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Le Bin GC, 2014, DEVELOPMENT, V141, P1001, DOI 10.1242/dev.096875; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lou XH, 2014, STEM CELL REP, V2, P382, DOI 10.1016/j.stemcr.2014.01.010; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Macaulay IC, 2015, NAT METHODS, V12, P519, DOI 10.1038/nmeth.3370; Maurer M, 2015, INT J FERTIL STERIL, V9, P346; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0                                                                ; Shin HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15464; Suzuki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07621; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; Vallier L, 2011, METHODS MOL BIOL, V690, P57, DOI 10.1007/978-1-60761-962-8_3; Vera-Rodriguez M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8601; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wells D, 2014, J MED GENET, V51, P553, DOI 10.1136/jmedgenet-2014-102497; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	50	10	10	40	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2017	550	7674					67	+		10.1038/nature24033				22	Multidisciplinary Sciences	Science & Technology - Other Topics	FI7XU	WOS:000412214100045	28953884				2018-01-05	
J	Xiao, YB; Ng, S; Nam, KH; Ke, AL				Xiao, Yibei; Ng, Sherwin; Nam, Ki Hyun; Ke, Ailong			How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration	NATURE			English	Article							ADAPTIVE IMMUNITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HOST FACTOR; DNA; ADAPTATION; ACQUISITION; SEQUENCES; REPEATS; SYSTEMS	CRISPR (clustered regularly interspaced short palindromic repeats) and the nearby Cas (CRISPR-associated) operon establish an RNA-based adaptive immunity system in prokaryotes(1-5). Molecular memory is created when a short foreign DNA-derived prespacer is integrated into the CRISPR array as a new spacer(6-9). Whereas the RNA-guided CRISPR interference mechanism varies widely among CRISPR-Cas systems, the spacer integration mechanism is essentially identical(7-9). The conserved Cas1 and Cas2 proteins form an integrase complex consisting of two distal Cas1 dimers bridged by a Cas2 dimer(6,10). The prespacer is bound by Cas1-Cas2 as a dual-forked DNA, and the terminal 3'-OH of each 3' overhang serves as an attacking nucleophile during integration(11-14). The prespacer is preferentially integrated into the leader-proximal region of the CRISPR array(1,7,10,15,) guided by the leader sequence and a pair of inverted repeats inside the CRISPR repeat(7,15-20). Spacer integration in the well-studied Escherichia coli type I-E CRISPR system also relies on the bacterial integration host factor(21,22). In type II-A CRISPR, however, Cas1-Cas2 alone integrates spacers efficiently in vitro(18); other Cas proteins (such as Cas9 and Csn2) have accessory roles in the biogenesis phase of prespacers(17,23). Here we present four structural snapshots from the type II-A system(24) of Enterococcus faecalis Cas1 and Cas2 during spacer integration. Enterococcus faecalis Cas1-Cas2 selectively binds to a splayed 30-base-pair prespacer bearing 4-nucleotide 3' overhangs. Three molecular events take place upon encountering a target: first, the Cas1-Cas2-prespacer complex searches for half-sites stochastically, then it preferentially interacts with the leader-side CRISPR repeat, and finally, it catalyses a nucleophilic attack that connects one strand of the leader-proximal repeat to the prespacer 3' overhang. Recognition of the spacer half-site requires DNA bending and leads to full integration. We derive a mechanistic framework to explain the stepwise spacer integration process and the leader-proximal preference.	[Xiao, Yibei; Ng, Sherwin; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14353 USA; [Nam, Ki Hyun] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea	Ke, AL (reprint author), Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14353 USA.	ak425@cornell.edu		Nam, Ki Hyun/0000-0003-3268-354X	NIH/NIGMS [GM118174, GM102543, P41-GM103403, S10-RR029205, GM-103485]; CHESS and MACCHESS; NSF [DMR-1332208]; US Department of Energy [DE-AC02-06CH11357]	This work is supported by NIH/NIGMS awards GM118174 and GM102543 to A.K. We thank D. Neau for assistance with data collection, and K. Rajashankar and I. Kriksunov for beamtime allocation. We thank P. Nguyen, R. Battaglia and A. Dolan for technical assistance and discussions. This work is based upon research conducted at NECAT, supported by NIH/NIGMS awards P41-GM103403 and S10-RR029205; and at CHESS and MACCHESS, supported by NSF award DMR-1332208 and NIH/NIGMS award GM-103485. This research used resources of the Advanced Photon Source, a US Department of Energy facility under contract no. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6                                                   ; Goren MG, 2016, CELL REP, V16, P2811, DOI 10.1016/j.celrep.2016.08.043; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255                                                       ; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shipman SL, 2017, NATURE, V547, P345, DOI 10.1038/nature23017; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	39	0	0	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2017	550	7674					137	+		10.1038/nature24020				16	Multidisciplinary Sciences	Science & Technology - Other Topics	FI7XU	WOS:000412214100061	28869593				2018-01-05	
J	Ruiz-Blanco, YB; Almeida, Y; Sotomayor-Torres, CM; Garcia, Y				Ruiz-Blanco, Y. B.; Almeida, Y.; Sotomayor-Torres, C. M.; Garcia, Y.			Unveiled electric profiles within hydrogen bonds suggest DNA base pairs with similar bond strengths	PLOS ONE			English	Article							AB-INITIO CALCULATIONS; SINGLE-MOLECULE; NANOCONTACTS; RECOGNITION; CRISPR-CAS9; TRANSPORT; STACKING; DYNAMICS; ACID	Electrical forces are the background of all the interactions occurring in biochemical systems. From here and by using a combination of ab-initio and ad-hoc models, we introduce the first description of electric field profiles with intrabond resolution to support a characterization of single bond forces attending to its electrical origin. This fundamental issue has eluded a physical description so far. Our method is applied to describe hydrogen bonds (HB) in DNA base pairs. Numerical results reveal that base pairs in DNA could be equivalent considering HB strength contributions, which challenges previous interpretations of thermodynamic properties of DNA based on the assumption that Adenine/Thymine pairs are weaker than Guanine/Cytosine pairs due to the sole difference in the number of HB. Thus, our methodology provides solid foundations to support the development of extended models intended to go deeper into the molecular mechanisms of DNA functioning.	[Ruiz-Blanco, Y. B.] Univ Cent Marta Abreu Las Villas, Fac Quim & Farm, Santa Clara, Villa Clara, Cuba; [Almeida, Y.] Ctr Mol Immunol, Syst Biol Direct, Havana, Cuba; [Sotomayor-Torres, C. M.] CSIC, ICN2, Campus UAB, Barcelona, Spain; [Sotomayor-Torres, C. M.] BIST, Campus UAB, Barcelona, Spain; [Sotomayor-Torres, C. M.] ICREA, Barcelona, Spain; [Almeida, Y.] Hamburg Ctr Ultrafast Imaging, Hamburg, Germany; [Almeida, Y.] Univ Hamburg, Dept Chem, Inst Biochem & Mol Biol, Hamburg, Germany; [Garcia, Y.] Univ Politecn Cataluna, Dept Math, ESAB, Esteve Terradas, Castelldefels, Spain	Garcia, Y (reprint author), Univ Politecn Cataluna, Dept Math, ESAB, Esteve Terradas, Castelldefels, Spain.	yamila.garcia@uv.es	Sotomayor Torres, Clivia/E-8418-2010	Sotomayor Torres, Clivia/0000-0001-9986-2716	Spanish MINECO [FIS2015-70862-P]; programme Severo Ochoa [SEV-2013-0295]; CERCA Programme/Generalitat de Catalunya	CMST acknowledges the financial support from the Spanish MINECO project PHENTOM (FIS2015-70862-P), the programme Severo Ochoa (Grant SEV-2013-0295) and funding from the CERCA Programme/Generalitat de Catalunya. Computational facilities have been provided by "Centro de Supercomputacion de Galicia" (CESGA).	Ahmad Mahmoud Al, 2016, Sci Rep, V6, P29089, DOI 10.1038/srep29089; Alberts B, 2003, NATURE, V421, P431, DOI 10.1038/nature01407; Arunan E, 2011, PURE APPL CHEM, V83, P1619, DOI 10.1351/PAC-REP-10-01-01; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Castro CE, 2015, NANOSCALE, V7, P5913, DOI 10.1039/c4nr07153k; Ceron-Carrasco JP, 2013, CHEM COMMUN, V49, P7578, DOI 10.1039/c3cc42593b; Chang S, 2009, NAT NANOTECHNOL, V4, P297, DOI [10.1038/nnano.2009.48, 10.1038/NNANO.2009.48]; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Feynman R, 1960, ENG SCI, V23, P22; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Garcia Y, 2008, INT J QUANTUM CHEM, V108, P1637, DOI 10.1002/qua.21636; Garcia Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.041402; Garcia Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34616; Garcia Y, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2953459; Garcia Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3158606; Garcia Y, 2013, J MODERN PHYS, V4-4, P522; Gorodetskaya IA, 2015, NAT CHEM, V7, P541, DOI 10.1038/nchem.2290; Guerra CF, 1999, CHEM-EUR J, V5, P3581; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Hobza P, 1999, CHEM REV, V99, P3247, DOI 10.1021/cr9800255                                                               ; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864                                                        ; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Ke YG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10935; Kelley SO, 2014, NAT NANOTECHNOL, V9, P969, DOI [10.1038/nnano.2014.261, 10.1038/NNANO.2014.261]; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poater J, 2012, ORG BIOMOL CHEM, V12; Poater J, 2011, CHEM COMMUN, V47, P7326, DOI 10.1039/c0cc04707d; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sponer J, 2001, BIOPOLYMERS, V61, P3, DOI 10.1002/bip.10048; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U                       ; Szatylowicz H, 2010, J CHEM INF MODEL, V50, P2151, DOI 10.1021/ci100288h; Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; Weymouth AJ, 2014, SCIENCE, V343, P1120, DOI 10.1126/science.1249502; Wong IY, 2013, GENE DEV, V27, P2397, DOI 10.1101/gad.226837.113; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454	42	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185638	10.1371/journal.pone.0185638				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FI9WM	WOS:000412360300052	28982182	gold			2018-01-05	
J	Somanath, P; Klein, RH; Knoepfler, PS				Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.			CRISPR-mediated HDAC2 disruption identifies two distinct classes of target genes in human cells	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HISTONE DEACETYLASE INHIBITORS; RNA-SEQ EXPERIMENTS; CANCER; NURD; COMPLEX; PLURIPOTENCY; REPRESSION	The transcriptional functions of the class I histone deacetylases (HDACs) HDAC1 and HDAC2 are mainly viewed as both repressive and redundant based on murine knockout studies, but they may have additional independent roles and their physiological functions in human cells are not as clearly defined. To address the individual epigenomic functions of HDAC2, here we utilized CRISPR-Cas9 to disrupt HDAC2 in human cells. We find that while HDAC2 null cells exhibited signs of cross-regulation between HDAC1 and HDAC2, specific epigenomic phenotypes were still apparent using RNA-seq and ChIP assays. We identified specific targets of HDAC2 repression, and defined a novel class of genes that are actively expressed in a partially HDAC2-dependent manner. While HDAC2 was required for the recruitment of HDAC1 to repressed HDAC2-gene targets, HDAC2 was dispensable for HDAC1 binding to HDAC2-activated targets, supporting the notion of distinct classes of targets. Both active and repressed classes of gene targets demonstrated enhanced histone acetylation and methylation in HDAC2-null cells. Binding of the HDAC1/2-associated SIN3A corepressor was altered at most HDAC2-targets, but without a clear pattern. Overall, our study defines two classes of HDAC2 targets in human cells, with a dependence of HDAC1 on HDAC2 at one class of targets, and distinguishes unique functions for HDAC2.	[Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA	Knoepfler, PS (reprint author), Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.; Knoepfler, PS (reprint author), Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA.	knoepfler@ucdavis.edu			National Institute of General Medical Sciences [5R01GM100782-05, 1R01GM116919-01]	This work was supported by the National Institute of General Medical Sciences, grants 5R01GM100782-05 to PSK, and 1R01GM116919-01 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697                                                          ; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Consortium E. P., 2013, NATURE, V489, P57; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kim JK, 2013, MOL CANCER RES, V11, P62, DOI 10.1158/1541-7786.MCR-12-0332; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Noh JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028103; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Penney J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa0069; Phelps MP, 2016, P NATL ACAD SCI USA; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saunders A, 2017, CELL REP, V18, P1713, DOI 10.1016/j.celrep.2017.01.055; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Seto E, 2014, COLD SPRING HARB PER, V6; Smith KT, 2009, INT J BIOCHEM CELL B, V41, P21, DOI 10.1016/j.biocel.2008.09.008; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tung PY, 2013, STEM CELLS, V31, P2330, DOI 10.1002/stem.1526; Varlakhanova N, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-20; Wagner FF, 2015, CHEM SCI, V6, P804, DOI 10.1039/c4sc02130d; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wei T, 2015, NUCLEIC ACIDS RES, P1; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3                                                   ; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185627	10.1371/journal.pone.0185627				21	Multidisciplinary Sciences	Science & Technology - Other Topics	FI9WM	WOS:000412360300050	28982113	gold			2018-01-05	
J	Wang, L; Chen, L; Li, R; Zhao, RR; Yang, MJ; Sheng, JP; Shen, L				Wang, Liu; Chen, Lin; Li, Rui; Zhao, Ruirui; Yang, Meijing; Sheng, Jiping; Shen, Lin			Reduced Drought Tolerance by CRISPR/Cas9-Mediated SlMAPK3 Mutagenesis in Tomato Plants	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY			English	Article						tomato plants; SlMAPK3; drought tolerance; CRISPR/Cas9; cell membrane; antioxidant enzymes	ACTIVATED PROTEIN-KINASE; HABROCHAITES ENHANCES TOLERANCE; MULTIPLE ABIOTIC STRESSES; SOLANUM-LYCOPERSICON; SIGNALING PATHWAYS; DISEASE RESISTANCE; HYDROGEN-PEROXIDE; LATER GENERATIONS; SALICYLIC-ACID; COLD-STORAGE	Drought stress is one of the most destructive environmental factors that affect tomato plants adversely. Mitogen-activated protein kinases (MAPKs) are important signaling molecules that respond to drought stress. In this study, SlMAPK3 was induced by drought stress, and the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (CRISPR/Cas9) system was utilized to generate slmapk3 mutants. Two independent T1 transgenic lines and wild-type (WT) tomato plants were used for analysis of drought tolerance. Compared with WT plants, slmapk3 mutants exhibited more severe wilting symptom, higher hydrogen peroxide content, lower antioxidant enzymes activities, and suffered more membrane damage under drought stress. Furthermore, knockout of SlMAPK3 led to up- or down-regulated expressions of drought stress responsive genes including SlLOX, SlGST, and SlDREB. The results suggest that SlMAPK3 is involved in drought response in tomato plants by protecting cell membranes from oxidative damage and modulating transcription of stress-related genes.	[Wang, Liu; Chen, Lin; Li, Rui; Zhao, Ruirui; Yang, Meijing; Shen, Lin] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Sheng, Jiping] Renmin Univ China, Sch Agr Econ & Rural Dev, Beijing 100872, Peoples R China	Shen, L (reprint author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.	shen5000@cau.edu.cn			National Natural Science Foundation of China [31371847, 31571893]; National Basic Research Program of China [2013CB127106]	This work was supported by the National Natural Science Foundation of China (Grants 31371847 and 31571893) and National Basic Research Program of China (No.2013CB127106).	Bae KS, 2016, EUR J PLANT PATHOL, V145, P331, DOI 10.1007/s10658-015-0847-9; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Campos PS, 2003, J PLANT PHYSIOL, V160, P283, DOI 10.1078/0176-1617-00833; Chen KL, 2014, METHODS, V69, P2, DOI 10.1016/j.ymeth.2014.02.013; Chen L, 2014, SCI HORTIC-AMSTERDAM, V176, P143, DOI 10.1016/j.scienta.2014.06.032; Ding ZS, 2007, PHYSIOL PLANTARUM, V130, P112, DOI 10.1111/j.1399-3054.2007.00893.x; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Farooq M, 2009, AGRON SUSTAIN DEV, V29, P185, DOI 10.1051/agro:2008021; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Haffani S, 2014, GRASS FORAGE SCI, V69, P323, DOI 10.1111/gfs.12034; HANSON AD, 1979, CROP SCI, V19, P489, DOI 10.2135/cropsci1979.0011183X001900040015x                                       ; Holley SR, 2003, PLANT PHYSIOL, V132, P1728, DOI 10.1104/pp.103.024414; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Lanzinger A, 2015, J AGR FOOD CHEM, V63, P4252, DOI 10.1021/acs.jafc.5b01114; Larrigaudiere C, 2004, J SCI FOOD AGR, V84, P1871, DOI 10.1002/jsfa.1850; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li C, 2014, BIOCHEM BIOPH RES CO, V443, P357, DOI 10.1016/j.bbrc.2013.11.061; Li JH, 2012, J EXP BOT, V63, P6407, DOI 10.1093/jxb/ers295; Liu H, 2015, PLANT SCI, V231, P198, DOI 10.1016/j.plantsci.2014.12.006; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mayrose M, 2004, J BIOL CHEM, V279, P14819, DOI 10.1074/jbc.M313388200; Mishra KB, 2012, PLANT SCI, V182, P79, DOI 10.1016/j.plantsci.2011.03.022; Munir S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31772; Munne-Bosch S, 2003, PLANTA, V217, P758, DOI 10.1007/s00425-003-1037-0; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nishitani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31481; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Petolino JF, 2015, IN VITRO CELL DEV-PL, V51, P1, DOI 10.1007/s11627-015-9663-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shan DP, 2007, NEW PHYTOL, V176, P70, DOI 10.1111/j.1469-8137.2007.02160.x; Shi J, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-22; SMITH CJS, 1990, MOL GEN GENET, V224, P477; Talbi S, 2015, ENVIRON EXP BOT, V111, P114, DOI 10.1016/j.envexpbot.2014.11.004; Tian SW, 2017, PLANT CELL REP, V36, P399, DOI 10.1007/s00299-016-2089-5; Wang FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154027; Wang JX, 2010, J INTEGR PLANT BIOL, V52, P442, DOI 10.1111/j.1744-7909.2010.00906.x; Wang PC, 2010, PLANT CELL, V22, P2981, DOI 10.1105/tpc.109.072959; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Xu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136960; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Yu L, 2015, PLANT CELL TISS ORG, V121, P21, DOI 10.1007/s11240-014-0675-1; Zhang B, 2006, J EXP BOT, V57, P3825, DOI 10.1093/jxb/erl151; Zhang L, 2011, PLANT MOL BIOL, V77, P17, DOI 10.1007/s11103-011-9788-7; Zhao DY, 2009, J FOOD SCI, V74, pC348, DOI 10.1111/j.1750-3841.2009.01156.x; Zheng YY, 2015, J AGR FOOD CHEM, V63, P5509, DOI 10.1021/acs.jafc.5b00437; Zhou XJ, 2017, J EXP BOT, V68, P1265, DOI 10.1093/jxb/erx026	53	0	0	46	46	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-8561	1520-5118		J AGR FOOD CHEM	J. Agric. Food Chem.	OCT 4	2017	65	39					8674	8682		10.1021/acs.jafc.7b02745				9	Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology	Agriculture; Chemistry; Food Science & Technology	FJ4NN	WOS:000412717300017	28873302				2018-01-05	
J	Egashira, S; Jinnin, M; Ajino, M; Shimozono, N; Okamoto, S; Tasaki, Y; Hirano, A; Ide, M; Kajihara, I; Aoi, J; Harada, M; Igata, T; Masuguchi, S; Fukushima, S; Ihn, H				Egashira, Sho; Jinnin, Masatoshi; Ajino, Manami; Shimozono, Naoki; Okamoto, Sayo; Tasaki, Yukino; Hirano, Ayaka; Ide, Maho; Kajihara, Ikko; Aoi, Jun; Harada, Miho; Igata, Toshikatsu; Masuguchi, Shinichi; Fukushima, Satoshi; Ihn, Hironobu			Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma	SCIENTIFIC REPORTS			English	Article							ANGIOPOIETIN-LIKE PROTEIN-2; HUMAN DERMAL FIBROBLASTS; GROWTH-FACTOR; RNA-SEQ; DERMATOFIBROSARCOMA PROTUBERANS; RECURRENT FUSION; LUNG-CANCER; GENE; EXPRESSION; EGFR	Cutaneous squamous cell carcinoma (cSCC) differs from SCC of other organs in its strong association with chronic sun exposure. However, the specific driver mutations in cSCC remain unknown. Fusion genes in established cSCC cell lines (A431 and DJM-1) were predicted by transcriptome sequence, and validated by Sanger sequence, fluorescence in situ hybridization and G-banding. By transcriptome sequencing, we identified fusion gene EGFR-PPARGC1A in A431, which were expressed in 31 of 102 cSCCs. The lesions harboring the fusion gene tended to be located in sun-exposed areas. In vivo cutaneous implantation of EGFR-PPARGC1A-expressing NIH3T3 induced tumors resembling human cSCC, indicating its potent tumorigenicity. NIH3T3 transfected with EGFR-PPARGC1A as well as A431 showed increased cell proliferation activity. With regard to underlying mechanism, EGFR-PPARGC1A protein causes constitutive tyrosine phosphorylation, and induces the phosphorylation of wild-type full-length epidermal growth factor receptor (EGFR) by dimerization. Conversely, the RNAi-mediated attenuation of EGFR or CRISPR/Cas9-mediated knockdown of the fusion gene in A431 led to a decrease in the cell number, and may have therapeutic value. Our findings advance the knowledge concerning genetic causes of cSCC and the function of EGFR, with potential implications for new diagnostic and therapeutic approaches.	[Egashira, Sho; Jinnin, Masatoshi; Ajino, Manami; Shimozono, Naoki; Okamoto, Sayo; Tasaki, Yukino; Hirano, Ayaka; Ide, Maho; Kajihara, Ikko; Aoi, Jun; Harada, Miho; Igata, Toshikatsu; Masuguchi, Shinichi; Fukushima, Satoshi; Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan	Jinnin, M (reprint author), Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	mjin@kumamoto-u.ac.jp					Antonescu CR, 2009, CANCER RES, V69, P7175, DOI 10.1158/0008-5472.CAN-09-2068; Aoi J, 2014, MOL CANCER RES, V12, P239, DOI 10.1158/1541-7786.MCR-13-0336; Aoi J, 2011, CANCER RES, V71, P7502, DOI 10.1158/0008-5472.CAN-11-1758; Bishayee A, 1999, MOL BIOL CELL, V10, P525, DOI 10.1091/mbc.10.3.525                                                            ; Cichocki M, 2014, MOL CELL BIOCHEM, V396, P221, DOI 10.1007/s11010-014-2157-5; Dooley TP, 2003, BIOCHEM BIOPH RES CO, V306, P1026, DOI 10.1016/S0006-291X(03)01099-4; FUJITA M, 1992, CANCER RES, V52, P5323; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Jelovac DB, 2016, INT J ORAL MAX SURG, V45, P700, DOI 10.1016/j.ijom.2015.11.014; Jiang YZ, 2014, ASIAN PAC J CANCER P, V15, P2309, DOI 10.7314/APJCP.2014.15.5.2309; Jinnin M, 2005, J CELL PHYSIOL, V202, P510, DOI 10.1002/jcp.20154; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kubo Y, 1999, J DERMATOL SCI, V19, P199, DOI 10.1016/S0923-1811(98)00058-9                                                   ; KWOK TT, 1994, CANCER RES, V54, P2834; Lin HQ, 2010, ANTICANCER RES, V30, P4899; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Makino T, 2010, BRIT J DERMATOL, V162, P717, DOI 10.1111/j.1365-2133.2009.09581.x; Mansoor A, 1996, AM J DERMATOPATH, V18, P351, DOI 10.1097/00000372-199608000-00004; Martin M, 2011, EMBNET J, V17, P1, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Miyoshi H, 1998, J VIROL, V72, P8150; Muchemwa FC, 2010, EUR J DERMATOL, V20, P390, DOI 10.1684/ejd.2010.0906; Muehleisen B, 2007, J CUTAN PATHOL, V34, P1, DOI 10.1111/j.1600-0560.2006.00576.x; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Noguchi H, 2010, HUM PATHOL, V41, P336, DOI 10.1016/j.humpath.2009.04.028; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Piao Y, 2009, CANCER GENE THER, V16, P256, DOI 10.1038/cgt.2008.75; Ramsey H, 2003, LEUKEMIA, V17, P1665, DOI 10.1038/sj.leu.2403048; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharma A, 2016, CLIN CANCER RES, V22, P4428, DOI 10.1158/1078-0432.CCR-15-2449; Sherborne A. L., 2016, CLIN CANC RES; Shimozono N, 2015, CANCER RES, V75, P4458, DOI 10.1158/0008-5472.CAN-15-0418; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stratigos A, 2015, EUR J CANCER, V51, P1989, DOI 10.1016/j.ejca.2015.06.110; Tahara-Hanaoka S, 2002, EXP HEMATOL, V30, P11, DOI 10.1016/S0301-472X(01)00761-5; Thangaretnam KP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07482-4; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; YAGI H, 1987, ARCH DERMATOL, V123, P902, DOI 10.1001/archderm.123.7.902; Yamada S, 2016, DRUG DISCOV THER, V10, P172, DOI 10.5582/ddt.2016.01032; Yamane K, 2013, J MOL MED, V91, P69, DOI 10.1007/s00109-012-0935-7; Yang H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07871-9; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhou JB, 2013, MOL MED REP, V7, P591, DOI 10.3892/mmr.2012.1183	47	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 4	2017	7								12654	10.1038/s41598-017-12836-z				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FI7FA	WOS:000412161000008	28978917	gold			2018-01-05	
J	Wu, XN; Shi, TT; He, YH; Wang, FF; Sang, R; Ding, JC; Zhang, WJ; Shu, XY; Shen, HF; Yi, J; Gao, X; Liu, W				Wu, Xiao-nan; Shi, Tao-tao; He, Yao-hui; Wang, Fei-fei; Sang, Rui; Ding, Jian-cheng; Zhang, Wen-juan; Shu, Xing-yi; Shen, Hai-feng; Yi, Jia; Gao, Xiang; Liu, Wen			Methylation of transcription factor YY2 regulates its transcriptional activity and cell proliferation	CELL DISCOVERY			English	Article						YY2; SET7/9; LSD1; lysine methylation; cell proliferation	YIN YANG 1; DOMAIN-CONTAINING PROTEINS; LYSINE METHYLATION; HISTONE DEMETHYLATION; FUNCTIONAL-CHARACTERIZATION; EXPRESSION ANALYSIS; MODIFYING ENZYMES; GENE-EXPRESSION; BINDING MOTIFS; METHYLTRANSFERASE	Yin Yang 1 (YY1) is a multifunctional DNA-binding transcription factor shown to be critical in a variety of biological processes, and its activity and function have been shown to be regulated by multitude of mechanisms, which include but are not limited to post-translational modifications (PTMs), its associated proteins and cellular localization. YY2, the paralog of YY1 in mouse and human, has been proposed to function redundantly or oppositely in a context-specific manner compared with YY1. Despite its functional importance, how YY2' s DNA-binding activity and function are regulated, particularly by PTMs, remains completely unknown. Here we report the firstPTM with functional characterization on YY2, namely lysine 247 monomethylation (K247me1), which was found to be dynamically regulated by SET7/9 and LSD1 both in vitro and in cultured cells. Functional study revealed that SET7/9-mediated YY2 methylation regulated its DNA-binding activity in vitro and in association with chromatin examined by chromatin immunoprecipitation coupled with sequencing (ChIP-seq) in cultured cells. Knockout of YY2, SET7/9 or LSD1 by CRISPR (clustered, regularly interspaced, short palindromic repeats)/Cas9-mediated gene editing followed by RNA sequencing (RNA-seq) revealed that a subset of genes was positively regulated by YY2 and SET7/9, but negatively regulated by LSD1, which were enriched with genes involved in cell proliferation regulation. Importantly, YY2-regulated gene transcription, cell proliferation and tumor growth were dependent, at least partially, on YY2 K247 methylation. Finally, somatic mutations on YY2 found in cancer, which are in close proximity to K247, altered its methylation, DNA-binding activity and gene transcription it controls. Our findings revealed the first PTM with functional implications imposed on YY2 protein, and linked YY2 methylation with its biological functions.	[Wu, Xiao-nan; Shi, Tao-tao; He, Yao-hui; Wang, Fei-fei; Sang, Rui; Ding, Jian-cheng; Zhang, Wen-juan; Shu, Xing-yi; Shen, Hai-feng; Yi, Jia; Gao, Xiang; Liu, Wen] Xiamen Univ, Fujian Prov Key Lab Innovat Drug Target Res, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China	Liu, W (reprint author), Xiamen Univ, Fujian Prov Key Lab Innovat Drug Target Res, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China.	w2liu@xmu.edu.cn			'985 project' Funds; 'Thousand Young Talents Program' Funds; Fundamental Research Funds for the Central University [2013121036, 20720150056]; National Natural Science Foundation of China [31371292, 31422030, 91440112, 81761128015, 31601048]; Natural Science Foundation of Fujian Province, China [2015J06007, 2017J01070]; Fujian Province Health Education Joint Research Project [WKJ2016-2-09]; Fujian Province Young Teachers Education and Scientific Research Projects [0250-Z0210503]	This work was supported by '985 project' Funds, 'Thousand Young Talents Program' Funds, the Fundamental Research Funds for the Central University (2013121036), National Natural Science Foundation of China (31371292, 31422030, 91440112 and 81761128015), Natural Science Foundation of Fujian Province, China (2015J06007) and Fujian Province Health Education Joint Research Project (WKJ2016-2-09) to WL, and the Fundamental Research Funds for the Central University (20720150056), National Natural Science Foundation of China (31601048), Natural Science Foundation of Fujian Province, China (2017J01070) and Fujian Province Young Teachers Education and Scientific Research Projects (0250-Z0210503) to X-NW.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bhalla SS, 2001, J BIOL CHEM, V276, P11439, DOI 10.1074/jbc.M100208200                                                          ; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Chen L, 2010, NUCLEIC ACIDS RES, V38, P4011, DOI 10.1093/nar/gkq112; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Deng Zhiyong, 2010, Transcription, V1, P81, DOI 10.4161/trns.1.2.12375; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Drews D, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-45; Ficzycz A, 2001, J BIOL CHEM, V276, P22819, DOI 10.1074/jbc.M011188200                                                          ; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080                                                          ; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Hongo F, 2005, BIOCHEM BIOPH RES CO, V336, P692, DOI 10.1016/j.bbrc.2005.08.150; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Jeong HM, 2014, BBA-MOL CELL RES, V1843, P2005, DOI 10.1016/j.bbamcr.2014.04.023; Kassardjian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050645; Keating S, 2013, EPIGENETICS-US, V8, P361, DOI 10.4161/epi.24234; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Klar M, 2005, MOL CELL BIOL, V25, P10159, DOI 10.1128/MCB.25.22.10159-10170.2005; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Luo CQ, 2006, GENOMICS, V87, P348, DOI 10.1016/j.ygeno.2005.11.001; Moore KE, 2014, BBA-GENE REGUL MECH, V1839, P1395, DOI 10.1016/j.bbagrm.2014.02.008; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nguyen N, 2004, J BIOL CHEM, V279, P25927, DOI 10.1074/jbc.M402525200; Nicholson Sarah, 2011, Critical Reviews in Oncogenesis, V16, P245; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Pradhan Sriharsa, 2009, Epigenetics, V4, P383; Ramkumar C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3598; Riman S, 2012, MOL CELL BIOL, V32, P797, DOI 10.1128/MCB.06466-11; Rincon-Arano H, 2005, J MOL BIOL, V349, P961, DOI 10.1016/j.jmb.2005.04.040; Rizkallah R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015928; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shrivastava A, 1996, P NATL ACAD SCI USA, V93, P10638, DOI 10.1073/pnas.93.20.10638                                                        ; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vella P, 2012, NUCLEIC ACIDS RES, V40, P3403, DOI 10.1093/nar/gkr1290; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1                                                   ; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Wu Z, 2017, FEBS J, V284, P1742; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Young NL, 2010, CELL MOL LIFE SCI, V67, P3983, DOI 10.1007/s00018-010-0475-7; Zhang Qiang, 2011, Critical Reviews in Oncogenesis, V16, P163; Zhang WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21718; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	68	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2056-5968			CELL DISCOV	Cell Discov.	OCT 3	2017	3								UNSP 17035	10.1038/celldisc.2017.35				22	Cell Biology	Cell Biology	FM3SP	WOS:000414928200001	29098080	gold			2018-01-05	
J	Guo, Y; Zhao, SL; Sheng, QH; Samuels, DC; Shyr, Y				Guo, Yan; Zhao, Shilin; Sheng, Quanhu; Samuels, David C.; Shyr, Yu			The discrepancy among single nucleotide variants detected by DNA and RNA high throughput sequencing data	BMC GENOMICS			English	Article						DNA-RNA difference; RNA editing; Single nucleotide variant	ABDOMINAL AORTIC-ANEURYSMS; BAK1 GENE VARIATION; SEQ	Background: High throughput sequencing technology enables the both the human genome and transcriptome to be screened at the single nucleotide resolution. Tools have been developed to infer single nucleotide variants (SNVs) from both DNA and RNA sequencing data. To evaluate how much difference can be expected between DNA and RNA sequencing data, and among tissue sources, we designed a study to examine the single nucleotide difference among five sources of high throughput sequencing data generated from the same individual, including exome sequencing from blood, tumor and adjacent normal tissue, and RNAseq from tumor and adjacent normal tissue. Results: Through careful quality control and analysis of the SNVs, we found little difference between DNA-DNA pairs (1%-2%). However, between DNA-RNA pairs, SNV differences ranged anywhere from 10% to 20%. Conclusions: Only a small portion of these differences can be explained by RNA editing. Instead, the majority of the DNA-RNA differences should be attributed to technical errors from sequencing and post-processing of RNAseq data. Our analysis results suggest that SNV detection using RNAseq is subject to high false positive rates.	[Guo, Yan; Zhao, Shilin; Sheng, Quanhu] Vanderbilt Univ, Dept Biomed Informat, 2220 Pierce Ave,571 PRB, Nashville, TN 37027 USA; [Samuels, David C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Vanderbilt Genet Inst, Nashville, TN 37232 USA; [Shyr, Yu] Vanderbilt Univ, Dept Biostat, 2220 Pierce Ave,571 PRB, Nashville, TN 37027 USA	Guo, Y (reprint author), Vanderbilt Univ, Dept Biomed Informat, 2220 Pierce Ave,571 PRB, Nashville, TN 37027 USA.; Shyr, Y (reprint author), Vanderbilt Univ, Dept Biostat, 2220 Pierce Ave,571 PRB, Nashville, TN 37027 USA.	Yan.guo@vanderbilt.edu; Yu.shyr@vanderbilt.edu	Samuels, David/A-5393-2008	Samuels, David/0000-0003-3529-7791	Center for Quantitative Sciences, Vanderbilt University;  [P30 CA68485]	The study was supported by P30 CA68485. The publication fee was paid by funding from Center for Quantitative Sciences, Vanderbilt University.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Daniels J, 1998, AM J HUM GENET, V62, P1189, DOI 10.1086/301816; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gottlieb B, 2009, HUM MUTAT, V30, P1043, DOI 10.1002/humu.21046; Guo Y, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-332; Guo Y, 2014, BRIEF BIOINFORM, V15, P879, DOI 10.1093/bib/bbt069; Guo Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S2; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; Guo Y, 2013, SCI WORLD J, DOI 10.1155/2013/895496; Guo Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-194; Han L, 2014, BRIEF BIOINFORM; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kleinman CL, 2012, SCIENCE, V335, DOI 10.1126/science.1209658; Kury S, 2010, HUM MUTAT, V31, P1174, DOI 10.1002/humu.21324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Miller AC, 2013, GENOME RES, V23, P679, DOI 10.1101/gr.147322.112; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Ramaswami G, 2013, NUCL ACIDS RES; Shendure J, 2008, NAT METHODS, V5, P585, DOI 10.1038/nmeth0708-585; Sheng QH, 2016, GENOMICS, V107, P163, DOI 10.1016/j.ygeno.2016.03.006; Wang J, 2015, BIOINFORMATICS, V31, P318, DOI 10.1093/bioinformatics/btu668; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang P, 2015, BRIEF BIOINFORM; Zhao SL, 2014, BIOMED RES INT, DOI 10.1155/2014/986048	31	1	1	4	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	OCT 3	2017	18			6					690	10.1186/s12864-017-4022-x				10	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FI6HI	WOS:000412094200005	28984205	gold			2018-01-05	
J	Li, XF; Hu, WX; Zhou, JJ; Huang, YQ; Peng, JP; Yuan, Y; Yu, JK; Zheng, S				Li, Xiaofen; Hu, Wangxiong; Zhou, Jiaojiao; Huang, Yanqin; Peng, Jiaping; Yuan, Ying; Yu, Jiekai; Zheng, Shu			CLCA1 suppresses colorectal cancer aggressiveness via inhibition of the Wnt/beta-catenin signaling pathway	CELL COMMUNICATION AND SIGNALING			English	Article						Chloride channel accessory 1; Colorectal cancer; Tumor suppressor; Early detection	ACTIVATED CHLORIDE CHANNEL; EPITHELIAL-MESENCHYMAL TRANSITIONS; CA2+-ACTIVATED CL-CHANNELS; BREAST-CANCER; ION CHANNELS; MOLECULAR CHARACTERIZATION; CELL-LINE; EXPRESSION; PROTEINS; FAMILY	Background: Chloride channel accessory 1 (CLCA1) belongs to the calcium-sensitive chloride conductance protein family, which is mainly expressed in the colon, small intestine and appendix. This study was conducted to investigate the functions and mechanisms of CLCA1 in colorectal cancer (CRC). Methods: The CLCA1 protein expression level in CRC patients was evaluated by enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC), and western blotting analysis. Using CRISPR/Cas9 technology, CLCA1-upregulated (CLCA1-ACT) and CLCA1-knockout cells (CLCA1-KO), as well as their respective negative controls (CLCA1-ACT-NC and CLCA1-KO-NC), were constructed from the SW620 cell line. Cell growth and metastatic ability were assessed both in vitro and in vivo. The association of CLCA1 with epithelial-mesenchymal transition (EMT) and other signaling pathways was determined by western blotting assays. Results: The expression level of CLCA1 in CRC tissues was significantly decreased compared with that in adjacent normal tissue (P< 0.05). Meanwhile, the serum concentration of CLCA1 in CRC patients was also significantly lower when compared with that of healthy controls (1.48 +/- 1.06 ng/mL vs 1.06 +/- 0.73 ng/mL, P = 0.0018). In addition, CLCA1 serum concentration and mRNA expression level in CRC tissues were inversely correlated with CRC metastasis and tumor stage. Upregulated CLCA1 suppressed CRC growth and metastasis in vitro and in vivo, whereas inhibition of CLCA1 led to the opposite results. Increased expression levels of CLCA1 could repress Wnt signaling and the EMT process in CRC cells. Conclusions: Our findings suggest that increased expression levels of CLCA1 can suppress CRC aggressiveness. CLCA1 functions as a tumor suppressor possibly via inhibition of the Wnt/beta-catenin signaling pathway and the EMT process.	[Li, Xiaofen; Hu, Wangxiong; Zhou, Jiaojiao; Huang, Yanqin; Peng, Jiaping; Yuan, Ying; Yu, Jiekai; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Canc Inst,Key Lab Canc Prevent & Intervent,China, Hangzhou, Zhejiang, Peoples R China; [Li, Xiaofen; Hu, Wangxiong; Zhou, Jiaojiao; Huang, Yanqin; Peng, Jiaping; Yuan, Ying; Yu, Jiekai; Zheng, Shu] Sichuan Univ, West China Hosp, Dept Abdominal Oncol, Chengdu, Sichuan, Peoples R China; [Yuan, Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China	Yu, JK; Zheng, S (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Canc Inst,Key Lab Canc Prevent & Intervent,China, Hangzhou, Zhejiang, Peoples R China.	yjk@zju.edu.cn; zhengshu@zju.edu.cn			Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B07]; National High Technology Research and Development Program of China [2012AA02A506]	This work was supported by the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (Grant No. 2014BAI09B07) and the National High Technology Research and Development Program of China (Grant No. 2012AA02A506).	Agnel M, 1999, FEBS LETT, V455, P295, DOI 10.1016/S0014-5793(99)00891-1; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Beckley JR, 2004, J BIOL CHEM, V279, P41634, DOI 10.1074/jbc.M408334200; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Bustin SA, 2001, DNA CELL BIOL, V20, P331, DOI 10.1089/10445490152122442                                                       ; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Gruber AD, 1999, CANCER RES, V59, P5488; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hoshino M, 2002, AM J RESP CRIT CARE, V165, P1132, DOI 10.1164/rccm.2107068; Kim JA, 1999, BIOCHEM BIOPH RES CO, V261, P682, DOI 10.1006/bbrc.1999.1108; Kim JA, 2003, BIOCHEM BIOPH RES CO, V309, P291, DOI 10.1016/j.bbrc.2003.07.004; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Li XR, 2004, ONCOGENE, V23, P1474, DOI 10.1038/sj.onc.1207249; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Loewen ME, 2004, AM J PHYSIOL-GASTR L, V287, pG33, DOI 10.1152/ajpgi.00023.2004; Mehrkhani F, 2009, COLORECTAL DIS, V11, P157, DOI 10.1111/j.1463-1318.2008.01556.x; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pauli BU, 2000, CLIN EXP PHARMACOL P, V27, P901, DOI 10.1046/j.1440-1681.2000.03358.x                                                ; Peruzzo R, 2016, EUR BIOPHYS J BIOPHY, V45, P685, DOI 10.1007/s00249-016-1143-0; Polakis P, 2000, GENE DEV, V14, P1837; Sala-Rabanal M, 2017, J BIOL CHEM, V292, P9164, DOI 10.1074/jbc.M117.788232; Sala-Rabanal M, 2015, MEDIAT INFLAMM, DOI 10.1155/2015/497387; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Sawa M, 2016, EXPERT OPIN THER TAR, V20, P419, DOI 10.1517/14728222.2016.1098619; Shiwarski DJ, 2014, CLIN CANCER RES, V20, P4673, DOI 10.1158/1078-0432.CCR-14-0363; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; Sparks AB, 1998, CANCER RES, V58, P1130; Szabo I, 1998, P NATL ACAD SCI USA, V95, P6169, DOI 10.1073/pnas.95.11.6169; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Wohlrab D, 1999, SKIN PHARMACOL APPL, V12, P257, DOI 10.1159/000066250; Yang B, 2015, CANCER-AM CANCER SOC, V121, P1570, DOI 10.1002/cncr.29235; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060861; Yu JK, 2016, ONCOTARGET, V7, P75279, DOI 10.18632/oncotarget.12143; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083943; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282	46	0	0	9	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1478-811X			CELL COMMUN SIGNAL	Cell Commun. Signal.	OCT 3	2017	15								38	10.1186/s12964-017-0192-z				13	Cell Biology	Cell Biology	FI7ZB	WOS:000412217600001	28974231	gold			2018-01-05	
J	Goto, T; Hirotsu, Y; Nakagomi, T; Shikata, D; Yokoyama, Y; Amemiya, K; Tsutsui, T; Kakizaki, Y; Oyama, T; Mochizuki, H; Miyashita, Y; Omata, M				Goto, Taichiro; Hirotsu, Yosuke; Nakagomi, Takahiro; Shikata, Daichi; Yokoyama, Yujiro; Amemiya, Kenji; Tsutsui, Toshiharu; Kakizaki, Yumiko; Oyama, Toshio; Mochizuki, Hitoshi; Miyashita, Yoshihiro; Omata, Masao			Detection of tumor-derived DNA dispersed in the airway improves the diagnostic accuracy of bronchoscopy for lung cancer	ONCOTARGET			English	Article						bronchial wash; bronchoscopy; lung cancer; mutation; next-generation sequencing	BRONCHIAL GENOMIC CLASSIFIER; RELEVANCE; EDITION; PLASMA	The diagnostic accuracy of bronchoscopy for detecting lung cancer, especially peripheral lung cancer with lesions outside the endoscopically visible range, remains unsatisfactory. The aim of this study was to perform next-generation sequencing on bronchoscopic specimens to determine whether this improves the accuracy of bronchoscopy for diagnosing lung cancer and to identify factors influencing sensitivity. The bronchoscopic sensitivity for diagnosing lung cancer was initially evaluated in 191 patients who underwent lobectomy after bronchoscopy at our hospital. Sputum, bronchial wash fluid, and resected lung cancer specimens were subsequently collected from 18 patients with peripheral small cell lung cancer for genomic analysis. DNA was extracted from formalin-fixed, paraffin-embedded surgical tissue specimens and the supernatant and cell fractions of sputum and bronchial wash fluid. Deep sequencing was performed using a lung cancer panel covering all exons of 53 lung cancer-related genes. The bronchoscopic sensitivity for diagnosing lung cancer at our hospital was 60.7%. Multivariate analysis revealed that this was influenced by tumor size and location, but not histological type or lymph node metastasis. The sensitivity was the highest for biopsy followed by curettage and bronchial wash specimens. DNA mutations homologous to those identified in the primary lesions were detected in the bronchial wash fluid of 10 patients (55.6%), while only 2 patients (11.1%) were diagnosed with lung cancer based on conventional cytological examinations. In conclusion, the addition of genomic analysis to routine pathological examinations improves the diagnostic accuracy of bronchoscopy.	[Goto, Taichiro; Nakagomi, Takahiro; Shikata, Daichi; Yokoyama, Yujiro; Tsutsui, Toshiharu; Kakizaki, Yumiko; Miyashita, Yoshihiro] Yamanashi Prefectural Cent Hosp, Lung Canc & Resp Dis Ctr, Yamanashi, Japan; [Hirotsu, Yosuke; Amemiya, Kenji; Mochizuki, Hitoshi; Omata, Masao] Yamanashi Cent Hosp, Genome Anal Ctr, Yamanashi, Japan; [Oyama, Toshio] Yamanashi Cent Hosp, Dept Pathol, Yamanashi, Japan; [Omata, Masao] Univ Tokyo, Tokyo, Japan	Goto, T (reprint author), Yamanashi Prefectural Cent Hosp, Lung Canc & Resp Dis Ctr, Yamanashi, Japan.	taichiro@1997.jukuin.keio.ac.jp			Yamanashi Prefecture; Yasuda Medical Foundation	This study was supported by a Grant-in-Aid for Genome Research Project from Yamanashi Prefecture (awarded to Y.H. and M.O.) and a grant from the Yasuda Medical Foundation (awarded to Y.H.).	Amemiya K, 2016, CANCER MED-US, V5, P3426, DOI 10.1002/cam4.950; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Board RE, 2010, BREAST CANCER RES TR, V120, P461, DOI 10.1007/s10549-010-0747-9; Bordi P, 2015, TRANSL LUNG CANCER R, V4, P584, DOI 10.3978/j.issn.2218-6751.2015.08.09; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gibbs AR, 2001, J CLIN PATHOL, V54, P498, DOI 10.1136/jcp.54.7.498; Goto T, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0744-x; Gray ES, 2015, ONCOTARGET, V6, P42008, DOI 10.18632/oncotarget.5788; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hirotsu Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3166-4; Memoli JSW, 2012, CHEST, V142, P385, DOI 10.1378/chest.11-1764; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Silvestri GA, 2015, NEW ENGL J MED, V373, P243, DOI 10.1056/NEJMoa1504601; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Tjensvoll K, 2016, MOL ONCOL, V10, P635, DOI 10.1016/j.molonc.2015.11.012; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Whitney DH, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0091-3; Xu S, 2016, CANCER LETT, V370, P324, DOI 10.1016/j.canlet.2015.11.005	23	0	0	0	0	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	OCT 3	2017	8	45					79404	79413		10.18632/oncotarget.18159				10	Oncology; Cell Biology	Oncology; Cell Biology	FI6MT	WOS:000412111300103	29108319	green_published			2018-01-05	
J	Lombardi, MS; Gillieron, C; Berkelaar, M; Gabay, C				Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem			Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis	PLOS ONE			English	Article							NF-KAPPA-B; RECEPTOR ACTIVATOR; PROTEIN-KINASE; C-FOS; ANTIINFLAMMATORY PHENOTYPE; BONE-RESORPTION; DIFFERENTIATION; MICE; MACROPHAGES; EXPRESSION	Osteoclasts are large multinucleated cells responsible for bone resorption. Excessive inflammatory activation of osteoclasts leads to bony erosions, which are the hallmark of several diseases such as rheumatoid arthritis (RA). Salt-inducible kinases (SIK) constitute a subfamily of kinases comprising three members (SIK1,-2, and -3). Inhibition of SIK kinase activity induces an anti-inflammatory phenotype in macrophages. Since osteoclasts originate from precursors of macrophage origin, we hypothesized a role of SIK in osteoclastogenesis. We analyzed SIK1,-2 and -3 expression and function in osteoclast differentiation using the mouse macrophage cell line RAW264.7 and bone marrow-derived macrophages (BMM). We show that all three SIK are expressed in fully differentiated osteoclasts and that in BMM-derived osteoclasts there is an increased expression of SIK1 and SIK3 proteins. Interestingly, the pan-SIK inhibitor HG-9-91-01 significantly inhibited osteoclastogenesis by dose dependently reducing osteoclast differentiation markers (i. e. CathepsinK, MMP-9 and TRAP) and bone resorbing activity. Analysis of the signaling pathways activated by RANKL in RAW cells showed that SIK inhibitors did not affect RANKL-induced ERK1/2, JNK, p38 or NF-.B activation, but induced a significant downregulation in c-Fos and NFATc1 protein levels, the two main transcription factors involved in the regulation of osteoclast-specific genes. Moreover, SIK inhibition partially increased the proteasome-mediated degradation of c-Fos. SIK2 and SIK3 knockout RAW cells were generated by the CRISPR/Cas9 approach. SIK2 KO and, to a lesser extent, SIK3 KO recapitulated the effect of SIK small molecule inhibitor, thus confirming the specificity of the effect of SIK inhibition on the reduction of osteoclastogenesis. Overall, our results support the notion that the SIK signaling pathway plays a significant role among the check-points controlling osteoclastogenesis. SIK kinase inhibitors could thus represent a potential novel therapy to prevent bone erosions.	[Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem] Univ Hosp Geneva, Div Rheumatol, Dept Internal Med Specialties, Geneva, Switzerland; [Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem] Univ Geneva, Dept Pathol & Immunol, Sch Med, Geneva, Switzerland; [Lombardi, Maria Stella] GSK Consumer Healthcare, Dept Preclin Dev, Nyon, Switzerland	Lombardi, MS; Gabay, C (reprint author), Univ Hosp Geneva, Div Rheumatol, Dept Internal Med Specialties, Geneva, Switzerland.; Lombardi, MS; Gabay, C (reprint author), Univ Geneva, Dept Pathol & Immunol, Sch Med, Geneva, Switzerland.; Lombardi, MS (reprint author), GSK Consumer Healthcare, Dept Preclin Dev, Nyon, Switzerland.	maria-stella.x.lombardi@gsk.com; cem.gabay@houge.ch			Rheumasearch Foundation; Institute of Arthritis Research (iAR); Swiss National Science Foundation (SNF) [310030_172674]	This work was supported by the Rheumasearch Foundation (grant to M.S. Lombardi) and by the Institute of Arthritis Research (iAR) and the Swiss National Science Foundation (SNF grant number 310030_172674) to C. Gabay.	Adamopoulos IE, 2015, NAT REV RHEUMATOL, V11, P189, DOI 10.1038/nrrheum.2014.198; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bagnis Claude, 2009, V515, P151, DOI 10.1007/978-1-59745-559-6_10; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BURGER EH, 1982, J EXP MED, V156, P1604, DOI 10.1084/jem.156.6.1604; Clark K, 2014, BIOCHEM SOC T, V42, P11, DOI 10.1042/BST20130124; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Darling NJ, 2017, BIOCHEM J, V474, P521, DOI 10.1042/BCJ20160646; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685                                                         ; Han KY, 2007, BIOCHEM PHARMACOL, V74, P911, DOI 10.1016/j.bcp.2007.06.044; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3                                                   ; Li X, 2015, SHOCK VIB, DOI 10.1155/2015/431476; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lombardi MS, 2016, J LEUKOCYTE BIOL, V99, P711, DOI 10.1189/jlb.2A0715-307R; Lubberts E, 2002, ARTHRITIS RHEUM, V46, P3055, DOI 10.1002/art.10607; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Ozanne J, 2015, BIOCHEM J, V465, P271, DOI 10.1042/BJ20141165; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan TCA, 2004, HISTOL HISTOPATHOL, V19, P1325, DOI 10.14670/HH-19.1325; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/endo.142.3.8031; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185426	10.1371/journal.pone.0185426				18	Multidisciplinary Sciences	Science & Technology - Other Topics	FI6UJ	WOS:000412131900017	28973003	gold			2018-01-05	
J	Visone, V; Han, WY; Perugino, G; del Monaco, G; She, QX; Rossi, M; Valenti, A; Ciaramella, M				Visone, Valeria; Han, Wenyuan; Perugino, Giuseppe; del Monaco, Giovanni; She, Qunxin; Rossi, Mose; Valenti, Anna; Ciaramella, Maria			In vivo and in vitro protein imaging in thermophilic archaea by exploiting a novel protein tag	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; DNA-ALKYLATION-DAMAGE; REVERSE GYRASE; SULFOLOBUS-SOLFATARICUS; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; DIRECTED EVOLUTION; FUSION PROTEINS; TOPOISOMERASE; EXPRESSION; METHYLTRANSFERASE	Protein imaging, allowing a wide variety of biological studies both in vitro and in vivo, is of great importance in modern biology. Protein and peptide tags fused to proteins of interest provide the opportunity to elucidate protein location and functions, detect protein-protein interactions, and measure protein activity and kinetics in living cells. Whereas several tags are suitable for protein imaging in mesophilic organisms, the application of this approach to microorganisms living at high temperature has lagged behind. Archaea provide an excellent and unique model for understanding basic cell biology mechanisms. Here, we present the development of a toolkit for protein imaging in the hyperthermophilic archaeon Sulfolobus islandicus. The system relies on a thermostable protein tag (H5) constructed by engineering the alkylguanine-DNA-alkyl-transferase protein of Sulfolobus solfataricus, which can be covalently labeled using a wide range of small molecules. As a suitable host, we constructed, by CRISPR-based genome-editing technology, a S. islandicus mutant strain deleted for the alkylguanine-DNA-alkyl-transferase gene (triangle ogt). Introduction of a plasmidborne H5 gene in this strain led to production of a functional H5 protein, which was successfully labeled with appropriate fluorescent molecules and visualized in cell extracts as well as in.ogt live cells. H5 was fused to reverse gyrase, a peculiar thermophile-specific DNA topoisomerase endowed with positive supercoiling activity, and allowed visualization of the enzyme in living cells. To the best of our knowledge, this is the first report of in vivo imaging of any protein of a thermophilic archaeon, filling an important gap in available tools for cell biology studies in these organisms.	[Visone, Valeria; Perugino, Giuseppe; del Monaco, Giovanni; Rossi, Mose; Valenti, Anna; Ciaramella, Maria] Natl Res Council Italy, Inst Biosci & Bioresources, Naples, Italy; [Han, Wenyuan; She, Qunxin] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Valenti, A; Ciaramella, M (reprint author), Natl Res Council Italy, Inst Biosci & Bioresources, Naples, Italy.	anna.valenti@ibbr.cnr.it; maria.ciaramella@ibbr.cnr.it		Ciaramella, Maria/0000-0003-1583-1694	Italian Ministry of Education and Research, Firb-Futuro in Ricerca, Nematic; Research Fund Denmark [DFF-0602-02196]	This work was supported by a) Italian Ministry of Education and Research, Firb-Futuro in Ricerca, Nematic to AV; b) Research Fund Denmark, DFF-0602-02196 to QS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliye N, 2015, APPL MICROBIOL BIOT, V99, P1205, DOI 10.1007/s00253-014-5975-1; Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Brochier-Armanet Celine, 2007, Archaea, V2, P83; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Contursi P, 2006, EXTREMOPHILES, V10, P615, DOI 10.1007/s00792-006-0017-2; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Grogan DW, 2009, BIOCHEM SOC T, V37, P88, DOI 10.1042/BST0370088; Gronemeyer T, 2006, PROTEIN ENG DES SEL, V19, P309, DOI 10.1093/protein/gzl014; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Han WY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071340; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Jamroze A, 2014, J BIOL CHEM, V289, P3231, DOI 10.1074/jbc.M113.517649; Johnsson N, 2003, CHEMBIOCHEM, V4, P803, DOI 10.1002/cbic.200200603; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Li YJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1044; Lipscomb GL, 2017, EXTREMOPHILES, V21, P603, DOI 10.1007/s00792-017-0929-z; Lulchev P, 2014, NUCLEIC ACIDS RES, V42, P8200, DOI 10.1093/nar/gku589; Miggiano R, 2013, J BACTERIOL, V195, P2728, DOI 10.1128/JB.02298-12; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; NADAL M, 1994, J BIOL CHEM, V269, P5255; Napoli A, 2005, NUCLEIC ACIDS RES, V33, P564, DOI 10.1093/nar/gki202; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Peng N, 2017, SCI CHINA LIFE SCI, V60, P370, DOI 10.1007/s11427-016-0355-8; Peng N, 2012, APPL ENVIRON MICROB, V78, P5630, DOI 10.1128/AEM.00855-12; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Perugino G, 2015, NUCLEIC ACIDS RES, V43, P8801, DOI 10.1093/nar/gkv774; Perugino G, 2012, J BIOL CHEM, V287, P4222, DOI 10.1074/jbc.M111.308320; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Schneider AFL, 2017, CURR OPIN BIOTECH, V48, P61, DOI 10.1016/j.copbio.2017.03.012; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Valenti A, 2010, J BIOL CHEM, V285, P36532, DOI 10.1074/jbc.M110.169029; Valenti A, 2009, NUCLEIC ACIDS RES, V37, P4287, DOI 10.1093/nar/gkp386; Vettone A, 2016, EXTREMOPHILES, V20, P1, DOI 10.1007/s00792-015-0791-9; Visone V, 2014, INT J MOL SCI, V15, P17162, DOI 10.3390/ijms150917162; Zhang CY, 2013, BIOCHEM SOC T, V41, P405, DOI 10.1042/BST20120285	42	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185791	10.1371/journal.pone.0185791				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FI6UJ	WOS:000412131900051	28973046	gold			2018-01-05	
J	Mazo-Vargas, A; Concha, C; Livraghi, L; Massardo, D; Wallbank, RWR; Zhang, LL; Papador, JD; Martinez-Najera, D; Jiggins, CD; Kronforst, MR; Breuker, CJ; Reed, RD; Patel, NH; McMillan, WO; Martin, A				Mazo-Vargas, Anyi; Concha, Carolina; Livraghi, Luca; Massardo, Darli; Wallbank, Richard W. R.; Zhang, Linlin; Papador, Joseph D.; Martinez-Najera, Daniel; Jiggins, Chris D.; Kronforst, Marcus R.; Breuker, Casper J.; Reed, Robert D.; Patel, Nipam H.; McMillan, W. Owen; Martin, Arnaud			Macroevolutionary shifts of WntA function potentiate butterfly wing-pattern diversity	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						Wnt signaling; pattern formation; evolutionary tinkering; gene co-option; CRISPR mutagenesis	COLOR PATTERN; HELICONIUS LEPIDOPTERA; EVOLUTION; NYMPHALIDAE; UNDERLIES; DROSOPHILA; NETWORKS	Butterfly wing patterns provide a rich comparative framework to study how morphological complexity develops and evolves. Here we used CRISPR/Cas9 somatic mutagenesis to test a patterning role for WntA, a signaling ligand gene previously identified as a hotspot of shape-tuning alleles involved in wing mimicry. We show that WntA loss-of-function causes multiple modifications of pattern elements in seven nymphalid butterfly species. In three butterflies with a conserved wing-pattern arrangement, WntA is necessary for the induction of stripe-like patterns known as symmetry systems and acquired a novel eyespot activator role specific to Vanessa forewings. In two Heliconius species, WntA specifies the boundaries between melanic fields and the light-color patterns that they contour. In the passionvine butterfly Agraulis, WntA removal shows opposite effects on adjacent pattern elements, revealing a dual role across the wing field. Finally, WntA acquired a divergent role in the patterning of interveinous patterns in the monarch, a basal nymphalid butterfly that lacks stripe-like symmetry systems. These results identify WntA as an instructive signal for the prepatterning of a biological system of exuberant diversity and illustrate how shifts in the deployment and effects of a single developmental gene underlie morphological change.	[Mazo-Vargas, Anyi; Zhang, Linlin; Reed, Robert D.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Concha, Carolina; Wallbank, Richard W. R.; Jiggins, Chris D.; McMillan, W. Owen] Smithsonian Trop Res Inst, Gamboa, Panama; [Livraghi, Luca; Breuker, Casper J.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Massardo, Darli; Kronforst, Marcus R.] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Wallbank, Richard W. R.; Jiggins, Chris D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Papador, Joseph D.; Martinez-Najera, Daniel; Patel, Nipam H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Patel, Nipam H.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Martin, Arnaud] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Martin, A (reprint author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	arnaud@gwu.edu		Mazo-Vargas, Anyi/0000-0001-9644-2871; McMillan, W. Owen/0000-0003-2805-2745	NSF [DGE-1650441, IOS-1354318, IOS-1557443, IOS-1452648]; NIH [GM108626]; Leverhulme Trust [RPG-2014-167]; Pew Charitable Trust; Nigel Groome PhD studentship (Oxford Brookes University); Smithsonian Institution	We thank Saad Arif, Nora Braak, Chris Day, Melanie Gibbs, Jonah Heller, Jose Hermina-Perez, Colin Morrison, Oscar Paneso, Manu Sanjeev, David Tian, Camille Tulure, Matthew Verosloff, and Hans Van Dyck for assistance with rearing, injecting, dissecting, and imaging butterflies; Lawrence Gilbert for sharing photographs and insights on Heliconius wing patterning; and Karin van der Burg, Bernardo Clavijo, David Jaffe, James Lewis, and James Mallet for providing access to genomic data. This work was supported by grants from the NSF (Grants DGE-1650441, IOS-1354318, IOS-1557443, and IOS-1452648); the NIH (Grant GM108626); the Leverhulme Trust (Grant RPG-2014-167); the Pew Charitable Trust; a Nigel Groome PhD studentship (Oxford Brookes University); and the Smithsonian Institution.	Abbasi R, 2015, EVOL DEV, V17, P63, DOI 10.1111/ede.12109; Binari RC, 1997, DEVELOPMENT, V124, P2623; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Carter JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144471; Dinwiddie A, 2014, DEV BIOL, V392, P404, DOI 10.1016/j.ydbio.2014.06.005; Gallant JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5817; Gilbert LE, 2003, ECOLOGY EVOLUTION TA; Huber B, 2015, HEREDITY, V114, P515, DOI 10.1038/hdy.2015.22; Koshikawa S, 2015, P NATL ACAD SCI USA, V112, P7524, DOI 10.1073/pnas.1509022112; Kristensen NP, 2007, ZOOTAXA, P699; Martin A, 2017, DIVERSITY EVOLUTION; Martin A, 2014, DEV BIOL, V395, P367, DOI 10.1016/j.ydbio.2014.08.031; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; Martin A, 2010, MOL BIOL EVOL, V27, P2864, DOI 10.1093/molbev/msq173; Monteiro A, 2016, CURR TOP DEV BIOL, V119, P205, DOI 10.1016/bs.ctdb.2016.03.003; Nijhout HF, 2010, ADV INSECT PHYSIOL, V38, P219, DOI 10.1016/S0065-2806(10)38002-7; NIJHOUT HF, 1990, BIOL J LINN SOC, V40, P357, DOI 10.1111/j.1095-8312.1990.tb00545.x; NIJHOUT HF, 1988, BIOL J LINN SOC, V33, P345, DOI 10.1111/j.1095-8312.1988.tb00449.x; NIJHOUT HF, 1990, PROC R SOC SER B-BIO, V239, P81, DOI 10.1098/rspb.1990.0009                                                          ; Nijhout HF, 1991, DEV EVOLUTION BUTTER; Otaki JM, 2012, ZOOL SCI, V29, P568, DOI 10.2108/zsj.29.568; Ozsu N, 2017, DEV BIOL, V429, P177, DOI 10.1016/j.ydbio.2017.06.030; Perry M, 2016, NATURE, V535, P280, DOI 10.1038/nature18616; Rebeiz M, 2015, ANNU REV GENOM HUM G, V16, P103, DOI 10.1146/annurev-genom-091212-153423; Schwanwitsch B. N., 1935, Acta Zoologica Stockholm, V16, P143; Schwanwitsch B. N., 1956, Entomologicheskoe Obozrenie, V35, P530; Serfas MS, 2005, DEV BIOL, V287, P416, DOI 10.1016/j.ydbio.2005.09.014; Taira W, 2015, ZOOL SCI, V32, P38, DOI 10.2108/zs140058; Togel M, 2008, DEV BIOL, V318, P29, DOI 10.1016/j.ydbio.2008.02.043; Van Belleghem SM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0052; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896; Yamaguchi Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3063; Zhang LL, 2017, GENETICS, V205, P1537, DOI 10.1534/genetics.116.196451; ZHANG LL, 2016, NAT COMMUN, V7	36	1	1	17	17	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 3	2017	114	40					10701	10706		10.1073/pnas.1708149114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FI6TX	WOS:000412130500067	28923954				2018-01-05	
J	Zhang, LL; Mazo-Vargas, A; Reed, RD				Zhang, Linlin; Mazo-Vargas, Anyi; Reed, Robert D.			Single master regulatory gene coordinates the evolution and development of butterfly color and iridescence	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						optix; CRISPR; iridescence; ommochrome; butterfly	WING PATTERNS; MIMICRY; NYMPHALIDAE; LEPIDOPTERA; DROSOPHILA; TRAITS	The optix gene has been implicated in butterfly wing pattern adaptation by genetic association, mapping, and expression studies. The actual developmental function of this gene has remained unclear, however. Here we used CRISPR/Cas9 genome editing to show that optix plays a fundamental role in nymphalid butterfly wing pattern development, where it is required for determination of all chromatic coloration. optix knockouts in four species show complete replacement of color pigments with melanins, with corresponding changes in pigment-related gene expression, resulting in black and gray butterflies. We also show that optix simultaneously acts as a switch gene for blue structural iridescence in some butterflies, demonstrating simple regulatory coordination of structural and pigmentary coloration. Remarkably, these optix knockouts phenocopy the recurring "black and blue" wing pattern archetype that has arisen on many independent occasions in butterflies. Here we demonstrate a simple genetic basis for structural coloration, and show that optix plays a deeply conserved role in butterfly wing pattern development.	[Zhang, Linlin; Mazo-Vargas, Anyi; Reed, Robert D.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Reed, RD (reprint author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	robertreed@cornell.edu		Mazo-Vargas, Anyi/0000-0001-9644-2871	National Science Foundation [IOS-1354318, IOS-1557443, DGE-1650441]	We thank Jacob Berv for assistance with phylogenetic analysis, Jason Dombroskie for assistance with collection work and imaging, Benjamin Brack for assistance with raising butterflies, and Arnaud Martin and members of the R.D.R. laboratory for discussion and input. This work was supported by National Science Foundation Grants IOS-1354318 and IOS-1557443 (to R.D.R.), and DGE-1650441 (to A.M.-V.).	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132                                                           ; Connahs H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2586-5; Dinwiddie A, 2014, DEV BIOL, V392, P404, DOI 10.1016/j.ydbio.2014.06.005; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hines HM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-288; Jiggins CD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0485; Kodandaramaiah U, 2009, EVOL DEV, V11, P489, DOI 10.1111/j.1525-142X.2009.00357.x; Kronforst MR, 2015, GENETICS, V200, P1, DOI 10.1534/genetics.114.172387; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewis JJ, 2016, CELL REP, V16, P2855, DOI 10.1016/j.celrep.2016.08.042; Maddison W. P., 2017, MESQUITE MODULAR SYS; Martin A, 2014, DEV BIOL, V395, P367, DOI 10.1016/j.ydbio.2014.08.031; Martin A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-7; Martin A, 2013, EVOLUTION, V67, P1235, DOI 10.1111/evo.12081; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; Mazo-Vargas A, 2017, P NATL ACAD SCI USA, V114, P10701, DOI 10.1073/pnas.1708149114; Monteiro A, 2012, BIOESSAYS, V34, P181, DOI 10.1002/bies.201100160; Nadeau NJ, 2016, NATURE, V534, P106, DOI 10.1038/nature17961; NIJHOUT HF, 1986, BIOL J LINN SOC, V28, P387, DOI 10.1111/j.1095-8312.1986.tb01766.x; Nijhout H F, 1991, SMITHSONIAN SERIES C; Nishikawa H, 2015, NAT GENET, V47, P405, DOI 10.1038/ng.3241; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Pena C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120928; Reed RD, 2008, P R SOC B, V275, P37, DOI 10.1098/rspb.2007.1115; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Van Belleghem SM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0052; van't Hof AE, 2016, NATURE, V534, P102, DOI 10.1038/nature17951; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Wallbank RWR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002353; Zhang L, 2017, DIVERSITY EVOLUTION; Zhang LL, 2017, GENETICS, V205, P1537, DOI 10.1534/genetics.116.196451; ZHANG LL, 2016, NAT COMMUN, V7	38	0	0	20	20	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 3	2017	114	40					10707	10712		10.1073/pnas.1709058114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FI6TX	WOS:000412130500068	28923944				2018-01-05	
J	Hughes, J; Dawson, R; Tea, M; McAninch, D; Piltz, S; Jackson, D; Stewart, L; Ricos, MG; Dibbens, LM; Harvey, NL; Thomas, P				Hughes, James; Dawson, Ruby; Tea, Melinda; McAninch, Dale; Piltz, Sandra; Jackson, Dominique; Stewart, Laura; Ricos, Michael G.; Dibbens, Leanne M.; Harvey, Natasha L.; Thomas, Paul			Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling	SCIENTIFIC REPORTS			English	Article							TUBEROUS SCLEROSIS COMPLEX; FOCAL CORTICAL DYSPLASIA; RNA-GUIDED ENDONUCLEASES; ONE-STEP GENERATION; MAMMALIAN TARGET; LYMPHATIC VASCULATURE; TUMOR-SUPPRESSOR; GIANT-CELLS; MOUSE MODEL; MUTATIONS	DEPDC5 mutations have recently been shown to cause epilepsy in humans. Evidence from in vitro studies has implicated DEPDC5 as a negative regulator of mTORC1 during amino acid insufficiency as part of the GATOR1 complex. To investigate the role of DEPDC5 in vivo we generated a null mouse model using targeted CRISPR mutagenesis. Depdc5 homozygotes display severe phenotypic defects between 12.5-15.5 dpc, including hypotrophy, anaemia, oedema, and cranial dysmorphology as well as blood and lymphatic vascular defects. mTORC1 hyperactivity was observed in the brain of knockout embryos and in fibroblasts and neurospheres isolated from knockout embryos and cultured in nutrient deprived conditions. Heterozygous mice appeared to be normal and we found no evidence of increased susceptibility to seizures or tumorigenesis. Together, these data support mTORC1 hyperactivation as the likely pathogenic mechanism that underpins DEPDC5 loss of function in humans and highlights the potential utility of mTORC1 inhibitors in the treatment of DEPDC5-associated epilepsy.	[Hughes, James; Dawson, Ruby; McAninch, Dale; Piltz, Sandra; Jackson, Dominique; Stewart, Laura; Thomas, Paul] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Hughes, James; Dawson, Ruby; McAninch, Dale; Piltz, Sandra; Jackson, Dominique; Stewart, Laura; Thomas, Paul] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia; [Tea, Melinda] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Tea, Melinda] SA Pathol, Adelaide, SA 5000, Australia; [Ricos, Michael G.; Dibbens, Leanne M.] Univ South Australia, Sch Pharm & Med Sci, Epilepsy Res Program, Adelaide, SA 5000, Australia	Thomas, P (reprint author), Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia.; Thomas, P (reprint author), Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia.	paul.thomas@adelaide.edu.au			National Health & Medical Research Council (NHMRC) [628952]; NHMRC [APP 1083690]; Australian Research Council Future Fellowship [FT130101254]; NHMRC Senior Research fellowship [1104718]	This research was supported by a Program Grant (# 628952, https://www.nhmrc.gov.au/) from the National Health & Medical Research Council (NHMRC) awarded to PT and LD. Work in the Harvey Laboratory was supported by a Project Grant from the NHMRC (APP 1083690). NLH is supported by an Australian Research Council Future Fellowship (FT130101254, http://www.arc.gov.au/) and LD by an NHMRC Senior Research fellowship (#1104718). The authors have no conflicts of interest to declare.	Au KS, 1999, AM J HUM GENET, V65, P1790, DOI 10.1086/302648                                                                  ; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Baulac S, 2015, ANN NEUROL, V77, P675, DOI 10.1002/ana.24368; Becker AJ, 2002, ANN NEUROL, V52, P29, DOI 10.1002/ana.10251; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crino PB, 2010, NEUROLOGY, V74, P1716, DOI 10.1212/WNL.0b013e3181e04325; Curatolo P, 2016, DRUGS, V76, P551, DOI 10.1007/s40265-016-0552-9; D'Gama AM, 2015, ANN NEUROL, V77, P720, DOI 10.1002/ana.24357; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Dibbens LM, 2013, NAT GENET, V45, P546, DOI 10.1038/ng.2599; Dutchak PA, 2015, CELL REP, V12, P371, DOI 10.1016/j.celrep.2015.06.042; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; French JA, 2016, LANCET, V388, P2153, DOI 10.1016/S0140-6736(16)31419-2; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Henske EP, 1996, AM J HUM GENET, V59, P400; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huang WC, 2017, NEURON, V93, P1094, DOI 10.1016/j.neuron.2017.01.033; Ishida S, 2013, NAT GENET, V45, P552, DOI 10.1038/ng.2601; Kazenwadel J, 2012, BLOOD, V119, P1283, DOI 10.1182/blood-2011-08-374363; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim TH, 2013, EPILEPSY RES, V104, P11, DOI 10.1016/j.eplepsyres.2012.10.005; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Kowalczyk MS, 2012, MAMM GENOME, V23, P404, DOI 10.1007/s00335-012-9398-y; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lal D, 2014, ANN NEUROL, V75, P788, DOI 10.1002/ana.24127; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li F, 2004, CANCER RES, V64, P6438; Lozovaya N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5563; Ma AP, 2014, HUM MOL GENET, V23, P693, DOI 10.1093/hmg/ddt456; Marsan E, 2016, NEUROBIOL DIS, V89, P180, DOI 10.1016/j.nbd.2016.02.010; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Panchaud N, 2013, CELL CYCLE, V12, P2948, DOI 10.4161/cc.26000; Peng Y, 2015, CANCER RES, V75, P378, DOI 10.1158/0008-5472.CAN-14-2315; Ricos MG, 2016, ANN NEUROL, V79, P120, DOI 10.1002/ana.24547; Robens BK, 2016, NEUROBIOL DIS, V95, P134, DOI 10.1016/j.nbd.2016.07.006; Ruppe V, 2014, EPILEPSIA, V55, P539, DOI 10.1111/epi.12545; Scheffer IE, 2014, ANN NEUROL, V75, P782, DOI 10.1002/ana.24126; Shayan R, 2007, GROWTH FACTORS, V25, P417, DOI 10.1080/08977190801932550; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	51	0	0	13	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 3	2017	7								12618	10.1038/s41598-017-12574-2				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FI6WZ	WOS:000412138800054	28974734	gold			2018-01-05	
J	Papizan, JB; Garry, GA; Brezprozvannaya, S; McAnally, JR; Bassel-Duby, R; Liu, N; Olson, EN				Papizan, James B.; Garry, Glynnis A.; Brezprozvannaya, Svetlana; McAnally, John R.; Bassel-Duby, Rhonda; Liu, Ning; Olson, Eric N.			Deficiency in Kelch protein Klhl31 causes congenital myopathy in mice	JOURNAL OF CLINICAL INVESTIGATION			English	Article							GIRDLE MUSCULAR-DYSTROPHY; MEMBRANE-ASSOCIATED PROTEIN; SKELETAL-MUSCLE; NEMALINE MYOPATHY; MYOFIBRILLAR MYOPATHIES; UBIQUITIN LIGASES; FILAMIN-BINDING; ACTININ-BINDING; GAMMA-FILAMIN; IN-VIVO	Maintenance of muscle structure and function depends on the precise organization of contractile proteins into sarcomeres and coupling of the contractile apparatus to the sarcoplasmic reticulum (SR), which serves as the reservoir for calcium required for contraction. Several members of the Kelch superfamily of proteins, which modulate protein stability as substrate-specific adaptors for ubiquitination, have been implicated in sarcomere formation. The Kelch protein Klhl31 is expressed in a muscle-specific manner under control of the transcription factor MEF2. To explore its functions in vivo, we created a mouse model of Klhl31 loss of function using the CRISPR-Cas9 system. Mice lacking Klhl31 exhibited stunted postnatal skeletal muscle growth, centronuclear myopathy, central cores, Z-disc streaming, and SR dilation. We used proteomics to identify several candidate Klhl31 substrates, including Filamin-C (FlnC). In the Klhl31-knockout mice, FlnC protein levels were highly upregulated with no change in transcription, and we further demonstrated that Klhl31 targets FlnC for ubiquitination and degradation. These findings highlight a role for Klhl31 in the maintenance of skeletal muscle structure and provide insight into the mechanisms underlying congenital myopathies.	Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; Univ Texas Southwestern Med Ctr Dallas, Paul D Wellstone Muscular Dystrophy Cooperat Res, Dallas, TX 75390 USA	Olson, EN (reprint author), Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu			NIH [DK-099653, AR-067294, HL-130253, HD-087351, 5F32HL123323-03]; Robert A. Welch Foundation [1-0025]; American Heart Association [13BGIA17150004]	We thank Robyn Leidel for assistance and advice of the University of Texas Southwestern Electron Microscopy Core Facility, Andrew Lemoff for advice with the MS analysis, and James Richardson and Dennis Burns for help with histology and imaging. We are grateful to M. Arthur Moseley, Erik Soderblom, and the Duke University School of Medicine for the use of the Proteomics and Metabolomics Shared Resource. We would also like to thank Laura Ingle and Eric Plautz of the University of Texas Southwestern Neuro-Models Facility for grip-strength testing. We are very grateful to Jose Cabrerra for assistance with graphics. This work was supported in part by grants from the NIH (DK-099653, AR-067294, HL-130253 and HD-087351) and the Robert A. Welch Foundation (grant 1-0025 to ENO). NL was supported by a Beginning-Grant-In-Aid (13BGIA17150004) from the American Heart Association. JBP was supported by a Ruth L. Kirschstein NRSA F32 NIH training grant (5F32HL123323-03).	Abou-Elhamd A, 2015, DEV BIOL, V402, P61, DOI 10.1016/j.ydbio.2015.02.024; Anderson DM, P NATL ACAD SCI US; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bertini E, 2011, SEMIN PEDIATR NEUROL, V18, P277, DOI 10.1016/j.spen.2011.10.010; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799                                                                    ; Cadot B, 2015, NUCLEUS-PHILA, V6, P373, DOI 10.1080/19491034.2015.1090073; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chevessier F, 2015, HUM MOL GENET, V24, P7207, DOI 10.1093/hmg/ddv421; Claeys KG, 2013, HAND CLINIC, V113, P1337, DOI 10.1016/B978-0-444-59565-2.00005-8; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Duggan DJ, 1997, NEW ENGL J MED, V336, P618, DOI 10.1056/NEJM199702273360904; Faulkner G, 2000, J BIOL CHEM, V275, P41234, DOI 10.1074/jbc.M007493200; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frohlich T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33362; Furst DO, 2013, ACTA NEUROPATHOL, V125, P33, DOI 10.1007/s00401-012-1054-9; Garg A, 2014, J CLIN INVEST, V124, P3529, DOI 10.1172/JCI74994; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Gupta VA, 2013, AM J HUM GENET, V93, P1108, DOI 10.1016/j.ajhg.2013.10.020; Guzzo RM, 2005, AM J PHYSIOL-HEART C, V288, pH1810, DOI 10.1152/ajpheart.01015.2004; Guzzo RM, 2004, BIOCHEM J, V381, P599, DOI 10.1042/BJ20031723; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Ishikawa T, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1098, DOI 10.1161/CIRCEP.111.969972; Kley RA, 2012, BRAIN, V135, P2642, DOI 10.1093/brain/aws200; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Kontro H, 2012, Eur J Histochem, V56, pe18, DOI 10.4081/ejh.2012.18; Kontro H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131990; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; LaBeau-DiMenna EM, 2012, P NATL ACAD SCI USA, V109, P17983, DOI 10.1073/pnas.1208408109; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1053/JNEUROSCI.4474-04.2005; Lim LE, 1998, CURR OPIN NEUROL, V11, P443, DOI 10.1097/00019052-199810000-00006; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Metzger T, 2012, NATURE, V484, P120, DOI 10.1038/nature10914; Millay DP, 2009, AM J PATHOL, V175, P1817, DOI 10.2353/ajpath.2009.090107; Nader M, 2012, AM J PHYSIOL-HEART C, V302, pH1138, DOI 10.1152/ajpheart.00872.2011; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Olive M, 2013, CURR OPIN NEUROL, V26, P527, DOI 10.1097/WCO.0b013e328364d6b1; Paivarinne H, 2001, ACTA DIABETOL, V38, P83; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rahimov F, 2013, J CELL BIOL, V201, P499, DOI 10.1083/jcb.201212142; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Sandoz PA, 2015, BIOCHEM SOC T, V43, P222, DOI 10.1042/BST20140272; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Schoser BGH, 2005, ANN NEUROL, V57, P591, DOI 10.1002/ana.20441; Selcen D, 1993, GENEREVIEWS; Sewry CA, 2008, J MUSCLE RES CELL M, V29, P231, DOI 10.1007/s10974-008-9155-8; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Spaich S, 2012, CIRC RES, V111, P1504, DOI 10.1161/CIRCRESAHA.112.271007; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115                                                           ; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004; Yu WS, 2008, MOL CELLS, V26, P443	62	0	0	5	5	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	OCT 2	2017	127	10					3730	3740		10.1172/JCI93445				11	Medicine, Research & Experimental	Research & Experimental Medicine	FI5JF	WOS:000412017800020	28872460				2018-01-05	
J	Shao, J; Xu, QP; Su, S; Meng, FY; Zou, ZY; Chen, FJ; Du, J; Qian, XP; Liu, BR				Shao, Jie; Xu, Qiuping; Su, Shu; Meng, Fanyan; Zou, Zhengyun; Chen, Fangjun; Du, Juan; Qian, Xiaoping; Liu, Baorui			Engineered cells for costimulatory enhancement combined with IL-21 enhance the generation of PD-1-disrupted CTLs for adoptive immunotherapy	CELLULAR IMMUNOLOGY			English	Article						Adoptive cell therapy; Checkpoint blockade; 4-1BB ligand; Interleukin-21; Clustered regularly interspaced short palindromic repeat	CYTOTOXIC T-LYMPHOCYTES; TUMOR-INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA PATIENTS; ANTI-PD-1 ANTIBODY; PD-1 BLOCKADE; IN-VITRO; GASTRIC-CARCINOMA; SOLID TUMORS; CANCER; THERAPY	Blockade of the immune cell checkpoint inhibitors programmed death 1 (PD-1) and programmed death-ligand 1 (PD-L1) has become a powerful tool in cancer treatment, which is effective across various solid cancer types and hematologic malignancies. Our previous studies showed that by reducing immune tolerance, clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR-Cas9) modified cytotoxic T lymphocytes (CTLs) rank highly in terms of immune responses and cytotoxicity. In this study, a genetically modified K562 cell line with surface expression of 4-1BBL was developed to expand PD-1-disrupted CTLs in vitro for further adoptive immunotherapy against cancer. Our findings demonstrate that after a long-term, up to 28 days, engineered cells for costimulatory enhancement (ECCE) combined with IL-21 promote the expansion of PD-1disrupted CTLs with a less differentiated "young" phenotype, enhanced immune response and superior cytotoxic effector characteristics. These new in vitro conditions represent a nimble and cost-effective approach to developing PD-1-disrupted CTLs with improved therapeutic potential.	[Liu, Baorui] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Baorui] Nanjing Univ, Clin Canc Inst, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China	Liu, BR (reprint author), Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Comprehens Canc, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Liu, BR (reprint author), Nanjing Univ, Clin Canc Inst, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	baoruiliu@nju.edu.cn			National Natural Science Foundation of China [81602106, 81572601]; Natural Science Foundation of Jiangsu Province [BK20150103, BK20151095]	This work was supported by grants from the National Natural Science Foundation of China (No. 81602106, 81572601), the Natural Science Foundation of Jiangsu Province (No. BK20150103, BK20151095).	Alvarez-Fernandez C, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0973-y; Alves NL, 2005, J IMMUNOL, V175, P755, DOI 10.4049/jimmunol.175.2.755                                                      ; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bukczynski J, 2004, P NATL ACAD SCI USA, V101, P1291, DOI 10.1073/pnas.0306567101; Bullock TNJ, 2017, CURR OPIN IMMUNOL, V45, P82, DOI 10.1016/j.coi.2017.02.001; Butler MO, 2007, CLIN CANCER RES, V13, P1857, DOI 10.1158/1078-0432.CCR-06-1905; Butler MO, 2014, IMMUNOL REV, V257, P191, DOI 10.1111/imr.12129; Chacon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060031; Dharmadhikari B, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1113367; Di Carlo E, 2004, J IMMUNOL, V172, P1540, DOI 10.4049/jimmunol.172.3.1540                                                     ; Dudley ME, 2013, J CLIN ONCOL, V31, P2152, DOI 10.1200/JCO.2012.46.6441; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Ferrari-Lacraz S, 2008, INT IMMUNOL, V20, P1009, DOI 10.1093/intimm/dxn059; Friedman KM, 2011, J IMMUNOTHER, V34, P651, DOI 10.1097/CJI.0b013e31823284c3; Gharibi T, 2016, IMMUNOBIOLOGY, V221, P357, DOI 10.1016/j.imbio.2015.09.021; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a                                              ; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li YQ, 2008, BLOOD, V111, P229, DOI 10.1182/blood-2007-05-089375; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261                                                     ; Li YF, 2010, J IMMUNOL, V184, P452, DOI 10.4049/jimmunol.0901101; Lim SH, 2016, EXPERT OPIN BIOL TH, V16, P397, DOI 10.1517/14712598.2016.1145652; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; Lloyd A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00221; Markley JC, 2010, BLOOD, V115, P3508, DOI 10.1182/blood-2009-09-241398; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Moroz A, 2004, J IMMUNOL, V173, P900, DOI 10.4049/jimmunol.173.2.900                                                      ; Okugawa K, 2004, ONCOL REP, V12, P725; Olson JA, 2013, IMMUNITY, V38, P1250, DOI 10.1016/j.immuni.2013.05.009; Orio J, 2015, CYTOTHERAPY, V17, P496, DOI 10.1016/j.jcyt.2014.12.009; POLLOK KE, 1993, J IMMUNOL, V150, P771; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Rosenberg SA, 2008, P NATL ACAD SCI USA, V105, P12643, DOI 10.1073/pnas.0806877105; Sluijter BJR, 2010, CLIN IMMUNOL, V137, P221, DOI 10.1016/j.clim.2010.07.009; Su S, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1249558; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Sussman JJ, 2004, CANCER RES, V64, P9124, DOI 10.1158/0008-5472.CAN-03-0376; Tang XJ, 2014, J BIOMED RES, V28, P468, DOI 10.7555/JBR.28.20140066; Tanoue K, 2017, CANCER RES, V77, P2040, DOI 10.1158/0008-5472.CAN-16-1577; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Teschner D, 2011, SCAND J IMMUNOL, V74, P155, DOI 10.1111/j.1365-3083.2011.02564.x; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang Li-Xin, 2004, J Transl Med, V2, P41, DOI 10.1186/1479-5876-2-41; Wang LL, 2016, CYTOTHERAPY, V18, P581, DOI 10.1016/j.jcyt.2015.11.021; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; Weber J, 2010, SEMIN ONCOL, V37, P430, DOI 10.1053/j.seminoncol.2010.09.005; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910                                                     	57	0	0	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0008-8749	1090-2163		CELL IMMUNOL	Cell. Immunol.	OCT	2017	320						38	45		10.1016/j.cellimm.2017.09.003				8	Cell Biology; Immunology	Cell Biology; Immunology	FQ4BY	WOS:000418303800005	28935250				2018-01-05	
J	French, S; Ellis, MJ; Coutts, BE; Brown, ED				French, Shawn; Ellis, Michael J.; Coutts, Brittney E.; Brown, Eric D.			Chemical genomics reveals mechanistic hypotheses for uncharacterized bioactive molecules in bacteria	CURRENT OPINION IN MICROBIOLOGY			English	Review							HIGH-THROUGHPUT; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; E. COLI; LIBRARY; FITNESS; CRISPR; MICROORGANISMS; EXPRESSION	In an effort to combat the perpetual emergence of new antibiotic-resistant human pathogens, research in industry and academe aims to find new means of controlling infection. The discovery of new antimicrobial chemicals is not the bottleneck in an era where high-throughput screening rapidly uncovers new bioactive compounds. Rather, the rate-limiting step in antimicrobial discovery pipelines is identifying mechanisms of action (MOA) of bioactive molecules produced by these increasingly large-scale efforts. Chemical genomics has proven to be of high value in providing mechanistic hypotheses for novel bioactive chemical matter. Several techniques fall under this blanket term, including interactions with deletion or transposon libraries, fluorescent or luminescent reporter library profiles, or deep sequencing approaches. Each of these provide unique and complementary outputs, and have high value in generating target lists for chemical screens, or assisting in downstream MOA discovery. We review here the broad usefulness of this technique to aid in MOA determination, to identify targets for new lead molecules, and to expand our mechanistic understanding of existing drugs.	[Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	Brown, ED (reprint author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	ebrown@mcmaster.ca			Foundation grant from the Canadian Institutes for Health Research [FRN 143215]; Canada Research Chair; Canadian Institutes for Health Research fellowship	This work was supported by a Foundation grant from the Canadian Institutes for Health Research (FRN 143215), and by a Tier I Canada Research Chair award to EDB. MJE was supported by a Canadian Institutes for Health Research fellowship.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baptist G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt655; Butland G, 2008, NAT METHODS, V5, P789, DOI [10.1038/nmeth.1239, 10.1038/NMETH.1239]; Cote J-P, 2016, MBIO, V7; Dar D, 2017, CURR OPIN MICROBIOL, V36, P111, DOI 10.1016/j.mib.2017.02.005; Dar D, 2016, SCIENCE, V352, DOI 10.1126/science.aad9822; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Elad T, 2015, BIOSENS BIOELECTRON, V68, P699, DOI 10.1016/j.bios.2015.01.067; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; French S, 2016, MOL BIOL CELL, V27, P1015, DOI 10.1091/mbc.E15-08-0573; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Heo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110215; Howden BP, 2013, ANTIMICROB AGENTS CH, V57, P3864, DOI 10.1128/AAC.00263-13; Howe JA, 2015, NATURE, V526, P672, DOI 10.1038/nature15542; Jia X, 2013, CELL, V152, P68, DOI 10.1016/j.cell.2012.12.019; John P, 2014, PNAS, V111, P12510; Kim S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13919; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kritikos G, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.14; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Melnyk AH, 2015, EVOL APPL, V8, P273, DOI 10.1111/eva.12196; Molina-Santiago C, 2015, ENVIRON MICROBIOL, V17, P3251, DOI 10.1111/1462-2920.12775; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Peters JM, 2015, CURR OPIN MICROBIOL, V27, P121, DOI 10.1016/j.mib.2015.08.007; Phillips JW, 2011, CHEM BIOL, V18, P955, DOI 10.1016/j.chembiol.2011.06.011; Porwollik S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099820; Pozsgai ER, 2012, APPL ENVIRON MICROB, V78, P778, DOI 10.1128/AEM.07098-11; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajagopal M, 2016, MBIO, V7, DOI 10.1128/mBio.00950-16; Roux D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1621; Shan Y, 2015, MBIO, V6, DOI 10.1128/mBio.00078-15; Shiver AL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006124; Stokes JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.28; Stokes JM, 2016, CELL CHEM BIOL, V23, P267, DOI 10.1016/j.chembiol.2015.12.011; Stokes JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03574; Tjaden B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0572-2; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wang H, 2017, CELL CHEM BIOL, V24, P576, DOI 10.1016/j.chembiol.2017.03.014; Wetmore KM, 2015, MBIO, V6, DOI 10.1128/mBio.00306-15; WHO, 2017, GLOB PRIOR LIST ANT; Yu J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-195; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	46	0	0	0	0	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5274	1879-0364		CURR OPIN MICROBIOL	Curr. Opin. Microbiol.	OCT	2017	39						42	47		10.1016/j.mib.2017.09.005				6	Microbiology	Microbiology	FQ5IQ	WOS:000418392800008	28957731				2018-01-05	
J	Lamas-Toranzo, I; Guerrero-Sanchez, J; Miralles-Bover, H; Alegre-Cid, G; Pericuesta, E; Bermejo-Alvarez, P				Lamas-Toranzo, I.; Guerrero-Sanchez, J.; Miralles-Bover, H.; Alegre-Cid, G.; Pericuesta, E.; Bermejo-Alvarez, P.			CRISPR is knocking on barn door	REPRODUCTION IN DOMESTIC ANIMALS			English	Article; Proceedings Paper	14th International Congress of the Spanish-Association-for-Animal=Reproduction (AERA)	NOV 09-11, 2017	Barcelona, SPAIN	Spanish Assoc Anim Reprod			RECOMBINANT HUMAN LACTOFERRIN; PLURIPOTENT STEM-CELLS; ZINC-FINGER NUCLEASES; BETA-LACTOGLOBULIN-FREE; ZYGOTE INJECTION; TRANSGENIC PIGS; EMBRYO MICROINJECTION; EFFICIENT GENERATION; DIRECTS PRODUCTION; ALPHA-LACTALBUMIN	Contents Genome modification at specific loci in livestock species was only achievable by performing homologous recombination in somatic cells followed by somatic cell nuclear transfer. The difficulty and inefficiency of this method have slowed down the multiple applications of genome modification in farm animals. The discovery of site-specific endonucleases has provided a different and more direct route for targeted mutagenesis, as these enzymes allow the ablation (KO) or insertion (KI) of specific genomic sequences on a single step, directly applied to zygotes. Clustered regularly interspaced short palindromic repeats (CRISPR), the last site-specific endonuclease to be developed, is a RNA-guided endonuclease, easy to engineer and direct to a given target site. This technology has been successfully applied to rabbits, swine, goats, sheep and cattle, situating genome editing in livestock species at an attainable distance, thereby empowering scientist to develop a myriad of applications. Genetically modified livestock animals can be used as biomodels to study human or livestock physiology and disease, as bioreactors to produce complex proteins, or as organ donors for transplantation. Specifically on livestock production, genome editing in farm animals may serve to improve productive genetic traits, to improve various animal products, to confer resistance to diseases or to minimize the environmental impact on farming. In this review, we provide an overview of the current methods for site-specific genome modification in livestock species, discuss potential and already developed applications of genome edition in farm animals and debate about the possibilities for approval of products derived from gene-edited animals for human consumption.	[Lamas-Toranzo, I.; Guerrero-Sanchez, J.; Miralles-Bover, H.; Alegre-Cid, G.; Pericuesta, E.; Bermejo-Alvarez, P.] INIA, Dept Reprod Anim, Madrid, Spain	Bermejo-Alvarez, P (reprint author), INIA, Dept Reprod Anim, Madrid, Spain.	borrillobermejo@hotmail.com			Spanish Ministry of Economy and Competitiveness [RYC-2012-10193, AGL2014-58739-R]; FPI	Spanish Ministry of Economy and Competitiveness, Grant/Award Number: RYC-2012-10193 and AGL2014-58739-R; FPI	Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Bermejo-Alvarez P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13691; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bertolini LR, 2016, TRANSGENIC RES, V25, P329, DOI 10.1007/s11248-016-9933-9; Bevacqua RJ, 2016, THERIOGENOLOGY, V86, P1886, DOI 10.1016/j.theriogenology.2016.06.010; Bleck GT, 1998, J ANIM SCI, V76, P3072; BRINSTER RL, 1989, P NATL ACAD SCI USA, V86, P7087, DOI 10.1073/pnas.86.18.7087; BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7; Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Burkard C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006206; Chuang CK, 2017, ANIM BIOTECHNOL, V28, P174, DOI 10.1080/10495398.2016.1246453; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Damak S, 1996, BIO-TECHNOL, V14, P185, DOI 10.1038/nbt0296-185; Dickman S, 1997, SCIENCE, V277, P1922, DOI 10.1126/science.277.5334.1922; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; EVANS MJ, 1985, COLD SPRING HARB SYM, V50, P685, DOI 10.1101/SQB.1985.050.01.084                                                     ; FDA, 2017, GUID IND REG INT ALT; Fears R, 2017, ELIFE, V6, DOI 10.7554/eLife.26295; Feng XJ, 2015, TRANSGENIC RES, V24, P73, DOI 10.1007/s11248-014-9818-8; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; Guo RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29855; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Jabed A, 2012, P NATL ACAD SCI USA, V109, P16811, DOI 10.1073/pnas.1210057109; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260                                                          ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jost B, 1999, NAT BIOTECHNOL, V17, P160, DOI 10.1038/6158; Kaiser GG, 2017, J DAIRY SCI, V100, P1605, DOI 10.3168/jds.2016-11173; Kang JT, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0206-5; Kato Y, 2000, J REPROD FERTIL, V120, P231, DOI 10.1530/reprod/120.2.231; Kolb AF, 2001, ADV EXP MED BIOL, V494, P411; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lillico SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21645; Lv QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25029; Ma TF, 2017, BOUND VALUE PROBL, V2017, P9; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Niu Y, 2017, ANIM GENET, V48, P242, DOI 10.1111/age.12515; Park K. E., 2016, INT J MOL SCI, V17; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep42458; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40176; Park KE, 2014, REPROD FERT DEVELOP, V26, P65, DOI 10.1071/RD13258; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; Petersen B, 2016, XENOTRANSPLANTATION, V23, P338, DOI 10.1111/xen.12258; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Reardon S, 2016, NATURE, V531, P160, DOI 10.1038/531160a; Reh WA, 2004, J DAIRY SCI, V87, P3510, DOI 10.3168/jds.S0022-0302(04)73486-4                                               ; Saeki K, 2004, P NATL ACAD SCI USA, V101, P6361, DOI 10.1073/pnas.0308111101; Sato M, 2015, INT J MOL SCI, V16, P17838, DOI 10.3390/ijms160817838; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Sheets TP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122031; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sheridan C, 2016, NAT BIOTECHNOL, V34, P117, DOI 10.1038/nbt0216-117; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Sola I, 1998, J VIROL, V72, P3762; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Song YN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01727-y; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Soto DA, 2016, TRANSGENIC RES, V25, P289, DOI 10.1007/s11248-016-9929-5; Spencer LT, 2005, NEW ENGL J MED, V352, P2030, DOI 10.1056/NEJM200505123521923; Sui TT, 2016, HUM MOL GENET, V25, P2661, DOI 10.1093/hmg/ddw125; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tan W, 2012, ADV GENET, V80, P37, DOI 10.1016/B978-0-12-404742-6.00002-8; Tao L, 2016, BIOCHEM BIOPH RES CO, V476, P225, DOI 10.1016/j.bbrc.2016.05.100; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; van Veen HA, 2012, J BIOTECHNOL, V162, P319, DOI 10.1016/j.jbiotec.2012.09.005; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Wang X., 2016, SCI REP, V6, P20620; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348; Wang XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164640; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32271; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Wells KD, 2016, TRANSGENIC RES, V25, P385, DOI 10.1007/s11248-016-9935-7; Whitelaw CBA, 2016, J DAIRY RES, V83, P3, DOI 10.1017/S0022029916000017; Whitelaw CBA, 2016, J PATHOL, V238, P247, DOI 10.1002/path.4648; Whitworth KM, 2017, TRANSGENIC RES, V26, P97, DOI 10.1007/s11248-016-9989-6; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whyte JJ, 2011, MOL REPROD DEV, V78, P879, DOI 10.1002/mrd.21333; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Yan Quanmei, 2014, Cell Regen (Lond), V3, P12, DOI 10.1186/2045-9769-3-12; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yu HH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101668; Yuan L., 2016, SCI REPORTS, V6, P22024; Zhang J, 2008, PROTEIN EXPRES PURIF, V57, P127, DOI 10.1016/j.pep.2007.10.015; Zhang XM, 2017, THERIOGENOLOGY, V91, P163, DOI 10.1016/j.theriogenology.2016.10.025	99	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0936-6768	1439-0531		REPROD DOMEST ANIM	Reprod. Domest. Anim.	OCT	2017	52			4	SI		39	47		10.1111/rda.13047				9	Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary Sciences	Agriculture; Reproductive Biology; Veterinary Sciences	FP8OS	WOS:000417905500005	29052327				2018-01-05	
J	Ma, YW; Yu, L; Pan, S; Gao, S; Chen, W; Zhang, X; Dong, W; Li, J; Zhou, R; Huang, L; Han, YL; Bai, L; Zhang, L; Zhang, LF				Ma, Yuanwu; Yu, Lei; Pan, Shuo; Gao, Shan; Chen, Wei; Zhang, Xu; Dong, Wei; Li, Jing; Zhou, Rui; Huang, Lan; Han, Yunlin; Bai, Lin; Zhang, Li; Zhang, Lianfeng			CRISPR/Cas9-mediated targeting of the Rosa26 locus produces Cre reporter rat strains for monitoring Cre-loxP-mediated lineage tracing	FEBS JOURNAL			English	Article						Cre reporter; Cre-loxP; CRISPR/Cas9; rat; Rosa26	EMBRYONIC STEM-CELLS; MOUTH-DISEASE VIRUS; ESTROGEN-RECEPTOR; KNOCKOUT RATS; WOLFRAM-SYNDROME; GENE; MICE; EXPRESSION; MOUSE; RECOMBINASE	The rat is an important laboratory animal for physiological, toxicological and pharmacological studies. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) is a simple and efficient tool to generate precise genetic modifications in rats, which will promote the accumulation of genetic resources and enable more precise studies of gene function. To monitor Cre-loxP-mediated excision in vivo, we generated a Cre reporter rat strain (Rosa26-imCherry) by knockin of a Cre reporter cassette at the Rosa26 locus using CRISPR/Cas9. Rosa26-imCherry rats exhibited inducible expression of the mCherry cassette (imCherry) using the Cre-loxP system, whereas normal rats exhibited ubiquitous expression of eGFP but not mCherry in the whole body. Injection of adeno-associated virus serotype 9-Cre into the hippocampus and skeletal muscle resulted in mCherry expression in virus-infected cells. Cre-loxP-mediated mCherry expression was then evaluated by crossing Rosa26-imCherry rats with transgenic rats ubiquitously expressing CAG-Cre, heart-specific alpha-MHC-Cre transgenic rats and liver-specific Alb-Cre knockin rats. Finally, using the established system the expression pattern of Cre driven by two endogenous gene promoters (Wfs1-Cre knockin rat, FabP2-Cre knockin rat) was traced. In summary, we demonstrated excision of the loxP-flanked allele in Rosa26-imCherry rats via activation of mCherry expression in the presence of Cre recombinase. This newly established Rosa26-imCherry rat strain represents a useful tool to facilitate Cre-expression pattern determination and tracing experiments.	[Ma, Yuanwu; Yu, Lei; Pan, Shuo; Gao, Shan; Chen, Wei; Zhang, Xu; Dong, Wei; Li, Jing; Zhou, Rui; Huang, Lan; Han, Yunlin; Bai, Lin; Zhang, Li; Zhang, Lianfeng] Chinese Acad Med Sci, Peking Union Med Coll, Inst Lab Anim Sci, Key Lab Human Dis Comparat Med,NHFPC, Beijing 100021, Peoples R China; [Ma, Yuanwu; Dong, Wei; Zhang, Li; Zhang, Lianfeng] Chinese Acad Med Sci, Neurosci Ctr, Beijing, Peoples R China	Zhang, L (reprint author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Lab Anim Sci, Key Lab Human Dis Comparat Med,NHFPC, Beijing 100021, Peoples R China.	zhanglf@cnilas.org			National Science and Technology Support Project of China [2014BAI02B01]; National Natural Science Foundation of China [31501001, 81571222]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-004]	The present work was supported in part by the National Science and Technology Support Project of China (2014BAI02B01), National Natural Science Foundation of China (31501001, 81571222) and CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-1-004).	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; Boyle MP, 2011, J COMP NEUROL, V519, P2061, DOI 10.1002/cne.22655; Carlsson M, 2000, J CLIN ENDOCR METAB, V85, P2801, DOI 10.1210/jc.85.8.2801                                                            ; de Felipe P, 1999, GENE THER, V6, P198, DOI 10.1038/sj.gt.3300811; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hatanaka M, 2011, HUM MOL GENET, V20, P1274, DOI 10.1093/hmg/ddq568; Hegele RA, 1996, J CLIN ENDOCR METAB, V81, P4334, DOI 10.1210/jc.81.12.4334                                                           ; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kobayashi T, 2012, STEM CELLS DEV, V21, P2981, DOI 10.1089/scd.2012.0065; Kootstra NA, 2003, MOL THER, V7, P623, DOI 10.1016/S1525-0016(03)00073-X; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Ma YW, 2016, RNA BIOL, V13, P605, DOI 10.1080/15476286.2016.1185591; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324                                                         ; METZGER D, 1995, J BIOL CHEM, V270, P9535, DOI 10.1074/jbc.270.16.9535                                                         ; Minton JAL, 2003, REV ENDOCR METAB DIS, V4, P53, DOI 10.1023/A:1021875403463                                                         ; Moran-Salvador E, 2013, J HEPATOL, V59, P1045, DOI 10.1016/j.jhep.2013.06.023; Noormets K, 2014, EXP CLIN ENDOCR DIAB, V122, P281, DOI 10.1055/s-0034-1372582; Noormets K, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-82; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.3.CO;2-7; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Palermo J, 1996, CIRC RES, V78, P504; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qiu CJ, 2014, J CELL MOL MED, V18, P2530, DOI 10.1111/jcmm.12385; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; RYAN MD, 1994, EMBO J, V13, P928; Smalley E, 2016, NAT BIOTECHNOL, V34, P893, DOI 10.1038/nbt0916-893; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007                                                                    ; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SWEETSER DA, 1987, J BIOL CHEM, V262, P16060; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tang XM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0351-z; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tein K, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00045; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Visnapuu T, 2013, BEHAV BRAIN RES, V244, P90, DOI 10.1016/j.bbr.2013.01.046; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	48	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2017	284	19					3262	3277		10.1111/febs.14188				16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FO8TW	WOS:000417161600009	28763160				2018-01-05	
J	Dahlhoff, M; Gaborit, N; Bultmann, S; Leonhardt, H; Yarden, Y; Schneider, MR				Dahlhoff, Maik; Gaborit, Nadege; Bultmann, Sebastian; Leonhardt, Heinrich; Yarden, Yosef; Schneider, Marlon R.			CRISPR-assisted receptor deletion reveals distinct roles for ERBB2 and ERBB3 in skin keratinocytes	FEBS JOURNAL			English	Article						ERBB2; ERBB3; HaCaT; skin; wound healing	GROWTH-FACTOR RECEPTOR; INHIBITION; LIGANDS; BIOLOGY; ACTIVATION; MIGRATION; CELLS; MODEL	While the epidermal growth factor receptor (EGFR) is an established regulator of skin development and homeostasis, the functions of the related tyrosine kinase receptors ERBB2 and ERBB3 in this tissue have only recently been examined. Previously reported, skin-specific deletion of each of these receptors in mice resulted in similar defects in keratinocyte proliferation and migration, resulting in impaired wound healing and tumorigenesis. Because both ERBB2 and ERBB3 are targets for treating an array of cancer types, it is important to examine the consequences of receptor inhibition in human keratinocytes. Here, we employed the CRISPR/Cas9 technology to generate HaCaT cells (an established human keratinocyte cell line) lacking ERBB2 or ERBB3. HaCaT clones lacking ERBB2 or ERBB3 showed comparable reductions in cell proliferation as assessed by BrdU staining. Apoptosis, in contrast, was reduced in ERBB3-deficient HaCaT cells only. Assessment of cell migration using a wound healing (scratch) assay showed that the closure of the wound gaps was completed by 48 h in mock and in ERBB3 knockout clones. In contrast, this process was considerably delayed in ERBB2 knockout clones, and a complete closure of the gap in the latter cells did not occur before 72 h. In conclusion, both ERBB2 and ERBB3 are essential for normal proliferation of skin keratinocytes, but in contrast to ERBB3, ERBB2 is essential for migration of human keratinocytes. These observations might bear significance to patient adverse effects of therapeutic agents targeting ERBB2 and ERBB3.	[Dahlhoff, Maik] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Munich, Germany; [Gaborit, Nadege; Yarden, Yosef] Weizmann Inst Sci, Dept Regulat Biol, Rehovot, Israel; [Bultmann, Sebastian; Leonhardt, Heinrich] Ludwig Maximilians Univ Munchen, Dept Biol 2, Human Biol & BioImaging, Munich, Germany; [Schneider, Marlon R.] German Fed Inst Risk Assessment BfR, German Ctr Protect Lab Animals Bf3R, Max Dohrn Str 8-10, D-10589 Berlin, Germany	Schneider, MR (reprint author), German Fed Inst Risk Assessment BfR, German Ctr Protect Lab Animals Bf3R, Max Dohrn Str 8-10, D-10589 Berlin, Germany.	marlon.schneider@bfr.bund.de	Leonhardt, Heinrich/B-2791-2014		Deutsche Forschungsgemeinschaft (DFG) [SCHN 1081/3-3]	This work was supported by a research grant of the Deutsche Forschungsgemeinschaft (DFG) to MRS (SCHN 1081/3-3).	Chiasson-MacKenzie C, 2015, J CELL BIOL, V211, P391, DOI 10.1083/jcb.201503081; Cote GM, 2012, NEW ENGL J MED, V367, P2150, DOI 10.1056/NEJMcibr1203156; Dahlhoff M, 2017, J INVEST DERMATOL, V137, P921, DOI 10.1016/j.jid.2016.11.023; Dahlhoff M, 2016, EXP DERMATOL, V25, P185, DOI 10.1111/exd.12946; Dahlhoff M, 2015, MOL ONCOL, V9, P1825, DOI 10.1016/j.molonc.2015.06.007; DSOUZA B, 1994, P NATL ACAD SCI USA, V91, P7202, DOI 10.1073/pnas.91.15.7202; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mulholland CB, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv550; Nanba D, 2013, J DERMATOL SCI, V72, P81, DOI 10.1016/j.jdermsci.2013.05.009; Nardone B, 2010, CLIN CANCER RES, V16, P4452, DOI 10.1158/1078-0432.CCR-10-0421; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593                                                                   ; Schneider MR, 2016, ONCOGENE, V35, P2949, DOI 10.1038/onc.2015.372; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Takahashi K, 1996, EXP CELL RES, V226, P214, DOI 10.1006/excr.1996.0221; Zhan RX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121551; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109	25	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	OCT	2017	284	19					3339	3349		10.1111/febs.14196				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FO8TW	WOS:000417161600013	28805349				2018-01-05	
J	Hsu, K; Lee, YK; Chew, A; Chiu, S; Lim, D; Greenhalgh, DG; Cho, K				Hsu, Karen; Lee, Young-Kwan; Chew, Alex; Chiu, Sophia; Lim, Debora; Greenhalgh, David G.; Cho, Kiho			Inherently variable responses to glucocorticoid stress among endogenous retroviruses isolated from 23 mouse strains	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Endogenous retrovirus; Mouse mammary tumor virus; Glucocorticoid; Glucocorticoid response element; Injury; Inflammation	MAMMARY-TUMOR VIRUS; BURN INJURY; HUMAN GENES; RETROELEMENTS; EXPRESSION; RECEPTORS; SEQUENCES; BACTERIAL; PROTEINS; GENOME	Active participation of endogenous retroviruses (ERVs) in disease processes has been exemplified by the finding that the HERV (human ERV)-W envelope protein is involved in the pathogenesis of multiple sclerosis, an autoimmune disease. We also demonstrated that injury-elicited stressors alter the expression of murine ERVs (MuERVs), both murine leukemia virus-type and mouse mammary tumor virus (MMTV)-type (MMTVMuERV). In this study, to evaluate MMTV-MuERVs' responses to stress (e.g., injury, infection)-elicited systemic glucocorticoid (GC) levels, we examined the GC-stress response of 64 MMTV-MuERV promoters isolated from the genomes of 23 mouse strains. All 64 promoters responded to treatment with a synthetic GC, dexamethasone (DEX), at a wide range from a 0.6- to 85.7-fold increase in reporter activity compared to no treatment. An analysis of the 10 lowest and 10 highest DEX responders revealed specific promoter elements exclusively present in either the three lowest or the two highest responders. Each promoter had a unique profile of transcription regulatory elements and the glucocorticoid response element (GRE) was identified in all promoters with the number of GREs ranging from 2 to 7. The three lowest DEX responders were the only promoters with two GREs. The findings from this study suggest that certain MMTV-MuERVs are more responsive to stress-elicited systemic GC elevation compared to the others. The mouse strain-specific genomic MMTV-MuERV profiles and individual MMTVMuERVs' differential responses to GC-stress might explain, at least in part, the variable inflammatory responses to injury and/or infection, often observed among different mouse strains. This article is part of a Special Issue entitled: Immune and Metabolic Alterations in Trauma and Sepsis edited by Dr. Raghavan Raju. (C) 2016 Elsevier B.V. All rights reserved.	[Hsu, Karen; Chew, Alex; Chiu, Sophia; Greenhalgh, David G.; Cho, Kiho] Shriners Hosp Children Northern Calif, Burn Res, Sacramento, CA 95817 USA; [Lee, Young-Kwan; Lim, Debora; Greenhalgh, David G.; Cho, Kiho] Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA	Cho, K (reprint author), Shriners Hosp Children Northern Calif, Burn Res, Sacramento, CA 95817 USA.; Cho, K (reprint author), Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA.	kcho@ucdavis.edu			Shriners of North America, Tampa, Florida [86800]; National Institutes of Health [R01GM071360]	This study was supported by grants from Shriners of North America, Tampa, Florida (grant number 86800) and the National Institutes of Health (grant number R01GM071360).	ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.immunol.13.1.459; ACHAORBEA H, 1991, IMMUNOL TODAY, V12, P356, DOI 10.1016/0167-5699(91)90066-3; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; BIDDLE FG, 1977, GENETICS, V85, P289; Boeke J. D., 1997, P343; BRANDTCARLSON C, 1993, VIROLOGY, V193, P171, DOI 10.1006/viro.1993.1113; Cho KH, 2002, J SURG RES, V104, P53, DOI 10.1006/jsre.2002.6410; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; DICKSON C, 1983, CURR TOP MICROBIOL, V106, P1; FRASER FC, 1951, PEDIATRICS, V8, P527; HUSEBY RA, 1950, CANCER RES, V10, P516; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x                                              ; KESHET E, 1991, ADV CANCER RES, V56, P215, DOI 10.1016/S0065-230X(08)60482-0; Kowalski PE, 1999, GENOMICS, V57, P371, DOI 10.1006/geno.1999.5787; Kowalski PE, 1998, J VIROL, V72, P6164; Lee YK, 2008, VIROLOGY, V373, P263, DOI 10.1016/j.virol.2007.10.043; Luther SA, 1997, ADV IMMUNOL, V65, P139, DOI 10.1016/S0065-2776(08)60743-9; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0                                                                ; Mager DL, 1999, GENOMICS, V59, P255, DOI 10.1006/geno.1999.5877                                                          ; Moore D H, 1979, Adv Cancer Res, V29, P347, DOI 10.1016/S0065-230X(08)60850-7; Purcell EM, 2006, SHOCK, V25, P135, DOI 10.1097/01.shk.0000190824.51653.32; TRUSS M, 1992, J STEROID BIOCHEM, V43, P365, DOI 10.1016/0960-0760(92)90071-P; Urnovitz HB, 1996, CLIN MICROBIOL REV, V9, P72; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Xu L, 1996, VIROLOGY, V215, P113, DOI 10.1006/viro.1996.0014	25	1	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	OCT	2017	1863	10	B		SI		2594	2600		10.1016/j.bbadis.2016.10.026				7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FN1VK	WOS:000415779100009	27816520				2018-01-05	
J	Groen, SC; Wamonje, F; Murphy, AM; Carr, JP				Groen, Simon C.; Wamonje, Francis; Murphy, Alex M.; Carr, John P.			Engineering resistance to virus transmission	CURRENT OPINION IN VIROLOGY			English	Article							PROMOTE VECTOR PERFORMANCE; RHOPALOSIPHUM-PADI-VIRUS; RNA SILENCING SUPPRESSOR; ATTRACT INSECT VECTORS; PLANT-VIRUSES; ARABIDOPSIS-THALIANA; DROUGHT TOLERANCE; EFFECTOR PROTEIN; HOST LOCATION; MOSAIC-VIRUS	Engineering plants for resistance to virus transmission by invertebrate vectors has lagged behind other forms of plant protection. Vectors typically transmit more than one virus. Thus, vector resistance could provide a wider range of protection than defenses directed solely against one virus or virus group. We discuss current knowledge of vector host virus interactions, the roles of viral gene products in host and vector manipulation, and the effects of semiochemicals on host vector interactions, and how this knowledge could be employed to disrupt transmission dynamics. We also discuss how resistance to vectors could be generated through genetic engineering or gene editing or indirectly through use of biocontrol using plant-resident viruses that infect vectors.	[Groen, Simon C.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Wamonje, Francis; Murphy, Alex M.; Carr, John P.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	Carr, JP (reprint author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	jpc1005@hermes.cam.ac.uk		Wamonje, Francis/0000-0002-4111-7884	Leverhulme Trust [F/09 741F, RPG-2012-667]; UK Biotechnological and Biological Sciences Research Council [BB/J011762/1, BB/P023223/1]	Work on these topics in the JPC lab was funded by the Leverhulme Trust (Grants F/09 741F and RPG-2012-667) and the UK Biotechnological and Biological Sciences Research Council (Grants BB/J011762/1 and BB/P023223/1). We thank all members of the Cambridge Plant Virology Group for stimulating discussions.	Bak A, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14493C, 10.1038/ncomms14493]; Ban L, 2007, J VIROL METHODS, V142, P136, DOI 10.1016/j.jviromet.2007.01.014; Ban LP, 2008, ENTOMOL EXP APPL, V127, P108, DOI 10.1111/j.1570-7458.2008.00675.x; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Blanc S, 2016, CURR OPIN INSECT SCI, V16, P36, DOI 10.1016/j.cois.2016.05.007; Boissot N, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0708-5; Bonning BC, 2014, NAT BIOTECHNOL, V32, P102, DOI 10.1038/nbt.2753; Bonning BC, 2010, ANNU REV ENTOMOL, V55, P129, DOI 10.1146/annurev-ento-112408-085457; Boquel S, 2011, EUR J PLANT PATHOL, V129, P507, DOI 10.1007/s10658-010-9732-8; Bosque G, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0129-8; Brault V, 2010, CR BIOL, V333, P524, DOI 10.1016/j.crvi.2010.04.001; Bruce TJA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11183; Casteel CL, 2006, ENTOMOL EXP APPL, V121, P67, DOI 10.1111/j.1570-8703.2006.00458.x; Casteel CL, 2015, PLANT PHYSIOL, V169, P209, DOI 10.1104/pp.15.00332; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Doring TF, 2007, ARTHROPOD-PLANT INTE, V1, P3, DOI 10.1007/s11829-006-9000-1; Dombrovsky A, 2013, VIRUS GENES, V46, P354, DOI 10.1007/s11262-012-0846-2; Elzinga DA, 2014, MOL PLANT MICROBE IN, V27, P747, DOI 10.1094/MPMI-01-14-0018-R; GILDOW FE, 1990, J INVERTEBR PATHOL, V55, P245, DOI 10.1016/0022-2011(90)90060-J; Gotz M, 2012, J VIROL, V86, P13241, DOI 10.1128/JVI.00880-12; Goggin FL, 2006, MOL PLANT MICROBE IN, V19, P383, DOI 10.1094/MPMI-19-0383; Groen SC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005790; Groen SC, 2013, PLANT CELL, V25, P4755, DOI 10.1105/tpc.113.113415; GUO HJ, 2016, FRONT PLANT SCI, V7; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Javaid S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34706; Jones RAC, 2014, ANN APPL BIOL, V164, P320, DOI 10.1111/aab.12123; Kanakala S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120329; Kerr CH, 2015, J VIROL, V89, P5919, DOI 10.1128/JVI.00463-15; Kim SH, 2016, SCIENCE, V351, P684, DOI 10.1126/science.aad3436; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Li P, 2017, NEW PHYTOL, V215, P699, DOI 10.1111/nph.14550; Li R, 2014, PLANT CELL, V26, P4991, DOI 10.1105/tpc.114.133181; Lindbo JA, 2017, PHYTOPATHOLOGY, V107, P624, DOI 10.1094/PHYTO-12-16-0442-RVW; Louis J, 2015, J EXP BOT, V66, P449, DOI 10.1093/jxb/eru454; Lozano-Duran R, 2011, PLANT CELL, V23, P1014, DOI 10.1105/tpc.110.080267; Lu SH, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010004; Luan JB, 2013, INSECT MOL BIOL, V22, P597, DOI 10.1111/imb.12048; Luan JB, 2013, ECOL LETT, V16, P390, DOI 10.1111/ele.12055; Manosalva P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8795; Martinez F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2394-y; Mauck KE, 2014, INTEGR COMP BIOL, V54, P193, DOI 10.1093/icb/icu012; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Maxwell DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152836; Moffett P, 2016, TRENDS PLANT SCI, V21, P369, DOI 10.1016/j.tplants.2016.04.002; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; National Academy of Sciences, 2016, GEN ENG CROPS EXP PR; OFORI FA, 1985, VIROLOGY, V144, P152, DOI 10.1016/0042-6822(85)90313-7; Palukaitis P, 2013, CURR OPIN PLANT BIOL, V16, P513, DOI 10.1016/j.pbi.2013.06.004; Paula DP, 2016, ENTOMOL EXP APPL, V159, P54, DOI 10.1111/eea.12419; Peng HC, 2016, PLANT PHYSIOL, V171, P2211, DOI 10.1104/pp.16.00295; Petek M, 2014, MOL ECOL, V23, P5378, DOI 10.1111/mec.12932; Pickett JA, 2016, NEW PHYTOL, V212, P856, DOI 10.1111/nph.14274; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Pyott DE, 2016, MOL PLANT PATHOL, V17, P1276, DOI 10.1111/mpp.12417; Rajabaskar D, 2014, VIRUS RES, V186, P32, DOI 10.1016/j.virusres.2013.11.005; Rausch MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155466; Ryabov EV, 2017, J INVERTEBR PATHOL, V147, P37, DOI 10.1016/j.jip.2016.10.002; Ryabov EV, 2009, P NATL ACAD SCI USA, V106, P8465, DOI 10.1073/pnas.0901389106; Salvaudon L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2959; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Tungadi T, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0754-0; van Kleeff PJM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01759; van Molken T, 2012, OECOLOGIA, V170, P433, DOI 10.1007/s00442-012-2322-z; van Zyl S, 2012, S AFR J ENOL VITIC, V33, P21; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Webster B, 2013, BEHAV ECOL, V24, P366, DOI 10.1093/beheco/ars172; Westwood JH, 2014, J GEN VIROL, V95, P733, DOI 10.1099/vir.0.060624-0; Westwood JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083066; Westwood JH, 2013, MOL PLANT PATHOL, V14, P158, DOI 10.1111/j.1364-3703.2012.00840.x; Whitehead SR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0034; Whitfield AE, 2015, CURR OPIN INSECT SCI, V8, P79, DOI 10.1016/j.cois.2015.01.009; Wu DW, 2017, CELL RES, V27, P402, DOI 10.1038/cr.2017.2; Xu P, 2008, NEW PHYTOL, V180, P911, DOI 10.1111/j.1469-8137.2008.02627.x; Zhang T, 2012, MOL ECOL, V21, P1294, DOI 10.1111/j.1365-294X.2012.05457.x; Ziebell H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00187	77	2	2	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1879-6257			CURR OPIN VIROL	Curr. Opin. Virol.	OCT	2017	26						20	27		10.1016/j.coviro.2017.07.005				8	Virology	Virology	FN1WS	WOS:000415782500006	28750351				2018-01-05	
J	Gal-On, A; Fuchs, M; Gray, S				Gal-On, Amit; Fuchs, Marc; Gray, Stewart			Generation of novel resistance genes using mutation and targeted gene editing	CURRENT OPINION IN VIROLOGY			English	Article							GENOME-LINKED PROTEIN; POTATO-VIRUS-Y; ZINC-FINGER NUCLEASES; RECESSIVE RESISTANCE; PLANT-VIRUSES; POTYVIRUS RESISTANCE; NATURAL VARIATION; EIF4E; VPG; OVEREXPRESSION	Classical breeding for virus resistance is a lengthy process and is restricted by the availability of resistance genes. Precise genome editing is a 'dream technology' to improve plants for virus resistance and these tools have opened new and very promising ways to generate virus resistant plants by disrupting host susceptibility genes, or by increasing the expression of viral resistance genes. However, precise targets must be identified and their roles understood to minimize potential negative effects on the plant. Nonetheless, the opportunities for genome editing are expanding, as are the technologies to generate effective and broad-spectrum resistance against plant viruses. Here we provide insights into recent progress related to gene targets and gene editing technologies.	[Gal-On, Amit] ARO, Volcani Ctr, Dept Plant Pathol, IL-50250 Bet Dagan, Israel; [Gal-On, Amit] ARO, Volcani Ctr, Dept Weed Res, IL-50250 Bet Dagan, Israel; [Fuchs, Marc] Cornell Univ, New York State Agr Expt Stn, Plant Pathol & Plant Microbe Biol Sect, Sch Integrat Plant Sci, Geneva, NY 14456 USA; [Gray, Stewart] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14853 USA; [Gray, Stewart] ARS, Dept Emerging Pest, Res Unit, USDA, Ithaca, NY 14853 USA; [Gray, Stewart] ARS, Dept Pathogen, Res Unit, USDA, Ithaca, NY 14853 USA	Gal-On, A (reprint author), ARO, Volcani Ctr, Dept Plant Pathol, IL-50250 Bet Dagan, Israel.; Gal-On, A (reprint author), ARO, Volcani Ctr, Dept Weed Res, IL-50250 Bet Dagan, Israel.	amitg@volcani.agri.gov.il			Israeli Ministry of Agriculture and Rural Development [20-10-0039]	The authors are grateful Dr. Victor Gaba for critical reading of the manuscript and to the editors for their kind invitation to contribute to the special issue of Current Opinion in Virology. This research was supported by the Chief Scientist of the Israeli Ministry of Agriculture and Rural Development (Project 20-10-0039). Contribution from the Agricultural Research Organization, The Volcani Center, Bet-Dagan, Israel.	Abdul-Razzak A, 2009, MOL PLANT PATHOL, V10, P109, DOI 10.1111/j.1364-3703.2008.00513.x; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Ali Z, 2016, SCI REP, P6; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Altpeter F, 2016, PLANT CELL, V28, P1510, DOI 10.1105/tpc.16.00196; Arcibal E, 2015, AM J POTATO RES; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Bastet A, 2017, TRENDS PLANT SCI, V22, P411, DOI 10.1016/j.tplants.2017.01.008; Cavatorta JR, 2008, J MOL EVOL, V67, P551, DOI 10.1007/s00239-008-9172-7; Cavatorta J, 2011, PLANT BIOTECHNOL J, V9, P1014, DOI 10.1111/j.1467-7652.2011.00622.x; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Chen W, 2014, VIRUS GENES, V48, P494, DOI 10.1007/s11262-014-1041-4; Cheng XF, 2015, VIRUSES-BASEL, V7, P4772, DOI 10.3390/v7082843; Chujo T, 2017, PLANT J, V91, P558, DOI 10.1111/tpj.13581; Cody WB, 2017, PLANT PHYSIOL, V175, P23, DOI 10.1104/pp.17.00411; Diaz-Pendon JA, 2004, MOL PLANT PATHOL, V5, P223, DOI 10.1111/J.1364-3703.2004.00223.X; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Duan H, 2012, TRANSGENIC RES, V21, P929, DOI 10.1007/s11248-011-9576-9; Fondong VN, 2016, PHYTOPATHOLOGY, V106, P1231, DOI 10.1094/PHYTO-03-16-0145-FI; Gazo BM, 2004, J BIOL CHEM, V279, P13584, DOI 10.1074/jbc.M311361200; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Hashimoto M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01695; Ji X, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.144, 10.1038/nplants.2015.144]; Jiang J, 2011, CURR OPIN VIROL, V1, P347, DOI 10.1016/j.coviro.2011.09.010; JORGENSEN JH, 1992, EUPHYTICA, V63, P141; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kang BC, 2007, PLANT BIOTECHNOL J, V5, P526, DOI 10.1111/j.1467-7652.2007.00262.x; Kim J, 2014, MOL PLANT PATHOL, V15, P615, DOI 10.1111/mpp.12120; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Moury B, 2004, MOL PLANT MICROBE IN, V17, P322, DOI 10.1094/MPMI.2004.17.3.322; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; Nicaise V, 2014, FRONT PLANT SCI, P5; PROVVIDENTI R, 1992, ARCH VIROL, P189; Pyott DE, 2016, MOL PLANT PATHOL; Quetier F, 2016, PLANT SCI, V242, P65, DOI 10.1016/j.plantsci.2015.09.003; Rodriguez-Hernandez AM, 2012, MOL PLANT PATHOL, V13, P755, DOI 10.1111/j.1364-3703.2012.00785.x; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Sera T, 2005, J VIROL, V79, P2614, DOI 10.1128/JVI.79.4.2614-2619.2005; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; van Schie CCN, 2014, ANNU REV PHYTOPATHOL, V52, P551, DOI 10.1146/annurev-phyto-102313-045854; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang AM, 2012, MOL PLANT PATHOL, V13, P795, DOI 10.1111/j.1364-3703.2012.00791.x; Wang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050627; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xu ML, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00338; Yeam I, 2007, PLANT CELL, V19, P2913, DOI 10.1105/tpc.107.050997; Yin K, 2015, SCI REP, P5; Zong Y, 2017, NAT BIOTECHNOL	54	0	0	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1879-6257			CURR OPIN VIROL	Curr. Opin. Virol.	OCT	2017	26						98	103		10.1016/j.coviro.2017.07.024				6	Virology	Virology	FN1WS	WOS:000415782500017	28802147				2018-01-05	
J	Fujihara, Y; Oji, A; Larasati, T; Kojima-Kita, K; Ikawa, M				Fujihara, Yoshitaka; Oji, Asami; Larasati, Tamara; Kojima-Kita, Kanako; Ikawa, Masahito			Human Globozoospermia-Related Gene Spata16 Is Required for Sperm Formation Revealed by CRISPR/Cas9-Mediated Mouse Models	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						genome editing; male infertility; mouse model; point mutation; spermatogenesis; testis	DISRUPTING ACROSOME FORMATION; CAUSES MALE-INFERTILITY; DPY19L2 DELETION; MEMBRANE PROTEIN; POINT MUTATIONS; BINDING-PROTEIN; MALE-FERTILITY; GOLGI PROTEIN; MICE LACKING; MAJOR CAUSE	A recent genetic analysis of infertile globozoospermic patients identified causative mutations in three genes: a protein interacting with C kinase 1 (PICK1), dpy 19-like 2 (DPY19L2), and spermatogenesis associated 16 (SPATA16). Although mouse models have clarified the physiological functions of Pick1 and Dpy19l2 during spermatogenesis, Spata16 remains to be determined. Globozoospermic patients carried a homozygous point mutation in SPATA16 at 848G -> A/R283Q. We generated CRISPR/Cas9-mediated mutant mice with the same amino acid substitution in the fourth exon of Spata16 to analyze the mutation site at R284Q, which corresponded with R283Q of mutated human SPATA16. We found that the point mutation in Spata16 was not essential for male fertility; however, deletion of the fourth exon of Spata16 resulted in infertile male mice due to spermiogenic arrest but not globozoospermia. This study demonstrates that Spata16 is indispensable for male fertility in mice, as well as in humans, as revealed by CRISPR/Cas9-mediated mouse models.	[Fujihara, Yoshitaka; Oji, Asami; Larasati, Tamara; Kojima-Kita, Kanako; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Fujihara, Yoshitaka; Oji, Asami; Ikawa, Masahito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Oji, Asami; Ikawa, Masahito] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Larasati, Tamara; Ikawa, Masahito] Osaka Univ, Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Kojima-Kita, Kanako; Ikawa, Masahito] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Ikawa, Masahito] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	Ikawa, M (reprint author), Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan.; Ikawa, M (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan.; Ikawa, M (reprint author), Osaka Univ, Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan.; Ikawa, M (reprint author), Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan.; Ikawa, M (reprint author), Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan.	fujihara@biken.osaka-u.ac.jp; oji-a@cdb.riken.jp; tamara@biken.osaka-u.ac.jp; kojima0208@patho.med.osaka-u.ac.jp; ikawa@biken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15H05573, JP25112007, JP17H01394]; Takeda Science Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD088412, P01HD087157]; Bill and Melinda Gates Foundation [OPP1160866]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI Grants (JP15H05573 to Yoshitaka Fujihara, JP25112007 and JP17H01394 to Masahito Ikawa); Takeda Science Foundation Grants to Yoshitaka Fujihara and Masahito Ikawa; the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD088412 and P01HD087157); and The Bill and Melinda Gates Foundation (Grand Challenges Explorations grant OPP1160866). We thank Naoko Nagasawa and the Biotechnology Research and Development (nonprofit organization) for technical assistance, and Julio M. Castaneda and Ferheen Abbasi for critical reading of the manuscript.	Audouard C, 2011, FERTIL STERIL, V95, P1475, DOI 10.1016/j.fertnstert.2010.12.006; CESARIO MM, 1994, J CELL SCI, V107, P561; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Coutton C, 2012, HUM REPROD, V27, P2549, DOI 10.1093/humrep/des160; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; Dam AHDM, 2007, AM J HUM GENET, V81, P813, DOI 10.1086/521314; Doran J, 2016, REPRODUCTION, V152, P91, DOI 10.1530/REP-15-0557; ElInati E, 2012, HUM MOL GENET, V21, P3695, DOI 10.1093/hmg/dds200; Fujihara Y, 2013, P NATL ACAD SCI USA, V110, P8111, DOI 10.1073/pnas.1222166110; Fujihara Y, 2013, TRANSGENIC RES, V22, P195, DOI 10.1007/s11248-012-9635-x; Fujihara Y, 2012, DEVELOPMENT, V139, P3583, DOI 10.1242/dev.081778; Funaki T, 2013, MOL BIOL CELL, V24, P2633, DOI 10.1091/mbc.E13-05-0234; Han F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.414; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; Li YH, 2016, NEUROCHEM INT, V98, P115, DOI 10.1016/j.neuint.2016.03.001; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Liu C, 2017, DEVELOPMENT, V144, P441, DOI 10.1242/dev.147074; Liu G, 2010, ASIAN J ANDROL, V12, P556, DOI 10.1038/aja.2010.47; Lu L, 2006, ASIAN J ANDROL, V8, P53, DOI 10.1111/j.1745-7262.2006.00089.x; Miyata H, 2016, P NATL ACAD SCI USA, V113, P7704, DOI 10.1073/pnas.1608458113; Muto M, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.133454; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Noveski P., 2013, J MED GENET, V16, P73, DOI [10.2478/bjmg-2013-002124265589, DOI 10.2478/BJMG-2013-002124265589]; Oberheide K, 2017, J BIOL CHEM, V292, P10845, DOI 10.1074/jbc.M117.784108; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; Ounis L, 2015, ASIAN J ANDROL, V17, P68, DOI 10.4103/1008-682X.136441; Paiardi C, 2011, SPERMATOGENESIS, V1, P52, DOI DOI 10.4161/SPMG.1.1.14698; Pierre V, 2012, DEVELOPMENT, V139, P2955, DOI 10.1242/dev.077982; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Takeya R, 2000, BIOCHEM BIOPH RES CO, V267, P149, DOI 10.1006/bbrc.1999.1932; Wang HN, 2014, CELL RES, V24, P852, DOI 10.1038/cr.2014.70; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Xu M, 2003, MOL HUM REPROD, V9, P9, DOI 10.1093/humrep/gag005; Xu X, 1999, NAT GENET, V23, P118; Yamaguchi R, 2008, GENES CELLS, V13, P851, DOI 10.1111/j.1365-2443.2008.01210.x; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899; Yatsenko AN, 2012, MOL HUM REPROD, V18, P14, DOI 10.1093/molehr/gar057; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zhu FX, 2013, MOL HUM REPROD, V19, P395, DOI 10.1093/molehr/gat018	44	0	0	0	0	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	OCT	2017	18	10							2208	10.3390/ijms18102208				13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FM0QL	WOS:000414671800190		gold			2018-01-05	
J	Kim, H; Ham, S; Jo, M; Lee, GH; Lee, YS; Shin, JH; Lee, Y				Kim, Hyojung; Ham, Sangwoo; Jo, Minkyung; Lee, Gum Hwa; Lee, Yun-Song; Shin, Joo-Ho; Lee, Yunjong			CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						CRISPR-Cas9; telomere; aging; mitochondria; Parkinson's disease	PARKINSONS-DISEASE; QUANTITATIVE PCR; MOUSE MODEL; HUMAN-CELLS; NEURODEGENERATION; ACTIVATION; SENESCENCE; UBIQUITINATION; CONTRIBUTES; MECHANISMS	Aging is considered the major risk factor for neurodegenerative diseases including Parkinson's disease (PD). Telomere shortening is associated with cellular senescence. In this regard, pharmacological or genetic inhibition of telomerase activity has been used to model cellular aging. Here, we employed CRISPR-Cas9 technology to instantly remove the telomere to induce aging in a neuroblastoma cell line. Expression of both Cas9 and guide RNA targeting telomere repeats ablated the telomere, leading to retardation of cell proliferation. Instant deletion of telomere in SH-SY5Y cells impaired mitochondrial function with diminished mitochondrial respiration and cell viability. Supporting the pathological relevance of cell aging by CRISPR-Cas9 mediated telomere removal, alterations were observed in the levels of PD-associated proteins including PTEN-induced putative kinase 1, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, nuclear respiratory factor 1, parkin, and aminoacyl tRNA synthetase complex interacting multifunctional protein 2. Significantly, alpha-synuclein expression in the background of telomere removal led to the enhancement of protein aggregation, suggesting positive feed-forward interaction between aging and PD pathogenesis. Collectively, our results demonstrate that CRISPR-Cas9 can be used to efficiently model cellular aging and PD.	[Kim, Hyojung; Ham, Sangwoo; Jo, Minkyung; Lee, Yun-Song; Shin, Joo-Ho; Lee, Yunjong] Sungkyunkwan Univ, Samsung Biomed Res Inst, Div Pharmacol, Dept Mol Cell Biol,Sch Med, Suwon, Gyeonggi Do, South Korea; [Lee, Gum Hwa] Chosun Univ, Coll Pharm, Gwangju 501759, South Korea; [Shin, Joo-Ho] Sungkyunkwan Univ, Single Cell Network Res Ctr, Sch Med, Suwon 440746, Gyeonggi Do, South Korea	Shin, JH; Lee, Y (reprint author), Sungkyunkwan Univ, Samsung Biomed Res Inst, Div Pharmacol, Dept Mol Cell Biol,Sch Med, Suwon, Gyeonggi Do, South Korea.; Shin, JH (reprint author), Sungkyunkwan Univ, Single Cell Network Res Ctr, Sch Med, Suwon 440746, Gyeonggi Do, South Korea.	hjung93@skku.edu; ham89p12@skku.edu; jmk4606@naver.com; gumhwalee@chosun.ac.kr; yslee@skku.edu; jshin24@skku.edu; ylee69@skku.edu		Lee, Yunjong/0000-0003-0182-2279; Ham, Sangwoo/0000-0003-4569-2584	National Research Foundation of Korea - Korea Ministry of Science, ICT, & Future Planning (MSIP) [NRF-2017M3C7A1043848, NRF-2016R1A5A2945889]	This research was supported by grants from the National Research Foundation of Korea (NRF-2017M3C7A1043848 and NRF-2016R1A5A2945889) funded by the Korea Ministry of Science, ICT, & Future Planning (MSIP).	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Beneke S, 2008, NUCLEIC ACIDS RES, V36, P6309, DOI 10.1093/nar/gkn615; Brahmachari S, 2016, J CLIN INVEST, V126, P2970, DOI 10.1172/JCI85456; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campos PB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00292; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47                                                           ; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chiodi I, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00133; Contestabile A, 2009, CURR MED CHEM, V16, P350, DOI 10.2174/092986709787002637                                                      ; de Magalhaes JP, 2004, EXP CELL RES, V300, P1, DOI 10.1016/j.yexcr.2004.07.006; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Flanary BE, 2003, J ANTI-AGING MED, V6, P299, DOI 10.1089/109454503323028894                                                      ; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4                                                   ; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001; Kong CM, 2013, FEBS J, V280, P3180, DOI 10.1111/febs.12326; LaFerla F. M., 2012, PERSPECT MED, V2, DOI 10.1101/cshperspect.a00632023002015; Lee Y., 2012, PERSPECT MED, V2, DOI 10.1101/cshperspect.a00932422960626; Lee Y, 2017, CELL REP, V18, P918, DOI 10.1016/j.celrep.2016.12.090; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242                                                      ; Li XT, 2016, ONCOTARGET, V7, P37825, DOI 10.18632/oncotarget.9339; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nair VD, 2006, APOPTOSIS, V11, P955, DOI 10.1007/s10495-006-6316-3; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Petrova NV, 2016, AGING CELL, V15, P999, DOI 10.1111/acel.12518; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Scheffold A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0364-x; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Xiong SQ, 2015, CELL REP, V12, P1391, DOI 10.1016/j.celrep.2015.07.047	40	0	0	2	2	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	OCT	2017	18	10							2093	10.3390/ijms18102093				14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	FM0QL	WOS:000414671800077		gold			2018-01-05	
J	Lawson, MJ; Camsund, D; Larsson, J; Baltekin, O; Fange, D; Elf, J				Lawson, Michael J.; Camsund, Daniel; Larsson, Jimmy; Baltekin, Ozden; Fange, David; Elf, Johan			In situ genotyping of a pooled strain library after characterizing complex phenotypes	MOLECULAR SYSTEMS BIOLOGY			English	Article						DuMPLING; live cell; microfluidic; single cell; strain libraries	ESCHERICHIA-COLI; GENE-EXPRESSION; CELLS; CRISPR; GENOME; ORGANIZATION; SELECTION; CIRCUITS; DYNAMICS; BACTERIA	In this work, we present a proof-of-principle experiment that extends advanced live cell microscopy to the scale of pool-generated strain libraries. We achieve this by identifying the genotypes for individual cells in situ after a detailed characterization of the phenotype. The principle is demonstrated by single-molecule fluorescence time-lapse imaging of Escherichia coli strains harboring barcoded plasmids that express a sgRNA which suppresses different genes in the E.coli genome through dCas9 interference. In general, the method solves the problem of characterizing complex dynamic phenotypes for diverse genetic libraries of cell strains. For example, it allows screens of how changes in regulatory or coding sequences impact the temporal expression, location, or function of a gene product, or how the altered expression of a set of genes impacts the intracellular dynamics of a labeled reporter.	[Lawson, Michael J.; Camsund, Daniel; Larsson, Jimmy; Baltekin, Ozden; Fange, David; Elf, Johan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Elf, J (reprint author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden.	johan.elf@icm.uu.se			Knut and Alice Wallenberg foundation; Swedish Research Council; European Research Council	E. Gullberg is gratefully acknowledged for providing the DA25184 strain that carries the spectinomycin resistance cassette and Prune Leroy for providing the LacY-YPet strain. The authors would like to thank George Church and Mats Nilsson for helpful discussions. In addition, the authors would like to acknowledge funding from the Knut and Alice Wallenberg foundation, the Swedish Research Council and the European Research Council.	Baltekin O, 2017, P NATL ACAD SCI USA, V114, P9170, DOI 10.1073/pnas.1708558114; Balzarotti F, 2017, SCIENCE, V355, P606, DOI 10.1126/science.aak9913; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Edelstein A., 2010, CURR PROTOC MOL BIOL, V14, P20, DOI DOI 10.1002/0471142727.MB1420S92; Engler C, 2013, METHODS MOL BIOL, V1073, P141, DOI 10.1007/978-1-62703-625-2_12; Garst AD, 2017, NAT BIOTECHNOL, V35, P48, DOI 10.1038/nbt.3718; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Keren L, 2016, CELL, V166, P1282, DOI 10.1016/j.cell.2016.07.024; Kuwada NJ, 2015, MOL MICROBIOL, V95, P64, DOI 10.1111/mmi.12841; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997                                                ; Liu Z, 2015, MOL CELL, V58, P644, DOI 10.1016/j.molcel.2015.02.033; Loy G, 2003, IEEE T PATTERN ANAL, V25, P959, DOI 10.1109/TPAMI.2003.1217601; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203                                                           ; Magnusson KEG, 2015, IEEE T MED IMAGING, V34, P911, DOI 10.1109/TMI.2014.2370951; Norman TM, 2013, NATURE, V503, P481, DOI 10.1038/nature12804; Otoupal PB, 2017, ACS SYNTH BIOL, V6, P94, DOI 10.1021/acssynbio.6b00050; Peters JM, 2016, CELL, V165, P1493, DOI 10.1016/j.cell.2016.05.003; Potvin-Trottier L, 2016, NATURE, V538, P514, DOI 10.1038/nature19841; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ranefall P, 2016, I S BIOMED IMAGING, P205, DOI 10.1109/ISBI.2016.7493245; Rogers JK, 2015, NUCLEIC ACIDS RES, V43, P7648, DOI 10.1093/nar/gkv616; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Shao KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024910; Shi H, 2017, NAT PROTOC, V12, P429, DOI 10.1038/nprot.2016.181; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Uphoff S, 2016, SCIENCE, V351, P1094, DOI 10.1126/science.aac9786; Vvedenskaya IO, 2015, MOL CELL, V60, P953, DOI 10.1016/j.molcel.2015.10.029; Wallden M, 2016, CELL, V166, P729, DOI 10.1016/j.cell.2016.06.052; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	43	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-4292			MOL SYST BIOL	Mol. Syst. Biol.	OCT	2017	13	10							947	10.15252/msb.20177951				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FN6XL	WOS:000416160000004	29042431	gold			2018-01-05	
J	Schmierer, B; Botla, SK; Zhang, JL; Turunen, M; Kivioja, T; Taipale, J				Schmierer, Bernhard; Botla, Sandeep K.; Zhang, Jilin; Turunen, Mikko; Kivioja, Teemu; Taipale, Jussi			CRISPR/Cas9 screening using unique molecular identifiers	MOLECULAR SYSTEMS BIOLOGY			English	Article						CRISPR/Cas; genetic screening; massively parallel lineage tracing; unique molecular identifiers	HUMAN-CELLS; GENETIC SCREENS; CRISPR-CAS9; GENOME; ACTIVATION; SYSTEM	Loss-of-function screening by CRISPR/Cas9 gene knockout with pooled, lentiviral guide libraries is a widely applicable method for systematic identification of genes contributing to diverse cellular phenotypes. Here, Random Sequence Labels (RSLs) are incorporated into the guide library, which act as unique molecular identifiers (UMIs) to allow massively parallel lineage tracing and lineage dropout screening. RSLs greatly improve the reproducibility of results by increasing both the precision and the accuracy of screens. They reduce the number of cells needed to reach a set statistical power, or allow a more robust screen using the same number of cells.	[Schmierer, Bernhard; Botla, Sandeep K.; Zhang, Jilin; Taipale, Jussi] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Turunen, Mikko; Kivioja, Teemu; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Res Program, Fac Med, Helsinki, Finland	Taipale, J (reprint author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.; Taipale, J (reprint author), Univ Helsinki, Genome Scale Biol Res Program, Fac Med, Helsinki, Finland.	jussi.taipale@ki.se		Botla, Sandeep/0000-0001-9937-0455; Schmierer, Bernhard/0000-0002-9082-7022	Academy of Finland [250345]; Knut and Alice Wallenberg Foundation [KAW 2013.0088]; Center for Innovative Medicine (CIMED) project grant "Growth Control and Cancer"	The authors would like to thank Drs Jenna Persson, Inderpreet Kaur Sur, and Minna Taipale for suggestions on the manuscript. Part of this work was carried out at Karolinska High Throughput Center (KHTC) and the High Throughput Genome Engineering Facility (HTGE) at Science for Life Laboratory, Sweden. This work was supported by the Academy of Finland, grant 250345; the Knut and Alice Wallenberg Foundation, grant KAW 2013.0088; and the Center for Innovative Medicine (CIMED) project grant "Growth Control and Cancer".	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/NMETH.4108, 10.1038/nmeth.4108]; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Sandler O, 2015, NATURE, V519, P468, DOI 10.1038/nature14318; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851	20	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-4292			MOL SYST BIOL	Mol. Syst. Biol.	OCT	2017	13	10							945	10.15252/msb.20177834				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FN6XL	WOS:000416160000002	28993443	gold			2018-01-05	
J	Qing, XB; Walter, J; Jarazo, J; Arias-Fuenzalida, J; Hillje, AL; Schwamborn, JC				Qing, Xiaobing; Walter, Jonas; Jarazo, Javier; Arias-Fuenzalida, Jonathan; Hillje, Anna-Lena; Schwamborn, Jens C.			CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and alpha-Synuclein modulation in dopaminergic neurons	STEM CELL RESEARCH			English	Article						LRRK2-G2019S; CRISPR/Cas9; piggyBac; Parkinson's disease; hiPS; alpha-Synuclein; Serine129 phosphorylated alpha-Synuclein	PLURIPOTENT STEM-CELLS; SPORADIC PARKINSONS-DISEASE; LEWY BODY; GENE-EXPRESSION; LRRK2; PHOSPHORYLATION; MUTATION; DNA; CRISPR-CAS9; PATHOLOGY	The p.G2019S mutation of the leucine-rich repeat kinase 2 (LRRK2) has been identified as the most prevalent genetic cause of familial and sporadic Parkinson's disease (PD). The Cre-LoxP recombination system has been used to correct the LRRK2-G2019S mutation in patient derived human induced pluripotent stem cells (hiPSCs) in order to generate isogenic controls. However, the remaining LoxP site can influence gene expression. In this study, we report the generation of a footprint-free LRRK2-G2019S isogenic hiPS cell line edited with the CRISPR/Cas9 and piggyBac technologies. We observed that the percentage of Tyrosine Hydroxylase (TH) positive neurons with a total neurite length of >2000 mu m was significantly reduced in LRRK2-G2019S dopaminergic (DA) neurons. The average branch number in LRRK2-G2019S DA neurons was also decreased. In addition, we have shown that in vitro TH positive neurons with a total neurite length of >2000 mu m were positive for Serine 129 phosphorylated (S129P) alpha-Synuclein (alpha S) and we hypothesize that S129P-alpha S plays a role in the maintenance or formation of long neurites. In summary, our footprint-free LRRK2-G2019S isogenic cell lines allow standardized, genetic background independent, in vitro PD modeling and provide newinsights into the role of LRRK2-G2019S and S129P-alpha S in the pathogenesis of PD. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license	[Qing, Xiaobing; Walter, Jonas; Jarazo, Javier; Arias-Fuenzalida, Jonathan; Hillje, Anna-Lena; Schwamborn, Jens C.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4367 Belvaux, Luxembourg	Schwamborn, JC (reprint author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4367 Belvaux, Luxembourg.	jens.schwamborn@uni.lu			Fonds National de la Recherche (FNR) (CORE) [C13/BM/5791363]; University Luxembourg Internal Research Project grant (MidNSCs); FNR (AFR, Aides a la Formation-Recherche); Fonds National de la Recherche (FNR) [INTER/15/10922184/LysoPD_NCL]; EU Joint Programme - Neurodegenerative Disease Research (JPND) project [INTER/JPND/14/02, INTER/JPND/15/11092422]; European Union [668738]; LCSB pluripotent stemcell core facility	We thank Dr. Jared Sterneckert (Technical University of Dresden, Germany), Dr. Thomas Gasser (German Center for Neurodegenerative Diseases, Tuebingen, Germany) and Dr. Bill Skarnes (The Wellcome Trust Sanger Institute, Cambridge, UK) for human iPSC lines. This project was supported by the LCSB pluripotent stemcell core facility. The JCS lab is supported by the Fonds National de la Recherche (FNR) (CORE, C13/BM/5791363) and by a University Luxembourg Internal Research Project grant (MidNSCs). X.Q., J.W and J.J. are supported by fellowships from the FNR (AFR, Aides a la Formation-Recherche). A.L.H. is supported by the Fonds National de la Recherche (FNR) (INTER/15/10922184/LysoPD_NCL). This is an EU Joint Programme - Neurodegenerative Disease Research (JPND) project (INTER/JPND/14/02; INTER/JPND/15/11092422). Further support comes from the SysMedPD project which has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668738. We also thank the private donors who support our work at the LCSB.	Alegre-Abarrategui J, 2008, NEUROPATH APPL NEURO, V34, P272, DOI 10.1111/j.1365-2990.2007.00888.x; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Barbeau A, 1984, Adv Neurol, V40, P333; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Li JQ, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-47; Mamais A, 2013, NEUROBIOL DIS, V58, P183, DOI 10.1016/j.nbd.2013.05.017; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; MARTIN WE, 1973, BRAIN, V96, P495, DOI 10.1093/brain/96.3.495                                                          ; McCormack AL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.50; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Muntane G, 2012, NEUROSCIENCE, V200, P106, DOI 10.1016/j.neuroscience.2011.10.042; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Oueslati A, 2016, J PARKINSON DIS, V6, P39, DOI 10.3233/JPD-160779; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001                                                ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Saito S, 2016, BIOL PHARM BULL, V39, P25, DOI 10.1248/bpb.b15-00701; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Sandor C, 2017, SCI REP-UK, V7, DOI 10.1038/srep41188; SeminoMora C, 1997, LAB INVEST, V76, P487; Siddiqui IJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24475; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990                                                 ; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	38	0	0	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	OCT	2017	24						44	50		10.1016/j.scr.2017.08.013				7	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FN5ZV	WOS:000416090100012	28826027	gold			2018-01-05	
J	Yuan, F; Guo, DS; Gaob, G; Liu, YL; Xu, YY; Wu, YH; Yang, F; Ke, XR; Lai, KY; Hong, LQ; Li, YX				Yuan, Fang; Guo, Dongsheng; Gaob, Ge; Liu, Yanli; Xu, Yingying; Wu, Yuhang; Yang, Fan; Ke, Xinrong; Lai, Keyu; Hong, Liangqing; Li, Yin-xiong			Generation of a KCNJ11 homozygous knockout human embryonic stem cell line WAe001-A-12 using CRISPR/Cas9	STEM CELL RESEARCH			English	Article								The ATP-sensitive potassium channel is an octameric complex, and one of its subunits, namely Kir6.2, is encoded by the KCNJ11 gene. Mutations in KCNJ11 result in hyperinsulinism or diabetes mellitus, associated with abnormal insulin secretion. Here, using CRISPR/Cas9 editing, we established a homozygous mutant KCNJ11 cell line, WAe001-A12, which was generated by a 62-bp deletion in the coding sequence of the human embryonic stem cell line H1. It was confirmed that this deletion in the KCNJ11 gene did not affect the protein expression levels of key pluripotent factors. Additionally, normal karyotype and differentiation potency were observed for the cell line. (C) 2017 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license	[Yuan, Fang; Li, Yin-xiong] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Yuan, Fang; Guo, Dongsheng; Gaob, Ge; Liu, Yanli; Xu, Yingying; Wu, Yuhang; Yang, Fan; Ke, Xinrong; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Publ Hlth, Guangzhou, Peoples R China; [Yuan, Fang; Guo, Dongsheng; Gaob, Ge; Liu, Yanli; Xu, Yingying; Wu, Yuhang; Yang, Fan; Ke, Xinrong; Lai, Keyu; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Yuan, Fang; Guo, Dongsheng; Gaob, Ge; Liu, Yanli; Xu, Yingying; Wu, Yuhang; Yang, Fan; Ke, Xinrong; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomputing, Guangzhou, Guangdong, Peoples R China; [Guo, Dongsheng; Liu, Yanli; Xu, Yingying; Ke, Xinrong; Li, Yin-xiong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hong, Liangqing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Kidney Transplantat, Guangzhou, Guangdong, Peoples R China	Hong, LQ (reprint author), 600 Tianhe Ave, Guangzhou 510000, Guangdong, Peoples R China.; Li, YX (reprint author), 190 Kaiyuan Ave,Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	horselq@163.com; li_yinxiong@gibh.ac.cn			Chinese Government Recruitment "Thousand Talents Program" [ODCCC2268]; Ministry of Science and Technology 973 Program [2015CB964700]; Guangdong Province Science and Technology Plan [2014B020225004, 2015B020230007, 2016B030301007]; Guangdong Provincial Natural Science Foundation [2014A030310058]	This work was financially supported by the Chinese Government Recruitment "Thousand Talents Program" (ODCCC2268) (Yinxiong Li), the Ministry of Science and Technology 973 Program (2015CB964700), the Guangdong Province Science and Technology Plan (2014B020225004, 2015B020230007, 2016B030301007), and Guangdong Provincial Natural Science Foundation (2014A030310058).	Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	4	0	0	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	OCT	2017	24						89	93		10.1016/j.scr.2017.08.016				5	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FN5ZV	WOS:000416090100020	29034901	gold			2018-01-05	
J	Romero-Moya, D; Castano, J; Santos-Ocana, C; Navas, P; Menendez, P				Romero-Moya, Damia; Castano, Julio; Santos-Ocana, Carlos; Navas, Placido; Menendez, Pablo			Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q(10) deficiency harboring a heterozygous mutation in COQ4 gene	STEM CELL RESEARCH			English	Article							PLURIPOTENT STEM-CELLS; HUMAN B-CELLS	Wereport the generation, CRISPR/Cas9-edition and characterization of induced pluripotent stem cell (iPSC) lines froma patient with coenzyme Q(10) deficiency harboring the heterozygous mutation c.483G > C inthe COQ4 gene. iPSCs were generated using non-integrative Sendai Viruses containing the reprogramming factors OCT4, SOX2, KLF4 and C-MYC. The iPSC lines carried the c.483G > C COQ4 mutation, silenced the OKSM expression and were mycoplasma-free. They were bona fide pluripotent cells as characterized by morphology, immunophenotype/gene expression for pluripotent-associatedmarkers/genes, NANOG and OCT4 promoter demethylation, karyotype and teratoma formation. The COQ4 mutation was CRISPR/Cas9 edited resulting in isogenic, diploid and off-target free COQ4-corrected iPSCs. (C) 2016 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.	[Romero-Moya, Damia; Castano, Julio; Menendez, Pablo] Univ Barcelona, Josep Carreras Leukemia Res Inst, Dept Biomed, Sch Med, Barcelona, Spain; [Santos-Ocana, Carlos; Navas, Placido] Univ Pablo Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Menendez, Pablo] ICREA, Barcelona, Spain	Romero-Moya, D; Menendez, P (reprint author), Univ Barcelona, Josep Carreras Leukemia Res Inst, Dept Biomed, Sch Med, Barcelona, Spain.; Menendez, P (reprint author), ICREA, Barcelona, Spain.	dromero@carrerasresearch.org; pmenendez@carrerasresearch.org		Santos Ocana, Carlos/0000-0002-2379-796X			Bueno C, 2016, LEUKEMIA, V30, P674, DOI 10.1038/leu.2015.294; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Montes R, 2009, CELL RES, V19, P698, DOI 10.1038/cr.2009.35; Munoz-Lopez A, 2016, STEM CELLS, V34, P581, DOI 10.1002/stem.2303; Ramos-Mejia V, 2012, STEM CELLS DEV, V21, P1145, DOI 10.1089/scd.2011.0248; Trevisson E, 2011, CURR OPIN NEUROL, V24, P449, DOI 10.1097/WCO.0b013e32834ab528	7	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	OCT	2017	24						144	147		10.1016/j.scr.2016.09.007				4	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FN5ZV	WOS:000416090100028	28465093	gold			2018-01-05	
J	Xue, YT; Zhu, MH; Qin, DJ; Li, YJ; Cen, XT; Sun, XF; Lian, WW; Liao, BJ				Xue, Yanting; Zhu, Minghui; Qin, Dajiang; Li, Yongjin; Cen, Xiaotong; Sun, Xiaofang; Lian, Wenwei; Liao, Baojian			Establishment of a congenital tooth agenesis related gene MSX1 knockout human embryonic stem cell lines by CRISPR-Cas9 technology	STEM CELL RESEARCH			English	Article								Human MSX1 gene ismapped to chromosome 4 and encodes a 303aa homeobox protein MSX1. MSX1 expression appears during early tooth development of vertebrate embryogenesis. Mutations in this protein are related to human tooth anomalie, cleft lip and palate and congenital ectodermal dysplasia syndrome. Most of the confirmed pathogenic mutations are located in exon2 encoded homeobox domain. Here, we report the establishment of MSX1 gene knockout human embryonic stem (hES) cell lines by CRISPR-Cas9 technology. These cell lines provide good materials for further studies of the roles MSX1 plays in human tooth development and congenital tooth agenesis. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.	[Zhu, Minghui; Li, Yongjin; Lian, Wenwei] Nanchang Univ, Affiliated Stomatol Hosp, Key Lab Oral Biomed, Nanchang 330006, Jiangxi, Peoples R China; [Xue, Yanting; Sun, Xiaofang] Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Guangdong Higher Educ Inst, Key Lab Reprod & Genet,Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China; [Xue, Yanting; Qin, Dajiang; Cen, Xiaotong; Liao, Baojian] Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou Inst Biomed, Guangzhou 510530, Guangdong, Peoples R China; [Xue, Yanting; Qin, Dajiang; Cen, Xiaotong; Liao, Baojian] Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou Inst Hlth, Guangzhou 510530, Guangdong, Peoples R China	Lian, WW (reprint author), Nanchang Univ, Affiliated Stomatol Hosp, Key Lab Oral Biomed, Nanchang 330006, Jiangxi, Peoples R China.; Liao, BJ (reprint author), Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou Inst Biomed, Guangzhou 510530, Guangdong, Peoples R China.; Liao, BJ (reprint author), Chinese Acad Sci, CAS Key Lab Regenerat Biol, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou Inst Hlth, Guangzhou 510530, Guangdong, Peoples R China.	lianwenwei1967@126.com; liao_baojian@gibh.ac.cn			China Post doctoral Science Foundation [2015M580738]; Guangdong Natural Science Foundation [2014A030313801, 2015A030310229]; Frontier and key technology innovation special grant from the Department of Science and Technology of Guangdong province [2014B020225006, 2016B030229008]; Guangdong Province Science and Technology Innovation Young Talents Program [2014TQ01R746]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2015293]; Pearl River Nova Program [201506010092]	This work is supported by grants from China Post doctoral Science Foundation (2015M580738), Guangdong Natural Science Foundation (2014A030313801, 2015A030310229), the Frontier and key technology innovation special grant from the Department of Science and Technology of Guangdong province (2014B020225006, 2016B030229008), and the Guangdong Province Science and Technology Innovation Young Talents Program (2014TQ01R746) the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2015293), the Pearl River Nova Program (201506010092). We thank Dr. Guangjin Pan for providing support in this work, and members of our labs (Yongli Shan, Bizhi Shang, Tian Zhang, Yanqi Zhang and Jiao Yao) for their kind help.	Antonchuk Jennifer, 2013, Methods Mol Biol, V946, P523, DOI 10.1007/978-1-62703-128-8_32; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573	4	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	OCT	2017	24						151	154		10.1016/j.scr.2017.05.008				4	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FN5ZV	WOS:000416090100030	29034883	gold			2018-01-05	
J	Liu, YL; Wu, FM; Zhuang, YQ; Guo, DS; Abbas, N; Wei, RZ; Wang, KP; Chen, Y; Tao, JW; Wu, YH; Yuan, F; Pan, TC; Yang, F; Lai, KY; Lai, LX; Li, YX				Liu, Yanli; Wu, Feima; Zhuang, Yuanqi; Guo, Dongsheng; Abbas, Nasir; Wei, Ruzi; Wang, Kepin; Chen, Yan; Tao, Jiawang; Wu, Yuhang; Yuan, Fang; Pan, Tingcai; Yang, Fan; Lai, Keyu; Lai, Liangxue; Li, Yin-xiong			Generation of three miR-122 knockout lines from a human embryonic stem cell line	STEM CELL RESEARCH			English	Article								miR-122 is the most abundant miRNA in the human liver, accounting for 52% of the entire hepatic miRNome. Previous studies have demonstrated that miR-122 plays key roles in hepatocyte growth, metabolism, and homeostasis. Here, we created three miR-122 knockout human embryonic stem cell line lines, WAe001-A-7, WAe001-A-8, and WAe001-A-9, using the CRISPR/Cas9 technique. These mutated cell lines retained their pluripotency, in vitro differentiation potential, normal morphology, and karyotype. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.	[Liu, Yanli; Wu, Feima; Zhuang, Yuanqi; Guo, Dongsheng; Abbas, Nasir; Wei, Ruzi; Chen, Yan; Tao, Jiawang; Wu, Yuhang; Yuan, Fang; Pan, Tingcai; Yang, Fan; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Liu, Yanli; Wu, Feima; Zhuang, Yuanqi; Guo, Dongsheng; Abbas, Nasir; Wei, Ruzi; Tao, Jiawang; Pan, Tingcai; Lai, Liangxue; Li, Yin-xiong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Yanli; Wu, Feima; Zhuang, Yuanqi; Guo, Dongsheng; Abbas, Nasir; Wei, Ruzi; Wang, Kepin; Chen, Yan; Tao, Jiawang; Wu, Yuhang; Yuan, Fang; Pan, Tingcai; Yang, Fan; Lai, Keyu; Lai, Liangxue; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Liu, Yanli; Wu, Feima; Zhuang, Yuanqi; Guo, Dongsheng; Abbas, Nasir; Wei, Ruzi; Chen, Yan; Tao, Jiawang; Wu, Yuhang; Yuan, Fang; Pan, Tingcai; Yang, Fan; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou, Guangdong, Peoples R China	Li, YX (reprint author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave,Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	li_yinxiong@gibh.ac.cn			National Basic Research Program of China 973 Program [2015CB964700]; Chinese Government Recruitment "Thousand Talents Program" [ODCCC2268]; Guangdong Province Science and Technology Plan [2016B030301007, 2015B020230007, 2014B020225004]; Haizhu District Science and Technology Plan [2014-CG-05]	This work is supported by the National Basic Research Program of China 973 Program (2015CB964700), Chinese Government Recruitment "Thousand Talents Program" (ODCCC2268, Yin-xiong Li), Guangdong Province Science and Technology Plan (2016B030301007, 2015B020230007, 2014B020225004), and Haizhu District Science and Technology Plan (2014-CG-05).	Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yang Y, 2016, J MOL CELL BIOL, V8, P174, DOI 10.1093/jmcb/mjw008	4	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	OCT	2017	24						164	168		10.1016/j.scr.2017.06.004				5	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FN5ZV	WOS:000416090100033	29034887	gold			2018-01-05	
J	Liu, YL; Ruzi, A; Guo, DS; Wu, FM; Liu, HK; Wu, H; Wu, YH; Yuan, F; Zhuang, YQ; Yang, F; Lai, KY; Lai, LX; Li, YX				Liu, Yanli; Ruzi, Aynisahan; Guo, Dongsheng; Wu, Feima; Liu, Haikun; Wu, Han; Wu, Yuhang; Yuan, Fang; Zhuang, Yuanqi; Yang, Fan; Lai, Keyu; Lai, Liangxue; Li, Yin-xiong			Generation of two MEN1 knockout lines from a human embryonic stem cell line	STEM CELL RESEARCH			English	Article							GENE	The MEN1 gene is cytogenetically located at 11q13.1 and encodes the nuclear protein menin, which is involved in cell proliferation, apoptosis, differentiation, and metabolism. Here, we generated two MEN1 knockout human embryonic stem cell lines, WAe001-A-4 and WAe001-A-5, by targeting exon-2 and exon-9 of MEN1 using the CRISPR/Cas9 technique. These cell lines maintained their pluripotency, in vitro differentiation potential, normal morphology, and karyotype. These human MEN1-mutated cell lines not only enlarge the pool of lab resources but also provide ideal models to dissect the detailed physio-pathological roles of the menin protein. (C) 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license.	[Liu, Yanli; Ruzi, Aynisahan; Guo, Dongsheng; Wu, Feima; Liu, Haikun; Wu, Yuhang; Yuan, Fang; Zhuang, Yuanqi; Yang, Fan; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Liu, Yanli; Ruzi, Aynisahan; Guo, Dongsheng; Wu, Feima; Zhuang, Yuanqi; Lai, Liangxue; Li, Yin-xiong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Yanli; Ruzi, Aynisahan; Guo, Dongsheng; Wu, Feima; Liu, Haikun; Wu, Han; Wu, Yuhang; Yuan, Fang; Zhuang, Yuanqi; Yang, Fan; Lai, Keyu; Lai, Liangxue; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Liu, Yanli; Ruzi, Aynisahan; Guo, Dongsheng; Wu, Feima; Liu, Haikun; Wu, Yuhang; Yuan, Fang; Zhuang, Yuanqi; Yang, Fan; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou, Guangdong, Peoples R China	Li, YX (reprint author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave,Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	li_yinxiong@gibh.ac.cn			National Basic Research Program of China 973 Program [2015CB964700]; Chinese Government Recruitment "Thousand Talents Program" [ODCCC2268]; Guangdong Province Science and Technology Plan [2016B030301007, 2015B020230007, 2014B020225004]; Haizhu District Science and Technology Plan [2014-CG-05]	This work is supported by the National Basic Research Program of China 973 Program (2015CB964700), Chinese Government Recruitment "Thousand Talents Program" (ODCCC2268, Yin-xiong Li), Guangdong Province Science and Technology Plan (2016B030301007, 2015B020230007, 2014B020225004), and Haizhu District Science and Technology Plan (2014-CG-05).	Heppner C, 1997, NAT GENET, V16, P375, DOI 10.1038/ng0897-375                                                              ; Heppner C, 1999, J CLIN ENDOCR METAB, V84, P216, DOI 10.1210/jc.84.1.216; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yang Y, 2016, J MOL CELL BIOL, V8, P174, DOI 10.1093/jmcb/mjw008	5	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1873-5061	1876-7753		STEM CELL RES	Stem Cell Res.	OCT	2017	24						169	173		10.1016/j.scr.2017.06.005				5	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology	Cell Biology; Biotechnology & Applied Microbiology	FN5ZV	WOS:000416090100034	29034888	gold			2018-01-05	
J	Medeiros, JD; Leite, LR; Pylro, VS; Oliveira, FS; Almeida, VM; Fernandes, GR; Salim, ACM; Araujo, FMG; Volpini, AC; Oliveira, G; Cuadros-Orellana, S				Medeiros, J. D.; Leite, L. R.; Pylro, V. S.; Oliveira, F. S.; Almeida, V. M.; Fernandes, G. R.; Salim, A. C. M.; Araujo, F. M. G.; Volpini, A. C.; Oliveira, G.; Cuadros-Orellana, S.			Single-cell sequencing unveils the lifestyle and CRISPR-based population history of Hydrotalea sp in acid mine drainage	MOLECULAR ECOLOGY			English	Article						acid mine drainage; CRISPR-Cas systems; Hydrotalea sp.; metal resistance; single-cell genomics	CAS SYSTEMS; GEN. NOV.; MICROBIAL COMMUNITIES; PALINDROMIC REPEATS; HIGH-THROUGHPUT; FOREST SOIL; EVOLUTION; CLASSIFICATION; RESISTANCE; DIVERSITY	Acid mine drainage (AMD) is characterized by an acid and metal-rich run-off that originates from mining systems. Despite having been studied for many decades, much remains unknown about the microbial community dynamics in AMD sites, especially during their early development, when the acidity is moderate. Here, we describe draft genome assemblies from single cells retrieved from an early-stage AMD sample. These cells belong to the genus Hydrotalea and are closely related to Hydrotalea flava. The phylogeny and average nucleotide identity analysis suggest that all single amplified genomes (SAGs) form two clades that may represent different strains. These cells have the genomic potential for denitrification, copper and other metal resistance. Two coexisting CRISPR-Cas loci were recovered across SAGs, and we observed heterogeneity in the population with regard to the spacer sequences, together with the loss of trailer-end spacers. Our results suggest that the genomes of Hydrotalea sp. strains studied here are adjusting to a quickly changing selective pressure at the microhabitat scale, and an important form of this selective pressure is infection by foreign DNA.	[Medeiros, J. D.; Leite, L. R.; Pylro, V. S.; Oliveira, F. S.; Almeida, V. M.; Fernandes, G. R.; Salim, A. C. M.; Araujo, F. M. G.; Volpini, A. C.; Oliveira, G.; Cuadros-Orellana, S.] FIOCRUZ MG, Rene Rachou Res Ctr, Biosyst Informat & Genom Grp, Belo Horizonte, MG, Brazil; [Medeiros, J. D.; Leite, L. R.; Oliveira, F. S.; Almeida, V. M.] Univ Fed Minas Gerais, Inst Biol Sci, Belo Horizonte, MG, Brazil; [Pylro, V. S.] Univ Sao Paulo, ESALQ USP, Coll Agr, Dept Soil Sci Luiz de Queiroz, Piracicaba, SP, Brazil; [Oliveira, G.] Vale Inst Technol Sustainable Dev, Belem, PA, Brazil; [Cuadros-Orellana, S.] Univ Catolica Maule, Ctr Biotecnol Recursos Nat, Fac Ciencias Agr & Forestales, Talca, Chile	Medeiros, JD (reprint author), FIOCRUZ MG, Rene Rachou Res Ctr, Biosyst Informat & Genom Grp, Belo Horizonte, MG, Brazil.	jdutramedeiros@gmail.com			Vale [1786221]; FAPEMIG [RED-00014-14]	Vale, Grant/Award Number: grant no. 1786221; FAPEMIG, Grant/Award Number: RED-00014-14	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Ayarza J. M., 2014, GENOME ANNOUNCEMENTS, V2, P1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baeseman JL, 2006, MICROB ECOL, V51, P232, DOI 10.1007/s00248-005-5155-z; Bailey VL, 2013, ISME J, V7, P2044, DOI 10.1038/ismej.2013.87; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Biswas A, 2014, BIOINFORMATICS, V30, P1805, DOI 10.1093/bioinformatics/btu114; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bondarczuk K, 2013, CELL BIOL TOXICOL, V29, P397, DOI 10.1007/s10565-013-9262-1; Brown C. T., 2015, STRAIN RECOVERY META, V33, P1041; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chakraborty S, 2010, MOL PHYLOGENET EVOL, V56, P878, DOI 10.1016/j.ympev.2010.05.020; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Dold B, 2014, MINERALS-BASEL, V4, P621, DOI 10.3390/min4030621; Druschel GK, 2004, GEOCHEM T, V5, P13, DOI 10.1186/1467-4866-5-13; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao JL, 2016, INT J SYST EVOL MICR, V66, P2730, DOI 10.1099/ijsem.0.001116; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hanada S, 2014, INT J SYST EVOL MICR, V64, P1359, DOI 10.1099/ijs.0.058594-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson DB, 2003, RES MICROBIOL, V154, P466, DOI 10.1016/S0923-2508(03)00114-1; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P518, DOI 10.1099/ijs.0.023002-0; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kuang JL, 2013, ISME J, V7, P1038, DOI 10.1038/ismej.2012.139; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leite L. R., 2016, GENOME ANNOUNCEMENTS, V4; Llorens-Mares T, 2015, ISME J, V9, P1648, DOI 10.1038/ismej.2014.254; Lo A. S., 2015, GENOME ANNOUNCEMENTS, V3; Lv YY, 2016, INT J SYST EVOL MICR, V66, P1785, DOI 10.1099/ijsem.0.000940; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Martijn J, 2015, ISME J, V9, P2373, DOI 10.1038/ismej.2015.46; Martinez-Garcia M, 2012, ISME J, V6, P113, DOI 10.1038/ismej.2011.84; Medeiros JD, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S8-A3; Medeiros JD, 2016, BRAZ J MICROBIOL, V47, P835, DOI 10.1016/j.bjm.2016.06.011; Mizuno CM, 2015, MBIO, V6, DOI 10.1128/mBio.02083-14; Mendez-Garcia C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00475; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nylander JAA, 2004, MRMODELTEST V2; Papirio S, 2014, BIODEGRADATION, V25, P425, DOI 10.1007/s10532-013-9671-0; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pereira LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096605; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rosenberg E., 2014, PROKARYOTES, P493, DOI DOI 10.1007/978-3-642-38954-2_137; Siddiqi MZ, 2016, INT J SYST EVOL MICR, V66, P2774, DOI 10.1099/ijsem.0.001053; Stepanauskas R., 2015, FRONTIERS MICROBIOLO, V6, P2014; Sun CL, 2016, ISME J, V10, P858, DOI 10.1038/ismej.2015.162; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Vavourakis CD, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00211; Weigold P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28958; Williams HTP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-17; Xie JP, 2011, APPL ENVIRON MICROB, V77, P991, DOI 10.1128/AEM.01798-10	63	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	OCT	2017	26	20					5541	5551		10.1111/mec.14294				11	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	FL0UV	WOS:000413927700013	28802076				2018-01-05	
J	Hynes, AP; Rousseau, GM; Lemay, ML; Horvath, P; Romero, DA; Fremaux, C; Moineau, S				Hynes, Alexander P.; Rousseau, Genevieve M.; Lemay, Marie-Laurence; Horvath, Philippe; Romero, Dennis A.; Fremaux, Christophe; Moineau, Sylvain			An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9	NATURE MICROBIOLOGY			English	Article							ADAPTATION; SYSTEMS; PROTEIN; THERMOPHILUS; MECHANISMS; RESISTANCE; IMMUNITY	The CRISPR-Cas system owes its utility as a genome-editing tool to its origin as a prokaryotic immune system. The first demonstration of its activity against bacterial viruses (phages) is also the first record of phages evading that immunity(1). This evasion can be due to point mutations(1), large-scale deletions(2), DNA modifications(3), or phage-encoded proteins that interfere with the CRISPR-Cas system, known as anti-CRISPRs (Acrs)(4). The latter are of biotechnological interest, as Acrs can serve as off switches for CRISPR-based genome editing(5). Every Acr characterized to date originated from temperate phages, genomic islands, or prophages(4-8), and shared properties with the first Acr discovered. Here, with a phage-oriented approach, we have identified an unrelated Acr in a virulent phage of Streptococcus thermophilus. In challenging a S. thermophilus strain CRISPR-immunized against a set of virulent phages, we found one that evaded the CRISPR-encoded immunity >40,000x more often than the others. Through systematic cloning of its genes, we identified an Acr solely responsible for the abolished immunity. We extended our findings by demonstrating activity in another S. thermophilus strain, against unrelated phages, and in another bacterial genus immunized using the heterologous SpCas9 system favoured for genome editing. This Acr completely abolishes SpCas9-mediated immunity in our assays.	[Hynes, Alexander P.; Rousseau, Genevieve M.; Lemay, Marie-Laurence; Moineau, Sylvain] Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Med Dent, Fac Sci & Genie,Grp Rech Ecol Buccale, Quebec City G1V 0A6, PQ, Canada; [Horvath, Philippe; Fremaux, Christophe] DuPont Nutr & Hlth, BP 10, F-86220 Dange St Romain, France; [Romero, Dennis A.] DuPont Nutr & Hlth, 3329 Agr Dr, Madison, WI 53716 USA; [Moineau, Sylvain] Univ Laval, Fac Med Dent, Felix dHerelle Reference Ctr Bacterial Viruses, Quebec City G1V 0A6, PQ, Canada	Moineau, S (reprint author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Med Dent, Fac Sci & Genie,Grp Rech Ecol Buccale, Quebec City G1V 0A6, PQ, Canada.; Moineau, S (reprint author), Univ Laval, Fac Med Dent, Felix dHerelle Reference Ctr Bacterial Viruses, Quebec City G1V 0A6, PQ, Canada.	Sylvain.Moineau@bcm.ulaval.ca		Moineau, Sylvain/0000-0002-2832-5101; HORVATH, Philippe/0000-0003-2015-8123	NSERC; Fonds de Recherche du Quebec-Nature et Technologies; Novalait; Op+Lait; Natural Sciences and Engineering Research Council of Canada (NSERC); DuPont	The authors thank M.-C. Jodeau and I. Chavichvily for the initial technical work on the efficiency of spacer acquisition in S. thermophilus DGCC7854. A.P.H. is supported by an NSERC Postdoctoral Fellowships award. M.-L.L. is supported by scholarships from the Fonds de Recherche du Quebec-Nature et Technologies, Novalait and Op+Lait. S.M. acknowledges funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Program and DuPont. S.M. holds a Tier 1 Canada Research Chair in Bacteriophages.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Bryson AL, 2015, MBIO, V6, DOI 10.1128/mBio.00648-15; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119; Hynes AP, 2017, NAT PROTOC, V12, P547, DOI 10.1038/nprot.2016.186; Hynes AP, 2016, MBIO, V7, DOI 10.1128/mBio.00202-16; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lemay ML, 2017, ACS SYNTH BIOL, V6, P1351, DOI 10.1021/acssynbio.6b00388; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; OSULLIVAN DJ, 1993, GENE, V137, P227, DOI 10.1016/0378-1119(93)90011-Q; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Rombel IT, 2002, GENE, V282, P33, DOI 10.1016/S0378-1119(01)00819-8; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407	34	1	1	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2058-5276			NAT MICROBIOL	NAT. MICROBIOL	OCT	2017	2	10					1374	1380		10.1038/s41564-017-0004-7				7	Microbiology	Microbiology	FM7PO	WOS:000415272500003	28785032				2018-01-05	
J	Vanaerschot, M; Lucantoni, L; Li, T; Combrinck, JM; Ruecker, A; Kumar, TRS; Rubiano, K; Ferreira, PE; Siciliano, G; Gulati, S; Henrich, PP; Ng, CL; Murithi, JM; Corey, VC; Duffy, S; Lieberman, OJ; Veiga, MI; Sinden, RE; Alano, P; Delves, MJ; Sim, KL; Winzeler, EA; Egan, TJ; Hoffman, SL; Avery, VM; Fidock, DA				Vanaerschot, Manu; Lucantoni, Leonardo; Li, Tao; Combrinck, Jill M.; Ruecker, Andrea; Kumar, T. R. Santha; Rubiano, Kelly; Ferreira, Pedro E.; Siciliano, Giulia; Gulati, Sonia; Henrich, Philipp P.; Ng, Caroline L.; Murithi, James M.; Corey, Victoria C.; Duffy, Sandra; Lieberman, Ori J.; Veiga, M. Isabel; Sinden, Robert E.; Alano, Pietro; Delves, Michael J.; Sim, Kim Lee; Winzeler, Elizabeth A.; Egan, Timothy J.; Hoffman, Stephen L.; Avery, Vicky M.; Fidock, David A.			Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity	NATURE MICROBIOLOGY			English	Article							HIGH-THROUGHPUT ASSAY; CHLOROQUINE RESISTANCE TRANSPORTER; PLASMODIUM-FALCIPARUM MALARIA; DRUG-RESISTANCE; ARTESUNATE-AMODIAQUINE; COMBINATION THERAPY; MATURE GAMETOCYTES; SEXUAL DEVELOPMENT; SCREENING ASSAY; METHYLENE-BLUE	Antimalarial compounds with dual therapeutic and transmission-blocking activity are desired as high-value partners for combination therapies. Here, we report the identification and characterization of hexahydroquinolines (HHQs) that show low nanomolar potency against both pathogenic and transmissible intra-erythrocytic forms of the malaria parasite Plasmodium falciparum. This activity translates into potent transmission-blocking potential, as shown by in vitro male gamete formation assays and reduced oocyst infection and prevalence in Anopheles mosquitoes. In vivo studies illustrated the ability of lead HHQs to suppress Plasmodium berghei blood-stage parasite proliferation. Resistance selection studies, confirmed by CRISPR-Cas9-based gene editing, identified the digestive vacuole membrane-spanning transporter PfMDR1 (P. falciparum multidrug resistance gene-1) as a determinant of parasite resistance to HHQs. Haemoglobin and haem fractionation assays suggest a mode of action that results in reduced haemozoin levels and might involve inhibition of host haemoglobin uptake into intra-erythrocytic parasites. Furthermore, parasites resistant to HHQs displayed increased susceptibility to several first-line antimalarial drugs, including lumefantrine, confirming that HHQs have a different mode of action to other antimalarials drugs for which PfMDR1 is known to confer resistance. This work evokes therapeutic strategies that combine opposing selective pressures on this parasite transporter as an approach to countering the emergence and transmission of multidrug-resistant P. falciparum malaria.	Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Lucantoni, Leonardo; Duffy, Sandra; Avery, Vicky M.] Griffith Univ, Griffith Inst Drug Discovery, Discovery Biol, Nathan, Qld 4111, Australia; [Li, Tao; Sim, Kim Lee; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD 20852 USA; [Combrinck, Jill M.] Univ Cape Town, Div Pharmacol, Dept Med, ZA-7925 Cape Town, South Africa; [Ruecker, Andrea; Sinden, Robert E.; Delves, Michael J.] Imperial Coll, Dept Life Sci, London SW7 2AZ, England; [Ferreira, Pedro E.; Veiga, M. Isabel] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, P-4710057 Braga, Portugal; [Siciliano, Giulia; Alano, Pietro] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Corey, Victoria C.; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Egan, Timothy J.] Univ Cape Town, Dept Chem, ZA-7700 Cape Town, South Africa; [Fidock, David A.] Columbia Univ, Div Infect Dis, Dept Med, Med Ctr, New York, NY 10032 USA; [Ruecker, Andrea] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Ruecker, Andrea] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford OX3 7FZ, England	Fidock, DA (reprint author), Columbia Univ, Div Infect Dis, Dept Med, Med Ctr, New York, NY 10032 USA.	df2260@cumc.columbia.edu	Vanaerschot, Manu/B-6812-2013	Vanaerschot, Manu/0000-0002-9141-2347; Veiga, Maria Isabel/0000-0002-2205-8102; Ferreira, Pedro/0000-0002-2682-7722	Bill and Melinda Gates Foundation [OPP1040399, OPP1054480]; National Institutes of Health [R01 AI103058, R01 AI50234, R01 AI110329]; Australian Research Council [LP120200557]; Medicines for Malaria Venture; Northern Portugal Regional Operational Programme (NORTE) under Portugal through European Regional Development Fund (FEDER)	The authors thank T.T. Diagana (Novartis Institute for Tropical Diseases, Singapore) for provision of the compounds, the Red Cross (Australia and the USA) for the provision of human blood for cell cultures, and G. Stevenson for assistance with the triaging of compounds following screening. The authors acknowledge the Bill and Melinda Gates Foundation (grant OPP1040399 to D.A.F. and V.M.A. and grant OPP1054480 to E.A.W. and D.A.F.), the National Institutes of Health (grant R01 AI103058 to E.A.W. and D.A.F., grant R01 AI50234 to D.A.F, and R01 AI110329 to T.J.E.), the Australian Research Council (LP120200557 to V.M.A.) and the Medicines for Malaria Venture for their continued support. P.E.F. and M.I.V. are supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER).	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Blagborough AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2840; Bolscher JM, 2015, J ANTIMICROB CHEMOTH, V70, P1357, DOI 10.1093/jac/dkv003; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bowman JD, 2014, ANTIMICROB AGENTS CH, V58, P811, DOI 10.1128/AAC.01500-13; Brunner R, 2013, J BIOL CHEM, V288, P22576, DOI 10.1074/jbc.M113.453159; Cevenini L, 2014, ANAL CHEM, V86, P8814, DOI 10.1021/ac502098w; Combrinck JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0729-9; Combrinck JM, 2013, ACS CHEM BIOL, V8, P133, DOI 10.1021/cb300454t; Corey VC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11901; Coulibaly B, 2015, J INFECT DIS, V211, P689, DOI 10.1093/infdis/jiu540; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; D'Alessandro S, 2013, J ANTIMICROB CHEMOTH, V68, P2048, DOI 10.1093/jac/dkt165; de Koning-Ward TF, 2015, NAT REV MICROBIOL, V13, P373, DOI 10.1038/nrmicro3450; de Mello CX, 2011, PARASITOL RES, V109, P927, DOI 10.1007/s00436-011-2335-2; Delves MJ, 2016, NAT PROTOC, V11, P1668, DOI 10.1038/nprot.2016.096; Delves MJ, 2013, ANTIMICROB AGENTS CH, V57, P3268, DOI 10.1128/AAC.00325-13; Dicko A, 2016, LANCET INFECT DIS, V16, P674, DOI 10.1016/S1473-3099(15)00479-X; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; Duffy S, 2012, AM J TROP MED HYG, V86, P84, DOI 10.4269/ajtmh.2012.11-0302; Ekland EH, 2011, FASEB J, V25, P3583, DOI 10.1096/fj.11-187401; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023875; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Flannery EL, 2013, J MED CHEM, V56, P7761, DOI 10.1021/jm400325j; Fletcher S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-343; Fukami T, 2012, DRUG METAB PHARMACOK, V27, P466, DOI 10.2133/dmpk.DMPK-12-RV-042; Gil JP, 2017, EXPERT REV ANTI-INFE, V15, P527, DOI 10.1080/14787210.2017.1313703; Goodyer ID, 1997, EXP PARASITOL, V86, P158, DOI 10.1006/expr.1997.4156; Hameed SP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7715; Josling GA, 2015, NAT REV MICROBIOL, V13, P573, DOI 10.1038/nrmicro3519; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Lucantoni L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45992; Lucantoni L, 2016, ANTIMICROB AGENTS CH, V60, P2097, DOI 10.1128/AAC.01949-15; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Manary MJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-63; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Miguel-Blanco C, 2015, ANTIMICROB AGENTS CH, V59, P3298, DOI 10.1128/AAC.04684-14; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; Pereira MR, 2011, ANTIMICROB AGENTS CH, V55, P3115, DOI 10.1128/AAC.01566-10; Petersen I, 2015, MOL MICROBIOL, V97, P381, DOI 10.1111/mmi.13035; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Pleeter P, 2010, MOL BIOCHEM PARASIT, V173, P158, DOI 10.1016/j.molbiopara.2010.05.012; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Plouffe DM, 2016, CELL HOST MICROBE, V19, P114, DOI 10.1016/j.chom.2015.12.001; Reiling SJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0791-3; Roberts L, 2008, ANTIMICROB AGENTS CH, V52, P1840, DOI 10.1128/AAC.01478-07; Rohrbach P, 2006, EMBO J, V25, P3000, DOI 10.1038/sj.emboj.7601203; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Ruecker A, 2014, ANTIMICROB AGENTS CH, V58, P7292, DOI 10.1128/AAC.03666-14; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanders NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105817; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sigala PA, 2014, ANNU REV MICROBIOL, V68, P259, DOI 10.1146/annurev-micro-091313-103537; Sinden RE, 2017, ADV PARASIT, V97, P147, DOI 10.1016/bs.apar.2016.09.004; Sun W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03743; Tanaka TQ, 2013, MOL BIOCHEM PARASIT, V188, P20, DOI 10.1016/j.molbiopara.2013.02.005; Tilley L, 2016, TRENDS PARASITOL, V32, P682, DOI [10.10164/j.pt.2016.05.010, 10.1016/j.pt.2016.05.010]; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tumwebaze P, 2017, J INFECT DIS, V215, P631, DOI 10.1093/infdis/jiw614; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; White NJ, 2013, LANCET INFECT DIS, V13, P175, DOI 10.1016/S1473-3099(12)70198-6; World Health Organization (WHO), 2016, WORLD MALARIA REPORT; Wunderlich Juliane, 2012, Front Biosci (Schol Ed), V4, P1424	71	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2058-5276			NAT MICROBIOL	NAT. MICROBIOL	OCT	2017	2	10					1403	1414		10.1038/s41564-017-0007-4				12	Microbiology	Microbiology	FM7PO	WOS:000415272500006	28808258				2018-01-05	
J	Hajj, KA; Whitehead, KA				Hajj, Khalid A.; Whitehead, Kathryn A.			Tools for translation: non-viral materials for therapeutic mRNA delivery	NATURE REVIEWS MATERIALS			English	Review							LIPID-LIKE NANOPARTICLES; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; CRISPR-CAS SYSTEM; IN-VIVO; DENDRITIC CELLS; T-CELLS; GENE DELIVERY; STEM-CELLS; POLYPLEX NANOMICELLES	In recent years, messenger RNA (mRNA) has come into the spotlight as a versatile therapeutic with the potential to prevent and treat a staggering range of diseases. Billions of dollars have been invested in the commercial development of mRNA drugs, with ongoing clinical trials focused on vaccines (for example, influenza and Zika viruses) and cancer immunotherapy (for example, myeloma, leukaemia and glioblastoma). Although significant progress has been made in the design of in vitro-transcribed mRNA that retains potency while minimizing unwanted immune responses, the widespread use of mRNA drugs requires the development of safe and effective drug delivery vehicles. In this Review, we provide an overview of the field of mRNA therapeutics and describe recent advances in the development of synthetic materials that encapsulate and deliver mRNA payloads.	[Hajj, Khalid A.; Whitehead, Kathryn A.] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA; [Whitehead, Kathryn A.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Whitehead, KA (reprint author), Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.	kawhite@cmu.edu			Defense Advanced Research Projects Agency (DARPA) [D16AP00143]	Funding was provided by the Defense Advanced Research Projects Agency (DARPA), grant number D16AP00143. The authors thank R. Weiss for his feedback on the manuscript.	Aini H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18743; Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696                                                                 ; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Anderson DM, 2003, HUM GENE THER, V14, P191, DOI 10.1089/10430340360535751; Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051; Baba M, 2015, J CONTROL RELEASE, V201, P41, DOI 10.1016/j.jconrel.2015.01.017; Badieyan ZS, 2016, J CONTROL RELEASE, V239, P137, DOI 10.1016/j.jconrel.2016.08.037; Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035; Balmayor ER, 2017, STEM CELLS DEV, V26, P25, DOI 10.1089/scd.2016.0171; Barrett DM, 2013, HUM GENE THER, V24, P717, DOI 10.1089/hum.2013.075; Barrett DM, 2011, HUM GENE THER, V22, P1575, DOI 10.1089/hum.2011.070; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799                                                                    ; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; Broos Katrijn, 2016, Mol Ther Nucleic Acids, V5, pe326, DOI 10.1038/mtna.2016.38; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Cavazzana M, 2016, HUM GENE THER, V27, P108, DOI 10.1089/hum.2015.137; Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen QX, 2017, MOL THER, V25, P92, DOI 10.1016/j.ymthe.2016.10.006; Cheng XW, 2016, ADV DRUG DELIVER REV, V99, P129, DOI 10.1016/j.addr.2016.01.022; Chiper M, 2017, J CONTROL RELEASE, V246, P60, DOI 10.1016/j.jconrel.2016.12.005; Choi HY, 2016, J CONTROL RELEASE, V235, P222, DOI 10.1016/j.jconrel.2016.06.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CONRY RM, 1995, CANCER RES, V55, P1397; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; Deering RP, 2014, EXPERT OPIN DRUG DEL, V11, P885, DOI 10.1517/17425247.2014.901308; DeRosa F, 2016, GENE THER, V23, P699, DOI 10.1038/gt.2016.46; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DIMITRIADIS GJ, 1978, NATURE, V274, P923, DOI 10.1038/274923a0                                                                ; Dong YZ, 2016, NANO LETT, V16, P842, DOI 10.1021/acs.nanolett.5b02428; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eshhar Z, 2001, J IMMUNOL METHODS, V248, P67, DOI 10.1016/S0022-1759(00)00343-4                                                   ; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fenton OS, 2016, ADV MATER, V28, P2939, DOI 10.1002/adma.201505822; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949                                                    ; Giacca M, 2012, J CONTROL RELEASE, V161, P377, DOI 10.1016/j.jconrel.2012.04.008; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hafez IM, 2001, GENE THER, V8, P1188, DOI 10.1038/sj.gt.3301506; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Harvie P, 1998, BIOPHYS J, V75, P1040, DOI 10.1016/S0006-3495(98)77593-9                                                   ; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hattinger E., 2015, J IMMUNOL RES, V2015; Hegde M, 2013, MOL THER, V21, P2087, DOI 10.1038/mt.2013.185; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Heiser A, 2002, J CLIN INVEST, V109, P409, DOI 10.1172/JCI14364; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jarzebinska A, 2016, ANGEW CHEM INT EDIT, V55, P9591, DOI 10.1002/anie.201603648; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Jiang C, 2017, CELL RES, V27, P440, DOI 10.1038/cr.2017.16; JIRIKOWSKI GF, 1992, SCIENCE, V255, P996, DOI 10.1126/science.1546298; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]; Josephson N, 2013, HEMATOL-AM SOC HEMAT, P261; Kaczmarek J. C., 2016, ANGEW CHEM, V128, P14012; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 1999, GENE THER, V6, P1092, DOI 10.1038/sj.gt.3300930; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2007, CURR OPIN DRUG DISC, V10, P523; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kranz LM, 2016, NATURE, V534, P396, DOI 10.1038/nature18300; Landesman-Milo D, 2014, DRUG DELIV TRANSL RE, V4, P96, DOI 10.1007/s13346-013-0158-7; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Lee BL, 2014, TRENDS CELL BIOL, V24, P360, DOI 10.1016/j.tcb.2013.12.002; Leonhardt C, 2014, NANOMED-NANOTECHNOL, V10, P679, DOI 10.1016/j.nano.2013.11.008; Li B, 2015, NANO LETT, V15, P8099, DOI 10.1021/acs.nanolett.5b03528; Li JH, 2017, ACS NANO, V11, P2531, DOI 10.1021/acsnano.6b08447; Li M, 2016, J CONTROL RELEASE, V228, P9, DOI 10.1016/j.jconrel.2016.02.043; Li WJ, 2007, PHARM RES, V24, P438, DOI 10.1007/s11095-006-9180-5; Lin CY, 2016, J CONTROL RELEASE, V235, P268, DOI 10.1016/j.jconrel.2016.06.001; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; LOCKARD RE, 1969, BIOCHEM BIOPH RES CO, V37, P204, DOI 10.1016/0006-291X(69)90720-7                                                    ; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lorenz C, 2011, RNA BIOL, V8, P627, DOI 10.4161/rna.8.4.15394; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Luo X, 2017, NANOSCALE, V9, P1575, DOI 10.1039/c6nr08496f; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Ma Z, 2005, BIOCHEM BIOPH RES CO, V330, P755, DOI 10.1016/j.bbrc.2005.03.041; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077                                                         ; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Mandl CW, 1998, NAT MED, V4, P1438, DOI 10.1038/4031                                                                    ; MARTINON F, 1993, EUR J IMMUNOL, V23, P1719, DOI 10.1002/eji.1830230749; Matsui A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15810; Maus MV, 2014, BLOOD, V123, P2625, DOI 10.1182/blood-2013-11-492231; McKinlay CJ, 2017, P NATL ACAD SCI USA, V114, pE448, DOI 10.1073/pnas.1614193114; Meijer HA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm830; Midoux P, 2015, EXPERT REV VACCINES, V14, P221, DOI 10.1586/14760584.2015.986104; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Murata-Hori M., 2005, ELS; Nair SK, 2000, NAT MED, V6, P1011; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; NEUMANN E, 1982, EMBO J, V1, P841; Oberli MA, 2017, NANO LETT, V17, P1326, DOI 10.1021/acs.nanolett.6b03329; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Perche F, 2011, NANOMED-NANOTECHNOL, V7, P445, DOI 10.1016/j.nano.2010.12.010; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Qiu P, 1996, GENE THER, V3, P262; Ramanj K, 1998, P NATL ACAD SCI USA, V95, P11886, DOI 10.1073/pnas.95.20.11886; Ramaswamy S, 2017, P NATL ACAD SCI USA, V114, pE1941, DOI 10.1073/pnas.1619653114; Rejman J, 2010, J CONTROL RELEASE, V147, P385, DOI 10.1016/j.jconrel.2010.07.124; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Roesler E, 2009, J ALLERGY CLIN IMMUN, V124, P1070, DOI 10.1016/j.jaci.2009.06.036; Rupp LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00462-8; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Schlake T, 2012, RNA BIOL, V9, P1319, DOI 10.4161/rna.22269; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8                                                    ; Smits E, 2004, LEUKEMIA, V18, P1898, DOI 10.1038/sj.leu.2403463; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tatiparti K, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7040077; Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Uchida S, 2016, BIOMATERIALS, V82, P221, DOI 10.1016/j.biomaterials.2015.12.031; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Vila A, 2002, J CONTROL RELEASE, V78, P15, DOI 10.1016/S0168-3659(01)00486-2                                                   ; Walsh CL, 2013, BIOCONJUGATE CHEM, V24, P36, DOI [10.1021/bc300346h, 10.3969/j.issn.1001-1978.2013.01.009]; Wang T, 2012, INT J PHARMACEUT, V427, P3, DOI 10.1016/j.ijpharm.2011.07.013; WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Whitehead KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5277; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wittrup A, 2015, NAT BIOTECHNOL, V33, P870, DOI 10.1038/nbt.3298; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wong CH, 2005, J ORG CHEM, V70, P4219, DOI 10.1021/jo050278f; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yao B, 2016, NAT REV NEUROSCI, V17, P537, DOI 10.1038/nrn.2016.70; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yoon SH, 2009, CANCER GENE THER, V16, P489, DOI 10.1038/cgt.2008.98; Zamecnik J, 2004, NEUROPATH APPL NEURO, V30, P338, DOI 10.1046/j.1365-2990.2003.0541.x; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhao MN, 2016, DRUG DELIV, V23, P2596, DOI 10.3109/10717544.2015.1038856; Zhou WZ, 1999, HUM GENE THER, V10, P2719, DOI 10.1089/10430349950016762                                                       	163	0	0	23	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2058-8437			NAT REV MATER	Nat. Rev. Mater.	OCT	2017	2	10							17056	10.1038/natrevmats.2017.56				17	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	FM6SS	WOS:000415188900004					2018-01-05	
J	Chen, JS; Doudna, JA				Chen, Janice S.; Doudna, Jennifer A.			The chemistry of Cas9 and its CRISPR colleagues	NATURE REVIEWS CHEMISTRY			English	Review							TARGET DNA RECOGNITION; STAPHYLOCOCCUS-AUREUS CAS9; ALTERED PAM SPECIFICITIES; RNA-GUIDED ENDONUCLEASE; PROVIDES ACQUIRED-RESISTANCE; GENOME EDITING SPECIFICITY; R-LOOP FORMATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HUMAN-CELLS	RNA-guided binding and cleavage of nucleic acids by CRISPR-Cas systems is a defining feature of bacterial and archaeal adaptive immunity against viruses and plasmids. As a result of their programmable ability to cut specific DNA and RNA sequences, Cas9 and related single-subunit effector proteins from CRISPR-Cas systems have been widely adopted for research and therapeutic genome engineering applications. In this Review, we discuss the chemistry of macromolecules involved in the multistep interference pathway used by CRISPR-Cas systems that mediate accurate nucleic acid target recognition and cutting. Although this Review mainly focuses on DNA interference by Cas9, we briefly explore nucleic acid targeting by the single-effector proteins Cas12 and Cas13 to emphasize the conserved themes of precision DNA and RNA cleavage within class 2 CRISPR-Cas systems. We further highlight the unique mechanisms of surveillance complex formation, substrate recognition and target cleavage in molecular detail across diverse single-subunit CRISPR-Cas interference proteins.	[Chen, Janice S.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu					Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Arslan Z, 2013, NUCLEIC ACIDS RES, V41, P6347, DOI 10.1093/nar/gkt315; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Bisaria N, 2017, CELL SYST, V4, P21, DOI 10.1016/j.cels.2016.12.010; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Chen L, 2013, NUCLEIC ACIDS RES, V41, P648, DOI 10.1093/nar/gks1015; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457; Dagdas YS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao0027; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Fellmann C, 2017, NAT REV DRUG DISCOV, V16, P89, DOI 10.1038/nrd.2016.238; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Gao P, 2016, CELL RES, V26, P901, DOI 10.1038/cr.2016.88; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Gorecka KM, 2013, NUCLEIC ACIDS RES, V41, P9945, DOI 10.1093/nar/gkt769; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Josephs EA, 2015, NUCLEIC ACIDS RES, V43, P8924, DOI 10.1093/nar/gkv892; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; KIM E, 2017, NAT COMMUN, V8; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Knott GJ, 2017, NAT STRUCT MOL BIOL, V24, P825, DOI 10.1038/nsmb.3466; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li CL, 2003, EMBO J, V22, P4014, DOI 10.1093/emboj/cdg377; Lim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13350; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu L, 2017, CELL, V170, P714, DOI 10.1016/j.cell.2017.06.050; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Liu TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170552; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mekler V, 2017, P NATL ACAD SCI USA, V114, P5443, DOI 10.1073/pnas.1619926114; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nelson P, 1999, P NATL ACAD SCI USA, V96, P14342, DOI 10.1073/pnas.96.25.14342; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467; Nishimasu H, 2017, MOL CELL, V67, P139, DOI 10.1016/j.molcel.2017.04.019; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Nowak CM, 2016, NUCLEIC ACIDS RES, V44, P9555, DOI 10.1093/nar/gkw908; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Osuka S., PREPRINT; Palermo G., 2017, J AM CHEM SOC; Palermo G, 2017, P NATL ACAD SCI USA, V114, P7260, DOI 10.1073/pnas.1707645114; Palermo G, 2016, ACS CENTRAL SCI, V2, P756, DOI 10.1021/acscentsci.6b00218; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Stella S, 2017, NATURE, V546, P559, DOI 10.1038/nature22398; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Thyme SB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11750; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tu M., 2017, NUCL ACIDS RES; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752                                                               ; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Westra ER, 2012, RNA BIOL, V9, P1134, DOI 10.4161/rna.21410; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xiao Y., 2017, CELL, V170; Yamada M, 2017, MOL CELL, V65, P1109, DOI 10.1016/j.molcel.2017.02.007; Yamano T, 2017, MOL CELL, V67, P633, DOI 10.1016/j.molcel.2017.06.035; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yee JK, 2016, FEBS J, V283, P3239, DOI 10.1111/febs.13760; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047232; Zheng T, 2017, SCI REP-UK, V7, DOI 10.1038/srep40638	174	0	0	14	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2397-3358			NAT REV CHEM	Nat. Rev. Chem.	OCT	2017	1	10							UNSP 0078	10.1038/s41570-017-0078				15	Chemistry, Multidisciplinary	Chemistry	FM7HB	WOS:000415244400004					2018-01-05	
J	Ren, L; Fan, SH; Wang, JH; Ruth, N; Qiao, C; Jia, Y; Yan, YC				Ren, Lei; Fan, Shuanghu; Wang, Junhuan; Ruth, Nahurira; Qiao, Cheng; Jia, Yang; Yan, Yanchun			Complete genome sequence of a phthalic acid esters degrading Mycobacterium sp YC-RL4	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Genome Sequence; Mycobacterium sp.; Biodegradation; Phthalic acid esters	N-BUTYL PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE; GORDONIA SP; BIODEGRADATION; DEGRADATION; HYDROLASE	Mycobacterium sp. YC-RL4 is capable of utilizing a broad range of phthalic acid esters (PAEs) as sole source of carbon and energy for growth. The preliminary studies demonstrated its high degrading efficiency and good performance during the bioprocess with environmental samples. Here, we present the complete genome of Mycobacterium sp. YC-RL4, which consists of one circular chromosome (5,801,417 bp) and one plasmid (252,568 bp). The genomic analysis and gene annotation were performed and many potential genes responsible for the biodegradation of PAEs were identified from the genome. These results may advance the investigation of bioremediation of PAEs-contaminated environments by strain YC-RL4. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Ren, Lei; Fan, Shuanghu; Wang, Junhuan; Ruth, Nahurira; Qiao, Cheng; Jia, Yang; Yan, Yanchun] Chinese Acad Agr Sci, Grad Sch, 12 Zhongguancun South St, Beijing, Peoples R China	Yan, YC (reprint author), Chinese Acad Agr Sci, Grad Sch, 12 Zhongguancun South St, Beijing, Peoples R China.	yanyanchun@caas.cn		Ren, Lei/0000-0003-3021-7246	National Natural Science Foundation of China [31540067, 31170119]; CAAS [0042014006, 0042012003, 0042011006]	This work was supported by the National Natural Science Foundation of China (31540067, 31170119), and Basic Research Fund of CAAS (0042014006, 0042012003 and 0042011006).	Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Blom A, 1998, ARCH ENVIRON CON TOX, V34, P306, DOI 10.1007/s002449900322                                                           ; Chang HK, 1998, J BACTERIOL, V180, P6529; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Hara H, 2010, APPL ENVIRON MICROB, V76, P1516, DOI 10.1128/AEM.02621-09; Jin DC, 2010, J MICROBIOL BIOTECHN, V20, P1440, DOI 10.4014/jmb.1004.04034; Jin DC, 2012, J HAZARD MATER, V221, P80, DOI 10.1016/j.jhazmat.2012.04.010; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Nishioka T, 2006, APPL ENVIRON MICROB, V72, P2394, DOI 10.1128/AEM.72.4.2394-2399.2006; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Quan CS, 2005, APPL MICROBIOL BIOT, V66, P702, DOI 10.1007/s00253-004-1683-6; Ren L, 2016, ENV SCI POLLUT RES; WANG JL, 1995, CHEMOSPHERE, V31, P4051, DOI 10.1016/0045-6535(95)80006-7; Xu XR, 2005, INT BIODETER BIODEGR, V55, P9, DOI 10.1016/j.ibiod.2004.05.005	15	0	0	5	5	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					607	609		10.1016/j.bjm.2016.09.022				3	Microbiology	Microbiology	FM0ZJ	WOS:000414697800001	28647306	gold			2018-01-05	
J	Simoes-Araujo, JL; Rumjanek, NG; Xavier, GR; Zilli, JE				Simoes-Araujo, Jean Luiz; Rumjanek, Norma Gouvea; Xavier, Gustavo Ribeiro; Zilli, Jerri Edson			Draft genome sequence of Bradyrhizobium manausense strain BR 3351(T), an effective symbiont isolated from Amazon rainforest	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Amazon forest; Biological nitrogen fixation; Next generation sequencing; Nodulation; Cowpea	EFFECTIVE NODULES; SP NOV.; VIGNA-UNGUICULATA; TRAP PLANT; SOILS; DIVERSITY; COWPEA	The strain BR 3351(T) (Bradyrhizobium manausense) was obtained from nodules of cowpea (Vigna unguiculata L. Walp) growing in soil collected from Amazon rainforest. Furthermore, it was observed that the strain has high capacity to fix nitrogen symbiotically in symbioses with cowpea. We report here the draft genome sequence of strain BR 3351T. The information presented will be important for comparative analysis of nodulation and nitrogen fixation for diazotrophic bacteria. A draft genome with 9,145,311 bp and 62.9% of GC content was assembled in 127 scaffolds using 100 by pair-end Illumina MiSeq system. The RAST annotation identified 8603 coding sequences, 51 RNAs genes, classified in 504 subsystems. Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Microbiologia.	[Simoes-Araujo, Jean Luiz; Rumjanek, Norma Gouvea; Xavier, Gustavo Ribeiro; Zilli, Jerri Edson] Embrapa Agrobiol, Seropedica, RJ, Brazil	Zilli, JE (reprint author), Embrapa Agrobiol, Seropedica, RJ, Brazil.	jerri.zilli@embrapa.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	We would like to thank to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the financial support and research fellowship (PQ) given to the authors.	da Silva K, 2014, INT J SYST EVOL MICR, V64, P3395, DOI 10.1099/ijs.0.063727-0; Guimaraes AA, 2012, APPL ENVIRON MICROB, V78, P6726, DOI 10.1128/AEM.01303-12; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Sanchez C, 2011, SOIL BIOL BIOCHEM, V43, P212, DOI 10.1016/j.soilbio.2010.09.020; Silva FV, 2012, BRAZ J MICROBIOL, V43, P682, DOI 10.1590/S1517-83822012000200033; Silva FV, 2014, INT J SYST EVOL MICR, V64, P2358, DOI 10.1099/ijs.0.061259-0; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tortosa G, 2015, SYMBIOSIS, V67, P125, DOI 10.1007/s13199-015-0341-3; Vincent JM, 1970, MANUAL PRACTICAL STU; Zilli JE, 2014, INT J SYST EVOL MICR, V64, P3950, DOI 10.1099/ijs.0.065458-0	10	0	0	2	2	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					610	611		10.1016/j.bjm.2016.10.025				2	Microbiology	Microbiology	FM0ZJ	WOS:000414697800002	28237675	gold			2018-01-05	
J	de Melo, RR; Persinoti, GF; Paixao, DAA; Squina, FM; Ruller, R; Sato, HH				de Melo, Ricardo Rodrigues; Persinoti, Gabriela Felix; Aluaredo Paixao, Douglas Antonio; Squina, Fabio Marcio; Ruller, Roberto; Sato, Helia Harumi			Draft genome sequence of Streptomyces sp strain F1, a potential source for glycoside hydrolases isolated from Brazilian soil	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Actinobacteria; Glycoside hydrolases; Streptomyces; Draft genome sequence; Soil bacteria		Here, we show the draft genome sequence of Streptomyces sp. F1, a strain isolated from soil with great potential for secretion of hydrolytic enzymes used to deconstruct cellulosic biomass. The draft genome assembly of Streptomyces sp. strain F1 has 69 contigs with a total genome size of 8,142,296 by and G+C 72.65%. Preliminary genome analysis identified 175 proteins as Carbohydrate-Active Enzymes, being 85 glycoside hydrolases organized in 33 distinct families. This draft genome information provides new insights on the key genes encoding hydrolytic enzymes involved in biomass deconstruction employed by soil bacteria. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[de Melo, Ricardo Rodrigues; Persinoti, Gabriela Felix; Aluaredo Paixao, Douglas Antonio; Squina, Fabio Marcio; Ruller, Roberto] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [de Melo, Ricardo Rodrigues; Sato, Helia Harumi] Univ Estadual Campinas UNICAMP, Fac Engn Alimentos, Dept Ciencia Alimentos, Campinas, SP, Brazil	Ruller, R (reprint author), CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.; Sato, HH (reprint author), Univ Estadual Campinas UNICAMP, Fac Engn Alimentos, Dept Ciencia Alimentos, Campinas, SP, Brazil.	roberto.ruller@bioetanol.org.br; heliah@fea.unicamp.br			Brazilian National Council for Scientific and Technological Development (CNPq)	The authors gratefully acknowledge the Brazilian National Council for Scientific and Technological Development (CNPq) for their financial support and fellowships, and CNPEM-CTBE for the use of Sequencing and Robotics NGS facility.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barbe V, 2011, J BACTERIOL, V193, P5055, DOI 10.1128/JB.05583-11; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Book AJ, 2014, APPL ENVIRON MICROB, V80, P4692, DOI 10.1128/AEM.01133-14; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Franco-Cirigliano MN, 2013, BIOMED RES INT, DOI 10.1155/2013/584207; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Semedo LTAS, 2004, INT J SYST EVOL MICR, V54, P1323, DOI 10.1099/ijs.0.02844-0; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Varghese NJ, 2015, NUCLEIC ACIDS RES, V43, P6761, DOI 10.1093/nar/gkv657; Wibberg D, 2016, J BIOTECHNOL, V222, P13, DOI 10.1016/j.jbiotec.2016.02.002	13	0	0	5	5	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					612	614		10.1016/j.bjm.2016.11.010				3	Microbiology	Microbiology	FM0ZJ	WOS:000414697800003	28359855	gold			2018-01-05	
J	Yang, YL; Lin, ES; Huang, SB				Yang, Yunlong; Lin, Ershu; Huang, Shaobin			Complete genome sequence of the aerobically denitrifying thermophilic bacterium Chelatococcus daeguensis TAD1	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Chelatococcus daeguensis TAD1; Complete genome sequencing; Aerobic denitrification	HETEROTROPHIC NITRIFICATION; BIOTRICKLING FILTER; NITRIC-OXIDE; WASTE-WATER; DENITRIFICATION; REMOVAL; NITROGEN; STRAIN	Chelatococcus daeguensis TAD1 is a themophilic bacterium isolated from a biotrickling filter used to treat NOx in Ruiming Power Plant, located in Guangzhou, China, which shows an excellent aerobic denitrification activity at high temperature. The complete genome sequence of this strain was reported in the present study. Genes related to the aerobic denitrification were identified through whole genome analysis. This work will facilitate the mechanism of aerobic denitrification and provide evidence for its potential application in the nitrogen removal. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Yang, Yunlong; Lin, Ershu] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Huang, Shaobin] Guangdong Regular Higher Educ Inst, Key Lab Environm Protect & Ecoremediat, Guangzhou, Guangdong, Peoples R China; [Huang, Shaobin] South China Univ Technol, Sch Environm & Energy, Guangzhou, Guangdong, Peoples R China	Huang, SB (reprint author), Guangdong Regular Higher Educ Inst, Key Lab Environm Protect & Ecoremediat, Guangzhou, Guangdong, Peoples R China.; Huang, SB (reprint author), South China Univ Technol, Sch Environm & Energy, Guangzhou, Guangdong, Peoples R China.	hshltyyl@126.com			National Natural Science Foundation of China [21407024]; Natural Science Foundation of Fujian Province [2015J01594]	This work was supported by the National Natural Science Foundation of China (no. 21407024) and the Natural Science Foundation of Fujian Province (no. 2015J01594).	Chen J, 2015, APPL MICROBIOL BIOT, V99, P10695, DOI 10.1007/s00253-015-6870-0; Duan JM, 2015, BIORESOURCE TECHNOL, V179, P421, DOI 10.1016/j.biortech.2014.12.057; He TX, 2016, BIORESOURCE TECHNOL, V200, P493, DOI 10.1016/j.biortech.2015.10.064; Liang W, 2012, BIORESOURCE TECHNOL, V125, P82, DOI 10.1016/j.biortech.2012.08.111; Liang W, 2012, J AIR WASTE MANAGE, V62, P509, DOI 10.1080/10962247.2012.660557; Padhi SK, 2013, INT BIODETER BIODEGR, V78, P67, DOI 10.1016/j.ibiod.2013.01.001; Sun ZY, 2016, BIORESOURCE TECHNOL, V220, P142, DOI 10.1016/j.biortech.2016.07.110; Yang YL, 2012, J HAZARD MATER, V203, P326, DOI 10.1016/j.jhazmat.2011.12.031	8	0	0	5	5	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					615	616		10.1016/j.bjm.2017.03.001				2	Microbiology	Microbiology	FM0ZJ	WOS:000414697800004	28610831	gold			2018-01-05	
J	Muthukamalam, S; Sivagangavathi, S; Dhrishya, D; Rani, SS				Muthukamalam, Santhakumar; Sivagangavathi, Sivalingam; Dhrishya, Dharmapal; Rani, Sadras Sudha			Characterization of dioxygenases and biosurfactants produced by crude oil degrading soil bacteria	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Crude oil; Biodegradation; Bacteria; Catechol dioxygenase; Biosurfactant	CATECHOL 1,2-DIOXYGENASE; DEGRADATION; BACILLUS; PURIFICATION; BIODEGRADATION; STRAINS	Role of microbes in bioremediation of oil spills has become inevitable owing to their eco friendly nature. This study focused on the isolation and characterization of bacterial strains with superior oil degrading potential from crude-oil contaminated soil. Three such bacterial strains were selected and subsequently identified by 16S rRNA gene sequence analysis as Corynebacterium aurimucosum, Acinetobacter baumannii and Microbacterium hydrocarbonoxydans respectively. The specific activity of catechol 1,2 dioxygenase (C12O) and catechol 2,3 dioxygenase (C23O) was determined in these three strains wherein the activity of C12O was more than that of C23O. Among the three strains, Microbacterium hydrocarbonoxydans exhibited superior crude oil degrading ability as evidenced by its superior growth rate in crude oil enriched medium and enhanced activity of dioxygenases. Also degradation of total petroleum hydrocarbon (TPH) in crude oil was higher with Microbacterium hydrocarbonoxydans. The three strains also produced biosurfactants of glycolipid nature as indicated d by biochemical, FTIR and GCMS analysis. These findings emphasize that such bacterial strains with superior oil degrading capacity may find their potential application in bioremediation of oil spills and conservation of marine and soil ecosystem. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Muthukamalam, Santhakumar; Sivagangavathi, Sivalingam; Dhrishya, Dharmapal; Rani, Sadras Sudha] Pondicherry Univ, Sch Life Sci, Dept Biochem & Mol Biol, Pondicherry 605014, India	Rani, SS (reprint author), Pondicherry Univ, Sch Life Sci, Dept Biochem & Mol Biol, Pondicherry 605014, India.	dr.ssrlab@gmail.com			UGC, New Delhi, India [CSIR-UGC-JRF 316979]	The authors duly acknowledge instrument support from the Department of Biochemistry and Molecular Biology, Pondicherry University, India and DST-FIST, Government of India. The first author (Muthukamalam S) conveys special thanks to UGC, New Delhi, India, for financial support in the form of Junior Research Fellowship (CSIR-UGC-JRF 316979; Ref no. 21/12/2014(ii)EU-V). The authors convey special thanks to Indian Oil Corporation Limited (IOCL), Chennai, Tamil Nadu, India for providing soil samples and crude oil.	Akintunde TA, 2015, EUR J BIOTECHNOL BIO, V3, P34; Anitha J, 2015, INT J ADV BIOL SCI, V2, P7; Arun Kumar, 2011, International Journal of Environmental Sciences, V1, P1420; Batista SB, 2006, BIORESOURCE TECHNOL, V97, P868, DOI 10.1016/j.biortech.2005.04.020; Binazadeh M, 2009, ENZYME MICROB TECH, V45, P195, DOI 10.1016/j.enzmictec.2009.06.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Briganti F, 1997, FEBS LETT, V416, P61, DOI 10.1016/S0014-5793(97)01167-8; Chandrasekaran EV, 1980, METHODS CARBOHYDRATE, V8, P89; Cenci G, 1997, APPL MICROBIOL BIOT, V47, P306, DOI 10.1007/s002530050931                                                           ; CHEN YP, 1990, APPL ENVIRON MICROB, V56, P1971; COOPER DG, 1987, APPL ENVIRON MICROB, V53, P224; Das K, 2007, BIORESOURCE TECHNOL, V98, P1339, DOI 10.1016/j.biortech.2006.05.032; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017                                                             ; FEIST CF, 1969, J BACTERIOL, V100, P869; Ferradji FZ, 2014, INT BIODETER BIODEGR, V86, P300, DOI 10.1016/j.ibiod.2013.10.003; Hassanshahian M, 2012, MAR POLLUT BULL, V64, P7, DOI 10.1016/j.marpolbul.2011.11.006; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hegeman GD, 1966, J BACTERIOL, V190, P5439; Kalyani ALT, 2014, INT J PHARM SCI REV, V25, P165; Kumari B, 2012, PROCESS BIOCHEM, V47, P2463, DOI 10.1016/j.procbio.2012.10.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lal B, 1996, J APPL BACTERIOL, V81, P355; Morikawa M, 2000, BBA-MOL CELL BIOL L, V1488, P211, DOI 10.1016/S1388-1981(00)00124-4; Nadaf N. H., 2011, Research Journal of Environmental and Earth Sciences, V3, P608; Bola OO, 2006, NATURE SCI, V4, P51; Ojo OA, 2006, AFR J BIOTECHNOL, V5, P333; Rahman KSM, 2002, BIORESOURCE TECHNOL, V85, P257, DOI 10.1016/S0960-8524(02)00119-0; Rashedi H., 2005, International Journal of Environmental Science and Technology, V2, P59; SAMBROOK J, 1989, MOL CLONING, V2, P1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sato H, 2002, CURR DRUG METAB, V3, P311, DOI 10.2174/1389200023337603                                                        ; Sepahi AA, 2008, IRAN J ENVIRON HEALT, V5, P149; Strachan PD, 1998, BIOCHEM J, V333, P741, DOI 10.1042/bj3330741                                                               ; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thavasi R, 2011, BIORESOURCE TECHNOL, V102, P772, DOI 10.1016/j.biortech.2010.08.099; Urszula G, 2009, BRAZ J MICROBIOL, V40, P285, DOI [10.1590/S1517-83822009000200014, 10.1590/S1517-838220090002000014]; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; Wenzhong Shen, 2008, Recent Patents on Chemical Engineering, V1, P27; Yakimov MM, 1996, BIOTECHNOL APPL BIOC, V23, P13; ZHANG YM, 1992, APPL ENVIRON MICROB, V58, P3276; Zhang ZZ, 2011, BIORESOURCE TECHNOL, V102, P4111, DOI 10.1016/j.biortech.2010.12.064	41	0	0	11	11	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					637	647		10.1016/j.bjm.2017.02.007				11	Microbiology	Microbiology	FM0ZJ	WOS:000414697800007	28629972	gold			2018-01-05	
J	Caamano, E; Loperena, L; Hinzpeter, I; Pradel, P; Gordillo, F; Corsini, G; Tello, M; Lavin, P; Gonzalez, AR				Caamano, Esteban; Loperena, Lyliam; Hinzpeter, Ivonne; Pradel, Paulina; Gordillo, Felipe; Corsini, Gino; Tello, Mario; Lavin, Paris; Gonzalez, Alex R.			Isolation and molecular characterization of Thraustochytrium strain isolated from Antarctic Peninsula and its biotechnological potential in the production of fatty acids	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Thraustochytrids; Antarctic; Docosahexaenoic acid; Eicosapentaenoic acid; Temperature	2 DISTINCT PATHWAYS; CHAIN OMEGA-3 OILS; OLEAGINOUS MICROORGANISMS; LIPID-ACCUMULATION; SCHIZOCHYTRIUM SP; MARINE PROTISTS; BIODIESEL; DHA; LABYRINTHULOMYCOTA; EXTRACTION	Thraustochytrids are unicellular protists belonging to the Labyrinthulomycetes class, which are characterized by the presence of a high lipid content that could replace conventional fatty acids. They show a wide geographic distribution, however their diversity in the Antarctic Region is rather scarce. The analysis based on the complete sequence of 18S rRNA gene showed that strain 34-2 belongs to the species Thraustochytrium kinnei, with 99% identity. The total lipid profile shows a wide range of saturated fatty acids with abundance of palmitic acid (16:0), showing a range of 16.1-19.7%. On the other hand, long-chain polyunsaturated fatty acids, mainly docosahexaenoic acid and eicosapentaenoic acid are present in a range of 24-48% and 6.1-9.3%, respectively. All factors analyzed in cells (biomass, carbon consumption and lipid content) changed with variations of culture temperature (10 degrees C and 25 degrees C). The growth in glucose at a temperature of 10 degrees C presented the most favorable conditions to produce omega-3fatty acid. This research provides the identification and characterization of a Thraustochytrids strain, with a total lipid content that presents potential applications in the production of nutritional supplements and as well biofuels. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Caamano, Esteban; Gonzalez, Alex R.] Univ Lagos, Dept Ciencias Biol, Lab Microbiol Ambiental & Extremofilos, Osorno, Chile; [Loperena, Lyliam] Univ Republica, Dept Bioingn, Inst Ingn Quim, Montevideo, Uruguay; [Hinzpeter, Ivonne] Univ Lagos, Dept Gobierno & Empresa, Osorno, Chile; [Pradel, Paulina] Univ La Frontera, Ctr Interacc Planta Suelo & Biotecnol Recursos Na, Lab Fisiol & Biol Mol Vegetal, Temuco, Chile; [Gordillo, Felipe] Univ Catolica Maule, Fac Ciencias Agr & Forestales, Ctr Biotecnol Recursos Nat, Talca, Chile; [Corsini, Gino] Univ Autonoma Chile, Inst Ciencias Biomed, Fac Ciencias Salud, Santiago, Chile; [Corsini, Gino] Univ Cient Sur, Lima, Peru; [Tello, Mario] Univ Santiago, Fac Quim & Biol, Dept Biol, Ctr Biotecnol Acuicola, Santiago, Chile; [Lavin, Paris] Univ Antofagasta, Inst Antofagasta, Lab Complejidad Microbiana & Ecol Func, Antofagasta, Chile	Gonzalez, AR (reprint author), Univ Lagos, Dept Ciencias Biol, Lab Microbiol Ambiental & Extremofilos, Osorno, Chile.	Alex.gonzalez@ulagos.cl		Tello, Mario/0000-0003-4573-6460; Lavin, Paris/0000-0002-8893-526X; Gonzalez, Alex/0000-0001-9968-8623	PROJECT from PROGRAMA PAI-CONICYT [79112042]; Universidad Autonoma de Chile [30/2014 DPI]; CONICYT Doctoral Fellowship [21130177]; Chilean Antarctic Institute Grants [DG_07-16];  [DIULA 09/14];  [Basales Usa1555 USACH-MECESUP]	The authors wish to thank Mauricio Quiroz for his valuable assistance in microscopy work and Barbara Burmeister for proof-reading the manuscript. This work was supported by DIULA 09/14 (AG), PROJECT 79112042 from PROGRAMA PAI-CONICYT (FG), Grant Basales Usa1555 USACH-MECESUP to MT, Fund Research Support 30/2014 DPI Universidad Autonoma de Chile to (GC) and CONICYT Doctoral Fellowship No 21130177 and Chilean Antarctic Institute Grants DG_07-16 (PP).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashford A, 2000, LIPIDS, V35, P1377, DOI 10.1007/s11745-000-0655-2; BAHNWEG G, 1974, AM J BOT, V61, P754, DOI 10.2307/2441791                                                                 ; Barnes DKA, 2006, GLOBAL ECOL BIOGEOGR, V15, P121, DOI 10.1111/j.1466-822x.2006.00216.x; Bongiorni L, 2005, AQUAT MICROB ECOL, V41, P299, DOI 10.3354/ame041299; Bowles RD, 1999, J BIOTECHNOL, V70, P193, DOI 10.1016/S0168-1656(99)00072-3; BREMER GB, 1995, HYDROBIOLOGIA, V295, P89, DOI 10.1007/BF00029115                                                              ; Chang KJL, 2014, MAR BIOTECHNOL, V16, P396, DOI 10.1007/s10126-014-9560-5; Chang KJL, 2012, APPL MICROBIOL BIOT, V93, P2215, DOI 10.1007/s00253-011-3856-4; Damude HG, 2007, LIPIDS, V42, P179, DOI 10.1007/s11745-007-3049-1; De Wever A, 2009, P R SOC B, V276, P3591, DOI 10.1098/rspb.2009.0994; Falk O, 2004, EUR J LIPID SCI TECH, V106, P837, DOI 10.1002/ejlt.200400978; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisher L, 2008, WORLD INTELLECT PROP; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ganuza E, 2007, APPL MICROBIOL BIOT, V76, P985, DOI 10.1007/s00253-007-1019-4; Gavrilescu M, 2005, BIOTECHNOL ADV, V23, P471, DOI 10.1016/j.biotechadv.2005.03.004; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Gupta A, 2012, BIOTECHNOL ADV, V30, P1733, DOI 10.1016/j.biotechadv.2012.02.014; Hinzpeter I, 2009, AFINIDAD, V66, P482; Honda D, 1999, J EUKARYOT MICROBIOL, V46, P637, DOI 10.1111/j.1550-7408.1999.tb05141.x                                              ; Honda D, 1998, MYCOL RES, V102, P439, DOI 10.1017/S0953756297005170; Jain R, 2004, MAR BIOTECHNOL, V6, P59; Jain R, 2007, MAR BIOL, V151, P1657, DOI 10.1007/s00227-007-0608-1; Johnson MB, 2009, ENERG FUEL, V23, P5179, DOI 10.1021/ef900704h; Khanna M, 2011, INTERFACE FOCUS, V1, P233, DOI 10.1098/rsfs.2010.0016; Leander CA, 2004, EUR J PROTISTOL, V40, P317, DOI 10.1016/j.ejop.2004.07.003; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; Lewis TE, 1999, MAR BIOTECHNOL, V1, P580, DOI 10.1007/PL00011813                                                              ; Matsuda T, 2012, J LIPID RES, V53, P1210, DOI 10.1194/jlr.M024935; Meng X, 2009, RENEW ENERG, V34, P1, DOI 10.1016/j.renene.2008.04.014; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593                                                         ; Miller MR, 2007, COMP BIOCHEM PHYS A, V148, P382, DOI 10.1016/j.cbpa.2007.05.018; Mo C, 2007, MAR BIOL, V140, P883; Mo CQ, 2001, MAR BIOTECHNOL, V3, P100, DOI 10.1007/s101260000069                                                           ; Moro I, 2003, PROTIST, V154, P331, DOI 10.1078/143446103322454103; Nagano N, 2011, J OLEO SCI, V60, P475, DOI 10.5650/jos.60.475; Nakahara T, 1996, J AM OIL CHEM SOC, V73, P1421, DOI 10.1007/BF02523506                                                              ; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Nichols PD, 2004, INFORM, V15, P383; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Qiu X, 2003, PROSTAG LEUKOTR ESS, V68, P181, DOI 10.1016/S0952-3278(02)00268-5; Raghukumar S, 2002, EUR J PROTISTOL, V38, P127, DOI 10.1078/0932-4739-00832; RAGHUKUMAR S, 1992, MAR BIOL, V113, P165, DOI 10.1007/BF00367650; Raghukumar S, 1996, ADV ZOOSPORIC FUNGI, P35; Raghukumar S, 2008, MAR BIOTECHNOL, V10, P631, DOI 10.1007/s10126-008-9135-4; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; RATLEDGE C, 2013, OCL, V20; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Shene C, 2013, EUR J LIPID SCI TECH, V115, P890, DOI 10.1002/ejlt.201200417; Singh A, 1997, ADV APPL MICROBIOL, V45, P271, DOI 10.1016/S0065-2164(08)70266-1; Singh P, 2014, APPL MICROBIOL BIOT, V98, P5789, DOI 10.1007/s00253-014-5780-x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Yang HL, 2010, MAR BIOTECHNOL, V12, P173, DOI 10.1007/s10126-009-9207-0	58	0	0	4	4	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					671	679		10.1016/j.bjm.2017.01.011				9	Microbiology	Microbiology	FM0ZJ	WOS:000414697800010	28651890	gold			2018-01-05	
J	Toma, MA; de Carvalho, TS; Guimaraes, AA; da Costa, EM; da Silva, JS; Moreira, FMD				Toma, Maira Akemi; de Carvalho, Teotonio Soares; Guimaraes, Amanda Azarias; da Costa, Elaine Martins; da Silva, Jacqueline Savona; de Souza Moreira, Fatima Maria			Tripartite symbiosis of Sophora tomentosa, rhizobia and arbuscular mycorhizal fungi	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Legumes; Diversity of rhizobia; Degraded areas	GENETIC DIVERSITY; WESTERN AMAZON; BACTERIA; NODULES; LEGUMES; GROWTH; PLANT; BREVIBACILLUS; SINORHIZOBIUM; PAENIBACILLUS	Sophora tomentosa is a pantropical legume species with potential for recovery of areas degraded by salinization, and for stabilization of sand dunes. However, few studies on this species have been carried out, and none regarding its symbiotic relationship with beneficial soil microorganisms. Therefore, this study aimed to evaluate the diversity of nitrogen-fixing bacteria isolated from nodules of Sophora tomentosa, and to analyze the occurrence of colonization of arbuscular mycorrhizal fungi on the roots of this legume in seafront soil. Thus, seeds, root nodules, and soil from the rhizosphere of Sophora tomentosa were collected. From the soil samples, trap cultures with this species were established to extract spores and to evaluate arbuscular mycorhizal fungi colonization in legume roots, as well as to capture rhizobia. Rhizobia strains were isolated from nodules collected in the field or from the trap cultures. Representative isolates of the groups obtained in the similarity dendrogram, based on phenotypic characteristics, had their 16S rRNA genes sequenced. The legume species showed nodules with indeterminate growth, and reddish color, distributed throughout the root. Fifty-one strains of these nodules were isolated, of which 21 were classified in the genus Bacillus, Breuibacillus, Paenibacillus, Rhizobium and especially Sinorhizobium. Strains closely related to Sinorhizobium adhaerens were the predominant bacteria in nodules. The other genera found, with the exception of Rhizobium, are probably endophytic bacteria in the nodules. Arbuscular mycorrhizal fungi was observed colonizing the roots, but arbuscular mycorhizal fungi spores were not found in the trap cultures. Therefore Sophora tomentosa is associated with both arbuscular mycorhizal fungi and nodulating nitrogen-fixing bacteria. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Toma, Maira Akemi; de Carvalho, Teotonio Soares; Guimaraes, Amanda Azarias; da Silva, Jacqueline Savona; de Souza Moreira, Fatima Maria] Univ Fed Lavras UFLA, Dept Ciencia Solo DCS, Lavras, MG, Brazil; [da Costa, Elaine Martins] Univ Fed Mato Grosso Sul UFMS, Campus Chapadao Sul, Chapadao Do Sul, MS, Brazil	Moreira, FMD (reprint author), Univ Fed Lavras UFLA, Dept Ciencia Solo DCS, Lavras, MG, Brazil.	fmoreira@dcs.ufla.br			CNPq; CAPES; FAPEMIG	The authors thank CNPq, CAPES and FAPEMIG funding agencies for the master's, doctoral and post-doctoral scholarships, and CNPq for the research productivity fellowship granted to FMS Moreira.	Nobrega RSA, 2004, CIENC AGROTEC, V28, P899, DOI 10.1590/S1413-70542004000400024; Ahlgren CL., 2009, FRENCH POLYNESIA UCB; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Claus D., 1986, BERGEYS MANUAL SYSTE, V2, P1105; da Costa EM, 2013, PESQUI AGROPECU BRAS, V48, P1275, DOI 10.1590/S0100-204X2013000900012; de Lajudie P, 1999, SYST APPL MICROBIOL, V22, P119, DOI 10.1016/S0723-2020(99)80035-6                                                   ; Degano CAM., 1999, REV BRASILEIRA BOT, V22, P1; Edwards SG, 2001, J APPL MICROBIOL, V91, P652, DOI 10.1046/j.1365-2672.2001.01430.x; Empresa Brasileira de Pesquisa Agropecuaria, 2013, LIM FERT MAN STAT RI, P430; EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA (EMBRAPA Centro Nacional de Pesquisa de Solos), 1997, MAN MET AN SOL, P212; Fred EB, 1928, LAB MANUAL GEN MICRO, P145; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Gomide PHO, 2014, MATO GROSSO SUL REV, V38, P1114; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823                                                                 ; Guimaraes AA, 2012, APPL ENVIRON MICROB, V78, P6726, DOI 10.1128/AEM.01303-12; Hay JD, 1984, NUTR CYCLING SEAFRON, P459; Hoagland DR, 1950, WATER CULTURE METHOD, P32; Huang J, 1995, CAN J BOT, V73, P1859, DOI 10.1139/b95-198                                                                 ; Hung MH, 2005, PEDOBIOLOGIA, V49, P577, DOI 10.1016/j.pedobi.2005.06.002; Hurr KA, 1999, J BIOGEOGR, V26, P565, DOI 10.1046/j.1365-2699.1999.00302.x; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581                                                              ; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9                                                   ; Krishnan HB, 1998, FEMS MICROBIOL LETT, V165, P215, DOI 10.1111/j.1574-6968.1998.tb13149.x; Lal S, 2009, INDIAN J MICROBIOL, V49, P2, DOI 10.1007/s12088-009-0008-y; Li JH, 2008, SOIL BIOL BIOCHEM, V40, P238, DOI 10.1016/j.soilbio.2007.08.014; Lima AS, 2009, PLANT SOIL, V319, P127, DOI 10.1007/s11104-008-9855-2; Lourenco J, 2009, ACTA BOT BRAS, V23, P239, DOI 10.1590/S0102-33062009000100025; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359                                                         ; Moreira FMS, 2006, SOIL MICROBIOLOGY BI, P729; Muresu R, 2008, FEMS MICROBIOL ECOL, V63, P383, DOI 10.1111/j.1574-6941.2007.00424.x; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433                                                       ; Nogueira Elisa Maria, 2006, Biotemas, V19, P41; Ormeno-Orrillo E, 2015, SYST APPL MICROBIOL, V38, P287, DOI 10.1016/j.syapm.2014.12.002; Panda AK, 2014, ANTON LEEUW INT J G, V105, P623, DOI 10.1007/s10482-013-0099-7; Panday D, 2011, INT J SYST EVOL MICR, V61, P2632, DOI 10.1099/ijs.0.028407-0; Pena R. C., 2000, Pacific Science, V54, P159; R Development Core Team,, 2013, R LANG ENV STAT COMP; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Santos EC, 2001, FLORESTA AMBIENTE, V8, P216; SYKES WR, 1968, NATURE, V218, P495, DOI 10.1038/218495a0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Veloso PH, 1991, CLASSIFICACAO VEGETA, P124; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Willems A, 2003, INT J SYST EVOL MICR, V53, P1207, DOI 10.1099/ijs.0.02264-0; Zamith Luiz Roberto, 2004, Acta Bot. Bras., V18, P161, DOI 10.1590/S0102-33062004000100014; Zhang DL, 2000, JINGXI FORESTRY SCI, V5, P26	47	0	0	4	4	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					680	688		10.1016/j.bjm.2017.03.007				9	Microbiology	Microbiology	FM0ZJ	WOS:000414697800011	28756029	gold			2018-01-05	
J	Shi, JF; Sun, CQ				Shi, Jun-Feng; Sun, Chang-Qing			Isolation, identification, and biocontrol of antagonistic bacterium against Botrytis cinerea after tomato harvest	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Antagonistic bacterium; Antifungal activity; Identification; Tomato	BIOLOGICAL-CONTROL; BLUE MOLD; POSTHARVEST DISEASES; GRAY MOLD; SEQUENCE-ANALYSIS; APPLE; FRUITS; ENVIRONMENT; VEGETABLES; EFFICACY	Tomato is one of the most important vegetables in the world. Decay after harvest is a major issue in the development of tomato industry. Currently, the most effective method for controlling decay after harvest is storage of tomato at low temperature combined with usage of chemical bactericide; however, long-term usage of chemical bactericide not only causes pathogen resistance but also is harmful for human health and environment. Biocontrol method for the management of disease after tomato harvest has great practical significance. In this study, antagonistic bacterium B-6-1 strain was isolated from the surface of tomato and identified as Enterobacter cowanii based on morphological characteristics and physiological and biochemical features combined with sequence analysis of 16SrDNA and ropB gene and construction of dendrogram. Effects of different concentrations of antagonistic bacterium E. cowanii suspension on antifungal activity after tomato harvest were analyzed by mycelium growth rate method. Results revealed that antifungal activity was also enhanced with increasing concentrations of antagonistic bacterium; inhibitory rates of 1 x 10(5) colony forming units (cfu)/mL antagonistic bacterial solution on Fusarium verticillioides, Alternaria tenuissima, and Botrytis cinerea were 46.31%, 67.48%, and 75.67%, respectively. By using in vivo inoculation method, it was further confirmed that antagonistic bacterium could effectively inhibit the occurrence of B. cinerae after tomato harvest, biocontrol effect of 1 x 10(9) cfu/mL zymotic fluid reached up to 95.24%, and antagonistic bacterium E. cowanii has biocontrol potential against B. cinerea after harvest of fruits and vegetables. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Shi, Jun-Feng] Shanxi Acad Agr Sci, Inst Agr Prod Storage & Fresh Keeping, Taiyuan, Shanxi, Peoples R China; [Sun, Chang-Qing] Shanxi Acad Agr Sci, Inst Crop Sci, Taiyuan, Shanxi, Peoples R China	Shi, JF (reprint author), Shanxi Acad Agr Sci, Inst Agr Prod Storage & Fresh Keeping, Taiyuan, Shanxi, Peoples R China.	sjfty@126.com			PostDocFund of Shanxi Academy of Agricultural Science [BSH-2015JJ-003]; Shanxi Province Science and Technology Research Project [20140311025-2]	The authors are grateful to PostDocFund of Shanxi Academy of Agricultural Science (No. BSH-2015JJ-003) and Shanxi Province Science and Technology Research Project (No. 20140311025-2).	Batta YA, 2007, BIOL TECHNOL, V43, P143; Brady CL, 2009, LETT APPL MICROBIOL, V49, P461, DOI 10.1111/j.1472-765X.2009.02692.x; Brady C, 2008, SYST APPL MICROBIOL, V31, P447, DOI 10.1016/j.syapm.2008.09.004; CHALUTZ E, 1990, PLANT DIS, V74, P134, DOI 10.1094/PD-74-0134                                                              ; Coenye T, 1999, INT J SYST BACTERIOL, V49, P405, DOI 10.1099/00207713-49-2-405                                                       ; Dik AJ, 1999, EUR J PLANT PATHOL, V105, P123, DOI 10.1023/A:1008778213278; Droby S, 2003, POSTHARVEST BIOL TEC, V27, P127, DOI 10.1016/S0925-5214(02)00046-7; [段军娜 Duan Junna], 2014, [植物保护学报, Acta Phytophylacica Sinica], V41, P61; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Fu QM, 2010, SEPARATION CHARACTER; Gang C, 2002, J FUDAN U NAT SCI, V41, P382; HINTON DM, 1995, MYCOPATHOLOGIA, V129, P117, DOI 10.1007/BF01103471; Holt JG, 1994, BERGEYS MANUAL DETER; JANISIEWICZ WJ, 1988, PHYTOPATHOLOGY, V78, P1697, DOI 10.1094/Phyto-78-1697; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150                                                             ; Mercier J, 2004, POSTHARVEST BIOL TEC, V31, P1, DOI 10.1016/j.postharvbio.2003.08.004; Mikani A, 2008, POSTHARVEST BIOL TEC, V48, P107, DOI 10.1016/j.postharvbio.2007.09.020; Mukhopadhyay K, 1996, MYCOPATHOLOGIA, V134, P151, DOI 10.1007/BF00436723; Nunes C, 2002, J APPL MICROBIOL, V92, P247, DOI 10.1046/j.1365-2672.2002.01524.x; Schena L, 2003, POSTHARVEST BIOL TEC, V30, P209, DOI 10.1016/S0925-5214(03)00111-X; Sebastien M, 2015, BIOL CONTROL, V89, P98, DOI 10.1016/j.biocontrol.2015.06.003; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846                                                       ; Veneziano A, 2004, FOOD CHEM, V87, P383, DOI 10.1016/j.foodchem.2003.12.009; Vero S, 2002, POSTHARVEST BIOL TEC, V26, P91, DOI 10.1016/S0925-5214(01)00199-5; WALKER GM, 1995, FEMS MICROBIOL LETT, V127, P213; Wang Qian, 2010, Wei Sheng Wu Xue Bao, V50, P1208; Wang YF, 2008, INT J FOOD MICROBIOL, V123, P234, DOI 10.1016/j.ijfoodmicro.2008.02.002; Wang YF, 2010, BIOL CONTROL, V53, P178, DOI 10.1016/j.biocontrol.2010.01.002; WISNIEWSKI ME, 1992, HORTSCIENCE, V27, P94; [习柳 Xi Liu], 2005, [中国农业科学, Scientia Agricultura Sinica], V38, P950; Yang H, 2000, ACTA PHYTOPATHOL SIN, V30, P107; Yang RX, 2005, IDENTIFICATION ENDOP; Zhang HY, 2007, J FOOD ENG, V78, P281, DOI 10.1016/j.jfoodeng.2005.09.027; Zhou T, 2002, CAN J PLANT PATHOL, V24, P154, DOI 10.1080/07060660309506990                                                       	36	0	0	3	3	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					706	714		10.1016/j.bjm.2017.03.002				9	Microbiology	Microbiology	FM0ZJ	WOS:000414697800014	28645650	gold			2018-01-05	
J	Ma, YL; Deng, Y; Xu, ZB; Liu, JY; Dong, JJ; Yin, H; Yu, JH; Chang, ZM; Wang, DF				Ma, Yanlin; Deng, Yang; Xu, Zhenbo; Liu, Junyan; Dong, Jianjun; Yin, Hua; Yu, Junhong; Chang, Zongming; Wang, Dongfeng			Development of a propidium monoazide-polymerase chain reaction assay for detection of viable Lactobacillus brevis in beer	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Propidium monoazide; Polymerase chain reaction; Beer spoilage bacteria; Lactobacillus brevis; horA	LACTIC-ACID BACTERIA; REAL-TIME PCR; ETHIDIUM MONOAZIDE; QUANTITATIVE PCR; LISTERIA-MONOCYTOGENES; PEDIOCOCCUS-DAMNOSUS; CAMPYLOBACTER-JEJUNI; HOP RESISTANCE; DEAD CELLS; SPOILAGE	The spoilage of beer by bacteria is of great concern to the brewer as this can lead to turbidity and abnormal flavors. The polymerase chain reaction (PCR) method for detection of beer-spoilage bacteria is highly specific and provides results much faster than traditional microbiology techniques. However, one of the drawbacks is the inability to differentiate between live and dead cells. In this paper, the combination of propidium monoazide (PMA) pretreatment and conventional PCR had been described. The established PMA-PCR identified beer spoilage Lactobacillus brevis based not on their identity, but on the presence of horA gene which we show to be highly correlated with the ability of beer spoilage LAB to grow in beer. The results suggested that the use of 30 mu g/mL or less of PMA did not inhibit the PCR amplification of DNA derived from viable L. brevis cells. The minimum amount of PMA to completely inhibit the PCR amplification of DNA derived from dead L. brevis cells was 2.0 mu g/mL. The detection limit of PMA-PCR assay described here was found to be 10 colony forming units (CFU)/reaction for the horA gene. Moreover, the horA-specific PMA-PCR assays were subjected to 18 reference isolates, representing 100% specificity with no false positive amplification observed. Overall the use of horA-specific PMA-PCR allows for a substantial reduction in the time required for detection of potential beer spoilage L. brevis and efficiently differentiates between viable and nonviable cells. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Ma, Yanlin; Deng, Yang; Dong, Jianjun; Yin, Hua; Yu, Junhong; Chang, Zongming] Tsingtao Brewery Co Ltd, State Key Lab Biol Fermentat Engn Beer, Qingdao, Peoples R China; [Ma, Yanlin; Deng, Yang; Wang, Dongfeng] Ocean Univ China, Coll Food Sci & Engn, Qingdao, Peoples R China; [Xu, Zhenbo; Liu, Junyan] South China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China	Deng, Y (reprint author), Tsingtao Brewery Co Ltd, State Key Lab Biol Fermentat Engn Beer, Qingdao, Peoples R China.; Deng, Y; Wang, DF (reprint author), Ocean Univ China, Coll Food Sci & Engn, Qingdao, Peoples R China.	dengyang719@hotmail.com; wangdf@ouc.edu.cn			China Postdoctoral Science Foundation [2015M582063]; State Key Laboratory of Biological Fermentation Engineering of Beer [K2016001]; State Key Laboratory of Food Science and Technology, Nanchang University [SKLF-KF-201415]	This work was financially supported by China Postdoctoral Science Foundation funded project (no. 2015M582063), the Open Research Fund of State Key Laboratory of Biological Fermentation Engineering of Beer (no. K2016001) and the Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University (no. SKLF-KF-201415).	Agusti G, 2010, HELICOBACTER, V15, P473, DOI 10.1111/j.1523-5378.2010.00794.x; Bae SW, 2009, APPL ENVIRON MICROB, V75, P2940, DOI 10.1128/AEM.01333-08; Best EL, 2003, FEMS MICROBIOL LETT, V229, P237, DOI 10.1016/S0378-1097(03)00845-0; Deng Y, 2015, INT J FOOD MICROBIOL, V206, P96, DOI 10.1016/j.ijfoodmicro.2015.04.046; Deng Y, 2014, J I BREWING, V120, P127, DOI 10.1002/jib.121; Flekna G, 2007, RES MICROBIOL, V158, P405, DOI 10.1016/j.resmic.2007.02.008; Fujii T, 2005, J APPL MICROBIOL, V98, P1209, DOI 10.1111/j.1365-2672.2005.02558.x; Haakensen M, 2009, INT J FOOD MICROBIOL, V130, P56, DOI 10.1016/j.ijfoodmicro.2009.01.001; Haakensen MC, 2007, J AM SOC BREW CHEM, V65, P157, DOI 10.1094/j.ASBCJ-2007-0611-01; Haakensen M, 2008, J AM SOC BREW CHEM, V66, P63, DOI 10.1094/ASBCJ-2008-0314-01; Hayashi N, 2001, APPL MICROBIOL BIOT, V55, P596, DOI 10.1007/s002530100600; Iijima K, 2007, J I BREWING, V113, P96, DOI 10.1002/j.2050-0416.2007.tb00262.x                                              ; Konietzny U, 2003, BRAZ J MICROBIOL, V34, P283, DOI 10.1590/S1517-83822003000400001; Nocker A, 2006, APPL ENVIRON MICROB, V72, P1997, DOI 10.1128/AEM.72.3.1997-2004.2006; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Rueckert A, 2005, J APPL MICROBIOL, V99, P1246, DOI 10.1111/j.1365-2672.2005.02728.x; Sakamoto K, 2003, INT J FOOD MICROBIOL, V89, P105, DOI 10.1016/S0168-1605(03)00153-3; Sakamoto K, 2001, J BACTERIOL, V183, P5371, DOI 10.1128/JB.183.18.5371-5375.2001; Sami M, 1997, J FERMENT BIOENG, V84, P1, DOI 10.1016/S0922-338X(97)82778-X; Sami M, 1997, J AM SOC BREW CHEM, V55, P137; Seinige D, 2014, APPL ENVIRON MICROB, V80, P2186, DOI 10.1128/AEM.03962-13; Simon MC, 1996, APPL ENVIRON MICROB, V62, P822; Suzuki K, 2006, LETT APPL MICROBIOL, V42, P392, DOI 10.1111/j.1472-765X.2006.01860.x; Suzuki K, 2004, LETT APPL MICROBIOL, V39, P240, DOI 10.1111/j.1472-765X.2004.01572.x	26	0	0	1	1	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					740	746		10.1016/j.bjm.2016.11.012				7	Microbiology	Microbiology	FM0ZJ	WOS:000414697800018	28633981	gold			2018-01-05	
J	Sanches, LA; Gomes, MD; Teixeira, RHF; Cunha, MPV; de Oliveira, MGX; Vieira, MAM; Gomes, TAT; Knobl, T				Sanches, Lilian Aparecida; Gomes, Marcelo da Silva; Friciello Teixeira, Rodrigo Hidalgo; Vieira Cunha, Marcos Paulo; Xavier de Oliveira, Maria Gabriela; Midolli Vieira, Monica Aparecida; Tardelli Gomes, Tania Aparecida; Knobl, Terezinha			Captive wild birds as reservoirs of enteropathogenic E-coli (EPEC) and Shiga-toxin producing E-coli (STEC)	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Diarrheagenic E. coli; Atypical EPEC; STEC; Avian diseases	STRAINS; RESISTANCE; VIRULENCE	Psittacine birds have been identified as reservoirs of diarrheagenic Escherichia coli, a subset of pathogens associated with mortality of children in tropical countries. The role of other orders of birds as source of infection is unclear. The aim of this study was to perform the molecular diagnosis of infection with diarrheagenic E. coli in 10 different orders of captive wild birds in the state of Sao Paulo, Brazil. Fecal samples were analyzed from 516 birds belonging to 10 orders: Accipitriformes, Anseriformes, Columbiformes, Falconiformes, Galliformes, Passeriformes, Pelecaniformes, Piciformes, Psittaciformes and Strigiformes. After isolation, 401 E. coli strains were subjected to multiplex PCR system with amplification of genes eae and bfp (EPEC), stxl and stx2 for STEC. The results of these tests revealed 23/401 (5.74%) positive strains for eae gene, 16/401 positive strains for the bfp gene (3.99%) and 3/401 positive for stx2 gene (0.75%) distributed among the orders of Psittaciformes, Strigiformes and Columbiformes. None of strains were positive for stxl gene. These data reveal the infection by STEC, typical and atypical EPEC in captive birds. The frequency of these pathotypes is low and restricted to few orders, but the data suggest the potential public health risk that these birds represent as reservoirs of diarrheagenic E. coli. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Sanches, Lilian Aparecida; Vieira Cunha, Marcos Paulo; Xavier de Oliveira, Maria Gabriela; Knobl, Terezinha] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Pathol, Sao Paulo, Brazil; [Gomes, Marcelo da Silva] Zool Municipal Sao Bernardo do Campo, Parque Estoril, Sao Bernardo Do Campo, SP, Brazil; [Friciello Teixeira, Rodrigo Hidalgo] Quinzinho Barros Zool Pk PZMQB, Sorocaba, SP, Brazil; [Midolli Vieira, Monica Aparecida; Tardelli Gomes, Tania Aparecida] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil	Knobl, T (reprint author), Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Pathol, Sao Paulo, Brazil.	tknobl@usp.br			CNPq; FAPESP [2014/07837-6]	This study was conducted with financial support from CNPq and FAPESP (2014/07837-6).	Ahmed AM, 2007, APPL ENV MICROBIOL; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480                                                          ; Costa ARF, 2010, REV PAN AMAZ SAUDE, V1, P77; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Cunha MPV, 2014, SCI WORLD J, DOI 10.1155/2014/289024; Davies YM, 2016, AVIAN PATHOL, V45, P194, DOI 10.1080/03079457.2016.1142066; Farooq S, 2009, LETT APPL MICROBIOL, V48, P692, DOI 10.1111/j.1472-765X.2009.02594.x; Gioia-Di Chiacchio RM, 2016, VET MICROBIOL, V184, P27, DOI 10.1016/j.vetmic.2016.01.004; Kobayashi H, 2009, APPL ENVIRON MICROB, V75, P292, DOI 10.1128/AEM.01534-08; Marietto-Goncalves Guilherme A, 2011, Open Microbiol J, V5, P72, DOI 10.2174/1874285801105010072; Mattes B.R., 2005, Arquivos do Instituto Biologico Sao Paulo, V72, P13; Vieira MAM, 2009, MUNDO SAUDE, V33, P406; Persad AK, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0027-2014; Sacristan C, 2014, AVIAN PATHOL, V43, P172, DOI 10.1080/03079457.2014.897683; Saidenberg ABS, 2012, INT SCHOLARLY RES NE, V2012, P1; Saidenberg AB, 2012, PESQUISA VET BRASIL, V32, P922, DOI 10.1590/S0100-736X2012000900017; Silva VL, 2009, CURR MICROBIOL, V59, P302, DOI 10.1007/s00284-009-9434-7; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385                                                          ; Vazquez B, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-45; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024	21	0	0	0	0	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					760	763		10.1016/j.bjm.2017.03.003				4	Microbiology	Microbiology	FM0ZJ	WOS:000414697800021	28619663	gold			2018-01-05	
J	Llanco, LA; Nakano, V; de Moraes, CTP; Piazza, RMF; Avila-Campos, MJ				Llanco, Luis A.; Nakano, Viviane; de Moraes, Claudia T. P.; Piazza, Roxane M. F.; Avila-Campos, Mario J.			Adhesion and invasion of Clostridium perfringens type A into epithelial cells	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Adhesion; Invasion; Clostridium perfringens type A; Necrotic enteritis; tpeL gene	NECROTIC ENTERITIS; TOXIN; PATHOGENESIS; PREVALENCE; DIVERSITY; ANIMALS	Clostridium perfringens is the causative agent for necrotic enteritis. It secretes the major virulence factors, and alpha- and NetB-toxins that are responsible for intestinal lesions. The TpeL toxin affects cell morphology by producing myonecrosis, but its role in the pathogenesis of necrotic enteritis is unclear. In this study, the presence of netB and tpeL genes in C. perfringens type A strains isolated from chickens with necrotic enteritis, their cytotoxic effects and role in adhesion and invasion of epithelial cells were evaluated. Six (27.3%) of the 22 C. perfringens type A strains were harboring the tpeL gene and produced morphological alterations in Vero cells after 6 h of incubation. Strains tpeL () induced strong cell rounding after 6 h of incubation and produced cell enlargement. None of the 22 strains harbored netB gene. All the six tpeL (+) gene strains were able to adhere to HEp-2 cells; however, only four of them (66.6%) were invasive. Thus, these results suggest that the presence of tpeL gene or TpeL toxin might be required for the adherence of bacteria to HEp-2 cells; however, it could not have any role in the invasion process. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Llanco, Luis A.; Nakano, Viviane; Avila-Campos, Mario J.] Univ Sao Paulo, Inst Biomed Sci, Anaerobe Lab, Sao Paulo, SP, Brazil; [de Moraes, Claudia T. P.; Piazza, Roxane M. F.] Butantan Inst, Bacteriol Lab, Sao Paulo, SP, Brazil	Avila-Campos, MJ (reprint author), Univ Sao Paulo, Dept Microbiol, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, SP, Brazil.	mariojac@usp.br			CNPq [158799/2012-7]; FAPESP [2013/17739-9]	The authors thank to Miss Marcia H. Fukugaiti for her technical support. Clostridium perfringens JGS 5369 was kindly provided by Dr. J.G. Songer at University of Arizona, USA. This study was supported by grant of CNPq No. 158799/2012-7 and FAPESP 2013/17739-9.	Amimoto K, 2007, MICROBIOL-SGM, V153, P1198, DOI 10.1099/mic.0.2006/002287-0; Baker AA, 2010, APPL ENVIRON MICROB, V76, P2961, DOI 10.1128/AEM.02459-09; BALL DW, 1993, INFECT IMMUN, V61, P2912; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Brady J, 2010, AVIAN PATHOL, V39, P475, DOI 10.1080/03079457.2010.521141; Coursodon CF, 2012, ANAEROBE, V18, P117, DOI 10.1016/j.anaerobe.2011.10.001; Llanco L. A., 2012, International Journal of Microbiology Research, V4, P290; Llanco LA, 2015, CURR MICROBIOL, V70, P330, DOI 10.1007/s00284-014-0722-5; Martin TG, 2009, VET MICROBIOL, V136, P202, DOI 10.1016/j.vetmic.2008.10.026; McClane BA, 2010, VIRULENCE, V1, P97, DOI 10.4161/viru.1.2.10679; Nagahama M, 2011, INFECT IMMUN, V79, P905, DOI 10.1128/IAI.01019-10; Nakano V, 2008, CLIN MICROBIOL INFEC, V14, P955, DOI 10.1111/j.1469-0691.2008.02069.x; Navaneethan U, 2008, NAT CLIN PRACT GASTR, V5, P637, DOI 10.1038/ncpgasthep1264; Olkowski AA, 2006, RES VET SCI, V81, P99, DOI 10.1016/j.rvsc.2005.10.006; Parker CT, 2009, CELL MICROBIOL, V11, P363, DOI 10.1111/j.1462-5822.2008.01272.x; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Richard J F, 1999, Int Microbiol, V2, P185; ROOD JI, 1991, MICROBIOL REV, V55, P621; Sambrook J, MOL CLONING LAB MANU; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216; Stackebrandt E, 1999, FEMS IMMUNOL MED MIC, V24, P253, DOI 10.1016/S0928-8244(99)00039-5; TANG P, 1993, J MICROBIOL METH, V18, P227, DOI 10.1016/0167-7012(93)90038-J; Varga JJ, 2008, INFECT IMMUN, V76, P4944, DOI 10.1128/IAI.00692-08	23	0	0	3	3	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					764	768		10.1016/j.bjm.2017.06.002				5	Microbiology	Microbiology	FM0ZJ	WOS:000414697800022	28720432				2018-01-05	
J	Song, YH; Lee, KT; Baek, JY; Kim, MJ; Kwon, MR; Kim, YJ; Park, MR; Ko, H; Lee, JS; Kim, KS				Song, Yun-Hee; Lee, Kyung-Tai; Baek, Jin-Young; Kim, Min-Ju; Kwon, Mi-Ra; Kim, Young-Joo; Park, Mi-Rim; Ko, Haesu; Lee, Jin-Sung; Kim, Keun-Sung			Isolation and characterization of a novel endo-beta-1,4-glucanase from a metagenomic library of the black-goat rumen	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Black goats; Endo-beta-1,4-glucanase; Glycosyl hydrolase family 5 (GH5); Metagenomic library; Rumen	TRICHODERMA-REESEI; IDENTIFICATION; CELLULASES; ENZYMES; GENE; BIOTECHNOLOGY; EXPRESSION; HYDROLASES; FAMILIES; CLONING	The various types of lignocellulosic biomass found in plants comprise the most abundant renewable bioresources on Earth. In this study, the ruminal microbial ecosystem of black goats was explored because of their strong ability to digest lignocellulosic forage. A metagenomic fosmid library containing 115,200 clones was prepared from the black-goat rumen and screened for a novel cellulolytic enzyme. The KG35 gene, containing a novel glycosyl hydrolase family 5 cellulase domain, was isolated and functionally characterized. The novel glycosyl hydrolase family 5 cellulase gene is composed of a 963-bp open reading frame encoding a protein of 320 amino acid residues (35.1 kDa). The deduced amino acid sequence showed the highest sequence identity (58%) for sequences from the glycosyl hydrolase family 5 cellulases. The novel glycosyl hydrolase family 5 cellulase gene was overexpressed in Escherichia coli. Substrate specificity analysis revealed that this recombinant glycosyl hydrolase family 5 cellulase functions as an endo-beta-1,4-glucanase. The recombinant KG35 endo-beta-1,4-glucanase showed optimal activity within the range of 30-50 degrees C at a pH of 6-7. The thermostability was retained and the pH was stable in the range of 30-50 degrees C at a pH of 5-7. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Song, Yun-Hee; Baek, Jin-Young; Kim, Min-Ju; Kim, Keun-Sung] Chung Ang Univ, Dept Food Sci & Technol, Ansung 456756, South Korea; [Lee, Kyung-Tai; Kwon, Mi-Ra; Kim, Young-Joo; Park, Mi-Rim; Ko, Haesu] Rural Dev Adm, Anim Genom & Bioinformat Div, Natl Inst Anim Sci, Wonju, South Korea; [Lee, Jin-Sung] Kyonggi Univ, Dept Biol Sci, Suwon, South Korea	Kim, KS (reprint author), Chung Ang Univ, Dept Food Sci & Technol, Ansung 456756, South Korea.; Lee, JS (reprint author), Kyonggi Univ, Dept Biol Sci, Suwon, South Korea.	lejis@daum.net; keunsung@cau.ac.kr			"Cooperative Research Programs for Agriculture Science and Technology Development", Rural Development Administration, Republic of Korea [PJ006649, PJ008701, PJ011163]	This work was carried out with the support of "Cooperative Research Programs for Agriculture Science and Technology Development (Project Nos. PJ006649, PJ008701 and PJ011163)", Rural Development Administration, Republic of Korea. J.-S. Lee (for in silico experiment design) and K.-S. Kim (for other experiment design) are co-corresponding authors of this work.	AMANN RI, 1995, MICROBIOL REV, V59, P143; Bhat MK, 1997, BIOTECHNOL ADV, V15, P583, DOI 10.1016/S0734-9750(97)00006-2; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Cheema TA, 2012, ANIM BIOTECHNOL, V23, P261, DOI 10.1080/10495398.2012.722156; Choi JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101127; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Feng Y, 2007, APPL MICROBIOL BIOT, V75, P319, DOI 10.1007/s00253-006-0820-9; Geng AL, 2012, APPL MICROBIOL BIOT, V96, P951, DOI 10.1007/s00253-012-3873-y; Gong Xia, 2012, BMC Res Notes, V5, P566, DOI 10.1186/1756-0500-5-566; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; Jing L, 2015, IND CROP PROD, V77, P666, DOI 10.1016/j.indcrop.2015.09.052; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Kuhad R. C., 2011, ENZYME RES, V2011, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; Lee CM, 2014, J MICROBIOL BIOTECHN, V24, P1196, DOI 10.4014/jmb.1405.05001; Lee ID, 2008, J KOR SOC GRASSL FOR, V38, P445; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackie RI, 2013, ENCY LIFE SCI; Mallerman J, 2015, J MICROBIOL BIOTECHN, V25, P57, DOI 10.4014/jmb.1401.01045; Mirete S, 2016, CURR OPIN BIOTECH, V38, P143, DOI 10.1016/j.copbio.2016.01.017; Nguyen NH, 2012, BIOSCI BIOTECH BIOCH, V76, P1075, DOI 10.1271/bbb.110786; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; RUSSELL JB, 1980, APPL ENVIRON MICROB, V39, P604; Sweeney MD, 2012, CATALYSTS, V2, P244, DOI 10.3390/catal2020244; WANG QP, 1993, J BIOL CHEM, V268, P14096; Zhao LG, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-101; Zhao SG, 2010, APPL ENVIRON MICROB, V76, P6701, DOI 10.1128/AEM.00361-10; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	32	0	0	0	0	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					801	808		10.1016/j.bjm.2017.03.006				8	Microbiology	Microbiology	FM0ZJ	WOS:000414697800028	28689814				2018-01-05	
J	Li, L; Mu, L; Wang, XJ; Yu, JF; Hu, RP; Li, Z				Li, Li; Mu, Lan; Wang, Xiaojuan; Yu, Jingfeng; Hu, Ruiping; Li, Zhen			A novel expression vector for the secretion of abaecin in Bacillus subtilis	BRAZILIAN JOURNAL OF MICROBIOLOGY			English	Article						Abaecin; Antimicrobial peptides; Bacillus subtilis; Expression	SIGNAL PEPTIDE; HETEROLOGOUS EXPRESSION; BETA-MANNANASE; GENE; PROMOTER; CLONING; SYSTEM; PHOSPHORYLATION; PURIFICATION; PROTEIN	This study aimed to describe a Bacillus subtilis expression system based on genetically modified B. subtilis. Abaecin, an antimicrobial peptide obtained from Apis mellifera, can enhance the effect of pore-forming peptides from other species on the inhibition of bacterial growth. For the exogenous expression, the abaecin gene was fused with a tobacco etch virus protease cleavage site, a promoter Pglv, and a mature beta-glucanase signal peptide. Also, a B. subtilis expression system was constructed. The recombinant abaecin gene was expressed and purified as a recombinant protein in the culture supernatant. The purified abaecin did not inhibit the growth of Escherichia coli strain K88. Cecropin A and hymenoptaecin exhibited potent bactericidal activities at concentrations of 1 and 1.5 mu M Combinatorial assays revealed that cecropin A and hymenoptaecin had sublethal concentrations of 0.3 and 0.5 mu M This potentiating functional interaction represents a promising therapeutic strategy. It provides an opportunity to address the rising threat of multidrug-resistant pathogens that are recalcitrant to conventional antibiotics. (C) 2017 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.	[Li, Li; Mu, Lan; Wang, Xiaojuan; Yu, Jingfeng; Hu, Ruiping] Inner Mongolia Med Univ, Coll Basic Med, Hohhot, Inner Mongolia, Peoples R China; [Li, Zhen] China Agr Univ, Coll Hort, Beijing, Peoples R China	Li, L; Hu, RP (reprint author), Inner Mongolia Med Univ, Coll Basic Med, Hohhot, Inner Mongolia, Peoples R China.	609532398@qq.com; 783674348@qq.com					CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x                                              ; Gu MJ, 2014, ASIAN AUSTRAL J ANIM, V27, P580, DOI 10.5713/ajas.2013.13744; Guan CR, 2016, NEW BIOTECHNOL, V33, P372, DOI 10.1016/j.nbt.2016.01.005; Gupta M, 2014, J BIOSCIENCES, V39, P747, DOI 10.1007/s12038-014-9481-5; He Q, 2015, J IND MICROBIOL BIOT, V42, P647, DOI 10.1007/s10295-014-1582-5; HEMILA H, 1992, GENE, V116, P27, DOI 10.1016/0378-1119(92)90625-Y; Heng C, 2005, BIOTECHNOL LETT, V27, P1731, DOI 10.1007/s10529-005-2743-4; Huang XL, 2015, J AGR FOOD CHEM, V63, P6430, DOI 10.1021/acs.jafc.5b01259; Ji SH, 2014, APPL BIOCHEM BIOTECH, V174, P231, DOI 10.1007/s12010-014-1047-3; Jia MM, 2013, J AGR FOOD CHEM, V61, P9428, DOI 10.1021/jf402636w; Joyet P, 2010, MOL MICROBIOL, V76, P1279, DOI 10.1111/j.1365-2958.2010.07175.x; Khezri M, 2016, BRAZ J MICROBIOL, V47, P47, DOI 10.1016/j.bjm.2015.11.019; Lee SJ, 2010, J BIOTECHNOL, V149, P16, DOI 10.1016/j.jbiotec.2010.06.021; Li RK, 2015, BIOTECHNOL APPL BIOC, V62, P64, DOI 10.1002/bab.1250; Li YX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09383; Liu YH, 2010, BIOTECHNOL LETT, V32, P119, DOI 10.1007/s10529-009-0112-4; Lu QD, 2010, ACTA CRYSTALLOGR F, V66, P1053, DOI 10.1107/S1744309110027582; Ma P, 2016, MICROBIOL-SGM, V162, P823, DOI 10.1099/mic.0.000266; Michna RH, 2014, NUCLEIC ACIDS RES, V42, pD692, DOI 10.1093/nar/gkt1002; Ogawa T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1425-4; Philibert T, 2016, J IND MICROBIOL BIOT, V43, P729, DOI 10.1007/s10295-016-1758-2; Pozsgai ER, 2012, APPL ENVIRON MICROB, V78, P778, DOI 10.1128/AEM.07098-11; Rahnamaeian M, 2016, PEPTIDES, V78, P17, DOI 10.1016/j.peptides.2016.01.016; Rubinstein SM, 2012, MOL MICROBIOL, V86, P426, DOI 10.1111/j.1365-2958.2012.08201.x; Saltykova E S, 2005, Zh Evol Biokhim Fiziol, V41, P404; Serrano M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005104; Song W, 2016, PROTEIN EXPRES PURIF, V124, P23, DOI 10.1016/j.pep.2016.04.008; Summpunn P, 2011, J MICROBIOL, V49, P86, DOI 10.1007/s12275-011-0357-1; Trang TPP, 2012, J BIOTECHNOL, V157, P167, DOI 10.1016/j.jbiotec.2011.10.006; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Xu J, 2016, ASIAN AUSTRALAS J AN; Zhang LC, 2015, J IND MICROBIOL BIOT, V42, P1369, DOI 10.1007/s10295-015-1673-y	32	0	0	3	3	SOC BRASILEIRA MICROBIOLOGIA	SAO PAULO	AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL	1517-8382	1678-4405		BRAZ J MICROBIOL	Braz. J. Microbiol.	OCT-DEC	2017	48	4					809	814		10.1016/j.bjm.2017.01.009				6	Microbiology	Microbiology	FM0ZJ	WOS:000414697800029	28651889	gold			2018-01-05	
J	Zacharopoulou, E; Gazouli, M; Tzouvala, M; Vezakis, A; Karamanolis, G				Zacharopoulou, Eirini; Gazouli, Maria; Tzouvala, Maria; Vezakis, Antonios; Karamanolis, George			The contribution of long non-coding RNAs in Inflammatory Bowel Diseases	DIGESTIVE AND LIVER DISEASE			English	Review						Biomarker; Biopsies; Crohn's disease; IBD genetics; Inflammatory bowel disease; Long non-coding RNAs; Plasma; Ulcerative colitis	ULCERATIVE-COLITIS; CROHNS-DISEASE; AUTOIMMUNE-DISEASES; EPITHELIAL-CELLS; HUMAN CANCERS; GENOME; MECHANISMS; EXPRESSION; LANDSCAPE; MICRORNAS	Inflammatory bowel diseases (IBDs) are multifactorial autoimmune diseases with growing prevalence but the interaction between genetic, environmental and immunologic factors in their development is complex and remains obscure. There is great need to understand their pathogenetic mechanisms and evolve diagnostic and therapeutic tools. Long non-coding RNAs (lncRNAs) are RNA molecules longer than 200 nucleotides that are known to interfere in gene regulation but their roles and functions have not yet been fully understood. While they are widely investigated in cancers, little is known about their contribution in other diseases. There is growing evidence that lncRNAs play critical role in regulation of immune system and that they interfere in the pathogenetic mechanisms of autoimmune diseases, like IBDs. Recent studies have identified lncRNAs in the proximity of IBD-associated genes and single nucleotide polymorphisms within IBD-associated lncRNAs as well. Furthermore, blood samples and pinch biopsies were also analyzed and a plethora of lncRNAs are found to be deregulated in Crohn's disease (CD), Ulcerative colitis (UC) or both. (Especially in UC samples the lncRNAs INFG-AS1 and BC012900 were found to be significantly up-regulated. Similarly, ANRIL, a 1ncRNA that nest different disease associated SNPs, is significantly down-regulated in inflamed IBD tissue.) This review aims at recording for the first time recent data about lncRNAs found to be deregulated in IBDs and discussing suggestive pathogenetic mechanisms and future use of lncRNAs as biomarkers. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Zacharopoulou, Eirini; Tzouvala, Maria] Gen Hosp Nikea & Piraeus Agios Panteleimon, Dept Gastroenterol, Nikea, Greece; [Gazouli, Maria] Univ Athens, Sch Med, Dept Basic Med Sci, Lab Biol, Athens, Greece; [Vezakis, Antonios] Univ Athens, Aretaieion Univ Hosp, Dept Surg 2, Athens, Greece; [Karamanolis, George] Univ Athens, Acad Dept Gastroenterol, Med Sch, Laiko Gen Hosp, Athens, Greece	Zacharopoulou, E (reprint author), Gen Hosp Nikea & Piraeus Agios Panteleimon, Dept Gastroenterol, Nikea, Greece.	eirinizachar@gmail.com					Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Archer K, 2015, INT J MOL SCI, V16, P23651, DOI 10.3390/ijms161023651; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Chen D, 2016, WORLD J GASTROENTERO, V22, P4716, DOI 10.3748/wjg.v22.i19.4716; Chen Wei-Xu, 2014, World J Gastrointest Pathophysiol, V5, P63, DOI 10.4291/wjgp.v5.i2.63; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fang YW, 2016, GENOM PROTEOM BIOINF, V14, P42, DOI 10.1016/j.gpb.2015.09.006; Feng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052782; Furlan G, 2016, WIRES RNA, V7, P702, DOI 10.1002/wrna.1359; Gloss BS, 2016, BBA-GENE REGUL MECH, V1859, P16, DOI 10.1016/j.bbagrm.2015.08.005; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haberman Y, 2017, INFLAMM BOWEL DIS, V23, pS3, DOI 10.1097/01.MIB.0000512519.99457.e4; Nguyen HTT, 2014, GASTROENTEROLOGY, V146, P508, DOI 10.1053/j.gastro.2013.10.021; Hrdlickova B, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0088-0; Huang Z, 2014, GUT, V63, P1247, DOI 10.1136/gutjnl-2012-304213; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kalla R, 2015, GUT, V64, P504, DOI 10.1136/gutjnl-2014-307891; Karlsson Oskar, 2016, Curr Environ Health Rep, V3, P178, DOI 10.1007/s40572-016-0092-1; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kenny EE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002559; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Li JQ, 2016, DNA CELL BIOL, V35, P459, DOI 10.1089/dna.2015.3187; Li R., 2016, INT J MOL SCI, V17; Lin JM, 2014, MODERN PATHOL, V27, P602, DOI 10.1038/modpathol.2013.152; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Lu CM, 2014, GASTROENTEROLOGY, V146, P188, DOI 10.1053/j.gastro.2013.09.006; Ma CH, 2016, TUMOR BIOL, V37, P1437, DOI 10.1007/s13277-015-4521-9; Marquez A, 2009, GENES IMMUN, V10, P631, DOI 10.1038/gene.2009.56; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mirza AH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0162-2; Mirza AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105723; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Nam JW, 2016, MOL CELLS, V39, P367, DOI 10.14348/molcells.2016.0039; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; Olesen MTJ, 2014, DRUG DELIV TRANSL RE, V4, P4, DOI 10.1007/s13346-013-0156-9; Padua D, 2016, AM J PHYSIOL-GASTR L, V311, pG446, DOI 10.1152/ajpgi.00212.2016; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Pennisi E, 2010, SCIENCE, V330, P574, DOI 10.1126/science.330.6004.574; Qiao YQ, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-87; Ricano-Ponce I, 2013, ANNU REV GENOM HUM G, V14, P325, DOI 10.1146/annurev-genom-091212-153450; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Schaefer JS, 2016, CURR OPIN GASTROEN, V32, P258, DOI 10.1097/MOG.0000000000000284; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Trachtenberg EA, 2000, HUM IMMUNOL, V61, P326, DOI 10.1016/S0198-8859(99)00134-2; Van Limbergen J, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.27; Wang HM, 2015, INT J CLIN EXP MED, V8, P11824; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang P, 2016, MOL MED REP, V13, P1195, DOI 10.3892/mmr.2015.4669; Wu F, 2016, INFLAMM BOWEL DIS, V22, P782, DOI 10.1097/MIB.0000000000000691; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Wu GC, 2015, AUTOIMMUN REV, V14, P798, DOI 10.1016/j.autrev.2015.05.004; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Yi JM, 2015, INTEST RES, V13, P112, DOI 10.5217/ir.2015.13.2.112; Zhang YZ, 2014, WORLD J GASTROENTERO, V20, P91, DOI 10.3748/wjg.v20.i1.91	71	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	OCT	2017	49	10					1067	1072		10.1016/j.dld.2017.08.003				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FM1OA	WOS:000414746000001	28869157				2018-01-05	
J	Hoshino, Y; Mizuno, S; Kato, K; Mizuno-Iijima, S; Tanimoto, Y; Ishida, M; Kajiwara, N; Sakasai, T; Miwa, Y; Takahashi, S; Yagami, K; Sugiyama, F				Hoshino, Yoshikazu; Mizuno, Seiya; Kato, Kanako; Mizuno-Iijima, Saori; Tanimoto, Yoko; Ishida, Miyuki; Kajiwara, Noriko; Sakasai, Tomoki; Miwa, Yoshihiro; Takahashi, Satoru; Yagami, Ken-ichi; Sugiyama, Fumihiro			Simple generation of hairless mice for in vivo imaging	EXPERIMENTAL ANIMALS			English	Article						CRISPR/Cas9; hairless; in vivo imaging; mouse	NONSENSE MUTATION; INDOCYANINE GREEN; TRANSGENIC MICE; MOLECULAR-BASIS; GENE; MOUSE; NUDE; SKIN; PROTEIN; HR	The in vivo imaging of mice makes it possible to analyze disease progress non-invasively through reporter gene expression. As the removal of hair improves the accuracy of in vivo imaging, gene-modified mice with a reporter gene are often crossed with Hos:HR-1 mutant mice homozygous for the spontaneous Hr(hr) mutation that exhibit a hair loss phenotype. However, it is time consuming to produce mice carrying both the reporter gene and mutant Hr(hr) gene by mating. In addition, there is a risk that genetic background of the gene-modified mice would be altered by mating. To resolve these issues, we established a simple method to generate hairless mice maintaining the original genetic background by CRISPR technology. First, we constructed the pX330 vector, which targets exon 3 of Hr. This DNA vector (5 ng/mu l) was microinjected into the pronuclei of C57BL/6J mice. Induced Hr gene mutations were found in many founders (76.1%) and these mutations were heritable. Next, we performed in vivo imaging using these gene-modified hairless mice. As expected, luminescent objects in their body were detected by in vivo imaging. This study clearly showed that hairless mice could be simply generated by the CRISPR/Cas9 system, and this method may be useful for in vivo imaging studies with various gene-modified mice.	[Hoshino, Yoshikazu; Mizuno, Seiya; Kato, Kanako; Mizuno-Iijima, Saori; Tanimoto, Yoko; Ishida, Miyuki; Kajiwara, Noriko; Sakasai, Tomoki; Miwa, Yoshihiro; Takahashi, Satoru; Yagami, Ken-ichi; Sugiyama, Fumihiro] Univ Tsukuba, Lab Anim Resource Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Hoshino, Yoshikazu] Hoshino Lab Anim Inc, 1405 Kouda, Bando, Ibaraki 3060606, Japan; [Hoshino, Yoshikazu; Sakasai, Tomoki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Biomed Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Mizuno, Seiya; Miwa, Yoshihiro; Takahashi, Satoru; Yagami, Ken-ichi; Sugiyama, Fumihiro] Univ Tsukuba, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan	Sugiyama, F (reprint author), Univ Tsukuba, Lab Anim Resource Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.				JSPS KAKENHI [JP26221004, JP15H04281, JP16K14589, JP16H01630]	This work was supported by JSPS KAKENHI Grant Number JP26221004, JP15H04281, JP16K14589, and JP16H01630. We thank the members of the Sugiyama Laboratory for helpful discussions and encouragement.	Ahmad W, 1998, GENOMICS, V53, P383, DOI 10.1006/geno.1998.5495; Arichi N, 2014, TRANSPL P, V46, P342, DOI 10.1016/j.transproceed.2013.11.129; Benavides F, 2009, J DERMATOL SCI, V53, P10, DOI 10.1016/j.jdermsci.2008.08.012; BYRD LG, 1993, IMMUNOGENETICS, V37, P157; Chang CC, 2016, CLIN IMAG, V40, P797, DOI 10.1016/j.clinimag.2016.03.003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168                                                       ; Fujii M, 2016, EXP DERMATOL, V25, P565, DOI 10.1111/exd.13015; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; Hasegawa Y, 2016, EXP ANIM TOKYO, V65, P319, DOI 10.1538/expanim.16-0016; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Khokhlova ON, 2017, J PHARMACOL TOX MET, V84, P11, DOI 10.1016/j.vascn.2016.10.005; Lai CW, 2016, MOL IMAGING BIOL, V18, P849, DOI 10.1007/s11307-016-0967-4; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575; Liu Y, 2010, VET PATHOL, V47, P167, DOI 10.1177/0300985809352970; Tran MTN, 2014, EXP ANIM TOKYO, V63, P311, DOI 10.1538/expanim.63.311                                                          ; Makino S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39608; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakanishi T, 2012, BONE, V51, P369, DOI 10.1016/j.bone.2012.06.012; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Ozeki H, 1996, PIGM CELL RES, V9, P265, DOI 10.1111/j.1600-0749.1996.tb00116.x; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; RESKEKUNZ AB, 1979, J EXP MED, V149, P228, DOI 10.1084/jem.149.1.228; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Sundberg JP, 2001, EUR J DERMATOL, V11, P357; Suzu S, 2000, EMBO J, V19, P5114, DOI 10.1093/emboj/19.19.5114; Suzuki O, 2013, EXP ANIM TOKYO, V62, P267, DOI 10.1538/expanim.62.267                                                          ; TAKAHASHI Y, 1992, J EXP MED, V175, P873, DOI 10.1084/jem.175.3.873; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303	31	0	0	0	0	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357	1881-7122		EXP ANIM TOKYO	Exp. Anim.	OCT	2017	66	4					437	445						9	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	FM2NY	WOS:000414822700016	28717054				2018-01-05	
J	Greiner, A; Kelterborn, S; Evers, H; Kreimer, G; Sizova, I; Hegemann, P				Greiner, Andre; Kelterborn, Simon; Evers, Heide; Kreimer, Georg; Sizova, Irina; Hegemann, Peter			Targeting of Photoreceptor Genes in Chlamydomonas reinhardtii via Zinc-Finger Nucleases and CRISPR/Cas9	PLANT CELL			English	Article							GREEN-ALGA CHLAMYDOMONAS; PHOTOPHOBIC RESPONSES; CRYPTOCHROME CONTROLS; PHYTOENE SYNTHASE; REVERSE GENETICS; MUTANT LIBRARY; HUMAN-CELLS; RED-LIGHT; GENOME; CAS9	The fast-growing biflagellated single-celled chlorophyte Chlamydomonas reinhardtii is the most widely used alga in basic research. The physiological functions of the 18 sensory photoreceptors are of particular interest with respect to Chlamydomonas development and behavior. Despite the demonstration of gene editing in Chlamydomonas in 1995, the isolation of mutants lacking easily ascertained newly acquired phenotypes remains problematic due to low DNA recombination efficiency. We optimized gene-editing protocols for several Chlamydomonas strains (including wild-type CC-125) using zinc-finger nucleases (ZFNs), genetically encoded CRISPR/associated protein 9 (Cas9) from Staphylococcus aureus and Streptococcus pyogenes, and recombinant Cas9 and developed protocols for rapidly isolating nonselectable gene mutants. Using this technique, we disrupted the photoreceptor genes COP1/2, COP3 (encoding channelrhodopsin 1 [ChR1]), COP4 (encoding ChR2), COP5, PHOT, UVR8, VGCC, MAT3, and aCRY and created the chr1 chr2 and uvr8 phot double mutants. Characterization of the chrl, chr2, and mat3 mutants confirmed the value of photoreceptor mutants for physiological studies. Genes of interest were disrupted in 5 to 15% of preselected clones (1 out of 4000 initial cells). Using ZFNs, genes were edited in a reliable, predictable manner via homologous recombination, whereas Cas9 primarily caused gene disruption via the insertion of cotransformed DNA. These methods should be widely applicable to research involving green algae.	[Greiner, Andre; Kelterborn, Simon; Evers, Heide; Sizova, Irina; Hegemann, Peter] Humboldt Univ, Inst Biol, Expt Biophys, D-10099 Berlin, Germany; [Kreimer, Georg] Friedrich Alexander Univ, Dept Biol, D-91058 Erlangen, Germany; [Sizova, Irina] Russian Acad Sci, Petersburg Nucl Phys Inst, Div Radiat Biophys, Gatchina 188350, Russia	Greiner, A; Sizova, I (reprint author), Humboldt Univ, Inst Biol, Expt Biophys, D-10099 Berlin, Germany.; Sizova, I (reprint author), Russian Acad Sci, Petersburg Nucl Phys Inst, Div Radiat Biophys, Gatchina 188350, Russia.	andregrein@gmail.com; irinasiz@yahoo.com			Deutsche Forschungsgemeinschaft [FOR1261]; Russian Foundation for Basic Research [17-54-45088]; Hertie Foundation; Deutsche Forschungsgemeinschaft (Leibniz grant)	We thank Margret Michalsky, Thi Bich Thao Nguyen, Mirjam Langenegger, and Francisca Boehning for excellent technical assistance; Wenshuang L and Patrick Segelitz for isolating the aCry disruption mutants; Suneel Kateriya and Lina Sciesielski for fruitful discussions; Roman Ulm for supplying the UVR8 antibody; Richard Chappuis for immunoblot analysis of our UVR8 knockouts; and Jun Minagawa for the phot-1 mating assay. We also thank the Benchling team for integrating the Chlamydomonas genome into the CRISPR/Cas9 guide RNA design tool upon request. This work was supported by the Deutsche Forschungsgemeinschaft (FOR1261 and Leibniz grant) and by the Russian Foundation for Basic Research (Grant 17-54-45088 to I.S.). P.H. is a Hertie Senior Professor for Neuro-science supported by the Hertie Foundation.	Awasthi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34646; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Beel B, 2012, PLANT CELL, V24, P2992, DOI 10.1105/tpc.112.098947; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boyd JS, 2011, MOL BIOL CELL, V22, P1421, DOI 10.1091/mbc.E10-11-0918; Boyd JS, 2011, BIOARCHITECTURE, V1, P196, DOI [10.4161/bioa.1.4.17697, DOI 10.4161/BIOA.1.4.17697]; Braun FJ, 1999, BIOPHYS J, V76, P1668, DOI 10.1016/S0006-3495(99)77326-1                                                   ; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Cheng X, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0183-5; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deisseroth K, 2017, SCIENCE, V357, P1111, DOI 10.1126/science.aan5544; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Engel BD, 2015, ELIFE, V4, DOI 10.7554/eLife.04889; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Galvan A, 2007, ADV EXP MED BIOL, V616, P77; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; GILLHAM NW, 1987, GENETICS, V115, P677; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Govorunova EG, 2004, BIOPHYS J, V86, P2342, DOI 10.1016/S0006-3495(04)74291-5                                                   ; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; HARZ H, 1992, PHILOS T ROY SOC B, V338, P39, DOI 10.1098/rstb.1992.0127; HEGEMANN P, 1989, CELL MOTIL CYTOSKEL, V14, P501, DOI 10.1002/cm.970140408; Holland EM, 1996, BIOPHYS J, V70, P924, DOI 10.1016/S0006-3495(96)79635-2                                                   ; Huang KY, 2003, P NATL ACAD SCI USA, V100, P6269, DOI 10.1073/pnas.0931459100; Inwood W, 2008, MOL PLANT, V1, P925, DOI 10.1093/mp/ssn046; Jakab G, 1997, BIOCHIMIE, V79, P387, DOI 10.1016/S0300-9084(97)86148-2; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang WZ, 2017, ALGAL RES, V26, P474, DOI 10.1016/j.algal.2017.04.001; Jiang WZ, 2017, PLANT CELL REP, V36, P1001, DOI 10.1007/s00299-017-2138-8; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kao PH, 2017, BIORESOURCE TECHNOL, V245, P1527, DOI 10.1016/j.biortech.2017.04.111; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228                                                          ; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Kouranova E, 2016, HUM GENE THER, V27, P464, DOI 10.1089/hum.2016.009; Li XB, 2016, PLANT CELL, V28, P367, DOI 10.1105/tpc.15.00465; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Luck M, 2017, J PLANT PHYSIOL, V217, P77, DOI 10.1016/j.jplph.2017.07.008; Luck M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401604; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCarthy SS, 2004, GENETICS, V168, P1249, DOI 10.1534/genetics.104.030635; Meinecke L, 2010, PLANT MOL BIOL, V72, P643, DOI 10.1007/s11103-010-9604-9; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mittelmeier TM, 2013, EUKARYOT CELL, V12, P1258, DOI 10.1128/EC.00111-13; Mittelmeier TM, 2011, J CELL BIOL, V193, P741, DOI 10.1083/jcb.201009131; Muller N, 2017, PLANT PHYSIOL, V174, P185, DOI 10.1104/pp.17.00349; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Penzkofer A, 2014, PHOTOCHEM PHOTOBIOL, V90, P773, DOI 10.1111/php.12246; Petroutsos D, 2016, NATURE, V537, P563, DOI 10.1038/nature19358; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roberts DGW, 2001, GENETICS, V158, P1037; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Schneider F, 2015, ANNU REV BIOPHYS, V44, P167, DOI 10.1146/annurev-biophys-060414-034014; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x                                                ; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399                                                          ; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3                                                   ; Sizova I, 2013, PLANT J, V73, P873, DOI 10.1111/tpj.12066; Spexard M, 2014, BIOCHEMISTRY-US, V53, P1041, DOI 10.1021/bi401599z; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Trippens J, 2012, PLANT CELL, V24, P4687, DOI 10.1105/tpc.112.103523; UHL R, 1990, BIOPHYS J, V58, P1295, DOI 10.1016/S0006-3495(90)82469-3                                                   ; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101                                                              ; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Yamano T, 2013, J BIOSCI BIOENG, V115, P691, DOI 10.1016/j.jbiosc.2012.12.020; Zheng XL, 2016, PLANT CELL REP, V35, P1545, DOI 10.1007/s00299-016-1967-1; Zhu CF, 2017, TRENDS PLANT SCI, V22, P38, DOI 10.1016/j.tplants.2016.08.009; Zorin B, 2005, EUKARYOT CELL, V4, P1264, DOI 10.1128/EC.4.7.1264-1272.2005; Zorin B, 2009, GENE, V432, P91, DOI 10.1016/j.gene.2008.11.028; Zou Y, 2017, PLANT PHYSIOL, V174, P1334, DOI 10.1104/pp.17.00493	79	2	2	7	7	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	1040-4651	1532-298X		PLANT CELL	Plant Cell	OCT	2017	29	10					2498	2518		10.1105/tpc.17.00659				21	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	FM2WB	WOS:000414861100018	28978758				2018-01-05	
J	Guntaka, NS; Healy, AR; Crawford, JM; Herzon, SB; Bruner, SD				Guntaka, Naga Sandhya; Healy, Alan R.; Crawford, Jason M.; Herzon, Seth B.; Bruner, Steven D.			Structure and Functional Analysis of CIbQ, an Unusual Intermediate-Releasing Thioesterase from the Colibactin Biosynthetic Pathway	ACS CHEMICAL BIOLOGY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; ESCHERICHIA-COLI; II THIOESTERASE; POLYKETIDE SYNTHASE; PHOSPHOPANTETHEINYL TRANSFERASE; BACTERIAL GENOTOXIN; BACILLUS-SUBTILIS; NATURAL-PRODUCTS; EXTENDER UNITS; CHAIN RELEASE	Colibactin is a genotoxic hybrid nonribosomal peptide/polyketide secondary metabolite produced by various pathogenic and probiotic bacteria residing in the human gut. The Presence of colibactin metabolites has been correlated to colorectal cancer formation in several studies. The specific function of many gene products in the colibactin gene cluster can be predicted. However, the role of ClbQ a type II editing thioesterase, has not been established. The importance of ClbQ has been demonstrated by genetic deletions that abolish colibactiii:cytotoxic activity, and recent studies suggest an atypical role in releasing pathway intermediates from the assembly line. Here we report the 2.0 angstrom crystal structure and biochemical characterization of ClbQ Our data reveal that ClbQ exhibits greater catalytic efficiency toward aryl-thioester substrates as compared to precolibactin intermediates and does, not discriminate among carrier proteins. Cyclized pyridone-containing colibactins, which are off-pathWay :derivatives, are not viable substrates for ClbQ while linear precursors are, supporting a role of ClbQ in facilitating the promiscuous off-loading of premature: precolibactin metabolites and novel insights into,colibactin biosynthesis.	[Guntaka, Naga Sandhya; Bruner, Steven D.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Healy, Alan R.; Crawford, Jason M.; Herzon, Seth B.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Healy, Alan R.; Crawford, Jason M.] Yale Univ, Chem Biol Inst, West Haven, CT 06516 USA; [Crawford, Jason M.] Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Herzon, Seth B.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Bruner, SD (reprint author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	bruner@ufl.edu		Healy, Alan R/0000-0002-1231-8353; Guntaka, Naga Sandhya/0000-0002-3753-6277	National Science Foundation [1411991]; National Institutes of Health [R01GM110506, 1DP2-CA 186575]	Financial support from the National Science Foundation (Grant 1411991 to S.D.B) and the National Institutes of Health (Grant R01GM110506 to S.B.H. and Grant 1DP2-CA 186575 to J.M.C) is gratefully acknowledged. We are grateful to the staff of LS-CAT 21-ID-G beamline at Argonne National Laboratory, IL, U.S.A., for assistance with X-ray data collection and processing. We also thank W. H. Chen for assistance in the crystal structure refinement. We thank E. Trautman for synthesizing N-myristoyl-D-Asn-SNAC.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Balskus EP, 2015, NAT PROD REP, V32, P1534, DOI 10.1039/c5np00091b; Bian XY, 2013, CHEMBIOCHEM, V14, P1194, DOI 10.1002/cbic.201300208; Brachmann AO, 2015, CHEM COMMUN, V51, P13138, DOI 10.1039/c5cc02718g; Brotherton CA, 2013, J AM CHEM SOC, V135, P3359, DOI 10.1021/ja312154m; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5                                                   ; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; Cougnoux A, 2012, J MOL BIOL, V424, P203, DOI 10.1016/j.jmb.2012.09.017; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Dimise EJ, 2008, P NATL ACAD SCI USA, V105, P15311, DOI 10.1073/pnas.0805451105; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dubois D, 2011, J BIOL CHEM, V286, P35562, DOI 10.1074/jbc.M111.221960; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felnagle EA, 2008, MOL PHARM, V5, P191, DOI 10.1021/mp700137g; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Geuking Markus B, 2014, Gut Microbes, V5, P411, DOI 10.4161/gmic.29330; Harvey BM, 2006, CHEMBIOCHEM, V7, P1435, DOI 10.1002/cbic.200500474; Healy AR, 2016, J AM CHEM SOC, V138, P15563, DOI 10.1021/jacs.6b10354; Healy AR, 2016, J AM CHEM SOC, V138, P5426, DOI 10.1021/jacs.6b02276; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Homburg S, 2007, FEMS MICROBIOL LETT, V275, P255, DOI 10.1111/j.1574-6968.2007.00889.x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Horsman ME, 2016, NAT PROD REP, V33, P183, DOI 10.1039/c4np00148f; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalaitzis JA, 2011, BIOORGAN MED CHEM, V19, P6633, DOI 10.1016/j.bmc.2011.04.024; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kotowska M, 2014, APPL MICROBIOL BIOT, V98, P7735, DOI 10.1007/s00253-014-5952-8; Li ZR, 2016, NAT CHEM BIOL, V12, P773, DOI 10.1038/nchembio.2157; Li ZR, 2015, CHEMBIOCHEM, V16, P1715, DOI 10.1002/cbic.201500239; Liu TG, 2006, CHEM BIOL, V13, P945, DOI 10.1016/j.chembiol.2006.07.006; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e                                                               ; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Oiler M., 2012, GUT MICROBES, V3, P501; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Raisch J, 2015, LAB INVEST, V95, P296, DOI 10.1038/labinvest.2014.161; Ritchie MK, 2016, J BIOL CHEM, V291, P3520, DOI 10.1074/jbc.M115.702597; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rui Z, 2010, J BIOL CHEM, V285, P24915, DOI 10.1074/jbc.M110.128850; Scaldaferri F, 2016, WORLD J GASTROENTERO, V22, P5505, DOI 10.3748/wjg.v22.i24.5505; Schneider A, 1998, ARCH MICROBIOL, V169, P404, DOI 10.1007/s002030050590; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Trautman EP, 2017, J AM CHEM SOC, V139, P4195, DOI 10.1021/jacs.7b00659; Vizcaino MI, 2014, J AM CHEM SOC, V136, P9244, DOI 10.1021/ja503450q; Whicher JR, 2011, J BIOL CHEM, V286, P22558, DOI 10.1074/jbc.M110.213512; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zha L, 2017, NAT CHEM BIOL, V13, P1063, DOI [10.1038/nchembio.2448, 10.1038/NCHEMBIO.2448]; Zha L, 2016, ACS CHEM BIOL, V11, P1287, DOI 10.1021/acschembio.6b00014; Zhou YJ, 2008, APPL ENVIRON MICROB, V74, P7235, DOI 10.1128/AEM.01012-08	58	0	0	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	OCT	2017	12	10					2598	2608		10.1021/acschembio.7b00479				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FK7TI	WOS:000413709700018	28846367				2018-01-05	
J	Deaner, M; Mejia, J; Alper, HS				Deaner, Matthew; Mejia, Julio; Alper, Hal S.			Enabling Graded and Large-Scale Multiplex of Desired Genes Using a Dual-Mode dCas9 Activator in Saccharomyces cerevisiae	ACS SYNTHETIC BIOLOGY			English	Article						CRISPR/dCas9; gene multiplexing; metabolic engineering; ribozymes; inducible sgRNAs	RNA-POLYMERASE-III; TRANSCRIPTION FACTORS; SYNTHETIC BIOLOGY; ESCHERICHIA-COLI; IN-VITRO; HAMMERHEAD RIBOZYMES; CRISPR INTERFERENCE; FATTY-ACIDS; YEAST; SYSTEM	Standard approaches for dCas9-based modification of gene expression are limited in the ability to multiplex targets, establish streamlined cassettes, and utilize commonly studied Pol II promoters. In this work, we repurpose the dCas9-VPR activator to act as a dual-mode activator/repressor that can be programmed solely on the basis of target position at gene loci. Furthermore, we implement this approach using a streamlined Pol II-ribozyme system that allows expression of many sgRNAs from a single transcript. By "stepping" dCas9-VPR within the promoter region and ORF we create graded activation and repression (respectively) of target genes, allowing precise control over multiplexed gene modulation. Expression from the Pol II system increased the net amount of sgRNA production in cells by 3.88-fold relative to the Pol III SNR52 promoter, leading to a significant improvement in dCas9-VPR repression strength. Finally, we utilize our Pol II system to create galactose-inducible switching of gene expression states and multiplex constructs capable of modulating up to 4 native genes from a single vector. Our approach represents a significant step toward minimizing DNA required to assemble CRISPR systems in eukaryotes while enhancing the efficacy (greater repression strength), scale (more sgRNAs), and scope (inducibility) of dCas9-mediated gene regulation.	[Deaner, Matthew; Mejia, Julio; Alper, Hal S.] Univ Texas Austin, McKetta Dept Chem Engn, 200 E Dean Keeton St,Stop C0400, Austin, TX 78712 USA; [Alper, Hal S.] Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway Ave, Austin, TX 78712 USA	Alper, HS (reprint author), Univ Texas Austin, McKetta Dept Chem Engn, 200 E Dean Keeton St,Stop C0400, Austin, TX 78712 USA.; Alper, HS (reprint author), Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway Ave, Austin, TX 78712 USA.	halper@che.utexas.edu			Camille Dreyfus Teacher-Scholar Award; Air Force Office of Scientific Research [FA9550-14-1-0089]; National Defense Science and Engineering (NDSEG)	This work was funded by the Camille Dreyfus Teacher-Scholar Award and the Air Force Office of Scientific Research under Award No. FA9550-14-1-0089. M.D. acknowledges a National Defense Science and Engineering (NDSEG) Graduate Fellowship.	Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Bothfeld W, 2017, ACS SYNTH BIOL, V6, P1296, DOI 10.1021/acssynbio.6b00257; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brown TS, 2004, J MOL BIOL, V341, P695, DOI 10.1016/j.jmb.2004.05.071; Carbonell A, 2011, NUCLEIC ACIDS RES, V39, P2432, DOI 10.1093/nar/gkq1051; Chadalavada DM, 2000, J MOL BIOL, V301, P349, DOI 10.1006/jmbi.2000.3953; Chavez A, 2015, NAT METHODS, V12, P2, DOI DOI 10.1038/NMETH.3312; Cress BF, 2016, NUCLEIC ACIDS RES, V44, P4472, DOI 10.1093/nar/gkw231; Cress BF, 2015, ACS SYNTH BIOL, V4, P987, DOI 10.1021/acssynbio.5b00012; Curran KA, 2015, ACS SYNTH BIOL, V4, P824, DOI 10.1021/sb5003357; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; Deaner M., 2016, ADV BIOCHEM ENG BIOT, DOI [10.1007/10_2016_8, DOI 10.1007/10_2016_8]; Deaner M, 2017, METAB ENG, V40, P14, DOI 10.1016/j.ymben.2017.01.012; DeLoache WC, 2015, NAT CHEM BIOL, V11, P465, DOI 10.1038/nchembio.1816; Elhadi D, 2016, METAB ENG, V38, P358, DOI 10.1016/j.ymben.2016.09.001; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Gander M. W., 2016, NAT COMMUN, V8, P41871; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gordon GC, 2016, METAB ENG, V38, P170, DOI 10.1016/j.ymben.2016.07.007; Guffanti E, 2006, J BIOL CHEM, V281, P23945, DOI 10.1074/jbc.M513814200; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jakociunas T, 2017, CURR OPIN BIOTECH, V46, P134, DOI 10.1016/j.copbio.2017.03.014; Jakounas T, 2015, METAB ENG, V28, P213, DOI [10.1016/j.ymbn.2015.01.008, 10.1016/j.ymben.2015.01.008]; Karim A. S., 2016, IND BIOTECHNOLOGY, P125; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim H. S., 2017, J BIOL CHEM M, V117; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Mazumder M, 2014, NUCLEIC ACIDS RES, V42, P9514, DOI 10.1093/nar/gku651; Mclsaac R. S., 2014, NUCLEIC ACIDS RES, V42, P1; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Orioli A, 2012, GENE, V493, P185, DOI 10.1016/j.gene.2011.06.015; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Renda BA, 2014, MOL BIOSYST, V10, P1668, DOI 10.1039/c3mb70606k; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Snitkin ES, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001294; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Watstein DM, 2015, METAB ENG, V31, P171, DOI 10.1016/j.ymben.2015.06.007; Way JC, 2014, CELL, V157, P151, DOI 10.1016/j.cell.2014.02.039; Williams TC, 2015, METAB ENG, V29, P124, DOI 10.1016/j.ymben.2015.03.008; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xu L., 2016, NUCLEIC ACIDS RES, V45, pe28; Xu P, 2014, P NATL ACAD SCI USA, V111, P11299, DOI 10.1073/pnas.1406401111; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	54	1	1	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	OCT	2017	6	10					1931	1943		10.1021/acssynbio.7b00163				13	Biochemical Research Methods	Biochemistry & Molecular Biology	FK7VK	WOS:000413715200015	28700213				2018-01-05	
J	Tao, P; Wu, XR; Tang, WC; Zhu, JG; Rao, V				Tao, Pan; Wu, Xiaorong; Tang, Wei-Chun; Zhu, Jingen; Rao, Venigalla			Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9	ACS SYNTHETIC BIOLOGY			English	Article						genome engineering; T4 bacteriophage; CRISPR; Cas9 nuclease; genome editing	DNA PACKAGING MOTOR; IN-VITRO; PHAGE THERAPY; RNA LIGASE; PROTEINS; PATHOGENS; MUTANTS; BINDING; SURFACE; SYSTEM	Bacteriophages likely constitute the largest biomass on Earth. However, very few phage genomes have been well-characterized, the tailed phage T4 genome being one of them. Even in T4, much of the genome remained uncharacterized. The classical genetic strategies are tedious, compounded by genome modifications such as cytosine hydroxylmethylation and glucosylation which makes T4 DNA resistant to most restriction endonucleases. Here, using the type-II CRISPR-Cas9 system, we report the editing of both modified (ghm-Cytosine) and unmodified (Cytosine) T4 genomes. The modified genome, however, is less susceptible to Cas9 nuclease attack when compared to the unmodified genome. The efficiency of restriction of modified phage infection varied greatly in a spacer-dependent manner, which explains some of the previous contradictory results. We developed a genome editing strategy by codelivering into E. coli a CRISPR-Cas9 plasmid and a donor plasmid containing the desired mutation(s). Single and multiple point mutations, insertions and deletions were introduced into both modified and unmodified genomes. As short as 50-bp homologous flanking arms were sufficient to generate recombinants that can be selected under the pressure of CRISPR-Cas9 nuclease. A 294-bp deletion in RNA ligase gene rnlB produced viable plaques, demonstrating the usefulness of this editing strategy to determine the essentiality of a given gene. These results provide the first demonstration of phage T4 genome editing that might be extended to other phage genomes in nature to create useful recombinants for phage therapy applications.	[Tao, Pan; Wu, Xiaorong; Tang, Wei-Chun; Zhu, Jingen; Rao, Venigalla] Catholica Univ Amer, Dept Biol, Washington, DC 20064 USA	Tao, P; Rao, V (reprint author), Catholica Univ Amer, Dept Biol, Washington, DC 20064 USA.	tao@cua.edu; rao@cua.edu			NIAID/NIH [AI111538, AI081726]	This work was supported by the NIAID/NIH Grants AI111538 and AI081726 to V.B.R.	AMITSUR M, 1989, EMBO J, V8, P2411; Bakhshinejad B, 2014, EXPERT OPIN DRUG DEL, V11, P1561, DOI 10.1517/17425247.2014.927437; Black LW, 2012, ADV VIRUS RES, V82, P119, DOI 10.1016/B978-0-12-394621-8.00018-2; Box AM, 2016, J BACTERIOL, V198, P578, DOI 10.1128/JB.00747-15; Bryson AL, 2015, MBIO, V6, DOI 10.1128/mBio.00648-15; CARLSON K, 1993, J BIOL CHEM, V268, P8908; Chanishvili N, 2012, ADV VIRUS RES, V83, P3, DOI 10.1016/B978-0-12-394438-2.00001-3; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; ISHII T, 1977, J MOL BIOL, V109, P487, DOI 10.1016/S0022-2836(77)80088-0; JABBAR MA, 1984, J VIROL, V51, P522; Karam J. D., 1994, MOL BIOL BACTERIOPHA; Karam JD, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-19; Kiro R, 2014, RNA BIOL, V11, P42, DOI 10.4161/rna.27766; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; LaFee S., 2017, NOVEL PHAGE THERAPY; Lemay ML, 2017, ACS SYNTH BIOL, V6, P1351, DOI 10.1021/acssynbio.6b00388; Li Q, 2006, J MOL BIOL, V363, P577, DOI 10.1016/j.jmb.2006.08.049; Lu TK, 2011, CURR OPIN MICROBIOL, V14, P524, DOI 10.1016/j.mib.2011.07.028; Martel B, 2014, NUCLEIC ACIDS RES, V42, P9504, DOI 10.1093/nar/gku628; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mosig G, 2001, P NATL ACAD SCI USA, V98, P8306, DOI 10.1073/pnas.131007398; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pires DP, 2016, MICROBIOL MOL BIOL R, V80, P523, DOI 10.1128/MMBR.00069-15; Pranjol MZI, 2015, VIRUSES-BASEL, V7, P268, DOI 10.3390/v7010268; Rao VB, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-356; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; RUNNELS JM, 1982, J MOL BIOL, V154, P273, DOI 10.1016/0022-2836(82)90064-X; Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI [10.1038/nrmicro3564, 10.1038/nrmicr03564]; SELICK HE, 1988, J BIOL CHEM, V263, P11336; Shivachandra SB, 2006, VIROLOGY, V345, P190, DOI 10.1016/j.virol.2005.10.037; Sun SY, 2010, CURR OPIN STRUC BIOL, V20, P114, DOI 10.1016/j.sbi.2009.12.006; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Sunderland KS, 2017, ANGEW CHEM INT EDIT, V56, P1964, DOI 10.1002/anie.201606181; Tao P, 2017, METHODS MOL BIOL, V1581, P255, DOI 10.1007/978-1-4939-6869-5_15; Tao Pan, 2016, Methods Mol Biol, V1403, P499, DOI 10.1007/978-1-4939-3387-7_28; Tao P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003495; Tao P, 2013, P NATL ACAD SCI USA, V110, P5846, DOI 10.1073/pnas.1300867110; Viertel TM, 2014, J ANTIMICROB CHEMOTH, V69, P2326, DOI 10.1093/jac/dku173; WILSON GG, 1979, NATURE, V280, P80, DOI 10.1038/280080a0                                                                ; Wittebole X, 2014, VIRULENCE, V5, P226, DOI 10.4161/viru.25991; Yap ML, 2014, FUTURE MICROBIOL, V9, P1319, DOI 10.2217/fmb.14.91; Yaung SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098811; Zhang ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000592	45	0	0	13	13	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	OCT	2017	6	10					1952	1961		10.1021/acssynbio.7b00179				10	Biochemical Research Methods	Biochemistry & Molecular Biology	FK7VK	WOS:000413715200017	28657724				2018-01-05	
J	Ha, SM; Chae, EY; Cha, JH; Kim, HH; Shin, HJ; Choi, WJ				Ha, Su Min; Chae, Eun Young; Cha, Joo Hee; Kim, Hak Hee; Shin, Hee Jung; Choi, Woo Jung			Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						BRCA mutation; breast cancer; MRI	INVASIVE DUCTAL CARCINOMA; HIGH FAMILIAL RISK; ESTROGEN-RECEPTOR; MAMMOGRAPHY; CARRIERS; WOMEN; SURVEILLANCE; ULTRASOUND; MRI; GRADE	OBJECTIVE. The purpose of this study is to retrospectively evaluate the relationships between the BRCA mutation types, imaging features, and pathologic findings of breast cancers in BRCA1 and BRCA2 mutation carriers. MATERIALS AND METHODS. We identified patients with breast cancer with BRCA gene mutations from January 2000 to December 2014. After excluding patients who underwent lesion excision before MRI, 99 BRCA1 and 103 BRCA2 lesions in 187 women (mean age, 39.7 and 40.4 years, respectively) were enrolled. Mammographic, sonographic, and MRI scans were reviewed according to the BI-RADS lexicon (5th edition). Pathologic data were reviewed, including the immunohistochemistry findings. The relationships between the BRCA mutations and both imaging and pathologic findings were analyzed. RESULTS. The distribution of molecular subtypes of tumors significantly differed by the mutation type. BRCA1 tumors were associated with the triple-negative subtype, whereas BRCA2 tumors were associated with the luminal B subtype (p = 0.002). At MRI, breast cancers with BRCA1 mutations exhibited a circumscribed margin (p = 0.032) and rim enhancement (p = 0.013). No significant differences in mass shape or kinetic features were observed at MRI. Cancers in BRCA1 mutation carriers tended to develop in the posterior location in the breast (p = 0.034). At mammography, no significant difference in the prevalence of calcifications was observed according to the mutation type. At sonography, BRCA1 lesions were found to be associated with posterior acoustic enhancement (p < 0.0001). CONCLUSION. Breast cancers with BRCA1 mutations tend to exhibit benign morphologic features at MRI, mammography, and sonography, compared with BRCA2 mutations. Lesion location may represent another difference on imaging among various genetic phenotypes.	[Ha, Su Min] Chung Ang Univ Hosp, Res Inst Radiol, Dept Radiol, Seoul, South Korea; [Chae, Eun Young; Cha, Joo Hee; Kim, Hak Hee; Shin, Hee Jung; Choi, Woo Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol,Res Inst Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea	Chae, EY (reprint author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol,Res Inst Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.	chaeey@hanmail.net					Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Blaichman J, 2012, AM J ROENTGENOL, V199, pW402, DOI 10.2214/AJR.11.7374; 차주희, 2013, [Journal of the Korean Society of Magnetic Resonance in Medicine, 대한자기공명의과학회지], V17, P207, DOI 10.13104/jksmrm.2013.17.3.207; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; D'Orsi CJSE, 2013, ACR BI RADS ATLAS BR; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4                                                   ; Gilbert FJ, 2009, RADIOLOGY, V252, P358, DOI 10.1148/radiol.2522081032; Jimenez RE, 2001, AM J SURG PATHOL, V25, P331, DOI 10.1097/00000478-200103000-00007                                                ; Kim WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116344; Krainer M, 1997, NEW ENGL J MED, V336, P1416, DOI 10.1056/NEJM199705153362003; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267                                              ; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424                                                   ; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lamb PM, 2000, CLIN RADIOL, V55, P40, DOI 10.1053/crad.1999.0333                                                          ; Larsen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064268; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Noh JM, 2013, J BREAST CANCER, V16, P308, DOI 10.4048/jbc.2013.16.3.308; Noh JM, 2012, BREAST CANCER RES TR, V131, P217, DOI 10.1007/s10549-011-1718-5; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374                                                        ; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rijnsburger AJ, 2010, J CLIN ONCOL, V28, P5265, DOI 10.1200/JCO.2009.27.2294; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75                                                        ; Schrading S, 2008, RADIOLOGY, V246, P58, DOI 10.1148/radiol.2461062173; Tilanus-Linthorst M, 2002, INT J CANCER, V102, P91, DOI 10.1002/ijc.10666; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Veltman J, 2008, EUR RADIOL, V18, P931, DOI 10.1007/s00330-008-0851-y; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Warner E, 2001, J CLIN ONCOL, V19, P3524, DOI 10.1200/JCO.2001.19.15.3524                                                     	31	0	0	4	4	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	OCT	2017	209	4					920	928		10.2214/AJR.16.16957				9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	FH8JM	WOS:000411440600039	28796549				2018-01-05	
J	Shi, TQ; Liu, GN; Ji, RY; Shi, K; Song, P; Ren, LJ; Huang, H; Ji, XJ				Shi, Tian-Qiong; Liu, Guan-Nan; Ji, Rong-Yu; Shi, Kun; Song, Ping; Ren, Lu-Jing; Huang, He; Ji, Xiao-Jun			CRISPR/Cas9-based genome editing of the filamentous fungi: the state of the art	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						CRISPR/Cas9; Application; Filamentous fungi; Genome editing	GAMMA-LINOLENIC ACID; FUNCTIONAL GENOMICS; BLAKESLEA-TRISPORA; RNA; CAS9; FERMENTATION; CRISPR-CAS9; SYSTEMS; TOOLS; ENDONUCLEASE	In recent years, a variety of genetic tools have been developed and applied to various filamentous fungi, which are widely applied in agriculture and the food industry. However, the low efficiency of gene targeting has for many years hampered studies on functional genomics in this important group of microorganisms. The emergence of CRISPR/Cas9 genome-editing technology has sparked a revolution in genetic research due to its high efficiency, versatility, and easy operation and opened the door for the discovery and exploitation of many new natural products. Although the application of the CRISPR/Cas9 system in filamentous fungi is still in its infancy compared to its common use in E. coli, yeasts, and mammals, the deep development of this system will certainly drive the exploitation of fungal diversity. In this review, we summarize the research progress on CRISPR/Cas9 systems in filamentous fungi and finally highlight further prospects in this area.	[Shi, Tian-Qiong; Liu, Guan-Nan; Ji, Rong-Yu; Shi, Kun; Song, Ping; Ren, Lu-Jing; Ji, Xiao-Jun] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, 30 South Puzhu Rd, Nanjing 211816, Jiangsu, Peoples R China; [Huang, He] Nanjing Tech Univ, Sch Pharmaceut Sci, 30 South Puzhu Rd, Nanjing 211816, Jiangsu, Peoples R China; [Huang, He] Nanjing Tech Univ, State Key Lab Mat Oriented Chem Engn, 5 Xinmofan Rd, Nanjing 210009, Jiangsu, Peoples R China; [Ren, Lu-Jing; Huang, He; Ji, Xiao-Jun] Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, 5 Xinmofan Rd, Nanjing 210009, Jiangsu, Peoples R China	Ji, XJ (reprint author), Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, 30 South Puzhu Rd, Nanjing 211816, Jiangsu, Peoples R China.; Ji, XJ (reprint author), Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, 5 Xinmofan Rd, Nanjing 210009, Jiangsu, Peoples R China.	xiaojunji@njtech.edu.cn		Ji, Xiao-Jun/0000-0002-6450-0229	National Natural Science Foundation of China [21376002, 21476111, 21776131]; Jiangsu Province Natural Science Foundation of China [BK20131405]; Program for Innovative Research Team in University of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported by the National Natural Science Foundation of China (Nos. 21376002, 21476111 and 21776131), the Jiangsu Province Natural Science Foundation of China (No. BK20131405), the Program for Innovative Research Team in University of Jiangsu Province, and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Andersen MR, 2013, P NATL ACAD SCI USA, V110, pE99, DOI 10.1073/pnas.1205532110; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P1335, DOI 10.1002/bit.25559; Auer TO, 2014, NAT PROTOC, V9, P2823, DOI 10.1038/nprot.2014.187; Bachu R, 2015, BIOTECHNOL BIOENG, V112, P2154, DOI 10.1002/bit.25629; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dufosse L, 2014, CURR OPIN BIOTECH, V26, P56, DOI 10.1016/j.copbio.2013.09.007; Dwiarti L, 2007, BIORESOURCE TECHNOL, V98, P3329, DOI 10.1016/j.biortech.2006.03.016; Dyal SD, 2005, FOOD RES INT, V38, P815, DOI 10.1016/j.foodres.2005.04.002; Estrela R, 2016, CURR OPIN BIOTECH, V38, P79, DOI 10.1016/j.copbio.2016.01.005; Fakas S, 2008, BIORESOURCE TECHNOL, V99, P5986, DOI 10.1016/j.biortech.2007.10.016; Fang H, 2015, FUEL, V143, P211, DOI 10.1016/j.fuel.2014.11.056; Fang YF, 2016, MOL PLANT PATHOL, V17, P127, DOI 10.1111/mpp.12318; Francis F, 2003, BIOCHEM ENG J, V15, P107, DOI 10.1016/S1369-703X(03)00027-5; Fu YQ, 2016, BIORESOURCE TECHNOL, V218, P410, DOI 10.1016/j.biortech.2016.06.127; Fuller KK, 2015, EUKARYOT CELL, V25, P709; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Harris LJ, 2016, FUNGAL BIOL-UK, V120, P111, DOI 10.1016/j.funbio.2015.10.010; Ji XJ, 2014, CRIT REV BIOTECHNOL, V34, P197, DOI 10.3109/07388551.2013.778229; Jiang DW, 2013, BIOTECHNOL ADV, V31, P1562, DOI 10.1016/j.biotechadv.2013.08.005; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kao P. H., 2017, BIORESOUR TECHNOL; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Kuck U, 2010, APPL MICROBIOL BIOT, V86, P51, DOI 10.1007/s00253-009-2416-7; Kuivanen J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0613-5; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Lecellier A, 2015, FOOD MICROBIOL, V45, P126, DOI 10.1016/j.fm.2014.01.002; Lee J, 2016, PLANT BIOTECHNOL J, V14, P448, DOI 10.1111/pbi.12465; Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mantzouridou FT, 2017, APPL MICROBIOL BIOT, V101, P1845, DOI 10.1007/s00253-016-7943-4; Marumo S, 2014, AGR BIOL CHEM TOKYO, V46, P1967; Mashimo T, 2014, DEV GROWTH DIFFER, V56, P46, DOI 10.1111/dgd.12110; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; MISHRA NC, 1973, P NATL ACAD SCI USA, V70, P3875, DOI 10.1073/pnas.70.12.3875; Nanou K, 2016, BIORESOURCE TECHNOL, V203, P198, DOI 10.1016/j.biortech.2015.12.053; Ng IS, 2016, J TAIWAN INST CHEM E, V68, P31, DOI 10.1016/j.jtice.2016.08.015; Nielsen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169712; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Qin H, 2017, PROCESS BIOCHEM, V56, P57, DOI 10.1016/j.procbio.2017.02.012; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ryan OW, 2014, METHOD ENZYMOL, V546, P473, DOI 10.1016/B978-0-12-801185-0.00023-4; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Shi TQ, 2017, BIOENGINEERED, V8, P124, DOI 10.1080/21655979.2016.1212138; Tang WJ, 2015, BIOCHEM ENG J, V99, P167, DOI 10.1016/j.bej.2015.03.025; Thrane Ulf, 2007, V18, P235, DOI 10.1007/4735_2007_0230; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Ward OP, 2012, BIOTECHNOL ADV, V30, P1119, DOI 10.1016/j.biotechadv.2011.09.012; Weber J, 2017, ACS SYNTH BIOL, V6, P62, DOI 10.1021/acssynbio.6b00203; Weld RJ, 2006, CELL RES, V16, P31, DOI 10.1038/sj.cr.7310006; Weyda I, 2017, J MICROBIOL METH, V135, P26, DOI 10.1016/j.mimet.2017.01.015; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xian M, 2002, CURR MICROBIOL, V44, P141, DOI 10.1007/s00284-001-0031-7; Xiong X, 2015, APPL MICROBIOL BIOT, V99, P1173, DOI 10.1007/s00253-014-6227-0; Xu Q, 2012, BIOTECHNOL ADV, V30, P1685, DOI 10.1016/j.biotechadv.2012.08.007; Yang MQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-I1; [殷朝敏 Yin Chaomin], 2017, [生物技术通报, Biotechnology Bulletin], V33, P58; Yu Jiujiang, 2005, Revista Iberoamericana de Micologia, V22, P194; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zhang Y, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0723-8; [郑武 Zheng Wu], 2015, [遗传, Hereditas(Beijing)], V37, P1003, DOI 10.16288/j.yczz.15-070; Zhou PP, 2017, BIORESOURCE TECHNOL, V224, P563, DOI 10.1016/j.biortech.2016.11.046	71	1	1	42	42	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	OCT	2017	101	20					7435	7443		10.1007/s00253-017-8497-9				9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FI6QU	WOS:000412122100003	28887634				2018-01-05	
J	Huang, P; Tong, DD; Sun, J; Li, Q; Zhang, FH				Huang, Ping; Tong, Dongdong; Sun, Jing; Li, Qing; Zhang, Fenghe			Generation and characterization of a human oral squamous carcinoma cell line SCC-9 with CRISPR/Cas9-mediated deletion of the p75 neurotrophin receptor	ARCHIVES OF ORAL BIOLOGY			English	Article						p75(NTR); CRISPR/Cas9; Knockout; Oral squamous carcinoma; Cruiser (TM); Enzyme; Therapy	NERVE GROWTH-FACTOR; ZINC-FINGER NUCLEASES; TAL EFFECTOR NUCLEASES; STEM-CELLS; TUMOR-SUPPRESSOR; DYSTROPHIN GENE; CANCER CELLS; HUMAN GENOME; IN-VITRO; P75(NTR)	Objective: To investigate the importance of the p75 neurotrophin receptor (p75(NTR)) in human tongue squamous carcinoma cells, we exploited the CRISPR/Cas9 technology to establish a p75(NTR)-knockout SCC-9 cell line and to explore the effect on biological functions. Materials and methods: The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated endonuclease (Cas9) system was used to generate genomic deletion mutants of p75(NTR) in the tongue squamous carcinoma cell lines SCC-9. Single-guide RNA (sgRNA) sequences were designed to target the p75(NTR) genomic sequence and were cloned into plasmid pGK1.1. The linearized vector was electroporated into SCC-9 cells and p75(NTR) deletion was confirmed using Cruiser (TM) enzyme digestion and PCR amplification. SCC-9 clones with successful deletion of p75(NTR) were identified and verified by sequencing and selected for functional testing in cell proliferation, invasion, migration, and colony-forming assays. Results: Compared with control cells, p75(NTR)-knockout SCC-9 cells showed significantly diminished abilities to proliferate, invade, migrate, and form colonies, indicating a reduction in pro-tumorigenic behavior. Conclusion: These data demonstrate, first, that the CRISPR/Cas9 system is a simplified method for generating p75(NTR) knockouts with relatively high efficiency, and second, that deletion of p75(NTR) suppresses several tumor promoting properties of SCC-9 cells, suggesting that p75(NTR) is a potential target for the development of novel therapies for tongue cancer.	[Huang, Ping] Shandong Univ, Qilu Hosp, Dept Gynecol, Shandong Prov Key Lab Oral Tissue Regenerat, Jinan 250012, Shandong, Peoples R China; [Tong, Dongdong; Li, Qing; Zhang, Fenghe] Shandong Univ, Shandong Prov Key Lab Oral Tissue Regenerat, Dept Oral & Maxillofacial Surg, Jinan 250012, Shandong, Peoples R China; [Sun, Jing] Shandong Univ, Shandong Prov Key Lab Oral Tissue Regenerat, Dept Bone Metab, Jinan 250012, Shandong, Peoples R China	Zhang, FH (reprint author), Shandong Univ, Shandong Prov Key Lab Oral Tissue Regenerat, Dept Oral & Maxillofacial Surg, Sch Stomatol, Wenhua West Rd 44-1, Jinan 250012, Shandong, Peoples R China.	zfengh@sdu.edu.cn			Shandong Province Key Research and Development Program [2015GSF1181481]; Foundation of Qilu Hospital of Shandong University [26010175616001]; Shandong Province Science and Technique Foundation [2014GGH218038]	This study was supported by grants from the Shandong Province Key Research and Development Program (No. 2015GSF1181481); the Supported by Foundation of Qilu Hospital of Shandong University (No. 26010175616001) to Huang P, and the Shandong Province Science and Technique Foundation (grant no. 2014GGH218038) to Professor Fenghe Z. Moreover, we thank Wei Gao, Xiaojing Liu, Xiujuan Wei, Jing Li, Haitao Wu, and Zhenglin Yang for their contributions to this study.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001                                                   ; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Chan MM, 2010, J CUTAN PATHOL, V37, P336, DOI 10.1111/j.1600-0560.2009.01349.x; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen YC, 2015, HUM MOL GENET, V24, P3764, DOI 10.1093/hmg/ddv120; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Dang CX, 2006, J GASTROEN HEPATOL, V21, P850, DOI 10.1111/j.1440-1746.2006.04074.x; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dimaras H, 2008, INT J CANCER, V122, P2023, DOI 10.1002/ijc.23356; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Harding TC, 2001, J BIOL CHEM, V276, P4531, DOI 10.1074/jbc.C000815200; Jin HF, 2007, NEOPLASIA, V9, P471, DOI 10.1593/neo.07175; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Khwaja F, 2003, MOL CARCINOGEN, V36, P153, DOI 10.1002/mc.10106; Khwaja F., 2006, BIOCH BIOPHYSICAL RE, V341; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kiyosue T, 2013, INT J CLIN ONCOL, V18, P154, DOI 10.1007/s10147-011-0358-4; Krygier S, 2002, INT J CANCER, V98, P1, DOI 10.1002/ijc.10160; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Marchetti D, 2004, J CELL BIOCHEM, V91, P206, DOI 10.1002/jcb.10649; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Okumura T, 2003, ONCOGENE, V22, P4017, DOI 10.1038/sj.onc.1206525; Park DS, 2000, J NEUROSCI, V20, P3104; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74                                                        ; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440                                                                ; PFLUG BR, 1992, CANCER RES, V52, P5403; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rabizadeh S, 2003, CYTOKINE GROWTH F R, V14, P225, DOI 10.1016/S1359-6101(03)00018-2; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren Q, 2015, SCI REPORTS, V5; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Soland TM, 2008, HISTOPATHOLOGY, V53, P62, DOI 10.1111/j.1365-2559.2008.03063.x; Tong DD, 2017, MOL MED REP, V15, P2521, DOI 10.3892/mmr.2017.6291; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200                                                          ; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Zhang P, 2009, CANCER LETT, V277, P227, DOI 10.1016/j.canlet.2008.12.015; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	55	0	0	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	OCT	2017	82						223	232		10.1016/j.archoralbio.2017.06.004				10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	FI8MX	WOS:000412257800033	28654784				2018-01-05	
J	Manya, H; Endo, T				Manya, Hiroshi; Endo, Tamao			Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Review						O-glycosylation; O-mannosyl glycan; Glycosyltransferase; Glycan biosynthesis; Muscular dystrophy; alpha-dystroglycanopathy; Ribitol-5-phosphate	CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; EYE-BRAIN DISEASE; HNK-1 CARBOHYDRATE EPITOPE; MUSCLE ALPHA-DYSTROGLYCAN; LAMININ-BINDING; N-ACETYLGLUCOSAMINYLTRANSFERASE; MOLECULAR-CLONING; DEFECTIVE GLYCOSYLATION; GLYCOPROTEIN COMPLEX	Background: O-mannosyl glycans have been found in a limited number of glycoproteins of the brain, nerves, and skeletal muscles, particularly in alpha-dystroglycan (alpha-DG). Defects in O-mannosyl glycan on alpha-DG are the primary cause of a group of congenital muscular dystrophies, which are collectively termed alpha-dystroglycanopathy. Recent studies have revealed various O-mannosyl glycan structures, which can be classified as core Ml, core M2, and core M3 glycans. Although many dystroglycanopathy genes are involved in core M3 processing, the structure and biosynthesis of core M3 glycan remains only partially understood. Scope of review: This review presents recent findings about the structure, biosynthesis, and pathology of O-mannosyl glycans. Major conclusions: Recent studies have revealed that the entire structure of core M3 glycan, including ribitol-5-phosphate, is a novel structure in mammals; its unique biosynthetic pathway has been elucidated by the identification of new causative genes for alpha-dystroglycanopathies and their functions. General significance: O-mannosyl glycan has a novel, unique structure that is important for the maintenance of brain and muscle functions. These findings have opened up a new field in glycoscience. These studies will further contribute to the understanding of the pathomechanism of alpha-dystroglycanopathy and the development of glycotherapeutics. This article is part of a Special Issue entitled Neuro-glycoscience, edited by Kenji Kadomatsu and Hiroshi Kitagawa.	[Endo, Tamao] Tokyo Metropolitan Geriatr Hosp, Res Team Mech Aging, Mol Glycobiol, Itabashi Ku, Tokyo 1730015, Japan; Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan	Endo, T (reprint author), Tokyo Metropolitan Geriatr Hosp, Res Team Mech Aging, Mol Glycobiol, Itabashi Ku, Tokyo 1730015, Japan.	manya@tmig.or.jp; endo@tmig.or.jp					Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V320, P39, DOI 10.1016/j.bbrc.2004.05.129; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Akasaka-Manya K, 2011, BIOCHEM BIOPH RES CO, V411, P721, DOI 10.1016/j.bbrc.2011.07.012; Ashikov A, 2013, GLYCOBIOLOGY, V23, P303, DOI 10.1093/glycob/cws153; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Barone R, 2012, ANN NEUROL, V72, P550, DOI 10.1002/ana.23632; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7                                                    ; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x; Briggs DC, 2016, NAT CHEM BIOL, V12, P810, DOI [10.1038/NCHEMBIO.2146, 10.1038/nchembio.2146]; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Carss KJ, 2013, AM J HUM GENET, V93, P29, DOI 10.1016/j.ajhg.2013.05.009; Chiba A, 1997, J BIOL CHEM, V272, P2156; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; Endo T, 2005, Acta Myol, V24, P64; Endo T, 2015, J BIOCHEM, V157, P1, DOI 10.1093/jb/mvu066; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Halmo SM, 2017, J BIOL CHEM, V292, P2101, DOI 10.1074/jbc.M116.764712; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Hennen E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201095; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; Inamori K, 2016, GLYCOBIOLOGY, V26, P1284, DOI 10.1093/glycob/cww075; Inamori K, 2013, GLYCOBIOLOGY, V23, P295, DOI 10.1093/glycob/cws152; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Kaneko M, 1999, FEBS LETT, V452, P237, DOI 10.1016/S0014-5793(99)00640-7; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kobayashi K, 1998, NATURE, V394, P388; Kudo T, 2007, GLYCOBIOLOGY, V17, P1, DOI 10.1093/glycob/cwl047; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Liu JM, 2006, MECH DEVELOP, V123, P228, DOI 10.1016/j.mod.2005.12.003; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Manya H., 2015, SUGAR CHAINS DECODIN, P235; Manya H., 2016, J BIOL CHEM, V161, P99; Manya H, 2008, NEUROMUSCULAR DISORD, V18, P45, DOI 10.1016/j.nmd.2007.08.002; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Manya H, 2010, J BIOCHEM, V147, P337, DOI 10.1093/jb/mvp170; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature000838; Morise J, 2014, GLYCOBIOLOGY, V24, P314, DOI 10.1093/glycob/cwt116; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Muntoni F, 2002, LANCET, V360, P1419, DOI 10.1016/S0140-6736(02)11397-3                                                   ; Nakagawa N, 2012, J BIOL CHEM, V287, P30823, DOI 10.1074/jbc.M112.363036; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605                                                       ; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Riemersma M, 2015, CHEM BIOL, V22, P1643, DOI 10.1016/j.chembiol.2015.10.014; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Sasaki N, 2005, BIOCHEM BIOPH RES CO, V333, P131, DOI 10.1016/j.bbrc.2005.05.082; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151                                                          ; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003                                                           ; Takahashi S, 2001, GLYCOBIOLOGY, V11, P37, DOI 10.1093/glycob/11.1.37; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Wright KM, 2012, NEURON, V76, P931, DOI 10.1016/j.neuron.2012.10.009; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Xu MC, 2016, HUM MOL GENET, V25, P1479, DOI 10.1093/hmg/ddw022; Yagi H, 2016, MOL CELL PROTEOMICS, V15, P3424, DOI 10.1074/mcp.M116.062729; Yaji S, 2015, GLYCOBIOLOGY, V25, P376, DOI 10.1093/glycob/cwu118; Yamada H, 1996, J NEUROCHEM, V66, P1518; Yang AC, 2013, MOL GENET METAB, V110, P345, DOI 10.1016/j.ymgme.2013.06.016; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3                                                   ; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yuen CT, 1997, J BIOL CHEM, V272, P8924	94	0	0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	OCT	2017	1861	10			SI		2462	2472		10.1016/j.bbagen.2017.06.024				11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FI3HR	WOS:000411849100007	28711406				2018-01-05	
J	Furukawa, K; Ohmi, Y; Ji, ST; Zhang, P; Bhuiyan, RH; Ohkawa, Y; Tajima, O; Hashimoto, N; Furukawa, K				Furukawa, Koichi; Ohmi, Yuhsuke; Ji, Shuting; Zhang, Pu; Bhuiyan, Robiul H.; Ohkawa, Yuki; Tajima, Orie; Hashimoto, Noboru; Furukawa, Keiko			Glycolipids: Essential regulator of neuro-inflammation, metabolism and gliomagenesis	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Review						Ganglioside; Knockout; Neurodegeneration; Inflammation; Complement; Astrocyte; Glioma	HEREDITARY SPASTIC PARAPLEGIA; GANGLIOSIDE BIOSYNTHESIS; CELL-MIGRATION; DEFICIENT MICE; SYNTHASE GENE; COMPLEX; SERIES; EXPRESSION; RECEPTOR; GLIOMAS	Gene knockout mice of glycosyltransferases have clearly showed roles of their products in the bodies, while there are examples where phenotype of knockout was much less severe than expected probably due to functional redundancy. The most striking novel finding obtained from ganglioside-deficient mice was that progressive inflammatory reaction took place, leading to neurodegeneration. In particular, dysfunction of complement regulatory proteins due to deteriorated architecture of lipid rafts seemed to be essential mechanisms for the inflammation. Furthermore, roles of gangliosides in neurons were demonstrated by neuron-specific transgenic of B4galnt1 with genetic background of B4galnt1 deficiency. From study of gene knockout mice of St8sia1, new roles of b-series gangliosides in leptin secretion from adipocytes, and roles of a-series gangliosides in leptin receptor, ObR in hypothalamus were demonstrated, leading to apparent intact balance of energy. Essential roles of b-series gangliosides in malignant properties of gliomas were also shown, suggesting their roles in the regulation of inflammation and proliferation in nervous tissues. How to apply these findings for the control of newly discovered patients with ganglioside deficiency remains to be investigated. This article is part of a Special Issue entitled Neuro-glycoscience, edited by Kenji Kadomatsu and Hiroshi Kitagawa.	[Furukawa, Koichi] Chubu Univ, Coll Life & Hlth, Dept Biomed Sci, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan; Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan	Furukawa, K (reprint author), Chubu Univ, Coll Life & Hlth, Dept Biomed Sci, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan.	koichi@isc.chubu.ac.jp			Ministry of Education, Culture, Sports and Technology of Japan (MEXT) [15H04696, 15K15080, 23110008, 16H01335]	This study was supported by Grants-in-Aids of the Ministry of Education, Culture, Sports and Technology of Japan (MEXT) (15H04696, 15K15080, 23110008, 16H01335).	Boukhris A, 2013, AM J HUM GENET, V93, P118, DOI 10.1016/j.ajhg.2013.05.006; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6                                                       ; Furukawa Koichi, 2014, Adv Neurobiol, V9, P307, DOI 10.1007/978-1-4939-1154-7_14; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; Ji ST, 2016, BIOCHEM BIOPH RES CO, V479, P453, DOI 10.1016/j.bbrc.2016.09.077; Ji ST, 2015, BIOCHEM BIOPH RES CO, V459, P189, DOI 10.1016/j.bbrc.2015.01.143; Komura N, 2016, NAT CHEM BIOL, V12, P402, DOI 10.1038/nchembio.2059; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731                                                                   ; Momota H, 2010, BRAIN TUMOR PATHOL, V27, P95, DOI 10.1007/s10014-010-0272-x; Ohkawa Y, 2015, J BIOL CHEM, V290, P16043, DOI 10.1074/jbc.M114.635755; Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x; Ohmi Y, 2009, P NATL ACAD SCI USA, V106, P22405, DOI 10.1073/pnas.0912336106; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; Okada M, 1996, CANCER RES, V56, P2844; SCHENGRUND CL, 1990, BRAIN RES BULL, V24, P131, DOI 10.1016/0361-9230(90)90297-D; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Vajn K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075720; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vukelic Z, 2007, GLYCOBIOLOGY, V17, P504, DOI 10.1093/glycob/cwm012; Wagener R, 1999, ACTA NEUROCHIR, V141, P1339, DOI 10.1007/s007010050439; Wakil SM, 2014, CLIN GENET, V86, P500, DOI 10.1111/cge.12312; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yamaguchi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34505; Yao DG, 2014, J NEUROSCI, V34, P880, DOI 10.1523/JNEUROSCI.3996-13.2014; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	32	0	0	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	OCT	2017	1861	10			SI		2479	2484		10.1016/j.bbagen.2017.06.007				6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FI3HR	WOS:000411849100009	28602513				2018-01-05	
J	Wang, H; Airola, MV; Reue, K				Wang, Huan; Airola, Michael V.; Reue, Karen			How lipid droplets "TAG" along: Glycerolipid synthetic enzymes and lipid storage	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article; Proceedings Paper	FASEB Summer Conference on Lipid Droplets - Dynamic Organelles in Metabolism and Beyond	JUL 24-29, 2016	Snowmass, CO	FASEB		Triacylglycerol synthesis; Acyltransferase; Mouse model; Human disease mutation	MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; PHOSPHATIDIC-ACID PHOSPHATASE; ACTIVATED RECEPTOR-GAMMA; CONGENITAL GENERALIZED LIPODYSTROPHY; COA-DIACYLGLYCEROL ACYLTRANSFERASE; INSULIN-STIMULATED PHOSPHORYLATION; SMALL-MOLECULE INHIBITOR; DYSTROPHY FLD MUTATION; 1 GENE-EXPRESSION; ACYL-COA	Triacylglycerols (TAG) serve as the predominant form of energy storage in mammalian cells, and TAG synthesis influences conditions such as obesity, fatty liver, and insulin resistance. In most tissues, the glycerol 3-phosphate pathway enzymes are responsible for TAG synthesis, and the regulation and function of these enzymes is therefore important for metabolic homeostasis. Here we review the sites and regulation of glycerol-3-phosphate acyltransferase (GPAT), acylglycerol-3-phosphate acyltransferase (AGPAT), lipin phosphatidic acid phosphatase (PAP), and diacylglycerol acyltransferase (DGAT) enzyme action. We highlight the critical roles that these enzymes play in human health by reviewing Mendelian disorders that result from mutation in the corresponding genes. We also summarize the valuable insights that genetically engineered mouse models have provided into the cellular and physiological roles of GPATs, AGPATs, lipins and DGATs. Finally, we comment on the status and feasibility of therapeutic approaches Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.	[Wang, Huan; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Airola, Michael V.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Reue, K (reprint author), Human Genet, Gonda 6357B,695 Charles E Young Dr South, Los Angeles, CA 90095 USA.	reuek@ucla.edu			Public Health Service [P01 HL90553, P01 HL028481, AHA 17SDG33410860]	We gratefully acknowledge support from Public Health Service P01 HL90553 and P01 HL028481 (K.R.) and AHA 17SDG33410860 (M.V.A.).	McCoull W., 2012, IDENTIFICATION OPTIM; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2016, J LIPID RES, V57, P616, DOI 10.1194/jlr.M065896; Agarwal AK, 2011, J BIOL CHEM, V286, P37676, DOI 10.1074/jbc.M111.250449; Ahmadian M, 2007, FUTURE LIPIDOL, V2, P229, DOI 10.2217/17460875.2.2.229; Albesa-Jove D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10906; Aneja KK, 2008, ARCH BIOCHEM BIOPHYS, V470, P35, DOI 10.1016/j.abb.2007.10.019; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M50056-JLR200; Bergounioux J, 2012, J PEDIATR-US, V160, P1052, DOI 10.1016/j.jpeds.2012.02.033; Birch A. M., 2017, DISCOVERY POTENT SEL; Birsoy K, 2013, J CELL SCI, V126, P1541, DOI 10.1242/jcs.104992; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bronnikov GE, 2008, BIOCHEM BIOPH RES CO, V367, P201, DOI 10.1016/j.bbrc.2007.12.127; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Canani R Berni, 2010, J PEDIAT GASTROENTER, V50, P1; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cautivo KM, 2016, MOL METAB, V5, P491, DOI 10.1016/j.molmet.2016.05.004; Chan HM, 2001, J CELL SCI, V114, P2363; Chandak PG, 2011, BBA-MOL CELL BIOL L, V1811, P1011, DOI 10.1016/j.bbalip.2011.08.010; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI200213880; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI 10.1172/JCI200214672; Chen H. C., 2002, DIABETES, V51; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Chen ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051320; Choi K, 2014, FEBS J, V281, P3048, DOI 10.1111/febs.12841; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Collison L. W., 2008, AM J PHYSL CELL PHYS, V295; Cortes VA, 2014, J LIPID RES, V55, P276, DOI 10.1194/jlr.M045799; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Crawford SE, 2016, CURR OPIN VIROL, V19, P11, DOI 10.1016/j.coviro.2016.05.008; Csaki LS, 2014, MOL METAB, V3, P145, DOI 10.1016/j.molmet.2013.11.008; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Cushman S. W., 1970, J CELL BIOL, V46; D'Aquila T, 2016, BBA-MOL CELL BIOL L, V1861, P730, DOI 10.1016/j.bbalip.2016.04.012; Das A, 2008, J LIPID RES, V49, P1770, DOI 10.1194/jlr.M800131-JLR200; Denison H, 2014, DIABETES OBES METAB, V16, P334, DOI 10.1111/dom.12221; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Dovala D, 2016, P NATL ACAD SCI USA, V113, pE6064, DOI 10.1073/pnas.1610746113; Dow R. L., 2011, DESIGN SYNTHESIS POT; Dow RL, 2013, BIOORGAN MED CHEM, V21, P5081, DOI 10.1016/j.bmc.2013.06.045; Dow RL, 2011, ACS MED CHEM LETT, V2, P407, DOI 10.1021/ml200051p; Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109; Eaton JM, 2014, J BIOL CHEM, V289, P18055, DOI 10.1074/jbc.M114.547604; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Ehara T, 2012, DIABETES, V61, P2442, DOI 10.2337/db11-1834; Elholm M, 2000, J LIPID RES, V41, P538; Ellis JM, 2012, TOXICOL PATHOL, V40, P513, DOI 10.1177/0192623311432298; Farese RV, 2016, J CELL BIOL, V212, P7, DOI 10.1083/jcb.201512056; Faris R, 2016, LIPIDS, V51, P291, DOI 10.1007/s11745-016-4121-5; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Fu M, 2004, J CLIN ENDOCR METAB, V89, P2916, DOI 10.1210/jc.2003-030485; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Gluchowsld N. L., 2017, J LIPID RES; Gomes KB, 2004, J CLIN ENDOCR METAB, V89, P357, DOI 10.1210/jc.2003-030415; Gonzalez-Baro MR, 2017, BBA-MOL CELL BIOL L, V1862, P49, DOI 10.1016/j.bbalip.2016.06.023; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Guha P, 2009, ARCH BIOCHEM BIOPHYS, V490, P85, DOI 10.1016/j.abb.2009.07.027; Gulvady AA, 2013, LIPIDS, V48, P3, DOI 10.1007/s11745-012-3741-7; HAAGSMAN HP, 1982, J BIOL CHEM, V257, P593; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200                                                          ; Hammond LE, 2002, MOL CELL BIOL, V22, P8204, DOI 10.1128/MCB.22.23.8204-8214.2002; Hammond LE, 2007, EXP MOL PATHOL, V82, P210, DOI 10.1016/j.yexmp.2006.12.004; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Heath RJ, 1998, J BACTERIOL, V180, P1425; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Holmes RS, 2010, COMP BIOCHEM PHYS D, V5, P45, DOI 10.1016/j.cbd.2009.09.004; Hong YB, 2016, HUM MUTAT, V37, P473, DOI 10.1002/humu.22959; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Hu M, 2013, HEPATOLOGY, V58, P1953, DOI 10.1002/hep.26589; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Igal RA, 2001, J BIOL CHEM, V276, P42205, DOI 10.1074/jbc.M103386200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ishimoto K, 2009, J BIOL CHEM, V284, P22195, DOI 10.1074/jbc.M109.028753; JERKINS AA, 1995, J BIOL CHEM, V270, P1416, DOI 10.1074/jbc.270.3.1416                                                          ; Jiang WH, 2015, J BIOL CHEM, V290, P23646, DOI 10.1074/jbc.M115.686519; Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009; Kadam KS, 2013, EUR J MED CHEM, V65, P337, DOI 10.1016/j.ejmech.2013.05.006; Kandre S, 2014, EUR J MED CHEM, V79, P203, DOI 10.1016/j.ejmech.2014.03.077; Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166; KENNEDY EP, 1957, FED PROC, V16, P847; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kim MO, 2013, BIOL PHARM BULL, V36, P1167, DOI 10.1248/bpb.b13-00152                                                           ; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; King AJ, 2010, EUR J PHARMACOL, V637, P155, DOI 10.1016/j.ejphar.2010.03.056; King AJ, 2009, J PHARMACOL EXP THER, V330, P526, DOI 10.1124/jpet.109.154047; Kok BPC, 2013, J LIPID RES, V54, P1662, DOI 10.1194/jlr.M036624; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Kuhajda F. P., 2011, AM J PHYSL REGUL INT, V301; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Layerenza JP, 2013, BBA-MOL CELL BIOL L, V1831, P327, DOI 10.1016/j.bbalip.2012.10.005; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee B, 2010, J LIPID RES, V51, P1770, DOI 10.1194/jlr.M002311; Lewin TM, 2008, BBA-MOL CELL BIOL L, V1781, P352, DOI 10.1016/j.bbalip.2008.05.001; Lewin Tal M., 1999, ANAL AMINO ACID MOTI; Linden D, 2004, J LIPID RES, V45, P1279, DOI 10.1194/jlr.M400010-JLR200; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2014, DIABETES, V63, P2320, DOI 10.2337/db13-0729; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Lorden G, 2017, J EXP MED, V214, P511, DOI 10.1084/jem.20161452; Lu B, 2005, J LIPID RES, V46, P2448, DOI 10.1194/jlr.M500258-JLR200; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348                                                              ; Ludwig EH, 2002, CLIN GENET, V62, P68, DOI 10.1034/j.1399-0004.2002.620109.x; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MARTINSANZ P, 1984, FEBS LETT, V175, P284, DOI 10.1016/0014-5793(84)80752-8; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Meegalla RL, 2002, BIOCHEM BIOPH RES CO, V298, P317, DOI 10.1016/S0006-291X(02)02466-X; Meyers CD, 2012, J CLIN LIPIDOL, V6, P266, DOI DOI 10.1016/J.JACL.2012.04.034; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; Mitra MS, 2013, P NATL ACAD SCI USA, V110, P642, DOI 10.1073/pnas.1213493110; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Mylonis I, 2012, J CELL SCI, V125, P3485, DOI 10.1242/jcs.106682; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Nakada Y, 2010, BIOORGAN MED CHEM, V18, P2785, DOI 10.1016/j.bmc.2010.01.067; Ohsaki Y, 2016, J CELL BIOL, V212, P29, DOI 10.1083/jcb.201507122; Ohshiro T, 2015, EXPERT OPIN THER PAT, V25, P145, DOI 10.1517/13543776.2014.989833; Oral EA, 2010, ENDOCR PRACT, V16, P324, DOI 10.4158/EP09155.RA; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Pellon-Maison M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100896; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051; Prasad SS, 2011, J LIPID RES, V52, P451, DOI 10.1194/jlr.M007575; Qian YM, 2011, J MED CHEM, V54, P2433, DOI 10.1021/jm101580m; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Reue K, 2000, J LIPID RES, V41, P1067; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Schmidt JA, 2010, BIOCHEM BIOPH RES CO, V397, P661, DOI 10.1016/j.bbrc.2010.05.149; Schober G, 2013, J LIPID RES, V54, P1369, DOI 10.1194/jlr.M035154; Schweitzer GG, 2015, JIMD REP, V23, P113, DOI 10.1007/8904_2015_440; Schweitzer GG, 2015, J LIPID RES, V56, P848, DOI 10.1194/jlr.M055962; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Sharma M, 2013, CURR OPIN RHEUMATOL, V25, P658, DOI 10.1097/BOR.0b013e328363eb08; Shimizu K., 2017, SCI SIGNAL, V10; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Slabas AR, 2002, J BIOL CHEM, V277, P43918, DOI 10.1074/jbc.M206429200; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651                                                                   ; SOORANNA SR, 1978, FEBS LETT, V95, P85, DOI 10.1016/0014-5793(78)80057-X; STALS HK, 1994, FEBS LETT, V343, P99, DOI 10.1016/0014-5793(94)80615-2; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Subauste AR, 2010, DIFFERENTIATION, V80, P140, DOI 10.1016/j.diff.2010.05.006; Take K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150976; Takeuchi K., 2009, AM J PHYSL ENDOCRINO, V296; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Temprano A, 2016, DIABETOLOGIA, V59, P1985, DOI 10.1007/s00125-016-4018-0; Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071; Tomimoto D, 2015, J PHARMACOL SCI, V129, P51, DOI 10.1016/j.jphs.2015.08.005; Tsai J., 2006, ARTERIOSCLER THROMB, V27; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Turnbull AP, 2001, STRUCTURE, V9, P347, DOI 10.1016/S0969-2126(01)00595-0; Uzbekov Rustem, 2013, BMC Res Notes, V6, P386, DOI 10.1186/1756-0500-6-386; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/003-073; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Vogel P, 2011, VET PATHOL, V48, P642, DOI 10.1177/0300985810383870; Wakimoto K, 2003, BIOCHEM BIOPH RES CO, V310, P296, DOI 10.1016/j.bbrc.2003.09.015; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang HJ, 2011, FEBS LETT, V585, P1979, DOI 10.1016/j.febslet.2011.05.035; Wang JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34117; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; Wei YC, 2015, J BIOL CHEM, V290, P4604, DOI 10.1074/jbc.M114.605642; WEISS SB, 1956, NATURE, V178, P594, DOI 10.1038/178594a0                                                                ; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Wydysh EA, 2009, J MED CHEM, V52, P3317, DOI 10.1021/jm900251a; Yamashita Atsushi, 2014, Biology (Basel), V3, P801, DOI 10.3390/biology3040801; Yazdi M, 2008, BIOCHEM BIOPH RES CO, V369, P1065, DOI 10.1016/j.bbrc.2008.02.156; Yeh VSC, 2012, J MED CHEM, V55, P1751, DOI 10.1021/jm201524g; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534; Yu Jinhai, 2015, [Biophysics Reports, 生物物理学报], V1, P41; Yu JH, 2015, BIOCHEM BIOPH RES CO, V460, P715, DOI 10.1016/j.bbrc.2015.03.095; Yu YH, 2002, J BIOL CHEM, V277, P50876, DOI 10.1074/jbc.M207353200; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200; Yun W., 2011, DISCOVERY OPTIMIZATI; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200; Zhang PX, 2017, BBA-BIOMEMBRANES, V1859, P1583, DOI 10.1016/j.bbamem.2017.04.007; Zhang PX, 2014, CELL CYCLE, V13, P3789, DOI 10.4161/15384101.2014.988105; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zhang PX, 2012, J BIOL CHEM, V287, P3485, DOI 10.1074/jbc.M111.296681; Zhang ZF, 2014, BIOCHEM PHARMACOL, V91, P74, DOI 10.1016/j.bcp.2014.07.002; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	220	0	0	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	OCT	2017	1862	10	B				1131	1145		10.1016/j.bbalip.2017.06.010				15	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI8LW	WOS:000412255100002	28642195				2018-01-05	
J	Zhang, XD; Heckmann, BL; Campbell, LE; Liu, J				Zhang, Xiaodong; Heckmann, Bradlee L.; Campbell, Latoya E.; Liu, Jun			GOS2: A small giant controller of lipolysis and adipose-liver fatty acid flux	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article; Proceedings Paper	FASEB Summer Conference on Lipid Droplets - Dynamic Organelles in Metabolism and Beyond	JUL 24-29, 2016	Snowmass, CO	FASEB		GOS2; ATGL; Lipolysis; Lipid droplet; Fatty acid; Triglyceride	SWITCH GENE 2; RETINOID-X-RECEPTOR; REVERSE CHOLESTEROL TRANSPORT; MEDIATED ADIPOCYTE LIPOLYSIS; TRIGLYCERIDE LIPASE PNPLA2; HORMONE-SENSITIVE LIPASE; ELEMENT-BINDING PROTEIN; LIPID STORAGE DISEASE; INSULIN-RESISTANCE; LXR-ALPHA	The discovery of adipose triglyceride lipase (ATGL) and its coactivator comparative gene identification-58 (CGI-58) provided a major paradigm shift in the understanding of intracellular lipolysis in both adipocytes and nonadipocyte cells. The subsequent discovery of GO/G1 switch gene 2 (GOS2) as a potent endogenous inhibitor of ATGL revealed a unique mechanism governing lipolysis and fatty acid (FA) availability. GOS2 is highly conserved in vertebrates, and exhibits cyclical expression pattern between adipose tissue and liver that is critical to lipid flux and energy homeostasis in these two tissues. Biochemical and cell biological studies have demonstrated that a direct interaction with ATGL mediates GOS2's inhibitory effects on lipolysis and lipid droplet degradation. In this review we examine evidence obtained from recent in vitro and in vivo studies that lends support to the proof-of-principle concept that GOS2 functions as a master regulator of tissue-specific balance of TG storage vs. mobilization, partitioning of metabolic fuels between adipose and liver, and the whole-body adaptive energy response. This article is part of a Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.	[Zhang, Xiaodong; Liu, Jun] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Scottsdale, AZ USA; [Zhang, Xiaodong; Liu, Jun] Mayo Clin, Hlth Program, Scottsdale, AZ USA; [Heckmann, Bradlee L.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Campbell, Latoya E.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Liu, Jun] Mayo Clin, Div Endocrinol, Scottsdale, AZ USA	Liu, J (reprint author), Mayo Clin Arizona, Hlth Program, Dept Biochem & Mol Biol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	liu.jun@mayo.edu			National Institutes of Health [DK089178, DK109096]	This work was supported by research grants from the National Institutes of Health (DK089178 and DK109096) to J.L. We have no potential conflicts of interest to report.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahn J, 2014, LIPIDS, V49, P1, DOI 10.1007/s11745-013-3866-3; Bachner D, 1998, DEV DYNAM, V213, P398; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Briand F, 2010, J LIPID RES, V51, P763, DOI 10.1194/jlr.M001552; Campbell LV, 2008, INT J OBESITY, V32, P723, DOI 10.1038/sj.ijo.0803772; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cerk I. K., 2014, J BIOL CHEM; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen PR, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030384; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; Choi H, 2014, CELL DEATH DIFFER, V21, P1071, DOI 10.1038/cdd.2014.26; Cingolani F, 2016, TRENDS ENDOCRIN MET, V27, P696, DOI 10.1016/j.tem.2016.06.003; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Colin S, 2008, ENDOCRINOLOGY, V149, P5128, DOI 10.1210/en.2008-0637; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Deng X, 2012, J BIOL CHEM, V287, P20132, DOI 10.1074/jbc.M112.347211; Ducheix S, 2013, BIOCHEM PHARMACOL, V86, P96, DOI 10.1016/j.bcp.2013.03.016; Ducheix S, 2013, J HEPATOL, V58, P984, DOI 10.1016/j.jhep.2013.01.006; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; El-Assaad W, 2015, DIABETOLOGIA, V58, P149, DOI 10.1007/s00125-014-3429-z; Fan YY, 2003, CARCINOGENESIS, V24, P1541, DOI 10.1093/carcin/bgg110; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gao MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065641; Genne-Bacon Elizabeth A., 2014, Yale Journal of Biology and Medicine, V87, P99; Gibson G, 2007, CURR BIOL, V17, pR295, DOI 10.1016/j.cub.2007.02.011; Girousse A, 2012, INT J OBESITY, V36, P581, DOI 10.1038/ijo.2011.113; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hara K, 2000, BRIT J NUTR, V84, pS235, DOI 10.1079/096582197388608; Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735; Heckmann BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156742; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Heier C, 2015, J BIOL CHEM, V290, P26141, DOI 10.1074/jbc.M115.671842; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jaeger D., 2015, J HEPATOL; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Jessen N., 2016, PHYS REP, V4; Jha P, 2014, HEPATOLOGY, V59, P858, DOI 10.1002/hep.26732; Joffe B, 1998, ENDOCRINE, V9, P139, DOI 10.1385/ENDO:9:2:139; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kannisto K, 2014, LIPIDS, V49, P71, DOI 10.1007/s11745-013-3853-8; Lee D., 2009, J BIOL CHEM; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Laurens C, 2016, MOL METAB, V5, P527, DOI 10.1016/j.molmet.2016.04.004; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Lin XB, 2005, AM J PHYSIOL-GASTR L, V288, pG1179, DOI 10.1152/ajpgi.00411.2004; Liu XJ, 2010, FEBS LETT, V584, P4330, DOI 10.1016/j.febslet.2010.09.027; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Ma T, 2014, CANCER BIOL THER, V15, P643, DOI 10.4161/cbt.28251; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839; Matsunaga N, 2016, EBIOMEDICINE, V13, P262, DOI 10.1016/j.ebiom.2016.10.008; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nielsen TS, 2012, J CLIN ENDOCR METAB, V97, pE1348, DOI 10.1210/jc.2012-1159; Nielsen TS, 2011, J CLIN ENDOCR METAB, V96, pE1293, DOI 10.1210/jc.2011-0149; Nishikawa S, 2008, TOXICOL PATHOL, V36, P850, DOI 10.1177/0192623308323920; Oh SA, 2011, J ANIM SCI, V89, P367, DOI 10.2527/jas.2010-3339; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Oosterveer MH, 2008, J BIOL CHEM, V283, P25437, DOI 10.1074/jbc.M801922200; Ou X, 2008, SCI CHINA SER C, V51, P418, DOI 10.1007/s11427-008-0054-4; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Petta S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122082; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322; Schreiber R, 2015, P NATL ACAD SCI USA, V112, P13850, DOI 10.1073/pnas.1516004112; Schweiger M., 2012, J LIPID RES; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Sharma AM, 1998, J MOL MED-JMM, V76, P568, DOI 10.1007/s001090050251                                                           ; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shin SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100905; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579                                                          ; Skopp A, 2016, ARCH PHYSIOL BIOCHEM, V122, P47, DOI 10.3109/13813455.2015.1122066; Steineger HH, 1998, J LIPID RES, V39, P744; Sugaya Y., 2016, J DIABETES; Sun XW, 2016, J BIOL CHEM, V291, P1115, DOI 10.1074/jbc.M115.668269; Svart M, 2016, DIABETES, V65, P1380, DOI 10.2337/db15-1645; Turnbull PC, 2016, AM J PHYSIOL-REG I, V310, pR125, DOI 10.1152/ajpregu.00062.2015; Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914                                                              ; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang YF, 2015, AM J PHYSIOL-CELL PH, V308, pC496, DOI 10.1152/ajpcell.00317.2014; Wang YT, 2013, CHIN CONT DECIS CONF, P2013; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Yamada T, 2014, LEUKEMIA RES, V38, P210, DOI 10.1016/j.leukres.2013.10.006; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178; Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yasuda T, 2010, ARTERIOSCL THROM VAS, V30, P781, DOI 10.1161/ATVBAHA.109.195693; Yim CY, 2016, CANCER RES, V76, P1204, DOI 10.1158/0008-5472.CAN-15-2265; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zagani R, 2015, ONCOTARGET, V6, P28282, DOI 10.18632/oncotarget.5061; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zanotti I, 2008, J LIPID RES, V49, P954, DOI 10.1194/jlr.M700254-JLR200; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zeng F, 2011, POULTRY SCI, V90, P1548, DOI 10.3382/ps.2010-01204; Zhang W, 2016, CELL REP, V15, P349, DOI 10.1016/j.celrep.2016.03.021; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747                                                         	121	1	1	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	OCT	2017	1862	10	B				1146	1154		10.1016/j.bbalip.2017.06.007				9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI8LW	WOS:000412255100003	28645852				2018-01-05	
J	Gao, GG; Chen, FJ; Zhou, LK; Su, L; Xu, DJ; Xu, L; Li, P				Gao, Guangang; Chen, Feng-Jung; Zhou, Linkang; Su, Lu; Xu, Dijin; Xu, Li; Li, Peng			Control of lipid droplet fusion and growth by CIDE family proteins	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article; Proceedings Paper	FASEB Summer Conference on Lipid Droplets - Dynamic Organelles in Metabolism and Beyond	JUL 24-29, 2016	Snowmass, CO	FASEB		CIDE proteins; Lipid homeostasis; Lipid droplet; Obesity; Lipid droplet fusion	FAT-SPECIFIC PROTEIN-27; ALPHA-LIKE EFFECTOR; ACTIVATED-RECEPTOR-ALPHA; ADIPOCYTE-SPECIFIC GENE; TUMOR-NECROSIS-FACTOR; INSULIN SENSITIVITY; HEPATIC STEATOSIS; N DOMAIN; TRANSCRIPTIONAL REGULATION; TRIACYLGLYCEROL SYNTHESIS	Cell death-inducing DFF45-like effector (CIDE) family proteins including Cidea, Cideb and Cidec/Fsp27 are expressed in many different tissues and are known as lipid droplet (LD)-and ER-associated proteins. Systematic analyses using genetically modified animal models have demonstrated that CIDE proteins play important roles in regulating various aspects of lipid homeostasis, including lipid storage, lipolysis and lipid secretion. Recent research in ours and other laboratories has revealed that CIDE proteins are crucial regulators of LD fusion and growth in the adipose tissue, liver, skin and mammary glands. CIDE-mediated LD fusion and growth is different from other membrane fusions in that it requires CIDE proteins to be enriched and clustered at the LD-LD contact sites (LDCS). The enriched CIDE proteins then allow the recruitment of other proteins to the LDCS and the formation of potential fusion pores. Neutral lipids in the smaller LDs of the contacted pair are transferred to the larger LDs, owing to the internal pressure difference, thus resulting in the fusion and growth of the LDs. This review summarizes the physiological roles of CIDE proteins in controlling lipid homeostasis, insulin sensitivity and the development of metabolic diseases including obesity, diabetes and fatty liver, with a particular focus on the role of CIDE proteins in controlling LD fusion and growth. This article is part of a Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.	[Gao, Guangang; Chen, Feng-Jung; Zhou, Linkang; Su, Lu; Xu, Dijin; Xu, Li; Li, Peng] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China	Xu, L; Li, P (reprint author), Tsinghua Univ, Sch Life Sci, Med Res Bldg, Beijing 100084, Peoples R China.	xulilulu@tsinghua.edu.cn; li-peng@mail.tsinghua.edu.cn			National Natural Science Foundation of China [31430040, 31690103, 31621063]; National Basic Research Program of the Ministry of Science and Technology of China [2013CB530602, 2016YFA0502002]	This work was supported by grants from the National Natural Science Foundation of China (31430040, 31690103 and 31621063) and from the National Basic Research Program of the Ministry of Science and Technology of China (2013CB530602 and 2016YFA0502002).	Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chan SC, 2007, BIOCHEM J, V408, P259, DOI 10.1042/BJ20070690; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; Christianson JL, 2010, J LIPID RES, V51, P3455, DOI 10.1194/jlr.M009498; Da L, 2006, BIOCHEM J, V393, P779, DOI 10.1042/BJ20051027; DANESCH U, 1992, J BIOL CHEM, V267, P7185; Erdtmann L, 2003, J BIOL CHEM, V278, P18256, DOI 10.1074/jbc.M209732200; Fawcett KA, 2008, DIABETES, V57, P2527, DOI 10.2337/db08-0422; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Hall AM, 2010, J LIPID RES, V51, P554, DOI 10.1194/jlr.M000976; Hall AM, 2010, OBESITY, V18, P417, DOI 10.1038/oby.2009.236; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Ito M, 2011, J LIPID RES, V52, P1450, DOI 10.1194/jlr.M012427; Ito M, 2010, J LIPID RES, V51, P1676, DOI 10.1194/jlr.M002147; Iwahana H, 2006, PROTEOMICS, V6, P6168, DOI 10.1002/pmic.200600384; Jinno Y, 2010, PROSTAG LEUKOTR ESS, V83, P75, DOI 10.1016/j.plefa.2010.05.002; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Langhi C, 2015, HEPATOLOGY, V61, P1227, DOI 10.1002/hep.27607; Lee SM, 2014, APOPTOSIS, V19, P428, DOI 10.1007/s10495-013-0941-4; Lee SM, 2013, ACTA CRYSTALLOGR F, V69, P1260, DOI 10.1107/S1744309113026444; Lee SM, 2013, BIOCHEM BIOPH RES CO, V439, P564, DOI 10.1016/j.bbrc.2013.09.018; Li D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-446; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Li JZ, 2010, BBA-MOL CELL BIOL L, V1801, P577, DOI 10.1016/j.bbalip.2010.01.012; Li XH, 2012, J LIPID RES, V53, P1877, DOI 10.1194/jlr.M026591; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Lugovskoy AA, 1999, CELL, V99, P747, DOI 10.1016/S0092-8674(00)81672-4; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Min J, 2011, MED ONCOL, V28, pS219, DOI 10.1007/s12032-010-9702-1; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Monks J, 2016, J PHYSIOL-LONDON, V594, P5899, DOI 10.1113/JP272390; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Omae N, 2012, MOL CELL ENDOCRINOL, V348, P297, DOI 10.1016/j.mce.2011.09.013; Park HH, 2015, APOPTOSIS, V20, P240, DOI 10.1007/s10495-014-1067-z; Peterfy M, 2001, NAT GENET, V27, P121; Pettersson AT, 2008, INT J OBESITY, V32, P1380, DOI 10.1038/ijo.2008.101; Puri V, 2008, J CLIN INVEST, V118, P2693, DOI 10.1172/JCI36554; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Qian H, 2017, J CLIN INVEST, V127, P1353, DOI 10.1172/JCI85963; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Schneider MR, 2016, EXP CELL RES, V340, P205, DOI 10.1016/j.yexcr.2015.11.008; Singaravelu R, 2013, BIOCHEM BIOPH RES CO, V441, P447, DOI 10.1016/j.bbrc.2013.10.080; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Tanaka N, 2015, J BIOL CHEM, V290, P3092, DOI 10.1074/jbc.M114.605980; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Vila-Brau A, 2013, J LIPID RES, V54, P592, DOI 10.1194/jlr.M028472; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang R, 2010, BIOCHEM J, V430, P245, DOI 10.1042/BJ20100701; Wang WS, 2012, NAT MED, V18, P235, DOI 10.1038/nm.2614; Wang ZQ, 2010, INT J OBESITY, V34, P1355, DOI 10.1038/ijo.2010.77; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; WILLIAMS PM, 1992, MOL ENDOCRINOL, V6, P1135, DOI 10.1210/me.6.7.1135; Wu CY, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-159; Wu LZ, 2014, DEV CELL, V30, P378, DOI 10.1016/j.devcel.2014.07.005; Wu LZ, 2014, SCI CHINA LIFE SCI, V57, P107, DOI 10.1007/s11427-013-4585-y; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139; Xu WY, 2016, J BIOL CHEM, V291, P4282, DOI 10.1074/jbc.M115.701094; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yonezawa T, 2009, BIOCHEM BIOPH RES CO, V384, P535, DOI 10.1016/j.bbrc.2009.05.012; Yu JH, 2017, SCI CHINA LIFE SCI, V60, P46, DOI 10.1007/s11427-016-0322-x; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang LJ, 2014, J LIPID RES, V55, P1279, DOI 10.1194/jlr.M046482; Zhang SS, 2014, MOL CELL BIOL, V34, P1827, DOI 10.1128/MCB.01723-13; Zhou LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6949; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	89	0	0	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	OCT	2017	1862	10	B				1197	1204		10.1016/j.bbalip.2017.06.009				8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI8LW	WOS:000412255100008	28648584				2018-01-05	
J	Rodriguez, MADR; Kersten, S				Rodriguez, Montserrat A. de la Rosa; Kersten, Sander			Regulation of lipid droplet-associated proteins by peroxisome proliferator-activated receptors	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article; Proceedings Paper	FASEB Summer Conference on Lipid Droplets - Dynamic Organelles in Metabolism and Beyond	JUL 24-29, 2016	Snowmass, CO	FASEB		PPARs; Lipid droplet; Lipid droplet-associated proteins; Perilipins	DIFFERENTIATION-RELATED PROTEIN; LOW-DENSITY-LIPOPROTEIN; FATTY-ACID HOMEOSTASIS; LEPTIN-DEFICIENT MICE; WHITE ADIPOSE-TISSUE; FOAM-CELL-FORMATION; GENE-EXPRESSION; PPAR-GAMMA; SKELETAL-MUSCLE; INSULIN-RESISTANCE	Excess fatty acids are stored in cells as triglycerides in specialized organelles called lipid droplets (LD). LD can be found in nearly all cell types and may expand during certain (patho)physiological conditions. The synthesis and breakdown of triglycerides and their deposition in LD is governed by a diverse set of enzymes and LD-associated proteins. These proteins serve structural roles in and around LD and regulate the activity of key lipogenic and lipolytic enzymes. The LD-associated proteins are subject to multiple regulatory mechanisms at the protein and gene expression level. A group of transcription factors that govern the expression of many LD-associated proteins are the Peroxisome Proliferator-Activated Receptors (PPARs). PPARs are lipid-activated transcription factors that play a key role in the regulation of lipid metabolism in liver (PPAR alpha), adipose tissue (PPAR gamma), and skeletal muscle (PPAR delta). This review provides an overview of the regulation of LD-associated proteins by PPARa, PPAR gamma, and PPAR gamma in adipose tissue, liver, macrophages, and skeletal muscle. It is concluded that many LD-associated proteins, including members of the PLIN family, CIDEC, CIDEA, HILPDA, FITM1, FITM2, and G0S2 are under direct transcriptional control of PPARs. Upregulation of LD-associated proteins by PPARs provides a mechanism to link uptake of lipids to regulation of lipid storage capacity. This article is part of a Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.	[Rodriguez, Montserrat A. de la Rosa; Kersten, Sander] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Stippeneng 4, NL-6708 WE Wageningen, Netherlands	Kersten, S (reprint author), Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	sanderkersten@wur.nl			Netherlands Organisation for Scientific Research [NWO-ALW 824.14.008]; Consejo Nacional de Ciencia y Tecnologia de Mexico [CONACYT 455071]	This work was supported by the Netherlands Organisation for Scientific Research (NWO-ALW 824.14.008) and by the Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT 455071).	Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9                                                   ; Barneda D, 2013, BBA-MOL CELL BIOL L, V1831, P924, DOI 10.1016/j.bbalip.2013.01.015; Barquissau V, 2016, MOL METAB, V5, P352, DOI 10.1016/j.molmet.2016.03.002; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Bindesboll C, 2013, J LIPID RES, V54, P1949, DOI 10.1194/jlr.M038992; Bojic LA, 2013, CURR OPIN LIPIDOL, V24, P171, DOI 10.1097/MOL.0b013e32835cc949; Bosma M, 2013, BBA-MOL CELL BIOL L, V1831, P844, DOI 10.1016/j.bbalip.2013.01.007; Bosma M, 2016, EXP CELL RES, V340, P180, DOI 10.1016/j.yexcr.2015.10.023; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Carr RM, 2016, EXP CELL RES, V340, P187, DOI 10.1016/j.yexcr.2015.10.021; Chawla A, 2001, NAT MED, V7, P48; Chen WQ, 2013, AM J PHYSIOL-ENDOC M, V304, pE770, DOI 10.1152/ajpendo.00523.2012; Chinetti G, 2001, NAT MED, V7, P53; Chinetti-Gbaguidi G, 2017, BIOCHIMIE, V136, P59, DOI 10.1016/j.biochi.2016.12.008; Christian M, 2013, HORM MOL BIOL CLIN I, V14, P87, DOI 10.1515/hmbci-2013-0028; Da L, 2006, BIOCHEM J, V393, P779, DOI 10.1042/BJ20051027; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; de Wilde J, 2010, FEBS J, V277, P761, DOI 10.1111/j.1742-4658.2009.07525.x; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dijk W, 2017, ENDOCRINOLOGY, V158, P1231, DOI 10.1210/en.2016-1809; DiStefano MT, 2016, MOL METAB, V5, P1149, DOI 10.1016/j.molmet.2016.09.009; DiStefano MT, 2015, J BIOL CHEM, V290, P15175, DOI 10.1074/jbc.M115.650184; El-Assaad W, 2015, DIABETOLOGIA, V58, P149, DOI 10.1007/s00125-014-3429-z; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; Feng YZ, 2014, ARCH PHYSIOL BIOCHEM, V120, P12, DOI 10.3109/13813455.2013.829105; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202                                                           ; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gross DA, 2014, CRIT REV BIOCHEM MOL, V49, P304, DOI 10.3109/10409238.2014.931337; Guo ZK, 2000, J APPL PHYSIOL, V89, P2057; Harris LALS, 2015, DIABETES, V64, P2757, DOI 10.2337/db14-1035; Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735; Hodgkinson CP, 2003, BIOCHEM BIOPH RES CO, V308, P505, DOI 10.1016/S0006-291X(03)01416-5; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gasto.2007.02.046; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y; Janssen AWF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1969-3; Jeninga EH, 2009, TRENDS ENDOCRIN MET, V20, P380, DOI 10.1016/j.tem.2009.04.005; JIANG HP, 1992, P NATL ACAD SCI USA, V89, P7856, DOI 10.1073/pnas.89.17.7856; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Karbowska J, 2012, NUTRITION, V28, P294, DOI 10.1016/j.nut.2011.06.009; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kim YJ, 2008, BIOCHEM BIOPH RES CO, V377, P297, DOI 10.1016/j.bbrc.2008.09.129; Langhi C, 2015, HEPATOLOGY, V61, P1227, DOI 10.1002/hep.27607; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Laurens C, 2016, SCI REP-UK, V6, DOI 10.1038/srep38310; Lee CH, 2006, P NATL ACAD SCI USA, V103, P2434, DOI 10.1073/pnas.0510815103; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Li H, 2012, DIABETES-METAB RES, V28, P145, DOI 10.1002/dmrr.1295; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036712; Li H, 2010, INT J MOL MED, V26, P231, DOI 10.3892/ijmm_00000457; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Li JZ, 2010, BBA-MOL CELL BIOL L, V1801, P577, DOI 10.1016/j.bbalip.2010.01.012; Liu SX, 2015, CARDIOVASC RES, V105, P20, DOI 10.1093/cvr/cvu214; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manickam R, 2017, BIOCHIMIE, V136, P42, DOI 10.1016/j.biochi.2016.11.010; Matsusue K, 2004, FASEB J, V18, P1477, DOI 10.1096/fj.04-1944fje; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Mattijssen F, 2014, J BIOL CHEM, V289, P19279, DOI 10.1074/jbc.M114.570044; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Moore KJ, 2001, NAT MED, V7, P41; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; Pawella LM, 2014, J HEPATOL, V60, P633, DOI 10.1016/j.jhep.2013.11.007; Persson J, 2007, BIOCHEM BIOPH RES CO, V363, P1020, DOI 10.1016/j.bbrc.2007.09.074; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rakhshandehroo M, 2010, PPAR RES, DOI 10.1155/2010/612089; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Rakhshandehroo Maryam, 2007, PPAR Res, V2007, P26839, DOI 10.1155/2007/26839; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Takahashi Y, 2010, BIOCHEM BIOPH RES CO, V399, P209, DOI 10.1016/j.bbrc.2010.07.056; Tan NS, 2016, PROG LIPID RES, V64, P98, DOI 10.1016/j.plipres.2016.09.001; Targett-Adams P, 2005, BBA-GENE STRUCT EXPR, V1728, P95, DOI 10.1016/j.bbaexp.2005.01.017; Thyagarajan N, 2017, LIPIDS, V52, P189, DOI 10.1007/s11745-017-4238-1; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X                                                    ; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Varela LM, 2015, J NUTR BIOCHEM, V26, P327, DOI 10.1016/j.jnutbio.2014.11.007; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Wang C, 2015, HEPATOLOGY, V61, P870, DOI 10.1002/hep.27409; Wang HJ, 2013, METHOD CELL BIOL, V116, P107, DOI 10.1016/B978-0-12-408051-5.00007-3; Wang RF, 2016, ANN HEPATOL, V15, P190, DOI 10.5604/16652681.1193709; Wang XK, 1999, FEBS LETT, V462, P145, DOI 10.1016/S0014-5793(99)01521-5; Wang Yuming, 2013, International Journal of Powertrains, V2, P1; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yu JH, 2015, BBA-MOL CELL RES, V1853, P918, DOI 10.1016/j.bbamcr.2015.01.020; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611	113	0	0	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	OCT	2017	1862	10	B				1212	1220		10.1016/j.bbalip.2017.07.007				9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI8LW	WOS:000412255100010	28735095				2018-01-05	
J	Brown, AL; Brown, JM				Brown, Amanda L.; Brown, J. Mark			Critical roles for alpha/beta hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article; Proceedings Paper	FASEB Summer Conference on Lipid Droplets - Dynamic Organelles in Metabolism and Beyond	JUL 24-29, 2016	Snowmass, CO	FASEB		ABHD5; CGI-58; ATGL; Adipocyte; Triacylglycerol; Lipase	ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; HORMONE-SENSITIVE LIPASE; ATHEROSCLEROTIC LESION DEVELOPMENT; STORAGE DISEASE; INSULIN-RESISTANCE; MEDIATED LIPOLYSIS; TRIACYLGLYCEROL METABOLISM; HEPATIC STEATOSIS	Mutations in the gene encoding comparative gene identification 58 (CGI-58), also known as a 13 hydrolase domain-containing 5 (ABHD5), cause neutral lipid storage disorder with ichthyosis (NLSDI). This inborn error in metabolism is characterized by ectopic accumulation of triacylglycerols (TAG) within cytoplasmic lipid droplets in multiple cell types. Studies over the past decade have clearly demonstrated that CGI-58 is a potent regulator of TAG hydrolysis in the disease-relevant cell types. However, despite the reproducible genetic link between CGI-58 mutations and TAG storage, the molecular mechanisms by which CGI-58 regulates TAG hydrolysis are still incompletely understood. It is clear that CGI-58 can regulate TAG hydrolysis by activating the major TAG hydrolase adipose triglyceride lipase (ATGL), yet CGI-58 can also regulate lipid metabolism via mechanisms that do not involve ATGL. This review highlights recent progress made in defining the physiologic and biochemical function of CGI-58, and its broader role in energy homeostasis. This article is part of a Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.	[Brown, Amanda L.; Brown, J. Mark] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	Brown, AL; Brown, JM (reprint author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	brownal6@ccf.org; brownm5@ccf.org			National Heart Lung and Blood Institute [R01 HL122283]; National Institutes of Digestive and Kidney Diseases [R01 DK060864]; National Institute of Alcohol Abuse and Alcoholism [P50 AA024333]; National Center for Advancing Translational Sciences [4UL1TR000439]; Case Comprehensive Cancer Center [P30 CA043703]; Cleveland Clinic Research Center of Excellence grant	We apologize for not being able to include discussion on all studies surrounding ABHD5/CGI-58 due to space constraints. The authors sincerely thank David Schumick (B.S., C.M.I.) for provided illustrations included in this work. The authors are supported by grants from the National Heart Lung and Blood Institute (R01 HL122283), National Institutes of Digestive and Kidney Diseases (R01 DK060864), the National Institute of Alcohol Abuse and Alcoholism (P50 AA024333), the National Center for Advancing Translational Sciences (4UL1TR000439), the Case Comprehensive Cancer Center (P30 CA043703), and a Cleveland Clinic Research Center of Excellence grant.	Aflaki E, 2013, CELL MOL LIFE SCI, V70, P2621, DOI 10.1007/s00018-013-1371-8; Aflaki E, 2011, J BIOL CHEM, V286, P7418, DOI 10.1074/jbc.M110.175703; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Akiyama M, 2008, AM J PATHOL, V173, P1349, DOI 10.2353/ajpath.2008.080005; Badin PM, 2012, J LIPID RES, V53, P839, DOI 10.1194/jlr.M019182; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Boeszoermenyi A, 2015, J BIOL CHEM, V290, P26361, DOI 10.1074/jbc.M115.682203; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Brown J. M., 2004, J LIPID RES, V48, P42062; Cakir M, 2010, ACTA PAEDIATR, V99, P1592, DOI 10.1111/j.1651-2227.2010.01869.x; Cakmak E, 2012, CLIN RES HEPATOL GAS, V36, pE34, DOI 10.1016/j.clinre.2011.12.007; Camus G, 2014, J BIOL CHEM, V289, P35770, DOI 10.1074/jbc.M114.587816; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Caux F, 2004, AM J MED GENET A, V129A, P214, DOI 10.1002/ajmg.a.30228; Caviglia J. M., 2009, BIOCHIM BIOPHYS ACTA, V179, P198; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553                                                          ; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; Chen WS, 2013, J CUTAN PATHOL, V40, P631, DOI 10.1111/cup.12147; Coassin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001239; Demignot S, 2014, BIOCHIMIE, V96, P48, DOI 10.1016/j.biochi.2013.07.009; Eichmann TO, 2015, J LIPID RES, V56, P1972, DOI 10.1194/jlr.M062372; Eichmann TO, 2012, J BIOL CHEM, V287, P41446, DOI 10.1074/jbc.M112.400416; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Ghosh AK, 2009, PLANT PHYSIOL, V151, P869, DOI 10.1104/pp.109.144261; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Goeritzer M, 2014, J LIPID RES, V55, P2562, DOI 10.1194/jlr.M052613; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Grond S, 2017, J INVEST DERMATOL, V137, P403, DOI 10.1016/j.jid.2016.09.025; Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; HILAIRE N, 1993, FEBS LETT, V328, P230, DOI 10.1016/0014-5793(93)80933-L; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; Hofer P, 2015, J BIOL CHEM, V290, P18438, DOI 10.1074/jbc.M114.628958; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913                                                     ; Hoy AJ, 2011, ENDOCRINOLOGY, V152, P48, DOI 10.1210/en.2010-0661; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Igal RA, 1997, J PEDIATR GASTR NUTR, V25, P541, DOI 10.1097/00005176-199711000-00011; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644                                                        ; James CN, 2010, P NATL ACAD SCI USA, V107, P17833, DOI 10.1073/pnas.0911359107; Janssen MCH, 2013, EUR J HUM GENET, V21, P807, DOI 10.1038/ejhg.2012.256; Jha P, 2014, HEPATOLOGY, V59, P858, DOI 10.1002/hep.26732; Khatib A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145806; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Lammers B, 2011, ARTERIOSCL THROM VAS, V31, P67, DOI 10.1161/ATVBAHA.110.215814; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121                                                                  ; Lord CC, 2016, CELL REP, V16, P939, DOI 10.1016/j.celrep.2016.06.049; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Lord CC, 2012, DIABETES, V61, P355, DOI 10.2337/db11-0994; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; MacPherson REK, 2013, AM J PHYSIOL-REG I, V304, pR644, DOI 10.1152/ajpregu.00418.2012; Mason RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103062; McLachlan DH, 2016, CURR BIOL, V26, P707, DOI 10.1016/j.cub.2016.01.019; McMahon D, 2014, J LIPID RES, V55, P1750, DOI 10.1194/jlr.M051151; Miao HM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11716; Miao HM, 2014, CELL REP, V7, P223, DOI 10.1016/j.celrep.2014.02.047; Montero-Moran G, 2010, J LIPID RES, V51, P709, DOI 10.1194/jlr.M001917; Nur BG, 2015, EUR J MED GENET, V58, P238, DOI 10.1016/j.ejmg.2015.01.011; Obrowsky S, 2013, J LIPID RES, V54, P425, DOI 10.1194/jlr.M031716; Ou JJ, 2014, CELL REP, V9, P1798, DOI 10.1016/j.celrep.2014.11.016; Park S, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27723; Park S, 2013, PLANT CELL, V25, P1726, DOI 10.1105/tpc.113.111898; Peng Y, 2016, AUTOPHAGY, V12, P2167, DOI 10.1080/15548627.2016.1217380; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Reilich P, 2011, J NEUROL, V258, P1987, DOI 10.1007/s00415-011-6055-4; Ronchetti A, 2008, J HEPATOL, V49, P474, DOI 10.1016/j.jhep.2008.05.027; ROZENSZAJN L, 1966, BLOOD-J HEMATOL, V28, P258; Sahu-Osen A, 2015, J LIPID RES, V56, P109, DOI 10.1194/jlr.M055004; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sanders MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42589; Sanders MA, 2015, CELL METAB, V22, P851, DOI 10.1016/j.cmet.2015.08.023; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Schreiber R, 2015, P NATL ACAD SCI USA, V112, P13850, DOI 10.1073/pnas.1516004112; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Senchenko VN, 2013, EPIGENETICS-US, V8, P409, DOI 10.4161/epi.24233; Shigenaga AM, 2016, SEMIN CELL DEV BIOL, V56, P174, DOI 10.1016/j.semcdb.2016.06.005; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; SLAVIN G, 1975, J CLIN PATHOL, V28, P701, DOI 10.1136/jcp.28.9.701                                                            ; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Srinivasan R, 2004, J PEDIATR-US, V144, P662, DOI 10.1016/j.jpeds.2004.01.036; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Vieyres G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005568; Wang Hong, 2011, J Biol Chem, V286, P15707, DOI 10.1074/jbc.M110.207779; WILLIAMS ML, 1991, BIOCHIM BIOPHYS ACTA, V1096, P162, DOI 10.1016/0925-4439(91)90055-E; Wolkart G, 2012, BRIT J PHARMACOL, V165, P380, DOI 10.1111/j.1476-5381.2011.01490.x; Xie M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005284; Xie P, 2015, ENDOCRINOLOGY, V156, P1648, DOI 10.1210/en.2014-1892; Xie P, 2014, BBA-MOL CELL BIOL L, V1841, P1683, DOI 10.1016/j.bbalip.2014.08.014; Xie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091652; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yang L, 2012, J LIPID RES, V53, P1245, DOI 10.1194/jlr.R024117; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178; Yao-Borengasser A, 2011, METABOLISM, V60, P1012, DOI 10.1016/j.metabol.2010.10.005; Young SG, 1995, J CLIN INVEST, V96, P2932, DOI 10.1172/JCI118365                                                               ; Zhang J, 2015, J BIOL CHEM, V290, P241, DOI 10.1074/jbc.A114.573857; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200; Zierler KA, 2013, J BIOL CHEM, V288, P9892, DOI 10.1074/jbc.M112.420620	111	1	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	OCT	2017	1862	10	B				1233	1241		10.1016/j.bbalip.2017.07.016				9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI8LW	WOS:000412255100012	28827091				2018-01-05	
J	Watt, MJ; Cheng, YS				Watt, Matthew J.; Cheng, Yunsheng			Triglyceride metabolism in exercising muscle	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article; Proceedings Paper	FASEB Summer Conference on Lipid Droplets - Dynamic Organelles in Metabolism and Beyond	JUL 24-29, 2016	Snowmass, CO	FASEB		Exercise; Skeletal muscle; Triglyceride; Adipose triglyceride lipase; Metabolism; Fatty acid	HORMONE-SENSITIVE LIPASE; HUMAN SKELETAL-MUSCLE; EPITHELIUM-DERIVED FACTOR; DIFFERENTIATION-RELATED PROTEIN; FATTY-ACID OXIDATION; GENE IDENTIFICATION-58 CGI-58; MODERATE-INTENSITY EXERCISE; DROPLET-ASSOCIATED PROTEIN; ENDURANCE-TRAINED MALES; G0/G1 SWITCH GENE	Triglycerides are stored within lipid droplets in skeletal muscle and can be hydrolyzed to produce fatty acids for energy production through beta-oxidation and oxidative phosphorylation. While there was some controversy regarding the quantitative importance of ntramyocellular triglyceride (IMTG) as a metabolic substrate, recent advances in proton magnetic resonance spectroscopy and confocal microscopy support earlier tracer and biopsy studies demonstrating a substantial contribution of IMTG to energy production, particularly during moderate intensity endurance exercise. This review provides an update on the understanding of IMTG utilization during exercise, with a focus on describing the key regulatory proteins that control IMTG breakdown and how these proteins respond to acute exercise and in the adaptation to exercise training. This article is part of a Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.	[Watt, Matthew J.; Cheng, Yunsheng] Monash Univ, Metab Dis & Obes Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Watt, Matthew J.; Cheng, Yunsheng] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia	Watt, MJ (reprint author), Monash Univ, 26 Innovat Walk, Clayton, Vic 3800, Australia.	matthew.watt@monash.edu			National Health and Medical Research Council of Australia [1077703]	MJW is supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia [grant number 1077703].	Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Alsted TJ, 2013, J PHYSIOL-LONDON, V591, P5141, DOI 10.1113/jphysiol.2013.260794; Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Alsted T. J., 2008, AM J PHYSL ENDOCRINO; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Badin PM, 2012, J LIPID RES, V53, P839, DOI 10.1194/jlr.M019182; Badin PM, 2011, DIABETES, V60, P1734, DOI 10.2337/db10-1364; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Biswas D, 2016, FASEB J, V30, P3822, DOI 10.1096/fj.201600571RR; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Chen WQ, 2013, AM J PHYSIOL-ENDOC M, V304, pE770, DOI 10.1152/ajpendo.00523.2012; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Covington JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091675; Crowe S, 2009, CELL METAB, V10, P40, DOI 10.1016/j.cmet.2009.06.001; DAGENAIS GR, 1976, J CLIN INVEST, V58, P421, DOI 10.1172/JCI108486; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Donsmark M, 2003, J PHYSIOL-LONDON, V550, P845, DOI 10.1113/jphysiol.2003.042333; Dube JJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE879, DOI 10.1152/ajpendo.00530.2014; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Eastmond PJ, 2006, PLANT CELL, V18, P665, DOI 10.1105/tpc.105.040543; Enevoldsen LH, 2001, J PHYSIOL-LONDON, V536, P871, DOI 10.1111/j.1469-7793.2001.t01-1-00871.x; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; ESSEN B, 1977, J PHYSIOL-LONDON, V265, P489, DOI 10.1113/jphysiol.1977.sp011726                                                  ; GARTON AJ, 1990, EUR J BIOCHEM, V191, P245, DOI 10.1111/j.1432-1033.1990.tb19116.x; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hagstrom-Toft E, 2002, DIABETES, V51, P3376, DOI 10.2337/diabetes.51.12.3376; Harber MP, 2008, INT J SPORTS MED, V29, P719, DOI 10.1055/s-2007-989442; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Helge JW, 2006, EUR J APPL PHYSIOL, V97, P566, DOI 10.1007/s00421-006-0220-y; Helge JW, 2001, J PHYSIOL-LONDON, V537, P1009, DOI 10.1113/jphysiol.2001.012933; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JIANG HP, 1992, P NATL ACAD SCI USA, V89, P7856, DOI 10.1073/pnas.89.17.7856; Jocken JWE, 2008, HISTOCHEM CELL BIOL, V129, P535, DOI 10.1007/s00418-008-0386-y; Kanaley J. A., 2009, J PHYSL; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Krssak M, 2000, J CLIN ENDOCR METAB, V85, P748, DOI 10.1210/jc.85.2.748; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Langfort J, 2000, BIOCHEM J, V351, P207, DOI 10.1042/0264-6021:3510207                                                       ; Langfort J, 1999, BIOCHEM J, V340, P459, DOI 10.1042/0264-6021:3400459                                                       ; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Laurens C, 2016, MOL METAB, V5, P527, DOI 10.1016/j.molmet.2016.04.004; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Louche K, 2013, J CLIN ENDOCR METAB, V98, P4863, DOI 10.1210/jc.2013-2058; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; MacPherson REK, 2015, APPL PHYSIOL NUTR ME, V40, P641, DOI 10.1139/apnm-2014-0485; MacPherson REK, 2013, AM J PHYSIOL-REG I, V304, pR644, DOI 10.1152/ajpregu.00418.2012; MacPherson REK, 2012, AM J PHYSIOL-REG I, V302, pR29, DOI 10.1152/ajpregu.00163.2011; Mason RR, 2015, TRENDS ENDOCRIN MET, V26, P144, DOI 10.1016/j.tem.2015.01.005; Mason RR, 2014, MOL METAB, V3, P652, DOI 10.1016/j.molmet.2014.06.002; Mason RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103062; Mason RR, 2012, AM J PHYSIOL-ENDOC M, V303, pE534, DOI 10.1152/ajpendo.00082.2012; Meex RCR, 2015, AM J PHYSIOL-ENDOC M, V308, pE960, DOI 10.1152/ajpendo.00598.2014; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; Mohktar RAM, 2016, AM J PHYSIOL-ENDOC M, V311, pE128, DOI 10.1152/ajpendo.00084.2016; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; Nielsen TS, 2011, J CLIN ENDOCR METAB, V96, pE1293, DOI 10.1210/jc.2011-0149; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Peters SJ, 2012, APPL PHYSIOL NUTR ME, V37, P724, DOI [10.1139/h2012-059, 10.1139/H2012-059]; Pollak NM, 2013, J LIPID RES, V54, P1092, DOI 10.1194/jlr.M034710; Pourteymour S., 2015, PHYS REP, V3; Prats C, 2006, J LIPID RES, V47, P2392, DOI 10.1194/jlr.M600247-JLR200; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; RAMOS SV, 2014, PHYS REP, V2; Roepstorff C, 2004, J PHYSIOL-LONDON, V560, P551, DOI 10.1113/jphysiol.2004.066480; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Sacchetti M, 2004, J PHYSIOL-LONDON, V561, P883, DOI 10.1113/jphysiol.2004.075135; Sahu-Osen A, 2015, J LIPID RES, V56, P109, DOI 10.1194/jlr.M055004; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Scherer PE, 1998, NAT BIOTECHNOL, V16, P581, DOI 10.1038/nbt0698-581; Schrauwen-Hinderling VB, 2003, J APPL PHYSIOL, V95, P2328, DOI 10.1152/japplphysiol.00304.2003; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Shan T, 2008, J ANIM SCI, V86, P1781, DOI 10.2527/jas.2007-0659; Shaw CS, 2012, AM J PHYSIOL-ENDOC M, V303, pE1158, DOI 10.1152/ajpendo.00272.2012; Shaw C, 2009, HISTOCHEM CELL BIOL, V131, P575, DOI 10.1007/s00418-009-0558-4; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u                                                               ; Shepherd SO, 2014, EXP PHYSIOL, V99, P894, DOI 10.1113/expphysiol.2014.078014; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; Shepherd SO, 2012, EXP PHYSIOL, V97, P970, DOI 10.1113/expphysiol.2012.064592; Smith AC, 2005, J PHYSIOL-LONDON, V565, P547, DOI 10.1113/jphysiol.2004.081687; Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007; Stellingwerff T, 2007, AM J PHYSIOL-ENDOC M, V292, pE1715, DOI 10.1152/ajpendo.00678.2006; Tan JSY, 2014, J GENET GENOMICS, V41, P251, DOI 10.1016/j.jgg.2014.03.003; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Turnbull PC, 2016, AM J PHYSIOL-REG I, V310, pR125, DOI 10.1152/ajpregu.00062.2015; Turnbull PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120136; van Loon LJC, 2006, PFLUG ARCH EUR J PHY, V451, P606, DOI 10.1007/s00424-005-1509-0; van Loon LJC, 2005, AM J PHYSIOL-ENDOC M, V289, pE482, DOI 10.1152/ajpendo.00092.2005; van Loon LJC, 2003, J PHYSIOL-LONDON, V553, P611, DOI 10.1113/jphysiol.2003.052431; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x                                                ; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Vigelso A, 2016, PHYSIOL RES, V65, P293; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang ZQ, 2010, INT J OBESITY, V34, P1355, DOI 10.1038/ijo.2010.77; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Watt MJ, 2004, FASEB J, V18, P1445, DOI 10.1096/fj.03-1067fje; Watt MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE120, DOI 10.1152/ajpendo.00542.2003; Watt MJ, 2003, J PHYSIOL-LONDON, V547, P301, DOI 10.1113/jphysiol.2002.034595; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; Watt MJ, 2002, J APPL PHYSIOL, V93, P1185, DOI 10.1152/japplphysiol.00197.2002; White LJ, 2003, J CLIN ENDOCR METAB, V88, P5638, DOI 10.1210/jc.2003-031006; WOLFE RR, 1990, AM J PHYSIOL, V258, pE382; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200                                                          ; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Wu JW, 2015, J INHERIT METAB DIS, V38, P85, DOI 10.1007/s10545-014-9767-7; Xie P, 2015, ENDOCRINOLOGY, V156, P1648, DOI 10.1210/en.2014-1892; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747                                                         	136	0	0	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	OCT	2017	1862	10	B				1250	1259		10.1016/j.bbalip.2017.06.015				10	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI8LW	WOS:000412255100014	28652193				2018-01-05	
J	Qi, YF; Sun, L; Yang, HY				Qi, Yanfei; Sun, Lei; Yang, Hongyuan			Lipid droplet growth and adipocyte development: mechanistically distinct processes connected by phospholipids	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article; Proceedings Paper	FASEB Summer Conference on Lipid Droplets - Dynamic Organelles in Metabolism and Beyond	JUL 24-29, 2016	Snowmass, CO	FASEB		Lipid droplets; Seipin; Lipin; CDP-DAG synthase; AGPAT2; BSCL2; Lipodystrophy	SEIP CONGENITAL LIPODYSTROPHY; BROWN ADIPOSE-TISSUE; ENDOPLASMIC-RETICULUM STRESS; CYCLIC PHOSPHATIDIC-ACID; PPAR-GAMMA; SACCHAROMYCES-CEREVISIAE; GENERALIZED LIPODYSTROPHY; CONTACT SITES; FAT STORAGE; GENE-EXPRESSION	The differentiation of preadipocytes into mature adipocytes is accompanied by the growth and formation of a giant, unilocular lipid droplet (LD). Mechanistically however, LD growth and adipogenesis are two different processes. Recent studies have uncovered a number of proteins that are able to regulate both LD dynamics and adipogenesis, such as SEIPIN, LIPIN and CDP-Diacylglycerol Synthases. It appears that phospholipids, phosphatidic acid in particular, play a critical role in both LD budding/growth and adipocyte development. This review summarizes recent advances, and aims to provide a better understanding of LD growth as well as adipogenesis, two critical aspects in mammalian fat storage. This article is part of a Special Issue entitled: Recent Advances in Lipid Droplet Biology edited by Rosalind Coleman and Matthijs Hesselink.	[Qi, Yanfei; Yang, Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Sun, Lei] DUKE NUS Grad Med Sch Singapore, 8 Coll Rd, Singapore 169857, Singapore	Yang, HY (reprint author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	h.rob.yang@unsw.edu.au		Yang, Hongyuan/0000-0002-8482-6031	National Health and Medical Research Council (NHMRC), Australia [1057852, 1078117]; Australian Research Council [DP130100457]; Singapore NRF fellowship [NRF-2011NRF-NRFF001-025]; Singapore National Research Foundation CBRG [NMRC/CBRG/0101/2016]	We sincerely apologize to those whose work could not be cited or discussed here due to limitations in space and scope. This work was supported by grants 1057852 and 1078117 from the National Health and Medical Research Council (NHMRC), Australia, and by grant DP130100457 from the Australian Research Council. H. Yang is a Senior Research Fellow of the NHMRC (1058237). L. Sun is supported by Singapore NRF fellowship: NRF-2011NRF-NRFF001-025 and by Singapore National Research Foundation CBRG grant NMRC/CBRG/0101/2016.	Agarwal AK, 2004, TRENDS MOL MED, V10, P440, DOI 10.1016/j.molmed.2004.07.009; Agarwal AK, 2003, J CLIN ENDOCR METAB, V88, P4840, DOI 10.1210/jc.2003-030855; Agarwal AK, 2012, CURR OPIN LIPIDOL, V23, P290, DOI 10.1097/MOL.0b013e328354fcf4; Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bi JF, 2014, CELL METAB, V19, P861, DOI 10.1016/j.cmet.2014.03.028; Binns D, 2010, BIOCHEMISTRY-US, V49, P10747, DOI 10.1021/bi1013003; Bishop-Bailey D, 2003, PROSTAG OTH LIPID M, V71, P1, DOI 10.1016/S0090-6980(03)00003-0; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Brown WV, 2016, J CLIN LIPIDOL, V10, P728, DOI 10.1016/j.jacl.2016.06.005; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200                                                          ; Cartwright BR, 2015, MOL BIOL CELL, V26, P726, DOI 10.1091/mbc.E14-08-1303; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Choudhary V, 2015, J CELL BIOL, V211, P261, DOI 10.1083/jcb.201505067; Cohen P, 2015, DIABETES, V64, P2346, DOI 10.2337/db15-0318; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Cui X, 2012, AM J PHYSIOL-ENDOC M, V302, pE705, DOI 10.1152/ajpendo.00237.2011; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Dollet L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35487; Dollet L, 2016, DIABETES, V65, P3410, DOI 10.2337/db16-0327; Dollet L, 2014, BIOCHIMIE, V96, P166, DOI 10.1016/j.biochi.2013.06.022; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fei WH, 2008, EUKARYOT CELL, V7, P401, DOI 10.1128/EC.00386-07; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/icb.200711136; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Fernandez-Murray JP, 2016, J LIPID RES, V57, P1789, DOI 10.1194/jlr.R070920; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; Grippa A, 2015, J CELL BIOL, V211, P829, DOI 10.1083/jcb.201502070; Gross DA, 2014, CRIT REV BIOCHEM MOL, V49, P304, DOI 10.3109/10409238.2014.931337; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Grundy SM, 2015, EUR J CLIN INVEST, V45, P1209, DOI 10.1111/eci.12519; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0075-3; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Ito D, 2008, NEUROBIOL DIS, V31, P266, DOI 10.1016/j.nbd.2008.05.004; Jacquier N, 2013, J CELL SCI, V126, P5198, DOI 10.1242/jcs.131896; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Jiang M, 2014, P NATL ACAD SCI USA, V111, P7054, DOI 10.1073/pnas.1324025111; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kohlwein SD, 2010, BBA-MOL CELL BIOL L, V1801, P222, DOI 10.1016/j.bbalip.2009.12.016; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liu L, 2014, DIABETES, V63, P2320, DOI 10.2337/db13-0729; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Mekahli D, 2011, COLD SPRING HARB PER, V3; Mori E, 2016, METABOLISM, V65, P543, DOI 10.1016/j.metabol.2015.12.015; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nolis T, 2014, J HUM GENET, V59, P16, DOI 10.1038/jhg.2013.107; Ohsaki Y, 2014, CHEM BIOL, V21, P86, DOI 10.1016/j.chembiol.2013.08.009; Oishi-Tanaka Y, 2010, CELL METAB, V12, P207, DOI 10.1016/j.cmet.2010.08.010; Pagac M, 2016, CELL REP, V17, P1546, DOI 10.1016/j.celrep.2016.10.037; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Peng XG, 2013, AM J PHYSIOL-ENDOC M, V304, pE160, DOI 10.1152/ajpendo.00401.2012; Peterfy M, 2001, NAT GENET, V27, P121; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051; Prieur X, 2013, DIABETOLOGIA, V56, P1813, DOI 10.1007/s00125-013-2926-9; Qi YF, 2016, J LIPID RES, V57, P767, DOI 10.1194/jlr.M060574; Qi YF, 2015, J BIOL CHEM, V290, P23282, DOI 10.1074/jbc.M115.677542; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; Raboud JM, 2010, HIV CLIN TRIALS, V11, P39, DOI 10.1310/hct1101-39; Robbins AL, 2015, TRENDS MOL MED, V21, P433, DOI 10.1016/j.molmed.2015.04.004; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Salo VT, 2016, EMBO J, V35, P2699, DOI 10.15252/embj.201695170; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Shao ML, 2016, CELL METAB, V23, P1167, DOI 10.1016/j.cmet.2016.04.023; Sim MFM, 2013, MOL METAB, V2, P38, DOI 10.1016/j.molmet.2012.11.002; Sim MFM, 2013, DIABETOLOGIA, V56, P2498, DOI 10.1007/s00125-013-3029-3; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Talukder MMU, 2015, MOL METAB, V4, P199, DOI 10.1016/j.molmet.2014.12.013; Tan JSY, 2014, J GENET GENOMICS, V41, P251, DOI 10.1016/j.jgg.2014.03.003; Thiam AR, 2017, J CELL SCI, V130, P315, DOI 10.1242/jcs.192021; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X                                                    ; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Tungsiripat M, 2010, AIDS, V24, P1291, DOI 10.1097/QAD.0b013e328339e274; Victoria B, 2010, DIABETIC MED, V27, P1178, DOI 10.1111/j.1464-5491.2010.03052.x; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Wang CW, 2015, CELL MOL LIFE SCI, V72, P2677, DOI 10.1007/s00018-015-1903-5; Wang CW, 2014, J CELL SCI, V127, P1214, DOI 10.1242/jcs.137737; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang H., 2016, ELIFE, V5; Wang QA, 2015, NAT CELL BIOL, V17, P1099, DOI 10.1038/ncb3217; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolinski H, 2015, BBA-MOL CELL BIOL L, V1851, P1450, DOI 10.1016/j.bbalip.2015.08.003; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Zhang PX, 2012, J BIOL CHEM, V287, P3485, DOI 10.1074/jbc.M111.296681; Zhou HY, 2016, MOL CELL BIOL, V36, P2027, DOI 10.1128/MCB.01120-15; Zhou HY, 2015, J LIPID RES, V56, P1912, DOI 10.1194/jlr.M060244; Zhou L., 2012, HEPATOLOGY; Zhou LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6949	124	0	0	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	OCT	2017	1862	10	B				1273	1283		10.1016/j.bbalip.2017.06.016				11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI8LW	WOS:000412255100016	28668300				2018-01-05	
J	Sato-Masumoto, N; Uchikura, T; Sugiwaki, H; Yoshimura, M; Masada, S; Atsumi, T; Watanabe, M; Tanaka, N; Uchiyama, N; Amakura, Y; Hakamatsuka, T				Sato-Masumoto, Naoko; Uchikura, Takashi; Sugiwaki, Hidemi; Yoshimura, Morio; Masada, Sayaka; Atsumi, Toshiyuki; Watanabe, Masato; Tanaka, Nobuyuki; Uchiyama, Nahoko; Amakura, Yoshiaki; Hakamatsuka, Takashi			Survey on the Original Plant Species of Crude Drugs Distributed as Cynanchi Wilfordii Radix and Its Related Crude Drugs in the Korean and Chinese Markets	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Cynanchum wilfordii; Cynanchum auriculatum; Polygonum multiflorum; high-performance thin-layer chromatography analysis; genetic polymorphism	CHEMICAL-ANALYSES; BOTANICAL ORIGIN; CHLOROPLAST DNA; AUTHENTICATION; PHYLOGENY	Cynanchi Wilfordii Radix (CWR) is used in Korea as a substitute for Polygoni Multifiori Radix (PMR), which is a crude drug traditionally used in East Asian countries. Recently, the use of Cynanchi Auriculati Radix (CAR) in place of PMR and CWR has emerged a major concern in the Korean market. In Japan, PMR is permitted to be distributed as a pharmaceutical regulated by the Japanese Pharmacopoeia 17th edition (JP17). Although CWR and CAR have not traditionally been used as medicines, CWR was recently introduced as a health food. The distribution of unfamiliar CWR-containing products could lead to the misuse of original species for PMR and CWR like in Korea. To prevent this situation, the original species of plant products distributed as PMR, CWR, and CAR in the Korean and Chinese markets were surveyed and identified by their genes and components. The results revealed that all two PMR in the Korean market were misapplied as CAR, and that CAR was incorrectly used in eight of thirteen products distributed as CWR in both markets. As PMR is strictly controlled by JP17, the risk of mistaking PMR for CWR and CAR would be low in Japan. In contrast, the less stringent regulation of health food products and the present situation of misidentification of CWR in the Korean and Chinese markets could lead to unexpected health hazards. To ensure the quality and safety of crude drugs, it is important to use the information about the genes and components of these crude drugs.	[Sato-Masumoto, Naoko; Masada, Sayaka; Uchiyama, Nahoko; Hakamatsuka, Takashi] Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan; [Uchikura, Takashi; Sugiwaki, Hidemi; Yoshimura, Morio; Amakura, Yoshiaki] Matsuyama Univ, Coll Pharmaceut Sci, Dept Pharmacognosy, 4-2 Bunkyo Cho, Matsuyama, Ehime 7908578, Japan; [Atsumi, Toshiyuki] Kyushu Univ Hlth & Welf, Sch Pharmaceut Sci, Dept Pharmacognosy, 1714-1 Yoshino, Nobeoka, Miyazaki 8828508, Japan; [Watanabe, Masato] Kumamoto Univ, Grad Sch Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan; [Tanaka, Nobuyuki] Natl Museum Nat & Sci, Dept Bot, 4-1-1 Amakubo, Tsukuba, Ibaraki 3050005, Japan	Uchiyama, N (reprint author), Natl Inst Hlth Sci, Div Pharmacognosy Phytochem & Narcot, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	nuchiyama@nihs.go.jp			Health Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare of Japan	We are very grateful to Tochimoto Tenkaido Co., Ltd., Uchidawakanyaku Ltd., and Matsuura Yakugyo Co., Ltd. for the provision of crude drugs distributed in the Chinese market. We thank Dr. Hajime Mizukami and Ms. Naoko Shintani of the MBK Herbarium for the provision of herbarium specimens of C. wilfordii, and the Takeda Garden for Medicinal Plant Conservation, Kyoto, Takeda Pharmaceutical Co., Ltd. and the Yamashina Botanical Garden, Nippon Shinyaku Co., Ltd. for the donation of the fresh leaves of P. multiflorum. This work was supported by a Health Labour Sciences Research Grant provided by the Ministry of Health, Labour and Welfare of Japan.	Chang A, 2012, PHYTOTHER RES, V26, P510, DOI 10.1002/ptr.3597; Division of Safety Information on Drug and Food National Institute of Health Sciences, 2015, FOODS SAF INF CHEM S, P22; Downie SR, 1996, AM J BOT, V83, P234, DOI 10.2307/2445943; U. S. Food and Drug Administration (FDA), FDA POIS PLANT DAT; Goda Y, 2014, JAPANESE CRUDE DRUGS, P643; Goda Y, 2008, YAKUGAKU ZASSHI, V128, P837, DOI 10.1248/yakushi.128.837; 강태선, 2015, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V30, P289; Kim MinKyeoung, 2013, Journal of Medicinal Plants Research, V7, P2584; Kletter C, 2004, PLANTA MED, V70, P993, DOI 10.1055/s-2004-832627; Korea Food and Drug Administration, 2002, KOR HERB PHARM, P98; Lee BJ, 2015, EVID-BASED COMPL ALT, V2015; Maruyama T, 2008, PLANTA MED, V74, P787, DOI 10.1055/s-2008-1074537; Maruyama T, 2007, CHEM PHARM BULL, V55, P1626, DOI 10.1248/cpb.55.1626; Maruyama T, 2014, J NAT MED-TOKYO, V68, P220, DOI 10.1007/s11418-013-0779-7; Masada-Atsumi S, 2014, BIOL PHARM BULL, V37, P454, DOI 10.1248/bpb.b13-00844                                                           ; Ministry of Health. Labour and Welfare, BAS POL GOOD MAN FOO; Ministry of Food and Drug safety, CYN WILF RAD; Nanjing University of Traditional Chinese Medicine ed, 2006, DICT CHIN TRAD MED, V1, P1007; Nanjing University of Traditional Chinese Medicine ed, 2006, DICT CHIN TRAD MED, V2, P3395; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152                                                              ; Taketani K, 2012, PARTNER PHARMACOGNOS, P374; Tate JA, 2003, SYST BOT, V28, P723; Thiers B, INDEX HERBARIORUM GL; UMIN Clinical Trials Registry (UMIN-CTR), CLIN STUD EFF SAF ES; Wakana D, 2012, JPN J FOOD CHEM SAFE, V19, P111; White TJ, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1139/B07-071; Zhang X, 2009, J PHARMACEUT BIOMED, V49, P715, DOI 10.1016/j.jpba.2009.01.009	28	0	0	2	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2017	40	10					1693	1699		10.1248/bpb.b17-00226                                                           				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FI5QE	WOS:000412038100012	28966240				2018-01-05	
J	Shvets, AA; Kolomeisky, AB				Shvets, Alexey A.; Kolomeisky, Anatoly B.			Mechanism of Genome Interrogation: How CRISPR RNA-Guided Cas9 Proteins Locate Specific Targets on DNA	BIOPHYSICAL JOURNAL			English	Article							SEARCH; SYSTEM; NUCLEASES; DYNAMICS; BACTERIA; ARCHAEA	The ability to precisely edit and modify a genome opens endless opportunities to investigate fundamental properties of living systems as well as to advance various medical techniques and bioengineering applications. This possibility is now close to reality due to a recent discovery of the adaptive bacterial immune system, which is based on clustered regularly interspaced short palindromic repeats (CRISPR)-associated proteins (Cas) that utilize RNA to find and cut the double-stranded DNA molecules at specific locations. Here we develop a quantitative theoretical approach to analyze the mechanism of target search on DNA by CRISPR RNA-guided Cas9 proteins, which is followed by a selective cleavage of nucleic acids. It is based on a discrete-state stochastic model that takes into account the most relevant physical-chemical processes in the system. Using a method of first-passage processes, a full dynamic description of the target search is presented. It is found that the location of specific sites on DNA by CRISPR Cas9 proteins is governed by binding first to protospacer adjacent motif sequences on DNA, which is followed by reversible transitions into DNA interrogation states. In addition, the search dynamics is strongly influenced by the off-target cutting. Our theoretical calculations allow us to explain the experimental observations and to give experimentally testable predictions. Thus, the presented theoretical model clarifies some molecular aspects of the genome interrogation by CRISPR RNA-guided Cas9 proteins.	[Shvets, Alexey A.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kolomeisky, Anatoly B.] Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA; [Kolomeisky, Anatoly B.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA	Kolomeisky, AB (reprint author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.; Kolomeisky, AB (reprint author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.	tolya@rice.edu			Welch Foundation [C-1559]; National Science Foundation (NSF) [CHE-1360979, CHE-1664218]; Center for Theoretical Biological Physics - National Science Foundation (NSF) [PHY-1427654]	A.B.K. acknowledges support from the Welch Foundation (grant No. C-1559), from the National Science Foundation (NSF) (grant No. CHE-1360979 and CHE-1664218), and from the Center for Theoretical Biological Physics sponsored by the National Science Foundation (NSF) (grant No. PHY-1427654).	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bauer M, 2012, BIOPHYS J, V102, P2321, DOI 10.1016/j.bpj.2012.04.008; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bisaria N, 2017, CELL SYST, V4, P21, DOI 10.1016/j.cels.2016.12.010; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Esadze A, 2014, NUCLEIC ACIDS RES, V42, P7039, DOI 10.1093/nar/gku418; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Hu JH, 2016, CELL CHEM BIOL, V23, P57, DOI 10.1016/j.chembiol.2015.12.009; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kochugaeva MP, 2017, BIOPHYS J, V112, P859, DOI 10.1016/j.bpj.2017.01.018; Kochugaeva MP, 2016, J PHYS A-MATH THEOR, V49, DOI 10.1088/1751-8113/49/44/444004; Kolomeisky AB, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3697763; Kolomeisky AB, 2011, PHYS CHEM CHEM PHYS, V13, P2088, DOI 10.1039/c0cp01966f; Koslover EF, 2011, BIOPHYS J, V101, P856, DOI 10.1016/j.bpj.2011.06.066; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shvets AA, 2016, J PHYS CHEM LETT, V7, P5022, DOI 10.1021/acs.jpclett.6b02371; Shvets AA, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4937938; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Veksler A, 2013, J PHYS CHEM B, V117, P12695, DOI 10.1021/jp311466f; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zheng WJ, 2017, PROTEINS, V85, P342, DOI 10.1002/prot.25229	31	0	0	33	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	OCT	2017	113	7					1416	1424		10.1016/j.bpj.2017.08.013				9	Biophysics	Biophysics	FJ2JC	WOS:000412551200006	28978436				2018-01-05	
J	Ng, IS; Tan, SI; Kao, PH; Chang, YK; Chang, JS				Ng, I-Son; Tan, Shih-I; Kao, Pei-Hsun; Chang, Yu-Kaung; Chang, Jo-Shu			Recent Developments on Genetic Engineering of Microalgae for Biofuels and Bio-Based Chemicals	BIOTECHNOLOGY JOURNAL			English	Review						CRISPR-Cas9; genetic engineering; microalgae; selection; transformation	ALGA HAEMATOCOCCUS-PLUVIALIS; FATTY-ACID BIOSYNTHESIS; DIATOM PHAEODACTYLUM-TRICORNUTUM; ACETYL-COA CARBOXYLASE; AGROBACTERIUM-MEDIATED TRANSFORMATION; DOMINANT SELECTABLE MARKER; PHYTOENE DESATURASE GENE; NITRATE REDUCTASE GENE; ZINC-FINGER NUCLEASES; RAPE BRASSICA-NAPUS	Microalgae serve as a promising source for the production of biofuels and bio-based chemicals. They are superior to terrestrial plants as feedstock in many aspects and their biomass is naturally rich in lipids, carbohydrates, proteins, pigments, and other valuable compounds. Due to the relatively slow growth rate and high cultivation cost of microalgae, to screen efficient and robust microalgal strains as well as genetic modifications of the available strains for further improvement are of urgent demand in the development of microalgae-based biorefinery. In genetic engineering of microalgae, transformation and selection methods are the key steps to accomplish the target gene modification. However, determination of the preferable type and dosage of antibiotics used for transformant selection is usually time-consuming and microalgal-strain-dependent. Therefore, more powerful and efficient techniques should be developed to meet this need. In this review, the conventional and emerging genome-editing tools (e.g., CRISPR-Cas9, TALEN, and ZFN) used in editing the genomes of nuclear, mitochondria, and chloroplast of microalgae are thoroughly surveyed. Although all the techniques mentioned above demonstrate their abilities to perform gene editing and desired phenotype screening, there still need to overcome higher production cost and lower biomass productivity, to achieve efficient production of the desired products in microalgal biorefineries.	[Ng, I-Son; Tan, Shih-I; Kao, Pei-Hsun; Chang, Jo-Shu] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan; [Ng, I-Son; Chang, Jo-Shu] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 70101, Taiwan; [Chang, Yu-Kaung] Ming Chi Univ Technol, Grad Sch Biochem Engn, New Taipei 24301, Taiwan	Ng, IS (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.; Ng, IS (reprint author), Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 70101, Taiwan.	yswu@mail.ncku.edu.tw			Ministry of Science and Technology in Taiwan [MOST 105-2221-E-006-225-MY3, MOST-105-2621-M-006-012-MY3, MOST-105-2218-E-006-021]	The authors are grateful to the financial support for this study provided by the Ministry of Science and Technology (MOST 105-2221-E-006-225-MY3, MOST-105-2621-M-006-012-MY3 and MOST-105-2218-E-006-021) in Taiwan.	ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; Ahmad AL, 2011, RENEW SUST ENERG REV, V15, P584, DOI 10.1016/j.rser.2010.09.018; Ahmad I, 2015, PLANT BIOTECHNOL J, V13, P540, DOI 10.1111/pbi.12278; Aikawa S, 2015, BIOTECHNOL J, V10, P886, DOI 10.1002/biot.201400344; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Armbrust EV, 1999, APPL ENVIRON MICROB, V65, P3121; Armstrong GA, 1996, FASEB J, V10, P228; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Banerjee C, 2016, BIOTECHNOL J, V11, P303, DOI 10.1002/biot.201500284; Bashir KMI, 2016, BIOTECHNOL BIOPROC E, V21, P224, DOI 10.1007/s12257-015-0386-4; Beckmann J, 2009, J BIOTECHNOL, V142, P70, DOI 10.1016/j.jbiotec.2009.02.015; Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Berg J. M., 2002, BIOCHEMISTRY; Botella-Pavia P, 2004, PLANT J, V40, P188, DOI 10.1111/j.1365-313X.2004.02198.x; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Budziszewski GJ, 1996, LIPIDS, V31, P557, DOI 10.1007/BF02523826; Calvin M., 1948, PATH CARBON PHOTOSYN; Cao Zhuan, 2006, Biotechnology Journal, V1, P68, DOI 10.1002/biot.200500008; Cha TS, 2012, WORLD J MICROB BIOT, V28, P1771, DOI 10.1007/s11274-011-0991-0; Chen CY, 2016, BIOTECHNOL J, V11, P336, DOI 10.1002/biot.201500272; Chen HL, 2008, J PHYCOL, V44, P768, DOI 10.1111/j.1529-8817.2008.00508.x; Chen J., 1998, J AGR BIOTECHNOL, V7, P316; Chen PH, 2012, ENERG ENVIRON SCI, V5, P8318, DOI 10.1039/c2ee21124f; Chisti Y, 2013, J BIOTECHNOL, V167, P201, DOI 10.1016/j.jbiotec.2013.07.020; Chow KC, 1999, PLANT CELL REP, V18, P778, DOI 10.1007/s002990050660                                                           ; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Coll JM, 2006, SPAN J AGRIC RES, V4, P316; Cordero BF, 2012, MAR DRUGS, V10, P2069, DOI 10.3390/md10092069; Cordero BF, 2011, MAR DRUGS, V9, P1607, DOI 10.3390/md9091607; Cordero BF, 2011, APPL MICROBIOL BIOT, V91, P341, DOI 10.1007/s00253-011-3262-y; Cordero BF, 2010, J PHYCOL, V46, P1229, DOI 10.1111/j.1529-8817.2010.00907.x; Courchesne NMD, 2009, J BIOTECHNOL, V141, P31, DOI 10.1016/j.jbiotec.2009.02.018; Couso I, 2011, BIOTECHNOL PROGR, V27, P54, DOI 10.1002/btpr.527; Cunningham FX, 2002, PURE APPL CHEM, V74, P1409, DOI 10.1351/pac200274081409                                                         ; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557                                                ; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200                                                          ; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x                                                ; Dawson HN, 1997, CURR MICROBIOL, V35, P356, DOI 10.1007/s002849900268; DEBUCHY R, 1989, EMBO J, V8, P2803; Del Campo JA, 2007, APPL MICROBIOL BIOT, V74, P1163, DOI 10.1007/s00253-007-0844-9; Deng XD, 2014, BIOTECHNOL LETT, V36, P2199, DOI 10.1007/s10529-014-1593-3; Dincer I, 2000, RENEW SUST ENERG REV, V4, P157, DOI 10.1016/S1364-0321(99)00011-8                                                   ; Diplock AT, 1998, BRIT J NUTR, V80, pS77, DOI 10.1079/BJN19980106                                                             ; Doetsch NA, 2001, CURR GENET, V39, P49, DOI 10.1007/s002940000174; Ducat DC, 2012, CURR OPIN CHEM BIOL, V16, P337, DOI 10.1016/j.cbpa.2012.05.002; DUNAHAY TG, 1993, BIOTECHNIQUES, V15, P452; Eilers U, 2016, J APPL PHYCOL, V28, P123, DOI 10.1007/s10811-015-0583-8; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; EVANS MCW, 1966, P NATL ACAD SCI USA, V55, P928, DOI 10.1073/pnas.55.4.928; Fan L, 1995, PLANT CELL PHYSIOL, V36, P1519; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gan SY, 2003, J APPL PHYCOL, V15, P345, DOI 10.1023/A:1025141913156; Gimpel JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01376; Gomaa MA, 2016, J APPL MICROBIOL, V121, P919, DOI 10.1111/jam.13232; Gong MY, 2016, BIOTECHNOL ADV, V34, P1396, DOI 10.1016/j.biotechadv.2016.10.005; Gordon GC, 2016, METAB ENG, V38, P170, DOI 10.1016/j.ymben.2016.07.007; Graham IA, 2007, CURR OPIN BIOTECH, V18, P142, DOI 10.1016/j.copbio.2007.01.014; Guiheneuf F, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00400, 10.3389/fpls.2010.00400]; Hariskos I, 2014, BIOTECHNOL J, V9, P739, DOI 10.1002/biot.201300142; Hawkins RL, 1999, CURR MICROBIOL, V38, P335, DOI 10.1007/PL00006813                                                              ; Hill J, 2007, AGRON SUSTAIN DEV, V27, P1, DOI 10.1051/agro:2007006; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huang CH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0595-3; Huang J. C., 2006, MICROBIOL BIOTECHNOL, V71, P473; Huang X, 1996, BOT MAR, V39, P467, DOI 10.1515/botm.1996.39.1-6.467; Inoue K, 1997, J BIOL CHEM, V272, P31747, DOI 10.1074/jbc.272.50.31747; Ivy JM, 1998, BIOTECHNOL GENET ENG, V15, P271, DOI 10.1080/02648725.1998.10647958                                                  ; Jankele R, 2014, BRIEF FUNCT GENOMICS, V13, P409, DOI 10.1093/bfgp/elu013; JARVIS EE, 1991, CURR GENET, V19, P317, DOI 10.1007/BF00355062                                                              ; JIANG P, 1994, J BACTERIOL, V176, P2814; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Johnson TJ, 2016, BIOTECHNOL PROGR, V32, P1357, DOI 10.1002/btpr.2358; Kao P. H., 2017, BIORESOUR TECHNOL; Kasai Y, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0277-0; Kathiresan S, 2009, J PHYCOL, V45, P642, DOI 10.1111/j.1529-8817.2009.00688.x; Kebeish R, 2007, NAT BIOTECHNOL, V25, P593, DOI 10.1038/nbt1299; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Kim J, 2009, PLANT CELL PHYSIOL, V50, P463, DOI 10.1093/pcp/pcp005; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77                                                    ; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; KINDLE KL, 1991, P NATL ACAD SCI USA, V88, P1721, DOI 10.1073/pnas.88.5.1721; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228                                                          ; Kubler J. E., 1994, J MAR BIOTECHNOL, V1, P165; Kumar SV, 2004, PLANT SCI, V166, P731, DOI 10.1016/j.plantsci.2003.11.012; KURTZMAN A L, 1991, Journal of Phycology, V27, P42; Lam MK, 2012, BIOTECHNOL ADV, V30, P673, DOI 10.1016/j.biotechadv.2011.11.008; Lan EI, 2015, METAB ENG, V31, P163, DOI 10.1016/j.ymben.2015.08.002; LANDRISCINA C, 1972, EUR J BIOCHEM, V29, P188, DOI 10.1111/j.1432-1033.1972.tb01974.x; Lapidot M, 2002, PLANT PHYSIOL, V129, P7, DOI 10.1104/pp.011023; Lenka SK, 2016, BIOTECHNOL ADV, V34, P1046, DOI 10.1016/j.biotechadv.2016.06.004; Leon R, 2007, J BIOTECHNOL, V130, P143, DOI 10.1016/j.jbiotec.2007.03.005; Leon-Banares R, 2004, TRENDS BIOTECHNOL, V22, P45, DOI 10.1016/j.tibtech.2003.11.003; Leoncini E, 2015, CANCER EPIDEM BIOMAR, V24, P1003, DOI 10.1158/1055-9965.EPI-15-0053; Li H, 2016, METAB ENG, V38, P293, DOI 10.1016/j.ymben.2016.09.006; Li Y, 2008, J PLANT PHYSIOL, V165, P1783, DOI 10.1016/j.jplph.2007.12.007; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Lieman-Hurwitz J, 2003, PLANT BIOTECHNOL J, V1, P43, DOI 10.1046/j.1467-7652.2003.00003.x; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Liu J, 2014, APPL MICROBIOL BIOT, V98, P5069, DOI 10.1007/s00253-014-5593-y; Liu J, 2013, PROCESS BIOCHEM, V48, P788, DOI 10.1016/j.procbio.2013.04.020; LJUNGDAH.L, 1965, J BACTERIOL, V89, P1055; Ljungdahl LG, 2009, ANNU REV MICROBIOL, V63, P1, DOI 10.1146/annurev.micro.091208.073617; Lodish H., 1995, MOL CELL BIOL; Lu YM, 2011, J APPL PHYCOL, V23, P673, DOI 10.1007/s10811-010-9559-x; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Markou G, 2013, BIOTECHNOL ADV, V31, P1532, DOI 10.1016/j.biotechadv.2013.07.011; Martin M, 2014, APPL ENERG, V135, P108, DOI 10.1016/j.apenergy.2014.08.054; Masuda T, 2003, PLANT MOL BIOL, V51, P757, DOI 10.1023/A:1022545118212; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Minoda A, 2004, PLANT CELL PHYSIOL, V45, P667, DOI 10.1093/pcp/pch087                                                              ; MINOT R, 1982, FEBS LETT, V142, P118, DOI 10.1016/0014-5793(82)80232-9; Miyahara M, 2013, BIOSCI BIOTECH BIOCH, V77, P874, DOI 10.1271/bbb.120936; Montgomery H, 2017, BIOFUEL RES J, V4, P536, DOI 10.18331/BRJ2017.4.1.2; Mussgnug JH, 2007, PLANT BIOTECHNOL J, V5, P802, DOI 10.1111/j.1467-7652.2007.00285.x; Namitha KK, 2010, CRIT REV FOOD SCI, V50, P728, DOI 10.1080/10408398.2010.499811; Napier JA, 2007, ANNU REV PLANT BIOL, V58, P295, DOI 10.1146/annurev.arplant.58.032806.103811; Ndikubwimana T, 2016, BIOTECHNOL J, V11, P315, DOI 10.1002/biot.201500175; Niu YF, 2013, MAR DRUGS, V11, P4558, DOI 10.3390/md11114558; Nymark M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24951; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Opsahl-Ferstad HG, 2003, PLANT SCI, V165, P349, DOI 10.1016/S0168-9452(03)00194-8; PAGE RA, 1994, BBA-LIPID LIPID MET, V1210, P369, DOI 10.1016/0005-2760(94)90242-9; Palpant NJ, 2013, GENE THER, V20, P121, DOI 10.1038/gt.2012.2; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; Peterhansel C, 2013, PLANT BIOLOGY, V15, P754, DOI 10.1111/j.1438-8677.2012.00681.x; PICATAGGIO S, 1992, BIO-TECHNOL, V10, P894, DOI 10.1038/nbt0892-894; Pienkos PT, 2009, BIOFUEL BIOPROD BIOR, V3, P431, DOI 10.1002/bbb.159; Pittman JK, 2011, BIORESOURCE TECHNOL, V102, P17, DOI 10.1016/j.biortech.2010.06.035; Proctor LM, 1997, AQUAT MICROB ECOL, V12, P105, DOI 10.3354/ame012105                                                               ; ubeda-Minguez P., 2015, J APPL PHYCOL, V27, P223; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Pulz O., 1998, BIOPROCESS ALGAE REA, P123; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Raines CA, 2003, PHOTOSYNTH RES, V75, P1, DOI 10.1023/A:1022421515027; Raines CA, 2011, PLANT PHYSIOL, V155, P36, DOI 10.1104/pp.110.168559; Ramachandra TV, 2009, IND ENG CHEM RES, V48, P8769, DOI 10.1021/ie900044j; Rathod J, 2013, PHOTOSYNTH RES, V118, P141, DOI 10.1007/s11120-013-9930-2; Rathore D, 2016, BIOFUEL RES J, V3, P380, DOI 10.18331/BRJ2016.3.2.3; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; ROBARTS RD, 1987, NEW ZEAL J MAR FRESH, V21, P391, DOI 10.1080/00288330.1987.9516235                                                   ; ROCHAIX JD, 1982, NATURE, V296, P70, DOI 10.1038/296070a0; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Salati S, 2017, BIORESOURCE TECHNOL, V230, P82, DOI 10.1016/j.biortech.2017.01.030; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sandmann G, 2006, METAB ENG, V8, P291, DOI 10.1016/j.ymben.2006.01.005; Sheehan J., 1998, NRELTP58024190, P328; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; Shimogawara K, 1998, GENETICS, V148, P1821; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Sizova I, 2013, PLANT J, V73, P873, DOI 10.1111/tpj.12066; SMITH S, 1994, FASEB J, V8, P1248; Song CW, 2015, BIOTECHNOL J, V10, P56, DOI 10.1002/biot.201400057; Song D, 2008, CHIN J BIOTECHNOL, V24, DOI DOI 10.1016/S1872-2075(08)60016-3; Specht EA, 2015, BIOTECHNOL J, V10, P473, DOI 10.1002/biot.201400172; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steinbrenner J, 2001, PLANT PHYSIOL, V125, P810, DOI 10.1104/pp.125.2.810; Steinbrenner J, 2006, APPL ENVIRON MICROB, V72, P7477, DOI 10.1128/AEM.01461-06; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Stoll C, 2005, EUR J LIPID SCI TECH, V107, P244, DOI 10.1002/ejlt.200590021; Subrahmanyam S, 1998, J BACTERIOL, V180, P4596; SUGIMOTO T, 1989, AGR BIOL CHEM TOKYO, V53, P885, DOI 10.1080/00021369.1989.10869369                                                  ; Sun Y, 2006, GENE, V377, P140, DOI 10.1016/j.gene.2006.03.018; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Tan CP, 2005, J MICROBIOL, V43, P361; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; ten Lohuis MR, 1998, PLANT J, V13, P427; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204                                                          ; Tian QL, 2014, BIOTECHNOL LETT, V36, P821, DOI 10.1007/s10529-013-1418-9; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Tran PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042196; VERWOERT IIGS, 1995, PLANT MOL BIOL, V27, P875, DOI 10.1007/BF00037016; Vieira AR, 2016, ANN ONCOL, V27, P81, DOI 10.1093/annonc/mdv381; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; Vioque A, 2007, ADV EXP MED BIOL, V616, P12; Wang CH, 2007, BIOTECHNOL BIOPROC E, V12, P180, DOI 10.1007/BF03028646                                                              ; Wang QT, 2016, PLANT J, V88, P1071, DOI 10.1111/tpj.13307; Wendt KE, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0514-7; Weselake RJ, 2008, J EXP BOT, V59, P3543, DOI 10.1093/jxb/ern206; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Whitney SM, 2009, PLANT PHYSIOL, V149, P1887, DOI 10.1104/pp.109.135210; Xie WH, 2014, MAR BIOTECHNOL, V16, P538, DOI 10.1007/s10126-014-9570-3; Xue J, 2015, METAB ENG, V27, P1, DOI 10.1016/j.ymben.2014.10.002; Yang B, 2016, BIOTECHNOL J, V11, P1244, DOI 10.1002/biot.201500617; Yang J, 2016, ALGAL RES, V15, P50, DOI 10.1016/j.algal.2016.02.004; Yao L, 2016, ACS SYNTH BIOL, V5, P207, DOI 10.1021/acssynbio.5b00264; Yeesang C, 2011, BIORESOURCE TECHNOL, V102, P3034, DOI 10.1016/j.biortech.2010.10.013; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Yu G, 2011, T ASABE, V54, P239; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	205	1	1	31	31	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	OCT	2017	12	10			SI				1600644	10.1002/biot.201600644				13	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FK2XX	WOS:000413347900001					2018-01-05	
J	Lee, SH; Kim, HP; Kang, JK; Song, SH; Han, SW; Kim, TY				Lee, Si-Hyun; Kim, Hwang-Phill; Kang, Jun-Kyu; Song, Sang-Hyun; Han, Sae-Won; Kim, Tae-You			Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer	CANCER RESEARCH AND TREATMENT			English	Article						RNA editing; Colorectal neoplasms; Transcriptome sequencing; GLI family zinc finger 1; Adenosine deaminase	HEPATOCELLULAR-CARCINOMA; HUMAN TRANSCRIPTOME; SOMATIC MUTATION; DNA; PROLIFERATION; DEAMINASES; DATABASE; COLON	Purpose RNA editing generates protein diversity by altering RNA sequences in coding regions without changing the overall DNA sequence. Adenosine-to-inosine (A-to-I) RNA editing events have recently been reported in some types of cancer, but they are rare in human colorectal cancer (CRC). Therefore, this study was conducted to identify diverse RNA editing in CRC. Materials and Methods We compared transcriptome data of 39 CRC samples and paired adjacent tissues from The Cancer Genome Atlas database to identify RNA editing patterns in CRC, focusing on canonical A-to-I RNA edits in coding sequence regions. We investigated nonsynonymous RNA editing patterns by comparing tumorand normal tissue transcriptome data. Results The number of RNA edits varied from 12 to 42 per sample. We also observed that hypo-and hyper-RNA editing patterns were distinguishable within the samples. We found 10 recurrent nonsynonymous RNA editing candidates in nine genes (PDLIM, NEIL1, SRP9, GLI1, APMAP, IGFBP7, ZNF358, COPA, and ZNF587B) and validated some by Sanger sequencing and the inosine chemical erasing assay. We further showed that editing at these positions was performed by the adenosine deaminase acting on RNA 1 enzyme. Most of these genes are hypoedited in CRC, but editing of GLI1 was increased in cancer tissues compared with normal tissues. Conclusion Our results show that nonsynonymous RNA editing patterns can be used to identify CRC patients and could serve as novel biomarkers for CRC.	[Lee, Si-Hyun; Kim, Hwang-Phill; Kang, Jun-Kyu; Han, Sae-Won; Kim, Tae-You] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Coll Med, Seoul, South Korea; [Kim, Hwang-Phill; Kang, Jun-Kyu; Song, Sang-Hyun; Kim, Tae-You] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea; [Han, Sae-Won; Kim, Tae-You] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Kim, TY (reprint author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.	kimty@snu.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health Welfare [HI14C1277]; Priority Research Centers Program through the NRF - Ministry of Education, Science and Technology, Republic of Korea [2009-0093820]; Doosan Yongkang Foundation [30-2013-015-0]; Ministry of Science, ICT & Future Planning [2016M3A9B6026918]	The authors are grateful to all members of our group for their helpful advice. This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (HI14C1277), by the Priority Research Centers Program through the NRF funded by the Ministry of Education, Science and Technology, Republic of Korea (2009-0093820), by the Doosan Yongkang Foundation (30-2013-015-0), and by the Ministry of Science, ICT & Future Planning (2016M3A9B6026918).	Akiyoshi T, 2006, GUT, V55, P991, DOI 10.1136/gut.2005.080333; Bar EE, 2007, AM J PATHOL, V170, P347, DOI 10.2353/ajpath.2007.060066; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584                                                                ; Kiran A, 2010, BIOINFORMATICS, V26, P1772, DOI 10.1093/bioinformatics/btq285; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Liu L, 2014, TUMOR BIOL, V35, P8875, DOI 10.1007/s13277-014-2160-1; Maas S, 2003, J BIOL CHEM, V278, P1391, DOI 10.1074/jbc.R200025200; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrn2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Oh JH, 1999, INT J CANCER, V81, P902, DOI 10.1002/(SICI)1097-0215(19990611)81:6<902::AID-IJC11>3.0.CO;2-T; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI [10.1038/nchembio.434, 10.1038/.NCHEMBIO.434]; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shimokawa T, 2013, RNA BIOL, V10, P321, DOI 10.4161/rna.23343; Verhagen HJMP, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.268; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yeo JC, 2010, P NATL ACAD SCI USA, V107, P20715, DOI 10.1073/pnas.1009231107	30	0	0	0	0	KOREAN CANCER ASSOCIATION	SEOUL	RM 1824, GWANGHWAMUN OFFICIA, 92 SAEMUNAN-RO, JONGNO-GU, SEOUL, 110-999, SOUTH KOREA	1598-2998	2005-9256		CANCER RES TREAT	Cancer Res. Treat.	OCT	2017	49	4					1077	1087		10.4143/crt.2016.301				11	Oncology	Oncology	FJ8GI	WOS:000413001500022	28161934	green_published			2018-01-05	
J	Nishimura, K; Fukagawa, T				Nishimura, Kohei; Fukagawa, Tatsuo			An efficient method to generate conditional knockout cell lines for essential genes by combination of auxin-inducible degron tag and CRISPR/Cas9	CHROMOSOME RESEARCH			English	Article						Aid; CRISPR/Cas9; Rapid degradation	CENP-H; DEPLETION; SYSTEM	Generation of cells with a loss-of-function mutation in a gene (knockout cells) is a valuable technique for studying the function of a given gene product. However, if the product of the target gene is essential for cell viability, conditional knockout cell lines must be generated. Recently, as gene editing technology using CRISPR/Cas9 has developed, it has become possible to produce conditional knockout cell lines using this technique. However, to obtain final conditional knockout cell lines, it is necessary to perform several experiments with multiple complicated steps. In this paper, we introduce an easy and efficient method to generate conditional knockout cell lines based on combining auxin-inducible degron (AID) technology with CRISPR/Cas9 gene editing. Our method only requires performing a single transfection and is therefore an easy and rapid method to obtain a conditional knockout cell line.	[Nishimura, Kohei; Fukagawa, Tatsuo] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Fukagawa, T (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan.	tfukagawa@fbs.osaka-u.ac.jp			MEXT KAKENHI Grant [25221106, 15H05972, 17K15041]	We are very grateful to R. Fukuoka and Y. Fukagawa for their technical assistance. This work was supported by MEXT KAKENHI Grant Numbers 25221106 and 15H05972 to TF and MEXT KAKENHI Grant Number 17K15041 to KN.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603                                                        ; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McKinley KL, 2017, DEV CELL, V40, P405, DOI 10.1016/j.devcel.2017.01.012; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	10	0	0	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	OCT	2017	25	3-4					253	260		10.1007/s10577-017-9559-7				8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FL3TS	WOS:000414147500005	28589221				2018-01-05	
J	Musunuru, K; Lagor, WR; Miano, JM				Musunuru, Kiran; Lagor, William R.; Miano, Joseph M.			What Do We Really Think About Human Germline Genome Editing, and What Does It Mean for Medicine?	CIRCULATION-CARDIOVASCULAR GENETICS			English	Article						American Heart Association; gene editing; genetics; mosaicism; mutation	PCSK9	Genome editing has captured widespread attention because of its potential therapeutic applications. Early studies with human embryos have established the feasibility of human germline genome editing but raise complex social, ethical, and legal questions. In light of the potential impact of genome editing on the practice of cardiovascular medicine, we surveyed approximate to 300 attendees at a recent American Heart Association conference to elicit their opinions on somatic and germline genome editing. The results were revealing and highlight the need to broadly engage the public and solicit the opinions of various constituencies before proceeding with clinical germline genome editing.	[Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Lagor, William R.] Baylor Coll Med, Dept Mol Physiol & Biophys, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14627 USA	Musunuru, K (reprint author), Univ Penn, 11-104 Smilow Ctr Translat Res,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	kiranmusunuru@gmail.com					Chadwick AC, 2017, ARTERIOSCL THROM VAS, V37, P1741, DOI 10.1161/ATVBAHA.117.309881; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Jarrett KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep44624; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Miano JM, 2016, ARTERIOSCL THROM VAS, V36, P1058, DOI 10.1161/ATVBAHA.116.304790; National Academy of Sciences, 2017, HUM GEN ED SCI ETH G; Ormond KE, 2017, AM J HUM GENET, V101, P167, DOI 10.1016/j.ajhg.2017.06.012; Pew Research Center, 2016, US PUBL WAR BIOM TEC	8	1	1	17	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1942-325X	1942-3268		CIRC-CARDIOVASC GENE	Circ.-Cardiovasc. Genet.	OCT	2017	10	5							UNSP e001910	10.1161/CIRCGENETICS.117.001910				3	Cardiac & Cardiovascular Systems; Genetics & Heredity	Cardiovascular System & Cardiology; Genetics & Heredity	FI6TP	WOS:000412129600001					2018-01-05	
J	Habibi, E; Stunnenberg, HG				Habibi, Ehsan; Stunnenberg, Hendrik G.			Transcriptional and epigenetic control in mouse pluripotency: lessons from in vivo and in vitro studies	CURRENT OPINION IN GENETICS & DEVELOPMENT			English	Review							EMBRYONIC STEM-CELLS; NAIVE PLURIPOTENCY; GROUND-STATE; SELF-RENEWAL; DNA METHYLATION; VITAMIN-C; PREIMPLANTATION EMBRYOS; PRIMED PLURIPOTENCY; BIVALENT PROMOTERS; ES CELLS	Pluripotent cells were first derived from mouse blastocysts several decades ago. Since then, our knowledge of the molecular events that occur in the pre-implantation embryo has been vastly progressing. The emergence of epigenetics has revolutionized stem cell and developmental biology and further deepened our understanding of the underlying molecular mechanisms controlling the early embryo development. In particular, the emergence of massive parallel sequencing technologies has opened new avenues and became indispensable tools in modern biology. Additionally, development of new and exciting techniques for genome manipulation (TALEN and CRISPR/Cas9) and in vivo imaging provide unique opportunities to perturb and trace biological systems at very high resolution. Finally, recent single-cell omics combined with sophisticated computational methodologies allow accurate, quantitative measurements for deconvolution of cellular variation in complex cell populations. Collectively, these achievements enabled the detailed characterization and monitoring of various cell states and trajectories during early stages of embryonic development. Here we review recent studies of the transcriptional and epigenetic changes during very early stages of mouse embryo development and compare these with pluripotent cells grown in vitro under different culture conditions. We discuss whether the in vitro cell states have an 'epiphenocopy' in the embryo and refine our understanding of the circuitries controlling pluripotency and lineage commitment during early stages of mouse development.	[Habibi, Ehsan; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Habibi, E; Stunnenberg, HG (reprint author), Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.	e.habibi@ncmls.ru.nl; h.stunnenberg@ncmls.ru.nl			CEU-ERC Advanced Grant SysStemCell [339431]	E.H. and HGS are supported by CEU-ERC Advanced Grant SysStemCell (No. 339431).	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boroviak T, 2014, NAT CELL BIOL, V16, P513, DOI 10.1038/ncb2965; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0                                                                ; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693                                                               ; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; D'Aniello C, 2017, STEM CELL REP, V8, P1, DOI 10.1016/j.stemcr.2016.11.011; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Denissov S, 2014, DEVELOPMENT, V141, P526, DOI 10.1242/dev.102681; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Fang L, 2016, STEM CELLS, V34, P565, DOI 10.1002/stem.2250; FAUST C, 1995, DEVELOPMENT, V121, P273; Faust C, 1998, DEVELOPMENT, V125, P4495; Fenelon JC, 2014, INT J DEV BIOL, V58, P163, DOI 10.1387/ijdb.140074bm; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Galonska C, 2015, CELL STEM CELL, V17, P462, DOI 10.1016/j.stem.2015.07.005; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hore TA, 2016, P NATL ACAD SCI USA, V113, P12202, DOI 10.1073/pnas.1608679113; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Li ZW, 2012, CELL STEM CELL, V10, P171, DOI 10.1016/j.stem.2011.12.016; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI [10.1038/nbt.1684, 10.1038/nbt1684]; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; Morris SA, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130104; Nakai-Futatsugi Y, 2013, BIOL PHARM BULL, V36, P166, DOI 10.1248/bpb.b12-00958                                                           ; Nichols J, 1996, MECH DEVELOP, V57, P123, DOI 10.1016/0925-4773(96)00531-X                                                    ; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048                                                          ; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Scognamiglio R, 2016, CELL, V164, P668, DOI 10.1016/j.cell.2015.12.033; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sharif J, 2011, PROG MOL BIOL TRANSL, V101, P289, DOI 10.1016/B978-0-12-387685-0.00008-1; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shimizu T, 2012, STEM CELLS, V30, P1394, DOI 10.1002/stem.1119; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadtfeld M, 2012, NAT GENET, V44, p[398, 391]; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; von Meyenn F, 2016, MOL CELL, V62, P983, DOI 10.1016/j.molcel.2016.06.005; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zheng H, 2016, MOL CELL, V63, P1066, DOI 10.1016/j.molcel.2016.08.032	78	0	0	5	5	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-437X	1879-0380		CURR OPIN GENET DEV	Curr. Opin. Genet. Dev.	OCT	2017	46						114	122		10.1016/j.gde.2017.07.005				9	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	FI4PR	WOS:000411955300015	28763675	gold			2018-01-05	
J	Calatayud, C; Carola, G; Consiglio, A; Raya, A				Calatayud, Carles; Carola, Giulia; Consiglio, Antonella; Raya, Angel			Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells	CURRENT OPINION IN GENETICS & DEVELOPMENT			English	Review							PLURIPOTENT STEM-CELLS; WIDE ASSOCIATION DATA; ALPHA-SYNUCLEIN; NEURAL DIFFERENTIATION; DOPAMINE NEURONS; RISK; EXPRESSION; ENHANCER; REVEALS; LOCUS	Patient-specific iPSC are being intensively exploited as experimental disease models. Even for late-onset diseases of complex genetic influence, such as Parkinson's disease (PD), the use of iPSC-based models is beginning to provide important insights into the genetic bases of PD heritability. Here, we present an update on recently reported genetic risk factors associated with PD. We discuss how iPSC technology, combined with targeted edition of the coding or noncoding genome, can be used to address clinical observations such as incomplete penetrance, and variability in phenoconversion or age-at-onset in familial PD. Finally, we also discuss the relevance of advanced iPSC/CRISPR/Cas9 disease models to ascertain causality in genotype-to-phenotype correlation studies of sporadic PD.	[Calatayud, Carles; Raya, Angel] Hosp Duran & Reynals, CMRB, 3rd Floor,Ave Gran Via 199-203, Lhospitalet De Llobregat 08908, Barcelona, Spain; [Calatayud, Carles; Carola, Giulia; Consiglio, Antonella] UB, Inst Biomed IBUB, Barcelona 08028, Spain; [Calatayud, Carles; Carola, Giulia; Consiglio, Antonella] UB, Dept Pathol & Expt Therapeut, Sch Med, Barcelona 08908, Spain; [Consiglio, Antonella] Univ Brescia, Dept Mol & Translat Med, I-25123 Brescia, Italy; [Consiglio, Antonella] Natl Inst Neurosci, I-25123 Brescia, Italy; [Raya, Angel] Ctr Networked Biomed Res Bioengn Biomat & Nanomed, Madrid 28029, Spain; [Raya, Angel] ICREA, Barcelona 08010, Spain	Raya, A (reprint author), Hosp Duran & Reynals, CMRB, 3rd Floor,Ave Gran Via 199-203, Lhospitalet De Llobregat 08908, Barcelona, Spain.; Consiglio, A (reprint author), UB, Inst Biomed IBUB, Barcelona 08028, Spain.; Consiglio, A (reprint author), UB, Dept Pathol & Expt Therapeut, Sch Med, Barcelona 08908, Spain.; Consiglio, A (reprint author), Univ Brescia, Dept Mol & Translat Med, I-25123 Brescia, Italy.; Consiglio, A (reprint author), Natl Inst Neurosci, I-25123 Brescia, Italy.; Raya, A (reprint author), Ctr Networked Biomed Res Bioengn Biomat & Nanomed, Madrid 28029, Spain.; Raya, A (reprint author), ICREA, Barcelona 08010, Spain.	aconsiglio@ibub.pcb.ub.es; araya@cmrb.eu	consiglio, antonella/G-1815-2016	consiglio, antonella/0000-0002-3988-6254; Raya, Angel/0000-0003-2189-9775	European Research Council-ERC [2012-StG-311736-PD-HUMMODEL]; Spanish Ministry of Economy and Competitiveness-MINECO [SAF2015-69706-R, BFU2013-49157-P]; Instituto de Salud Carlos III-ISCIII/FEDER (Red de Terapia Celular) [TerCel RD16/0011/0024]; AGAUR [2014-SGR-1460]; CERCA Programme/Generalitat de Catalunya; Spanish Ministry of Education-MEC [FPU12/03332]; Economy and Competitiveness-MINECO [BES-2014-069603]	The authors are indebted to all the members of our laboratories for fruitful discussions, and to David Maynar for excellent artwork. Research from the authors' laboratories is supported by the European Research Council-ERC (2012-StG-311736-PD-HUMMODEL), the Spanish Ministry of Economy and Competitiveness-MINECO (SAF2015-69706-R and BFU2013-49157-P), Instituto de Salud Carlos III-ISCIII/FEDER (Red de Terapia Celular - TerCel RD16/0011/0024), AGAUR (2014-SGR-1460), and CERCA Programme/Generalitat de Catalunya. C.C. and G.C. are partially supported by pre-doctoral fellowships from the Spanish Ministry of Education-MEC (FPU12/03332) and Economy and Competitiveness-MINECO (BES-2014-069603), respectively.	Ambroziak W, 2015, J APPL GENET, V56, P451, DOI 10.1007/s13353-015-0282-9; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Bras J, 2015, CELL, V160, P570, DOI 10.1016/j.cell.2015.01.019; Carcamo-Orive I, 2017, CELL STEM CELL, V20, P518, DOI 10.1016/j.stem.2016.11.005; Chai C, 2013, CURR GENOMICS, V14, P486, DOI 10.2174/1389202914666131210195808; Chang KH, 2016, PARKINSONISM RELAT D, V24, P81, DOI 10.1016/j.parkreldis.2016.01.001; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Coetzee SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep30509; DeBoever C, 2017, CELL STEM CELL, V20, P533, DOI 10.1016/j.stem.2017.03.009; Deng HX, 2016, NAT GENET, V48, P733, DOI 10.1038/ng.3589; Farlow JL, 2016, JAMA NEUROL, V73, P68, DOI 10.1001/jamaneurol.2015.3266; Fernandez-Santiago R, 2015, EMBO MOL MED, V7, P1529, DOI 10.15252/emmm.201505439; Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2; Gan-Or Z, 2012, ARCH NEUROL-CHICAGO, V69, P105, DOI 10.1001/archneurol.2011.924; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Ivatt RM, 2014, P NATL ACAD SCI USA, V111, P8494, DOI 10.1073/pnas.1321207111; Jansen IE, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1147-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Kumar KR, 2011, SEMIN NEUROL, V31, P433, DOI 10.1055/s-0031-1299782; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee CT, 2015, CELL REP, V10, P616, DOI 10.1016/j.celrep.2014.12.050; Lee G, 2010, NAT METHODS, V7, P25, DOI [10.1038/NMETH.F.283, 10.1038/nmeth.f.283]; Li M, 2016, NAT MED, V22, P649, DOI 10.1038/nm.4096; Lin L, 2016, CELL REP, V15, P2411, DOI 10.1016/j.celrep.2016.05.022; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Marchetto M.C., 2016, MOL PSYCHIAT; Marder K, 2015, NEUROLOGY, V85, P89, DOI 10.1212/WNL.0000000000001708; Mazzulli JR, 2016, J NEUROSCI, V36, P7693, DOI 10.1523/JNEUROSCI.0628-16.2016; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mok KY, 2016, LANCET NEUROL, V15, P585, DOI 10.1016/S1474-4422(16)00071-5; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nenasheva VV, 2016, MOL NEUROBIOL; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pihlstrom L, 2015, MOVEMENT DISORD, V30, P577, DOI 10.1002/mds.26073; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spataro N, 2015, HUM MOL GENET, V24, P2023, DOI 10.1093/hmg/ddu616; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Torrent R, 2015, J CLIN MED, V4, P548, DOI 10.3390/jcm4040548; Trinh J, 2016, LANCET NEUROL, V15, P1246, DOI 10.1016/S1474-4422(16)30203-4; Vermunt MW, 2014, CELL REP, V9, P767, DOI 10.1016/j.celrep.2014.09.023; Woodard CM, 2014, CELL REP, V9, P1173, DOI 10.1016/j.celrep.2014.10.023; Yamada-Fowler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099294; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Young JE, 2015, CELL STEM CELL, V16, P373, DOI 10.1016/j.stem.2015.02.004; Zeltner N, 2015, CURR OPIN CELL BIOL, V37, P102, DOI 10.1016/j.ceb.2015.10.008	59	0	0	20	20	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-437X	1879-0380		CURR OPIN GENET DEV	Curr. Opin. Genet. Dev.	OCT	2017	46						123	131		10.1016/j.gde.2017.06.002				9	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	FI4PR	WOS:000411955300016	28759872				2018-01-05	
J	Bluhm, B; Ehlen, HWA; Holzer, T; Georgieva, VS; Heilig, J; Pitzler, L; Etich, J; Bortecen, T; Frie, C; Probst, K; Niehoff, A; Belluoccio, D; Van den Bergen, J; Brachvogel, B				Bluhm, Bjorn; Ehlen, Harald W. A.; Holzer, Tatjana; Georgieva, Veronika S.; Heilig, Juliane; Pitzler, Lena; Etich, Julia; Bortecen, Toman; Frie, Christian; Probst, Kristina; Niehoff, Anja; Belluoccio, Daniele; Van den Bergen, Jocelyn; Brachvogel, Bent			miR-322 stabilizes MEK1 expression to inhibit RAF/MEK/ERK pathway activation in cartilage	DEVELOPMENT			English	Article						MEK; Cartilage; MAPK; miR-322; CRISPR; Stabilization	CHONDROCYTE PROLIFERATION; CELLS; DIFFERENTIATION; MOUSE; MINERALIZATION; HOMEOSTASIS; ABLATION; COLLAGEN; MICE	Cartilage originates from mesenchymal cell condensations that differentiate into chondrocytes of transient growth plate cartilage or permanent cartilage of the articular joint surface and trachea. MicroRNAs fine-tune the activation of entire signaling networks and thereby modulate complex cellular responses, but so far only limited data are available on miRNAs that regulate cartilage development. Here, we characterize a miRNA that promotes the biosynthesis of a key component in the RAF/MEK/ERK pathway in cartilage. Specifically, by transcriptome profiling we identified miR-322 to be upregulated during chondrocyte differentiation. Among the various miR-322 target genes in the RAF/MEK/ERK pathway, only Mek1 was identified as a regulated target in chondrocytes. Surprisingly, an increased concentration of miR-322 stabilizes Mek1 mRNA to raise protein levels and dampen ERK1/2 phosphorylation, while cartilage-specific inactivation of miR322 in mice linked the loss of miR-322 to decreased MEK1 levels and to increased RAF/MEK/ERK pathway activation. Such mice died perinatally due to tracheal growth restriction and respiratory failure. Hence, a single miRNA can stimulate the production of an inhibitory component of a central signaling pathway to impair cartilage development.	[Bluhm, Bjorn; Ehlen, Harald W. A.; Holzer, Tatjana; Georgieva, Veronika S.; Pitzler, Lena; Etich, Julia; Bortecen, Toman; Frie, Christian; Probst, Kristina; Brachvogel, Bent] Univ Cologne, Med Fac, Dept Pediat & Adolescent Med, Expt Neonatol, D-50931 Cologne, Germany; [Bluhm, Bjorn; Ehlen, Harald W. A.; Holzer, Tatjana; Georgieva, Veronika S.; Pitzler, Lena; Etich, Julia; Bortecen, Toman; Frie, Christian; Probst, Kristina; Brachvogel, Bent] Univ Cologne, Med Fac, Ctr Biochem, D-50931 Cologne, Germany; [Heilig, Juliane; Niehoff, Anja] German Sport Univ Cologne, Inst Biomech & Orthopaed, D-50931 Cologne, Germany; [Heilig, Juliane; Niehoff, Anja; Brachvogel, Bent] Univ Cologne, CCMB, D-50931 Cologne, Germany; [Belluoccio, Daniele; Van den Bergen, Jocelyn] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Belluoccio, Daniele] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Van den Bergen, Jocelyn] Univ Melbourne, Dept Pediat, Parkville, Vic 3052, Australia	Brachvogel, B (reprint author), Univ Cologne, Med Fac, Dept Pediat & Adolescent Med, Expt Neonatol, D-50931 Cologne, Germany.; Brachvogel, B (reprint author), Univ Cologne, Med Fac, Ctr Biochem, D-50931 Cologne, Germany.; Brachvogel, B (reprint author), Univ Cologne, CCMB, D-50931 Cologne, Germany.	bent.brachvogel@uni-koeln.de	Niehoff, Anja/K-6626-2015		Deutsche Forschungsgemeinschaft (DFG) [BR2304/5-3, BR2304/7-1, BR2304/9-1]; Koln Fortune - Universitat zu Koln [136/2013, 120/2014]	This work was supported by the Deutsche Forschungsgemeinschaft (DFG BR2304/5-3, BR2304/7-1, BR2304/9-1) and by Koln Fortune - Universitat zu Koln (136/2013, 120/2014)	ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Belluoccio D, 2010, J BONE MINER RES, V25, P1267, DOI 10.1002/jbmr.30; Belluoccio D, 2010, J BONE MINER RES, V25, P141, DOI 10.1359/jbmr.090710; Blumbach K, 2008, MATRIX BIOL, V27, P306, DOI 10.1016/j.matbio.2007.11.007; Bock KR, 2000, CHEST, V118, P468, DOI 10.1378/chest.118.2.468; Boucherat O, 2014, DEVELOPMENT, V141, P3197, DOI 10.1242/dev.110254; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Chen Z., 2015, COMPUTATIONAL INTELL, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0142809; Cole-Jeffrey CT, 2012, ANAT REC, V295, P764, DOI 10.1002/ar.22432; Decker RS, 2017, DEV BIOL, V426, P56, DOI 10.1016/j.ydbio.2017.04.006; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Etich J, 2015, MATRIX BIOL, V43, P27, DOI 10.1016/j.matbio.2015.02.014; Ford-Hutchinson AF, 2007, J BONE MINER RES, V22, P1245, DOI 10.1359/JBMR.070420; Gabler J, 2015, TISSUE ENG PT A, V21, P2840, DOI [10.1089/ten.tea.2015.0352, 10.1089/ten.TEA.2015.0352]; Girkontaite I, 1996, MATRIX BIOL, V15, P231, DOI 10.1016/S0945-053X(96)90114-6; Gradus B, 2011, DEV BIOL, V360, P58, DOI 10.1016/j.ydbio.2011.09.002; Heilig J, 2016, BONE, V83, P48, DOI 10.1016/j.bone.2015.10.007; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Hillman Noah H, 2012, Clin Perinatol, V39, P769, DOI 10.1016/j.clp.2012.09.009; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Lai EC, 2015, RNA, V21, P675, DOI 10.1261/rna.051193.115; Llobet-Navas D, 2014, GENE DEV, V28, P765, DOI 10.1101/gad.237404.114; Marchand A, 2016, BBA-MOL BASIS DIS, V1862, P611, DOI 10.1016/j.bbadis.2016.01.010; Matsushita T, 2012, PROTEIN KINASES; Nakashima T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014334; Orang AV, 2014, INT J GENOMICS, DOI 10.1155/2014/970607; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.3.CO;2-3; Park CY, 2012, CELL REPORTS, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitzler L, 2016, STEM CELLS, V34, P1297, DOI 10.1002/stem.2308; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Romeis B, 1989, MIKROSKOPISCHE TECHN; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sher ZA, 2016, AIMS GENET, V3, P60, DOI 10.3934/genet.2016.1.60; Stauber Martin, 2008, V455, P273, DOI 10.1007/978-1-59745-104-8_19; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wang YM, 2011, J BONE MINER RES, V26, P1437, DOI 10.1002/jbmr.359; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081	40	0	0	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	OCT 1	2017	144	19					3562	3577		10.1242/dev.148429				16	Developmental Biology	Developmental Biology	FI6QG	WOS:000412120700016	28851708				2018-01-05	
J	Mellott, DO; Thisdelle, J; Burke, RD				Mellott, Dan O.; Thisdelle, Jordan; Burke, Robert D.			Notch signaling patterns neurogenic ectoderm and regulates the asymmetric division of neural progenitors in sea urchin embryos	DEVELOPMENT			English	Article						Neural progenitor; Asymmetric mitosis; Apoptosis; SoxC; Delta; Notch reporter; Neural evolution; Strongylocentrotus purpuratus	CENTRAL-NERVOUS-SYSTEM; CELL FATE; DROSOPHILA-MELANOGASTER; SPECIFICATION; GENE; EVOLUTION; NEURONS; GENOME; DIFFERENTIATION; MECHANISMS	We have examined regulation of neurogenesis by Delta/Notch signaling in sea urchin embryos. At gastrulation, neural progenitors enter S phase coincident with expression of Sp-SoxC. We used a BAC containing GFP knocked into the Sp-SoxC locus to label neural progenitors. Live imaging and immunolocalizations indicate that Sp-SoxC-expressing cells divide to produce pairs of adjacent cells expressing GFP. Over an interval of about 6 h, one cell fragments, undergoes apoptosis and expresses high levels of activated Caspase3. A Notch reporter indicates that Notch signaling is activated in cells adjacent to cells expressing Sp-SoxC. Inhibition of gamma-secretase, injection of Sp-Delta morpholinos or CRISPR/Cas9-induced mutation of Sp-Delta results in supernumerary neural progenitors and neurons. Interfering with Notch signaling increases neural progenitor recruitment and pairs of neural progenitors. Thus, Notch signaling restricts the number of neural progenitors recruited and regulates the fate of progeny of the asymmetric division. We propose a model in which localized signaling converts ectodermal and ciliary band cells to neural progenitors that divide asymmetrically to produce a neural precursor and an apoptotic cell.	[Mellott, Dan O.; Thisdelle, Jordan; Burke, Robert D.] Univ Victoria, Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada	Burke, RD (reprint author), Univ Victoria, Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada.	rburke@uvic.ca		Burke, Robert/0000-0001-5527-4410	Natural Sciences and Engineering Research Council of Canada [2016-03737]	This work was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (2016-03737) to R.D.B.	Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Beer AJ, 2001, BIOL BULL, V200, P268, DOI 10.2307/1543509; Bhat KM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005317; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Burke RD, 2014, GENESIS, V52, P208, DOI 10.1002/dvg.22750; Byrne M, 2007, EVOL DEV, V9, P432, DOI 10.1111/j.1525-142X.2007.00189.x                                                ; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Croce JC, 2010, DEVELOPMENT, V137, P83, DOI 10.1242/dev.044149; Cunningham D, 2014, DEV BIOL, V386, P252, DOI 10.1016/j.ydbio.2013.12.001; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Erwin DH, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0036; Foltz K. R., 2004, METHOD CELL BIOL, V74, P40; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823                                          ; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Garner S, 2016, DEVELOPMENT, V143, P286, DOI 10.1242/dev.124503; Hansson EM, 2006, DEV NEUROSCI-BASEL, V28, P118, DOI 10.1159/000090758; Hartenstein V, 2015, DEV CELL, V32, P390, DOI 10.1016/j.devcel.2015.02.004; Hudson C, 2016, WIRES DEV BIOL, V5, P538, DOI 10.1002/wdev.239; JAN YN, 1995, NEURON, V14, P1; Jarvela AMC, 2016, DEVELOPMENT, V143, P4214, DOI 10.1242/dev.134999; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Krupke O, 2014, METHODS MOL BIOL, V1128, P147, DOI 10.1007/978-1-62703-974-1_9; Lapraz F, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000248; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Liebeskind BJ, 2016, TRENDS ECOL EVOL, V31, P127, DOI 10.1016/j.tree.2015.12.005; Lin CY, 2016, DEV BIOL, V409, P420, DOI 10.1016/j.ydbio.2015.11.018; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Materna SC, 2012, DEV BIOL, V364, P77, DOI 10.1016/j.ydbio.2012.01.017; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Nakajima Y, 2004, EVOL DEV, V6, P95, DOI 10.1111/j.1525-142X.2004.04011.x                                                ; Peterson KJ, 2016, ORG DIVERS EVOL, V16, P401, DOI 10.1007/s13127-016-0270-x; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Range RC, 2016, DEVELOPMENT, V143, P1523, DOI 10.1242/dev.128165; Ransick A, 2006, DEV BIOL, V297, P587, DOI 10.1016/j.ydbio.2006.05.037; Rentzsch F, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.257; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Rottinger E, 2006, DEVELOPMENT, V133, P4341, DOI 10.1242/dev.02603; Ryan K, 2016, ELIFE, V5, DOI 10.7554/eLife.16962; Saudemont A, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1001259, DOI 10.1371/J0URNAL.PGEN.1001259]; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Sherwood DR, 1999, DEVELOPMENT, V126, P1703; Sweet HC, 2002, DEVELOPMENT, V129, P1945; Takacs CM, 2004, DEV BIOL, V269, P152, DOI 10.1016/j.ydbio.2004.01.023; Torii KU, 2012, TRENDS CELL BIOL, V22, P438, DOI 10.1016/j.tcb.2012.06.002; Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749; VIELKIND U, 1989, HISTOCHEMISTRY, V91, P81, DOI 10.1007/BF00501916; Wei Z, 2016, DEVELOPMENT, V143, P298, DOI 10.1242/dev.125989; Wei Z, 2012, DEVELOPMENT, V139, P1662, DOI 10.1242/dev.075051; Wei Z, 2011, P NATL ACAD SCI USA, V108, P9143, DOI 10.1073/pnas.1018513108; Wei Z, 2009, DEVELOPMENT, V136, P1179, DOI 10.1242/dev.032300; Yaguchi J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006001; Yaguchi J, 2012, DEV BIOL, V363, P74, DOI 10.1016/j.ydbio.2011.12.024; Yaguchi S, 2006, DEVELOPMENT, V133, P2337, DOI 10.1242/dev.02396; Yaguchi S, 2007, DEV BIOL, V302, P494, DOI 10.1016/j.ydbio.2006.10.010; Yaguchi S, 2011, DEVELOPMENT, V138, P4233, DOI 10.1242/dev.069856; Yaguchi S, 2010, DEV BIOL, V347, P71, DOI 10.1016/j.ydbio.2010.08.009; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	62	0	0	7	7	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	OCT 1	2017	144	19					3602	3611		10.1242/dev.151720				10	Developmental Biology	Developmental Biology	FI6QG	WOS:000412120700019	28851710				2018-01-05	
J	Mao, CX; Wen, X; Jin, S; Zhang, YQ				Mao, Chuan-Xi; Wen, Xue; Jin, Shan; Zhang, Yong Q.			Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in Drosophila	DISEASE MODELS & MECHANISMS			English	Article						Acetylation; Drosophila; Microtubule; Tauopathy	ALPHA-TUBULIN GENE; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; HDAC6 INHIBITOR; NEURONS; DEACETYLASE; EXPRESSION; MIGRATION; PROTEINS; KATANIN	Tau normally associates with and stabilizes microtubules (MTs), but is hyperphosphorylated and aggregated into neurofibrillary tangles in Alzheimer's disease and related neurodegenerative diseases, which are collectively known as tauopathies. MTs are regulated by different forms of post-translational modification, including acetylation; acetylated MTs represent a more stable microtubule population. In our previous study, we showed that inhibition of histone deacetylase 6 (HDAC6), which deacetylates tubulin at lysine 40, rescues defects in MTs and in neuromuscular junction growth caused by tau overexpression. However, HDAC6 also acts on other proteins that are involved in distinct biological processes unrelated to tubulins. In order to examine directly the role of increased tubulin acetylation against tau toxicity, we generated a site-directed alpha-tubulin(K40Q) mutation by CRISPR/Cas9 technology to mimic the acetylated MTs and found that acetylation-mimicking a-tubulin rescued tau-induced MT defects and neuromuscular junction developmental abnormalities. We also showed that late administration of ACY-1215 and tubastatin A, two potent and selective inhibitors of HDAC6, rescued the tau-induced MT defects after the abnormalities had already become apparent. Overall, our results indicate that increasing MT acetylation by either genetic manipulations or drugs might be used as potential strategies for intervention in tauopathies.	[Mao, Chuan-Xi; Zhang, Yong Q.] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Wen, Xue; Jin, Shan] Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China; [Wen, Xue; Jin, Shan] Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan 430062, Hubei, Peoples R China; [Zhang, Yong Q.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Zhang, YQ (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China.; Jin, S (reprint author), Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China.; Jin, S (reprint author), Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan 430062, Hubei, Peoples R China.; Zhang, YQ (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	jinshan@hubu.edu.cn; yqzhang@genetics.ac.cn		Zhang, Yong/0000-0003-0581-4882	National Natural Science Foundation of China [81070909, 31230045, 31110103907, 31490590, 31500839]; Ministry of Science and Technology of the People's Republic of China [2014CB942803, 2016YFA0501000]; Chinese Academy of Sciences [XDB02020400]	This work was supported by the National Natural Science Foundation of China [81070909 and 31230045 to S.J.; 31110103907 and 31490590 to Y.Q.Z.; 31500839 to C.M.], the Ministry of Science and Technology of the People's Republic of China [2014CB942803 and 2016YFA0501000], and the Chinese Academy of Sciences [XDB02020400].	Aguilar A, 2014, MOL BIOL CELL, V25, P1854, DOI 10.1091/mbc.E13-10-0609; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chee FC, 2005, NEUROBIOL DIS, V20, P918, DOI 10.1016/j.nbd.2005.05.029; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Chu CW, 2011, MOL BIOL CELL, V22, P448, DOI 10.1091/mbc.E10-03-0203; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Cook C, 2012, HUM MOL GENET, V21, P2936, DOI 10.1093/hmg/dds125; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Du GP, 2010, MOL BIOL CELL, V21, P2128, DOI 10.1091/mbc.E10-03-0200; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; HALL JL, 1985, NUCLEIC ACIDS RES, V13, P207, DOI 10.1093/nar/13.1.207; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003                                                ; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jin S, 2009, DEVELOPMENT, V136, P1571, DOI 10.1242/dev.029983; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Li L, 2012, J NEUROSCI, V32, P12673, DOI 10.1523/JNEUROSCI.0016-12.2012; Liu NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16869; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Mao CX, 2014, DEVELOPMENT, V141, P1064, DOI 10.1242/dev.097774; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; MATTHEWS KA, 1989, DEV BIOL, V132, P45, DOI 10.1016/0012-1606(89)90203-0; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Chen J., 2014, PLOS ONE, V9; THEURKAUF WE, 1986, P NATL ACAD SCI USA, V83, P8477, DOI 10.1073/pnas.83.22.8477; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Walter WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042218; Xiong Y, 2013, P NATL ACAD SCI USA, V110, P4604, DOI 10.1073/pnas.1207586110; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhang L, 2014, J ALZHEIMERS DIS, V41, P1193, DOI 10.3233/JAD-140066	57	1	1	7	7	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	OCT 1	2017	10	10					1245	1252		10.1242/dmm.028316				8	Cell Biology; Pathology	Cell Biology; Pathology	FJ1VY	WOS:000412509700007	28819043	gold			2018-01-05	
J	Fujita, T; Kitaura, F; Yuno, M; Suzuki, Y; Sugano, S; Fujii, H				Fujita, Toshitsugu; Kitaura, Fusako; Yuno, Miyuki; Suzuki, Yutaka; Sugano, Sumio; Fujii, Hodaka			Locus-specific ChIP combined with NGS analysis reveals genomic regulatory regions that physically interact with the Pax5 promoter in a chicken B cell line	DNA RESEARCH			English	Article						chromosomal interaction; ChIP; iChIP; in vitro enChIP; Pax5	CHROMOSOME CONFORMATION CAPTURE; CHROMATIN IMMUNOPRECIPITATION; HISTONE MODIFICATIONS; BINDING-SPECIFICITY; EFFICIENT ISOLATION; GENE-EXPRESSION; PROTEINS; CRISPR; IDENTIFICATION; ORGANIZATION	Chromosomal interactions regulate genome functions, such as transcription, via dynamic chromosomal organization in the nucleus. In this study, we attempted to identify genomic regions that physically bind to the promoter region of the Pax5 gene, which encodes a master regulator for B cell lineage commitment, in a chicken B cell line, DT40, with the goal of obtaining mechanistic insight into transcriptional regulation through chromosomal interaction. We found that the Pax5 promoter bound to multiple genomic regions using locus-specific chromatin immunoprecipitation (locus-specific ChIP), a method for locus-specific isolation of target genomic regions, in combination with next-generation sequencing (NGS). Comparing chromosomal interactions in wild-type DT40 with those in a macrophage-like counterpart, we found that some of the identified chromosomal interactions were organized in a B cell-specific manner. In addition, deletion of a B cell-specific interacting genomic region in chromosome 11, which was marked by active enhancer histone modifications, resulted in moderate but significant down-regulation of Pax5 transcription. Together, these results suggested that Pax5 transcription in DT40 is regulated by B cell-specific inter-chromosomal interactions. Moreover, these analyses showed that locus-specific ChIP combined with NGS analysis is useful for non-biased identification of functional genomic regions that physically interact with a locus of interest.	[Fujita, Toshitsugu; Fujii, Hodaka] Hirosaki Univ, Grad Sch Med, Dept Biochem & Genome Biol, Hirosaki, Aomori 0368562, Japan; [Fujita, Toshitsugu; Kitaura, Fusako; Yuno, Miyuki; Fujii, Hodaka] Osaka Univ, Res Inst Microbial Dis, Combined Program Microbiol & Immunol, Chromatin Biochem Res Grp, Suita, Osaka 5650871, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan	Fujii, H (reprint author), Hirosaki Univ, Grad Sch Med, Dept Biochem & Genome Biol, Hirosaki, Aomori 0368562, Japan.; Fujii, H (reprint author), Osaka Univ, Res Inst Microbial Dis, Combined Program Microbiol & Immunol, Chromatin Biochem Res Grp, Suita, Osaka 5650871, Japan.	hodaka@biken.osaka-u.ac.jp	Fujii, Hodaka/A-2420-2008	Fujii, Hodaka/0000-0003-1296-4256	Takeda Science Foundation; Inamori Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [25830131, 15K06895, 15H04329, 23118516, 25118512, 15H01354, 221S0002, 16H06279]	This work was supported by the Takeda Science Foundation (T.F.), Inamori Foundation (T.F.), Grant-in-Aid for Young Scientists (B) (#25830131) (T.F.), Grant-in-Aid for Scientific Research (C) (#15K06895) (T.F.), and Grant-in-Aid for Scientific Research (B) (#15H04329) (T.F., H.F.), Grant-in-Aid for Scientific Research on Innovative Areas 'Cell Fate' (#23118516) (T.F.), 'Transcription Cycle' (#25118512 and #15H01354) (H.F.), 'Genome Science' (#221S0002) (T.F., H.F.) (16H06279) (T.F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Agelopoulos M, 2012, CELL REP, V1, P350, DOI 10.1016/j.celrep.2012.03.003; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Byrum SD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt822; Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chang H, 2004, CHROMOSOME RES, V12, P299, DOI 10.1023/B:CHRO.0000021947.17128.96                                              ; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Fujii H, 2015, INT J MOL SCI, V16, P21802, DOI 10.3390/ijms160921802; Fujita T., 2013, ISRN BIOCH, V2013; Fujita T, 2012, ADV BIOSCI BIOTECHNO, V3, P626, DOI DOI 10.4236/ABB.2012.35081; Fujita T, 2017, GENES CELLS, V22, P506, DOI 10.1111/gtc.12492; Fujita T, 2016, GENES CELLS, V21, P370, DOI 10.1111/gtc.12341; Fujita T, 2016, GENE REGUL SYST BIO, V10, P1, DOI 10.4137/GRSB.S32520; Fujita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123387; Fujita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116579; Fujita T, 2014, BMC MOL BIOL, V15, DOI 10.1186/s12867-014-0026-0; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fujita T, 2012, MOL BIOL REP, V39, P9613, DOI 10.1007/s11033-012-1825-3; Fujita T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026109; Fujita T, 2011, GENE, V477, P24, DOI 10.1016/j.gene.2011.01.008; Fullwood MJ, 2009, J CELL BIOCHEM, V107, P30, DOI 10.1002/jcb.22116; Gao F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-345; Gavrilov AA, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1322; Gavrilov AA, 2013, NUCLEIC ACIDS RES, V41, P3563, DOI 10.1093/nar/gkt067; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McCullagh E, 2010, NAT CELL BIOL, V12, P954, DOI 10.1038/ncb2097; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Pourfarzad F, 2013, CELL REP, V4, P589, DOI 10.1016/j.celrep.2013.07.004; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472                                                         ; Seki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095374; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598                                                          ; TRASK BJ, 1991, TRENDS GENET, V7, P149, DOI 10.1016/0168-9525(91)90378-4; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; WALKER GC, 1984, MICROBIOL REV, V48, P60; Williamson I, 2014, GENE DEV, V28, P2778, DOI 10.1101/gad.251694.114; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Zhang YQ, 2017, ONCOTARGET, V8, P34177, DOI 10.18632/oncotarget.10918	60	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	OCT	2017	24	5					537	548		10.1093/dnares/dsx023				12	Genetics & Heredity	Genetics & Heredity	FJ8LG	WOS:000413018400008	28586432	gold			2018-01-05	
J	Tamura, I; Shirafuta, Y; Jozaki, K; Kajimura, T; Shinagawa, M; Maekawa, R; Taketani, T; Asada, H; Sato, S; Tamura, H; Sugino, N				Tamura, Isao; Shirafuta, Yuichiro; Jozaki, Kousuke; Kajimura, Takuya; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Asada, Hiromi; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro			Novel Function of a Transcription Factor WT1 in Regulating Decidualization in Human Endometrial Stromal Cells and Its Molecular Mechanism	ENDOCRINOLOGY			English	Article							HISTONE ACETYLATION STATUS; MANGANESE SUPEROXIDE-DISMUTASE; BINDING PROTEIN-1 PROMOTER; HUMAN GENOME; C/EBP-BETA; PROGESTERONE-RECEPTOR; DNA METHYLATION; GRANULOSA-CELLS; CYCLIC-AMP; GENE WT1	The Wilms tumor suppressor gene (WT1) encodes an essential transcription factor regulating mammalian urogenital development. However, the function of WT1 in human endometrium is still unclear. The current study examined the involvement of WT1 in the regulation of IGF-binding protein-1 (IGFBP-1) and prolactin (PRL), which are specific markers of decidualization, in human endometrial stromal cells (ESCs) undergoing decidualization. ESCs isolated from proliferative-phase endometrium were incubated with cyclic adenosine monophosphate (cAMP) to induce decidualization. cAMP increased WT1 expression with the induction of IGFBP-1 and PRL. Knockdown of WT1 by small interfering RNA inhibited cAMP-induced expression of IGFBP-1 and PRL. cAMP also induced the recruitment of WT1 to the IGFBP-1 and PRL promoters. To investigate the mechanism by which WT1 is upregulated by cAMP, we focused on C/EBP beta, a gene that regulates the expression of many genes during decidualization. Knockdown of C/EBP beta decreased cAMP-increased WT1 expression. cAMP increased the recruitment of C/EBP beta to the WT1 enhancer that is located approximately 14,000 bp downstream from the transcription start site. To test the endogenous function of the WT1 enhancer region onWT1expression, the endogenousWT1 enhancer region was deleted by CRISPR/Cas9 system in HEK293 cells. The increase of WT1 expression by cAMP was not observed in the enhancer-deleted clones. Chromatin immunoprecipitation assay revealed that this enhancer region has high levels of H3K27ac and H3K4me1, which are active enhancer marks. These results show the role of WT1 in regulating decidualization in human ESCs. C/EBP beta is an upstreamgene that regulatesWT1expression by binding to the novel enhancer region.	[Tamura, Isao; Shirafuta, Yuichiro; Jozaki, Kousuke; Kajimura, Takuya; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Asada, Hiromi; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan	Sugino, N (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	sugino@yamaguchi-u.ac.jp			JSPS KAKENHI [15K10720, 15K20145, 15K20146, 16K11091, 16K11142, 16K20191, 16K20194]	This work was supported in part by JSPS KAKENHI Grants 15K10720, 15K20145, 15K20146, 16K11091, 16K11142, 16K20191, and 16K20194.	Anthony FW, 2003, J SOC GYNECOL INVEST, V10, P509, DOI 10.1016/S1071-5576(03)00147-3; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; Gao JG, 1999, MOL CELL ENDOCRINOL, V153, P11, DOI 10.1016/S0303-7207(99)00096-9                                                   ; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Laird S, 2006, REPROD BIOMED ONLINE, V13, P13, DOI 10.1016/S1472-6483(10)62011-1                                                   ; Lee Hong Jun, 2014, Ann Pediatr Endocrinol Metab, V19, P100, DOI 10.6065/apem.2014.19.2.100; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Li ZW, 2016, CELL STEM CELL, V19, P516, DOI 10.1016/j.stem.2016.07.016; Liang XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22744; Love JD, 2006, J PEDIATR SURG, V41, DOI 10.1016/j.jpedsurg.2006.07.012; Lynch VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006845; Maekawa R, 2016, MOL ENDOCRINOL, V30, P335, DOI 10.1210/me.2015-1058; Makrigiannakis A, 2001, J CLIN ENDOCR METAB, V86, P5964, DOI 10.1210/jc.86.12.5964; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Matsuzaki S, 2006, FERTIL STERIL, V86, P554, DOI 10.1016/j.fertnstert.2006.02.101; Motamedi FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5444; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Okada M, 2016, ENDOCRINOLOGY, V157, P3344, DOI 10.1210/en.2016-1264; PARK S, 1993, NAT GENET, V4, P415, DOI 10.1038/ng0893-415; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/endo.141.9.7789; Qiu X, 2008, J BIOL CHEM, V283, P25774, DOI 10.1074/jbc.M801178200; Rather MI, 2014, J BIOL CHEM, V289, P968, DOI 10.1074/jbc.M113.483255; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Shandilya J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5903; Sultana Shamima, 2017, Reproductive Medicine and Biology, V16, P170, DOI 10.1002/rmb2.12028; Tamura I, 2014, MOL ENDOCRINOL, V28, P1656, DOI 10.1210/me.2014-1117; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tamura I, 2012, ENDOCRINOLOGY, V153, P5612, DOI 10.1210/en.2012-1420; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Tang MY, 2005, MOL HUM REPROD, V11, P237, DOI 10.1093/molehr/gah149; VAL P, 2003, NUCL RECEPT, V1, P8, DOI DOI 10.1186/1478-1336-1-8); Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Wang DF, 2007, MOL CELL BIOCHEM, V300, P239, DOI 10.1007/s11010-006-9388-z; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhang Qian, 2016, Reproductive Medicine and Biology, V15, P95, DOI 10.1007/s12522-015-0226-4; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	55	0	0	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	OCT	2017	158	10					3696	3707		10.1210/en.2017-00478				12	Endocrinology & Metabolism	Endocrinology & Metabolism	FI9BO	WOS:000412298700053	28977591				2018-01-05	
J	Lucas, D; O'Leary, HA; Ebert, BL; Cowan, CA; Tremblay, CS				Lucas, Daniel; O'Leary, Heather A.; Ebert, Benjamin L.; Cowan, Chad A.; Tremblay, Cedric S.			Utility of CRISPRICas9 systems in hematology research	EXPERIMENTAL HEMATOLOGY			English	Article							GENOME; CRISPR-CAS9; MUTATIONS; MODELS	Since the end of the 20th century, novel approaches have emerged to manipulate experimental models of hematological disorders so that they more accurately mirror what is observed in the clinical setting. Despite these technological advances, the characterization of crucial genes for benign or malignant hematological disorders remains challenging, given the dynamic nature of the hematopoietic system and the genetic heterogeneity of these disorders. To overcome this limitation, genome-editing technologies have been developed to manipulate the genome specifically via deletion, insertion, or modification of targeted loci. These technologies have progressed swiftly, allowing their common use to investigate genetic function in experimental hematology. Among them, homologous-recombination mediated targeting technologies have facilitated the manipulation of specific loci by generating knock-out and knock-in models. Despite promoting significant advances in our understanding of the molecular mechanisms involved in hematology, these inefficient, time-consuming, and labor-intensive approaches did not permit the development of cellular or animal models, recapitulating the complexity of hematological disorders. On October 26, 2016, Drs. Ben Ebert and Chad Cowan shared their knowledge of and experience with the utilization of CRISPR for models of myeloid malignancy, disease, and novel therapeutics in an International Society for Experimental Hematology webinar titled "Utility of CRISPR/Cas9 Systems in Hematology Research."Here, we provide an overview of the topics they covered, including their insights into the novel applications of the technique and its strengths and limitations. Copyright (C) 2017 Published by Elsevier Inc. on behalf of ISEH - International Society for Experimental Hematology.	[Lucas, Daniel] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [O'Leary, Heather A.] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, 980 West Walnut St,R3-C321D, Indianapolis, IN 46202 USA; [Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ebert, Benjamin L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Ebert, Benjamin L.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Cowan, Chad A.] Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Cowan, Chad A.] Broad Inst, Cambridge, MA USA; [Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Tremblay, Cedric S.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia	O'Leary, HA (reprint author), Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, 980 West Walnut St,R3-C321D, Indianapolis, IN 46202 USA.; Tremblay, CS (reprint author), Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia.	haoleary@iupui.edu; cedric.tremblay@monash.edu					Bejar R, 2014, BLOOD, V124, P2705, DOI 10.1182/blood-2014-06-582809; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Ebert B, WEBINAR SERIES INT S; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020	8	0	0	12	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	OCT	2017	54						1	3		10.1016/j.exphem.2017.06.006				3	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	FI2OL	WOS:000411778100001	28668351				2018-01-05	
J	Gundry, MC; Dever, DP; Yudovich, D; Bauer, DE; Haas, S; Wilkinson, AC; Singbrant, S				Gundry, Michael C.; Dever, Daniel P.; Yudovich, David; Bauer, Daniel E.; Haas, Simon; Wilkinson, Adam C.; Singbrant, Sofie			Technical considerations for the use of CRISPR/Cas9 in hematology research	EXPERIMENTAL HEMATOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; STAPHYLOCOCCUS-AUREUS CAS9; IN-VIVO; SATURATING MUTAGENESIS; ADENOASSOCIATED VIRUS; SELF-RENEWAL; OFF-TARGET; GENOME; CRISPR-CAS9; VULNERABILITIES	The hematopoietic system is responsible for transporting oxygen and nutrients, fighting infections, and repairing tissue damage. Hematopoietic system dysfunction therefore causes a range of serious health consequences. Lifelong hematopoiesis is maintained by repopulating multipotent hematopoietic stem cells (HSCs) that replenish shorter -lived, mature blood cell types. A prokaryotic mechanism of immunity, the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 nuclease system, has been recently "repurposed" to mutate mammalian genomes efficiently and in a sequence -specific manner. The application of this genomeediting technology to hematology has afforded new approaches for functional genomics and even the prospect of "correcting" dysfunctional HSCs in the treatment of serious genetic hematological diseases. In this Perspective, we provide an overview of three recent CRISPR/ Cas9 methods in hematology: gene disruption, gene targeting, and saturating mutagenesis. We also summarize the technical considerations and advice provided during the May 2017 International Society of Experimental Hematology New Investigator Committee webinar on the same topic. (C) 2017 ISEH Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.	[Gundry, Michael C.] Baylor Coll Med, Ctr Cell & Gene Therapy, Stem Cells & Regenerat Med Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dever, Daniel P.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Yudovich, David; Singbrant, Sofie] Lund Univ, Lund Stem Cell Ctr, Div Mol Med & Gene Therapy, Lund, Sweden; [Bauer, Daniel E.] Harvard Med Sch, Harvard Stern Cell Inst, Boston Childrens Hosp,Dana Faber Canc Inst, Div Hematol Oncol,Dept Pediat Oncol,Harvard Stem, Boston, MA USA; [Haas, Simon] DKFZ German Canc Res Ctr, Heidelberg Inst Stem Cell Technol & Expt Med, Heidelberg, Germany; [Haas, Simon] DKFZ German Canc Res Ctr, Div Stem Cells & Canc, Heidelberg, Germany; [Wilkinson, Adam C.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Wilkinson, AC (reprint author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, 265 Campus Dr, Stanford, CA 94305 USA.	adamcw@stanford.edu			Baylor College of Medicine Medical Scientist Training Program (Texas, USA); Cancer Prevention & Research Institute of Texas (Texas, USA) [RP160283]; National Institute of Diabetes and Digestive and Kidney Diseases-National Institutes of Health (NIH, USA) [K08DK093705, R03DK109232]; National Heart, Lung, and Blood Institute (NIH, USA) [DP20D022716]; Burroughs Wellcome Fund (USA); American Society of Hematology (USA); Doris Duke Charitable Foundation (USA); Charles H. Hood Foundation (USA); Cooley's Anemia Foundation (USA); Bloodwise (UK) Visiting Fellowship [15050]; National Institutes of Health (NIH, USA) National Center for Advancing Translational Science Clinical and Translational Science Award [UL1 TR001085]; Swedish Foundation for Medical Research (Sweden); StemTherapy (Sweden); Crafoordska Foundation (Sweden); Ake Wiberg Foundation (Sweden)	MCG is supported by the Baylor College of Medicine Medical Scientist Training Program (Texas, USA) and Cancer Prevention & Research Institute of Texas grant RP160283 (Texas, USA). DEB is supported by National Institute of Diabetes and Digestive and Kidney Diseases-National Institutes of Health (NIH, USA) grants K08DK093705 and R03DK109232, National Heart, Lung, and Blood Institute (NIH, USA) grant DP20D022716, the Burroughs Wellcome Fund (USA), the American Society of Hematology (USA), the Doris Duke Charitable Foundation (USA), the Charles H. Hood Foundation (USA), and Cooley's Anemia Foundation (USA). ACW is funded by a Bloodwise (UK) Visiting Fellowship (15050) and the National Institutes of Health (NIH, USA) National Center for Advancing Translational Science Clinical and Translational Science Award (UL1 TR001085). SS is supported by the Swedish Foundation for Medical Research (Sweden), StemTherapy (Sweden), The Crafoordska Foundation (Sweden), and the Ake Wiberg Foundation (Sweden).	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Canver MC, 2017, NAT GENET, V49, P625, DOI 10.1038/ng.3793; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2017, METHODS, V121, P9, DOI 10.1016/j.ymeth.2017.04.003; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Felfly Hady, 2014, J Stem Cells, V9, P163, DOI jsc.2014.9.3.163; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gersbach CA, 2014, NAT METHODS, V11, P1009, DOI 10.1038/nmeth.3113; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park CY, 2008, NAT PROTOC, V3, P1932, DOI 10.1038/nprot.2008.194; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Porteus MH, 2003, MOL CELL BIOL, V23, P3558, DOI 10.1128/MCB.23.10.3558-3565.2003; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048	44	0	0	10	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0301-472X	1873-2399		EXP HEMATOL	Exp. Hematol.	OCT	2017	54						4	11		10.1016/j.exphem.2017.07.006				8	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	FI2OL	WOS:000411778100002	28757433				2018-01-05	
J	Ferreira, R; Gatto, F; Nielsen, J				Ferreira, Raphael; Gatto, Francesco; Nielsen, Jens			Exploiting off-targeting in guide-RNAs for CRISPR systems for simultaneous editing of multiple genes	FEBS LETTERS			English	Article						computational tool; CRISPR; synthetic biology	SACCHAROMYCES-CEREVISIAE; STREPTOCOCCUS-THERMOPHILUS; DNA; DESIGN; ACID; SPECIFICITY; IMMUNITY; YEASTS; CAS9	Bioinformatics tools to design guide-RNAs (gRNAs) in Clustered Regularly Interspaced Short Palindromic Repeats systems mostly focused on minimizing off-targeting to enhance efficacy of genome editing. However, there are circumstances in which off-targeting might be desirable to target multiple genes simultaneously with a single gRNA. We termed these gRNAs as promiscuous gRNAs. Here, we present a computational workflow to identify promiscuous gRNAs that putatively bind to the region of interest for a defined list of genes in a genome. We experimentally validated two promiscuous gRNA for gene deletion, one targeting FAA1 and FAA4 and one targeting PLB1 and PLB2, thus demonstrating that multiplexed genome editing through design of promiscuous gRNA can be performed in a time and cost-effective manner.	[Ferreira, Raphael; Gatto, Francesco; Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn Syst & Synthet Biol, Gothenburg, Sweden; [Ferreira, Raphael; Nielsen, Jens] Chalmers Univ Technol, Novo Nordisk Fdn, Ctr Biosustainabil, Gothenburg, Sweden; [Gatto, Francesco] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Nielsen, Jens] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Lyngby, Denmark	Ferreira, R (reprint author), Chalmers Univ Technol, Syst & Synthet Biol, Kemivagen 10, SE-41296 Gothenburg, Sweden.	nielsenj@chalmers.se			Novo Nordisk Foundation; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research	The authors acknowledge the Novo Nordisk Foundation, the Knut and Alice Wallenberg Foundation, and the Swedish Foundation for Strategic Research for funding support.	Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hough SH, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1618-8; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jensen ED, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0664-2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Perez AR, 2017, NAT BIOTECHNOL, V35, P347, DOI 10.1038/nbt.3804; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Richardson SM, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4557; Scharnewski M, 2008, FEBS J, V275, P2765, DOI 10.1111/j.1742-4658.2008.06417.x; Teixeira PG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0663-3; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	30	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1873-3468			FEBS LETT	FEBS Lett.	OCT	2017	591	20					3288	3295		10.1002/1873-3468.12835				8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FK8OC	WOS:000413767100012	28884816				2018-01-05	
J	Falabella, M; Sun, LQ; Barr, J; Pena, AZ; Kershaw, EE; Gingras, S; Goncharova, EA; Kaufman, BA				Falabella, Micol; Sun, Linqing; Barr, Justin; Pena, Andressa Z.; Kershaw, Erin E.; Gingras, Sebastien; Goncharova, Elena A.; Kaufman, Brett A.			Single-Step qPCR and dPCR Detection of Diverse CRISPR-Cas9 Gene Editing Events In Vivo	G3-GENES GENOMES GENETICS			English	Article							GENOME; CAS9; SCREEN; PCR	Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR-associated protein 9 (Cas9)-based technology is currently the most flexible means to create targeted mutations by recombination or indel mutations by nonhomologous end joining. During mouse transgenesis, recombinant and indel alleles are often pursued simultaneously. Multiple alleles can be formed in each animal to create significant genetic complexity that complicates the CRISPR-Cas9 approach and analysis. Currently, there are no rapid methods to measure the extent of on-site editing with broad mutation sensitivity. In this study, we demonstrate the allelic diversity arising from targeted CRISPR editing in founder mice. Using this DNA sample collection, we validated specific quantitative and digital PCR methods (qPCR and dPCR, respectively) for measuring the frequency of on-target editing in founder mice. We found that locked nucleic acid (LNA) probes combined with an internal reference probe (Drop-Off Assay) provide accurate measurements of editing rates. The Drop-Off LNA Assay also detected on-target CRISPR-Cas9 gene editing in blastocysts with a sensitivity comparable to PCR-clone sequencing. Lastly, we demonstrate that the allele-specific LNA probes used in qPCR competitor assays can accurately detect recombinant mutations in founder mice. In summary, we show that LNA-based qPCR and dPCR assays provide a rapid method for quantifying the extent of on-target genome editing in vivo, testing RNA guides, and detecting recombinant mutations.	[Falabella, Micol; Sun, Linqing; Kaufman, Brett A.] Univ Pittsburgh, Sch Med, Dept Med,Div Cardiol, Ctr Metab & Mitochondrial Med, 200 Lothrop St BST E1241, Pittsburgh, PA 15261 USA; [Falabella, Micol; Sun, Linqing; Kaufman, Brett A.] Univ Pittsburgh, Vasc Med Inst, 200 Lothrop St BST E1241, Pittsburgh, PA 15261 USA; [Barr, Justin] Integrated DNA Technol, Coralville, IA 52241 USA; [Pena, Andressa Z.] Univ Pittsburgh, Dept Med, Sch Med, Vasc Med Inst, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Sch Med, Div Endocrinol, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Gingras, Sebastien] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Goncharova, Elena A.] Univ Pittsburgh, Dept Med, Sch Med,Vasc Med Inst, Div Pulm Allergy & Crit Care Med, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Goncharova, Elena A.] Univ Pittsburgh, Dept Bioengn, 930 Scaife Hall, Pittsburgh, PA 15261 USA	Kaufman, BA (reprint author), Univ Pittsburgh, Sch Med, Dept Med,Div Cardiol, Ctr Metab & Mitochondrial Med, 200 Lothrop St BST E1241, Pittsburgh, PA 15261 USA.; Kaufman, BA (reprint author), Univ Pittsburgh, Vasc Med Inst, 200 Lothrop St BST E1241, Pittsburgh, PA 15261 USA.	bkauf@pitt.edu			Center for Metabolism and Mitochondrial Medicine; Vascular Medicine Institute at the University of Pittsburgh; National Institutes of Health (NIH) [R01GM110424]; NIH [R01HL130261]	We would like to thank Rachael A. Gordon for assistance with initial CRISPR guide selection, and Chunming Bi and the University of Pittsburgh School of Medicine Transgenic and Gene Targeting Core for microinjection of zygotes and production of mice used in this study. This work was supported by the Center for Metabolism and Mitochondrial Medicine and the Vascular Medicine Institute at the University of Pittsburgh. B.A.K. and M.F. were supported by National Institutes of Health (NIH) grant R01GM110424. A.Z.P. and E.A.G. were supported by NIH grant R01HL130261.	Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Brass N, 1998, BIOTECHNIQUES, V24, P22; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dehairs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28973; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kc R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32048; Kolesar JE, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1324; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mouritzen P, 2003, EXPERT REV MOL DIAGN, V3, P27, DOI 10.1586/14737159.3.1.27                                                         ; Oliver D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129457; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruiz S, 2016, MOL CELL, V62, P307, DOI 10.1016/j.molcel.2016.03.006; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368; Zentilin L, 2007, NAT PROTOC, V2, P2092, DOI 10.1038/nprot.2007.299; Zhang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32565	25	0	0	6	6	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	OCT	2017	7	10					3533	3542		10.1534/g3.117.300123				10	Genetics & Heredity	Genetics & Heredity	FJ2IQ	WOS:000412549600027	28860183	gold			2018-01-05	
J	Gombash, SE; Cowley, CJ; Fitzgerald, JA; Lepak, CA; Neides, MG; Hook, K; Todd, LJ; Wang, GD; Mueller, C; Kaspar, BK; Bielefeld, EC; Fischer, AJ; Wood, JD; Foust, KD				Gombash, S. E.; Cowley, C. J.; Fitzgerald, J. A.; Lepak, C. A.; Neides, M. G.; Hook, K.; Todd, L. J.; Wang, G-D; Mueller, C.; Kaspar, B. K.; Bielefeld, E. C.; Fischer, A. J.; Wood, J. D.; Foust, K. D.			Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques	GENE THERAPY			English	Article							ADENOASSOCIATED VIRUS VECTOR; SMALL-INTESTINE; TRANSGENE EXPRESSION; MYENTERIC NEURONS; DISTAL COLON; AAV; MOUSE; BRAIN; SEROTYPES; IMMUNOREACTIVITY	Characterization of adeno-associated viral vector (AAV) mediated gene delivery to the enteric nervous system (ENS) was recently described in mice and rats. In these proof-of-concept experiments, we show that intravenous injections of clinically relevant AAVs can transduce the ENS in guinea pigs and non-human primates. Neonatal guinea pigs were given intravenous injections of either AAV8 or AAV9 vectors that contained a green fluorescent protein (GFP) expression cassette or phosphate-buffered saline. Piglets were euthanized three weeks post injection and tissues were harvested for immunofluorescent analysis. GFP expression was detected in myenteric and submucosal neurons along the length of the gastrointestinal tract in AAV8 injected guinea pigs. GFP-positive neurons were found in dorsal motor nucleus of the vagus and dorsal root ganglia. Less transduction occurred in AAV9treated tissues. Gastrointestinal tissues were analyzed from young cynomolgus macaques that received systemic injection of AAV9 GFP. GFP expression was detected in myenteric neurons of the stomach, small and large intestine. These data demonstrate that ENS gene delivery translates to larger species. This work develops tools for the field of neurogastroenterology to explore gut physiology and anatomy using emerging technologies such as optogenetics and gene editing. It also provides a basis to develop novel therapies for chronic gut disorders.	[Gombash, S. E.; Cowley, C. J.; Fitzgerald, J. A.; Lepak, C. A.; Neides, M. G.; Todd, L. J.; Kaspar, B. K.; Fischer, A. J.; Foust, K. D.] Ohio State Univ, Dept Neurosci, 660 BRT,460W 12th Ave, Columbus, OH 43210 USA; [Hook, K.] Ohio State Univ, Dept Neurosci, SUCCESS Program, Columbus, OH 43210 USA; [Wang, G-D; Wood, J. D.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Mueller, C.] UMASS Med Sch, Dept Pediat, Neurol Gene Therapy Ctr, Worcester, MA USA; [Kaspar, B. K.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Kaspar, B. K.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Bielefeld, E. C.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA	Gombash, SE (reprint author), Ohio State Univ, Dept Neurosci, 660 BRT,460W 12th Ave, Columbus, OH 43210 USA.	sara.gombashlampe@osumc.edu			NIH T32 [5T32NS077984-02]; NIH RC2 [NS69476-01]	This work was partially supported by NIH T32# 5T32NS077984-02 (SEG) and NIH RC2 #NS69476-01 (BKK). We thank Emily Armstrong (Ohio State University, Columbus, OH, USA) for assistance with tissue processing. Also, We thank Christian Mueller (UMASS Medical School, Worcester, MA, USA) for providing vector and Brian K Kaspar (Nationwide Children's Hospital, Columbus, OH, USA) for donation of the cynomologus macaque tissues.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Levy BDFA, 2007, INT J NEUROSCI, V117, P1481, DOI 10.1080/15569520701502716; Benskey MJ, 2015, MOL THER, V23, P488, DOI 10.1038/mt.2015.7; Bergner AJ, 2014, J COMP NEUROL, V522, P514, DOI 10.1002/cne.23423; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Buckinx R, 2016, NEUROGASTROENT MOTIL, V28, P299, DOI 10.1111/nmo.12724; Buckley MM, 2014, J PHYSIOL-LONDON, V592, P5235, DOI 10.1113/jphysiol.2014.279968; Budenz CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08619; Bundoc Virgilio G, 2003, Curr Opin Allergy Clin Immunol, V3, P375, DOI 10.1097/00130832-200310000-00010; Byrne LC, 2015, MOL THER, V23, P290, DOI 10.1038/mt.2014.181; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; COSTA M, 1986, PROG BRAIN RES, V68, P217, DOI 10.1016/S0079-6123(08)60241-1; Curthoys IS, 2011, EXP BRAIN RES, V210, P347, DOI 10.1007/s00221-010-2499-5; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; de Leeuw CN, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0232-4; Deng HW, 2016, J OCUL PHARMACOL TH, V32, P196, DOI 10.1089/jop.2015.0053; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Di Giovangiulio M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00590; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Furness JB, 2006, ENTERIC NERVOUS SYSTEM, P1; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; Gaj T, 2016, MOL THER, V24, P458, DOI 10.1038/mt.2015.151; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gombash SE, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00081, 10.3389/fnmo1.2014.00081]; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Harrington AM, 2010, PROG HISTOCHEM CYTO, V44, P173, DOI 10.1016/j.proghi.2009.10.001; Lin Z, 2002, NEUROGASTROENT MOTIL, V14, P197, DOI 10.1046/j.1365-2982.2002.00317.x                                                ; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Lomax AE, 2000, CELL TISSUE RES, V302, P59, DOI 10.1007/s004410000260; Lomax AEG, 1999, J AUTONOM NERV SYST, V76, P45, DOI 10.1016/S0165-1838(99)00008-9; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; Mendell JR, 2016, MOL THER, V24, pS190, DOI 10.1016/S1525-0016(16)33289-0                                                   ; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Neddens J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027337; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Orandle MS, 2007, J VIROL, V81, P6265, DOI 10.1128/JVI.02671-06; Penaud-Budloo M, 2008, J VIROL, V82, P7875, DOI 10.1128/JVI.00649-08; PODSAKOFF G, 1994, J VIROL, V68, P5656; Portales-Casamar E, 2010, P NATL ACAD SCI USA, V107, P16589, DOI 10.1073/pnas.1009158107; Quinson N, 2001, CELL TISSUE RES, V305, P3, DOI 10.1007/s004410100395                                                           ; Samaranch L, 2012, HUM GENE THER, V23, P382, DOI 10.1089/hum.2011.200; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Shimano T, 2013, BRAIN RES, V1511, P138, DOI 10.1016/j.brainres.2012.10.030; STEELE PA, 1991, NEUROSCIENCE, V45, P227, DOI 10.1016/0306-4522(91)90119-9; von Jonquieres G, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmol.2016.00013, 10.3389/fnmol.2010.00013]; Wang D, 2014, EXPERT OPIN DRUG DEL, V11, P345, DOI 10.1517/17425247.2014.871258; Wang DB, 2010, MOL THER, V18, P2064, DOI 10.1038/mt.2010.191; Wang GP, 2014, GENE THER, V21, P958, DOI 10.1038/gt.2014.73; Wang GD, 2005, AM J PHYSIOL-GASTR L, V289, pG614, DOI 10.1152/ajpgi.00119.2005; Watakabe A, 2015, NEUROSCI RES, V93, P144, DOI 10.1016/j.neures.2014.09.002; Weinberg MS, 2013, NEUROPHARMACOLOGY, V69, P82, DOI 10.1016/j.neuropharm.2012.03.004; WOOLF NK, 1991, TRANSPLANT P, V23, P32; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	56	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	OCT	2017	24	10					640	648		10.1038/gt.2017.72				9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FK8AK	WOS:000413729100005	28771235				2018-01-05	
J	Zhang, SW; Fan, GF; Hao, Y; Hammell, M; Wilkinson, JE; Tonks, NK				Zhang, Siwei; Fan, Gaofeng; Hao, Yuan; Hammell, Molly; Wilkinson, John Erby; Tonks, Nicholas K.			Suppression of protein tyrosine phosphatase N23 predisposes to breast tumorigenesis via activation of FYN kinase	GENES & DEVELOPMENT			English	Article						FYN; PTPN23; breast cancer; tumor suppressor; tyrosine phosphorylation	MAMMARY EPITHELIAL-CELLS; HD-PTP; CHROMOSOME 3P21.3; PROGENITOR CELLS; PROSTATE-CANCER; HUMAN GENOME; IN-VITRO; SRC; EXPRESSION; GENE	Disruption of the balanced modulation of reversible tyrosine phosphorylation has been implicated in the etiology of various human cancers, including breast cancer. Protein Tyrosine Phosphatase N23 (PTPN23) resides in chromosomal region 3p21.3, which is hemizygously or homozygously lost in some breast cancer patients. In a loss-of-function PTPome screen, our laboratory identified PTPN23 as a suppressor of cell motility and invasion in mammary epithelial and breast cancer cells. Now, our TCGA (The Cancer Genome Atlas) database analyses illustrate a correlation between low PTPN23 expression and poor survival in breast cancers of various subtypes. Therefore, we investigated the tumor-suppressive function of PTPN23 in an orthotopic transplantation mouse model. Suppression of PTPN23 in Comma 1D beta cells induced breast tumors within 56 wk. In PTPN23-depleted tumors, we detected hyperphosphorylation of the autophosphorylation site tyrosine in the SRC family kinase (SFK) FYN as well as Tyr142 in beta-catenin. We validated the underlying mechanism of PTPN23 function in breast tumorigenesis as that of a key phosphatase that normally suppresses the activity of FYN in two different models. We demonstrated that tumor outgrowth from PTPN23-deficient BT474 cells was suppressed in a xenograft model in vivo upon treatment with AZD0530, an SFK inhibitor. Furthermore, double knockout of FYN and PTPN23 via CRISPR/CAS9 also attenuated tumor outgrowth from PTPN23 knockout Cal51 cells. Overall, this mechanistic analysis of the tumor-suppressive function of PTPN23 in breast cancer supports the identification of FYN as a therapeutic target for breast tumors with heterozygous or homozygous loss of PTPN23.	[Zhang, Siwei; Fan, Gaofeng; Hao, Yuan; Hammell, Molly; Tonks, Nicholas K.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Zhang, Siwei] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Fan, Gaofeng] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Wilkinson, John Erby] Univ Michigan, Dept Pathol, Unit Lab Anim Med, Ann Arbor, MI 48109 USA	Tonks, NK (reprint author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu			Animal Shared Resource and Flow Cytometry Shared Resource; National Institutes of Health [CA53840]; Cold Spring Harbor Laboratory Cancer Centre Support Grant [CA45508]; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Irving Hansen Foundation; Estate of Thomas C. Nelson; Robertson Research Fund	We thank Mikala Egeblad (Cold Spring Harbor Laboratory, NY) for the Cal51 and MDA-MB-468 cell lines, Christopher Vakoc (Cold Spring Harbor Laboratory, NY) for the CAS9 expression construct and sgRNA expression constructs LRG (Lenti_sgR-NA_EFS_GFP) and LRCh (Lenti_sgRNA_EFS_mCherry), Arnim Pause (McGill University, Montreal, Canada) for the polycolonal PTPN23 antibody, and Senthil K. Muthuswamy (Harvard University, MA) for sharing the CD cell line as well as for many helpful discussions. This work was performed with assistance from Cold Spring Harbor Laboratory Shared Resources, especially support from the Animal Shared Resource and Flow Cytometry Shared Resource. This work was supported by National Institutes of Health grant CA53840 to N.K.T., and Cold Spring Harbor Laboratory Cancer Centre Support Grant CA45508. N.K.T. is also grateful for support from the Gladowsky Breast Cancer Foundation, the Don Monti Memorial Research Foundation, the Irving Hansen Foundation, the Estate of Thomas C. Nelson, and the Robertson Research Fund. S.Z. and N.K.T. designed the experiments. S.Z. contributed to all aspects of the experimental work. G.F. contributed to the RNAi screen and provided insightful thoughts and discussion. Y.H. and M.H. contributed to the bioinformatics analysis. J.E.W. contributed to the pathology studies. All of the authors contributed to the analysis of the data. S.Z. and N.K.T. wrote the paper. N.K.T. directed the study.	Ali N, 2013, CURR BIOL, V23, P453, DOI 10.1016/j.cub.2013.02.033; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Angeloni Debora, 2007, Briefings in Functional Genomics & Proteomics, V6, P19, DOI 10.1093/bfgp/elm007; Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869                                                          ; Banh RS, 2016, NAT CELL BIOL, V18, P803, DOI 10.1038/ncb3376; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Chan G, 2009, BLOOD, V113, P4414, DOI 10.1182/blood-2008-10-182626; Charpin C, 2009, INT J CANCER, V124, P2124, DOI 10.1002/ijc.24177; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Deugnier MA, 2006, DEV BIOL, V293, P414, DOI 10.1016/j.ydbio.2006.02.007; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; EHMANN UK, 1987, J NATL CANCER I, V78, P751; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Freiss G, 2004, CRIT REV ONCOL HEMAT, V52, P9, DOI 10.1016/j.critrevonc.2004.05.004; Garcia S, 2007, INT J ONCOL, V31, P49; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Gingras MC, 2009, INT J DEV BIOL, V53, P1069, DOI 10.1387/ijdb.082820mg; Gingras MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005105; Hardy S, 2015, ONCOGENE, V34, P986, DOI 10.1038/onc.2014.33; Harris IS, 2014, ONCOGENE, V33, P1047, DOI 10.1038/onc.2013.24; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Huang JH, 2003, J BIOL CHEM, V278, P48367, DOI 10.1074/jbc.M308213200; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; KAWAKAMI T, 1988, P NATL ACAD SCI USA, V85, P3870, DOI 10.1073/pnas.85.11.3870                                                         ; Kharitidi D, 2015, CELL REP, V13, P599, DOI 10.1016/j.celrep.2015.09.024; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Labbe DP, 2016, CANCER RES, V76, P3130, DOI 10.1158/0008-5472.CAN-15-1501; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lessard L, 2012, CANCER RES, V72, P1529, DOI 10.1158/0008-5472.CAN-11-2602; LeVea CM, 2000, BREAST CANCER RES TR, V64, P221, DOI 10.1023/A:1006410509740; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Manteghi S, 2016, CELL REP, V15, P1893, DOI 10.1016/j.celrep.2016.04.076; Martin FT, 2010, BREAST CANCER RES TR, V124, P317, DOI 10.1007/s10549-010-0734-1; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510                                                          ; Nguyen TH, 2002, J BIOL CHEM, V277, P24274, DOI 10.1074/jbc.M111683200; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pagarigan KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061084; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Posadas EM, 2009, BJU INT, V103, P171, DOI 10.1111/j.1464-410X.2008.08009.x; Radke I, 2006, BRIT J CANCER, V95, P347, DOI 10.1038/sj.bjc.6603261; Rajaram M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003789; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Ramesh M, 2015, J BIOL CHEM, V290, P9646, DOI 10.1074/jbc.M114.627968; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Schneble N, 2017, GLIA, V65, P416, DOI 10.1002/glia.23100; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Tanaka K, 2013, J BIOL CHEM, V288, P23990, DOI 10.1074/jbc.M113.478891; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876                                                      ; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Toyooka S, 2000, BIOCHEM BIOPH RES CO, V278, P671, DOI 10.1006/bbrc.2000.3870; Tsujikawa K, 2002, MOL CANCER RES, V1, P155; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang XS, 2010, BREAST CANCER RES TR, V119, P453, DOI 10.1007/s10549-009-0404-3; Xu J, 2015, J NEUROCHEM, V134, P629, DOI 10.1111/jnc.13160; Xu RZ, 2005, BLOOD, V106, P3142, DOI 10.1182/blood-2004-10-4057; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yu M, 2012, MOL CELL BIOL, V32, P3913, DOI 10.1128/MCB.00068-12; Yuan TC, 2010, J BIOL CHEM, V285, P14861, DOI 10.1074/jbc.M109.099879; Zhao S, 2015, ONCOGENE, V34, P3885, DOI 10.1038/onc.2014.326; Zheng J, 2000, ANTICANCER RES, V20, P11; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	92	0	0	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	OCT 1	2017	31	19					1939	1957		10.1101/gad.304261.117				19	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	FL2OA	WOS:000414054000003	29066500				2018-01-05	
J	Morgan, MAJ; Rickels, RA; Collings, CK; He, XL; Cao, KX; Herz, HM; Cozzolino, KA; Abshiru, NA; Marshall, SA; Rendleman, EJ; Sze, CC; Piunti, A; Kelleher, NL; Savas, JN; Shilatifard, A				Morgan, Marc A. J.; Rickels, Ryan A.; Collings, Clayton K.; He, Xiaolin; Cao, Kaixiang; Herz, Hans-Martin; Cozzolino, Kira A.; Abshiru, Nebiyu A.; Marshall, Stacy A.; Rendleman, Emily J.; Sze, Christie C.; Piunti, Andrea; Kelleher, Neil L.; Savas, Jeffrey N.; Shilatifard, Ali			A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation	GENES & DEVELOPMENT			English	Article						BRWD; PHIP; COMPASS; histone methylation; Tudor domain; H3K4	INTERACTING PROTEIN PHIP; CHROMATIN MODIFICATIONS; LYSINE-4 METHYLATION; FAMILY; BROMODOMAIN; DROSOPHILA; MUTATIONS; ENHANCERS; RECOGNITION; EXPRESSION	Histone H3 Lys4 (H3K4) methylation is a chromatin feature enriched at gene cis-regulatory sequences such as promoters and enhancers. Here we identify an evolutionarily conserved factor, BRWD2/PHIP, which colocalizes with histone H3K4 methylation genome-wide in human cells, mouse embryonic stem cells, and Drosophila. Biochemical analysis of BRWD2 demonstrated an association with the Cullin-4-RING ubiquitin E3 ligase-4 (CRL4) complex, nucleosomes, and chromatin remodelers. BRWD2/PHIP binds directly to H3K4 methylation through a previously unidentified chromatin-binding module related to Royal Family Tudor domains, which we named the Crypto Tudor domain. Using CRISPR-Cas9 genetic knockouts, we demonstrate that COMPASS H3K4 methyltransferase family members differentially regulate BRWD2/PHIP chromatin occupancy. Finally, we demonstrate that depletion of the single Drosophila homolog dBRWD3 results in altered gene expression and aberrant patterns of histone H3 Lys27 acetylation at enhancers and promoters, suggesting a cross-talk between these chromatin modifications and transcription through the BRWD protein family.	[Morgan, Marc A. J.; Rickels, Ryan A.; Collings, Clayton K.; He, Xiaolin; Cao, Kaixiang; Marshall, Stacy A.; Rendleman, Emily J.; Sze, Christie C.; Piunti, Andrea; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA; [Herz, Hans-Martin] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA; [Cozzolino, Kira A.; Savas, Jeffrey N.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Abshiru, Nebiyu A.; Kelleher, Neil L.] Northwestern Univ, Feinberg Sch Med, Dept Chem, Chicago, IL 60611 USA	Shilatifard, A (reprint author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA.	ash@northwestern.edu		Cao, Kaixiang/0000-0001-9953-1503	National Cancer Institute (NCI) Cancer Center [P30CA060553]; National Resource for Translational and Developmental Proteomics [P41GM108569]; National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders [R00 DC-013805]; NIH NCI [R35CA197569]	We thank Dr. Dan Foltz and Dr. Edwin Smith for insightful discussions. We thank Jaydeep Singh and Annika Krueger for technical assistance. We thank the Proteomics Core Facility at Northwestern University, which is supported by National Cancer Institute (NCI) Cancer Center Support Grant P30CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center, and the National Resource for Translational and Developmental Proteomics supported by P41GM108569. The Savas laboratory is supported by an R00 DC-013805 award from the National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders. Studies related to the COMPASS family in the Shilatifard laboratory are supported by a generous Outstanding Investigator Award from the NIH NCI (R35CA197569).	Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Cao KX, 2017, GENE DEV, V31, P787, DOI 10.1101/gad.294744.116; Cavadini S, 2016, NATURE, V531, P598, DOI 10.1038/nature17416; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; D'Costa A, 2006, MECH DEVELOP, V123, P591, DOI 10.1016/j.mod.2006.06.007; De Semir D, 2012, P NATL ACAD SCI USA, V109, P7067, DOI 10.1073/pnas.1119949109; den Besten W, 2012, NAT STRUCT MOL BIOL, V19, P511, DOI 10.1038/nsmb.2269; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Farhang-Fallah J, 2000, J BIOL CHEM, V275, P40492, DOI 10.1074/jbc.C000611200; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fujisawa T, 2017, NAT REV MOL CELL BIO, V18, P246, DOI 10.1038/nrm.2016.143; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hickox AE, 2017, J NEUROSCI, V37, P1320, DOI 10.1523/JNEUROSCI.2267-16.2016; Hu DQ, 2017, MOL CELL, V65, P460, DOI 10.1016/j.molcel.2017.01.013; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu DQ, 2013, NAT STRUCT MOL BIOL, V20, P1093, DOI 10.1038/nsmb.2653; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Ihry RJ, 2014, GENETICS, V196, P767, DOI 10.1534/genetics.113.159707; Ji X, 2015, P NATL ACAD SCI USA, V112, P3841, DOI 10.1073/pnas.1502971112; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot2006.98; Li N, 2016, MOL CELL, V63, P470, DOI 10.1016/j.molcel.2016.06.035; Li SA, 2010, FEBS LETT, V584, P4121, DOI 10.1016/j.febslet.2010.08.042; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mandal M, 2015, NAT IMMUNOL, V16, P1094, DOI 10.1038/ni.3249; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ozturk N, 2013, P NATL ACAD SCI USA, V110, P4980, DOI 10.1073/pnas.1303234110; Pattabiraman S, 2015, J CELL BIOL, V208, P53, DOI 10.1083/jcb.201404109; Philipps DL, 2008, DEV BIOL, V317, P72, DOI 10.1016/j.ydbio.2008.02.018; Piunti A, 2017, NAT MED, V23, P493, DOI 10.1038/nm.4296; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Raman M, 2015, NAT CELL BIOL, V17, P1356, DOI 10.1038/ncb3238; Rickels R, 2016, MOL CELL, V63, P318, DOI 10.1016/j.molcel.2016.06.018; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Savitsky P, 2016, CELL REP, V17, P2724, DOI 10.1016/j.celrep.2016.11.014; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shen HJ, 2016, CELL, V165, P331, DOI 10.1016/j.cell.2016.02.064; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shih HT, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006262; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Su ZL, 2015, FASEB J, V29; Surface LE, 2016, CELL REP, V14, P1142, DOI 10.1016/j.celrep.2015.12.100; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vo BT, 2017, CELL REP, V18, P2907, DOI 10.1016/j.celrep.2017.02.073; Webster E., 2016, COLD SPRING HARB MOL, V2; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Zheng YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3203	70	0	0	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	OCT 1	2017	31	19					2003	2014		10.1101/gad.305201.117				12	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	FL2OA	WOS:000414054000007	29089422				2018-01-05	
J	de Roo, JJD; Breukel, C; Chhatta, AR; Linssen, MM; Vloemans, SA; Salvatori, D; Mikkers, HMM; Verbeek, SJ; Staal, FJT				de Roo, Jolanda. J. D.; Breukel, Cor; Chhatta, Amiet R.; Linssen, Margot M.; Vloemans, Sandra A.; Salvatori, Daniela; Mikkers, Harald M. M.; Verbeek, Sjef J.; Staal, Frank J. T.			Axin2-mTurquoise2: A novel reporter mouse model for the detection of canonical Wnt signalling	GENESIS			English	Article						Axin2-mTurquoise2; CRISPR-Cas9; mouse model	BETA-CATENIN; FUNCTIONAL INTERACTION; STEM-CELL; TRANSCRIPTION; HEMATOPOIESIS; TUMORS; LIVER	The canonical Wnt signalling pathway has been implicated in organogenesis and self-renewal of essentially all stem cell systems. In vivo reporter systems are crucial to assess the role of Wnt signalling in the biology and pathology of stem cell systems. We set out to develop a Turquoise (TQ) fluorescent protein based Wnt reporter. We used a CRISPR-Cas9 approach to insert a TQ fluorescent protein encoding gene into the general Wnt target gene Axin2, thereby establishing a Wnt reporter mouse similar to previously generated Wnt reporter mice but with the mTurquoise2 gene instead of E. coli-beta-galactosidase (LacZ). The use of mTurquoise2 is especially important in organ systems in which cells need to a be alive for further experimentation such as in vitro activation or transplantation studies. We here report successful generation of Axin2-TQ mice and show that cells from these mice faithfully respond to Wnt signals. High Wnt signals were detected in the intestinal crypts, a classical Wnt signalling site in vivo, and by flow cytometry in the thymus. These mice are an improved tool to further elucidate the role of Wnt signalling in vivo.	[de Roo, Jolanda. J. D.; Chhatta, Amiet R.; Vloemans, Sandra A.; Staal, Frank J. T.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, L3-35,POB 9600, NL-2300 RC Leiden, Netherlands; [Breukel, Cor; Verbeek, Sjef J.] Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands; [Chhatta, Amiet R.; Mikkers, Harald M. M.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Linssen, Margot M.; Salvatori, Daniela] Leiden Univ, Med Ctr, Dept Cent Lab Anim Facil, Leiden, Netherlands	Staal, FJT (reprint author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, L3-35,POB 9600, NL-2300 RC Leiden, Netherlands.	f.j.t.staal@lumc.nl			Universiteit Leiden [2012-02]	Universiteit Leiden, Grant/Award Number: 2012-02	Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Luis TC, 2012, LEUKEMIA, V26, P414, DOI 10.1038/leu.2011.387; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon Randall T, 2004, Sci STKE, V2004, ptr5, DOI 10.1126/stke.2402004tr5; Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291                                                         ; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tiemessen MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001430; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	23	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	OCT	2017	55	10							e23068	10.1002/dvg.23068				7	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	FK2WR	WOS:000413344300002					2018-01-05	
J	Bar-Yaacov, D; Mordret, E; Towers, R; Biniashvili, T; Soyris, C; Schwartz, S; Dahan, O; Pilpel, Y				Bar-Yaacov, Dan; Mordret, Ernest; Towers, Ruth; Biniashvili, Tammy; Soyris, Clara; Schwartz, Schraga; Dahan, Orna; Pilpel, Yitzhak			RNA editing in bacteria recodes multiple proteins and regulates an evolutionarily conserved toxin-antitoxin system	GENOME RESEARCH			English	Article							ESCHERICHIA-COLI; ADENOSINE-DEAMINASE; MITOCHONDRIAL-DNA; GENE FAMILY; TRANSCRIPTOME; TADA; SITES	Adenosine (A) to inosine (I) RNA editing is widespread in eukaryotes. In prokaryotes, however, A-to-I RNA editing was only reported to occur in tRNAs but not in protein-coding genes. By comparing DNA and RNA sequences of Escherichia coli, we show for the first time that A-to-I editing occurs also in prokaryotic mRNAs and has the potential to affect the translated proteins and cell physiology. We found 15 novel A-to-I editing events, of which 12 occurred within known protein-coding genes where they always recode a tyrosine (TAC) into a cysteine (TGC) codon. Furthermore, we identified the tRNA-specific adenosine deaminase (tadA) as the editing enzyme of all these editing sites, thus making it the first identified RNA editing enzyme that modifies both tRNAs and mRNAs. Interestingly, several of the editing targets are self-killing toxins that belong to evolutionarily conserved toxin-antitoxin pairs. We focused on hokB, a toxin that confers antibiotic tolerance by growth inhibition, as it demonstrated the highest level of such mRNA editing. We identified a correlated mutation pattern between the edited and a DNA hard-coded Cys residue positions in the toxin and demonstrated that RNA editing occurs in hokB in two additional bacterial species. Thus, not only the toxin is evolutionarily conserved but also the editing itself within the toxin is. Finally, we found that RNA editing in hokB increases as a function of cell density and enhances its toxicity. Our work thus demonstrates the occurrence, regulation, and functional consequences of RNA editing in bacteria.	[Bar-Yaacov, Dan; Mordret, Ernest; Towers, Ruth; Biniashvili, Tammy; Soyris, Clara; Schwartz, Schraga; Dahan, Orna; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Pilpel, Y (reprint author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il		Bar Yaacov, Dan/0000-0002-0599-5153	DIP foundation	We thank the DIP foundation for grant support. We thank the Minerva Foundation for establishment of the Minerva Center for Live Emulation of Genome Evolution in the Lab. We thank Professor Jan Michiels and Dr. Natalie Verstraeten from KU Leuven-University of Leuven for providing strains and plasmids. We thank Dima Zabezhinsky for his help in the confocal microscopy analysis. We thank Shlomit Gilad and the INCPM center at the Weizmann Institute for their part in sequencing the total DNA and RNA samples of E. coli. We thank Nathalie Balaban, Erez Levanon, Avigdor Eldar, Rotem Sorek, Deborah Fass, and all the people in the Pilpel lab for useful discussion and comments.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bar-Yaacov D, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002557; Bar-Yaacov D, 2013, GENOME RES, V23, P1789, DOI 10.1101/gr.161265.113; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808                                           ; Gerdes K, 2015, MOL CELL, V59, P1, DOI 10.1016/j.molcel.2015.06.019; Grice LF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0279-3; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Leskinen K, 2015, MICROBIOL-SGM, V161, P285, DOI 10.1099/mic.0.083097-0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; Liu HQ, 2016, GENOME RES, V26, P499, DOI 10.1101/gr.199877.115; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Pedersen K, 1999, MOL MICROBIOL, V32, P1090, DOI 10.1046/j.1365-2958.1999.01431.x                                                ; POULSEN LK, 1992, MOL MICROBIOL, V6, P895, DOI 10.1111/j.1365-2958.1992.tb01540.x; POULSEN LK, 1991, MOL MICROBIOL, V5, P1627, DOI 10.1111/j.1365-2958.1991.tb01910.x; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang IX, 2016, GENOME RES, V26, P1544, DOI 10.1101/gr.207878.116; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362                                                            ; Yokobori S, 2013, NUCLEIC ACIDS RES, V41, P6531, DOI 10.1093/nar/gkt356; Zhidkov I, 2011, MITOCHONDRION, V11, P924, DOI 10.1016/j.mito.2011.08.005	35	0	0	12	12	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2017	27	10					1696	1703		10.1101/gr.222760.117				8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FI6PS	WOS:000412119200008	28864459				2018-01-05	
J	Bulkescher, R; Starkuviene, V; Erfle, H				Bulkescher, Ruben; Starkuviene, Vytaute; Erfle, Holger			Solid-phase reverse transfection for intracellular delivery of functionally active proteins	GENOME RESEARCH			English	Article							MAMMALIAN-CELLS; CAS9 PROTEIN; LIVING CELLS; DISRUPTION; MICROSCOPY; ANTIBODIES; SPINDLE; EG5	Delivery of large and functionally active biomolecules across cell membranes presents a challenge in cell biological experimentation. For this purpose, we developed a novel solid-phase reverse transfection method that is suitable for the intracellular delivery of proteins into mammalian cells with preservation of their function. We show results for diverse application areas of the method, ranging from antibody-mediated inhibition of protein function to CRISPR/Cas9-based gene editing in living cells. Our method enables prefabrication of "ready to transfect" substrates carrying diverse proteins. This allows their easy distribution and standardization of biological assays across different laboratories.	[Bulkescher, Ruben; Starkuviene, Vytaute; Erfle, Holger] Heidelberg Univ, BioQuant, D-69120 Heidelberg, Germany; [Starkuviene, Vytaute] Vilnius Univ, Life Sci Ctr, LT-10223 Vilnius, Lithuania	Erfle, H (reprint author), Heidelberg Univ, BioQuant, D-69120 Heidelberg, Germany.	holger.erfle@bioquant.uni-heidelberg.de			Federal Ministry of Education and Research (BMBF) [FKZ 031A298]; CellNetworks-Cluster of Excellence [EXC81]; Baden-Wurttemberg Stiftung	This project is funded by a grant (RNA-Code: FKZ 031A298) by the Federal Ministry of Education and Research (BMBF). The Viro-Quant-CellNetworks RNAi Screening Facility is supported by the CellNetworks-Cluster of Excellence (EXC81) and by the Baden-Wurttemberg Stiftung. We thank Dr. Matthew Betts (Heidelberg University) for carefully reading the manuscript and helpful comments, Dr. Rainer Saffrich (Heidelberg University) for the introduction to microinjection, and Jurgen Beneke for support with robotics.	Blangy A, 1995, CELL, V83, P1159; Bradbury AM, 2015, NATURE, V520, P295, DOI 10.1038/520295b; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777                                                           ; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; FUCHTBAUER A, 1985, EMBO J, V4, P2807; Kaestner L, 2015, BIOORG MED CHEM LETT, V25, P1171, DOI 10.1016/j.bmcl.2015.01.018; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803                                                         ; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Putnam AJ, 2003, AM J PHYSIOL-CELL PH, V284, pC627, DOI 10.1152/ajpcell.00137.2002; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Slowing II, 2007, J AM CHEM SOC, V129, P8845, DOI 10.1021/ja0719780; Thompson DB, 2012, METHOD ENZYMOL, V503, P293, DOI 10.1016/B978-0-12-396962-0.00012-4; Vaishya R, 2015, EXPERT OPIN DRUG DEL, V12, P415, DOI 10.1517/17425247.2015.961420; Wakana Y, 2013, J CELL BIOL, V202, P241, DOI 10.1083/jcb.201303163; Wang J, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/6138251; Wu YC, 2015, NAT METHODS, V12, P439, DOI [10.1038/NMETH.3357, 10.1038/nmeth.3357]; Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	26	0	0	4	4	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	OCT	2017	27	10					1752	1758		10.1101/gr.215103.116				7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FI6PS	WOS:000412119200013	28874398				2018-01-05	
J	Ahmad, N; Mukhtar, Z				Ahmad, Niaz; Mukhtar, Zahid			Genetic manipulations in crops: Challenges and opportunities	GENOMICS			English	Review						Genetic modifications of crops; Precise genome editing; Removal of selection markers; Gene flow from GM crops; Non-nuclear transformation	PLASTID TRANSFORMATION TECHNOLOGY; SITE-SPECIFIC RECOMBINATION; SELECTABLE MARKER GENES; T-DNA TRANSFER; AGROBACTERIUM-TUMEFACIENS; TRANSGENIC PLANTS; C-4 PHOTOSYNTHESIS; CHLOROPLAST TRANSFORMATION; CAROTENOID BIOSYNTHESIS; TRANSPLASTOMIC TOBACCO	An alarming increase in the human population necessitates doubling the world food production in the next few decades. Although a number of possible biotechnological measures are under consideration, central to these efforts is the development of transgenic crops to produce more food, and the traits with which plants could better adapt to adverse environmental conditions in a changing climate. The emergence of new tools for the introduction of foreign genes into plants has increased both our knowledge and the capacity to develop transgenic plants. In addition, a better understanding of genetic modifications has allowed us to study the impact that genetically modified crop plants may have on the environment. This article discusses different techniques routinely used to carry out genetic modifications in plants while highlighting challenges with them, which future research must address to increase acceptance of GM crops for meeting food security challenges effectively.	[Ahmad, Niaz; Mukhtar, Zahid] NIBGE, Agr Biotechnol Div, Jhang Rd, Faisalabad, Pakistan	Ahmad, N (reprint author), NIBGE, Agr Biotechnol Div, Jhang Rd, Faisalabad, Pakistan.	nahmad@nibge.org		Ahmad, Niaz/0000-0002-9391-2089	Higher Education Commission (HEC) of Pakistan; Punjab Agricultural Research Board (PARB), Govt. of the Punjab (Pakistan)	Higher Education Commission (HEC) of Pakistan and the Punjab Agricultural Research Board (PARB), Govt. of the Punjab (Pakistan) fund research work in authors laboratories.	Adachi T, 2007, BIOSCI BIOTECH BIOCH, V71, P2266, DOI 10.1271/bbb.70241; Ahmad N, 2016, J EXP BOT, V67, P5945, DOI 10.1093/jxb/erw360; Ahmad N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041722; Ahmad N, 2012, PLANTA, V235, P863, DOI 10.1007/s00425-011-1584-8; Ahmad P, 2012, BIOTECHNOL ADV, V30, P524, DOI 10.1016/j.biotechadv.2011.09.006; Espinoza-Sanchez EA, 2016, PLANT BIOTECHNOL REP, V10, P61, DOI 10.1007/s11816-016-0386-7; Apel W, 2009, PLANT PHYSIOL, V151, P59, DOI 10.1104/pp.109.140533; Arakawa T, 1997, TRANSGENIC RES, V6, P403, DOI 10.1023/A:1018487401810; ARENCIBIA A, 1995, PLANT CELL REP, V14, P305, DOI 10.1007/BF00232033; ARNOLD W, 1988, J MOL BIOL, V203, P715, DOI 10.1016/0022-2836(88)90205-7; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331                                                        ; Boyce J. A., 2010, Journal of Allergy and Clinical Immunology, V126, pS1; Brookes G., 1996, J AGROBIOTECHNOL MAN, V23, P76; Chen Hao, 2013, Curr Opin Plant Biol, V16, P255, DOI 10.1016/j.pbi.2013.03.007; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5                                                    ; Christey MC, 2001, IN VITRO CELL DEV-PL, V37, P687; Christou P, 2013, TRENDS BIOTECHNOL, V31, P125, DOI 10.1016/j.tibtech.2013.01.006; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200                                                          ; Corneille S, 2001, PLANT J, V27, P171, DOI 10.1046/j.1365-313x.2001.01068.x; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; [Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Eichenseer H, 2008, J ECON ENTOMOL, V101, P555, DOI 10.1603/0022-0493(2008)101[555:FASOWB]2.0.CO;2; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; Estevan J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-67; Fischer N, 1996, MOL GEN GENET, V251, P373, DOI 10.1007/s004380050179; Fuentes P, 2016, ELIFE, V5, DOI 10.7554/eLife.13664; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gelvin SB, 2000, ANNU REV PLANT PHYS, V51, P223, DOI 10.1146/annurev.arplant.51.1.223; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gilbert N, 2013, NATURE, V497, P24, DOI 10.1038/497024a; Gnanasekaran T., 2016, J EXP BOT; Harada H, 2014, TRANSGENIC RES, V23, P303, DOI 10.1007/s11248-013-9750-3; Hibberd JM, 2016, NATURE, V538, P177, DOI 10.1038/538177b; HOEKEMA A, 1984, EMBO J, V3, P3043; Iamtham S, 2000, NAT BIOTECHNOL, V18, P1172, DOI 10.1038/81161; Ji QZ, 2014, NUCLEIC ACIDS RES, V42, P6158, DOI 10.1093/nar/gku243; Jung SK, 2014, BIOTECHNOL PROGR, V30, P905, DOI 10.1002/btpr.1888; Jung SK, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/405842; Kanchiswamy CN, 2015, TRENDS BIOTECHNOL, V33, P489, DOI 10.1016/j.tibtech.2015.04.002; Kellogg EA, 2013, CURR BIOL, V23, pR594, DOI 10.1016/j.cub.2013.04.066; Khan M.O., 2017, PROTIEN PEP IN PRESS; Kittiwongwattana C, 2007, PLANT MOL BIOL, V64, P137, DOI 10.1007/s11103-007-9140-4; Klaus SMJ, 2004, NAT BIOTECHNOL, V22, P225, DOI 10.1038/nbt933; Kolotilin I, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-65; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Kumar S, 2012, METAB ENG, V14, P19, DOI 10.1016/j.ymben.2011.11.005; Leegood RC, 2013, J PLANT PHYSIOL, V170, P378, DOI 10.1016/j.jplph.2012.10.011; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Liu C, 2014, NUCLEIC ACIDS RES, V42, P6106, DOI 10.1093/nar/gku284; Liu XJ, 2017, METHODS, V121, P94, DOI 10.1016/j.ymeth.2017.03.009; Longoni P, 2015, BIOMED RES INT, DOI 10.1155/2015/289759; Lossl A, 2005, PLANT CELL PHYSIOL, V46, P1462, DOI 10.1093/pcp/pci157; Lossl A, 2003, PLANT CELL REP, V21, P891, DOI 10.1007/s00299-003-0610-0; Lozano-Juste J, 2014, TRENDS PLANT SCI, V19, P284, DOI 10.1016/j.tplants.2014.02.014; Lu YH, 2013, P NATL ACAD SCI USA, V110, pE623, DOI 10.1073/pnas.1216898110; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Maliga P, 2003, TRENDS BIOTECHNOL, V21, P20, DOI 10.1016/S0167-7799(02)00007-0; Maliga P, 2002, CURR OPIN PLANT BIOL, V5, P164, DOI 10.1016/S1369-5266(02)00248-0; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mukhtar C.Z., 2009, THESIS; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Occhialini A, 2016, PLANT J, V85, P148, DOI 10.1111/tpj.13098; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Ort DR, 2015, P NATL ACAD SCI USA, V112, P8529, DOI 10.1073/pnas.1424031112; Pasoreck E.K., 2016, PLANT BIOTECHNOL J, P1; Paul JW, 2016, PLANT CELL REP, V35, P1417, DOI 10.1007/s00299-016-1985-z; Petersen K, 2011, PLANT MOL BIOL, V76, P311, DOI 10.1007/s11103-011-9742-8; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Pollack A., 2000, NY TIMES; Price GD, 2011, PLANT PHYSIOL, V155, P20, DOI 10.1104/pp.110.164681; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rolland V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00185; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Sainsbury F, 2014, CURR OPIN PLANT BIOL, V19, P1, DOI 10.1016/j.pbi.2014.02.003; Saunders K, 2013, NEW PHYTOL, V200, P16, DOI 10.1111/nph.12204; Saxena B, 2014, J BIOSCIENCES, V39, P33, DOI 10.1007/s12038-013-9402-z; SCHEID OM, 1991, MOL GEN GENET, V228, P104; Sharwood RE, 2016, CURR OPIN PLANT BIOL, V31, P135, DOI 10.1016/j.pbi.2016.04.002; STACHEL SE, 1986, CELL, V46, P325, DOI 10.1016/0092-8674(86)90653-7; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; TAKEMOTO D, 2014, PART BOMB MED TRANS, V1127, P91, DOI DOI 10.1007/978-1-62703-986-4_7; Teh AYH, 2014, PLANT BIOTECHNOL J, V12, P300, DOI 10.1111/pbi.12137; THOMASHOW MF, 1980, NATURE, V283, P794, DOI 10.1038/283794a0                                                                ; Tian J, 2014, J EXP BOT, V65, P311, DOI 10.1093/jxb/ert381; Tzfira T, 2002, TRENDS CELL BIOL, V12, P121, DOI 10.1016/S0962-8924(01)02229-2                                                   ; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Varallyay E, 2014, NUCLEIC ACIDS RES, V42, P599, DOI 10.1093/nar/gkt846; Whitney SM, 2015, P NATL ACAD SCI USA, V112, P3564, DOI 10.1073/pnas.1420536112; Wurbs D, 2007, PLANT J, V49, P276, DOI 10.1111/j.1365-313X.2006.02960.x; Yabuta Y, 2013, TRANSGENIC RES, V22, P391, DOI 10.1007/s11248-012-9656-5; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zaidi SSEA, 2017, TRENDS PLANT SCI, V22, P550, DOI 10.1016/j.tplants.2017.05.001; Zhang YL, 2017, PROG MOL BIOL TRANSL, V149, P133, DOI 10.1016/bs.pmbts.2017.03.008; Zhang Z., 2014, VIRUS INDUCED GENE S, P173; Zhao MM, 2014, PLANT J, V79, P440, DOI 10.1111/tpj.12579	110	0	0	50	50	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543	1089-8646		GENOMICS	Genomics	OCT	2017	109	5-6					494	505		10.1016/j.ygeno.2017.07.007				12	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FK8EF	WOS:000413739900020	28778540				2018-01-05	
J	Kohn, DB				Kohn, Donald B.			Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene Therapy	HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA			English	Article						Gene therapy; Hematopoietic stem cells; Gammaretroviral vector; Lentiviral vector; Gene editing; Site-specific endonucleases; Homologous recombination	SEVERE COMBINED IMMUNODEFICIENCY; HUMAN BETA-GLOBIN; ADENOSINE-DEAMINASE DEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; BONE-MARROW CELLS; PROGENITOR CELLS; CD34(+) CELLS; LENTIVIRAL VECTOR; RETROVIRAL TRANSFER; NONHUMAN-PRIMATES	Gene therapy using hematopoietic stem cells (HSCs) has developed over the past 3 decades, with progressive improvements in efficacy and safety. Autologous transplantation of HSCs modified with murine gammaretroviral vectors first showed clinical benefits for patients with several primary immune deficiencies, but some of these patients suffered complications from vector-related genotoxicity. Lentiviral vectors have been used recently for gene additions to HSCs and have yielded clinical benefits for primary immune deficiencies, metabolic diseases, and hemoglobinopathies, without vector-related complications. Gene editing using site-specific endonucleases is emerging as a promising technology for gene therapy and is moving into clinical trials.	[Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	Kohn, DB (reprint author), 3163 Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA.	dkohn1@mednet.ucla.edu					Hacein-Bey Abina S, 2015, JAMA-J AM MED ASSOC, V313, P50; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; ANDERSON WF, 1980, NEW ENGL J MED, V303, P1293, DOI 10.1056/NEJM198011273032210                                                     ; Baldwin K, 2015, STEM CELLS, V33, P1532, DOI 10.1002/stem.1957; Bauer TR, 1998, BLOOD, V91, P1520; BELMONT JW, 1986, NATURE, V322, P385, DOI 10.1038/322385a0; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Candotti F, 2012, BLOOD, V120, P3635, DOI 10.1182/blood-2012-02-400937; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Case SS, 1999, P NATL ACAD SCI USA, V96, P2988, DOI 10.1073/pnas.96.6.2988; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Charrier S, 2005, GENE THER, V12, P597, DOI 10.1038/sj.gt.3302440; Chhabra A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aae0501; Cicalese MP, 2016, BLOOD, V128, P45, DOI 10.1182/blood-2016-01-688226; CONE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6349, DOI 10.1073/pnas.81.20.6349; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Daniel MG, 2016, TRENDS CELL BIOL, V26, P202, DOI 10.1016/j.tcb.2015.10.002; Dao MA, 1998, BLOOD, V92, P4612; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Ravin SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8856; de Sio FRS, 2006, BLOOD, V107, P4257; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1                                                   ; DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125; Dravid GG, 2011, ADV DRUG DELIVER REV, V63, P331, DOI 10.1016/j.addr.2010.12.006; Dunbar CE, 1998, HUM GENE THER, V9, P2629, DOI 10.1089/hum.1998.9.17-2629; EGLITIS MA, 1985, SCIENCE, V230, P1395, DOI 10.1126/science.2999985                                                         ; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Fredrickson DS, 1991, BIOMEDICAL POLITICS, P258; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949                                                    ; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002716; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Gaspar HB, 2015, MOL THER, V23, pS102, DOI 10.1016/S1525-0016(16)33866-7                                                   ; Goncz KK, 2002, GENE THER, V9, P691, DOI 10.1038/sj.gt.3301743                                                           ; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GRUBER HE, 1985, SCIENCE, V230, P1057, DOI 10.1126/science.3864246                                                         ; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Jacobs P, 1980, WASHINGTON POST; KARLSSON S, 1988, P NATL ACAD SCI USA, V85, P6062, DOI 10.1073/pnas.85.16.6062; KOHN DB, 1995, NAT MED, V1, P1017, DOI 10.1038/nm1095-1017; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kurre P, 2001, MOL THER, V3, P920, DOI 10.1006/mthe.2001.0328; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lisowski L, 2008, BRIT J HAEMATOL, V141, P335, DOI 10.1111/j.1365-2141.2008.07098.x; Malech HL, 1997, P NATL ACAD SCI USA, V94, P12133, DOI 10.1073/pnas.94.22.12133; MARKOWITZ D, 1988, J VIROL, V62, P1120; May C, 2000, NATURE, V406, P82; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; MERCOLA KE, 1980, SCIENCE, V208, P1033, DOI 10.1126/science.6246577; MILLER AD, 1991, J VIROL, V65, P2220; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895                                                            ; MORITZ T, 1994, J CLIN INVEST, V93, P1451, DOI 10.1172/JCI117122                                                               ; Palchaudhuri R, 2016, NAT BIOTECHNOL, V34, P738, DOI 10.1038/nbt.3584; Petrillo C, 2015, MOL THER, V23, P352, DOI 10.1038/mt.2014.193; Pollok KE, 1998, J VIROL, V72, P4882; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Roselli EA, 2010, EMBO MOL MED, V2, P315, DOI 10.1002/emmm.201000083; Santilli G, 2011, MOL THER, V19, P122, DOI 10.1038/mt.2010.226; Jr Schmeck HM, 1981, NY TIMES; Schmidt M, 2003, NAT MED, V9, P463, DOI 10.1038/nm844; SCHUENING FG, 1991, BLOOD, V78, P2568; Shaw KL, 2017, J CLIN INVEST, V120, P3635; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Urbinati F, 2015, EXP HEMATOL, V43, P346, DOI 10.1016/j.exphem.2015.01.009; Wang CX, 2014, BLOOD, V124, P913, DOI 10.1182/blood-2013-12-546218; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; WILLIAMSON B, 1980, NATURE, V284, P397, DOI 10.1038/284397a0; Wivel NA, 2014, HUM GENE THER, V25, P19, DOI 10.1089/hum.2013.2524; Wu T, 2000, MOL THER, V1, P285, DOI 10.1006/mthe.2000.0034; Zufferey R, 1998, J VIROL, V72, P9873	81	0	0	7	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8588	1558-1977		HEMATOL ONCOL CLIN N	Hematol. Oncol. Clin. North Am.	OCT	2017	31	5					721	+		10.1016/j.hoc.2017.06.006				16	Oncology; Hematology	Oncology; Hematology	FI7CR	WOS:000412154200002	28895843				2018-01-05	
J	Athanasopoulos, T; Munye, MM; Yanez-Munoz, RJ				Athanasopoulos, Takis; Munye, Mustafa M.; Yanez-Munoz, Rafael J.			Nonintegrating Gene Therapy Vectors	HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA			English	Article						Nonintegrating; Gene therapy; Adenovirus vectors; Adeno-associated virus vectors; Poxvirus vector; Integration-deficient lentiviral vectors (IDLVs); Plasmid; Genome editing	DEFICIENT LENTIVIRAL VECTORS; SEVERE COMBINED IMMUNODEFICIENCY; HUMAN DENDRITIC CELLS; IN-VIVO; TRANSGENE EXPRESSION; ADENOASSOCIATED VIRUS; HEMOPHILIA-B; ARTIFICIAL CHROMOSOMES; EPISOMAL VECTORS; POXVIRUS VECTORS	Gene delivery vectors that do not rely on host cell genome integration offer several advantages for gene transfer, chiefly the avoidance of insertional mutagenesis and position effect variegation. However, unless engineered for replication and segregation, nonintegrating vectors will dilute progressively in proliferating cells, and are not exempt of epigenetic effects. This article provides an overview of the main nonintegrating viral (adenoviral, adeno-associated viral, integration-deficient retro-lentiviral, poxviral), and nonviral (plasmid vectors, artificial chromosomes) vectors used for preclinical and clinical cell and gene therapy applications. Particular emphasis is placed on their use in hematologic disease.	[Athanasopoulos, Takis; Munye, Mustafa M.] GSK Med Res Ctr, Cell & Gene Therapy Discovery Res, Platform Technol & Sci, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England; [Yanez-Munoz, Rafael J.] Royal Holloway Univ London, AGCTlab Org, Ctr Biomed Sci, Sch Biol Sci, Egham TW20 0EX, Surrey, England	Yanez-Munoz, RJ (reprint author), Royal Holloway Univ London, AGCTlab Org, Ctr Biomed Sci, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	rafael.yanez@royalholloway.ac.uk			Association Francaise contre les Myopathies Genoma Espana [14781]; European Union; Primary Immunodeficiency Association [2002/13]; Friends of Guy's Hospital [393]; Medical Research Council [G0301182]; SouthWest London Academic Network, Action Medical Research [SP4394]; Spinal Research [TR1004_04]; SMA Trust [HMR01140]; Royal Holloway, University of London; Clinigene [LSBH-CT-2006-018933/200805f, LSBH-CT-2006-018933/200805m]	R.J. Yanez-Munoz is the Editor-in-Chief of Gene Therapy. Research in the Yanez-Munoz laboratory has been funded by Association Francaise contre les Myopathies (14781) Genoma Espana, the European Union, the Primary Immunodeficiency Association (2002/13), the Friends of Guy's Hospital (393), the Medical Research Council (G0301182), the SouthWest London Academic Network, Action Medical Research (SP4394), Clinigene (LSBH-CT-2006-018933/Flexibility Funding 200805f and LSBH-CT-2006-018933/Flexibility Funding 200805m), Spinal Research (TR1004_04), The SMA Trust (HMR01140), and Royal Holloway, University of London. T. Athanasopou los and M. M. Munye are GSK employees. GSK's publication practices are intended to uphold GSK's commitment to the values of patient focus, transparency, and integrity.	Abboud G, 2016, J VIROL, V90, P129, DOI 10.1128/JVI.01894-15; Athanasopoulos T, 2000, INT J MOL MED, V6, P363; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Basu J, 2005, TRENDS MOL MED, V11, P251, DOI 10.1016/j.molmed.2005.03.006; Binny C, 2012, BLOOD, V119, P957, DOI 10.1182/blood-2011-09-377630; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Budker V, 1998, GENE THER, V5, P272, DOI 10.1038/sj.gt.3300572; Burshtyn DN, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00007; Cai YJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01911; Callan MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151800; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; Carmen IH, 2001, MOL THER, V3, P425, DOI 10.1006/mthe.2001.0305; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cianciola NL, 2017, J VIROL, V91, DOI 10.1128/JVI.01904-16; Cots D, 2013, CURR GENE THER, V13, P370, DOI 10.2174/156652321305131212125338                                                ; Crudele JM, 2015, BLOOD, V125, P1553, DOI 10.1182/blood-2014-07-588194; Daenthanasanmak A, 2012, VACCINE, V30, P5118, DOI 10.1016/j.vaccine.2012.05.063; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501                                                                 ; FECHHEIMER M, 1987, P NATL ACAD SCI USA, V84, P8463, DOI 10.1073/pnas.84.23.8463; FRALEY R, 1980, J BIOL CHEM, V255, P431; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949                                                    ; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Galla M, 2004, MOL CELL, V16, P309, DOI 10.1016/j.molcel.2004.09.023                                                    ; Gao X, 1996, BIOCHEMISTRY-US, V35, P1027, DOI 10.1021/bi952436a; George L, 2017, HAEMOPHILIA, V23, P15; GREEN MR, 1983, CELL, V35, P137, DOI 10.1016/0092-8674(83)90216-7; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639                                                              ; High KH, 2014, HAEMOPHILIA, V20, P43, DOI 10.1111/hae.12411; Huser D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000985; Jin SY, 2013, BLOOD, V121, P3825, DOI 10.1182/blood-2013-02-486779; Joglekar AV, 2013, MOL THER, V21, P1705, DOI 10.1038/mt.2013.106; KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kymalainen H, 2014, HUM GENE THER, V25, P428, DOI 10.1089/hum.2013.172; Laakkonen JP, 2015, HUM GENE THER, V26, P518, DOI 10.1089/hum.2015.095; Latchman DS, 2005, CURR OPIN MOL THER, V7, P415; Li LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069879; LITTLE RD, 1989, P NATL ACAD SCI USA, V86, P1598, DOI 10.1073/pnas.86.5.1598; Liu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10225; Lu JM, 2013, MOL THER, V21, P954, DOI 10.1038/mt.2013.33; Lu-Nguyen NB, 2014, HUM GENE THER, V25, P631, DOI 10.1089/hum.2014.003; Miller N, 2012, NAT REV DRUG DISCOV, V11, DOI 10.1038/nrd3572; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023                                                           ; Moldt B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-60; Monjezi R, 2017, LEUKEMIA, V31, P186, DOI 10.1038/leu.2016.180; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Moroziewicz D, 2005, CURR OPIN MOL THER, V7, P317; Munye MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23125; Musayev FN, 2015, J BIOL CHEM, V290, P27487, DOI 10.1074/jbc.M115.669960; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; NEUMANN E, 1982, EMBO J, V1, P841; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; Park Arnold, 2016, Mol Ther Methods Clin Dev, V3, P16057, DOI 10.1038/mtm.2016.57; Parks RJ, 1999, GENE THER, V6, P1565, DOI 10.1038/sj.gt.3300995; Pasi J, 2016, HAEMOPHILIA, V22, P151; Peluffo H, 2013, GENE THER, V20, P645, DOI 10.1038/gt.2012.78; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; Pol J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1115641; Poxviridae Moss B., 2013, FIELDS VIROLOGY, P2129; ROGERS S, 1968, NATURE, V219, P749, DOI 10.1038/219749a0; Saydaminova Kamola, 2015, Mol Ther Methods Clin Dev, V1, P14057, DOI 10.1038/mtm.2014.57; Scherer O, 2015, J IMMUNOL METHODS, V422, P118, DOI 10.1016/j.jim.2015.04.007; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4; Smith LJ, 2014, MOL THER, V22, P1625, DOI 10.1038/mt.2014.107; Smith RP, 2015, HUM GENE THER, V26, P377, DOI 10.1089/hum.2014.123; Srivastava A, 2016, CURR OPIN VIROL, V21, P75, DOI 10.1016/j.coviro.2016.08.003; Staunstrup NH, 2009, MOL THER, V17, P1205, DOI 10.1038/mt.2009.10; Tareen SU, 2014, MOL THER, V22, P575, DOI 10.1038/mt.2013.278; Tedesco FS, 2015, CHROMOSOME RES, V23, P135, DOI 10.1007/s10577-014-9460-6; TERHEGGEN HG, 1975, Z KINDERHEILKD, V119, P1, DOI 10.1007/BF00464689; Torres R, 2014, GENE THER, V21, P343, DOI 10.1038/gt.2014.1; Vanderplasschen A., 2003, Current Gene Therapy, V3, P583, DOI 10.2174/1566523034578168; Vargas J, 2004, HUM GENE THER, V15, P361, DOI 10.1089/104303404322959515; Vargas J, 2008, ANTIVIR RES, V80, P288, DOI 10.1016/j.antiviral.2008.06.015; Verardi PH, 2012, HUM VACC IMMUNOTHER, V8, P961, DOI 10.4161/hv.21080; Vigna E, 2000, J GENE MED, V2, P308; Volz A, 2017, ADV VIRUS RES, V97, P187, DOI 10.1016/bs.aivir.2016.07.001; Wanisch K, 2009, MOL THER, V17, P1316, DOI 10.1038/mt.2009.122; Wilde B, 2009, NEPHROL DIAL TRANSPL, V24, P2151, DOI 10.1093/ndt/gfp019; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Zinn E, 2015, CELL REP, V12, P1056, DOI 10.1016/j.celrep.2015.07.019; Zufferey R, 1998, J VIROL, V72, P9873	88	0	0	12	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8588	1558-1977		HEMATOL ONCOL CLIN N	Hematol. Oncol. Clin. North Am.	OCT	2017	31	5					753	+		10.1016/j.hoc.2017.06.007				19	Oncology; Hematology	Oncology; Hematology	FI7CR	WOS:000412154200004	28895845				2018-01-05	
J	Lux, CT; Scharenberg, AM				Lux, Christopher T.; Scharenberg, Andrew M.			Therapeutic Gene Editing Safety and Specificity	HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA			English	Article						Gene therapy; Safety; Specific; Gene editing; Off-target	ZINC-FINGER NUCLEASES; CRISPR-CAS NUCLEASES; IN-VIVO; GENOME; CLEAVAGE; CELLS; ARCHITECTURE; MUTAGENESIS; SEQ	Therapeutic gene editing is significant for medical advancement. Safety is intricately linked to the specificity of the editing tools used to cut at precise genomic targets. Improvements can be achieved by thoughtful design of nucleases and repair templates, analysis of off-target editing, and careful utilization of viral vectors. Advancements in DNA repair mechanisms and development of new generations of tools improve targeting of specific sequences while minimizing risks. It is important to plot a safe course for future clinical trials. This article reviews safety and specificity for therapeutic gene editing to spur dialogue and advancement.	[Lux, Christopher T.] Seattle Childrens Hosp, Dept Pediat, Canc & Blood Disorders Ctr, 4800 Sand Point Way NE, Seattle, WA 98105 USA; [Scharenberg, Andrew M.] Seattle Childrens Hosp, Dept Pediat, 4800 Sand Point Way NE, Seattle, WA 98105 USA; [Scharenberg, Andrew M.] Seattle Childrens Hosp, Dept Immunol, 4800 Sand Point Way NE, Seattle, WA 98105 USA	Lux, CT (reprint author), Seattle Childrens Hosp, Dept Pediat, Canc & Blood Disorders Ctr, 4800 Sand Point Way NE, Seattle, WA 98105 USA.	Christopher.Lux@seattlechildrens.org			NHLBI NIH HHS [R01 HL136135, K12 HL087165]		Bibikova M, 2002, GENETICS, V161, P1169; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Collins FS, 2015, STATEMENT NIH FUNDIN; Committee on Human Gene Editing: Scientific Medical and Ethical Considerations National Academy of Sciences National Academy of Medicine National Academies of Sciences Engineering and Medicine, 2017, HUM GEN ED SCI ETH G; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujikawa T, 2006, MOL PLANT MICROBE IN, V19, P342, DOI 10.1094/MPMI-19-0342; Handel EM, 2009, MOL THER, V17, P104, DOI 10.1038/mt.2008.233; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jones Benjamin S, 2014, Front Pharmacol, V5, P254, DOI 10.3389/fphar.2014.00254; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2015, NAT METHODS, V12, P465, DOI 10.1038/nmeth.3330; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Petek LM, 2010, MOL THER, V18, P983, DOI 10.1038/mt.2010.35; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Senis E, 2014, BIOTECHNOL J, V9, P1402, DOI 10.1002/biot.201400046; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Srivastava A, 2016, CURR OPIN VIROL, V21, P75, DOI 10.1016/j.coviro.2016.08.003; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wright DA, 2014, BIOCHEM J, V462, P15, DOI 10.1042/BJ20140295	31	0	0	13	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8588	1558-1977		HEMATOL ONCOL CLIN N	Hematol. Oncol. Clin. North Am.	OCT	2017	31	5					787	+		10.1016/j.hoc.2017.05.002				10	Oncology; Hematology	Oncology; Hematology	FI7CR	WOS:000412154200006	28895847				2018-01-05	
J	Ando, D; Meyer, K				Ando, Dale; Meyer, Kathleen			Gene Editing Regulatory and Translation to Clinic	HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA			English	Article						Genome editing; Zinc finger nucleases; Hematopoietic stem and progenitor cells; CCR5; Genotoxicity; Safety assessment	DOUBLE-STRAND BREAKS; HEMATOPOIETIC STEM-CELLS; ZINC-FINGER NUCLEASES; HIV-1 INFECTION; HISTONE H2AX; IN-VIVO; 53BP1; CCR5; THERAPY; TRANSPLANTATION	The clinical application and regulatory strategy of genome editing for ex vivo cell therapy is derived from the intersection of 2 fields of study: viral vector gene therapy trials and clinical trials with ex vivo purification and engraftment of CD34(+) hematopoietic stem cells, T cells, and tumor cell vaccines. This article covers the regulatory and translational preclinical activities needed for a genome editing clinical trial modifying hematopoietic stem cells and the genesis of this current strategy based on previous clinical trials using genome-edited T cells. The SB-728 zinc finger nuclease platform is discussed because this is the most clinically advanced genome editing technology.	[Ando, Dale] Gene Editing & Gene Therapy Consulting, 159 Venado Corte, Walnut Creek, CA 94598 USA; [Meyer, Kathleen] Sangamo Therapeut, Nonclin Dev, 501 Canal Blvd,Suite A100, Richmond, CA 94804 USA	Ando, D (reprint author), Gene Editing & Gene Therapy Consulting, 159 Venado Corte, Walnut Creek, CA 94598 USA.; Meyer, K (reprint author), Sangamo Therapeut, Nonclin Dev, 501 Canal Blvd,Suite A100, Richmond, CA 94804 USA.	dgando@aol.com; kmeyer@sangamo.com					Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Deeks SG, 2002, MOL THER, V5, P788, DOI 10.1006/mthe.2002.0611; DiGiusto DL, 2016, MOL THER-METH CLIN D, V3, P1; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jansen J, 2005, J CELL MOL MED, V9, P37, DOI 10.1111/j.1582-4934.2005.tb00335.x                                              ; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kuramoto K, 2004, BLOOD, V104, P1273, DOI 10.1182/blood-2003-08-2935; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Nemunaitis J, 1999, CANCER GENE THER, V6, P322, DOI 10.1038/sj.cgt.7700019                                                          ; PUCK TT, 1956, J EXP MED, V103, P273, DOI 10.1084/jem.103.2.273; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Risueno RM, 2011, BLOOD, V117, P7112, DOI 10.1182/blood-2011-01-329078; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477                                                    ; Slavin S, 1998, BLOOD, V91, P756; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Wang GP, 2009, MOL THER, V17, P844, DOI 10.1038/mt.2009.16; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Yannaki E, 2013, HUM GENE THER, V24, P852, DOI 10.1089/hum.2013.163	38	0	0	2	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8588	1558-1977		HEMATOL ONCOL CLIN N	Hematol. Oncol. Clin. North Am.	OCT	2017	31	5					797	+		10.1016/j.hoc.2017.06.002				13	Oncology; Hematology	Oncology; Hematology	FI7CR	WOS:000412154200007	28895848				2018-01-05	
J	Rogers, GL; Cannon, PM				Rogers, Geoffrey L.; Cannon, Paula M.			Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases	HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA			English	Article						Gene therapy; HIV; Gene editing; Targeted nuclease; Cas9; AAV	ZINC-FINGER-NUCLEASES; HIV-1 PROVIRAL DNA; CD4(+) T-CELLS; SEQUENCE-SPECIFIC ANTIMICROBIALS; BROADLY NEUTRALIZING ANTIBODIES; HEMATOPOIETIC STEM-CELLS; IN-VIVO; CRISPR/CAS9 SYSTEM; NONHUMAN-PRIMATES; RNA INTERFERENCE	Advances in gene therapy technologies, particularly in gene editing, are suggesting new avenues for the treatment of human immunodeficiency virus and other infectious diseases. This article outlines recent developments in antiviral gene therapies, including those based on the disruption of entry receptors or that target viral genomes using targeted nucleases, such as the CRISPR/Cas9 system. In addition, new ways to express circulating antiviral factors, such as antibodies, and approaches to harness and engineer the immune system to provide an antiviral effect that is not naturally achieved are described.	[Rogers, Geoffrey L.; Cannon, Paula M.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, 2011 Zonal Ave,HMR 413A, Los Angeles, CA 90033 USA	Cannon, PM (reprint author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, 2011 Zonal Ave,HMR 413A, Los Angeles, CA 90033 USA.	pcannon@usc.edu					Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Alhoot MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034060; Alhoot MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001410; Ali A, 2016, J VIROL, V90, P6999, DOI 10.1128/JVI.00805-16; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Badia R, 2014, J ANTIMICROB CHEMOTH, V69, P1755, DOI 10.1093/jac/dku072; Balazs AB, 2013, NAT BIOTECHNOL, V31, P647, DOI 10.1038/nbt.2618; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bobbin ML, 2016, ANNU REV PHARMACOL, V56, P103, DOI 10.1146/annurev-pharmtox-010715-103633; Braff D, 2016, ADV DRUG DELIVER REV, V105, P35, DOI 10.1016/j.addr.2016.04.006; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chinn LW, 2010, J INFECT DIS, V202, P1836, DOI 10.1086/657322; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621                                                           ; Dampier W., 2014, MOJ IMMUNOL, V1; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; DiGiusto DL, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.67; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Ebina H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120047; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Ely A, 2016, MOL THER, V24, P671, DOI 10.1038/mt.2016.43; Feelixge HSD, 2016, ANTIVIR RES, V126, P90, DOI 10.1016/j.antiviral.2015.12.007; Fuchs SP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005090; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Galvani AP, 2005, MICROBES INFECT, V7, P302, DOI 10.1016/j.micinf.2004.12.006; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Grimm Dirk, 2007, Hematology Am Soc Hematol Educ Program, P473; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507                                                     ; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Huang Diana D, 2008, Curr HIV/AIDS Rep, V5, P33, DOI 10.1007/s11904-008-0006-4; Jackson HJ, 2016, NAT REV CLIN ONCOL, V13, P370, DOI 10.1038/nrclinonc.2016.36; Jahan Shah, 2011, Genet Vaccines Ther, V9, P15, DOI 10.1186/1479-0556-9-15; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Kiem HP, 2012, CELL STEM CELL, V10, P137, DOI 10.1016/j.stem.2011.12.015; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kohn DB, 2016, BLOOD, V127, P2553, DOI 10.1182/blood-2016-01-678136; Kumar SRP, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.34; Lagenaur LA, 2011, MUCOSAL IMMUNOL, V4, P648, DOI 10.1038/mi.2011.30; Leibman RS, 2015, MOL THER, V23, P1149, DOI 10.1038/mt.2015.70; Lewis AD, 2002, J VIROL, V76, P8769, DOI 10.1128/JVI.76.17.8769-8775.2002; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Limberis MP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006299; Limsirichai P, 2016, MOL THER, V24, P499, DOI 10.1038/mt.2015.213; Liu L, 2015, J VIROL, V89, P6685, DOI 10.1128/JVI.00474-15; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lundstrom K, 2015, VIRUSES-BASEL, V7, P4482, DOI 10.3390/v7082830; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Martinez-Navio JM, 2016, MOL THER, V24, P76, DOI 10.1038/mt.2015.191; Miles B, 2016, TRENDS MICROBIOL, V24, P338, DOI 10.1016/j.tim.2016.02.006; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Peterson CW, 2016, BLOOD, V127, P2416, DOI 10.1182/blood-2015-09-672337; Pires DP, 2016, MICROBIOL MOL BIOL R, V80, P523, DOI 10.1128/MMBR.00069-15; Porichis F, 2012, CURR HIV-AIDS REP, V9, P81, DOI [10.1007/s11904-011-0106-4, 10.1007/s11904-011-0106]; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Saayman SM, 2016, MOL THER, V24, P488, DOI 10.1038/mt.2015.202; Sahu GK, 2013, VIROLOGY, V446, P268, DOI 10.1016/j.virol.2013.08.002; Santa-Marta M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00343; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Saunders KO, 2015, J VIROL, V89, P8334, DOI 10.1128/JVI.00908-15; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Skaricic D, 2008, VIROLOGY, V378, P79, DOI 10.1016/j.virol.2008.04.016; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stephenson KE, 2016, CURR OPIN IMMUNOL, V41, P39, DOI 10.1016/j.coi.2016.05.011; Stone D, 2016, HUM GENET, V135, P1071, DOI 10.1007/s00439-016-1686-2; Strong CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125652; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Voit RA, 2013, MOL THER, V21, P786, DOI 10.1038/mt.2012.284; Wang CX, 2016, BLOOD, V127, P2546, DOI 10.1182/blood-2016-01-678144; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; WANG JB, 2016, NUCL ACIDS RES, V44; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Wang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083908; White MK, 2015, DISCOV MED, V19, P255; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Yi GH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.52; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; Yuan JY, 2012, MOL THER, V20, P849, DOI 10.1038/mt.2011.310; Zhen AJ, 2015, MOL THER, V23, P1358, DOI 10.1038/mt.2015.102; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z	104	0	0	19	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8588	1558-1977		HEMATOL ONCOL CLIN N	Hematol. Oncol. Clin. North Am.	OCT	2017	31	5					883	+		10.1016/j.hoc.2017.06.008				14	Oncology; Hematology	Oncology; Hematology	FI7CR	WOS:000412154200013	28895854				2018-01-05	
J	Abramowski-Mock, U; Delhove, JM; Qasim, W				Abramowski-Mock, Ulrike; Delhove, Juliette M.; Qasim, Waseem			Gene Modified T Cell Therapies for Hematological Malignancies	HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA			English	Article						Gene therapy; Gene editing; Adoptive immunotherapy; T cell receptor; Chimeric antigen receptor; Lentiviral vectors; Leukemia; Lymphoma	CHIMERIC-ANTIGEN-RECEPTOR; ACUTE MYELOID-LEUKEMIA; ZINC-FINGER NUCLEASES; B-CELL; CANCER-IMMUNOTHERAPY; ADOPTIVE IMMUNOTHERAPY; IMMUNE CHECKPOINTS; MULTIPLE-MYELOMA; CLINICAL-TRIAL; LYMPHOCYTES	This article focuses on clinical applications of T cells transduced to express recombinant T-cell receptor and chimeric antigen receptor constructs directed toward hematological malignancies, and considers newer strategies incorporating gene-editing technologies to address graft-versus-host disease and host-mediated rejection. Recent data from clinical trials are reviewed, and an overview is provided of current and emerging manufacturing processes; consideration is also given to new developments in the pipeline.	[Abramowski-Mock, Ulrike; Delhove, Juliette M.; Qasim, Waseem] UCL, Mol & Cellular Immunol Unit, UCL Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England	Qasim, W (reprint author), UCL, Mol & Cellular Immunol Unit, UCL Great Ormond St Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	w.qasim@ucl.ac.uk			Cellectis/Servier, Miltenyi Biotec, Bellicum, and Autolus Ltd; Autolus and Orchard Therapeutics; National Institute for Health Research [NIHR RP 2014-05-007]; Biomedical Research Centre at UCL Great Ormond Street Institute of Child Health; Innovate UK [167152]	U. Abramowski-Mock and J.M. Delhove declare that they have no conflict of interest. W. Qasim holds contract research/trials funding from Cellectis/Servier, Miltenyi Biotec, Bellicum, and Autolus Ltd, and has received consulting fees from Autolus and Orchard Therapeutics; W. Qasim has a patent application pending for gene-edited T cells. W. Qasim/ U. Abramowski-Mock supported by National Institute for Health Research (grant no: NIHR RP 2014-05-007), which also supports the Biomedical Research Centre at UCL Great Ormond Street Institute of Child Health. J.M. Delhove is supported by Innovate UK (grant no: 167152). Molecular and Cellular Immunology Unit, University college London, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK	Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brudno JN, 2016, J CLIN ONCOL, V34, P1112, DOI 10.1200/JCO.2015.64.5929; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Casati A, 2013, CANCER IMMUNOL IMMUN, V62, P1563, DOI 10.1007/s00262-013-1459-x; Cruz CRY, 2013, BLOOD, V122, P2965, DOI 10.1182/blood-2013-06-506741; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Deniger DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128151; Fraietta JA, 2016, BLOOD, V127, P1117, DOI 10.1182/blood-2015-11-679134; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guo B, 2016, J CELL IMMUNOTHER, V2, P28, DOI DOI 10.1016/J.JOCIT.2014.11.001; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Jensen MC, 2010, BIOL BLOOD MARROW TR, V16, P1245, DOI 10.1016/j.bbmt.2010.03.014; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; Kenderian SS, 2015, LEUKEMIA, V29, P1637, DOI 10.1038/leu.2015.52; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; lwai Y., 2002, P NATL ACAD SCI USA, V99, P12293; Mardiros A, 2015, CURR OPIN HEMATOL, V22, P484, DOI 10.1097/MOH.0000000000000190; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mock U, 2016, CYTOTHERAPY, V18, P1002, DOI 10.1016/j.jcyt.2016.05.009; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Ochi T, 2011, BLOOD, V118, P1495, DOI 10.1182/blood-2011-02-337089; Osborn MJ, 2016, MOL THER, V24, P570, DOI 10.1038/mt.2015.197; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Priesner C, 2016, HUM GENE THER, V27, P860, DOI 10.1089/hum.2016.091; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Qasim W, 2015, BLOOD, V126, P2046; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Qasim W, 2015, J HEPATOL, V62, P486, DOI 10.1016/j.jhep.2014.10.001; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Ramos CA, 2016, J CLIN INVEST, V126, P2588, DOI 10.1172/JCI86000; Reardon S, 2016, NATURE NEWS; Ritchie DS, 2013, MOL THER, V21, P2122, DOI 10.1038/mt.2013.154; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rothe A, 2015, BLOOD, V125, P4024, DOI 10.1182/blood-2014-12-614636; Ruella M, 2016, J CLIN INVEST, V126, P3814, DOI 10.1172/JCI87366; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sallusto F, 2014, J IMMUNOL, V192, P708; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Schmitt TM, 2013, BLOOD, V122, P348, DOI 10.1182/blood-2013-01-478164; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Singh Nathan, 2014, Cancer Immunol Res, V2, P1059, DOI 10.1158/2326-6066.CIR-14-0051; Sledzinska A, 2015, MOL ONCOL, V9, P1936, DOI 10.1016/j.molonc.2015.10.008; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang QS, 2015, MOL THER, V23, P184, DOI 10.1038/mt.2014.164; Wang WS, 2009, INT IMMUNOL, V21, P1065, DOI 10.1093/intimm/dxp072; Wang XL, 2016, BLOOD, V127, P2980, DOI 10.1182/blood-2015-12-686725; Wang Y, 2014, CLIN IMMUNOL, V155, P160, DOI 10.1016/j.clim.2014.10.002; Xu Y, 2014, BLOOD, V123, P3750, DOI 10.1182/blood-2014-01-552174; Xue S, 2005, CLIN EXP IMMUNOL, V139, P167, DOI 10.1111/j.1365-2249.2005.02715.x	78	0	0	6	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8588	1558-1977		HEMATOL ONCOL CLIN N	Hematol. Oncol. Clin. North Am.	OCT	2017	31	5					913	+		10.1016/j.hoc.2017.06.005				15	Oncology; Hematology	Oncology; Hematology	FI7CR	WOS:000412154200015	28895856				2018-01-05	
J	Nakayama, T; Wu, J; Galvin-Parton, P; Weiss, J; Andriola, MR; Hill, RS; Vaughan, DJ; El-Quessny, M; Barry, BJ; Partlow, JN; Barkovich, AJ; Ling, JQ; Mochida, GH				Nakayama, Tojo; Wu, Jiang; Galvin-Parton, Patricia; Weiss, Jody; Andriola, Mary R.; Hill, R. Sean; Vaughan, Dylan J.; El-Quessny, Malak; Barry, Brenda J.; Partlow, Jennifer N.; Barkovich, A. James; Ling, Jiqiang; Mochida, Ganeshwaran H.			Deficient activity of alanyl-tRNA synthetase underlies an autosomal recessive syndrome of progressive microcephaly, hypomyelination, and epileptic encephalopathy	HUMAN MUTATION			English	Article						AARS; aminoacylation defect; hypomyelination; microcephaly; transfer RNA	MARIE-TOOTH-DISEASE; AARS MUTATION; NEUROPATHY; MEDICINE; ATROPHY; BINDING	Aminoacyl-transfer RNA (tRNA) synthetases ligate amino acids to specific tRNAs and are essential for protein synthesis. Although alanyl-tRNA synthetase (AARS) is a synthetase implicated in a wide range of neurological disorders from Charcot-Marie-Tooth disease to infantile epileptic encephalopathy, there have been limited data on their pathogenesis. Here, we report loss-offunction mutations in AARS in two siblings with progressive microcephaly with hypomyelination, intractable epilepsy, and spasticity. Whole-exome sequencing identified that the affected individuals were compound heterozygous for mutations in AARS gene, c.2067dupC (p.Tyr690Leufs*3) and c.2738G>A (p.Gly913Asp). A lymphoblastoid cell line developed from one of the affected individuals showed a strong reduction in AARS abundance. The mutations decrease aminoacylation efficiency by 70%-90%. The p.Tyr690Leufs*3 mutation also abolished editing activity required for hydrolyzing misacylated tRNAs, thereby increasing errors during aminoacylation. Our study has extended potential mechanisms underlying AARS-related disorders to include destabilization of the protein, aminoacylation dysfunction, and defective editing activity.	[Nakayama, Tojo; Hill, R. Sean; Vaughan, Dylan J.; El-Quessny, Malak; Barry, Brenda J.; Partlow, Jennifer N.; Mochida, Ganeshwaran H.] Boston Childrens Hosp, Dept Med, Div Genet & Genom, 300 Longwood Ave,BCH3150, Boston, MA 02115 USA; [Nakayama, Tojo; Hill, R. Sean; Vaughan, Dylan J.; El-Quessny, Malak; Barry, Brenda J.; Partlow, Jennifer N.; Mochida, Ganeshwaran H.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Nakayama, Tojo; Mochida, Ganeshwaran H.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Wu, Jiang; Ling, Jiqiang] Univ Texas Hlth Sci Ctr Houston, Med Sch, Dept Microbiol & Mol Genet, 6431 Fannin St,MSE R268, Houston, TX 77030 USA; [Galvin-Parton, Patricia; Weiss, Jody; Andriola, Mary R.] SUNY Stony Brook, Med Ctr, Dept Pediat, Stony Brook, NY 11794 USA; [Hill, R. Sean; Barry, Brenda J.; Partlow, Jennifer N.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Ling, Jiqiang] Grad Sch Biomed Sci, Houston, TX USA; [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA; [El-Quessny, Malak] Univ Calif Berkeley, Neurosci Grad Program, Berkeley, CA 94720 USA	Mochida, GH (reprint author), Boston Childrens Hosp, Dept Med, Div Genet & Genom, 300 Longwood Ave,BCH3150, Boston, MA 02115 USA.; Ling, JQ (reprint author), Univ Texas Hlth Sci Ctr Houston, Med Sch, Dept Microbiol & Mol Genet, 6431 Fannin St,MSE R268, Houston, TX 77030 USA.	jiqiang.ling@uth.tmc.edu; Ganesh.Mochida@childrens.harvard.edu			Manton Center for Orphan Disease Research; NINDS [R01NS035129]; NIH/Fogarty International Center [R21TW008223]; NIGMS [R01GM115431]; Dubai Harvard Foundation for Medical Research; Japan Foundation for Pediatric Research; Japan Society for the Promotion of Science; F. Hoffmann-La Roche Ltd.; Qatar National Research Fund; Boston Children's Hospital Faculty Career Development Award	Contract grant sponsors: Manton Center for Orphan Disease Research; NINDS (R01NS035129); NIH/Fogarty International Center (R21TW008223); NIGMS (R01GM115431); Dubai Harvard Foundation for Medical Research; Japan Foundation for Pediatric Research; Japan Society for the Promotion of Science; F. Hoffmann-La Roche Ltd.; Qatar National Research Fund; Boston Children's Hospital Faculty Career Development Award.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039                                                                  ; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Bansagi B, 2015, J NEUROL, V262, P1899, DOI 10.1007/s00415-015-7778-4; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065                                                            ; England JD, 2009, NEUROLOGY, V72, P185, DOI [10.1212/01.wnl.0000336370.51010.a1, 10.1212/01.wnl.0000336370.51010.al]; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617                                                ; Kodera H, 2015, J HUM GENET, V60, P97, DOI 10.1038/jhg.2014.103; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Liu Y, 2014, P NATL ACAD SCI USA, V111, P17570, DOI 10.1073/pnas.1420196111; Liu YT, 2014, NEUROLOGY, V83, P612, DOI 10.1212/WNL.0000000000000691; Mascarenhas A.P., 2008, PROTEIN ENG, P153; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; McMillan HJ, 2015, J CHILD NEUROL, V30, P1037, DOI 10.1177/0883073814553272; Motley WW, 2015, NEUROLOGY, V84, P2040, DOI 10.1212/WNL.0000000000001583; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Simons C, 2015, AM J HUM GENET, V96, P675, DOI 10.1016/j.ajhg.2015.02.012; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Wolf NI, 2014, ANN NEUROL, V76, P134, DOI 10.1002/ana.24167; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhang XC, 2014, AM J HUM GENET, V94, P547, DOI 10.1016/j.ajhg.2014.03.003	26	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-7794	1098-1004		HUM MUTAT	Hum. Mutat.	OCT	2017	38	10					1348	1354		10.1002/humu.23250				7	Genetics & Heredity	Genetics & Heredity	FI2BA	WOS:000411740400007	28493438				2018-01-05	
J	Burnett, DL; Parish, IA; Masle-Farquhar, E; Brink, R; Goodnow, CC				Burnett, Deborah L.; Parish, Ian A.; Masle-Farquhar, Etienne; Brink, Robert; Goodnow, Christopher C.			Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation	IMMUNOLOGY AND CELL BIOLOGY			English	Article							REACTIVE B-CELLS; CHRONIC VIRAL-INFECTION; T FOLLICULAR HELPER; GENE MUTATION; PLASMA-CELL; AUTOIMMUNITY; DISEASE; RESPONSES; DELETION; ANTIGEN	Inherited mutations in lipopolysaccharide-responsive beige-like anchor (LRBA) cause a recessive human immune dysregulation syndrome with memory B-cell and antibody deficiency (common variable immunodeficiency), inflammatory bowel disease, enlarged spleen and lymph nodes, accumulation of activated T cells and multiple autoimmune diseases. To understand the pathogenesis of the syndrome, C57BL/6 mice carrying a homozygous truncating mutation in Lrba were produced using CRISPR/Cas9-mediated gene targeting. These mice revealed that LRBA has a critical, cell-autonomous role in promoting cytotoxic T-lymphocyte antigen-4 (CTLA-4) accumulation within CD4 effector T cells and FOXP3(+) T-regulatory cells (Tregs). In young mice, or in chimeric mice where only half of the T cells are LRBA deficient, low CTLA-4 was the only detectable abnormality in Tregs, whereas in old mice FOXP3 was also decreased. Low CTLA-4 did not translate into increased CD86 on B cells unless the LRBA-deficient mice were immunised, and neither immunisation nor chronic lymphocytic choriomeningitis virus infection precipitated immune dysregulation. LRBA deficiency did not alter antigen-specific B-cell activation, germinal centre (GC) formation, isotype switching or affinity maturation. Paradoxically, CD86 was decreased on GC B cells in LRBA-deficient mice, pointing to compensatory mechanisms for controlling CD86 in the face of low CTLA-4. These results add to the experimental rationale for treating LRBA deficiency with the CTLA4-Ig fusion protein, Abatacept, and pose questions about the limitations of laboratory experiments in mice to reproduce human disease in natura.	[Burnett, Deborah L.; Masle-Farquhar, Etienne; Brink, Robert; Goodnow, Christopher C.] Garvan Inst Med Res, Immunol Div, 384 Victoria St, Sydney, NSW 2010, Australia; [Parish, Ian A.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia	Goodnow, CC (reprint author), Garvan Inst Med Res, Immunol Div, 384 Victoria St, Sydney, NSW 2010, Australia.	c.goodnow@garvan.org.au			NHMRC [1108800, 1016953, 1113904, 1081858]; NIH [U19 AI100627]; Ritchie Family Foundation	We thank the Garvan Institute ABR, GMG and Flow Cytometry facilities for expert animal husbandry, genotyping and cell sorting. This work was supported by NHMRC Project Grant 1108800, NHMRC Program Grants 1016953 and 1113904, NIH Grant U19 AI100627 and NHMRC Fellowship 1081858, and by the Ritchie Family Foundation.	Alangari A, 2012, J ALLERGY CLIN IMMUN, V130, P481, DOI 10.1016/j.jaci.2012.05.043; Alhakeem SS, 2015, ANN NY ACAD SCI, V1362, P239, DOI 10.1111/nyas.12802; Alkhairy OK, 2016, J CLIN IMMUNOL, V36, P33, DOI 10.1007/s10875-015-0224-7; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Burns SO, 2012, J ALLERGY CLIN IMMUN, V130, P1428, DOI 10.1016/j.jaci.2012.07.035; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Charbonnier LM, 2015, J ALLERGY CLIN IMMUN, V135, P217, DOI 10.1016/j.jaci.2014.10.019; Cullinane AR, 2013, TRAFFIC, V14, P749, DOI 10.1111/tra.12069; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; FEUCHTER AE, 1992, GENOMICS, V13, P1237, DOI 10.1016/0888-7543(92)90041-P; Gamez-Diaz L, 2016, J ALLERGY CLIN IMMUN, V137, P223, DOI 10.1016/j.jaci.2015.09.025; Garcia B, 1996, EUR J IMMUNOL, V26, P2364, DOI 10.1002/eji.1830261014; Hou TZ, 2017, BLOOD, V129, P1458, DOI 10.1182/blood-2016-10-745174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Klocke K, 2016, P NATL ACAD SCI USA, V113, pE2383, DOI 10.1073/pnas.1603892113; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lee S, 2016, J ALLERGY CLIN IMMUN, V137, P327, DOI 10.1016/j.jaci.2015.08.036; Levy E, 2016, CLIN IMMUNOL, V168, P88, DOI 10.1016/j.clim.2016.03.006; Lo B, 2015, SCIENCE, V349, P436, DOI [10.1126/science.aaa1663, DOI 10.1126/SCIENCE.AAA1663]; Lopez-Herrera G, 2012, AM J HUM GENET, V90, P986, DOI 10.1016/j.ajhg.2012.04.015; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Parish IA, 2014, J CLIN INVEST, V124, P3455, DOI [10.1172/JC166108, 10.1172/JCI66108]; Paterson AM, 2015, J EXP MED, V212, P1603, DOI 10.1084/jem.20141030; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x                                                  ; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651                                                           ; Revel-Vilk S, 2015, CLIN IMMUNOL, V159, P84, DOI 10.1016/j.clim.2015.04.007; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sari S, 2016, J CLIN IMMUNOL, V36, P8, DOI 10.1007/s10875-015-0220-y; Schreiner F, 2016, J CLIN ENDOCR METAB, V101, P898, DOI 10.1210/jc.2015-3382; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Seidel MG, 2015, J ALLERGY CLIN IMMUN, V135, P1384, DOI 10.1016/j.jaci.2014.10.048; Serwas NK, 2015, INFLAMM BOWEL DIS, V21, P40, DOI 10.1097/MIB.0000000000000266; Sindhava V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011445; Tesi B, 2016, J CLIN IMMUNOL, V36, P480, DOI 10.1007/s10875-016-0289-y; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Wang JW, 2001, J IMMUNOL, V166, P4586, DOI 10.4049/jimmunol.166.7.4586                                                     ; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Yi TS, 2015, IMMUNITY, V43, P764, DOI 10.1016/j.immuni.2015.08.021; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205                                                         	49	0	0	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0818-9641	1440-1711		IMMUNOL CELL BIOL	Immunol. Cell Biol.	OCT	2017	95	9					775	788		10.1038/icb.2017.50				14	Cell Biology; Immunology	Cell Biology; Immunology	FJ4AT	WOS:000412676500007	28611475				2018-01-05	
J	Huang, YP; Wang, YJ; Zeng, BS; Liu, ZX; Xu, XJ; Meng, Q; Huang, YP; Yang, G; Vasseur, L; Gurr, GM; You, MS				Huang, Yuping; Wang, Yajun; Zeng, Baosheng; Liu, Zhaoxia; Xu, Xuejiao; Meng, Qian; Huang, Yongping; Yang, Guang; Vasseur, Liette; Gurr, Geoff M.; You, Minsheng			Functional characterization of Pol III U6 promoters for gene knockdown and knockout in Plutella xylostella	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						CRISPR/Cas9; Diamondback moth; Lepidoptera; Pest control; shRNA; sgRNA	SHORT HAIRPIN RNAS; BOMBYX-MORI; EXPRESSION; TRANSCRIPTION; CRISPR/CAS9; SILKWORM; SYSTEM; DRIVE; CELLS	RNA polymerase type III (Pol-III) promoters such as U6 are commonly used to express small RNAs, including short hairpin RNAs (shRNAs) and single guide RNAs (sgRNAs). Functional U6 promoters are widely used in CRISPR systems, and their characterization can facilitate genome editing of non-model organisms. In the present study, six U6 small nuclear RNA (snRNA) promoters containing two conserved elements of a proximal sequence element (PSEA) and a TATA box, were identified and characterized in the diamondback moth (Plutella xylostella) genome. Relative efficiency of the U6 promoters to express shRNA induced EGFP knockdown was tested in a P. xylostella cell line, revealing that the PxU6:3 promoter had the strongest expression effect. Further work with the PxU6:3 promoter showed its efficacy in EGFP knockout using CRISPR/Cas9 system in the cells. The expression plasmids with versatile Pxabd-A gene specific sgRNA driven by the PxU6:3 promoter, combined with Cas9 mRNA, could induce mutagenesis at specific genomic loci in vivo. The phenotypes induced by sgRNA expression plasmids were similar to those done in vitro transcription sgRNAs. A plasmid with two tandem arranged PxU6:3:sgRNA expression cassettes targeting Pxabd-A loci was generated, which caused a 28,856 bp fragment deletion, suggesting that the multi-sgRNA expression plasmid can be used for multi-targeting. Our work indicates that U6 snRNA promoters can be used for functional studies of genes with the approach of reverse genetics in P. xylostella. These essential promoters also provide valuable potential for CRISPR-derived gene drive as a tactic for population control in this globally significant pest. (C) 2017 Elsevier Ltd. All rights reserved.	[Huang, Yuping; Wang, Yajun; Liu, Zhaoxia; Xu, Xuejiao; Meng, Qian; Yang, Guang; Vasseur, Liette; Gurr, Geoff M.; You, Minsheng] Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian Taiwan Cro, Fuzhou 350002, Fujian, Peoples R China; [Huang, Yuping; Wang, Yajun; Liu, Zhaoxia; Xu, Xuejiao; Meng, Qian; Yang, Guang; Vasseur, Liette; Gurr, Geoff M.; You, Minsheng] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou 350002, Fujian, Peoples R China; [Huang, Yuping; Wang, Yajun; Liu, Zhaoxia; Xu, Xuejiao; Meng, Qian; Yang, Guang; Vasseur, Liette; Gurr, Geoff M.; You, Minsheng] Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou 350002, Fujian, Peoples R China; [Huang, Yuping; Wang, Yajun; Liu, Zhaoxia; Xu, Xuejiao; Meng, Qian; Yang, Guang; Gurr, Geoff M.; You, Minsheng] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Innovat Ctr Ecol Control Crop, Fuzhou 350002, Fujian, Peoples R China; [Huang, Yuping; Wang, Yajun; Liu, Zhaoxia; Xu, Xuejiao; Meng, Qian; Yang, Guang; You, Minsheng] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou 350002, Fujian, Peoples R China; [Zeng, Baosheng; Huang, Yongping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Vasseur, Liette] Brock Univ, Dept Biol Sci, 1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada; [Gurr, Geoff M.] Charles Sturt Univ, Graham Ctr, Orange, NSW 2800, Australia	You, MS (reprint author), Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian Taiwan Cro, Fuzhou 350002, Fujian, Peoples R China.; You, MS (reprint author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou 350002, Fujian, Peoples R China.	msyou@iae.fjau.edu.cn			National Natural Science Foundation of China [31320103922, 31230061]	This Research was supported by the National Natural Science Foundation of China (No. 31320103922 and No. 31230061).	Alphey L, 2016, NAT BIOTECHNOL, V34, P149, DOI 10.1038/nbt.3473; BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999                                                         ; Chen Lei, 2016, [Zoological Research, 动物学研究], V37, P220, DOI 10.13918/j.issn.2095-8137.2016.4.220; Dahlberg J.E., 1988, GENES TRANSCRIPTION, P38; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hernandez G, 2007, NUCLEIC ACIDS RES, V35, P21, DOI 10.1093/nar/gkl982; Huang YP, 2016, INSECT BIOCHEM MOLEC, V75, P98, DOI 10.1016/j.ibmb.2016.06.004; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lobo S., 1994, TRANSCRIPTION MECH R, P127; Ma DY, 2015, GENOM PROTEOM BIOINF, V13, P336, DOI 10.1016/j.gpb.2015.12.001; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.12; Makinen PI, 2006, J GENE MED, V8, P433, DOI 10.1002/jgm.860; Miles LA, 2016, FEBS J, V283, P3170, DOI 10.1111/febs.13770; Ohtsuka Daisuke, 2008, Journal of Insect Biotechnology and Sericology, V77, P125; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ranganathan V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5516; Tanaka H, 2009, MOL BIOTECHNOL, V41, P173, DOI 10.1007/s12033-008-9108-x; Wise TG, 2007, ANIM BIOTECHNOL, V18, P153, DOI 10.1080/10495390600867515; Zeng BS, 2017, J BIOL CHEM, V292, P11659, DOI [10.1074/jbc.M117.777797, 10.1074/jbc.m117.777797]; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; Zhang XX, 2014, INT J MOL SCI, V15, P2596, DOI 10.3390/ijms15022596	24	0	0	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	OCT	2017	89						71	78		10.1016/j.ibmb.2017.08.009				8	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	FK0NT	WOS:000413177300008	28890398				2018-01-05	
J	Zuo, YY; Wang, H; Xu, YJ; Huang, JL; Wu, SW; Wu, YD; Yang, YH				Zuo, Yayun; Wang, Hui; Xu, Yanjun; Huang, Jianlei; Wu, Shuwen; Wu, Yidong; Yang, Yihua			CRISPR/Cas9 mediated G4946E substitution in the ryanodine receptor of Spodoptera exigua confers high levels of resistance to diamide insecticides	INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						CRISPR/Cas9; Ryanodine receptor; Diamide; Resistance; Beet armyworm	ZINC-FINGER NUCLEASES; PLUTELLA-XYLOSTELLA; ANTHRANILIC DIAMIDE; FIELD POPULATIONS; DIAMONDBACK MOTH; DROSOPHILA-MELANOGASTER; LEPIDOPTERA-NOCTUIDAE; HELICOVERPA-ARMIGERA; BINDING-SITES; CHLORANTRANILIPROLE	Diamide insecticides selectively activate insect ryanodine receptors (RyRs), inducing uncontrolled release of calcium ions, and causing muscle contraction, paralysis and eventually death. The RyR(G4946E) substitution associated with diamide resistance has been identified in three lepidopteran pests, Plutella xylostella, Tuta absoluta and Chilo suppressalis. Recently, the T. absoluta RyR(G4946V) mutation was knocked into the model insect Drosophila melanogaster by CRISPR/Cas9 mediated genome editing and provided in vivo functional confirmation for its role in diamide resistance. In the present study, we successfully introduced the RyR(G4946E) mutation with CRISPR/Cas9 technology into a lepidopteran pest of global importance, Spodoptera exigua. The genome-edited strain (named 4946E) homozygous for the SeRyR(G4946E) mutation exhibited 223-, 336- and >1000-fold resistance to chlorantraniliprole, cyantraniliprole and flubendiamide, respectively when compared to the wild type strain (WHS) of S. exigua. Reciprocal crossing experiments revealed that the target-site resistance in strain 4946E underlies an autosomal and almost recessive mode of inheritance for anthranilic diamides, whereas it was completely recessive for flubendiamide. Our results not only provided in vivo functional validation of the RyR(G4946E) mutation in conferring high levels of resistance to diamide insecticides for the first time in a controlled genetic background of a lepidopteran pest, but also revealed slight differences on the level of resistance between anthranilic diamides (chlorantraniliprole and cyantraniliprole) and flubendiamide conferred by the SeRyR(G4946E) mutation. (C) 2017 Elsevier Ltd. All rights reserved.	[Zuo, Yayun; Wang, Hui; Xu, Yanjun; Huang, Jianlei; Wu, Shuwen; Wu, Yidong; Yang, Yihua] Nanjing Agr Univ, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China	Yang, YH (reprint author), Nanjing Agr Univ, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China.	zuoyayun0734@163.com; 2016102091@njau.edu.cn; 2016102098@njau.edu.cn; 2014102100@njau.edu.cn; swwu@njau.edu.cn; wyd@njau.edu.cn; yhyang@njau.edu.cn		Wu, Yidong/0000-0003-3456-3373	Ministry of Agriculture of China [2016YFD0200500]; National Natural Science Foundation of China [3157110692]; Innovation Team Program for Jiangsu universities [2013-6]	This work was funded by grants from the Ministry of Agriculture of China (No. 2016YFD0200500), the National Natural Science Foundation of China (No. 3157110692) and the Innovation Team Program for Jiangsu universities (No. 2013-6). Dr. Ralf Nauen was thanked for comments and polishing on an earlier version of this paper.	Beumer KJ, 2013, G3-GENES GENOM GENET, V3, P657, DOI 10.1534/g3.112.005439; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Caboni P, 2008, J AGR FOOD CHEM, V56, P7696, DOI 10.1021/jf8014816; Che WN, 2013, J ECON ENTOMOL, V106, P1855, DOI 10.1603/EC13128; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485; Douris V, 2017, INSECT BIOCHEM MOLEC, V87, P127, DOI 10.1016/j.ibmb.2017.06.013; Douris V, 2016, P NATL ACAD SCI USA, V113, P14692, DOI 10.1073/pnas.1618258113; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Foster SP, 2012, PEST MANAG SCI, V68, P629, DOI 10.1002/ps.2306; Guo L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06924; Guo L, 2014, PEST MANAG SCI, V70, P1083, DOI 10.1002/ps.3651; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Isaacs AK, 2012, CHEM RES TOXICOL, V25, P1571, DOI 10.1021/tx300326m; Kato K, 2009, BIOCHEMISTRY-US, V48, P10342, DOI 10.1021/bi900866s; Lahm GP, 2007, BIOORG MED CHEM LETT, V17, P6274, DOI 10.1016/j.bmc1.2007.09.012; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Lahm GP, 2005, BIOORG MED CHEM LETT, V15, P4898, DOI 10.1016/j.bmcl.2005.08.034; Lai TC, 2011, PESTIC BIOCHEM PHYS, V101, P198, DOI 10.1016/j.pestbp.2011.09.006; LeOra Software, 2002, POL PLUS US GUID PRO; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Masaki T, 2006, J PESTIC SCI, V31, P484, DOI 10.1584/jpestics.31.484                                                         ; Nauen R., 2016, ADV INSECT CONTROL R, P219; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Qi SZ, 2014, J AGR FOOD CHEM, V62, P4077, DOI 10.1021/jf501236h; Qi SZ, 2013, PESTIC BIOCHEM PHYS, V107, P321, DOI 10.1016/j.pestbp.2013.09.004; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Roditakis E, 2017, INSECT BIOCHEM MOLEC, V80, P11, DOI 10.1016/j.ibmb.2016.11.003; Roditakis E, 2015, J PEST SCI, V88, P9, DOI 10.1007/s10340-015-0643-5; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Selby TP, 2013, BIOORG MED CHEM LETT, V23, P6341, DOI 10.1016/j.bmcl.2013.09.076; Somers J, 2015, INSECT BIOCHEM MOLEC, V64, P116, DOI 10.1016/j.ibmb.2015.01.018; Steinbach D, 2015, INSECT BIOCHEM MOLEC, V63, P14, DOI 10.1016/j.ibmb.2015.05.001; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Taning CNT, 2017, J INSECT PHYSIOL, V98, P245, DOI 10.1016/j.jinsphys.2017.01.007; Tao Y, 2013, INSECT BIOCHEM MOLEC, V43, P820, DOI 10.1016/j.ibmb.2013.06.006; Teixeira LA, 2013, PESTIC BIOCHEM PHYS, V106, P76, DOI 10.1016/j.pestbp.2013.01.010; Tohnishi M, 2005, J PESTIC SCI, V30, P354, DOI 10.1584/jpestics.30.354; Troczka B, 2012, INSECT BIOCHEM MOLEC, V42, P873, DOI 10.1016/j.ibmb.2012.09.001; Troczka BJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14680; Uchiyama T, 2014, APPL ENTOMOL ZOOL, V49, P529, DOI 10.1007/s13355-014-0283-x; Wang J, 2017, INSECT BIOCHEM MOLEC, V87, P147, DOI 10.1016/j.ibmb.2017.07.002; Wang J, 2016, INSECT BIOCHEM MOLEC, V76, P11, DOI 10.1016/j.ibmb.2016.06.008; Wang XL, 2012, J ECON ENTOMOL, V105, P1019, DOI 10.1603/EC12059; Yao R, 2017, PEST MANAG SCI, V73, P1169, DOI 10.1002/ps.4439; Yu ZS, 2014, BIOL OPEN, V3, P271, DOI 10.1242/bio.20147682; Zhu L., 2015, SCI REP, P18103; Zimmer CT, 2016, INSECT BIOCHEM MOLEC, V73, P62, DOI 10.1016/j.ibmb.2016.04.007	51	0	0	9	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0965-1748	1879-0240		INSECT BIOCHEM MOLEC	Insect Biochem. Mol. Biol.	OCT	2017	89						79	85		10.1016/j.ibmb.2017.09.005				7	Biochemistry & Molecular Biology; Entomology	Biochemistry & Molecular Biology; Entomology	FK0NT	WOS:000413177300009	28912111				2018-01-05	
J	Suarez, CE; Bishop, RP; Alzan, HF; Poole, WA; Cooke, BM				Suarez, C. E.; Bishop, R. P.; Alzan, H. F.; Poole, W. A.; Cooke, B. M.			Advances in the application of genetic manipulation methods to apicomplexan parasites	INTERNATIONAL JOURNAL FOR PARASITOLOGY			English	Article; Proceedings Paper	4th International Meeting on Apicomplexan Parasites in Farm Animals (ApiCOWplexa)	OCT 11-14, 2017	Madrid, SPAIN			Apicomplexan; Genetic manipulation; Transfection; Gene editing; CRISPR/Cas9	BABESIA-BOVIS MEROZOITES; APICAL MEMBRANE ANTIGEN-1; TOXOPLASMA-GONDII; TRANSIENT TRANSFECTION; PLASMODIUM-FALCIPARUM; CRYPTOSPORIDIUM-PARVUM; STABLE EXPRESSION; MALARIA PARASITE; EIMERIA-TENELLA; FLUORESCENT PROTEIN	Apicomplexan parasites such as Babesia, Theileria, Eimeria, Cryptosporidium and Toxoplasma greatly impact animal health globally, and improved, cost-effective measures to control them are urgently required. These parasites have complex multi-stage life cycles including obligate intracellular stages. Major gaps in our understanding of the biology of these relatively poorly characterised parasites and the diseases they cause severely limit options for designing novel control methods. Here we review potentially important shared aspects of the biology of these parasites, such as cell invasion, host cell modification, and asexual and sexual reproduction, and explore the potential of the application of relatively well-established or newly emerging genetic manipulation methods, such as classical transfection or gene editing, respectively, for closing important gaps in our knowledge of the function of specific genes and proteins, and the biology of these parasites. In addition, genetic manipulation methods impact the development of novel methods of control of the diseases caused by these economically important parasites. Transient and stable transfection methods, in conjunction with whole and deep genome sequencing, were initially instrumental in improving our understanding of the molecular biology of apicomplexan parasites and paved the way for the application of the more recently developed gene editing methods. The increasingly efficient and more recently developed gene editing methods, in particular those based on the CRISPR/Cas9 system and previous conceptually similar techniques, are already contributing to additional gene function discovery using reverse genetics and related approaches. However, gene editing methods are only possible due to the increasing availability of in vitro culture, transfection, and genome sequencing and analysis techniques. We envisage that rapid progress in the development of novel gene editing techniques applied to apicomplexan parasites of veterinary interest will ultimately lead to the development of novel and more efficient methods for disease control. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.	[Suarez, C. E.] Washington State Univ, Anim Dis Res Unit, USDA ARS, 3003 ADBF,POB 646630, Pullman, WA 99164 USA; [Suarez, C. E.; Bishop, R. P.; Alzan, H. F.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Bishop, R. P.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Alzan, H. F.] Natl Res Ctr, Parasitol & Anim Dis Dept, Giza, Egypt; [Poole, W. A.; Cooke, B. M.] Monash Univ, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Poole, W. A.; Cooke, B. M.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Suarez, CE; Cooke, BM (reprint author), ARS, Anim Dis Res Unit, USDA, Pullman, WA 99164 USA.	ces@vetmed.wsu.edu; brian.cooke@monash.edu		Alzan, Heba/0000-0002-0260-7813	Egyptian government, Ministry of High Education and Scientific Research; United States Department of Agriculture-Agriculture Research Service Current Research Information System Project [5348-32000-028-00D]	HFA was supported by a scholarship provided by the Egyptian government, Ministry of High Education and Scientific Research. Thanks to Jacob Laughery and Paul Lacy for their assistance in the preparation of the manuscript. We acknowledge support by the United States Department of Agriculture-Agriculture Research Service Current Research Information System Project No. 5348-32000-028-00D.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Adamson R, 2001, MOL BIOCHEM PARASIT, V114, P53, DOI 10.1016/S0166-6851(01)00238-9; Adl SM, 2007, SYSTEMATIC BIOL, V56, P684, DOI 10.1080/10635150701494127; Allred DR, 2004, MOL BIOCHEM PARASIT, V134, P27, DOI 10.1016/j.molbiopara.2003.09.012; Alzan HF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2143-3; Alzan HF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004983; Alzan HF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163791; Asada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125993; Asada M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035227; Asada M, 2012, MOL BIOCHEM PARASIT, V181, P162, DOI 10.1016/j.molbiopara.2011.11.001; Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105; Bastos RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067765; Beverley SM, 2015, NATURE, V523, P413, DOI 10.1038/nature14636; BONNIN A, 1995, J EUKARYOT MICROBIOL, V42, P395, DOI 10.1111/j.1550-7408.1995.tb01601.x; Brown KM, 2017, MBIO, V8, DOI 10.1128/mBio.00375-17; Calhoun SF, 2017, MBIO, V8, DOI 10.1128/mBio.00547-17; Cerede O, 2005, J EXP MED, V201, P453, DOI [10.1084/jem.20041672, 10.1080/jem.20041672]; Chartier C, 2012, SMALL RUMINANT RES, V103, P84, DOI 10.1016/j.smallrumres.2011.10.022; Cui YB, 2016, PARASITOL INT, V65, P641, DOI 10.1016/j.parint.2016.08.011; Dantas-Torres Filipe, 2015, International Journal for Parasitology Parasites and Wildlife, V4, P452, DOI 10.1016/j.ijppaw.2015.07.001; Darghouth M. A., 1999, Parassitologia (Rome), V41, P33; De Goeyse I, 2015, VET PARASITOL, V208, P238, DOI 10.1016/j.vetpar.2015.01.013; deCastro JJ, 1997, VET PARASITOL, V71, P77, DOI 10.1016/S0304-4017(97)00033-2; Di Giulio G, 2009, TRENDS PARASITOL, V25, P85, DOI 10.1016/j.pt.2008.11.007; Dobdelaere D., 1999, ANNU REV MICROBIOL, V53, P1; Dzikowski R, 2006, MOL MICROBIOL, V59, P364, DOI 10.1111/j.1365-2958.2005.05007.x; Florin-Christensen M., 2014, PARASITOLOGY, V28, P1; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2755.2004; Gaffar FR, 2004, MOL BIOCHEM PARASIT, V136, P25, DOI 10.1016/j.molbiopara.2004.02.006; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giles JR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-189; GOONEWARDENE R, 1993, P NATL ACAD SCI USA, V90, P5234, DOI 10.1073/pnas.90.11.5234; Gubbels MJ, 2012, INT J PARASITOL, V42, P1071, DOI 10.1016/j.ijpara.2012.09.009; Hao LL, 2007, MOL BIOCHEM PARASIT, V153, P213, DOI 10.1016/j.molbiopara.2007.02.005; Howe DK, 1997, METHODS, V13, P123, DOI 10.1006/meth.1997.0505; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huynh MH, 2014, INFECT IMMUN, V82, P4358, DOI 10.1128/IAI.01877-14; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Karbowiak Grzegorz, 2014, Annals of Parasitiology, V60, P37; Kats LM, 2006, TRENDS PARASITOL, V22, P269, DOI 10.1016/j.pt.2006.04.001; Kelleher M, 1998, MOL BIOCHEM PARASIT, V97, P21, DOI 10.1016/S0166-6851(98)00128-5; Kemp LE, 2013, FEMS MICROBIOL REV, V37, P607, DOI 10.1111/1574-6976.12013; Kepczynski M, 2016, BBA-BIOMEMBRANES, V1858, P2362, DOI 10.1016/j.bbamem.2016.02.038; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041; Li W, 2009, MOL BIOCHEM PARASIT, V168, P143, DOI 10.1016/j.molbiopara.2009.07.003; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Ma DY, 2015, GENOM PROTEOM BIOINF, V13, P336, DOI 10.1016/j.gpb.2015.12.001; Marsolier J, 2015, NATURE, V520, P378, DOI 10.1038/nature14044; McFadden GI, 2017, INT J PARASITOL, V47, P137, DOI 10.1016/j.ijpara.2016.08.005; Mogollon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168362; Mota CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03978-1; Novikov YM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-389; Oldiges DP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005152; Peng D., 2015, MICROB GENOM, V1, DOI DOI 10.1099/MGEN.0.000033; Pieszko M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003933; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022; Salama AA, 2013, EXP PARASITOL, V135, P623, DOI 10.1016/j.exppara.2013.09.017; Sato S, 2011, CELL MOL LIFE SCI, V68, P1285, DOI 10.1007/s00018-011-0646-1; Shen B., 2014, MBIO, V5; Shen B., 2014, MBIO, V5, P1114, DOI DOI 10.1128/MBI0.01114-14; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sidik SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100450; Silva MG, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1859-9; Silva MG, 2010, PARASITOL INT, V59, P294, DOI 10.1016/j.parint.2010.03.004; Smith TG, 2002, TRENDS PARASITOL, V18, P315, DOI 10.1016/S1471-4922(02)02292-4; Smolarz B, 2014, ARCH MICROBIOL, V196, P1, DOI 10.1007/s00203-013-0944-0; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; Suarez C. E., 2007, Parassitologia (Rome), V49, P67; Suarez CE, 2008, EXP PARASITOL, V118, P498, DOI 10.1016/j.exppara.2007.10.013; Suarez CE, 2006, INT J PARASITOL, V36, P965, DOI 10.1016/j.ijpara.2006.02.022; Suarez CE, 2015, MOL BIOCHEM PARASIT, V202, P23, DOI 10.1016/j.molbiopara.2015.09.003; Suarez CE, 2010, VET PARASITOL, V167, P205, DOI 10.1016/j.vetpar.2009.09.022; Suarez CE, 2009, INT J PARASITOL, V39, P289, DOI 10.1016/j.ijpara.2008.08.006; Suarez CE, 2004, INT J PARASITOL, V34, P1177, DOI 10.1016/j.ijpara.2004.07.001; Swapna LS, 2017, CRIT REV BIOCHEM MOL, V52, P254, DOI 10.1080/10409238.2017.1290043; Templeton TJ, 2016, PARASITOLOGY, V143, P1, DOI 10.1017/S0031182015001213; Tokarevich N, 2017, INT J CIRCUMPOL HEAL, V76, DOI 10.1080/22423982.2017.1298882; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Visendi P, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar015; Wahlgren M, 2017, NAT REV MICROBIOL, V15, P479, DOI 10.1038/nrmicro.2017.47; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yan WC, 2009, INT J PARASITOL, V39, P109, DOI 10.1016/j.ijpara.2008.06.013; Zhang GH, 2010, VACCINE, V28, P7243, DOI 10.1016/j.vaccine.2010.08.096	87	1	1	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-7519	1879-0135		INT J PARASITOL	Int. J. Parasit.	OCT	2017	47	12					701	710		10.1016/j.ijpara.2017.08.002				10	Parasitology	Parasitology	FJ8ZV	WOS:000413058100002	28893636	gold			2018-01-05	
J	Patwardhan, RS; Pal, D; Checker, R; Sharma, D; Sandur, SK				Patwardhan, Raghavendra S.; Pal, Debojyoti; Checker, Rahul; Sharma, Deepak; Sandur, Santosh K.			Baicalein induces cell death in murine T cell lymphoma via inhibition of thioredoxin system	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Baicalein; Thioredoxin reductase; Cancer stem cells; ASK1; EL4	ACUTE LYMPHOBLASTIC-LEUKEMIA; ACTIVATED PROTEIN-KINASE; OXIDATIVE-STRESS; INDUCED APOPTOSIS; STEM-CELLS; IN-VITRO; EXPRESSION; CANCER; GLUTATHIONE; INDUCTION	We have earlier demonstrated the radioprotective potential of baicalein using murine splenic lymphocytes. Here, we have studied the effect of baicalein on murine T cell lymphoma EL4 cells and investigated the underlying mechanism of action. We observed that baicalein induced a dose dependent cell death in EL4 cells in vitro and significantly reduced the frequency of cancer stem cells. Previously, we have reported that murine and human T cell lymphoma cells have increased oxidative stress tolerance capacity due to active thioredoxin system. Hence, we monitored the effect of baicalein on thioredoxin system in EL4 cells. Docking studies revealed that baicalein could bind to the active site of thioredoxin reductase. Baicalein treatment led to significant reduction in the activity of thioredoxin reductase and nuclear levels of thioredoxin-1 thereby increasing ASK1 levels and caspase-3 activity. Interestingly, CRISPR-Cas9 based knock-out of ASK1 or over-expression of thioredoxin-1 abolished anti-tumor effects of baicalein in EL4 cells. Further, baicalein administration significantly reduced intra-peri-toneal tumor burden of EL4 cells in C57BL/6 mice. Thus, our study describes anti-tumor effects of baicalein in EL4 cells via inhibition of thioredoxin system.	[Patwardhan, Raghavendra S.; Pal, Debojyoti; Checker, Rahul; Sharma, Deepak; Sandur, Santosh K.] Homi Bhabha Natl Inst, Bhabha Atom Res Ctr, Modular Labs, Radiat Biol & Hlth Sci Div, Mumbai 400094, Maharashtra, India; [Patwardhan, Raghavendra S.; Pal, Debojyoti; Checker, Rahul; Sharma, Deepak; Sandur, Santosh K.] Homi Bhabha Natl Inst, Mumbai 400094, Maharashtra, India	Sharma, D; Sandur, SK (reprint author), Homi Bhabha Natl Inst, Bhabha Atom Res Ctr, Modular Labs, Radiat Biol & Hlth Sci Div, Mumbai 400094, Maharashtra, India.; Sharma, D; Sandur, SK (reprint author), Homi Bhabha Natl Inst, Mumbai 400094, Maharashtra, India.	dsharma@barc.gov.in; sskumar@barc.gov.in			Department of Atomic Energy, Government of India	This work is funded by Department of Atomic Energy, Government of India.	Chao JI, 2007, MOL CANCER THER, V6, P3039, DOI 10.1158/1535-7163.MCT-07-0281; Checker R, 2015, CANCER LETT, V357, P265, DOI 10.1016/j.canlet.2014.11.031; Chen HJ, 2014, CANCER LETT, V354, P5, DOI 10.1016/j.canlet.2014.08.003; Chen YC, 2006, TOXICOL APPL PHARM, V216, P263, DOI 10.1016/j.taap.2006.05.008; Ding X. Z., 1999, LIPOXYGENASE INHIBIT, P392; Fan GW, 2013, INFLAMMATION, V36, P1584, DOI 10.1007/s10753-013-9703-2; Holmgren J. L. a. A., 2012, ANTIOXID REDOX SIGN, V17, P10; HUANG HC, 1994, EUR J PHARM-MOLEC PH, V268, P73, DOI 10.1016/0922-4106(94)90121-X                                                    ; Huang Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-48; Iwata S, 1997, J IMMUNOL, V158, P3108; Karlenius Therese Christina, 2010, Cancers (Basel), V2, P209, DOI 10.3390/cancers2020209; Kim Seok Jin, 2011, Korean J Hematol, V46, P211, DOI 10.5045/kjh.2011.46.4.211; Kondo N, 2004, J IMMUNOL, V172, P442, DOI 10.4049/jimmunol.172.1.442                                                      ; Kumagai T, 2007, LEUKEMIA RES, V31, P523, DOI 10.1016/j.leukres.2006.08.019; Kumar S, 1999, CARCINOGENESIS, V20, P1761, DOI 10.1093/carcin/20.9.1761                                                        ; Li YC, 2004, FOOD CHEM TOXICOL, V42, P37, DOI 10.1016/j.fct.2003.08.014; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Moti N, 2015, ONCOGENE, V34, P1843, DOI 10.1038/onc.2014.112; Mougiakakos D, 2011, BLOOD, V117, P857, DOI 10.1182/blood-2010-09-307041; Park GB, 2016, MOL CELL BIOCHEM, V412, P247, DOI 10.1007/s11010-015-2631-8; Patwardhan RS, 2015, FREE RADICAL RES, V49, P1218, DOI 10.3109/10715762.2015.1056180; Patwardhan RS, 2014, FREE RADICAL BIO MED, V68, P52, DOI 10.1016/j.freeradbiomed.2013.11.004; Patwardhan RS, 2016, BIOCHEM PHARMACOL, V108, P75, DOI 10.1016/j.bcp.2016.03.013; Patwardhan RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065929; Probst L, 2017, BIOCHEM PHARMACOL, V140, P41, DOI 10.1016/j.bcp.2017.06.112; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shao LE, 2001, CANCER RES, V61, P7333; Sharma D, 2012, BIOTECHNIQUES, V53, P57, DOI 10.2144/0000113854; Shi WY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111832; Shieh DE, 2006, AM J CHINESE MED, V34, P245, DOI 10.1142/S0192415X06003801; Singh VK, 2015, HEALTH PHYS, V108, P607, DOI 10.1097/HP.0000000000000279; Wilankar C, 2011, CURR PHARM DESIGN, V17, P2176, DOI 10.2174/138161211796957463; Zhou YX, 2013, EUR J PHARM SCI, V49, P649, DOI 10.1016/j.ejps.2013.04.016	34	0	0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	OCT	2017	91		A				45	52		10.1016/j.biocel.2017.08.015				8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FL0DG	WOS:000413880900006	28864268				2018-01-05	
J	Zhou, GH; Duan, YJ; Ma, GE; Wu, WY; Hu, ZP; Chen, N; Chee, YL; Cui, J; Samad, A; Matsubara, JA; Mukai, S; D'Amore, PA; Lei, HT				Zhou, Guohong; Duan, Yajiang; Ma, Gaoen; Wu, Wenyi; Hu, Zhengping; Chen, Na; Chee, Yewlin; Cui, Jing; Samad, Arif; Matsubara, Joanne A.; Mukai, Shizuo; D'Amore, Patricia A.; Lei, Hetian			Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						MDM2; CRISPR/Cas9; SNP309; RPE; PVR	GROWTH-FACTORS; SP1 PHOSPHORYLATION; GENE-TRANSCRIPTION; EXPERIMENTAL-MODEL; DETACHMENT; P53; EXPRESSION; RECEPTOR; PROTEIN; IDENTIFICATION	PURPOSE. The murine double minute (MDM) 2 is a critical negative regulator of the p53 tumor suppressor, and MDM2 SNP309G is associated with a higher risk of proliferative vitreoretinopathy (PVR); in addition, the MDM2 T309G created using clustered regularly interspaced short palindromic repeats (CRISPR)/associated endonuclease (Cas) 9 enhances normal rabbit vitreous-induced expression of MDM2 and survival of primary human retinal pigment epithelial (hRPE) cells in vitro. The goal of this study was to determine whether this MDM2 T309G contributes to the development of experimental PVR. METHODS. hRPE cells expressing MDM2 T309G or T309T only were treated with vitreous from human PVR donors (HV). The expression of MDM2 and p53 in the treated cells was examined by Western blot. The in vitro vitreous-induced cellular responses, such as contraction were assessed, and PVR was induced by intravitreal injection of the hRPE cells with MDM2 T309G or T309T only into rabbit eyes. RESULTS. Western blot analyses indicated that treatment of hRPE cells with HV led to a significant increase (1.7 +/- 0.2-fold) in the expression of MDM2 and a significant decrease in p53 in the cells expressing MDM2 T309G compared with those with MDM2 T309T. In addition, HV promoted contraction of the hRPE cells expressing MDM2 T309G significantly more than those with MDM2 T309T only. Furthermore, MDM2 T309G in the hRPE cells enhanced the development of PVR in a rabbit model. CONCLUSIONS. The MDM2 SNP309 in RPE cells enhances their potential of PVR pathogenesis.	[Zhou, Guohong; Duan, Yajiang; Ma, Gaoen; Wu, Wenyi; Hu, Zhengping; Chen, Na; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Schepens Eye Res Inst Massachusetts Eye & Ear, Boston, MA USA; [Zhou, Guohong; Duan, Yajiang] Shanxi Eye Hosp, Taiyuan, Shanxi, Peoples R China; [Ma, Gaoen] Xinxiang Med Univ, Dept Ophthalmol, Affiliated Hosp 3, Eye Hosp, Xinxiang, Henan, Peoples R China; [Chee, Yewlin; Mukai, Shizuo] Harvard Med Sch, Massachusetts Eye & Ear Dept Ophthalmol, Boston, MA USA; [Cui, Jing; Matsubara, Joanne A.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada; [Samad, Arif] Dalhousie Univ, Halifax, NS, Canada	Lei, HT (reprint author), Harvard Med Sch, Schepens Eye Res Inst Massachusetts Eye & Ear, Dept Ophthalmol, 20 Staniford St, Boston, MA 02114 USA.	Hetian_lei@meei.harvard.edu			National Institutes of Health, National Eye Institute [R01 EY012509, P30EY003790]	Supported by National Institutes of Health, National Eye Institute Grants R01 EY012509 (HL) and (in part) Core Grant P30EY003790.	Agrawal RN, 2007, NAT PROTOC, V2, P67, DOI 10.1038/nprot.2007.4; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022                                                      ; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Cehofski LJ, 2014, BIOANALYSIS, V6, P3051, DOI 10.4155/bio.14.227; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Cui J, 2009, EXP EYE RES, V88, P438, DOI 10.1016/j.exer.2008.10.020; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Di Lauro S, 2016, J OPHTHALMOL, DOI 10.1155/2016/7807596; Duan YJ, 2016, J BIOL CHEM, V291, P16339, DOI 10.1074/jbc.M116.729467; FASTENBERG DM, 1982, AM J OPHTHALMOL, V93, P559, DOI 10.1016/S0002-9394(14)77369-6                                                   ; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Huang Xionggao, 2017, Invest Ophthalmol Vis Sci, V58, P1228, DOI 10.1167/iovs.16-20537; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Leaver PK, 1989, CLIN EXP OPHTHALMOL, V227, P323; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Lei HT, 2015, MOL CELL BIOL, V35, P1673, DOI 10.1128/MCB.01248-14; Lei HT, 2012, AM J PATHOL, V181, P866, DOI 10.1016/j.ajpath.2012.05.036; Lei HT, 2011, INVEST OPHTH VIS SCI, V52, P5016, DOI 10.1167/iovs.11-7442; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lei H, 2010, AM J PATHOL, V177, P132, DOI 10.2353/ajpath.2010.090604; Lei HT, 2009, INVEST OPHTH VIS SCI, V50, P3394, DOI 10.1167/iovs.08-3042; Lei H, 2009, J BIOL CHEM, V284, P6329, DOI 10.1074/jbc.M808426200; Ma GE, 2016, INVEST OPHTH VIS SCI, V57, P3935, DOI 10.1167/iovs.16-19405; Mandal N, 2015, J OPHTHALMOL, V2015; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pastor-Idoate S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082283; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Pennock S, 2011, AM J PATHOL, V179, P2931, DOI 10.1016/j.ajpath.2011.08.043; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu WY, 2017, EXP EYE RES, V161, P116, DOI 10.1016/j.exer.2017.06.007; Wubben TJ, 2016, OPHTHALMOLOGY, V123, P1553, DOI 10.1016/j.ophtha.2016.02.040	41	0	0	2	2	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	OCT	2017	58	12					5361	5367		10.1167/iovs.17-22045				7	Ophthalmology	Ophthalmology	FL5JN	WOS:000414272100037	29049737	gold			2018-01-05	
J	Esmaeili Rastaghi, AR; Spotin, A; Khataminezhad, MR; Jafarpour, M; Alaeenovin, E; Najafzadeh, N; Samei, N; Taleshi, N; Mohammadi, S; Parvizi, P				Esmaeili Rastaghi, Ahmad Reza; Spotin, Adel; Khataminezhad, Mohammad Reza; Jafarpour, Mostafa; Alaeenovin, Elnaz; Najafzadeh, Narmin; Samei, Neda; Taleshi, Neda; Mohammadi, Somayeh; Parvizi, Parviz			Evaluative Assay of Nuclear and Mitochondrial Genes to Diagnose Leishmania Species in Clinical Specimens	IRANIAN JOURNAL OF PUBLIC HEALTH			English	Article						Leishmania species; ITS-rDNA; Hsp70; Cyt b; Diagnosis; Iran	ZOONOTIC CUTANEOUS LEISHMANIASIS; MOLECULAR CHARACTERIZATION; DIPTERA PSYCHODIDAE; 1ST DETECTION; CYTOCHROME-B; IRAN; PCR; PHLEBOTOMUS; DIVERSITY; SANDFLIES	Background: Leishmaniasis as an emerging and reemerging disease is increasing worldwide with high prevalence and new incidence in recent years. For epidemiological investigation and accurate identification of Leishmania species, three nuclear and mitochondrial genes (ITS-rDNA, Hsp70, and Cyt b) were employed and analyzed from clinical samples in three important Zoonotic Cutaneous Leishmaniasis (ZCL) foci of Iran. Methods: In this cross-sectional/descriptive study conducted in 2014-15, serous smears of lesions were directly prepared from suspected patients of ZCL in Turkmen in northeast, Abarkouh in center and Shush district in southwest of Iran. They were directly prepared from suspected patients and DNA was extracted. Two nuclear genes of ITS-rDNA, Hsp70 and one mitochondrial gene of Cyt b within Leishmania parasites were amplified. RFLP was performed on PCR-positive samples. PCR products were sequenced, aligned and edited with sequencher 4.1.4 and phylogenic analyses performed using MEGA 5.05 software. Results: Overall, 203 out of 360 clinical samples from suspected patients were Leishmania positive using routine laboratory methods and 231 samples were positive by molecular techniques. L. major L. tropica, and L. turanica were firmly identified by employing different molecular genes and phylogenic analyses. Conclusion: By combining different molecular genes, Leishmania parasites were identified accurately. The sensitivity and specificity three genes were evaluated and had more advantages to compare routine laboratory methods. ITS-rDNA gene is more appropriate for firm identification of Leishmania species.	[Esmaeili Rastaghi, Ahmad Reza; Spotin, Adel; Alaeenovin, Elnaz; Najafzadeh, Narmin; Samei, Neda; Taleshi, Neda; Mohammadi, Somayeh; Parvizi, Parviz] Pasteur Inst Iran, Parasitol Dept, Mol Systemat Lab, Tehran, Iran; [Spotin, Adel] Tabriz Univ Med Sci, Dept Med Parasitol & Mycol, Fac Med, Tabriz, Iran; [Khataminezhad, Mohammad Reza; Jafarpour, Mostafa; Samei, Neda; Taleshi, Neda] Islamic Azad Univ, Tonekabon Branch, Dept Biol, Tonekabon, Iran	Parvizi, P (reprint author), Pasteur Inst Iran, Parasitol Dept, Mol Systemat Lab, Tehran, Iran.	parp@pasteur.ac.ir		Esmaeili Rastaghi, Ahmad Reza/0000-0002-9807-6374	Pasteur Institute of Iran [501]	Pasteur Institute of Iran supported the work; grant 501awarded to Dr. Parviz Parvizi. The authors would like to thank Health Care authorities and patients for their help and support during this study. We thank Mehdi Baghban for helping with the field working in Molecular Systematic Laboratory. A part of this research through MSc studentships to Neda Samei based at the Pasteur Institute of Iran, and registered for Islamic Azad University, Tonekabon, Iran.	Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Bensoussan E, 2006, J CLIN MICROBIOL, V44, P1435, DOI 10.1128/JCM.44.4.1435-1439.2006; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bordbar A, 2014, ACTA TROP, V133, P69, DOI 10.1016/j.actatropica.2014.01.016; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243; Vilas VJD, 2014, VET REC, V175, P42, DOI 10.1136/vr.g4378; HOWELL N, 1988, J MOL BIOL, V203, P607, DOI 10.1016/0022-2836(88)90195-7; Jafari R, 2013, ASIAN PAC J TROP MED, V6, P792, DOI 10.1016/S1995-7645(13)60140-6; Mirzaei A, 2011, EXP PARASITOL, V129, P375, DOI 10.1016/j.exppara.2011.08.020; Mohammadi S, 2016, J ARTHROPOD-BORNE DI, V10, P55; Najafzadeh N, 2014, REV SOC BRAS MED TRO, V47, P599, DOI 10.1590/0037-8682-0164-2014; Parvizi P, 2008, TROP MED INT HEALTH, V13, P1159, DOI 10.1111/j.1365-3156.2008.02121.x; Parvizi P, 2005, ACTA TROP, V93, P75, DOI 10.1016/j.actatropica.2004.09.007; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Spotin Adel, 2015, Iranian Biomedical Journal, V19, P149, DOI 10.7508/ibj.2015.03.004; Spotin A, 2014, BIOMED RES INT, DOI 10.1155/2014/913510; Tellevik MG, 2014, ACTA TROP, V137, P99, DOI 10.1016/j.actatropica.2014.05.008; WHO, 1990, CONTR LEISHM REP WHO; Yaghoobi-Ershadi MR, 2012, J ARTHROPOD-BORNE DI, V6, P1; Zahraei-Ramazani A, 2015, J ARTHROPOD-BORNE DI, V9, P84; Zangger H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002006	21	0	0	1	1	IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY	TEHRAN	SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN	2251-6085	2251-6093		IRAN J PUBLIC HEALTH	Iran J. Public Health	OCT	2017	46	10					1422	1429						8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	FJ0FI	WOS:000412383500015					2018-01-05	
J	Stewart, SE; Menzies, SA; Popa, SJ; Savinykh, N; Harrison, AP; Lehner, PJ; Moreau, K				Stewart, Sarah E.; Menzies, Sam A.; Popa, Stephanie J.; Savinykh, Natalia; Harrison, Anna Petrunkina; Lehner, Paul J.; Moreau, Kevin			A genome-wide CRISPR screen reconciles the role of N-linked glycosylation in galectin-3 transport to the cell surface	JOURNAL OF CELL SCIENCE			English	Article						Galectin; Glycosylation; Unconventional secretion	UNCONVENTIONAL PROTEIN SECRETION; RETICULUM-GOLGI COMPLEX; HAMSTER OVARY CELLS; LARGE GENE LISTS; CONGENITAL DISORDERS; BINDING-PROTEINS; HEART-FAILURE; LECTIN; RECEPTORS; MECHANISMS	Galectins are a family of lectin binding proteins expressed both intracellularly and extracellularly. Galectin-3 (Gal-3, also known as LGALS3) is expressed at the cell surface; however, Gal-3 lacks a signal sequence, and the mechanism of Gal-3 transport to the cell surface remains poorly understood. Here, using a genome-wide CRISPR/Cas9 forward genetic screen for regulators of Gal-3 cell surface localization, we identified genes encoding glycoproteins, enzymes involved in N-linked glycosylation, regulators of ER-Golgi trafficking and proteins involved in immunity. The results of this screening approach led us to address the controversial role of N-linked glycosylation in the transport of Gal-3 to the cell surface. We find that N-linked glycoprotein maturation is not required for Gal-3 transport from the cytosol to the extracellular space, but is important for cell surface binding. Additionally, secreted Gal-3 is predominantly free and not packaged into extracellular vesicles. These data support a secretion pathway independent of N-linked glycoproteins and extracellular vesicles.	[Stewart, Sarah E.; Popa, Stephanie J.; Moreau, Kevin] Univ Cambridge, Metab Res Labs, Wellcome Trust Med Res Council Inst Metab Sci, Cambridge CB2 0QQ, England; [Menzies, Sam A.; Lehner, Paul J.] Cambridge Inst Med Res, Dept Med, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England; [Savinykh, Natalia; Harrison, Anna Petrunkina] Univ Cambridge, Dept Med, NIHR Cambridge BRC Cell Phenotyping Hub, Cambridge CB2 0QQ, England	Moreau, K (reprint author), Univ Cambridge, Metab Res Labs, Wellcome Trust Med Res Council Inst Metab Sci, Cambridge CB2 0QQ, England.	km510@cam.ac.uk		Popa, Steph/0000-0002-3424-4674; Moreau, Kevin/0000-0002-3688-3998	Wellcome Trust [100574/Z/12/Z, 101835/Z/13/Z]; Medical Research Council [MRC_MC_UU_12012/5]; National Institute for Health Research	This work was supported by the Wellcome Trust [100574/Z/12/Z; 101835/Z/13/Z to P.J.L.; Wellcome Trust PhD studentship to S.A.M. and S.J.P.], Medical Research Council [MRC_MC_UU_12012/5 to S.E.S. and K.M.] and National Institute for Health Research [to N.S. and A.P.H.]. Deposited in PMC for release after 6 months.	Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Albahri Z, 2015, AM J PEDIAT, V1, P6; Boyle KB, 2013, CURR OPIN MICROBIOL, V16, P339, DOI 10.1016/j.mib.2013.03.010; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chauhan S, 2016, DEV CELL, V39, P13, DOI 10.1016/j.devcel.2016.08.003; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; CHO MJ, 1995, J BIOL CHEM, V270, P5207, DOI 10.1074/jbc.270.10.5207                                                         ; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Crump CA, 2007, J VIROL, V81, P7380, DOI 10.1128/JVI.00222-07; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121                                                        ; Feeley EM, 2017, P NATL ACAD SCI USA, V114, pE1698, DOI 10.1073/pnas.1615771114; Freeze HH, 2015, ANNU REV NEUROSCI, V38, P105, DOI 10.1146/annurev-neuro-071714-034019; Grunewald S, 2002, PEDIATR RES, V52, P618, DOI 10.1203/01.PDR.0000031921.02259.35; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Jagodzinski A, 2015, INT J CARDIOL, V192, P33, DOI 10.1016/j.ijcard.2015.05.040; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; KUMAR R, 1989, MOL CELL BIOL, V9, P5713, DOI 10.1128/MCB.9.12.5713                                                           ; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Mazurek N, 2012, CELL DEATH DIFFER, V19, P523, DOI 10.1038/cdd.2011.123; Medvedeva EA, 2016, MINERVA CARDIOANGIOL, V64, P595; Mehul B, 1997, J CELL SCI, V110, P1169; Menon RP, 1999, EUR J BIOCHEM, V264, P569, DOI 10.1046/j.1432-1327.1999.00671.x; Monticelli M, 2016, J INHERIT METAB DIS, V39, P765, DOI 10.1007/s10545-016-9954-9; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Priglinger CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070011; Rabinovich GA, 2002, J LEUKOCYTE BIOL, V71, P741; Rabouille C, 2017, TRENDS CELL BIOL, V27, P230, DOI 10.1016/j.tcb.2016.11.007; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI 10.1145/359340.359342                                                           ; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SATO S, 1993, EXP CELL RES, V207, P8, DOI 10.1006/excr.1993.1157; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026                                                           ; Seelenmeyer C, 2008, FEBS LETT, V582, P1362, DOI 10.1016/j.febslet.2008.03.024; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377                                                             ; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Thijssen VL, 2015, BBA-REV CANCER, V1855, P235, DOI 10.1016/j.bbcan.2015.03.003; Timms RT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11786; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Xin M, 2015, BIOMED PHARMACOTHER, V69, P179, DOI 10.1016/j.biopha.2014.11.024	54	1	1	3	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	OCT 1	2017	130	19					3234	+		10.1242/jcs.206425				23	Cell Biology	Cell Biology	FI4YY	WOS:000411987700009	28775154				2018-01-05	
J	Ma, X; Feng, HH; Liang, CY; Liu, XJ; Zeng, FY; Wang, Y				Ma, Xing; Feng, Huanhuan; Liang, Chunyan; Liu, Xiaojia; Zeng, Fanyu; Wang, Yong			Mesoporous silica as micro/nano-carrier: From passive to active cargo delivery, a mini review	JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY			English	Review						Mesoporous silica; Micro/nano-carrier; Drug delivery; Self-propulsion; Active carrier	PHOTODYNAMIC THERAPY; DRUG-DELIVERY; 5-AMINOLEVULINIC ACID; IN-VIVO; JANUS NANOMOTORS; ENZYME CATALYSIS; CO-DELIVERY; NANOPARTICLES; CANCER; NANOMEDICINE	Mesoporous silica has been widely explored for biomedical applications due to its unique structure and good biocompatibility. In particular it exhibits superior properties as micro/nano-carriers in the biomedical field. We explore their potentials in controlled drug/gene co-delivery and photodynamic therapy for cancer treatment both in vitro and in vivo. By incorporating mesoporous silica nanoparticles (MSNP) with two-dimensional nanomaterial, graphene oxide nano-sheet, we utilize MSNP in cellular bio-imaging with squaraine dye. Meanwhile, through delicate combination between mesoporous silica micro/nano carriers with catalytic/bio-catalytic reactions, we manage to achieve self-propelled micro/nano-motors based on mesoporous silica that are capable of transporting cargos in an active manner. Especially, enzyme powered mesoporous silica motors can be powered by physiologically available fuels such as glucose and urea, which are advantageous for future biomedical use. Motion control on both velocity and movement direction provides a powerful tool for targeted drug delivery. Therefore, such mesoporous silica based active carriers pave way to the solution of targeted drug delivery for cancer treatment in future nano-medicine field. (C) 2017 Published by Elsevier Ltd on behalf of The editorial office of Journal of Materials Science & Technology.	[Ma, Xing; Feng, Huanhuan; Liang, Chunyan; Liu, Xiaojia; Zeng, Fanyu; Wang, Yong] Harbin Inst Technol Shenzhen, Sate Key Lab Adv Welding & Joining, Shenzhen 518055, Peoples R China; [Ma, Xing] Harbin Inst Technol, Key Lab Microsyst & Microstruct Mfg, Minist Educ, Harbin 150001, Heilongjiang, Peoples R China	Ma, X; Feng, HH (reprint author), Harbin Inst Technol Shenzhen, Sate Key Lab Adv Welding & Joining, Shenzhen 518055, Peoples R China.	maxing@hit.edu.cn; fenghuanhuan@hit.edu.cn			Key Laboratory of Micro-systems and Micro-structures Manufacturing of Ministry of Education, Harbin Institute of Technology [2016KM007]	The authors gratefully acknowledge the financial support from Key Laboratory of Micro-systems and Micro-structures Manufacturing of Ministry of Education, Harbin Institute of Technology (2016KM007).	Abdelmohsen LKEA, 2016, ACS NANO, V10, P2652, DOI 10.1021/acsnano.5b07689; Ajayaghosh A, 2003, CHEM SOC REV, V32, P181, DOI 10.1039/b204251g; Ambrogio MW, 2011, ACCOUNTS CHEM RES, V44, P903, DOI 10.1021/ar200018x; Asefa T, 2012, CHEM RES TOXICOL, V25, P2265, DOI 10.1021/tx300166u; Avirah RR, 2012, ORG BIOMOL CHEM, V10, P911, DOI 10.1039/c1ob06588b; Baeza A, 2015, EXPERT OPIN DRUG DEL, V12, P319, DOI 10.1517/17425247.2014.953051; Bunea AI, 2015, BIOSENS BIOELECTRON, V67, P42, DOI 10.1016/j.bios.2014.05.062; Chen HM, 2012, J DENT SCI, V7, P307, DOI 10.1016/j.jds.2012.03.023; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Dey KK, 2015, NANO LETT, V15, P8311, DOI 10.1021/acs.nanolett.5b03935; Gao W, 2015, ACS NANO, V9, P117, DOI 10.1021/nn507097k; Gao W, 2014, NANOSCALE, V6, P10486, DOI 10.1039/c4nr03124e; He CB, 2014, J AM CHEM SOC, V136, P5181, DOI 10.1021/ja4098862; Hocine O, 2010, INT J PHARMACEUT, V402, P221, DOI 10.1016/j.ijpharm.2010.10.004; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0                                                                ; Li JX, 2016, ACS NANO, V10, P9536, DOI 10.1021/acsnano.6b04795; Luo Z, 2013, ACS NANO, V7, P10271, DOI 10.1021/nn404676w; Ma X, 2016, J AM CHEM SOC, V138, P13782, DOI 10.1021/jacs.6b06857; Ma X, 2016, ACS NANO, V10, P9111, DOI 10.1021/acsnano.6b04108; Ma X, 2016, ACS NANO, V10, P3597, DOI 10.1021/acsnano.5b08067; Ma X, 2015, NANO LETT, V15, P7043, DOI 10.1021/acs.nanolett.5b03100; Ma X, 2015, ACS APPL MATER INTER, V7, P10671, DOI 10.1021/acsami.5b03087; Ma X, 2015, J AM CHEM SOC, V137, P4976, DOI 10.1021/jacs.5b02700; Ma X, 2015, CHEM COMMUN, V51, P5467, DOI 10.1039/c4cc08285k; Ma X, 2014, ANTIOXID REDOX SIGN, V21, P707, DOI 10.1089/ars.2012.5076; Ma X, 2013, ACS APPL MATER INTER, V5, P12860, DOI 10.1021/am404578h; Ma X, 2013, CHEM-EUR J, V19, P15593, DOI 10.1002/chem.201302736; Ma X, 2012, ADV HEALTHC MATER, V1, P690, DOI 10.1002/adhm.201200123; Markman JL, 2013, ADV DRUG DELIVER REV, V65, P1866, DOI 10.1016/j.addr.2013.09.019; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Sreejith S, 2012, J AM CHEM SOC, V134, P17346, DOI 10.1021/ja305352d; Teng IT, 2013, BIOMATERIALS, V34, P7462, DOI 10.1016/j.biomaterials.2013.06.001; Tu J, 2012, BIOMATERIALS, V33, P7903, DOI 10.1016/j.biomaterials.2012.07.025; Tu YF, 2017, ACS NANO, V11, P1957, DOI 10.1021/acsnano.6b08079; Vivero-Escoto JL, 2010, SMALL, V6, P1952, DOI 10.1002/smll.200901789; Wang W., 2014, ANGEW CHEM INT EDIT, V126, P3265, DOI DOI 10.1002/ANGE.201309629; Wang Y, 2015, ADV MATER, V27, P576, DOI 10.1002/adma.201401124; Wu YJ, 2014, ACS APPL MATER INTER, V6, P10476, DOI 10.1021/am502458h; Wu ZG, 2013, ANGEW CHEM INT EDIT, V52, P7000, DOI 10.1002/anie.201301643; YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988                                                             ; Zhang Q, 2014, ADV FUNCT MATER, V24, P2450, DOI 10.1002/adfm.201302988; Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060034	42	0	0	28	28	JOURNAL MATER SCI TECHNOL	SHENYANG	72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA	1005-0302			J MATER SCI TECHNOL	J. Mater. Sci. Technol.	OCT	2017	33	10					1067	1074		10.1016/j.jmst.2017.06.007				8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	FL4TO	WOS:000414224600001					2018-01-05	
J	Liu, S; Yu, X; Wang, QK; Liu, ZP; Xiao, QQ; Hou, PP; Hu, Y; Hou, W; Yang, ZQ; Guo, DY; Chen, SL				Liu, Shuai; Yu, Xiao; Wang, Qiankun; Liu, Zhepeng; Xiao, Qiaoqiao; Hou, Panpan; Hu, Ying; Hou, Wei; Yang, Zhanqiu; Guo, Deyin; Chen, Shuliang			Specific Expression of Interferon-gamma Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits Tumorigenesis	JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Synergistic activation mediator (SAM); CRISPR-dCas9; humanized interferon-gamma; JAK-STAT signaling pathway; tumorigenesis	ESCHERICHIA-COLI; GENE-EXPRESSION; PROTEIN; PURIFICATION; CRISPR-CAS9; CELLS; ASSOCIATION; INFECTION; PROMOTER; SEQUENCE	The synergistic activation mediator (SAM) system can robustly activate endogenous gene expression by a single-guide RNA. This transcriptional modulation has been shown to enhance gene promoter activity and leads to epigenetic changes. Human interferon-gamma is a common natural glycoprotein involved in antiviral effects and inhibition of cancer cell growth. Large quantities of high-purity interferon-gamma are important for medical research and clinical therapy. To investigate the possibility of employing the SAM system to enhance endogenous human interferon-gamma with normal function in innate immunity, we designed 10 single-guide RNAs that target 200 bp upstream of the transcription start sites of the interferon-gamma genome, which could significantly activate the interferon-gamma promoter reporter. We confirmed that the system can effectively and highly activate interferon-gamma expression in several humanized cell lines. Moreover, we found that the interferon-gamma induced by the SAM system could inhibit tumorigenesis. Taken together, our results reveal that the SAM system can modulate epigenetic traits of non-immune cells through activating interferon-gamma expression and triggering JAK-STAT signaling pathways. Thus, this strategy could offer a novel approach to inhibit tumorigenesis without using exogenous interferon-gamma.	[Liu, Shuai; Wang, Qiankun; Liu, Zhepeng; Xiao, Qiaoqiao; Hou, Wei; Yang, Zhanqiu; Guo, Deyin; Chen, Shuliang] Wuhan Univ, Sch Basic Med Sci, Wuhan 430071, Hubei, Peoples R China; [Yu, Xiao] Hubei Prov Ctr Dis Control & Prevent, Inst Infect Dis Control & Prevent, Wuhan 430079, Hubei, Peoples R China; [Hou, Panpan; Hu, Ying] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Guo, Deyin] Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Shuliang] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA	Guo, DY; Chen, SL (reprint author), Wuhan Univ, Sch Basic Med Sci, Wuhan 430071, Hubei, Peoples R China.; Guo, DY (reprint author), Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou 510080, Guangdong, Peoples R China.; Chen, SL (reprint author), Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA.	guode-yin@mail.sysu.edu.cn; Chen-shu-liang@whu.edu.cn			Natural Science Foundation of China [81401659]; China Postdoctoral Science Foundation [2015T80838, 2014M560622]; China Scholarship Council; China National Special Research Program of Major Infectious Diseases [2014ZX10001003]; Hubei Provincial Science & Technology Innovation Team Grant [2012FFA043]; Wuhan University Experiment Technology Project Funding [WHU-2014-SYJS-02/204610400022]	We thank Yilin Li for technical assistance. We also thank Dr. Corine St. Gelais for revising the article. This work was supported by the Natural Science Foundation of China (81401659), China Postdoctoral Science Foundation (2015T80838 and 2014M560622), and the scholarship from the China Scholarship Council. The work was partially funded by the China National Special Research Program of Major Infectious Diseases (2014ZX10001003) and Hubei Provincial Science & Technology Innovation Team Grant (#2012FFA043). We are grateful to Dr. Ying Hu for the confocal assay with Wuhan University Experiment Technology Project Funding (WHU-2014-SYJS-02/204610400022).	ARAKAWA T, 1987, BIOCHEMISTRY-US, V26, P5428, DOI 10.1021/bi00391a032; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chen YJ, 2005, BIOCHEM BIOPH RES CO, V335, P616, DOI 10.1016/j.bbrc.2005.07.116; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Falahi F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00022; FIESCHKO JC, 1987, BIOTECHNOL BIOENG, V29, P1113, DOI 10.1002/bit.260290911; FRIESEL R, 1987, J CELL BIOL, V104, P689, DOI 10.1083/jcb.104.3.689; Ghosalkar A, 2008, PROTEIN EXPRES PURIF, V60, P103, DOI 10.1016/j.pep.2008.02.006; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187                                                     ; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ji HYY, 2016, MOL THER, V24, P508, DOI 10.1038/mt.2016.7; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324                                                                   ; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lu XM, 2014, BIOMED RES INT, DOI 10.1155/2014/261631; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Mohammadian-Mosaabadi J, 2007, PROTEIN EXPRES PURIF, V51, P147, DOI 10.1016/j.pep.2006.07.002; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nandre RM, 2013, COMP IMMUNOL MICROB, V36, P537, DOI 10.1016/j.cimid.2013.06.002; Paulus C, 2006, P NATL ACAD SCI USA, V103, P3840, DOI 10.1073/pnas.0600007103; Petrov S, 2010, PROTEIN EXPRES PURIF, V73, P70, DOI 10.1016/j.pep.2010.03.026; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reddy PK, 2007, PROTEIN EXPRES PURIF, V52, P123, DOI 10.1016/j.pep.2006.08.013; Rodel F, 2005, STRAHLENTHER ONKOL, V181, P456, DOI 10.1007/s00066-005-1361-3; Rosowski EE, 2014, INFECT IMMUN, V82, P706, DOI 10.1128/IAI.01291-13; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Sedger LM, 1999, J IMMUNOL, V163, P920; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Subramaniam PS, 2000, J CELL SCI, V113, P2771; Tan HK, 2008, BIOTECHNOL APPL BIOC, V49, P247, DOI 10.1042/BA20070032; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; van Essen D, 2009, PLOS BIOL, V7, P549, DOI 10.1371/journal.pbio.1000073; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482	40	0	0	0	0	KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY	SEOUL	KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL 135-703, SOUTH KOREA	1017-7825	1738-8872		J MICROBIOL BIOTECHN	J. Microbiol. Biotechnol.	OCT	2017	27	10					1855	1866		10.4014/jmb.1705.05081				12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	FK9IU	WOS:000413825600016	28838224				2018-01-05	
J	Wolfs, E; Holvoet, B; Ordovas, L; Breuls, N; Helsen, N; Schonberger, M; Raitano, S; Struys, T; Vanbilloen, B; Casteels, C; Sampaolesi, M; Van Laere, K; Lambrichts, I; Verfaillie, CM; Deroose, CM				Wolfs, Esther; Holvoet, Bryan; Ordovas, Laura; Breuls, Natacha; Helsen, Nicky; Schonberger, Matthias; Raitano, Susanna; Struys, Tom; Vanbilloen, Bert; Casteels, Cindy; Sampaolesi, Maurilio; Van Laere, Koen; Lambrichts, Ivo; Verfaillie, Catherine M.; Deroose, Christophe M.			Molecular Imaging of Human Embryonic Stem Cells Stably Expressing Human PET Reporter Genes After Zinc Finger Nuclease-Mediated Genome Editing	JOURNAL OF NUCLEAR MEDICINE			English	Article						genome editing; stem cells; reporter genes; PET; noninvasive imaging	POSITRON-EMISSION-TOMOGRAPHY; SODIUM-IODIDE SYMPORTER; TRANSGENE EXPRESSION; NEUROENDOCRINE TUMORS; THERAPY; INTEGRATION; GENERATION; REVEALS; CANCER; NIS	Molecular imaging is indispensable for determining the fate and persistence of engrafted stem cells. Standard strategies for transgene induction involve the use of viral vectors prone to silencing and insertional mutagenesis or the use of nonhuman genes. Methods: We used zinc finger nucleases to induce stable expression of human imaging reporter genes into the safe-harbor locus adeno-associated virus integration site 1 in human embryonic stem cells. Plasmids were generated carrying reporter genes for fluorescence, bioluminescence imaging, and human PET reporter genes. Results: In vitro assays confirmed their functionality, and embryonic stem cells retained differentiation capacity. Teratoma formation assays were performed, and tumors were imaged over time with PET and bioluminescence imaging. Conclusion: This study demonstrates the application of genome editing for targeted integration of human imaging reporter genes in human embryonic stem cells for longterm molecular imaging.	[Wolfs, Esther; Holvoet, Bryan; Breuls, Natacha; Vanbilloen, Bert; Casteels, Cindy; Van Laere, Koen; Deroose, Christophe M.] Katholieke Univ Leuven, Dept Imaging & Pathol, Mol Small Anim Imaging Ctr, Nucl Med & Mol Imaging, Leuven, Belgium; [Ordovas, Laura; Helsen, Nicky; Raitano, Susanna; Verfaillie, Catherine M.] Katholieke Univ Leuven, Stem Cell Inst, Leuven, Belgium; [Ordovas, Laura; Helsen, Nicky; Raitano, Susanna; Verfaillie, Catherine M.] Katholieke Univ Leuven, Stem Cell Biol & Embryol, Dept Dev & Regenerat, Leuven, Belgium; [Breuls, Natacha; Sampaolesi, Maurilio] Katholieke Univ Leuven, Translat Cardiomyol Lab, Dept Dev & Regenerat, Leuven, Belgium; [Schonberger, Matthias] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Struys, Tom; Lambrichts, Ivo] Univ Hasselt, Biomed Res Inst, Morphol Res Grp, Histol Lab, Diepenbeek, Belgium	Deroose, CM (reprint author), UZ Leuven, Div Nucl Med, Campus Gasthuisberg,Herestr 49, B-3000 Leuven, Belgium.	christophe.deroose@uzleuven.be		Ordovas, Laura/0000-0003-3982-1263; Verfaillie, Catherine/0000-0001-7564-4079	IWT; IWT [IWT/OZM/090838]; IACS [BPAMER3/08/04]; Government of Aragon [FMI048/08]; FWO [G.0667.07, G.0975.11]; KU Leuven [ETH-C1900-PF, EME-C2161-GOA/11/012]; IWT (IWT-HEPSTEM); IWT (IWT-HILIM-3D); BELSPO (BELSPO-IUAP-DEVREPAIR); HeMiBio [266777]	Christophe M. Deroose and Koen Van Laere are senior clinical investigators of the Flemish Fund for Scientific Research (FWO). Cindy Casteels is a postdoctoral fellow of FWO. Bryan Holvoet and Natacha Breuls are PhD students funded by IWT. Laura Ordovas was funded by IWT (IWT/OZM/090838), IACS (BPAMER3/08/04), and the Government of Aragon (FMI048/08). Funding to Christophe M. Deroose was from FWO (G.0667.07 and G.0975.11), KU Leuven (ETH-C1900-PF and EME-C2161-GOA/11/012), IWT (IWT-HEPSTEM and IWT-HILIM-3D), BELSPO (BELSPO-IUAP-DEVREPAIR), and HeMiBio (FP7-HEALTH, project 266777). No other potential conflict of interest relevant to this article was reported.	Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Collin J, 2011, STEM CELLS, V29, P1021, DOI 10.1002/stem.658; Cotugno G, 2011, HUM GENE THER, V22, P189, DOI 10.1089/hum.2010.098; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Deroose CM, 2016, J NUCL MED, V57, P1949, DOI 10.2967/jnumed.116.179234; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Gambhir SS, 2000, P NATL ACAD SCI USA, V97, P2785, DOI 10.1073/pnas.97.6.2785; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Jacobs A, 2001, LANCET, V358, P727, DOI 10.1016/S0140-6736(01)05904-9; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; KOTIN RM, 1992, EMBO J, V11, P5071; Krishnan M, 2005, FASEB J, V19, P106, DOI 10.1096/fj.05-4551fje; Li M, 2014, J BIOL CHEM, V289, P4594, DOI 10.1074/jbc.R113.488247; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Min JJ, 2003, EUR J NUCL MED MOL I, V30, P1547, DOI 10.1007/s00259-003-1238-6; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Paulmurugan R, 2004, CANCER RES, V64, P2113, DOI 10.1158/0008-5472.CAN-03-2972                                                   ; Penheiter AR, 2012, CURR GENE THER, V12, P33; Pennisi E, 2013, SCIENCE, V341, P833, DOI 10.1126/science.341.6148.833; Penuelas I, 2005, GASTROENTEROLOGY, V128, P1787, DOI 10.1053/j.gastro.2005.03.024; Phelps ME., 2012, PET MOL IMAGING ITS, P130; Raitano S, 2015, STEM CELL REP, V4, P16, DOI 10.1016/j.stemcr.2014.12.001; Ramachandra CJA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr409; Reubi JC, 2000, EUR J NUCL MED, V27, P273, DOI 10.1007/s002590050034                                                           ; REUBI JC, 1990, METABOLISM, V39, P78, DOI 10.1016/0026-0495(90)90217-Z                                                    ; Reubi JC, 2017, J NUCL MED, V58, P300, DOI 10.2967/jnumed.116.177733; Roelandt Philip, 2013, Methods Mol Biol, V997, P141, DOI 10.1007/978-1-62703-348-0_11; Serganova I, 2007, NUCL MED BIOL, V34, P791, DOI 10.1016/j.nucmedbio.2007.05.009; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Van Binnebeek S, 2016, EUR RADIOL, V26, P900, DOI 10.1007/s00330-015-3882-1; Van Sande J, 2003, ENDOCRINOLOGY, V144, P247, DOI 10.1210/en.2002-220744; Wang YM, 2012, CIRC RES, V111, P1494, DOI 10.1161/CIRCRESAHA.112.274969; Wolfs E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094833; Yaghoubi SS, 2012, THERANOSTICS, V2, P374, DOI 10.7150/thno.3677; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yang HH, 2003, PROSTATE, V55, P39, DOI 10.1002/pros.10208; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	42	0	0	2	2	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	OCT	2017	58	10					1659	1665		10.2967/jnumed.117.189779				7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	FI4YH	WOS:000411985900025	28596158				2018-01-05	
J	Song, R; Wang, ZD; Schapira, M				Song, Richard; Wang, Zhong-Duo; Schapira, Matthieu			Disease Association and Druggability of WD40 Repeat Proteins	JOURNAL OF PROTEOME RESEARCH			English	Article						WD40; WDR; cancer; disease association; druggability; regulation of transcription; ubiquitin proteasome system; therapeutic target; human proteome; CRISPR knockout screen	SMALL-MOLECULE INHIBITION; SUBUNIT GENE GNB3; UBIQUITIN LIGASE; DNA-DAMAGE; COMPLEX; BINDING; CANCER; HYPERTENSION; NETWORKS; ATG16L1	WD40 repeat (WDR) domains are protein interaction scaffolds that represent one of the largest protein families in human, and a first WDR inhibitor-an allosteric antagonist of polycomb repressive complex 2-just entered the clinic. A systematic analysis of the CORUM database of protein complexes shows that WDR is the most represented domain in transcriptional regulation and one of the most prevalent in the ubiquitin proteasome system, two pathways of high relevance to drug discovery. Parsing the literature and the vulnerability of cancer cell lines to CRISPR knockout indicates that WDR proteins are targets of interest in oncology and other disease areas. A quantitative analysis of WDR structures reveals that druggable binding pockets can be found on multiple surfaces of these multifaceted protein interaction platforms. These data support the development of chemical probes to further interrogate WDR proteins as an emerging therapeutic target class.	[Song, Richard; Wang, Zhong-Duo; Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada; [Wang, Zhong-Duo] Guangdong Ocean Univ, Fisheries Coll, Zhanjiang 524025, Guangdong, Peoples R China	Schapira, M (reprint author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Schapira, M (reprint author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada.	matthieu.schapira@utoronto.ca			AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD] [115766]; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust	The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Benjafield AV, 1998, HYPERTENSION, V32, P1094, DOI 10.1161/01.HYP.32.6.1094                                                        ; Couture JF, 2013, EPIGENETICS-US, V8, P349, DOI 10.4161/epi.24177; Danoviz ME, 2006, CLIN EXP PHARMACOL P, V33, P248, DOI 10.1111/j.1440-1681.2006.04353.x; Davis RJ, 2014, CANCER CELL, V26, P455, DOI [10.1016/j.cce11.2014.09.013, 10.1016/j.ccell.2014.09.013]; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/NCHEMBIO.1859, 10.1038/nchembio.1859]; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; He YP, 2017, NAT CHEM BIOL, V13, P389, DOI 10.1038/nchembio.2306; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hengstenberg C, 2001, CARDIOVASC RES, V49, P820, DOI 10.1016/S0008-6363(00)00292-3; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Kiani JG, 2005, NEUROENDOCRINOL LETT, V26, P87; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu LH, 2012, BIOINFORMATICS, V28, P2205, DOI 10.1093/bioinformatics/bts340; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Qi W, 2017, NAT CHEM BIOL, V13, P381, DOI 10.1038/nchembio.2304; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959                                                                  ; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947                                                                  ; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Senisterra G, 2013, BIOCHEM J, V449, P151, DOI 10.1042/BJ20121280; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thomas LR, 2015, CANCER RES, V75, P4012, DOI 10.1158/0008-5472.CAN-15-1216; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pD339, DOI 10.1093/nar/gku1023; Wu Y, 2016, NAT STRUCT MOL BIOL, V23, P933, DOI 10.1038/nsmb.3284; Xu C, 2016, GENE DEV, V30, P2376, DOI 10.1101/gad.288340.116; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	40	0	0	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	OCT	2017	16	10					3766	3773		10.1021/acs.jproteome.7b00451				8	Biochemical Research Methods	Biochemistry & Molecular Biology	FJ5KC	WOS:000412789400026	28956604				2018-01-05	
J	Honda, A; Ogura, A				Honda, Arata; Ogura, Atsuo			Rabbit models for biomedical research revisited via genome editing approaches	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Gene targeting; Genome editing; Knockin; Knockout; Rabbit	PLURIPOTENT STEM-CELLS; CRISPR/CAS9 SYSTEM; DIFFERENTIATION CAPACITY; TYROSINASE GENE; ES CELLS; KNOCK-IN; GENERATION; MICE; NAIVE; MUTATION	Although the laboratory rabbit has long contributed to many paradigmatic studies in biology and medicine, it is often considered to be a "classical animal model" because in the last 30 years, the laboratory mouse has been more often used, thanks to the availability of embryonic stem cells that have allowed the generation of gene knockout (KO) animals. However, recent genome-editing strategies have changed this unrivaled condition; so far, more than 10 mammalian species have been added to the list of KO animals. Among them, the rabbit has distinct advantages for application of genome-editing systems, such as easy application of superovulation, consistency with fertile natural mating, well-optimized embryo manipulation techniques, and the short gestation period. The rabbit has now returned to the stage of advanced biomedical research.	[Honda, Arata] Univ Miyazaki, Org Promot Tenure Track, Miyazaki 8891692, Japan; [Honda, Arata; Ogura, Atsuo] RIKEN, BioResource Ctr, Ibaraki 3050074, Japan	Honda, A (reprint author), Univ Miyazaki, Org Promot Tenure Track, Miyazaki 8891692, Japan.	a-honda@med.miyazaki-u.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988			Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Capecchi MR, 2001, NAT MED, V7, P1086, DOI 10.1038/nm1001-1086                                                             ; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Honda A, 2013, J BIOL CHEM, V288, P26157, DOI 10.1074/jbc.M113.502492; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706, DOI 10.1016/S1472-6483(10)60320-3                                                   ; Honsho K, 2015, J REPROD DEVELOP, V61, P13, DOI 10.1262/jrd.2014-098; Isotani A, 2011, GENES CELLS, V16, P397, DOI 10.1111/j.1365-2443.2011.01495.x; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lv QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25029; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Sui TT, 2016, HUM MOL GENET, V25, P2661, DOI 10.1093/hmg/ddw125; Yan Quanmei, 2014, Cell Regen (Lond), V3, P12, DOI 10.1186/2045-9769-3-12; Yang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25161; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; YIN MR, 2015, SC REP, V5; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024	29	0	0	3	3	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	OCT	2017	63	5					435	438		10.1262/jrd.2017-053                                                            				4	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	FK6MA	WOS:000413616600001	28579598	green_published			2018-01-05	
J	Asmar, R; Sonett, JR; Singh, G; Mansukhani, MM; Borczuk, AC				Asmar, Ramsey; Sonett, Joshua R.; Singh, Gopal; Mansukhani, Mahesh M.; Borczuk, Alain C.			Use of of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience	JOURNAL OF THORACIC ONCOLOGY			English	Article						Multiple primary lung cancer; Staging; Driver mutations; Intrapulmonary metastasis	TNM CLASSIFICATION; SURGICAL-TREATMENT; CANCER; METASTASES; ADENOCARCINOMAS; MANAGEMENT; PROPOSALS; SURVIVAL; OUTCOMES; EDITION	Objective: The staging of multiple pulmonary adenocarcinomas requires the distinction of intrapulmonary metastasis (IPM) from multiple primary lung cancers (MPLCs). This can be challenging in some patients, and the addition of data from oncogenic driver mutations in these tumors may be helpful in this determination. Methods: As a proof of principle, molecular driver results from primary tumors and their metastases in 45 patients were compared (cohort 1). Then, 69 patients with a total of 154 synchronous or metachronous lung carcinomas were identified, and the pathologic findings were compared with oncogenic driver mutation. Each patient was assigned a highest potential T or M category on the basis of clinical, histopathologic, and molecular findings (cohort 2). Results: The concordance rate of EGFR, KRAS, BRAF, and ALK receptor tyrosine kinase gene (ALK) mutations was 96% in cohort 1. In cohort 2, 36% of multiple same-lobe nodules were MPLCs, 40% were IPM, and 24% were non informative by molecular findings. Of nodules with multiple lobe involvement, 81.5% were MPLCs and 7.4% were IPM, with 11% noninformative. Of metachronous tumors, 52.9% were MPLCs. Overall survival was 100% at 2 years, 95% at 3 years, and 80% at 4 years in patients with available follow-up. Conclusions: Oncogenic driver mutations are concordant between primary tumors and metastasis. The largest proportion of MPLCs was seen in tumors of multiple lobes, but with a substantial proportion of MPLCs among single-lobe nodules and with metachronous tumors. Overall survival was higher than expected for the respective highest T or M category, which is in support of the high frequency of MPLC. (C) 2017 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.	[Asmar, Ramsey] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Sonett, Joshua R.; Singh, Gopal] Columbia Univ, Med Ctr, Dept Surg, New York, NY USA; [Mansukhani, Mahesh M.; Borczuk, Alain C.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA	Borczuk, AC (reprint author), Weill Cornell Med, Dept Pathol, 1300 York Ave ST10-1000A, New York, NY 10065 USA.	Alb9003@med.cornell.edu					Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aguilo R, 2008, EUR J CARDIO-THORAC, V34, P1075, DOI 10.1016/j.ejcts.2008.08.004; Arai J, 2012, LUNG CANCER, V77, P281, DOI 10.1016/j.lungcan.2012.04.003; Cortot AB, 2010, CANCER-AM CANCER SOC, V116, P2682, DOI 10.1002/cncr.25014; Daniels M, 2012, J THORAC DIS, V4, P155, DOI 10.3978/j.issn.2072-1439.2012.02.01; DESCHAMPS C, 1990, J THORAC CARDIOV SUR, V99, P769; Detterbeck FC, 2016, J THORAC ONCOL, V11, P681, DOI 10.1016/j.jtho.2015.12.114; Dumont P, 1998, CHEST, V113, P391, DOI 10.1378/chest.113.2.391                                                         ; Eberth JM, 2014, LUNG CANCER, V85, P379, DOI 10.1016/j.lungcan.2014.07.002; Finley DJ, 2010, J THORAC ONCOL, V5, P197, DOI 10.1097/JTO.0b013e3181c814c5; Girard N, 2009, CLIN CANCER RES, V15, P5184, DOI 10.1158/1078-0432.CCR-09-0594; Hurria A, 2003, CA-CANCER J CLIN, V53, P325, DOI 10.3322/canjclin.53.6.325                                                       ; Johnson BE, 1997, SEMIN ONCOL, V24, P492; Kim Byung Chul, 2014, Genomics & Informatics, V12, P50, DOI 10.5808/GI.2014.12.2.50; LI ZH, 1994, AM J PATHOL, V144, P303; Liu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13200; Lopez-Encuentra A, 2005, ANN THORAC SURG, V79, P974, DOI 10.1016/j.athoracsur.2004.06.004; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Moffatt-Bruce SD, 2010, ANN THORAC SURG, V90, P388, DOI 10.1016/j.athoracsur.2010.03.059; Murphy SJ, 2014, J CLIN ONCOL, V32, P4050, DOI 10.1200/JCO.2014.56.7644; Ono K, 2009, CANCER, V115, P3489, DOI 10.1002/cncr.24382; Rami-Porta R, 2007, J THORAC ONCOL, V2, P593, DOI 10.1097/JTO.0b013e31807a2f81                                                    ; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Rizzo JM, 2012, CANCER PREV RES, V5, P887, DOI 10.1158/1940-6207.CAPR-11-0432; ROSENGART TK, 1991, ANN THORAC SURG, V52, P773, DOI 10.1016/0003-4975(91)91209-E                                                    ; Sartori G, 2008, AM J CLIN PATHOL, V129, P202, DOI 10.1309/THU13F3JRJVWLM30; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Schneider F, 2016, MODERN PATHOL, V29, P735, DOI 10.1038/modpathol.2016.66; Shah AA, 2012, ANN THORAC SURG, V93, P1055, DOI 10.1016/j.athoracsur.2011.12.070; Sherwood J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0207-9; Tanvetyanon T, 2013, ANN ONCOL, V24, P889, DOI 10.1093/annonc/mds495; Vazquez M, 2009, LUNG CANCER, V64, P148, DOI 10.1016/j.lungcan.2008.08.009; Vignot S, 2013, J CLIN ONCOL, V31, P2167, DOI 10.1200/JCO.2012.47.7737; Waits AE, 2016, AM J CLIN PATHOL, V145, P244, DOI 10.1093/ajcp/aqv025; Xue XY, 2013, J INT MED RES, V41, P1779, DOI 10.1177/0300060513504707; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; ZHOU XD, 2016, MEDICINE BALTIMORE, V95	37	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1556-0864	1556-1380		J THORAC ONCOL	J. Thorac. Oncol.	OCT	2017	12	10					1524	1535		10.1016/j.jtho.2017.06.012				12	Oncology; Respiratory System	Oncology; Respiratory System	FI4DK	WOS:000411919700010	28647671				2018-01-05	
J	Hoffman, L; Jensen, CC; Yoshigi, M; Beckerle, M				Hoffman, Laura; Jensen, Christopher C.; Yoshigi, Masaaki; Beckerle, Mary			Mechanical signals activate p38 MAPK pathway-dependent reinforcement of actin via mechanosensitive HspB1	MOLECULAR BIOLOGY OF THE CELL			English	Article							HEAT-SHOCK PROTEINS; VASCULAR ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; FOCAL ADHESIONS; STRESS FIBERS; F-ACTIN; MOLECULAR CHAPERONES; KINASE ACTIVATION; FILAMENT DYNAMICS; TRACTIONAL FORCES	Despite the importance of a cell's ability to sense and respond to mechanical force, the molecular mechanisms by which physical cues are converted to cell-instructive chemical information to influence cell behaviors remain to be elucidated. Exposure of cultured fibroblasts to uniaxial cyclic stretch results in an actin stress fiber reinforcement response that stabilizes the actin cytoskeleton. p38 MAPK signaling is activated in response to stretch, and inhibition of p38 MAPK abrogates stretch-induced cytoskeletal reorganization. Here we show that the small heat shock protein HspB1 (hsp25/27) is phosphorylated in stretch-stimulated mouse fibroblasts via a p38 MAPK-dependent mechanism. Phosphorylated HspB1 is recruited to the actin cytoskeleton, displaying prominent accumulation on actin "comet tails" that emanate from focal adhesions in stretch-stimulated cells. Site-directed mutagenesis to block HspB1 phosphorylation inhibits the protein's cytoskeletal recruitment in response to mechanical stimulation. HspB1-null cells, generated by CRISPR/Cas9 nuclease genome editing, display an abrogated stretch-stimulated actin reinforcement response and increased cell migration. HspB1 is recruited to sites of increased traction force in cells geometrically constrained on micropatterned substrates. Our findings elucidate a molecular pathway by which a mechanical signal is transduced via activation of p38 MAPK to influence actin remodeling and cell migration via a zyxin-independent process.	[Hoffman, Laura; Jensen, Christopher C.; Yoshigi, Masaaki; Beckerle, Mary] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Hoffman, Laura; Beckerle, Mary] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Yoshigi, Masaaki] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; [Beckerle, Mary] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Beckerle, M (reprint author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.; Beckerle, M (reprint author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.; Beckerle, M (reprint author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	Mary.beckerle@hci.utah.edu			Mike Redd at the University of Utah Fluorescence Microscopy Core Facility [1S10RR024761-01]; National Institutes of Health [R01-GM50877]; Huntsman Cancer Foundation; Cancer Center Support [2-P30-CA042014]	We are grateful to Timothy Dahlem at the University of Utah Mutation Generation and Detection Core Facility and Mike Redd at the University of Utah Fluorescence Microscopy Core Facility (NCCR Shared Equipment Grant No. 1S10RR024761-01). Ken Boucher of the Biostatistics Shared Resource at the Huntsman Cancer Institute provided guidance with statistical analysis. Haley Halberg and Ioana Pop provided valuable assistance with image processing and analysis. We appreciate reagents shared by Jon Dean at the University of Oxford, United Kingdom, and Matthias Gaestel at the Hannover Medical School, Germany. Diana Lim provided expert figure design and preparation. This work was supported by the National Institutes of Health (R01-GM50877 to M. C. B.) and the Huntsman Cancer Foundation. The Cancer Center Support Grant (2-P30-CA042014) awarded to the Huntsman Cancer Institute provided developmental funds and supported shared resources critical to this project.	Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; An SS, 2004, J APPL PHYSIOL, V96, P1701, DOI 10.1152/japplphysiol.01129.2003; Ateshian GA, 2012, ANNU REV BIOMED ENG, V14, P97, DOI [10.1146/annurev-bioeng-071910-124726, 10.1146/annurev.bioeng-071910-124726]; BECKERLE MC, 1986, J CELL BIOL, V103, P1679, DOI 10.1083/jcb.103.5.1679; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Boudreault F, 2010, AM J RESP CELL MOL, V43, P64, DOI 10.1165/rcmb.2009-0092OC; BROWN SS, 1981, J CELL BIOL, V88, P487, DOI 10.1083/jcb.88.3.487; Bryantsev AL, 2002, CELL STRESS CHAPERON, V7, P146, DOI 10.1379/1466-1268(2002)007<0146:DPAAOH>2.0.CO;2; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cellbio.4.1.487; Byers H.R., 1984, Cell and Muscle Motility, V5, P83; Chapin LM, 2012, BIOPHYS J, V103, P2082, DOI 10.1016/j.bpj.2012.09.038; Chaudhuri S, 2008, AM J RESP CELL MOL, V39, P270, DOI 10.1165/rcmb.2007-0263OC; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Clarke JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068978; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; COLLIER NC, 1986, J CELL BIOL, V103, P1495, DOI 10.1083/jcb.103.4.1495; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; CRAWFORD AW, 1991, J BIOL CHEM, V266, P5847; Crowe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077383; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Damarla M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004600; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0                                                    ; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; FLANAGAN MD, 1980, J BIOL CHEM, V255, P835; Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139; Galkin VE, 2012, CURR BIOL, V22, pR96, DOI 10.1016/j.cub.2011.12.010; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963; Guay J, 1997, J CELL SCI, V110, P357; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Gupton SL, 2007, J CELL SCI, V120, P3475, DOI 10.1242/jcs.006049; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; Horton ER, 2016, EXP CELL RES, V343, P7, DOI 10.1016/j.yexcr.2015.10.025; Hotamisligil G. S., 2016, COLD SPRING HARB PER, V8; Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67; Huot J, 1997, CIRC RES, V80, P383; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078                                                                 ; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5                                                   ; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505                                                            ; Li S, 1996, AM J PHYSIOL-CELL PH, V271, pC994; Luxton GWG, 2011, NUCLEUS-AUSTIN, V2, P173, DOI [10.4161/nucl.2.3.16243, 10.1073/pnas.1000824108]; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nguyen HT, 2000, AM J PHYSIOL-CELL PH, V279, pC1155; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com                                                           ; Peng GE, 2011, MOL BIOL CELL, V22, P3986, DOI 10.1091/mbc.E11-04-0379; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Richard MN, 2007, J BIOL CHEM, V282, P23081, DOI 10.1074/jbc.M703602200; Rodriguez-Carballo Eddie, 2016, Front Cell Dev Biol, V4, P40, DOI 10.3389/fcell.2016.00040; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6                                                    ; Salinthone S, 2008, PHARMACOL THERAPEUT, V119, P44, DOI 10.1016/j.pharmthera.2008.04.005; Sawada Y, 2001, J CELL SCI, V114, P1221; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Shimozawa T, 2009, BIOPHYS J, V96, P1036, DOI 10.1016/j.bpj.2008.09.056; Smith MA, 2014, TRENDS CELL BIOL, V24, P575, DOI [10.1016/j.tcb.2014.04.009, 10.1016/J.tcb.2014.04.009]; Smith MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069378; Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008; Sousa AM, 2007, J CELL BIOCHEM, V100, P1581, DOI 10.1002/jcb.21154; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Uyeda TQP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026200; Wang JX, 2005, J BIOL CHEM, V280, P7273, DOI 10.1074/jbc.M410819200; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yan J, 2015, CELL MOL BIOENG, V8, P151, DOI 10.1007/s12195-014-0364-5; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Yoshigi M, 2003, CYTOM PART A, V55A, P109, DOI 10.1002/cyto.a.10076; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhang D, 2000, NAT MED, V6, P556	97	0	0	4	4	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	OCT 1	2017	28	20					2661	2675		10.1091/mbc.E17-02-0087				15	Cell Biology	Cell Biology	FI6OE	WOS:000412115100007	28768826				2018-01-05	
J	Yu, Q; Tan, RZ; Gan, Q; Zhong, X; Wang, YQ; Zhou, J; Wang, L				Yu, Qin; Tan, Rui-Zhi; Gan, Quan; Zhong, Xia; Wang, You-Qiang; Zhou, Jing; Wang, Li			A Novel Rat Model of Nonalcoholic Fatty Liver Disease Constructed Through CRISPR/Cas-Based Hydrodynamic Injection	MOLECULAR BIOTECHNOLOGY			English	Article						NAFLD; Pten; CRISPR/CAS9; Hydrodynamic injection; Rats	MICE; GENERATION; SYSTEM; CANCER; PTEN; CAS9; STEATOHEPATITIS; IMMUNITY; DNA	CRISPR/Cas technology has been widely used in generating conventional and conditional gene knockout animals through germline mutation. A recent study has demonstrated that CRISPR/Cas system also worked on nongermline mutation in mice liver via hydrodynamic injection of vector plasmid to blood circulation. However, whether this is also applied to rat and what is the optimal concentration of vector plasmid still need to be studied. Here, we attempted to use pX330-Pten plasmid to knock down the expression of Pten in rat liver for generation of nonalcoholic fatty liver disease (NAFLD) rat model. A range of pX330-Pten dosages (75, 150 and 300 mu g/100 g) in 10 ml of saline water was injected into the blood circulation of SD rats within 30 s by tail vein injection. The data showed that, 9 weeks after injection, no differences of TC, AST and ALT were found between control and the treatment groups (low-dose, mid-dose, high-dose and fat-diet groups). However, the high-dose group revealed severe lipid deposition and significant knockdown of Pten, which was validated by western blot and real-time PCR. Notably, lipid deposition and Pten knockdown were detected in the liver of animals from the high-dose group as early as 6 weeks after injection. Taken together, our findings demonstrated that hydrodynamic injection of pX330-Pten plasmid at the dosage of 300 mu g/100 g can knock down the expression of Pten in rat liver efficiently, resulting in lipid deposition as well as NAFLD. Taken together, this study presents a novel and efficient method to edit genome in rat liver.	[Yu, Qin] Southwest Med Univ, Sch Basic Med Sci, Luzhou 646000, Sichuan, Peoples R China; [Tan, Rui-Zhi; Zhong, Xia; Wang, Li] Southwest Med Univ, Affiliated Tradit Med Hosp, Res Ctr Combine Tradit Chinese & Western Med, Luzhou 646000, Sichuan, Peoples R China; [Gan, Quan] Southwest Med Univ, Sch Integrated Tradit Chinese & Western Med, Luzhou 646000, Sichuan, Peoples R China; [Wang, You-Qiang] Southwest Med Univ, Affiliated Tradit Med Hosp, Clin Lab, Luzhou 646000, Sichuan, Peoples R China; [Zhou, Jing] Southwest Med Univ, Sch Clin Med, Luzhou 646000, Sichuan, Peoples R China	Wang, L (reprint author), Southwest Med Univ, Affiliated Tradit Med Hosp, Res Ctr Combine Tradit Chinese & Western Med, Luzhou 646000, Sichuan, Peoples R China.	wangli120@swmu.edu.cn			Scientific Research Fund of SiChuan Provincial Education Department [16ZA0202]; Youth Funding Program of Southwest Medical University [2015QN-119]; Affiliated Traditional Medicine Hospital; Southwest Medical University; National College Students Innovation and Entrepreneurship Training Program [2016088]	This work was supported by Scientific Research Fund of SiChuan Provincial Education Department (16ZA0202), the Youth Funding Program of Southwest Medical University (2015QN-119), the Affiliated Traditional Medicine Hospital and Southwest Medical University joint program, the National College Students Innovation and Entrepreneurship Training Program (No. 2016088). We thank Dr. Jingyi Sheng for revising this manuscript.	Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Czarnek M, 2016, POSTEP HIG MED DOSW, V70, P901, DOI 10.5604/17322693.1216379                                                        ; Souza Mônica Rodrigues de Araújo, 2012, Arq. Gastroenterol., V49, P89, DOI 10.1590/S0004-28032012000100015; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; GALLITALIADOROS LA, 1995, J IMMUNOL METHODS, V181, P1, DOI 10.1016/0022-1759(95)00017-5; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Lim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13350; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuda S., 2013, ISRN ENDOCRINOL, V2013, DOI [DOI 10.1155/2013/472432, 10.1155/2013/472432]; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Olszanecki R, 2005, J PHYSIOL PHARMACOL, V56, P627; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Peyrou M, 2010, DIGEST DIS, V28, P236, DOI 10.1159/000282095; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	26	0	0	5	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1073-6085	1559-0305		MOL BIOTECHNOL	Mol. Biotechnol.	OCT	2017	59	9-10					365	373		10.1007/s12033-017-0025-8				9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FJ7MP	WOS:000412943700001	28695481				2018-01-05	
J	Shukla, P; Singh, NK; Gautam, R; Ahmed, I; Yadav, D; Sharma, A; Kirti, PB				Shukla, Pawan; Singh, Naveen Kumar; Gautam, Ranjana; Ahmed, Israr; Yadav, Deepanker; Sharma, Akanksha; Kirti, Pulugurtha Bharadwaja			Molecular Approaches for Manipulating Male Sterility and Strategies for Fertility Restoration in Plants	MOLECULAR BIOTECHNOLOGY			English	Review						Pollination control system; Cysteine protease-cystatin; Barnase-barstar; Male sterility; Genetic manipulation; Genetic engineering; Cytoplasmic male sterility; Genetic male sterility; Hybrid production	CYTOPLASMIC MALE-STERILITY; TRANSGENIC TOBACCO PLANTS; SITE-SPECIFIC RECOMBINATION; GENE RESTORES FERTILITY; MITOCHONDRIAL ORFB GENE; HYBRID SEED PRODUCTION; NUCLEAR MALE-STERILITY; OPEN READING FRAME; ORYZA-SATIVA L.; GLUTAMINE-SYNTHETASE	Usable pollination control systems have proven to be effective system for the development of hybrid crop varieties, which are important for optimal performance over varied environments and years. They also act as a biocontainment to check horizontal transgene flow. In the last two decades, many genetic manipulations involving genes controlling the production of cytotoxic products, conditional male sterility, altering metabolic processes, post-transcriptional gene silencing, RNA editing and chloroplast engineering methods have been used to develop a proper pollination control system. In this review article, we outline the approaches used for generating male sterile plants using an effective pollination control system to highlight the recent progress that occurred in this area. Furthermore, we propose possible future directions for biotechnological improvements that will allow the farmers to buy hybrid seed once for many generations in a cost-effective manner.	[Shukla, Pawan; Singh, Naveen Kumar; Gautam, Ranjana; Ahmed, Israr; Yadav, Deepanker; Sharma, Akanksha; Kirti, Pulugurtha Bharadwaja] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500046, Andhra Prades, India; [Shukla, Pawan] Cent Silk Board, Cent Sericultural Res & Training Inst, NH-1A, Pampore 192121, J&K, India; [Singh, Naveen Kumar] Agr Res Org, Volcani Ctr, 68 HaMaccabim Rd,POB 15159, IL-7505101 Rishon Leziyyon, Israel	Shukla, P; Kirti, PB (reprint author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500046, Andhra Prades, India.; Shukla, P (reprint author), Cent Silk Board, Cent Sericultural Res & Training Inst, NH-1A, Pampore 192121, J&K, India.	shklpwn@gmail.com; naveenks11@gmail.com; ranjana.gautam9@gmail.com; iahmed67@gmail.com; deepankerbhu@gmail.com; akankshasharma81@gmail.com; pbkirti@uohyd.ac.in		Yadav, Deepanker/0000-0001-6186-7052			Acquaah G, 2009, PRINCIPLES PLANT GEN; Agati G, 2007, NEW PHYTOL, V174, P77, DOI 10.1111/j.1469-8137.2007.01986.x; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Araya A., 1998, ELECTRON J BIOTECHN, V1; Bae HK, 2010, PLANT BREEDING, V129, P647, DOI 10.1111/j.1439-0523.2010.01784.x; Bayer M, 2005, MOL BREEDING, V15, P193, DOI 10.1007/s11032-004-5042-1; BECKER TW, 1992, PLANT MOL BIOL, V19, P367, DOI 10.1007/BF00023384; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Budar F, 2008, ANN PLANT REV FLOWER, V20, P147; Cao BH, 2010, GENET MOL BIOL, V33, P298, DOI 10.1590/S1415-47572010005000043; Chakraborty A, 2015, PLANTA, V241, P1463, DOI 10.1007/s00425-015-2269-5; Chang ZY, 2016, P NATL ACAD SCI USA, V113, P14145, DOI 10.1073/pnas.1613792113; CHAUDHURY AM, 1993, PLANT CELL, V5, P1277; Cigan AM, 2017, PLANT BIOTECHNOL J, V15, P379, DOI 10.1111/pbi.12633; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0                                                                ; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Cren M, 1999, PLANT CELL PHYSIOL, V40, P1187, DOI 10.1093/oxfordjournals.pcp.a029506                                              ; De Cosa B, 2001, NAT BIOTECHNOL, V19, P71, DOI 10.1038/83559; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Dubois F, 1996, PLANT MOL BIOL, V31, P803, DOI 10.1007/BF00019468; Engelke T, 2010, J EXP BOT, V61, P2693, DOI 10.1093/jxb/erq105; FAO U, 2009, ROME HIGHLEVEL EXPER; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Fischer R, 1997, PLANT J, V11, P489, DOI 10.1046/j.1365-313X.1997.11030489.x; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; GUALBERTO JM, 1990, NUCLEIC ACIDS RES, V18, P3771, DOI 10.1093/nar/18.13.3771; Guerineau F, 2003, PLANT BIOTECHNOL J, V1, P33, DOI 10.1046/j.1467-7652.2003.00002.x; HANDA H, 1995, CURR GENET, V28, P546, DOI 10.1007/BF00518167; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; HANSON MR, 1991, ANNU REV GENET, V25, P461, DOI 10.1146/annurev.ge.25.120191.002333                                             ; Hawkes T, 2011, PLANT BIOTECHNOL J, V9, P301, DOI 10.1111/j.1467-7652.2010.00549.x; Heiser V, 1997, PLANT SCI, V127, P61, DOI 10.1016/S0168-9452(97)00118-0; HERNOULD M, 1993, P NATL ACAD SCI USA, V90, P2370, DOI 10.1073/pnas.90.6.2370                                                          ; Hird DL, 2000, TRANSGENIC RES, V9, P91, DOI 10.1023/A:1008992619413; Hirsche J, 2009, THEOR APPL GENET, V118, P235, DOI 10.1007/s00122-008-0892-2; Hofig KP, 2006, PLANT BIOTECHNOL J, V4, P333, DOI 10.1111/j.1467-7652.2006.00185.x; HORNER HT, 1995, CROP SCI, V35, P1527, DOI 10.2135/cropsci1995.0011183X003500060002x                                       ; Huang J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00030; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kaul M, 1987, MALE STERILITY HIGHE, V1005, P116; Kempe K, 2011, MOL BREEDING, V27, P417, DOI 10.1007/s11032-011-9555-0; Kim DH, 2007, PLANT MOL BIOL, V63, P519, DOI 10.1007/s11103-006-9106-y; Kriete G, 1996, PLANT J, V9, P809, DOI 10.1046/j.1365-313X.1996.9060809.x; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Mackenzie S, 1999, PLANT CELL, V11, P571; Mansoor S, 2006, TRENDS PLANT SCI, V11, P559, DOI 10.1016/j.tplants.2006.09.010; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0                                                                ; MARIANI C, 1992, NATURE, V357, P384, DOI 10.1038/357384a0; Marimuthu MPA, 2011, SCIENCE, V331, P876, DOI 10.1126/science.1199682; McConn M, 1996, PLANT CELL, V8, P403; Miller JK, 2010, PLANT SCI, V179, P645, DOI 10.1016/j.plantsci.2010.08.006; Myers N, 1999, CURR SCI INDIA, V76, P507; Nawaz-ul-Rehman MS, 2007, MOL BIOTECHNOL, V36, P159, DOI 10.1007/s12033-007-0025-1; Nizampatnam NR, 2011, PLANT MOL BIOL, V76, P557, DOI 10.1007/s11103-011-9789-6; Nizampatnam NR, 2009, PLANTA, V229, P987, DOI 10.1007/s00425-009-0888-4; Pande S., 2002, Indian Phytopathology, V55, P444; Pinstrup-Andersen P., 2000, Agricultural biotechnology and the poor: Proceedings of an International Conference, Washington, DC, USA, 21-22 October, 1999., P159; Rao GS, 2017, PLANT SCI, V256, P139, DOI 10.1016/j.plantsci.2016.12.001; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Ribarits A, 2007, PLANT BIOTECHNOL J, V5, P483, DOI 10.1111/j.1467-7652.2007.00256.x; Ruiz ON, 2005, PLANT PHYSIOL, V138, P1232, DOI 10.1104/pp.104.057729; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; SCHUSTER W, 1990, MOL CELL BIOL, V10, P2428, DOI 10.1128/MCB.10.5.2428                                                           ; Sharma HC, 2002, PLANT SCI, V163, P381, DOI 10.1016/S0168-9452(02)00133-4; Shukla P, 2016, PLANT SCI, V246, P52, DOI 10.1016/j.plantsci.2016.02.010; Shukla P, 2014, FUNCT INTEGR GENOMIC, V14, P307, DOI 10.1007/s10142-014-0367-2; Singh SP, 2010, PLANT BIOTECHNOL J, V8, P1005, DOI 10.1111/j.1467-7652.2010.00527.x; Singh SP, 2015, SCI REP-UK, V5, DOI 10.1038/srep11274; Souza A. J., 2007, SCI AGR, V64, P645, DOI DOI 10.1590/S0103-90162007000600014; VANDERMEER IM, 1992, PLANT CELL, V4, P253; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9                                                   ; Wise RP, 1999, J HERED, V90, P380, DOI 10.1093/jhered/90.3.380; Woo MO, 2008, PLANT J, V54, P190, DOI 10.1111/j.1365-313X.2008.03405.x; WORRALL D, 1992, PLANT CELL, V4, P759, DOI 10.1105/tpc.4.7.759                                                             ; XU HL, 1995, P NATL ACAD SCI USA, V92, P2106, DOI 10.1073/pnas.92.6.2106; Yamamoto MP, 2008, PLANT J, V54, P1027, DOI 10.1111/j.1365-313X.2008.03473.x; YOUNG EG, 1987, CELL, V50, P41, DOI 10.1016/0092-8674(87)90660-X; Yui R, 2003, PLANT J, V34, P57, DOI 10.1046/j.1365-313X.2003.01779.x; Zabaleta E, 1996, P NATL ACAD SCI USA, V93, P11259, DOI 10.1073/pnas.93.20.11259                                                        	81	0	0	5	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1073-6085	1559-0305		MOL BIOTECHNOL	Mol. Biotechnol.	OCT	2017	59	9-10					445	457		10.1007/s12033-017-0027-6				13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FJ7MP	WOS:000412943700008	28791615				2018-01-05	
J	Marschall, LA				Marschall, Laurence A.			A Crack in Creation: Gene Editing and The Unthinkable Power to Control Evolution	NATURAL HISTORY			English	Book Review																DOUDNA JA, 2017, CRACK CREATION GENE	1	0	0	0	0	NATURAL HISTORY MAGAZINE	NEW YORK	36 WEST 25TH STREET, FIFTH FLOOR, NEW YORK, NY 10010 USA	0028-0712			NAT HIST	Nat. Hist.	OCT	2017	125	9					46	47						2	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	FI1AD	WOS:000411660300021					2018-01-05	
J	Lee, JH; Jung, SM; Yang, KM; Bae, E; Ahn, SG; Park, JS; Seo, D; Kim, M; Ha, J; Lee, J; Kim, JH; Kim, JH; Ooshima, A; Park, J; Shin, D; Lee, YS; Lee, S; van Loo, G; Jeong, J; Kim, SJ; Park, SH				Lee, Ji-Hyung; Jung, Su Myung; Yang, Kyung-Min; Bae, Eunjin; Ahn, Sung Gwe; Park, Jin Seok; Seo, Dongyeob; Kim, Minbeom; Ha, Jihoon; Lee, Jaewon; Kim, Jun-Hyeong; Kim, Jun Hwan; Ooshima, Akira; Park, Jinah; Shin, Donghyuk; Lee, Youn Sook; Lee, Sangho; van Loo, Geert; Jeong, Joon; Kim, Seong-Jin; Park, Seok Hee			A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1	NATURE CELL BIOLOGY			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; NECROSIS-FACTOR-ALPHA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ZINC-FINGER PROTEIN; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CELL-MIGRATION; TUMOR-CELLS; TGF-BETA	Although the ubiquitin-editing enzyme A20 is a key player in inflammation and autoimmunity, its role in cancer metastasis remains unknown. Here we show that A20 monoubiquitylates Snail1 at three lysine residues and thereby promotes metastasis of aggressive basal-like breast cancers. A20 is significantly upregulated in human basal-like breast cancers and its expression level is inversely correlated with metastasis-free patient survival. A20 facilitates TGF-beta 1-induced epithelial-mesenchymal transition (EMT) of breast cancer cells through multi-monoubiquitylation of Snail1. Monoubiquitylated Snail1 has reduced affinity for glycogen synthase kinase 3 beta (GSK3 beta), and is thus stabilized in the nucleus through decreased phosphorylation. Knockdown of A20 or overexpression of Snail1 with mutation of the monoubiquitylated lysine residues into arginine abolishes lung metastasis in mouse xenograft and orthotopic breast cancer models, indicating that A20 and monoubiquitylated Snail1 are required for metastasis. Our findings uncover an essential role of the A20-Snail1 axis in TGF-beta 1-induced EMT and metastasis of basal-like breast cancers.			parks@skku.edu		Shin, Donghyuk/0000-0002-8272-6133	Ministry for Health and Welfare, Republic of Korea [1520120]; National Research Foundation grant of Korea - Ministry of Science, ICR & Future Planning [2015R1A2A2A05001344, SRC 2017R1A5A1014560]	This work was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1520120) and in part by National Research Foundation grant of Korea (2015R1A2A2A05001344 and SRC 2017R1A5A1014560) funded by the Ministry of Science, ICR & Future Planning.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Cascione L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055910; Catrysse L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.154; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chen SY, 2015, LEUKEMIA RES, V39, P976, DOI 10.1016/j.leukres.2015.06.004; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Diaz VM, 2014, CELL ADHES MIGR, V8, P418, DOI 10.4161/19336918.2014.969998; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Dong BF, 2012, BIOCHEM BIOPH RES CO, V418, P433, DOI 10.1016/j.bbrc.2012.01.056; Eiseler T, 2012, J BIOL CHEM, V287, P32367, DOI 10.1074/jbc.M112.370999; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Guo QD, 2009, EXPERT OPIN THER TAR, V13, P733, DOI 10.1517/14728220903045018; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319; Hovelmeyer N, 2011, EUR J IMMUNOL, V41, P595, DOI 10.1002/eji.201041313; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI [10.1016/j.cce11.2014.09.002, 10.1016/j.ccell.2014.09.002]; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Kim CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018000; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Lippens S, 2011, CELL DEATH DIFFER, V18, P1845, DOI 10.1038/cdd.2011.55; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552                                                                   ; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	59	0	0	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2017	19	10					1260	+		10.1038/ncb3609				29	Cell Biology	Cell Biology	FI5HP	WOS:000412013400018	28892081				2018-01-05	
J	Braun, DA; Rao, J; Mollet, G; Schapiro, D; Daugeron, MC; Tan, WZ; Gribouval, O; Boyer, O; Revy, P; Jobst-Schwan, T; Schmidt, JM; Lawson, JA; Schanze, D; Ashraf, S; Ullmann, JFP; Hoogstraten, CA; Boddaert, N; Collinet, B; Martin, G; Liger, D; Lovric, S; Furlano, M; Guerrera, IC; Sanchez-Ferras, O; Hu, JF; Boschat, AC; Sanquer, S; Menten, B; Vergult, S; De Rocker, N; Airik, M; Hermle, T; Shril, S; Widmeier, E; Gee, HY; Choi, WI; Sadowski, CE; Pabst, WL; Warejko, JK; Daga, A; Basta, T; Matejas, V; Scharmann, K; Kienast, SD; Behnam, B; Beeson, B; Begtrup, A; Bruce, M; Ch'ng, GS; Lin, SP; Chang, JH; Chen, CH; Cho, MT; Gaffney, PM; Gipson, PE; Hsu, CH; Kari, JA; Ke, YY; Kiraly-Borri, C; Lai, WM; Lemyre, E; Littlejohn, RO; Masri, A; Moghtaderi, M; Nakamura, K; Ozaltin, F; Praet, M; Prasad, C; Prytula, A; Roeder, ER; Rump, P; Schnur, RE; Shiihara, T; Sinha, MD; Soliman, NA; Soulami, K; Sweetser, DA; Tsai, WH; Tsai, JD; Topaloglu, R; Vester, U; Viskochil, DH; Vatanavicharn, N; Waxler, JL; Wierenga, KJ; Wolf, MTF; Wong, SN; Leidel, SA; Truglio, G; Dedon, PC; Poduri, A; Mane, S; Lifton, RP; Bouchard, M; Kannu, P; Chitayat, D; Magen, D; Callewaert, B; van Tilbeurgh, H; Zenker, M; Antignac, C; Hildebrandt, F				Braun, Daniela A.; Rao, Jia; Mollet, Geraldine; Schapiro, David; Daugeron, Marie-Claire; Tan, Weizhen; Gribouval, Olivier; Boyer, Olivia; Revy, Patrick; Jobst-Schwan, Tilman; Schmidt, Johanna Magdalena; Lawson, Jennifer A.; Schanze, Denny; Ashraf, Shazia; Ullmann, Jeremy F. P.; Hoogstraten, Charlotte A.; Boddaert, Nathalie; Collinet, Bruno; Martin, Gaelle; Liger, Dominique; Lovric, Svjetlana; Furlano, Monica; Guerrera, I. Chiara; Sanchez-Ferras, Oraly; Hu, Jennifer F.; Boschat, Anne-Claire; Sanquer, Sylvia; Menten, Bjorn; Vergult, Sarah; De Rocker, Nina; Airik, Merlin; Hermle, Tobias; Shril, Shirlee; Widmeier, Eugen; Gee, Heon Yung; Choi, Won-Il; Sadowski, Carolin E.; Pabst, Werner L.; Warejko, Jillian K.; Daga, Ankana; Basta, Tamara; Matejas, Verena; Scharmann, Karin; Kienast, Sandra D.; Behnam, Babak; Beeson, Brendan; Begtrup, Amber; Bruce, Malcolm; Ch'ng, Gaik-Siew; Lin, Shuan-Pei; Chang, Jui-Hsing; Chen, Chao-Huei; Cho, Megan T.; Gaffney, Patrick M.; Gipson, Patrick E.; Hsu, Chyong-Hsin; Kari, Jameela A.; Ke, Yu-Yuan; Kiraly-Borri, Cathy; Lai, Wai-ming; Lemyre, Emmanuelle; Littlejohn, Rebecca Okashah; Masri, Amira; Moghtaderi, Mastaneh; Nakamura, Kazuyuki; Ozaltin, Fatih; Praet, Marleen; Prasad, Chitra; Prytula, Agnieszka; Roeder, Elizabeth R.; Rump, Patrick; Schnur, Rhonda E.; Shiihara, Takashi; Sinha, Manish D.; Soliman, Neveen A.; Soulami, Kenza; Sweetser, David A.; Tsai, Wen-Hui; Tsai, Jeng-Daw; Topaloglu, Rezan; Vester, Udo; Viskochil, David H.; Vatanavicharn, Nithiwat; Waxler, Jessica L.; Wierenga, Klaas J.; Wolf, Matthias T. F.; Wong, Sik-Nin; Leidel, Sebastian A.; Truglio, Gessica; Dedon, Peter C.; Poduri, Annapurna; Mane, Shrikant; Lifton, Richard P.; Bouchard, Maxime; Kannu, Peter; Chitayat, David; Magen, Daniella; Callewaert, Bert; van Tilbeurgh, Herman; Zenker, Martin; Antignac, Corinne; Hildebrandt, Friedhelm			Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly	NATURE GENETICS			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSFER-RNA MODIFICATION; GALLOWAY-MOWAT SYNDROME; GENOME MAINTENANCE; MASS-SPECTROMETRY; SECKEL-SYNDROME; YEAST; DNA; KINASE; WDR73	Galloway-Mowat syndrome (GAMOS) is an autosomal-recessive disease characterized by the combination of early-onset nephrotic syndrome (SRNS) and microcephaly with brain anomalies. Here we identified recessive mutations in OSGEP, TP53RK, TPRKB, and LAGE3, genes encoding the four subunits of the KEOPS complex, in 37 individuals from 32 families with GAMOS. CRISPR-Cas9 knockout in zebrafish and mice recapitulated the human phenotype of primary microcephaly and resulted in early lethality. Knockdown of OSGEP, TP53RK, or TPRKB inhibited cell proliferation, which human mutations did not rescue. Furthermore, knockdown of these genes impaired protein translation, caused endoplasmic reticulum stress, activated DNA-damage-response signaling, and ultimately induced apoptosis. Knockdown of OSGEP or TP53RK induced defects in the actin cytoskeleton and decreased the migration rate of human podocytes, an established intermediate phenotype of SRNS. We thus identified four new monogenic causes of GAMOS, describe a link between KEOPS function and human disease, and delineate potential pathogenic mechanisms.	[Braun, Daniela A.; Rao, Jia; Schapiro, David; Tan, Weizhen; Jobst-Schwan, Tilman; Schmidt, Johanna Magdalena; Lawson, Jennifer A.; Ashraf, Shazia; Hoogstraten, Charlotte A.; Lovric, Svjetlana; Airik, Merlin; Hermle, Tobias; Shril, Shirlee; Widmeier, Eugen; Gee, Heon Yung; Choi, Won-Il; Sadowski, Carolin E.; Pabst, Werner L.; Warejko, Jillian K.; Daga, Ankana; Hildebrandt, Friedhelm] Boston Childrens Hosp, Harvard Med Sch, Boston, MA USA; [Mollet, Geraldine; Gribouval, Olivier; Boyer, Olivia; Martin, Gaelle; Furlano, Monica; Antignac, Corinne] INSERM, Imagine Inst, Lab Hereditary Kidney Dis, UMR1163, Paris, France; [Mollet, Geraldine; Gribouval, Olivier; Boyer, Olivia; Revy, Patrick; Boddaert, Nathalie; Martin, Gaelle; Furlano, Monica; Antignac, Corinne] Univ Paris 05, Sorbonne Paris Cite, Imagine Inst, Paris, France; [Daugeron, Marie-Claire; Collinet, Bruno; Liger, Dominique; Basta, Tamara; van Tilbeurgh, Herman] Univ Paris Sud, Univ Paris Saclay, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Boyer, Olivia] Hop Necker Enfants Malad, AP HP, Dept Pediat Nephrol, Paris, France; [Revy, Patrick] INSERM, U1163, Imagine Inst, Lab Genome Dynam Immune Syst, Paris, France; [Schanze, Denny; Zenker, Martin] Univ Hosp Magdeburg, Inst Human Genet, Magdeburg, Germany; [Ullmann, Jeremy F. P.; Truglio, Gessica; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, Epilepsy Genet Program, Boston, MA USA; [Ullmann, Jeremy F. P.; Truglio, Gessica; Poduri, Annapurna] Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA USA; [Ullmann, Jeremy F. P.; Poduri, Annapurna] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Boddaert, Nathalie] INSERM, U1163, Imagine Inst, Lab Mol & Pathophysiol Bases Cognit Disorders, Paris, France; [Boddaert, Nathalie] INSERM, U1000, Paris, France; [Boddaert, Nathalie] Hop Necker Enfants Malad, AP HP, Dept Pediat Radiol, Paris, France; [Collinet, Bruno] Sorbonne Univ, UPMC, UFR 927, Sci Vie, Paris, France; [Collinet, Bruno] Univ Paris 06, Sorbonne Univ, Inst Mineral Phys Mat & Cosmochim, UPMC,UMR 7590, Paris, France; [Furlano, Monica] Univ Autonoma Barcelona, Nephrol Dept, Fundacio Puigvert, IIB St Pau, Barcelona, Spain; [Furlano, Monica] REDINREN, Barcelona, Spain; [Guerrera, I. Chiara] Univ Paris 05, Struct Fedarat Rech Necker, INSERM, US24 CNRS UMS3633,Proteom Platform 3P5 Necker, Paris, France; [Sanchez-Ferras, Oraly; Bouchard, Maxime] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Sanchez-Ferras, Oraly; Bouchard, Maxime] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Hu, Jennifer F.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Hu, Jennifer F.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Boschat, Anne-Claire] Imagine Inst, Mass Spectrometry Platform, Paris, France; [Sanquer, Sylvia] Hop Necker Enfants Malad, AP HP, Dept Metabol & Prote Biochem, Paris, France; [Sanquer, Sylvia] Paris Descartes Sorbonne Paris Cite Univ, INSERM, UMR S1124, Paris, France; [Menten, Bjorn; Vergult, Sarah; De Rocker, Nina; Callewaert, Bert] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Widmeier, Eugen] Univ Freiburg, Dept Med, Div Renal, Fac Med,Med Ctr, Freiburg, Germany; [Gee, Heon Yung] Yonsei Univ, Coll Med, Dept Pharmacol, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Matejas, Verena] Friedrich Alexander Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Scharmann, Karin; Kienast, Sandra D.; Leidel, Sebastian A.] Max Planck Inst Mol Biomed, Munster, Germany; [Scharmann, Karin; Kienast, Sandra D.; Leidel, Sebastian A.] Univ Munster, Cells in Motion Cluster Excellence, Munster, Germany; [Behnam, Babak] Iran Univ Med Sci, Dept Med Genet & Mol Biol, Tehran, Iran; [Behnam, Babak] NHGRI, NIH, Undiagnosed Dis Program, Common Fund,Off Director,Med Genet Branch, Bethesda, MD USA; [Beeson, Brendan; Bruce, Malcolm] Princess Margaret Hosp, Dept Diagnost Imaging, Perth, WA, Australia; [Beeson, Brendan; Bruce, Malcolm] King Edward Mem Hosp, Perth, WA, Australia; [Begtrup, Amber; Cho, Megan T.; Schnur, Rhonda E.] GeneDx, Gaithersburg, MD USA; [Ch'ng, Gaik-Siew] Kuala Lumpur Hosp, Dept Genet, Kuala Lumpur, Malaysia; [Lin, Shuan-Pei] MacKay Childrens Hosp, Dept Pediat Genet, Taipei, Taiwan; [Lin, Shuan-Pei; Tsai, Jeng-Daw] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Chang, Jui-Hsing; Hsu, Chyong-Hsin; Tsai, Jeng-Daw] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan; [Chen, Chao-Huei; Ke, Yu-Yuan] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Gaffney, Patrick M.] Oklahoma Med Res Fdn, Dept Arthrit & Clin Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Gipson, Patrick E.] Univ Michigan, Internal Med & Pediat Div Adult & Pediat Nephrol, Ann Arbor, MI 48109 USA; [Kari, Jameela A.] King Abdulaziz Univ, Pediatr Nephrol Ctr Excellence, Jeddah, Saudi Arabia; [Kari, Jameela A.] King Abdulaziz Univ, Pediat Dept, Jeddah, Saudi Arabia; [Kiraly-Borri, Cathy] Princess Margaret Hosp Children, Genet Serv Western Australia, Subiaco, WA, Australia; [Kiraly-Borri, Cathy] King Edward Mem Hosp Women, Subiaco, WA, Australia; [Lai, Wai-ming] Princess Margaret Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Lemyre, Emmanuelle] Univ Montreal, CHU St Justine, Dept Pediat, Serv Genet Med, Montreal, PQ, Canada; [Littlejohn, Rebecca Okashah; Roeder, Elizabeth R.] Baylor Coll Med, Dept Pediat, San Antonio, TX USA; [Littlejohn, Rebecca Okashah; Roeder, Elizabeth R.] Baylor Coll Med, Dept Human Mol Genet, Houston, TX USA; [Masri, Amira] Univ Jordan, Dept Pediat, Div Child Neurol, Fac Med, Amman, Jordan; [Moghtaderi, Mastaneh] Univ Tehran Med Sci, Chron Kidney Dis Res Ctr, Tehran, Iran; [Nakamura, Kazuyuki; Shiihara, Takashi] Yamagata Univ, Sch Med, Dept Pediat, Yamagata, Japan; [Ozaltin, Fatih; Topaloglu, Rezan] Hacettepe Univ, Fac Med, Dept Pediat Nephrol, Ankara, Turkey; [Ozaltin, Fatih] Hacettepe Univ, Fac Med, Nephrogenet Lab, Ankara, Turkey; [Ozaltin, Fatih] Hacettepe Univ, Ctr Biobanking & Genom, Ankara, Turkey; [Praet, Marleen] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium; [Prasad, Chitra] Western Univ, London Hlth Sci Ctr, Dept Genet Metab & Pediat, London, ON, Canada; [Prytula, Agnieszka] Ghent Univ Hosp, Dept Pediat, Ghent, Belgium; [Rump, Patrick] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Sinha, Manish D.] Evelina London Childrens Hosp, Kings Coll London, Dept Paediat Nephrol, Guys & St Thomas NHS Fdn Trust, London, England; [Soliman, Neveen A.] Cairo Univ, Kasr Al Ainy Sch Med, Ctr Pediat Nephrol & Transplantat, Dept Pediat, Cairo, Egypt; [Soliman, Neveen A.] Egyptian Grp Orphan Renal Dis, Cairo, Egypt; [Soulami, Kenza] Ibn Rochd Univ Hosp, Dept Nephrol, Casablanca, Morocco; [Sweetser, David A.; Waxler, Jessica L.] Massachusetts Gen Hosp Children, Div Med Genet, Boston, MA USA; [Tsai, Wen-Hui] Chi Mei Med Ctr, Dept Pediat, Div Genet & Metab, Tainan, Taiwan; [Tsai, Jeng-Daw] Taipei Med Univ Hosp, Dept Pediat, Taipei, Taiwan; [Tsai, Jeng-Daw] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Vester, Udo] Univ Hosp Essen, Dept Pediat II, Essen, Germany; [Viskochil, David H.] Univ Utah, Sch Med, Div Med Genet, Dept Pediat, Salt Lake City, UT USA; [Vatanavicharn, Nithiwat] Mahidol Univ, Div Med Genet, Dept Pediat, Fac Med,Siriraj Hosp, Bangkok, Thailand; [Wierenga, Klaas J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Wolf, Matthias T. F.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Pediat Nephrol, Dallas, TX USA; [Wong, Sik-Nin] Tuen Mun Hosp, Dept Pediat & Adolescent Med, Tuen Mun, Hong Kong, Peoples R China; [Leidel, Sebastian A.] Univ Munster, Med Fac, Munster, Germany; [Dedon, Peter C.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dedon, Peter C.] Singapore MIT Alliance Res & Technol, Infect Dis IRG, Singapore, Singapore; [Mane, Shrikant; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; [Lifton, Richard P.] Rockefeller Univ, Lab Human Genet & Genom, 1230 York Ave, New York, NY 10021 USA; [Kannu, Peter; Chitayat, David] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Pediat, Toronto, ON, Canada; [Magen, Daniella] Pediat Nephrol Inst, Rambam Hlth Care Campus, Haifa, Israel; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France	Hildebrandt, F (reprint author), Boston Childrens Hosp, Harvard Med Sch, Boston, MA USA.; Antignac, C (reprint author), INSERM, Imagine Inst, Lab Hereditary Kidney Dis, UMR1163, Paris, France.; Antignac, C (reprint author), Univ Paris 05, Sorbonne Paris Cite, Imagine Inst, Paris, France.; Zenker, M (reprint author), Univ Hosp Magdeburg, Inst Human Genet, Magdeburg, Germany.; Antignac, C (reprint author), Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France.	martin.zenker@med.ovgu.de; corinne.antignac@inserm.fr; friedhelm.hildebrandt@childrens.harvard.edu	Prytula, Agnieszka/N-8036-2015	Prytula, Agnieszka/0000-0001-9551-8758; Behnam, Babak/0000-0002-1266-1602; Gribouval, Olivier/0000-0003-0238-8224; Braun, Daniela Anne/0000-0003-3146-1566; ANTIGNAC, Corinne/0000-0002-9934-4940; Mollet, Geraldine/0000-0003-4685-5736	National Institutes of Health [DK076683]; Howard Hughes Medical Institute; ASN Foundation for Kidney Research; National Human Genome Research Institute, National Institutes of Health; German National Academy of Sciences Leopoldina [LPDS-2015-07]; National Research Foundation of Korea, Ministry of Science, ICT and Future planning [2015R1D1A1A01056685]; Yonsei University College of Medicine [2015-32-0047]; NIH [K08-DK095994-05]; Children's Clinical Research Advisory Committee (CCRAC); Children's Medical Center, Dallas; Fonds de la Recherche du Quebec-Sante (FRQS); Canadian Institutes for Health Research [MOP-84470]; KRESCENT; McGill Integrated Cancer Research Training (MICRTP); Deutsche Forschungsgemeinschaft (DFG) [Jo 1324/1-1]; German Research Foundation, DFG [HE 7456/1-1]; Agence Nationale de la Recherche [ANR-12-BSV1-0033.01]; European Union's Seventh Framework Programme [305608-EURenOmics]; Fondation Recherche Medicale [DEQ20150331682]; 'Investissements d'avenir' program [ANR-10-IAHU-01]; Spanish Society of Nephrology; Catalan Society of Nephrology; Department of Health by National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Deutsche Forschungsgemeinschaft [SFB423]; Singapore National Research Foundation under the Singapore-MIT Alliance for Research and Technology; National Institute of Environmental Health Science [ES017010, ES022858, ES002109]; National Science Foundation [MCB-1412379]; European Community's Seventh Framework Programme [2012305608]; Hacettepe University [06A101008]; COBRE [P30 GM110766]; Dutch Kidney Foundation; Max Planck Society; European Research Council [ERC-2012-StG310489-tRNAmodi]; Boston Children's Hospital	We are grateful to the families and participating individuals for their contribution. We thank the Yale Center for Mendelian Genomics (U54HG006504) and the Care4Rare Canada Consortium for WES. We acknowledge D. Ogino (Yamagata University) for providing the nephrology data for patient B60, H. Sartelet (Departement de Pathologie, CHU-Sainte-Justine, Universite de Montreal) for providing pathology pictures from the renal biopsy from patient B80, S. Blaser (Hospital for Sick Children, Department of Pediatrics, Division of Neuroradiology, University of Toronto) for providing cranial imaging for patient DC, and S. Ameli (Children's Medical Center, Tehran University of Medical Sciences) for providing DNA samples of family B50. We thank A. Reis and A. Ekici (Institute of Human Genetics, University of Erlangen-Nuremberg) for supporting the initial GAMOS mapping study conducted by M.Z. We thank D. Libri (Institut Jacques Monod) and M. Saleem (University of Bristol) for reagents. This research was supported by funding from the National Institutes of Health (DK076683) and the Howard Hughes Medical Institute to F.H. F.H. was also supported as the William E. Harmon Professor. W.T. was supported by the ASN Foundation for Kidney Research. B. Behnam was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (Common Fund). N.D.R., S.V. and B. Callewaert were supported as a research fellow, a postdoctoral research fellow, and a senior clinical investigator, respectively, of the Fund for Scientific Research, Flanders. E.W. was supported by the German National Academy of Sciences Leopoldina (LPDS-2015-07). H.Y.G. was supported by the National Research Foundation of Korea, Ministry of Science, ICT and Future planning (2015R1D1A1A01056685) and by the Yonsei University College of Medicine (2015-32-0047). M.T.F.W. was supported by K08-DK095994-05 (NIH) and the Children's Clinical Research Advisory Committee (CCRAC), Children's Medical Center, Dallas. M. B. was supported by a Senior Research Scholar Award from Fonds de la Recherche du Quebec-Sante (FRQS) and a grant from the Canadian Institutes for Health Research (MOP-84470). O.S.-F. was supported by a KRESCENT Post-Doctoral Fellowship and a McGill Integrated Cancer Research Training (MICRTP) fellowship. T.J.-S. was supported by grant Jo 1324/1-1 from the Deutsche Forschungsgemeinschaft (DFG). T.H. was supported by the German Research Foundation, DFG fellowship (HE 7456/1-1). C.A. was supported by grants from the Agence Nationale de la Recherche (GenPod project ANR-12-BSV1-0033.01), the European Union's Seventh Framework Programme (FP7/2007-2013/no 305608-EURenOmics), the Fondation Recherche Medicale (DEQ20150331682) and the 'Investissements d'avenir' program (ANR-10-IAHU-01). M.F. was supported by grants from the Spanish Society of Nephrology and the Catalan Society of Nephrology. M. D. S. acknowledges financial support from the Department of Health by the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. M.Z. was supported by the Deutsche Forschungsgemeinschaft (SFB423). Work in the laboratory of P.C.D. was supported by the Singapore National Research Foundation under the Singapore-MIT Alliance for Research and Technology, the National Institute of Environmental Health Science (ES017010, ES022858, ES002109) and the National Science Foundation (MCB-1412379).; F.O. was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) (EURenOmics; grant 2012305608). The Nephrogenetics Laboratory at Hacettepe University was established by the Hacettepe University Infrastructure Project (grant 06A101008). P.M.G. was supported by a COBRE Grant (P30 GM110766). C.A.H. was supported by the Dutch Kidney Foundation. S.A.L. was supported by the Max Planck Society and the European Research Council (ERC-2012-StG310489-tRNAmodi). A. Poduri was supported by the Boston Children's Hospital Translational Research Program.	Ameziane N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9829; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Colin E, 2014, AM J HUM GENET, V95, P637, DOI 10.1016/j.ajhg.2014.10.011; Costessi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042822; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; Edvardson S, 2017, EUR J HUM GENET, V25, P545, DOI 10.1038/ejhg.2017.30; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI [10.1172/JCI79504, 10.1122/JCI79504]; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hecker A, 2008, EMBO J, V27, P2340, DOI 10.1038/emboj.2008.157; Hecker A, 2009, BIOCHEM SOC T, V37, P29, DOI 10.1042/BST0370029; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hildebrandt F, 2009, KIDNEY INT, V75, P669, DOI 10.1038/ki.2008.693; Jinks RN, 2015, BRAIN, V138, P2173, DOI 10.1093/brain/awv153; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lipecka J, 2016, PROTEOMICS, V16, P1852, DOI 10.1002/pmic.201600103; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018; Oberto J, 2009, NUCLEIC ACIDS RES, V37, P5343, DOI 10.1093/nar/gkp557; Peterson D, 2010, CANCER RES, V70, P6325, DOI 10.1158/0008-5472.CAN-10-0015; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Saleem MA, 2002, J AM SOC NEPHROL, V13; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Thiaville PC, 2016, MICROB CELL, V3, P29; Thuring K, 2016, METHODS, V107, P48, DOI 10.1016/j.ymeth.2016.03.019; Touzot F, 2010, P NATL ACAD SCI USA, V107, P10097, DOI 10.1073/pnas.0914918107; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Vodopiutz J, 2015, HUM MUTAT, V36, P1021, DOI 10.1002/humu.22828; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wan LCK, 2017, NUCLEIC ACIDS RES, V45, P805, DOI 10.1093/nar/gkw1181; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; Zhang WH, 2015, NUCLEIC ACIDS RES, V43, P3358, DOI 10.1093/nar/gkv155	55	0	0	8	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2017	49	10					1529	+		10.1038/ng.3933				13	Genetics & Heredity	Genetics & Heredity	FI3JD	WOS:000411855800018	28805828				2018-01-05	
J	Will, AJ; Cova, G; Osterwalder, M; Chan, WL; Wittler, L; Brieske, N; Heinrich, V; de Villartay, JP; Vingron, M; Klopocki, E; Visel, A; Lupianez, DG; Mundlos, S				Will, Anja J.; Cova, Giulia; Osterwalder, Marco; Chan, Wing-Lee; Wittler, Lars; Brieske, Norbert; Heinrich, Verena; de Villartay, Jean-Pierre; Vingron, Martin; Klopocki, Eva; Visel, Axel; Lupianez, Dario G.; Mundlos, Stefan			Composition and dosage of a multipartite enhancer cluster control developmental expression of Ihh (Indian hedgehog)	NATURE GENETICS			English	Article							SHADOW ENHANCERS; SUPER-ENHANCER; MOUSE EMBRYOS; HUMAN GENOME; REVEALS; ARCHITECTURE; CERNUNNOS; ELEMENTS; ALTERS; TISSUE	Copy number variations (CNVs) often include noncoding sequences and putative enhancers, but how these rearrangements induce disease is poorly understood. Here we investigate CNVs involving the regulatory landscape of IHH (encoding Indian hedgehog), which cause multiple, highly localized phenotypes including craniosynostosis and synpolydactyly(1,2). We show through transgenic reporter and genome-editing studies in mice that Ihh is regulated by a constellation of at least nine enhancers with individual tissue specificities in the digit anlagen, growth plates, skull sutures and fingertips. Consecutive deletions, resulting in growth defects of the skull and long bones, showed that these enhancers function in an additive manner. Duplications, in contrast, caused not only dose-dependent upregulation but also misexpression of Ihh, leading to abnormal phalanges, fusion of sutures and syndactyly. Thus, precise spatiotemporal control of developmental gene expression is achieved by complex multipartite enhancer ensembles. Alterations in the composition of such clusters can result in gene misexpression and disease.	[Will, Anja J.; Cova, Giulia; Chan, Wing-Lee; Brieske, Norbert; Lupianez, Dario G.; Mundlos, Stefan] Max Planck Inst Mol Genet, RG Dev & Dis, Berlin, Germany; [Will, Anja J.; Cova, Giulia; Chan, Wing-Lee; Lupianez, Dario G.; Mundlos, Stefan] Charite, Inst Med & Human Genet, Berlin, Germany; [Osterwalder, Marco; Visel, Axel] Lawrence Berkeley Natl Lab, MS 84 171, Berkeley, CA USA; [Chan, Wing-Lee; Lupianez, Dario G.; Mundlos, Stefan] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Wittler, Lars] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Heinrich, Verena; Vingron, Martin] Max Planck Inst Mol Genet, Dept Computat Mol Biol, Berlin, Germany; [de Villartay, Jean-Pierre] Univ Paris 05, Inst Imagine, Genome Dynam Immune Syst Lab, INSERM,Sorbonne Paris Cite,UMR 1163, Paris, France; [Klopocki, Eva] Julius Maximilians UnivWurzburg, Inst Human Genet, Bioctr, Wurzburg, Germany; [Visel, Axel] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Visel, Axel] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	Lupianez, DG; Mundlos, S (reprint author), Max Planck Inst Mol Genet, RG Dev & Dis, Berlin, Germany.; Lupianez, DG; Mundlos, S (reprint author), Charite, Inst Med & Human Genet, Berlin, Germany.; Lupianez, DG; Mundlos, S (reprint author), Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.	lupianez@molgen.mpg.de; mundlos@molgen.mpg.de			Deutsche Forschungsgemeinschaft; European Community's Seventh Framework Programme [602300]; Swiss National Science Foundation (SNSF); National Institutes of Health [R01HG003988, U54HG006997, U01DE024427]	We thank the sequencing core, transgenic unit and animal facilities of the Max Planck Institute for Molecular Genetics for technical assistance. This study was supported by a grant from the Deutsche Forschungsgemeinschaft to S.M. and E.K. S.M. was supported by the European Community's Seventh Framework Programme, grant agreement 602300 (SYBIL). M.O. was supported by a Swiss National Science Foundation (SNSF) fellowship. A.V. was supported by National Institutes of Health grants R01HG003988, U54HG006997, U01DE024427 and U01DE024427.	Anderson E, 2012, TRENDS GENET, V28, P364, DOI 10.1016/j.tig.2012.03.012; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andrey G, 2017, GENOME RES, V27, P223, DOI 10.1101/gr.213066.116; Artus J, 2011, METHODS MOL BIOL, V693, P37, DOI 10.1007/978-1-60761-974-1_3; Barroso E, 2015, AM J MED GENET A, V167, P902, DOI 10.1002/ajmg.a.36811; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Cannavo E, 2016, CURR BIOL, V26, P38, DOI 10.1016/j.cub.2015.11.034; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunipace L, 2011, DEVELOPMENT, V138, P4075, DOI 10.1242/dev.069146; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hernandez-Martinez R, 2009, DEVELOPMENT, V136, P3669, DOI 10.1242/dev.041954; Hill RE, 2007, DEV GROWTH DIFFER, V49, P439, DOI 10.1111/j.1440-169x.2007.00943.x; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Klopocki E, 2011, AM J HUM GENET, V88, P70, DOI 10.1016/j.ajhg.2010.11.006; Kraft K., 2015, CELL REP; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Perry MW, 2012, CURR BIOL, V22, P2247, DOI 10.1016/j.cub.2012.09.051; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072                                                          ; van de Werken HJG, 2012, METHOD ENZYMOL, V513, P89, DOI 10.1016/B978-0-12-391938-0.00004-5; Vera G, 2013, MOL CELL BIOL, V33, P701, DOI 10.1128/MCB.01057-12; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Witte F, 2010, P NATL ACAD SCI USA, V107, P14211, DOI 10.1073/pnas.1009314107	40	0	0	5	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2017	49	10					1539	+		10.1038/ng.3939				8	Genetics & Heredity	Genetics & Heredity	FI3JD	WOS:000411855800019	28846100				2018-01-05	
J	Knott, GJ; East-Seletsky, A; Cofsky, JC; Holton, JM; Charles, E; O'Connell, MR; Doudna, JA				Knott, Gavin J.; East-Seletsky, Alexandra; Cofsky, Joshua C.; Holton, James M.; Charles, Emeric; O'Connell, Mitchell R.; Doudna, Jennifer A.			Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme	NATURE STRUCTURAL & MOLECULAR BIOLOGY			English	Article							CRISPR-CAS SYSTEMS; STRUCTURE REFINEMENT; ADAPTIVE IMMUNITY; RECOGNITION; ENDORIBONUCLEASE; CRYSTALLOGRAPHY; PROKARYOTES; PROTEINS; CLEAVAGE; BIOLOGY	CRISPR adaptive immune systems protect bacteria from infections by deploying CRISPR RNA (crRNA)-guided enzymes to recognize and cut foreign nucleic acids. Type VI-A CRISPR-Cas systems include the Cas13a enzyme, an RNA-activated RNase capable of crRNA processing and single-stranded RNA degradation upon target-transcript binding. Here we present the 2.0-angstrom resolution crystal structure of a crRNA-bound Lachnospiraceae bacterium Cas13a (LbaCas13a), representing a recently discovered Cas13a enzyme subtype. This structure and accompanying biochemical experiments define the Cas13a catalytic residues that are directly responsible for crRNA maturation. In addition, the orientation of the foreign-derived target-RNA-specifying sequence in the protein interior explains the conformational gating of Cas13a nuclease activation. These results describe how Cas13a enzymes generate functional crRNAs and how catalytic activity is blocked before target-RNA recognition, with implications for both bacterial immunity and diagnostic applications.	[Knott, Gavin J.; East-Seletsky, Alexandra; Cofsky, Joshua C.; Charles, Emeric; O'Connell, Mitchell R.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Holton, James M.; Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Holton, James M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Holton, James M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [O'Connell, Mitchell R.] Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Rochester, NY USA; [O'Connell, Mitchell R.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY USA	Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.	doudna@berkeley.edu		O'Connell, Mitchell/0000-0002-8642-3973; Knott, Gavin J./0000-0002-9007-6273	Howard Hughes Medical Institute; Paul Allen Institute; National Science Foundation [MCB-1244557]	We thank N. Ma and K. Zhou for technical assistance, C.L. Gee for assistance with refinement, the 8.3.1 beamline staff at the Advanced Light Source, and members of the Doudna laboratory for helpful discussions. G.J.K. acknowledges support from the Howard Hughes Medical Institute. This work was supported in part by the Paul Allen Institute, the National Science Foundation (grant MCB-1244557), and the Howard Hughes Medical Institute.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hochstrasser ML, 2015, TRENDS BIOCHEM SCI, V40, P58, DOI 10.1016/j.tibs.2014.10.007; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Li H, 2015, STRUCTURE, V23, P13, DOI 10.1016/j.str.2014.10.006; Liu L, 2017, CELL, V170, P714, DOI 10.1016/j.cell.2017.06.050; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nakanishi K, 2016, WIRES RNA, V7, P637, DOI 10.1002/wrna.1356; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	41	1	1	11	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1545-9993	1545-9985		NAT STRUCT MOL BIOL	Nat. Struct. Mol. Biol.	OCT	2017	24	10					825	+		10.1038/nsmb.3466				11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI8UQ	WOS:000412278000009	28892041				2018-01-05	
J	Ma, J; Xiang, H; Donnelly, DJ; Meng, FR; Xu, HM; Durnford, D; Li, XQ				Ma, Jin; Xiang, Heng; Donnelly, Danielle J.; Meng, Fan-Rui; Xu, Huimin; Durnford, Dion; Li, Xiu-Qing			Genome editing in potato plants by agrobacterium-mediated transient expression of transcription activator-like effector nucleases	PLANT BIOTECHNOLOGY REPORTS			English	Article						Non-transgenic; Agroinfiltration; Site-specific mutagenesis; Polyploid plants; Allele specificity; Vegetatively propagated plants; Somatic genome manipulation; Molecular breeding	DNA-BINDING SPECIFICITY; DOUBLE-STRAND BREAKS; TARGETED MUTAGENESIS; TAL EFFECTORS; III EFFECTORS; CRISPR/CAS9 SYSTEM; RNA; ARABIDOPSIS; TRANSFORMATION; ENDONUCLEASE	Genome editing (also known as targeted mutation) has promise for molecular breeding. Compared with the CRISPR/Cas9 system, the transcription activator-like effector nucleases (TALENs) have likely a lesser off-target rate in genome editing. Both a rapid test system for the functionality of designed TALENs and an effective delivery system for introducing the TALENs to plants are critical for successful target mutation. TALENs have usually been tested in protoplasts or introduced to plants with viral vectors. However, plant regeneration from protoplast culture can generate extensive somatic variation. Viral vectors are not always available, and plants edited by these vectors usually require virus elimination. Here, we used a non-viral, Agrobacterium-mediated transient expression approach, to serve both rapid test and effective delivery of TALENs into two vegetatively propagated potato cultivars, Solanum tuberosum Russet Burbank and Shepody. Two TALENs with different molecular weights (22 and 27 aa-repeat modules) were expressed to target two endogenous genes (starch branching enzyme and an acid invertase) by Agrobacterium-mediated infiltration (agroinfiltration) into leaves of potato plants. The infiltrated leaf DNA was analyzed using restriction site loss assay and subsequent DNA sequencing. Deep sequencing of these tetraploid cultivars was also conducted to determine the zygosity at the targeted chromosomal loci. TALENs, with different molecular weights, successfully agroinfiltrated and induced mutations at both targeted loci.	[Ma, Jin; Xiang, Heng; Li, Xiu-Qing] Agr & Agri Food Canada, Fredericton Res & Dev Ctr, 850 Lincoln Rd,POB 20280, Fredericton, NB E3B 4Z7, Canada; [Ma, Jin; Meng, Fan-Rui] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada; [Xiang, Heng] Southwest Univ, Coll Anim Sci & Technol, Chongqing 400715, Peoples R China; [Donnelly, Danielle J.] McGill Univ, Dept Plant Sci, 21,111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Xu, Huimin] Canadian Food Inspect Agcy, Charlottetown Lab, 93 Mt Edward Rd, Charlottetown, PE C1A 5T1, Canada; [Durnford, Dion] Univ New Brunswick, Dept Biol, 10 Bailey Dr, Fredericton, NB E3B 5A3, Canada	Li, XQ (reprint author), Agr & Agri Food Canada, Fredericton Res & Dev Ctr, 850 Lincoln Rd,POB 20280, Fredericton, NB E3B 4Z7, Canada.	Xiu-Qing.Li@agr.gc.ca			Agriculture and Agri-Food Canada A-base; Natural Sciences and Engineering Research Council of Canada (NSERC); New Brunswick Agricultural Innovation Program	We thank Muhammad Haroon, Agriculture and Agri-Food Canada, for his general support in the laboratory and his technical support in plant and DNA preparation. The research funding was from Agriculture and Agri-Food Canada A-base, the Natural Sciences and Engineering Research Council of Canada (NSERC), and the deep sequencing was supported by the New Brunswick Agricultural Innovation Program.	Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Bhaskar PB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005812; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chen KL, 2014, PLANT CELL REP, V33, P575, DOI 10.1007/s00299-013-1539-6; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; de Lange O, 2014, PLANT J, V78, P753, DOI 10.1111/tpj.12431; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Fichtner F, 2014, PLANTA, V239, P921, DOI 10.1007/s00425-014-2029-y; Guo JL, 2010, PLANT CELL TISS ORG, V103, P103, DOI 10.1007/s11240-010-9759-8; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Higgins VJ, 1998, CAN J PLANT PATHOL, V20, P150, DOI 10.1080/07060669809500420                                                       ; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877                                                          ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Khoshnoodi J, 1996, EUR J BIOCHEM, V242, P148, DOI 10.1111/j.1432-1033.1996.0148r.x; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; LI XQ, 1988, CURR GENET, V13, P261, DOI 10.1007/BF00387773; Li X-Q, 1988, GENETIC MANIPULATION, P131; Liu X, 2011, MOL GENET GENOMICS, V286, P109, DOI 10.1007/s00438-011-0632-1; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Marton I, 2010, PLANT PHYSIOL, V154, P1079, DOI 10.1104/pp.110.164806; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nassar AMK, 2011, AM J POTATO RES, V88, P387, DOI 10.1007/s12230-011-9204-5; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nicolia A, 2015, J BIOTECHNOL, V204, P17, DOI 10.1016/j.jbiotec.2015.03.021; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sun ZJ, 2013, J INTEGR PLANT BIOL, V55, P1092, DOI 10.1111/jipb.12091; Voytas DF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001877; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Xiang H, 2016, PLANT MOL BIOL REP, V34, P172, DOI 10.1007/s11105-015-0912-8; Xing T, 2011, PLANT SIGNAL BEHAV, V6, P1469, DOI 10.4161/psb.6.10.17345; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	54	0	0	7	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1863-5466	1863-5474		PLANT BIOTECHNOL REP	Plant Biotechnol. Rep.	OCT	2017	11	5					249	258		10.1007/s11816-017-0448-5				10	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	FL2UQ	WOS:000414075600001					2018-01-05	
J	Lehniger, MK; Finster, S; Melonek, J; Oetke, S; Krupinska, K; Schmitz-Linneweber, C				Lehniger, Marie-Kristin; Finster, Sabrina; Melonek, Joanna; Oetke, Svenja; Krupinska, Karin; Schmitz-Linneweber, Christian			Global RNA association with the transcriptionally active chromosome of chloroplasts	PLANT MOLECULAR BIOLOGY			English	Article						Chloroplast; RNA processing; RNA binding; Nucleoids; TAC = transcriptionally active chromosome	PLASTID GENE-EXPRESSION; BINDING PROTEINS; BARLEY CHLOROPLASTS; ARABIDOPSIS PTAC14; MESSENGER-RNAS; DNA; POLYMERASE; NUCLEOIDS; TRANSLATION; COMPONENTS	Chloroplast genomes are organized as a polyploid DNA-protein structure called the nucleoid. Transcriptionally active chloroplast DNA together with tightly bound protein factors can be purified by gel filtration as a functional entity called the transcriptionally active chromosome (TAC). Previous proteomics analyses of nucleoids and of TACs demonstrated a considerable overlap in protein composition including RNA binding proteins. Therefore the RNA content of TAC preparations from Nicotiana tabacum was determined using whole genome tiling arrays. A large number of chloroplast RNAs was found to be associated with the TAC. The pattern of RNAs attached to the TAC consists of RNAs produced by different chloroplast RNA polymerases and differs from the pattern of RNA found in input controls. An analysis of RNA splicing and RNA editing of selected RNA species demonstrated that TAC-associated RNAs are processed to a similar extent as the RNA in input controls. Thus, TAC fractions contain a specific subset of the processed chloroplast transcriptome.	[Lehniger, Marie-Kristin; Finster, Sabrina; Schmitz-Linneweber, Christian] Humboldt Univ, Inst Biol, Philippstr 11-13, D-10115 Berlin, Germany; [Oetke, Svenja; Krupinska, Karin] Christian Albrechts Univ Kiel, Inst Bot, Olshaussenstr 40, D-24098 Kiel, Germany; [Melonek, Joanna] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Crawley, WA 6009, Australia	Schmitz-Linneweber, C (reprint author), Humboldt Univ, Inst Biol, Philippstr 11-13, D-10115 Berlin, Germany.; Krupinska, K (reprint author), Christian Albrechts Univ Kiel, Inst Bot, Olshaussenstr 40, D-24098 Kiel, Germany.	kkrupinska@bot.uni-kiel.de; smitzlic@rz.hu-berlin.de			Deutsche Forschungsgemeinschaft [SCHM 1698/5-1]; Einstein foundation (Einstein Stiftung Berlin); IRI for Life Sciences	Generous funding by the Deutsche Forschungsgemeinschaft (Grant No. SCHM 1698/5-1) and the Einstein foundation (Einstein Stiftung Berlin) to CSL is gratefully acknowledged. Support of M.-K. L. by the IRI for Life Sciences is gratefully acknowledged.	Allison LA, 1996, EMBO J, V15, P2802; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Beligni MV, 2008, PLANT MOL BIOL, V67, P389, DOI 10.1007/s11103-008-9328-2; Bohne AV, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00257; Bollenbach TJ, 2009, PLANT MOL BIOL, V69, P541, DOI 10.1007/s11103-008-9436-z; BULOW S, 1987, CURR GENET, V12, P157, DOI 10.1007/BF00434671; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Finster S, 2013, PLANT J, V76, P849, DOI 10.1111/tpj.12339; FREYER R, 1993, PLANT J, V4, P621, DOI 10.1046/j.1365-313X.1993.04040621.x                                             ; Gao ZP, 2012, PLANT SIGNAL BEHAV, V7, P1354, DOI [10.1104/pp.111.184762;PMID:22010110, 10.4161/psb.21618]; Gao ZP, 2011, PLANT PHYSIOL, V157, P1733, DOI 10.1104/pp.111.184762; Ghatak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016019; Hajdukiewicz PTJ, 1997, EMBO J, V16, P4041, DOI 10.1093/emboj/16.13.4041; HALLICK RB, 1976, BIOCHEMISTRY-US, V15, P3039, DOI 10.1021/bi00659a016; Hertel S, 2013, PLANT PHYSIOL, V163, P1686, DOI 10.1104/pp.113.227579; IGLOI GL, 1992, CRIT REV PLANT SCI, V10, P525; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUPINSKA K, 1994, J PLANT PHYSIOL, V143, P298, DOI 10.1016/S0176-1617(11)81635-4                                                   ; Kupsch C, 2012, PLANT CELL, V24, P4266, DOI 10.1105/tpc.112.103002; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Marechal A, 2009, P NATL ACAD SCI USA, V106, P14693, DOI 10.1073/pnas.0901710106; Melonek J, 2016, BBA-PROTEINS PROTEOM, V1864, P1016, DOI 10.1016/j.bbapap.2016.03.009; Melonek J, 2012, PLANT CELL, V24, P3060, DOI 10.1105/tpc.112.099721; Melonek J, 2010, PLANTA, V232, P471, DOI 10.1007/s00425-010-1183-0; Miyagi T, 1998, MOL GEN GENET, V257, P299, DOI 10.1007/s004380050651                                                           ; Nakamura T, 2001, J BIOL CHEM, V276, P147, DOI 10.1074/jbc.M008817200; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4                                                   ; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Pfalz J, 2013, TRENDS PLANT SCI, V18, P186, DOI 10.1016/j.tplants.2012.11.003; POULSEN C, 1983, CARLSBERG RES COMMUN, V48, P57, DOI 10.1007/BF02906170; Qi YF, 2012, J EXP BOT, V63, P1251, DOI 10.1093/jxb/err347; RABILLOUD T, 1992, ELECTROPHORESIS, V13, P429, DOI 10.1002/elps.1150130190; Ruwe H, 2016, NUCLEIC ACIDS RES, V44, P7406, DOI 10.1093/nar/gkw466; Sekine K, 2002, J BIOL CHEM, V277, P24399, DOI 10.1074/jbc.M201714200; Shaver JM, 2008, PLANT PHYSIOL, V146, P1064, DOI 10.1104/pp.107.112946; Suck R, 1996, CURR GENET, V30, P515, DOI 10.1007/s002940050164; Trifa Y, 2000, MOL GEN GENET, V263, P642, DOI 10.1007/s004380051212; Tsudzuki T, 2001, J MOL EVOL, V53, P327, DOI 10.1007/s002390010222; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x                                                ; Yagi Y, 2012, P NATL ACAD SCI USA, V109, P7541, DOI 10.1073/pnas.1119403109; YAO WB, 1989, NUCLEIC ACIDS RES, V17, P9583, DOI 10.1093/nar/17.23.9583; Zerges W, 1998, J CELL BIOL, V140, P101, DOI 10.1083/jcb.140.1.101	44	0	0	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	OCT	2017	95	3					303	311		10.1007/s11103-017-0649-x				9	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	FK2HC	WOS:000413302300007	28887777				2018-01-05	
J	Abadi, S; Yan, WX; Amar, D; Mayrose, I				Abadi, Shiran; Yan, Winston X.; Amar, David; Mayrose, Itay			A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action	PLOS COMPUTATIONAL BIOLOGY			English	Article							OFF-TARGET SITES; RNA-GUIDED ENDONUCLEASES; HUMAN-CELLS; CRISPR/CAS9 SYSTEMS; CAS9 ENDONUCLEASE; DIGENOME-SEQ; IN-VIVO; DNA; NUCLEASES; SPECIFICITY	The adaptation of the CRISPR-Cas9 system as a genome editing technique has generated much excitement in recent years owing to its ability to manipulate targeted genes and genomic regions that are complementary to a programmed single guide RNA (sgRNA). However, the efficacy of a specific sgRNA is not uniquely defined by exact sequence homology to the target site, thus unintended off-targets might additionally be cleaved. Current methods for sgRNA design are mainly concerned with predicting off-targets for a given sgRNA using basic sequence features and employ elementary rules for ranking possible sgRNAs. Here, we introduce CRISTA (CRISPR Target Assessment), a novel algorithm within the machine learning framework that determines the propensity of a genomic site to be cleaved by a given sgRNA. We show that the predictions made with CRISTA are more accurate than other available methodologies. We further demonstrate that the occurrence of bulges is not a rare phenomenon and should be accounted for in the prediction process. Beyond predicting cleavage efficiencies, the learning process provides inferences regarding patterns that underlie the mechanism of action of the CRISPR-Cas9 system. We discover that attributes that describe the spatial structure and rigidity of the entire genomic site as well as those surrounding the PAM region are a major component of the prediction capabilities.	[Abadi, Shiran; Mayrose, Itay] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, Tel Aviv, Israel; [Yan, Winston X.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Yan, Winston X.] Harvard Med Sch, Grad Program Biophys, Boston, MA USA; [Yan, Winston X.] Harvard Med Sch, Harvard MIT Div Hlth Sci & Technol, Boston, MA USA; [Amar, David] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel; [Amar, David] Stanford Univ, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Mayrose, I (reprint author), Tel Aviv Univ, Dept Mol Biol & Ecol Plants, Tel Aviv, Israel.	itaymay@post.tau.ac.il			ministry of agriculture of Israel [383/15]; Rothschild Caesarea Foundation; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; Manna Program in Food Safety and Security; Naomi Prawer Kadar Foundation through Tel Aviv University; Paul & Daisy Soros Fellowship for New Americans; National Institute of General Medical Sciences [T32GM007753]	This work was supported by a research grant 383/15 awarded by the ministry of agriculture of Israel to IM and PhD fellowships provided by the Rothschild Caesarea Foundation (to SA), Edmond J. Safra Center for Bioinformatics at Tel-Aviv University (to SA and DA), and travel fellowships (to SA) provided by the Manna Program in Food Safety and Security, and the Naomi Prawer Kadar Foundation through the Tel Aviv University GRTF Program. Part of the work was done while DA was visiting the Simons Institute for the Theory of Computing. WXY is supported by a Paul & Daisy Soros Fellowship for New Americans and by award Number T32GM007753 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324                                                         ; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321; Chen L, 2014, CRISPR P WEB TOOL SY; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Doench JG, 2016, ALL RIGHTS RESERVED, V34, P184; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dror I, 2015, GENOME RES, V25, P1268, DOI 10.1101/gr.184671.114; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304                                                          ; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hancock SP, 2013, NUCLEIC ACIDS RES, V41, P6750, DOI 10.1093/nar/gkt357; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; MacPherson CR, 2015, NAT BIOTECHNOL, V33, P805, DOI 10.1038/nbt.3291; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Martin F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091507; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pennisi E., 2013, SCIENCE, P341; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Rosenbloom KR, 2014, NUCLEIC ACIDS RES, V43, pD670, DOI DOI 10.1093/NAR/GKU; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xiao A, 2014, BIOINFORMATICS; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu H, 2015, GENOME RES, P1; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Lab, 2013, OPT CRISPR DES; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437	74	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	OCT	2017	13	10							e1005807	10.1371/journal.pcbi.1005807				24	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	FL3UB	WOS:000414148800054	29036168	gold			2018-01-05	
J	Hammond, AM; Kyrou, K; Bruttini, M; North, A; Galizi, R; Karlsson, X; Kranjc, N; Carpi, FM; D'Aurizio, R; Crisanti, A; Nolan, T				Hammond, Andrew M.; Kyrou, Kyros; Bruttini, Marco; North, Ace; Galizi, Roberto; Karlsson, Xenia; Kranjc, Nace; Carpi, Francesco M.; D'Aurizio, Romina; Crisanti, Andrea; Nolan, Tony			The creation and selection of mutations resistant to a gene drive over multiple generations in the malaria mosquito	PLOS GENETICS			English	Article							HOMING ENDONUCLEASE GENES; VECTOR; POPULATIONS; SYSTEM	Gene drives have enormous potential for the control of insect populations of medical and agricultural relevance. By preferentially biasing their own inheritance, gene drives can rapidly introduce genetic traits even if these confer a negative fitness effect on the population. We have recently developed gene drives based on CRISPR nuclease constructs that are designed to disrupt key genes essential for female fertility in the malaria mosquito. The construct copies itself and the associated genetic disruption from one homologous chromosome to another during gamete formation, a process called homing that ensures the majority of offspring inherit the drive. Such drives have the potential to cause long-lasting, sustainable population suppression, though they are also expected to impose a large selection pressure for resistance in the mosquito. One of these population suppression gene drives showed rapid invasion of a caged population over 4 generations, establishing proof of principle for this technology. In order to assess the potential for the emergence of resistance to the gene drive in this population we allowed it to run for 25 generations and monitored the frequency of the gene drive over time. Following the initial increase of the gene drive we observed a gradual decrease in its frequency that was accompanied by the spread of small, nucleaseinduced mutations at the target gene that are resistant to further cleavage and restore its functionality. Such mutations showed rates of increase consistent with positive selection in the face of the gene drive. Our findings represent the first documented example of selection for resistance to a synthetic gene drive and lead to important design recommendations and considerations in order to mitigate for resistance in future gene drive applications.	[Hammond, Andrew M.; Kyrou, Kyros; Galizi, Roberto; Karlsson, Xenia; Kranjc, Nace; Carpi, Francesco M.; Crisanti, Andrea; Nolan, Tony] Imperial Coll London, Dept Life Sci, London, England; [Bruttini, Marco] Polo Innovaz Genom Genet & Biol, Siena, Italy; [North, Ace] Univ Oxford, Dept Zool, Oxford, England; [D'Aurizio, Romina] CNR, Inst Informat & Telemat, LISM, Pisa, Italy	Crisanti, A; Nolan, T (reprint author), Imperial Coll London, Dept Life Sci, London, England.	acrs@imperial.ac.uk; t.nolan@imperial.ac.uk		Nolan, Tony/0000-0002-2982-8333; Bruttini, Marco/0000-0003-1063-2522; Galizi, Roberto/0000-0003-3134-7480	Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation	This work was supported by a grant from the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Champer J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006796; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hong CC, 1996, GENETICS, V143, P1653; Marshall JM., 2016, BIORXIV; Miles A., 2016, BIORXIV; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964; Papathanos PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-65; RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P10, DOI 10.1093/jmedent/31.1.10                                                         ; ROGNES T, 2016, PEER J, V4, P15583; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969                                                                  ; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Vella M, 2017, BIORXIV; WHO, 2016, WHO WORLD MAL REP; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	26	1	1	11	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	OCT	2017	13	10							e1007039	10.1371/journal.pgen.1007039				16	Genetics & Heredity	Genetics & Heredity	FL3YB	WOS:000414161300014	28976972	gold			2018-01-05	
J	Kirby, LE; Koslowsky, D				Kirby, Laura E.; Koslowsky, Donna			Mitochondrial dual-coding genes in Trypanosoma brucei	PLOS NEGLECTED TROPICAL DISEASES			English	Article							COMBINED TRANSMEMBRANE TOPOLOGY; SIGNAL PEPTIDE PREDICTION; CYTOCHROME-C-OXIDASE; GUIDE RNA GENES; MESSENGER-RNA; PHYTOMONAS-SERPENS; KINETOPLAST DNA; LEISHMANIA-TARENTOLAE; KREBS CYCLE; PROTEIN	Trypanosoma brucei is transmitted between mammalian hosts by the tsetse fly. In the mammal, they are exclusively extracellular, continuously replicating within the bloodstream. During this stage, the mitochondrion lacks a functional electron transport chain (ETC). Successful transition to the fly, requires activation of the ETC and ATP synthesis via oxidative phosphorylation. This life cycle leads to a major problem: in the bloodstream, the mitochondrial genes are not under selection and are subject to genetic drift that endangers their integrity. Exacerbating this, T. brucei undergoes repeated population bottlenecks as they evade the host immune system that would create additional forces of genetic drift. These parasites possess several unique genetic features, including RNA editing of mitochondrial transcripts. RNA editing creates open reading frames by the guided insertion and deletion of U-residues within the mRNA. A major question in the field has been why this metabolically expensive system of RNA editing would evolve and persist. Here, we show that many of the edited mRNAs can alter the choice of start codon and the open reading frame by alternative editing of the 5' end. Analyses of mutational bias indicate that six of the mitochondrial genes may be dual-coding and that RNA editing allows access to both reading frames. We hypothesize that dual-coding genes can protect genetic information by essentially hiding a non-selected gene within one that remains under selection. Thus, the complex RNA editing system found in the mitochondria of trypanosomes provides a unique molecular strategy to combat genetic drift in non-selective conditions.	[Kirby, Laura E.; Koslowsky, Donna] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Koslowsky, D (reprint author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	koslowsk@msu.edu			National Institutes of Health [R03AI0902]; Berttina B. Wentworth Endowed fellowship fund	Funding for this project was provided from the National Institutes of Health; Grant R03AI0902 to DK. In addition, LEK was supported in part by the Berttina B. Wentworth Endowed fellowship fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGABIAN N, 1980, AM J TROP MED HYG, V29, P1043, DOI 10.4269/ajtmh.1980.29.1043                                                      ; Aphasizheva I, 2013, RNA BIOL, V10, P1679, DOI 10.4161/rna.26733; Belshaw R, 2007, GENOME RES, V17, P1496, DOI 10.1101/gr.6305707; Bender T, 2015, EMBO J, V34, P911, DOI 10.15252/embj.201490197; Brandes N, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0128-3; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Buhrman H, 2013, ARXIV13071163V1QBIOP; Chung WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/journal.pcbi.0030091; CORELL RA, 1994, MOL BIOCHEM PARASIT, V64, P65, DOI 10.1016/0166-6851(94)90135-X; COVELLO PS, 1993, TRENDS GENET, V9, P265, DOI 10.1016/0168-9525(93)90011-6                                                    ; David V, 2015, MBIO, V6, DOI 10.1128/mBio.01498-15; Duarte M, 2014, J BIOENERG BIOMEMBR, V46, P299, DOI 10.1007/s10863-014-9556-x; Firth AE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-75; Firth AE, 2005, BIOINFORMATICS, V21, P282, DOI 10.1093/bioinformatics/bti007; Gibson W., 2012, VECTORS, V5, P71, DOI DOI 10.1186/1756-3305-5-71; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Gray MW, 2012, BIOCHEMISTRY-US, V51, P5235, DOI 10.1021/bi300419r; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Greif G, 2015, MUTAT RES-FUND MOL M, V773, P69, DOI 10.1016/j.mrfmmm.2015.01.008; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hannaert V., 2003, KINETOPLASTID BIOL D, V2, P11, DOI DOI 10.1186/1475-9292-2-11; Harrington ED, 2008, BMC GENOMICS, V9, P335; Hong M, 2003, PROTIST, V154, P265, DOI 10.1078/143446103322166554; HUDSON KM, 1980, PARASITE IMMUNOL, V2, P57, DOI 10.1111/j.1365-3024.1980.tb00043.x; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kirby LE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004793; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Koslowsky D, 2014, NUCLEIC ACIDS RES, V42, P1873, DOI 10.1093/nar/gkt973; LANDWEBER LF, 1993, NATURE, V363, P179, DOI 10.1038/363179a0                                                                ; Leeder WM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29810; Liang H, 2006, GENOME RES, V16, P190, DOI 10.1101/gr.4246506; Liang H, 2010, CELL RES, V20, P508, DOI 10.1038/cr.2010.62; Maslov DA, 1998, MOL BIOCHEM PARASIT, V93, P225, DOI 10.1016/S0166-6851(98)00028-0; Maslov DA, 2010, MOL BIOCHEM PARASIT, V173, P107, DOI 10.1016/j.molbiopara.2010.05.013; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; Morrison LJ, 2016, TRENDS PARASITOL, V32, P599, DOI 10.1016/j.pt.2016.04.012; Mouilleron H, 2016, NUCLEIC ACIDS RES, V44, P14, DOI 10.1093/nar/gkv1218; Nawathean P, 2000, CURR GENET, V38, P95, DOI 10.1007/s002940000135; NORMARK S, 1983, ANNU REV GENET, V17, P499, DOI 10.1146/annurev.ge.17.120183.002435                                             ; Oberle M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001023; Ochsenreiter T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001566; Ochsenreiter T, 2008, MOL CELL BIOL, V28, P5595, DOI 10.1128/MCB.00637-08; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peleg O, 2004, J MOL EVOL, V59, P520, DOI 10.1007/s00239-004-2644-5; Porcel BM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004007; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; READ LK, 1992, J BIOL CHEM, V267, P1123; Ribrioux S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-122; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Saunders EC, 2010, PARASITOLOGY, V137, P1303, DOI 10.1017/S0031182010000077; Savill NJ, 1999, P ROY SOC B-BIOL SCI, V266, P611, DOI 10.1098/rspb.1999.0680; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003841; Speijer D, 2006, IUBMB LIFE, V58, P91, DOI 10.1080/15216540600551355; Speijer Dave, 2008, V20, P199; Stafkova J, 2016, MOL MICROBIOL, V100, P442, DOI 10.1111/mmi.13325; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Stoltzfus A, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-35; Sykes S, 2015, EUKARYOT CELL, V14, P206, DOI 10.1128/EC.00214-14; Sykes SE, 2013, EUKARYOT CELL, V12, P78, DOI 10.1128/EC.00269-12; Szempruch A, 2015, RNA, V21, P1; THIEMANN OH, 1994, EMBO J, V13, P5689; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Verner Z, 2014, MOL BIOCHEM PARASIT, V193, P55, DOI 10.1016/j.molbiopara.2014.02.003; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8; Xu Y, 2014, NATURE, V515, P448, DOI 10.1038/nature13670; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	73	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2017	11	10							e0005989	10.1371/journal.pntd.0005989				19	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL5JJ	WOS:000414271400047	28991908	gold			2018-01-05	
J	Cheng, JW; Park, DE; Berrios, C; White, EA; Arora, R; Yoon, R; Branigan, T; Xiao, TF; Westerling, T; Federation, A; Zeid, R; Strober, B; Swanson, SK; Florens, L; Bradner, JE; Brown, M; Howley, PM; Padi, M; Washburn, MP; DeCaprio, JA				Cheng, Jingwei; Park, Donglim Esther; Berrios, Christian; White, Elizabeth A.; Arora, Reety; Yoon, Rosa; Branigan, Timothy; Xiao, Tengfei; Westerling, Thomas; Federation, Alexander; Zeid, Rhamy; Strober, Benjamin; Swanson, Selene K.; Florens, Laurence; Bradner, James E.; Brown, Myles; Howley, Peter M.; Padi, Megha; Washburn, Michael P.; DeCaprio, James A.			Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis	PLOS PATHOGENS			English	Article							SMALL T-ANTIGEN; PROTEIN IDENTIFICATION TECHNOLOGY; HISTONE ACETYLTRANSFERASE COMPLEX; HUMAN HOUSEKEEPING GENES; PLURIPOTENT STEM-CELLS; EMBRYONIC STEM; TRANSCRIPTIONAL REPRESSION; PROTEOMIC ANALYSIS; LUNG-CANCER; C-MYC	Merkel cell carcinoma (MCC) frequently contains integrated copies of Merkel cell polyomavirus DNA that express a truncated form of Large T antigen (LT) and an intact Small T antigen (ST). While LT binds RB and inactivates its tumor suppressor function, it is less clear how ST contributes to MCC tumorigenesis. Here we show that ST binds specifically to the MYC homolog MYCL (L-MYC) and recruits it to the 15-component EP400 histone acetyltransferase and chromatin remodeling complex. We performed a large-scale immunoprecipitation for ST and identified co-precipitating proteins by mass spectrometry. In addition to protein phosphatase 2A (PP2A) subunits, we identified MYCL and its heterodimeric partner MAX plus the EP400 complex. Immunoprecipitation for MAX and EP400 complex components confirmed their association with ST. We determined that the ST-MYCL-EP400 complex binds together to specific gene promoters and activates their expression by integrating chromatin immunoprecipitation with sequencing (ChIP-seq) and RNA-seq. MYCL and EP400 were required for maintenance of cell viability and cooperated with ST to promote gene expression in MCC cell lines. A genome-wide CRISPR-Cas9 screen confirmed the requirement for MYCL and EP400 in MCPyV-positive MCC cell lines. We demonstrate that ST can activate gene expression in a EP400 and MYCL dependent manner and this activity contributes to cellular transformation and generation of induced pluripotent stem cells.	[Cheng, Jingwei; Park, Donglim Esther; Berrios, Christian; Arora, Reety; Yoon, Rosa; Branigan, Timothy; Xiao, Tengfei; Westerling, Thomas; Federation, Alexander; Zeid, Rhamy; Strober, Benjamin; Bradner, James E.; Brown, Myles; DeCaprio, James A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cheng, Jingwei; Westerling, Thomas; Bradner, James E.; Brown, Myles; DeCaprio, James A.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Cheng, Jingwei; Westerling, Thomas; Bradner, James E.; Brown, Myles; Padi, Megha; DeCaprio, James A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Park, Donglim Esther; Yoon, Rosa; Branigan, Timothy; Federation, Alexander; Zeid, Rhamy] Harvard Univ, Grad Sch Arts & Sci, Boston, MA 02115 USA; [Berrios, Christian; White, Elizabeth A.; Howley, Peter M.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA; [Xiao, Tengfei; Brown, Myles] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO USA; [Padi, Megha] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [White, Elizabeth A.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA; [Arora, Reety] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Bradner, James E.] Novartis Inst Biomed Res, Cambridge, MA USA	DeCaprio, JA (reprint author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; DeCaprio, JA (reprint author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; DeCaprio, JA (reprint author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	james_decaprio@dfci.harvard.edu		Federation, Alexander/0000-0002-7771-1148; Arora, Reety/0000-0002-1871-9297	US Public Health Service [R01CA63113, R01CA173023, P01CA050661, R35CA197262, F31CA213464, F31CA177274, F31CA189328]; NIH [K25 HG006031]; Wellcome Trust DBT India Alliance Early Career Fellowship [IA/E/14/1/501773]; Stowers Institute for Medical Research	This work was supported in part by US Public Health Service grants (report.nih.gov) R01CA63113 and R01CA173023 to JAD; P01CA050661 to JAD and PMH; R35CA197262 to PMH; F31CA213464 to DEP; F31CA177274 to CB, F31CA189328 to TB. MP was supported by NIH K25 HG006031. RA was supported by Wellcome Trust DBT India Alliance Early Career Fellowship (IA/E/14/1/501773) (www.wellcomedbt.org). SKS, LF, and MPW were supported by the Stowers Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Berrios C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006020; Borchert S, 2014, J VIROL, V88, P3144, DOI 10.1128/JVI.02916-13; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Cheng JW, 2013, J VIROL, V87, P6118, DOI 10.1128/JVI.00385-13; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Florens Laurence, 2006, V328, P159; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131                                                      ; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Griffiths DA, 2013, J VIROL, V87, P13853, DOI 10.1128/JVI.02159-13; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Harms PW, 2015, CANCER RES, V75, P3720, DOI 10.1158/0008-5472.CAN-15-0702; Hatton KS, 1996, MOL CELL BIOL, V16, P1794; Heath M, 2008, J AM ACAD DERMATOL, V58, P375, DOI 10.1016/j.jaad.2007.11.020; Henriksen JR, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-1; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Hesbacher S, 2016, ONCOTARGET, V7, P32956, DOI 10.18632/oncotarget.8793; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kurland JF, 2008, CANCER RES, V68, P3624, DOI 10.1158/0008-5472.CAN-07-6552; Kwun HJ, 2015, J VIROL, V89, P4191, DOI 10.1128/JVI.00157-15; Kwun HJ, 2013, CELL HOST MICROBE, V14, P125, DOI 10.1016/j.chom.2013.06.008; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu X, 2011, J BIOL CHEM, V286, P17079, DOI 10.1074/jbc.M110.192856; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8                                                   ; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5054, DOI 10.1128/MCB.22.14.5054-5063.2002; Paulson KG, 2009, J INVEST DERMATOL, V129, P1547, DOI 10.1038/jid.2008.365; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rodig SJ, 2012, J CLIN INVEST, V122, P4645, DOI 10.1172/JCI64116; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142329; Shuda M, 2015, P NATL ACAD SCI USA, V112, P5875, DOI 10.1073/pnas.1505787112; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Starrett GJ, 2017, MBIO, V8, DOI 10.1128/mBio.02079-16; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Swanson Selene K., 2009, V492, P1, DOI 10.1007/978-1-59745-493-3_1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomas LR, 2016, ONCOGENE, V35, P3613, DOI 10.1038/onc.2015.416; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Tworkowski KA, 2008, P NATL ACAD SCI USA, V105, P6103, DOI 10.1073/pnas.0802095105; Verhaegen ME, 2015, J INVEST DERMATOL, V135, P1415, DOI 10.1038/jid.2014.446; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Wasylishen AR, 2011, ONCOGENE, V30, P3727, DOI 10.1038/onc.2011.88; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701                                                             ; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290	81	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	OCT	2017	13	10							e1006668	10.1371/journal.ppat.1006668				31	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	FL3YS	WOS:000414163300022	29028833	gold			2018-01-05	
J	Gang, SS; Castelletto, ML; Bryant, AS; Yang, E; Mancuso, N; Lopez, JB; Pellegrini, M; Hallem, EA				Gang, Spencer S.; Castelletto, Michelle L.; Bryant, Astra S.; Yang, Emily; Mancuso, Nicholas; Lopez, Jacqueline B.; Pellegrini, Matteo; Hallem, Elissa A.			Targeted mutagenesis in a human-parasitic nematode	PLOS PATHOGENS			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; STRONGYLOIDES-STERCORALIS; C-ELEGANS; PARASTRONGYLOIDES-TRICHOSURI; UNC-22 GENE; TRANSGENESIS; RATTI; CRISPR/CAS9; TRANSFORMATION	Parasitic nematodes infect over 1 billion people worldwide and cause some of the most common neglected tropical diseases. Despite their prevalence, our understanding of the biology of parasitic nematodes has been limited by the lack of tools for genetic intervention. In particular, it has not yet been possible to generate targeted gene disruptions and mutant phenotypes in any parasitic nematode. Here, we report the development of a method for introducing CRISPR-Cas9-mediated gene disruptions in the human-parasitic threadworm Strongyloides stercoralis. We disrupted the S. stercoralis twitchin gene unc-22, resulting in nematodes with severe motility defects. Ss-unc-22 mutations were resolved by homology-directed repair when a repair template was provided. Omission of a repair template resulted in deletions at the target locus. Ss-unc-22 mutations were heritable; we passed Ss-unc-22 mutants through a host and successfully recovered mutant progeny. Using a similar approach, we also disrupted the unc-22 gene of the rat-parasitic nematode Strongyloides ratti. Our results demonstrate the applicability of CRISPR-Cas9 to parasitic nematodes, and thereby enable future studies of gene function in these medically relevant but previously genetically intractable parasites.	[Gang, Spencer S.; Hallem, Elissa A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Castelletto, Michelle L.; Bryant, Astra S.; Yang, Emily; Lopez, Jacqueline B.; Hallem, Elissa A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Mancuso, Nicholas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Hallem, EA (reprint author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Hallem, EA (reprint author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	ehallem@ucla.edu		Bryant, Astra/0000-0002-0887-2044; Pellegrini, Matteo/0000-0001-9355-9564	Whitcome Predoctoral Training Program; UCLA Molecular Biology Institute; Ruth L. Kirschstein National Research Service Award [AI007323]; National Science Foundation East Asia and Pacific Summer Institute Fellowship [1414655]; UCLA Undergraduate Research Scholar Program; UCLA-Howard Hughes Medical Institute Pathways; Burroughs-Wellcome Fund Investigators in the Pathogenesis of Disease Award, NIH New Innovator [1DP2DC014596]; Howard Hughes Medical Institute Faculty Scholar Award	This work was funded by the Whitcome Predoctoral Training Program, UCLA Molecular Biology Institute, Ruth L. Kirschstein National Research Service Award AI007323, and National Science Foundation East Asia and Pacific Summer Institute Fellowship Award 1414655 (SSG); the UCLA Undergraduate Research Scholar Program (EY); the UCLA-Howard Hughes Medical Institute Pathways to Success Program (JBL); and a Burroughs-Wellcome Fund Investigators in the Pathogenesis of Disease Award, NIH New Innovator Award 1DP2DC014596, and Howard Hughes Medical Institute Faculty Scholar Award (EAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Barstead R, 2012, G3-GENES GENOM GENET, V2, P1415, DOI 10.1534/g3.112.003830; Boatin BA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001547; BRENNER S, 1974, GENETICS, V77, P71; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Castelletto ML, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004305; Chen L, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-24; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dulovic A, 2016, EXP PARASITOL, V168, P25, DOI 10.1016/j.exppara.2016.06.005; Egli D, 2017, BIORXIV; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Flibotte S, 2010, GENETICS, V185, P431, DOI 10.1534/genetics.110.116616; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gang SS, 2016, MOL BIOCHEM PARASIT, V208, P23, DOI 10.1016/j.molbiopara.2016.05.007; Grant WN, 2006, INT J PARASITOL, V36, P453, DOI 10.1016/j.ijpara.2005.11.009; Grant WN, 2006, INT J PARASITOL, V36, P475, DOI 10.1016/j.ijpara.2005.12.002; Guo L, 2015, EXP PARASITOL, V158, P2, DOI 10.1016/j.exppara.2015.03.001; Howe KL, 2016, NUCLEIC ACIDS RES, V44, pD774, DOI 10.1093/nar/gkv1217; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hunt VL, 2016, NAT GENET, V48, P299, DOI 10.1038/ng.3495; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Junio AB, 2008, EXP PARASITOL, V118, P253, DOI 10.1016/j.exppara.2007.08.018; Katic I, 2015, G3-GENES GENOM GENET, V5, P1649, DOI 10.1534/g3.115.019273; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0                                                   ; Lemmens BBLG, 2011, CHROMOSOMA, V120, P1, DOI 10.1007/s00412-010-0296-3; Li X, 2011, MOL BIOCHEM PARASIT, V179, P114, DOI 10.1016/j.molbiopara.2011.06.002; Li XS, 2006, INT J PARASITOL, V36, P671, DOI 10.1016/j.ijpara.2005.12.007; Lok JB, 2017, PARASITOLOGY, V144, P327, DOI 10.1017/S0031182016000391; Lok JB, 2007, STRONGYLOIDES STERCO; Mello C, 1995, METHOD CELL BIOL, V48, P451; MOERMAN DG, 1979, GENETICS, V91, P95; MOERMAN DG, 1988, GENE DEV, V2, P93, DOI 10.1101/gad.2.1.93; NOLAN TJ, 1993, J INFECT DIS, V168, P1479, DOI 10.1093/infdis/168.6.1479                                                       ; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Peng D, 2014, MBIO, V6, DOI DOI 10.1128/MBIO.02097-14; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Schafer Theodore W, 2006, Curr Gastroenterol Rep, V8, P312, DOI 10.1007/s11894-006-0052-2; Shao HG, 2017, INT J PARASITOL, V47, P511, DOI 10.1016/j.ijpara.2017.04.003; Shao HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002871; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; van Schendel R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8394; Viney M, 2017, PARASITOLOGY, V144, P285, DOI 10.1017/S0031182016000020; Viney ME, 2015, BIOL STRONGYLOIDES S; Ward JD, 2015, GENETICS, V201, P1279, DOI 10.1534/genetics.115.182717; Zhu XX, 2014, SCI REP-UK, V4, DOI 10.1038/srep06420	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	OCT	2017	13	10							e1006675	10.1371/journal.ppat.1006675				31	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	FL3YS	WOS:000414163300027	29016680	gold			2018-01-05	
J	Ma, LY; Boucher, JI; Paulsen, J; Matuszewski, S; Eide, CA; Ou, JH; Eickelberg, G; Press, RD; Zhu, LHJ; Druker, BJ; Branford, S; Wolfe, SA; Jensen, JD; Schiffer, CA; Green, MR; Bolon, DN				Ma, Leyuan; Boucher, Jeffrey I.; Paulsen, Janet; Matuszewski, Sebastian; Eide, Christopher A.; Ou, Jianhong; Eickelberg, Garrett; Press, Richard D.; Zhu, Lihua Julie; Druker, Brian J.; Branford, Susan; Wolfe, Scot A.; Jensen, Jeffrey D.; Schiffer, Celia A.; Green, Michael R.; Bolon, Daniel N.			CRISPR-Cas9-mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						BCR-ABL; CRISPR-Cas9-based genome editing; drug resistance; saturated mutagenesis; tyrosine kinase inhibitors	CHRONIC MYELOID-LEUKEMIA; BCR-ABL; MAMMALIAN-CELLS; MUTATION; PROTEIN; MECHANISMS; INHIBITORS	Developing tools to accurately predict the clinical prevalence of drug-resistant mutations is a key step toward generating more effective therapeutics. Here we describe a high-throughput CRISPR-Cas9-based saturated mutagenesis approach to generate comprehensive libraries of point mutations at a defined genomic location and systematically study their effect on cell growth. As proof of concept, we mutagenized a selected region within the leukemic oncogene BCR-ABL1. Using bulk competitions with a deep-sequencing readout, we analyzed hundreds of mutations under multiple drug conditions and found that the effects of mutations on growth in the presence or absence of drug were critical for predicting clinically relevant resistant mutations, many of which were cancer adaptive in the absence of drug pressure. Using this approach, we identified all clinically isolated BCR-ABL1 mutations and achieved a prediction score that correlated highly with their clinical prevalence. The strategy described here can be broadly applied to a variety of oncogenes to predict patient mutations and evaluate resistance susceptibility in the development of new therapeutics.	[Ma, Leyuan; Ou, Jianhong; Zhu, Lihua Julie; Wolfe, Scot A.; Green, Michael R.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Ma, Leyuan; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Boucher, Jeffrey I.; Paulsen, Janet; Wolfe, Scot A.; Schiffer, Celia A.; Bolon, Daniel N.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Matuszewski, Sebastian; Jensen, Jeffrey D.] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Matuszewski, Sebastian; Jensen, Jeffrey D.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Eide, Christopher A.; Druker, Brian J.] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97239 USA; [Eide, Christopher A.; Druker, Brian J.] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; [Eickelberg, Garrett; Press, Richard D.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Pathol, Portland, OR 97239 USA; [Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Lihua Julie] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Branford, Susan] SA Pathol, Ctr Canc Biol, Dept Genet & Mol Pathol, Adelaide, SA 5000, Australia; [Branford, Susan] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia; [Branford, Susan] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia; [Branford, Susan] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Jensen, Jeffrey D.] Arizona State Univ, Sch Life Sci, Ctr Evolut & Med, Tempe, AZ 85281 USA	Green, MR (reprint author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.; Green, MR (reprint author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.; Bolon, DN (reprint author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Michael.Green@umassmed.edu; Dan.Bolon@umassmed.edu		Matuszewski, Sebastian/0000-0002-4393-9283; Press, Richard/0000-0002-2103-5144	NIH [R01CA163926, R21CA175664]	We thank Sara Deibler for providing editorial assistance and the University of Massachusetts Medical School Deep Sequencing Core Facility for deep sequencing. This work was supported by NIH Grant R01CA163926 (to M.R.G.), and NIH Grant R21CA175664 (to D.N.B.). M.R.G. is also an investigator of the Howard Hughes Medical Institute.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9                                                   ; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312                                                         ; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gottesman MM, 2016, ANNU REV PHARMACOL, V56, P85, DOI 10.1146/annurev-pharmtox-010715-103111; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jones D, 2009, J MOL DIAGN, V11, P4, DOI 10.2353/jmoldx.2009.080095; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Nalam MNL, 2013, CHEM BIOL, V20, P1116, DOI 10.1016/j.chembiol.2013.07.014; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagenaar TR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12171; Wylie CS, 2011, P NATL ACAD SCI USA, V108, P9916, DOI 10.1073/pnas.1017572108; Zabriskie MS, 2014, CANCER CELL, V26, P428, DOI 10.1016/j.ccr.2014.07.006; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	26	0	0	1	1	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 1	2017	114	44					11751	11756		10.1073/pnas.1708268114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FL3MO	WOS:000414127400069	29078326				2018-01-05	
J	Kanjee, U; Gruring, C; Chaand, M; Lin, KM; Egan, E; Manzo, J; Jones, PL; Yu, T; Barker, R; Weekes, MP; Duraisingh, MT				Kanjee, Usheer; Gruring, Christof; Chaand, Mudit; Lin, Kai-Min; Egan, Elizabeth; Manzo, Jale; Jones, Patrick L.; Yu, Tiffany; Barker, Robert, Jr.; Weekes, Michael P.; Duraisingh, Manoj T.			CRISPR/Cas9 knockouts reveal genetic interaction between strain-transcendent erythrocyte determinants of &ITPlasmodium falciparum&IT invasion	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						BSG; CD44; CRISPR/Cas9; Plasmodium falciparum; parasite invasion	RED-BLOOD-CELLS; CHRONIC MYELOGENOUS LEUKEMIA; POSITIVE PHILADELPHIA-CHROMOSOME; PARASITE PLASMODIUM-FALCIPARUM; HEMATOPOIETIC STEM-CELLS; MALARIA PARASITE; IN-VITRO; MONOCARBOXYLATE TRANSPORTERS; RETICULOCYTE MATURATION; CRISPR-CAS9 SYSTEM	During malaria blood-stage infections, Plasmodium parasites inter act with the RBC surface to enable invasion followed by intracellular proliferation. Critical factors involved in invasion have been identified using biochemical and genetic approaches including specific knockdowns of genes of interest from primary CD34(+) hematopoietic stem cells (cRBCs). Here we report the development of a robust in vitro culture system to produce RBCs that allow the gen eration of gene knockouts via CRISPR/Cas9 using the immortal JK-1 erythroleukemia line. JK-1 cells spontaneously differentiate, generating cells at different stages of erythropoiesis, including terminally differentiated nucleated RBCs that we term "jkRBCs." A screen of small-molecule epigenetic regulators identified several bromodomain-specific inhibitors that promote differentiation and enable production of synchronous populations of jkRBCs. Global surface proteomic profiling revealed that jkRBCs express all known P. falciparum host receptors in a similar fashion to cRBCs and that multiple P. falciparum strains invade jkRBCs at comparable levels to cRBCs and RBCs. Using CRISPR/Cas9, we deleted two host factors, basigin (BSG) and CD44, for which no natural nulls exist. BSG interacts with the parasite ligand Rh5, a prominent vaccine candidate. A BSG knockout was completely refractory to parasite invasion in a strain- transcendent manner, confirming the essential role for BSG during invasion. CD44 was recently identified in an RNAi screen of blood group genes as a host factor for invasion, and we show that CD44 knockout results in strain-transcendent reduction in invasion. Furthermore, we demonstrate a functional interaction between these two determinants in mediating P. faldparum erythrocyte invasion.	[Kanjee, Usheer; Gruring, Christof; Chaand, Mudit; Egan, Elizabeth; Manzo, Jale; Yu, Tiffany; Duraisingh, Manoj T.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lin, Kai-Min; Weekes, Michael P.] Cambridge Inst Med Res, Cambridge CB2 OXY, England; [Jones, Patrick L.; Barker, Robert, Jr.] Sanofi Genzyme, Waltham, MA 02451 USA; [Egan, Elizabeth] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Duraisingh, MT (reprint author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	mduraisi@hsph.harvard.edu			NIH [R01AI091787, R01HL139337]; Wellcome Trust Senior Clinical Research Fellowship [108070/Z/15/Z]; Swiss National Science Foundation Postdoctoral Fellowship; Canadian Institutes of Health Research Postdoctoral Fellowship; Bill and Melinda Gates Foundation [OPP1023594]	The P. falciparum 3D7attB and Dd2attB parasite lines were a kind gift from Prof. David Fidock (Columbia University). The TdTomato plasmid was a kind gift from Prof. Matthias Marti (University of Glasgow). The LentiCas9-Blast and LentiGuide-Puro vectors were gifts from John Doench and David Root (Broad Institute). We thank James Williamson (Cambridge Institute for Medical Research) for assistance with mass spectrometry and Stewart Rudnicki and Katrina Rudnicki (Institute of Chemistry and Cell Biology at Harvard Medical School) for assistance with preparing the chemical library for screening. U.K. was supported by a Canadian Institutes of Health Research Postdoctoral Fellowship. C.G. was supported by a Swiss National Science Foundation Postdoctoral Fellowship. M.P.W. was supported by Wellcome Trust Senior Clinical Research Fellowship 108070/Z/15/Z. This work was supported by NIH Grants R01AI091787 and R01HL139337 (to M.T.D.) and by Bill and Melinda Gates Foundation Grant OPP1023594 (to M.T.D.).	Aingaran M, 2012, CELL MICROBIOL, V14, P983, DOI 10.1111/j.1462-5822.2012.01786.x; Aniweh Y, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12747; Bei AK, 2010, J INFECT DIS, V202, P1722, DOI 10.1086/657157; Bosman GJCGM, 2008, TRANSFUSION, V48, P827, DOI 10.1111/j.1537-2995.2007.01630.x; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; BRECHER G, 1950, AM J CLIN PATHOL, V20, P1079; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Bustamante LY, 2013, VACCINE, V31, P373, DOI 10.1016/j.vaccine.2012.10.106; Chen L, 2014, ELIFE, V3, DOI 10.7554/eLife.04187; Coleman BI, 2012, CELL HOST MICROBE, V12, P739, DOI 10.1016/j.chom.2012.11.004; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Crosnier C, 2013, MOL CELL PROTEOMICS, V12, P3976, DOI 10.1074/mcp.O113.028357; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dhalluin C, 1999, NATURE, V399, P491; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; Dumas AR, 2004, LEUKEMIA RES, V28, P1329, DOI 10.1016/j.leukres.2004.04.013; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Egan ES, 2015, SCIENCE, V348, P711, DOI 10.1126/science.aaa3526; Fernandez-Becerra C, 2013, MEM I OSWALDO CRUZ, V108, P801, DOI 10.1590/0074-0276108062013019; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Florence B, 2001, FRONT BIOSCI, V6, pD1008, DOI 10.2741/Florence; FURUKAWA T, 1994, LEUKEMIA, V8, P171; Gallenkamp D, 2014, CHEMMEDCHEM, V9, P438, DOI 10.1002/cmdc.201300434; Gautier EF, 2016, CELL REP, V16, P1470, DOI 10.1016/j.celrep.2016.06.085; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Grass GD, 2013, J BIOL CHEM, V288, P26089, DOI 10.1074/jbc.M113.497685; Guinet F, 1996, J CELL BIOL, V135, P269, DOI 10.1083/jcb.135.1.269; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; HARRISON FL, 1981, BIOCHEM J, V194, P789, DOI 10.1042/bj1940789                                                               ; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Hu XT, 1998, LEUKEMIA RES, V22, P817, DOI 10.1016/S0145-2126(98)00073-3; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127                                                         ; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaushansky K, 2015, WILLIAMS HEMATOLOGY; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Lange PF, 2014, J PROTEOME RES, V13, P2028, DOI 10.1021/pr401191w; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Lim C, 2016, AM J HEMATOL, V91, P852, DOI 10.1002/ajh.24383; Lim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2612; Liu J, 2010, BLOOD, V115, P2021, DOI 10.1182/blood-2009-08-241182; Lotem J, 2002, SEMIN CANCER BIOL, V12, P339, DOI 10.1016/S1044-579X(02)00054-8; Lotem J, 2006, ONCOGENE, V25, P7663, DOI 10.1038/sj.onc.1209816; LOZZIO CB, 1975, BLOOD, V45, P321; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; OKUNO Y, 1990, CANCER, V66, P1544, DOI 10.1002/1097-0142(19901001)66:7<1544::AID-CNCR2820660719>3.0.CO;2-9             ; Ord RL, 2015, HUM VACC IMMUNOTHER, V11, P1465, DOI 10.1080/21645515.2015.1026496; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5                                                    ; PAPAYANNOPOULOU T, 1988, BLOOD, V72, P1029; Park A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095101; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Paul AS, 2015, CELL HOST MICROBE, V18, P49, DOI 10.1016/j.chom.2015.06.003; Paul AS, 2015, CURR OPIN HEMATOL, V22, P220, DOI 10.1097/MOH.0000000000000135; Pesciotta EN, 2012, J PROTEOMICS, V76, P194, DOI 10.1016/j.jprot.2012.08.010; Picaud S, 2015, CANCER RES, V75, P5106, DOI 10.1158/0008-5472.CAN-15-0236; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Ringrose JH, 2008, J PROTEOME RES, V7, P3060, DOI 10.1021/pr8001029; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Rozenberg G, 2011, MICROSCOPIC HAEMATOL; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salesse S, 2002, ONCOGENE, V21, P8547, DOI 10.1038/sj.onc.1206082; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SEIGNEURIN D, 1987, EXP HEMATOL, V15, P822; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X                                                   ; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Spring FA, 1997, EUR J IMMUNOL, V27, P891, DOI 10.1002/eji.1830270414                                                          ; Stonestrom AJ, 2015, BLOOD, V125, P2825, DOI 10.1182/blood-2014-10-607309; Tamez PA, 2009, BLOOD, V114, P3652, DOI 10.1182/blood-2009-07-231894; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; van Gestel RA, 2010, J PROTEOMICS, V73, P456, DOI 10.1016/j.jprot.2009.08.010; Vangamudi B, 2015, CANCER RES, V75, P3865, DOI 10.1158/0008-5472.CAN-14-3798; Verma SK, 2012, ACS MED CHEM LETT, V3, P1091, DOI 10.1021/ml3003346; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e; Weiss GE, 2016, TRENDS PARASITOL, V32, P284, DOI 10.1016/j.pt.2015.12.007; Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; World Health Organisation, 2015, WORLD MAL REP 2015; Williams AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002991; Wilson MC, 2016, MOL CELL PROTEOMICS, V15, P1938, DOI 10.1074/mcp.M115.057315; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715; Zucconi BE, 2016, BIOCHEMISTRY-US, V55, P3727, DOI 10.1021/acs.biochem.6b00480	108	0	0	3	3	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 1	2017	114	44					E9356	E9365		10.1073/pnas.1711310114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FL3MO	WOS:000414127400023	29078358				2018-01-05	
J	Sinnamon, JR; Kim, SY; Corson, GM; Song, Z; Nakai, H; Adelman, JP; Mandel, G				Sinnamon, John R.; Kim, Susan Y.; Corson, Glen M.; Song, Zhen; Nakai, Hiroyuki; Adelman, John P.; Mandel, Gail			Site-directed RNA repair of endogenous Mecp2 RNA in neurons	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						RNA editing; MeCP2; Rett syndrome; ADAR2	CPG-BINDING PROTEIN-2; RETT-SYNDROME MUTATIONS; ADENOSINE-DEAMINASE; NEUROLOGICAL SYMPTOMS; ADENOASSOCIATED VIRUS; PHENOTYPIC SEVERITY; CEREBRAL-CORTEX; EDITING ENZYME; MOUSE MODELS; GENE-THERAPY	Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (MECP2). A distinct disorder results from MECP2 gene duplication, suggesting that therapeutic approaches must restore close to normal levels of MECP2. Here, we apply the approach of site-directed RNA editing to repair, at the mRNA level, a disease-causing guanosine to adenosine (G > A) mutation in the mouse MeCP2 DNA binding domain. To mediate repair, we exploit the catalytic domain of Adenosine Deaminase Acting on RNA (ADAR2) that deaminates A to inosine (I) residues that are subsequently translated as G. We fuse the ADAR2 domain, tagged with a nuclear localization signal, to an RNA binding peptide from bacteriophage lambda. In cultured neurons from mice that harbor an RTT patient G > A mutation and express engineered ADAR2, along with an appropriate RNA guide to target the enzyme, 72% of Mecp2 mRNA is repaired. Levels of MeCP2 protein are also increased significantly. Importantly, as in wild-type neurons, the repaired MeCP2 protein is enriched in heterochromatic foci, reflecting restoration of normal MeCP2 binding to methylated DNA. This successful use of site-directed RNA editing to repair an endogenous mRNA and restore protein function opens the door to future in vivo applications to treat RTT and other diseases.	[Sinnamon, John R.; Kim, Susan Y.; Corson, Glen M.; Adelman, John P.; Mandel, Gail] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Song, Zhen; Nakai, Hiroyuki] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Mandel, G (reprint author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	mandelg@ohsu.edu			Rett Syndrome Research Trust; NIH [NS087726, NS088399]	We thank Drs. Maria Montiel-Gonzalez and Joshua Rosenthal (Marine Biological Laboratories) for kindly providing the initial Editase construct and for useful discussions. We also thank Dr. Paul Brehm (Vollum Institute, OHSU) and members of the G.M. laboratory for advice during the course of the work and Ms. Christine Schmidt (Vollum Institute, OHSU) for excellent technical support. We acknowledge the laboratories of Drs. Michael E. Greenberg (Harvard Medical School) and Adrian Bird (Wellcome Trust Centre for Cell Biology, University of Edinburgh) for advice and encouragement through the Rett Syndrome Research Trust (RSRT) Consortium. This work was supported by NIH Grants NS087726 (to G.M.) and NS088399 (to H.N.) and the Rett Syndrome Research Trust (G.M.).	Amir RE, 1999, NAT GENET, V23, P185; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Austin RJ, 2002, J AM CHEM SOC, V124, P10966, DOI 10.1021/ja026610b; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581                                                           ; Belichenko NP, 2009, NEUROBIOL DIS, V34, P71, DOI 10.1016/j.nbd.2008.12.016; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Brown K, 2016, HUM MOL GENET, V25, P558, DOI 10.1093/hmg/ddv496; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chen LL, 2012, CURR TOP MICROBIOL, V353, P111, DOI 10.1007/82_2011_149; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cuddapah VA, 2014, J MED GENET, V51, P152, DOI 10.1136/jmedgenet-2013-102113; Dawson TR, 2004, J BIOL CHEM, V279, P4941, DOI 10.1074/jbc.M310068200; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371                                                               ; Earley LF, 2017, J VIROL, V91, DOI 10.1128/JVI.01980-16; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537                                                           ; Fyfe S, 2003, J CHILD NEUROL, V18, P709, DOI 10.1177/08830738030180100301; Gadalla KKE, 2017, MOL THER-METH CLIN D, V5, P180, DOI 10.1016/j.omtm.2017.04.007; Gadalla KKE, 2013, MOL THER, V21, P18, DOI 10.1038/mt.2012.200; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495                                                      ; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899                                                                   ; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hanswillemenke A, 2015, J AM CHEM SOC, V137, P15875, DOI 10.1021/jacs.5b10216; Heckman LD, 2014, ELIFE, V3, DOI 10.7554/eLife.02676; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Kallman AM, 2003, NUCLEIC ACIDS RES, V31, P4874, DOI 10.1093/nar/gkg681; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kuttan A, 2012, P NATL ACAD SCI USA, V109, pE3295, DOI 10.1073/pnas.1212548109; Lagger S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006793; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Linhoff MW, 2015, CELL, V163, P246, DOI 10.1016/j.cell.2015.09.002; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Maas S, 1996, J BIOL CHEM, V271, P12221, DOI 10.1074/jbc.271.21.12221                                                        ; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; Matthews MM, 2016, NAT STRUCT MOL BIOL, V23, P426, DOI 10.1038/nsmb.3203; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Montiel-Gonzalez MF, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw738; Montiel-Gonzalez MF, 2013, P NATL ACAD SCI USA, V110, P18285, DOI 10.1073/pnas.1306243110; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; O'Connell MA, 1998, METHODS, V15, P51, DOI 10.1006/meth.1998.0605; Percy AK, 2010, ANN NEUROL, V68, P951, DOI 10.1002/ana.22154; Phelps KJ, 2015, NUCLEIC ACIDS RES, V43, P1123, DOI 10.1093/nar/gku1345; Robinson L, 2012, BRAIN, V135, P2699, DOI 10.1093/brain/aws096; Ross PD, 2016, HUM MOL GENET, V25, P4389, DOI 10.1093/hmg/ddw269; Schneider MF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku272; Schule B, 2008, CLIN GENET, V74, P116, DOI 10.1111/j.1399-0004.2008.01005.x; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Sinnett SE, 2017, MOL THER-METH CLIN D, V5, P106, DOI 10.1016/j.omtm.2017.04.006; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stuss DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031896; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vogel P, 2014, CHEMMEDCHEM, V9, P2021, DOI 10.1002/cmdc.201402139; Vogel P, 2014, ANGEW CHEM INT EDIT, V53, P6267, DOI 10.1002/anie.201402634; Wang YR, 2016, NUCLEIC ACIDS RES, V44, P9872, DOI 10.1093/nar/gkw799; Wong SK, 2001, RNA, V7, P846, DOI 10.1017/S135583820101007X                                                       ; WOOLF TM, 1995, P NATL ACAD SCI USA, V92, P8298, DOI 10.1073/pnas.92.18.8298; Yang JH, 1997, P NATL ACAD SCI USA, V94, P4354, DOI 10.1073/pnas.94.9.4354; Yang Y, 2016, ACS CHEM BIOL, V11, P2706, DOI 10.1021/acschembio.6b00450	77	0	0	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 1	2017	114	44					E9395	E9402		10.1073/pnas.1715320114				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FL3MO	WOS:000414127400027	29078406				2018-01-05	
J	Zakany, J; Darbellay, F; Mascrez, B; Necsulea, A; Duboule, D				Zakany, Jozsef; Darbellay, Fabrice; Mascrez, Benedicte; Necsulea, Anamaria; Duboule, Denis			Control of growth and gut maturation by &ITHoxD&IT genes and the associated lncRNA &ITHaglr&IT	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						lncRNA; digestive system; Hox regulation; growth control; CRISPR-cas9	HOX GENES; FUNCTIONAL HIERARCHY; HOMEOTIC GENES; COMPLEX; MICE; TRANSCRIPTION; TRANSFORMATIONS; MORPHOGENESIS; COLINEARITY; EXPRESSION	During embryonic development, Hox genes participate in the building of a functional digestive system in metazoans, and genetic conditions involving these genes lead to important, sometimes lethal,growth retardation. Recently, this phenotype was obtained after deletion of Haglr, the Hoxd antisense growth-associated long non-coding RNA (IncRNA) located between Hoxd1 and Hoxd3. In this study, we have analyzed the function of Hoxd genes in delayed growth trajectories by looking at several nested targeted deficiencies of the mouse HoxD cluster. Mutant pups were severely stunted during the suckling period, but many recovered after weaning. After comparing seven distinct HoxD alleles, including CRISPR/Cas9 deletions involving Haglr, we identified Hoxd3 as the critical component for the gut to maintain milk-digestive competence. This essential function could be abrogated by the dominant-negative effect of HOXD10 as shown by a genetic rescue approach, thus further illustrating the importance of posterior prevalence in Hox gene function. A role for the IncRNA Haglr in the control of post-natal growth could not be corroborated.	[Zakany, Jozsef; Mascrez, Benedicte; Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva 4, Switzerland; [Darbellay, Fabrice; Necsulea, Anamaria; Duboule, Denis] Ecole Polytech Fed Lausanne, Fed Inst Technol Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Necsulea, Anamaria] Univ Claude Bernard Lyon 1, CNRS, Lab Biometry & Evolutionary Biol, F-69662 Villeurbanne, France	Duboule, D (reprint author), Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva 4, Switzerland.; Duboule, D (reprint author), Ecole Polytech Fed Lausanne, Fed Inst Technol Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	Denis.Duboule@epfl.ch			European Research Council [SystemHox 232790, RegulHox 588029]; Swiss National Research Fund [310030B_138662]; University of Geneva; EPFL	We thank members of the D.D. laboratories for sharing material and discussions, the histology platform at Ecole Polytechnique Federale (Lausanne) (EPFL), the genomics platform in Geneva, Olivier Schaad for advice on statistical analyses, and Thomas Alexander McKee for discussions. This work was supported by funds from the EPFL, the University of Geneva, Swiss National Research Fund Grant 310030B_138662, European Research Council Grants SystemHox 232790 and RegulHox 588029, and the Claraz Foundation (D.D.).	BACHILLER D, 1994, EMBO J, V13, P1930; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Burglin TR, 2016, CHROMOSOMA, V125, P497, DOI 10.1007/s00412-015-0543-8; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541                                                           ; CONDIE BG, 1993, DEVELOPMENT, V119, P579; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delpretti S, 2013, CELL REP, V5, P137, DOI 10.1016/j.celrep.2013.09.002; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; Duboule D, 1999, P NATL ACAD SCI USA, V96, P322, DOI 10.1073/pnas.96.2.322                                                           ; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; GONZALEZREYES A, 1990, NATURE, V344, P78, DOI 10.1038/344078a0; GOUAT P, 1992, Z SAUGETIERKD, V57, P183; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077                                                                ; Gummalla M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002720; Guo T, 2011, NAT NEUROSCI, V14, P31, DOI 10.1038/nn.2710; Gurdziel K, 2016, DEV DYNAM, V245, P614, DOI [10.1002/DVDY.24399, 10.1002/dvdy.24399]; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; HORAN GSB, 1995, DEV BIOL, V169, P359, DOI 10.1006/dbio.1995.1150; Kmita M, 2000, GENE DEV, V14, P198; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; Kondo T, 1996, DEVELOPMENT, V122, P2651; Rivas ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003252; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Neal MD, 2013, J IMMUNOL, V190, P3541, DOI 10.4049/jimmunol.1202264; Padmanabhan P, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-60; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schep R, 2016, P NATL ACAD SCI USA, V113, pE7720, DOI 10.1073/pnas.1617141113; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; Tan DP, 1996, P NATL ACAD SCI USA, V93, P8247, DOI 10.1073/pnas.93.16.8247; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Theiler K, 1989, HOUSE MOUSE ATLAS EM, P150; Tschopp P, 2012, DEVELOPMENT, V139, P929, DOI 10.1242/dev.076794; Tschopp P, 2011, ANNU REV GENET, V45, P145, DOI 10.1146/annurev-genet-102209-163429; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Walthall K, 2005, BIRTH DEFECTS RES B, V74, P132, DOI 10.1002/bdrb.20040; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Zacchetti G, 2007, DEVELOPMENT, V134, P3967, DOI 10.1242/dev.010991; Zakany J, 1999, NATURE, V401, P761; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6; Zakany J, 2012, CURR BIOL, V22, P1676, DOI 10.1016/j.cub.2012.06.067	45	0	0	0	0	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 1	2017	114	44					E9290	E9299		10.1073/pnas.1712511114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FL3MO	WOS:000414127400016	29042517				2018-01-05	
J	Hemmings, SMJ; Malan-Muller, S; van den Heuvel, LL; Demmitt, BA; Stanislawski, MA; Smith, DG; Bohr, AD; Stamper, CE; Hyde, ER; Morton, JT; Marotz, CA; Siebler, PH; Braspenning, M; Van Criekinge, W; Hoisington, AJ; Brenner, LA; Postolache, TT; McQueen, MB; Krauter, KS; Knight, R; Seedat, S; Lowry, CA				Hemmings, Sian M. J.; Malan-Mueller, Stefanie; van den Heuvel, Leigh L.; Demmitt, Brittany A.; Stanislawski, Maggie A.; Smith, David G.; Bohr, Adam D.; Stamper, Christopher E.; Hyde, Embriette R.; Morton, James T.; Marotz, Clarisse A.; Siebler, Philip H.; Braspenning, Maarten; Van Criekinge, Wim; Hoisington, Andrew J.; Brenner, Lisa A.; Postolache, Teodor T.; McQueen, Matthew B.; Krauter, Kenneth S.; Knight, Rob; Seedat, Soraya; Lowry, Christopher A.			The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study	PSYCHOSOMATIC MEDICINE			English	Article						childhood trauma; C-reactive protein; immunoregulation; inflammation; microbiome; posttraumatic stress disorder	REGULATORY T-CELLS; MULTIPLE-SCLEROSIS RISK; C-REACTIVE PROTEIN; EARLY-LIFE STRESS; QUALITY-OF-LIFE; GUT MICROBIOTA; SOUTH-AFRICA; INTERPERSONAL VIOLENCE; INTESTINAL MICROBIOTA; PSYCHIATRIC-DISORDERS	Objective: Inadequate immunoregulation and elevated inflammation may be risk factors for posttraumatic stress disorder (PTSD), and microbial inputs are important determinants of immunoregulation; however, the association between the gut microbiota and PTSD is unknown. This study investigated the gut microbiome in a South African sample of PTSD-affected individuals and trauma-exposed (TE) controls to identify potential differences in microbial diversity or microbial community structure. Methods: The Clinician-Administered PTSD Scale for DSM-5 was used to diagnose PTSD according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria. Microbial DNA was extracted from stool samples obtained from 18 individuals with PTSD and 12 TE control participants. Bacterial 16S ribosomal RNA gene V3/V4 amplicons were generated and sequenced. Microbial community structure, alpha-diversity, and beta-diversity were analyzed; random forest analysis was used to identify associations between bacterial taxa and PTSD. Results: There were no differences between PTSD and TE control groups in alpha- or beta-diversity measures (e.g., alpha-diversity: Shannon index, t = 0.386, p =.70; beta-diversity, on the basis of analysis of similarities: Bray-Curtis test statistic = -0.033, p =.70); however, random forest analysis highlighted three phyla as important to distinguish PTSD status: Actinobacteria, Lentisphaerae, and Verrucomicrobia. Decreased total abundance of these taxa was associated with higher Clinician-Administered PTSD Scale scores (r = -0.387, p =.035). Conclusions: In this exploratory study, measures of overall microbial diversity were similar among individuals with PTSD and TE controls; however, decreased total abundance of Actinobacteria, Lentisphaerae, and Verrucomicrobia was associated with PTSD status.	[Hemmings, Sian M. J.; Malan-Mueller, Stefanie; van den Heuvel, Leigh L.; Seedat, Soraya] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Psychiat, Tygerberg, South Africa; [Demmitt, Brittany A.; Krauter, Kenneth S.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Smith, David G.] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; [Bohr, Adam D.; Stamper, Christopher E.; Siebler, Philip H.; McQueen, Matthew B.; Lowry, Christopher A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Demmitt, Brittany A.; Bohr, Adam D.; McQueen, Matthew B.; Krauter, Kenneth S.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Stanislawski, Maggie A.] Univ Colorado, Dept Epidemiol, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat & Neurol, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.; Lowry, Christopher A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Anschutz Med Campus, Aurora, CO USA; [Stanislawski, Maggie A.] US Dept Vet Affairs, Denver, CO USA; [Hyde, Embriette R.; Marotz, Clarisse A.; Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Morton, James T.; Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA; [Braspenning, Maarten] Univ Ghent, NXT Dx, Ghent, Belgium; [Van Criekinge, Wim] Univ Ghent, Dept Math Modelling, Stat & Bioinformat, Ghent, Belgium; [Hoisington, Andrew J.] US Air Force Acad, Dept Civil & Environm Engn, Colorado Springs, CO 80840 USA; [Hoisington, Andrew J.; Brenner, Lisa A.; Postolache, Teodor T.; Lowry, Christopher A.] MVM CoRE, Denver, CO USA; [Brenner, Lisa A.; Postolache, Teodor T.; Lowry, Christopher A.] VA Rocky Mt Mental Illness Res Educ & Clin Ctr MI, Denver, CO USA; [Postolache, Teodor T.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	Lowry, CA (reprint author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.; Lowry, CA (reprint author), Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA.	christopher.lowry@colorado.edu		Knight, Rob/0000-0002-0975-9019	Medical Research Council of South Africa (MRC Flagship Grant) [RFA-UFSP-01-2013]; South African Research Chair in Posttraumatic Stress Disorder - Department of Science and Technology; National Research Foundation; Alfred P. Sloan Foundation [G-2015-14165, G-2016-7077]; Colorado Clinical and Translational Sciences Institute [CNSTT-15-145]; Colorado Department of Public Health and Environment [DCEED-3510]; National Institutes of Health [R01 DA019921]; Department of Veterans Affairs Office of Research and Development [1 I21 RX002232-01]; Office of Naval Research [N00014-15-1-2809]; University of Maryland, Joint Institute for Food Safety and Applied Nutrition; US Food and Drug Administration [FDU.001418]; Veterans Affairs Administration from CSRD [MHBA-016-15S]; Rocky Mountain MIRECC, Denver, CO	L.L.H., S.M.J.H., S.M.M., and S.S. are supported by the Medical Research Council of South Africa (MRC Flagship Grant RFA-UFSP-01-2013). S.M.J.H., S.M.M., and S.S. are supported by the South African Research Chair in Posttraumatic Stress Disorder, funded by the Department of Science and Technology and the National Research Foundation. C.A.L. is currently receiving funding from the Alfred P. Sloan Foundation (G-2015-14165, G-2016-7077), Colorado Clinical and Translational Sciences Institute (CNSTT-15-145), Colorado Department of Public Health and Environment (DCEED-3510), the National Institutes of Health (R01 DA019921), the Department of Veterans Affairs Office of Research and Development (1 I21 RX002232-01), and the Office of Naval Research (N00014-15-1-2809). T.T.P. is supported by the University of Maryland, Joint Institute for Food Safety and Applied Nutrition, and the US Food and Drug Administration through the cooperative agreement FDU.001418, the Veterans Affairs Administration through Merit Award MHBA-016-15S from CSR&D, and the Rocky Mountain MIRECC, Denver, CO. Christopher A. Lowry serves on the Scientific Advisory Board of Immodulon Therapeutics. For the remaining authors, none were declared.	Alloza I, 2012, GENES IMMUN, V13, P253, DOI 10.1038/gene.2011.81; ALVERDY J, 1991, ANN SURG, V214, P719, DOI 10.1097/00000658-199112000-00012; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; Bemstein D, 1998, MANUAL CHILDHOOD TRA; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bercik P, 2010, GASTROENTEROLOGY, V139, P2102, DOI 10.1053/j.gastro.2010.06.063; Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324                                                         ; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; De Bellis MD, 2014, CHILD ADOL PSYCH CL, V23, P185, DOI 10.1016/j.chc.2014.01.002; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Dinan TG, 2014, MOL PSYCHIATR, V19, P1252, DOI 10.1038/mp.2014.93; Eraly SA, 2014, JAMA PSYCHIAT, V71, P423, DOI 10.1001/jamapsychiatry.2013.4374; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Freier E, 2010, PSYCHONEUROENDOCRINO, V35, P663, DOI 10.1016/j.psyneuen.2009.10.005; Garcia-Rodenas CL, 2006, J PEDIATR GASTR NUTR, V43, P16, DOI 10.1097/01.mpg.0000226376.95623.9f; Genuer R, 2015, R J, V7, P19; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez-Gallego C, 2016, BENEF MICROBES, V7, P571, DOI 10.3920/BM2016.0009; Guo G, 2009, STRESS, V12, P478, DOI 10.3109/10253890802642188; Harder MN, 2013, J CLIN ENDOCR METAB, V98, pE801, DOI 10.1210/jc.2012-4169; Heath NM, 2013, CYTOKINE, V63, P172, DOI 10.1016/j.cyto.2013.04.030; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Higuchi T, 1997, J BACTERIOL, V179, P3362, DOI 10.1128/jb.179.10.3362-3364.1997                                                ; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Ishwaran H, PACKAGE RANDOMFOREST; Jergovic M, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00049; Jergovic M, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-43; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Jorgensen BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103398; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; Karl JP, 2017, AM J PHYSIOL-GASTR L, V312, pG559, DOI 10.1152/ajpgi.00066.2017; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kullberg MC, 1998, INFECT IMMUN, V66, P5157; Lill CM, 2013, J MED GENET, V50, P140, DOI 10.1136/jmedgenet-2012-101411; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Lowry Christopher A, 2016, Curr Environ Health Rep, V3, P270, DOI 10.1007/s40572-016-0100-5; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Maes M, 1999, BIOL PSYCHIAT, V45, P833, DOI 10.1016/S0006-3223(98)00131-0; Mendlowicz MV, 2000, AM J PSYCHIAT, V157, P669, DOI 10.1176/appi.ajp.157.5.669                                                      ; Morath J, 2014, J PSYCHIATR RES, V54, P1, DOI 10.1016/j.jpsychires.2014.03.016; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI [10.2471/BLT.06.037184, 10.2471/BLT.06.03'7184]; O'Donovan A, 2015, BIOL PSYCHIAT, V77, P365, DOI 10.1016/j.biopsych.2014.06.015; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Pervanidou P, 2007, PSYCHONEUROENDOCRINO, V32, P991, DOI 10.1016/j.psyneuen.2007.07.001; Plantinga L, 2013, BRAIN BEHAV IMMUN, V30, P125, DOI 10.1016/j.bbi.2013.01.081; Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161; Reber SO, 2016, PSYCHONEUROENDOCRINO, V74, P221, DOI 10.1016/j.psyneuen.2016.08.031; Reber SO, 2016, P NATL ACAD SCI USA, V113, pE3130, DOI 10.1073/pnas.1600324113; Rook GAW, 2014, CLIN EXP IMMUNOL, V177, P1, DOI 10.1111/cei.12269; Rook GA, 2009, HYGIENE HYPOTHESIS D, V1; Rook GAW, 2013, OLD HERBORN U MONOGR, P61; Rook GAW, 2008, TRENDS IMMUNOL, V29, P150, DOI 10.1016/j.it.2008.01.002; Rook GAW, 2015, BRAIN RES, V1617, P47, DOI 10.1016/j.brainres.2014.04.004; Rook GAW, 2014, ADV EXP MED BIOL, V817, P319, DOI 10.1007/978-1-4939-0897-4_15; Rook Graham A. W., 2013, Evolution Medicine and Public Health, P14, DOI 10.1093/emph/eos005; Rook Graham A. W., 2013, Evolution Medicine and Public Health, P46, DOI 10.1093/emph/eot004; Rook GAW, 2012, DRUG DISCOV TODAY, V17, P451, DOI 10.1016/j.drudis.2012.03.018; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Seedat S, 2013, SAJP-S AFR J PSYCHI, V19, P187; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Sommershof A, 2009, BRAIN BEHAV IMMUN, V23, P1117, DOI 10.1016/j.bbi.2009.07.003; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; Spitzer C, 2010, J PSYCHIATR RES, V44, P15, DOI 10.1016/j.jpsychires.2009.06.002; Stein MB, 2016, JAMA PSYCHIAT, V73, P695, DOI 10.1001/jamapsychiatry.2016.0350; Thayer Z, 2017, AM J HUM BIOL, V29; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Tursich M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.56; Viatte S, 2012, ANN RHEUM DIS, V71, P1984, DOI 10.1136/annrheumdis-2011-201225; Wang CM, 2010, WORLD J DIABETES, V1, P27, DOI 10.4239/wjd.v1.i2.27; Weathers F. W., 2013, PTSD CHECKLIST DSM 5; World Health Organization, VIOL PREV EV; Widom CS, 1999, AM J PSYCHIAT, V156, P1223; Williams SL, 2007, J TRAUMA STRESS, V20, P845, DOI 10.1002/jts.20252; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690                                                         ; Zhang B, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1128; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zijlmans MAC, 2015, PSYCHONEUROENDOCRINO, V53, P233, DOI 10.1016/j.psyneuen.2015.01.006; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625; [Anonymous], 2012, CENSUS 2011 CENSUS B	99	1	1	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	OCT	2017	79	8					936	946		10.1097/PSY.0000000000000512				11	Psychiatry; Psychology; Psychology, Multidisciplinary	Psychiatry; Psychology	FJ9DB	WOS:000413070100014	28700459				2018-01-05	
J	Wu, LP; Xie, JS; Li, T; Mai, ZH; Wang, L; Wang, XP; Chen, TS				Wu, Liping; Xie, Jinshan; Li, Tan; Mai, Zihao; Wang, Lu; Wang, Xiaoping; Chen, Tongsheng			Gene delivery ability of polyethylenimine and polyethylene glycol dual-functionalized nanographene oxide in 11 different cell lines	ROYAL SOCIETY OPEN SCIENCE			English	Article						polyethylenimine; polyethylene glycol; graphene oxide; gene delivery; transfection efficiency	GRAPHENE OXIDE; PLASMID DELIVERY; THERAPY; SYSTEM; ACTIVATION; TRANSFECTION; CRISPR-CAS9; COMPLEXES; VECTOR; FRET	We recently developed a polyethylenimine (PEI) and polyethylene glycol (PEG) dual-functionalized reduced graphene oxide (GO) (PEG-nrGO-PEI, RGPP) for highefficient gene delivery in HepG2 and Hela cell lines. To evaluate the feasibility and applicability of RGPP as a gene delivery carrier, we here assessed the transfection efficiency of RGPP on gene plasmids and siRNA in 11 different cell lines. Commercial polyalkyleneimine cation transfection reagent (TR) was used as comparison. In HepG2 cells, RGPP exhibited much stronger delivery ability for siRNA and large size plasmids than TR. For green fluorescent protein (GFP) plasmid, RGPP showed about 47.1% of transfection efficiency in primary rabbit articular chondrocytes, and about 27% of transfection efficiency in both SH-SY5Y and A549 cell lines. RGPP exhibited about 37.2% of GFP plasmid transfection efficiency in EMT6 cells and about 26.0% of GFP plasmid transfection efficiency in LO2 cells, but induced about 33% of cytotoxicity in both cell lines. In 4T1 and H9C2 cell lines, RGPP had less than 10% of GFP plasmid transfection efficiency. Collectively, RGPP is a potential nano-carrier for high-efficiency gene delivery, and needs to be further optimized for different cell lines.	[Wu, Liping; Xie, Jinshan; Li, Tan; Mai, Zihao; Wang, Lu; Chen, Tongsheng] South China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Xie, Jinshan; Wang, Xiaoping] Jinan Univ, Affiliated Hosp 1, Dept Pain Management, Guangzhou, Guangdong, Peoples R China	Chen, TS (reprint author), South China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.; Wang, XP (reprint author), Jinan Univ, Affiliated Hosp 1, Dept Pain Management, Guangzhou, Guangdong, Peoples R China.	txp2938@jnu.edu.cn; chentsh@scnu.edu.cn			National Natural Science Foundation of China [61527825, 81471699]; Guangdong Province Science and Technology Plan Project [2014B090901060]	This work was supported by the National Natural Science Foundation of China (61527825 and 81471699) and the Guangdong Province Science and Technology Plan Project (2014B090901060).	Bieber T, 2002, J CONTROL RELEASE, V82, P441, DOI 10.1016/S0168-3659(02)00129-3; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Burnett JC, 2012, CURR OPIN IMMUNOL, V24, P625, DOI 10.1016/j.coi.2012.08.013; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cerutti H, 2011, EUKARYOT CELL, V10, P1164, DOI 10.1128/EC.05106-11; Collins BC, 2013, NAT METHODS, V10, P1246, DOI [10.1038/nmeth.2703, 10.1038/NMETH.2703]; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Dyer MR, 2000, MOL THER, V1, P213, DOI 10.1006/mthe.2000.0044; Feng LZ, 2013, SMALL, V9, P1989, DOI 10.1002/smll.201202538; Feng LZ, 2011, NANOSCALE, V3, P1252, DOI 10.1039/c0nr00680g; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; Gaidukov L, 2011, J BIOL CHEM, V286, P18452, DOI 10.1074/jbc.M111.229872; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017                                                             ; Ivanusic D, 2014, BIOTECHNIQUES, V57, P188, DOI 10.2144/000114215; Jin L, 2014, THERANOSTICS, V4, P240, DOI 10.7150/thno.6914; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Kim H, 2014, SMALL, V10, P117, DOI 10.1002/smll.201202636; Kim H, 2011, BIOCONJUGATE CHEM, V22, P2558, DOI 10.1021/bc200397j; Li F, 2015, J BIOMED NANOTECHNOL, V11, P1776, DOI 10.1166/jbn.2015.2151; Li T, 2016, ACS APPL MATER INTER, V8, P31311, DOI 10.1021/acsami.6b09915; Li T, 2016, J MATER CHEM B, V4, P2972, DOI 10.1039/c6tb00486e; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Maurel D, 2008, NAT METHODS, V5, P561, DOI 10.1038/NMETH.1213; Merlin JL, 2002, DRUG NEWS PERSPECT, V15, P445, DOI 10.1358/dnp.2002.15.7.840080                                                    ; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ogris M, 1998, GENE THER, V5, P1425, DOI 10.1038/sj.gt.3300745; Onuki R, 2002, P NATL ACAD SCI USA, V99, P14716, DOI 10.1073/pnas.232177599; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quan YY, 2016, FREE RADICAL BIO MED, V94, P135, DOI 10.1016/j.freeradbiomed.2016.02.026; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Ungaro F, 2003, J PHARMACEUT BIOMED, V31, P143, DOI 10.1016/S0731-7085(02)00571-X                                                   ; Wang CY, 2016, RSC ADV, V6, P22461, DOI 10.1039/c5ra21475k; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wong JKL, 2017, TRENDS BIOTECHNOL, V35, P434, DOI 10.1016/j.tibtech.2016.12.009; Xu XM, 2008, J BIOMED MATER RES A, V84A, P1038, DOI 10.1002/jbm.a.31479; Yan L, 2013, CARBON, V57, P120, DOI 10.1016/j.carbon.2013.01.042; Yin D, 2016, ONCOL RES, V23, P229, DOI 10.3727/096504016X14550280421449; Yin D, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/10/105102; Yin WX, 2005, ANAL BIOCHEM, V346, P289, DOI 10.1016/j.ab.2005.08.029; Zhang C, 2004, METHODS, V33, P144, DOI 10.1016/j.ymeth.2003.11.004; Zhang J, 2013, PART PART SYST CHAR, V30, P794, DOI 10.1002/ppsc.201300107; Zhang LM, 2013, J MATER CHEM B, V1, P749, DOI 10.1039/c2tb00096b; Zhang ZY, 2011, ACTA BIOCHIM POL, V58, P297; Zhao CB, 2014, CELL SIGNAL, V26, P2223, DOI 10.1016/j.cellsig.2014.07.001; Lagunavicius ZA, 2010, US Patent, Patent No. [20100041739., 20100041739]	59	0	0	15	15	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	2054-5703			ROY SOC OPEN SCI	R. Soc. Open Sci.	OCT	2017	4	10							170822	10.1098/rsos.170822				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FL1HP	WOS:000413965600030	29134085	gold			2018-01-05	
J	Ibragimov, AN; Kozlov, EN; Kurbidaeva, AS; Ryabichko, SS; Shidlovskii, YV				Ibragimov, A. N.; Kozlov, E. N.; Kurbidaeva, A. S.; Ryabichko, S. S.; Shidlovskii, Yu. V.			Current technics for visualizing RNA in a cell	RUSSIAN JOURNAL OF GENETICS			English	Article						RNA visualization; aptamers; CRISPR-Cas; FISH; RNA-binding proteins	GREEN FLUORESCENT PROTEIN; MATERNAL MESSENGER-RNA; CRISPR-CAS SYSTEMS; LIVING CELLS; XENOPUS OOCYTES; IN-SITU; ADAPTIVE IMMUNITY; BINDING PROTEINS; GENE-EXPRESSION; DROSOPHILA EMBRYOS	The study of RNA functions in a cell is based on the methods of labeling and detection of these molecules. In recent years, considerable progress has been made in this area, making it possible to detect RNA in amounts to one molecule with high specificity and to track the dynamics of spatial RNA distribution in the living cell. The review presents the latest developments in the field of in situ hybridization and the use of RNA aptamers and RNA-binding proteins. The prospects of using the CRISPR-Cas system for RNA visualization are discussed in detail.	[Ibragimov, A. N.; Kozlov, E. N.; Kurbidaeva, A. S.; Ryabichko, S. S.; Shidlovskii, Yu. V.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Shidlovskii, Yu. V.] Sechenov First Moscow State Med Univ, Dept Biol & Gen Genet, Moscow 119048, Russia	Shidlovskii, YV (reprint author), Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia.; Shidlovskii, YV (reprint author), Sechenov First Moscow State Med Univ, Dept Biol & Gen Genet, Moscow 119048, Russia.	yul.biogen@gmail.com			Ministry of Education and Science of the Russian Federation [14.613.21.0036, RFMEFI61315X0036]	This study was supported by the Ministry of Education and Science of the Russian Federation (grant no. 14.613.21.0036) (unique identifier of the project RFMEFI61315X0036).	Abil Z, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-7; Abudayyeh O.O., 2016, SCIENCE, V1, P417, DOI [10.1101/054742, DOI 10.1101/054742]; AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; Amrute-Nayak M, 2012, NAT CELL BIOL, V14, P416, DOI 10.1038/ncb2446; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bothma JP, 2014, P NATL ACAD SCI USA, V111, P10598, DOI 10.1073/pnas.1410022111; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dolgosheina EV, 2014, ACS CHEM BIOL, V9, P2412, DOI 10.1021/cb500499x; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Filipovska A, 2011, RNA BIOL, V8, P978, DOI 10.4161/rna.8.6.17907; Filonov GS, 2015, CHEM BIOL, V22, P649, DOI 10.1016/j.chembiol.2015.04.018; Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x; Fontenete S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125494; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gaspar I, 2015, WIRES DEV BIOL, V4, P135, DOI 10.1002/wdev.170; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Haim-Vilmovsky L, 2011, RNA, V17, P2249, DOI 10.1261/rna.029637.111; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hansen CH, 2013, NAT METHODS, V10, P869, DOI [10.1038/nmeth.2601, 10.1038/NMETH.2601]; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Huang H, 2014, NAT CHEM BIOL, V10, P686, DOI [10.1038/NCHEMBIO.1561, 10.1038/nchembio.1561]; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; JEFFERY WR, 1983, DEV BIOL, V99, P408, DOI 10.1016/0012-1606(83)90290-7; JEFFERY WR, 1985, DEV BIOL, V110, P217, DOI 10.1016/0012-1606(85)90078-8; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jung J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks837; Katz ZB, 2012, GENE DEV, V26, P1885, DOI 10.1101/gad.190413.112; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Lange S, 2008, TRAFFIC, V9, P1256, DOI 10.1111/j.1600-0854.2008.00763.x; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; LEHMANN R, 1991, DEVELOPMENT, V112, P679; LITMAN P, 1994, NEURON, V13, P1463, DOI 10.1016/0896-6273(94)90432-4                                                    ; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Lubeck E, 2014, NAT METHODS, V11, P360, DOI 10.1038/nmeth.2892; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mannack L.V., 2016, F1000RESEARCH, V5, P775; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0                                                                ; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; MOWRY KL, 1992, SCIENCE, V255, P991, DOI 10.1126/science.1546297; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Okuda M, 2017, NUCLEIC ACIDS RES, V45, P1404, DOI 10.1093/nar/gkw794; Oomoto I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv614; Ouellet J, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00029; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rath AK, 2015, CURR OPIN BIOTECH, V31, P42, DOI 10.1016/j.copbio.2014.07.012; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158                                                           ; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Shank NI, 2013, J AM CHEM SOC, V135, P242, DOI 10.1021/ja308629w; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Strack RL, 2013, NAT METHODS, V10, P1219, DOI [10.1038/NMETH.2701, 10.1038/nmeth.2701]; Valencia-Burton M, 2007, NAT METHODS, V4, P421, DOI 10.1038/NMETH1023; Wang Y, 2013, FEBS J, V280, P3755, DOI 10.1111/febs.12367; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Warner KD, 2014, NAT STRUCT MOL BIOL, V21, P658, DOI 10.1038/nsmb.2865; Weatheritt RJ, 2014, NAT STRUCT MOL BIOL, V21, P833, DOI 10.1038/nsmb.2876; Weibrecht I, 2013, NAT PROTOC, V8, P355, DOI 10.1038/nprot.2013.006; Weil TT, 2008, CURR BIOL, V18, P1055, DOI 10.1016/j.cub.2008.06.046; Wu B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03615; Xiao Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh024; Yamada T, 2011, ANAL CHEM, V83, P5708, DOI 10.1021/ac2009405; YISRAELI JK, 1988, NATURE, V336, P592, DOI 10.1038/336592a0                                                                ; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; You MX, 2015, ANNU REV BIOPHYS, V44, P187, DOI 10.1146/annurev-biophys-060414-033954; Zhang JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17295; Zhang WJ, 2013, J MOL DIAGN, V15, P754, DOI 10.1016/j.jmoldx.2013.06.005; Zhang ZJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01775	101	0	0	3	3	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1022-7954	1608-3369		RUSS J GENET+	Russ. J. Genet.	OCT	2017	53	10					1080	1090		10.1134/S1022795417100040				11	Genetics & Heredity	Genetics & Heredity	FJ8DN	WOS:000412992200003					2018-01-05	
J	Borland, MG; Yao, PL; Kehres, EM; Lee, C; Pritzlaff, AM; Ola, E; Wagner, AL; Shannon, BE; Albrecht, PP; Zhu, BK; Kang, BH; Robertson, GP; Gonzalez, FJ; Peters, JM				Borland, Michael G.; Yao, Pei-Li; Kehres, Ellen M.; Lee, Christina; Pritzlaff, Amanda M.; Ola, Elizabeth; Wagner, Ashley L.; Shannon, Brooke E.; Albrecht, Prajakta P.; Zhu, Bokai; Kang, Boo-Hyon; Robertson, Gavin P.; Gonzalez, Frank J.; Peters, Jeffrey M.			Editor's Highlight: PPAR beta/delta and PPAR gamma Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis	TOXICOLOGICAL SCIENCES			English	Article						peroxisome proliferator-activated receptor-beta; delta; (PPAR beta; delta); peroxisome proliferator-activated receptor-gamma; (PPAR gamma); melanoma; cell proliferation; xenografts; cancer	ACTIVATED-RECEPTOR-BETA/DELTA; HUMAN HACAT KERATINOCYTES; CELLS IN-VITRO; CANCER-CELLS; MALIGNANT-MELANOMA; HUMAN MELANOCYTES; EXPRESSION; LIGANDS; DELTA; PROLIFERATION	Skin tumorigenesis results from DNA damage, increased inflammation, and evasion of apoptosis. The peroxisome proliferator-activated receptors (PPARs) can modulate these mechanisms in non-melanoma skin cancer. However, limited data exists regarding the role of PPARs in melanoma. This study examined the effect of proliferator-activated receptor-beta/delta (PPAR beta/delta) and PPAR gamma on cell proliferation, anchorage-dependent clonogenicity, and ectopic xenografts in the UACC903 human melanoma cell line. Stable overexpression of either PPAR beta/delta or PPAR gamma enhanced ligand-induced expression of a PPAR beta/delta/PPAR gamma target gene in UACC903 cell lines as compared with controls. The induction of target gene expression by ligand activation of PPAR gamma was not altered by overexpression of PPAR beta/delta, or vice versa. Stable overexpression of either PPAR beta/delta or PPAR gamma reduced the percentage of cells in the G1 and S phase of the cell cycle, and increased the percentage of cells in the G2/M phase of the cell cycle in UACC903 cell lines as compared with controls. Ligand activation of PPAR beta/delta did not further alter the distribution of cells within each phase of the cell cycle. By contrast, ligand activation of PPAR gamma enhanced these changes in stable UACC903 cells overexpressing PPAR gamma compared with controls. Stable overexpression of either PPAR beta/delta or PPAR gamma and/or ligand activation of either PPAR beta/delta or PPAR gamma inhibited cell proliferation, and anchorage-dependent clonogenicity of UACC903 cell lines as compared with controls. Further, overexpression of either PPAR beta/delta or PPAR gamma and/or ligand activation of either PPAR beta/delta or PPAR gamma inhibited ectopic xenograft tumorigenicity derived from UACC903 melanoma cells as compared with controls, and this was likely due in part to induction of apoptosis. Results from these studies demonstrate the antitumorigenic effects of both PPAR beta/delta and PPAR gamma and suggest that targeting these receptors may be useful for primary or secondary melanoma chemoprevention.	[Borland, Michael G.; Yao, Pei-Li; Lee, Christina; Albrecht, Prajakta P.; Zhu, Bokai; Peters, Jeffrey M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Borland, Michael G.; Kehres, Ellen M.; Pritzlaff, Amanda M.; Ola, Elizabeth; Wagner, Ashley L.; Shannon, Brooke E.] Bloomsburg Univ Penn, Dept Chem & Biochem, Bloomsburg, PA 17815 USA; [Kang, Boo-Hyon] Nonclin Res Inst, Yongin 17162, Gyeonggi Do, South Korea; [Robertson, Gavin P.] Penn State Univ, Melanoma & Skin Canc Ctr, Dept Pharmacol, Hershey, PA 17033 USA; [Robertson, Gavin P.] Penn State Univ, Melanoma & Skin Canc Ctr, Dept Pathol, Hershey, PA 17033 USA; [Robertson, Gavin P.] Penn State Univ, Melanoma & Skin Canc Ctr, Dept Dermatol, Hershey, PA 17033 USA; [Robertson, Gavin P.] Penn State Univ, Melanoma & Skin Canc Ctr, Dept Surg, Hershey, PA 17033 USA; [Robertson, Gavin P.] Penn State Univ, Melanoma Therapeut Program, Hershey, PA 17033 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA	Peters, JM (reprint author), Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA.	jmp21@psu.edu			National Institutes of Health [CA124533, CA140369]; Bloomsburg University (BU) Academic Enhancement Funds; BU Research & Scholarship Grant; BU Margin of Excellence Grant	This work supported in part by the National Institutes of Health (CA124533, CA140369, J.M.P.), Bloomsburg University (BU) Academic Enhancement Funds (M.G.B. and E.M.K.), a BU Research & Scholarship Grant (M.G.B.), and a BU Margin of Excellence Grant (M.G.B.).	Ahmed N, 2008, BRIT J CANCER, V98, P1415, DOI 10.1038/sj.bjc.6604306; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Borland MG, 2008, MOL PHARMACOL, V74, P1429, DOI 10.1124/mol.108.050609; Borland MG, 2011, CELL SIGNAL, V23, P2039, DOI 10.1016/j.cellsig.2011.07.020; Botton T, 2009, J INVEST DERMATOL, V129, P1208, DOI 10.1038/jid.2008.346; Chen J. H., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/695797; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Eastham LL, 2008, PHARM RES, V25, P1327, DOI 10.1007/s11095-007-9524-9; Errington TM, 2014, ELIFE, V3, DOI 10.7554/eLife.04333; Foreman JE, 2011, MOL CARCINOGEN, V50, P884, DOI 10.1002/mc.20757; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Franklin C, 2017, EJSO-EUR J SURG ONC, V43, P604, DOI 10.1016/j.ejso.2016.07.145; Freudlsperger C, 2007, ANTICANCER RES, V27, P207; Freudlsperger C, 2006, ANTI-CANCER DRUG, V17, P325, DOI 10.1097/00001813-200603000-00011; Freudlsperger C, 2008, PPAR RES, DOI 10.1155/2008/503797; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Girroir EE, 2008, TOXICOLOGY, V243, P236, DOI 10.1016/j.tox.2007.10.023; Hager GL, 2012, BBA-GENE REGUL MECH, V1819, P631, DOI 10.1016/j.bbagrm.2012.05.002; Ham SA, 2014, AM J CANCER RES, V4, P674; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Howlader N, 1975, SEER CANC STAT REV; Kang HY, 2004, BRIT J DERMATOL, V150, P462, DOI 10.1111/j.1365-2133.2004.05844.x                                                ; Klopper JP, 2010, PPAR RES, DOI 10.1155/2010/729876; Klopper JP, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-16; Kunz M, 2014, EUR J CELL BIOL, V93, P1, DOI 10.1016/j.ejcb.2013.12.002; Meyer S, 2010, PPAR RES, DOI 10.1155/2010/848645; Michiels JF, 2010, PFLUG ARCH EUR J PHY, V459, P689, DOI 10.1007/s00424-009-0776-6; Mossner R, 2002, J INVEST DERMATOL, V119, P576, DOI 10.1046/j.1523-1747.2002.01861.x; Nunez NP, 2006, CANCER LETT, V236, P133, DOI 10.1016/j.canlet.2005.05.009; Papi A, 2009, ONCOL REP, V21, P1083, DOI 10.3892/or_00000327; Paulitschke V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046103; Pear WS, 1998, BLOOD, V92, P3780; Peters JM, 2015, TRENDS ENDOCRIN MET, V26, P595, DOI 10.1016/j.tem.2015.09.004; Peters Jeffrey M, 2015, Curr Pharmacol Rep, V1, P121; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Placha W, 2003, MELANOMA RES, V13, P447, DOI 10.1097/01.cmr.0000056270.56735.d3; Sertznig P, 2008, AM J CLIN DERMATOL, V9, P15, DOI 10.2165/00128071-200809010-00002                                                ; Sertznig P, 2009, ANTICANCER RES, V29, P3647; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Shtivelman E, 2014, ONCOTARGET, V5, P1701, DOI 10.18632/oncotarget.1892                                                        ; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Wang D, 2012, ONCOGENE, V31, P1013, DOI 10.1038/onc.2011.299; Yao PL, 2017, MOL CARCINOGEN, V56, P1472, DOI 10.1002/mc.22607; Yao PL, 2015, ONCOTARGET, V6, P36319, DOI 10.18632/oncotarget.5415; Yao PL, 2014, MOL CANCER THER, V13, P1008, DOI 10.1158/1535-7163.MCT-13-0836; Zhang TW, 2016, PIGM CELL MELANOMA R, V29, P266, DOI 10.1111/pcmr.12459; Zhu B, 2014, ONCOGENE, V33, P5348, DOI 10.1038/onc.2013.477; Zhu BK, 2012, MOL CELL BIOL, V32, P2065, DOI 10.1128/MCB.00092-12	50	0	0	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	OCT	2017	159	2					436	448		10.1093/toxsci/kfx147				13	Toxicology	Toxicology	FI7UI	WOS:000412203900013	28962521				2018-01-05	
J	Nordgren, KKS; Hampton, M; Wallace, KB				Nordgren, Kendra K. S.; Hampton, Marshall; Wallace, Kendall B.			Editor's Highlight: The Altered DNA Methylome of Chronic Doxorubicin Exposure in Sprague Dawley Rats	TOXICOLOGICAL SCIENCES			English	Article						doxorubicin; methylation; epigenetics; Rbm20; Nmnat2; Klhl29	FAMILIAL DILATED CARDIOMYOPATHY; ACUTE LYMPHOBLASTIC-LEUKEMIA; CONGESTIVE-HEART-FAILURE; GENE-EXPRESSION PROFILE; MITOCHONDRIAL-DNA; CARDIOVASCULAR-DISEASE; ATRIAL-FIBRILLATION; BRUGADA-SYNDROME; MUTATIONS; CARDIOTOXICITY	Doxorubicin (DOX) is a widely used treatment for human cancers, but increases the risk of life-threatening congestive heart failure (CHF). DOX-induced mitochondrial damage is cumulative and persistent, similar to that observed clinically for risk of CHF. Recent evidence suggests the persistent nature of this injury is caused by altered regulation of genes important to normal cardiac functioning. We hypothesize that chronic DOX therapy is associated with epigenetic modifications of DNA methylation status, particularly in critical regulators of mitochondrial function and capacity. Cardiac tissue from Sprague Dawley rats receiving injections of DOX (2 mg/kg, s.c.) or saline once a week for 6 weeks, followed by 5 weeks of drug-free holiday was used for Reduced Representation Bisulfite Sequencing to map specific sites of DNA methylation. Comparison of these methylomes indicated DOX exposure alters DNA methylation landscapes, and identified 14 genes with highly altered methylation status. Preliminary functional effects of DNA methylation changes were characterized by quantifying mRNA expression of selected targets (Rbm20, Nmnat2, Klhl29, Cacna1c, Scn5a.) Gene expression of Rbm20, Klhl29, and Nmnat2 were significantly altered in DOX treated animals; Klhl29 and Nmnat2 demonstrated significant decreases in protein expression corresponding to gene expression. Through an epigenotype-to-phenotype approach, this study identifies potential markers and molecular regulators of irreversible DOX-induced cardiovascular toxicity associated with clinically limiting CHF. However, none of the most prevalent genes identified directly relate to mitochondrial structure or function. Thus, the investigation fails to demonstrate a direct association between this altered methylome and persistent mitochondrionopathy associated with chronic doxorubicin cardiac toxicity.	[Nordgren, Kendra K. S.; Wallace, Kendall B.] Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth Campus,1035 Univ Dr,211 SMed, Duluth, MN 55812 USA; [Hampton, Marshall] Univ Minnesota Duluth, Dept Math, Duluth, MN 55812 USA	Nordgren, KKS (reprint author), Univ Minnesota, Sch Med, Dept Biomed Sci, Duluth Campus,1035 Univ Dr,211 SMed, Duluth, MN 55812 USA.	knordgre@d.umn.edu			Whiteside Institute for Clinical Research; 3M Company; MN Drive	Whiteside Institute for Clinical Research, the 3M Company, and MN Drive.	BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Berthiaume JM, 2007, CARDIOVASC TOXICOL, V7, P178, DOI 10.1007/s12012-007-0026-0; Bezzina CR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P80, DOI 10.1161/CIRCEP.108.791434; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Cai Y, 2012, FEBS LETT, V586, P866, DOI 10.1016/j.febslet.2012.02.014; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carvalho RA, 2010, TOXICOLOGY, V270, P92, DOI 10.1016/j.tox.2010.01.019; Chan KHK, 2014, CIRC-CARDIOVASC GENE, V7, P911, DOI 10.1161/CIRCGENETICS.114.000676; Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; Dejeux E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-68; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Fettig P, 2006, FASEB J, V20, pA1188; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Frustaci A, 2005, CIRCULATION, V112, P3680, DOI 10.1161/CIRCULATIONAHA.105.520999; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Ge JB, 2008, CIRC-ARRHYTHMIA ELEC, V1, P83, DOI 10.1161/CIRCEP.107.750752; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gottesman O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046419; Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693; Halder I, 2016, J AM COLL CARDIOL, V67, P1391, DOI 10.1016/S0735-1097(16)31392-4                                                   ; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Hsu CP, 2008, BIOL CHEM, V389, P221, DOI 10.1515/BC.2008.032; Kai Y, 2006, MITOCHONDRION, V6, P299, DOI 10.1016/j.mito.2006.10.002; Klajic J, 2014, CLIN CANCER RES, V20, P6357, DOI 10.1158/1078-0432.CCR-14-0297; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li DX, 2010, CTS-CLIN TRANSL SCI, V3, P90, DOI 10.1111/j.1752-8062.2010.00198.x; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; Maatz H, 2014, J CLIN INVEST, V124, P3419, DOI 10.1172/JCI74523; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; METTLER FP, 1977, CANCER RES, V37, P2705; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra1105239; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447                                                          ; Palmeira CM, 1997, BBA-BIOENERGETICS, V1321, P101, DOI 10.1016/S0005-2728(97)00055-8; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Serrano J, 1999, BBA-BIOENERGETICS, V1411, P201, DOI 10.1016/S0005-2728(99)00011-0; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Sorensen K, 1997, J CLIN ONCOL, V15, P61, DOI 10.1200/JCO.1997.15.1.61                                                        ; Szikriszt B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0963-7; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wallace KB, 2007, CARDIOVASC TOXICOL, V7, P101, DOI 10.1007/s12012-007-0008-2; Wilde AAM, 2005, HEART, V91, P1352, DOI 10.1136/hrt.2004.046334; Wyles SP, 2016, HUM MOL GENET, V25, P254, DOI 10.1093/hmg/ddv468; Yong WS, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0075-3; Zhang Y, 2011, INT J CANCER, V128, P551, DOI 10.1002/ijc.25365; Zheng TY, 2011, CURR EYE RES, V36, P449, DOI 10.3109/02713683.2011.559301; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0; Zhou SY, 2001, CANCER RES, V61, P771; Zima AV, 2004, J PHYSIOL-LONDON, V555, P727, DOI 10.1113/jphysiol.2003.055848	61	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	OCT	2017	159	2					470	479		10.1093/toxsci/kfx150				10	Toxicology	Toxicology	FI7UI	WOS:000412203900016	28962528				2018-01-05	
J	Wahid, B; Usman, S; Ali, A; Saleem, K; Rafique, S; Naz, Z; Ashfaq, HA; Idrees, M				Wahid, Braira; Usman, Sana; Ali, Amjad; Saleem, Komal; Rafique, Shazia; Naz, Zara; Ashfaq, Hafiz Ahsan; Idrees, Muhammad			Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections	VIRAL IMMUNOLOGY			English	Review						CRISPR-Cas; HPV; HIV; HSV; HCV; HBV; JCV; antiviral defense	EPSTEIN-BARR-VIRUS; HEPATITIS-B-VIRUS; INHIBIT HIV-1 REPLICATION; RNA-GUIDED ENDONUCLEASE; CRISPR/CAS9 SYSTEM; HUMAN-CELLS; IN-VIVO; GENOME; GENE; CRISPR-CAS9	The clustered regularly interspaced palindromic repeats (CRISPR)/Cas systems have rapidly transitioned from intriguing prokaryotic defense systems to an efficient therapeutic tool. This cutting-edge technology is currently revolutionizing to combat hostile viruses because of its reproducibility, high potency, ease of use, limited off-target activity, and development of quick immune response against viruses. CRISPR gene editing technology eliminates the virus by breaking the DNA that ultimately halts viral replication. This review summarizes the advancements that have been made in the use of CRISPR-Cas technology in viral therapeutics.	[Wahid, Braira; Usman, Sana; Ali, Amjad; Saleem, Komal; Ashfaq, Hafiz Ahsan; Idrees, Muhammad] Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore 5400, Pakistan; [Rafique, Shazia] Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; [Idrees, Muhammad] Vice Chancellor Hazara Univ, Mansehra, Pakistan	Ali, A (reprint author), Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore 5400, Pakistan.	amjad.camb@pu.edu.pk					Aubert M, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.75; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bi HL, 2016, INSECT SCI, V23, P469, DOI 10.1111/1744-7917.12341; Block TM, 2015, ANTIVIR RES, V121, P69, DOI 10.1016/j.antiviral.2015.06.014; Carte J, 2014, MOL MICROBIOL, V93, P98, DOI 10.1111/mmi.12644; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Chen XZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000792; Cohen JI, 2009, PEDIATR TRANSPLANT, V13, P393, DOI 10.1111/j.1399-3046.2008.01095.x; Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hedskog C, 2015, J VIRAL HEPATITIS, V22, P871, DOI 10.1111/jvh.12405; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hu Z, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/612823; Kennedy EM, 2015, VIROLOGY, V479, P213, DOI 10.1016/j.virol.2015.02.024; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liang X, 2016, SCI REP, V6, P1038; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Maldarelli C., 2016, POPULAR SCI; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146; Saayman S, 2015, EXPERT OPIN BIOL TH, V15, P819, DOI 10.1517/14712598.2015.1036736; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Senis E, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw805; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sohn JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008093; Tang YD, 2016, VIRUS RES, V225, P33, DOI 10.1016/j.virusres.2016.09.004; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; Wahid B, 2017, EUR J GASTROEN HEPAT, V29, P979, DOI 10.1097/MEG.0000000000000895; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; White MK, 2014, CLIN MICROBIOL REV, V27, P463, DOI 10.1128/CMR.00124-13; [Anonymous], 2017, GLOB HLTH OBS GHO DA; Wollebo HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136046; Xu AT, 2015, BIOTECHNOL LETT, V37, P1265, DOI 10.1007/s10529-015-1796-2; Young SAM, 2015, ASIAN J ANDROL, V17, P623, DOI 10.4103/1008-682X.153851; Yu L, 2015, ONCOTARGETS THER, V8, P37, DOI 10.2147/OTT.S64092; Yuan M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030072; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zhang HM, 2016, ENDOCR PRACT, V22, P412, DOI 10.4158/EP15994.OR; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zheng ZM, 2006, FRONT BIOSCI, V11, P2286, DOI 10.2741/1971; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z	61	0	0	6	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0882-8245	1557-8976		VIRAL IMMUNOL	Viral Immunol.	OCT	2017	30	8					552	559		10.1089/vim.2017.0055				8	Immunology; Virology	Immunology; Virology	FJ3RH	WOS:000412648900003	28825529				2018-01-05	
J	Zentner, GE; Wade, MJ				Zentner, Gabriel E.; Wade, Michael J.			The promise and peril of CRISPR gene drives Genetic variation and inbreeding may impede the propagation of gene drives based on the CRISPR genome editing technology	BIOESSAYS			English	Review						Cas9; CRISPR; daisy drive; gene drive; homing endonuclease; segregation distortion	EFFECT SELFISH GENES; DROSOPHILA-MELANOGASTER; BACILLUS-THURINGIENSIS; NUCLEASE SPECIFICITY; POPULATION-STRUCTURE; NATURAL-POPULATIONS; MALARIA MOSQUITO; AEDES-ALBOPICTUS; MEIOTIC DRIVE; VECTOR	Gene drives are selfish genetic elements that use a variety of mechanisms to ensure they are transmitted to subsequent generations at greater than expected frequencies. Synthetic gene drives based on the clustered regularly interspersed palindromic repeats (CRISPR) genome editing system have been proposed as a way to alter the genetic characteristics of natural populations of organisms relevant to the goals of public health, conservation, and agriculture. Here, we review the principles and potential applications of CRISPR drives, as well as means proposed to prevent their uncontrolled spread. We also focus on recent work suggesting that factors such as natural genetic variation and inbreeding may represent substantial impediments to the propagation of CRISPR drives.	[Zentner, Gabriel E.; Wade, Michael J.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Wade, MJ (reprint author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mjwade@indiana.edu			Indiana University startup funds; Indiana University Faculty Research Support Program	This work was supported by Indiana University startup funds (to GEZ) and the Indiana University Faculty Research Support Program (to GEZ and MJW).	Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Beeman RW, 1999, HEREDITY, V82, P529, DOI 10.1038/sj.hdy.6885150; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; BULL JJ, 2017, EVOL MED PUBLIC HLTH, V2017, P1, DOI DOI 10.1093/EMPH/E0W030; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2009, GENES CONFLICT BIOL; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Champer J, 2017, BIORXIV; Champer J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006796; Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074254; Charlesworth B., 2010, ELEMENTS EVOLUTIONAR; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CRAIG GB, 1960, SCIENCE, V132, P1887, DOI 10.1126/science.132.3443.1887; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Donnelly MJ, 1999, HEREDITY, V83, P408, DOI 10.1038/sj.hdy.6885930; Drury DW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601910; Duke SO, 2017, PEST MANAGE SCI; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Galizi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31139; Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977; Gantz VM, 2016, BIOESSAYS, V38, P50, DOI 10.1002/bies.201500102; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Godfray H.C.J., 1997, P211, DOI 10.1017/CBO9780511721946.013; Gotelli NJ, 2000, ECOL LETT, V3, P257, DOI 10.1046/j.1461-0248.2000.00138.x; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; HARTL DL, 1970, EVOLUTION, V24, P538, DOI 10.1111/j.1558-5646.1970.tb01789.x; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545                                                                ; Ihle S, 2006, MOL BIOL EVOL, V23, P790, DOI 10.1093/molbev/msj096; Jacobs MS, 2003, AM NAT, V161, P837, DOI 10.1086/375174; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Larracuente AM, 2012, GENETICS, V192, P33, DOI 10.1534/genetics.112.141390; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; Marshall JM, 2009, J THEOR BIOL, V258, P250, DOI 10.1016/j.jtbi.2009.01.031; Min J, 2017, BIORXIV; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; National Academies of Sciences Engineering and Medicine, 2016, GEN DRIV HOR ADV SCI; Noble C, 2016, BIORXIV; Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964; Olorunniji FJ, 2016, BIOCHEM J, V473, P673, DOI 10.1042/BJ20151112; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; RAJU NB, 1994, MYCOLOGIA, V86, P461, DOI 10.2307/3760737; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969                                                                  ; Schimenti J, 2000, TRENDS GENET, V16, P240, DOI 10.1016/S0168-9525(00)02020-5; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; Siegwart M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00381; Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Takeuchi R, 2014, P NATL ACAD SCI USA, V111, P4061, DOI 10.1073/pnas.1321030111; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491                                                       ; Vella MR, 2017, BIORXIV; WADE MJ, 1994, GENETICS, V138, P1309; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587                                                   ; World Health Organization, 2016, FACT SHEET WORLD MAL; World Health Organization, 2016, VECT BORN DIS; WILLIS ER, 1950, J ECON ENTOMOL, V43, P927, DOI 10.1093/jee/43.6.927                                                            ; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Wu B, 2016, NAT BIOTECHNOL, V34, P137, DOI 10.1038/nbt.3444; Wu Xuebing, 2014, Quant Biol, V2, P59; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Yuval B, 2006, ANNU REV ENTOMOL, V51, P413, DOI 10.1146/annurev.ento.51.110104.151058; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; [Anonymous], 1975, NATURE, V256, P355	81	0	0	31	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0265-9247	1521-1878		BIOESSAYS	Bioessays	OCT	2017	39	10							1700109	10.1002/bies.201700109				9	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	FI2EL	WOS:000411750400009					2018-01-05	
J	D'Agati, G; Beltre, R; Sessa, A; Burger, A; Zhou, Y; Mosimann, C; White, RM				D'Agati, Gianluca; Beltre, Rosanna; Sessa, Anna; Burger, Alexa; Zhou, Yi; Mosimann, Christian; White, Richard M.			A defect in the mitochondrial protein Mpv17 underlies the transparent casper zebrafish	DEVELOPMENTAL BIOLOGY			English	Article							DNA DEPLETION; NEURAL-CREST; WEB TOOL; ENCODES; CRISPR/CAS9; MUTAGENESIS; CHOPCHOP	The casper strain of zebrafish is widely used in studies ranging from cancer to neuroscience. casper offers the advantage of relative transparency throughout adulthood, making it particularly useful for in vivo imaging by epifluorescence, confocal, and light sheet microscopy. casper was developed by selective breeding of two previously described recessive pigment mutants: 1) nacre, which harbors an inactivating mutation of the mitfa gene, rendering the fish devoid of pigmented melanocytes; and 2) roy orbison, a mutant with a so-far unidentified genetic cause that lacks reflective iridophores. To clarify the molecular nature of the roy orbison mutation, such that it can inform studies using casper, we undertook an effort to positionally clone the roy orbison mutation. We find that roy orbison is caused by an intronic defect in the gene mpvl 7, encoding an inner mitochondrial membrane protein that has been implicated in the human mitochondrial DNA depletion syndrome. The roy orbison mutation is phenotypically and molecularly remarkably similar to another zebrafish iridophore mutant called transparent. Using Cas9-induced crispants and germline mutants with a disrupted mpv17 open reading frame, we show in trans-heterozygote embryos that new frameshift alleles of mpv17, roy orbison, and transparent fail to complement each other. Our work provides genetic evidence that both roy orbison and transparent affect the mpv17 locus by a similar if not identical genetic lesion. Identification of mpv17 mutants will allow for further work probing the relationship between mitochondrial function and pigmentation, which has to date received little attention.	[D'Agati, Gianluca; Burger, Alexa; Mosimann, Christian] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Beltre, Rosanna; Sessa, Anna; Zhou, Yi] Childrens Hosp, Hematol &Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [White, Richard M.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA; [White, Richard M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	Mosimann, C (reprint author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.; White, RM (reprint author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	christian.mosimann@imls.uzh.ch; whiter@mskcc.org			Canton of Zikich and the Foundation for Research in Science; Humanities at the University of Ziirich; Swiss National Science Foundation (SNSF) professorship [PPOOP3_139093]; Marie Curie Career Integration Grant from the European Commission [CIG PCIG14-GA-2013-631984]; UM URPP "Translational Cancer Research"; Swiss Cancer League research; Swiss Bridge Foundation; UZH CanDoc Forschungskredit; NIH Director's New Innovator Award [DP2CA186572]; Mentored Clinical Scientist Research Career Development Award [K08AR055368]; Melanoma Research Alliance Young Investigator Award; Alan and Sandra Gerry Metastasis Research; Harry J. Lloyd Foundation	This work was supported by the Canton of Zikich and the Foundation for Research in Science and the Humanities at the University of Ziirich, a Swiss National Science Foundation (SNSF) professorship [PPOOP3_139093] and a Marie Curie Career Integration Grant from the European Commission [CIG PCIG14-GA-2013-631984] to CM.; an UM URPP "Translational Cancer Research" grant to A.B.; a Swiss Cancer League research grant and funding by the Swiss Bridge Foundation to C.M. and A.B. a UZH CanDoc Forschungskredit to G.D. The NIH Director's New Innovator Award (DP2CA186572), Mentored Clinical Scientist Research Career Development Award (K08AR055368), The Melanoma Research Alliance Young Investigator Award, The Alan and Sandra Gerry Metastasis Research Initiative at the Memorial Sloan Kettering Cancer Center, The Harry J. Lloyd Foundation and Consano (RM.W.).	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Chen EY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003727; Freeman JL, 2009, GENE CHROMOSOME CANC, V48, P155, DOI 10.1002/gcc.20623; Higdon CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067801; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lindsay H, 2016, NAT BIOTECHNOL, V34, P701, DOI 10.1038/nbt.3628; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lollgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; McGowan KA, 2016, ELIFE, V5, DOI 10.7554/eLife.14239; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Parichy DM, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12332; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; Ren JQ, 2002, VISION RES, V42, P293, DOI 10.1016/S0042-6989(01)00284-X                                                   ; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Zhou Y, 2011, METHOD CELL BIOL, V104, P287, DOI 10.1016/B978-0-12-374814-0.00016-1	21	0	0	8	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	OCT 1	2017	430	1					11	17		10.1016/j.ydbio.2017.07.017				7	Developmental Biology	Developmental Biology	FH6QP	WOS:000411302100002	28760346				2018-01-05	
J	Fok, ET; Scholefield, J; Fanucchi, S; Mhlanga, MM				Fok, Ezio T.; Scholefield, Janine; Fanucchi, Stephanie; Mhlanga, Musa M.			The emerging molecular biology toolbox for the study of long noncoding RNA biology	EPIGENOMICS			English	Review						CRISPR/Cas9; epigenetic regulation; functional genomics; gene transcription; long noncoding RNA; single molecule FISH	GREEN FLUORESCENT PROTEIN; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; X-CHROMOSOME; HUMAN GENOME; TRANSCRIPTION; CHROMATIN; CRISPR; LNCRNA; IDENTIFICATION	Long noncoding RNAs (lncRNAs) have been implicated in many biological processes. However, due to the unique nature of lncRNAs and the consequential difficulties associated with their characterization, there is a growing disparity between the rate at which lncRNAs are being discovered and the assignment of biological function to these transcripts. Here we present a molecular biology toolbox equipped to help dissect aspects of lncRNA biology and reveal functionality. We outline an approach that begins with a broad survey of genome-wide, high-throughput datasets to identify potential lncRNA candidates and then narrow the focus on specific methods that are well suited to interrogate the transcripts of interest more closely. This involves the use of imaging-based strategies to validate these candidates and observe the behaviors of these transcripts at single molecule resolution in individual cells. We also describe the use of gene editing tools and interactome capture techniques to interrogate functionality and infer mechanism, respectively. With the emergence of lncRNAs as important molecules in healthy and diseased cellular function, it remains crucial to deepen our understanding of their biology.	[Fok, Ezio T.; Scholefield, Janine; Fanucchi, Stephanie; Mhlanga, Musa M.] CSIR, Gene Express & Biophys Grp, Biosci, Pretoria, Gauteng, South Africa; [Fok, Ezio T.; Scholefield, Janine; Fanucchi, Stephanie; Mhlanga, Musa M.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Chem Syst & Synthet Biol, Cape Town, Western Cape, South Africa; [Mhlanga, Musa M.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal	Mhlanga, MM (reprint author), CSIR, Gene Express & Biophys Grp, Biosci, Pretoria, Gauteng, South Africa.; Mhlanga, MM (reprint author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Chem Syst & Synthet Biol, Cape Town, Western Cape, South Africa.; Mhlanga, MM (reprint author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	obwan@mhlangalab.org			Biomedical Translational and Research Initiative (BTRI) of the Council of Scientific and Industrial Research (CSIR); University of Cape Town (UCT) [V6GBT60]	The authors of this publication are supported by the Biomedical Translational and Research Initiative (BTRI) of the Council of Scientific and Industrial Research (CSIR) and The University of Cape Town (UCT) (project V6GBT60). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Aparicio-Prat E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2086-z; Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bose DA, 2017, CELL, V168, P135, DOI 10.1016/j.cell.2016.12.020; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dunagin M, 2015, METHODS MOL BIOL, V1262, P3, DOI 10.1007/978-1-4939-2253-6_1; Durruthy-Durruthy J, 2016, NAT GENET, V48, P44, DOI 10.1038/ng.3449; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Goyal A., 2016, NUCLEIC ACIDS RES, V45, pe12; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hargittai MRS, 2000, RNA, V6, P1672, DOI 10.1017/S135583820000128X                                                       ; Hawkes EJ, 2016, CELL REP, V16, P3087, DOI 10.1016/j.celrep.2016.08.045; Hinten M, 2016, METHODS MOL BIOL, V1402, P147, DOI 10.1007/978-1-4939-3378-5_12; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lai F, 2015, NATURE, V525, P399, DOI 10.1038/nature14906; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lennox KA, 2016, NUCLEIC ACIDS RES, V44, P863, DOI 10.1093/nar/gkv1206; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Liu YY, 2017, J BIOL CHEM, V292, P5624, DOI 10.1074/jbc.M116.769034; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P11046, DOI 10.1073/pnas.1612826113; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Paralkar VR, 2016, MOL CELL, V62, P104, DOI 10.1016/j.molcel.2016.02.029; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0                                                                ; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Shibayama Y, 2017, METHODS MOL BIOL, V1468, P19, DOI 10.1007/978-1-4939-4035-6_3; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Somarowthu S, 2015, MOL CELL, V58, P353, DOI 10.1016/j.molcel.2015.03.006; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103                                                            ; Tijerina P, 2007, NAT PROTOC, V2, P2608, DOI 10.1038/nprot.2007.380; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang YW, 2014, ELIFE, V3, DOI 10.7554/eLife.02046; Yin YF, 2015, CELL STEM CELL, V16, P504, DOI 10.1016/j.stem.2015.03.007; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715; Zhu ZR, 2014, METHOD ENZYMOL, V546, P215, DOI 10.1016/B978-0-12-801185-0.00011-8	70	0	0	8	8	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1750-1911	1750-192X		EPIGENOMICS-UK	Epigenomics	OCT	2017	9	10					1317	1327		10.2217/epi-2017-0062				11	Genetics & Heredity	Genetics & Heredity	FI1CV	WOS:000411668500006	28875715				2018-01-05	
J	Cen, Y; Timmermans, B; Souffriau, B; Thevelein, JM; Van Dijck, P				Cen, Yuke; Timmermans, Bea; Souffriau, Ben; Thevelein, Johan M.; Van Dijck, Patrick			Comparison of genome engineering using the CRISPR-Cas9 system in C. glabrata wild-type and lig4 strains	FUNGAL GENETICS AND BIOLOGY			English	Article						Candida glabrata; CRISPR-Cas9; Non-homologous end Joining	CANDIDA-GLABRATA; GENE; EPIDEMIOLOGY; YEAST	Candida glabrata is reported as the second most prevalent human opportunistic fungal pathogen in North America and is threatening patients all over the world. Its incidence is rising, while it has developed resistance to the most widely used antifungal drugs, necessitating new approaches based on better insight into the biology of the organism. Despite its close phylogenetic relationship with Saccharomyces cerevisiae, generating precise genomic alterations in this species is problematic. Previously we have shown that deletion of LIG4, which encodes an enzyme involved in Non-Homologous End Joining (NHEJ), strongly enhances the probability of obtaining correctly modified transformants. In this work we used the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR associated protein 9 (Cas9) system to genetically engineer the C. glabrata genome, targeting the genes ADE2, MET15 and SOK2, located on different chromosomes. We used the CRISPR-Cas9 technology to replace the open reading frame (ORF) by the SAT1 selective marker or introduced a premature stop codon in ADE2 and MET15,"as they are easily scored by their adenine or methionine auxotrophy, respectively. The SOK2 gene was modified by insertion of a triple HA-tag sequence and the transformants were verified in a western blot. The CRISPR-Cas9 mediated targeting efficiency varies depending on the gene targeted and the genetic modification performed. We show that CRISPR-Cas9 mediated genome editing is more efficient than the conventional method in the wild-type strain, moreover it has the big advantage being marker-free. In previous work, we showed that the targeting efficiency is highly increased in the lig4A strain using the conventional way to delete genes in C. glabrata. Using the CRISPR-Cas9 system in this strain, the percentage of correct transformants is consistently higher compared to the wild-type strain. This indicates that using the lig4 mutant as such is already a strong improvement, while the CRISPR-Cas9 gives the additional advantage of not leaving a scar or marker and that it therefore can be used to generate multiple modifications.	Katholieke Univ Leuven, Lab Mol Cell Biol, Kasteelpk Arenberg 31,Bus 2438, B-3001 Leuven, Belgium; VIB KU Leuven Ctr Microbiol, Leuven, Belgium; [Cen, Yuke] Zhejiang Univ Technol, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China	Van Dijck, P (reprint author), Katholieke Univ Leuven, VIB KU Leuven Ctr Microbiol, Lab Mol Cell Biol, Kasteelpk Arenberg 31,Bus 2438, B-3001 Heverlee, Belgium.	Patrick.vandijck@kuleuven.vib.be		Van Dijck, Patrick/0000-0002-1542-897X	KU Leuven (Concerted Research Actions) [GOA/13/006]; China Scholarship Council [2010833102]	We acknowledge Taiga Miyazaki and Hironobu Nakayama for their generous gift of C. glabrata strain 2001HT. We thank Ilse Palmans for excellent technical assistance. This work was supported by the Research Fund of KU Leuven (Concerted Research Actions GOA/13/006) and by a Ph.D. scholarship (file no. 2010833102) from the China Scholarship Council to Y.C.	Cen YK, 2015, EUKARYOT CELL, V14, P783, DOI 10.1128/EC.00281-14; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eulder L., 2016, SCI REP, V6, P35766; Ho HL, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov066; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B                      ; Lass-Florl C, 2009, MYCOSES, V52, P197, DOI 10.1111/j.1439-0507.2009.01691.x; Miyazaki T, 2010, ANTIMICROB AGENTS CH, V54, P1639, DOI 10.1128/AAC.01364-09; Pan XW, 2000, MOL CELL BIOL, V20, P8364, DOI 10.1128/MCB.20.22.8364-8372.2000                                                ; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; REAUME SE, 1949, ARCH BIOCHEM, V22, P331; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Schwarzmuller T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004211; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Ueno K., 2007, EUKARYOT CELL, V7, P2168; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Wallace-Salinas V, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0056-5; WARD MP, 1995, MOL CELL BIOL, V15, P6854; ZHOU PB, 1994, GENE, V142, P135, DOI 10.1016/0378-1119(94)90368-9	20	0	0	20	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	OCT	2017	107						44	50		10.1016/j.fgb.2017.08.004				7	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	FI3HK	WOS:000411848400006	28822858				2018-01-05	
J	Kayansamruaj, P; Dong, HT; Hirono, I; Kondo, H; Senapin, S; Rodkhum, C				Kayansamruaj, Pattanapon; Ha Thanh Dong; Hirono, Ikuo; Kondo, Hidehiro; Senapin, Saengchan; Rodkhum, Channarong			Comparative genome analysis of fish pathogen Flavobacterium columnare reveals extensive sequence diversity within the species	INFECTION GENETICS AND EVOLUTION			English	Article						Comparative genomics; Flavobacterium columnare; Genetic diversity; Pan-genome; Taxonomy	RIBOSOMAL-RNA GENES; PANGASIANODON-HYPOPHTHALMUS; CONCURRENT INFECTIONS; RAPID ANNOTATION; STRIPED CATFISH; NILE TILAPIA; TOOL; VIRULENCE; BACTERIAL; DISEASE	Flavobacterium columnare is one of the deadliest fish pathogens causing devastating mortality in various freshwater fish species globally. To gain an insight into bacterial genomic contents and structures, comparative genome analyses were performed using the reference and newly sequenced genomes of F. columnare including genomovar I, II and I/ II strains isolated from Thailand, Europe and the USA. Bacterial genomes varied in size from 3.09 to 3.39 Mb (2714 to 3101 CDSs). The pan-genome analysis revealed open pan-genome nature of F. columnare strains, which possessed at least 4953 genes and tended to increase progressively with the addition of a new genome. Genomic islands (GIs) present in bacterial genomes were diverse, in which 65% (39 out of 60) of possible GIswere strain-specific. A CRISPR/cas investigation indicated at least two different CRISPR systems with varied spacer profiles. On the other hand, putative virulence genes, including those related to gliding motility, type IX secretion system (T9SS), outer membrane proteins (Omp), were equally distributed among F. columnare strains. The MLSA scheme categorized bacterial strains into nine different sequence types (ST 9-17). Phylogenetic analyses based on either 16S rRNA, MLSA and concatenated SNPs of core genome revealed the diversity of F. columnare strains. DNA homology analysis indicated that the estimated digital DNA-DNA hybridization (dDDH) between strains of genomovar I and II can be as low as 42.6%, while the three uniquely tilapia originated strains from Thailand (1214, NK01 and 1215) were clearly dissimilar to other F. columnare strains as the dDDH values were only 27.7-30.4%. Collectively, this extensive diversity among bacterial strains suggested that species designation of F. columnare would potentially require re-emendation. (C) 2017 Elsevier B.V. All rights reserved.	[Kayansamruaj, Pattanapon; Rodkhum, Channarong] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Microbiol, Bangkok 10330, Thailand; [Kayansamruaj, Pattanapon] Kasetsart Univ, Fac Fisheries, Dept Aquaculture, Bangkok 10900, Thailand; [Ha Thanh Dong] King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Hirono, Ikuo; Kondo, Hidehiro] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Tokyo, Japan; [Senapin, Saengchan] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok, Thailand	Rodkhum, C (reprint author), Chulalongkorn Univ, Fac Vet Sci, Dept Vet Microbiol, Bangkok 10330, Thailand.; Kayansamruaj, P (reprint author), Kasetsart Univ, Fac Fisheries, Dept Aquaculture, Bangkok 10900, Thailand.	pattanapon.k@ku.th; Channarong.R@chula.ac.th	Dong, Ha/N-4300-2016	Dong, Ha/0000-0002-7190-757X	Ratchadaphiseksomphot Endowment Fund; Chulalongkorn University [CU-59-023-FW]	This research project received financial support from Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship and In-depth Research Cluster Project of Chulalongkorn University (Grant number: CU-59-023-FW). We thank all staff and students at the Laboratory of Genome Science, Tokyo University of Marine Science for providing technical assistance and laboratory equipment.	Arias CR, 2004, J APPL MICROBIOL, V97, P421, DOI 10.1111/j.1365-2672.2004.02314.x; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Ashrafi R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0576-4; Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628; Barony GM, 2015, DIS AQUAT ORGAN, V117, P1, DOI 10.3354/dao02931; Bartelme R. P., 2016, GENOME ANNOUNC, V4; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0; Brynildsrud O, 2014, ISME J, V8, P746, DOI 10.1038/ismej.2013.186; Castillo D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152515; Chaudhari NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24373; Darwish AM, 2005, MOL CELL PROBE, V19, P267, DOI 10.1016/j.mcp.2005.04.003; Declercq AM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-27; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Dong HT, 2016, J FISH DIS, V39, P649, DOI 10.1111/jfd.12385; Dong HT, 2015, J FISH DIS, V38, P901, DOI 10.1111/jfd.12304; Figueiredo HCP, 2005, J FISH DIS, V28, P199, DOI 10.1111/j.1365-2761.2005.00616.x; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Dong HT, 2015, AQUACULTURE, V448, P427, DOI 10.1016/j.aquaculture.2015.06.027; Dong HT, 2015, AQUACULTURE, V448, P142, DOI 10.1016/j.aquaculture.2015.05.046; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Koton Yael, 2014, Front Microbiol, V5, P803, DOI 10.3389/fmicb.2014.00803; Kumru S., 2016, GENOME ANNOUNC, V4; Kunttu HMT, 2009, MICROB PATHOGENESIS, V46, P21, DOI 10.1016/j.micpath.2008.10.001; Laanto E, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-170; Laanto E, 2011, APPL ENVIRON MICROB, V77, P7868, DOI 10.1128/AEM.05574-11; LaFrentz BR, 2014, J FISH DIS, V37, P657, DOI 10.1111/jfd.12166; LaFrentz BR, 2012, DIS AQUAT ORGAN, V101, P115, DOI 10.3354/dao02522; LaFrentz B. R., 2016, J FISH DIS; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Liao YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08747; McBride MJ, 2015, CURR OPIN MICROBIOL, V28, P72, DOI 10.1016/j.mib.2015.07.016; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Tien NT, 2012, DIS AQUAT ORGAN, V100, P83, DOI 10.3354/dao02478; Olivares-Fuster O, 2007, FEMS MICROBIOL LETT, V269, P63, DOI 10.1111/j.1574-6968.2006.00605.x; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Prasad Y, 2011, J ENVIRON BIOL, V32, P161; Rahman M.M., 2010, Journal of Biological Sciences, V10, P800, DOI 10.3923/jbs.2010.800.804; Rosinski-Chupin I, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-252; Schleifer KH, 2009, SYST APPL MICROBIOL, V32, P533, DOI 10.1016/j.syapm.2009.09.002; Shoemaker CA, 2008, VET MICROBIOL, V127, P353, DOI 10.1016/j.vetmic.2007.09.003; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tekedar HC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00588; Tekedar HC, 2012, J BACTERIOL, V194, P2763, DOI 10.1128/JB.00281-12; Triyanto, 1999, FISH PATHOL, V34, P65; Triyanto Wakabayashi. H., 1999, FISH PATHOL, V34, P65; Underwood AP, 2005, CLIN MICROBIOL INFEC, V11, P770, DOI 10.1111/j.1469-0691.2005.01210.x; Verma DK, 2013, J GEN APPL MICROBIOL, V59, P417; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463                                                       ; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Xia X., 2013, COMP GENOMICS; Zhang Y., 2016, GENOME ANNOUNC, V4	55	2	2	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	OCT	2017	54						7	17		10.1016/j.meegid.2017.06.012				11	Infectious Diseases	Infectious Diseases	FH8PU	WOS:000411461400003	28624550				2018-01-05	
J	Hong, KW; Hani, AWA; Murni, CANA; Pusparani, RR; Chong, CK; Verasahib, K; Yusoff, WNW; Noordin, NM; Tee, KK; Yin, WF; Yu, CY; Ang, GY; Chan, KG				Hong, Kar-Wai; Hani, A. W. Asmah; Murni, C. A. Nurul Aina; Pusparani, R. R.; Chong, Chee Kheong; Verasahib, Khebir; Yusoff, Wan Noraini W.; Noordin, Noorliza M.; Tee, Kok Keng; Yin, Wai-Fong; Yu, Choo Yee; Ang, Geik Yong; Chan, Kok-Gan			Comparative genomic and phylogenetic analysis of a toxigenic clinical isolate of Corynebacterium diphtheriae strain B-D-16-78 from Malaysia	INFECTION GENETICS AND EVOLUTION			English	Article						Diphtheria; Toxin; Mitis; Genome; CRISPR-Cas; Malaysia	CRISPR-CAS SYSTEMS; SHORT PALINDROMIC REPEATS; MOLECULAR EPIDEMIOLOGY; ESCHERICHIA-COLI; TOXIN GENE; SEQUENCE; EVOLUTION; BACTERIA; DNA; CLASSIFICATION	In this study, we report the comparative genomics and phylogenetic analysis of Corynebacterium diphtheriae strain B-D-16- 78 that was isolated from a clinical specimen in 2016. The complete genome of C. diphtheriae strain B-D-16- 78 was sequenced using PacBio Single Molecule, Real-Time sequencing technology and consists of a 2,474,151-bp circular chromosome with an average GC content of 53.56%. The core genome of C. diphtheriae was also deduced from a total of 74 strains with complete or draft genome sequences and the core genome-based phylogenetic analysis revealed close genetic relationship among strains that shared the same MLST allelic profile. In the context of CRISPR-Cas system, which confers adaptive immunity against re-invading DNA, 73 out of 86 spacer sequences were found to be unique to Malaysian strains which harboured only type-II-C and/or type-I-E-a systems. A total of 48 tox genes which code for the diphtheria toxin were retrieved from the 74 genomes and with the exception of one truncated gene, only nucleotide substitutions were detected when compared to the tox gene sequence of PW8. More than half were synonymous substitution and only two were nonsynonymous substitutions whereby H24Y was predicted to have a damaging effect on the protein function whilst T262V was predicted to be tolerated. Both toxigenic and non-toxigenic toxin-gene bearing strains have been isolated in Malaysia but the repeated isolation of toxigenic strains with the same MLST profile suggests the possibility of some of these strains may be circulating in the population. Hence, efforts to increase herd immunity should be continued and supported by an effective monitoring and surveillance systemto track, manage and control outbreak of cases. (C) 2017 Elsevier B.V. All rights reserved.	[Hong, Kar-Wai; Yin, Wai-Fong; Chan, Kok-Gan] Univ Malaya, Div Genet & Mol Biol, Inst Biol Sci, Kuala Lumpur, Malaysia; [Hani, A. W. Asmah; Murni, C. A. Nurul Aina; Pusparani, R. R.; Verasahib, Khebir; Yusoff, Wan Noraini W.; Noordin, Noorliza M.] Minist Hlth, Dis Control Div, Natl Publ Hlth Lab, Kuala Lumpur, Malaysia; [Chong, Chee Kheong] Minist Hlth, Dis Control Div, Kuala Lumpur, Malaysia; [Tee, Kok Keng] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Yu, Choo Yee; Ang, Geik Yong] Univ Teknol MARA Selangor UiTM, Integrat Pharmacogen Inst iPROMISE, Puncak Alam, Selangor, Malaysia; [Ang, Geik Yong] Univ Teknol MARA Selangor UiTM, Fac Sports Sci & Recreat, Shah Alam, Selangor, Malaysia	Chan, KG (reprint author), Univ Malaya, Div Genet & Mol Biol, Inst Biol Sci, Kuala Lumpur, Malaysia.	kokgan@um.edu.my	Lahuddin, Haslinda/S-1588-2017; Tee, Kok Keng/A-8148-2008	Tee, Kok Keng/0000-0002-7923-5448; YU, CHOO YEE/0000-0002-8453-5023	University of Malaya-Ministry of Higher Education High Impact Research Grants (UM-MOHE) [UM.C/625/1/HIR/MOHE/CHAN/14/1, H-50001-A000027, UM.C/625/1/HIR/MOHE/CHAN/01, A000001-50001, PG085-2015B]	The authors would like to thank the Director of Health Malaysia for permission to publish this paper. Our sincere gratitude to all the National Public Health Laboratory staffs who have contributed to this work on the isolation and preliminary studies of the isolates. This project was financially supported by University of Malaya-Ministry of Higher Education High Impact Research Grants (UM-MOHE HIR Grant UM.C/625/1/HIR/MOHE/CHAN/14/1, no. H-50001-A000027; UM-MOHE HIR Grant UM.C/625/1/HIR/MOHE/CHAN/01, no. A000001-50001) which are awarded to KGC and PPP Grant (PG085-2015B) awarded to KWH, which are gratefully acknowledged.	Abdullah N.H., 2016, DESK DIRECTOR GEN HL; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Bolt F, 2010, J CLIN MICROBIOL, V48, P4177, DOI 10.1128/JCM.00274-10; Hamborsky J, 2015, EPIDEMIOLOGY PREVENT; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Chan KG, 2016, EXPERT REV ANTI-INFE, V14, P617, DOI 10.1080/14787210.2016.1193005; Chaudhari NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24373; CHEN ST, 1976, TROP GEOGR MED, V28, P211; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; De Zoysa A, 2000, J CLIN MICROBIOL, V38, P3843; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; DEZOYSA A, 1995, J CLIN MICROBIOL, V33, P1080; Doyle CJ, 2017, EMERG INFECT DIS, V23, P105, DOI 10.3201/eid2301.160584; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Forde BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104400; Funke G, 1997, CLIN MICROBIOL REV, V10, P125; GALAZKA AM, 1995, EUR J EPIDEMIOL, V11, P95, DOI 10.1007/BF01719954; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hadfield TL, 2000, J INFECT DIS, V181, pS116, DOI 10.1086/315551; Holmes RK, 2000, J INFECT DIS, V181, pS156, DOI 10.1086/315554; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; LEONG D, 1985, J BACTERIOL, V163, P1114; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Melnikov V.G., 2000, P 6 INT M EUR LAB WO, P60; Melnikov V. G., 2004, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P3; Mokrousov I, 2005, J CLIN MICROBIOL, V43, P1662, DOI 10.1128/JCM.43.4.1662-1668.2005; Nakao H, 1997, RES MICROBIOL, V148, P45, DOI 10.1016/S0923-2508(97)81899-2; Nakao H, 1998, DIAGN MICR INFEC DIS, V30, P167, DOI 10.1016/S0732-8893(97)00237-X; Popovic T, 1996, J INFECT DIS, V174, P1064, DOI 10.1093/infdis/174.5.1064                                                       ; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Richter C, 2012, VIRUSES-BASEL, V4, P2291, DOI 10.3390/v4102291; Sangal V, 2016, INFECT GENET EVOL, V43, P364, DOI 10.1016/j.meegid.2016.06.024; Sangal V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1980-8; Sangal V, 2014, INFECT GENET EVOL, V21, P54, DOI 10.1016/j.meegid.2013.10.019; Sangal V, 2013, MICROBIOL-SGM, V159, P2118, DOI 10.1099/mic.0.070235-0; Shulman ST, 2004, PEDIATR RES, V55, P163, DOI 10.1203/01.PDR.0000101756.93542.09; Sulakvelidze A, 1999, J CLIN MICROBIOL, V37, P3265; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Tiwari T.S.P., 2008, INT ENCY PUBLIC HLTH, P195; Trost E, 2012, J BACTERIOL, V194, P3199, DOI 10.1128/JB.00183-12; Whitman W, 2012, BERGEYS MANUAL SYSTE, V5; World Health Organization, 2016, DIPHTH REP CAS WHO V; World Health Organization, 2016, 3 DOS DIPHTH TOX TET; World Health Organization, 2016, WHO VACC PREV DIS MO; Yong D, 2016, J BIOTECHNOL, V217, P51, DOI 10.1016/j.jbiotec.2015.11.009; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zakikhany K., 2014, EUROSURVEILLANCE, P19; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047232	53	0	0	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	OCT	2017	54						263	270		10.1016/j.meegid.2017.07.015				8	Infectious Diseases	Infectious Diseases	FH8PU	WOS:000411461400033	28711373				2018-01-05	
J	Thomas, P; Semmler, T; Eichhorn, I; Lubke-Becker, A; Werckenthin, C; Abdel-Glil, MY; Wieler, LH; Neubauer, H; Seyboldt, C				Thomas, Prasad; Semmler, Torsten; Eichhorn, Inga; Luebke-Becker, Antina; Werckenthin, Christiane; Abdel-Glil, Mostafa Y.; Wieler, Lothar H.; Neubauer, Heinrich; Seyboldt, Christian			First report of two complete Clostridium chauvoei genome sequences and detailed in silico genome analysis	INFECTION GENETICS AND EVOLUTION			English	Article						Clostridium chauvoei; Complete circular genomes; Spo0A; CRISPR; fliC	SOLUBLE SPORE PROTEINS; PERFRINGENS SPORES; GENUS CLOSTRIDIUM; RAPID ANNOTATION; RNA GENES; RESISTANCE; ACID; TOOL; VISUALIZATION; GERMINATION	Clostridium (C.) chauvoei is a Gram-positive, spore forming, anaerobic bacterium. It causes black leg in ruminants, a typically fatal histotoxic myonecrosis. High quality circular genome sequences were generated for the C. chauvoei type strain DSM7528(T) (ATCC 10092(T)) and a field strain 12S0467 isolated in Germany. The origin of replication (oriC) was comparable to that of Bacillus subtilis in structure with two regions containing DnaA boxes. Similar prophages were identified in the genomes of both C. chauvoei strains which also harbored hemolysin and bacterial spore formation genes. A CRISPR type I-B system with limited variations in the repeat number was identified. Sporulation and germination process related geneswere homologous to that of the Clostridia cluster I group but novel variations for regulatory genes were identified indicative for strain specific control of regulatory events. Phylogenomics showed a higher relatedness to C. septicumthan to other so far sequenced genomes of species belonging to the genus Clostridium. Comparative genome analysis of three C. chauvoei circular genome sequences revealed the presence of few inversions and translocations in locally collinear blocks (LCBs). The species genome also shows a large number of genes involved in proteolysis, genes for glycosyl hydrolases andmetal iron transportation genes which are presumably involved in virulence and survival in the host. Three conserved flagellar genes (fliC) were identified in each of the circular genomes. In conclusion this is the first comparative analysis of circular genomes for the species C. chauvoei, enabling insights into genome composition and virulence factor variation. (C) 2017 The Authors. Published by Elsevier B.V.	[Thomas, Prasad; Abdel-Glil, Mostafa Y.; Neubauer, Heinrich; Seyboldt, Christian] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Naumburger Str 96A, D-07743 Jena, Germany; [Eichhorn, Inga; Luebke-Becker, Antina] Freie Univ, Inst Microbiol & Epizoot, Dept Vet Med, Robert von Ostertag Str 7-13,Bldg 35, D-14163 Berlin, Germany; [Semmler, Torsten; Wieler, Lothar H.] Robert Koch Inst, Nordufer 20, D-13353 Berlin, Germany; [Werckenthin, Christiane] Lebensmittel & Vet Inst Oldenburg, LAVES, Martin Niemoller Str 2, D-26133 Oldenburg, Germany	Seyboldt, C (reprint author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Bacterial Infect & Zoonoses, Naumburger Str 96a, D-07743 Jena, Germany.	prasadthomas99@gmail.com; semmlert@rki.de; inga.eichhorn@fu-berlin.de; antina.luebke-becker@fu-berlin.de; christiane.werckenthin@laves.niedersachsen.de; mostafa.abdel-glil@fli.de; wielerlh@rki.de; heinrich.neubauer@fli.de; christian.seyboldt@fli.de			The ICAR-International Fellowship from Indian Council of Agricultural Research (ICAR), New Delhi, India	The ICAR-International Fellowship from Indian Council of Agricultural Research (ICAR), New Delhi, India, for Prasad Thomas is gratefully acknowledged.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Altschul S. F., 1997, NUCL ACIDS RES, V25; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Benamar S., 2016, GENOME ANNOUNC, V4; Binnewies Tim T., 2006, Functional & Integrative Genomics, V6, P165, DOI 10.1007/s10142-006-0027-2; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Briggs GS, 2012, J BACTERIOL, V194, P5162, DOI 10.1128/JB.00865-12; Brown SD, 2014, BIOTECHNOL BIOFUELS, V7, P1; Carter AT, 2015, RES MICROBIOL, V166, P303, DOI 10.1016/j.resmic.2014.10.010; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812                                                       ; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A., 2008, INT J PLANT GENOMICS, V2008, DOI DOI 10.1155/2008/619832; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Durre P., 2014, MICROBIOLOGY SPECTRU, V2; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Eisen JA, 2000, GENOME BIOL, V1; Falquet L., 2013, GENOME ANNOUNC, V1; Fan SQ, 2016, J BASIC MICROB, V56, P347, DOI 10.1002/jobm.201500582; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Fang PK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-725; Fouts DE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks757; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Frey J, 2015, RES MICROBIOL, V166, P384, DOI 10.1016/j.resmic.2014.10.013; Frey J, 2012, VACCINE, V30, P5500, DOI 10.1016/j.vaccine.2012.06.050; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66; Hunt M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0849-0; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jayaramaiah U, 2016, ANAEROBE, V39, P77, DOI 10.1016/j.anaerobe.2016.03.004; Kalia VC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-18; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kevorkian Y, 2016, BIOCHIMIE, V122, P243, DOI 10.1016/j.biochi.2015.07.023; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kuhnert P, 1996, INT J SYST BACTERIOL, V46, P1174, DOI 10.1099/00207713-46-4-1174                                                      ; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lange M, 2010, MOL CELL PROBE, V24, P204, DOI 10.1016/j.mcp.2010.03.003; Liao YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08747; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Meaney CA, 2016, INT J FOOD MICROBIOL, V216, P25, DOI 10.1016/j.ijfoodmicro.2015.08.024; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Nagano N, 2008, J CLIN MICROBIOL, V46, P1545, DOI 10.1128/JCM.01895-07; Nowell VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032271; Orsburn BC, 2010, MOL MICROBIOL, V75, P178, DOI 10.1111/j.1365-2958.2009.06975.x; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Paredes-Sabja D, 2008, INT J FOOD MICROBIOL, V122, P333, DOI 10.1016/j.ijfoodmicro.2007.12.006; Paredes-Sabja D, 2008, J BACTERIOL, V190, P1190, DOI 10.1128/JB.01748-07; Paredes-Sabja D, 2011, MICROB PATHOGENESIS, V51, P384, DOI 10.1016/j.micpath.2011.05.006; Paredes-Sabja D, 2009, APPL ENVIRON MICROB, V75, P3813, DOI 10.1128/AEM.00048-09; Pettit LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-160; Porcheron Gaelle, 2013, Front Cell Infect Microbiol, V3, P90, DOI 10.3389/fcimb.2013.00090; Raju D, 2007, APPL ENVIRON MICROB, V73, P2048, DOI 10.1128/AEM.02500-06; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; Sasaki Y, 2002, VET MICROBIOL, V86, P257, DOI 10.1016/S0378-1135(02)00002-0; Sasaki Y, 2000, J VET MED SCI, V62, P1275, DOI 10.1292/jvms.62.1275; Seemann T., 2014, BIOINFORMATICS; Selzer J, 1996, J BIOL CHEM, V271, P25173, DOI 10.1074/jbc.271.41.25173                                                        ; SETLOW P, 1988, ANNU REV MICROBIOL, V42, P319, DOI 10.1146/annurev.mi.42.100188.001535                                             ; Setlow P, 1994, SOC APPL BACTERIOL S, V23, P49; Skarin H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-185; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stackebrandt E, 1999, FEMS IMMUNOL MED MIC, V24, P253, DOI 10.1016/S0928-8244(99)00039-5; Talukdar PK, 2015, RES MICROBIOL, V166, P225, DOI 10.1016/j.resmic.2014.12.001; TAMURA Y, 1995, MICROBIOL-UK, V141, P605, DOI 10.1099/13500872-141-3-605                                                      ; TAMURA Y, 1984, INFECT IMMUN, V43, P612; TANAKA M, 1987, INFECT IMMUN, V55, P1779; Useh NM, 2006, VET REC, V158, P100, DOI 10.1136/vr.158.3.100                                                            ; Usharani J, 2015, ANAEROBE, V33, P48, DOI 10.1016/j.anaerobe.2015.02.001; Vilei EM, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-2; Weatherhead JE, 2012, J INFECTION, V64, P225, DOI 10.1016/j.jinf.2011.09.004; Woudstra C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00757; Xiao YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127036; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	87	0	0	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	OCT	2017	54						287	298		10.1016/j.meegid.2017.07.018				12	Infectious Diseases	Infectious Diseases	FH8PU	WOS:000411461400037	28720440	gold			2018-01-05	
J	Negahdaripour, M; Nezafat, N; Hajighahramani, N; Rahmatabadi, SS; Ghasemi, Y				Negahdaripour, Manica; Nezafat, Navid; Hajighahramani, Nasim; Rahmatabadi, Seyyed Soheil; Ghasemi, Younes			Investigating CRISPR-Cas systems in Clostridium botulinum via bioinformatics tools	INFECTION GENETICS AND EVOLUTION			English	Article						Botulinum toxin; Bioinformatics; Clostridium botulinum; CRISPR (clustered regularly interspaced short palindromic repeats); Cas (CRISPR-associated) proteins; Direct repeat	IN-SILICO; ADAPTIVE IMMUNITY; ESCHERICHIA-COLI; DIVERSITY; VIRULENCE; CLASSIFICATION; PERSPECTIVES; NEUROTOXINS; PROKARYOTES; BACTERIA	The Clustered regularly interspaced short palindromic repeats (CRISPR) systems are a type of innate immunity found in some prokaryotes, which protect them against alien genetic elements by targeting foreign nucleic acids. Some other functions are also attributed to these systems. Clostridium botulinum bacteria produce botulinum neurotoxins (BoNT), one of the deadliest known toxins for humans and some animals. Food poisoning due to these bacteria is still a challenge in food industries. On the other hand, BoNT has been widely investigated for therapeutic applications including differentmuscle disorders. Bont genesmay be located on bacterial chromosomes, plasmids, or even prophages. Generally, the genomes of Cl. botulinum show a high level of plasticity. In order to investigate the presence and characteristics of CRISPRs in these anaerobe bacteria, an in silico study on 113 CRISPR arrays identified in 38 Cl. botulinumstrainswas performed. A high occurrence of CRISPR arrays (80%) were found, with a remarkable frequency on plasmids. Several (CRISPR-associated) Cas proteins from different types were recognized in the studied strains, which were mostly Cas6. The CRISPR-Cas systems were identified as type I or III, but no type II. The spacers showed more homology with bacterial plasmids than phages. Active CRISPR-Cas systems can prevent the transfer of foreign genes, which may also include bont genes. This study provides the first insight into the probable roles of CRISPR-Cas systems in Cl. botulinum strains such as toxigenicity. (C) 2017 Elsevier B.V. All rights reserved.	[Negahdaripour, Manica; Hajighahramani, Nasim; Rahmatabadi, Seyyed Soheil; Ghasemi, Younes] Shiraz Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Shiraz, Iran; [Negahdaripour, Manica; Nezafat, Navid; Hajighahramani, Nasim; Rahmatabadi, Seyyed Soheil; Ghasemi, Younes] Shiraz Univ Med Sci, Pharmaceut Sci Res Ctr, Shiraz, Iran; [Ghasemi, Younes] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Biotechnol, Shiraz, Iran; [Negahdaripour, Manica; Ghasemi, Younes] Shiraz Univ Med Sci, Biotechnol Res Ctr, Shiraz, Iran	Ghasemi, Y (reprint author), Shiraz Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Shiraz, Iran.	ghasemiy@sums.ac.ir	Ghasemi, Younes/A-3577-2010	Ghasemi, Younes/0000-0003-4172-0672; Negahdaripour, Manica/0000-0002-4265-1499	Research Council of Shiraz University of Medical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran [13435]	This study was supported by Grant No. 13435 from the Research Council of Shiraz University of Medical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.	Alkhnbashi OS, 2014, BIOINFORMATICS, V30, pI489, DOI 10.1093/bioinformatics/btu459; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Biswas Ambarish, 2015, Methods Mol Biol, V1311, P77, DOI 10.1007/978-1-4939-2687-9_5; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Briner AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133661; Carter AT, 2011, J BACTERIOL, V193, P2351, DOI 10.1128/JB.00072-11; Connan C, 2015, RES MICROBIOL, V166, P332, DOI 10.1016/j.resmic.2014.12.012; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dressler D, 2005, ARQ NEURO-PSIQUIAT, V63, P180, DOI 10.1590/S0004-282X2005000100035; Fagerlund RD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0824-9; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hajighahramani N, 2017, INFECT GENET EVOL, V48, P83, DOI 10.1016/j.meegid.2016.12.010; Heussler GE, 2016, J BACTERIOL, V198, P1481, DOI 10.1128/JB.00086-16; Hill KK, 2015, TOXICON, V107, P2, DOI 10.1016/j.toxicon.2015.09.011; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Iacobino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071324; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Louwen R, 2013, BIOCHEM SOC T, V41, P1475, DOI 10.1042/BST20130127; Luvisetto S, 2015, TOXINS, V7, P3818, DOI 10.3390/toxins7093818; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Montecucco C, 2015, MBIO, V6, DOI 10.1128/mBio.02131-14; Negahdaripour M, 2017, CURR PROTEOMICS, V14, P112, DOI 10.2174/1570164614666170106110848; Negahdaripour M, 2016, CYTOKINE GROWTH F R, V32, P41, DOI 10.1016/j.cytogfr.2016.06.002; Nezafat N, 2017, MOL BIOSYST, V13, P699, DOI 10.1039/c6mb00772d; Nezafat N, 2014, J THEOR BIOL, V349, P121, DOI 10.1016/j.jtbi.2014.01.018; Peck MW, 2011, FOOD MICROBIOL, V28, P183, DOI 10.1016/j.fm.2010.03.005; Pyne ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep25666; Rahmatabadi SS, 2016, J BASIC MICROB, V56, P645, DOI 10.1002/jobm.201500707; Rossetto O, 2014, NAT REV MICROBIOL, V12, P535, DOI 10.1038/nrmicro3295; Rossi F, 2014, FOOD MICROBIOL, V42, P232, DOI 10.1016/j.fm.2014.04.004; Sampson TR, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00037; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sanozky-Dawes R, 2015, MICROBIOL-SGM, V161, P1752, DOI 10.1099/mic.0.000129; Skarin H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-185; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Smith TJ, 2015, RES MICROBIOL, V166, P290, DOI 10.1016/j.resmic.2014.09.007; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Williamson CHD, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2502-z; Wolfsheimer S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021902; Woudstra C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00757; Zamani M, 2015, INT J PEPT RES THER, V21, P261, DOI 10.1007/s10989-015-9454-z; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; ZUKER M, 1984, B MATH BIOL, V46, P591, DOI 10.1007/BF02459506	56	0	0	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	OCT	2017	54						355	373		10.1016/j.meegid.2017.06.027				19	Infectious Diseases	Infectious Diseases	FH8PU	WOS:000411461400045	28684374				2018-01-05	
J	Machado, RG; Eames, BF				Machado, R. Grecco; Eames, B. Frank			Using Zebrafish to Test the Genetic Basis of Human Craniofacial Diseases	JOURNAL OF DENTAL RESEARCH			English	Review						zebrafish genetics; GWA; transgenesis; CRISPR; noncoding mutations; adult phenotype	GENOME-WIDE ASSOCIATION; ZINC-FINGER NUCLEASES; CRANIAL NEURAL CREST; CLEFT-PALATE; DANIO-RERIO; VERTEBRATE CHROMOSOMES; TRANSGENIC ZEBRAFISH; CRISPR-CAS9 SYSTEM; ANIMAL-MODELS; MUTATIONS	Genome-wide association studies (GWASs) opened an innovative and productive avenue to investigate the molecular basis of human craniofacial disease. However, GWASs identify candidate genes only; they do not prove that any particular one is the functional villain underlying disease or just an unlucky genomic bystander. Genetic manipulation of animal models is the best approach to reveal which genetic loci identified from human GWASs are functionally related to specific diseases. The purpose of this review is to discuss the potential of zebrafish to resolve which candidate genetic loci are mechanistic drivers of craniofacial diseases. Many anatomic, embryonic, and genetic features of craniofacial development are conserved among zebrafish and mammals, making zebrafish a good model of craniofacial diseases. Also, the ability to manipulate gene function in zebrafish was greatly expanded over the past 20 y, enabling systems such as Gateway Tol2 and CRISPR-Cas9 to test gain-and loss-of-function alleles identified from human GWASs in coding and noncoding regions of DNA. With the optimization of genetic editing methods, large numbers of candidate genes can be efficiently interrogated. Finding the functional villains that underlie diseases will permit new treatments and prevention strategies and will increase understanding of how gene pathways operate during normal development.	[Machado, R. Grecco; Eames, B. Frank] Univ Saskatchewan, Dept Anat & Cell Biol, 3D01-107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada	Eames, BF (reprint author), Univ Saskatchewan, Dept Anat & Cell Biol, 3D01-107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	b.frank@usask.ca			Saskatchewan Health Research Foundation; Canadian Institutes of Health Research	This work was supported by the Saskatchewan Health Research Foundation and Canadian Institutes of Health Research. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Beaty Terri H, 2016, F1000Res, V5, P2800; Bedell VM, 2015, METHODS MOL BIOL, V1239, P291, DOI 10.1007/978-1-4939-1862-1_17; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Benusiene E, 2003, J APPL GENET, V44, P95; Bhatia S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005193; Bhatia S, 2014, HUM GENET, V133, P815, DOI 10.1007/s00439-014-1424-6; Bielczyk-Maczynska E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004450; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4                  ; Dale RM, 2011, DEV BIOL, V357, P518, DOI 10.1016/j.ydbio.2011.06.020; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; Deml B, 2015, BIRTH DEFECTS RES A, V103, P630, DOI 10.1002/bdra.23397; Dermitzakis ET, 2009, SCIENCE, V326, P239, DOI 10.1126/science.1182009; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Driever W, 1996, DEVELOPMENT, V123, P37; Eames BF, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-23; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Ghassibe-Sabbagh M, 2011, AM J HUM GENET, V88, P150, DOI 10.1016/j.ajhg.2011.01.003; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Haffter P, 1996, DEVELOPMENT, V123, P1; Hammond Chrissy L, 2012, Front Endocrinol (Lausanne), V3, P91, DOI 10.3389/fendo.2012.00091; Harris MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000206; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Huysseune A, 1998, ANAT EMBRYOL, V198, P289, DOI 10.1007/s004290050185                                                           ; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kim YI, 2013, MOL CELLS, V36, P145, DOI 10.1007/s10059-013-0117-7; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kury S, 2017, AM J HUM GENET, V100, P352, DOI 10.1016/j.ajhg.2017.01.003; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Lawson ND, 2016, TRENDS CELL BIOL, V26, P77, DOI 10.1016/j.tcb.2015.11.005; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Pabic P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004726; Leslie EJ, 2015, AM J HUM GENET, V96, P397, DOI 10.1016/j.ajhg.2015.01.004; Leslie EJ, 2013, AM J MED GENET C, V163, P246, DOI 10.1002/ajmg.c.31381; Li MY, 2008, EUR J HUM GENET, V16, P635, DOI 10.1038/sj.ejhg.5202007; Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu LY, 2013, DIS MODEL MECH, V6, P1271, DOI 10.1242/dmm.011726; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mackay Eirinn W, 2013, Bonekey Rep, V2, P445, DOI 10.1038/bonekey.2013.179; Maddison LA, 2014, METHODS MOL BIOL, V1101, P393, DOI 10.1007/978-1-62703-721-1_19; Mariotti M, 2015, CLIN CASES MINER BON, V12, P188, DOI 10.11138/ccmbm/2015.12.2.188; McGurk PD, 2014, JOVE-J VIS EXP, V83, P51190; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Mork L, 2015, CURR TOP DEV BIOL, V115, P235, DOI 10.1016/bs.ctdb.2015.07.001; Moro E, 2013, MOL GENET GENOMICS, V288, P231, DOI 10.1007/s00438-013-0750-z; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Brien KP, 2004, HUM MUTAT, V24, P112, DOI 10.1002/humu.20068; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rattanasopha S, 2012, EUR J HUM GENET, V20, P1058, DOI 10.1038/ejhg.2012.55; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Simpson MA, 2009, CLIN GENET, V75, P271, DOI 10.1111/j.1399-0004.2008.01118.x; Stanier P, 2012, FRONT ORAL BIOL, V16, P71, DOI 10.1159/000337618; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Swartz ME, 2011, DEV DYNAM, V240, P2204, DOI 10.1002/dvdy.22713; Taher L, 2011, GENOME RES, V21, P1139, DOI 10.1101/gr.119016.110; Van Otterloo E, 2016, DEV BIOL, V415, P171, DOI 10.1016/j.ydbio.2016.01.017; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wright JB, 2016, TRENDS GENET, V32, P526, DOI 10.1016/j.tig.2016.06.004; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402                                                      ; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917	87	1	1	9	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	OCT	2017	96	11			SI		1192	1199		10.1177/0022034517722776				8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	FH8GN	WOS:000411431200003	28767277				2018-01-05	
J	Zou, T; He, ZY; Qu, LY; Liu, MX; Zeng, J; Liang, YL; Wang, T; Chen, D; Xiao, Q; Zhu, J; Liang, YY; Deng, QM; Wang, SQ; Zheng, AP; Wang, LX; Li, P; Li, SC				Zou, Ting; He, Zhiyuan; Qu, Lingyun; Liu, Mingxing; Zeng, Jing; Liang, Yanling; Wang, Tao; Chen, Dan; Xiao, Qiao; Zhu, Jun; Liang, Yueyang; Deng, Qiming; Wang, Shiquan; Zheng, Aiping; Wang, Lingxia; Li, Ping; Li, Shuangcheng			Knockout of OsACOS12 caused male sterility in rice	MOLECULAR BREEDING			English	Article						Rice; Arabidopsis; ACOS5; OsACOS12; Male sterility	POLLEN EXINE DEVELOPMENT; ANTHER DEVELOPMENT; WALL DEVELOPMENT; SPOROPOLLENIN SYNTHESIS; ARABIDOPSIS-THALIANA; POSTMEIOTIC ANTHER; ORYZA-SATIVA; PROTEIN; TAPETUM; BIOSYNTHESIS	Pollen development in flowering plants is critical for male reproductive success. The pollen wall that protects the pollen from various environment stresses and bacterial infections plays an essential role in pollen development. The formation of pollen wall is associated with the biosynthesis and transport of sporopollenin components. ACOS5 in Arabidopsis encodes an acyl-CoA synthetase 5 required for sporopollenin biosynthesis. We identified the rice homolog of ACOS5 as OsACOS12. The CRISPR/Cas9-mediated OsACOS12 knockout mutant has complete male sterility due to a defect in pollen wall formation. beta-Glucuronidase reporter gene analysis and RNA in situ hybridization indicated that OsACOS12 was specifically expressed in tapetum and microspores. The subcellular localization of OsACOS12-YFP demonstrated that OsACOS12 protein was primarily localized in the endoplasmic reticulum and nucleus. Our results suggest that OsACOS12 plays a critical and conserved role in pollen wall formation and pollen development and has implications in rice breeding.	[Zou, Ting; He, Zhiyuan; Qu, Lingyun; Liu, Mingxing; Zeng, Jing; Liang, Yanling; Wang, Tao; Chen, Dan; Xiao, Qiao; Zhu, Jun; Liang, Yueyang; Deng, Qiming; Wang, Shiquan; Zheng, Aiping; Wang, Lingxia; Li, Ping; Li, Shuangcheng] Sichuan Agr Univ, State Key Lab Hybrid Rice, Chengdu 611130, Sichuan, Peoples R China; [Zou, Ting; He, Zhiyuan; Qu, Lingyun; Liu, Mingxing; Zeng, Jing; Liang, Yanling; Wang, Tao; Chen, Dan; Xiao, Qiao; Zhu, Jun; Liang, Yueyang; Deng, Qiming; Wang, Shiquan; Zheng, Aiping; Wang, Lingxia; Li, Ping; Li, Shuangcheng] Sichuan Agr Univ, Rice Res Inst, 211 Huimin Rd, Wenjiang 611130, Sichuan, Peoples R China; [Zhu, Jun; Deng, Qiming; Wang, Shiquan; Wang, Lingxia; Li, Ping; Li, Shuangcheng] Sichuan Agr Univ, Minist Educ, Key Lab Crop Genet Resources & Improvement, Yaan 625014, Sichuan, Peoples R China	Li, P; Li, SC (reprint author), Sichuan Agr Univ, Minist Educ, Key Lab Crop Genet Resources & Improvement, Yaan 625014, Sichuan, Peoples R China.	liping6575@163.com; lisc926105@163.com			National Natural Science Foundation of China [91435102, 31570004]; Sichuan provincial funding for distinguished young scholars [2015JQ0048]; State Key Laboratory of Hybrid Rice (Hunan Hybrid Rice Research Center) [2016KF10]	This work was supported by the National Natural Science Foundation of China (91435102 and 31570004), the Sichuan provincial funding for distinguished young scholars (2015JQ0048), and the Open Research Fund of State Key Laboratory of Hybrid Rice (Hunan Hybrid Rice Research Center, 2016KF10).	Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; BEDINGER P, 1992, PLANT CELL, V4, P879, DOI 10.1105/tpc.4.8.879                                                             ; Blackmore S, 2007, NEW PHYTOL, V174, P483, DOI 10.1111/j.1469-8137.2007.02060.x; Chang Z, 2016, P NATL ACAD SCI US; Chen XM, 2002, DEVELOPMENT, V129, P1085; Chen Y, 2016, PLANT PHYSIOL, V172, P244, DOI 10.1104/pp.16.00774; Dobritsa AA, 2010, PLANT PHYSIOL, V153, P937, DOI 10.1104/pp.110.157446; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Fellenberg C, 2015, TRENDS PLANT SCI, V20, P212, DOI 10.1016/j.tplants.2015.01.011; Fu ZZ, 2014, PLANT CELL, V26, P1512, DOI 10.1105/tpc.114.123745; Gomez JF, 2015, J INTEGR PLANT BIOL, V57, P876, DOI 10.1111/jipb.12425; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; He X, 2012, PLANT MOL BIOL, V79, P157, DOI 10.1007/s11103-012-9902-5; HESLOPHARRISON J, 1968, SCIENCE, V161, P230, DOI 10.1126/science.161.3838.230; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jiang J, 2013, PLANT BIOLOGY, V15, P249, DOI 10.1111/j.1438-8677.2012.00706.x; Jung KH, 2005, PLANT CELL, V17, P2705, DOI 10.1105/tpc.105.034090; Kim SS, 2010, PLANT CELL, V22, P4045, DOI 10.1105/tpc.110.080028; Ko SS, 2014, PLANT CELL, V26, P2486, DOI 10.1105/tpc.114.126292; Lallemand B, 2013, PLANT PHYSIOL, V162, P616, DOI 10.1104/pp.112.213124; Li H, 2011, PLANT PHYSIOL, V156, P615, DOI 10.1104/pp.111.175760; Li H, 2010, PLANT SIGNAL BEHAV, V5, P1121, DOI 10.4161/psb.5.9.12562; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Li Y, 2016, PLANT BIOLOGY, V16, P256; Liang W, 2016, IMPROVING FOOD SECUR; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; Niu NN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2396; Qin P, 2013, PLANT CELL PHYSIOL, V54, P138, DOI 10.1093/pcp/pcs162; Quilichini TD, 2015, THESIS, V113, P170, DOI DOI 10.1016/J.PHYTOCHEM.2014.05.002; Quilichini TD, 2014, ANN BOT-LONDON, V114, P1189, DOI 10.1093/aob/mcu042; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shi JX, 2015, TRENDS PLANT SCI, V20, P741, DOI 10.1016/j.tplants.2015.07.010; Shi J, 2011, PLANT CELL, V23, P2225, DOI 10.1105/tpc.111.087528; Souza CD, 2008, NEW PHYTOL, V179, P987, DOI 10.1111/j.1469-8137.2008.02534.x; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang W, 2014, ACTA CRYSTALLOGR F, V70, P758, DOI 10.1107/S2053230X14008486; Wang YB, 2013, PHYSIOL PLANTARUM, V149, P13, DOI 10.1111/ppl.12018; Wu LN, 2014, PLANT CELL REP, V33, P1881, DOI 10.1007/s00299-014-1666-8; Wu YZ, 2016, PLANT BIOTECHNOL J, V14, P1046, DOI 10.1111/pbi.12477; Xu D, 2016, PLANT PHYSL; Yang X, 2017, PLANTA, V11, P1; Yang XJ, 2014, J INTEGR PLANT BIOL, V56, P979, DOI 10.1111/jipb.12212; Zhang DB, 2016, SUBCELL BIOCHEM, V86, P315, DOI 10.1007/978-3-319-25979-6_13; Zhang DB, 2014, SIGNAL COMMUN PLANTS, P49, DOI 10.1007/978-3-319-06511-3_4; Zhang DB, 2014, CURR OPIN PLANT BIOL, V17, P49, DOI 10.1016/j.pbi.2013.11.001; Zhang DB, 2011, J GENET GENOMICS, V38, P379, DOI 10.1016/j.jgg.2011.08.001; Zhang DB, 2009, CHINESE SCI BULL, V54, P2342, DOI 10.1007/s11434-009-0348-3; Zhang DS, 2010, PLANT PHYSIOL, V154, P149, DOI 10.1104/pp.110.158865; Zhao GC, 2015, PLANT PHYSIOL, V169, P2064, DOI 10.1104/pp.15.00262; Zhou H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37395	53	0	0	42	42	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	OCT	2017	37	10							126	10.1007/s11032-017-0722-9				12	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	FH4PN	WOS:000411138800011					2018-01-05	
J	Nieves-Cordones, M; Mohamed, S; Tanoi, K; Kobayashi, NI; Takagi, K; Vernet, A; Guiderdoni, E; Perin, C; Sentenac, H; Very, AA				Nieves-Cordones, Manuel; Mohamed, Sonia; Tanoi, Keitaro; Kobayashi, Natsuko I.; Takagi, Keiko; Vernet, Aurore; Guiderdoni, Emmanuel; Perin, Christophe; Sentenac, Herve; Very, Anne-Alienor			Production of low-Cs+ rice plants by inactivation of the K+ transporter OsHAK1 with the CRISPR-Cas system	PLANT JOURNAL			English	Article						rice; cesium; HAK1; CRISPR-Cas; soil contamination by radioactivity	HIGH-AFFINITY POTASSIUM; ORYZA-SATIVA L.; ARABIDOPSIS-THALIANA; FUKUSHIMA PREFECTURE; FUNCTIONAL-CHARACTERIZATION; SALT TOLERANCE; CESIUM UPTAKE; PADDY FIELD; AKT1; MECHANISMS	The occurrence of radiocesium in food has raised sharp health concerns after nuclear accidents. Despite being present at low concentrations in contaminated soils (below mu M), cesium (Cs+) can be taken up by crops and transported to their edible parts. This plant capacity to take up Cs+ from low concentrations has notably affected the production of rice (Oryza sativa L.) in Japan after the nuclear accident at Fukushima in 2011. Several strategies have been put into practice to reduce Cs+ content in this crop species such as contaminated soil removal or adaptation of agricultural practices, including dedicated fertilizer management, with limited impact or pernicious side- effects. Conversely, the development of biotechnological approaches aimed at reducing Cs+ accumulation in rice remain challenging. Here, we show that inactivation of the Cs+-permeable K+ transporter OsHAK1 with the CRISPR-Cas system dramatically reduced Cs+ uptake by rice plants. Cs+ uptake in rice roots and in transformed yeast cells that expressed OsHAK1 displayed very similar kinetics parameters. In rice, Cs+ uptake is dependent on two functional properties of OsHAK1: (i) a poor capacity of this system to discriminate between Cs+ and K+; and (ii) a high capacity to transport Cs+ from very low external concentrations that is likely to involve an active transport mechanism. In an experiment with a Fukushima soil highly contaminated with 137 Cs+, plants lacking OsHAK1 function displayed strikingly reduced levels of 137 Cs+ in roots and shoots. These results open stimulating perspectives to smartly produce safe food in regions contaminated by nuclear accidents.	[Nieves-Cordones, Manuel; Mohamed, Sonia; Sentenac, Herve; Very, Anne-Alienor] Univ Montpellier, Montpellier SupAgro, Biochim & Physiol Mol Plantes, Inst Biol Integrat Plantes,UMR 5004,CNRS,INRA 386, F-34060 Montpellier 2, France; [Mohamed, Sonia; Vernet, Aurore; Guiderdoni, Emmanuel; Perin, Christophe] CIRAD, UMR AGAP, F-34398 Montpellier 5, France; [Tanoi, Keitaro; Kobayashi, Natsuko I.; Takagi, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Tanoi, Keitaro] Japan Sci & Technol Agcy JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Nieves-Cordones, Manuel] CEBAS CSIC, Dept Nutr Vegetal, Campus Espinardo, Murcia 30100, Spain	Nieves-Cordones, M; Very, AA (reprint author), Univ Montpellier, Montpellier SupAgro, Biochim & Physiol Mol Plantes, Inst Biol Integrat Plantes,UMR 5004,CNRS,INRA 386, F-34060 Montpellier 2, France.; Nieves-Cordones, M (reprint author), CEBAS CSIC, Dept Nutr Vegetal, Campus Espinardo, Murcia 30100, Spain.	mncordones@gmail.com; very@supagro.inra.fr		Nieves-Cordones, Manuel/0000-0002-4015-0981; Sentenac, Herve/0000-0003-3641-4822	ANR IA grant [ANR-11-RSNR-0005 Demeterres]; Precursory Research for Embryonic Science and Technology (PRESTO) program from the Japan Science and Technology Agency (JST) [15665950]	We are grateful to Jin Miao for providing pOsgRNA and pHUbi-Cas9 vectors and to Alonso Rodriguez-Navarro for providing pYPGE15 vector, to Murielle Portefaix for transgenic plant production, to Christian Chaine and Remy Michel for their help in greenhouse management, and to Anne-Cecile Meunier for assistance in sgRNA cloning. OsHAK1 cDNA was obtained from the KOME library (Japan). The T-DNA insertion line in OsHAK1 was obtained from Gynheung An. This work was supported by an ANR IA grant (ANR-11-RSNR-0005 Demeterres), to E.G. and H.S., and by a Precursory Research for Embryonic Science and Technology (PRESTO) program from the Japan Science and Technology Agency (JST) (15665950) to K.T.	Aleman F, 2009, ENVIRON EXP BOT, V65, P263, DOI 10.1016/j.envexpbot.2008.09.011; Banuelos MA, 2002, PLANT PHYSIOL, V130, P784, DOI 10.1104/pp.007781; Bertl A, 2003, MOL MICROBIOL, V47, P767, DOI 10.1046/j.1365-2958.2003.03335.x; Bongaarts J, 2009, PHILOS T R SOC B, V364, P2985, DOI 10.1098/rstb.2009.0137; Broadley MR, 2001, J EXP BOT, V52, P839, DOI 10.1093/jexbot/52.357.839                                                       ; BRUNELLI JP, 1993, YEAST, V9, P1299, DOI 10.1002/yea.320091203; Caballero F, 2012, PLANT CELL PHYSIOL, V53, P2047, DOI 10.1093/pcp/pcs140; Chen G, 2015, PLANT CELL ENVIRON, V38, P2747, DOI 10.1111/pce.12585; Collander R, 1941, PLANT PHYSIOL, V16, P691, DOI 10.1104/pp.16.4.691; EPSTEIN E, 1952, PLANT PHYSIOL, V27, P457, DOI 10.1104/pp.27.3.457; EPSTEIN E, 1963, P NATL ACAD SCI USA, V49, P684, DOI 10.1073/pnas.49.5.684; Fujimura S, 2016, J ENVIRON RADIOACTIV, V153, P188, DOI 10.1016/j.jenvrad.2016.01.001; Fujiwara T., 2013, AGR IMPLICATIONS FUK, P29; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Ishikawa S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02243-9; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Kato N, 2015, SOIL SCI PLANT NUTR, V61, P179, DOI 10.1080/00380768.2014.995584; Khatodia S, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00506, 10.3389/fpls.2016.00506]; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kobayashi D, 2010, BIOSCI BIOTECH BIOCH, V74, P203, DOI 10.1271/bbb.90638; Kobayashi NI, 2016, FUNCT PLANT BIOL, V43, P151, DOI 10.1071/FP15245; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Lepage H, 2015, J ENVIRON RADIOACTIV, V147, P157, DOI 10.1016/j.jenvrad.2015.05.003; Li JW, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-48; MAATHUIS FJM, 1994, P NATL ACAD SCI USA, V91, P9272, DOI 10.1073/pnas.91.20.9272; Martinez-Cordero MA, 2004, PLANT MOL BIOL, V56, P413, DOI 10.1007/s11103-004-3845-4; Mian A, 2011, PLANT J, V68, P468, DOI 10.1111/j.1365-313X.2011.04701.x; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nemoto K, 2013, AGR IMPLICATIONS FUK, P19, DOI DOI 10.1007/978-4-431-54328-2; Nieves-Cordones M, 2008, PLANT MOL BIOL, V68, P521, DOI 10.1007/s11103-008-9388-3; Nieves-Cordones M, 2007, PLANT SCI, V172, P273, DOI 10.1016/j.plantsci.2006.09.003; Nieves-Cordones M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00992; Nieves-Cordones M, 2010, MOL PLANT, V3, P326, DOI 10.1093/mp/ssp102; Nihei N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08653; Ohmori Y, 2014, J PLANT RES, V127, P67, DOI 10.1007/s10265-013-0618-7; Ohmori Y, 2014, J PLANT RES, V127, P57, DOI 10.1007/s10265-013-0616-9; Qi Z, 2008, J EXP BOT, V59, P595, DOI 10.1093/jxb/erm330; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Rodriguez-Navarro A, 2000, BBA-REV BIOMEMBRANES, V1469, P1, DOI 10.1016/S0304-4157(99)00013-1; Rubio F, 2000, PHYSIOL PLANTARUM, V109, P34, DOI 10.1034/j.1399-3054.2000.100106.x; Rubio F, 2008, PHYSIOL PLANTARUM, V134, P598, DOI 10.1111/j.1399-3054.2008.01168.x; Sakai M, 2014, ENVIRON POLLUT, V187, P112, DOI 10.1016/j.envpol.2014.01.002; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Santa-Maria GE, 1997, PLANT CELL, V9, P2281, DOI 10.1105/tpc.9.12.2281                                                           ; Schaart JG, 2016, TRENDS PLANT SCI, V21, P438, DOI 10.1016/j.tplants.2015.11.006; Scherzer S, 2015, P NATL ACAD SCI USA, V112, P7309, DOI 10.1073/pnas.1507810112; SHEAHAN JJ, 1993, PLANT J, V3, P647, DOI 10.1111/j.1365-313X.1993.00647.x                                                ; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Spalding EP, 1999, J GEN PHYSIOL, V113, P909, DOI 10.1085/jgp.113.6.909; Szczerba MW, 2008, J EXP BOT, V59, P3415, DOI 10.1093/jxb/ern190; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.plant.54.031902.134831; Very AA, 2014, J PLANT PHYSIOL, V171, P748, DOI 10.1016/j.jplph.2014.01.011; Wakabayashi S, 2016, J ENVIRON RADIOACTIV, V157, P102, DOI 10.1016/j.jenvrad.2016.03.010; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; White PJ, 2000, NEW PHYTOL, V147, P241, DOI 10.1046/j.1469-8137.2000.00704.x; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhu YG, 2000, J EXP BOT, V51, P1635, DOI 10.1093/jexbot/51.351.1635	61	0	0	24	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	OCT	2017	92	1					43	56		10.1111/tpj.13632				14	Plant Sciences	Plant Sciences	FH6ZF	WOS:000411329300005	28670755				2018-01-05	
J	Vu, GTH; Cao, HX; Fauser, F; Reiss, B; Puchta, H; Schubert, I				Vu, Giang T. H.; Cao, Hieu X.; Fauser, Friedrich; Reiss, Bernd; Puchta, Holger; Schubert, Ingo			Endogenous sequence patterns predispose the repair modes of CRISPR/Cas9-induced DNA double-stranded breaks in Arabidopsis thaliana	PLANT JOURNAL			English	Article						amplicon sequencing; DNA double-stranded break repair; genome stability; site-directed mutagenesis; homology-directed repair (HDR); non-homologous end-joining (NHEJ)	SOMATIC PLANT-CELLS; HOMOLOGOUS RECOMBINATION; GENE REPLACEMENT; GENOME EVOLUTION; NUCLEASES; MECHANISM; PATHWAYS; SYSTEM; BARLEY	The possibility to predict the outcome of targeted DNA double-stranded break (DSB) repair would be desirable for genome editing. Furthermore the consequences of mis-repair of potentially cell-lethal DSBs and the underlying pathways are not yet fully understood. Here we study the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-induced mutation spectra at three selected endogenous loci in Arabidopsis thaliana by deep sequencing of long amplicon libraries. Notably, we found sequence-dependent genomic features that affected the DNA repair outcome. Deletions of 1-bp to <1000-bp size and/or very short insertions, deletions >1 kbp (all due to NHEJ) and deletions combined with insertions between 5-bp to >100 bp [caused by a synthesis-dependent strand annealing (SDSA)-like mechanism] occurred most frequently at all three loci. The appearance of single-stranded annealing events depends on the presence and distance between repeats flanking the DSB. The frequency and size of insertions is increased if a sequence with high similarity to the target site was available in cis. Most deletions were linked to pre-existing microhomology. Deletion and/or insertion mutations were blunt-end ligated or via de novo generated microhomology. While most mutation types and, to some degree, their predictability are comparable with animal systems, the broad range of deletion mutations seems to be a peculiar feature of the plant A. thaliana.	[Vu, Giang T. H.; Cao, Hieu X.; Schubert, Ingo] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Gatersleben, Stadt Seeland, Germany; [Fauser, Friedrich; Puchta, Holger] Karlsruhe Inst Technol, Bot Inst 2, POB 6980, D-76049 Karlsruhe, Germany; [Reiss, Bernd] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Cao, Hieu X.] Martin Luther Univ Halle Wittenberg, Inst Biol, Weinbergweg 10, D-06120 Halle, Germany; [Fauser, Friedrich] Princeton Univ, Lewis Thomas Lab 119, Dept Mol Biol, Princeton, NJ 08544 USA	Vu, GTH; Schubert, I (reprint author), Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Gatersleben, Stadt Seeland, Germany.	vu@ipk-gatersleben.de; schubert@ipk-gatersleben.de	Cao, Hieu/Q-2457-2015	Cao, Hieu/0000-0003-1230-4127; Puchta, Holger/0000-0003-1073-8546; Vu, Giang/0000-0001-8394-9067	German Research Foundation [SCHU 951/18-1]; European Research Council [AdG_20100317 RECBREED]	This study is supported by the German Research Foundation (SCHU 951/18-1) to I.S. and the European Research Council (AdG_20100317 RECBREED to H.P.).	Aryan A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01603; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Cao HX, 2016, INT J GENOMICS, DOI 10.1155/2016/5078796; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Gorbunova V, 1997, NUCLEIC ACIDS RES, V25, P4650, DOI 10.1093/nar/25.22.4650; Hartlerode AJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006410; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kirik A, 2000, EMBO J, V19, P5562, DOI 10.1093/emboj/19.20.5562; Koole W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4216; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379; McVey M, 2016, ANNU REV GENET, V50, P393, DOI 10.1146/annurev-genet-120215-035243; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Orel N, 2003, PLANT J, V35, P604, DOI 10.1046/j.1365-313X.2003.01832.x; Osakabe Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26685; Pacher M, 2017, PLANT J, V90, P819, DOI 10.1111/tpj.13469; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Puchta H, 1999, METH MOL B, V113, P447; Puchta H, 1998, PLANT J, V13, P331, DOI 10.1046/j.1365-313X.1998.00035.x                                                ; Puchta H, 2017, CURR OPIN PLANT BIOL, V36, P1, DOI 10.1016/j.pbi.2016.11.011; Puchta H, 2012, PLANT CELL, V24, P4324, DOI 10.1105/tpc.112.101824; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salomon S, 1998, EMBO J, V17, P6086, DOI 10.1093/emboj/17.20.6086                                                        ; Schiml S, 2016, P NATL ACAD SCI USA, V113, P7266, DOI 10.1073/pnas.1603823113; Schubert I, 2016, TRENDS PLANT SCI, V21, P749, DOI 10.1016/j.tplants.2016.06.003; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shen H, 2017, G3-GENES GENOM GENET, V7, P193, DOI 10.1534/g3.116.035204; Siebert R, 2002, PLANT CELL, V14, P1121, DOI 10.1105/tpc.001727; Steinert J, 2016, PLANT CELL REP, V35, P1429, DOI 10.1007/s00299-016-1981-3; Tan EP, 2015, GENESIS, V53, P225, DOI 10.1002/dvg.22835; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; vansKregten M., 2016, NAT PLANTS, V2, P16164; Vu GTH, 2017, NEW PHYTOL, V214, P1712, DOI 10.1111/nph.14490; Vu GTH, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.04.0021; Vu GTH, 2014, PLANT CELL, V26, P2156, DOI 10.1105/tpc.114.126607; Watanabe K, 2016, J EXP BOT, V67, P1433, DOI 10.1093/jxb/erv537; Wendeler E, 2015, PLANT J, V81, P548, DOI 10.1111/tpj.12749; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890	47	0	0	18	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	OCT	2017	92	1					57	67		10.1111/tpj.13634				11	Plant Sciences	Plant Sciences	FH6ZF	WOS:000411329300006	28696528				2018-01-05	
J	Ehrke-Schulz, E; Zhang, WL; Gao, J; Ehrhardt, A				Ehrke-Schulz, Eric; Zhang, Wenli; Gao, Jian; Ehrhardt, Anja			Recent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors	HUMAN GENE THERAPY			English	Review						long-term therapeutic effects; designer nucleases; Adenovirus hybrid vectors; Sleeping Beauty transposase	SLEEPING-BEAUTY TRANSPOSASE; IN-VIVO; GENE-TRANSFER; HIGH-CAPACITY; T-CELLS; MUTATIONAL ANALYSIS; NONHUMAN-PRIMATES; CATHETER DELIVERY; MAMMALIAN-CELLS; DNA-BINDING	Adenovirus (Ad)-based vectors are efficient gene-transfer vehicles to deliver foreign DNA into living organisms, offering large cargo capacity and low immunogenicity and genotoxicity. As Ad shows low integration rates of their genomes into host chromosomes, vector-derived gene expression decreases due to continuous cell cycling in regenerating tissues and dividing cell populations. To overcome this hurdle, adenoviral delivery can be combined with mechanisms leading to maintenance of therapeutic DNA and long-term effects of the desired treatment. Several hybrid Ad vectors (AdV) exploiting various strategies for long-term treatment have been developed and characterized. This review summarizes recent developments of preclinical approaches using hybrid AdVs utilizing either the Sleeping Beauty transposase system for somatic integration into host chromosomes or designer nucleases, including transcription activator-like effector nucleases and clustered regularly interspaced short palindromic repeats/CRISPR-associated protein-9 nuclease for permanent gene editing. Further options on how to optimize these vectors further are discussed, which may lead to future clinical applications of these versatile gene-therapy tools.	[Ehrke-Schulz, Eric; Zhang, Wenli; Gao, Jian; Ehrhardt, Anja] Witten Herdecke Univ, Ctr Biomed Educ & Res ZBAF, Chair Virol & Microbiol, Dept Human Med,Fac Hlth, Witten, Germany	Ehrhardt, A (reprint author), Witten Herdecke Univ, Chair Virol & Microbiol ZBAF, Dept Human Med, Fac Hlth, Stockumer Str 10, D-58453 Witten, Germany.	anja.ehrhardt@uni-wh.de			German Duchenne Foundation Aktion Benny und Co e.V.; Witten Herdecke University internal research [IFF2017-12]; German Research Foundation (DFG) [SPP1230]; Chinese Scholarship Council (CSC)	This work was supported by the German Duchenne Foundation Aktion Benny und Co e.V., Witten Herdecke University internal research funding (IFF2017-12) to E.E-S, the SPP1230 provided by the German Research Foundation (DFG) to A.E., and the Chinese Scholarship Council (CSC) to J.G.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boehme P, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.44; Boehme P, 2015, CURR GENE THER, V15, P255, DOI 10.2174/1566523215666150126121353; Bowers WJ, 2006, MOL THER, V13, P580, DOI 10.1016/j.ymthe.2005.11.011; Bradley RR, 2012, J VIROL, V86, P625, DOI 10.1128/JVI.06254-11; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Brunetti-Pierri N, 2012, MOL THER, V20, P1863, DOI 10.1038/mt.2012.143; Brunetti-Pierri N, 2009, MOL THER, V17, P327, DOI 10.1038/mt.2008.257; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Crystal RG, 2014, HUM GENE THER, V25, P3, DOI 10.1089/hum.2013.2527; Dedieu JF, 1997, J VIROL, V71, P4626; Donahue RE, 2009, BLOOD, V114, P2530, DOI 10.1182/blood-2009-04-214403; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Gao GP, 1996, J VIROL, V70, P8934; Hausl MA, 2010, MOL THER, V18, P1896, DOI 10.1038/mt.2010.169; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Holkers M, 2014, METHODS, V69, P179, DOI 10.1016/j.ymeth.2014.02.017; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2004, MOL THER, V9, P147, DOI 10.1016/j.ymthe.2003.11.009; Jager L, 2009, HUM GENE THER, V20, P883, DOI 10.1089/hum.2009.020; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kebriaei P, 2016, J CLIN INVEST, V126, P3363, DOI 10.1172/JCI86721; Koo T, 2017, NUCLEIC ACIDS RES, V45, P7897, DOI 10.1093/nar/gkx490; Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Li C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30422; Luo WY, 2012, GENE THER, V19, P844, DOI 10.1038/gt.2011.129; Lusky M, 1998, J VIROL, V72, P2022; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maggio I, 2016, SCI REP-UK, V6, DOI 10.1038/srep37051; Maggio I, 2016, NUCLEIC ACIDS RES, V44, P1449, DOI 10.1093/nar/gkv1540; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mitani K., 2002, Current Gene Therapy, V2, P135, DOI 10.2174/1566523024605591; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Muther N, 2009, VIRUSES-BASEL, V1, P1295, DOI 10.3390/v1031295; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Rauschhuber C, 2012, EUR J CELL BIOL, V91, P2, DOI 10.1016/j.ejcb.2011.01.006; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Richter M, 2016, BLOOD, V128, P2206, DOI 10.1182/blood-2016-04-711580; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Sakurai F, 2003, MOL THER, V8, P813, DOI 10.1016/S1525-0016(03)00243-0; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180                                                              ; Seregin SS, 2009, EXPERT OPIN BIOL TH, V9, P1521, DOI 10.1517/14712590903307388; Shayakhmetov DM, 2002, J VIROL, V76, P1135, DOI 10.1128/JVI.76.3.1135-1143.2002; Smith CA, 1998, HUM GENE THER, V9, P1419, DOI 10.1089/hum.1998.9.10-1419                                                      ; Soifer HS, 2004, CURR GENE THER, V4, P373; Tang J, 2004, GENE THER, V11, P1408, DOI 10.1038/sj.gt.3302316; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HJ, 2007, J VIROL, V81, P12785, DOI 10.1128/JVI.01732-07; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407                                                         ; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2004, MOL CELL BIOL, V24, P9239, DOI 10.1128/MCB.24.20.92309-9247.2004; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024; Zhang WL, 2017, CELL REP, V19, P1698, DOI 10.1016/j.celrep.2017.05.008; Zhang WL, 2014, CURR GENE THER, V14, P10, DOI 10.2174/1566523213666131223130024; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075344	65	0	0	5	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1043-0342	1557-7422		HUM GENE THER	Hum. Gene Ther.	OCT	2017	28	10	1		SI		833	841		10.1089/hum.2017.140				9	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FI3DA	WOS:000411835800005	28854818				2018-01-05	
J	Xue, HP; Wu, ZW; Qiao, DD; Tong, C; Zhao, X				Xue, Huping; Wu, Zhaowei; Qiao, Dandan; Tong, Chao; Zhao, Xin			Global acquisition of genetic material from different bacteria into the staphylococcal cassette chromosome elements of a Staphylococcus epidermidis isolate	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS			English	Article						Methicillin-resistant Staphylococcus aureus; Staphylococcal cassette chromosome; element; Assembly; Genetic material exchange; Restriction-modification system; USA300	METHICILLIN RESISTANCE; AUREUS USA300; HEAVY-METAL; EVOLUTION; INFECTION; GENOMICS; SEQUENCE; INSIGHTS; CADMIUM; CLONING	Staphylococcus epidermidis has been suggested as a main reservoir of methicillin resistance and virulence genes facilitating the evolution of Staphylococcus aureus as a successful pathogen. However, it remains a mystery where and how S. epidermidis obtains these numerous genes to serve as the reservoir. In this study, methicillin-resistant S. epidermidis isolate NW32 from a mastitic milk sample was sequenced and its staphylococcal cassette chromosome (SCC) elements were characterised. The SCC composite island covered 3.5% of the genome and consisted of three intact SCC elements carrying resistance genes against beta-lactam antibiotics, several heavy metals and polyamines as well as genes for utilisation of sorbitol as a carbon source. Analysis of the postulated evolutionary route suggested that the three SCC elements were assembled fromgenetic material from various bacterial species (staphylococci, streptococci, salinicocci and Lysinibacillus) from three habitats (human, soil and cow) in different countries (Asia, North America, South America and Europe). We propose that the hsdS restriction-modification profile and the lack of CRISPR (clustered regularly interspaced short palindromic repeat) sequences in this bacterium may facilitate the genetic exchange of SCC elements among different staphylococcal species. (C) 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.	[Xue, Huping; Wu, Zhaowei; Qiao, Dandan; Tong, Chao; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada	Zhao, X (reprint author), McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada.	xin.zhao@mcgill.ca			China Post-doctoral Science Foundation [2015M572606]; University Scientific Research Fund project [Z109021431]; National Natural Science Foundation of China [31372282, 31602023]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-04715]	This work was supported by a grant from the China Post-doctoral Science Foundation [grant no. 2015M572606], a University Scientific Research Fund project [fund no. Z109021431] and two grants from the National Natural Science Foundation of China [grant no. 31372282 and grant no. 31602023]. This work was also partially supported from a discovery grant by the Natural Sciences and Engineering Research Council of Canada [fund no. RGPIN-2016-04715].	AYOUBI P, 1991, J BACTERIOL, V173, P1617, DOI 10.1128/jb.173.5.1617-1622.1991                                                 ; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Boyd DA, 2000, INFECT IMMUN, V68, P925, DOI 10.1128/IAI.68.2.925-930.2000                                                   ; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Chlebowicz MA, 2010, ANTIMICROB AGENTS CH, V54, P783, DOI 10.1128/AAC.00696-09; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Clinical and Laboratory Standards Institute, 2004, M31S1 CLSI; Didelot X, 2016, NAT REV MICROBIOL, V14, P150, DOI 10.1038/nrmicro.2015.13; Dubilier N, 2015, NATURE, V526, P631, DOI 10.1038/526631a; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; FRIEDMAN SA, 1977, J BACTERIOL, V130, P991; Glaser P, 2016, MBIO, V7, DOI 10.1128/mBio.02183-15; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449; Jain M, 2010, PLANT SOIL ENVIRON, V56, P263; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Knight GM, 2012, J ANTIMICROB CHEMOTH, V67, P2514, DOI 10.1093/jac/dks245; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Meric G, 2015, GENOME BIOL EVOL, V7, P1313, DOI 10.1093/gbe/evv066; Monk IR, 2015, MBIO, V6, DOI 10.1128/mBio.00308-15; Navratna V, 2010, J BACTERIOL, V192, P134, DOI 10.1128/JB.00822-09; Otto M, 2013, BIOESSAYS, V35, P4, DOI 10.1002/bies.201200112; Pehrsson EC, 2016, NATURE, V533, P212, DOI 10.1038/nature17672; Planet PJ, 2015, J INFECT DIS, V212, P1874, DOI 10.1093/infdis/jiv320; Roberts GA, 2013, NUCLEIC ACIDS RES, V41, P7472, DOI 10.1093/nar/gkt535; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Sowmya M, 2014, J ENVIRON BIOL, V35, P655; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.18280799; Thurlow LR, 2013, CELL HOST MICROBE, V13, P100, DOI 10.1016/j.chom.2012.11.012; van der Mee-Marquet NL, 2016, J INFECT DIS, V213, P1362, DOI 10.1093/infdis/jiv490; Von Dach E, 2016, J INFECT DIS, V213, P1370, DOI 10.1093/infdis/jiv489; Wakefield N, 2015, FEBS LETT, V589, P3197, DOI 10.1016/j.febslet.2015.09.005; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wu ZW, 2015, ANTIMICROB AGENTS CH, V59, P7597, DOI 10.1128/AAC.01692-15; Xue HP, 2015, ANTIMICROB AGENTS CH, V59, P5788, DOI 10.1128/AAC.04831-14	40	0	0	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-8579	1872-7913		INT J ANTIMICROB AG	Int. J. Antimicrob. Agents	OCT	2017	50	4					581	587		10.1016/j.ijantimicag.2017.06.015				7	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	FI3UF	WOS:000411894800012	28705673				2018-01-05	
J	Bohnsack, JP; Patel, VK; Morrow, AL				Bohnsack, John Peyton; Patel, Vraj K.; Morrow, A. Leslie			Ethanol Exposure Regulates Gabra1 Expression via Histone Deacetylation at the Promoter in Cultured Cortical Neurons	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							GAMMA-AMINOBUTYRIC-ACID; PROTEIN-KINASE-C; GABA-BENZODIAZEPINE-RECEPTOR; SUBUNIT MESSENGER-RNAS; RAT CEREBRAL-CORTEX; GENE-EXPRESSION; BEHAVIORAL-RESPONSES; SYNAPTIC PLASTICITY; ALCOHOL DEPENDENCY; SURFACE EXPRESSION	gamma-Aminobutyric acid A receptors (GABA(A)-Rs) mediate the majority of inhibitory neurotransmission in the adult brain. The alpha 1-containing GABA(A)-Rs are the most prominent subtype in the adult brain and are important in both homeostatic function and several disease pathologies including alcohol dependence, epilepsy, and stress. Ethanol exposure causes a decrease of alpha 1 transcription and peptide expression both in vivo and in vitro, but the mechanism that controls the transcriptional regulation is unknown. Because ethanol is known to activate epigenetic regulation of gene expression, we tested the hypothesis that ethanol regulates alpha 1 expression through histone modifications in cerebral cortical cultured neurons. We found that class I histone deacetylases (HDACs) regulate ethanol-induced changes in alpha 1 gene and protein expression as pharmacologic inhibition or knockdown of HDAC1-3 prevents the effects of ethanol exposure. Targeted histone acetylation associated with the Gabra1 promoter using CRISPR (clustered regularly interspaced palindromic repeat) dCas9-P300 (a nuclease-null Cas9 fused with a histone acetyltransferase) increases histone acetylation and prevents the decrease of Gabra1 expression. In contrast, there was no effect of a mutant histone acetyltransferase or generic transcriptional activator or targeting P300 to a distant exon. Conversely, using a dCas9-KRAB construct that increases repressive methylation (H3K9me3) does not interfere with ethanol-induced histone deacetylation. Overall our results indicate that ethanol deacetylates histones associated with the Gabra1 promoter through class I HDACs and that pharmacologic, genetic, or epigenetic intervention prevents decreases in alpha 1 expression in cultured cortical neurons.	[Bohnsack, John Peyton; Morrow, A. Leslie] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Morrow, A. Leslie] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Bohnsack, John Peyton; Patel, Vraj K.; Morrow, A. Leslie] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA	Morrow, AL (reprint author), 3027 Thurston Bowles Bldg,CB 7178, Chapel Hill, NC 27599 USA.	morrow@med.unc.edu		Bohnsack, John/0000-0002-8713-4436	National Institutes of Health National Institute on Alcohol Abuse and Alcoholism [P60-AA11605]; Bowles Center for Alcohol Studies	This work was supported by the National Institutes of Health National Institute on Alcohol Abuse and Alcoholism [Grant P60-AA11605] (to A. L. M.) and the Bowles Center for Alcohol Studies.	Agudelo M, 2011, ALCOHOL CLIN EXP RES, V35, P1550, DOI 10.1111/j.1530-0277.2011.01492.x; Amato L, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005063; Lopez-Moreno JA, 2015, ALCOHOL CLIN EXP RES, V39, P1939, DOI 10.1111/acer.12850; Arora DS, 2013, NEUROPSYCHOPHARMACOL, V38, P1674, DOI 10.1038/npp.2013.65; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bohnsack JP, 2016, NEUROPHARMACOLOGY, V105, P124, DOI 10.1016/j.neuropharm.2016.01.009; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1385/JMN/31:01:47; Cagetti E, 2003, MOL PHARMACOL, V63, P53, DOI 10.1124/mol.63.1.53                                                             ; Cagetti E, 2004, NEUROPHARMACOLOGY, V46, P570, DOI 10.1016/j.neuropharm.2003.10.001; Carlson SL, 2013, J PHARMACOL EXP THER, V345, P317, DOI 10.1124/jpet.112.201954; Devaud LL, 1999, PHARMACOL BIOCHEM BE, V64, P841, DOI 10.1016/S0091-3057(99)00164-1; DEVAUD LL, 1995, MOL PHARMACOL, V48, P861; Devaud LL, 1997, J NEUROCHEM, V69, P126; DEVAUD LL, 1995, ALCOHOL CLIN EXP RES, V19, P350, DOI 10.1111/j.1530-0277.1995.tb01514.x; Devaud LL, 1995, NIAAA RES MONOGRAPH, P219; Di XJ, 2013, CHEM BIOL, V20, P1456, DOI [10.1016/j.chembiol.2013.09.020, 10.1016/j.chembio1.2013.09.020]; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Farris SP, 2015, MOL PSYCHIATR, V20, P1438, DOI 10.1038/mp.2014.159; Fatemi SH, 2009, J AUTISM DEV DISORD, V39, P223, DOI 10.1007/s10803-008-0646-7; Grabenstatter HL, 2012, EPILEPSIA, V53, P71, DOI 10.1111/epi.12036; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hanson JE, 2013, J NEUROSCI, V33, P5924, DOI 10.1523/JNEUROSCI.3162-12.2013; Herman MA, 2016, J NEUROSCI, V36, P10729, DOI 10.1523/JNEUROSCI.1267-16.2016; Herman MA, 2013, J NEUROSCI, V33, P3284, DOI 10.1523/JNEUROSCI.2490-12.2013; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hoftman GD, 2015, SCHIZOPHRENIA BULL, V41, P180, DOI 10.1093/schbul/sbt178; Hollister L E, 1990, Recent Dev Alcohol, V8, P233; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu YH, 2008, J BIOL CHEM, V283, P9328, DOI 10.1074/jbc.M705110200; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kennedy PJ, 2013, NAT NEUROSCI, V16, P434, DOI 10.1038/nn.3354; Kralic JE, 2005, J CLIN INVEST, V115, P774, DOI 10.1172/JCI200523625; Kumar S, 2002, J NEUROCHEM, V82, P110, DOI 10.1046/j.1471-4159.2002.00943.x; Kumar S, 2010, MOL PHARMACOL, V77, P793, DOI 10.1124/mol.109.063016; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Kuzmochka C, 2014, ENDOCRINOLOGY, V155, P4762, DOI 10.1210/en.2014-1565; Liang J, 2004, J PHARMACOL EXP THER, V310, P1234, DOI 10.1124/jpet.104.067983; Liang J, 2007, J NEUROSCI, V27, P12367, DOI 10.1523/JNEUROSCI.2786-07.2007; Lingford-Hughes AR, 2000, ALCOHOL CLIN EXP RES, V24, P1449, DOI 10.1097/00000374-200009000-00018; Lingford-Hughes AR, 1998, BRIT J PSYCHIAT, V173, P116, DOI 10.1192/bjp.173.2.116; LingfordHughes AR, 1997, J NUCL MED, V38, P399; Lund IV, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162396; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI [10.1073/pnas.1213364110/-/DCSupplemental, 10.1073/pnas.1213364110]; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; MHATRE MC, 1992, MOL PHARMACOL, V42, P415; MONTPIED P, 1991, MOL PHARMACOL, V39, P157; Moonat S, 2013, BIOL PSYCHIAT, V73, P763, DOI 10.1016/j.biopsych.2013.01.012; MORROW AL, 1991, ANN NY ACAD SCI, V625, P496, DOI 10.1111/j.1749-6632.1991.tb33880.x; MORROW AL, 1988, J PHARMACOL EXP THER, V246, P158; Pandey SC, 2005, ALCOHOL CLIN EXP RES, V29, P176, DOI 10.1097/01.ALC.0000153550.31168.ID; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Pandey SC, 2017, NEUROPHARMACOLOGY, V122, P74, DOI 10.1016/j.neuropharm.2017.02.002; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Poulter MO, 2008, BIOL PSYCHIAT, V64, P645, DOI 10.1016/j.biopsych.2008.05.028; Romieu P, 2008, J NEUROSCI, V28, P9342, DOI 10.1523/JNEUROSCI.0379-08.2008; Sanna E, 2003, J NEUROSCI, V23, P11711; Simon-O'Brien E, 2015, ADDICT BIOL, V20, P676, DOI 10.1111/adb.12161; Taylor C, 2008, ALCOHOL ALCOHOLISM, V43, P614, DOI 10.1093/alcalc/agn056; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; VanLint C, 1996, GENE EXPRESSION, V5, P245; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Warnault V, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.4; Werner DF, 2011, J NEUROCHEM, V116, P554, DOI 10.1111/j.1471-4159.2010.07140.x	66	0	0	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	OCT 1	2017	363	1					1	11		10.1124/jpet.117.242446				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FH9GE	WOS:000411518200001	28798030				2018-01-05	
J	Teshigawara, R; Cho, J; Kameda, M; Tada, T				Teshigawara, Rika; Cho, Junkwon; Kameda, Masahiro; Tada, Takashi			Mechanism of human somatic reprogramming to iPS cell	LABORATORY INVESTIGATION			English	Review							PLURIPOTENT STEM-CELLS; GROUND-STATE PLURIPOTENCY; TO-EPITHELIAL TRANSITION; GENERATION; MOUSE; EXPRESSION; MICRORNAS; FIBROBLASTS; LINEAGE; ROUTES	Somatic reprogramming to induced pluripotent stem cells (iPSC) was realized in the year 2006 in mice, and in 2007 in humans, by transiently forced expression of a combination of exogenous transcription factors. Human and mouse iPSCs are distinctly reprogrammed into a 'primed' and a 'naive' state, respectively. In the last decade, puzzle pieces of somatic reprogramming have been collected with difficulty. Collectively, dissecting reprogramming events and identification of the hallmark of sequentially activated/silenced genes have revealed mouse somatic reprogramming in fragments, but there is a long way to go toward understanding the molecular mechanisms of human somatic reprogramming, even with developing technologies. Recently, an established human intermediately reprogrammed stem cell (iRSC) line, which has paused reprogramming at the endogenous OCT4-negative/exogenous transgene-positive pre-MET (mesenchymal-toepithelial- transition) stage can resume reprogramming into endogenous OCT4-positive iPSCs only by change of culture conditions. Genome-editing-mediated visualization of endogenous OCT4 activity with GFP in living iRSCs demonstrates the timing of OCT4 activation and entry to MET in the reprogramming toward iPSCs. Applications of genome-editing technology to pluripotent stem cells will reshape our approaches for exploring molecular mechanisms.	[Teshigawara, Rika; Cho, Junkwon; Kameda, Masahiro; Tada, Takashi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Dev Epigenome, Kyoto, Japan	Tada, T (reprint author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Dev Epigenome, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	ttada@infront.kyoto-u.ac.jp					Boward B, 2016, STEM CELLS, V34, P1427, DOI 10.1002/stem.2345; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; David L, 2014, STEM CELL RES, V12, P754, DOI 10.1016/j.scr.2014.03.007; Esteban MA, 2012, CURR OPIN GENET DEV, V22, P423, DOI 10.1016/j.gde.2012.09.004; Frisa PS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-10; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Greder LV, 2012, STEM CELLS, V30, P2596, DOI 10.1002/stem.1216; Gu KL, 2016, CELL RES, V26, P350, DOI 10.1038/cr.2016.2; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Higuchi A, 2015, LAB INVEST, V95, P26, DOI 10.1038/labinvest.2014.132; Hirano K, 2012, STEM CELLS DEV, V21, P1287, DOI 10.1089/scd.2011.0283; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hussein SMI, 2012, CURR OPIN GENET DEV, V22, P435, DOI 10.1016/j.gde.2012.08.007; Jackson SA, 2016, STEM CELL REP, V6, P302, DOI 10.1016/j.stemcr.2016.01.009; Krause MN, 2016, BIOCHEM BIOPH RES CO, V473, P693, DOI 10.1016/j.bbrc.2015.11.120; Lamouille S, 2013, CURR OPIN CELL BIOL, V25, P200, DOI 10.1016/j.ceb.2013.01.008; Leonardo TR, 2012, NAT CELL BIOL, V14, P1114, DOI 10.1038/ncb2613; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li X, 2014, INT J DEV BIOL, V58, P21, DOI 10.1387/ijdb.140007XL; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nagata S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048699; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nefzger CM, 2014, JOVE-J VIS EXP, V91; Nishimura K, 2014, STEM CELL REP, V3, P915, DOI 10.1016/j.stemcr.2014.08.014; Ohgushi M, 2011, TRENDS CELL BIOL, V21, P274, DOI 10.1016/j.tcb.2011.02.004; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Park J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171300; Park SJ, 2017, STEM CELLS DEV, V26, P734, DOI 10.1089/scd.2016.0320; Pasque V, 2015, CURR OPIN CELL BIOL, V37, P75, DOI 10.1016/j.ceb.2015.10.006; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singh Vimal Kishor, 2015, J Stem Cells, V10, P43; Sridharan R, 2008, CELL STEM CELL, V2, P295, DOI 10.1016/j.stem.2008.03.015; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Teshigawara R, 2016, DEVELOPMENT, V143, P15, DOI 10.1242/dev.130344; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Tonge PD, 2014, NATURE, V516, P192, DOI 10.1038/nature14047; Vallot C, 2017, CELL STEM CELL, V20, P102, DOI 10.1016/j.stem.2016.10.014; Waddington Simon N, 2016, Curr Stem Cell Rep, V2, P9; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhou Yiye, 2013, [Genomics, Proteomics & Bioinformatics, 基因组蛋白质组与生物信息学报], V11, P284, DOI 10.1016/j.gpb.2013.09.008	62	0	0	10	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	OCT	2017	97	10					1152	1157		10.1038/labinvest.2017.56				6	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	FI5NN	WOS:000412031200004	28530648				2018-01-05	
J	Webber, BR; O'Connor, KT; McElmurry, RT; Durgin, EN; Eide, CR; Lees, CJ; Riddle, MJ; Mathews, WE; Frank, NY; Kluth, MA; Ganss, C; Moriarity, BS; Frank, MH; Osborn, MJ; Tolar, J				Webber, Beau R.; O'Connor, Kyle T.; McElmurry, Ron T.; Durgin, Elise N.; Eide, Cindy R.; Lees, Christopher J.; Riddle, Megan J.; Mathews, Wendy E.; Frank, Natasha Y.; Kluth, Mark A.; Ganss, Christoph; Moriarity, Branden S.; Frank, Markus H.; Osborn, Mark J.; Tolar, Jakub			Rapid generation of Col7a1(-/-) mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells	LABORATORY INVESTIGATION			English	Article							GENOME MODIFICATION; STROMAL CELLS; NSG MICE; DISEASE; THERAPY; CRISPR/CAS9; MECHANISMS; PHENOTYPE; NUCLEASES; CARCINOMA	Recessive dystrophic epidermolysis bullosa (RDEB) is a debilitating and ultimately lethal blistering disease caused by mutations to the Col7a1 gene. Development of novel cell therapies for the treatment of RDEB would be fostered by having immunodeficient mouse models able to accept human cell grafts; however, immunodeficient models of many genodermatoses such as RDEB are lacking. To overcome this limitation, we combined the clustered regularly interspaced short palindromic repeats and associated nuclease (CRISPR/Cas9) system with microinjection into NOD/SCID IL2ryc(null) (NSG) embryos to rapidly develop an immunodeficient Col7a1(-/-) mouse model of RDEB. Through dose optimization, we achieve F0 biallelic knockout efficiencies exceeding 80%, allowing us to quickly generate large numbers of RDEB NSG mice for experimental use. Using this strategy, we clearly demonstrate important strain-specific differences in RDEB pathology that could underlie discordant results observed between independent studies and establish the utility of this system in proof-of-concept human cellular transplantation experiments. Importantly, we uncover the ability of a recently identified skin resident immunomodulatory dermal mesenchymal stem cell marked by ABCB5 to reduce RDEB pathology and markedly extend the lifespan of RDEB NSG mice via reduced skin infiltration of inflammatory myeloid derivatives.	[Webber, Beau R.; McElmurry, Ron T.; Durgin, Elise N.; Eide, Cindy R.; Lees, Christopher J.; Riddle, Megan J.; Mathews, Wendy E.; Moriarity, Branden S.; Osborn, Mark J.; Tolar, Jakub] Univ Minnesota, Sch Med, Dept Pediat, Div Blood & Marrow Transplantat, 420 Delaware St SE,MMC 366, Minneapolis, MN 55455 USA; [O'Connor, Kyle T.] Univ Minnesota, Mouse Genet Lab Shared Resource, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Frank, Natasha Y.] Boston VA Healthcare Syst, Dept Med, West Roxbury, MA USA; [Frank, Natasha Y.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Kluth, Mark A.; Ganss, Christoph] Rheacell GmbH & Co KG, Heidelberg, Germany; [Kluth, Mark A.; Ganss, Christoph] Ticeba GmbH, Heidelberg, Germany; [Moriarity, Branden S.; Osborn, Mark J.; Tolar, Jakub] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Frank, Markus H.] Harvard Med Sch, Transplant Res Program, Boston Childrens Hosp, Boston, MA USA; [Frank, Markus H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Harvard Skin Dis Res Ctr, Boston, MA USA; [Frank, Markus H.] Edith Cowan Univ, Sch Med Sci, Joondalup, WA, Australia; [Frank, Markus H.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Osborn, Mark J.; Tolar, Jakub] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Osborn, Mark J.; Tolar, Jakub] Asan Minnesota Inst Innovating Transplantat, Seoul, South Korea	Tolar, J (reprint author), Univ Minnesota, Sch Med, Dept Pediat, Div Blood & Marrow Transplantat, 420 Delaware St SE,MMC 366, Minneapolis, MN 55455 USA.	tolar003@umn.edu		Tolar, Jakub/0000-0002-0957-4380	NIH [R01EY025794, R01AR063070, P01CA065493, 8UL1TR000114-02, T32HL007062]; Department of Veterans Affairs VA Merit Review Award VA RRD [1I01RX000989]; Harvard Stem Cell Institute Seed Grant	We thank Dr. George Murphy, Brigham and Women's Hospital, Harvard Medical School, for critical reading of the manuscript. This work was supported in part by NIH Grant R01EY025794 (to MHF and NYF), the Department of Veterans Affairs VA Merit Review Award VA RR&D 1I01RX000989 (to NYF), and a Harvard Stem Cell Institute Seed Grant (to MHF). JT is supported in part by NIH R01AR063070 and P01CA065493. MJO is supported by NIH 8UL1TR000114-02. BRW is supported by NIH T32HL007062.	Behringer R, 2014, MANIPULATING MOUSE E; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Galipeau J, 2016, CYTOTHERAPY, V18, P151, DOI 10.1016/j.jcyt.2015.11.008; Heinonen S, 1999, J CELL SCI, V112, P3641; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jiang DS, 2016, STEM CELLS, V34, P2393, DOI 10.1002/stem.2417; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Landel CP, 2013, TRANSGENIC RES, V22, P179, DOI 10.1007/s11248-012-9629-8; Lee Y., 2013, ADV BIOSCI BIOTECHNO, V4, P19, DOI [10.4236/abb.2013.48A3003, DOI 10.4236/ABB.2013.48A3003]; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; NOMURA K, 1988, J INVEST DERMATOL, V90, P170, DOI 10.1111/1523-1747.ep12462164; Nystrom A, 2015, EMBO MOL MED, V7, P1211, DOI 10.15252/emmm.201505061; Odorisio T, 2014, HUM MOL GENET, V23, P3907, DOI 10.1093/hmg/ddu102; Osborn MJ, 2016, MOL THER, V24, P570, DOI 10.1038/mt.2015.197; Pourreyron C, 2007, J INVEST DERMATOL, V127, P2438, DOI 10.1038/sj.jid.5700878; Schatton T, 2015, CELL REP, V12, P1564, DOI 10.1016/j.celrep.2015.08.010; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; South AP, 2010, DERMATOL CLIN, V28, P171, DOI 10.1016/j.det.2009.10.023; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Sweeney CL, 2017, HUM GENE THER, V28, P565, DOI 10.1089/hum.2017.005; Tolar J, 2013, LANCET, V382, P1214, DOI 10.1016/S0140-6736(13)61897-8; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; Tolar J, 2009, BLOOD, V113, P1167, DOI 10.1182/blood-2008-06-161299; Uitto J, 2017, MATRIX BIOL, V57-58, P76, DOI 10.1016/j.matbio.2016.07.009; Uitto J, 2012, J INVEST DERMATOL, V132, P820, DOI [10.1038/skinbio.2012.6, 10.1038/jid.2011.389]; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	29	0	0	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	OCT	2017	97	10					1218	1224		10.1038/labinvest.2017.85				7	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	FI5NN	WOS:000412031200010	28892093				2018-01-05	
J	Nihongaki, Y; Furuhata, Y; Otabe, T; Hasegawa, S; Yoshimoto, K; Sato, M				Nihongaki, Yuta; Furuhata, Yuichi; Otabe, Takahiro; Hasegawa, Saki; Yoshimoto, Keitaro; Sato, Moritoshi			CRISPR-Cas9-based photoactivatable transcription systems to induce neuronal differentiation	NATURE METHODS			English	Article							GENE ACTIVATION; CELLS	Our improved CRISPR-Cas9-based photoactivatable transcription systems, CPTS2.0 and Split-CPTS2.0, enable high blue-light-inducible activation of endogenous target genes in various human cell lines. We achieved reversible activation of target genes with CPTS2.0 and induced neuronal differentiation in induced pluripotent stem cells (iPSCs) by upregulating NEUROD1 with Split-CPTS2.0.	[Nihongaki, Yuta; Otabe, Takahiro; Hasegawa, Saki; Yoshimoto, Keitaro; Sato, Moritoshi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Furuhata, Yuichi] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan; [Nihongaki, Yuta] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA	Sato, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	cmsato@mail.ecc.u-tokyo.ac.jp		Nihongaki, Yuta/0000-0002-9818-9344	Japan Science and Technology Agency (START); Japan Science and Technology Agency (CREST) [JPMJCR1653]; Japan Society for the Promotion of Science (JSPS) [15J05897, 15J08446]	This work was supported by the Japan Science and Technology Agency (START and CREST grant JPMJCR1653 to M.S.) and the Japan Society for the Promotion of Science (JSPS) (grants to M.S.; JSPS Research Fellowships for Young Scientists to Y.N. (15J05897) and Y.F. (15J08446)).	Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Miyamoto T, 2012, NAT CHEM BIOL, V8, P465, DOI [10.1038/NCHEMBIO.922, 10.1038/nchembio.922]; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	19	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	OCT	2017	14	10					963	+		10.1038/NMETH.4430				6	Biochemical Research Methods	Biochemistry & Molecular Biology	FI5DR	WOS:000412002700015	28892089				2018-01-05	
J	Chow, RD; Guzman, CD; Wang, GC; Schmidt, F; Youngblood, MW; Ye, LP; Errami, Y; Dong, MB; Martinez, MA; Zhang, SS; Renauer, P; Bilguvar, K; Gunel, M; Sharp, PA; Zhang, F; Platt, RJ; Chen, SD				Chow, Ryan D.; Guzman, Christopher D.; Wang, Guangchuan; Schmidt, Florian; Youngblood, Mark W.; Ye, Lupeng; Errami, Youssef; Dong, Matthew B.; Martinez, Michael A.; Zhang, Sensen; Renauer, Paul; Bilguvar, Kaya; Gunel, Murat; Sharp, Phillip A.; Zhang, Feng; Platt, Randall J.; Chen, Sidi			AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma	NATURE NEUROSCIENCE			English	Article							INTEGRATED GENOMIC ANALYSIS; ENGINEERED MOUSE MODELS; NEXT-GENERATION; ADJUVANT TEMOZOLOMIDE; ADULT GLIOBLASTOMA; CANCER-THERAPY; HUMAN-CELLS; P53; SURVIVAL; GLIOMAS	A causative understanding of genetic factors that regulate glioblastoma pathogenesis is of central importance. Here we developed an adeno-associated virus-mediated, autochthonous genetic CRISPR screen in glioblastoma. Stereotaxic delivery of a virus library targeting genes commonly mutated in human cancers into the brains of conditional-Cas9 mice resulted in tumors that recapitulate human glioblastoma. Capture sequencing revealed diverse mutational profiles across tumors. The mutation frequencies in mice correlated with those in two independent patient cohorts. Co-mutation analysis identified co-occurring driver combinations such as B2m-Nf1, Mll3-Nf1 and Zc3h13-Rb1, which were subsequently validated using AAV minipools. Distinct from Nf1-mutant tumors, Rb1-mutant tumors are undifferentiated and aberrantly express homeobox gene clusters. The addition of Zc3h13 or Pten mutations altered the gene expression profiles of Rb1 mutants, rendering them more resistant to temozolomide. Our study provides a functional landscape of gliomagenesis suppressors in vivo.	[Chow, Ryan D.; Guzman, Christopher D.; Wang, Guangchuan; Youngblood, Mark W.; Ye, Lupeng; Errami, Youssef; Dong, Matthew B.; Martinez, Michael A.; Zhang, Sensen; Renauer, Paul; Bilguvar, Kaya; Gunel, Murat; Chen, Sidi] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Chow, Ryan D.; Guzman, Christopher D.; Wang, Guangchuan; Ye, Lupeng; Errami, Youssef; Dong, Matthew B.; Martinez, Michael A.; Zhang, Sensen; Renauer, Paul; Chen, Sidi] Yale Univ, Sch Med, Syst Biol Inst, West Haven, CT 06516 USA; [Chow, Ryan D.; Youngblood, Mark W.; Dong, Matthew B.; Gunel, Murat; Chen, Sidi] Yale Univ, Sch Med, Med Scientist Training Program, New Haven, CT 06520 USA; [Guzman, Christopher D.; Renauer, Paul; Chen, Sidi] Yale Univ, Sch Med, Biol & Biomed Sci Program, New Haven, CT 06520 USA; [Guzman, Christopher D.; Chen, Sidi] Yale Univ, Sch Med, Immunobiol Program, New Haven, CT 06520 USA; [Guzman, Christopher D.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Schmidt, Florian; Platt, Randall J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Schmidt, Florian; Platt, Randall J.] Univ Basel, Dept Chem, Basel, Switzerland; [Youngblood, Mark W.; Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Bilguvar, Kaya; Gunel, Murat] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT USA; [Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA USA; [Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA USA; [Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chen, Sidi] Yale Univ, Sch Med, Ctr Comprehens Canc, New Haven, CT 06510 USA; [Chen, Sidi] Yale Univ, Sch Med, Stem Cell Ctr, New Haven, CT 06520 USA	Chen, SD (reprint author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Chen, SD (reprint author), Yale Univ, Sch Med, Syst Biol Inst, West Haven, CT 06516 USA.; Chen, SD (reprint author), Yale Univ, Sch Med, Med Scientist Training Program, New Haven, CT 06520 USA.; Chen, SD (reprint author), Yale Univ, Sch Med, Biol & Biomed Sci Program, New Haven, CT 06520 USA.; Chen, SD (reprint author), Yale Univ, Sch Med, Immunobiol Program, New Haven, CT 06520 USA.; Platt, RJ (reprint author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.; Platt, RJ (reprint author), Univ Basel, Dept Chem, Basel, Switzerland.; Chen, SD (reprint author), Yale Univ, Sch Med, Ctr Comprehens Canc, New Haven, CT 06510 USA.; Chen, SD (reprint author), Yale Univ, Sch Med, Stem Cell Ctr, New Haven, CT 06520 USA.	rplatt@ethz.ch; sidi.chen@yale.edu		Martinez, Michael/0000-0003-1178-7139; Chow, Ryan/0000-0002-1872-6307	Yale SBI/Genetics Startup Fund; Damon Runyon [DRG-2117-12, DFS-13-15]; Melanoma Research Alliance [412806, 16-003524]; St. Baldrick's Foundation [426685]; American Cancer Society [IRG 58-012-54]; Breast Cancer Alliance; Cancer Research Institute (CLIP); AACR [499395]; DoD [W81XWH-17-1-0235]; NIH/NCI [1U54CA209992, 5P50CA196530-A10805, 4P50CA121974-A08306]; NCCRMSE; ETH Zurich; McGovern Institute; NSF [1122374]; NIH [R01-CA133404, R01-GM034277, T32GM007499]; NIH (CCNE); Skoltech Center; Casimir-Lambert Fund; NIH/NIMH [5DP1-MH100706, 1R01-MH110049]; NSF; NY Stem Cell Foundation; HHMI; Poitras Foundation; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; NIH MSTP training grant [T32GM007205]; RJ Anderson Fellowship; CRI Irvington Postdoctoral Fellowship	We thank all members of the Chen, Sharp, Zhang and Platt laboratories, as well as our colleagues in the Yale Department of Genetics, Systems Biology Institute, Yale Cancer Center and Stem Cell Center, Koch Institute and Broad Institute at MIT for assistance and/or discussions. We thank the Center for Genome Analysis, Center for Molecular Discovery, High Performance Computing Center, West Campus Analytical Chemistry Core and West Campus Imaging Core and Keck Biotechnology Resource Laboratory at Yale, as well as Swanson Biotechnology Center at MIT, for technical support. S.C. is supported by Yale SBI/Genetics Startup Fund, Damon Runyon (DRG-2117-12; DFS-13-15), Melanoma Research Alliance (412806, 16-003524), St. Baldrick's Foundation (426685), American Cancer Society (IRG 58-012-54), Breast Cancer Alliance, Cancer Research Institute (CLIP), AACR (499395), DoD (W81XWH-17-1-0235) and NIH/NCI (1U54CA209992, 5P50CA196530-A10805, 4P50CA121974-A08306). R.J.P. is supported by NCCRMSE and ETH Zurich, the McGovern Institute and NSF (1122374). P.A.S. is supported by NIH (R01-CA133404, R01-GM034277, CCNE), Skoltech Center and the Casimir-Lambert Fund. F.Z. is supported by the NIH/NIMH (5DP1-MH100706 and 1R01-MH110049), NSF, NY Stem Cell Foundation, HHMI, Poitras, Simons, Paul G. Allen Family, Vallee Foundations, D.R. Cheng and B. Metcalfe. C.D.G. and P.R. are supported by an NIH Graduate Training Grant (T32GM007499). R.D.C., M.B.D. and M.W.Y. are supported by an NIH MSTP training grant (T32GM007205). F.S. is supported by NCCRMSE and ETH Zurich. G.W. is supported by RJ Anderson and CRI Irvington Postdoctoral Fellowships.	Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108; Aithal Madhuri G S, 2015, Brain Tumor Res Treat, V3, P24, DOI 10.14791/btrt.2015.3.1.24; Alcantara L. S., 2009, CANCER CELL, V15, P45, DOI DOI 10.1016/J.CCR.2008.12.006; American Brain Tumor Association, 2016, GLIOBL MAL ASTR; Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Bale TA, 2016, CANCER GENET-NY, V209, P321, DOI 10.1016/j.cancergen.2016.06.002; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Berns A, 2010, NATURE, V468, P519, DOI 10.1038/468519a; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473                                                         ; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen SD, 2014, GENE DEV, V28, P1054, DOI 10.1101/gad.239681.114; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Claus EB, 2006, CANCER, V106, P1358, DOI 10.1002/cncr.21733; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Feng ZH, 2008, CELL CYCLE, V7, P842, DOI 10.4161/cc.7.7.5657                                                             ; Franklin K. B. J, 2013, MOUSE BRAIN STEREOTA; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gao J., 2013, SCI SIGNAL, V6, pl1, DOI DOI 10.1126/SCISIGNAL.2004088; Guo FJ, 2010, ONCOL REP, V23, P1449, DOI 10.3892/or_00000783; Hainaut P, 2013, CURR OPIN ONCOL, V25, P50, DOI 10.1097/CCO.0b013e32835b651e; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535                                                                ; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huse JT, 2009, BRAIN PATHOL, V19, P132, DOI 10.1111/j.1750-3639.2008.00234.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Napoli M, 2017, BRIT J CANCER, V116, P149, DOI 10.1038/bjc.2016.384; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patil V, 2015, ONCOTARGET, V6, P43452, DOI 10.18632/oncotarget.6171; Perry A, 2009, BRAIN PATHOL, V19, P81, DOI 10.1111/j.1750-3639.2008.00167.x; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qazi M, 2014, METHODS MOL BIOL, V1210, P37, DOI 10.1007/978-1-4939-1435-7_4; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reilly KM, 2000, NAT GENET, V26, P109; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schmid RS, 2012, BRAIN RES BULL, V88, P72, DOI 10.1016/j.brainresbull.2011.06.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330                                                            ; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; WEITZMAN MD, 1994, P NATL ACAD SCI USA, V91, P5808, DOI 10.1073/pnas.91.13.5808; Yeung JT, 2013, CLIN CANCER RES, V19, P1816, DOI 10.1158/1078-0432.CCR-12-2861	68	2	2	18	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2017	20	10					1329	+		10.1038/nn.4620				17	Neurosciences	Neurosciences & Neurology	FI1IM	WOS:000411686400005	28805815				2018-01-05	
J	Kadyk, LC; DeWitt, ND; Gomperts, B				Kadyk, Lisa C.; DeWitt, Natalie D.; Gomperts, Brigitte			Proceedings: Regenerative Medicine for Lung Diseases: A CIRM Workshop Report	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Lung; Regenerative medicine; Stem cells; Clinical trials; Gene therapy; Organoids; Mesenchymal stromal cells; Engraftment; Lung diseases; Cellular therapeutics; Induced pluripotent stem cells; Bioengineering; In vivo imaging; Disease modeling	PLURIPOTENT STEM-CELLS; CYSTIC-FIBROSIS; LONG-TERM; THERAPY; GENE; TRANSPLANTATION; INJURY; REPAIR; MOUSE; TRIAL	The mission of the California Institute of Regenerative Medicine (CIRM) is to accelerate treatments to patients with unmet medical needs. In September 2016, CIRM sponsored a workshop held at the University of California, Los Angeles, to discuss regenerative medicine approaches for treatment of lung diseases and to identify the challenges remaining for advancing such treatments to the clinic and market approval. Workshop participants discussed current preclinical and clinical approaches to regenerative medicine in the lung, as well as the biology of lung stem cells and the role of stem cells in the etiology of various lung diseases. The outcome of this effort was the recognition that whereas transient cell delivery approaches are leading the way in the clinic, recent advances in the understanding of lung stem cell biology, in vitro and in vivo disease modeling, gene editing and replacement methods, and cell engraftment approaches raise the prospect of developing cures for some lung diseases in the foreseeable future. In addition, advances in in vitro modeling using lung organoids and "lung on a chip" technology are setting the stage for high quality small molecule drug screening to develop treatments for lung diseases with complex biology.	[Kadyk, Lisa C.] Calif Inst Regenerat Med, Oakland, CA USA; [DeWitt, Natalie D.] Accendo Sci, San Francisco, CA USA; [Gomperts, Brigitte] Univ Calif Los Angeles, Dept Pediat, Jonsson Comprehens Canc Ctr, Childrens Discovery & Innovat Inst,Broad Stem Cel, Los Angeles, CA 90024 USA; [Gomperts, Brigitte] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Pulm Med, Childrens Discovery & Innovat Inst,Broad Stem Cel, Los Angeles, CA 90024 USA	Gomperts, B (reprint author), 108333 Le Conte Ave,A2-410 MDCC, Los Angeles, CA 90095 USA.	bgomperts@mednet.ucla.edu			CIRM educational [EDUC1.3]	We thank the workshop participants for their valuable contributions: Denise Al-Alam (Children's Hospital Los Angeles), Eric Ahrens (UCSD), Hal Chapman (UCSF), Greg Cosgrove (Pulmonary Fibrosis Foundation), Larry Couture (Orbsen Therapeutics), Ramona Doyle (UCSF), John Engelhardt (University of Iowa), Amy Firth (USC), Paul Frech (CIRM), Marilyn Glassberg (University of Miami), Tracy Grikscheit (Children's Hospital Los Angeles), Valeria Hatcher (PFF advocate), Mark Krasnow (Stanford), Steven Kesten (SKC Life Sciences), Michael Matthay (UCSF), Parviz Minoo (USC), Laura Niklason (Yale University), Pat Olson (CIRM), Scott Randell (University of North Carolina), Yair Reisner (Weizmann Institute of Science), Kelly Shepard (CIRM), Bill Skach (Cystic Fibrosis Foundation), Isabel Stenzel Byrnes (CF advocate), Duncan Stewart (Ottawa Hospital Research Institute), Barry Stripp (Cedars Sinai Medical Center), Jennifer Sucre (Vanderbilt University), Bernard Thebaud (Ottawa Hospital Research Institute), Bruce Trapnell (Cincinnati Children's Hospital), Preethi Vijayaraj (UCLA), and David Warburton (Children's Hospital Los Angeles). This workshop was supported by CIRM educational grant EDUC1.3 to Brigitte Gomperts.	Ahrens ET, 2014, MAGN RESON MED, V72, P1696, DOI 10.1002/mrm.25454; Benam KH, 2016, CELL SYST, V3, P456, DOI 10.1016/j.cels.2016.10.003; Bonetto F, 2011, INT J CANCER, V129, P365, DOI 10.1002/ijc.25672; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098; Elborn JS, 2017, J CYST FIBROS, V16, P163, DOI 10.1016/j.jcf.2016.11.009; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Ghosh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122823; Glassberg MK, 2017, CHEST, V151, P971, DOI 10.1016/j.chest.2016.10.061; Granton J, 2015, CIRC RES, V117, P645, DOI 10.1161/CIRCRESAHA.114.305951; Hawkins Finn, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS50, DOI 10.1513/AnnalsATS.201410-457MG; Konar D, 2016, BIOMED ENG COMPUT BI, V7, P16, DOI 10.4137/BECB.S34252; Liu KD, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0022-z; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Pierro M, 2013, THORAX, V68, P475, DOI 10.1136/thoraxjnl-2012-202323; Rosen C, 2015, NAT MED, V21, P869, DOI 10.1038/nm.3889; Saini Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139270; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Schott JW, 2016, MOL THER, V24, P1513, DOI [10.1038/mt.2016.743, 10.1038/mt.2016.143]; Srinivas M, 2013, JOVE-J VIS EXP, V81, DOI DOI 10.3791/50802; Sucre JMS, 2016, AM J PHYSIOL-LUNG C, V310, pL889, DOI 10.1152/ajplung.00446.2015; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Wilkinson DC, 2016, STEM CELL TRANSL MED, V5, P1; Yan ZY, 2015, HUM GENE THER CL DEV, V26, P38, DOI 10.1089/humc.2014.154; Yan ZY, 2013, MOL THER, V21, P2181, DOI 10.1038/mt.2013.92	30	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	OCT	2017	6	10					1823	1828		10.1002/sctm.17-0047				6	Cell & Tissue Engineering	Cell Biology	FI3OB	WOS:000411872700001	28791807	gold			2018-01-05	
J	Adkar, SS; Brunger, JM; Willard, VP; Wu, CL; Gersbach, CA; Guilak, F				Adkar, Shaunak S.; Brunger, Jonathan M.; Willard, Vincent P.; Wu, Chia-Lung; Gersbach, Charles A.; Guilak, Farshid			Genome Engineering for Personalized Arthritis Therapeutics	TRENDS IN MOLECULAR MEDICINE			English	Review							PLURIPOTENT STEM-CELLS; JUVENILE IDIOPATHIC ARTHRITIS; DNA-BINDING SPECIFICITY; ZINC-FINGER PROTEINS; RHEUMATOID-ARTHRITIS; IN-VIVO; OSTEOARTHRITIS SUSCEPTIBILITY; MUSCULAR-DYSTROPHY; INTRAARTICULAR INJECTION; ARTICULAR CHONDROCYTES	Arthritis represents a family of complex joint pathologies responsible for the majority of musculoskeletal conditions. Nearly all diseases within this family, including osteoarthritis, rheumatoid arthritis, and juvenile idiopathic arthritis, are chronic conditions with few or no disease-modifying therapeutics available. Advances in genome engineering technology, most recently with CRISPR-Cas9, have revolutionized our ability to interrogate and validate genetic and epigenetic elements associated with chronic diseases such as arthritis. These technologies, together with cell reprogramming methods, including the use of induced pluripotent stem cells, provide a platform for human disease modeling. We summarize new evidence from genome-wide association studies and genomics that substantiates a genetic basis for arthritis pathogenesis. We also review the potential contributions of genome engineering in the development of new arthritis therapeutics.	[Adkar, Shaunak S.; Wu, Chia-Lung; Guilak, Farshid] Washington Univ, Dept Orthoped Surg, St Louis, MO 63110 USA; [Adkar, Shaunak S.; Wu, Chia-Lung; Guilak, Farshid] Shriners Hosp Children St Louis, St Louis, MO 63110 USA; [Adkar, Shaunak S.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Brunger, Jonathan M.; Gersbach, Charles A.; Guilak, Farshid] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Willard, Vincent P.; Guilak, Farshid] Cytex Therapeut Inc, Durham, NC 27705 USA	Guilak, F (reprint author), Washington Univ, Dept Orthoped Surg, St Louis, MO 63110 USA.; Guilak, F (reprint author), Shriners Hosp Children St Louis, St Louis, MO 63110 USA.; Guilak, F (reprint author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.; Gersbach, CA; Guilak, F (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.; Guilak, F (reprint author), Cytex Therapeut Inc, Durham, NC 27705 USA.	Charles.gersbach@duke.edu; guilak@wustl.edu			Nancy Taylor Foundation for Chronic Diseases; Arthritis Foundation; Thorek Memorial Foundation; Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; NIH [AR061042, AG46927, AR48852, AG15768, AR48182, AR067467, AR065956, OD008586, GM119914, HG007900, DA036865, AR069085]; NSF CAREER Award [CBET-1151035]; Collaborative Research Center of the AO Foundation, Davos, Switzerland	We would like to acknowledge the support by the Nancy Taylor Foundation for Chronic Diseases, the Arthritis Foundation, the Thorek Memorial Foundation, the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group, NIH grants AR061042, AG46927, AR48852, AG15768, AR48182, AR067467, AR065956, OD008586, GM119914, HG007900, DA036865, AR069085, NSF CAREER Award CBET-1151035, and the Collaborative Research Center of the AO Foundation, Davos, Switzerland.	Ajeganova S, 2016, ANN RHEUM DIS, V75, P867, DOI 10.1136/annrheumdis-2014-207080; Amarilyo G, 2016, SEMIN ARTHRITIS RHEU, V46, P312, DOI 10.1016/j.semarthrit.2016.07.001; Ang YS, 2016, CELL, V167, P1734, DOI 10.1016/j.cell.2016.11.033; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827                                                                  ; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Brunger JM, 2017, STEM CELL REP, V8, P1202, DOI 10.1016/j.stemcr.2017.03.022; Brunger JM, 2017, ARTHRITIS RHEUMATOL, V69, P1111, DOI 10.1002/art.39982; Brunger JM, 2014, P NATL ACAD SCI USA, V111, pE798, DOI 10.1073/pnas.1321744111; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chapman K, 2008, HUM MOL GENET, V17, P1497, DOI 10.1093/hmg/ddn038; Chevalier X, 2009, ARTHRIT RHEUM-ARTHR, V61, P344, DOI 10.1002/art.24096; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Craft AM, 2015, NAT BIOTECHNOL, V33, P638, DOI [10.10.38/nbt.3210, 10.1038/nbt.3210]; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Evans CH, 2013, TRANSL RES, V161, P205, DOI 10.1016/j.trsl.2013.01.002; Farhang N, 2017, TISSUE ENG PT A, V23, P738, DOI [10.1089/ten.tea.2016.0441, 10.1089/ten.TEA.2016.0441]; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Furman BD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4591; Gao XQ, 2014, BIOMATERIALS, V35, P6859, DOI 10.1016/j.biomaterials.2014.04.113; Garaulet G, 2013, MOL THER, V21, P119, DOI 10.1038/mt.2012.131; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; Gibson GJ, 2017, NAT REV RHEUMATOL, V13, P205, DOI 10.1038/nrrheum.2017.6; Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073; Haag S, 2015, J IMMUNOL, V194, P2539, DOI 10.4049/jimmunol.1402238; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hinks A, 2016, ANN RHEUM DIS, V76, P765; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hollenbach JA, 2010, ARTHRITIS RHEUM-US, V62, P1781, DOI 10.1002/art.27424; Huang Y, 2016, MATRIX BIOL, V56, P74, DOI 10.1016/j.matbio.2016.04.002; Huemer C, 2002, J RHEUMATOL, V29, P1531; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kerschbaumer A, 2016, WIEN KLIN WOCHENSCHR, V128, P791, DOI 10.1007/s00508-016-1111-9; Khoury M, 2007, J GENE MED, V9, P596, DOI 10.1002/jgm.1053; Kilpinen H, 2017, NATURE, V546, P370, DOI 10.1038/nature22403; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Kim SH, 2002, MOL THER, V6, P591, DOI 10.1006/mthe.2002.0711; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Klann T. S., 2017, NAT BIOTECHNOL, V7, P46545; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Lee J, 2015, FASEB J, V29, P3399, DOI 10.1096/fj.14-269720; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Loeser RF, 2010, CLIN GERIATR MED, V26, P371, DOI 10.1016/j.cger.2010.03.002; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Louka ML, 2016, GENE, V587, P27, DOI 10.1016/j.gene.2016.04.019; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Martel-Pelletier J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.72; Matzko ME, 2012, J AM ACAD ORTHOP SUR, V20, P536, DOI 10.5435/JAAOS-20-08-536; McAlindon TE, 2017, JAMA-J AM MED ASSOC, V317, P1967, DOI 10.1001/jama.2017.5283; Mercer AC, 2012, NUCLEIC ACIDS RES, V40, P11163, DOI 10.1093/nar/gks875; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/ng2005; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; Molenaar ETH, 2004, ARTHRITIS RHEUM, V50, P36, DOI 10.1002/art.11481; Muller-Kuller U, 2015, NUCLEIC ACIDS RES, V43, P1577, DOI 10.1093/nar/gkv019; Nam JL, 2017, ANN RHEUM DIS, V76, P1108, DOI 10.1136/annrheumdis-2016-210713; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Pan F, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-404; Panoutsopoulou K, 2011, ANN RHEUM DIS, V70, P864, DOI 10.1136/ard.2010.141473; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Rachakonda PS, 2008, ARTHRITIS RHEUM-US, V58, P2088, DOI 10.1002/art.23598; Ramos-Casals M, 2008, BEST PRACT RES CL RH, V22, P847, DOI 10.1016/j.berh.2008.09.008; Reynard LN, 2014, HUM GENET, V133, P1059, DOI 10.1007/s00439-014-1447-z; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Saad MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131960; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen N, 2017, ONCOTARGET, V8, P20784, DOI 10.18632/oncotarget.15265; Shi SL, 2013, J CELL BIOCHEM, V114, P908, DOI 10.1002/jcb.24430; Simeonov D. R., 2016, BIORXIV; Singh JA, 2015, ARTHRITIS RHEUMATOL, V67, DOI 10.1002/art.39480; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Sokumbi O, 2012, MAYO CLIN PROC, V87, P739, DOI 10.1016/j.mayocp.2012.04.011; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tao Ke, 2017, J Exp Orthop, V4, P4, DOI 10.1186/s40634-017-0077-5; Tao K, 2016, J ORTHOP RES, V34, P2181, DOI 10.1002/jor.23228; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P3265, DOI 10.1002/art.27688; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van de Loo FAJ, 2004, GENE THER, V11, P581, DOI 10.1038/sj.gt.3302182; Virk MS, 2011, MOL THER, V19, P960, DOI 10.1038/mt.2011.2; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Willard VP, 2014, ARTHRITIS RHEUMATOL, V66, P3062, DOI 10.1002/art.38780; Wu CL, 2015, ANN RHEUM DIS, V74, P2076, DOI 10.1136/annrheumdis-2014-205601; Xin XN, 2014, STEM CELL TRANSL MED, V3, P1125, DOI 10.5966/sctm.2013-0128; Yamashita A, 2015, STEM CELL REP, V4, P404, DOI 10.1016/j.stemcr.2015.01.016; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775; Yan H, 2016, P NATL ACAD SCI USA, V113, pE6199, DOI 10.1073/pnas.1608245113; Yang MZ, 2014, BONE, V69, P118, DOI 10.1016/j.bone.2014.09.005; Yokoyama K, 2015, ARTHRITIS RHEUMATOL, V67, P302, DOI 10.1002/art.38912; Yousef GM, 2012, CLIN CHEM, V58, P661, DOI 10.1373/clinchem.2011.181073; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3	124	0	0	7	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1471-4914	1471-499X		TRENDS MOL MED	Trends Mol. Med	OCT	2017	23	10					917	931		10.1016/j.molmed.2017.08.002				15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FI3QU	WOS:000411882400005	28887050				2018-01-05	
J	Elsner, C; Bohne, J				Elsner, Carina; Bohne, Jens			The retroviral vector family: something for everyone	VIRUS GENES			English	Review						Viral vectors; Integration; Cell therapy; Reprogramming; Cas9; Tet-system	SEVERE COMBINED IMMUNODEFICIENCY; MURINE LEUKEMIA-VIRUS; EMBRYONIC STEM-CELLS; LENTIVIRAL VECTOR; IN-VIVO; GENE-THERAPY; ADENOASSOCIATED VIRUS; TRANSGENE EXPRESSION; HEMATOPOIETIC-CELLS; MICRORNA REGULATION	After 30 years of retroviral vector research it became clear that the parental viruses can be both friend and foe. Especially human immunodeficiency virus sparked a global pandemic, but could be converted into a versatile tool for cell therapy. For all retroviral genera, the way from virus to vector was similar resulting in split-vector systems based on the separation of the genes needed for vector particle formation and transgene expression. The first gene therapy trials, although clinically effective, revealed the genotoxicity of retroviral vectors caused by insertional mutagenesis. This issue was solved using self-inactivating vectors carrying weaker cellular promoters. Further fine-tuning was able to generate inducible systems. The current toolbox also contains vectors for the generation of induced pluripotent stem cells or efficient RNA interference. More recently the application of CRISPR-Cas9-mediated gene editing led to the development of genome-wide small guide RNA libraries targeting all human genes and single lentiviral vectors for an easy delivery of Cas9.	[Elsner, Carina; Bohne, Jens] Hannover Med Sch, Inst Virol, Carl Neuberg Str 1, D-30625 Hannover, Germany	Bohne, J (reprint author), Hannover Med Sch, Inst Virol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	bohne.jens@mh-hannover.de			Else-Kroner-Fresenius-Stiftung [2014_A88]	We would like to thank V. Melhorn for providing initial art work. This review was partially funded by the Else-Kroner-Fresenius-Stiftung given to J.B. (2014_A88).	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Alexander BL, 2007, GENE THER, V14, P1754, DOI 10.1038/sj.gt.3303075; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; COFFIN JM, 1997, RETROVIRUSES; Devroe Eric, 2002, BMC Biotechnol, V2, P15, DOI 10.1186/1472-6750-2-15; Dull T, 1998, J VIROL, V72, P8463; Flint S. J., 2009, PRINCIPLES VIROLOGY; Furger A, 2001, J VIROL, V75, P11735, DOI 10.1128/JVI.75.23.11735-11746.2001; Gentner B, 2012, TISSUE ANTIGENS, V80, P393, DOI 10.1111/tan.12002; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Glimm H, 2005, BLOOD, V106, P893, DOI 10.1182/blood-2004-07-2859; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GREZ M, 1990, P NATL ACAD SCI USA, V87, P9202, DOI 10.1073/pnas.87.23.9202                                                         ; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Heinz N, 2011, HUM GENE THER, V22, P166, DOI 10.1089/hum.2010.099; Herzog RW, 2010, DISCOV MED, V9, P105; Kobinger GP, 2001, NAT BIOTECHNOL, V19, P225, DOI 10.1038/85664; Koponen JK, 2003, GENE THER, V10, P459, DOI 10.1038/sj.gt.3301889; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Kuehle J, 2014, MOL THER, V22, P919, DOI 10.1038/mt.2014.4; Lachmann N, 2015, GENE THER, V22, P883, DOI 10.1038/gt.2015.61; Lindemann D, 2011, VIRUSES-BASEL, V3, P561, DOI 10.3390/v3050561; Lock L F, 1991, Curr Top Microbiol Immunol, V171, P27; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naldini L, 2016, SCIENCE, V353, P1101, DOI 10.1126/science.aah6192; Narezkina A, 2004, J VIROL, V78, P11656, DOI 10.1128/JVI.78.21.11656-11663.2004; Ogert RA, 1996, J VIROL, V70, P3834; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Russell SJ, 1999, J GENE MED, V1, P300, DOI 10.1002/(SICI)1521-2254(199909/10)1:5<300::AID-JGM59>3.0.CO;2-T                 ; SAMULSKI RJ, 1991, EMBO J, V10, P3941; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Schott JW, 2014, GENE THER, V21, P938, DOI 10.1038/gt.2014.69; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; SORGE J, 1983, J VIROL, V48, P667; Suerth JD, 2012, MOL THER, V20, P1022, DOI 10.1038/mt.2011.309; Suerth JD, 2010, J VIROL, V84, P6626, DOI 10.1128/JVI.00182-10; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; VARMUS HE, 1982, SCIENCE, V216, P812, DOI 10.1126/science.6177038                                                         ; Vieyra DS, 2007, STEM CELLS, V25, P2559, DOI 10.1634/stemcells.2007-0248; Vigna E, 2005, MOL THER, V11, P763, DOI 10.1016/j.ymthe.2004.11.017; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Wodrich H, 2001, J VIROL, V75, P10670, DOI 10.1128/JVI.75.22.10670-10682.2001; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194                                                         ; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1999, J VIROL, V73, P2886	65	1	1	7	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	OCT	2017	53	5					714	722		10.1007/s11262-017-1489-0				9	Genetics & Heredity; Virology	Genetics & Heredity; Virology	FI6IF	WOS:000412097300007	28762206				2018-01-05	
J	Binder, H; Hopp, L; Schweiger, MR; Hoffmann, S; Juhling, F; Kerick, M; Timmermann, B; Siebert, S; Grimm, C; Nersisyan, L; Arakelyan, A; Herberg, M; Buske, P; Loeffler-Wirth, H; Rosolowski, M; Engel, C; Przybilla, J; Peifer, M; Friedrichs, N; Moeslein, G; Odenthal, M; Hussong, M; Peters, S; Holzapfel, S; Nattermann, J; Hueneburg, R; Schmiegel, W; Royer-Pokora, B; Aretz, S; Kloth, M; Kloor, M; Buettner, R; Galle, J; Loeffler, M				Binder, Hans; Hopp, Lydia; Schweiger, Michal R.; Hoffmann, Steve; Juehling, Frank; Kerick, Martin; Timmermann, Bernd; Siebert, Susann; Grimm, Christina; Nersisyan, Lilit; Arakelyan, Arsen; Herberg, Maria; Buske, Peter; Loeffler-Wirth, Henry; Rosolowski, Maciej; Engel, Christoph; Przybilla, Jens; Peifer, Martin; Friedrichs, Nicolaus; Moeslein, Gabriela; Odenthal, Margarete; Hussong, Michelle; Peters, Sophia; Holzapfel, Stefanie; Nattermann, Jacob; Hueneburg, Robert; Schmiegel, Wolff; Royer-Pokora, Brigitte; Aretz, Stefan; Kloth, Michael; Kloor, Matthias; Buettner, Reinhard; Galle, Joerg; Loeffler, Markus			Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome	JOURNAL OF PATHOLOGY			English	Article						mismatch repair; hereditary cancer; tumour heterogeneity; immune editing	MISMATCH-REPAIR DEFICIENCY; GENE-EXPRESSION PATTERNS; MICROSATELLITE INSTABILITY; COLON-CANCER; ULCERATIVE-COLITIS; SEQUENCING DATA; METHYLATOR PHENOTYPE; MUTATION CARRIERS; CROHNS-DISEASE; MLH1	Colorectal cancer (CRC) arising in Lynch syndrome (LS) comprises tumours with constitutional mutations in DNA mismatch repair genes. There is still a lack of whole-genome and transcriptome studies of LS-CRC to address questions about similarities and differences in mutation and gene expression characteristics between LS-CRC and sporadic CRC, about the molecular heterogeneity of LS-CRC, and about specific mechanisms of LS-CRC genesis linked to dysfunctional mismatch repair in LS colonic mucosa and the possible role of immune editing. Here, we provide a first molecular characterization of LS tumours and of matched tumour-distant reference colonic mucosa based on whole-genome DNA-sequencing and RNA-sequencing analyses. Our data support two subgroups of LS-CRCs, G1 and G2, whereby G1 tumours show a higher number of somatic mutations, a higher amount of microsatellite slippage, and a different mutation spectrum. The gene expression phenotypes support this difference. Reference mucosa of G1 shows a strong immune response associated with the expression of HLA and immune checkpoint genes and the invasion of CD4+ T cells. Such an immune response is not observed in LS tumours, G2 reference and normal (non-Lynch) mucosa, and sporadic CRC. We hypothesize that G1 tumours are edited for escape from a highly immunogenic microenvironment via loss of HLA presentation and T-cell exhaustion. In contrast, G2 tumours seem to develop in a less immunogenic microenvironment where tumour-promoting inflammation parallels tumourigenesis. Larger studies on non-neoplastic mucosa tissue of mutation carriers are required to better understand the early phases of emerging tumours. Copyright (C) 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.	[Binder, Hans; Hopp, Lydia; Hoffmann, Steve; Juehling, Frank; Herberg, Maria; Buske, Peter; Loeffler-Wirth, Henry; Przybilla, Jens; Galle, Joerg] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Haertelstr 16-18, D-04107 Leipzig, Germany; [Schweiger, Michal R.; Kerick, Martin; Siebert, Susann; Grimm, Christina; Peifer, Martin; Friedrichs, Nicolaus; Odenthal, Margarete; Hussong, Michelle; Kloth, Michael; Buettner, Reinhard] Univ Hosp Cologne, Inst Pathol, Ctr Integrated Oncol, Cologne, Germany; [Schweiger, Michal R.; Kerick, Martin; Siebert, Susann; Grimm, Christina; Hussong, Michelle] Univ Hosp Cologne, Translat Epigen, Cologne, Germany; [Schweiger, Michal R.; Kerick, Martin; Timmermann, Bernd; Siebert, Susann; Grimm, Christina; Hussong, Michelle] Max Planck Inst Mol Genet, Berlin, Germany; [Juehling, Frank] INSERM, U1110, Inst Rech Malad Virales & Hepat, Strasbourg, France; [Juehling, Frank] Univ Strasbourg, Strasbourg, France; [Nersisyan, Lilit; Arakelyan, Arsen] Natl Acad Sci, Inst Mol Biol, Grp Bioinformat, Yerevan, Armenia; [Rosolowski, Maciej; Engel, Christoph; Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Moeslein, Gabriela] Univ Witten Herdecke, HELIOS Clin, Dept Hereditary Tumour Syndromes, Surg Ctr, Wuppertal, Germany; [Peters, Sophia; Holzapfel, Stefanie; Aretz, Stefan] Univ Bonn, Univ Hosp Bonn, Inst Human Genet, Ctr Hereditary Tumour Syndromes, Bonn, Germany; [Nattermann, Jacob; Hueneburg, Robert] Univ Bonn, Univ Hosp Bonn, Dept Internal Med 1, Ctr Hereditary Tumour Syndromes, Bonn, Germany; [Schmiegel, Wolff] Ruhr Univ Bochum, Dept Med Haematol & Oncol, Knappschaftskrankenhaus, Bochum, Germany; [Royer-Pokora, Brigitte] Heinrich Heine Univ, Inst Human Genet & Anthropol, Dusseldorf, Germany; [Kloor, Matthias] Univ Hosp Heidelberg, Inst Pathol, Dept Appl Tumour Biol, Heidelberg, Germany; [Kloor, Matthias] DKFZ German Canc Res Ctr Heidelberg, Clin Cooperat Unit Appl Tumour Biol, Heidelberg, Germany; [Kloor, Matthias] Univ Hosp Heidelberg, Mol Med Partnership Unit, Heidelberg, Germany; [Kloor, Matthias] EMBL Heidelberg, Heidelberg, Germany	Binder, H (reprint author), Univ Leipzig, Interdisciplinary Ctr Bioinformat, Haertelstr 16-18, D-04107 Leipzig, Germany.	binder@izbi.uni-leipzig.de	Schweiger, Michal/H-5270-2015	Schweiger, Michal/0000-0002-4672-0623; Arakelyan, Arsen/0000-0002-6851-1056; Peifer, Martin/0000-0002-5243-5503; Grimm, Christina/0000-0002-4676-8870	German Federal Ministry of Education and Science (BMBF) (PTJ) [HNPCC-Sys 031 6065A]; BMBF [FFE-0034, WTZ ARM II-010]; Volkswagen Foundation; HNPCC-Sys [7432]	We appreciate the support of Mrs Dr Katja Rillich in coordinating this project. This publication was financially supported by the German Federal Ministry of Education and Science (BMBF) (PTJ grant HNPCC-Sys 031 6065A). This work was further supported by BMBF project grants No. FFE-0034 (oBIG) and No. WTZ ARM II-010 (Pathway Maps) (HB, LH, HLW, AA, and LN) and the Volkswagen Foundation (Lichtenberg program, MRS). The results shown here are in part based on data generated by the TCGA Research Network (http://cancergenome.nih.gov/.) Access has been granted under project number 7432 (HNPCC-Sys).	Ahadova A, 2016, FAM CANCER, V15, P579, DOI 10.1007/s10689-016-9899-z; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Andrew S, 2010, FASTQC QUALITY CONTR; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Angelova M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078058; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Annese V, 2002, J MED GENET, V39, P332, DOI 10.1136/jmg.39.5.332; Arakelyan A, 2013, BIOINFORMATICS, V29, P518, DOI 10.1093/bioinformatics/bts730; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Bernal M, 2012, CANCER IMMUNOL IMMUN, V61, P1359, DOI 10.1007/s00262-012-1321-6; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Binder H, 2015, BIG DATA ANAL BIOINF, P359; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boland CR, 2016, FAM CANCER, V15, P395, DOI 10.1007/s10689-016-9885-5; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI 10.1053/j.gastro.2009.12.064; Briggs S, 2013, J PATHOL, V230, P148, DOI 10.1002/path.4185; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Drescher KM, 2009, FAM CANCER, V8, P231, DOI 10.1007/s10689-009-9233-0; Echterdiek F, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1075692; Engel C, 2010, CLIN GASTROENTEROL H, V8, P174, DOI 10.1016/j.cgh.2009.10.003; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Gullotti L, 2011, LAB INVEST, V91, P1695, DOI 10.1038/labinvest.2011.109; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hopp L, 2013, SYSTEMS BIOMED, V1, P99, DOI DOI 10.4161/SYSB.25897; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Kastrinos F, 2008, CANCER EPIDEM BIOMAR, V17, P2044, DOI 10.1158/1055-9965.EPI-08-0301; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Kloor M, 2012, LANCET ONCOL, V13, P598, DOI 10.1016/S1470-2045(12)70109-2; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lal N, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.976052; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee J, 2012, ONCOGENE, V31, P1242, DOI 10.1038/onc.2011.320; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; lesRolle A-F, 2015, J TRANSL MED, V13, P199; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Linnebacher M, 2001, INT J CANCER, V93, P6, DOI 10.1002/ijc.1298; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Loffler-Wirth H, 2015, BIOINFORMATICS, V31, P3225, DOI 10.1093/bioinformatics/btv342; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Maccaroni E, 2015, ONCOTARGET, V6, P38737, DOI 10.18632/oncotarget.5395; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagasaka T, 2008, GASTROENTEROLOGY, V134, P1950, DOI 10.1053/j.gastro.2008.02.094; Nersisyan L, 2016, J BIOINFORMATICS KNO, V4, P46; Oliveira C, 2004, HUM MOL GENET, V13, P2303, DOI 10.1093/hmg/ddh238; Olsen J, 2009, INFLAMM BOWEL DIS, V15, P1032, DOI 10.1002/ibd.20879; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pokorny RM, 1997, ANN SURG, V225, P718, DOI 10.1097/00000658-199706000-00009                                                ; Qiu RY, 2015, P NATL ACAD SCI USA, V112, P10914, DOI 10.1073/pnas.1505655112; Robinson KL, 2007, J NATL CANCER I, V99, P291, DOI 10.1093/jnci/djk051; Scarpa M, 2014, WORLD J GASTROENTERO, V20, P6774, DOI 10.3748/wjg.v20.i22.6774; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Sconocchia G, 2014, NEOPLASIA, V16, P31, DOI 10.1593/neo.131568; Sekine S, 2017, MODERN PATHOL, V30, P1144, DOI 10.1038/modpathol.2017.39; Staffa L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121980; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surmann EM, 2015, CANCER IMMUNOL IMMUN, V64, P357, DOI 10.1007/s00262-014-1638-4; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Takemoto N, 2004, JPN J CLIN ONCOL, V34, P90, DOI 10.1093/jjco/hyh018                                                             ; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Toronen P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-307; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681                                                         ; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Wirth H, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-18; Wirth H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-306	83	0	0	18	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3417	1096-9896		J PATHOL	J. Pathol.	OCT	2017	243	2					242	254		10.1002/path.4948				13	Oncology; Pathology	Oncology; Pathology	FH4KT	WOS:000411123400011	28727142				2018-01-05	
J	Mitsunobu, H; Teramoto, J; Nishida, K; Kondo, A				Mitsunobu, Hitoshi; Teramoto, Jun; Nishida, Keiji; Kondo, Akihiko			Beyond Native Cas9: Manipulating Genomic Information and Function	TRENDS IN BIOTECHNOLOGY			English	Review							CONTROLLING GENE-EXPRESSION; SINGLE-STRANDED-DNA; RNA EDITING ENZYME; CRISPR-CAS9 SYSTEM; MAMMALIAN-CELLS; TRANSCRIPTIONAL ACTIVATOR; ESCHERICHIA-COLI; ENDOGENOUS GENES; DEAMINASE; NUCLEASES	Clustered regularly interspaced short palindromic repeats (CRISPR)-mediated manipulation of genomic information is becoming more versatile by combining nuclease-deficient CRISPR systems with a wide variety of effectors including base-editing deaminases, transcriptional regulators, and epigenetic modifiers. The programmable binding ability of CRISPR systems is essential when the systems are employed as targeting domains to recruit the effectors to specific genomic loci. The discovery of a variety of Cas9 orthologs and engineered variants enables high-fidelity genome editing and a wider selection of genomic targets, and CRISPR-mediated deaminases enable more precise and predictable genome editing compared with CRISPR nuclease-based editing. Finally, combining transcriptional regulators with CRISPR systems can control expression of specific genes in a genome. Some applications and future challenges of CRISPR-derived tools are also discussed.	[Mitsunobu, Hitoshi; Teramoto, Jun; Nishida, Keiji; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan	Kondo, A (reprint author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.; Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015		New Energy and Industrial Technology Development Organization (NEDO); Special Coordination Fund for Promoting Science and Technology; Creation of Innovative Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe) from the Ministry of Education, Culture, Sports and Technology (MEXT) of Japan; JSPS KAKENHI [26119710, 16K14654, 15K18647]; Cross-Ministerial Strategic Innovation Promotion Program (SIP)	We thank Dr Christopher John Vavricka, Jr for critical reading of the manuscript. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO). This work was also partly supported by a Special Coordination Fund for Promoting Science and Technology, Creation of Innovative Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe) from the Ministry of Education, Culture, Sports and Technology (MEXT) of Japan; JSPS KAKENHI (Grant Number 26119710, 16K14654, and 15K18647); and by Cross-Ministerial Strategic Innovation Promotion Program (SIP).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Choudhury S. R., 2016, ONCOTARGET, V7, P1; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cress BF, 2016, NUCLEIC ACIDS RES, V44, P4472, DOI 10.1093/nar/gkw231; Davis K. M., 2015, NAT CHEM, P395; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gao SL, 2016, J IND MICROBIOL BIOT, V43, P1085, DOI 10.1007/s10295-016-1789-8; Gao XF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku836; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gleditzsch D, 2016, NUCLEIC ACIDS RES, V44, P5872, DOI 10.1093/nar/gkw469; Hamilton CE, 2010, RNA BIOL, V7, P220, DOI 10.4161/rna.7.2.11344                                                           ; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hirano M, 2015, BIOESSAYS, V37, P877, DOI 10.1002/bies.201400178; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; HUANG YH, 2016, BLOOD, V128; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knisbacher BA, 2016, TRENDS GENET, V32, P16, DOI 10.1016/j.tig.2015.10.005; Komor AC, 2016, NATURE, V61, P5985, DOI DOI 10.1038/NATUREL7946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Li J., 2016, MOL PLANT, V10, P1794; Liu L, 2017, MOL CELL, V65, P310, DOI 10.1016/j.molcel.2016.11.040; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Majsec K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0643-5; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishida K., 2016, SCIENCE, V353; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Pradeepa MM, 2016, NAT GENET, V48, P681, DOI 10.1038/ng.3550; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rath D, 2015, NUCLEIC ACIDS RES, V43, P237, DOI 10.1093/nar/gku1257; Richter F, 2016, NUCLEIC ACIDS RES, V44, P10003, DOI 10.1093/nar/gkw930; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stepper P., 2016, NUCLEIC ACIDS RES, V13, P484; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yang H, 2016, CELL, V167, P1814, DOI 10.1016/j.cell.2016.11.053; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001; ZHANG YG, 2015, SCI REP UK, V5	94	0	0	20	20	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0167-7799	1879-3096		TRENDS BIOTECHNOL	Trends Biotechnol.	OCT	2017	35	10					983	996		10.1016/j.tibtech.2017.06.004				14	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FH5NT	WOS:000411214700010	28739220				2018-01-05	
J	Soppe, JA; Lebbink, RJ				Soppe, Jasper Adriaan; Lebbink, Robert Jan			Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans	TRENDS IN MICROBIOLOGY			English	Review							HEPATITIS-B-VIRUS; RNA-GUIDED ENDONUCLEASE; EPSTEIN-BARR-VIRUS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; DUCHENNE MUSCULAR-DYSTROPHY; INHIBIT HIV-1 REPLICATION; PLURIPOTENT STEM-CELLS; ZINC-FINGER NUCLEASES; CD4(+) T-CELLS; IN-VIVO	The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) systems are RNA-guided sequence-specific prokaryotic antiviral immune systems. In prokaryotes, small RNA molecules guide Cas effector endonucleases to invading foreign genetic elements in a sequence-dependent manner, resulting in DNA cleavage by the endonuclease upon target binding. A rewired CRISPR/Cas9 system can be used for targeted and precise genome editing in eukaryotic cells. CRISPR/Cas has also been harnessed to target human pathogenic viruses as a potential new antiviral strategy. Here, we review recent CRISPR/Cas9-based approaches to combat specific human viruses in humans and discuss challenges that need to be overcome before CRISPR/Cas9 may be used in the clinic as an antiviral strategy.	[Soppe, Jasper Adriaan; Lebbink, Robert Jan] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Lebbink, RJ (reprint author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	r.j.lebbink-2@umcutrecht.nl			Dutch Cancer Society [UU 2012-5667]; Dr. FP Fischer Foundation (Utrecht, The Netherlands); Stichting Vrienden UMC Utrecht	We would like to thank the members of the Wiertz and Lebbink laboratory for fruitful discussions. This work was supported by grants from the Dutch Cancer Society (UU 2012-5667), the Dr. FP Fischer Foundation (Utrecht, The Netherlands), and the "Stichting Vrienden UMC Utrecht".	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Benjamin R, 2016, HUM GENET, V135, P1059, DOI 10.1007/s00439-016-1678-2; Bialek JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158294; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Bogerd HP, 2015, P NATL ACAD SCI USA, V112, pE7249, DOI 10.1073/pnas.1516305112; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Chou YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36921; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621                                                           ; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dong CS, 2015, ANTIVIR RES, V118, P110, DOI 10.1016/j.antiviral.2015.03.015; Duan DS, 2016, CURR OPIN VIROL, V21, P16, DOI 10.1016/j.coviro.2016.07.006; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Fine EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10777; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Goldberg GW, 2015, NAT REV IMMUNOL, V15, P717, DOI 10.1038/nri3910; Gori JL, 2015, HUM GENE THER, V26, P443, DOI 10.1089/hum.2015.074; Griffiths PD, 2012, LANCET INFECT DIS, V12, P790, DOI 10.1016/S1473-3099(12)70197-4; Gu WG, 2015, TRENDS BIOTECHNOL, V33, P172, DOI 10.1016/j.tibtech.2014.12.006; Haynes BF, 2015, CURR OPIN IMMUNOL, V35, P39, DOI 10.1016/j.coi.2015.05.007; Hill GM, 2014, DM-DIS MON, V60, P239, DOI 10.1016/j.disamonth.2014.03.003; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Horst D, 2011, IMMUNOL CELL BIOL, V89, P359, DOI 10.1038/icb.2010.129; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hu Z, 2014, BIOMED RES INT, DOI 10.1155/2014/612823; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Ji HYY, 2016, MOL THER, V24, P508, DOI 10.1038/mt.2016.7; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; KAMINSKI R, 2016, SCI REP UK, V6; Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555; Karimova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13734; Kennedy EM, 2017, ANNU REV MED, V68, P401, DOI 10.1146/annurev-med-051215-031129; Kennedy EM, 2015, VIROLOGY, V476, P196, DOI 10.1016/j.virol.2014.12.001; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Lebbink RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41968; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029                                            ; Limsirichai P, 2016, MOL THER, V24, P499, DOI 10.1038/mt.2015.213; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu X, 2015, J GEN VIROL, V96, P2252, DOI 10.1099/vir.0.000159; Liu YC, 2016, ASIAN J ANDROL, V18, P475, DOI 10.4103/1008-682X.157399; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Longnecker RM, 2013, FIELDS VIROLOGY, V6, P1898; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Martin AR, 2016, ANNU REV MED, V67, P215, DOI 10.1146/annurev-med-011514-023043; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Ok CY, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.82; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Paulus C, 2010, REV MED VIROL, V20, P34, DOI 10.1002/rmv.632; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Price AA, 2016, TRENDS MICROBIOL, V24, P294, DOI 10.1016/j.tim.2016.01.005; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rasmussen TA, 2016, CURR OPIN HIV AIDS, V11, P394, DOI 10.1097/COH.0000000000000279; Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146; Roizman B, 2013, ANNU REV MICROBIOL, V67, P355, DOI 10.1146/annurev-micro-092412-155654; Saayman SM, 2016, MOL THER, V24, P488, DOI 10.1038/mt.2015.202; Sakuma T, 2016, GENES CELLS, V21, P1253, DOI 10.1111/gtc.12437; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Seeger C, 2016, MOL THER, V24, P1258, DOI 10.1038/mt.2016.94; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tavazzi E, 2012, REV MED VIROL, V22, P18, DOI 10.1002/rmv.710; Taylor GS, 2015, ANNU REV IMMUNOL, V33, P787, DOI 10.1146/annurev-immunol-032414-112326; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Ueda S, 2016, MICROBIOL IMMUNOL, V60, P483, DOI 10.1111/1348-0421.12395; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; van Diemen F.R., 2016, CELL MICROBIOL; Wald A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P656; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang G, 2016, CELL REP, V17, P2819, DOI 10.1016/j.celrep.2016.11.057; Wang G, 2016, MOL THER, V24, P522, DOI 10.1038/mt.2016.24; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554; Wang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083908; Wang Z, 2016, CELL REP, V15, P481, DOI 10.1016/j.celrep.2016.03.042; White MK, 2015, DISCOV MED, V19, P255; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Wollebo HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136046; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yin CR, 2016, AIDS, V30, P1163, DOI 10.1097/QAD.0000000000001079; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yoder KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep29530; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Yu L, 2015, ONCOTARGETS THER, V8, P37, DOI 10.2147/OTT.S64092; Yuan JY, 2012, MOL THER, V20, P849, DOI 10.1038/mt.2011.310; Yuen KS, 2017, METHODS MOL BIOL, V1498, P23, DOI 10.1007/978-1-4939-6472-7_2; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zhu W, 2016, VIRUS RES, V217, P125, DOI 10.1016/j.virusres.2016.04.003; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	147	1	1	36	36	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0966-842X	1878-4380		TRENDS MICROBIOL	Trends Microbiol.	OCT	2017	25	10					833	850		10.1016/j.tim.2017.04.005				18	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	FH2OD	WOS:000410978700008	28522157				2018-01-05	
J	Maljevic, S; Reid, CA; Petrou, S				Maljevic, Snezana; Reid, Christopher A.; Petrou, Steven			Models for discovery of targeted therapy in genetic epileptic encephalopathies	JOURNAL OF NEUROCHEMISTRY			English	Review						disease models; epilepsy; induced pluripotent stem cells; ion channels; therapy	GAIN-OF-FUNCTION; CHILDHOOD ABSENCE EPILEPSY; SEVERE MYOCLONIC EPILEPSY; POTASSIUM CHANNEL GENE; PLURIPOTENT STEM-CELLS; DE-NOVO MUTATIONS; FAMILIAL NEONATAL CONVULSIONS; NEURONAL SODIUM-CHANNEL; FEBRILE SEIZURES PLUS; HUMAN BRAIN ORGANOIDS	Epileptic encephalopathies are severe disorders emerging in the first days to years of life that commonly include refractory seizures, various types of movement disorders, and different levels of developmental delay. In recent years, many de novo occurring variants have been identified in individuals with these devastating disorders. To unravel disease mechanisms, the functional impact of detected variants associated with epileptic encephalopathies is investigated in a range of cellular and animal models. This review addresses efforts to advance and use such models to identify specific molecular and cellular targets for the development of novel therapies. We focus on ion channels as the best-studied group of epilepsy genes. Given the clinical and genetic heterogeneity of epileptic encephalopathy disorders, experimental models that can reflect this complexity are critical for the development of disease mechanisms-based targeted therapy. The convergence of technological advances in gene sequencing, stem cell biology, genome editing, and high throughput functional screening together with massive unmet clinical needs provides unprecedented opportunities and imperatives for precision medicine in epileptic encephalopathies.	[Maljevic, Snezana; Reid, Christopher A.; Petrou, Steven] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Petrou, Steven] Univ Melbourne, Melbourne, Vic, Australia	Petrou, S (reprint author), Florey Inst Neurosci & Mental Hlth, Kenneth Myer Bldg,30 Royal Parade, Parkville, Vic 3052, Australia.	steven.petrou@florey.edu.au		Maljevic, Snezana/0000-0003-1876-5872	National Health and Medical Research Council (NHMRC) of Australia [10915693]; NHMRC fellowship [1005050]; Dowd Fellowship; Florey Institute of Neuroscience and Mental Health; Florey Institute of Neuroscience and Mental Health from Operational Infrastructure Support Grant	The authors declare no conflict of interest. We thank Umesh Nair for carefully reading this manuscript. This work was supported by the National Health and Medical Research Council (NHMRC) of Australia through a Program grant 10915693 to S.P and C.A.R. S.P. was supported by a NHMRC fellowship 1005050. C.A.R. acknowledges the support of the Dowd Fellowship. This study was also supported by The Florey Institute of Neuroscience and Mental Health acknowledges the strong support from the Victorian Government and, in particular, the funding from the Operational Infrastructure Support Grant.	Addis L., 2017, SCI REP, V7, P66, DOI 10.1038/s41598-017-00115-w; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Ben-Shalom R, 2017, BIOL PSYCHIAT, V82, P224, DOI 10.1016/j.biopsych.2017.01.009; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Blanchard MG, 2015, J MED GENET, V52, P330, DOI 10.1136/jmedgenet-2014-102813; Boerma RS, 2016, NEUROTHERAPEUTICS, V13, P192, DOI 10.1007/s13311-015-0372-8; Boison D, 2017, CURR OPIN NEUROL, V30, P187, DOI 10.1097/WCO.0000000000000432; Briz CG, 2017, JOVE-J VIS EXP, DOI 10.3791/55139; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Calhoun JD, 2016, EPILEPSIA, V57, pE103, DOI 10.1111/epi.13390; Carroll LS, 2016, PSYCHIAT GENET, V26, P60, DOI 10.1097/YPG.0000000000000110; Carvill GL, 2014, NEUROLOGY, V82, P1245, DOI 10.1212/WNL.0000000000000291; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53                                                               ; Cheah CS, 2013, CHANNELS, V7, P468, DOI 10.4161/chan.26023; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Chong PF, 2016, ANN NEUROL, V79, P502, DOI 10.1002/ana.24598; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Cunningham M, 2014, CELL STEM CELL, V15, P559, DOI 10.1016/j.stem.2014.10.006; d'Ydewalle C, 2017, NEURON, V93, P66, DOI 10.1016/j.neuron.2016.11.033; Damaj L, 2015, EUR J HUM GENET, V23, P1505, DOI 10.1038/ejhg.2015.21; Danquah W, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8463; Sampaio LPD, 2016, ARQ NEURO-PSIQUIAT, V74, P842, DOI 10.1590/0004-282X20160116; Delavar HM, 2016, J MEMBRANE BIOL, V249, P215, DOI 10.1007/s00232-016-9883-4; Devinsky O, 2017, NEW ENGL J MED, V376, P2011, DOI 10.1056/NEJMoa1611618; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Duszyc K, 2015, J APPL GENET, V56, P49, DOI 10.1007/s13353-014-0243-8; Edvardson S, 2013, J MED GENET, V50, P118, DOI 10.1136/jmedgenet-2012-101223; Escayg A, 2000, NAT GENET, V24, P343; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Fukuoka M, 2017, BRAIN DEV-JPN, V39, P80, DOI 10.1016/j.braindev.2016.08.002; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gardella E, 2016, ANN NEUROL, V79, P428, DOI 10.1002/ana.24580; Giordano G, 2011, METHODS MOL BIOL, V758, P13, DOI 10.1007/978-1-61779-170-3_2; Guerrini R, 2014, NEUROTHERAPEUTICS, V11, P269, DOI 10.1007/s13311-014-0267-0; Harkin LA, 2002, AM J HUM GENET, V70, P530, DOI 10.1086/338710; Harkin LA, 2007, BRAIN, V130, P843, DOI 10.1093/brain/awm002; Harrill JA, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0099-9; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Hattiangady B, 2008, EXP NEUROL, V212, P468, DOI 10.1016/j.expneurol.2008.04.040; Hedrich UBS, 2014, J NEUROSCI, V34, P14874, DOI 10.1523/JNEUROSCI.0721-14.2014; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Heron SE, 2002, LANCET, V360, P851, DOI 10.1016/S0140-6736(02)09968-3; Higurashi N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-19; Howden SE, 2015, STEM CELL REP, V5, P1109, DOI [10.1016/j.stemer.2015.10.009, 10.1016/j.stemcr.2015.10.009]; Howell KB, 2015, NEUROLOGY, V85, P958, DOI 10.1212/WNL.0000000000001926; Hsiao J, 2016, EBIOMEDICINE, V9, P257, DOI 10.1016/j.ebiom.2016.05.011; Illes S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-93; Imaizumi Y, 2014, J NEUROCHEM, V129, P388, DOI 10.1111/jnc.12625; Janve VS, 2016, ANN NEUROL, V79, P806, DOI 10.1002/ana.24631; Jiao J, 2013, HUM MOL GENET, V22, P4241, DOI 10.1093/hmg/ddt275; Johannesen K, 2016, NEUROLOGY, V87, P1140, DOI 10.1212/WNL.0000000000003087; Johnson MR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7031; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Kang JQ, 2016, JAMA NEUROL, V73, P1009, DOI 10.1001/jamaneurol.2016.0449; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; Kilstrup-Nielsen C, 2012, NEURAL PLAST, DOI 10.1155/2012/728267; Kim DS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00109; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Larsen J, 2015, NEUROLOGY, V84, P480, DOI 10.1212/WNL.0000000000001211; Lemke JR, 2016, NEUROLOGY, V86, P2171, DOI 10.1212/WNL.0000000000002740; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Li D, 2016, AM J HUM GENET, V99, P802, DOI 10.1016/j.ajhg.2016.07.013; Liao Y, 2010, NEUROLOGY, V75, P1454, DOI 10.1212/WNL.0b013e3181f8812e; Liao YX, 2010, BRAIN, V133, P1403, DOI 10.1093/brain/awq057; Lim CX, 2016, J MED GENET, V53, P217, DOI 10.1136/jmedgenet-2015-103508; Liu J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.203; Liu Y, 2013, ANN NEUROL, V74, P128, DOI 10.1002/ana.23897; Lo Sardo V, 2017, NAT BIOTECHNOL, V35, P69, DOI 10.1038/nbt.3749; Macdonald RL, 2012, JASPERS BASIC MECH E; Makinson CD, 2014, NEUROBIOL DIS, V68, P16, DOI 10.1016/j.nbd.2014.03.014; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; Maljevic S, 2014, PROG BRAIN RES, V213, P17, DOI 10.1016/B978-0-444-63326-2.00002-8; Markham MR, 2013, J NEUROPHYSIOL, V109, P1713, DOI 10.1152/jn.00875.2012; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Miceli F, 2015, J NEUROSCI, V35, P3782, DOI 10.1523/JNEUROSCI.4423-14.2015; Miceli F, 2015, EPILEPSIA, V56, pE15, DOI 10.1111/epi.12887; Mignot C, 2016, J MED GENET, V53, P511, DOI 10.1136/jmedgenet-2015-103451; Mikati MA, 2015, ANN NEUROL, V78, P995, DOI 10.1002/ana.24520; Millichap John J, 2016, Neurol Genet, V2, pe96, DOI 10.1212/NXG.0000000000000096; Milligan CJ, 2014, ANN NEUROL, V75, P581, DOI 10.1002/ana.24128; Moller RS, 2017, NEUROLOGY, V88, P483, DOI 10.1212/WNL.0000000000003565; Moller RS, 2015, EPILEPSIA, V56, pE114, DOI 10.1111/epi.13071; Morrow Thomas, 2017, Manag Care, V26, P36; Myers CT, 2016, AM J HUM GENET, V99, P287, DOI 10.1016/j.ajhg.2016.06.003; Nakamura K, 2013, NEUROLOGY, V81, P992, DOI 10.1212/WNL.0b013e3182a43e57; Nava C, 2014, NAT GENET, V46, P640, DOI 10.1038/ng.2952; Neves V, 2016, TRENDS BIOTECHNOL, V34, P36, DOI 10.1016/j.tibtech.2015.10.005; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Niday Z, 2017, J NEUROSCI, V37, P576, DOI [10.1523/JNEUROSCI.1425-16.2016, 10.1523/JNEUROSCI.1425-16.2017]; Noh GJ, 2012, EUR J MED GENET, V55, P281, DOI 10.1016/j.ejmg.2011.12.010; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331; Ogiwara I, 2012, EPILEPSIA, V53, pe200, DOI 10.1111/epi.12040; Oliva M, 2012, EPILEPSIA, V53, P1849, DOI 10.1111/j.1528-1167.2012.03631.x; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Otto JF, 2009, EPILEPSIA, V50, P1752, DOI 10.1111/j.1528-1167.2009.02100.x; Papandreou A, 2016, DEV MED CHILD NEUROL, V58, P416, DOI 10.1111/dmcn.12976; Parent JM, 2015, NAT NEUROSCI, V18, P360, DOI 10.1038/nn.3944; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pippucci T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082154; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5                                                   ; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214; Raab S, 2014, STEM CELLS INT, DOI 10.1155/2014/768391; Ramadan W, 2017, CLIN GENET, V92, P327, DOI 10.1111/cge.12999; Rao G, 2017, NEUROPSYCH DIS TREAT, V13, P585, DOI 10.2147/NDT.S114786; Reid CA, 2013, NEUROLOGY, V80, P1003, DOI 10.1212/WNL.0b013e3182872867; Reid CA, 2009, PROG NEUROBIOL, V87, P41, DOI 10.1016/j.pneurobio.2008.09.016; Reinson K, 2016, AM J MED GENET A, V170, P2173, DOI 10.1002/ajmg.a.37678; Rossi M, 2017, EUR J HUM GENET, V25, P376, DOI 10.1038/ejhg.2016.163; Rundfeldt C, 2000, NEUROSCI LETT, V282, P73, DOI 10.1016/S0304-3940(00)00866-1; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Saitsu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15199; Schattling B., 2016, ACTIVITY NAV1 2 PROM, V1; Schauwecker PE, 2011, EPILEPSY RES, V97, P1, DOI 10.1016/j.eplepsyres.2011.09.005; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schock SC, 2012, J NEUROSCI METH, V205, P324, DOI 10.1016/j.jneumeth.2012.01.016; Schoeler NE, 2013, EPILEPSY RES, V106, P1, DOI 10.1016/j.eplepsyres.2013.06.002; Schubert J, 2014, NAT GENET, V46, P1327, DOI 10.1038/ng.3130; Shbarou R, 2016, SEMIN PEDIATR NEUROL, V23, P134, DOI 10.1016/j.spen.2016.06.002; Shen DD, 2017, BRAIN, V140, P49, DOI 10.1093/brain/aww272; Shetty AK, 2016, NEUROSCI BIOBEHAV R, V62, P35, DOI 10.1016/j.neubiorev.2015.12.014; Shi XY, 2009, BRAIN DEV-JPN, V31, P758, DOI 10.1016/j.braindev.2009.08.009; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5                                                   ; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25                                                               ; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Smigiel R, 2016, AM J MED GENET A, V170, P3265, DOI 10.1002/ajmg.a.37887; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Suls A, 2013, AM J HUM GENET, V93, P967, DOI 10.1016/j.ajhg.2013.09.017; Sun YS, 2016, ELIFE, V5, DOI 10.7554/eLife.13073; Syrbe S, 2015, NAT GENET, V47, P393, DOI 10.1038/ng.3239; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Thiffault I, 2015, J GEN PHYSIOL, V146, P399, DOI 10.1085/jgp.201511444; Thompson CH, 2017, P NATL ACAD SCI USA, V114, P1696, DOI 10.1073/pnas.1615774114; Tompson Debra J, 2016, J Pediatr Pharmacol Ther, V21, P404; Torkamani A, 2014, ANN NEUROL, V76, P529, DOI 10.1002/ana.24263; Upadhya D., 2016, CURR PROTOC STEM CEL, V38; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Wagnon JL, 2015, HUM MOL GENET, V24, P506, DOI 10.1093/hmg/ddu470; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516                                                                  ; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Warner TA, 2016, HUM MOL GENET, V25, P3192, DOI 10.1093/hmg/ddw168; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x                                              ; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wirrell EC, 2016, CAN J NEUROL SCI, V43, pS13, DOI 10.1017/cjn.2016.249; Wolff M, 2017, BRAIN, V140, P1316, DOI 10.1093/brain/awx054; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	166	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2017	143	1					30	48		10.1111/jnc.14134				19	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	FH3DX	WOS:000411026200003	28742937				2018-01-05	
J	Yuan, JY; Chen, SS; Jiao, W; Wang, LF; Wang, LM; Ye, WX; Lu, J; Hong, DL; You, SL; Cheng, ZK; Yang, DL; Chen, ZJ				Yuan, Jingya; Chen, Sushu; Jiao, Wu; Wang, Longfei; Wang, Limei; Ye, Wenxue; Lu, Jie; Hong, Delin; You, Siliang; Cheng, Zhukuan; Yang, Dong-Lei; Chen, Z. Jeffrey			Both maternally and paternally imprinted genes regulate seed development in rice	NEW PHYTOLOGIST			English	Article						DNA methylation; epigenetics; miniature inverted-repeat transposable element (MITE); noncoding RNA; rice; seed development	SHOOT APICAL MERISTEM; INFLORESCENCE ARCHITECTURE; TRANSCRIPTION FACTOR; FLOWER DEVELOPMENT; HANABA-TARANU; BRACT SUPPRESSION; FAMILY GENES; MAIZE; ARABIDOPSIS; FATE	Genetic imprinting refers to the unequal expression of paternal and maternal alleles of a gene in sexually reproducing organisms, including mammals and flowering plants. Although many imprinted genes have been identified in plants, the functions of these imprinted genes have remained largely uninvestigated. We report genome-wide analysis of gene expression, DNA methylation and small RNAs in the rice endosperm and functional tests of five imprinted genes during seed development using Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated gene9 (CRISPR/Cas9) gene editing technology. In the rice endosperm, we identified 162 maternally expressed genes (MEGs) and 95 paternally expressed genes (PEGs), which were associated with miniature inverted-repeat transposable elements, imprinted differentially methylated loci and some 21-22 small interfering RNAs (siRNAs) and long noncoding RNAs (lncRNAs). Remarkably, one-third of MEGs and nearly one-half of PEGs were associated with grain yield quantitative trait loci. Most MEGs and some PEGs were expressed specifically in the endosperm. Disruption of two MEGs increased the amount of small starch granules and reduced grain and embryo size, whereas mutation of three PEGs reduced starch content and seed fertility. Our data indicate that both MEGs and PEGs in rice regulate nutrient metabolism and endosperm development, which optimize seed development and offspring fitness to facilitate parental-offspring coadaptation. These imprinted genes and mechanisms could be used to improve the grain yield of rice and other cereal crops.	[Yuan, Jingya; Chen, Sushu; Jiao, Wu; Wang, Longfei; Wang, Limei; Ye, Wenxue; Hong, Delin; You, Siliang; Yang, Dong-Lei; Chen, Z. Jeffrey] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, 1 Weigang Rd, Nanjing 210095, Jiangsu, Peoples R China; [Lu, Jie; Chen, Z. Jeffrey] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Lu, Jie; Chen, Z. Jeffrey] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Cheng, Zhukuan] Chinese Acad Sci, Inst Genet & Dev Biol, 1 West Beichen Rd, Beijing 100101, Peoples R China	Chen, ZJ (reprint author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, 1 Weigang Rd, Nanjing 210095, Jiangsu, Peoples R China.; Chen, ZJ (reprint author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.; Chen, ZJ (reprint author), Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	zjchen@austin.utexas.edu	hong, delin/R-3398-2017	hong, delin/0000-0002-2899-9739	National Natural Science Foundation of China [31290213, 91631302]; National Science Foundation [MCB1110857]; Research and Education Innovation Consortium of Jiangsu Province; Jiangsu Collaborative Innovation Center for Modern Crop Production	We are indebted to Professor Susan Wessler (University of California, Riverside, CA, USA) for constructive discussions and insightful comments to improve the manuscript. We thank Dr Yan Hu for coordinating sequencing activities and Professor Ling Jiang for helping with rice cultivation at Nanjing Agricultural University. Funding for this research was provided by the National Natural Science Foundation of China (31290213 and 91631302), National Science Foundation (MCB1110857), Research and Education Innovation Consortium of Jiangsu Province (2013-2015) and Jiangsu Collaborative Innovation Center for Modern Crop Production. The authors declare no competing interests of this work.	Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Bai XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19022; Bartlett ME, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00508; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2010, DEVELOPMENT, V137, P1243, DOI 10.1242/dev.048348; Derbyshire P, 2013, PLANT PHYSIOL, V161, P1291, DOI 10.1104/pp.112.212340; Ding L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005479; Endress PK, 2010, J SYST EVOL, V48, P225, DOI 10.1111/j.1759-6831.2010.00087.x; Eveland AL, 2014, GENOME RES, V24, P431, DOI 10.1101/gr.166397.113; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Goethe J. W, 1790, METAMORPHOSIS PLANTS; Hepworth SR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01052; Houston K, 2012, THEOR APPL GENET, V125, P33, DOI 10.1007/s00122-012-1814-x; Kellogg E. A., 2000, Grasses: systematics and evolution., P149; Kellogg EA, 2000, MONOCOTS SYSTEMATICS, P84; Komatsu M, 2003, DEVELOPMENT, V130, P3841, DOI 10.1242/dev.00564; Laudencia-Chingcuanco D, 2002, DEVELOPMENT, V129, P2629; Lee DY, 2012, PLANT J, V69, P445, DOI 10.1111/j.1365-313X.2011.04804.x; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1                                                   ; Miyoshi K, 2004, P NATL ACAD SCI USA, V101, P875, DOI 10.1073/pnas.2636936100; Nawy T, 2010, DEV CELL, V19, P103, DOI 10.1016/j.devcel.2010.06.004; Perreta MG, 2009, BOT REV, V75, P377, DOI 10.1007/s12229-009-9038-8; Poursarebani N, 2015, GENETICS, V201, P155, DOI 10.1534/genetics.115.176628; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Richards Robert John, 2002, ROMANTIC CONCEPTION; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Tanaka W, 2013, PLANT CELL PHYSIOL, V54, P313, DOI 10.1093/pcp/pct016; Thompson BE, 2009, PLANT PHYSIOL, V149, P38, DOI 10.1104/pp.108.129619; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Wagner GP, 2014, HOMOLOGY GENES EVOLU; Wang LP, 2009, CELL RES, V19, P598, DOI 10.1038/cr.2009.36; Weberling F, 1989, MORPHOLOGY FLOWERS I; Whipple CJ, 2010, PLANT CELL, V22, P565, DOI 10.1105/tpc.109.073536; Zhang DB, 2014, ANNU REV PLANT BIOL, V65, P553, DOI 10.1146/annurev-arplant-050213-040104; Zhang XL, 2013, PLANT CELL, V25, P83, DOI 10.1105/tpc.112.107854; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869; Zondlo SC, 1999, PLANT J, V19, P259, DOI 10.1046/j.1365-313X.1999.00523.x	40	4	4	21	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	OCT	2017	216	2			SI		373	387		10.1111/nph.14510				15	Plant Sciences	Plant Sciences	FH2JI	WOS:000410964800009	28295376				2018-01-05	
J	Rao, CT; Chin, D; Ensminger, AW				Rao, Chitong; Chin, Denny; Ensminger, Alexander W.			Priming in a permissive type I-C CRISPR-Cas system reveals distinct dynamics of spacer acquisition and loss	RNA			English	Article						CRISPR-Cas; type I-C; primed adaptation; spacer loss; Legionella	QUORUM SENSING CONTROLS; ADAPTIVE IMMUNE-SYSTEM; ESCHERICHIA-COLI; FOREIGN DNA; STREPTOCOCCUS-THERMOPHILUS; VITRO RECONSTITUTION; ADAPTATION; SEQUENCE; TARGET; INTERFERENCE	CRISPR-Cas is a bacterial and archaeal adaptive immune system that uses short, invader-derived sequences termed spacers to target invasive nucleic acids. Upon recognition of previously encountered invaders, the system can stimulate secondary spacer acquisitions, a process known as primed adaptation. Previous studies of primed adaptation have been complicated by intrinsically high interference efficiency of most systems against bona fide targets. As such, most primed adaptation to date has been studied within the context of imperfect sequence complementarity between spacers and targets. Here, we take advantage of a native type I-C CRISPR-Cas system in Legionella pneumophila that displays robust primed adaptation even within the context of a perfectly matched target. Using next-generation sequencing to survey acquired spacers, we observe strand bias and positional preference that are consistent with a 3'-5' translocation of the adaptation machinery. We show that spacer acquisition happens in a wide range of frequencies across the plasmid, including a remarkable hotspot that predominates irrespective of the priming strand. We systematically characterize protospacer sequence constraints in both adaptation and interference and reveal extensive flexibilities regarding the protospacer adjacent motif in both processes. Lastly, in a strain with a genetically truncated CRISPR array, we observe increased interference efficiency, which, when coupled with forced maintenance of a targeted plasmid, provides a useful experimental system to study spacer loss. Based on these observations, we propose that the Legionella pneumophila type I-C system represents a powerful model to study primed adaptation and the interplay between CRISPR interference and adaptation.	[Rao, Chitong; Chin, Denny; Ensminger, Alexander W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1M1, Canada; [Ensminger, Alexander W.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1M1, Canada; [Ensminger, Alexander W.] Publ Hlth Ontario, Toronto, ON M5G 1M1, Canada	Ensminger, AW (reprint author), Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1M1, Canada.; Ensminger, AW (reprint author), Univ Toronto, Dept Biochem, Toronto, ON M5G 1M1, Canada.; Ensminger, AW (reprint author), Publ Hlth Ontario, Toronto, ON M5G 1M1, Canada.	alex.ensminger@utoronto.ca			Canadian Institutes of Health Research [PHT-148819]; University of Toronto, Connaught Fund [NR-2015-16]; Ontario Research Fund [30364]; Canada Foundation for Innovation	This work was supported by a Project Grant from the Canadian Institutes of Health Research (PHT-148819), the University of Toronto, Connaught Fund (NR-2015-16), and an infrastructure grant from the Canada Foundation for Innovation and the Ontario Research Fund (30364) to A.W.E. The authors thank members of the Centre for the Analysis of Genome Evolution and Function (CAGEF) at the University of Toronto for performing Illumina sequencing. We thank members of the Ensminger laboratory for helpful discussions and for careful reading of the manuscript and the reviewers for their careful and constructive suggestions.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Heler R, 2014, MOL MICROBIOL, V93, P1, DOI 10.1111/mmi.12640; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2017, NUCLEIC ACIDS RES, V45, P4642, DOI 10.1093/nar/gkx229; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Majsec K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0643-5; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Patterson AG, 2016, MOL CELL, V64, P1102, DOI 10.1016/j.molcel.2016.11.012; Qiu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149533; Rao CT, 2016, CELL MICROBIOL, V18, P1319, DOI 10.1111/cmi.12586; Rao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064129; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Richter C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049549; Rollins MF, 2017, P NATL ACAD SCI USA, V114, pE5113, DOI 10.1073/pnas.1616395114; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Severinov K., 2016, FRONT MOL BIOSCI, V3, P45, DOI 10.3389/fmolb.2016.00045; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Strotskaya A, 2017, NUCLEIC ACIDS RES, V45, P1946, DOI 10.1093/nar/gkx042; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2015, CURR BIOL, V25, P1043, DOI 10.1016/j.cub.2015.01.065; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xue CY, 2016, MOL CELL, V64, P826, DOI 10.1016/j.molcel.2016.09.033; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	73	0	0	3	3	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	OCT	2017	23	10					1525	1538		10.1261/rna.062083.117				14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FH1XD	WOS:000410932100005	28724535				2018-01-05	
J	Barman, HK; Rasal, KD; Chakrapani, V; Ninawe, AS; Vengayil, DT; Asrafuzzaman, S; Sundaray, JK; Jayasankar, P				Barman, Hirak Kumar; Rasal, Kiran Dashrath; Chakrapani, Vemulawada; Ninawe, A. S.; Vengayil, Doyil T.; Asrafuzzaman, Syed; Sundaray, Jitendra K.; Jayasankar, Pallipuram			Gene editing tools: state-of-the-art and the road ahead for the model and non-model fishes	TRANSGENIC RESEARCH			English	Review						Aquaculture; Genome editing; ZFN; TALEN; CRISPR/Cas9	ZINC-FINGER NUCLEASES; SPERMATOGONIAL STEM-CELLS; TRANSGENIC FISH; LABEO-ROHITA; VERTEBRATE CELLS; IN-VITRO; KNOCK-IN; HOMOLOGOUS RECOMBINATION; TARGETED MUTAGENESIS; GENOME	Advancements in the DNA sequencing technologies and computational biology have revolutionized genome/transcriptome sequencing of non-model fishes at an affordable cost. This has led to a paradigm shift with regard to our heightened understandings of structure-functional relationships of genes at a global level, from model animals/fishes to non-model large animals/fishes. Whole genome/transcriptome sequencing technologies were supplemented with the series of discoveries in gene editing tools, which are being used to modify genes at pre-determined positions using programmable nucleases to explore their respective in vivo functions. For a long time, targeted gene disruption experiments were mostly restricted to embryonic stem cells, advances in gene editing technologies such as zinc finger nuclease, transcriptional activator-like effector nucleases and CRISPR (clustered regulatory interspaced short palindromic repeats)/CRISPR-associated nucleases have facilitated targeted genetic modifications beyond stem cells to a wide range of somatic cell lines across species from laboratory animals to farmed animals/fishes. In this review, we discuss use of different gene editing tools and the strategic implications in fish species for basic and applied biology research.	[Barman, Hirak Kumar; Rasal, Kiran Dashrath; Chakrapani, Vemulawada; Sundaray, Jitendra K.; Jayasankar, Pallipuram] ICAR Cent Inst Freshwater Aquaculture, Fish Genet & Biotechnol Div, Bhubaneswar 751002, Odisha, India; [Ninawe, A. S.] Minist Sci & Technol, Dept Biotechnol, CGO Complex,Block 3,Lodhi Rd, New Delhi 110003, India; [Vengayil, Doyil T.; Asrafuzzaman, Syed] SERB, 5 & 5A Lower Ground Floor,Vasant Sq Mall,Sect B, New Delhi 110070, India	Barman, HK (reprint author), ICAR Cent Inst Freshwater Aquaculture, Fish Genet & Biotechnol Div, Bhubaneswar 751002, Odisha, India.	hkbarman68@hotmail.com			National Agricultural Science Fund (NASF); Indian Council of Agricultural Research (ICAR); Department of Biotechnology (DBT); Department of Science and Technology, Government of India	This is an outcome of various research projects funded by the National Agricultural Science Fund (NASF), Indian Council of Agricultural Research (ICAR), Department of Biotechnology (DBT) and Department of Science and Technology, Government of India. The Director, ICAR-CIFA is acknowledged for facilities provided for the operation of these projects.	ABRAC (Agricultural Biotechnology Research Advisory Committee U.S. Department of Agriculture), 1995, PERF STAND SAF COND; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Ansai S, 2014, DEV GROWTH DIFFER, V56, P98, DOI 10.1111/dgd.12104; Ansai S, 2012, DEV GROWTH DIFFER, V54, P546, DOI 10.1111/j.1440-169X.2012.01357.x; Arakawa Hiroshi, 2006, Subcell Biochem, V40, P1; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Barman HK, 2010, CURR SCI INDIA, V99, P1030; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Barman HK, 2015, CELL MOL BIOL LETT, V20, P237, DOI 10.1515/cmble-2015-0010; Barman HK, 2006, BIOCHEM BIOPH RES CO, V345, P1547, DOI 10.1016/j.bbrc.2006.05.079; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Britton JR, 2013, NATURE, V498, P171, DOI 10.1038/498171e; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Cao J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw660; Chakrapani V, 2016, DEV COMP IMMUNOL, V61, P242, DOI 10.1016/j.dci.2016.04.009; Chen L, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-24; Chen T T, 1996, Biotechnol Annu Rev, V2, P205, DOI 10.1016/S1387-2656(08)70011-5; Clifford H, 2014, BMC P, V8; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Das Mahapatra K, 2008, AQUACULTURE, V279, P29, DOI 10.1016/j.aquaculture.2008.03.054; Dehler CE, 2016, MAR BIOTECHNOL, V18, P449, DOI 10.1007/s10126-016-9708-6; Dong ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028897; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Edvardsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108622; FAO, 2015, FISH AQ STAT; Feijo RG, 2016, MAR BIOTECHNOL, V18, P117, DOI 10.1007/s10126-015-9676-2; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YP, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00088; Gomez-Chiarri M, 2012, REV FISH SCI, V20, P183, DOI [10.1080/10641262.2012.707103, DOI 10.1080/10641262.2012.707103]; Gong ZY, 2003, BIOCHEM BIOPH RES CO, V308, P58, DOI 10.1016/S0006-291X(03)01282-8; GONG ZY, 1995, CURR TOP DEV BIOL, V30, P177, DOI 10.1016/S0070-2153(08)60567-0; Gonzales APW, 2014, METHOD ENZYMOL, V546, P377, DOI 10.1016/B978-0-12-801185-0.00018-0; Grover A, 2016, CRIT REV BIOTECHNOL, V36, P290, DOI 10.3109/07388551.2014.959891; Hallennan EM, 2007, APPL ANIM BEHAV SCI, V104, P265, DOI 10.1016/j.applanim.2006.09.008; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hochegger H, 2006, REV PROTOCOLS DT40 R, DOI [10.1007/978-1-4020-4896-8_18, DOI 10.1007/978-1-4020-4896-8_18]; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101                                                         ; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Huang P, 2014, METHODS, V69, P67, DOI 10.1016/j.ymeth.2014.02.010; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kikuchi H, 2010, ADV GENET RES, V2; Kikuchi Hidehiko, 2006, Subcell Biochem, V40, P225; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kirchmaier S, 2015, GENETICS, V199, P905, DOI 10.1534/genetics.114.173849; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Kohn DB, 2016, BLOOD, V127, P2553, DOI 10.1182/blood-2016-01-678136; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lee O, 2015, CRIT REV TOXICOL, V45, P124, DOI 10.3109/10408444.2014.965805; Li MH, 2014, GENETICS, V197, P591, DOI 10.1534/genetics.114.163667; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lo Presti R, 2009, ITAL J ANIM SCI, V8, P299; Lopez-Obando M, 2016, G3-GENES GENOM GENET, V6, P3647, DOI 10.1534/g3.116.033266; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Millar K, 2007, J AGR ENVIRON ETHIC, V20, P437, DOI 10.1007/s10806-007-9051-z; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mohanta R, 2014, TRANSGENIC RES, V23, P601, DOI 10.1007/s11248-014-9798-8; Mohapatra C, 2014, MOL BIOL REP, V41, P6433, DOI 10.1007/s11033-014-3525-7; Mohapatra C, 2010, MAR GENOM, V3, P157, DOI 10.1016/j.margen.2010.09.002; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.3.CO;2-2; Nayak S, 2016, ZYGOTE, V24, P814, DOI 10.1017/S0967199416000149; Ninawe AS, 2017, AQUACULT INT, V25, P251, DOI 10.1007/s10499-016-0026-9; Panda RP, 2011, THERIOGENOLOGY, V76, P241, DOI 10.1016/j.theriogenology.2011.01.031; Patra SK, 2015, THERIOGENOLOGY, V84, P268, DOI 10.1016/j.theriogenology.2015.03.017; Powell R, 2000, BIOLOGICAL RESOURCE MANAGEMENT: CONNECTING SCIENCE AND POLICY, P173; Qin ZK, 2016, MAR BIOTECHNOL, V18, P255, DOI 10.1007/s10126-016-9687-7; Rasal K. D., 2016, Journal of FisheriesSciences.com, V10, P52; Rasal KD, 2017, GENE REP, V6, P81, DOI 10.1016/j.genrep.2016.12.004; Rasmussen RS, 2007, COMPR REV FOOD SCI F, V6, P2, DOI 10.1111/j.1541-4337.2007.00013.x; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sanematsu F, 2006, J BIOL CHEM, V281, P13817, DOI 10.1074/jbc.M511590200; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Satrimafitrah P, 2016, CHROMOSOME RES, V24, P161, DOI 10.1007/s10577-015-9510-8; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheridan C, 2016, NAT BIOTECHNOL, V34, P117, DOI 10.1038/nbt0216-117; Sundaray JK, 2016, AQUACULT INT, V24, P1089, DOI 10.1007/s10499-016-9973-4; Takehana Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5157; Taylor J, 2015, J BIOMOL SCREEN, V20, P1040, DOI 10.1177/1087057115590069; Thresher RE, 2014, BIOL INVASIONS, V16, P1201, DOI 10.1007/s10530-013-0477-0; Tidwell JH, 2001, EMBO REP, V2, P958, DOI 10.1093/embo-reports/kve236; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang BM, 2015, BIOTECHNIQUES, V59, P201, DOI 10.2144/000114339; Wargelius A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21284; Wettstein Rahel, 2016, Methods Mol Biol, V1341, P321, DOI 10.1007/7651_2015_213; Wright DA, 2014, BIOCHEM J, V462, P15, DOI 10.1042/BJ20140295; Yano A, 2014, MAR BIOTECHNOL, V16, P243, DOI 10.1007/s10126-013-9546-8; [叶星 YE Xing], 2011, [遗传, Hereditas(Beijing)], V33, P494, DOI 10.3724/SP.J.1005.2011.00494; Zbikowska HM, 2003, TRANSGENIC RES, V12, P379, DOI 10.1023/A:1024267416522; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhong ZM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22953; Zu Y, 2013, NAT METHODS, V10, P329, DOI [10.1038/NMETH.2374, 10.1038/nmeth.2374]	98	0	0	22	22	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	OCT	2017	26	5					577	589		10.1007/s11248-017-0030-5				13	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FH1UR	WOS:000410925700001	28681201				2018-01-05	
J	You, ZY; Qian, QJ; Wang, YR; Che, JQ; Ye, LP; Shen, LR; Zhong, BX				You, Zhengying; Qian, Qiujie; Wang, Yiran; Che, Jiaqian; Ye, Lupeng; Shen, Lirong; Zhong, Boxiong			Transgenic silkworms secrete the recombinant glycosylated MRJP1 protein of Chinese honeybee, Apis cerana cerana	TRANSGENIC RESEARCH			English	Article						Royal jelly (RJ); AccMRJP1; Bombyx mori; Glycosylation; Posterior silk gland (PSG)	BOMBYX-MORI L; PIGGYBAC TRANSPOSON; 57-KDA PROTEIN; ROYAL; SILK; TRANSFORMATION; EXPRESSION; GENE; IDENTIFICATION; MUTAGENESIS	Major royal jelly protein-1 (MRJP1) is the most abundant glycoprotein of royal jelly (RJ) and is considered a potential component of functional foods. In this study, we used silkworm transgenic technology to obtain five transgenic silkworm lineages expressing the exogenous recombinant Chinese honeybee, Apis cerana cerana, protein-1 (rAccMRJP1) under the control of a fibroin light chain (Fib-L) promoter in the posterior silk glands. The protein was successfully secreted into cocoons; specifically, the highest rAccMRJP1 protein content was 0.78% of the dried cocoons. Our results confirmed that the protein band of the exogenous rAccMRJP1 protein expressed in the transgenic silkworm lineages was a glycosylated protein. Therefore, this rAccMRJP1 protein could be used as an alternative standard protein sample to measure the freshness of RJ. Moreover, we also found that the overall trend between the expression of the endogenous and exogenous genes was that the expression level of the endogenous Fib-L gene declined as the expression of the exogenous rAccMRJP1 gene increased in the transgenic silkworm lineages. Thus, by employing genome editing technology to reduce silk protein expression levels, a silkworm bioreactor expression system could be developed as a highly successful system for producing various valuable heterologous proteins, potentially broadening the applications of the silkworm.	[You, Zhengying; Qian, Qiujie; Che, Jiaqian; Ye, Lupeng; Zhong, Boxiong] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Qian, Qiujie] Haining Sericulture Technol Extens Stn Zhejiang P, Haining, Zhejiang, Peoples R China; [Wang, Yiran; Shen, Lirong] Zhejiang Univ, Fuli Inst Food Sci, Dept Food Sci & Nutr, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China	Zhong, BX (reprint author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China.; Shen, LR (reprint author), Zhejiang Univ, Fuli Inst Food Sci, Dept Food Sci & Nutr, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China.	shenlirong@zju.edu.cn; bxzhong@zju.edu.cn			National Basic Research Program of China [2012CB114601]; China Postdoctoral Science Foundation [2016M591989]; National Natural Science Foundation of China [31271848]	This work was supported by the grants from the National Basic Research Program of China (No. 2012CB114601); the China Postdoctoral Science Foundation (No. 2016M591989); the National Natural Science Foundation of China (No. 31271848).	Albert T, 2004, J INSECT PHYSIOL, V50, P51, DOI 10.1016/j.jinsphys.2003.09.008; Bincoletto C, 2005, INT IMMUNOPHARMACOL, V5, P679, DOI 10.1016/j.intimp.2004.11.015; Emori Y, 1999, BIOTHERAPY JPN, V13, P281; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2                                                   ; GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G                                                    ; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Judova J, 2004, BIOL PLANTARUM, V48, P185, DOI 10.1023/B:BIOP.0000033443.60872.f1; Kamakura M, 2001, J NUTR SCI VITAMINOL, V47, P394; Kamakura M, 2001, BIOSCI BIOTECH BIOCH, V65, P277, DOI 10.1271/bbb.65.277; Kamakura M, 2001, BIOCHEM BIOPH RES CO, V282, P865, DOI 10.1006/bbrc.2001.4656; Kucharski R, 1998, NATURWISSENSCHAFTEN, V85, P343, DOI 10.1007/s001140050512                                                           ; LERCKER G, 1981, LIPIDS, V16, P912, DOI 10.1007/BF02534997; Ma L, 2011, CELL RES, V21, P934, DOI 10.1038/cr.2011.36; Ma S, 2014, SCI REP, V4, P4489; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Muller-Steffner H, 2010, PROTEIN EXPRES PURIF, V70, P151, DOI 10.1016/j.pep.2009.10.003; Nagai T, 2001, FOOD CHEM, V75, P237, DOI 10.1016/S0308-8146(01)00193-5; Sajwan S, 2013, INSECT BIOCHEM MOLEC, V43, P17, DOI 10.1016/j.ibmb.2012.10.011; Salazar-Olivo LA, 2005, TOXICOL IN VITRO, V19, P645, DOI 10.1016/j.tiv.2005.03.001; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Shen LR, 2015, J ZHEJIANG UNIV-SC B, V16, P155, DOI 10.1631/jzus.B1400223; Shen LR, 2010, J AGR FOOD CHEM, V58, P9190, DOI 10.1021/jf1007133; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tamura S, 2009, PROTEOMICS, V9, P5534, DOI 10.1002/pmic.200900541; Tamura T, 2000, NAT BIOTECHNOL, V18, P81; TAMURA T, 1987, FOLIA PHARMACOL JPN, V89, P73, DOI 10.1254/fpj.89.73; Tao T, 2008, J AGR FOOD CHEM, V56, P9464, DOI 10.1021/jf8018497; Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x; Tomita M, 2011, BIOTECHNOL LETT, V33, P645, DOI 10.1007/s10529-010-0498-z; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang F, 2013, TRANSGENIC RES, V22, P925, DOI 10.1007/s11248-013-9695-6; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; Ye LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08301; Zhang L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-135; Zhang L, 2012, J PROTEOMICS, V75, P5327, DOI 10.1016/j.jprot.2012.06.008; Zhao AC, 2010, TRANSGENIC RES, V19, P29, DOI 10.1007/s11248-009-9295-7; Zhong BX, 2007, ACTA BIOCH BIOPH SIN, V39, P117, DOI 10.1111/j.1745-7270.2007.00252.x	42	0	0	14	14	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	OCT	2017	26	5					653	663		10.1007/s11248-017-0034-1				11	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FH1UR	WOS:000410925700007	28801873				2018-01-05	
J	Kriz, V; Krausova, M; Buresova, P; Dobes, J; Hrckulak, D; Babosova, O; Svec, J; Korinek, V				Kriz, Vitezslav; Krausova, Michaela; Buresova, Petra; Dobes, Jan; Hrckulak, Dusan; Babosova, Olga; Svec, Jiri; Korinek, Vladimir			Establishment of a tagged variant of Lgr4 receptor suitable for functional and expression studies in the mouse	TRANSGENIC RESEARCH			English	Article						Genome editing; Hemagglutinin tag; Knock-in; R-spondin; TALENs; Wnt signaling	POSTNATAL MAMMARY-GLAND; INTESTINAL STEM-CELLS; HAIR FOLLICLE; STEM/PROGENITOR CELLS; WNT/BETA-CATENIN; SELF-RENEWAL; NULL MICE; WNT; PROTEOME; IDENTIFICATION	Leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) is produced in a broad spectrum of mouse embryonic and adult tissues and its deficiency results in embryonal or perinatal lethality. The LGR4 function was mainly related to its potentiation of canonical Wnt signaling; however, several recent studies associate LGR4 with additional signaling pathways. To obtain a suitable tool for studying the signaling properties of Lgr4, we generated a tagged variant of the Lgr4 receptor using gene targeting in the mouse oocyte. The modified Lgr4 allele expresses the Lgr4 protein fused with a triple hemagglutinin (3HA) tag located at the extracellular part of the protein. The allele is fully functional, enabling tracking of Lgr4 expression in the mouse tissues. We also show that via surface labeling, the 3HA tag allows direct isolation and analysis of living Lgr4-positive cells obtained from the small intestinal crypts. Finally, the HA tag-specific antibody can be employed to characterize the biochemical features of Lgr4 and to identify possible biding partners of the protein in cells derived from various mouse tissues.	[Kriz, Vitezslav; Krausova, Michaela; Buresova, Petra; Dobes, Jan; Hrckulak, Dusan; Babosova, Olga; Svec, Jiri; Korinek, Vladimir] Acad Sci Czech Republ, Inst Mol Genet, Videnska 1083, CR-14220 Prague 4, Czech Republic	Korinek, V (reprint author), Acad Sci Czech Republ, Inst Mol Genet, Videnska 1083, CR-14220 Prague 4, Czech Republic.	korinek@img.cas.cz	Babosova, Olga/S-3527-2017	Babosova, Olga/0000-0001-7036-6807; Buresova, Petra/0000-0003-0018-1975	Grant Agency of the Czech Republic [14-33952S]; Ministry of Education, Youth and Sports [LO1419]; Academy of Sciences of the Czech Republic [RVO 68378050]; CCP [LM2015040]; OP RDI [CZ.1.05/2.1.00/19.0395]	We thank S. Takacova for critically reading the manuscript. We also thank P. Talacko and K. Harant for mass spectrometry analysis. We express our special thanks to R. Sedlacek, P. Kasparek, and the members of the Transgenic and Archiving Module, the Czech Centre for Phenogenomics (CCP), for generation of transgenic mice. This work was supported by the Grant Agency of the Czech Republic Grant No. 14-33952S, by the Ministry of Education, Youth and Sports (project LO1419), and by the Academy of Sciences of the Czech Republic (RVO 68378050). Animal work was supported by CCP (project no. LM2015040) and OP RDI CZ.1.05/2.1.00/19.0395 (project: Higher quality and capacity for transgenic models).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Flemr M, 2013, CELL, V155, P807, DOI 10.1016/j.cell.2013.10.001; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hsu PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106804; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kasparek P, 2014, FEBS LETT, V588, P3982, DOI 10.1016/j.febslet.2014.09.014; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539                                                                ; Li CL, 2014, MOL CELL BIOL, V34, P1649, DOI 10.1128/MCB.00023-14; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774                                                          ; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mohri Y, 2008, DEV DYNAM, V237, P2235, DOI 10.1002/dvdy.21639; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0                                                   ; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144	45	0	0	7	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	OCT	2017	26	5					689	701		10.1007/s11248-017-0027-0				13	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FH1UR	WOS:000410925700010	28634819	gold			2018-01-05	
J	Menoret, S; Tesson, L; Remy, S; Usal, C; Ouisse, LH; Brusselle, L; Chenouard, V; Anegon, I				Menoret, Severine; Tesson, Laurent; Remy, Severine; Usal, Claire; Ouisse, Laure-Helene; Brusselle, Lucas; Chenouard, Vanessa; Anegon, Ignacio			Advances in transgenic animal models and techniques	TRANSGENIC RESEARCH			English	Article						Transgenic; Genome editing; CRISPR; TALEN; ZFN; Animal models; Zygote; iPS cells; ES cells; Microinjection; Electroporation; Gene drive	LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-E; KNOCKOUT RATS; CRISPR RNA; MICE; HYPERCHOLESTEROLEMIA; NUCLEASES; GENOME; CPF1; ATHEROSCLEROSIS	On May 11th and 12th 2017 was held in Nantes, France, the international meeting "Advances in transgenic animal models and techniques'' (http://www.trm.univ-nantes.fr/). This biennial meeting is the fifth one of its kind to be organized by the Transgenic Rats ImmunoPhenomic (TRIP) Nantes facility (http://www.tgr.nantes.inserm.fr/). The meeting was supported by private companies (SONIDEL, Scionics computer innovation, New England Biolabs, MERCK, genOway, Journal Disease Models and Mechanisms) and by public institutions (International Society for Transgenic Technology, University of Nantes, INSERM UMR 1064, SFR Franc, ois Bonamy, CNRS, Re'gion Pays de la Loire, Biogenouest, TEFOR infrastructure, ITUN, IHU-CESTI and DHU-Oncogeffe and Labex IGO). Around 100 participants, from France but also from different European countries, Japan and USA, attended the meeting.	[Menoret, Severine; Tesson, Laurent; Remy, Severine; Usal, Claire; Ouisse, Laure-Helene; Brusselle, Lucas; Chenouard, Vanessa; Anegon, Ignacio] Univ Nantes, UMR 1064, Ctr Rech Transplantat & Immunol, INSERM, Nantes, France; [Menoret, Severine; Tesson, Laurent; Remy, Severine; Usal, Claire; Ouisse, Laure-Helene; Brusselle, Lucas; Chenouard, Vanessa; Anegon, Ignacio] CHU Nantes, ITUN, Nantes, France; [Menoret, Severine; Tesson, Laurent; Remy, Severine; Usal, Claire; Ouisse, Laure-Helene; Brusselle, Lucas; Chenouard, Vanessa; Anegon, Ignacio] CNRS, UMS3556, SFR Francois Bonamy, Platform Rat Transgenesis ImmunoPhen, Nantes, France	Anegon, I (reprint author), Univ Nantes, UMR 1064, Ctr Rech Transplantat & Immunol, INSERM, Nantes, France.	ianegon@nantes.inserm.fr			LabCom SOURIRAT Project [ANR-1-4LAB5-0008]; "TEFOR" "Investissements d'Avenir" [ANRII-INSB-0014]; Labex IGO Project "Investissements d'Avenir" [ANR-11-LABX-0016-01]; IHU-Cesti Project "Investissements d'Avenir" [ANR-10-IBHU-005]; Nantes Metropole; Region Pays de la Loire	LabCom SOURIRAT Project (ANR-1-4LAB5-0008), "TEFOR" "Investissements d'Avenir" (ANRII-INSB-0014), Labex IGO Project "Investissements d'Avenir" (ANR-11-LABX-0016-01) and IHU-Cesti Project "Investissements d'Avenir" (ANR-10-IBHU-005) as well as Nantes Metropole and Region Pays de la Loire.	Beaghton A, 2017, GENETICS, V205, P1587, DOI 10.1534/genetics.116.197632; Brault V, 2007, Handb Exp Pharmacol, P29; Dong D, 2016, NATURE, V532, P522, DOI 10.1038/nature17944; Duchon A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00104; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; Fischer K, 2016, SCI REP, V6, P29081; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Getz GS, 2016, J LIPID RES, V57, P758, DOI 10.1194/jlr.R067249; Geurts AM, 2015, HYPERTENSION, V65, P447, DOI 10.1161/HYPERTENSIONAHA.114.04179; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Herault Y, 2012, PROG BRAIN RES, V197, P169, DOI 10.1016/B978-0-444-54299-1.00009-1; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jung CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31455; Kaneko Takehito, 2017, Methods Mol Biol, V1630, P81, DOI 10.1007/978-1-4939-7128-2_7; Kaneko T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142755; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Karvelis T, 2017, METHODS, V121, P3, DOI 10.1016/j.ymeth.2017.03.006; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Larcher T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110371; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Menoret S, 2010, EUR J IMMUNOL, V40, P2932, DOI 10.1002/eji.201040939; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Mussolino C, 2013, NAT BIOTECHNOL, V31, P208, DOI 10.1038/nbt.2527; Osborn MJ, 2013, J IMMUNOL, V190, P1481, DOI 10.4049/jimmunol.1203041; Ouisse LH, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-016-0322-5; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	34	0	0	12	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-8819	1573-9368		TRANSGENIC RES	Transgenic Res.	OCT	2017	26	5					703	708		10.1007/s11248-017-0038-x				6	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FH1UR	WOS:000410925700011	28780744				2018-01-05	
J	Ji, QQ; Guo, CP; Xie, C; Wu, YD; Zhang, P; Li, H; Lu, YJ				Ji, Qianqian; Guo, Caiping; Xie, Chen; Wu, Yingdan; Zhang, Pei; Li, Hui; Lu, Yongjun			Genetically engineered cell lines for alpha 1-antitrypsin expression	BIOTECHNOLOGY LETTERS			English	Article						AAVS1 locus; alpha 1-Antitrypsin deficiency; CRISPR/Cas9; Homologous recombination	RECOMBINANT ALPHA-1-ANTITRYPSIN; DEFICIENCY; INTEGRATION; LOCUS; ZZ	To establish genetically modified cell lines that can produce functional alpha 1-antitrypsin (AAT), by CRISPR/Cas9-assisted homologous recombination. alpha 1-Antitrypsin deficiency (AATD) is a monogenic heritable disease that often results in lungs and liver damage. Current augmentation therapy is expensive and in short of supply. To develop a safer and more effective therapeutic strategy for AATD, we integrated the AAT gene (SERPINA1, NG_008290.1) into the AAVS1 locus of human cell line HEK293T and assessed the safety and efficacy of CRISPR/Cas9 on producing potential therapeutic cell lines. Cell clones obtained had the AAT gene integrated at the AAVS1 locus and secreted approx. 0.04 g/l recombinant AAT into the medium. Moreover, the secreted AAT showed an inhibitory activity that is comparable to plasma AAT. CRISPR/Cas9-mediated engineering of human cells is a promising alternative for generating isogenic cell lines with consistent AAT production. This work sheds new light on the generation of therapeutic liver stem cells for AATD.	[Ji, Qianqian; Lu, Yongjun] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Guo, Caiping; Xie, Chen; Wu, Yingdan; Zhang, Pei; Li, Hui] Shenzhen Weiguang Biol Prod Co Ltd, Shenzhen, Peoples R China; [Lu, Yongjun] 135 Xin Gang Xi Rd, Guangzhou 510275, Guangdong, Peoples R China	Lu, YJ (reprint author), 135 Xin Gang Xi Rd, Guangzhou 510275, Guangdong, Peoples R China.	luyj@mail.sysu.edu.cn			China Postdoctoral Science Foundation [2015M582465]	This work was supported by China Postdoctoral Science Foundation (Grant No. 2015M582465).	Blanchard V, 2011, BIOTECHNOL BIOENG, V108, P2118, DOI 10.1002/bit.23158; Blanco I, 2004, J RHEUMATOL, V31, P2082; Chiuchiolo MJ, 2013, HUM GENE THER CL DEV, V24, P161, DOI 10.1089/humc.2013.168; de Serres FJ, 2012, THER ADV RESPIR DIS, V6, P277, DOI 10.1177/1753465812457113; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; FEINSTEIN G, 1973, BIOCHEM BIOPH RES CO, V50, P1020, DOI 10.1016/0006-291X(73)91508-8; Hansen HG, 2016, BIOTECHNOL J, V11, P1648, DOI 10.1002/biot.201600409; Henckaerts E, 2009, P NATL ACAD SCI USA, V106, P7571, DOI 10.1073/pnas.0806821106; Lee KJ, 2013, GLYCOCONJUGATE J, V30, P537, DOI 10.1007/s10719-012-9453-7; Ross D, 2012, J BIOTECHNOL, V162, P262, DOI 10.1016/j.jbiotec.2012.09.018; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Wang ZH, 2013, ANAL BIOCHEM, V437, P20, DOI 10.1016/j.ab.2013.02.006; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	14	0	0	8	8	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0141-5492	1573-6776		BIOTECHNOL LETT	Biotechnol. Lett.	OCT	2017	39	10					1471	1476		10.1007/s10529-017-2391-5				6	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FH1YF	WOS:000410935000004	28721587				2018-01-05	
J	Han, JY; Lee, IG; Shin, S; Kim, M; Jang, JH; Park, J				Han, Ji Yoon; Lee, In Goo; Shin, Soyoung; Kim, Myungshin; Jang, Ja Hyun; Park, Joonhong			The first patient with sporadic X-linked intellectual disability with de novo ZDHHC9 mutation identified by targeted next-generation sequencing	EUROPEAN JOURNAL OF MEDICAL GENETICS			English	Article						X-linked intellectual disability; ZDHHC9; de novo hemizygous mutation; Targeted next-generation sequencing	MENTAL-RETARDATION; IMPAIRMENT; EPILEPSY; GENE	X-linked intellectual disability (XLID) is a genetically heterogeneous disorder involving more than 100 genes known to date. Here, we describe a Korean male infant with global developmental delay. He had neither facial dysmorphism nor skeletal abnormalities. Bayley scale of infant and toddler development third edition (Bayley-III) measured at age of 2 years revealed marked global developmental delays without Marfanoid habitus, structural brain abnormalities, or epilepsy. The patient's cognitive, motor, and language developmental ages were 8-9 months, 12 months, and 9 months, respectively. Targeted next-generation sequencing revealed a de novo mutation [NM_001008222.2(ZDHHC9): c.286C > T (p.(Arg96Trp))] in the affected patient. This mutation has been reported previously in a family XLID with Marfanoid features. Sanger sequencing analysis of the proband and his parents revealed that the missense mutation was present in the proband only (absent in his parents). This indicates that the mutation is de novo in origin. To the best of our knowledge, this is the first report describing sporadic XLID with de novo ZDHHC9 mutation identified by targeted next-generation sequencing. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Han, Ji Yoon; Lee, In Goo] Catholic Univ Korea, Dept Pediat, Coll Med, Seoul, South Korea; [Shin, Soyoung; Kim, Myungshin; Park, Joonhong] Catholic Univ Korea, Dept Lab Med, Coll Med, Seoul, South Korea; [Jang, Ja Hyun] Green Gross Genome, Dept Lab Med, Yongin, South Korea	Park, J (reprint author), Catholic Univ Korea, Daejeon St Marys Hosp, Dept Lab Med, Coll Med, 64 Daeheung Ro, Daejeon 34943, South Korea.	miziro@catholic.ac.kr					Baker K, 2015, ANN CLIN TRANSL NEUR, V2, P559, DOI 10.1002/acn3.196; Bathelt J, 2016, NEUROIMAGE-CLIN, V12, P655, DOI 10.1016/j.nicl.2016.07.016; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Callier P, 2013, CLIN GENET, V84, P507, DOI 10.1111/cge.12094; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Masurel-Paulet A, 2014, AM J MED GENET A, V164, P789, DOI 10.1002/ajmg.a.36348; Mitchell DA, 2014, J BIOL CHEM, V289, P18582, DOI 10.1074/jbc.M114.567420; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tzschach A, 2015, EUR J HUM GENET, V23, P1513, DOI 10.1038/ejhg.2015.5	20	0	0	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1769-7212	1878-0849		EUR J MED GENET	Eur. J. Med. Genet.	OCT	2017	60	10					499	503		10.1016/j.ejmg.2017.07.002				5	Genetics & Heredity	Genetics & Heredity	FH1OB	WOS:000410908200001	28687527				2018-01-05	
J	Suarez-Amaran, L; Usai, C; Di Scala, M; Godoy, C; Ni, Y; Hommel, M; Palomo, L; Segura, V; Olague, C; Vales, A; Ruiz-Ripa, A; Buti, M; Salido, E; Prieto, J; Urban, S; Rodriguez-Frias, F; Aldabe, R; Gonzalez-Aseguinolaza, G				Suarez-Amaran, Lester; Usai, Carla; Di Scala, Marianna; Godoy, Cristina; Ni, Yi; Hommel, Mirja; Palomo, Laura; Segura, Victor; Olague, Cristina; Vales, Africa; Ruiz-Ripa, Alicia; Buti, Maria; Salido, Eduardo; Prieto, Jesus; Urban, Stephan; Rodriguez-Frias, Francisco; Aldabe, Rafael; Gonzalez-Aseguinolaza, Gloria			A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-beta induction	JOURNAL OF HEPATOLOGY			English	Article						Hepatitis delta virus; Hepatitis B virus; HDV/HBV co-infection; Mouse model; AAV; Liver injury; Innate immune response	HEPATITIS-DELTA-VIRUS; B-VIRUS; INTRAHEPATIC EXPRESSION; INFECTION; REPLICATION; RNA; PATHOGENESIS; HEPATOCYTES; DISEASE; ANTIGEN	Background & Aims: Studying hepatitis delta virus (HDV) and developing new treatments is hampered by the limited availability of small animal models. Herein, a description of a robust mouse model of HDV infection that mimics several important characteristics of the human disease is presented. Methods: HDV and hepatitis B virus (HBV) replication competent genomes were delivered to the mouse liver using adenoassociated viruses (AAV; AAV-HDV and AAV-HBV). Viral load, antigen expression and genomes were quantified at different time points after AAV injection. Furthermore, liver pathology, genome editing, and the activation of the innate immune response were evaluated. Results: AAV-HDV infection initiated HDV replication in mouse hepatocytes. Genome editing was confirmed by the presence of small and large HDV antigens and sequencing. Viral replication was detected for 45 days, even after the AAV-HDV vector had almost disappeared. In the presence of HBV, HDV infectious particles were detected in serum. Furthermore, as observed in patients, co-infection was associated with the reduction of HBV antigen expression and the onset of liver damage that included the alteration of genes involved in the development of liver pathologies. HDV replication induced a sustained type I interferon response, which was significantly reduced in immunodeficient mice and almost absent in mitochondrial antiviral signaling protein (MAVS)-deficient mice. Conclusion: The animal model described here reproduces important characteristics of human HDV infection and provides a valuable tool for characterizing the viral infection and for developing new treatments. Furthermore, MAVS was identified as a main player in HDV detection and adaptive immunity was found to be involved in the amplification of the innate immune response. Lay summary: Co-infection with hepatitis B and D virus (HBV and HDV, respectively) often causes a more severe disease condition than HBV alone. Gaining more insight into HDV and developing new treatments is hampered by limited availability of adequate immune competent small animal models and new ones are needed. Here, a mouse model of HDV infection is described, which mimics several important characteristics of the human disease, such as the initiation and maintenance of replication in murine hepatocytes, genome editing and, in the presence of HBV, generation of infectious particles. Lastly, the involvement of an adaptive immunity and the intracellular signaling molecule MAVS in mounting a strong and lasting innate response was shown. Thus, our model serves as a useful tool for the investigation of HDV biology and new treatments. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Suarez-Amaran, Lester; Usai, Carla; Di Scala, Marianna; Hommel, Mirja; Palomo, Laura; Olague, Cristina; Vales, Africa; Prieto, Jesus; Aldabe, Rafael; Gonzalez-Aseguinolaza, Gloria] Ctr Appl Med Res CIMA, Gene Therapy & Regulat Gene Express Program, Avda Pio 12 55, Pamplona 31008, Spain; [Suarez-Amaran, Lester; Usai, Carla; Di Scala, Marianna; Hommel, Mirja; Palomo, Laura; Segura, Victor; Olague, Cristina; Vales, Africa; Prieto, Jesus; Aldabe, Rafael; Gonzalez-Aseguinolaza, Gloria] Inst Invest Sanitaria Navarra IdiSNA, Calle Irunlarrea 3, Pamplona 31008, Spain; [Godoy, Cristina; Ruiz-Ripa, Alicia; Buti, Maria; Rodriguez-Frias, Francisco] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Godoy, Cristina; Ruiz-Ripa, Alicia; Buti, Maria; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Biochem, Liver Pathol Unit, Barcelona, Spain; [Olague, Cristina; Ruiz-Ripa, Alicia; Buti, Maria; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Microbiol, Liver Pathol Unit, Barcelona, Spain; [Olague, Cristina; Ruiz-Ripa, Alicia; Buti, Maria; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Microbiol, Virol Unit, Barcelona, Spain; [Ni, Yi; Urban, Stephan] Univ Hosp Heidelberg, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Segura, Victor] Univ Navarra, Ctr Appl Med Res CIMA, Bioinformat Unit, Pamplona, Spain; [Salido, Eduardo] Ctr Biomed Res Rare Dis CIBERER, Dept Pathol, San Cristobal la Laguna, Sc Tenerife, Spain; [Prieto, Jesus] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain; [Suarez-Amaran, Lester] Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Di Scala, Marianna] Fdn Ctr Nacl Invest Cardiovasc, Madrid, Spain	Gonzalez-Aseguinolaza, G (reprint author), Ctr Appl Med Res CIMA, Gene Therapy & Regulat Gene Express Program, Avda Pio 12 55, Pamplona 31008, Spain.	ggasegui@unav.es	Aldabe, Rafael/F-3112-2015	Aldabe, Rafael/0000-0002-9461-020X	Secretaria de Estado de Investigacion, Desarrollo e Innovacion, Ministerio de Economia y Competitividad [SAF2015-70028-R, SAF2012-39578]; FPU fellowship from Spanish Ministry of Education; FPI fellowship from Spanish Ministry of Economy and Competitiveness	SAF2015-70028-R and SAF2012-39578 (Secretaria de Estado de Investigacion, Desarrollo e Innovacion, Ministerio de Economia y Competitividad). Lester Suarez was supported by an FPU fellowship from the Spanish Ministry of Education and Carla Usai is supported by an FPI fellowship from the Spanish Ministry of Economy and Competitiveness.	Abbasi A, 2014, JCPSP-J COLL PHYSICI, V24, P624, DOI 09.2014/JCPSP.624627; Aldabe R, 2015, PATHOGENS, V4, P46, DOI 10.3390/pathogens4010046; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P541, DOI 10.3851/IMP2598; Bracci L, 2008, EXPERT REV VACCINES, V7, P373, DOI 10.1586/14760584.7.3.373; Chang JH, 2001, J VIROL, V75, P3469, DOI 10.1128/JVI.75.7.3469-3473.2001                                                 ; Chang JH, 2008, J VIROL, V82, P1118, DOI 10.1128/JVI.01758-07; Chen RX, 2010, VIRUSES-BASEL, V2, P131, DOI 10.3390/v2010131; CHU CM, 1992, J HEPATOL, V16, P153, DOI 10.1016/S0168-8278(05)80108-4; COLOMBO P, 1991, J HEPATOL, V12, P64, DOI 10.1016/0168-8278(91)90911-T; DAVIES SE, 1992, AM J CLIN PATHOL, V98, P554; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; Flores R, 2012, SEMIN LIVER DIS, V32, P201, DOI 10.1055/s-0032-1323624; Giersch Katja, 2015, J Clin Transl Hepatol, V3, P220, DOI 10.14218/JCTH.2015.00018; Giersch K, 2015, J HEPATOL, V63, P346, DOI 10.1016/j.jhep.2015.03.011; Govindarajan S, 1990, Hepatology, V11, P703, DOI 10.1002/hep.1840110427; GUIDOTTI LG, 1995, J VIROL, V69, P6158; He WH, 2016, J VIROL, V90, P8866, DOI 10.1128/JVI.00901-16; He WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004840; High KA, 2016, HUM MOL GENET, V25, pR36, DOI 10.1093/hmg/ddv475; Hirai-Yuki A, 2016, SCIENCE, V353, P1541, DOI 10.1126/science.aaf8325; Homs M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158557; Kabacam G, 2014, LIVER INT, V34, P1207, DOI 10.1111/liv.12376; Kabacam G, 2012, CLIN INFECT DIS, V55, P645, DOI 10.1093/cid/cis459; Koh C, 2015, LANCET INFECT DIS, V15, P1167, DOI 10.1016/S1473-3099(15)00074-2; Kramer MG, 2003, MOL THER, V7, P375, DOI 10.1016/S1525-0016(02)00060-6; Lau DTY, 1999, HEPATOLOGY, V30, P546, DOI 10.1002/hep.510300217; LAU JYN, 1992, J CLIN PATHOL, V45, P314, DOI 10.1136/jcp.45.4.314; Lutgehetmann M, 2012, HEPATOLOGY, V55, P685, DOI 10.1002/hep.24758; Murillo O, 2016, J HEPATOL, V64, P419, DOI 10.1016/j.jhep.2015.09.014; Negro F, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021550; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Oshiumi H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00200; Rizzetto M, 2016, LIVER INT, V36, P135, DOI 10.1111/liv.13018; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Taylor JM, 2006, CURR TOP MICROBIOL, V307, P1; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; WEINER AJ, 1988, J VIROL, V62, P594; Williams V, 2009, J GEN VIROL, V90, P2759, DOI 10.1099/vir.0.011239-0; Winer BY, 2015, CURR OPIN VIROL, V13, P109, DOI 10.1016/j.coviro.2015.06.004; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	41	1	1	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	OCT	2017	67	4					669	679		10.1016/j.jhep.2017.05.010				11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FG9RE	WOS:000410775900004	28527664				2018-01-05	
J	Wei, L; Chiu, DKC; Tsang, FHC; Law, CT; Cheng, CLH; Au, SLK; Lee, JMF; Wong, CCL; Ng, IOL; Wong, CM				Wei, Lai; Chiu, David Kung-Chun; Tsang, Felice Ho-Ching; Law, Cheuk-Ting; Cheng, Carol Lai-Hung; Au, Sandy Leung-Kuen; Lee, Joyce Man-Fong; Wong, Carmen Chak-Lui; Ng, Irene Oi-Lin; Wong, Chun-Ming			Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3	JOURNAL OF HEPATOLOGY			English	Article						Epigenetics; Histone modifications; G9a; Gene amplification; miR-1; RARRES3	COMPARATIVE GENOMIC HYBRIDIZATION; ADVANCED HEPATOCELLULAR-CARCINOMA; LYSINE METHYLTRANSFERASE; EARLY EMBRYOGENESIS; BREAST-CANCER; CELLS; METHYLATION; METASTASIS; APOPTOSIS; DIFFERENTIATION	Background & Aims: Hepatocellular carcinoma (HCC) is a major leading cause of cancer mortality worldwide. Epigenetic deregulation is a common trait of human HCC. G9s is an important epigenetics regulator however, its role in liver carcinogenesis remains to be investigated. Methods: Gene expressions were determined by RNA-Seq and qRT-PCR. G9a knockdown and knockout cell lines were established by lentiviral-based shRNA and CRISPR/Cas9 gene editing system. Tumor-promoting functions of G9a was studied in both HCC cell lines and nude mice model. The downstream targets of G9a were identified by RNA-Seq and confirmed by ChIP assay. The therapeutic value of G9a inhibitors was evaluated both in vitro and in vivo. Results: We identified G9a as a frequently upregulated histone methyltransferase in human HCCs. Upregulation of G9a was significantly associated with HCC progression and aggressive clinicopathological features. Functionally, we demonstrated that inactivation of G9a by RNAi knockdown, CRISPR/Cas9 knockout, and pharmacological inhibition remarkably abolished H3K9 di-methylation and suppressed HCC cell proliferation and metastasis in both in vitro and in vivo models. Mechanistically, we showed that the frequent upregulation of G9a in human HCCs was attributed to gene copy number gain at chromosome 6p21. In addition, we identified miR-1 as a negative regulator of G9a. Loss of miR-1 relieved the post-transcriptional repression on G9a and contributed to its upregulation in human HCC. Utilizing RNA sequencing, we identified the tumor suppressor RARRES3 as a critical target of G9a. Epigenetic silencing of RARRES3 contributed to the tumor-promoting function of G9a. Conclusion: This study shows a frequent deregulation of miR-1/ G9a/RARRES3 axis in liver carcinogenesis, highlighting the pathological significance of G9a and its therapeutic potential in HCC treatment. Lay summary: In this study, we identified G9a histone methyltransferase was frequently upregulated in human HCC and contributes to epigenetic silencing of tumor suppressor gene RARRES3 in liver cancer. Targeting G9a may be a novel approach for HCC treatment. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[Wei, Lai; Chiu, David Kung-Chun; Tsang, Felice Ho-Ching; Law, Cheuk-Ting; Cheng, Carol Lai-Hung; Au, Sandy Leung-Kuen; Lee, Joyce Man-Fong; Wong, Carmen Chak-Lui; Ng, Irene Oi-Lin; Wong, Chun-Ming] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Wei, Lai; Chiu, David Kung-Chun; Tsang, Felice Ho-Ching; Law, Cheuk-Ting; Cheng, Carol Lai-Hung; Au, Sandy Leung-Kuen; Lee, Joyce Man-Fong; Wong, Carmen Chak-Lui; Ng, Irene Oi-Lin; Wong, Chun-Ming] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Wei, Lai; Tsang, Felice Ho-Ching; Wong, Chun-Ming] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China	Ng, IOL; Wong, CM (reprint author), Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China.; Ng, IOL; Wong, CM (reprint author), Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China.	iolng@hku.hk; jackwong@pathology.hku.hk	WONG, Chun-Ming/A-6739-2009	WONG, Chun-Ming/0000-0002-2497-7858	National Natural Science Foundation of China General Program [81572446]; Hong Kong Research Grants Council [T12-704/16R]; General Research Funds [17115815, HKU780612M]	The study was supported by National Natural Science Foundation of China General Program (81572446), and Hong Kong Research Grants Council Theme-based Research Scheme (T12-704/16R) and General Research Funds (17115815 and HKU780612M). I.O. L. Ng is Loke Yew Professor in Pathology.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Chen YJ, 2000, GASTROENTEROLOGY, V119, P431, DOI 10.1053/gast.2000.9373; Chochi Y, 2009, J PATHOL, V217, P677, DOI 10.1002/path.2491; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; DiSepio D, 1998, P NATL ACAD SCI USA, V95, P14811, DOI 10.1073/pnas.95.25.14811; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Ellinger J, 2010, PROSTATE, V70, P61, DOI 10.1002/pros.21038; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fan DNY, 2013, HEPATOLOGY, V57, P637, DOI 10.1002/hep.26083; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Higuchi E, 2003, ONCOGENE, V22, P4627, DOI 10.1038/sj.onc.1206235; Hsu TH, 2015, CELL DEATH DIFFER, V22, P1561, DOI 10.1038/cdd.2015.90; Hsu TH, 2012, FEBS LETT, V586, P1287, DOI 10.1016/j.febslet.2012.03.020; Hua KT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-189; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127                                                         ; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Lee SH, 2009, ONCOGENE, V28, P184, DOI 10.1038/onc.2008.377; Li KC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-172; Lin YW, 1999, EUR J CANCER, V35, P652, DOI 10.1016/S0959-8049(98)00430-4; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lu ZY, 2013, ANTI-CANCER DRUG, V24, P484, DOI 10.1097/CAD.0b013e32835ffdbb; Moinzadeh P, 2005, BRIT J CANCER, V92, P935, DOI 10.1038/sj.bjc.6602448; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Morales M, 2014, EMBO MOL MED, V6, P865, DOI 10.15252/emmm.201303675; Pang A, 2003, CANCER GENET CYTOGEN, V146, P8, DOI 10.1016/S0165-4608(03)00103-1; Ren AS, 2015, BIOCHEM BIOPH RES CO, V459, P10, DOI 10.1016/j.bbrc.2015.01.068; Scharadin TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023230; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Sonoki T, 2001, BLOOD, V98, P2837, DOI 10.1182/blood.V98.9.2837; Sturniolo MT, 2003, J BIOL CHEM, V278, P48066, DOI 10.1074/jbc.M307215200; Tachibana M, 2002, GENE DEV, V16, P1779, DOI [10.1101/gad.989402, 10.1101/gad989402]; Tsai FM, 2007, CELL SIGNAL, V19, P989, DOI 10.1016/j.cellsig.2006.11.005; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wong CCY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017873; Wong CM, 2008, LIVER INT, V28, P160, DOI 10.1111/j.1478-3231.2007.01637.x; Wong CM, 2016, HEPATOLOGY, V63, P474, DOI 10.1002/hep.28304	45	1	1	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	OCT	2017	67	4					758	769		10.1016/j.jhep.2017.05.015				12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FG9RE	WOS:000410775900013	28532996				2018-01-05	
J	de Galarreta, MR; Lujambio, A				de Galarreta, Marina Ruiz; Lujambio, Amaia			Therapeutic editing of hepatocyte genome in vivo	JOURNAL OF HEPATOLOGY			English	Review						Gene editing; Meganucleases; ZFNs; TALENs; CRISPR-Cas nucleases; Liver hereditary diseases	ZINC-FINGER NUCLEASES; STRAND BREAK REPAIR; STAPHYLOCOCCUS-AUREUS CAS9; HUMAN-CELLS; LIVER-DISEASE; GENE-THERAPY; HOMING ENDONUCLEASE; TAL EFFECTORS; HEPATOCELLULAR CARCINOMAS; HOMOLOGOUS RECOMBINATION	The recent development of gene editing platforms enables making precise changes in the genome of eukaryotic cells. Programmable nucleases, such as meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and clustered regularly interspaced short palindromic repeat (CRISPR)-associated nucleases have revolutionized the way research is conducted as they facilitate the rapid production of mutant or knockout cellular and animal models. These same genetic tools can potentially be applied to cure or alleviate a variety of diseases, including genetic diseases that lack an efficient therapy. Thus, gene editing platforms could be used for correcting mutations that cause a disease, restoration of the expression of genes that are missing, or be used for the removal of deleterious genes or viral genomes. In the context of liver diseases, genome editing could be developed to treat not only hereditary monogenic liver diseases but also hepatitis B infection and diseases that have both genetic and non-genetic components. While the prospect of translating these therapeutic strategies to a clinical setting is highly appealing, there are numerous challenges that need to be addressed first. Safety, efficiency, specificity, and delivery are some of the obstacles that will need to be addressed before each specific gene treatment is safely used in patients. Here, we discuss the most used gene editing platforms, their mechanisms of action, their potential for liver disease treatment, the most pressing challenges, and future prospects. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.	[de Galarreta, Marina Ruiz; Lujambio, Amaia] Icahn Sch Med Mt Sinai, Oncol Sci Dept, New York, NY 10029 USA; [de Galarreta, Marina Ruiz; Lujambio, Amaia] Icahn Sch Med Mt Sinai, Dept Med, Tisch Canc Inst, Liver Canc Program,Div Liver Dis, 1470 Madison Ave Hess 6-111, New York, NY 10029 USA; [Lujambio, Amaia] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Lujambio, A (reprint author), Icahn Sch Med Mt Sinai, Dept Med, Tisch Canc Inst, Liver Canc Program,Div Liver Dis, 1470 Madison Ave Hess 6-111, New York, NY 10029 USA.	amaia.lujam-bio@mssm.edu		Lujambio, Amaia/0000-0002-2798-1481	Fundacion Alfonso Martin Escudero; Department of Defense (DoD) Translational Team Science Award [CA150272P2]; DoD [CA150178]; American Association for the Study of Liver Diseases (AASLD) Pinnacle Award; Icahn School of Medicine at Mount Sinai	The authors gratefully thank the following funding agencies: MRG is funded by Fundacion Alfonso Martin Escudero and Department of Defense (DoD) Translational Team Science Award (CA150272P2). AL is funded by Department of Defense (DoD) Translational Team Science Award (CA150272P2), DoD Career Development Award (CA150178), American Association for the Study of Liver Diseases (AASLD) Pinnacle Award, and Icahn School of Medicine at Mount Sinai Seed Funding.	Alam S, 2016, INDIAN J PEDIATR, V83, P1321, DOI 10.1007/s12098-016-2097-z; Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Fagiuoli S, 2013, J HEPATOL, V59, P595, DOI 10.1016/j.jhep.2013.04.004; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P2136, DOI 10.1111/j.1572-0241.2008.01955.x; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao S, 2012, ANN BIOMED ENG, V40, P1851, DOI 10.1007/s10439-012-0555-y; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gissen P, 2015, J HEPATOL, V63, P1023, DOI 10.1016/j.jhep.2015.06.015; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Handel EM, 2012, HUM GENE THER, V23, P321, DOI 10.1089/hum.2011.140; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5                                                   ; Hirsch ML, 2010, GENE THER, V17, P1175, DOI 10.1038/gt.2010.65; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kattenhorn LM, 2016, HUM GENE THER, V27, P947, DOI 10.1089/hum.2016.160; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller DG, 2006, NAT BIOTECHNOL, V24, P1022, DOI 10.1038/nbt1231; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Naldini L, 1999, THROMB HAEMOSTASIS, V82, P552; Nault JC, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1095271; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Porteus MH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0859-y; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706.5715.2003; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smih F, 1995, NUCLEIC ACIDS RES, V23, P5012, DOI 10.1093/nar/23.24.5012; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0                                                                ; Sussman D, 2004, J MOL BIOL, V342, P31, DOI 10.1016/j.jmb.2004.07.031; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Thoene JG, 2004, COMMUNITY GENET, V7, P169, DOI 10.1159/000082255; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weber ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097579; West SC, 2000, COLD SPRING HARB SYM, V65, P315, DOI 10.1101/sqb.2000.65.315                                                         ; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	107	0	0	20	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	OCT	2017	67	4					818	828		10.1016/j.jhep.2017.05.012				11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FG9RE	WOS:000410775900019	28527665	gold			2018-01-05	
J	Schaller, T; Bulli, L; Pollpeter, D; Betancor, G; Kutzner, J; Apolonia, L; Herold, N; Burk, R; Malim, MH				Schaller, Torsten; Bulli, Lorenzo; Pollpeter, Darja; Betancor, Gilberto; Kutzner, Juliane; Apolonia, Luis; Herold, Nikolas; Burk, Robin; Malim, Michael H.			Effects of Inner Nuclear Membrane Proteins SUN1/UNC-84A and SUN2/UNC-84B on the Early Steps of HIV-1 Infection	JOURNAL OF VIROLOGY			English	Article						CA; HIV-1; SUN1; SUN2; cyclophilin A; early infection; nuclear envelope; nuclear import; nuclear pore complex; transmitted founder virus	IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL RESTRICTION FACTORS; LINC COMPLEX; NONDIVIDING CELLS; TERMINAL DOMAIN; SUN PROTEINS; NUCLEOPORIN NUP153; POSITIVE SELECTION; LENTIVIRAL VECTORS; DENDRITIC CELLS	Human immunodeficiency virus type 1 (HIV-1) infection of dividing and nondividing cells involves regulatory interactions with the nuclear pore complex (NPC), followed by translocation to the nucleus and preferential integration into genomic areas in proximity to the inner nuclear membrane (INM). To identify host proteins that may contribute to these processes, we performed an overexpression screen of known membrane-associated NE proteins. We found that the integral transmembrane proteins SUN1/UNC84A and SUN2/UNC84B are potent or modest inhibitors of HIV-1 infection, respectively, and that suppression corresponds to defects in the accumulation of viral cDNA in the nucleus. While laboratory strains (HIV-1NL4.3 and HIV-1IIIB) are sensitive to SUN1-mediated inhibition, the transmitted founder viruses RHPA and ZM247 are largely resistant. Using chimeric viruses, we identified the HIV-1 capsid (CA) protein as a major determinant of sensitivity to SUN1, and in vitro-assembled capsid-nucleocapsid (CANC) nanotubes captured SUN1 and SUN2 from cell lysates. Finally, we generated SUN1(-/-) and SUN2(-/-) cells by using CRISPR/Cas9 and found that the loss of SUN1 had no effect on HIV-1 infectivity, whereas the loss of SUN2 had a modest suppressive effect. Taken together, these observations suggest that SUN1 and SUN2 may function redundantly to modulate postentry, nuclear-associated steps of HIV-1 infection. IMPORTANCE HIV-1 causes more than 1 million deaths per year. The life cycle of HIV-1 has been studied extensively, yet important steps that occur between viral capsid release into the cytoplasm and the expression of viral genes remain elusive. We propose here that the INM components SUN1 and SUN2, two members of the linker of nucleoskeleton and cytoskeleton (LINC) complex, may interact with incoming HIV-1 replication complexes and affect key steps of infection. While overexpression of these proteins reduces HIV-1 infection, disruption of the individual SUN2 and SUN1 genes leads to a mild reduction or no effect on infectivity, respectively. We speculate that SUN1/SUN2 may function redundantly in early HIV-1 infection steps and therefore influence HIV-1 replication and pathogenesis.	[Schaller, Torsten; Bulli, Lorenzo; Kutzner, Juliane; Burk, Robin] Univ Hosp Heidelberg, Dept Infect Dis, Virol, Heidelberg, Germany; [Schaller, Torsten; Pollpeter, Darja; Betancor, Gilberto; Apolonia, Luis; Malim, Michael H.] Kings Coll London, Dept Infect Dis, London, England; [Schaller, Torsten; Bulli, Lorenzo] Goethe Univ, Inst Med Virol, Frankfurt, Germany; [Herold, Nikolas] Karolinska Hosp, Astrid Lindgren Childrens Hosp, Childhood Canc Res Unit, Stockholm, Sweden; [Herold, Nikolas] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Childrens & Womens Hlth, Stockholm, Sweden	Schaller, T (reprint author), Univ Hosp Heidelberg, Dept Infect Dis, Virol, Heidelberg, Germany.; Schaller, T; Malim, MH (reprint author), Kings Coll London, Dept Infect Dis, London, England.; Schaller, T (reprint author), Goethe Univ, Inst Med Virol, Frankfurt, Germany.	torsten.schaller@med.uni-heidelberg.de; michael.malim@kcl.ac.uk	Herold, Nikolas/M-6927-2016	Herold, Nikolas/0000-0001-9468-4543; Malim, Michael/0000-0002-7699-2064; Apolonia, Luis/0000-0002-9451-6117	UK Medical Research Council [G1000196, MR/M001199/1]; Wellcome Trust [106223/Z/14/Z]; National Institutes of Health [DA033773]; European Commission [PIIF-GA-2012-329679]; Department of Health via a National Institute for Health Research; Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust [guysbrc-2012-1]; Swedish Children's Cancer Foundation [TJ2016-0040]; German Research Foundation (DFG) [SCHA1950/1-1]; Federal Ministry of Education and Research of Germany (BMBF) [0316170 C]; HIVERA: EURECA project [01KI1307B]; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS) [SFB1129]; Medical Faculty of the University of Heidelberg	This work was supported by the UK Medical Research Council (G1000196, MR/M001199/1), the Wellcome Trust (106223/Z/14/Z), the National Institutes of Health (DA033773), the European Commission's Seventh Framework Programme (FP7/2007-2013) under grant agreement PIIF-GA-2012-329679 (to D.P.), the Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust (guysbrc-2012-1), the Swedish Children's Cancer Foundation (TJ2016-0040 to N.H.), the German Research Foundation (DFG) (SCHA1950/1-1 to T.S.), and partially through the Federal Ministry of Education and Research of Germany (BMBF) Immunoquant project (0316170 C) and the HIVERA: EURECA project (01KI1307B). We acknowledge funding through the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS), as well as through SFB1129 Project 5 to R.B., and we thank the Medical Faculty of the Goethe University Frankfurt and the Medical Faculty of the University of Heidelberg for financial support.	Apolonia L, 2007, MOL THER, V15, P1947, DOI 10.1038/sj.mt.6300281; Bichel K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-81; Boateng KA, 2013, DEV CELL, V24, P196, DOI [10.1016/j.devce1.2012.12.002, 10.1016/j.devcel.2012.12.002]; Borrego-Pinto J, 2012, J CELL SCI, V125, P1099, DOI 10.1242/jcs.087049; Bulli L, 2016, J VIROL, V90, P7469, DOI 10.1128/JVI.00458-16; Chang W, 2015, NUCLEUS-PHILA, V6, P77, DOI 10.1080/19491034.2015.1004947; Chen CY, 2012, CELL, V149, P565, DOI 10.1016/j.cell.2012.01.059; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Crabbe L, 2012, CELL REP, V2, P1521, DOI 10.1016/j.celrep.2012.11.019; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Donahue DA, 2017, J VIROL, V91, DOI 10.1128/JVI.02303-16; Donahue DA, 2016, J VIROL, V90, P4199, DOI 10.1128/JVI.03202-15; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Fricke T, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0068-x; Gob Eva, 2011, Commun Integr Biol, V4, P440, DOI 10.4161/cib.4.4.15369; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goujon C, 2015, J VIROL, V89, P4676, DOI 10.1128/JVI.00169-15; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hoffenberg S, 2000, J BIOL CHEM, V275, P24661, DOI 10.1074/jbc.M909600199; Hulme AE, 2015, J VIROL, V89, P5350, DOI 10.1128/JVI.00476-15; Jacque JM, 2006, NATURE, V441, P641, DOI 10.1038/nature04682; Johnson WE, 2009, IMMUNOGENETICS, V61, P163, DOI 10.1007/s00251-009-0358-y; Lahaye X, 2016, CELL REP; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lee K, 2012, J VIROL, V86, P3851, DOI 10.1128/JVI.06607-11; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lemke CT, 2012, J VIROL, V86, P6643, DOI 10.1128/JVI.00493-12; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Li P, 2015, NUCLEIC ACIDS RES, V43, P9874, DOI 10.1093/nar/gkv1058; Lin DH, 2013, J MOL BIOL, V425, P1318, DOI 10.1016/j.jmb.2013.01.021; Link J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004099; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Liu Z. H., 2015, HIGHWAY, V2015, P1, DOI DOI 10.1007/S12035-014-9039-4; Lottersberger F, 2015, CELL, V163, P880, DOI 10.1016/j.cell.2015.09.057; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Luxton GWG, 2011, NUCLEUS-AUSTIN, V2, P173, DOI [10.4161/nucl.2.3.16243, 10.1073/pnas.1000824108]; Lv XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep17940; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Matreyek KA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003693; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Matsumoto A, 2015, CANCER MED-US, V4, P1547, DOI 10.1002/cam4.495; Meehan AM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003969; Meinke P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004605; Mendez-Lopez I, 2012, CHROMOSOMA, V121, P153, DOI 10.1007/s00412-012-0360-2; Meyerson NR, 2014, VIROLOGY, V454, P291, DOI 10.1016/j.virol.2014.02.029; Mulky A, 2008, J VIROL, V82, P5860, DOI 10.1128/JVI.00076-08; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nishioka Y, 2016, NUCLEUS-PHILA, V7, P572, DOI 10.1080/19491034.2016.1260802; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Patel JT, 2014, NUCLEUS-PHILA, V5, P462, DOI 10.4161/nucl.36232; Peng K, 2014, ELIFE, V3, DOI 10.7554/eLife.04114; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Qi ML, 2008, J VIROL, V82, P12001, DOI 10.1128/JVI.01518-08; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schaller T, 2007, J VIROL, V81, P11713, DOI 10.1128/JVI.01468-07; Schaller T, 2007, J VIROL, V81, P10055, DOI 10.1128/JVI.00616-07; Schaller T, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-29; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Scherthan H, 2011, CHROMOSOMA, V120, P151, DOI 10.1007/s00412-010-0295-4; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science1075119; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Talamas JA, 2011, J CELL BIOL, V194, P27, DOI 10.1083/jcb.201012154; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Turgay Y, 2014, J CELL BIOL, V204, P1099, DOI 10.1083/jcb.201310116; Wang WJ, 2012, CELL RES, V22, P1440, DOI 10.1038/cr.2012.126; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yap MW, 2007, VIROLOGY, V365, P302, DOI 10.1016/j.virol.2007.04.005; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhou LX, 2010, FEBS LETT, V584, P3013, DOI 10.1016/j.febslet.2010.05.038	96	1	1	9	9	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	OCT	2017	91	19							UNSP e00463-17	10.1128/JVI.00463-17				21	Virology	Virology	FG4TX	WOS:000410261600005		green_published			2018-01-05	
J	Yang, XY; Chen, L; He, JX; Yu, WC				Yang, Xiaoyu; Chen, Lei; He, Junxian; Yu, Weichang			Knocking out of carotenoid catabolic genes in rice fails to boost carotenoid accumulation, but reveals a mutation in strigolactone biosynthesis	PLANT CELL REPORTS			English	Article						Carotenoid catabolism; CRISPR/Cas9; Strigolactone; Genome editing; Oryza sativa	ABSCISIC-ACID; FRUIT-GROWTH; CRISPR/CAS9; SPECIFICITY; DNA; ARABIDOPSIS; GENERATION; PROVITAMIN; NUCLEASES; ENDOSPERM	Key message Targeted mutations in five carotenoid catabolism genes failed to boost carotenoid accumulation in rice seeds, but produced dwarf and high tillering mutants when OsCCD7 gene was knocked out. Carotenoids play an important role in human diet as a source of vitamin A. Rice is a major staple food in Asia, but does not accumulate carotenoids in the endosperm because of the low carotenoid biosynthesis or the degradation in metabolism. In this study, the CRISPR/Cas9 system was investigated in the targeted knockout of five rice carotenoid catabolic genes (OsCYP97A4, OsDSM2, OsCCD4a, OsCCD4b and OsCCD7) and in an effort to increase beta-carotene accumulation in rice endosperm. Transgenic plants that expressed OsNLSCas9 and sgRNAs were generated by Agrobacterium-mediated transformation. Various knockout mutations were identified at the T0 generation of the transgenic rice by TILLING and direct sequencing of the PCR products amplified from the target sites. Carotenoids were not accumulated in both mono-allelic and bi-allelic knockout mutations of the five genes. However, transgenic plants with homozygous or bi-allelic mutations to the OsCCD7 gene were extremely dwarfish with more tillers and lower seed setting than other transgenic or nontransgenic plants. This phenotype was similar to the previously reported ccd7 mutants, which are defective in the biosynthesis of strigolactone, a plant hormone that regulates branching in plants and tiller formation in rice.	[Yang, Xiaoyu; Yu, Weichang] Shenzhen Univ, Coll Life Sci, Guangdong Prov Key Lab Plant Epigenet, Shenzhen 518060, Peoples R China; [Yang, Xiaoyu] Shenzhen Univ, Coll Optoelect Engn, Key Lab Optoelect Devices & Syst, Minist Educ & Guangdong Prov, Shenzhen, Peoples R China; [Chen, Lei] Chinese Univ Hong Kong, Shenzhen Res Inst, State Key Lab Agrobiotechnol, Shenzhen, Peoples R China; [He, Junxian] Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Sha Tin, Hong Kong, Peoples R China	Yu, WC (reprint author), Shenzhen Univ, Coll Life Sci, Guangdong Prov Key Lab Plant Epigenet, Shenzhen 518060, Peoples R China.; He, JX (reprint author), Chinese Univ Hong Kong, Sch Life Sci, State Key Lab Agrobiotechnol, Sha Tin, Hong Kong, Peoples R China.	jxhe@cuhk.edu.hk; wyu@szu.edu.cn		Yu, Weichang/0000-0003-0726-4239	National Natural Science Foundation of China [31271422]; Shenzhen Peacock Innovation Team Project [KQTD201101]; Guangdong Innovation Research Team Fund [2014ZT05S078]; Natural Science Foundation of Guangdong Province [2015A030310421]; Hong Kong RGC AoE Project [AoE/M-05/12]	This work was supported in part by the National Natural Science Foundation of China (Project No. 31271422) to WY, Shenzhen Peacock Innovation Team Project (No. KQTD201101) to WY and JH, Guangdong Innovation Research Team Fund (2014ZT05S078) to WY, Natural Science Foundation of Guangdong Province (Project No. 2015A030310421) to LC, and Hong Kong RGC AoE Project AoE/M-05/12 to JH. We thank Chao Sun, Meiting Wu, Linlin Luo and Ye Jin for assistance in analyzing the off-target cleavage activity.	Burkhardt PK, 1997, PLANT J, V11, P1071, DOI 10.1046/j.1365-313X.1997.11051071.x; Cao YunFei, 2008, Frontiers of Agriculture in China, V2, P253, DOI 10.1007/s11703-008-0052-0; Cardoso C, 2014, P NATL ACAD SCI USA, V111, P2379, DOI 10.1073/pnas.1317360111; Du H, 2010, PLANT PHYSIOL, V154, P1304, DOI 10.1104/pp.110.163741; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; FISCHER RA, 1966, AUST J AGR RES, V17, P281, DOI 10.1071/AR9660281                                                               ; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gautier H, 2001, ANN BOT-LONDON, V88, P645, DOI 10.1006/anbo.2001.1518; Gonzalez-Jorge S, 2013, PLANT CELL, V25, P4812, DOI 10.1105/tpc.113.119677; Hikosaka S, 2003, J HORTIC SCI BIOTECH, V78, P775, DOI 10.1080/14620316.2003.11511698                                                  ; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ilg A, 2010, PLANTA, V232, P691, DOI 10.1007/s00425-010-1205-y; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Kulkarni KP, 2014, J GENET, V93, P389, DOI 10.1007/s12041-014-0389-5; Lv MZ, 2012, PLANT CELL PHYSIOL, V53, P987, DOI 10.1093/pcp/pcs041; Marcelis LFM, 2004, J EXP BOT, V55, P2261, DOI 10.1093/jxb/erh245; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Nisar N, 2015, MOL PLANT, V8, P68, DOI 10.1016/j.molp.2014.12.007; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Schaub P, 2005, PLANT PHYSIOL, V138, P441, DOI 10.1104/pp.104.057927; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Umehara M, 2010, PLANT CELL PHYSIOL, V51, P1118, DOI 10.1093/pcp/pcq084; Vallabhaneni R, 2010, ARCH BIOCHEM BIOPHYS, V504, P104, DOI 10.1016/j.abb.2010.07.019; Vogel JT, 2008, J BIOL CHEM, V283, P11364, DOI 10.1074/jbc.M710106200; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yeum KJ, 2002, ANNU REV NUTR, V22, P483, DOI 10.1146/annurev.nutr.22.010402.102834; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zou JH, 2005, PLANTA, V222, P604, DOI 10.1007/s00425-005-0007-0	31	0	0	32	32	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	OCT	2017	36	10					1533	1545		10.1007/s00299-017-2172-6				13	Plant Sciences	Plant Sciences	FG9VY	WOS:000410789200002	28676963				2018-01-05	
J	Partier, A; Gay, G; Tassy, C; Beckert, M; Feuillet, C; Barret, P				Partier, A.; Gay, G.; Tassy, C.; Beckert, M.; Feuillet, C.; Barret, P.			Molecular and FISH analyses of a 53-kbp intact DNA fragment inserted by biolistics in wheat (Triticum aestivum L.) genome	PLANT CELL REPORTS			English	Article						Wheat; Biolistic transformation; FISH; Large fragment; Gene cassettes	IN-SITU HYBRIDIZATION; PLANT-TRANSFORMATION; WEIGHT DNA; TRANSGENE EXPRESSION; HEXAPLOID WHEAT; RICE; GENE; CHROMOSOMES; BOMBARDMENT; VECTOR	Key message A large, 53-kbp, intact DNA fragment was inserted into the wheat (Triticum aestivum L.) genome. FISH analyses of individual transgenic events revealed multiple insertions of intact fragments. Transferring large intact DNA fragments containing clusters of resistance genes or complete metabolic pathways into the wheat genome remains a challenge. In a previous work, we showed that the use of dephosphorylated cassettes for wheat transformation enabled the production of simple integration patterns. Here, we used the same technology to produce a cassette containing a 44-kb Arabidopsis thaliana BAC, flanked by one selection gene and one reporter gene. This 53-kb linear cassette was integrated in the bread wheat (Triticum aestivum L.) genome by biolistic transformation. Our results showed that transgenic plants harboring the entire cassette were generated. The inheritability of the cassette was demonstrated in the T1 and T2 generation. Surprisingly, FISH analysis performed on T1 progeny of independent events identified double genomic insertions of intact fragments in non-homoeologous positions. Inheritability of these double insertions was demonstrated by FISH analysis of the T1 generation. Relative conclusions that can be drawn from molecular or FISH analysis are discussed along with future prospects of the engineering of large fragments for wheat transformation or genome editing.	[Partier, A.; Gay, G.; Tassy, C.; Beckert, M.; Feuillet, C.; Barret, P.] INRA, Unite Mixte Rech 1095, Domaine Crouel, Genet Divers & Ecophysiol Cereales, F-63039 Clermont Ferrand 2, France	Barret, P (reprint author), INRA, Unite Mixte Rech 1095, Domaine Crouel, Genet Divers & Ecophysiol Cereales, F-63039 Clermont Ferrand 2, France.	pierre.barret@inra.fr			INRA; program Investments for the Future [ANR-11-BTBR-0006-GENIUS]	This work was supported by INRA grants and the publication was supported by the program Investments for the Future (grant ANR-11-BTBR-0006-GENIUS) managed by the French National Research Agency. We are grateful to Arabidopsis Biological Resource Center for providing the BAC clones. We thank Ludovic Georges for technical help with FISH analyses. Special thanks to the greenhouse team, especially Richard Blanc, for taking care of the plants.	Adachi T, 2007, BIOSCI BIOTECH BIOCH, V71, P2266, DOI 10.1271/bbb.70241; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barret P, 1998, THEOR APPL GENET, V96, P177, DOI 10.1007/s001220050725; Chang YL, 2011, GENOME, V54, P437, DOI [10.1139/G11-011, 10.1139/g11-011]; Cheng M, 1997, PLANT PHYSIOL, V115, P971, DOI 10.1104/pp.115.3.971                                                            ; Danilova TV, 2014, THEOR APPL GENET, V127, P715, DOI 10.1007/s00122-013-2253-z; Ercolano MR, 2004, MOL BREEDING, V13, P15, DOI 10.1023/B:MOLB.0000012326.01128.5d; Frary A, 2001, TRANSGENIC RES, V10, P121, DOI 10.1023/A:1008924726270; Fu XD, 2000, TRANSGENIC RES, V9, P11, DOI 10.1023/A:1008993730505; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hamilton CM, 1997, GENE, V200, P107, DOI 10.1016/S0378-1119(97)00388-0; Holme IB, 2013, PLANT BIOTECHNOL J, V11, P395, DOI 10.1111/pbi.12055; Hu YY, 2008, EUR J ORAL SCI, V116, P113, DOI 10.1111/j.1600-0722.2007.00519.x; JEFFERSON RA, 1987, PLANT MOL BIOL REP, V5, P387; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Liu YG, 2000, PLANT J, V23, P687, DOI 10.1046/j.1365-313x.2000.00827.x; Mirzaghaderi G, 2010, BIOL PLANTARUM, V54, P252, DOI 10.1007/s10535-010-0044-9; Mirzaghaderi G, 2010, AFR J BIOTECHNOL, V9, P314; MONACO AP, 1994, TRENDS BIOTECHNOL, V12, P280, DOI 10.1016/0167-7799(94)90140-6; Mullen J, 1998, MOL BREEDING, V4, P449, DOI 10.1023/A:1009646004272                                                         ; Nakano A, 2005, MOL GENET GENOMICS, V273, P123, DOI 10.1007/s00438-005-1116-y; Naqvi S, 2010, TRENDS PLANT SCI, V15, P48, DOI 10.1016/j.tplants.2009.09.010; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Peterson D.G., 2000, J AGR GENOMICS, V2000, P5; Phan BH, 2007, TRANSGENIC RES, V16, P341, DOI 10.1007/s11248-006-9041-3; RAYBURN AL, 1986, J HERED, V77, P253, DOI 10.1093/oxfordjournals.jhered.a110231                                           ; Saidi S, 2007, GENE, V401, P97, DOI 10.1016/j.gene.2007.06.023; Sambrook J, 1989, MOL CLONING LAB MANU; Schwarzacher T., 2000, PRACTICAL IN SITU HY; Shi X, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-33; Song J, 2003, THEOR APPL GENET, V107, P958, DOI 10.1007/s00122-003-1334-9; Sparks CA, 2014, METHODS MOL BIOL, V1099; Stoger E, 1998, TRANSGENIC RES, V7, P463, DOI 10.1023/A:1008833324193; Tassy C., 2006, Plant Molecular Biology Reporter, V24, P247, DOI 10.1007/BF02914064; Tassy C, 2014, PLANT CELL TISS ORG, V119, P171, DOI 10.1007/s11240-014-0524-2; VASIL V, 1992, BIO-TECHNOL, V10, P667, DOI 10.1038/nbt0692-667; Wada N, 2009, PLANT CELL REP, V28, P759, DOI 10.1007/s00299-009-0678-2; Wang YF, 2015, PLANT CELL REP, V34, P1049, DOI 10.1007/s00299-015-1764-2; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wright M, 2001, PLANT CELL REP, V20, P429, DOI 10.1007/s002990100318; Yao Q, 2006, J EXP BOT, V57, P3737, DOI 10.1093/jxb/erl145	44	0	0	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	OCT	2017	36	10					1547	1559		10.1007/s00299-017-2173-5				13	Plant Sciences	Plant Sciences	FG9VY	WOS:000410789200003	28667403				2018-01-05	
J	Wild, EJ; Tabrizi, SJ				Wild, Edward J.; Tabrizi, Sarah J.			Therapies targeting DNA and RNA in Huntington's disease	LANCET NEUROLOGY			English	Review							SPINAL MUSCULAR-ATROPHY; CAG REPEAT; ANTISENSE OLIGONUCLEOTIDES; MOUSE MODEL; CEREBROSPINAL-FLUID; OBSERVATIONAL DATA; POTENTIAL THERAPY; CLINICAL-TRIALS; GENE-THERAPY; TRACK-HD	No disease-slowing treatment exists for Huntington's disease, but its monogenic inheritance makes it an appealing candidate for the development of therapies targeting processes close to its genetic cause. Huntington's disease is caused by CAG repeat expansions in the HTT gene, which encodes the huntingtin protein; development of therapies to target HTT transcription and the translation of its mRNA is therefore an area of intense investigation. Huntingtin-lowering strategies include antisense oligonucleotides and RNA interference targeting mRNA, and zinc finger transcriptional repressors and CRISPR-Cas9 methods aiming to reduce transcription by targeting DNA. An intrathecally delivered antisense oligonucleotide that aims to lower huntingtin is now well into its first human clinical trial, with other antisense oligonucleotides expected to enter trials in the next 1-2 years and virally delivered RNA interference and zinc finger transcriptional repressors in advanced testing in animal models. Recent advances in the design and delivery of therapies to target HTT RNA and DNA are expected to improve their efficacy, safety, tolerability, and duration of effect in future studies.	[Wild, Edward J.; Tabrizi, Sarah J.] UCL, Huntingtons Dis Ctr, Inst Neurol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	Wild, EJ (reprint author), UCL, Huntingtons Dis Ctr, Inst Neurol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.	e.wild@ucl.ac.uk			Medical Research Council UK; CHDI Foundation Inc; European Huntington's Disease Network; Wellcome Trust; EU FP7 Health Call; Huntington's Disease Association of the UK; Rosetrees Trust; Takeda Pharmaceuticals; CHDI Foundation; National Institute for Health Research UCL Hospitals Biomedical Research Centre; UCL Leonard Wolfson Experimental Neurology Centre	EJW has research funding from the Medical Research Council UK, CHDI Foundation Inc, and European Huntington's Disease Network. SJT has research funding from the Medical Research Council UK, Wellcome Trust, EU FP7 Health Call, European Huntington's Disease Network, Huntington's Disease Association of the UK, Rosetrees Trust, Takeda Pharmaceuticals, and CHDI Foundation. The authors are supported, in part, by the National Institute for Health Research UCL Hospitals Biomedical Research Centre and the UCL Leonard Wolfson Experimental Neurology Centre.	Agrawal S, 2004, NAT BIOTECHNOL, V22, P1533, DOI 10.1038/nbt1042; Agustin-Pavon C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0128-x; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Butland SL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-126; Butler D, 2015, CHIRAL CONTROL; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Byrne LM, 2016, J HUNTINGTONS DIS, V5, P1, DOI 10.3233/JHD-160196; Chan JHP, 2006, CLIN EXP PHARMACOL P, V33, P533, DOI 10.1111/j.1440-1681.2006.04403.x; Chi X, 2017, DRUG DISCOV TODAY, V22, P823, DOI 10.1016/j.drudis.2017.01.013; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Crooke ST, 2016, MOL THER, V24, P1771, DOI 10.1038/mt.2016.136; Datson NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171127; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Doherty EM, 2017, CHDI FDN ANN THER C; Dragatsis I, 2000, NAT GENET, V26, P300; Evers MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024308; Fidler B., 2016, ALNYLAM SCRAPS RNAI; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Garriga-Canut M, 2012, P NATL ACAD SCI USA, V109, pE3136, DOI 10.1073/pnas.1206506109; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Hammond SM, 2016, P NATL ACAD SCI USA, V113, P10962, DOI 10.1073/pnas.1605731113; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hersch S, 2017, NEUROLOGY S16, V88; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kay C, 2015, MOL THER, V23, P1759, DOI 10.1038/mt.2015.128; Keiser MS, 2016, HUM MOL GENET, V25, pR53, DOI 10.1093/hmg/ddv442; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; LARROUY B, 1992, GENE, V121, P189, DOI 10.1016/0378-1119(92)90121-5; Leavitt B, 2016, NEUROLOGY S16, V86; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2012, AM J HUM GENET, V90, P434, DOI 10.1016/j.ajhg.2012.01.005; Liu WZ, 2008, NAT METHODS, V5, P951, DOI 10.1038/nmeth.1261; Lu XH, 2012, NEURON, V74, P964, DOI 10.1016/j.neuron.2012.06.001; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; Mestre T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006455.pub2; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354                                                      ; Miniarikova J, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.7; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Rafii MS, 2015, J PREV ALZHEIMERS DI, V10, P274; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rue L, 2016, J CLIN INVEST, V126, P4319, DOI 10.1172/JCI83185; Samaranch L, 2017, GENE THER, V24, P253, DOI 10.1038/gt.2017.14; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Savic N, 2016, TRANSL RES, V168, P15, DOI 10.1016/j.trsl.2015.09.008; Shanley M., 2017, IONIS HTT RX STUDY H; Shin JW, 2016, HUM MOL GENET, V25, P4566, DOI 10.1093/hmg/ddw286; Stanek L., 2015, CHDI FDN ANN THER C; Stiles DK, 2012, EXP NEUROL, V233, P463, DOI 10.1016/j.expneurol.2011.11.020; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tartari M, 2008, MOL BIOL EVOL, V25, P330, DOI 10.1093/molbev/msm258; US Food and Drug Administration, 1998, HUM GENE THER, V9, P1513; US Food and Drug Administration, 2016, FDA APPR 1 DRUG SPIN; Vassena R, 2016, HUM REPROD UPDATE, V22, P411, DOI 10.1093/humupd/dmw005; Vijayvargia R, 2016, ELIFE, V5, DOI 10.7554/eLife.11184; Wang N, 2014, NAT MED, V20, P540, DOI 10.1038/nm.3514; Wild EJ, 2015, J CLIN INVEST, V125, P1979, DOI 10.1172/JCI80743; Wild EJ, 2014, HUNTINGTONS DIS; Yang S, 2017, J CLIN INVEST, V127, P2719, DOI 10.1172/JCI92087; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zeitler B, 2014, MOL THER, V22, pS233	76	2	2	51	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2017	16	10					837	847		10.1016/S1474-4422(17)30280-6                                                   				11	Clinical Neurology	Neurosciences & Neurology	FG5PI	WOS:000410379900020	28920889				2018-01-05	
J	Romanov, GA; Sukhoverov, VS				Romanov, Georgy A.; Sukhoverov, Victor S.			Arginine CGA codons as a source of nonsense mutations: a possible role in multivariant gene expression, control of mRNA quality, and aging	MOLECULAR GENETICS AND GENOMICS			English	Article						CpG methylation; Premature termination codons (PTCs); Nonsense-mediated mRNA decay (NMD); Selenoproteins; Codon redefinition; Selenocysteine insertion sequence (SECIS); mRNA quality control; Epigenetic aging program (EAP)	DNA METHYLATION; CYTOSINE DEAMINATION; CPG DINUCLEOTIDE; HUMAN CANCERS; P53 GENE; DISEASE; DECAY; AGE; MUTAGENESIS; GENOME	Methylation of cytosine residues in DNA of higher eukaryotes, including humans, creates "hot spots" of C -> T transitions in the genome. The predominantly methylated sequence in mammalian DNAs is CG (CpG). Among CGcontaining codons, CGA codons for arginine are unique due to their ability to create stop codons TGA (UGA in mRNA) upon epigenetic-mediated mutation. As such nonsense mutations can have a strong adverse effect on the cell and organism, we have performed a study, on the example of human genes, aimed to characterise the anticipated effects of epigenetic- mediated nonsense mutations CGA -> TGA in somatic cells. It is commonly accepted that premature termination codons (PTCs) lead to the biosynthesis of truncated and usually inactive proteins. In addition, transcripts with PTC can be destroyed by a nonsense-mediated mRNA decay (NMD) machinery. We have considered the cell potentialities (gene families, diploidy, and alternative splicing) to overcome the worst consequences of nonsense mutation. As a special case, in the biosynthesis of a particular group of proteins called selenoproteins, the mutation CGA -> UGA would not lead to the premature translation termination and NMD but rather to the insertion of selenocysteine or cysteine instead of former arginine. The finding of SECIS (Sel insertion sequence)-like structures in a variety of mRNAs allowed us to postulate the existence of facultative selenoproteins, whose biosynthesis might be coupled with the redefinition of premature UGA stop codons arising upon mutations, as in the case of "classic" selenoproteins. Nevertheless, a detailed structural analysis of 165 transcripts has shown that roughly 80-90% of functional human mRNAs are potential substrates for NMD upon the PTC emergence. A hypothesis was put forward highlighting a role of arginine CGA codons together with glutamine CAA and CAG codons in the control of mRNA quality and life span. According to this hypothesis, the conversion of the ribonucleic codons CGA, CAA, or CAG into stop codons UGA, UAA or UAG owing to spontaneous or enzymatic cytosine deamination might serve as a trigger for the transcript destruction by NMD (C -> U control). Thus, the consequences of epigenetic-mediated nonsense mutations are diverse and may largely depend on the structure of the transcript (CGA codon position, the presence and position of introns and SECIS elements, and splicing potential) of the cognate gene. However, this diversity and the presumable role of CGA codons in performing the everyday function by controlling whether genes are expressed correctly do not exclude their long-term role as limiters of the cell and organism life span. Thus, the presumable role of CGA codons in genome functioning and stability opens new perspectives to influence aging and concomitant deceases by codon editing.	[Romanov, Georgy A.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Romanov, Georgy A.] Russian Acad Sci, Timiryazev Inst Plant Physiol, Botanicheskaya 35, Moscow 127276, Russia; [Sukhoverov, Victor S.] Russian Acad Sci, Trapeznikov Inst Control Sci, Profsoyuznaya 65, Moscow 117997, Russia	Romanov, GA (reprint author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia.; Romanov, GA (reprint author), Russian Acad Sci, Timiryazev Inst Plant Physiol, Botanicheskaya 35, Moscow 127276, Russia.	gromanov@yahoo.com	Romanov, Georgy/A-2028-2008		Molecular and Cell Biology Program of the Presidium of the Russian Academy of Sciences	This work was partially supported by Molecular and Cell Biology Program of the Presidium of the Russian Academy of Sciences.	Anisimov VN, 2008, MOL PHYSL MECH AGING, V1; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499                                                            ; Buijs A, 2013, CANCER GENET-NY, V206, P140, DOI 10.1016/j.cancergen.2013.04.001; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; COOPER DN, 1990, HUM GENET, V85, P55; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426                                                              ; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Fujii A, 2015, CANCER GENET-NY, V208, P271, DOI 10.1016/j.cancergen.2014.12.005; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516                                                         ; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552; Lewin B, 2008, GENES 9; Longo VD, 2005, NAT REV GENET, V6, DOI 10.1038/nrg1706; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225                                                           ; Malousi A, 2012, MOL GENET GENOMICS, V287, P631, DOI 10.1007/s00438-012-0703-y; Mazin AL, 2009, AGEING RES REV, V8, P314, DOI 10.1016/j.arr.2009.04.005; Mazzio EA, 2012, EPIGENETICS-US, V7, P119, DOI 10.4161/epi.7.2.18764; Milholland B, 2015, ONCOTARGET, V6, P24627, DOI 10.18632/oncotarget.5685; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; Petit V, 2009, J MOL BIOL, V385, P65, DOI 10.1016/j.jmb.2008.10.043; Podolskiy DI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12157; Ponomarenko EA, 2016, INT J ANAL CHEM, DOI 10.1155/2016/7436849; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1744803; Romanov GA, 2015, RUSS J DEV BIOL+, V46, P78, DOI 10.1134/S106236041502006X; ROMANOV GA, 1981, BIOCHIM BIOPHYS ACTA, V653, P204, DOI 10.1016/0005-2787(81)90156-8; Romanov GA, 1980, NAUCH DOKL VYSSH SHK, V11, P5; Schormann N, 2014, PROTEIN SCI, V23, P1667, DOI 10.1002/pro.2554; Seyedali A, 2014, RNA, V20, P1248, DOI 10.1261/rna.043463.113; Sohail A, 2002, BIOCHEMISTRY-US, V41, P11325, DOI 10.1021/bi026332t; Tobe R, 2013, J BIOL CHEM, V288, P14709, DOI 10.1074/jbc.M112.446666; Toma KG, 2015, RNA, V21, P887, DOI 10.1261/rna.048637.114; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Trindade Lucas S., 2013, Frontiers in Genetics, V4, P25, DOI 10.3389/fgene.2013.00025; Vanyushin BF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P488, DOI 10.1007/s10541-005-0143-y                                                       ; Wolters Stefanie, 2013, Frontiers in Genetics, V4, P19, DOI 10.3389/fgene.2013.00019; Ying H, 2011, GENOME BIOL EVOL, V3, P938, DOI 10.1093/gbe/evr021; Yoshida K, 2011, LEUKEMIA, V25, P184, DOI 10.1038/leu.2010.241	44	0	0	5	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-4615	1617-4623		MOL GENET GENOMICS	Mol. Genet. Genomics	OCT	2017	292	5					1013	1026		10.1007/s00438-017-1328-y				14	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FG5SH	WOS:000410396100006					2018-01-05	
J	Van Ry, PM; Fontelonga, TM; Barraza-Flores, P; Sarathy, A; Nunes, AM; Burkin, DJ				Van Ry, Pam M.; Fontelonga, Tatiana M.; Barraza-Flores, Pamela; Sarathy, Apurva; Nunes, Andreia M.; Burkin, Dean J.			ECM-Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies	COMPREHENSIVE PHYSIOLOGY			English	Article							MDX MOUSE MODEL; CELL-MEMBRANE REPAIR; SKELETAL-MUSCLE DIFFERENTIATION; SARCOGLYCAN-DEFICIENT MICE; HUMAN ARTICULAR-CARTILAGE; UTROPHIN GENE-TRANSFER; COLLAGEN-VI; EXTRACELLULAR-MATRIX; GLYCOPROTEIN COMPLEX; LIMB-GIRDLE	Extracellular matrix (ECM) myopathies and muscular dystrophies are a group of genetic diseases caused by mutations in genes encoding proteins that provide critical links between muscle cells and the extracellular matrix. These include structural proteins of the ECM, muscle cell receptors, enzymes, and intracellular proteins. Loss of adhesion within the myomatrix results in progressive muscle weakness. For many ECM muscular dystrophies, symptoms can occur any time after birth and often result in reduced life expectancy. There are no cures for the ECM-related muscular dystrophies and treatment options are limited to palliative care. Several therapeutic approaches have been explored to treat muscular dystrophies including gene therapy, gene editing, exon skipping, embryonic, and adult stem cell therapy, targeting genetic modifiers, modulating inflammatory responses, or preventing muscle degeneration. Recently, protein therapies that replace components of the defective myomatrix or enhance muscle and/or extracellular matrix integrity and function have been explored. Preclinical studies for many of these biologics have been promising in animal models of these muscle diseases. This review aims to summarize the ECM muscular dystrophies for which protein therapies are being developed and discuss the exciting potential and possible limitations of this approach for treating this family of devastating genetic muscle diseases. (C) 2017 American Physiological Society.	[Van Ry, Pam M.; Fontelonga, Tatiana M.; Barraza-Flores, Pamela; Sarathy, Apurva; Nunes, Andreia M.; Burkin, Dean J.] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA; [Nunes, Andreia M.] Univ Lisbon, Dept Biol Anim, Ctr Ecol Evolucao & Alteracoes Ambientais, Fac Ciencias, Lisbon, Portugal	Burkin, DJ (reprint author), Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA.	dburkin@medicine.nevada.edu		Nunes, Andreia/0000-0001-9996-013X	NIH/NIAMS [R01AR053697, R01AR064338]; Orphan Disease Center at University of Pennsylvania; Mick Hitchcock Scholarships; Struggle Against Muscular Dystrophy; Fundacao para a Ciencia e a Tecnologia (FCT); CureCMD; SAM	This study was supported by grants from NIH/NIAMS R01AR053697, R01AR064338, CureCMD and SAM to D. J. Burkin. P. M. Van Ry is supported by a postdoctoral fellowship from Orphan Disease Center at University of Pennsylvania. A. Sarathy, T. M. Fontelonga, and P. Barraza-Flores were supported by Mick Hitchcock Scholarships. P. Barraza-Fontelonga is supported by a fellowship from Struggle Against Muscular Dystrophy (SAM). A. M. Nunes is supported by a fellowship from Fundacao para a Ciencia e a Tecnologia (FCT).	Aartsma-Rus A, 2014, NUCLEIC ACID THER, V24, P1, DOI 10.1089/nat.2014.1500; Abdel-Hamid H, 2012, CURR OPIN NEUROL, V25, P604, DOI 10.1097/WCO.0b013e328357f44c; Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Allamand Valerie, 2010, Neuromuscul Disord, V20, P346, DOI 10.1016/j.nmd.2010.02.012; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Amenta AR, 2012, J NEUROSCI, V32, P2324, DOI 10.1523/JNEUROSCI.4610-11.2012; Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Anderson JL, 2002, BRAIN, V125, P4, DOI 10.1093/brain/awf012; Andreia N, HUM MOL GENET, V26, P2018; ANGELINI C, 1994, MUSCLE NERVE, V17, P386, DOI 10.1002/mus.880170405; Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; BARBUJANI G, 1990, HUM GENET, V84, P522; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Bastian A, 2015, ROM J INTERN MED, V53, P13, DOI 10.1515/rjim-2015-0002; Beenakker EAC, 2005, ARCH NEUROL-CHICAGO, V62, P128, DOI 10.1001/archneur.62.1.128; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Bentzinger CF, 2013, BIOESSAYS, V35, P231, DOI 10.1002/bies.201200063; Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com; Berardi E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00119; Bertini E, 2011, SEMIN PEDIATR NEUROL, V18, P277, DOI 10.1016/j.spen.2011.10.010; Betts C, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.30; Bonifati MD, 2000, MUSCLE NERVE, V23, P1344, DOI 10.1002/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Bonnemann Carsten G, 2011, Handb Clin Neurol, V101, P81, DOI 10.1016/B978-0-08-045031-5.00005-0; Borg K, 1992, J Hist Neurosci, V1, P145; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801                                                           ; Burkin DJ, 2005, AM J PATHOL, V166, P253, DOI 10.1016/S0002-9440(10)62249-3; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279                                                           ; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Butterfield RJ, 2013, HUM MUTAT, V34, P1558, DOI 10.1002/humu.22429; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Call JA, 2011, J APPL PHYSIOL, V111, P200, DOI 10.1152/japplphysiol.00248.2011; Camby I, 2002, J NEUROPATH EXP NEUR, V61, P585, DOI 10.1093/jnen/61.7.585                                                           ; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Carmignac V, 2011, HUM MOL GENET, V20, P4891, DOI 10.1093/hmg/ddr427; Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Cerri DG, 2008, GLYCOBIOLOGY, V18, P842, DOI 10.1093/glycob/cwn079; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chien YH, 2013, PEDIATR NEONATOL, V54, P219, DOI 10.1016/j.pedneo.2013.03.009; Cho A, 2017, MUSCLE NERVE, V55, P727, DOI 10.1002/mus.25396; CHU ML, 1990, ANN NY ACAD SCI, V580, P55, DOI 10.1111/j.1749-6632.1990.tb17917.x; Clausse N, 1999, Angiogenesis, V3, P317, DOI 10.1023/A:1026584523789; Connolly AM, 2001, NEUROMUSCULAR DISORD, V11, P703, DOI 10.1016/S0960-8966(01)00232-2                                                   ; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cozzoli A, 2011, NEUROPATH APPL NEURO, V37, P243, DOI 10.1111/j.1365-2990.2010.01106.x; Crawford GE, 2000, J CELL BIOL, V150, P1399, DOI 10.1083/jcb.150.6.1399                                                          ; Crippa S, 2011, J CELL BIOL, V193, P1197, DOI 10.1083/jcb.201011099; Crosbie RH, 2000, HUM MOL GENET, V9, P2019, DOI 10.1093/hmg/9.13.2019; Crosbie RH, 1999, J CELL BIOL, V145, P153, DOI 10.1083/jcb.145.1.153; Crosbie RH, 1997, J BIOL CHEM, V272, P31221, DOI 10.1074/jbc.272.50.31221                                                        ; D'Angelo MG, 2012, PHARMACOL RES, V65, P472, DOI 10.1016/j.phrs.2012.01.006; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Decrouy A, 1997, GENE THER, V4, P401, DOI 10.1038/sj.gt.3300407                                                           ; Delfin DA, 2012, NEUROMUSCULAR DISORD, V22, P1006, DOI 10.1016/j.nmd.2012.05.002; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Ebihara S, 2000, PHYSIOL GENOMICS, V3, P133; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754; Ervasti J M, 1993, Mol Cell Biol Hum Dis Ser, V3, P139; FENICHEL GM, 1991, ARCH NEUROL-CHICAGO, V48, P575, DOI 10.1001/archneur.1991.00530180027012                                            ; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2                                                    ; Finkel RS, 2010, J CHILD NEUROL, V25, P1158, DOI 10.1177/0883073810371129; Fisher R, 2001, NEUROMUSCULAR DISORD, V11, P713, DOI 10.1016/S0960-8966(01)00220-6                                                   ; Gao QQ, 2015, COMPR PHYSIOL, V5, P1223, DOI 10.1002/cphy.c140048; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; Glentis A, 2014, CELL ADH MIGR, V8; Goldring K, 2002, NEUROMUSCULAR DISORD, V12, P183, DOI 10.1016/S0960-8966(01)00280-2; Goldring K, 2002, J CELL SCI, V115, P355; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6                                                   ; GU MJ, 1994, J CELL SCI, V107, P175; Guiraud S, 2015, ANNU REV GENOM HUM G, V16, P281, DOI 10.1146/annurev-genom-090314-025003; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442; Haase H, 2006, FASEB J, V20, P865, DOI 10.1096/fj.05-5414com; Hack AA, 2000, J CELL SCI, V113, P2535; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534; He B, 2012, MOL THER, V20, P727, DOI 10.1038/mt.2012.5; HEISKANEN M, 1995, GENOMICS, V29, P801, DOI 10.1006/geno.1995.9008                                                          ; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Heydemann A, 2007, TRENDS CARDIOVAS MED, V17, P55, DOI 10.1016/j.tcm.2006.12.002                                                       ; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2                                                    ; Holt KH, 1998, J BIOL CHEM, V273, P34667, DOI 10.1074/jbc.273.52.34667; Hwang M, 2011, AM J PHYSIOL-CELL PH, V301, pC106, DOI 10.1152/ajpcell.00382.2010; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649                                                           ; Jung D, 1996, FEBS LETT, V381, P15, DOI 10.1016/0014-5793(96)00056-7; Kato N, 2007, JAPANESE J NEPHROLOG, V49, P992; Kayali R, 2012, HUM MOL GENET, V21, P4007, DOI 10.1093/hmg/dds223; KISSEL JT, 1993, NEUROLOGY, V43, P532, DOI 10.1212/WNL.43.3_Part_1.532                                                     ; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kleopa KA, 2006, HUM MOL GENET, V15, P1623, DOI 10.1093/hmg/ddl083; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kota J, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000112; Kuang W, 1999, LAB INVEST, V79, P1601; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lawlor MW, 2013, HUM MOL GENET, V22, P1525, DOI 10.1093/hmg/ddt003; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lechner BE, 2006, MUSCLE NERVE, V34, P347, DOI 10.1002/mus.20596; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; LEVINE BA, 1990, FEBS LETT, V263, P159, DOI 10.1016/0014-5793(90)80728-2; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Lostal W, 2014, HUM GENE THER, V25, P552, DOI 10.1089/hum.2013.210; Lovering RM, 2005, PHYS THER, V85, P1372; Magli A, 2013, STEM CELLS, V31, P59, DOI 10.1002/stem.1254; Malafarina V, 2012, MATURITAS, V71, P109, DOI 10.1016/j.maturitas.2011.11.012; Marshall JL, 2012, HUM MOL GENET, V21, P4378, DOI 10.1093/hmg/dds271; Marshall JL, 2012, J CELL BIOL, V197, P1009, DOI 10.1083/jcb.201110032; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; MATSUMURA K, 1994, NEUROMUSCULAR DISORD, V4, P115, DOI 10.1016/0960-8966(94)90002-7; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MCBRIDE OW, 1990, GENOMICS, V6, P219, DOI 10.1016/0888-7543(90)90560-H; Meinen S, 2011, EMBO MOL MED, V3, P465, DOI 10.1002/emmm.201100151; Mendell JR, 2013, MUSCLE NERVE, V48, P21, DOI 10.1002/mus.23810; Mendell JR, 2012, NEUROSCI LETT, V527, P90, DOI 10.1016/j.neulet.2012.04.078; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Mercado ML, 2006, FASEB J, V20, P1724, DOI 10.1096/fj.05-5124fje; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q            ; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y                  ; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054                                                                ; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Moorwood C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026169; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Mostacciuolo ML, 1996, HUM GENET, V97, P277, DOI 10.1007/BF02185752                                                              ; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Nastase MV, 2012, J HISTOCHEM CYTOCHEM, V60, P963, DOI 10.1369/0022155412456380; Nelson CA, 2011, AM J PATHOL, V178, P2611, DOI 10.1016/j.ajpath.2011.02.024; Nguyen N, 2014, J BIOL CHEM, V289, P3209, DOI 10.1074/jbc.M113.525154; Ngo ST, 2007, INT J BIOCHEM CELL B, V39, P863, DOI 10.1016/j.biocel.2006.10.012; Nguyen HH, 2002, P NATL ACAD SCI USA, V99, P5616, DOI 10.1073/pnas.082613599; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Nigro V, 2011, CURR OPIN NEUROL, V24, P429, DOI 10.1097/WCO.0b013e32834aa38d; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; OFFNER H, 1990, J NEUROIMMUNOL, V28, P177, DOI 10.1016/0165-5728(90)90032-I; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F                                                    ; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135                                                           ; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107                                                                  ; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PEARCE M, 1993, HUM MOL GENET, V2, P1765, DOI 10.1093/hmg/2.11.1765; Peter AK, 2008, J CELL BIOL, V183, P419, DOI 10.1083/jcb.200808027; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; PONS F, 1993, NEUROMUSCULAR DISORD, V3, P507, DOI 10.1016/0960-8966(93)90106-T                                                    ; Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102; Quattrocelli M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000284; Quijano-Roy S, 2012, LAMA2 RELATED MUSCUL; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385                                                           ; Rafii MS, 2006, J CELL PHYSIOL, V209, P439, DOI 10.1002/jcp.20740; Reichert JM, 2003, NAT REV DRUG DISCOV, V2, P695, DOI 10.1038/nrd1178; Reitter B, 1995, BRAIN DEV-JPN, V17, P39, DOI 10.1016/0387-7604(95)00015-1; Rinaldi F, 2014, TRANSL RES, V163, P409, DOI 10.1016/j.trsl.2013.11.006; Rocha CT, 2010, CURR NEUROL NEUROSCI, V10, P267, DOI 10.1007/s11910-010-0119-1; Rooney JE, 2012, AM J PATHOL, V180, P1593, DOI 10.1016/j.ajpath.2011.12.019; Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106; Rooney JE, 2009, AM J PATHOL, V174, P256, DOI 10.2353/ajpath.2009.080522; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; ROUGHLEY PJ, 1993, BIOCHEM J, V295, P421, DOI 10.1042/bj2950421                                                               ; ROUGHLEY PJ, 1989, BIOCHEM J, V262, P823, DOI 10.1042/bj2620823                                                               ; Ruegg UT, 2013, CURR OPIN NEUROL, V26, P577, DOI 10.1097/WCO.0b013e328364fbaf; Ruegg UT, 2002, NEUROMUSCULAR DISORD, V12, pS155, DOI 10.1016/S0960-8966(02)00095-0; Saito T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012239; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Sasaki T, 2002, EXP CELL RES, V275, P185, DOI 10.1006/excr.2002.5499; Scheele S, 2007, J MOL MED-JMM, V85, P825, DOI 10.1007/s00109-007-0182-5; Schultz E, 2006, DEV DYNAM, V235, P3230, DOI 10.1002/dvdy.20976; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Secco M, 2013, STEM CELL REV REP, V9, P93, DOI 10.1007/s12015-012-9380-9; Shavlakadze T, 2004, MOL THER, V10, P829, DOI 10.1016/j.ymthe.2004.07.026; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; TAKEMITSU M, 1991, BIOCHEM BIOPH RES CO, V180, P1179, DOI 10.1016/S0006-291X(05)81320-8; Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033                                                                    ; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Todorov PT, 2007, CANCER RES, V67, P11419, DOI 10.1158/0008-5472.CAN-07-2602; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; TRACEY I, 1995, LANCET, V345, P1260, DOI 10.1016/S0140-6736(95)90923-0; TSIM KWK, 1992, J CELL BIOL, V118, P1201, DOI 10.1083/jcb.118.5.1201; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; Tunggal P, 2000, MICROSC RES TECHNIQ, V51, P214, DOI 10.1002/1097-0029(20001101)51:3<214::AID-JEMT2>3.0.CO;2-J                       ; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; VAILLEND C, 1995, BEHAV GENET, V25, P569, DOI 10.1007/BF02327580; van den Brule F, 2003, LAB INVEST, V83, P377, DOI 10.1097/01.LAB.0000059949.01480.40; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Van Ry PM, 2015, MOL THER, V23, P1285, DOI 10.1038/mt.2015.105; Van Ry PM, 2014, HUM MOL GENET, V23, P383, DOI 10.1093/hmg/ddt428; vandenBrule F, 1997, DEV DYNAM, V209, P399, DOI 10.1002/(SICI)1097-0177(199708)209:4<399::AID-AJA7>3.0.CO;2-D; von Maltzahn J, 2012, P NATL ACAD SCI USA, V109, P20614, DOI 10.1073/pnas.1215765109; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Wang L, 2000, LAB INVEST, V80, P1233, DOI 10.1038/labinvest.3780131; WEIL D, 1988, AM J HUM GENET, V42, P435; Weisleder N, 2012, SCI TRANS MED, V4, P139; Weisleder N, 2011, J VIS EXP; Weisleder N, 2008, CELL CALCIUM, V43, P1, DOI 10.1016/j.ceca.2007.10.006; Weldon D, 2009, ANN ALLERG ASTHMA IM, V103, P91, DOI 10.1016/S1081-1206(10)60159-7; WELLER B, 1990, J NEUROL SCI, V100, P9, DOI 10.1016/0022-510X(90)90005-8; Welser JV, 2009, AM J PATHOL, V175, P1545, DOI 10.2353/ajpath.2009.090052; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Xia B, 2002, DEV BIOL, V242, P58, DOI 10.1006/dbio.2001.0530; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; Yu QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059627; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zhang XT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3703; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440; Zou Y, 2008, J NEUROPATH EXP NEUR, V67, P144, DOI 10.1097/nen.0b013e3181634ef7	234	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2040-4603			COMPR PHYSIOL	Compr. Physiol.	OCT	2017	7	4					1519	1536		10.1002/cphy.c150033				18	Physiology	Physiology	FG8FV	WOS:000410665700016	28915335				2018-01-05	
J	Peischard, S; Piccini, I; Strutz-Seebohm, N; Greber, B; Seebohm, G				Peischard, Stefan; Piccini, Ilaria; Strutz-Seebohm, Nathalie; Greber, Boris; Seebohm, Guiscard			From iPSC towards cardiac tissue-a road under construction	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						Cardiac differentiation; Induced pluripotent stem cell; Myocyte physiology; Signaling pathway; Long QT syndrome	PLURIPOTENT STEM-CELLS; LONG-QT SYNDROME; HIPSC-DERIVED CARDIOMYOCYTES; ENGINEERED HEART-TISSUE; BEAT RATE VARIABILITY; IN-VITRO MATURATION; HUMAN ESCS; DIFFERENTIATION; MODULATION; PHENOTYPES	The possibility to generate induced pluripotent stem cells (iPSC) opens the way to generate virtually all cell types of our human body. In combination with modern gene editing techniques like CRISPR/CAS, a new set of powerful tools becomes available for life science. Scientific fields like genotype and cell type-specific pharmacology, disease modeling, stem cell biology, and developmental biology have been dramatically fostered and their faces have been changed. However, as golden as the age of iPSC-derived cells and their manipulation has started, the shine begins to tarnish. Researchers face more and more practical problems intrinsic to the system. These problems are related to the specific culturing conditions which are not yet sufficient to mimic the natural environment of native stem cells differentiating towards adult cells. However, researchers work hard to uncover these factors. Here, we review a common standard approach to generate iPSCs and transduce these to iPSC cardiomyocytes. Further, we review recent achievements and discuss their current limitations and future perspectives. We are on track, but the road is still under construction.	[Peischard, Stefan; Piccini, Ilaria; Strutz-Seebohm, Nathalie; Seebohm, Guiscard] Univ Hosp Muenster, Dept Cardiovasc Med, IfGH, Myocellular Elect & Mol Biol, D-48149 Munster, Germany; [Piccini, Ilaria; Greber, Boris] Max Planck Inst Mol Biomed, Human Stem Cell Pluripotency Grp, D-48149 Munster, Germany; [Piccini, Ilaria; Greber, Boris] Max Planck Gesell, Chem Genom Ctr, D-44227 Munster, Germany; [Piccini, Ilaria; Seebohm, Guiscard] IMF, Munster, Germany; [Seebohm, Guiscard] Univ Klinikum Munster, Dept Kardiol & Angiol, Inst Genet Herzerkrankungen IfGH, D-48149 Munster, Germany	Seebohm, G (reprint author), Univ Hosp Muenster, Dept Cardiovasc Med, IfGH, Myocellular Elect & Mol Biol, D-48149 Munster, Germany.; Seebohm, G (reprint author), IMF, Munster, Germany.; Seebohm, G (reprint author), Univ Klinikum Munster, Dept Kardiol & Angiol, Inst Genet Herzerkrankungen IfGH, D-48149 Munster, Germany.	guiscard.seebohm@ukmuenster.de			 [DFG-SE1077/3-3];  [IMF-SE 121410]	We thank Timo Strunker (Centre of Reproductive Medicine and Andrology University of Munster) for the conscientious reading, commenting, and correction of the manuscript. G.S. was supported by DFG-SE1077/3-3 and IMF-SE 121410.	Acimovic I, 2014, BIOMED RES INT, DOI 10.1155/2014/512831; Barbuti A, 2015, PHARMACOL REV, V67, P368, DOI 10.1124/pr.114.009597; Batalov I, 2015, BIOMARK INSIGHTS, V10, P71, DOI 10.4137/BMI.S20050; Bellin M, 2013, EMBO J, V32, P3161, DOI 10.1038/emboj.2013.240; Ben-Ari M, 2014, HEART RHYTHM, V11, P1808, DOI 10.1016/j.hrthm.2014.05.037; Bruneau BG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008292; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Chen Z, 2016, CARDIOLOGY, V134, P436; Christ T, 2015, P NATL ACAD SCI USA, V112, pE1968, DOI 10.1073/pnas.1503347112; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065963; David R, 2012, PHYSIOLOGY, V27, P119, DOI 10.1152/physiol.00044.2011; Dell'Era P, 2015, WORLD J STEM CELLS, V7, P329, DOI 10.4252/wjsc.v7.i2.329; Eschenhagen T, 2015, CARDIOVASC RES, V105, P424, DOI 10.1093/cvr/cvv017; Frank S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041958; Greber B, 2015, P NATL ACAD SCI USA, V112, pE1969, DOI 10.1073/pnas.1503762112; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Hassani SN, 2014, STEM CELL REV REP, V10, P16, DOI 10.1007/s12015-013-9473-0; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Hirt MN, 2014, J MOL CELL CARDIOL, V74, P151, DOI 10.1016/j.yjmcc.2014.05.009; Hoekstra M, 2012, FRONT PHYSL, V3, P346; Iancu CB, 2015, ROM J MORPHOL EMBRYO, V56, P1255; JIANG W, 2016, MATH PROBL ENG; Jonsson MKB, 2012, J MOL CELL CARDIOL, V52, P998, DOI 10.1016/j.yjmcc.2012.02.002; Jung JJ, 2014, STEM CELL REP, V2, P592, DOI 10.1016/j.stemcr.2014.03.006; Kadari A, 2015, STEM CELL REV REP, V11, P560, DOI 10.1007/s12015-014-9564-6; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim HS, 2007, BIOCHEM BIOPH RES CO, V361, P732, DOI 10.1016/j.bbrc.2007.07.045; Kleger A, 2010, CIRCULATION, V122, P1823, DOI 10.1161/CIRCULATIONAHA.110.971721; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Limpitikul WB, 2017, CIRC RES, V120, P39, DOI 10.1161/CIRCRESAHA.116.309283; Liu ZW, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/825307; Ma DR, 2013, INT J CARDIOL, V168, P5277, DOI 10.1016/j.ijcard.2013.08.015; Mandel Y, 2012, CIRCULATION, V125, P883, DOI 10.1161/CIRCULATIONAHA.111.045146; Mannhardt I, 2016, STEM CELL REP, V7, P29, DOI 10.1016/j.stemcr.2016.04.011; Masumoto H, 2016, SCI REP UK, V6, P29933; Matschke V, 2016, CELL PHYSIOL BIOCHEM, V40, P1549, DOI 10.1159/000453205; Mehta A, 2014, CARDIOVASC RES, V102, P497, DOI 10.1093/cvr/cvu060; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Okata S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34198; Olesen MS, 2013, CARDIOVASC RES, V98, P488, DOI 10.1093/cvr/cvt028; Paige SL, 2015, CIRC RES, V116, P341, DOI 10.1161/CIRCRESAHA.116.302752; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Piccini I, 2015, GENOM DATA, V4, P69, DOI 10.1016/j.gdata.2015.03.008; Rao J, 2016, CELL STEM CELL, V18, P341, DOI 10.1016/j.stem.2015.11.019; Sala L, 2017, CARDIOVASC RES; Ryan K, 2004, HUM GENE THER, V15, P842, DOI 10.1089/1043034041839280; Saito Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138193; Sala L, 2016, EMBO MOL MED, V8, P1065, DOI 10.15252/emmm.201606260; Sanguinetti MC, 2002, NAT MED, V8, P18, DOI 10.1038/nm0102-18                                                               ; Shinnawi Rami, 2014, Curr Treat Options Cardiovasc Med, V16, P331, DOI 10.1007/s11936-014-0331-4; Sinnecker D, 2016, EUR HEART J, V37, P1019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Talkhabi M, 2016, LIFE SCI, V145, P98, DOI 10.1016/j.lfs.2015.12.023; Terrenoire C, 2013, J GEN PHYSIOL, V141, P61, DOI 10.1085/jgp.201210899; Uzun AU, 2016, FRONT PHARM, V7, P300; van den Ameele J, 2012, EMBO REP, V13, P355, DOI 10.1038/embor.2012.23; Wang YM, 2014, J AM COLL CARDIOL, V64, P451, DOI 10.1016/j.jacc.2014.04.057; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xi JY, 2010, FASEB J, V24, P2739, DOI 10.1096/fj.09-145177; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu T, 2013, CIRC J, V77, P1297, DOI 10.1253/circj.CJ-12-0977; Zhang M, 2015, STEM CELLS, V33, P1456, DOI 10.1002/stem.1964; Zhang M, 2014, P NATL ACAD SCI USA, V111, pE5383, DOI 10.1073/pnas.1419553111; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163	70	0	0	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	OCT	2017	469	10					1233	1243		10.1007/s00424-017-2003-1				11	Physiology	Physiology	FG2KG	WOS:000409928500001		gold			2018-01-05	
J	Muller, T; Dewitz, C; Schmitz, J; Schroder, AS; Brasen, JH; Stockwell, BR; Murphy, JM; Kunzendorf, U; Krautwald, S				Mueller, Tammo; Dewitz, Christin; Schmitz, Jessica; Schroeder, Anna Sophia; Braesen, Jan Hinrich; Stockwell, Brent R.; Murphy, James M.; Kunzendorf, Ulrich; Krautwald, Stefan			Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						Ferroptosis; ACSL4; Necroptosis; MLKL; Ischemia-reperfusion injury	REGULATED NECROSIS; CANCER-CELLS; MLKL; DOMAIN; ACTIVATION; MECHANISMS; APOPTOSIS; PHOSPHORYLATION; INFLAMMATION; TRIGGERS	Ferroptosis is a recently recognized caspase-independent form of regulated cell death that is characterized by the accumulation of lethal lipid ROS produced through iron-dependent lipid peroxidation. Considering that regulation of fatty acid metabolism is responsible for the membrane-resident pool of oxidizable fatty acids that undergo lipid peroxidation in ferroptotic processes, we examined the contribution of the key fatty acid metabolism enzyme, acyl-CoA synthetase long-chain family member 4 (ACSL4), in regulating ferroptosis. By using CRISPR/Cas9 technology, we found that knockout of Acsl4 in ferroptosis-sensitive murine and human cells conferred protection from erastin- and RSL3-induced cell death. In the same cell types, deletion of mixed lineage kinase domain-like (Mlkl) blocked susceptibility to necroptosis, as expected. Surprisingly, these studies also revealed ferroptosis and necroptosis are alternative, in that resistance to one pathway sensitized cells to death via the other pathway. These data suggest a mechanism by which one regulated necrosis pathway compensates for another when either ferroptosis or necroptosis is compromised. We verified the synergistic contributions of ferroptosis and necroptosis to tissue damage during acute organ failure in vivo. Interestingly, in the course of pathophysiological acute ischemic kidney injury, ACSL4 was initially upregulated and its expression level correlated with the severity of tissue damage. Together, our findings reveal ACSL4 to be a reliable biomarker of the emerging cell death modality of ferroptosis, which may also serve as a novel therapeutic target in preventing pathological cell death processes.	[Mueller, Tammo; Dewitz, Christin; Schroeder, Anna Sophia; Kunzendorf, Ulrich; Krautwald, Stefan] Univ Hosp Schleswig Holstein, Dept Nephrol & Hypertens, Campus Kiel,Georges Kohler Haus,Fleckenstr 4, D-24105 Kiel, Germany; [Schmitz, Jessica; Braesen, Jan Hinrich] Leibniz Univ Hannover, Dept Pathol, D-30625 Hannover, Germany; [Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Murphy, James M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Murphy, James M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Krautwald, S (reprint author), Univ Hosp Schleswig Holstein, Dept Nephrol & Hypertens, Campus Kiel,Georges Kohler Haus,Fleckenstr 4, D-24105 Kiel, Germany.	krautwald@nephro.uni-kiel.de	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949	Medical Faculty of Kiel University; Dr. Werner Jackstadt-Stiftung; Fresenius Medical Care Germany; NIH [R01CA09706]; National Health and Medical Research Council of Australia [1057905, 1067289, 1105754, 1124735, IRIISS 9000220]; Victorian Government Operational Infrastructure Support	We thank Janina Kahl, Maike Berger and Katja Bruch for excellent technical assistance. This work is funded by the Medical Faculty of Kiel University (to CD and SK), Dr. Werner Jackstadt-Stiftung (to CD and SK), and Fresenius Medical Care Germany (to UK and SK). BRS is supported by NIH grant R01CA09706. JMM acknowledges funding from the National Health and Medical Research Council of Australia (1057905, 1067289, 1105754, 1124735 and IRIISS 9000220) and Victorian Government Operational Infrastructure Support.	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/nchembio.2239, 10.1038/NCHEMBIO.2239]; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Duprez L, 2012, J BIOL CHEM, V287, P14863, DOI 10.1074/jbc.M111.288670; Galluzzi L, 2014, SEMIN CELL DEV BIOL, V35, P24, DOI 10.1016/j.semcdb.2014.02.006; Gonzalez-Juarbe N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005337; Goodall ML, 2016, DEV CELL, V37, P337, DOI 10.1016/j.devcel.2016.04.018; He SD, 2016, CELL MOL LIFE SCI, V73, P2177, DOI 10.1007/s00018-016-2192-3; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Krautwald S, 2016, CELL MOL LIFE SCI, V73, P2269, DOI 10.1007/s00018-016-2200-7; Li JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.241; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; Morioka S, 2014, J CELL BIOL, V204, P607, DOI 10.1083/jcb.201305070; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tanzer MC, 2015, BIOCHEM J, V471, P255, DOI 10.1042/BJ20150678; Vanden Berghe T, 2016, CELL MOL LIFE SCI, V73, P2137, DOI 10.1007/s00018-016-2189-y; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Xia BQ, 2016, CELL RES, V26, P517, DOI 10.1038/cr.2016.26; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P1338, DOI 10.1016/j.bbrc.2016.08.124; Zhu S, 2017, CANCER RES, V77, P2064, DOI 10.1158/0008-5472.CAN-16-1979	43	0	0	19	19	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	OCT	2017	74	19					3631	3645		10.1007/s00018-017-2547-4				15	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FG1HE	WOS:000409545200012	28551825	gold			2018-01-05	
J	Koch-Edelmann, S; Banhart, S; Saied, EM; Rose, L; Aeberhard, L; Laue, M; Doellinger, J; Arenz, C; Heuer, D				Koch-Edelmann, Sophia; Banhart, Sebastian; Saied, Essa M.; Rose, Laura; Aeberhard, Lukas; Laue, Michael; Doellinger, Joerg; Arenz, Christoph; Heuer, Dagmar			The cellular ceramide transport protein CERT promotes Chlamydia psittaci infection and controls bacterial sphingolipid uptake	CELLULAR MICROBIOLOGY			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; INCLUSION MEMBRANE; TRACHOMATIS INCLUSION; ENDOPLASMIC-RETICULUM; GENETIC-ANALYSIS; GENOME SEQUENCE; INC PROTEINS; RAB GTPASES; SPHINGOMYELIN; PNEUMONIAE	Chlamydiaceae are bacterial pathogens that cause diverse diseases in humans and animals. Despite their broad host and tissue tropism, all Chlamydia species share an obligate intracellular cycle of development and have evolved sophisticated mechanisms to interact with their eukaryotic host cells. Here, we have analysed interactions of the zoonotic pathogen Chlamydia psittaci with a human epithelial cell line. We found that C.psittaci recruits the ceramide transport protein (CERT) to its inclusion. Chemical inhibition and CRISPR/Cas9-mediated knockout of CERT showed that CERT is a crucial factor for C.psittaci infections thereby affecting different stages of the infection including inclusion growth and infectious progeny formation. Interestingly, the uptake of fluorescently labelled sphingolipids in bacteria inside the inclusion was accelerated in CERT-knockout cells indicating that C.psittaci can exploit CERT-independent sphingolipid uptake pathways. Moreover, the CERT-specific inhibitor HPA-12 strongly diminished sphingolipid transport to inclusions of infected CERT-knockout cells, suggesting that other HPA-12-sensitive factors are involved in sphingolipid trafficking to C.psittaci. Further analysis is required to decipher these interactions and to understand their contributions to bacterial development, host range, tissue tropism, and disease outcome.	[Koch-Edelmann, Sophia; Banhart, Sebastian; Rose, Laura; Aeberhard, Lukas; Heuer, Dagmar] Robert Koch Inst, Jr Res Grp Sexually Transmitted Bacterial Pathoge, Berlin, Germany; [Saied, Essa M.; Arenz, Christoph] Humboldt Univ Zu Berlin, Dept Chem, Organ & Bioorgan Chem, Berlin, Germany; [Saied, Essa M.] Suez Canal Univ, Chem Dept, Fac Sci, Ismailia, Egypt; [Laue, Michael] Robert Koch Inst, Adv Light & Electron Microscopy ZBS 4, Berlin, Germany; [Doellinger, Joerg] Robert Koch Inst, Prote & Spect ZBS 6, Berlin, Germany	Heuer, D (reprint author), Robert Koch Inst, Jr Res Grp Sexually Transmitted Bacterial Pathoge, Berlin, Germany.	heuerd@rki.de	Arenz, Christoph/D-1841-2010		Deutsche Forschungsgemeinschaft [HE6008/1-2, HE6008/11]; Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft, Grant/Award Number: HE6008/1-2 and HE6008/11; Federal Ministry of Education and Research (BMBF)	Aeberhard L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004883; Agaisse H, 2014, INFECT IMMUN, V82, P2037, DOI 10.1128/IAI.01530-14; Almeida F, 2012, J BACTERIOL, V194, P6574, DOI 10.1128/JB.01428-12; Banhart S, 2014, ANTIMICROB AGENTS CH, V58, P5537, DOI 10.1128/AAC.03457-14; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; Bocker S, 2014, INT J MED MICROBIOL, V304, P542, DOI 10.1016/j.ijmm.2014.03.005; Borth N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016692; Braun PR, 2008, J BACTERIOL, V190, P1822, DOI 10.1128/JB.01240-07; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Charruyer A, 2008, J BIOL CHEM, V283, P16682, DOI 10.1074/jbc.M800799200; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fechtner T, 2016, CELL MICROBIOL, V18, P1094, DOI 10.1111/cmi.12569; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877                                                         ; Hackstadt T, 1996, EMBO J, V15, P964; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; HODINKA RL, 1986, INFECT IMMUN, V54, P855; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Hybiske K, 2007, INFECT IMMUN, V75, P3925, DOI 10.1128/IAI.00106-07; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kalman S, 1999, NAT GENET, V21, P385; Knittler MR, 2014, INT J MED MICROBIOL, V304, P877, DOI 10.1016/j.ijmm.2014.06.010; Kokes M, 2015, CELL HOST MICROBE, V17, P716, DOI 10.1016/j.chom.2015.03.014; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Kusebauch U, 2016, CELL, V166, P766, DOI 10.1016/j.cell.2016.06.041; Lagae S, 2014, J MED MICROBIOL, V63, P399, DOI 10.1099/jmm.0.064675-0; Laroucau K., 2015, EURO SURVEILLANCE, V20; Lipinski AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000615; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lucas AL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00068; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mehlitz A, 2010, J CELL BIOL, V190, P143, DOI 10.1083/jcb.200909095; Mirrashidi KM, 2015, CELL HOST MICROBE, V18, P109, DOI 10.1016/j.chom.2015.06.004; Mojica SA, 2015, MOL BIOL CELL, V26, P1918, DOI 10.1091/mbc.E14-11-1530; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Nans A, 2015, MICROBES INFECT, V17, P727, DOI 10.1016/j.micinf.2015.08.004; Norkin LC, 2001, EXP CELL RES, V266, P229, DOI 10.1006/excr.2001.5202; Nunes A, 2014, INFECT GENET EVOL, V23, P49, DOI 10.1016/j.meegid.2014.01.029; Ouellette SP, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00112; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Sachse K, 2015, SYST APPL MICROBIOL, V38, P99, DOI 10.1016/j.syapm.2014.12.004; Saied EM, 2015, FUTURE MED CHEM, V7, P1971, DOI 10.4155/fmc.15.126; Saied EM, 2014, CHEM-ASIAN J, V9, P2092, DOI 10.1002/asia.201402241; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363                                                           ; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x                                                ; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x                                                ; Sixt BS, 2016, ANNU REV MICROBIOL, V70, P179, DOI 10.1146/annurev-micro-102215-095539; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; TIPPLES G, 1993, MOL MICROBIOL, V8, P1105, DOI 10.1111/j.1365-2958.1993.tb01655.x; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Voigt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035097; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wu HY, 2016, MICROBIOL RES, V183, P19, DOI 10.1016/j.micres.2015.11.005; Yao JW, 2015, J BIOL CHEM, V290, P18874, DOI 10.1074/jbc.M115.657148; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200                                                          ; Zolg DP, 2017, NAT METHODS, V14, P259, DOI [10.1038/NMETH.4153, 10.1038/nmeth.4153]; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553	72	0	0	12	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-5814	1462-5822		CELL MICROBIOL	Cell Microbiol.	OCT	2017	19	10							e12752	10.1111/cmi.12752				13	Cell Biology; Microbiology	Cell Biology; Microbiology	FF9GB	WOS:000409323700002					2018-01-05	
J	Wacker, R; Eickel, N; Schmuckli-Maurer, J; Annoura, T; Niklaus, L; Khan, SM; Guan, JL; Heussler, VT				Wacker, Rahel; Eickel, Nina; Schmuckli-Maurer, Jacqueline; Annoura, Takeshi; Niklaus, Livia; Khan, Shahid M.; Guan, Jun-Lin; Heussler, Volker T.			LC3-association with the parasitophorous vacuole membrane of Plasmodium berghei liver stages follows a noncanonical autophagy pathway	CELLULAR MICROBIOLOGY			English	Article							CELL-DEATH; ATG8-PE DECONJUGATION; TOXOPLASMA-GONDII; MALARIA PARASITE; HOST HEPATOCYTES; LC3; PROTEINS; PHAGOCYTOSIS; REVEALS; FUSION	Eukaryotic cells can employ autophagy to defend themselves against invading pathogens. Upon infection by Plasmodium berghei sporozoites, the host hepatocyte targets the invader by labelling the parasitophorous vacuole membrane (PVM) with the autophagy marker protein LC3. Until now, it has not been clear whether LC3 recruitment to the PVM is mediated by fusion of autophagosomes or by direct incorporation. To distinguish between these possibilities, we knocked out genes that are essential for autophagosome formation and for direct LC3 incorporation into membranes. The CRISPR/Cas9 system was employed to generate host cell lines deficient for either FIP200, a member of the initiation complex for autophagosome formation, or ATG5, responsible for LC3 lipidation and incorporation of LC3 into membranes. Infection of these knockout cell lines with P.berghei sporozoites revealed that LC3 recruitment to the PVM indeed depends on functional ATG5 and the elongation machinery, but not on FIP200 and the initiation complex, suggesting a direct incorporation of LC3 into the PVM. Importantly, in P.berghei-infected ATG5(-/-) host cells, lysosomes still accumulated at the PVM, indicating that the recruitment of lysosomes follows an LC3-independent pathway.	[Wacker, Rahel; Eickel, Nina; Schmuckli-Maurer, Jacqueline; Niklaus, Livia; Heussler, Volker T.] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Wacker, Rahel; Eickel, Nina; Niklaus, Livia] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Annoura, Takeshi] NIID, Dept Parasitol, Tokyo, Japan; [Khan, Shahid M.] Leiden Univ, Ctr Infect Dis, Med Ctr, Leiden, Netherlands; [Guan, Jun-Lin] Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH USA	Heussler, VT (reprint author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	heussler@izb.unibe.ch			Swiss National Science Foundation [310030_159519, 316030_145013, 51RTPO_151032]; Japan Society for the Promotion of Science [GR16106]	Swiss National Science Foundation, Grant/Award Number: 310030_159519 and 316030_145013; SystemsX, Grant/Award Number: 51RTPO_151032; Japan Society for the Promotion of Science, Grant/Award Number: GR16106	Agop-Nersesian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02156-7; Annoura T, 2012, VACCINE, V30, P2662, DOI 10.1016/j.vaccine.2012.02.010; Bano N, 2007, INT J PARASITOL, V37, P1329, DOI 10.1016/j.ijpara.2007.04.005; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boonhok R, 2016, P NATL ACAD SCI USA, V113, pE3519, DOI 10.1073/pnas.1525606113; Burda PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004760; CALVOCALLE JM, 1994, EXP PARASITOL, V79, P362, DOI 10.1006/expr.1994.1098; Choi J, 2014, IMMUNITY, V40, P924, DOI 10.1016/j.immuni.2014.05.006; COGSWELL FB, 1992, CLIN MICROBIOL REV, V5, P26; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; da Silva ML, 2012, TRAFFIC, V13, P1351, DOI 10.1111/j.1600-0854.2012.01398.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Eickel N, 2013, AUTOPHAGY, V9, P568, DOI 10.4161/auto.23689; Florey O, 2015, AUTOPHAGY, V11, P88, DOI 10.4161/15548627.2014.984277; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Grutzke J, 2014, TRAFFIC, V15, P362, DOI 10.1111/tra.12151; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.odd.4401936; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P682, DOI 10.4269/ajtmh.1983.32.682                                                       ; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaiser G, 2016, MOL MICROBIOL, V102, P775, DOI 10.1111/mmi.13490; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Knodler LA, 2011, CELL MICROBIOL, V13, P1319, DOI 10.1111/j.1462-5822.2011.01632.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012                                                               ; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morvan J, 2009, AUTOPHAGY, V5, P676, DOI 10.4161/auto.5.5.8378                                                           ; Mostowy S, 2013, CELL MICROBIOL, V15, P395, DOI 10.1111/cmi.12063; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nguyen T. T., 2016, ASIA PACIFIC J TOURI, P1; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Park S, 2016, AUTOPHAGY, V12, P1153, DOI 10.1080/15548627.2016.1178447; Petersen W., 2017, MOL BIOL CELL; Ploemen IHJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050772; Prado M, 2015, AUTOPHAGY, V11, P1561, DOI 10.1080/15548627.2015.1067361; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rennenberg A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000825; Romao S, 2013, J CELL BIOL, V203, P757, DOI 10.1083/jcb.201308173; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Selleck EM, 2015, MBIO, V6, DOI 10.1128/mBio.01157-15; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Spielmann T, 2012, INT J MED MICROBIOL, V302, P179, DOI 10.1016/j.ijmm.2012.07.011; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Thieleke-Matos C, 2016, CELL MICROBIOL, V18, P437, DOI 10.1111/cmi.12524; Van De Sand C., 2005, MOL MICROBIOLOGY; World Health Organisation, 2015, WORLD MAL REP 2015; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652; Zhao C., 2016, RODENT MALARIA LIVER, P1	60	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-5814	1462-5822		CELL MICROBIOL	Cell Microbiol.	OCT	2017	19	10							e12754	10.1111/cmi.12754				13	Cell Biology; Microbiology	Cell Biology; Microbiology	FF9GB	WOS:000409323700004		gold			2018-01-05	
J	Gupta, PR; Huckfeldt, RM				Gupta, Priya R.; Huckfeldt, Rachel M.			Gene therapy for inherited retinal degenerations: initial successes and future challenges	JOURNAL OF NEURAL ENGINEERING			English	Review						inherited retinal degeneration; gene therapy; genome editing	LEBER CONGENITAL AMAUROSIS; LINKED RETINITIS-PIGMENTOSA; RECOMBINANT ADENOASSOCIATED VIRUS; OPTICAL COHERENCE TOMOGRAPHY; COMPACTED DNA NANOPARTICLES; PLURIPOTENT STEM-CELLS; SEVERE COMBINED IMMUNODEFICIENCY; HIGH-EFFICIENCY TRANSDUCTION; KNOCKOUT MOUSE MODELS; IN-VIVO	Inherited retinal degenerations are a clinically and genetically heterogeneous group of conditions that have historically shared an untreatable course. In recent years, however, a wide range of therapeutic strategies have demonstrated efficacy in preclinical studies and entered clinical trials with a common goal of improving visual function for patients affected with these conditions. Gene therapy offers a particularly elegant and precise opportunity to target the causative genetic mutations underlying these monogenic diseases. The present review will provide an overview of gene therapy with particular emphasis on key clinical results to date and challenges for the future.	[Gupta, Priya R.; Huckfeldt, Rachel M.] Harvard Med Sch, Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA USA	Huckfeldt, RM (reprint author), Massachusetts Eye & Ear, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.	rachel_huckfeldt@meei.harvard.edu			Research to Prevent Blindness Medical Student Research Fellowship	PG is supported by a Research to Prevent Blindness Medical Student Research Fellowship.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/ng0501-92; Afione SA, 1996, J VIROL, V70, P3235; Aguirre G D, 1998, Mol Vis, V4, P23; Aleman TS, 2007, INVEST OPHTH VIS SCI, V48, P4759, DOI 10.1167/iovs.07-0453; Ali RR, 1996, HUM MOL GENET, V5, P591, DOI 10.1093/hmg/5.5.591; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Amado D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000659; Anand V, 2002, MOL THER, V5, P125, DOI 10.1006/mthe.2002.0525; Anastasakis A, 2012, RETINA-J RET VIT DIS, V32, P358, DOI 10.1097/IAE.0b013e31821a891a; Annear MJ, 2011, GENE THER, V18, P53, DOI 10.1038/gt.2010.111; Ashtari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086068; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Auricchio A, 2003, VISION RES, V43, P913, DOI 10.1016/S0042-6989(02)00676-4; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Ayton LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115239; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Banin E, 2015, MOL THER, V23, P1423, DOI 10.1038/mt.2015.114; Bassuk AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19969; Beltran WA, 2017, MOL THER, V25, P1866, DOI 10.1016/j.ymthe.2017.05.004; Beltran WA, 2015, P NATL ACAD SCI USA, V112, pE5844, DOI 10.1073/pnas.1509914112; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Bennett J, 2003, GENE THER, V10, P977, DOI 10.1038/sj.gt.3302030; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Berkowitz AL, 2016, NEW ENGL J MED, V375, P196, DOI 10.1056/NEJMc1600188; Binley K, 2013, INVEST OPHTH VIS SCI, V54, P4061, DOI 10.1167/iovs.13-11871; Bittner AK, 2011, INVEST OPHTH VIS SCI, V52, P6370, DOI 10.1167/iovs.11-7195; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Boye SL, 2016, J VIROL, V90, P4215, DOI 10.1128/JVI.00200-16; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Brandli A, 2016, EYE BRAIN, V8, P15, DOI 10.2147/EB.S70822; Braun TA, 2013, HUM MOL GENET, V22, P5136, DOI 10.1093/hmg/ddt367; Bujakowska KM, 2017, GENET MED, V19, P643, DOI 10.1038/gim.2016.158; Burnight E R, 2014, COLD SPRING HARB PER, V5; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Campochiaro P. A., 2016, GENE THER, V28, P99, DOI [10.1089/hum.2016.11727710144, DOI 10.1089/HUM.2016.11727710144]; Caruso RC, 2010, INVEST OPHTH VIS SCI, V51, P5304, DOI 10.1167/iovs.10-5559; Carvalho LS, 2011, HUM MOL GENET, V20, P3161, DOI 10.1093/hmg/ddr218; Catuogno S, 2016, PHARMACEUTICALS, V9, DOI 10.3390/ph9040069; Cepko CL, 2013, HUM GENE THER, V24, P242, DOI 10.1089/hum.2013.050; Cereso N, 2017, J NEURAL ENG, V14; Cereso N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.11; Chadderton N, 2009, MOL THER, V17, P593, DOI 10.1038/mt.2008.301; Chen YY, 2017, PHARMACOL RES, V115, P1, DOI 10.1016/j.phrs.2016.10.031; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Colella P, 2014, GENE THER, V21, P450, DOI 10.1038/gt.2014.8; Collaco RF, 1999, GENE, V238, P397, DOI 10.1016/S0378-1119(99)00347-9                                                   ; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Cronin T, 2014, EMBO MOL MED, V6, P1175, DOI 10.15252/emmm.201404077; Dalkara D, 2016, HUM GENE THER, V27, P134, DOI 10.1089/hum.2015.147; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Drolet DW, 2016, NUCLEIC ACID THER, V26, P127, DOI 10.1089/nat.2015.0573; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Duebel J, 2015, CURR OPIN OPHTHALMOL, V26, P226, DOI 10.1097/ICU.0000000000000140; Edwards TL, 2016, NEW ENGL J MED, V374, P1996, DOI 10.1056/NEJMc1509501; Ehlers JP, 2016, EYE, V30, P193, DOI 10.1038/eye.2015.255; Eid A, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.111; Ellingford J M, 2016, MED GENET, V53, P761; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Fileta JB, 2014, OPHTHAL SURG LAS IM, V45, P143, DOI 10.3928/23258160-20140306-08; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; Fischer MD, 2017, MOL THER, V25, P1854, DOI 10.1016/j.ymthe.2017.05.005; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Flotte TR, 2005, HUM GENE THER, V16, P401, DOI 10.1089/hum.2005.16.401; Franklin C, 2017, EJSO-EUR J SURG ONC, V43, P604, DOI 10.1016/j.ejso.2016.07.145; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057                                                        ; Garber K, 2015, NAT BIOTECHNOL, V33, P890, DOI 10.1038/nbt0915-890; Gaudet D, 2016, HUM GENE THER, V27, P916, DOI 10.1089/hum.2015.158; Georgiadis A, 2016, GENE THER, V23, P857, DOI 10.1038/gt.2016.66; Gonenc B, 2014, IEEE INT CONF ROBOT, P1399, DOI 10.1109/ICRA.2014.6907035; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616                                                            ; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hauer J, 2010, NEW ENGL J MED, V363, P355, DOI DOI 10.1056/NEJM0A1000164; Han ZC, 2015, FASEB J, V29, P2535, DOI 10.1096/fj.15-270363; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Han ZC, 2012, NANOMEDICINE-UK, V7, P521, DOI [10.2217/NNM.11.158, 10.2217/nnm.11.158]; Haq W, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00108; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hippert C, 2016, ADV EXP MED BIOL, V854, P579, DOI 10.1007/978-3-319-17121-0_77; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Ivanova E, 2016, EXP EYE RES, V150, P81, DOI 10.1016/j.exer.2015.05.013; Jacobson SG, 2008, INVEST OPHTH VIS SCI, V49, P4573, DOI 10.1167/iovs.08-2121; Jacobson SG, 2006, INVEST OPHTH VIS SCI, V47, P4113, DOI 10.1167/iovs.06-0424; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Jones MK, 2017, PROG RETIN EYE RES, V58, P1, DOI 10.1016/j.preteyeres.2017.01.004; KARNA J, 1986, ACTA OPHTHALMOL, V64, P1; Karvelis T, 2017, METHODS, V121, P3, DOI 10.1016/j.ymeth.2017.03.006; Kay CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062097; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koch SF, 2017, P NATL ACAD SCI USA, V114, P5259, DOI 10.1073/pnas.1615394114; Koch SF, 2015, J CLIN INVEST, V125, P3704, DOI 10.1172/JCI82462; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255                                                        ; Kronenberg S, 2001, EMBO REP, V2, P997, DOI 10.1093/embo-reports/kve234; Kuo CY, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0615-8; Kuriyan AE, 2017, NEW ENGL J MED, V376, P1047, DOI 10.1056/NEJMoa1609583; Lai C. M., 2004, GENET VACCINES THER, V2, P3; Leaderer D, 2016, EXP EYE RES, V145, P380, DOI 10.1016/j.exer.2016.02.009; Lewis PM, 2015, BRAIN RES, V1595, P51, DOI 10.1016/j.brainres.2014.11.020; LI ZY, 1995, J NEUROSCI, V15, P5429; Lipinski DM, 2015, MOL THER, V23, P1308, DOI 10.1038/mt.2015.68; Lipinski DM, 2013, PROG RETIN EYE RES, V32, P22, DOI 10.1016/j.preteyeres.2012.09.001; Luo YHL, 2016, PROG RETIN EYE RES, V50, P89, DOI 10.1016/j.preteyeres.2015.09.003; MacLaren RE, 2016, LANCET, V388, P635, DOI 10.1016/S0140-6736(16)30783-8; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Margolis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086253; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139                                                              ; Mason D, 2015, J CONTROL RELEASE, V215, P101, DOI 10.1016/j.jconrel.2015.08.001; McTaggart KE, 2002, HUM MUTAT, V20, P189, DOI 10.1002/humu.10114; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Michalakis S, 2017, J GENE MED, V19, DOI 10.1002/jgm.2944; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Millington-Ward S, 2011, MOL THER, V19, P642, DOI 10.1038/mt.2010.293; Minella AL, 2014, GENE THER, V21, P913, DOI 10.1038/gt.2014.65; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Morrison C, 2015, NAT BIOTECHNOL, V33, P217, DOI 10.1038/nbt0315-217; Mowat FM, 2014, GENE THER, V21, P96, DOI 10.1038/gt.2013.64; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; O'Reilly M, 2007, AM J HUM GENET, V81, P127, DOI 10.1086/519025; Omlor AJ, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0223-5; Pang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035250; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Pawlyk BS, 2016, GENE THER, V23, P196, DOI 10.1038/gt.2015.93; Pelletier V, 2007, HUM MUTAT, V28, P81, DOI 10.1002/humu.20417; Petit L, 2017, HUM GENE THER, V28, P464, DOI 10.1089/hum.2017.020; Petit L, 2016, HUM GENE THER, V27, P563, DOI 10.1089/hum.2016.040; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Preising MN, 2009, OPHTHALMOLOGY, V116, P1201, DOI 10.1016/j.ophtha.2009.01.016; Puppo A, 2014, GENE THER, V21, P855, DOI 10.1038/gt.2014.57; Ramachandran PS, 2017, HUM GENE THER, V28, P154, DOI 10.1089/hum.2016.111; Rao RC, 2017, AM J OPHTHALMOL, V179, P32, DOI 10.1016/j.ajo.2017.04.007; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Regalado A., 2015, MIT TECHNOLOGY REV; Robert L, 2011, OPHTHALMIC RES, V45, P155, DOI 10.1159/000313992; Ruan GX, 2017, MOL THER, V25, P331, DOI 10.1016/j.ymthe.2016.12.006; Santos-Ferreira TF, 2017, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00105; Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; Sengillo JD, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020053; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Simunovic MP, 2016, INVEST OPHTH VIS SCI, V57, P6033, DOI 10.1167/iovs.16-20230; Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226; Soto F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00395; SRIVASTAVA A, 1983, J VIROL, V45, P555; Srivastava A, 2016, CURR OPIN VIROL, V21, P75, DOI 10.1016/j.coviro.2016.08.003; Starr CJ, 2004, P NATL ACAD SCI USA, V101, P2572, DOI 10.1073/pnas.0308474100; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Stingl K, 2015, VISION RES, V111, P149, DOI 10.1016/j.visres.2015.03.001; Stolberg S G, 1999, NY TIMES MAGAZI 1128, P149; Stolberg Sheryl Gay, 1999, N Y Times Mag, P136; Strettoi E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00494; Stroes ES, 2008, ARTERIOSCL THROM VAS, V28, P2303, DOI 10.1161/ATVBAHA.108.175620; Sun NF, 2014, CRIT REV ONCOL HEMAT, V89, P352, DOI 10.1016/j.critrevonc.2013.10.006; Tee JJL, 2016, BRIT J OPHTHALMOL, V100, P1022, DOI 10.1136/bjophthalmol-2015-307698; Testa F, 2013, OPHTHALMOLOGY, V120, P1283, DOI 10.1016/j.ophtha.2012.11.048; Thiadens AAHJ, 2009, OPHTHALMOLOGY, V116, P1984, DOI 10.1016/j.ophtha.2009.03.053; Tolmachova T, 2006, J CLIN INVEST, V116, P386, DOI 10.1172/JCI26617; Tolmachova T, 2013, J MOL MED, V91, P825, DOI 10.1007/s00109-013-1006-4; Tolmachova T, 2012, J GENE MED, V14, P158, DOI 10.1002/jgm.1652; Tolmachova T, 2010, INVEST OPHTH VIS SCI, V51, P4913, DOI 10.1167/iovs.09-4892; Toychiev AH, 2013, J NEUROSCI, V33, P13972, DOI 10.1523/JNEUROSCI.2399-13.2013; Trapani I, 2014, PROG RETIN EYE RES, V43, P108, DOI 10.1016/j.preteyeres.2014.08.001; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Uren PJ, 2014, MOL VIS, V20, P1612; Vamos R, 2011, INVEST OPHTH VIS SCI, V52, P8425, DOI 10.1167/iovs.11-7780; VANBOKHOVEN H, 1994, HUM MOL GENET, V3, P1041, DOI 10.1093/hmg/3.7.1041                                                            ; Vandenberghe LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053463; Vandenberghe LH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002103; vandenHurk JAJM, 1997, HUM MOL GENET, V6, P851, DOI 10.1093/hmg/6.6.851                                                             ; Vasireddy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061396; Weleber RG, 2016, OPHTHALMOLOGY, V123, P1606, DOI 10.1016/j.ophtha.2016.03.003; Wiley LA, 2015, PROG RETIN EYE RES, V44, P15, DOI 10.1016/j.preteyeres.2014.10.002; Wilson JM, 2009, MOL GENET METAB, V96, P151, DOI 10.1016/j.ymgme.2008.12.016; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Wojtal D, 2016, AM J HUM GENET, V98, P90, DOI 10.1016/j.ajhg.2015.11.012; Woodard KT, 2016, J VIROL, V90, P9878, DOI 10.1128/JVI.01568-16; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yang ZL, 2002, HUM MOL GENET, V11, P605, DOI 10.1093/hmg/11.5.605                                                            ; Ye GJ, 2016, HUM GENE THER, V27, P72, DOI 10.1089/hum.2015.130; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; Yoshihara M, 2017, STEM CELL REV REP, V13, P7, DOI 10.1007/s12015-016-9680-6; Yue L, 2016, PROG RETIN EYE RES, V53, P21, DOI 10.1016/j.preteyeres.2016.05.002; Zallen DT, 2000, TRENDS GENET, V16, P272; Zallocchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094272; Zarbin M, 2016, TRENDS MOL MED, V22, P115, DOI 10.1016/j.molmed.2015.12.007; Zhang AY, 2015, INVEST OPHTH VIS SCI, V56, P8158, DOI 10.1167/iovs.14-15751; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zhou G, 2016, ONCOTARGET, V7, P13446, DOI 10.18632/oncotarget.7178; Zinn E, 2015, CELL REP, V12, P1056, DOI 10.1016/j.celrep.2015.07.019; Zulliger R, 2015, J CONTROL RELEASE, V219, P471, DOI 10.1016/j.jconrel.2015.10.007	229	0	0	27	27	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	OCT	2017	14	5							051002	10.1088/1741-2552/aa7a27				19	Engineering, Biomedical; Neurosciences	Engineering; Neurosciences & Neurology	FE5NG	WOS:000408257600001	28829759				2018-01-05	
J	Holmes, CM; Ghafari, M; Abbas, A; Saravanan, V; Nemenman, I				Holmes, Caroline M.; Ghafari, Mahan; Abbas, Anzar; Saravanan, Varun; Nemenman, Ilya			Luria-Delbruck, revisited: the classic experiment does not rule out Lamarckian evolution	PHYSICAL BIOLOGY			English	Article						Lamarck; Darwin; Luria-Delbruck fluctuation test; Bayesian model selection; maximum likelihood	FLUCTUATION ANALYSIS; MUTATION; MUTANTS; NUMBER; MECHANISMS; BACTERIA; COLI	We re-examined data from the classic Luria-Delbruck fluctuation experiment, which is often credited with establishing a Darwinian basis for evolution. We argue that, for the Lamarckian model of evolution to be ruled out by the experiment, the experiment must favor pure Darwinian evolution over both the Lamarckian model and a model that allows both Darwinian and Lamarckian mechanisms (as would happen for bacteria with CRISPR-Cas immunity). Analysis of the combined model was not performed in the original 1943 paper. The Luria-Delbruck paper also did not consider the possibility of neither model fitting the experiment. Using Bayesian model selection, we find that the Luria-Delbruck experiment, indeed, favors the Darwinian evolution over purely Lamarckian. However, our analysis does not rule out the combined model, and hence cannot rule out Lamarckian contributions to the evolutionary dynamics.	[Holmes, Caroline M.; Ghafari, Mahan; Nemenman, Ilya] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Holmes, Caroline M.; Nemenman, Ilya] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Abbas, Anzar; Saravanan, Varun] Emory Univ, Neurosci Program, Atlanta, GA 30322 USA; [Nemenman, Ilya] Emory Univ, Initiat Theory & Modeling Living Syst, Atlanta, GA 30322 USA	Nemenman, I (reprint author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.; Nemenman, I (reprint author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.; Nemenman, I (reprint author), Emory Univ, Initiat Theory & Modeling Living Syst, Atlanta, GA 30322 USA.	ilya.nemenman@emory.edu			NSF [PoLS-1410978]; James S McDonnell Foundation [220020321]; NIH NINDS [R01 NS084844]; Woodruff Scholars Program; Laney Graduate School at Emory University	This work was partially supported by NSF Grant No. PoLS-1410978, James S McDonnell Foundation Grant No. 220020321, NIH NINDS R01 NS084844, Woodruff Scholars Program and Laney Graduate School at Emory University.	Angerer WP, 2001, J MATH BIOL, V42, P145, DOI 10.1007/s002850000053; ARMITAGE P, 1952, J ROY STAT SOC B, V14, P1; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bartlett M. S., 1978, INTRO STOCHASTIC PRO; HANTKE K, 1978, J BACTERIOL, V135, P190; Hayes W, 1964, STUDIES BASIC GENETI; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822                                                                  ; Jablonka F, 2002, ANN NY ACAD SCI, V981, P82; JAEGER G, 1995, GENETICA, V96, P217, DOI 10.1007/BF01439575                                                              ; JONES ME, 1994, GENETICS, V136, P1209; Kendall D, 1952, ANN I H POINCARE, V13, P43; KOCH AL, 1982, MUTAT RES, V95, P129, DOI 10.1016/0027-5107(82)90252-4                                                    ; Koonin EV, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0111-z; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080                                                              ; LEDERBERG J, 1952, J BACTERIOL, V63, P399; Luria SE, 1943, GENETICS, V28, P491; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564                                                                 ; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI 10.1162/neco.1992.4.3.415                                                       ; MacKay D. J. C., 2003, INFORM THEORY INFERE; MANDELBROT B, 1974, J APPL PROBAB, V11, P437, DOI 10.2307/3212688                                                                 ; Montgomery-Smith S, 2016, ARXIV160804175; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; SARKAR S, 1991, GENETICS, V127, P257; STEWART FM, 1991, GENETICA, V84, P51, DOI 10.1007/BF00123984; STEWART FM, 1990, GENETICS, V124, P175; TAYLOR AL, 1963, P NATL ACAD SCI USA, V50, P1043, DOI 10.1073/pnas.50.6.1043                                                          ; Ycart B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080958; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0                                                   ; Zheng Q, 2007, MATH BIOSCI, V209, P500, DOI 10.1016/j.mbs.2007.03.003	30	0	0	14	14	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1478-3967	1478-3975		PHYS BIOL	Phys. Biol.	OCT	2017	14	5							055004	10.1088/1478-3975/aa8230				9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FE4MZ	WOS:000408189300001	28825411				2018-01-05	
J	Hosur, V; Low, BE; Avery, C; Shultz, LD; Wiles, MV				Hosur, Vishnu; Low, Benjamin E.; Avery, Cindy; Shultz, Leonard D.; Wiles, Michael V.			Development of Humanized Mice in the Age of Genome Editing	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						CRISPR/Cas9; IMMUNODEFICIENT; HUMANIZED; SITE-SPECIFIC ENDONUCLEASES; NSG; TRANSGENIC MICE	SEVERE COMBINED IMMUNODEFICIENCY; SCID IL2R-GAMMA(NULL) MICE; HUMAN IMMUNE-SYSTEM; MOUSE MODELS; CELL ENGRAFTMENT; GAMMA-CHAIN; BLOOD; GENERATION; TRANSPLANTATION; HEMATOPOIESIS	Mice are the most commonly used model organisms to study human disease. Many genetic human diseases can be recapitulated by modifying the mouse genome allowing the testing of existing and novel therapeutics, including combinatorial therapeutics, without putting humans at risk. Specifically, the development of "humanized" mice, that is, severely immunodeficient mice engrafted with functional human hematopoietic and immune cells and tissues, has revolutionized our ability to study and model human diseases in preclinical in vivo systems. Until recently it has been challenging to develop strains of humanized mice with targeted mutations or that transgenically express human genes with site-specific mutations, and can permit optimal growth of functional human cells and tissues. However, recent advances in targeted nuclease-based genetic engineering have enabled precise modification and development of humanized mouse models at an unprecedented pace. These modifications permit optimal growth of functional human cells and tissues and can be used to replicate human genetically determined diseases. (C) 2017 Wiley Periodicals, Inc.	[Hosur, Vishnu; Low, Benjamin E.; Avery, Cindy; Shultz, Leonard D.; Wiles, Michael V.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Wiles, MV (reprint author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	michael.wiles@jax.org			NIH [OD018259, R21 OD023800-01, UC4 DK104218]; NCI [P30CA034196]	Grant sponsor: NIH; Grant numbers: OD018259, R21 OD023800-01, UC4 DK104218; Grant sponsor: NCI; Grant number: P30CA034196.	Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Brehm MA, 2014, J IMMUNOL METHODS, V410, P3, DOI 10.1016/j.jim.2014.02.011; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Christianson SW, 1996, CELL IMMUNOL, V171, P186, DOI 10.1006/cimm.1996.0193; Covassin L, 2013, CLIN EXP IMMUNOL, V174, P372, DOI 10.1111/cei.12180; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Greenblatt MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044664; Greiner DL, 2011, ANN NY ACAD SCI, V1245, P55, DOI 10.1111/j.1749-6632.2011.06318.x; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166                                                             ; Grimm D, 2016, SCIENCE, V353, P433, DOI 10.1126/science.353.6298.433; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974                                                        ; Hollis Roger P, 2003, Reprod Biol Endocrinol, V1, P79, DOI 10.1186/1477-7827-1-79; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Landel CP, 2013, TRANSGENIC RES, V22, P179, DOI 10.1007/s11248-012-9629-8; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Low BE, 2016, METHODS MOL BIOL, V1438, P19, DOI 10.1007/978-1-4939-3661-8_2; Lowry P A, 1996, Biol Blood Marrow Transplant, V2, P15; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Olorunniji FJ, 2016, BIOCHEM J, V473, P673, DOI 10.1042/BJ20151112; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pflumio F, 1996, BLOOD, V88, P3731; Rathinam C, 2011, BLOOD, V118, P3119, DOI 10.1182/blood-2010-12-326926; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477                                                    ; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933                                                         ; Vallender EJ, 2013, ILAR J, V54, P154, DOI 10.1093/ilar/ilt044; Vandamme TF, 2015, EUR J PHARMACOL, V759, P84, DOI 10.1016/j.ejphar.2015.03.046; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wege AK, 2011, INT J CANCER, V129, P2194, DOI 10.1002/ijc.26159; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108; Zhou QJ, 2014, CANCER LETT, V344, P13, DOI 10.1016/j.canlet.2013.10.015	50	0	0	63	63	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	OCT	2017	118	10					3043	3048		10.1002/jcb.26002				6	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FD2YN	WOS:000407400800003	28332231				2018-01-05	
J	Lin, JC; Zhou, YZ; Liu, JQ; Chen, J; Chen, WS; Zhao, S; Wu, ZH; Wu, N				Lin, Jiachen; Zhou, Yangzhong; Liu, Jiaqi; Chen, Jia; Chen, Weisheng; Zhao, Sen; Wu, Zhihong; Wu, Nan			Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						CRISPR/Cas TECHNOLOGY; GENE EDITING; DISEASE MODELING; GENE THERAPY; GENETIC SCREENING	PLURIPOTENT STEM-CELLS; SCALE CRISPR-CAS9 KNOCKOUT; GENOME-EDITING TOOLS; DOUBLE-STRAND BREAKS; GENETIC SCREENS; CHIP-SEQ; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; CAS SYSTEM; RNA	Based on the tremendous progress of the understanding on the CRISPR-Cas systems, the application CRISPR/Cas technology has been extended into increasing scenarios in biological and biomedical investigation. The potency of gene editing has been greatly improved by the rapid development of engineered Cas9 variants and modified CRISPR platforms. As advanced sequencing technology identified vast causative genetic basis for human diseases, CRISPR toolkits are now able to mediate precise genetic disruption or correction in vitro and in vivo. In this review, we have discussed the recent development of the CRISPR/Cas gene-editing technology and the extensive applications of the CRISPR platforms in biological and biomedical investigation, including disease modeling in animal and human cell line, development of gene therapy, as well as high-throughput genetic screening. (C) 2017 Wiley Periodicals, Inc.	[Lin, Jiachen; Liu, Jiaqi; Chen, Jia; Chen, Weisheng; Zhao, Sen; Wu, Nan] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Orthoped Surg, Beijing, Peoples R China; [Lin, Jiachen; Zhou, Yangzhong; Liu, Jiaqi; Chen, Jia; Chen, Weisheng; Zhao, Sen; Wu, Zhihong; Wu, Nan] Chinese Acad Med Sci, Beijing, Peoples R China; [Lin, Jiachen; Zhou, Yangzhong; Liu, Jiaqi; Chen, Jia; Chen, Weisheng; Zhao, Sen; Wu, Zhihong; Wu, Nan] Beijing Key Lab Genet Res Skeletal Deform, Beijing, Peoples R China; [Lin, Jiachen; Zhou, Yangzhong; Chen, Jia; Chen, Weisheng; Zhao, Sen; Wu, Zhihong; Wu, Nan] Chinese Acad Med Sci, Med Res Ctr Orthoped, Beijing, Peoples R China; [Zhou, Yangzhong] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Internal Med, Beijing, Peoples R China; [Liu, Jiaqi] Chinese Acad Med Sci, Dept Breast Surg Oncol, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China; [Liu, Jiaqi] Peking Union Med Coll, Beijing, Peoples R China; [Wu, Zhihong] Beijing Union Med Coll Hosp, Dept Cent Lab, Peking Union Med Coll, Beijing, Peoples R China; [Wu, Nan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Wu, N (reprint author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Wu, N (reprint author), Beijing Union Med Coll Hosp, Med Res Ctr Orthoped, Peking Union Med Coll, Dept Orthopaed Surg, 1 Shuaifuyuan, Beijing 100730, Peoples R China.; Wu, N (reprint author), Chinese Acad Med Sci, Beijing Key Lab Genet Res Skeletal Deform, 1 Shuaifuyuan, Beijing 100730, Peoples R China.	dr.wunan@pumch.cn		Liu, Jiaqi/0000-0002-9775-2342; Wu, Nan/0000-0002-9429-2889	National Natural Science Foundation of China [81501852, 81472046, 81472045]; Beijing Nova Program [Z161100004916123]; Beijing Natural Science Foundation [7172175]; Beijing Nova Program Interdisciplinary Collaborative Project [xxjc201717]; Milstein Medical Asian American Partnership Foundation Fellowship Award in Translational Medicine; Central Level Public Interest Program for Scientific Research Institute [2016ZX310177]; Distinguished Youth foundation of Peking Union Medical College Hospital [JQ201506]; CAMS Initiative for Innovative Medicine [2016-I2M-3-003]; PUMC Youth Fund [3332016006]; Fundamental Research Funds for the Central Universities [3332016006]	Grant sponsor: National Natural Science Foundation of China; Grant numbers: 81501852, 81472046, 81472045; Grant sponsor: Beijing Nova Program; Grant number: Z161100004916123; Grant sponsor: Beijing Natural Science Foundation; Grant number: 7172175; Grant sponsor: Beijing Nova Program Interdisciplinary Collaborative Project; Grant number: xxjc201717; Grant sponsor: 2016 Milstein Medical Asian American Partnership Foundation Fellowship Award in Translational Medicine; Grant sponsor: The Central Level Public Interest Program for Scientific Research Institute; Grant number: 2016ZX310177; Grant sponsor: Distinguished Youth foundation of Peking Union Medical College Hospital; Grant number: JQ201506; Grant sponsor: CAMS Initiative for Innovative Medicine; Grant number: 2016-I2M-3-003; Grant sponsor: PUMC Youth Fund & the Fundamental Research Funds for the Central Universities; Grant number: 3332016006.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bezzerides VJ, 2017, CIRC J, V81, P12, DOI 10.1253/circj.CJ-16-1113; Bhinge A, 2017, STEM CELL REP, V8, P856, DOI 10.1016/j.stemcr.2017.02.019; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Brabetz O, 2017, MOL THER-NUCL ACIDS, V6, P243, DOI 10.1016/j.omtn.2016.12.012; Briner AE, 2014, APPL ENVIRON MICROB, V80, P994, DOI 10.1128/AEM.03015-13; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carroll KJ, 2016, P NATL ACAD SCI USA, V113, P338, DOI 10.1073/pnas.1523918113; Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213; Chang CW, 2015, CELL REP, V12, P1668, DOI 10.1016/j.celrep.2015.08.013; Chen WS, 2016, ONCOTARGET, V7, P57430, DOI 10.18632/oncotarget.10619; Chen ZH, 2017, NAT BIOTECHNOL, V35, P543, DOI 10.1038/nbt.3843; Chiang TWW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24356; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; de Bruin LMO, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00250; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Donovan KF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170445; Drawnel FM, 2014, CELL REP, V9, P810, DOI 10.1016/j.celrep.2014.09.055; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Genga RM, 2016, METHODS, V101, P36, DOI 10.1016/j.ymeth.2015.10.014; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Giri S, 2011, ACS NANO, V5, P1580, DOI 10.1021/nn102873w; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guernet A, 2016, MOL CELL, V63, P526; Guernet A, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1227894; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guo YX, 2017, CIRC RES, V120, P1874, DOI 10.1161/CIRCRESAHA.116.310283; Hartenian E, 2015, FEBS J, V282, P1383, DOI 10.1111/febs.13248; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Howden SE, 2016, STEM CELL REP, V7, P508, DOI 10.1016/j.stemcr.2016.07.001; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/NMETH.4108, 10.1038/nmeth.4108]; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05290; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Liang WC, 2017, J CELL BIOCHEM, V118, P530, DOI 10.1002/jcb.25722; Liu JQ, 2017, HUM GENET, V136, P1, DOI 10.1007/s00439-016-1739-6; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679                                                            ; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Mun J, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1326-9; Mungenast AE, 2016, MOL CELL NEUROSCI, V73, P13, DOI 10.1016/j.mcn.2015.11.010; Myers KS, 2015, METHODS, V86, P80, DOI 10.1016/j.ymeth.2015.05.022; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Peng JY, 2015, FEBS J, V282, P2089, DOI 10.1111/febs.13251; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reid DA, 2015, ONCOTARGET, V6, P15730, DOI 10.18632/oncotarget.4593                                                        ; Rutter GA, 2016, CELL STEM CELL, V19, P281, DOI 10.1016/j.stem.2016.08.010; Sakuma T, 2016, NAT PROTOC, V11, P118, DOI 10.1038/nprot.2015.140; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Savic D, 2015, GENOME RES, V25, P1581, DOI 10.1101/gr.193540.115; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; McKenna A, 2016, SCIENCE, V353; Shi ZD, 2017, CELL STEM CELL, V20, P675, DOI 10.1016/j.stem.2017.01.001; Singh V, 2017, J CELL BIOCH; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Song B, 2015, STEM CELLS DEV, V24, P1053, DOI 10.1089/scd.2014.0347; Sweeney CL, 2017, HUM GENE THER; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Teo AKK, 2015, MOL METAB, V4, P593, DOI 10.1016/j.molmet.2015.06.006; Trevisan M, 2015, VIRUSES-BASEL, V7, P3835, DOI 10.3390/v7072800; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang G, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.152; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weber J, 2015, P NATL ACAD SCI USA, V112, P13982, DOI 10.1073/pnas.1512392112; White MK, 2017, J CELL BIOCH; Wong ASL, 2016, P NATL ACAD SCI USA, V113, P2544, DOI 10.1073/pnas.1517883113; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829; Xiong X, 2017, ACS SYNTH BIOL, V6, P1034, DOI 10.1021/acssynbio.6b00358; Xu CL, 2017, P NATL ACAD SCI USA, V114, P722, DOI 10.1073/pnas.1615735114; Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022; Xue HY, 2016, J MED GENET, V53, P91, DOI 10.1136/jmedgenet-2015-103409; Yan Quanmei, 2014, Cell Regen (Lond), V3, P12, DOI 10.1186/2045-9769-3-12; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yang YY, 2016, STEM CELL TRANSL MED, V5, P8, DOI 10.5966/sctm.2015-0157; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; ZHANG YG, 2015, SCI REP UK, V5; Zhang Y, 2017, STEM CELL REP, V8, P648, DOI 10.1016/j.stemcr.2017.01.012; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zuo QS, 2017, J CELL BIOCHEM, V118, P2380, DOI 10.1002/jcb.25900	112	0	0	100	100	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	OCT	2017	118	10					3061	3071		10.1002/jcb.26198				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FD2YN	WOS:000407400800006	28590031				2018-01-05	
J	Shu, MS; Fu, R; Wang, WD				Shu, Mengshi; Fu, Rui; Wang, Wendi			A BACTERIOPHAGE MODEL BASED ON CRISPR/CAS IMMUNE SYSTEM IN A CHEMOSTAT	MATHEMATICAL BIOSCIENCES AND ENGINEERING			English	Article; Proceedings Paper	Workshop on Current Topics in Mathematical Biology (CTMB)	DEC 18-20, 2015	Shanghai Normal Univ, Shanghai, PEOPLES R CHINA		Shanghai Normal Univ	Bacteriophage; bifurcation; bistability; backward; evolution	COMPETITION; INFECTION; THERAPY; GROWTH; CAS	Clustered regularly interspaced short palindromic repeats(CRISPRs) along with Cas proteins are a widespread immune system across bacteria and archaea. In this paper, a mathematical model in a chemostat is proposed to investigate the effect of CRISPR/Cas on the bacteriophage dynamics. It is shown that the introduction of CRISPR/Cas can induce a backward bifurcation and transcritical bifurcation. Numerical simulations reveal the coexistence of a stable infection-free equilibrium with an infection equilibrium, or a stable infection-free equilibrium with a stable periodic solution.	[Shu, Mengshi; Fu, Rui; Wang, Wendi] Southwest Univ, Sch Math & Stat, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Chongqing 400715, Peoples R China	Wang, WD (reprint author), Southwest Univ, Sch Math & Stat, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Chongqing 400715, Peoples R China.	1040250727@qq.com; 527274397@qq.com; wendi@swu.edu.cn			NSF of China [11571284]	Supported in part by the NSF of China (11571284).	Aviram I, 2014, B MATH BIOL, V76, P225, DOI 10.1007/s11538-013-9917-3; Beretta E, 2001, NONLINEAR ANAL-REAL, V2, P35, DOI 10.1016/S0362-546X(99)00285-0; Beretta E, 1998, MATH BIOSCI, V149, P57, DOI 10.1016/S0025-5564(97)10015-3; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Buckling A, 2012, ADV EXP MED BIOL, V751, P347, DOI 10.1007/978-1-4614-3567-9_16; Bull JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094690; Cairns BJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000253; Calsina A, 2014, NONLINEAR ANAL-REAL, V15, P100, DOI 10.1016/j.nonrwa.2013.06.004; CAMPBELL A, 1961, EVOLUTION, V15, P153, DOI 10.2307/2406076; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Dennehy J.J, 2012, INT J EVOLUTIONARY B, V2012; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; DUCKWORTH DH, 1976, BACTERIOL REV, V40, P793; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Gourley SA, 2005, SIAM J APPL MATH, V65, P550, DOI 10.1137/S0036139903436613; Hale J, 1993, APPL MATH SCI; Han Z, 2012, MATH BIOSCI ENG, V9, P737, DOI 10.3934/mbe.2012.9.737; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; HSU SB, 1978, SIAM J APPL MATH, V34, P760, DOI 10.1137/0134064                                                                 ; Hsu S. B., 1977, APPL MATH, V32, P366; Iranzo J, 2013, J BACTERIOL, V195, P3834, DOI 10.1128/JB.00412-13; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Levin BR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001171; [李铁民 Li Tiemin], 2011, [微生物学报, Acta Microbiologica Sinica], V51, P1297; Lin M, 2012, NONLINEAR ANAL-REAL, V13, P2540, DOI 10.1016/j.nonrwa.2012.02.016; Ma YanBin, 2012, Chinese Veterinary Science / Zhongguo Shouyi Kexue, V42, P657; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9; Northcott K, 2012, J MATH BIOL, V64, P1043, DOI 10.1007/s00285-011-0439-z; Perko L., 1993, TEXTS APPL MATH, V7; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Robledo G, 2012, NONLINEAR ANAL-REAL, V13, P582, DOI 10.1016/j.nonrwa.2011.07.049; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Smith H. L., 2012, MATH BIOL, V64, P951; THIEME HR, 1992, J MATH BIOL, V30, P755; THIEME HR, 1993, SIAM J MATH ANAL, V24, P407, DOI 10.1137/0524026                                                                 ; Usmani R.A., 1987, APPL LINEAR ALGEBRA; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6                                                   ; Vidurupola SW, 2014, STOCH ANAL APPL, V32, P427, DOI 10.1080/07362994.2014.889922; Wang W, 2004, MATH BIOSCI, V190, P97, DOI 10.1016/j.mbs.2004.11.001; Weld RJ, 2004, J THEOR BIOL, V227, P1, DOI 10.1016/S0022-5193(03)00262-5; Zhao X., 2003, DYNAMICAL SYSTEMS PO	48	0	0	22	22	AMER INST MATHEMATICAL SCIENCES-AIMS	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1547-1063	1551-0018		MATH BIOSCI ENG	Math. Biosci. Eng.	OCT-DEC	2017	14	5-6			SI		1361	1377		10.3934/mbe.2017070				17	Mathematical & Computational Biology	Mathematical & Computational Biology	EW5OE	WOS:000402555000016	29161865				2018-01-05	
J	Kim, YH; Park, SJ; Choe, SH; Lee, JR; Cho, HM; Kim, SU; Kim, JS; Sim, BW; Song, BS; Lee, Y; Jin, YB; Hong, JJ; Jeong, KJ; Kang, P; Baek, SH; Lee, SR; Huh, JW; Chang, KT				Kim, Young-Hyun; Park, Sang-Je; Choe, Se-Hee; Lee, Ja-Rang; Cho, Hyeon-Mu; Kim, Sun-Uk; Kim, Ji-Su; Sim, Bo-Woong; Song, Bong-Seok; Lee, Youngjeon; Jin, Yeung Bae; Hong, Jung-Joo; Jeong, Kang-Jin; Kang, Philyong; Baek, Seung-Ho; Lee, Sang-Rae; Huh, Jae-Won; Chang, Kyu-Tae			Identification and characterization of the tyrosinase gene (TYR) and its transcript variants (TYR_1 and TYR_2) in the crab-eating macaque (Macaca fascicularis)	GENE			English	Article						Albinism; RACE; Alternative splicing; Exon skipping; Non-human primate; Macaque	ALBINISM TYPE-1 OCA1; MOLECULAR-BASIS; MUTATION; MOUSE; MELANIN; MONKEY; MODEL; BIOSYNTHESIS; PIGMENTATION; CRISPR/CAS9	Tyrosinase is a copper-containing enzyme that regulates melanin biosynthesis and is encoded by the tyrosinase (TYR) gene. Previous studies demonstrated that mutations in TYR could lead to oculocutaneous albinism type 1 (OCA1) owing to the failure of melanin formation. Although a previous study found that albinism in the rhesus monkey was derived from a mutation in TYR, the identification and characterization of this gene in non-human primates has not been achieved thus far. Thus, using the rapid amplification of cDNA ends (RACE) and internal reverse transcription PCR (RT-PCR) we identified the full-length sequence of TYR in the crab-eating macaque, and two different transcript variants (TYR_1 and TYR_2). While TYR_1 comprised five exons and its coding sequence was highly similar to that of humans, TYR_2 comprised four exons and was generated by a third-exon-skipping event. Interestingly, these two transcripts were also present in the African green monkey (Old World monkey) and the common marmoset (New World monkey). Deduced amino acid sequence analyses revealed that TYR_2 had a shorter C-terminal region than TYR_1 owing to the exon-skipping event. Thus, the present study is the first to identify and characterize a full-length TYR gene in a non-human primate, while the further validation of the third-exon-skipping in TYR indicates that this event is well conserved in the primate lineage. Therefore, this study provides useful and important information for the study of albinism using non-human primate models.	[Kim, Young-Hyun; Park, Sang-Je; Choe, Se-Hee; Lee, Ja-Rang; Cho, Hyeon-Mu; Kim, Sun-Uk; Kim, Ji-Su; Sim, Bo-Woong; Song, Bong-Seok; Lee, Youngjeon; Jin, Yeung Bae; Hong, Jung-Joo; Jeong, Kang-Jin; Kang, Philyong; Baek, Seung-Ho; Lee, Sang-Rae; Huh, Jae-Won; Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongju 28116, South Korea; [Kim, Young-Hyun; Park, Sang-Je; Choe, Se-Hee; Lee, Ja-Rang; Cho, Hyeon-Mu; Kim, Sun-Uk; Kim, Ji-Su; Sim, Bo-Woong; Song, Bong-Seok; Lee, Youngjeon; Jin, Yeung Bae; Hong, Jung-Joo; Jeong, Kang-Jin; Kang, Philyong; Baek, Seung-Ho; Lee, Sang-Rae; Huh, Jae-Won; Chang, Kyu-Tae] Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Cheongju 28116, South Korea; [Kim, Young-Hyun; Choe, Se-Hee; Cho, Hyeon-Mu; Kim, Sun-Uk; Kim, Ji-Su; Lee, Youngjeon; Lee, Sang-Rae; Huh, Jae-Won; Chang, Kyu-Tae] Korea Univ Sci & Technol UST, KRIBB Sch Biosci, Dept Funct Genom, Daejeon 34113, South Korea	Huh, JW; Chang, KT (reprint author), Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongju 28116, South Korea.	huhjw@kribb.re.kr; changkt@kribb.re.kr			Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program Grants [KGM4241743, KGM4611714]	This work was supported by the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program Grants (KGM4241743 & KGM4611714).	Balu K, 2013, GENE, V513, P184, DOI 10.1016/j.gene.2012.09.128; Banerjee A, 2016, GENE, V592, P99, DOI 10.1016/j.gene.2016.07.046; Beermann F, 2004, MAMM GENOME, V15, P749, DOI [10.1007/s00335-004-4002-8, 10.1007/s00335-04-4002-8]; Blaszczyk WM, 2007, ANIM GENET, V38, P421, DOI 10.1111/j.1365-2052.2007.01619.x; Blaszczyk WM, 2005, PIGM CELL RES, V18, P144, DOI 10.1111/j.1600-0749.2005.00227.x; CANOVAS FG, 1982, J BIOL CHEM, V257, P8738; Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054; Challa AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155812; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Ding B, 2000, MUTAT RES-FUND MOL M, V449, P1, DOI 10.1016/S0027-5107(00)00008-7                                                   ; Edvardsen RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108622; Dame MCF, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-62; Freeman WM, 2010, BIOL PSYCHIAT, V68, P219, DOI 10.1016/j.biopsych.2010.01.028; Fryer JP, 2001, J INVEST DERMATOL, V117, P1261, DOI 10.1046/j.0022-202x.2001.01549.x                                                ; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; HEARING VJ, 1991, FASEB J, V5, P2902; Heo JH, 2011, J ALZHEIMERS DIS, V25, P517, DOI 10.3233/JAD-2011-102079; Higashino A, 2011, ZOOL SCI, V28, P85, DOI 10.2108/zsj.28.85; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Huh JW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-163; Imes DL, 2006, ANIM GENET, V37, P175, DOI 10.1111/j.1365-2052.2005.01409.x; Joly M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109393; Kalahroudi VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106656; Kamaraj B, 2014, BIOMED RES INT, DOI 10.1155/2014/905472; Kavanagh K, 2010, METABOLISM, V59, P914, DOI 10.1016/j.metabol.2010.02.010; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim YH, 2016, GENE, V577, P236, DOI 10.1016/j.gene.2015.11.051; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473                                                         ; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Lee JR, 2017, MOL CELLS, V40, P100, DOI 10.14348/molcells.2017.2204; Lee J.R., 2016, INT J GENOMICS, V2016; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mizuno S, 2014, MAMM GENOME, V25, P327, DOI 10.1007/s00335-014-9524-0; MULLER G, 1988, EMBO J, V7, P2723; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Osada N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-90; Park SH, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1111/PPL.12281; Schmutz SM, 2004, MAMM GENOME, V15, P62, DOI 10.1007/s00335-002-2249-5; Schnur RE, 1996, J INVEST DERMATOL, V106, P1137, DOI 10.1111/1523-1747.ep12340185; Seruggia D, 2015, NUCLEIC ACIDS RES, V43, P4855, DOI 10.1093/nar/gkv375; Shook BC, 2010, J MED CHEM, V53, P8104, DOI 10.1021/jm100971t; Sibal L R, 2001, ILAR J, V42, P74; Taylor K, 2010, J IMMUNOTOXICOL, V7, P114, DOI [10.3109/15476910903213539, 10.1080/15476910903213539]; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; Tomkinson A, 2010, ALLERGY, V65, P69, DOI 10.1111/j.1398-9995.2009.02156.x; Toyofuku K, 2001, BIOCHEM J, V355, P259, DOI 10.1042/0264-6021:3550259; Warren R, 2011, MICROB PATHOGENESIS, V50, P12, DOI 10.1016/j.micpath.2010.10.002; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7	53	0	0	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	SEP 30	2017	630						21	27		10.1016/j.gene.2017.07.047				7	Genetics & Heredity	Genetics & Heredity	FI2NG	WOS:000411775000004	28756020	gold			2018-01-05	
J	Mishra, A; Hawkins, RD				Mishra, Arpit; Hawkins, R. David			Three-dimensional genome architecture and emerging technologies: looping in disease	GENOME MEDICINE			English	Review							CAPTURE HI-C; GILFORD-PROGERIA-SYNDROME; RANGE CHROMATIN INTERACTIONS; CHROMOSOME CONFORMATION; GENE-EXPRESSION; HIGH-RESOLUTION; PROXIMITY-LIGATION; MUTATION-RATES; REGULATORY DNA; MAMMALIAN GENOME	Genome compaction is a universal feature of cells and has emerged as a global regulator of gene expression. Compaction is maintained by a multitude of architectural proteins, long non-coding RNAs (lncRNAs), and regulatory DNA. Each component comprises interlinked regulatory circuits that organize the genome in three-dimensional (3D) space to manage gene expression. In this review, we update the current state of 3D genome catalogues and focus on how recent technological advances in 3D genomics are leading to an enhanced understanding of disease mechanisms. We highlight the use of genome-wide chromatin conformation capture (Hi-C) coupled with oligonucleotide capture technology (capture Hi-C) to map interactions between gene promoters and distal regulatory elements such as enhancers that are enriched for disease variants from genome-wide association studies (GWASs). We discuss how aberrations in architectural units are associated with various pathological outcomes, and explore how recent advances in genome and epigenome editing show great promise for a systematic understanding of complex genetic disorders. Our growing understanding of 3D genome architecture-coupled with the ability to engineer changes in it-may create novel therapeutic opportunities.	[Mishra, Arpit; Hawkins, R. David] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Div Med Genet,Dept Med,Dept Genome Sci, Seattle, WA 98195 USA	Hawkins, RD (reprint author), Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Div Med Genet,Dept Med,Dept Genome Sci, Seattle, WA 98195 USA.	rdhawk@uw.edu			National Institutes of Health: NIAMS and NIDDK; US-Israel Binational Science Foundation	RDH is supported by the National Institutes of Health: NIAMS and NIDDK; and the US-Israel Binational Science Foundation.	Ay F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0745-7; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Barutcu AR, 2016, J CELL PHYSIOL, V231, P31, DOI 10.1002/jcp.25062; Beagrie RA, 2017, NATURE, V543, P519, DOI 10.1038/nature21411; Bell AC, 2000, NATURE, V405, P482; BILLIA F, 1992, MOL BRAIN RES, V14, P101, DOI 10.1016/0169-328X(92)90016-5; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Cairns J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0992-2; Catarino RR, 2017, NAT GENET, V49, P972, DOI 10.1038/ng.3904; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Corradin O, 2016, NAT GENET, V48, P1313, DOI 10.1038/ng.3674; Dao LTM, 2017, NAT GENET, V49, P1073, DOI 10.1038/ng.3884; Davies JOJ, 2017, NAT METHODS, V14, P125, DOI 10.1038/nmeth.4146; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; Davison LJ, 2012, HUM MOL GENET, V21, P322, DOI 10.1093/hmg/ddr468; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Diao YR, 2017, NAT METHODS, V14, P629, DOI [10.1038/nmeth.4264, 10.1038/NMETH.4264]; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fang RX, 2016, CELL RES, V26, P1345, DOI 10.1038/cr.2016.137; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Forcato M, 2017, NAT METHODS, V14, P679, DOI 10.1038/nmeth.4325; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Freire-Pritchett P, 2017, ELIFE, V6, DOI 10.7554/eLife.21926; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hark AT, 2000, NATURE, V405, P486; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hottentot QP, 2017, METHODS MOL BIOL, V1492, P185, DOI 10.1007/978-1-4939-6442-0_13; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Jager R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7178; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Joshi O, 2015, CELL STEM CELL, V17, P748, DOI 10.1016/j.stem.2015.11.010; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Klein FA, 2015, BIOINFORMATICS, V31, P3085, DOI 10.1093/bioinformatics/btv335; Kolovos P, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-10; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Krijger PHL, 2016, NAT REV MOL CELL BIO, V17, P771, DOI 10.1038/nrm.2016.138; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; LI GP, 2017, NUCL ACIDS RES, V45; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lupianez DG, 2016, TRENDS GENET, V32, P225, DOI 10.1016/j.tig.2016.01.003; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/NMETH.3205, 10.1038/nmeth.3205]; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Martin P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10069; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; McGovern A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1078-x; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Medrano-Fernandez A, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0263-x; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI [10.1038/NMTH.3999, 10.1038/nmeth.3999]; Nagano T, 2017, NATURE, V547, P61, DOI 10.1038/nature23001; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nolen LD, 2013, HUM MOL GENET, V22, P4180, DOI 10.1093/hmg/ddt265; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Osborne CS, 2017, CHROMOSOME RES, V25, P15, DOI 10.1007/s10577-016-9546-4; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Phanstiel DH, 2015, BIOINFORMATICS, V31, P3092, DOI 10.1093/bioinformatics/btv336; Platt JL, 2016, EMBO REP, V17, P1410, DOI 10.15252/embr.201642198; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Rajarajan P, 2016, NAT REV NEUROSCI, V17, P681, DOI 10.1038/nrn.2016.124; Ramani V, 2017, NAT METHODS, V14, P263, DOI [10.1038/NMETH.4155, 10.1038/nmeth.4155]; Ramani V, 2016, GENOM PROTEOM BIOINF, V14, P7, DOI 10.1016/j.gpb.2016.01.002; Rao SSP, 2015, CELL, V162, P687, DOI 10.1016/j.cell.2015.07.024; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Sahlen P, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0727-9; Sajan SA, 2012, ANNU REV GENOM HUM G, V13, P59, DOI 10.1146/annurev-genom-090711-163818; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sati S, 2017, CHROMOSOMA, V126, P33, DOI 10.1007/s00412-016-0593-6; Sauria MEG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0806-y; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schmitt AD, 2016, NAT REV MOL CELL BIO, V17, P743, DOI 10.1038/nrm.2016.104; Schmitt AD, 2016, CELL REP, V17, P2042, DOI 10.1016/j.celrep.2016.10.061; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Victoria-Acosta G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14838; Walczak A, 2013, J NEUROSCI, V33, P2507, DOI 10.1523/JNEUROSCI.1085-12.2013; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Xie SQ, 2017, MOL CELL, V66, P285, DOI 10.1016/j.molcel.2017.03.007; Yardimci GG, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1161-y; Zhan YX, 2017, GENOME RES, V27, P479, DOI 10.1101/gr.212803.116; Zhang Y, 2008, GENOME BIOL, V9, pR137, DOI DOI 10.1186/GB-2008-9-9-R137; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	127	0	0	16	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-994X			GENOME MED	Genome Med.	SEP 30	2017	9								87	10.1186/s13073-017-0477-2				14	Genetics & Heredity	Genetics & Heredity	FI6BD	WOS:000412072800001		gold			2018-01-05	
J	Yu, YJ; Nangia-Makker, P; Farhana, L; Majumdar, APN				Yu, Yingjie; Nangia-Makker, Pratima; Farhana, Lulu; Majumdar, Adhip P. N.			A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells	MOLECULAR CANCER			English	Article						miRNA biogenesis; lncRNA-miRNA crosstalk; cancer stem cells	LONG NONCODING RNA; STEM-LIKE CELLS; MICRORNA BIOGENESIS; COLORECTAL-CANCER; PROSTATE-CANCER; DOWN-REGULATION; POOR-PROGNOSIS; MESSENGER-RNAS; RISK-FACTOR; MIR-21	Background: Although both long and micro RNAs are emerging as important functional components in colorectal cancer (CRC) progression and metastasis, the mechanism of their interaction remains poorly understood. CCAT2 (Colon cancer-associated transcript-2), a long noncoding RNA (lncRNA), has been reported to be over-expressed in CRC and is found to promote tumor growth. miRNAs, a class of naturally occurring short RNAs negatively control the expression of target genes by cleaving mRNA or through translation repression. Recently, we reported that miR-145 and miR-21 cooperate to regulate colon cancer stem cell (CSC) proliferation and differentiation. Considering that CCAT2 is mainly located in the nucleus and miRNA maturation process begins in the nucleus, we hypothesize that CCAT2 selectively blocks miR-145 maturation process, resulting in decreased mature miR-145 affecting colon CSC proliferation and differentiation. Methods: The levels of CCAT2 were manipulated by transfection of CCAT2 expression plasmid or knockdown by siRNA or by CRISPR/Cas9. Quantitative RT-PCR was performed to examine the expression of CCAT2 and pri-, pre- and mature miR-145/21. Fluorescence in situ hybridization (FISH) was used to visualize CCAT2 in the cells. In vitro processing of pri-miRNA-145 was performed using T7 RNA polymerase and recombinant human Dicer. Results: We have observed that modulated expression of CCAT2 regulates the expression of miR-145 in colon cancer HCT-116 and HT-29 cells. Knockout of CCAT2 increases miR-145 and negatively regulates miR-21 in HCT-116 cells, impairs proliferation and differentiation. In contrast, stable up-regulation of CCAT2 decreases mature miR-145 and increases the expression of several CSC markers in colon cancer cells. We have also observed that CCAT2 is enriched in the nucleus and correlates with the expression of pre-miR-145 but not pre-miR-21 in HCT-116 cells. These results indicate CCAT2 selectively blocks miR-145 maturation by inhibiting pre-miR-145 export to cytoplasm. Further, we revealed that CCAT2 blocks cleavage of pre-miR-145 by Dicer in vitro. Conclusions: Our results identify CCAT2 as a negative regulator of miRNA-145 biogenesis, and expose a novel mechanism of lncRNA-miRNA crosstalk.	[Yu, Yingjie; Nangia-Makker, Pratima; Farhana, Lulu; Majumdar, Adhip P. N.] Dept Vet Affairs Med Ctr, 4646 John R, Detroit, MI 48201 USA; [Nangia-Makker, Pratima; Majumdar, Adhip P. N.] Karmanos Canc Inst, Detroit, MI 48201 USA; [Yu, Yingjie; Nangia-Makker, Pratima; Farhana, Lulu; Majumdar, Adhip P. N.] Wayne State Univ, Dept Internal Med, Detroit, MI 48201 USA	Yu, YJ; Majumdar, APN (reprint author), Dept Vet Affairs Med Ctr, 4646 John R, Detroit, MI 48201 USA.	aa5142@wayne.edu; a.majumdar@wayne.edu			(APNM) from the NIH [1R21CA175916]; Department of Veteran Affairs [I101BX001927]	The authors would like to thank Dr. George A Calin, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, for kindly providing pcDNA-CCAT2 plasmid and empty vector. This study was supported by grants (APNM) from the NIH (1R21CA175916) and the Department of Veteran Affairs (I101BX001927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahadi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24922; Cai Y, 2015, ONCOTARGETS THER, V8, P2657, DOI 10.2147/OTT.S90485; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ishimaru S, 2012, ANN SURG ONCOL, V19, P2853, DOI 10.1245/s10434-012-2278-6; Kamatani A, 2013, MED MOL MORPHOL, V46, P166, DOI 10.1007/s00795-013-0020-5; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kim YK, 2016, P NATL ACAD SCI USA, V113, pE1881, DOI 10.1073/pnas.1602532113; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JW, 2015, BRIEF BIOINFORM, V16, P806, DOI 10.1093/bib/bbu048; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lund E, 2006, COLD SPRING HARB SYM, V71, P59, DOI 10.1101/sqb.2006.71.050                                                         ; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Martinez I, 2017, P NATL ACAD SCI USA, V114, pE4961, DOI 10.1073/pnas.1618732114; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Nautiyal J, 2012, AM J PHYSIOL-GASTR L, V302, pG655, DOI 10.1152/ajpgi.00323.2011; Patel BB, 2009, BIOCHEM BIOPH RES CO, V378, P344, DOI 10.1016/j.bbrc.2008.10.179; Qiu MT, 2014, TUMOR BIOL, V35, P5375, DOI 10.1007/s13277-014-1700-z; Redis RS, 2016, MOL CELL, V61, P520, DOI 10.1016/j.molcel.2016.01.015; Redis RS, 2013, ONCOTARGET, V4, P1748, DOI 10.18632/oncotarget.1292                                                        ; Seok H, 2016, MOL CELLS, V39, P375, DOI 10.14348/molcells.2016.0013; Shukla S, 2014, BBA-GEN SUBJECTS, V1840, P3494, DOI 10.1016/j.bbagen.2014.09.017; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Wang CY, 2015, INT J CLIN EXP PATHO, V8, P779; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu Y, 2014, MICRORNA TARGETED CA, P139, DOI 10.1007/978-3-319-05134-5_8; Yu YJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0372-7; Yu YJ, 2013, TRANSL ONCOL, V6, P180, DOI 10.1593/tlo.12397; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zaman MS, 2010, BR J CANC; Zhang XL, 2015, J SURG ONCOL, V111, P834, DOI 10.1002/jso.23888	41	0	0	9	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1476-4598			MOL CANCER	Mol. Cancer	SEP 30	2017	16								155	10.1186/s12943-017-0725-5				11	Biochemistry & Molecular Biology; Oncology	Biochemistry & Molecular Biology; Oncology	FI5KO	WOS:000412022100001	28964256	gold			2018-01-05	
J	El Refaey, M; Xu, L; Gao, YD; Canan, BD; Adesanya, TMA; Warner, SC; Akagi, K; Symer, DE; Mohler, PJ; Ma, JJ; Janssen, PML; Han, RZ				El Refaey, Mona; Xu, Li; Gao, Yandi; Canan, Benjamin D.; Adesanya, T. M. Ayodele; Warner, Sarah C.; Akagi, Keiko; Symer, David E.; Mohler, Peter J.; Ma, Jianjie; Janssen, Paul M. L.; Han, Renzhi			In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice	CIRCULATION RESEARCH			English	Article						cardiomyopathies; dystrophin; gene editing; mice; muscular dystrophy	DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; MUSCLE FUNCTION; DELIVERY; CARDIOMYOPATHY; NUCLEASES; FIBROSIS; THERAPY; CELLS; CAS9	Rationale: Duchenne muscular dystrophy is a severe inherited form of muscular dystrophy caused by mutations in the reading frame of the dystrophin gene disrupting its protein expression. Dystrophic cardiomyopathy is a leading cause of death in Duchenne muscular dystrophy patients, and currently no effective treatment exists to halt its progression. Recent advancement in genome editing technologies offers a promising therapeutic approach in restoring dystrophin protein expression. However, the impact of this approach on Duchenne muscular dystrophy cardiac function has yet to be evaluated. Therefore, we assessed the therapeutic efficacy of CRISPR (clustered regularly interspaced short palindromic repeats)-mediated genome editing on dystrophin expression and cardiac function in mdx/Utr(+/-) mice after a single systemic delivery of recombinant adeno-associated virus. Objective: To examine the efficiency and physiological impact of CRISPR-mediated genome editing on cardiac dystrophin expression and function in dystrophic mice. Methods and Results: Here, we packaged SaCas9 (clustered regularly interspaced short palindromic repeat-associated 9 from Staphylococcus aureus) and guide RNA constructs into an adeno-associated virus vector and systemically delivered them to mdx/Utr(+/-)neonates. We showed that CRIPSR-mediated genome editing efficiently excised the mutant exon 23 in dystrophic mice, and immunofluorescence data supported the restoration of dystrophin protein expression in dystrophic cardiac muscles to a level approaching 40%. Moreover, there was a noted restoration in the architecture of cardiac muscle fibers and a reduction in the extent of fibrosis in dystrophin-deficient hearts. The contractility of cardiac papillary muscles was also restored in CRISPR-edited cardiac muscles compared with untreated controls. Furthermore, our targeted deep sequencing results confirmed that our adeno-associated virus-CRISPR/Cas9 strategy was very efficient in deleting the approximate to 23 kb of intervening genomic sequences. Conclusions: This study provides evidence for using CRISPR-based genome editing as a potential therapeutic approach for restoring dystrophic cardiomyopathy structurally and functionally.	[El Refaey, Mona; Xu, Li; Gao, Yandi; Adesanya, T. M. Ayodele; Ma, Jianjie; Han, Renzhi] Ohio State Univ, Biophys Grad Program, Davis Heart & Lung Res Inst, Dept Surg,Biomed Sci Grad Program,Wexner Med Ctr, Columbus, OH 43210 USA; [Canan, Benjamin D.; Mohler, Peter J.; Janssen, Paul M. L.] Ohio State Univ, Wexner Med Ctr, Dept Physiol & Cell Biol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Warner, Sarah C.; Symer, David E.] Ohio State Univ, Ctr Comprehens Canc, Genom Shared Resource, Columbus, OH 43210 USA; [Akagi, Keiko; Symer, David E.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Symer, David E.] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; [Symer, David E.] Ohio State Univ, Dept Biomed Informat Adjunct, Columbus, OH 43210 USA	Han, RZ (reprint author), Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA.	renzhi.han@osumc.edu			US National Institutes of Health [R01HL116546, R01 AR064241, R01AR070752, R01AR061385]; National Institutes of Health [T32HL098039]; National Cancer Institute [P30CA016058]	R. Han is supported by US National Institutes of Health grants (R01HL116546 and R01 AR064241). J. Ma is supported by US National Institutes of Health grants (R01AR070752 and R01AR061385). M. El Refaey is a recipient of the National Institutes of Health T32 postdoctoral fellowship (T32HL098039). The Genomics Shared Resource of the OSU Comprehensive Cancer Center is supported in part by National Cancer Institute grant number P30CA016058.	Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Biesiadecki BJ, BIOPHYS REV, V6, P273; Biesiadecki Brandon J, 2014, Biophys Rev, V6, P273, DOI 10.1007/s12551-014-0143-5; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chicoine LG, 2014, MOL THER, V22, P713, DOI 10.1038/mt.2013.246; Delfin DA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-68; Duncan FJ, 2015, MOL THER, V23, P638, DOI 10.1038/mt.2015.9; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Grose WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039233; Hoffman E P, 1992, Biotechnology, V24, P457; Janssen PML, 2010, AM J PHYSIOL-HEART C, V299, pH1092, DOI 10.1152/ajpheart.00417.2010; Janssen PM, AM J PHYSL HEART CIR, V299, pH1092; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McNally EM, 2007, ANNU REV MED, V58, P75, DOI 10.1146/annurev.med.58.011706.144703; McNally EM, 2017, JAMA CARDIOL, V2, P199, DOI 10.1001/jamacardio.2016.4910; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Moriuchi T, 1993, Tokushima J Exp Med, V40, P83; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Pozsgai ER, 2016, GENE THER, V23, P57, DOI 10.1038/gt.2015.80; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Rincon MY, 2015, CARDIOVASC RES, V108, P4, DOI 10.1093/cvr/cvv205; Rodino-Klapac LR, 2013, HUM MOL GENET, V22, P4929, DOI 10.1093/hmg/ddt342; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sweeney JA, 2002, VIROLOGY, V295, P284, DOI 10.1006/viro.2002.1406; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Unger EF, 2017, ANN NEUROL, V81, P162, DOI 10.1002/ana.24842; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	42	1	1	9	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7330	1524-4571		CIRC RES	Circ.Res.	SEP 29	2017	121	8					923	+		10.1161/CIRCRESAHA.117.310996				24	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	FJ5QN	WOS:000412807600013	28790199				2018-01-05	
J	Ogrodzki, P; Forsythe, SJ				Ogrodzki, Pauline; Forsythe, Stephen J.			DNA-Sequence Based Typing of the Cronobacter Genus Using MLST, CRISPR-cas Array and Capsular Profiling	FRONTIERS IN MICROBIOLOGY			English	Article						Cronobacter; genotyping; genomes; MLST; capsule; CRISPR-cas profiles	POWDERED INFANT FORMULA; ENTERAL FEEDING TUBES; INTENSIVE-CARE-UNIT; ENTEROBACTER-SAKAZAKII; NECROTIZING ENTEROCOLITIS; PROCESSING ENVIRONMENTS; SICCIBACTER-TURICENSIS; NEONATAL MENINGITIS; PRODUCTION FACILITY; BIOFILM FORMATION	The Cronobacter genus is composed of seven species, within which a number of pathovars have been described. The most notable infections by Cronobacter spp. are of infants through the consumption of contaminated infant formula. The description of the genus has greatly improved in recent years through DNA sequencing techniques, and this has led to a robust means of identification. However some species are highly clonal and this limits the ability to discriminate between unrelated strains by some methods of genotyping. This article updates the application of three genotyping methods across the Cronobacter genus. The three genotyping methods were multilocus sequence typing (MLST), capsular profiling of the K-antigen and colanic acid (CA) biosynthesis regions, and CRISPR-cas array profiling. A total of 1654 MLST profiled and 286 whole genome sequenced strains, available by open access at the PubMLST Cronobacter database, were used this analysis. The predominance of C. sakazakii and C. malonaticus in clinical infections was confirmed. The majority of clinical strains being in the C. sakazakii clonal complexes (CC) 1 and 4, sequence types (ST) 8 and 12 and C. malonaticus ST7. The capsular profile K2:CA2, previously proposed as being strongly associated with C. sakazakii and C. malonaticus isolates from severe neonatal infections, was also found in C. turicensis, C. dublinensis and C. universalis. The majority of CRISPR-cas types across the genus was the I-E (Ecoli) type. Some strains of C. dublinensis and C. muytjensii encoded the I-F (Ypseudo) type, and others lacked the cas gene loci. The significance of the expanding profiling will be of benefit to researchers as well as governmental and industrial risk assessors.	[Ogrodzki, Pauline] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England; [Forsythe, Stephen J.] Foodmicrobe Com, Nottingham, England	Forsythe, SJ (reprint author), Foodmicrobe Com, Nottingham, England.	steveforsythe@foodmicrobe.com			Nottingham Trent University; Wellcome Trust	The authors gratefully thank Nottingham Trent University for their financial support (PO). This publication made use of the Cronobacter Multi Locus Sequence Typing website http://pubmlst.org/cronobacter/) developed by Keith Jolley and sited at the University of Oxford (Maiden et al., 2013). The development of this site has been funded by the Wellcome Trust. The authors thank the numerous collaborators who have submitted sequences to the open access Cronobacter PubMLST database.	Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Almajed FS, 2016, MICROB PATHOGENESIS, V90, P55, DOI 10.1016/j.micpath.2015.11.014; Alsonosi A, 2015, EUR J CLIN MICROBIOL, V34, P1979, DOI 10.1007/s10096-015-2440-8; Alzahrani H, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv085; Arbatsky NP, 2010, CARBOHYD RES, V345, P2090, DOI 10.1016/j.carres.2010.07.014; Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barron JC, 2007, J FOOD PROTECT, V70, P2111, DOI 10.4315/0362-028X-70.9.2111                                                     ; Blazkova M, 2015, APPL ENVIRON MICROB, V81, P5574, DOI 10.1128/AEM.00277-15; Broge T, 2013, J PEDIATR INFECT DIS, V2, pE1, DOI 10.1093/jpids/pit021; Carleton H., 2016, MICROBE, V11, P311, DOI DOI 10.1128/MICR0BE.11.311.1; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; CDC, 2010, MULT OUTBR HUM SALM; Centers for Disease Control and Prevention (CDC), 2001, MMWR-MORBID MORTAL W, V51, P297; Chap J, 2009, INT J FOOD MICROBIOL, V136, P185, DOI 10.1016/j.ijfoodmicro.2009.08.005; Chaturvedi N, 2015, ARCH MICROBIOL, V197, P1141, DOI 10.1007/s00203-015-1147-7; Craven HM, 2010, J APPL MICROBIOL, V109, P1044, DOI 10.1111/j.1365-2672.2010.04733.x; Czerwicka M, 2010, CARBOHYD RES, V345, P908, DOI 10.1016/j.carres.2010.01.020; Food and Agricultural Organization-World Health Organization, 2006, MICR RISK ASS SER, V10; Food and Agriculture Organization of the United Nations [ FAO], 2004, MICR RISK ASS SER, V6, DOI [10.1111/j.1740-8709.2004.00008.x, DOI 10.1111/J.1740-8709.2004.00008.X]; Food and Agricultural Organization-World Health Organization, 2008, MICR RISK ASS SER, V15; Fei P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00316; Fei P, 2015, APPL ENVIRON MICROB, V81, P5430, DOI 10.1128/AEM.01390-15; Forsythe SJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1121; Franco AA, 2011, INFECT IMMUN, V79, P1578, DOI 10.1128/IAI.01165-10; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garcia-Gutierrez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131935; Grim CJ, 2012, APPL ENVIRON MICROB, V78, P6035, DOI 10.1128/AEM.01457-12; Grim CJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-366; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hariri S, 2013, EMERG INFECT DIS, V19, P175, DOI 10.3201/eid1901.120649; Holy O, 2014, EPIDEMIOL MIKROBI IM, V63, P69; Holy O, 2014, J HOSP INFECT, V86, P169, DOI 10.1016/j.jhin.2013.09.011; Hurrell E, 2009, INT J FOOD MICROBIOL, V136, P227, DOI 10.1016/j.ijfoodmicro.2009.08.007; Hurrell E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-146; Iversen C, 2004, LETT APPL MICROBIOL, V38, P378, DOI 10.1111/j.1472-765X.2004.01507.x; Iversen C, 2003, TRENDS FOOD SCI TECH, V14, P443, DOI 10.1016/S0924-2244(03)00155-9; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Jackson EE, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0768-6; Jackson EE, 2015, J FOOD PROTECT, V78, P1191, DOI 10.4315/0362-028X.JFP-14-563; Jackson EE, 2015, INT J SYST EVOL MICR, V65, P1335, DOI 10.1099/ijs.0.000108; Jacobs C, 2011, J DAIRY SCI, V94, P3801, DOI 10.3168/jds.2011-4318; Jarvis KG, 2011, APPL ENVIRON MICROB, V77, P4017, DOI 10.1128/AEM.00162-11; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Joseph Susan, 2013, Microb Inform Exp, V3, P3, DOI 10.1186/2042-5783-3-3; Joseph S, 2013, MOL CELL PROBE, V27, P137, DOI 10.1016/j.mcp.2013.02.002; Joseph S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049455; Joseph S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00397; Joseph S, 2012, INT J SYST EVOL MICR, V62, P1277, DOI 10.1099/ijs.0.032292-0; Joseph S, 2011, EMERG INFECT DIS, V17, P1713, DOI 10.3201/eid1709.110260; Killer J, 2015, FOODBORNE PATHOG DIS, V12, P514, DOI 10.1089/fpd.2014.1884; Kim H, 2006, APPL ENVIRON MICROB, V72, P5846, DOI 10.1128/AEM.00654-06; Kloepper TH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-22; Kothary MH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00134; Kucerova E, 2011, QUAL ASSUR SAF CROP, V3, P104, DOI 10.1111/j.1757-837X.2011.00104.x; Kucerova E, 2010, PLOS ONE, V5, pA51, DOI 10.1371/journal.pone.0009556; Liu H, 2013, FEMS MICROBIOL LETT, V344, P60, DOI 10.1111/1574-6968.12155; MacLean LL, 2010, CARBOHYD RES, V345, P1932, DOI 10.1016/j.carres.2010.06.020; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Masood N., 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00782-13, DOI 10.1128/GEN0MEA.00782-13]; Masood N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1961-y; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Miled-Bennour R, 2010, INT J FOOD MICROBIOL, V139, P116, DOI 10.1016/j.ijfoodmicro.2010.01.045; Muller A, 2013, J FOOD PROTECT, V76, P883, DOI 10.4315/0362-028X.JFP-12-521; Mullane N, 2008, APPL ENVIRON MICROB, V74, P3783, DOI 10.1128/AEM.02302-07; Nadon C, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.23.30544; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Ogrodzki P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1960-z; Ogrodzki P, 2016, FUTURE MICROBIOL, V11, P1507, DOI 10.2217/fmb-2016-0070; Patrick ME, 2014, EMERG INFECT DIS, V20, P1520, DOI 10.3201/eid2009.140545; Pava-Ripoll M, 2012, APPL ENVIRON MICROB, V78, P7891, DOI 10.1128/AEM.02195-12; Power K, 2013, GENDER THEOL SPIRITU, P1; Ravisankar S, 2014, J PERINATOL, V34, P408, DOI 10.1038/jp.2014.14; Reich F, 2010, INT J FOOD MICROBIOL, V140, P214, DOI 10.1016/j.ijfoodmicro.2010.03.031; Schmid M, 2009, RES MICROBIOL, V160, P608, DOI 10.1016/j.resmic.2009.08.013; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Sonbol H, 2013, INT DAIRY J, V30, P1, DOI 10.1016/j.idairyj.2012.11.004; Stephan R, 2014, INT J SYST EVOL MICR, V64, P3402, DOI 10.1099/ijs.0.059832-0; Sun YM, 2011, APPL ENVIRON MICROB, V77, P2209, DOI 10.1128/AEM.02229-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Townsend S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-64; Townsend SM, 2007, MICROBIOL-SGM, V153, P3538, DOI 10.1099/mic.0.2007/009316-0; Townsend SM, 2008, MICROBIOL-SGM, V154, P3659, DOI 10.1099/mic.0.2008/021980-0; Van Acker J, 2001, J CLIN MICROBIOL, V39, P293, DOI 10.1128/JCM.39.1.293-297.2001; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Yan QQ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00256; Yin Shuang, 2013, Appl Environ Microbiol, V79, P5710, DOI 10.1128/AEM.00950-13; Zeng HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40206	92	1	1	16	16	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	SEP 29	2017	8								1875	10.3389/fmicb.2017.01875				15	Microbiology	Microbiology	FI3YX	WOS:000411907200001	29033918	gold			2018-01-05	
J	Fredriksson-Lidman, K; Van Itallie, CM; Tietgens, AJ; Anderson, JM				Fredriksson-Lidman, Karin; Van Itallie, Christina M.; Tietgens, Amber J.; Anderson, James M.			Sorbin and SH3 domain-containing protein 2 (SORBS2) is a component of the acto-myosin ring at the apical junctional complex in epithelial cells	PLOS ONE			English	Article							VINCULIN-BINDING PROTEIN; TIGHT JUNCTION; STRESS FIBERS; CYTOSKELETAL ORGANIZATION; INTERACTING PROTEIN; ADAPTER PROTEIN; ZONULA ADHERENS; ALPHA-ACTININ; LIPID RAFTS; E-CADHERIN	SORBS2 is a scaffolding protein associated with Abl/Arg non-receptor tyrosine kinase pathways and is known to interact with actin and several other cytoskeletal proteins in various cell types. Previous BioID proximity labeling of tight and adherens junction proteins suggested that SORBS2 is a component of the apical junction complex of epithelial cells. We asked whether SORBS2 plays a previously unappreciated role in controlling perijunctional actin and tight junction barrier function. Using super resolution imaging we confirmed that SORBS2 is localized at the apical junction complex but farther from the membrane than ZO-1 and located partially overlapping both the tight- and adherens junctions with a periodic concentration that alternates with myosin IIB in polarized epithelial cells. Overexpression of GFP-SORBS2 recruited alpha-actinin, vinculin and N-WASP, and possibly CIP4 to cellular junctions. However, CRISPR-Cas9 knock-out of SORBS2 did not alter the localization- or immunofluorescent staining intensity of these or several other junctional- and cytoskeletal proteins. SORBS2 knock-out also did not affect the barrier function as measured by TER and dextran flux; nor did it change actin-dependent junction re-assembly as measured by Ca2+-switch and Latrunculin-B wash-out assays. The kinetics of HGF-induced cell scattering and wound healing, and dextran flux increase induced by PDGF also were unaffected by SORBS2 knock-out. SORBS2 concentrates with apical junctional actin that accumulates in response to knock-down of ZO-1 and ZO-2. In spite of our finding that SORBS2 is clearly a component of the apical junction complex, it does not appear to be required for either normal tight- or adherens junction assembly, structure or function or for growth factor-mediated changes in tight junction dynamics.	[Fredriksson-Lidman, Karin; Van Itallie, Christina M.; Tietgens, Amber J.; Anderson, James M.] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bldg 10, Bethesda, MD 20892 USA	Fredriksson-Lidman, K (reprint author), NHLBI, Lab Tight Junct Struct & Funct, NIH, Bldg 10, Bethesda, MD 20892 USA.	karin.fredriksson@nih.gov			Division of Intramural Research, National Institutes of Health (US) [ZIA HL006207]	This research was supported by the Division of Intramural Research, National Institutes of Health (US), ZIA HL006207, Dr. James M. Anderson.	ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141                                                          ; Anekal PV, 2015, J BIOL CHEM, V290, P2112, DOI 10.1074/jbc.M114.610725; Anekal PV, 2014, J BIOL CHEM; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Cestra G, 2005, P NATL ACAD SCI USA, V102, P1731, DOI 10.1073/pnas.0409376102; Chang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107961; Chen VC, 2006, J PROTEOME RES, V5, P2123, DOI 10.1021/pr0602161; Choi W, 2016, J CELL BIOL, V213, P243, DOI 10.1083/jcb.201506115; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fredriksson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117074; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391                                                           ; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo ZH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005473; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hallock PT, 2016, MOL CELL BIOL, V36, P262, DOI 10.1128/MCB.00775-15; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu SQ, 2017, NAT CELL BIOL, V19, P133, DOI 10.1038/ncb3466; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Kassianidou E, 2015, BBA-MOL CELL RES, V1853, P3065, DOI 10.1016/j.bbamcr.2015.04.006; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kimura A, 2001, P NATL ACAD SCI USA, V98, P9098, DOI 10.1073/pnas.151252898; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Lechuga S, 2015, AM J PHYSIOL-GASTR L, V308, pG745, DOI 10.1152/ajpgi.00446.2014; Li R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124960; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc/.E03-09.0696; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roignot J, 2010, CANCER LETT, V288, P116, DOI 10.1016/j.canlet.2009.06.030; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sanger JM, 2010, CYTOSKELETON, V67, P808, DOI 10.1002/cm.20490; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Soubeyran P, 2003, BIOCHEM J, V370, P29, DOI 10.1042/BJ20021539; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Van Itallie CM, 2015, MOL BIOL CELL, V26, P2769, DOI 10.1091/mbc.E15-04-0232; Van Itallie CM, 2014, J CELL SCI, V127, P885, DOI 10.1242/jcs.140475; Van Itallie CM, 2013, J BIOL CHEM, V288, P13775, DOI 10.1074/jbc.M113.466193; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7                                                   ; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Yuan ZQ, 2005, J BIOL CHEM, V280, P21483, DOI 10.1071/jbc.M50097200; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	56	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2017	12	9							e0185448	10.1371/journal.pone.0185448				24	Multidisciplinary Sciences	Science & Technology - Other Topics	FI5MG	WOS:000412027700019	28961272	gold			2018-01-05	
J	Alzubi, J; Pallant, C; Mussolino, C; Howe, SJ; Thrasher, AJ; Cathomen, T				Alzubi, Jamal; Pallant, Celeste; Mussolino, Claudio; Howe, Steven J.; Thrasher, Adrian J.; Cathomen, Toni			Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model	SCIENTIFIC REPORTS			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; ZINC-FINGER NUCLEASES; GENE-THERAPY; HEMATOPOIETIC PROGENITORS; FUNCTIONAL CORRECTION; TALE NUCLEASES; IN-VITRO; EXPRESSION; PATIENT	The generation of T cells from pluripotent stem cells (PSCs) is attractive for investigating T cell development and validating genome editing strategies in vitro. X-linked severe combined immunodeficiency (X-SCID) is an immune disorder caused by mutations in the IL2RG gene and characterised by the absence of T and NK cells in patients. IL2RG encodes the common gamma chain, which is part of several interleukin receptors, including IL-2 and IL-7 receptors. To model X-SCID in vitro, we generated a mouse embryonic stem cell (ESC) line in which a disease-causing human IL2RG gene variant replaces the endogenous Il2rg locus. We developed a stage-specific T cell differentiation protocol to validate genetic correction of the common G691A mutation with transcription activator-like effector nucleases. While all ESC clones could be differentiated to hematopoietic precursor cells, stage-specific analysis of T cell maturation confirmed early arrest of T cell differentiation at the T cell progenitor stage in X-SCID cells. In contrast, genetically corrected ESCs differentiated to CD4 + or CD8 + single-positive T cells, confirming correction of the cellular X-SCID phenotype. This study emphasises the value of PSCs for disease modelling and underlines the significance of in vitro models as tools to validate genome editing strategies before clinical application.	[Alzubi, Jamal; Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Med Ctr, Inst Transfus Med & Gene Therapy, Freiburg, Germany; [Alzubi, Jamal; Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Ctr Chron Immunodeficiency, Med Ctr, Freiburg, Germany; [Pallant, Celeste; Howe, Steven J.; Thrasher, Adrian J.] UCL, Inst Child Hlth, London, England; [Thrasher, Adrian J.] NHS Fdn Trust, Great Ormond St Hosp, London, England; [Cathomen, Toni] Univ Freiburg, Fac Med, Freiburg, Germany; [Pallant, Celeste; Howe, Steven J.] GlaxoSmithKline Plc, Stevenage, Herts, England	Cathomen, T (reprint author), Univ Freiburg, Med Ctr, Inst Transfus Med & Gene Therapy, Freiburg, Germany.; Cathomen, T (reprint author), Univ Freiburg, Ctr Chron Immunodeficiency, Med Ctr, Freiburg, Germany.; Cathomen, T (reprint author), Univ Freiburg, Fac Med, Freiburg, Germany.	toni.cathomen@uniklinik-freiburg.de		Cathomen, Toni/0000-0002-7757-4630	German Federal Ministry of Education and Research [ReGene-01GN1003D, BMBF-01EO0803]; European Commission's 7th Framework Programme [PERSIST-222878, Supersist-601958]; Wellcome Trust [104807/Z/14/Z]; Medical Research Council	We thank Nadine Dannemann (deceased) and Shamim H. Rahman for experimental support, Karin PikeOverzet, Sebastian Fuchs, and Luigi Naldini for scientific advice, Juan Carlos Zuniga-Pflucker and Axel Schambach for materials, and Nils Craig-Muller for proof-reading of the manuscript. This work was supported by grants from the German Federal Ministry of Education and Research [ReGene-01GN1003D and BMBF-01EO0803 to T.C.], the European Commission's 7th Framework Programme [PERSIST-222878 to A.J.T. and T.C., and Supersist-601958 to A.J.T.], The Wellcome Trust [104807/Z/14/Z to A.J.T.], and the Medical Research Council [studentship to C.P.].	Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chang CW, 2015, CELL REP, V12, P1668, DOI 10.1016/j.celrep.2015.08.013; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; CONLEY ME, 1990, J CLIN INVEST, V85, P1548, DOI 10.1172/JCI114603; Cornu TI, 2017, NAT MED, V23, P415, DOI 10.1038/nm.4313; de Bruin LMO, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00250; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dreyer AK, 2015, BIOMATERIALS, V69, P191, DOI 10.1016/j.biomaterials.2015.07.057; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Galic Z, 2006, P NATL ACAD SCI USA, V103, P11742, DOI 10.1073/pnas.0604244103; Galic Z, 2009, STEM CELLS, V27, P100, DOI 10.1634/stemcells.2008-0813; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002716; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kokron CM, 1997, J CLIN IMMUNOL, V17, P109, DOI 10.1023/A:1027322314256; Lachmann N, 2014, AM J RESP CRIT CARE, V189, P167, DOI 10.1164/rccm.201306-1012OC; Laskowski TJ, 2016, STEM CELL REP, V7, P139, DOI 10.1016/j.stemcr.2016.06.003; Ma N, 2013, J BIOL CHEM, V288, P34671, DOI 10.1074/jbc.M113.496174; McKinney-Freeman SL, 2008, BLOOD, V111, P4944, DOI 10.1182/blood-2007-11-124644; Menon T, 2015, CELL STEM CELL, V16, P367, DOI 10.1016/j.stem.2015.02.005; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731                                                     ; Miller JFAP, 2002, IMMUNOL REV, V185, P7, DOI 10.1034/j.1600-065X.2002.18502.x; Morishima T, 2014, HAEMATOLOGICA, V99, P19, DOI 10.3324/haematol.2013.083873; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Park CY, 2014, P NATL ACAD SCI USA, V111, P9253, DOI 10.1073/pnas.1323941111; PUCK JM, 1993, HUM MOL GENET, V2, P1099, DOI 10.1093/hmg/2.8.1099; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rahman SH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005239; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Touzot F, 2015, BLOOD, V125, P3563, DOI 10.1182/blood-2014-12-616003; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Williams DA, 2014, STEM CELL TRANSL MED, V3, P636, DOI 10.5966/sctm.2013-0206; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161	55	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 29	2017	7								12475	10.1038/s41598-017-12750-4				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FI5OB	WOS:000412032600041	28963568	gold			2018-01-05	
J	Rodrigues, NF; Christoff, AP; Da Fonseca, GC; Kulcheski, FR; Margis, R				Rodrigues, Nureyev F.; Christoff, Ana P.; Da Fonseca, Guilherme C.; Kulcheski, Franceli R.; Margis, Rogerio			Unveiling Chloroplast RNA Editing Events Using Next Generation Small RNA Sequencing Data	FRONTIERS IN PLANT SCIENCE			English	Article						small RNA; chloroplast; RNA editing; NGS; SNP genotyping	PENTATRICOPEPTIDE REPEAT PROTEINS; A-TO-I; PHOTOOXIDATIVE STRESS; ARABIDOPSIS-THALIANA; PLANT MITOCHONDRIAL; BINDING PROTEINS; GENE-EXPRESSION; PHOTOSYSTEM-II; NDH COMPLEX; SITES	Organellar RNA editing involves the modification of nucleotide sequences to maintain conserved protein functions, mainly by reverting non-neutral codon mutations. The loss of plastid editing events, resulting from mutations in RNA editing factors or through stress interference, leads to developmental, physiological and photosynthetic alterations. Recently, next generation sequencing technology has generated the massive discovery of sRNA sequences and expanded the number of sRNA data. Here, we present amethod to screen chloroplast RNA editing using public sRNA libraries from Arabidopsis, soybean and rice. We mapped the sRNAs against the nuclear, mitochondrial and plastid genomes to confirm predicted cytosine to uracil (C-to-U) editing events and identify new editing sites in plastids. Among the predicted editing sites, 40.57, 34.78, and 25.31% were confirmed using sRNAs from Arabidopsis, soybean and rice, respectively. SNP analysis revealed 58.2, 43.9, and 37.5% new C-to-U changes in the respective species and identified known and new putative adenosine to inosine (A-to-I) RNA editing in tRNAs. The present method and data reveal the potential of sRNA as a reliable source to identify new and confirm known editing sites.	[Rodrigues, Nureyev F.; Christoff, Ana P.; Margis, Rogerio] Univ Fed Rio Grande do Sul, Dept Genet, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Da Fonseca, Guilherme C.; Margis, Rogerio] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Kulcheski, Franceli R.] Univ Fed Santa Catarina, Dept Biol Celular Genet & Embriol, Programa Posgrad Biol Celular & Desenvolvimento, Florianopolis, SC, Brazil; [Margis, Rogerio] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil	Margis, R (reprint author), Univ Fed Rio Grande do Sul, Dept Genet, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Margis, R (reprint author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.; Margis, R (reprint author), Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil.	rogerio.margis@ufrgs.br	Cordenonsi da Fonseca, Guilherme/E-5500-2015; MARGIS, ROGERIO/A-7230-2008	Cordenonsi da Fonseca, Guilherme/0000-0002-0007-9834; MARGIS, ROGERIO/0000-0002-2871-4473	CNPq; FAPERGS/CAPES-DOCFIX [1634-2551/13-9]; INCT-MCTIC;  [309030/2015-3]	RM is the recipient of a research fellowship 309030/2015-3, NR is the recipient of a Ph.D. fellowship, and AC and GdF are the recipients of Post-Doctoral fellowships from CNPq. FK was sponsored by a FAPERGS/CAPES-DOCFIX (1634-2551/13-9) grant. The present study was also partially supported through a grant from INCT-MCTIC.	Baniulis D, 2008, PHOTOCHEM PHOTOBIOL, V84, P1349, DOI 10.1111/j.1751-1097.2008.00444.x; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Neto LB, 2015, PLANT CELL REP, V34, P1899, DOI 10.1007/s00299-015-1836-3; Casano LM, 2001, PLANT PHYSIOL, V125, P1450, DOI 10.1104/pp.125.3.1450; Chateigner-Boutin AL, 2003, NUCLEIC ACIDS RES, V31, P2586, DOI 10.1093/nar/gkg354; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Chateigner-Boutin AL, 2010, RNA BIOL, V7, P213, DOI 10.4161/rna.7.2.11343                                                           ; Chen HY, 2015, FUNCT INTEGR GENOMIC, V15, P131, DOI 10.1007/s10142-014-0422-z; Chen YC, 2008, ANAL BIOCHEM, V375, P46, DOI 10.1016/j.ab.2007.12.037; Cheng SF, 2016, PLANT J, V85, P532, DOI 10.1111/tpj.13121; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; da Fonseca GC, 2016, PLANT SCI, V246, P62, DOI 10.1016/j.plantsci.2016.01.011; Delannoy E, 2009, PLANT CELL, V21, P2058, DOI 10.1105/tpc.109.066654; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Elias Y, 2005, BIOCHEMISTRY-US, V44, P12057, DOI 10.1021/bi050499f; Germain A, 2015, PLANT J, V83, P546, DOI 10.1111/tpj.12892; Guo WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117075; Hayes ML, 2015, J BIOL CHEM, V290, P10136, DOI 10.1074/jbc.M114.631630; Horvath EM, 2000, PLANT PHYSIOL, V123, P1337, DOI 10.1104/pp.123.4.1337; Hotto AM, 2012, TRENDS PLANT SCI, V17, P737, DOI 10.1016/j.tplants.2012.08.002; Karcher D, 2002, CURR GENET, V41, P48, DOI 10.1007/s00294-002-0278-y; Karcher D, 2009, RNA, V15, P1251, DOI 10.1261/rna.1600609; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Kode V, 2005, PLANT J, V44, P237, DOI 10.1111/j.1365-313X.2005.02533.x; Komine Y, 2002, P NATL ACAD SCI USA, V99, P4085, DOI 10.1073/pnas.052327599; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Liu J, 2015, PLANT J, V82, P731, DOI 10.1111/tpj.12845; Long RC, 2015, PHYSIOL PLANTARUM, V154, P13, DOI 10.1111/ppl.12266; Manuell A, 2004, BIOCHEM SOC T, V32, P601, DOI 10.1042/BST0320601                                                              ; Martin M, 2004, PHYSIOL PLANTARUM, V122, P443, DOI 10.1111/j.1399-3054.2004.00417.x; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Miyata Y, 2008, PLANT BIOLOGY, V10, P250, DOI 10.1111/j.1438-8677.2007.00027.x; Miyata Y, 2004, J PLANT PHYSIOL, V161, P113, DOI 10.1078/0176-1617-01220; Monde RA, 2000, PLANT J, V21, P61, DOI 10.1046/j.1365-313x.2000.00653.x; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Nakajima Y, 2001, CURR GENET, V40, P209, DOI 10.1007/s002940100249; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Peng LW, 2011, BBA-BIOENERGETICS, V1807, P945, DOI 10.1016/j.bbabio.2010.10.015; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Pokhrel R, 2013, BIOCHEMISTRY-US, V52, P4758, DOI 10.1021/bi301700u; Rogalski M, 2008, NAT STRUCT MOL BIOL, V15, P192, DOI 10.1038/nsmb.1370; Rudinger M, 2009, MOL GENET GENOMICS, V281, P473, DOI 10.1007/s00438-009-0424-z; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Ruwe H, 2016, NUCLEIC ACIDS RES, V44, P7406, DOI 10.1093/nar/gkw466; Ruwe H, 2012, NUCLEIC ACIDS RES, V40, P3106, DOI 10.1093/nar/gkr1138; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sasaki Y, 2001, J BIOL CHEM, V276, P3937, DOI 10.1074/jbc.M008166200; Schallenberg-Rudinger M, 2013, RNA BIOL, V10, P1549, DOI 10.4161/rna.25755; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Su AAH, 2011, BIOCHEMISTRY-MOSCOW+, V76, P932, DOI 10.1134/S0006297911080098; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Tikkanen M, 2012, BBA-BIOENERGETICS, V1817, P232, DOI 10.1016/j.bbabio.2011.05.005; Tillich M, 2005, PLANT J, V43, P708, DOI 10.1111/j.1365-313X.2005.02484.x; Tillich M, 2006, MOL BIOL EVOL, V23, P1912, DOI 10.1093/molbev/msl054; Tseng CC, 2013, PLANT MOL BIOL, V82, P375, DOI 10.1007/s11103-013-0069-5; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; Tsudzuki T, 2001, J MOL EVOL, V53, P327, DOI 10.1007/s002390010222; Van den Bekerom RJM, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt035; Wolf PG, 2004, GENE, V339, P89, DOI 10.1016/j.gene.2004.06.018; Wu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep36007; Xu T, 2015, PLANTA, V242, P963, DOI 10.1007/s00425-015-2318-0; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x; Zimmer SL, 2009, PLANT J, V59, P88, DOI 10.1111/j.1365-313X.2009.03853.x	71	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	SEP 29	2017	8								1686	10.3389/fpls.2017.01686				13	Plant Sciences	Plant Sciences	FI4GC	WOS:000411928100001	29033962	gold			2018-01-05	
J	Kim, OH; Cho, HJ; Han, E; Hong, TI; Ariyasiri, K; Choi, JH; Hwang, KS; Jeong, YM; Yang, SY; Yu, K; Park, DS; Oh, HW; Davis, EE; Schwartz, CE; Lee, JS; Kim, HG; Kim, CH				Kim, Oc-Hee; Cho, Hyun-Ju; Han, Enna; Hong, Ted Inpyo; Ariyasiri, Krishan; Choi, Jung-Hwa; Hwang, Kyu-Seok; Jeong, Yun-Mi; Yang, Se-Yeol; Yu, Kweon; Park, Doo-Sang; Oh, Hyun-Woo; Davis, Erica E.; Schwartz, Charles E.; Lee, Jeong-Soo; Kim, Hyung-Goo; Kim, Cheol-Hee			Zebrafish knockout of Down syndrome gene, DYRK1A, shows social impairments relevant to autism	MOLECULAR AUTISM			English	Article						Autism; Down syndrome; Knockout; Zebrafish; DYRK1A; Social interaction; Shoaling; Group behavior	SYNDROME CRITICAL REGION; COMPUTER ANIMATED FISH; 2 UNRELATED PATIENTS; DANIO-RERIO; INTELLECTUAL DISABILITY; BEHAVIORAL-RESPONSES; LOCOMOTOR-ACTIVITY; SHOALING BEHAVIOR; LARVAL ZEBRAFISH; MURINE MODEL	Background: DYRK1A maps to the Down syndrome critical region at 21q22. Mutations in this kinase-encoding gene have been reported to cause microcephaly associated with either intellectual disability or autism in humans. Intellectual disability accompanied by microcephaly was recapitulated in a murine model by overexpressing Dyrk1a which mimicked Down syndrome phenotypes. However, given embryonic lethality in homozygous knockout (KO) mice, no murine model studies could present sufficient evidence to link Dyrk1a dysfunction with autism. To understand the molecular mechanisms underlying microcephaly and autism spectrum disorders (ASD), we established an in vivo dyrk1aa KO model using zebrafish. Methods: We identified a patient with a mutation in the DYRK1A gene using microarray analysis. Circumventing the barrier of murine model studies, we generated a dyrk1aa KO zebrafish using transcription activator-like effector nuclease (TALEN)-mediated genome editing. For social behavioral tests, we have established a social interaction test, shoaling assay, and group behavior assay. For molecular analysis, we examined the neuronal activity in specific brain regions of dyrk1aa KO zebrafish through in situ hybridization with various probes including c-fos and crh which are the molecular markers for stress response. Results: Microarray detected an intragenic microdeletion of DYRK1A in an individual with microcephaly and autism. From behavioral tests of social interaction and group behavior, dyrk1aa KO zebrafish exhibited social impairments that reproduce human phenotypes of autism in a vertebrate animal model. Social impairment in dyrk1aa KO zebrafish was further confirmed by molecular analysis of c-fos and crh expression. Transcriptional expression of c-fos and crh was lower than that of wild type fish in specific hypothalamic regions, suggesting that KO fish brains are less activated by social context. Conclusions: In this study, we established a zebrafish model to validate a candidate gene for autism in a vertebrate animal. These results illustrate the functional deficiency of DYRK1A as an underlying disease mechanism for autism. We also propose simple social behavioral assays as a tool for the broader study of autism candidate genes.	[Kim, Oc-Hee; Han, Enna; Hong, Ted Inpyo; Ariyasiri, Krishan; Choi, Jung-Hwa; Hwang, Kyu-Seok; Jeong, Yun-Mi; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, Daejeon 34134, South Korea; [Kim, Oc-Hee; Cho, Hyun-Ju; Yang, Se-Yeol; Yu, Kweon; Park, Doo-Sang; Oh, Hyun-Woo; Lee, Jeong-Soo] Korean Res Inst Biosci & Biotechnol, Daejeon 34141, South Korea; [Cho, Hyun-Ju; Yang, Se-Yeol; Yu, Kweon; Lee, Jeong-Soo] Korea Univ Sci & Technol, Dept Funct Genom, Daejeon 34113, South Korea; [Davis, Erica E.] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27701 USA; [Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Lee, Jeong-Soo] Korea Inst Sci & Technol, Dementia DTC R&D Convergence Program, Seoul 02792, South Korea; [Kim, Hyung-Goo] Augusta Univ, Dept Neurosci & Regenerat Med, Dept OB GYN, Augusta, GA 30912 USA	Kim, CH (reprint author), Chungnam Natl Univ, Dept Biol, Daejeon 34134, South Korea.; Lee, JS (reprint author), Korean Res Inst Biosci & Biotechnol, Daejeon 34141, South Korea.; Lee, JS (reprint author), Korea Univ Sci & Technol, Dept Funct Genom, Daejeon 34113, South Korea.; Lee, JS (reprint author), Korea Inst Sci & Technol, Dementia DTC R&D Convergence Program, Seoul 02792, South Korea.; Kim, HG (reprint author), Augusta Univ, Dept Neurosci & Regenerat Med, Dept OB GYN, Augusta, GA 30912 USA.	jeongsoo@kribb.re.kr; hkim@augusta.edu; zebrakim@cnu.ac.kr			National Research Foundation (NRF) of Korea grants [2014R1A2A1A11053562, 2015M3A9A8029261]; Chungnam National University; KRIBB Research Initiative Program; National Research Council of Science & Technology (NST) grant [CRC-15-04-KIST]; National Research Foundation (NRF) of Korea grant [2016M3A9A5919255]; National Institutes of Health (NIH) grant [R01 MH106826]	C.-H.K. was supported by the National Research Foundation (NRF) of Korea grants (2014R1A2A1A11053562 and 2015M3A9A8029261) and the research fund of Chungnam National University; J.-S.L. was supported by the KRIBB Research Initiative Program and the National Research Council of Science & Technology (NST) grant (CRC-15-04-KIST); D.-S.P. was supported by the National Research Foundation (NRF) of Korea grant (2016M3A9A5919255); E.E.D. was supported by the National Institutes of Health (NIH) grant R01 MH106826.	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Arque G, 2009, NEUROBIOL DIS, V36, P312, DOI 10.1016/j.nbd.2009.07.027; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Barallobre MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.253; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bronicki LM, 2015, EUR J HUM GENET, V23, P1482, DOI 10.1038/ejhg.2015.29; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Buske C, 2011, PROG NEURO-PSYCHOPH, V35, P1409, DOI 10.1016/j.pnpbp.2010.09.003; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020                                                ; DeVries AC, 2002, HORM BEHAV, V41, P405, DOI 10.1006/hbeh.2002.1780; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Dreosti E, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00039; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Gerlai R, 2014, J NEUROSCI METH, V234, P59, DOI 10.1016/j.jneumeth.2014.04.028; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Green J, 2012, J NEUROSCI METH, V210, P266, DOI 10.1016/j.jneumeth.2012.07.017; Guedj F, 2012, NEUROBIOL DIS, V46, P190, DOI 10.1016/j.nbd.2012.01.007; Herget U, 2014, J COMP NEUROL, V522, P1542, DOI 10.1002/cne.23480; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang XL, 2015, HUM MOL GENET, V24, P6540, DOI 10.1093/hmg/ddv364; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Kang JE, 2005, J NEUROSCI RES, V81, P62, DOI 10.1002/jnr.20534; Kim CH, 2000, NATURE, V407, P913; Kim HG, 2012, AM J HUM GENET, V91, P56, DOI 10.1016/j.ajhg.2012.05.005; Kim HG, 2010, AM J HUM GENET, V87, P465, DOI 10.1016/j.ajhg.2010.08.018; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Labonne JDJ, 2016, HUM GENET, V135, P757, DOI 10.1007/s00439-016-1668-4; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lau BYB, 2011, P NATL ACAD SCI USA, V108, P2581, DOI 10.1073/pnas.1018275108; Livne ZB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006445; Maaswinkel H, 2013, PHARMACOL BIOCHEM BE, V108, P16, DOI 10.1016/j.pbb.2013.04.009; May M, 2015, HUM MOL GENET, V24, P4848, DOI 10.1093/hmg/ddv208; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Miller N, 2013, BEHAV BRAIN RES, V240, P192, DOI 10.1016/j.bbr.2012.11.033; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Park JS, 2016, MOL CELLS, V39, P750, DOI 10.14348/molcells.2016.0173; Parker MO, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00063; Qin MY, 2014, ZEBRAFISH, V11, P185, DOI 10.1089/zeb.2013.0969; Reyhanian N, 2011, AQUAT TOXICOL, V105, P41, DOI 10.1016/j.aquatox.2011.05.009; Rihel J, 2010, METHOD CELL BIOL, V100, P281, DOI 10.1016/B978-0-12-384892-5.00011-6; ROAK BJO, 2012, SCIENCE, V338, P1619; Ruaud L, 2015, EUR J MED GENET, V58, P168, DOI 10.1016/j.ejmg.2014.12.014; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Senst L, 2016, ELIFE, V5, DOI 10.7554/eLife.18726; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104; Stewart AM, 2014, PROG NEURO-PSYCHOPH, V50, P27, DOI 10.1016/j.pnpbp.2013.11.014; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thomazeau A, 2014, J NEUROSCI, V34, P1138, DOI 10.1523/JNEUROSCI.2852-13.2014; van Bon BWM, 2016, MOL PSYCHIATR, V21, P126, DOI 10.1038/mp.2015.5; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Wright D, 2006, NAT PROTOC, V1, P1828, DOI 10.1038/nprot.2006.287; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Ziv L, 2013, MOL PSYCHIATR, V18, P681, DOI 10.1038/mp.2012.64	65	0	0	7	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2040-2392			MOL AUTISM	Mol. Autism	SEP 29	2017	8								50	10.1186/s13229-017-0168-2				14	Genetics & Heredity; Neurosciences	Genetics & Heredity; Neurosciences & Neurology	FI6YJ	WOS:000412142400001	29021890	gold			2018-01-05	
J	O'Geen, H; Ren, CH; Nicolet, CM; Perez, AA; Halmai, J; Le, VM; Mackay, JP; Farnham, PJ; Segal, DJ				O'Geen, Henriette; Ren, Chonghua; Nicolet, Charles M.; Perez, Andrew A.; Halmai, Julian; Le, Victoria M.; Mackay, Joel P.; Farnham, Peggy J.; Segal, David J.			dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression	NUCLEIC ACIDS RESEARCH			English	Article							ZINC-FINGER PROTEINS; GENOME-WIDE ANALYSIS; RNA-GUIDED ENDONUCLEASE; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; EPIGENETIC REGULATION; ENDOGENOUS GENES; COMPLEX 2; CHIP-SEQ; SYSTEM	Distinct epigenomic profiles of histone marks have been associated with gene expression, but questions regarding the causal relationship remain. Here we investigated the activity of a broad collection of genomically targeted epigenetic regulators that could write epigenetic marks associated with a repressed chromatin state (G9A, SUV39H1, Kruppel-associated box (KRAB), DNMT3A as well as the first targetable versions of Ezh2 and Friend of GATA-1 (FOG1)). dCas9 fusions produced target gene repression over a range of 0- to 10-fold that varied by locus and cell type. dCpf1 fusions were unable to repress gene expression. The most persistent gene repression required the action of several effector domains; however, KRAB-dCas9 did not contribute to persistence in contrast to previous reports. A 'direct tethering' strategy attaching the Ezh2 methyltransferase enzyme to dCas9, as well as a 'recruitment' strategy attaching the N-terminal 45 residues of FOG1 to dCas9 to recruit the endogenous nucleosome remodeling and deacetylase complex, were both successful in targeted deposition of H3K27me3. Surprisingly, however, repression was not correlated with deposition of either H3K9me3 or H3K27me3. Our results suggest that so-called repressive histone modifications are not sufficient for gene repression. The easily programmable dCas9 toolkit allowed precise control of epigenetic information and dissection of the relationship between the epigenome and gene regulation.	[O'Geen, Henriette; Ren, Chonghua; Halmai, Julian; Le, Victoria M.; Segal, David J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [O'Geen, Henriette; Ren, Chonghua; Halmai, Julian; Le, Victoria M.; Segal, David J.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Ren, Chonghua; Perez, Andrew A.] South China Normal Univ, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China; [Nicolet, Charles M.; Farnham, Peggy J.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90089 USA; [Mackay, Joel P.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	Segal, DJ (reprint author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Segal, DJ (reprint author), Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA.	djsegal@ucdavis.edu			National Institutes of Health (NIH) [CA204563]; Australian Research Council [DP160104106]; Foundation for Angelman Syndrome Therapeutics	National Institutes of Health (NIH) [CA204563 to D.J.S.]; Australian Research Council [DP160104106 to J.P.M]; Foundation for Angelman Syndrome Therapeutics [to D.J.S]. The open access publication charge for this paper has been waived by Oxford University Press - NAR Editorial Board members are entitled to one free paper per year in recognition of their work on behalf of the journal.	Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Cano-Rodriguez D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12284; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Falahi F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00022; Falahi F, 2013, MOL CANCER RES, V11, P1029, DOI 10.1158/1541-7786.MCR-12-0567; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hilton IB, 2015, GENOME RES, V25, P1442, DOI 10.1101/gr.190124.115; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Jamieson K, 2016, GENOME RES, V26, P97, DOI 10.1101/gr.194555.115; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127                                                         ; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427                                               ; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; O'Geen H, 2010, METHODS MOL BIOL, V649, P437, DOI 10.1007/978-1-60761-753-2_27; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Ren CH, 2015, CELL MOL LIFE SCI, V72, P2763, DOI 10.1007/s00018-015-1874-6; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Ross J, 2012, MOL CELL BIOL, V32, P3624, DOI 10.1128/MCB.00163-12; Rush Margaret, 2009, Epigenetics, V4, P404; Saathoff H, 2015, BIOORGAN MED CHEM, V23, P960, DOI 10.1016/j.bmc.2015.01.023; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302                                                              ; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Stepper P, 2017, NUCLEIC ACIDS RES, V45, P1703, DOI 10.1093/nar/gkw1112; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tak YG, 2016, NUCLEIC ACIDS RES, V44, P4123, DOI 10.1093/nar/gkv1530; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0                                                   ; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; You JS, 2011, P NATL ACAD SCI USA, V108, P14497, DOI 10.1073/pnas.1111309108; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	61	0	0	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	SEP 29	2017	45	17					9901	9916		10.1093/nar/gkx578				16	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FI5FO	WOS:000412008000013	28973434				2018-01-05	
J	Jones, DL; Leroy, P; Unoson, C; Fange, D; Curic, V; Lawson, MJ; Elf, J				Jones, Daniel Lawson; Leroy, Prune; Unoson, Cecilia; Fange, David; Curic, Vladimir; Lawson, Michael J.; Elf, Johan			Kinetics of dCas9 target search in Escherichia coli	SCIENCE			English	Article							CRISPR RNA; LIVING CELLS; HOMOLOGOUS RECOMBINATION; LAC REPRESSOR; INTERROGATION; ENDONUCLEASE; SEQUENCE; DYNAMICS; IMMUNITY	How fast can a cell locate a specific chromosomal DNA sequence specified by a single-stranded oligonucleotide? To address this question, we investigate the intracellular search processes of the Cas9 protein, which can be programmed by a guide RNA to bind essentially any DNA sequence. This targeting flexibility requires Cas9 to unwind the DNA double helix to test for correct base pairing to the guide RNA. Here we study the search mechanisms of the catalytically inactive Cas9 (dCas9) in living Escherichia coli by combining single-molecule fluorescence microscopy and bulk restriction-protection assays. We find that it takes a single fluorescently labeled dCas9 6 hours to find the correct target sequence, which implies that each potential target is bound for less than 30 milliseconds. Once bound, dCas9 remains associated until replication. To achieve fast targeting, both Cas9 and its guide RNA have to be present at high concentrations.	[Jones, Daniel Lawson; Leroy, Prune; Unoson, Cecilia; Fange, David; Curic, Vladimir; Lawson, Michael J.; Elf, Johan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Elf, J (reprint author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden.	johan.elf@icm.uu.se			European Research Council; Knut and Alice Wallenberg Foundation; Vetenskapsradet	The authors thank K. Abruzzi for supplying the plasmid pAFS52 and I. Fonfara and E. Charpentier for help with making S. pyogenes protein lysates. This work was supported by the European Research Council, the Knut and Alice Wallenberg Foundation, and Vetenskapsradet.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Fei JY, 2015, SCIENCE, V347, P1371, DOI 10.1126/science.1258849; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891                                                          ; Greene EC, 2016, J BIOL CHEM, V291, P11572, DOI 10.1074/jbc.R116.724807; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Ma HH, 2016, J CELL BIOL, V214, P529, DOI 10.1083/jcb.201604115; Marraffini L. A., 2016, STREPTOCOCCUS PYOGEN; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615	19	0	0	15	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2017	357	6358					1420	1423		10.1126/science.aah7084				4	Multidisciplinary Sciences	Science & Technology - Other Topics	FI3QH	WOS:000411880800052	28963258				2018-01-05	
J	Bak, RO; Dever, DP; Reinisch, A; Hernandez, DC; Majeti, R; Porteus, MH				Bak, Rasmus O.; Dever, Daniel P.; Reinisch, Andreas; Hernandez, David Cruz; Majeti, Ravindra; Porteus, Matthew H.			Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6	ELIFE			English	Article							ACUTE MYELOID-LEUKEMIA; HUMAN T-CELLS; CORD-BLOOD; SELF-RENEWAL; CAS9 RIBONUCLEOPROTEINS; IN-VIVO; INTEGRATION; ENGRAFTMENT; HIV; DIFFERENTIATION	Precise and efficient manipulation of genes is crucial for understanding the molecular mechanisms that govern human hematopoiesis and for developing novel therapies for diseases of the blood and immune system. Current methods do not enable precise engineering of complex genotypes that can be easily tracked in a mixed population of cells. We describe a method to multiplex homologous recombination (HR) in human hematopoietic stem and progenitor cells and primary human T cells by combining rAAV6 donor delivery and the CRISPR/Cas9 system delivered as ribonucleoproteins (RNPs). In addition, the use of reporter genes allows FACS-purification and tracking of cells that have had multiple alleles or loci modified by HR. We believe this method will enable broad applications not only to the study of human hematopoietic gene function and networks, but also to perform sophisticated synthetic biology to develop innovative engineered stem cell-based therapeutics.	[Bak, Rasmus O.; Dever, Daniel P.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Reinisch, Andreas; Hernandez, David Cruz; Majeti, Ravindra] Stanford Univ, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Reinisch, Andreas; Hernandez, David Cruz; Majeti, Ravindra] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Med, Stanford, CA 94305 USA; [Reinisch, Andreas; Hernandez, David Cruz; Majeti, Ravindra] Stanford Univ, Canc Inst, Dept Med, Stanford, CA 94305 USA; [Bak, Rasmus O.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Bak, Rasmus O.] Aarhus Univ, AIAS, Aarhus, Denmark	Porteus, MH (reprint author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Majeti, R (reprint author), Stanford Univ, Div Hematol, Dept Med, Stanford, CA 94305 USA.; Majeti, R (reprint author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Med, Stanford, CA 94305 USA.; Majeti, R (reprint author), Stanford Univ, Canc Inst, Dept Med, Stanford, CA 94305 USA.	rmajeti@stanford.edu; mporteus@stanford.edu			Danish Council for Independent Research [DFF-1333-00106B, DFF-1331-00735B]; Stanford Child Health Research Institute; Austrian Research Council; Amon G. Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; National Institutes of Health [PN2EY018244, R01-CA188055, R01- AI097320, R01-AI120766]; Stanford Ludwig Center for Cancer Stem Cell Research; New York Stem Cell Foundation	Danish Council for Independent Research DFF-1333-00106B Rasmus O Bak; Stanford Child Health Research Institute Postdoctoral Award Daniel P Dever; Austrian Research Council Erwin Schroedinger Postdoctoral Fellowship Andreas Reinisch; Amon G. Carter Foundation Matthew H Porteus; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research Scholar Award Matthew H Porteus; National Institutes of Health PN2EY018244 Matthew H Porteus; Stanford Ludwig Center for Cancer Stem Cell Research Ravindra Majeti; National Institutes of Health R01-CA188055 Ravindra Majeti; New York Stem Cell Foundation Robertson Investigator Ravindra Majeti; Danish Council for Independent Research DFF-1331-00735B Rasmus O Bak; National Institutes of Health R01- AI097320 Matthew H Porteus; National Institutes of Health R01-AI120766 Matthew H Porteus	Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Bak RO, 2017, CELL REP, V20, P750, DOI 10.1016/j.celrep.2017.06.064; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Brown A, 2016, ACS SYNTH BIOL, V5, P582, DOI 10.1021/acssynbio.6b00056; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chan SM, 2015, NAT MED, V21, P90, DOI 10.1038/nm.3788; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; De Witt MA, 2016, SCI TRANSL MED, V8; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; KOTIN RM, 1992, EMBO J, V11, P5071; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Mullenders J, 2015, J EXP MED, V212, P1833, DOI 10.1084/jem.20151323; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Popat U, 2015, BLOOD, V125, P2885, DOI 10.1182/blood-2015-01-607366; Reinisch A, 2016, NAT MED, V22, P812, DOI 10.1038/nm.4103; Saydaminova Kamola, 2015, Mol Ther Methods Clin Dev, V1, P14057, DOI 10.1038/mtm.2014.57; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Sweeney CL, 2017, MOL THER, V25, P321, DOI 10.1016/j.ymthe.2016.11.012; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317; Voit RA, 2014, NUCLEIC ACIDS RES, V42, P1365, DOI 10.1093/nar/gkt947; Voit RA, 2013, MOL THER, V21, P786, DOI 10.1038/mt.2012.284; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	50	0	0	0	0	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	SEP 28	2017	6								e27873	10.7554/eLife.27873.001				19	Biology	Life Sciences & Biomedicine - Other Topics	FK7YC	WOS:000413722800001					2018-01-05	
J	Li, JW; Handler, AM				Li, Jianwei; Handler, Alfred M.			Temperature-dependent sex-reversal by a transformer-2 gene-edited mutation in the spotted wing drosophila, Drosophila suzukii	SCIENTIFIC REPORTS			English	Article							ANASTREPHA-SUSPENSA; MELANOGASTER; EXPRESSION; GERMLINE; FEMALES; SYSTEM; GENOME; MALES	Female to male sex reversal was achieved in an emerging agricultural insect pest, Drosophila suzukii, by creating a temperature-sensitive point mutation in the sex-determination gene, transformer-2 (tra-2), using CRISPR/Cas9 (clustered regularly interspaced palindromic repeats/CRISPR-associated) homology-directed repair gene-editing. Ds-tra-2(ts2) mutants developed as normal fertile XX and XY adults at permissive temperatures below 20 degrees C, but at higher restrictive temperatures (26 to 29 degrees C) chromosomal XX females developed as sterile intersexuals with a predominant male phenotype, while XY males developed with normal morphology, but were sterile. The temperature-dependent function of the Ds-TRA-2(ts2) protein was also evident by the up-and down-regulation of female-specific Ds-Yolk protein 1 (Ds-Yp1) gene expression by temperature shifts during adulthood. This study confirmed the temperature-dependent function of a gene-edited mutation and provides a new method for the more general creation of conditional mutations for functional genomic analysis in insects, and other organisms. Furthermore, it provides a temperature-dependent system for creating sterile male populations useful for enhancing the efficacy of biologically-based programs, such as the sterile insect technique (SIT), to control D. suzukii and other insect pest species of agricultural and medical importance.	[Li, Jianwei; Handler, Alfred M.] ARS, USDA, Ctr Med Agr & Vet Entomol, 1700 SW 23rd Dr, Gainesville, FL 32608 USA	Li, JW (reprint author), ARS, USDA, Ctr Med Agr & Vet Entomol, 1700 SW 23rd Dr, Gainesville, FL 32608 USA.	jianwei.li@ars.usda.gov		Li, Jianwei/0000-0002-0262-3901	USDA National Institute of Food and Agriculture [2016-67013-25087]	We thank Shelley Olson, Sara Brennan and G. Patrick Whitmer for technical assistance. This project was supported by the USDA-AFRI Foundational Program competitive grant no. 2016-67013-25087 from the USDA National Institute of Food and Agriculture (to A.M.H.).	AMREIN H, 1990, EMBO J, V9, P3619; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; BELOTE JM, 1985, CELL, V40, P339, DOI 10.1016/0092-8674(85)90148-5; BELOTE JM, 1982, P NATL ACAD SCI-BIOL, V79, P1568, DOI 10.1073/pnas.79.5.1568; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; BELOTE JM, 1983, DEV BIOL, V95, P512, DOI 10.1016/0012-1606(83)90054-4                                                    ; BELOTE JM, 1980, GENETICS, V96, P165; Chiu JC, 2013, G3-GENES GENOM GENET, V3, P2257, DOI 10.1534/g3.113.008185; FUJIHARA T, 1978, J HERED, V69, P229, DOI 10.1093/oxfordjournals.jhered.a108936                                           ; GARABEDIAN MJ, 1985, P NATL ACAD SCI USA, V82, P1396, DOI 10.1073/pnas.82.5.1396; Handler AM, 2002, GENETICA, V116, P137, DOI 10.1023/A:1020924028450; HANDLER AM, 1977, J EXP ZOOL, V202, P389, DOI 10.1002/jez.1402020309; Haye T, 2016, J PEST SCI, V89, P643, DOI 10.1007/s10340-016-0737-8; HOOPER GHS, 1972, J ECON ENTOMOL, V65, P1; Housden BE, 2017, NAT REV GENET, V18, P24, DOI 10.1038/nrg.2016.118; Housden BE, 2014, METHOD ENZYMOL, V546, P415, DOI 10.1016/B978-0-12-801185-0.00019-2; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459                                                            ; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Posnien N., 2009, COLD SPRING HARB PRO, V2009; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Sarno F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-140; Schetelig MF, 2013, GENETICA, V141, P189, DOI 10.1007/s10709-013-9717-6; Schetelig MF, 2012, P NATL ACAD SCI USA, V109, P9348, DOI 10.1073/pnas.1203352109; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P51, DOI 10.1016/j.ibmb.2011.10.007; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; SCHUPBACH T, 1982, DEV BIOL, V89, P117, DOI 10.1016/0012-1606(82)90300-1                                                    ; SUZUKI DT, 1967, P NATL ACAD SCI USA, V57, P907, DOI 10.1073/pnas.57.4.907                                                           ; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673                                                          ; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Vreysen M.J., 2007, AREA WIDE CONTROL IN	34	0	0	13	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 28	2017	7								12363	10.1038/s41598-017-12405-4				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FI5CL	WOS:000411998800002	28959033	gold			2018-01-05	
J	Zhu, CM; Yang, JN; Shyu, C				Zhu, Chuanmei; Yang, Jiani; Shyu, Christine			Setaria Comes of Age: Meeting Report on the Second International Setaria Genetics Conference	FRONTIERS IN PLANT SCIENCE			English	Article						Setaria; genetic model; agronomically important traits; drought tolerance; inflorescence architecture; C-4 photosynthesis; millet; translational research	C-4 PHOTOSYNTHESIS; FOXTAIL MILLET; MODEL SYSTEM; VIRIDIS; TRANSFORMATION; SEQUENCE; ITALICA; GRASSES	Setaria viridis is an emerging model for cereal and bioenergy grasses because of its short stature, rapid life cycle and expanding genetic and genomic toolkits. Its close phylogenetic relationship with economically important crops such as maize and sorghum positions Setaria as an ideal model system for accelerating discovery and characterization of crop genes that control agronomically important traits. The Second International Setaria Genetics Conference was held on March 6-8, 2017 at the Donald Danforth Plant Science Center, St. Louis, MO, United States to discuss recent technological breakthroughs and research directions in Setaria (presentation abstracts can be downloaded at https://www.brutnelllab.org/setaria). Here, we highlight topics presented in the conference including inflorescence architecture, C-4 photosynthesis and abiotic stress. Genetic and genomic toolsets including germplasm, mutant populations, transformation and gene editing technologies are also discussed. Since the last meeting in 2014, the Setaria community has matured greatly in the quality of research being conducted. Outreach and increased communication with maize and other plant communities will allow broader adoption of Setaria as a model system to translate fundamental discovery research to crop improvement.	[Zhu, Chuanmei; Yang, Jiani; Shyu, Christine] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Shyu, C (reprint author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	cshyu@danforthcenter.org			National Science Foundation (NSF) [IOS-1413824]; DDPSC; US Department of Agriculture - National Institute of Food and Agriculture [2014-67012-22269]; US Department of Energy [DE-SC0008769]	CZ is supported by National Science Foundation (NSF) grant IOS-1413824 to Elizabeth A. Kellogg. JY is supported by DDPSC, and CS is supported by a US Department of Agriculture - National Institute of Food and Agriculture Postdoctoral Fellowship (2014-67012-22269) and US Department of Energy Award (DE-SC0008769).	Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Demirci Y., 2017, J CELL PHYSL, DOI 10.1002/jcp.25970; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Huang P, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.54; Huang P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01781; Huang P, 2016, CURR OPIN PLANT BIOL, V31, P91, DOI 10.1016/j.pbi.2016.03.014; Huang P, 2014, MOL ECOL, V23, P4912, DOI 10.1111/mec.12907; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Kikuchi K, 2017, PLANT GENET GENOMICS, V19, P323, DOI 10.1007/978-3-319-45105-3_19; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Martins Polyana Kelly, 2015, Biotechnol Rep (Amst), V6, P61, DOI 10.1016/j.btre.2015.02.006; Mathan J, 2016, DEVELOPMENT, V143, P3283, DOI 10.1242/dev.134072; Pant SR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01885; Rellan-Alvarez R, 2015, ELIFE, V4, DOI 10.7554/eLife.07597; Saha P, 2016, PLANT J, V86, P89, DOI 10.1111/tpj.13148; Sebastian J, 2016, P NATL ACAD SCI USA, V113, P8861, DOI 10.1073/pnas.1604021113; Van Eck J, 2015, METHODS MOL BIOL, V1223, P57, DOI 10.1007/978-1-4939-1695-5_5	22	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	SEP 28	2017	8								1562	10.3389/fpls.2017.01562				5	Plant Sciences	Plant Sciences	FI3WZ	WOS:000411902200001	29033954	gold			2018-01-05	
J	Zhang, PP; Zhang, YX; Sun, LP; Sinumporn, S; Yang, ZF; Sun, B; Xuan, DD; Li, ZH; Yu, P; Wu, WX; Wang, KJ; Cao, LY; Cheng, SH				Zhang, Peipei; Zhang, Yingxin; Sun, Lianping; Sinumporn, Sittipun; Yang, Zhengfu; Sun, Bin; Xuan, Dandan; Li, Zihe; Yu, Ping; Wu, Weixun; Wang, Kejian; Cao, Liyong; Cheng, Shihua			The Rice AAA-ATPase OsFIGNL1 Is Essential for Male Meiosis	FRONTIERS IN PLANT SCIENCE			English	Article						Oryza sativa; meiosis; male sterility; OsFIGNL1; chromosomes	ELEGANS FIDGETIN HOMOLOG; STRANDED BREAK REPAIR; HUMAN RAD51 PROTEIN; CHROMOSOME SYNAPSIS; ANTHER DEVELOPMENT; CROSSOVER FORMATION; C. ELEGANS; DNA-REPAIR; RECOMBINATION; ARABIDOPSIS	Meiosis is crucial in reproduction of plants and ensuring genetic diversity. Although several genes involved in homologous recombination and DNA repair have been reported, their functions in rice (Oryza sativa) male meiosis remain poorly understood. Here, we isolated and characterized the rice OsFIGNL1 (OsFidgetin-like 1) gene, encoding a conserved AAA-ATPase, and explored its function and importance in male meiosis and pollen formation. The rice Osfignl1 mutant exhibited normal vegetative growth, but failed to produce seeds and displayed pollen abortion phenotype. Phenotypic comparisons between the wild-type and Osfignl1 mutant demonstrated that OsFIGNL1 is required for anther development, and that the recessive mutation of this gene causes male sterility in rice. Complementation and CRISPR/Cas9 experiments demonstrated that wild-type OsFIGNL1 is responsible for the male sterility phenotype. Subcellular localization showed that OsFIGNL1-green fluorescent protein was exclusively localized in the nucleus of rice protoplasts. Male meiosis in the Osfignl1 mutant exhibited abnormal chromosome behavior, including chromosome bridges and multivalent chromosomes at diakinesis, lagging chromosomes, and chromosome fragments during meiosis. Yeast two-hybrid assays demonstrated OsFIGNL1 could interact with RAD51A1, RAD51A2, DMC1A, DMC1B, and these physical interactions were further confirmed by BiFC assay. Taken together, our results suggest that OsFIGNL1 plays an important role in regulation of male meiosis and anther development.	[Zhang, Peipei; Zhang, Yingxin; Sun, Lianping; Sinumporn, Sittipun; Yang, Zhengfu; Sun, Bin; Xuan, Dandan; Li, Zihe; Yu, Ping; Wu, Weixun; Wang, Kejian; Cao, Liyong; Cheng, Shihua] China Natl Rice Res Inst, Key Lab Zhejiang Super Rice Res, Hangzhou, Zhejiang, Peoples R China; [Zhang, Peipei; Zhang, Yingxin; Sun, Lianping; Sinumporn, Sittipun; Yang, Zhengfu; Sun, Bin; Xuan, Dandan; Li, Zihe; Yu, Ping; Wu, Weixun; Wang, Kejian; Cao, Liyong; Cheng, Shihua] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Peipei] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Cao, LY; Cheng, SH (reprint author), China Natl Rice Res Inst, Key Lab Zhejiang Super Rice Res, Hangzhou, Zhejiang, Peoples R China.; Cao, LY; Cheng, SH (reprint author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	caolycgf@mail.hz.zj.cn; shcheng@mail.hz.zj.cn		Wang, Kejian/0000-0002-8385-6714	National Key Transform Program [2016ZX08001-002]; National Natural Science Foundation of China [31501290]; Zhejiang Provincial Natural Science Foundation of China [LQ14C130003]; Super Rice Breeding Innovation Team of the Chinese Academy of Agricultural Sciences Innovation Project [CAAS-ASTIP-2013-CNRRI]; Rice Heterosis Mechanism Research Innovation Team of the Chinese Academy of Agricultural Sciences Innovation Project [CAAS-ASTIP-2013-CNRRI]	We would like to thank Prof. Jian Zhang (China National Rice Research Institute) for critical proof reading, feedback, and editing of the manuscript. This work was supported by grants from the National Key Transform Program (# 2016ZX08001-002), the National Natural Science Foundation of China (# 31501290), the Zhejiang Provincial Natural Science Foundation of China (Grant # LQ14C130003), and the Super Rice Breeding Innovation Team and Rice Heterosis Mechanism Research Innovation Team of the Chinese Academy of Agricultural Sciences Innovation Project (CAAS-ASTIP-2013-CNRRI).	Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X                                                   ; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Bleuyard JY, 2004, EMBO J, V23, P439, DOI 10.1038/sj.emboj.7600055; Bugreev DV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5198; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Couteau F, 1999, PLANT CELL, V11, P1623, DOI 10.1105/tpc.11.9.1623; Cox GA, 2000, NAT GENET, V26, P383; Da Ines O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003787; Dray E, 2006, PLANT PHYSIOL, V140, P1059, DOI 10.1104/pp.105.075838; Edlinger B, 2011, J EXP BOT, V62, P1545, DOI 10.1093/jxb/erq421; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI [10.1146/annurev.biochern.77.061306.125255, 10.1146/annurev.biochem.77.061306.125255]; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Ghabrial A, 1999, NAT CELL BIOL, V1, P354; Girard C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005369; Higgins JD, 2005, GENE DEV, V19, P2488, DOI 10.1101/gad.354705; Ji JH, 2013, CHROMOSOMA, V122, P363, DOI 10.1007/s00412-013-0421-1; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kou YJ, 2012, J EXP BOT, V63, P5323, DOI 10.1093/jxb/ers190; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500                                          ; Kurzbauer MT, 2012, PLANT CELL, V24, P2058, DOI 10.1105/tpc.112.098459; L'Hote D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027582; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00377; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Li WX, 2006, CELL RES, V16, P402, DOI 10.1038/sj.cr.7310052; Li WX, 2005, PLANT PHYSIOL, V138, P965, DOI 10.1104/pp.104.058347; Li WX, 2004, P NATL ACAD SCI USA, V101, P10596, DOI 10.1073/pnas.0404110101; Lin JZ, 2009, PLANT CELL REP, V28, P1065, DOI 10.1007/s00299-009-0706-2; Luke-Glaser S, 2007, J CELL SCI, V120, P3179, DOI 10.1242/jcs.015883; Luo Q, 2013, MOL PLANT, V6, P729, DOI 10.1093/mp/sss145; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Milman N, 2009, MOL CELL BIOL, V29, P5998, DOI 10.1128/MCB.01127-09; Morozumi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075451; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321                                                           ; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nonomura KL, 2004, PLANT CELL, V16, P1008, DOI 10.1105/tpc.020701; Onitake A, 2012, J STRUCT BIOL, V179, P143, DOI 10.1016/j.jsb.2012.04.022; Peng WT, 2013, J BIOL CHEM, V288, P29305, DOI 10.1074/jbc.M113.502559; Pezza RJ, 2010, BIOPHYS J, V99, P3763, DOI 10.1016/j.bpj.2010.10.028; Pradillo M, 2014, FRONT PLANT SCI, V5, P1, DOI DOI 10.3389/FPLS.2014.00023; Pradillo M, 2012, PLANT J, V69, P921, DOI 10.1111/j.1365-313X.2011.04845.x; Rajanikant C, 2008, PLANT MOL BIOL, V68, P479, DOI 10.1007/s11103-008-9385-6; Sakane I, 2008, NUCLEIC ACIDS RES, V36, P4266, DOI 10.1093/nar/gkn405; Schommer C, 2003, PLANT J, V36, P1, DOI 10.1046/j.1365-313X.2003.01850.x; Seeliger K, 2012, NEW PHYTOL, V193, P364, DOI 10.1111/j.1469-8137.2011.03947.x; Shen Y, 2012, J CELL SCI, V125, P2581, DOI 10.1242/jcs.090993; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tang D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00167; Tao JY, 2007, PLANT J, V51, P919, DOI 10.1111/j.1365-313X.2007.03190.x; Uanschou C, 2013, PLANT CELL, V25, P4924, DOI 10.1105/tpc.113.118521; Vajjhala PR, 2006, FEBS J, V273, P2357, DOI 10.1111/j.1742-4658.2006.05238.x; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Wang CL, 2016, J EXP BOT, V67, P1447, DOI 10.1093/jxb/erv540; Wang HJ, 2016, PLANT PHYSIOL, V171, P230, DOI 10.1104/pp.16.00167; Wang Y, 2011, MOL BIOL CELL, V22, P1878, DOI 10.1091/mbc.E10-12-1011; Wu WX, 2013, P NATL ACAD SCI USA, V110, P2775, DOI 10.1073/pnas.1213962110; Wu Z, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00021; Yakushiji Y, 2004, FEBS LETT, V578, P191, DOI 10.1016/j.febslet.2004.11.009; Yang Y, 2005, EXP CELL RES, V304, P50, DOI 10.1016/j.yexcr.2004.11.014; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan JS, 2013, P NATL ACAD SCI USA, V110, P10640, DOI 10.1073/pnas.1220662110; Zhang BW, 2015, J EXP BOT, V66, P5713, DOI 10.1093/jxb/erv253; Zhang DB, 2011, J GENET GENOMICS, V38, P379, DOI 10.1016/j.jgg.2011.08.001; Zhang DS, 2010, PLANT PHYSIOL, V154, P149, DOI 10.1104/pp.110.158865; Zhao XY, 2016, CELL CYCLE, V15, P2367, DOI 10.1080/15384101.2016.1204059; Zhou SR, 2011, PLANT CELL, V23, P111, DOI 10.1105/tpc.109.073692	70	0	0	23	23	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	SEP 27	2017	8								1639	10.3389/fpls.2017.01639				17	Plant Sciences	Plant Sciences	FI3WQ	WOS:000411901300001	29021797	gold			2018-01-05	
J	Kim, H; Feng, L; He, QY; Deng, TT; Jun, X; Feng, J; Coarfa, C; Putluri, N; Dan, L; Zhou, SY				Kim, Hyeung; Feng Li; He, Quanyuan; Deng, Tingting; Jun Xu; Feng Jin; Coarfa, Cristian; Putluri, Nagireddy; Dan Liu; Zhou Songyang			Systematic analysis of human telomeric dysfunction using inducible telosome/shelterin CRISPR/Cas9 knockout cells	CELL DISCOVERY			English	Article						CRISPR/Cas9; inducible knockout; metabolism; POT1 isoform; telomere; telosome/shelterin	ABERRANT HOMOLOGOUS RECOMBINATION; MITOCHONDRIAL-DNA DAMAGE; LENGTH REGULATOR TRF1; MAMMALIAN TELOMERES; GENE-EXPRESSION; INDEPENDENT CONTROL; MOUSE TELOMERES; POT1 PROTEINS; PROTECTION; TPP1	CRISPR/Cas9 technology enables efficient loss-of-function analysis of human genes using somatic cells. Studies of essential genes, however, require conditional knockout (KO) cells. Here, we describe the generation of inducible CRISPR KO human cell lines for the subunits of the telosome/shelterin complex, TRF1, TRF2, RAP1, TIN2, TPP1 and POT1, which directly interact with telomeres or can bind to telomeres through association with other subunits. Homozygous inactivation of several subunits is lethal in mice, and most loss-of-function studies of human telomere regulators have relied on RNA interference-mediated gene knockdown, which suffers its own limitations. Our inducible CRISPR approach has allowed us to more expediently obtain large numbers of KO cells in which essential telomere regulators have been inactivated for biochemical and molecular studies. Our systematic analysis revealed functional differences between human and mouse telomeric proteins in DNA damage responses, telomere length and metabolic control, providing new insights into how human telomeres are maintained.	[Kim, Hyeung; He, Quanyuan; Dan Liu; Zhou Songyang] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Feng Li; Deng, Tingting; Zhou Songyang] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangzhou, Guangdong, Peoples R China; [Feng Li; Deng, Tingting; Zhou Songyang] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Jun Xu; Dan Liu] Baylor Coll Med, Cell Based Assay Screening Serv Core, Houston, TX 77030 USA; [Feng Jin; Coarfa, Cristian; Putluri, Nagireddy] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Feng Jin; Coarfa, Cristian; Putluri, Nagireddy] Baylor Coll Med, Adv Technol Core, Houston, TX 77030 USA	Zhou, SY (reprint author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Zhou, SY (reprint author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangzhou, Guangdong, Peoples R China.; Zhou, SY (reprint author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	songyang@bcm.edu		Jin, Feng/0000-0002-9099-9318	National Key Research and Development Program of China [2017YFA0102800, 2017YFA0102801]; National Natural Science Foundation of China [NSFC 91640119, 81330055]; Science and Technology Planning Project of Guangdong Province [2015B020228002]; Guangzhou Science and Technology Project [201605030012]; NIGMS [GM095599]; NCI [CA211653]; CPRIT [RP160462, RP120092]; Welch Foundation [Q-1673, HL131744]; C-BASS Shared Resource at the Dan L Duncan Cancer Center (DLDCC) of Baylor College of Medicine [P30CA125123]; Proteomic and Metabolomic Core Facility [NCI/2P30CA125123-09]; Dan L Duncan Cancer Center (DLDCC)	This work was supported by the National Key Research and Development Program of China (2017YFA0102800 and 2017YFA0102801), National Natural Science Foundation of China (NSFC 91640119 and 81330055), Science and Technology Planning Project of Guangdong Province (2015B020228002) and Guangzhou Science and Technology Project (201605030012). We would also like to acknowledge the support of NIGMS GM095599, NCI CA211653, CPRIT RP160462, the Welch Foundation Q-1673, HL131744 and the C-BASS Shared Resource (with special thanks to Dr JX) at the Dan L Duncan Cancer Center (DLDCC) of Baylor College of Medicine (P30CA125123). This research was also made possible through the support by the CPRIT Core Facility Support Award RP120092, Proteomic and Metabolomic Core Facility, NCI/2P30CA125123-09 Shared Resources Metabolomics core, and funds from the Dan L Duncan Cancer Center (DLDCC).	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092; Barrientos KS, 2008, MOL CELL BIOL, V28, P5251, DOI 10.1128/MCB.00048-08; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Baumann P, 2006, CELL, V126, P33, DOI 10.1016/j.cell.2006.06.027; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785                                                         ; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Carneiro T, 2010, NATURE, V467, P228, DOI 10.1038/nature09353; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen LY, 2012, MOL CELL, V47, P839, DOI 10.1016/j.molcel.2012.07.002; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; Churikov D, 2006, MOL CELL BIOL, V26, P6971, DOI 10.1128/MCB.01011-06; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080                                                          ; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3                                                   ; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6                                                    ; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; He QY, 2015, CELL STEM CELL, V17, P273, DOI 10.1016/j.stem.2015.07.022; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Hockemeyer D, 2015, NAT STRUCT MOL BIOL, V22, P848, DOI 10.1038/nsmb.3083; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabir S, 2014, CELL REP, V9, P1273, DOI 10.1016/j.celrep.2014.10.014; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; Kim SH, 1999, NAT GENET, V23, P405; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2                                                   ; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lue NF, 2013, NAT STRUCT MOL BIOL, V20, P10, DOI 10.1038/nsmb.2483; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martinez P, 2013, CELL REP, V3, P2059, DOI 10.1016/j.celrep.2013.05.030; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705                                                        ; Nakashima M, 2013, J BIOL CHEM, V288, P33171, DOI 10.1074/jbc.M113.518175; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861                                                         ; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Robles-Espinoza CD, 2015, MOL CANCER RES, V13, P211, DOI 10.1158/1541-7786.MCR-14-0305; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Sarek G, 2015, NAT STRUCT MOL BIOL, V22, P867, DOI 10.1038/nsmb.3093; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Schmidt JC, 2015, GENE DEV, V29, P1095, DOI 10.1101/gad.263863.115; Sexton AN, 2014, GENE DEV, V28, P1885, DOI 10.1101/gad.246819.114; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singhapol C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052989; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000                                                 ; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; von Rundstedt FC, 2016, J UROLOGY, V195, P1911, DOI 10.1016/j.juro.2016.01.039; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Yang Q, 2007, CANCER RES, V67, P11677, DOI 10.1158/0008-5472.CAN-07-1390; Ye JZ, 2004, J BIOL CHEM, V16, P16; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zhou SY, 2006, CRIT REV EUKAR GENE, V16, P103, DOI 10.1615/CritRevEukarGeneExpr.v16.i2.10                                          	96	0	0	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2056-5968			CELL DISCOV	Cell Discov.	SEP 26	2017	3								UNSP 17034	10.1038/celldisc.2017.34				17	Cell Biology	Cell Biology	FM3SL	WOS:000414927700001	28955502	gold			2018-01-05	
J	Gulbranson, DR; Davis, EM; Demmitt, BA; Ouyang, Y; Ye, YH; Yu, HJ; Shen, JS				Gulbranson, Daniel R.; Davis, Eric M.; Demmitt, Brittany A.; Ouyang, Yan; Ye, Yihong; Yu, Haijia; Shen, Jingshi			RABIF/MSS4 is a Rab-stabilizing holdase chaperone required for GLUT4 exocytosis	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						GLUT4; exocytosis; Rab GTPase; CRISPR screen; vesicle transport	WIDE CRISPR SCREEN; MEMBRANE-FUSION; NUCLEOTIDE EXCHANGE; GLUCOSE-TRANSPORTER; HUMAN GENOME; HUMAN-CELLS; GENETIC SCREENS; PROTEIN; INSULIN; GTPASES	Rab GTPases are switched from their GDP-bound inactive conformation to a GTP-bound active state by guanine nucleotide exchange factors (GEFs). The first putative GEFs isolated for Rabs are RABIF (Rab-interacting factor)/MSS4 (mammalian suppressor of Sec4) and its yeast homolog DSS4 (dominant suppressor of Sec4). However, the biological function and molecular mechanism of these molecules remained unclear. In a genome-wide CRISPR genetic screen, we isolated RABIF as a positive regulator of exocytosis. Knockout of RABIF severely impaired insulin-stimulated GLUT4 exocytosis in adipocytes. Unexpectedly, we discovered that RABIF does not function as a GEF, as previously assumed. Instead, RABIF promotes the stability of Rab10, a key Rab in GLUT4 exocytosis. In the absence of RABIF, Rab10 can be efficiently synthesized but is rapidly degraded by the proteasome, leading to exocytosis defects. Strikingly, restoration of Rab10 expression rescues exocytosis defects, bypassing the requirement for RABIF. These findings reveal a crucial role of RABIF in vesicle transport and establish RABIF as a Rab-stabilizing holdase chaperone, a previously unrecognized mode of Rab regulation independent of its GDP-releasing activity. Besides Rab10, RABIF also regulates the stability of two other Rab GTPases, Rab8 and Rab13, suggesting that the requirement of holdase chaperones is likely a general feature of Rab GTPases.	[Gulbranson, Daniel R.; Davis, Eric M.; Demmitt, Brittany A.; Ouyang, Yan; Yu, Haijia; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Demmitt, Brittany A.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Ye, Yihong] NIDDK, Lab Mol Biol, NIH, Bethesda, MD 20892 USA; [Yu, Haijia] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China	Yu, HJ; Shen, JS (reprint author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.; Yu, HJ (reprint author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.	haijiayu@gmail.com; jingshi.shen@colorado.edu			NIH [DK095367, GM102217]; Pew Scholar Award; University of Colorado Seed Grant; American Heart Association	We thank Drs. Shingo Kajimura, Frances Brodsky, Gus Lienhard, Joaquin Espinosa, Gia Voeltz, and Cynthia Mastick for providing reagents; Drs. David James, David Sabatini, Tim Wang, Juan Bonifacino, Soyeon Park, and David Gershlick for insightful advice; Tom Blumenthal, Ding Xue, Ben Weaver, and Dwight Klemm for helpful discussions; Yuming Han, Thomas Lee, Katrina Diener, Jeff Reece, and Molishree Joshi for technical assistance; and members of the J.S. group for discussions and assistance. This work was supported by NIH Grants DK095367 (to J.S.) and GM102217 (to J.S.), a Pew Scholar Award (to J.S.), a University of Colorado Seed Grant (to J.S.), and an American Heart Association Predoctoral Fellowship (to D.R.G.).	Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Antonescu CN, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016964; Aslamy A, 2017, AM J PHYSIOL-REG I, V312, pR739, DOI 10.1152/ajpregu.00002.2017; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; BURTON J, 1993, NATURE, V361, P464, DOI 10.1038/361464a0; Collins RN, 1997, J BIOL CHEM, V272, P18281, DOI 10.1074/jbc.272.29.18281; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Davis EM, 2015, CELL REP, V11, P1727, DOI 10.1016/j.celrep.2015.05.026; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Erde J, 2014, J PROTEOME RES, V13, P1885, DOI 10.1021/pr4010019; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gaisano HY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00349; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ioannou MS, 2015, J CELL BIOL, V208, P629, DOI 10.1083/jcb.201407068; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; MOYA M, 1993, NATURE, V361, P460, DOI 10.1038/361460a0; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Nuoffer C, 1997, MOL BIOL CELL, V8, P1305; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Rathore SS, 2011, MOL BIOL CELL, V22, P2612, DOI 10.1091/mbc.E11-03-0190; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Schekman R, 2004, CELL, V116, pS19; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Smith Susan J M, 2002, Methods Mol Biol, V189, P13; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Trefely S, 2015, J BIOL CHEM, V290, P25834, DOI 10.1074/jbc.M115.658815; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wixler V, 2011, BIOL CHEM, V392, P239, DOI 10.1515/BC.2011.022; Xiong X, 2016, ANNU REV GENOM HUM G, V17, P131, DOI 10.1146/annurev-genom-083115-022258; Yu HJ, 2016, P NATL ACAD SCI USA, V113, P4362, DOI 10.1073/pnas.1517259113; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Yu HJ, 2013, J BIOL CHEM, V288, P18885, DOI 10.1074/jbc.M113.465450; Yu HJ, 2013, MOL BIOL CELL, V24, P1176, DOI 10.1091/mbc.E12-11-0810; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu ZY, 2001, BIOCHEMISTRY-US, V40, P15699, DOI 10.1021/bi0116792; Zhu ZY, 2001, BIOCHEMISTRY-US, V40, P3027, DOI 10.1021/bi002680o	74	0	0	2	2	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 26	2017	114	39					E8224	E8233		10.1073/pnas.1712176114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FI1OR	WOS:000411704000014	28894007				2018-01-05	
J	Hidalgo-Cantabrana, C; Crawley, AB; Sanchez, B; Barrangou, R				Hidalgo-Cantabrana, Claudio; Crawley, Alexandra B.; Sanchez, Borja; Barrangou, Rodolphe			Characterization and Exploitation of CRISPR Loci in Bifidobacterium longum	FRONTIERS IN MICROBIOLOGY			English	Article						CRISPR-Cas systems; genotyping; probiotics; Bifidobacterium longum	COMPLETE GENOME SEQUENCE; CAS SYSTEMS; STREPTOCOCCUS-THERMOPHILUS; GENUS BIFIDOBACTERIUM; VERTICAL TRANSMISSION; EVOLUTION; DIVERSITY; CLASSIFICATION; GENERATION; COMPLEX	Diverse CRISPR-Cas systems provide adaptive immunity in many bacteria and most archaea, via a DNA-encoded, RNA-mediated, nucleic-acid targeting mechanism. Over time, CRISPR loci expand via iterative uptake of invasive DNA sequences into the CRISPR array during the adaptation process. These genetic vaccination cards thus provide insights into the exposure of strains to phages and plasmids in space and time, revealing the historical predatory exposure of a strain. These genetic loci thus constitute a unique basis for genotyping of strains, with potential of resolution at the strain-level. Here, we investigate the occurrence and diversity of CRISPR-Cas systems in the genomes of various Bifidobacterium longum strains across three sub-species. Specifically, we analyzed the genomic content of 66 genomes belonging to Blongumsubsp. longum, Blongumsubsp. infant is and Blongusubspsu is, and identified 25 strains that carry 29 total CRISPR-Cas systems. We identify various Type I and Type II CRISPR-Cas systems that are widespread in this species, notably I-C, I-E, and II-C. Noteworthy, Type I-C systems showed extended CRISPR arrays, with extensive spacer diversity. We show how these hypervariable loci can be used to gain insights into strain origin, evolution and phylogeny, and can provide discriminatory sequences to distinguish even clonal isolates. By investigating CRISPR spacer sequences, we reveal their origin and implicate phages and prophages as drivers of CRISPR immunity expansion in this species, with redundant targeting of select prophages. Analysis of CRISPR spacer origin also revealed novel PAM sequences. Our results suggest that CRISPR-Cas immune systems are instrumental in mounting diversified viral resistance in B. l o n g u m, and show that these sequences are useful for typing across three subspecies.	[Hidalgo-Cantabrana, Claudio; Crawley, Alexandra B.; Barrangou, Rodolphe] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Hidalgo-Cantabrana, Claudio; Sanchez, Borja] IPLA CSIC, Dept Microbiol & Biochem Dairy Prod, Dairy Res Inst Asturias, Villaviciosa, Spain	Barrangou, R (reprint author), North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	rbarran@ncsu.edu			North Carolina State University; North Carolina Ag Foundation	This study was funded by start-up funds from North Carolina State University and the North Carolina Ag Foundation.	Almeida F, 2017, J MICROBIOL METH, V133, P55, DOI 10.1016/j.mimet.2016.12.020; Altmann F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162983; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Andersen JM, 2016, GENOME BIOL EVOL, V8, P2841, DOI 10.1093/gbe/evw203; Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204; Averina OV, 2012, RUSS J GENET+, V48, P1103, DOI 10.1134/S1022795412110026; Bachmann NL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-389; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Barros MPS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108353; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Boto L, 2010, P R SOC B, V277, P819, DOI 10.1098/rspb.2009.1679; Brandt K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00657; Bresson JL, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4369; Briner AE, 2016, CURR OPIN MICROBIOL, V31, P101, DOI 10.1016/j.mib.2016.03.006; Briner AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133661; Briner AE, 2014, APPL ENVIRON MICROB, V80, P994, DOI 10.1128/AEM.03015-13; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Bunesova V, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0867-4; Chaplin AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135658; Chenoll E. C. F., 2013, J PROBIOTICS HLTH, V1, P106, DOI [10.4172/2329-8901.1000106, DOI 10.4172/2329-8901.1000106]; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Douillard FP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003683; Duranti S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0282-6; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FAO/WHO:, 2002, GUID EV PROB FOOD; Ferrario C, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv009; Freidlin PJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3560-6; Gogleva AA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-202; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Ham JS, 2011, J BACTERIOL, V193, P5044, DOI 10.1128/JB.05620-11; Hao YL, 2011, J BACTERIOL, V193, P787, DOI 10.1128/JB.01213-10; Hidalgo-Cantabrana C, 2017, CURR OPIN MICROBIOL, V37, P79, DOI 10.1016/j.mib.2017.05.015; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kala S, 2014, P NATL ACAD SCI USA, V111, P6022, DOI 10.1073/pnas.1320952111; Kanesaki Y., 2014, GENOME ANNOUNC, V2, DOI 10.1128/genomeA.01311-14; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelly WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30768; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Koskela KA, 2015, ENVIRON MICROBIOL, V17, P4306, DOI 10.1111/1462-2920.12816; Kovanen SM, 2014, J APPL MICROBIOL, V117, P249, DOI 10.1111/jam.12503; Kwon SK, 2015, J BIOTECHNOL, V214, P169, DOI 10.1016/j.jbiotec.2015.09.039; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Lewis ZT, 2016, PEDIATR RES, V79, P445, DOI 10.1038/pr.2015.244; Lewis ZT, 2013, ANAEROBE, V19, P62, DOI 10.1016/j.anaerobe.2012.12.005; Lugli GA, 2016, ENVIRON MICROBIOL, V18, P2196, DOI 10.1111/1462-2920.13154; Lugli GA, 2014, APPL ENVIRON MICROB, V80, P6383, DOI 10.1128/AEM.02004-14; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; Milani C, 2015, APPL ENVIRON MICROB, V81, P7078, DOI 10.1128/AEM.02037-15; Milani C, 2014, APPL ENVIRON MICROB, V80, P6290, DOI 10.1128/AEM.02308-14; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Morovic W, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01747; R Development Core Team,, 2008, R LANG ENV STAT COMP; Sanozky-Dawes R, 2015, MICROBIOL-SGM, V161, P1752, DOI 10.1099/mic.0.000129; Shariat N, 2015, MICROBIOL-SGM, V161, P374, DOI 10.1099/mic.0.000005; Shariat N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-254; Shkoporov AN, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00234-13, DOI 10.1128/GEN0MEA.00234-13]; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Sneath PHA, 1973, NUMERICAL TAXONOMY; Sola Christophe, 2015, Methods Mol Biol, V1311, P91, DOI 10.1007/978-1-4939-2687-9_6; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Sun HH, 2015, FOODBORNE PATHOG DIS, V12, P68, DOI 10.1089/fpd.2014.1792; Sun L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8548; Tojo R, 2014, WORLD J GASTROENTERO, V20, P15163, DOI 10.3748/wjg.v20.i41.15163; Tupikin A. E., 2016, GENOME ANNOUNC, V4, DOI [10.1128/genomeA.01411-16, DOI 10.1128/GENOMEA.01411-16]; Ventura M, 2009, APPL ENVIRON MICROB, V75, P6929, DOI 10.1128/AEM.01112-09; Wang JF, 2016, ENVIRON MICROBIOL, V18, P2143, DOI 10.1111/1462-2920.12923; Xie XL, 2017, VET MICROBIOL, V203, P81, DOI 10.1016/j.vetmic.2017.02.010; Xu X Q, 2017, Zhonghua Yu Fang Yi Xue Za Zhi, V51, P237, DOI 10.3760/cma.j.issn.0253-9624.2017.03.009; Chug M. J., 2017, Google Patents, Patent No. [WO 2016186245 A1, 2016186245]	81	0	0	10	10	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	SEP 26	2017	8								1851	10.3389/fmicb.2017.01851				16	Microbiology	Microbiology	FI2DX	WOS:000411748800002	29033911	gold			2018-01-05	
J	Oesterle, S; Gerngross, D; Schmitt, S; Roberts, TM; Panke, S				Oesterle, Sabine; Gerngross, Daniel; Schmitt, Steven; Roberts, Tania Michelle; Panke, Sven			Efficient engineering of chromosomal ribosome binding site libraries in mismatch repair proficient Escherichia coli	SCIENTIFIC REPORTS			English	Article							PROTEIN EXPRESSION; REPLACEMENT; EVOLUTION; PRECISE; PATHWAY; DESIGN; DNA	Multiplexed gene expression optimization via modulation of gene translation efficiency through ribosome binding site (RBS) engineering is a valuable approach for optimizing artificial properties in bacteria, ranging from genetic circuits to production pathways. Established algorithms design smart RBS-libraries based on a single partially-degenerate sequence that efficiently samples the entire space of translation initiation rates. However, the sequence space that is accessible when integrating the library by CRISPR/Cas9-based genome editing is severely restricted by DNA mismatch repair (MMR) systems. MMR efficiency depends on the type and length of the mismatch and thus effectively removes potential library members from the pool. Rather than working in MMR-deficient strains, which accumulate off-target mutations, or depending on temporary MMR inactivation, which requires additional steps, we eliminate this limitation by developing a pre-selection rule of genome-library-optimized-sequences (GLOS) that enables introducing large functional diversity into MMR-proficient strains with sequences that are no longer subject to MMR-processing. We implement several GLOS-libraries in Escherichia coli and show that GLOS-libraries indeed retain diversity during genome editing and that such libraries can be used in complex genome editing operations such as concomitant deletions. We argue that this approach allows for stable and efficient fine tuning of chromosomal functions with minimal effort.	[Oesterle, Sabine; Gerngross, Daniel; Schmitt, Steven; Roberts, Tania Michelle; Panke, Sven] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland	Panke, S (reprint author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	sven.panke@bsse.ethz.ch		Roberts, Tania/0000-0001-9518-3011; Gerngross, Daniel/0000-0002-9188-2277	Swiss National Science Foundation [310030_143645]; NCCR Molecular Systems Engineering	We thank George Church for providing strain EcNR1 (Addgene strain #26930), Luciano Marraffini for pCas9 (Addgene plasmid #42876) and pCRISPR (Addgene plasmid #42875), Victor de Lorenzo for pSEVA431, Andreas Bosshart for pAB92 and Diana Ostos Rangel for the pSEVA261_ribX plasmids. We thank Lukas A. Widmer for critical reviewing of the RedLibs v1.1.0 script and this manuscript. We thank Irene Wuthrich, Tsvetan Kardashliev and Markus Jeschek for critical reading of the manuscript and scientific discussions as well as Christian Beisel and the Genomics Facility Basel (D-BSSE, ETH Zurich) for NGS and Susana Posada Cespedes for her help with the NGS analysis. This work was supported by the Swiss National Science Foundation (project PROTSWITCH #310030_143645) and the NCCR Molecular Systems Engineering.	Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Bonde MT, 2016, NAT METHODS, V13, P233, DOI [10.1038/NMETH.3727, 10.1038/nmeth.3727]; Bonde MT, 2015, ACS SYNTH BIOL, V4, P17, DOI 10.1021/sb5001565; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; Ceroni F, 2015, NAT METHODS, V12, P415, DOI [10.1038/NMETH.3339, 10.1038/nmeth.3339]; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.243959100; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Farasat I, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20134955; Fernandez-Rodriguez J, 2017, NAT CHEM BIOL, V13, P706, DOI 10.1038/nchembio.2390; Gallagher RR, 2014, NAT PROTOC, V9, P2301, DOI 10.1038/nprot.2014.082; Garst A. D., 2016, NAT BIOTECHNOL, V35, P1; Guo DY, 2015, J INTEGR BIOINFORMAT, V12, DOI 10.2390/biecoll-jib-2015-283; Hohmann HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P115; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jeschek M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11163; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Koziol J., 1966, PHOTOCHEM PHOTOBIOL, V5, P41; Lennen RM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1090; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Liang LY, 2017, METAB ENG, V41, P1, DOI 10.1016/j.ymben.2017.02.009; Ng CY, 2015, METAB ENG, V29, P86, DOI 10.1016/j.ymben.2015.03.001; Nyerges A, 2016, P NATL ACAD SCI USA, V113, P2502, DOI 10.1073/pnas.1520040113; Nyerges A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku105; [Anonymous], 2017, GENOME BASED METABOL, DOI DOI 10.1016/BS.AAMBS.2017.07.001; Pedrolli D, 2015, FEBS J, V282, P3230, DOI 10.1111/febs.13226; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Sambrook J, 2001, MOL CLONING LAB MANU; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Sawitzke JA, 2011, J MOL BIOL, V407, P45, DOI 10.1016/j.jmb.2011.01.030; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Silva F, 2012, BIOTECHNOL ADV, V30, P691, DOI 10.1016/j.biotechadv.2011.12.005; Waites M. J., 2002, INT J FOOD MICROBIOL, V77; Wang HH, 2011, NUCLEIC ACIDS RES, V39, P7336, DOI 10.1093/nar/gkr183; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wei TY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22646; Wu G, 2016, TRENDS BIOTECHNOL, V34, P652, DOI 10.1016/j.tibtech.2016.02.010; [Anonymous], 1992, BIOCH NOMENCLATURE R	41	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 26	2017	7								12327	10.1038/s41598-017-12395-3				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FI1FP	WOS:000411677500031	28951570	gold			2018-01-05	
J	Chen, XY; Janssen, JM; Liu, J; Maggio, I; t' Jong, AEJ; Mikkers, HMM; Goncalves, MAFV				Chen, Xiaoyu; Janssen, Josephine M.; Liu, Jin; Maggio, Ignazio; t' Jong, Anke E. J.; Mikkers, Harald M. M.; Goncalves, Manuel A. F. V.			In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting	NATURE COMMUNICATIONS			English	Article							HOMOLOGY-DIRECTED REPAIR; PLURIPOTENT STEM-CELLS; TARGETED GENE ADDITION; NUCLEASES; VECTOR; SPECIFICITY; CAS9; RECOMBINATION; EFFICIENCY; CHROMATIN	Precise genome editing involves homologous recombination between donor DNA and chromosomal sequences subjected to double-stranded DNA breaks made by programmable nucleases. Ideally, genome editing should be efficient, specific, and accurate. However, besides constituting potential translocation-initiating lesions, double-stranded DNA breaks (targeted or otherwise) are mostly repaired through unpredictable and mutagenic nonhomologous recombination processes. Here, we report that the coordinated formation of paired single-stranded DNA breaks, or nicks, at donor plasmids and chromosomal target sites by RNA-guided nucleases based on CRISPR-Cas9 components, triggers seamless homology-directed gene targeting of large genetic payloads in human cells, including pluripotent stem cells. Importantly, in addition to significantly reducing the mutagenicity of the genome modification procedure, this in trans paired nicking strategy achieves multiplexed, single-step, gene targeting, and yields higher frequencies of accurately edited cells when compared to the standard double-stranded DNA break-dependent approach.	[Chen, Xiaoyu; Janssen, Josephine M.; Liu, Jin; Maggio, Ignazio; t' Jong, Anke E. J.; Mikkers, Harald M. M.; Goncalves, Manuel A. F. V.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands	Goncalves, MAFV (reprint author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	M.Goncalves@lumc.nl		Goncalves, Manuel/0000-0002-8111-1073; Chen, Xiaoyu/0000-0003-4009-8156	Dutch Prinses Beatrix Spierfonds [W.OR11-18]; French AFMTelethon [16621]; China Scholarship Council-Leiden University Joint Scholarship Programme	The authors thank Hester Boersma and Daniela Salvatori for their technical assistance with the teratoma assays and Karoly Szuhai and Danielle de Jong for their FISH karyotyping of iPSCs (all from the Leiden University Medical Center, Leiden, the Netherlands). Axel Schambach (Institute of Experimental Hematology, Hannover, Germany), Anna Gram (Leiden University Medical Center, Leiden, the Netherlands), and Alessandra Recchia (University of Modena and Reggio Emilia, Modena, Italy) are gratefully acknowledged for providing the construct for generating iPSCs, the PuroR. T2A. EGFP ORF and the pSh. AAVS1. eGFP donor plasmid (herein named pDonor. ES1), respectively. The authors also thank Rob Hoeben for his critical reading of the manuscript and Steve Cramer for his assistance with the logistics (both from the Leiden University Medical Center, Leiden, the Netherlands). The authors thank Ron Wolterbeek Department of Medical Statistics and Bioinformatics, Leiden University Medical Center) for his help with the statistical analysis using the IBM SPSS Statistics 23 software package. This work was supported by the Dutch Prinses Beatrix Spierfonds (W.OR11-18) and the French AFMTelethon (16621). X.C. is the recipient of a Ph.D. research fellowship from the China Scholarship Council-Leiden University Joint Scholarship Programme.	Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Brielmeier M, 1998, NUCLEIC ACIDS RES, V26, P2082, DOI 10.1093/nar/26.9.2082; Cannan WJ, 2016, J CELL PHYSIOL, V231, P3, DOI 10.1002/jcp.25048; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Coluccio A, 2013, MOL THER, V21, P1695, DOI 10.1038/mt.2013.143; Dambrot C, 2013, DIFFERENTIATION, V85, P101, DOI 10.1016/j.diff.2013.01.001; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Goncalves MAFV, 2004, VIROLOGY, V321, P287, DOI 10.1016/j.virol.2004.01.007; Goncalves MAFV, 2012, NUCLEIC ACIDS RES, V40, P3443, DOI 10.1093/nar/gkr1234; Goncalves MAFV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003084; HE XJ, 2016, NUCL ACIDS RES, V44; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233                                                       ; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lackner DH, 2015, NAT COMMUN, V6; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Liu JC, 2014, TRENDS CELL BIOL, V24, P268, DOI 10.1016/j.tcb.2014.03.002; Maggio I, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0316-x; Maggio I, 2015, TRENDS BIOTECHNOL, V33, P280, DOI 10.1016/j.tibtech.2015.02.011; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2016, NAT BIOTECHNOL, V34, P210, DOI 10.1038/nbt0216-210c; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; NIWA H, 1991, GENE, V108, P193; Papapetrou EP, 2016, MOL THER, V24, P678, DOI 10.1038/mt.2016.38; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2013, CELL, V155, P479, DOI 10.1016/j.cell.2013.09.040; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Robert F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0215-6; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Szuhai K, 2006, NAT PROTOC, V1, P264, DOI 10.1038/nprot.2006.41; Thomson JA, 1998, SCIENCE, V282, P1827; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wang CX, 2016, BLOOD, V127, P2546, DOI 10.1182/blood-2016-01-678144; Wang JB, 2012, GENOME RES, V22, P1316, DOI 10.1101/gr.122879.111; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	47	0	0	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	SEP 22	2017	8								657	10.1038/s41467-017-00687-1				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FH9JL	WOS:000411526700002	28939824	gold			2018-01-05	
J	Niu, D; Wei, HJ; Lin, L; George, H; Wang, T; Lee, H; Zhao, HY; Wang, Y; Kan, YN; Shrock, E; Lesha, E; Wang, G; Luo, YL; Qing, YB; Jiao, DL; Zhao, H; Zhou, XY; Wang, SQ; Wei, H; Guell, M; Church, GM; Yang, LH				Niu, Dong; Wei, Hong-Jiang; Lin, Lin; George, Haydy; Wang, Tao; Lee, Hsiu; Zhao, Hong-Ye; Wang, Yong; Kan, Yinan; Shrock, Ellen; Lesha, Emal; Wang, Gang; Luo, Yonglun; Qing, Yubo; Jiao, Deling; Zhao, Heng; Zhou, Xiaoyang; Wang, Shouqi; Wei, Hong; Gueell, Marc; Church, George M.; Yang, Luhan			Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9	SCIENCE			English	Article							INFECTION; GENOMES; CELLS; PERVS	Xenotransplantation is a promising strategy to alleviate the shortage of organs for human transplantation. In addition to the concerns about pig-to-human immunological compatibility, the risk of cross-species transmission of porcine endogenous retroviruses (PERVs) has impeded the clinical application of this approach. We previously demonstrated the feasibility of inactivating PERV activity in an immortalized pig cell line. We now confirm that PERVs infect human cells, and we observe the horizontal transfer of PERVs among human cells. Using CRISPR-Cas9, we inactivated all of the PERVs in a porcine primary cell line and generated PERV-inactivated pigs via somatic cell nuclear transfer. Our study highlights the value of PERV inactivation to prevent cross-species viral transmission and demonstrates the successful production of PERV-inactivated animals to address the safety concern in clinical xenotransplantation.	[Niu, Dong; George, Haydy; Wang, Tao; Lee, Hsiu; Kan, Yinan; Lesha, Emal; Wang, Gang; Gueell, Marc; Church, George M.; Yang, Luhan] eGenesis, Cambridge, MA 02139 USA; [Niu, Dong] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Wei, Hong-Jiang; Zhao, Hong-Ye; Qing, Yubo; Jiao, Deling; Zhao, Heng] Yunnan Agr Univ, State Key Lab Conservat & Utilizat Bioresources, Kunming 650201, Yunnan, Peoples R China; [Wei, Hong-Jiang; Qing, Yubo; Jiao, Deling; Zhao, Heng] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming 650201, Yunnan, Peoples R China; [Lin, Lin; Luo, Yonglun] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Wang, Yong; Zhou, Xiaoyang; Wei, Hong] Third Mil Med Univ, Dept Lab Anim Sci, Coll Basic Med Sci, Chongqing 400038, Peoples R China; [Shrock, Ellen; Church, George M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Wang, Shouqi] Res Inst Shenzhen Jinxinnong Technol, Shenzhen 518106, Peoples R China; [Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Yang, LH (reprint author), eGenesis, Cambridge, MA 02139 USA.	luhan.yang@egenesisbio.com	Wang, Tobias/I-7946-2013; Luo, Yonglun/C-4708-2013	Wang, Tobias/0000-0002-4350-3682; Luo, Yonglun/0000-0002-0007-7759; Guell, Marc/0000-0003-4000-7912; church, george/0000-0001-6232-9969	eGenesis; NIH [P50 HG005550]; Danish Research Council for Independent Research [DFF-1337-00128]; Sapere Aude Young Research Talent Prize [DFF-1335-00763]; Human Frontiers Science Program Long-Term Fellowship; Major Program on Basic Research Projects of Yunnan Province, China [2014FC006]	We thank J. Markmann from Massachusetts General Hospital and P. O'Connell from Sydney University for providing advice on xenotransplantation; J. Hu from the Alt lab at Boston Children's Hospital for assistance with junction capture sequencing; Y. Takeuchi from University College London for comments on virus interference; T. Ferrante from the Wyss Institute, Harvard University, for assistance with embryo imaging; and members of the Seidman lab at Harvard Medical School for advice regarding ddPCR. This study was mainly funded by eGenesis and was also funded by NIH grant P50 HG005550. Y.L. was funded by the Danish Research Council for Independent Research (grant DFF-1337-00128) and the Sapere Aude Young Research Talent Prize (grant DFF-1335-00763). M.G. was funded by a Human Frontiers Science Program Long-Term Fellowship. Some of the pig production was funded by the Major Program on Basic Research Projects of Yunnan Province, China (grant 2014FC006). PERV elements genotyping Illumina MiSeq data have been uploaded to the European Nucleotide Archive hosted by the European Bioinformatics Institute, with the submission reference PRJEB11222. L.Y. is the Chief Scientific Officer and board member of eGenesis. G.M.C. is the cofounder and scientific advisor of eGenesis. L.Y. is an inventor on provisional U.S. patent applications 62/487,898 and 62/527,702 that are submitted by eGenesis and cover PERV-inactivated pig production.	BENDINELLI M, 1985, ADV CANCER RES, V45, P125, DOI 10.1016/S0065-230X(08)60268-7; Denner J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080215; Deschamps JY, 2005, XENOTRANSPLANTATION, V12, P91, DOI 10.1111/j.1399-3089.2004.00199.x; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Moalic Y, 2006, J VIROL, V80, P10980, DOI 10.1128/JVI.00904-06; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Shafran D, 2014, WORLD J SURG, V38, P1650, DOI 10.1007/s00268-014-2639-3; Wegman-Points LJ, 2014, REDOX BIOL, V2, P847, DOI 10.1016/j.redox.2014.06.006; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x	11	11	11	56	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2017	357	6357					1303	1307		10.1126/science.aan4187				5	Multidisciplinary Sciences	Science & Technology - Other Topics	FH7BX	WOS:000411337700048	28798043				2018-01-05	
J	Karkute, SG; Singh, AK; Gupta, OP; Singh, PM; Singh, B				Karkute, Suhas G.; Singh, Achuit K.; Gupta, Om P.; Singh, Prabhakar M.; Singh, Bijendra			CRISPR/Cas9 Mediated Genome Engineering for Improvement of Horticultural Crops	FRONTIERS IN PLANT SCIENCE			English	Review						CRISPR/Cas9; genome editing; vegetables; fruits; horticultural crops	GUIDE RNA; TOMATO; PLANTS; RESISTANCE; EXPRESSION; NUCLEASE; CUCUMBER; SYSTEM; MODEL	Horticultural crops are an important part of agriculture for food as well as nutritional security. However, several pests and diseases along with adverse abiotic environmental factors pose a severe threat to these crops by affecting their quality and productivity. This warrants the effective and accelerated breeding programs by utilizing innovative biotechnological tools that can tackle aforementioned issues. The recent technique of genome editing by Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) has greatly advanced the breeding for crop improvement due to its simplicity and high efficiency over other nucleases such as Zinc Finger Nucleases and Transcription Activator Like Effector Nucleases. CRISPR/Cas9 tool contains a non-specific Cas9 nuclease and a single guide RNA that directs Cas9 to the specific genomic location creating double-strand breaks and subsequent repair process creates insertion or deletion mutations. This is currently the widely adopted tool for reverse genetics, and crop improvement in large number of agricultural crops. The use of CRISPR/Cas9 in horticultural crops is limited to few crops due to lack of availability of regeneration protocols and sufficient sequence information in many horticultural crops. In this review, the present status of applicability of CRISPR/Cas9 in horticultural crops was discussed along with the challenges and future potential for possible improvement of these crops for their yield, quality, and resistance to biotic and abiotic stress.	[Karkute, Suhas G.; Singh, Achuit K.; Singh, Prabhakar M.; Singh, Bijendra] ICAR Indian Inst Vegetable Res, Div Vegetable Improvement, Varanasi, Uttar Pradesh, India; [Gupta, Om P.] ICAR Indian Inst Wheat & Barley Res, Div Qual & Basic Sci, Karnal, Haryana, India	Karkute, SG (reprint author), ICAR Indian Inst Vegetable Res, Div Vegetable Improvement, Varanasi, Uttar Pradesh, India.	S.Karkute@icar.gov.in		karkute, suhas/0000-0003-2693-0639	ICAR-Indian Institute of Vegetable Research, Varanasi	This work was supported by the ICAR-Indian Institute of Vegetable Research, Varanasi.	Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Andersson M, 2017, PLANT CELL REP, V36, P117, DOI 10.1007/s00299-016-2062-3; Ashraf M, 2010, BIOTECHNOL ADV, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; BHATTACHARYYA MK, 1990, CELL, V60, P115, DOI 10.1016/0092-8674(90)90721-P; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Butler NM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01045; Cardi T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00241; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chandrasekaran J, 2016, MOL PLANT PATHOL, V17, P1140, DOI 10.1111/mpp.12375; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Hayut SF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15605; Jia HG, 2017, PLANT BIOTECHNOL J, V15, P817, DOI 10.1111/pbi.12677; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kishi-Kaboshi M, 2017, PLANT CELL PHYSIOL, V58, P216, DOI 10.1093/pcp/pcw222; Klap C, 2017, PLANT BIOTECHNOL J, V15, P634, DOI 10.1111/pbi.12662; KLOSGEN RB, 1986, MOL GEN GENET, V203, P237, DOI 10.1007/BF00333960; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/srep43320; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mazier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029595; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakajima I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177966; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Peng AH, 2017, PLANT BIOTECHNOL J, V15, P1509, DOI 10.1111/pbi.12733; Rodriguez-Hernandez AM, 2012, MOL PLANT PATHOL, V13, P755, DOI 10.1111/j.1364-3703.2012.00785.x; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Shang Y, 2014, SCIENCE, V346, P1084, DOI 10.1126/science.1259215; Slavin JL, 2012, ADV NUTR, V3, P506, DOI 10.3945/an.112.002154; Song GY, 2016, CROP J, V4, P75, DOI 10.1016/j.cj.2015.12.002; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tian SW, 2017, PLANT CELL REP, V36, P399, DOI 10.1007/s00299-016-2089-5; Ueta R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00501-4; Wang LX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01333; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wang Y, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0787-3; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xiong JS, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.19; Xu C, 2016, GENE DEV, V30, P2048, DOI 10.1101/gad.288415.116; Zhou XJ, 2017, J EXP BOT, V68, P1265, DOI 10.1093/jxb/erx026	48	0	0	66	66	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	SEP 22	2017	8								1635	10.3389/fpls.2017.01635				6	Plant Sciences	Plant Sciences	FH9BU	WOS:000411502200001	28970844	gold			2018-01-05	
J	Kirchner, TW; Niehaus, M; Debener, T; Schenk, MK; Herde, M				Kirchner, Thomas W.; Niehaus, Markus; Debener, Thomas; Schenk, Manfred K.; Herde, Marco			Efficient generation of mutations mediated by CRISPR/Cas9 in the hairy root transformation system of Brassica carinata	PLOS ONE			English	Article							AGROBACTERIUM-RHIZOGENES; RNA INTERFERENCE; GENE; PLANTS; NUCLEASES; CELLS; ARABIDOPSIS; MECHANISMS; EXPRESSION; SEQUENCE	A protocol for the induction of site-directed deletions and insertions in the genome of Brassica carinata with CRISPR is described. The construct containing the Cas9 nuclease and the guide RNA (gRNA) was delivered by the hairy root transformation technique, and a successful transformation was monitored by GFP fluorescence. PAGE analysis of an amplified region, presumably containing the deletions and insertions, demonstrated up to seven different indels in one transgenic root and in all analyzed roots a wildtype allele of the modified gene was not detectable. Interestingly, many of these mutations consisted of relatively large indels with up to 112 bp. The exact size of the deletions was determined to allow an estimation whether the targeted gene was not functional due to a considerable deletion or a frame shift within the open reading frame. This allowed a direct phenotypic assessment of the previously characterized roots and, in fact, deletions in FASCICLIN-LIKE ARABINOGALACTAN PROTEIN 1 (BcFLA1) -a gene with an expression pattern consistent with a role in root hair architecture-resulted in shorter root hairs compared to control roots ectopically expressing an allele of the gene that cannot be targeted by the gRNA in parallel to the CRISPR construct. As an additional line of evidence, we monitored BcFLA1 expression with qPCR and detected a significant reduction of the transcript in roots with an active CRISPR construct compared to the control, although residual amounts of the transcript were detected, possibly due to inefficient nonsense-mediated mRNA decay. Additionally, the presence of deletions and insertions were verified by Sanger sequencing of the respective amplicons. In summary we demonstrate the successful application of CRISPR/Cas9 in hairy roots of B. carinata, the proof of its effectiveness and its effect on the root hair phenotype. This study paves the way for experimental strategies involving the phenotypic assessment of gene lesions by CRISPR which do not require germline transmission.	[Kirchner, Thomas W.; Niehaus, Markus; Schenk, Manfred K.; Herde, Marco] Leibniz Univ Hannover, Inst Plant Nutr, Hannover, Germany; [Debener, Thomas] Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany	Herde, M (reprint author), Leibniz Univ Hannover, Inst Plant Nutr, Hannover, Germany.	mherde@pflern.un-hannover.de			German Research Foundation (DFG) [GRK1798]	This work was funded by the German Research Foundation (DFG, http://www.dfg.de) as part of the Research Training Group (GRK1798) "Signaling at the Plant-Soil Interface".	Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dadami E, 2013, FEBS LETT, V587, P706, DOI 10.1016/j.febslet.2013.01.045; Ding YD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00703; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Harper BK, 1999, NAT BIOTECHNOL, V17, P1125, DOI 10.1038/15114; Iaffaldano B, 2016, IND CROP PROD, V89, P356, DOI 10.1016/j.indcrop.2016.05.029; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kahl G, 2012, J PLANT BIOCHEM BIOT, V21, pS119, DOI 10.1007/s13562-012-0129-y; Knoll A, 2014, CHROMOSOME RES, V22, P191, DOI 10.1007/s10577-014-9415-y; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Michno JM, 2015, GM CROPS FOOD, V6, P243, DOI 10.1080/21645698.2015.1106063; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708                                                                   ; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shan G, 2010, INT J BIOCHEM CELL B, V42, P1243, DOI 10.1016/j.biocel.2009.04.023; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veena V, 2007, IN VITRO CELL DEV-PL, V43, P383, DOI 10.1007/s11627-007-9096-8; Vieweg MF, 2004, MOL PLANT MICROBE IN, V17, P62, DOI 10.1094/MPMI.2004.17.1.62; Wang K, 2015, J BIOTECHNOL, V214, P128, DOI 10.1016/j.jbiotec.2015.09.029; WANG LX, 2016, FRONT PLANT SCI, V7; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zhang DD, 2016, J GENET GENOMICS, V43, P251, DOI 10.1016/j.jgg.2016.03.001; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	0	0	13	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2017	12	9							e0185429	10.1371/journal.pone.0185429				20	Multidisciplinary Sciences	Science & Technology - Other Topics	FH9IR	WOS:000411524700032	28937992	gold			2018-01-05	
J	Martinez-Martinez, E; Ibarrola, J; Fernandez-Celis, A; Santamaria, E; Fernandez-Irigoyen, J; Rossignol, P; Jaisser, F; Lopez-Andres, N				Martinez-Martinez, Ernesto; Ibarrola, Jaime; Fernandez-Celis, Amaya; Santamaria, Enrique; Fernandez-Irigoyen, Joaquin; Rossignol, Patrick; Jaisser, Frederic; Lopez-Andres, Natalia			Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts	SCIENTIFIC REPORTS			English	Article							HEART-FAILURE; CARDIOTROPHIN-1; EXPRESSION; GALECTIN-3; FIBROSIS; ALDOSTERONE; HYPERTROPHY; ASSOCIATION; REGULATOR; DISEASE	Cardiac fibrosis is characterized by an excessive accumulation of extracellular matrix components, including collagens. Galectin-3 (Gal-3) and Cardiotrophin-1 (CT-1) are two profibrotic molecules that mediate Aldosterone (Aldo)-induced cardiac fibrosis. However the underlying mechanisms are not well defined. Our aim is to characterize changes in the proteome of human cardiac fibroblasts treated with Aldo, Gal-3 or CT-1 to identify new common proteins that might be new therapeutic targets in cardiac fibrosis. Using a quantitative proteomic approach in human cardiac fibroblasts, our results show that Aldo, Gal-3 and CT-1 modified the expression of 30, 17 and 89 proteins respectively, being common the reticulocalbin (RCN) family members. RCN-3 down-regulation triggered by Aldo, Gal-3 and CT-1 was verified. Treatment with recombinant RCN-3 decreased collagens expression in human cardiac fibroblasts through Akt phosphorylation. Interestingly, CRISPR/Cas9-mediated activation of RCN-3 decreased collagen production in human cardiac fibroblasts. In addition, recombinant RCN-3 blocked the profibrotic effects of Aldo, Gal-3 and CT-1. Interestingly, RCN-3 blunted the increase in collagens expression induced by other profibrotic stimuli, angiotensin II, in human cardiac fibroblasts. Our results suggest that RCN-3 emerges as a new potential negative regulator of collagen production and could represent a therapeutic target in the context of cardiac fibrosis.	[Martinez-Martinez, Ernesto; Ibarrola, Jaime; Fernandez-Celis, Amaya; Lopez-Andres, Natalia] Inst Invest Sanitaria Navarra IdiSNA, Fdn Miguel Servet, Navarrabiomed, Cardiovasc Translat Res, Pamplona, Spain; [Martinez-Martinez, Ernesto; Jaisser, Frederic] Univ Paris 06, Ctr Rech Cordeliers, INSERM UMRS Team 1138, Paris, France; [Santamaria, Enrique; Fernandez-Irigoyen, Joaquin] Univ Publ Navarra, Navarra Inst Hlth Res, IDISNA, Proteored ISCIII,Prote Unit,Navarrabiomed,Dept Sa, Pamplona, Spain; [Rossignol, Patrick; Jaisser, Frederic; Lopez-Andres, Natalia] Univ Lorraine, CHRU Nancy, FCRIN INI CRCT, INSERM,Ctr Invest Clin Plurithemat 1433,UMR 1116, Nancy, France	Lopez-Andres, N (reprint author), Inst Invest Sanitaria Navarra IdiSNA, Fdn Miguel Servet, Navarrabiomed, Cardiovasc Translat Res, Pamplona, Spain.; Lopez-Andres, N (reprint author), Univ Lorraine, CHRU Nancy, FCRIN INI CRCT, INSERM,Ctr Invest Clin Plurithemat 1433,UMR 1116, Nancy, France.	natalia.lopez.andres@navarra.es	Jaisser, Frederic/P-4287-2017	Jaisser, Frederic/0000-0001-9051-1901; Martinez-Martinez, Ernesto/0000-0002-3011-2041	Instituto de Salud Carlos III-FEDER [CP13/00221]; Fondo de Investigaciones Sanitarias [PI15/02160]; FIBROTARGETS [602904]; COST ADMIRE network [BM1301]; RHU [ANR-15-RHUS-0004]; ISCIII [PT13/0001]; FEDER; ISCIII	This work was supported by Miguel Servet contract CP13/00221 from the "Instituto de Salud Carlos III-FEDER, a way to build Europe", Fondo de Investigaciones Sanitarias [PI15/02160], FIBROTARGETS project (Grant agreement number FP7 #602904) and the FP7 funded COST ADMIRE network (BM1301). PR and FJ were supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second "Investissements d'Avenir" programme (reference: ANR-15-RHUS-0004). The Proteomics Unit of Navarrabiomed is a member of Proteored, PRB2-ISCIII, and is supported by grant PT13/0001, of the PE I+D+I 2013-2016 funded by ISCIII and FEDER.	Alexander JS, 2007, J MOL NEUROSCI, V32, P169, DOI 10.1007/s12031-007-0018-3; Calvier L, 2015, JACC-HEART FAIL, V3, P59, DOI 10.1016/j.jchf.2014.08.002; Cohn JN, 2000, AM J HYPERTENS, V13, p74S, DOI 10.1016/S0895-7061(00)00271-5; Dai B, 2013, CELL PHYSIOL BIOCHEM, V32, P960, DOI 10.1159/000354499; Davis J, 2014, J MOL CELL CARDIOL, V70, P9, DOI 10.1016/j.yjmcc.2013.10.019; Drobic V, 2007, AM J PHYSIOL-HEART C, V293, pH1053, DOI 10.1152/ajpheart.00935.2006; Dube P, 2011, AM J MED SCI, V342, P503, DOI 10.1097/MAJ.0b013e3182327527; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gonzalez A, 2009, CARDIOVASC RES, V81, P509, DOI 10.1093/cvr/cvn235; Grzeskowiak R, 2003, CARDIOVASC RES, V59, P400, DOI 10.1016/S0008-6363(03)00426-7; Haghikia A, 2014, CARDIOVASC RES, V102, P281, DOI 10.1093/cvr/cvu034; Janicki JS, 2002, J CARD FAIL, V8, pS319, DOI 10.1054/jcaf.2002.129260; Jin JW, 2016, AM J RESP CELL MOL, V54, P410, DOI 10.1165/rcmb.2015-0036OC; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kramann N, 2014, CARDIOVASC RES, V102, P88, DOI 10.1093/cvr/cvu024; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Lopez B, 2014, HYPERTENSION, V63, P483, DOI 10.1161/HYPERTENSIONAHA.113.02654; Lopez-Andres N, 2008, ENDOCRINOLOGY, V149, P4970, DOI 10.1210/en.2008-0120; Lopez-Andres N, 2011, AM J PHYSIOL-HEART C, V301, pH2372, DOI 10.1152/ajpheart.00283.2011; Lopez-Andres N, 2010, J HYPERTENS, V28, P1261, DOI 10.1097/HJH.0b013e328337fe42; Martinez-Martinez E, 2015, HYPERTENSION, V66, P767, DOI 10.1161/HYPERTENSIONAHA.115.05876; Martinez-Martinez E., 2017, J PROTEOMICS; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Swynghedauw B, 1999, PHYSIOL REV, V79, P215; Tsuji A, 2006, BIOCHEM J, V396, P51, DOI 10.1042/BJ20051524; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Zelaya MV, 2015, ONCOTARGET, V6, P39437, DOI 10.18632/oncotarget.6254; Zhang Y, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-53; Zhao QD, 2015, CIRCULATION, V131, P643, DOI 10.1161/CIRCULATIONAHA.114.011079	33	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 22	2017	7								12192	10.1038/s41598-017-12305-7				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FH8HO	WOS:000411434900058	28939891	gold			2018-01-05	
J	Song, J; Yang, DS; Ruan, JX; Zhang, JF; Chen, YE; Xu, J				Song, Jun; Yang, Dongshan; Ruan, Jinxue; Zhang, Jifeng; Chen, Yuqing Eugene; Xu, Jie			Production of immunodeficient rabbits by multiplex embryo transfer and multiplex gene targeting	SCIENTIFIC REPORTS			English	Article							ANIMAL-MODELS; HUMANIZED MICE; KNOCK-IN; EXPRESSION; GENERATION; MUTATIONS; IDENTIFICATION; DEFICIENCY; PROGRESS; DISEASE	Immunodeficient mice have been used predominantly in biomedical research. Realizing that large animal species may have an enhanced ability to predict clinical outcome relative to mice, we worked to develop immunodeficient rabbits by CRISPR/Cas9. We first demonstrated that multiplex embryo transfer efficiently produced multiple lines of single-gene mutant (SGM) founders. Embryos microinjected with single sgRNA targeting FOXN1, RAG2, IL2RG or PRKDC were pooled for embryo transfer. As few as three recipients were used to produce twenty SGM founders for four genes. We then demonstrated the powerful multiplex targeting capacity of CRISPR/Cas9. First, two genes on the same chromosome were targeted simultaneously, resulting in three RAG1/RAG2 double-gene mutant (DGM) founders. Next we microinjected forty-five embryos each with five sgRNAs targeting FOXN1, RAG1, RAG2, IL2RG and PRKDC, and transferred them to two recipients. Five founders were produced: one SGM, two DGM, one triple-gene mutant and one quadruple-gene mutant. The present work demonstrates that multiplex embryo transfer and multiplex gene targeting can be used to quickly and efficiently generate mutant rabbit founders. Four lines of SGM (e.g. FOXN1, RAG2, IL2RG, and PRKDC) immunodeficient rabbits, as well as multigenic mutant immunodeficient rabbits have been produced. These animals may prove useful for biomedical research.	[Song, Jun; Yang, Dongshan; Ruan, Jinxue; Zhang, Jifeng; Chen, Yuqing Eugene; Xu, Jie] Univ Michigan, Med Ctr, Ctr Adv Models Translat Sci & Therapeut, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA	Chen, YE; Xu, J (reprint author), Univ Michigan, Med Ctr, Ctr Adv Models Translat Sci & Therapeut, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	echenum@med.umich.edu; jiex@umich.edu			NIH [R41AI122510]; UMMC	This work was supported by NIH grant R41AI122510 to J.X., and UMMC internal fund to CAMTraST (Y.E.C.)	Barbar S. D., PLOS ONE, V11; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cibelli J, 2013, CELL STEM CELL, V12, P271, DOI 10.1016/j.stem.2013.01.004; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; de Villartay JP, 2003, CURR OPIN IMMUNOL, V15, P592, DOI 10.1016/S0952-7915(03)00101-8; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang GY, 2011, CURR OPIN NEPHROL HY, V20, P391, DOI 10.1097/MNH.0b013e328347768a; Kajikawa O, 2005, GENE, V344, P193, DOI 10.1016//j.gene.2004.09.032; Kenney LL, 2016, AM J TRANSPLANT, V16, P389, DOI 10.1111/ajt.13520; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Meier N, 1999, MECH DEVELOP, V89, P215, DOI 10.1016/S0925-4773(99)00218-X; Notarangelo LD, 2016, NAT REV IMMUNOL, V16, P234, DOI 10.1038/nri.2016.28; Pattanayak V, 2014, METHOD ENZYMOL, V546, P47, DOI 10.1016/B978-0-12-801185-0.00003-9; Peng XW, 2015, COMPARATIVE MED, V65, P499; Salgado-Pabon W, 2014, NAT REV MICROBIOL, V12, P585, DOI 10.1038/nrmicro3308; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Song J, 2013, CELL RES, V23, P1059, DOI 10.1038/cr.2013.85; Strandberg KL, 2016, METHODS MOL BIOL, V1396, P81, DOI 10.1007/978-1-4939-3344-0_7; TAKAHASHI Y, 1992, J EXP MED, V175, P873, DOI 10.1084/jem.175.3.873; Tian J, 2012, REPROD DOMEST ANIM, V47, P544, DOI 10.1111/j.1439-0531.2011.01915.x; van der Burg M, 2009, CURR OPIN ALLERGY CL, V9, P503, DOI 10.1097/ACI.0b013e3283327e41; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Whitelaw CBA, 2016, J PATHOL, V238, P247, DOI 10.1002/path.4648; Yan Quanmei, 2014, Cell Regen (Lond), V3, P12, DOI 10.1186/2045-9769-3-12; Yang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25161; Yang DS, 2013, JOVE-J VIS EXP, DOI 10.3791/50957; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	33	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 22	2017	7								12202	10.1038/s41598-017-12201-0				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FH8HO	WOS:000411434900068	28939872	gold			2018-01-05	
J	Johnston, CD; Skeete, CA; Fomenkov, A; Roberts, RJ; Rittling, SR				Johnston, Christopher D.; Skeete, Chelsey A.; Fomenkov, Alexey; Roberts, Richard J.; Rittling, Susan R.			Restriction-modification mediated barriers to exogenous DNA uptake and incorporation employed by Prevotella intermedia	PLOS ONE			English	Article							CRISPR-CAS SYSTEMS; STREPTOCOCCUS-THERMOPHILUS; ESCHERICHIA-COLI; SINGLE-MOLECULE; CELLULAR DEFENSE; S-MODIFICATION; WEB TOOL; BACTERIA; METHYLTRANSFERASES; INTERFERENCE	Prevotella intermedia, a major periodontal pathogen, is increasingly implicated in human respiratory tract and cystic fibrosis lung infections. Nevertheless, the specific mechanisms employed by this pathogen remain only partially characterized and poorly understood, largely due to its total lack of genetic accessibility. Here, using Single Molecule, Real-Time ( SMRT) genome and methylome sequencing, bisulfite sequencing, in addition to cloning and restriction analysis, we define the specific genetic barriers to exogenous DNA present in two of the most widespread laboratory strains, P. intermedia ATCC 25611 and P. intermedia Strain 17. We identified and characterized multiple restriction-modification (R-M) systems, some of which are considerably divergent between the two strains. We propose that these R-M systems are the root cause of the P. intermedia transformation barrier. Additionally, we note the presence of conserved Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) systems in both strains, which could provide a further barrier to exogenous DNA uptake and incorporation. This work will provide a valuable resource during the development of a genetic system for P. intermedia, which will be required for fundamental investigation of this organism's physiology, metabolism, and pathogenesis in human disease.	[Johnston, Christopher D.; Skeete, Chelsey A.; Rittling, Susan R.] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA; [Johnston, Christopher D.; Rittling, Susan R.] Harvard Sch Dent Med, Boston, MA 02115 USA; [Fomenkov, Alexey; Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA	Johnston, CD (reprint author), Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA 02142 USA.; Johnston, CD (reprint author), Harvard Sch Dent Med, Boston, MA 02115 USA.	cjohnston@forsyth.org			Forsyth Institute Pilot Grant Program; National Institute of Dental and Craniofacial Research of the National Institutes of Health [R01-DE22380]; New England Biolabs, Inc.	This study was carried out with internal financial support from The Forsyth Institute Pilot Grant Program and by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number #R01-DE22380, www.nidcr.nih.gov. The funder provided support in the form of salaries for authors (CDJ and SRR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. AF and RJR also acknowledge and New England Biolabs, Inc. for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accetto T, 2005, FEMS MICROBIOL LETT, V247, P177, DOI 10.1016/j.femsle.2005.05.016; Alkhnbashi OS, 2016, BIOINFORMATICS, V32, P576, DOI 10.1093/bioinformatics/btw454; Anton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127446; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R, 2009, MICROBE, V4, P224; Beaulaurier J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8438; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Biswas A, 2013, RNA BIOL, V10, P817, DOI 10.4161/rna.24046; Blumenthal RM, 1988, GENE, V74, P269; Brook I, 2003, CHEST, V124, P832, DOI 10.1378/chest.124.3.832; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Clark TA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-4; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Croucher NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6471; Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dorn BR, 1998, INFECT IMMUN, V66, P6054; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Froger A, 2007, J VISUALIZED EXPT JO; Genereux DP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn691; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; He W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12368; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; Ibrahim M, 2017, FUNCT INTEGR GENOMIC, V17, P513, DOI 10.1007/s10142-017-0550-3; Iyer D, 2010, INFECT IMMUN, V78, P2385, DOI 10.1128/IAI.00510-09; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Lees J, 2015, NAT REV MICROBIOL, V13, DOI 10.1038/nrmicro3435; Leung KP, 2002, PLASMID, V48, P64, DOI 10.1016/S0147-619X(02)00011-2                                                   ; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427                                               ; Loenen WA, 2013, NUCLEIC ACIDS RES; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; Makarova KS, 2017, CELL, V168, P946, DOI 10.1016/j.cell.2017.02.018; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Matsui A, 2014, INFECT IMMUN, V82, P4068, DOI 10.1128/IAI.02256-14; Murphy J, 2013, APPL ENVIRON MICROB, V79, P7547, DOI 10.1128/AEM.02229-13; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Nagaoka K, 2014, INFECT IMMUN, V82, P587, DOI 10.1128/IAI.00943-13; Naito M, 2016, DNA RES, V23, P11, DOI 10.1093/dnares/dsv032; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Piknova M, 2004, LETT APPL MICROBIOL, V38, P311, DOI 10.1111/j.1472-765X.2004.01483.x; Pingoud A, 2014, NUCLEIC ACIDS RES, V42, P7489, DOI 10.1093/nar/gku447; Price VJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00064-16; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563                                                           ; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sambrook J., 2006, CSH PROTOC, V2006, P1, DOI DOI 10.1101/PDB.PR0T3944; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Seshasayee ASN, 2012, NUCLEIC ACIDS RES, V40, P7066, DOI 10.1093/nar/gks390; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sukackaite R, 2012, NUCLEIC ACIDS RES, V40, P7552, DOI 10.1093/nar/gks332; Suzuki H, 2012, HOST MIMICKING STRAT; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Ulrich M, 2010, THORAX, V65, P978, DOI 10.1136/thx.2010.137745; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Vasu K, 2012, P NATL ACAD SCI USA, V109, pE1287, DOI 10.1073/pnas.1119226109; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101                                             ; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Yoshimoto H, 1997, FEMS MICROBIOL LETT, V152, P175, DOI 10.1111/j.1574-6968.1997.tb10425.x; Zhang GQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002987; Zhang Q, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1512-4; Zhu DK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3040-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2017	12	9							e0185234	10.1371/journal.pone.0185234				30	Multidisciplinary Sciences	Science & Technology - Other Topics	FH7CN	WOS:000411339900130	28934361	gold			2018-01-05	
J	Billon, P; Bryant, EE; Joseph, SA; Nambiar, TS; Hayward, SB; Rothstein, R; Ciccia, A				Billon, Pierre; Bryant, Eric E.; Joseph, Sarah A.; Nambiar, Tarun S.; Hayward, Samuel B.; Rothstein, Rodney; Ciccia, Alberto			CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons	MOLECULAR CELL			English	Article							MESSENGER-RNA DECAY; CHROMOSOMAL TRANSLOCATIONS; DEAMINASE FUSIONS; MAMMALIAN-CELLS; GENOME; CANCER; DNA; BREAKS; HYPERMUTATION; MUTATIONS	Standard CRISPR-mediated gene disruption strategies rely on Cas9-induced DNA double-strand breaks (DSBs). Here, we show that CRISPR-dependent base editing efficiently inactivates genes by precisely converting four codons (CAA, CAG, CGA, and TGG) into STOP codons without DSB formation. To facilitate gene inactivation by induction of STOP codons (iSTOP), we provide access to a database of over 3.4 million single guide RNAs (sgRNAs) for iSTOP (sgSTOPs) targeting 97%-99% of genes in eight eukaryotic species, and we describe a restriction fragment length polymorphism (RFLP) assay that allows the rapid detection of iSTOP-mediated editing in cell populations and clones. To simplify the selection of sgSTOPs, our resource includes annotations for off-target propensity, percentage of isoforms targeted, prediction of nonsense-mediated decay, and restriction enzymes for RFLP analysis. Additionally, our database includes sgSTOPs that could be employed to precisely model over 32,000 cancer-associated nonsense mutations. Altogether, this work provides a comprehensive resource for DSB-free gene disruption by iSTOP.	[Billon, Pierre; Joseph, Sarah A.; Nambiar, Tarun S.; Hayward, Samuel B.; Rothstein, Rodney; Ciccia, Alberto] Columbia Univ, Med Ctr, Dept Genet & Dev, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Bryant, Eric E.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Ciccia, A (reprint author), Columbia Univ, Med Ctr, Dept Genet & Dev, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA.	ac3685@cumc.columbia.edu			NIH T32 training grants [T32CA009503, T32GM008798, R01CA197774, R01GM117064, R35GM118180]	We thank Yannick Doyon for critical reading of the manuscript and for kindly communicating unpublished data. pCMV-BE3 was a gift from David Liu (Addgene plasmid # 73021), MLM3636 was a gift from Keith Joung (Addgene plasmid # 43860), and eSpCas9(1.1) was a gift from Feng Zhang (Addgene plasmid # 71814). Plasmids generated in this study have been deposited in Addgene. This work was supported by NIH T32 training grants T32CA009503 and T32GM008798 (to E.E.B.), R01CA197774 and R01GM117064 (to A.C.), and R35GM118180 (to R.R.).	Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/nmeth.4265, 10.1038/NMETH.4265]; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Bordeira-Carrico R, 2012, TRENDS MOL MED, V18, P667, DOI 10.1016/j.molmed.2012.09.004; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Elsasser SJ, 2016, NAT METHODS, V13, P158, DOI [10.1038/NMETH.3701, 10.1038/nmeth.3701]; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jasin M, 2016, DNA REPAIR, V44, P6, DOI 10.1016/j.dnarep.2016.05.001; Jones HD, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.11, 10.1038/nplants.2014.11]; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kuscu C, 2017, NAT METHODS, V14, P710, DOI 10.1038/nmeth.4327; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Plosky BS, 2016, MOL CELL, V62, P477, DOI 10.1016/j.molcel.2016.05.006; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rees Holly A, 2017, Nat Commun, V8, P15790, DOI 10.1038/ncomms15790; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roukos V, 2014, NAT CELL BIOL, V16, P293, DOI 10.1038/ncb2941; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Tokheim CJ, 2016, P NATL ACAD SCI USA, V113, P14330, DOI 10.1073/pnas.1616440113; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Williamson L, 2017, CELL, V168, P843, DOI 10.1016/j.cell.2017.01.019; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	50	2	2	10	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1097-2765	1097-4164		MOL CELL	Mol. Cell	SEP 21	2017	67	6					1068	+		10.1016/j.molcel.2017.08.008				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FH7CE	WOS:000411338600017	28890334				2018-01-05	
J	Sharifnia, T; Hong, AL; Painter, CA; Boehm, JS				Sharifnia, Tanaz; Hong, Andrew L.; Painter, Corrie A.; Boehm, Jesse S.			Emerging Opportunities for Target Discovery in Rare Cancers	CELL CHEMICAL BIOLOGY			English	Review							ADENOID CYSTIC CARCINOMA; GASTROINTESTINAL STROMAL TUMOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; LENTIVIRAL RNAI LIBRARY; GENOME-WIDE ASSOCIATION; SMALL-MOLECULE PROBES; RENAL-CELL CARCINOMA; OF-THE-LITERATURE; OVARIAN-CANCER; DRUG-SENSITIVITY	Rare cancers pose unique challenges to research due to their low incidence. Barriers include a scarcity of tissue and experimental models to enable basic research and insufficient patient accrual for clinical studies. Consequently, an understanding of the genetic and cellular features of many rare cancer types and their associated vulnerabilities has been lacking. However, new opportunities are emerging to facilitate discovery of therapeutic targets in rare cancers. Online platforms are allowing patients with rare cancers to organize on an unprecedented scale, tumor genome sequencing is now routinely performed in research and clinical settings, and the efficiency of patient-derived model generation has improved. New CRISPR/Cas9 and small-molecule libraries permit cancer dependency discovery in a rapid and systematic fashion. In parallel, large-scale studies of common cancers now provide reference datasets to help interpret rare cancer profiling data. Together, these advances motivate consideration of new research frameworks to accelerate rare cancer target discovery.	[Sharifnia, Tanaz; Hong, Andrew L.; Painter, Corrie A.; Boehm, Jesse S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Hong, Andrew L.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Hong, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA	Painter, CA; Boehm, JS (reprint author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	painter@broadinstitute.org; boehm@broadinstitute.org			Katie Moore Fund for Rare Cancer Research at the Broad Institute of Harvard and MIT; Chordoma Foundation; CureSearch for Children's Cancer; Alex's Lemonade Stand Foundation for Childhood Cancer; National Cancer Institute [P50CA101942]	The authors would like to thank Lauren Solomon, Susanna M. Hamilton, Mathias Wawer, Josh Campbell, and Zarko Boskovic for assistance with figures; Josh Sommer of the Chordoma Foundation for providing chordoma-pertinent source material and reviewing the manuscript; Gilles Frydman, David Sandak, Shubhroz Gill, Zuzana Tothova, Steven Corsello, and Paul Clemons for helpful discussions; and Joanne Kotz and Justine Levin-Allerhand for providing critical feedback on the manuscript. This work was generously supported by The Katie Moore Fund for Rare Cancer Research at the Broad Institute of Harvard and MIT, by the Chordoma Foundation, by CureSearch for Children's Cancer, by Alex's Lemonade Stand Foundation for Childhood Cancer, by National Cancer Institute grant P50CA101942, and by an anonymous donor.	Abrams J., 2014, AM SOC CLIN ONCOL ED, V2014, P71, DOI DOI 10.14694/; Afani L, 2016, CANCER RADIOTHER, V20, P400, DOI 10.1016/j.canrad.2015.12.007; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Arikan M, 2014, EKLEM HAST CERRAHISI, V25, P126, DOI 10.5606/ehc.2014.28; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511                                                         ; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bandopadhayay P, 2016, NAT GENET, V48, P273, DOI 10.1038/ng.3500; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Beck AH, 2010, ONCOGENE, V29, P845, DOI 10.1038/onc.2009.381; Blay JY, 2016, LANCET ONCOL, V17, pE62, DOI 10.1016/S1470-2045(15)00388-5; Boehm JS, 2015, NAT REV GENET, V16, P373, DOI 10.1038/nrg3967; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bossi D, 2016, CANCER DISCOV, V6, P650, DOI 10.1158/2159-8290.CD-15-1200; Brait M, 2017, BRIT J CANCER, V116, P515, DOI 10.1038/bjc.2016.450; Brastianos PK, 2014, NAT GENET, V46, P161, DOI 10.1038/ng.2868; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Burdett T., 2017, NHGRI EBI CATALOG PU; Call J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-90; Call Jerry, 2010, J Gastrointest Cancer, V41, P60, DOI 10.1007/s12029-009-9111-x; Callaway E, 2014, NATURE, V511, P518, DOI 10.1038/511518a; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Cancer Genome Atlas, 2005, NIH LAUNCH COMPR EFF; Casali PG, 2015, ANN ONCOL, V26, P300, DOI 10.1093/annonc/mdu459; Chalfin HJ, 2016, BJU INT, V118, P864, DOI 10.1111/bju.13606; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cohen MH, 2002, CLIN CANCER RES, V8, P935; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Cui Q, 2016, HUM MOL GENET, V25, P3626, DOI 10.1093/hmg/ddw200; Daemen A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r110; Dagher R, 2002, CLIN CANCER RES, V8, P3034; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Demetri GD, 2001, SEMIN ONCOL, V28, P19, DOI 10.1016/S0093-7754(01)90099-5; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401                                                     ; Edris B, 2012, J PATHOL, V227, P223, DOI 10.1002/path.3986; Fishbein L, 2017, CANCER CELL, V31, P181, DOI 10.1016/j.ccell.2017.01.001; Fishman MC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006800; Foundation Medicine, 2016, FDN MED ANN REL MOL; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Frydman GJ, 2009, J PARTICIPAT MED, V1, pe12; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gatta G, 2011, EUR J CANCER, V47, P2493, DOI 10.1016/j.ejca.2011.08.008; Gazdar AF, 2010, LUNG CANCER, V68, P309, DOI 10.1016/j.lungcan.2009.12.005; Genome Aggregation Database, 2017, GNOMAD BROWS BET; Global Alliance for Genomics and Health, 2016, SCIENCE, V352, P1278; Greenlee RT, 2010, PUBLIC HEALTH REP, V125, P28, DOI 10.1177/003335491012500106                                                      ; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hanaford AR, 2016, CLIN CANCER RES, V22, P3903, DOI 10.1158/1078-0432.CCR-15-3011; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Harris M.H., 2016, JAMA ONCOL; Hauber AB, 2011, PATIENT PREFER ADHER, V5, P307, DOI 10.2147/PPA.S20445; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Hong AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11987; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Howard T. P., 2016, COLD SPRING HARB SYM, V81, P237, DOI 10.1101/sqb.2016.81.031070; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Ince TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8419; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; ISBER, 2012, BIOPRESERV BIOBANK, V10, P79, DOI [DOI 10.1089/BIO.2012.1022, 10.1089/bio.2012.1022]; Izumchenko E, 2016, CLIN PHARMACOL THER, V99, P612, DOI 10.1002/cpt.354; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karatayli-Ozgursoy S, 2016, ACTA OTORHINOLARYNGO, V36, P289, DOI 10.14639/0392-100X-807; Katz MS, 2016, JAMA ONCOL, V2, P392, DOI 10.1001/jamaoncol.2015.3960; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Leiomyosarcoma Direct Research Foundation, 2016, PAR TISS BLOCK DON; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lewis TB, 2007, MODERN PATHOL, V20, P397, DOI 10.1038/modpathol.3800755; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; The Life Raft Group, 2000, BATTL DRAG; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Martelotto LG, 2015, J PATHOL, V237, P179, DOI 10.1002/path.4573; Masters JRW, 2010, NAT REV CANCER, V10, P441, DOI 10.1038/nrc2852; Masters JRW, 2000, NAT REV MOL CELL BIO, V1, P233, DOI 10.1038/35043102                                                                ; Matulonis UA, 2016, ANN ONCOL, V27, P1013, DOI 10.1093/annonc/mdw133; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735                                                         ; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mirabello L, 2015, CANCER DISCOV, V5, P920, DOI 10.1158/2159-8290.CD-15-0125; Mody RJ, 2015, JAMA-J AM MED ASSOC, V314, P913, DOI 10.1001/jama.2015.10080; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Mullighan CG, 2013, SEMIN HEMATOL, V50, P314, DOI 10.1053/j.seminhematol.2013.10.001; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Multiple Myeloma Research Foundation, 2015, MULT MYEL RES FDN RE; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; National Cancer Institute, 2016, NCI COLL MULT MYEL R; National Cancer Institute, 2016, SEER CANC STAT REV C, P1975; National Cancer Institute, 2007, SYN EP RES RAR CANC; NCCN Guidelines, 2017, BON CANC VERS 2 2017; NCCN Guidelines, 2017, BREAST CANC VERS 2 2; NCCN Guidelines, 2017, PROST CANC VERS 2 20; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Oie HK, 1996, J CELL BIOCHEM, P24; Oikawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9070; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Orphanet, 2016, PREV INC RAR DIS BIB; Panageas KS, 2015, EXPERT REV CLIN PHAR, V8, P661, DOI 10.1586/17512433.2015.1088382; Panda P. K., 2016, BMJ CASE REP; Parsons D. W., 2016, JAMA ONCOL; Pavia-Jimenez A, 2014, NAT PROTOC, V9, P1848, DOI 10.1038/nprot.2014.108; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Morelli MP, 2012, J CLIN ONCOL, V30, pE45, DOI 10.1200/JCO.2011.36.9678; Pillay N, 2012, NAT GENET, V44, P1185, DOI 10.1038/ng.2419; Price ND, 2007, P NATL ACAD SCI USA, V104, P3414, DOI 10.1073/pnas.0611373104; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rasmussen SM, 2015, CYTOM PART B-CLIN CY, V88, P40, DOI 10.1002/cyto.b.21192; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Ross JS, 2014, AM J SURG PATHOL, V38, P235, DOI 10.1097/PAS.0000000000000102; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schreiber SL, 2015, CELL, V161, P1252, DOI 10.1016/j.cell.2015.05.023; Schreiber SL, 2011, P NATL ACAD SCI USA, V108, P6699, DOI 10.1073/pnas.1103205108; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Seltzer ED, 2014, J CANCER SURVIV, V8, P349, DOI 10.1007/s11764-014-0348-4; Sharifnia T, 2014, P NATL ACAD SCI USA, V111, P18661, DOI 10.1073/pnas.1412228112; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simonetti G, 2016, NEUROL SCI, V37, P1727, DOI 10.1007/s10072-016-2640-8; Somiari SB, 2015, ADV EXP MED BIOL, V864, P11, DOI 10.1007/978-3-319-20579-3_2; Stein LD, 2015, NATURE, V523, P149, DOI 10.1038/523149a; Stephens PJ, 2013, J CLIN INVEST, V123, P2965, DOI 10.1172/JCI67201; Stransky N, 2015, NATURE, V528, P84, DOI 10.1038/nature15736; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Tan SB, 2003, BRIT MED J, V327, P47, DOI 10.1136/bmj.327.7405.47; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tomich J, 2017, ULTRASOUND Q, V33, P46, DOI 10.1097/RUQ.0000000000000274; Townsend EC, 2016, CANCER CELL, V30, P183, DOI 10.1016/j.ccell.2016.06.008; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; US Food & Drug Administration, 2017, FDA APPR 1 CANC TREA; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vaught J, 2009, BIOPRESERV BIOBANK, V7, P143, DOI 10.1089/bio.2010.0003; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weroha SJ, 2014, CLIN CANCER RES, V20, P1288, DOI 10.1158/1078-0432.CCR-13-2611; Wetterstrand K.A., 2016, DNA SEQUENCING COST; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Worhunsky DJ, 2015, J SURG ONCOL, V111, P808, DOI 10.1002/jso.23904; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yu CN, 2016, NAT BIOTECHNOL, V34, P419, DOI 10.1038/nbt.3460; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055; Zheng SY, 2016, CANCER CELL, V30, P363, DOI 10.1016/j.ccell.2016.07.013; [Anonymous], 2001, NY TIMES; [Anonymous], 2009, NY TIMES	185	0	0	8	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2451-9448			CELL CHEM BIOL	Cell Chem. Biol.	SEP 21	2017	24	9					1075	1091		10.1016/j.chembiol.2017.08.002				17	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FH6ZH	WOS:000411329500004	28938087				2018-01-05	
J	Zhang, YP; Mu, W; Wang, HY				Zhang, Yongping; Mu, Wei; Wang, Haoyi			Gene editing in T cell therapy	JOURNAL OF GENETICS AND GENOMICS			English	Review						Gene editing; CRISPR-Cas9; T cells	CHIMERIC-ANTIGEN-RECEPTOR; ZINC-FINGER-NUCLEASES; TUMOR-INFILTRATING LYMPHOCYTES; RNA-GUIDED ENDONUCLEASE; OFF-TARGET CLEAVAGE; HIV-1 PROVIRAL DNA; METASTATIC MELANOMA; IN-VIVO; CANCER-IMMUNOTHERAPY; COMBINATION IMMUNOTHERAPY	The adoptive transfer of engineered T cells for the treatment of cancer, autoimmunity, and infectious disease is a rapidly growing field that has shown great promise. Gene editing holds tremendous potential for further improvements of T cell therapy. Here we review the applications of gene editing in various T cell therapies, focusing on antiviral strategies and cancer immunotherapies, and discuss the challenges and future prospects. Copyright (C) 2017, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.	[Zhang, Yongping; Mu, Wei; Wang, Haoyi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100190, Peoples R China; [Zhang, Yongping] Peking Univ, Dept Hematol, Aerosp Ctr Hosp, Aerosp Clin Med Coll, Beijing 100049, Peoples R China; [Mu, Wei; Wang, Haoyi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Wang, HY (reprint author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100190, Peoples R China.; Wang, HY (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wanghaoyi@ioz.ac.cn			National Natural Science Foundation of China [31471215]; National High-tech R&D Program (863 Program) [2015AA020307]; Young Thousand Talent Project	This work was supported by the National Natural Science Foundation of China (No. 31471215) and the National High-tech R&D Program (863 Program) (2015AA020307). H.W. is supported by the "Young Thousand Talent Project."	Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Aparicio S, 2015, NAT REV CANCER, V15, P311, DOI 10.1038/nrc3944; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beane JD, 2015, MOL THER, V23, P1380, DOI 10.1038/mt.2015.71; Berdien B, 2014, GENE THER, V21, P539, DOI 10.1038/gt.2014.26; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brown CE, 2015, CLIN CANCER RES, V21, P4062, DOI 10.1158/1078-0432.CCR-15-0428; Cannon PM, 2014, NAT BIOTECHNOL, V32, P314, DOI 10.1038/nbt.2868; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; COLE DJ, 1995, CANCER RES, V55, P748; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Didigu CA, 2014, BLOOD, V123, P61, DOI 10.1182/blood-2013-08-521229; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Ebina H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120047; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Finney HM, 2004, J IMMUNOL, V172, P104, DOI 10.4049/jimmunol.172.1.104                                                      ; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027                                                          ; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gorak-Stolinska P, 2001, J LEUKOCYTE BIOL, V70, P756; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hirano F, 2005, CANCER RES, V65, P1089; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoffman RM, 2015, NAT REV CANCER, V15, P451, DOI 10.1038/nrc3972; Hoffmann C, 2007, EUR J MED RES, V12, P385; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Kalams SA, 1999, J VIROL, V73, P6715; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Katz SC, 2015, CLIN CANCER RES, V21, P3149, DOI 10.1158/1078-0432.CCR-14-1421; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Kunkele A, 2015, CANCER IMMUNOL RES, V3, P368, DOI 10.1158/2326-6066.CIR-14-0200; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882                                                     ; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; Lloyd A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00221; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; MacLeod DT, 2017, MOL THER, V25, P949, DOI 10.1016/j.ymthe.2017.02.005; Maher S, 2002, IMMUNOL CELL BIOL, V80, P131, DOI 10.1046/j.1440-1711.2002.01068.x; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mei Y, 2016, J GENET GENOMICS, V43, P63, DOI 10.1016/j.jgg.2016.01.001; Menger L, 2016, CANCER RES, V76, P2087, DOI 10.1158/0008-5472.CAN-15-3352; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8                                                   ; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/mt.sj.6300104; Patel S, 2016, CYTOTHERAPY, V18, P931, DOI 10.1016/j.jcyt.2016.04.007; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pignatti P, 2001, CLIN EXP RHEUMATOL, V19, P339; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Ren JT, 2017, CLIN CANCER RES, V23, P2255, DOI 10.1158/1078-0432.CCR-16-1300; Ren JT, 2017, ONCOTARGET, V8, P17002, DOI 10.18632/oncotarget.15218; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Su S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40272; Su S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20070; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Torikai H, 2013, BLOOD, V122, P1341, DOI 10.1182/blood-2013-03-478255; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Valton J, 2015, MOL THER, V23, P1507, DOI 10.1038/mt.2015.104; von Kalle C, 2014, HUM GENE THER, V25, P475, DOI 10.1089/hum.2014.2525; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Xu L, 2017, MOL THER, V25, P1782, DOI 10.1016/j.ymthe.2017.04.027; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yuan JY, 2012, MOL THER, V20, P849, DOI 10.1038/mt.2011.310; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y., 2017, FRONT MED; Zhu WJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0150-z; Zitvogel L, 2012, ONCOIMMUNOLOGY, V1, P1223, DOI 10.4161/onci.21335	122	0	0	9	9	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	SEP 20	2017	44	9					415	422		10.1016/j.jgg.2017.09.002				8	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FK8CE	WOS:000413734200002					2018-01-05	
J	Yang, B; Li, XS; Lei, LQ; Chen, J				Yang, Bei; Li, Xiaosa; Lei, Liqun; Chen, Jia			APOBEC: From mutator to editor	JOURNAL OF GENETICS AND GENOMICS			English	Review						Base editor; Base editing; APOBEC; CRISPR/Cas9; Mutagenesis	B MESSENGER-RNA; INDUCED CYTIDINE DEAMINASE; SINGLE-STRANDED-DNA; VIRUS TYPE-1 VIF; POLYNUCLEOTIDE (DEOXY)CYTIDINE DEAMINASES; CLASS-SWITCH RECOMBINATION; HUMAN CANCER GENOMES; HYPER-IGM SYNDROME; CRYSTAL-STRUCTURE; BREAST-CANCER	APOBECs (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like) are a family of cytidine deaminases that prefer single-stranded nucleic acids as substrates. Besides their physiological functions, APOBEC family members have been found to cause hypermutations of cancer genomes, which could be correlated with cancer development and poor prognosis. Recently, APOBEC family members have been combined with the versatile CRISPR/Cas9 system to perform targeted base editing or induce hypermutagenesis. This combination improved the CRISPR/Cas9-mediated gene editing at single-base precision, greatly enhancing its usefulness. Here, we review the physiological functions and structural characteristics of APOBEC family members and their roles as endogenous mutators that contribute to hypermutations during carcinogenesis. We also review the various iterations of the APOBEC-CRISPR/Cas9 gene-editing tools, pointing out their features and limitations as well as the possibilities for future developments. Copyright (C) 2017, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.	[Yang, Bei] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China; [Li, Xiaosa; Lei, Liqun; Chen, Jia] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Yang, B (reprint author), ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China.; Chen, J (reprint author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	yangbei@shanghaitech.edu.cn; chenjia@shanghaitech.edu.cn		Yang, Bei/0000-0001-5389-3859	National Natural Science Foundation of China [31600619, 31600654]; Shanghai Municipal Science and Technology Commission [16PJ1407000, 16PJ1407500]	We are grateful to Drs. Anthony V. Furano and Li Yang for their valuable discussions and comments to this manuscript. This work is supported by grants from the National Natural Science Foundation of China (Nos. 31600619 and 31600654) and Shanghai Municipal Science and Technology Commission (Nos. 16PJ1407000 and 16PJ1407500).	Ahasan MM, 2015, BIOCHEM BIOPH RES CO, V457, P295, DOI 10.1016/j.bbrc.2014.12.103; Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Balakrishnan L., 2013, COLD SPRING HARB PER, V5; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Blanc V, 2003, J BIOL CHEM, V278, P41198, DOI 10.1074/jbc.M302951200; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pns.0730835100; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2016, BIOCHEMISTRY-US, V55, P2944, DOI 10.1021/acs.biochem.6b00382; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Caglayan M, 2015, DNA REPAIR, V35, P85, DOI 10.1016/j.dnarep.2015.09.010; Caval V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6129; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chan K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003149; Chan L, 1997, BBA-LIPID LIPID MET, V1345, P11, DOI 10.1016/S0005-2760(96)00156-7; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen J, 2015, DNA REPAIR, V32, P43, DOI 10.1016/j.dnarep.2015.04.012; Chen J, 2014, ELIFE, V3, DOI 10.7554/eLife.02001; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen QH, 2016, J MOL BIOL, V428, P2661, DOI 10.1016/j.jmb.2016.03.031; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; Cyranoski D, 2016, NATURE, V535, P476, DOI 10.1038/nature.2016.20302; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Davidson Nicholas O., 1995, Current Opinion in Lipidology, V6, P70, DOI 10.1097/00041433-199504000-00002; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Faltas BM, 2016, NAT GENET, V48, P1490, DOI 10.1038/ng.3692; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gooch BD, 2008, VIROLOGY, V379, P118, DOI 10.1016/j.virol.2008.06.013; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Greider CW, 1999, CELL, V97, P419, DOI 10.1016/S0092-8674(00)80750-3                                                   ; Hasler J, 2011, P NATL ACAD SCI USA, V108, P18366, DOI 10.1073/pnas.1106729108; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9                                                   ; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kanu N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1042-9; Kazanov MD, 2015, CELL REP, V13, P1103, DOI 10.1016/j.celrep.2015.09.077; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033                                                                ; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kock J, 2008, J GEN VIROL, V89, P1184, DOI 10.1099/vir.0.83507-0; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kuscu C, 2017, NAT METHODS, V14, P710, DOI 10.1038/nmeth.4327; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Liang PP, 2017, PROTEIN CELL, V8, P601, DOI 10.1007/s13238-017-0418-2; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925                                                          ; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; Lu YM, 2017, MOL PLANT, V10, P523, DOI 10.1016/j.molp.2016.11.013; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4                                                   ; Marin M, 2008, J VIROL, V82, P987, DOI 10.1128/JVI.01078-07; Marino D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155422; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.7270-7277.2005; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956                                                          ; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Mukhopadhyay D, 2002, AM J HUM GENET, V70, P38, DOI 10.1086/337952                                                                  ; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470                                                        ; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura H, 2015, NAT GENET, V47, P1003, DOI 10.1038/ng.3375; Nakashima M, 2016, J VIROL, V90, P1034, DOI 10.1128/JVI.02369-15; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nishida K., 2016, SCIENCE, V353; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Nordentoft I, 2014, CELL REP, V7, P1649, DOI 10.1016/j.celrep.2014.04.038; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Okuyama S, 2012, INT J CANCER, V130, P1294, DOI 10.1002/ijc.26114; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Packer MS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01055-9; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pinder J, 2015, NUCLEIC ACIDS RES, V43, P9379, DOI 10.1093/nar/gkv993; Pinto Y, 2016, GENOME RES, V26, P579, DOI 10.1101/gr.199240.115; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9                                                   ; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Richardson SR, 2014, ELIFE, V3, DOI 10.7554/eLife.02008; Robert F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0215-6; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994                                                             ; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Salter JD, 2016, TRENDS BIOCHEM SCI, V41, P578, DOI 10.1016/j.tibs.2016.05.001; Salter JD, 2014, TRENDS BIOCHEM SCI, V39, P373, DOI 10.1016/j.tibs.2014.07.001; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrader CE, 2009, PHILOS T R SOC B, V364, P645, DOI 10.1098/rstb.2008.0200; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Seplyarskiy VB, 2016, GENOME RES, V26, P174, DOI 10.1101/gr.197046.115; Shaban NM, 2016, J MOL BIOL, V428, P2307, DOI 10.1016/j.jmb.2016.04.026; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shi K, 2015, J BIOL CHEM, V290, P28120, DOI 10.1074/jbc.M115.679951; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Smith JL, 2010, J VIROL, V84, P12599, DOI 10.1128/JVI.01437-10; Song J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS10548.PMID:26817820; Starrett GJ, 2016, NAT COMMUN, V7, P12918; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Taylor BJM, 2014, ELIFE, V3, DOI 10.7554/eLife.03553; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Verhalen B, 2016, J VIROL, V90, P6379, DOI 10.1128/JVI.00771-16; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Walser JC, 2008, GENOME RES, V18, P1403, DOI 10.1101/gr.076455.108; Walser JC, 2010, GENOME RES, V20, P875, DOI 10.1101/gr.103283.109; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wilson SH, 2014, ELIFE, V3, DOI 10.7554/eLife.03068; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang Y, 1997, P NATL ACAD SCI USA, V94, P13075, DOI 10.1073/pnas.94.24.13075; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00175-6; Zheng H, 2016, P NATL ACAD SCI USA, V113, P11283, DOI 10.1073/pnas.1607606113; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zong Y, 2017, NAT BIOTECHNOL, V35, P438, DOI 10.1038/nbt.3811	206	0	0	2	2	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	SEP 20	2017	44	9					423	437		10.1016/j.jgg.2017.04.009				15	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FK8CE	WOS:000413734200003					2018-01-05	
J	Shang, WJ; Wang, F; Fan, GF; Wang, HP				Shang, Wanjing; Wang, Fei; Fan, Gaofeng; Wang, Haopeng			Key elements for designing and performing a CRISPR/Cas9-based genetic screen	JOURNAL OF GENETICS AND GENOMICS			English	Review						CRISPR; Cas9; Genetic screen	WIDE CRISPR SCREEN; ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; HUMAN T-CELLS; GENOME-WIDE; RNAI SCREEN; MUTAGENESIS SCREEN; FUNCTIONAL GENOMICS; IDENTIFIES GENES; TRANSCRIPTIONAL ACTIVATION	Reverse genetic screens are invaluable for uncovering gene functions, but are traditionally hampered by some technical limitations. Over the past few years, since the advent of the revolutionary CRISPR/Cas9 technology, its power in genome editing has been harnessed to overcome the traditional limitations in reverse genetic screens, with successes in various biological contexts. Here, we outline these CRISPR/Cas9-based screens, provide guidance on the design of effective screens and discuss the potential future directions of development of this field. Copyright (C) 2017, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.	[Shang, Wanjing; Wang, Fei; Fan, Gaofeng; Wang, Haopeng] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Shang, Wanjing; Wang, Fei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Shang, Wanjing; Wang, Fei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Fan, GF; Wang, HP (reprint author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	fangf@shanghaitech.edu.cn; wanghp@shanghaitech.edu.cn			National Natural Science Foundation of China [31670919]; 1000-Youth Elite Program of China	The authors thank T. Chi (ShanghaiTech University) for critical reading of the manuscript. This work was supported by the grant from the National Natural Science Foundation of China (No. 31670919 to H.W.), as well as from the 1000-Youth Elite Program of China to H.W.	Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bassett AR, 2015, J GENET GENOMICS, V42, P301, DOI 10.1016/j.jgg.2015.03.011; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman KM, 2015, CELL REP, V10, P1828, DOI 10.1016/j.celrep.2015.02.040; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen WH, 2017, J AM CHEM SOC, V139, P3790, DOI 10.1021/jacs.6b13317; Chi S., 2016, BIOMED RES INT, V2016; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dang Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0846-3; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Donovan KF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170445; Gayle S, 2017, BLOOD, V129, P1768, DOI [10.1182/blood-2016-09736892, 10.1182/blood-2016-09-736892]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Guo DS, 2016, STEM CELL RES, V17, P670, DOI 10.1016/j.scr.2016.11.014; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Haga K, 2016, P NATL ACAD SCI USA, V113, pE6248, DOI 10.1073/pnas.1605575113; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Han X, 2016, ANGEW CHEM INT EDIT, V55, P8561, DOI 10.1002/anie.201601984; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hedlund E., 2017, MOL ASP MED; Hong AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11987; Horlbeck M. A., 2016, ELIFE, V5; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Katigbak A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38968; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kurata M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36199; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; O'Donnell KA, 2012, P NATL ACAD SCI USA, V109, pE1377, DOI 10.1073/pnas.1115433109; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Peng JY, 2015, FEBS J, V282, P2089, DOI 10.1111/febs.13251; Rauscher B, 2017, NUCLEIC ACIDS RES, V45, pD679, DOI 10.1093/nar/gkw997; Ren QP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08865; Ruiz S, 2016, MOL CELL, V62, P307, DOI 10.1016/j.molcel.2016.03.006; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Song CQ, 2017, GASTROENTEROLOGY, V152, P1161, DOI 10.1053/j.gastro.2016.12.002; Tan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168968; Tian RJ, 2015, P NATL ACAD SCI USA, V112, pE1594, DOI 10.1073/pnas.1503286112; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; VIRREIRAWINTER S, 2016, SCI REP, V6; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu YZ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.14; Xia P, 2016, ENVIRON SCI TECHNOL, V50, P10682, DOI 10.1021/acs.est.6b02328; Xu CL, 2017, P NATL ACAD SCI USA, V114, P722, DOI 10.1073/pnas.1615735114; ZHANG LL, 2016, NAT COMMUN, V7; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhong CQ, 2015, CELL STEM CELL, V17, P221, DOI 10.1016/j.stem.2015.06.005; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	95	0	0	7	7	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	SEP 20	2017	44	9					439	449		10.1016/j.jgg.2017.09.005				11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FK8CE	WOS:000413734200004					2018-01-05	
J	Liu, YY; Ma, SY; Chang, JS; Zhang, T; Wang, XG; Shi, R; Zhang, JD; Lu, W; Liu, Y; Xia, QY				Liu, Yuanyuan; Ma, Sanyuan; Chang, Jiasong; Zhang, Tong; Wang, Xiaogang; Shi, Run; Zhang, Jianduo; Lu, Wei; Liu, Yue; Xia, Qingyou			Tissue-specific genome editing of laminA/C in the posterior silk glands of Bombyx mori	JOURNAL OF GENETICS AND GENOMICS			English	Article						CRISPR/Cas9 system; Genome editing; PiggyBac transposon; Posterior silk gland; Endoreplication	TARGETED MUTAGENESIS; RNA INTERFERENCE; NUCLEAR LAMINS; HUMAN-CELLS; GENE; CRISPR-CAS9; SYSTEM; CRISPR/CAS9; TECHNOLOGIES; MECHANICS	The RNA-guided CRISPR/Cas9 system has been shown to be a powerful tool for genome editing in various organisms. A comprehensive toolbox for multiplex genome editing has been developed for the silkworm, Bombyx mori, a lepidopteran model insect of economic importance. However, as previous methods mainly relied on delivery of transient Cas9/guide RNA (gRNA), they could not be used in loss-of-function studies of essential genes. Here, we report a simple and versatile tissue-specific genome editing strategy. We perform a proof-of-principle demonstration by establishing and crossing two transgenic B. mori lines, one expressing Cas9 protein in the posterior silk glands (PSGs) and the other constitutively expressing BmlaminA/C (BmLMN) gRNA. All BmLMN alleles in the PSG cells were edited precisely at the target genome region, resulting in diverse mutations. mRNA expression of BmLMN was reduced by up to 75%, and only very low levels of BmLaminA/C protein were detected. Knockout of BmLMN produced obvious defects in gland cell development and cocoon production. In this study, we developed an efficient strategy for spatially controlled genome editing, providing unprecedented opportunities for investigating the function of essential/lethal genes in B. mori, with potential application for other insects. Copyright (C) 2017, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.	[Liu, Yuanyuan; Ma, Sanyuan; Chang, Jiasong; Zhang, Tong; Wang, Xiaogang; Shi, Run; Zhang, Jianduo; Lu, Wei; Liu, Yue; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Ma, Sanyuan; Xia, Qingyou] Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Chongqing 400716, Peoples R China; [Zhang, Jianduo] DBNBiotechnol Ctr, Beijing 100089, Peoples R China	Xia, QY (reprint author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.; Xia, QY (reprint author), Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Chongqing 400716, Peoples R China.	xiaqy@swu.edu.cn			National Natural Science Foundation of China [31530071]; Chongqing Postdoctoral Science Foundation [Xm2015024]	We thank Zhiwei Chen, Yufeng Li and Le Sun for assistance with the PSG collection and preparation. This work was supported by the grants from the National Natural Science Foundation of China (No. 31530071) and the Chongqing Postdoctoral Science Foundation (Xm2015024).	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Bai MZ, 2016, J GENET GENOMICS, V43, P289, DOI 10.1016/j.jgg.2016.02.003; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Capanni C, 2003, EXP CELL RES, V291, P122, DOI 10.1016/S0014-4827(03)00395-1; Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corrigan-Curay J, 2015, MOL THER, V23, P796, DOI 10.1038/mt.2015.54; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Di Donato V, 2016, GENOME RES, V26, P681, DOI 10.1101/gr.196170.115; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8                                                   ; GAGE LP, 1974, J MOL BIOL, V86, P97; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937                                                          ; Liu YY, 2014, INSECT BIOCHEM MOLEC, V49, P35, DOI 10.1016/j.ibmb.2014.03.010; Ma S, 2014, SCI REP, V4, P4489; Ma SY, 2013, INSECT BIOCHEM MOLEC, V43, P1079, DOI 10.1016/j.ibmb.2013.08.009; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mei Y, 2016, J GENET GENOMICS, V43, P63, DOI 10.1016/j.jgg.2016.01.001; Mezzadra R, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.13; Munkacsy G, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.66; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2008.00676.x, 10.1111/j.1582-4934.2009.00676.x]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sabatelli P, 2001, MUSCLE NERVE, V24, P826, DOI 10.1002/mus.1076; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Suetsugu Y, 2013, G3-GENES GENOM GENET, V3, P1481, DOI 10.1534/g3.113.006239; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; SUZUKI Y, 1972, J MOL BIOL, V70, P637, DOI 10.1016/0022-2836(72)90563-3; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Zhang CD, 2012, J INSECT PHYSIOL, V58, P974, DOI 10.1016/j.jinsphys.2012.04.017; Zuleger N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r14	48	0	0	2	2	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1673-8527	1873-5533		J GENET GENOMICS	J. Genet. Genomics	SEP 20	2017	44	9					451	459		10.1016/j.jgg.2017.09.003				9	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FK8CE	WOS:000413734200005					2018-01-05	
J	Glenn, OC; Tagliafierro, L; Beach, TG; Woltjer, RL; Chiba-Falek, O				Glenn, Omolara-Chinue; Tagliafierro, Lidia; Beach, Thomas G.; Woltjer, Randy L.; Chiba-Falek, Ornit			Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168	FRONTIERS IN GENETICS			English	Article						SNCA gene; Parkinson's disease; gene expression; translation of GWAS findings	GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; COMMON VARIANTS; MESSENGER-RNA; RISK-FACTORS; SUSCEPTIBILITY; AGGREGATION; DISORDERS; REPEATS	The SNCA intronic single nucleotide polymorphism (SNP), rs356168, has been associated with Parkinson's disease (PD) in large genome wide association studies (GWAS). Recently, the PD-risk allele, rs356168-G was shown to increase SNCA-mRNA expression using genome edited human induced pluripotent stem cells (iPSC)-derived neurons. In this study, as means of validation, we tested the effect of rs356168 on total SNCA-mRNA levels using brain tissues, temporal and frontal cortex, from healthy control donors. Carriers of the rs356168-G allele demonstrated a borderline significant decrease of SNCA-mRNA levels in temporal brain tissues (p = 0.02) compared to individuals homozygous for the 'A' allele. Similar trend, but weak, was observed in the analysis of frontal cortex samples, however, this analysis did not reach statistical significance. These results conflict with the recently reported effect of SNCA SNP rs356168 described above. Our study conveys the need to carefully interpret the precise molecular mechanism by which rs356168, or another tightly linked variant, affects the regulation of SNCA expression. The regulatory mechanisms that contribute to the observed associations between PD and the SNCA-3 0 linkage disequilibrium region warrant further investigations.	[Glenn, Omolara-Chinue; Tagliafierro, Lidia; Chiba-Falek, Ornit] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27708 USA; [Glenn, Omolara-Chinue; Tagliafierro, Lidia; Chiba-Falek, Ornit] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Woltjer, Randy L.] Oregon Hlth & Sci Univ, Dept Pathol, Layton Aging & Alzheimers Dis Ctr, Portland, OR 97201 USA	Chiba-Falek, O (reprint author), Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27708 USA.; Chiba-Falek, O (reprint author), Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC 27708 USA.	o.chibafalek@duke.edu			National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01 NS085011]	This work was funded in part by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01 NS085011 to OC-F].	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655                                                                  ; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Cronin KD, 2009, HUM MOL GENET, V18, P3274, DOI 10.1093/hmg/ddp265; Doege CA, 2014, BIOL PSYCHIAT, V75, P558, DOI 10.1016/j.biopsych.2014.01.007; Dumitriu A, 2012, PARKINSONS DIS-US, DOI 10.1155/2012/614212; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Gross CC, 2017, P NATL ACAD SCI USA, V114, pE908, DOI 10.1073/pnas.1619059114; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Huddleston J, 2016, GENETICS, V202, P1251, DOI 10.1534/genetics.115.180539; Huh CJ, 2016, ELIFE, V5, DOI 10.7554/elife.18648; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Linnertz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007480; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661                                                          ; Mata IF, 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI 10.1001/archneurol.2010.279; McCarthy JJ, 2011, NEUROGENETICS, V12, P59, DOI 10.1007/s10048-010-0263-4; Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Myhre R, 2008, ACTA NEUROL SCAND, V118, P320, DOI 10.1111/j.1600-0404.2008.01019.x; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045                                                   ; Qiang L, 2013, NEURON, V78, P957, DOI 10.1016/j.neuron.2013.06.002; Rhinn H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2032; Ross OA, 2007, MECH AGEING DEV, V128, P378, DOI 10.1016/j.mad.2007.04.002; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Saul R, 2016, HUM MUTAT, V37, P877, DOI 10.1002/humu.23023; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278                                                         ; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tagliafierro L, 2016, NEUROGENETICS, V17, P145, DOI 10.1007/s10048-016-0478-0; Willems T, 2014, GENOME RES, V24, P1894, DOI 10.1101/gr.177774.114; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4	45	0	0	2	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-8021			FRONT GENET	Front. Genet.	SEP 20	2017	8								133	10.3389/fgene.2017.00133				6	Genetics & Heredity	Genetics & Heredity	FH8LZ	WOS:000411448400001	28979294	gold			2018-01-05	
J	Roggenkamp, E; Giersch, RM; Wedeman, E; Eaton, M; Turnquist, E; Schrock, MN; Alkotami, L; Jirakittisonthon, T; Schluter-Pascua, SE; Bayne, GH; Wasko, C; Halloran, M; Finnigan, GC				Roggenkamp, Emily; Giersch, Rachael M.; Wedeman, Emily; Eaton, Muriel; Turnquist, Emily; Schrock, Madison N.; Alkotami, Linah; Jirakittisonthon, Thitikan; Schluter-Pascua, Samantha E.; Bayne, Gareth H.; Wasko, Cory; Halloran, Megan; Finnigan, Gregory C.			CRISPR-UnLOCK: Multipurpose Cas9-Based Strategies for Conversion of Yeast Libraries and Strains	FRONTIERS IN MICROBIOLOGY			English	Article						CRISPR; Cas9; budding yeast; libraries; marker-less integration; gene drive; gene tagging	PROTEIN-PROTEIN INTERACTIONS; GREEN FLUORESCENT PROTEIN; PCR-BASED STRATEGY; SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; BUDDING YEAST; IN-VIVO; INTEGRATION VECTORS; FUNCTIONAL-ANALYSIS; SHUTTLE VECTORS	Saccharomyces cerevisiae continues to serve as a powerful model system for both basic biological research and industrial application. The development of genome-wide collections of individually manipulated strains (libraries) has allowed for high-throughput genetic screens and an emerging global view of this single-celled Eukaryote. The success of strain construction has relied on the innate ability of budding yeast to accept foreign DNA and perform homologous recombination, allowing for efficient plasmid construction (in vivo) and integration of desired sequences into the genome. The development of molecular toolkits and "integration cassettes" have provided fungal systems with a collection of strategies for tagging, deleting, or over-expressing target genes; typically, these consist of a C-terminal tag (epitope or fluorescent protein), a universal terminator sequence, and a selectable marker cassette to allow for convenient screening. However, there are logistical and technical obstacles to using these traditional genetic modules for complex strain construction (manipulation of many genomic targets in a single cell) or for the generation of entire genome-wide libraries. The recent introduction of the CRISPR/Cas gene editing technology has provided a powerful methodology for multiplexed editing in many biological systems including yeast. We have developed four distinct uses of the CRISPR biotechnology to generate yeast strains that utilizes the conversion of existing, commonly-used yeast libraries or strains. We present Cas9-based, marker-less methodologies for (i) N-terminal tagging, (ii) C-terminally tagging yeast genes with 18 unique fusions, (vi) conversion of fluorescently-tagged strains into newly engineered (or codon optimized) variants, and finally, (iv) use of a Cas9 "gene drive" system to rapidly achieve a homozygous state for a hypomorphic query allele in a diploid strain. These CRISPR-based methods demonstrate use of targeting universal sequences previously introduced into a genome.	[Roggenkamp, Emily; Giersch, Rachael M.; Wedeman, Emily; Eaton, Muriel; Turnquist, Emily; Schrock, Madison N.; Alkotami, Linah; Bayne, Gareth H.; Wasko, Cory; Halloran, Megan; Finnigan, Gregory C.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Jirakittisonthon, Thitikan] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Schluter-Pascua, Samantha E.] Kansas State Univ, Dept Biol, Manhattan, KS 66506 USA; [Eaton, Muriel] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Finnigan, GC (reprint author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	gfinnigan@ksu.edu			Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM 103418]; Johnson Cancer Research Center at Kansas State University; College of Arts and Sciences at Kansas State University	We thank Nicoleta Ploscariu (Kansas State University) for laboratory assistance and comments and Jeremy Thorner (University of California, Berkeley) for helpful advice. This project was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM 103418 to GF. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of health. This work was also supported by an Innovative Research Award (to GF) and an Undergraduate Cancer Research Award (to ET) from the Johnson Cancer Research Center at Kansas State University. Additional support included Undergraduate Research Awards from the College of Arts and Sciences at Kansas State University (to ER, MS, and RG).	Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r                                                               ; Bao ZH, 2015, ACS SYNTH BIOL, V4, P585, DOI 10.1021/sb500255k; Benard V, 2002, METHOD ENZYMOL, V345, P349; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; Berry LK, 2016, ELIFE, V5, DOI 10.7554/eLife.13053; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Booher Keith R., 2008, Biotechnology Journal, V3, P524, DOI 10.1002/biot.200800012; Brachmann CB, 1998, YEAST, V14, P115; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cabantous S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02854; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804                                                             ; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cinelli RAG, 2000, PHOTOCHEM PHOTOBIOL, V71, P771, DOI 10.1562/0031-8655(2000)071<0771:TEGFPA>2.0.CO;2                                 ; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cronan JE, 2005, J NUTR BIOCHEM, V16, P416, DOI 10.1016/j.jnutbio.2005.03.017; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dreissig S, 2017, PLANT J, V91, P565, DOI 10.1111/tpj.13601; DUPLAY P, 1984, J BIOL CHEM, V259, P606; Eckert-Boulet N, 2012, YEAST, V29, P323, DOI 10.1002/yea.2912; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159                                                            ; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Finnigan G.C., 2015, BIOPROTOC, V5, pe1521; Finnigan GC, 2016, MOL BIOL CELL, V27, P2708, DOI 10.1091/mbc.E16-05-0337; Finnigan GC, 2016, G3-GENES GENOM GENET, V6, P2147, DOI 10.1534/g3.116.029801; Finnigan GC, 2015, GENETICS, V200, P841, DOI [10.1534/genetics.115.176495, 10.1534/genetics.115.176503]; Finnigan GC, 2015, GENETICS, V200, P821, DOI [10.1534/genetics.115.176503, 10.1534/genetics.115.176495]; FLICK JS, 1990, MOL CELL BIOL, V10, P4757, DOI 10.1128/MCB.10.9.4757                                                           ; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gardner JM, 2014, METHODS MOL BIOL, V1205, P45, DOI 10.1007/978-1-4939-1363-3_5; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Germino M, 2006, YEAST, V23, P763, DOI 10.1002/yea.1388; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Heasley LR, 2016, MOL BIOL CELL, V27, P442, DOI 10.1091/mbc.E15-10-0721; Hilpert K, 2001, PROTEIN ENG, V14, P803, DOI 10.1093/protein/14.10.803; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; Hope EA, 2017, GENETICS, V206, P1153, DOI 10.1534/genetics.116.198895; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Houser JR, 2012, YEAST, V29, P519, DOI 10.1002/yea.2932; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jensen ED, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0664-2; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Kaishima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35932; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim SJ, 2017, APPL MICROBIOL BIOT, V101, P2241, DOI 10.1007/s00253-017-8172-1; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W                ; Krauss N, 2008, PROTEINS, V73, P552, DOI 10.1002/prot.22080; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Landgraf D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163950; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Liu GB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174128; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Malcova I, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow027; Maruta N, 2016, METHODS MOL BIOL, V1363, P145, DOI 10.1007/978-1-4939-3115-6_12; Mayfield JA, 2012, GENETICS, V190, P1308, DOI 10.1534/genetics.111.137471; McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008; Miller KE, 2015, J MOL BIOL, V427, P2039, DOI 10.1016/j.jmb.2015.03.005; MITCHELL DA, 1994, J BIOL CHEM, V269, P21540; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moqtaderi Z, 2008, YEAST, V25, P287, DOI 10.1002/yea.1581; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rajkumar AS, 2012, ACS SYNTH BIOL, V1, P483, DOI 10.1021/sb300045j; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Ross-Macdonald P, 1999, NATURE, V402, P413; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Ryan OW, 2014, METHOD ENZYMOL, V546, P473, DOI 10.1016/B978-0-12-801185-0.00023-4; Sambrook J, 2001, MOL CLONING LAB MANU; Sasano Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30278; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shen Y, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4791; Si T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15187; SIKORSKI RS, 1989, GENETICS, V122, P19; Slubowski CJ, 2015, YEAST, V32, P379, DOI 10.1002/yea.3065; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sung H, 2005, FEMS YEAST RES, V5, P943, DOI 10.1016/j.femsyr.2005.03.008; Sung MK, 2008, YEAST, V25, P301, DOI 10.1002/yea.1588; Sung MK, 2013, GENOME RES, V23, P736, DOI 10.1101/gr.148346.112; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Vidal M, 2014, NAT METHODS, V11, P1203, DOI 10.1038/nmeth.3182; Vorvis C, 2008, YEAST, V25, P651, DOI 10.1002/yea.1611; Wang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176184; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4                                                    ; Wosika V, 2016, MOL GENET GENOMICS, V291, P2231, DOI 10.1007/s00438-016-1249-1; Xie ZX, 2017, SCIENCE, V355, DOI 10.1126/science.aaf4704; Xu DR, 2012, MOL BIOL CELL, V23, P3677, DOI 10.1091/mbc.E12-01-0046	110	0	0	20	20	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	SEP 20	2017	8								1773	10.3389/fmicb.2017.01773				24	Microbiology	Microbiology	FH7GZ	WOS:000411354000001	28979241	gold			2018-01-05	
J	Deffit, SN; Yee, BA; Manning, AC; Rajendren, S; Vadlamani, P; Wheeler, EC; Domissy, A; Washburn, MC; Yeo, GW; Hundley, HA				Deffit, Sarah N.; Yee, Brian A.; Manning, Aidan C.; Rajendren, Suba; Vadlamani, Pranathi; Wheeler, Emily C.; Domissy, Alain; Washburn, Michael C.; Yeo, Gene W.; Hundley, Heather A.			The C. elegans neural editome reveals an ADAR target mRNA required for proper chemotaxis	ELIFE			English	Article							CAENORHABDITIS-ELEGANS; BINDING PROTEINS; INNATE IMMUNITY; BRAIN; GENE; TRANSCRIPTOME; EXPRESSION; DEFICIENT; STABILITY; MECHANISM	ADAR proteins alter gene expression both by catalyzing adenosine (A) to inosine (I) RNA editing and binding to regulatory elements in target RNAs. Loss of ADARs affects neuronal function in all animals studied to date. Caenorhabditis elegans lacking ADARs exhibit reduced chemotaxis, but the targets responsible for this phenotype remain unknown. To identify critical neural ADAR targets in C. elegans, we performed an unbiased assessment of the effects of ADR-2, the only A-to-I editing enzyme in C. elegans, on the neural transcriptome. Development and implementation of publicly available software, SAILOR, identified 7361 A-to-I editing events across the neural transcriptome. Intersecting the neural editome with adr-2 associated gene expression changes, revealed an edited mRNA, clec-41, whose neural expression is dependent on deamination. Restoring clec-41 expression in adr-2 deficient neural cells rescued the chemotaxis defect, providing the first evidence that neuronal phenotypes of ADAR mutants can be caused by altered gene expression.	[Deffit, Sarah N.; Manning, Aidan C.; Vadlamani, Pranathi; Hundley, Heather A.] Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA; [Yee, Brian A.; Wheeler, Emily C.; Domissy, Alain; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Yee, Brian A.; Wheeler, Emily C.; Domissy, Alain; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA; [Rajendren, Suba; Washburn, Michael C.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Yeo, Gene W.] Agcy Sci Technol & Res, Mol Engn Lab, Singapore, Singapore; [Yeo, Gene W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore	Hundley, HA (reprint author), Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA.; Yeo, GW (reprint author), Univ Calif San Diego, Stem Cell Program, Dept Cellular & Mol Med, San Diego, CA 92103 USA.; Yeo, GW (reprint author), Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA.; Yeo, GW (reprint author), Agcy Sci Technol & Res, Mol Engn Lab, Singapore, Singapore.; Yeo, GW (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.	geneyeo@ucsd.edu; hahundle@indiana.edu		Hundley, Heather/0000-0002-9106-9016	American Cancer Society [RSG-15-051-RMC]; Indiana Clinical and Translational Sciences Institute; National Science Foundation; National Institutes of Health [1F32GM119257-01A1, T32GM00866, HG004659, NS075449]	American Cancer Society RSG-15-051-RMC Heather A Hundley; Indiana Clinical and Translational Sciences Institute Sarah N Deffit; National Science Foundation Emily C Wheeler; National Institutes of Health 1F32GM119257-01A1 Sarah N Deffit; National Institutes of Health T32GM00866 Emily C Wheeler; National Institutes of Health HG004659 Gene W Yeo; National Institutes of Health NS075449 Gene W Yeo; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Alon S, 2015, ELIFE, V4, DOI 10.7554/eLife.05198; Anantharaman A, 2017, NUCLEIC ACIDS RES, V45, P4189, DOI 10.1093/nar/gkw1304; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; BAHN JH, 2015, NATURE COMMUNICATION, V6; Bajad P, 2017, RNA BIOL, V3, P1; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; Behm M, 2016, TRENDS GENET, V32, P165, DOI 10.1016/j.tig.2015.12.005; Brannan KW, 2016, MOL CELL, V64, P282, DOI 10.1016/j.molcel.2016.09.003; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI [10.1074/mcp.M600392-MCP200, 10.1038/nbt829]; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Fu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000224; Goldstein B, 2017, GENOME RES, V27, P462, DOI 10.1101/gr.211169.116; Goodman RA, 2012, CURR TOP MICROBIOL, V353, P1, DOI 10.1007/82_2011_144; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Higuchi M, 2000, NATURE, V406, P78; Hundley HA, 2008, RNA, V14, P2050, DOI 10.1261/rna.1165008; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Kaletsky R, 2016, NATURE, V529, P92, DOI 10.1038/nature16483; Kowalski JR, 2014, MOL CELL NEUROSCI, V58, P62, DOI 10.1016/j.mcn.2013.12.001; Kurtzer GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177459; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JB, 2013, NAT NEUROSCI, V16, P1518, DOI 10.1038/nn.3539; Liscovitch-Brauer N, 2017, CELL, V169; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Peter A, 2016, COMMON WORKFLOW LANG; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235                                                            ; SAVVA YA, 2016, FRONTIERS GENETICS, V7; Spencer WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112102; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Tajaddod M, 2016, CHROMOSOMA, V125, P51, DOI 10.1007/s00412-015-0526-9; TARIQ A, 2012, FRONTIERS NEUROSCIEN, V6; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Tomaselli S, 2014, CELL TISSUE RES, V356, P527, DOI 10.1007/s00441-014-1863-3; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; WANG JL, 2016, PEER J, V4; Washburn MC, 2014, CELL REP, V6, P599, DOI 10.1016/j.celrep.2014.01.011; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107; Wessels HH, 2016, GENOME RES, V26, P1000, DOI 10.1101/gr.200386.115; Whipple JM, 2015, RNA, V21, P786, DOI 10.1261/rna.048801.114; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Zhao HQ, 2015, GENOME RES, V25, P66, DOI 10.1101/gr.176107.114	54	1	1	20	20	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	SEP 19	2017	6								e28625	10.7554/eLife.28625				21	Biology	Life Sciences & Biomedicine - Other Topics	FJ9HU	WOS:000413086100001		gold			2018-01-05	
J	Weh, E; Takeuchi, H; Muheisen, S; Haltiwanger, RS; Semina, EV				Weh, Eric; Takeuchi, Hideyuki; Muheisen, Sanaa; Haltiwanger, Robert S.; Semina, Elena V.			Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome	PLOS ONE			English	Article							THROMBOSPONDIN TYPE-1 REPEATS; ER QUALITY-CONTROL; O-FUCOSYLATION; B3GALTL MUTATION; C-MANNOSYLATION; PROTEIN; IDENTIFICATION; DEFICIENCY; SECRETION; APOPTOSIS	Peters Plus Syndrome (PPS) is a rare autosomal recessive disease characterized by ocular defects, short stature, brachydactyly, characteristic facial features, developmental delay and other highly variable systemic defects. Classic PPS is caused by loss-of-function mutations in the B3GLCT gene encoding for a beta 3-glucosyltransferase that catalyzes the attachment of glucose via a beta 1-3 glycosidic linkage to O-linked fucose on thrombospondin type 1 repeats (TSRs). B3GLCT was shown to participate in a non-canonical ER quality control mechanism; however, the exact molecular processes affected in PPS are not well understood. Here we report the identification and characterization of two zebrafish orthologs of the human B3GLCT gene, b3glcta and b3glctb. The b3glcta and b3glctb genes encode for 496-aa and 493-aa proteins with 65% and 57% identity to human B3GLCT, respectively. Expression studies demonstrate that both orthologs are widely expressed with strong presence in embryonic tissues affected in PPS. In vitro glucosylation assays demonstrated that extracts from wildtype embryos contain active b3glct enzyme capable of transferring glucose from UDP-glucose to an O-fucosylated TSR, indicating functional conservation with human B3GLCT. To determine the developmental role of the zebrafish genes, single and double b3glct knockouts were generated using TALEN-induced genome editing. Extracts from double homozygous b3glct(-/-) embryos demonstrated complete loss of in vitro b3glct activity. Surprisingly, b3glct(-/-) homozygous fish developed normally. Transcriptome analyses of head and trunk tissues of b3glct(-/-) 24-hpf embryos identified 483 shared differentially regulated transcripts that may be involved in compensation for b3glct function in these embryos. The presented data show that both sequence and function of B3GLCT/b3glct genes is conserved in vertebrates. At the same time, complete b3glct deficiency in zebrafish appears to be inconsequential and possibly compensated for by a yet unknown mechanism.	[Weh, Eric; Muheisen, Sanaa; Semina, Elena V.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Weh, Eric; Muheisen, Sanaa; Semina, Elena V.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Weh, Eric; Semina, Elena V.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Semina, Elena V.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [Weh, Eric] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; [Takeuchi, Hideyuki] Nagoya Univ, Sch Med, Dept Mol Biochem, Nagoya, Aichi, Japan	Semina, EV (reprint author), Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA.; Semina, EV (reprint author), Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA.; Semina, EV (reprint author), Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA.	esemina@mcw.edu		Semina, Elena/0000-0003-0531-3586	National Institutes of Health [R01EY015518, R01GM061126, P30EY001931]; Children's Hospital of Wisconsin	This work was supported by the National Institutes of Health awards R01EY015518 (EVS), R01GM061126 (RSH), and P30EY001931 as well as funds provided by the Children's Hospital of Wisconsin (EVS).	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Al-Gazali L, 2009, AM J MED GENET A, V149A, P251, DOI 10.1002/ajmg.a.32626; Aldahmesh MA, 2013, HUM MUTAT, V34, P1195, DOI 10.1002/humu.22374; Aliferis K, 2010, OPHTHALMIC GENET, V31, P205, DOI 10.3109/13816810.2010.512355; Arakawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30795; Carvalho A, 2017, EUR J PHARM; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chou JY, 2014, CURR TOP MEMBR, V73, P357, DOI 10.1016/B978-0-12-800223-0.00010-4; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Corso-Diaz X, 2012, MOL VIS, V18, P2770; D'Osualdo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130635; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231                                                                  ; Dassie-Ajdid J, 2009, CLIN GENET, V76, P490, DOI 10.1111/j.1399-0004.2009.01253.x; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; DEALMEIDA JCC, 1991, J MED GENET, V28, P277, DOI 10.1136/jmg.28.4.277                                                            ; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Du JG, 2010, DEV BIOL, V346, P25, DOI 10.1016/j.ydbio.2010.07.008; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Faletra F, 2011, OPHTHALMIC GENET, V32, P256, DOI 10.3109/13816810.2011.587082; Gosselin P, 2013, NUCLEIC ACIDS RES, V41, P7783, DOI 10.1093/nar/gkt569; Gu Y, 2012, ACTA PHARMACOL SIN, V33, P941, DOI 10.1038/aps.2012.60; Guo CX, 2015, J CELL MOL MED, V19, P2273, DOI 10.1111/jcmm.12619; Haldeman-Englert CR, 2009, AM J MED GENET A, V149A, P1842, DOI 10.1002/ajmg.a.32980; Hanna NN, 2010, J AAPOS, V14, P181, DOI 10.1016/j.jaapos.2010.02.003; Harissi-Dagher Mona, 2008, Int Ophthalmol Clin, V48, P35, DOI 10.1097/IIO.0b013e318169526c; Hay DL, 2016, BIOCHEM SOC T, V44, P568, DOI 10.1042/BST20150237; Heinonen TYK, 2003, BIOCHEM BIOPH RES CO, V309, P166, DOI 10.1016/S0006-291X(03)01540-7; Hess D, 2008, J BIOL CHEM, V283, P7354, DOI 10.1074/jbc.M710251200; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Kapoor S, 2008, INDIAN J PEDIATR, V75, P635, DOI 10.1007/s12098-008-0122-6; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Le Goff C, 2011, HUM MOL GENET, V20, pR163, DOI 10.1093/hmg/ddr361; Leonhard-Melief C, 2010, METHOD ENZYMOL, V480, P401, DOI 10.1016/S0076-6879(10)80018-7; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Motoyama O, 2010, CLIN EXP NEPHROL, V14, P381, DOI 10.1007/s10157-010-0283-2; Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7; Nishizaka H, 1996, J IMMUNOL, V156, P2309; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Planells-Ferrer L, 2016, J NEUROCHEM, V139, P11, DOI 10.1111/jnc.13729; Preissler S, 2017, NAT STRUCT MOL BIOL, V24, P23, DOI 10.1038/nsmb.3337; Reis LM, 2008, AM J MED GENET A, V146A, P2603, DOI 10.1002/ajmg.a.32498; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Shimizu R, 2010, CONGENIT ANOM, V50, P197, DOI 10.1111/j.1741-4520.2010.00282.x; Siala O, 2012, GENE, V507, P68, DOI 10.1016/j.gene.2012.06.052; Sorokina EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021122; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71; Tuli N, 2009, CASES J, V2; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Weh E, 2014, CLIN GENET, V86, P142, DOI 10.1111/cge.12241; Wenniger-Prick LJJMMD, 2002, ANN GENET-PARIS, V45, P97; WESTBERG J, 1995, GENOMICS, V29, P1, DOI 10.1006/geno.1995.1208                                                          ; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yang Y, 2005, MOL CELLS, V20, P173; Yiu WH, 2010, CELL BIOCHEM FUNCT, V28, P31, DOI 10.1002/cbf.1613	70	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2017	12	9							e0184903	10.1371/journal.pone.0184903				19	Multidisciplinary Sciences	Science & Technology - Other Topics	FH4XT	WOS:000411166600051	28926587	gold			2018-01-05	
J	Huang, HT; Seo, HS; Zhang, T; Wang, Y; Jiang, B; Li, Q; Buckley, DL; Nabet, B; Roberts, JM; Paulk, J; Dastjerdi, S; Winter, GE; McLauchlan, H; Moran, J; Bradner, JE; Eck, MJ; Dhe-Paganon, S; Zhao, JJ; Gray, NS				Huang, Hai-Tsang; Seo, Hyuk-Soo; Zhang, Tinghu; Wang, Yubao; Jiang, Baishan; Li, Qing; Buckley, Dennis L.; Nabet, Behnam; Roberts, Justin M.; Paulk, Joshiawa; Dastjerdi, Shiva; Winter, Georg E.; McLauchlan, Hilary; Moran, Jennifer; Bradner, James E.; Eck, Michael J.; Dhe-Paganon, Sirano; Zhao, Jean J.; Gray, Nathanael S.			MELK is not necessary for the proliferation of basal-like breast cancer cells	ELIFE			English	Article							LEUCINE-ZIPPER KINASE; TARGET VALIDATION; STEM-CELLS; IN-VIVO; PHOSPHORYLATION; INHIBITORS; REFINEMENT; EXPRESSION; DISCOVERY; RADIATION	Thorough preclinical target validation is essential for the success of drug discovery efforts. In this study, we combined chemical and genetic perturbants, including the development of a novel selective maternal embryonic leucine zipper kinase (MELK) inhibitor HTH-01-091, CRISPR/ Cas9-mediated MELK knockout, a novel chemical-induced protein degradation strategy, RNA interference and CRISPR interference to validate MELK as a therapeutic target in basal-like breast cancers (BBC). In common culture conditions, we found that small molecule inhibition, genetic deletion, or acute depletion of MELK did not significantly affect cellular growth. This discrepancy to previous findings illuminated selectivity issues of the widely used MELK inhibitor OTSSP167, and potential off-target effects of MELK-targeting short hairpins. The different genetic and chemical tools developed here allow for the identification and validation of any causal roles MELK may play in cancer biology, which will be required to guide future MELK drug discovery efforts. Furthermore, our study provides a general framework for preclinical target validation.	[Huang, Hai-Tsang; Seo, Hyuk-Soo; Zhang, Tinghu; Wang, Yubao; Jiang, Baishan; Li, Qing; Eck, Michael J.; Dhe-Paganon, Sirano; Zhao, Jean J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Huang, Hai-Tsang; Zhang, Tinghu; Wang, Yubao; Jiang, Baishan; Li, Qing; Eck, Michael J.; Zhao, Jean J.; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Buckley, Dennis L.; Nabet, Behnam; Roberts, Justin M.; Paulk, Joshiawa; Dastjerdi, Shiva; Winter, Georg E.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [McLauchlan, Hilary; Moran, Jennifer] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Coll Life Sci, Dundee, Scotland; [Bradner, James E.] Harvard Med Sch, Dept Med, Boston, MA USA; [Bradner, James E.] Novartis Inst Biomed Res, Cambridge, MA USA	Zhao, JJ; Gray, NS (reprint author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Zhao, JJ; Gray, NS (reprint author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	jean_zhao@dfci.harvard.edu; nathanael_gray@dfci.harvard.edu		Nabet, Behnam/0000-0002-6738-4200	Dana-Farber Cancer Institute Accelerator Fund; Damon Runyon Cancer Research Foundation [DRG-2196-14]; American Cancer Society [PF-17-010-01-CDD]	Dana-Farber Cancer Institute Accelerator Fund Hai-Tsang Huang Tinghu Zhang Yubao Wang Jean JZhao Nathanael S Gray; Damon Runyon Cancer Research Foundation DRG-2196-14 Dennis L Buckley; American Cancer Society PF-17-010-01-CDD Behnam Nabet; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Badouel C, 2010, EXP CELL RES, V316, P2166, DOI 10.1016/j.yexcr.2010.04.019; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Blot J, 2002, DEV BIOL, V241, P327, DOI 10.1006/dbio.2001.0525; BRINKMAN EK, 2014, NUCL ACIDS RES, V42; Cho YS, 2014, BIOCH BIOPHYSICAL RE, V447, P7; Choi S, 2011, BIOCHEM BIOPH RES CO, V412, P207, DOI 10.1016/j.bbrc.2011.07.060; Chung SY, 2012, ONCOTARGET, V3, P1629; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb MA, 2017, NATURE, V543, P270, DOI 10.1038/nature21688; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Ganguly R, 2014, MOL CANCER THER, V13, P1393, DOI 10.1158/1535-7163.MCT-13-0764; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Ji WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153518; Johnson CN, 2015, ACS MED CHEM LETT, V6, P25, DOI 10.1021/ml5001245; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaelin WG, 2017, NAT REV CANCER, V17, P441, DOI 10.1038/nrc.2017.32; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Komatsu M, 2013, INT J ONCOL, V42, P478, DOI 10.3892/ijo.2012.1744; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu R, 2015, CANCER BIOL THER, V16, P317, DOI 10.1080/15384047.2014.1002360; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Pickard MR, 2009, BREAST CANC RES, V11; R Core Team, 2016, R LANG ENV STAT COMP; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Speers C, 2016, CLIN CANCER RES, V22, P5864, DOI 10.1158/1078-0432.CCR-15-2711; Toure BB, 2016, J MED CHEM, V59, P4711, DOI 10.1021/acs.jmedchem.6b00052; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763; Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701                                                             ; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Yu K, 2001, ENDOCR-RELAT CANCER, V8, P249, DOI 10.1677/erc.0.0080249	57	2	2	3	3	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	SEP 19	2017	6								e26693	10.7554/eLife.26693				29	Biology	Life Sciences & Biomedicine - Other Topics	FH3UJ	WOS:000411075200001		gold			2018-01-05	
J	Joris, M; Schloesser, M; Baurain, D; Hanikenne, M; Muller, M; Motte, P				Joris, Marine; Schloesser, Marie; Baurain, Denis; Hanikenne, Marc; Muller, Marc; Motte, Patrick			Number of inadvertent RNA targets for morpholino knockdown in Danio rerio is largely underestimated: evidence from the study of Ser/Arg-rich splicing factors	NUCLEIC ACIDS RESEARCH			English	Article							SR PROTEINS; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; ZEBRAFISH; GENOME; ANTISENSE; TRANSCRIPTION; BIOCONDUCTOR; TRANSLATION; CRISPR/CAS9	Although the involvement of Ser/Arg-rich (SR) proteins in RNA metabolism is well documented, their role in vertebrate development remains elusive. We, therefore, elected to take advantage of the zebrafish model organism to study the SR genes' functions using the splicing morpholino (sMO) microinjection and the programmable site-specific nucleases. Consistent with previous research, we revealed discrepancies between the mutant and morphant phenotypes and we show that these inconsistencies may result from a large number of unsuspected inadvertent morpholino RNA targets. While microinjection of MOs directed against srsf5a (sMOsrsf5a) led to developmental defects, the corresponding homozygous mutants did not display any phenotypic traits. Furthermore, microinjection of sMOsrsf5a into srsf5a-/led to the previously observed morphant phenotype. Similar findings were observed for other SR genes. sMOsrsf5a alternative target genes were identified using deep mRNA sequencing. We uncovered that only 11 consecutive bases complementary to sMOsrsf5a are sufficient for binding and subsequent blocking of splice sites. In addition, we observed that sMOsrsf5a secondary targets can be reduced by increasing embryos growth temperature after microinjection. Our data contribute to the debate about MO specificity, efficacy and the number of unknown targeted sequences.	[Joris, Marine; Schloesser, Marie; Hanikenne, Marc; Motte, Patrick] Univ Liege, Lab Funct Genom & Plant Mol Imaging, InBioS, PhytoSystems, B-4000 Liege, Belgium; [Joris, Marine; Schloesser, Marie; Baurain, Denis; Hanikenne, Marc; Motte, Patrick] Univ Liege, Ctr Assistance Technol Microscopy CAREm, B-4000 Liege, Belgium; [Baurain, Denis] Univ Liege, InBioS PhytoSYSTEMS, Eukaryot Phylogen, B-4000 Liege, Belgium; [Muller, Marc] Univ Liege, Lab Organogenesis & Regenerat, GIGA Res, B-4000 Liege, Belgium	Joris, M; Motte, P (reprint author), Univ Liege, Lab Funct Genom & Plant Mol Imaging, InBioS, PhytoSystems, B-4000 Liege, Belgium.; Joris, M; Motte, P (reprint author), Univ Liege, Ctr Assistance Technol Microscopy CAREm, B-4000 Liege, Belgium.	marine.joris@doct.ulg.ac.be; patrick.motte@ulg.ac.be			'Fonds National de la Recherche Scientifique-FNRS' [FRFC] [2.4631.11F, CDR J.0080.15]; 'Fonds Speciaux du Conseil de la Recherche' from the University of Liege; FRIA (Fonds de la Recherche pour l'Industrie et l'Agriculture, Belgium Doctoralship); University of Liege 'Credit de demarrage' [SFRD-12/04]; Chercheur Qualifie du F.N.R.S. (Fonds National de la Recherche Scientifique, Belgium); Fonds De La Recherche Scientifique-FNRS; University of Liege	'Fonds National de la Recherche Scientifique-FNRS' [FRFC no2.4631.11F, CDR J.0080.15 to D.B.]; 'Fonds Speciaux du Conseil de la Recherche' from the University of Liege; FRIA (Fonds de la Recherche pour l'Industrie et l'Agriculture, Belgium Doctoralship (to M.J.)); University of Liege 'Credit de demarrage 2012' SFRD-12/04 (to D.B.); Chercheur Qualifie du F.N.R.S. (Fonds National de la Recherche Scientifique, Belgium) (to M.H., M.M.). Funding for open access charge: Fonds De La Recherche Scientifique-FNRS and University of Liege.	Anko ML, 2014, SEMIN CELL DEV BIOL, V32, P11, DOI 10.1016/j.semcdb.2014.03.011; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Blum M, 2015, DEV CELL, V35, P145, DOI 10.1016/j.devcel.2015.09.017; Bradley T, 2015, RNA, V21, P75, DOI 10.1261/rna.043893.113; Coffman JA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-6; Coonrod SA, 2001, GENESIS, V30, P198, DOI 10.1002/gene.1065                                                               ; Corey DR, 2001, GENOME BIOL, V2; De Souza AT, 2006, NUCLEIC ACIDS RES, V34, P4486, DOI 10.1093/nar/gkl609; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#                         ; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Howard J.M., 2015, REV RNA, V6, P93, DOI DOI 10.1002/WRNA.1260; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7                                                   ; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kos R, 2001, DEVELOPMENT, V128, P1467; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Lawson ND, 2016, TRENDS CELL BIOL, V26, P77, DOI 10.1016/j.tcb.2015.11.005; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Mockenhaupt S, 2015, SEMIN CELL DEV BIOL, V47-48, P32, DOI 10.1016/j.semcdb.2015.10.018; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nutt SL, 2001, GENESIS, V30, P110, DOI 10.1002/gene.1042; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; RING HJ, 1994, MOL CELL BIOL, V14, P7499, DOI 10.1128/MCB.14.11.7499                                                          ; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Stainier DYR, 2015, DEV CELL, V32, P7, DOI 10.1016/j.devcel.2014.12.012; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	51	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	SEP 19	2017	45	16					9547	9557		10.1093/nar/gkx638				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FH4CB	WOS:000411096400030	28934490				2018-01-05	
J	Zhang, F; Wang, LK; Qi, B; Zhao, B; Ko, EE; Riggan, ND; Chin, KV; Qiao, H				Zhang, Fan; Wang, Likai; Qi, Bin; Zhao, Bo; Ko, Eun Esther; Riggan, Nathaniel D.; Chin, Kevin; Qiao, Hong			EIN2 mediates direct regulation of histone acetylation in the ethylene response	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						histone acetylation; ethylene; Arabidopsis; CRISPR/dCas9; ChIP-reChIP-seq	RECEPTOR GENE FAMILY; ARABIDOPSIS-THALIANA; PLANT-GROWTH; PROTEIN; ACID; ETR1; CTR1; GAS; ACETYLTRANSFERASE; DEACETYLATION	Ethylene gas is essential for developmental processes and stress responses in plants. Although the membrane-bound protein EIN2 is critical for ethylene signaling, the mechanism by which the ethylene signal is transduced remains largely unknown. Here we show the levels of H3K14Ac and H3K23Ac are correlated with the levels of EIN2 protein and demonstrate EIN2 C terminus (EIN2-C) is sufficient to rescue the levels of H3K14/23Ac of ein2-5 at the target loci, using CRISPR/dCas9-EIN2-C. Chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) and ChIP-reChIP-seq analyses revealed that EIN2-C associates with histone partially through an interaction with EIN2 nuclear-associated protein1 (ENAP1), which preferentially binds to the genome regions that are associated with actively expressed genes both with and without ethylene treatments. Specifically, in the presence of ethylene, ENAP1-binding regions are more accessible upon the interaction with EIN2, and more EIN3 proteins bind to the loci where ENAP1 is enriched for a quick response. Together, these results reveal EIN2-C is the key factor regulating H3K14Ac and H3K23Ac in response to ethylene and uncover a unique mechanism by which ENAP1 interacts with chromatin, potentially preserving the open chromatin regions in the absence of ethylene; in the presence of ethylene, EIN2 interacts with ENAP1, elevating the levels of H3K14Ac and H3K23Ac, promoting more EIN3 binding to the targets shared with ENAP1 and resulting in a rapid transcriptional regulation.	[Zhang, Fan; Wang, Likai; Zhao, Bo; Ko, Eun Esther; Riggan, Nathaniel D.; Chin, Kevin; Qiao, Hong] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Zhang, Fan; Wang, Likai; Qi, Bin; Zhao, Bo; Ko, Eun Esther; Riggan, Nathaniel D.; Chin, Kevin; Qiao, Hong] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Qi, Bin] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Qiao, H (reprint author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Qiao, H (reprint author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	hqiao@austin.utexas.edu			National Institutes of Health [NIH-1R01GM115879-01]	We thank S. Sung and his laboratory members for comments, V. Iyer and S. Roux for proofreading, and Natalie Ahn and Nancy Vega for plants and laboratory maintenance. We thank the Salk Institute Genomic Analysis Laboratory for providing seeds. We thank the genomic sequencing and analysis facility of the Institute of Cellular and Molecular Biology at The University of Texas at Austin for RNA-seq and ChIP-seq. We thank V. Iyer for advice on ChIP-seq data analysis. This work was supported by grants from the National Institutes of Health (to H.Q.) (NIH-1R01GM115879-01).	Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Andrews S, 2013, FASTQC QUALITY CONTR; Bai MY, 2012, PLANT CELL, V24, P4917, DOI 10.1105/tpc.112.105163; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Bardet AF, 2012, NAT PROTOC, V7, P45, DOI 10.1038/nprot.2011.420; Bisson MMA, 2011, PLANT SIGNAL BEHAV, V6, P164, DOI [10.4161/psb.6.1.14034, 10.4161/psb.5.12.14034]; Bleecker AB, 1998, PHILOS T ROY SOC B, V353, P1405, DOI 10.1098/rstb.1998.0295; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Colville A, 2011, PLANT CELL REP, V30, P1969, DOI 10.1007/s00299-011-1105-z; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3                                                   ; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7                                                   ; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ju CL, 2015, PLANT PHYSIOL, V169, P85, DOI 10.1104/pp.15.00845; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lee K, 2016, J PLANT PHYSIOL, V191, P95, DOI 10.1016/j.jplph.2015.12.006; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WY, 2015, CELL, V163, P670, DOI 10.1016/j.cell.2015.09.037; Liu X, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-145; Merchante C, 2015, CELL, V163, P684, DOI 10.1016/j.cell.2015.09.036; Ortega-Martinez O, 2007, SCIENCE, V317, P507, DOI 10.1126/science.1143409; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Perrella G, 2013, PLANT CELL, V25, P3491, DOI 10.1105/tpc.113.114835; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Ramikie TS, 2014, NEURON, V81, P1111, DOI 10.1016/j.neuron.2014.01.012; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812                                                         ; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526                                                        ; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang LK, 2017, BMC GENOMICS, V18, DOI [10.1186/s12864-017-3929-6, 10.1186/s12891-017-1902-9]; Wang Z, 2013, PLANT CELL, V25, P149, DOI 10.1105/tpc.112.108191; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Wu MF, 2015, ELIFE, V4, DOI 10.7554/eLife.09269; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing DH, 2015, PLANT CELL, V27, P3294, DOI 10.1105/tpc.15.00641; Yamamuro C, 2016, MOL PLANT, V9, P57, DOI 10.1016/j.molp.2015.10.008; Zhang F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006437; Zhang F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13018; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514; Zhu YX, 2010, CHINESE SCI BULL, V55, P2198, DOI 10.1007/s11434-010-3193-2; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	56	0	0	8	8	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 19	2017	114	38					10274	10279		10.1073/pnas.1707937114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FH4UH	WOS:000411157100084	28874528	green_published			2018-01-05	
J	Ling, L; Kokoza, VA; Zhang, CY; Aksoy, E; Raikhel, AS				Ling, Lin; Kokoza, Vladimir A.; Zhang, Changyu; Aksoy, Emre; Raikhel, Alexander S.			MicroRNA-277 targets insulin-like peptides 7 and 8 to control lipid metabolism and reproduction in Aedes aegypti mosquitoes	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						microRNA; insulin; metabolism; reproduction; mosquito	YELLOW-FEVER MOSQUITO; INSULIN-LIKE PEPTIDES; FAT-BODY; LIFE-SPAN; ZIKA VIRUS; DROSOPHILA; INSECTS; ELEGANS; ENERGY; VITELLOGENESIS	Hematophagous female mosquitoes transmit numerous devastating human diseases, including malaria, dengue fever, Zika virus, and others. Because of their obligatory requirement of a vertebrate blood meal for reproduction, these mosquitoes need a lot of energy; therefore, understanding the molecular mechanisms linking metabolism and reproduction is of particular importance. Lipids are the major energy store providing the fuel required for host seeking and reproduction. They are essential components of the fat body, a metabolic tissue that is the insect analog of vertebrate liver and adipose tissue. In this study, we found that microRNA-277 (miR-277) plays an important role in regulating mosquito lipid metabolism. The genetic disruption of miR-277 using the CRISPR-Cas9 system led to failures in both lipid storage and ovary development. miR-277 mimic injection partially rescued these phenotypic manifestations. Examination of subcellular localization of FOXO protein via CRISPR-assisted, single-stranded oligodeoxynucleotide-mediated homology-directed repair revealed that insulin signaling is upregulated in response to miR-277 depletion. In silico target prediction identified that insulin-like peptides 7 and 8 (ilp7 and ilp8) are putative targets of miR-277; RNA immunoprecipitation and a luciferase reporter assay confirmed that ilp7 and ilp8 are direct targets of this miRNA. CRISPR-Cas9 depletion of ilp7 and ilp8 led to metabolic and reproductive defects. These depletions identified differential actions of ILP7 and ILP8 in lipid homeostasis and ovarian development. Thus, miR-277 plays a critical role in mosquito lipid metabolism and reproduction by targeting ilp7 and ilp8, and serves as a monitor to control ILP7 and ILP8 mRNA levels.	[Ling, Lin; Kokoza, Vladimir A.; Zhang, Changyu; Aksoy, Emre; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Ling, Lin; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Aksoy, Emre] Univ Calif Riverside, Grad Program Genet Gen & Bioinformat, Riverside, CA 92521 USA	Raikhel, AS (reprint author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (reprint author), Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	alexander.raikhel@ucr.edu			National Institutes of Health [R01 AI113729, R01 AI036959]	This work was supported by National Institutes of Health Grants R01 AI113729 and R01 AI036959 (to A.S.R.).	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Briegel H, 2002, J INSECT PHYSIOL, V48, P547, DOI 10.1016/S0022-1910(02)00072-0; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Burks DJ, 2000, NATURE, V407, P377; Clifton ME, 2012, J INSECT PHYSIOL, V58, P1007, DOI 10.1016/j.jinsphys.2012.05.005; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Fontana R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020087; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Judd ET, 2011, AGING CELL, V10, P972, DOI 10.1111/j.1474-9726.2011.00737.x; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107; LAW JH, 1989, J BIOL CHEM, V264, P16335; Liu GJ, 2015, MOL BIOL EVOL, V32, P623, DOI 10.1093/molbev/msu323; Liu SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/pnas.1416278111; Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; McNeil CJ, 2017, J TROP PEDIATRICS, V63, P242, DOI 10.1093/tropej/fmw080; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Moretti F, 2010, RNA, V16, P2493, DOI 10.1261/rna.2384610; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1; SOCHA R, 1991, J INSECT PHYSIOL, V37, P805, DOI 10.1016/0022-1910(91)90077-D; STRONG L, 1967, J INSECT PHYSIOL, V13, P495, DOI 10.1016/0022-1910(67)90061-3; THOMSEN E, 1955, J EXP BIOL, V32, P692; Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007; VANHANDEL E, 1993, J INSECT PHYSIOL, V39, P831, DOI 10.1016/0022-1910(93)90115-8; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang XL, 2017, P NATL ACAD SCI USA, V114, pE2709, DOI 10.1073/pnas.1619326114; Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Xu WL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S4; Zhang XF, 2017, P NATL ACAD SCI USA, V114, pE1895, DOI 10.1073/pnas.1701474114; Zhang Y, 2016, P NATL ACAD SCI USA, V113, pE4828, DOI 10.1073/pnas.1609792113; Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009; Ziegler R, 2001, J INSECT PHYSIOL, V47, P623, DOI 10.1016/S0022-1910(00)00158-X	53	0	0	30	30	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 19	2017	114	38					E8017	E8024		10.1073/pnas.1710970114				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FH4UH	WOS:000411157100021	28874536				2018-01-05	
J	Yu, QH; Wang, BK; Li, N; Tang, YP; Yang, SB; Yang, T; Xu, J; Guo, CM; Yan, P; Wang, Q; Asmutola, P				Yu, Qing-Hui; Wang, Baike; Li, Ning; Tang, Yaping; Yang, Shengbao; Yang, Tao; Xu, Juan; Guo, Chunmiao; Yan, Peng; Wang, Qiang; Asmutola, Patiguli			CRISPR/Cas9-induced Targeted Mutagenesis and Gene Replacement to Generate Long-shelf Life Tomato Lines	SCIENTIFIC REPORTS			English	Article							HIGH-EFFICIENCY; ARABIDOPSIS-THALIANA; RIPENING MUTANT; SYSTEM; PLANTS; FRUIT; CRISPR-CAS9; NUCLEASES; RIN; TRANSFORMATION	Quickly and precisely gain genetically enhanced breeding elites with value-adding performance traits is desired by the crop breeders all the time. The present of gene editing technologies, especially the CRISPR/Cas9 system with the capacities of efficiency, versatility and multiplexing provides a reasonable expectation towards breeding goals. For exploiting possible application to accelerate the speed of process at breeding by CRISPR/Cas9 technology, in this study, the Agrobacterium tumefaciens-mediated CRISPR/Cas9 system transformation method was used for obtaining tomato ALC gene mutagenesis and replacement, in absence and presence of the homologous repair template. The average mutation frequency (72.73%) and low replacement efficiency (7.69%) were achieved in T-0 transgenic plants respectively. None of homozygous mutation was detected in T-0 transgenic plants, but one plant carry the heterozygous genes (Cas9/*-ALC/alc) was stably transmitted to T-1 generations for segregation and genotyping. Finally, the desired alc homozygous mutants without T-DNA insertion (*/*-alc/alc) in T-1 generations were acquired and further confirmed by genotype and phenotype characterization, with highlight of excellent storage performance, thus the recessive homozygous breeding elites with the character of long-shelf life were generated. Our results support that CRISPR/Cas9-induced gene replacement via HDR provides a valuable method for breeding elite innovation in tomato.	[Yu, Qing-Hui; Wang, Baike; Li, Ning; Tang, Yaping; Yang, Shengbao; Yang, Tao; Xu, Juan; Guo, Chunmiao; Yan, Peng; Wang, Qiang; Asmutola, Patiguli] Xinjiang Acad Agr Sci, Inst Hort, Urumqi 830091, Peoples R China	Yu, QH (reprint author), Xinjiang Acad Agr Sci, Inst Hort, Urumqi 830091, Peoples R China.	yuqinghui98@sina.com			S&T innovation talents cultivation project for excellent youth of Xinjiang [2014721023]; major project in the "12th Five-year" Plans for ST of Xinjiang [201230116-3]; special fund for agro-scientific research in the public interest of China [201303115]	The present study was supported by grants from the S&T innovation talents cultivation project for excellent youth of Xinjiang (2014721023), and grants from the major project in the "12th Five-year" Plans for S&T of Xinjiang (201230116-3) and special fund for agro-scientific research in the public interest of China (201303115). We also thank Dr. Caixie Gao (Institute of Genetics and Developmental Biology, CAS) for kindly offered the plasmid of CRISSPR/Cas9 system.	Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bota J, 2014, GENET RESOUR CROP EV, V61, P1131, DOI 10.1007/s10722-014-0096-3; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Casals J, 2012, GENET RESOUR CROP EV, V59, P219, DOI 10.1007/s10722-011-9677-6; Casals J, 2011, EUR FOOD RES TECHNOL, V233, P331, DOI 10.1007/s00217-011-1517-6; Cermak T, 2017, PLANT CELL, V29, P1196, DOI 10.1105/tpc.16.00922; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Eid A, 2016, PLANT CELL REP, V35, P1555, DOI 10.1007/s00299-016-2000-4; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Garg N, 2008, EUPHYTICA, V159, P275, DOI 10.1007/s10681-007-9486-3; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Huang SW, 2016, NAT GENET, V48, P109, DOI 10.1038/ng.3484; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Ishii T, 2016, PLANT CELL REP, V35, P1507, DOI 10.1007/s00299-016-1974-2; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jones HD, 2015, GM CROPS FOOD, V6, P223, DOI 10.1080/21645698.2015.1134405; Komor AC, 2016, NATURE, V61, P5985, DOI DOI 10.1038/NATUREL7946; KOPELIOVITCH E, 1982, J AM SOC HORTIC SCI, V107, P361; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mao YF, 2016, PLANT BIOTECHNOL J, V14, P519, DOI 10.1111/pbi.12468; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; MCGLASSON WB, 1987, HORTSCIENCE, V22, P632; Naveen Garg, 2008, Journal of Crop Improvement, V22, P17, DOI 10.1080/15427520802042697; Pan C., 2016, NAT SCI REP, V6, P24765, DOI DOI 10.1038/SREP24765; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Puchta H, 2014, PLANT J, V78, P727, DOI 10.1111/tpj.12338; Quan J, 2009, PLOS ONE, V4, pe6441, DOI DOI 10.1371/J0URNAL.P0NE.0006441; RICK CM, 1956, ADV GENET, V8, P267, DOI 10.1016/S0065-2660(08)60504-0; Robinson RW, 1968, TOMATO GENETICS COOP, V18, P36; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; Schwartz CM, 2016, ACS SYNTH BIOL, V5, P356, DOI 10.1021/acssynbio.5b00162; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sivankalyani V, 2014, SCI HORTIC-AMSTERDAM, V165, P357, DOI 10.1016/j.scienta.2013.11.034; Sun XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10342; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Tigchelaar EC, 1973, REP TOMATO GENET COO, V23, P33; Waltz E, 2016, NATURE, V532, P293, DOI 10.1038/nature.2016.19754; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhang DD, 2016, J GENET GENOMICS, V43, P251, DOI 10.1016/j.jgg.2016.03.001; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhao P, 2016, CELL RES, V26, P633, DOI 10.1038/cr.2016.46	49	0	0	40	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 19	2017	7								11874	10.1038/s41598-017-12262-1				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FH4XG	WOS:000411165100051	28928381	gold			2018-01-05	
J	Merienne, N; Vachey, G; de Longprez, L; Meunier, C; Zimmer, V; Perriard, G; Canales, M; Mathias, A; Herrgott, L; Beltraminelli, T; Maulet, A; Dequesne, T; Pythoud, C; Rey, M; Pellerin, L; Brouillet, E; Perrier, AL; du Pasquier, R; Degion, N				Merienne, Nicolas; Vachey, Gabriel; de Longprez, Lucie; Meunier, Cecile; Zimmer, Virginie; Perriard, Guillaume; Canales, Mathieu; Mathias, Amandine; Herrgott, Lucas; Beltraminelli, Tim; Maulet, Axelle; Dequesne, Thomas; Pythoud, Catherine; Rey, Maria; Pellerin, Luc; Brouillet, Emmanuel; Perrier, Anselme L.; du Pasquier, Renaud; Degion, Nicole			The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes	CELL REPORTS			English	Article							PLURIPOTENT STEM-CELLS; HUNTINGTONS-DISEASE; MOUSE MODEL; IN-VIVO; TRANSGENE EXPRESSION; MUTANT HUNTINGTIN; LENTIVIRAL VECTOR; MUSCULAR-DYSTROPHY; PARKINSONS-DISEASE; CAG REPEATS	Neurodegenerative disorders are a major public health problem because of the high frequency of these diseases. Genome editing with the CRISPR/Cas9 system is making it possible to modify the sequence of genes linked to these disorders. We designed the KamiCas9 self-inactivating editing system to achieve transient expression of the Cas9 protein and high editing efficiency. In the first application, the gene responsible for Huntington's disease (HD) was targeted in adult mouse neuronal and glial cells. Mutant huntingtin (HTT) was efficiently inactivated in mouse models of HD, leading to an improvement in key markers of the disease. Sequencing of potential off-targets with the constitutive Cas9 system in differentiated human iPSC revealed a very low incidence with only one site above background level. This off-target frequency was significantly reduced with the KamiCas9 system. These results demonstrate the potential of the self-inactivating CRISPR/Cas9 editing for applications in the context of neurodegenerative diseases.	[Merienne, Nicolas; Vachey, Gabriel; Zimmer, Virginie; Herrgott, Lucas; Beltraminelli, Tim; Dequesne, Thomas; Pythoud, Catherine; Rey, Maria; Degion, Nicole] Lausanne Univ Hosp, LCMN, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland; [Merienne, Nicolas; Vachey, Gabriel; Zimmer, Virginie; Herrgott, Lucas; Beltraminelli, Tim; Dequesne, Thomas; Pythoud, Catherine; Rey, Maria; Degion, Nicole] Lausanne Univ Hosp, LCMN, Neurosci Res Ctr CRN, CH-1011 Lausanne, Switzerland; [de Longprez, Lucie; Brouillet, Emmanuel] CEA, DRF, Inst Francois Jacob, Mol Imaging Res Ctr MIRCen, F-92265 Fontenay Aux Roses, France; [de Longprez, Lucie; Brouillet, Emmanuel] Univ Paris Saclay, Univ Paris Sud, Neurodegenerat Dis Lab, CNRS,CEA,UMR9199, F-92265 Fontenay Aux Roses, France; [Meunier, Cecile] Univ Lausanne, Lab Neuroenerget, Dept Physiol, CH-1011 Lausanne, Switzerland; [Perriard, Guillaume; Canales, Mathieu; Mathias, Amandine; du Pasquier, Renaud] Lausanne Univ Hosp, Lab Neuroimmunol, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland; [Perriard, Guillaume; Canales, Mathieu; Mathias, Amandine; du Pasquier, Renaud] Lausanne Univ Hosp, Lab Neuroimmunol, Neurosci Res Ctr CRN, CH-1011 Lausanne, Switzerland; [Maulet, Axelle; Perrier, Anselme L.] INSERM, UMR861, I Stem, AFM, F-91100 Corbeil Essonnes, France; [du Pasquier, Renaud] Lausanne Univ Hosp, Dept Clin Neurosci, Serv Neurol, CH-1011 Lausanne, Switzerland	Degion, N (reprint author), Lausanne Univ Hosp, LCMN, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland.; Degion, N (reprint author), Lausanne Univ Hosp, LCMN, Neurosci Res Ctr CRN, CH-1011 Lausanne, Switzerland.	nicole.deglon@chuv.ch		Pellerin, Luc/0000-0002-1016-1970; Deglon, Nicole/0000-0003-4475-9476	Swiss National Science Foundation [31003A-165834]; Association Francaise contre les Myopathies (AFM-Telethon); Agence Nationale pour la Recherche, Neuratris [ANR-11-INBS-0011]; Laboratoire d'Excellence Revive (Investissement d'Avenir) [ANR-10-LABX-73]; French National Health Institute (INSERM); Novartis Foundation; EU Joint Programme-Neurodegenerative Disease Research (JPND) [643417]; aegis of JPND (France, French National Research Agency [ANR]); aegis of JPND (Switzerland, State Secretariat for Education, Research, and Innovation [SERI]); aegis of JPND (Swiss National Science Foundation) [FN 31ND30-166947/1]; Fondation pour la Recherche Medicale	We would like to thank Dr. Jean-Yves Chatton and the Cellular Imaging Facility (CIF) (University of Lausanne) for valuable advice concerning microscopy. We thank Dr. Keith Harshman and the Lausanne Genomic Technologies Facility (University of Lausanne) for NGS. We thank Dr. S. Zeitlin, Dr. M. Levine, and Dr. S. Humbert for their help in getting the breeders for starting our Ki140CAG mouse colony. We thank Prof. Micah Murray for the language and grammar corrections. This work was supported by grants from the Swiss National Science Foundation (31003A-165834), Association Francaise contre les Myopathies (AFM-Telethon), the Agence Nationale pour la Recherche, Neuratris (Grant Q5 "Investment for the Future''; ANR-11-INBS-0011), Laboratoire d'Excellence Revive (Investissement d'Avenir; ANR-10-LABX-73), the French National Health Institute (INSERM), the Novartis Foundation, and the EU Joint Programme-Neurodegenerative Disease Research (JPND) Project (Grant Agreement No. 643417). This specific part of the project is supported through the following organizations under the aegis of JPND (http://www. neurodegenerationresearch.eu/) (France, French National Research Agency [ANR], Switzerland, State Secretariat for Education, Research, and Innovation [SERI], and the Swiss National Science Foundation FN 31ND30-166947/1). N.M. and N.D. are co-inventors on a patent application filed by Lausanne University Hospital and relating to CRISPR (WO 2016/020399 A1, PCT/EP2015/067986). The plasmid containing the GfaABC1D promoter is available under a material transfer agreement (MTA) from Dr. Brenner (Birmingham, AL). L.d.L. is recipient of a PhD fellowship from the Fondation pour la Recherche Medicale.	An M.C., 2014, PLOS CURR, V6; Arber C, 2015, DEVELOPMENT, V142, P1375, DOI 10.1242/dev.117093; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Boissart C, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.71; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Cambon K, 2017, MOL THER-METH CLIN D, V5, P259, DOI 10.1016/j.omtm.2017.05.001; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; de Almeida LP, 2002, J NEUROSCI, V22, P3473; de Leeuw B, 2006, J NEUROSCI RES, V83, P744, DOI 10.1002/jnr.20776; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Dietrich P, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006846; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Dragatsis I, 2000, NAT GENET, V26, P300; Drouet V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099341; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Favre D, 2002, J VIROL, V76, P11605, DOI 10.1128/JVI.76.22.11605-11611.2002; Hirano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075896; Jarraya B, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000130; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kolli N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040754; Lee HK, 2015, STEM CELL RES, V15, P325, DOI 10.1016/j.scr.2015.07.004; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259                                                            ; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Merienne N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00106; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nicoleau C, 2013, STEM CELLS, V31, P1763, DOI 10.1002/stem.1462; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0                                                   ; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shin A, 2017, HUM MOL GENET, V26, P1258, DOI 10.1093/hmg/ddx033; Shin JW, 2016, HUM MOL GENET, V25, P4566, DOI 10.1093/hmg/ddw286; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith A., 2016, HD INSIGHTS, V13, P10; Southwell AL, 2012, TRENDS MOL MED, V18, P634, DOI 10.1016/j.molmed.2012.09.001; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; van Dellen A, 2000, NEUROREPORT, V11, P3751, DOI 10.1097/00001756-200011270-00032                                                ; Wang GH, 2016, P NATL ACAD SCI USA, V113, P3359, DOI 10.1073/pnas.1524575113; Wu YT, 2016, LANCET NEUROL, V15, P116, DOI 10.1016/S1474-4422(15)00092-7; Yang S, 2017, J CLIN INVEST, V127, P2719, DOI 10.1172/JCI92087; Yang WL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00030; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155                                                              ; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	59	0	0	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	SEP 19	2017	20	12					2980	2991		10.1016/j.celrep.2017.08.075				12	Cell Biology	Cell Biology	FH4LZ	WOS:000411127400021	28930690	gold			2018-01-05	
J	Tagde, A; Markert, T; Rajabi, H; Hiraki, M; Alam, M; Bouillez, A; Avigan, D; Anderson, K; Kufe, D				Tagde, Ashujit; Markert, Tahireh; Rajabi, Hasan; Hiraki, Masayuki; Alam, Maroof; Bouillez, Audrey; Avigan, David; Anderson, Kenneth; Kufe, Donald			Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma	ONCOTARGET			English	Article						MUC1-C; multiple myeloma; BMI1; RING1; RING2	BREAST-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR; H2A UBIQUITYLATION; PLASMA-CELLS; HISTONE H2A; STEM-CELLS; C-MYC; ONCOPROTEIN; EXPRESSION	The polycomb repressive complex 1 (PRC1) includes the BMI1, RING1 and RING2 proteins. BMI1 is required for survival of multiple myeloma (MM) cells. The MUC1-C oncoprotein is aberrantly expressed by MM cells, activates MYC and is also necessary for MM cell survival. The present studies show that targeting MUC1-C with (i) stable and inducible silencing and CRISPR/Cas9 editing and (ii) the pharmacologic inhibitor GO-203, which blocks MUC1-C function, downregulates BMI1, RING1 and RING2 expression. The results demonstrate that MUC1-C drives BMI1 transcription by a MYC-dependent mechanism. MUC1-C thus promotes MYC occupancy on the BMI1 promoter and thereby activates BMI1 expression. We also show that the MUC1-C -> MYC pathway induces RING2 expression. Moreover, in contrast to BMI1 and RING2, we found that MUC1-C drives RING1 by an NF-kappa B p65-dependent mechanism. Targeting MUC1-C and thereby the suppression of these key PRC1 proteins was associated with downregulation of the PRC1 E3 ligase activity as evidenced by decreases in ubiquitylation of histone H2A. Targeting MUC1-C also resulted in activation of the PRC1-repressed tumor suppressor genes, PTEN, CDNK2A and BIM. These findings identify a heretofore unrecognized role for MUC1-C in the epigenetic regulation of MM cells.	[Tagde, Ashujit; Markert, Tahireh; Rajabi, Hasan; Hiraki, Masayuki; Alam, Maroof; Bouillez, Audrey; Avigan, David; Anderson, Kenneth; Kufe, Donald] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA	Kufe, D (reprint author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dana Farber Canc Inst, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu			National Cancer Institute of the National Institutes of Health [P50CA100707, R01CA097098, R01CA166480]	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers P50CA100707, R01CA097098 and R01CA166480.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Baldus SE, 2007, HISTOL HISTOPATHOL, V22, P889, DOI 10.14670/HH-22.889; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Bouillez A, 2016, CANCER RES, V76, P1538, DOI 10.1158/0008-5472.CAN-15-1804; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Cho JH, 2013, J BIOL CHEM, V288, P3406, DOI 10.1074/jbc.M112.422931; Cloosen S, 2006, BRIT J HAEMATOL, V135, P513, DOI 10.1111/j.1365-2141.2006.06331.x; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005                                                    ; De Vos J, 2002, ONCOGENE, V21, P6848, DOI 10.1038/sj.onc.1205868; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deola S, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-35; Dimri M, 2016, ONCOTARGET, V7, P36220, DOI 10.18632/oncotarget.8811; Hasegawa M, 2016, ONCOTARGET, V7, P11756, DOI 10.18632/oncotarget.7598; Hiraki M, 2017, ONCOGENE, V36, P2791, DOI 10.1038/onc.2016.439; Hiraki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26643; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jagani Z, 2010, CANCER RES, V70, P5528, DOI 10.1158/0008-5472.CAN-09-4229; Kawano T, 2008, INT J ONCOL, V33, P153; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOKHORST HM, 1994, BLOOD, V84, P2269; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Ohtsubo M, 2008, P NATL ACAD SCI USA, V105, P10396, DOI 10.1073/pnas.0800672105; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Paydas S, 2001, LEUKEMIA RES, V25, P221, DOI 10.1016/S0145-2126(00)00111-9; Raina D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135156; Rajabi H, 2016, ONCOGENE, V35, P6439, DOI 10.1038/onc.2016.180; Rajabi H, 2014, ONCOGENE, V33, P1680, DOI 10.1038/onc.2013.114; Rajabi H, 2012, J BIOL CHEM, V287, P10703, DOI 10.1074/jbc.M111.323311; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Rizo A, 2009, BLOOD, V114, P1498, DOI 10.1182/blood-2009-03-209734; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Tagde A, 2016, ONCOTARGET, V7, P38974, DOI 10.18632/oncotarget.9777; Tagde A, 2016, BLOOD, V127, P2587, DOI 10.1182/blood-2015-07-659151; Takahashi H, 2015, ONCOGENE, V34, P5187, DOI 10.1038/onc.2014.442; Tassone P, 2005, CLIN CANCER RES, V11, P4251, DOI 10.1158/1078-0432.CCR-04-2611                                                   ; Treon SP, 1999, BLOOD, V93, P1287; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yin L, 2012, BLOOD, V119, P810, DOI 10.1182/blood-2011-07-369686; Yin L, 2010, MOL PHARMACOL, V78, P166, DOI 10.1124/mol.110.065011; Yong KJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6066; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077	53	0	0	5	5	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	SEP 19	2017	8	41					69237	69249		10.18632/oncotarget.20144				13	Oncology; Cell Biology	Oncology; Cell Biology	FH4TA	WOS:000411153300006	29050200	green_published			2018-01-05	
J	Amin, EM; Liu, Y; Deng, S; Tan, KS; Chudgar, N; Mayo, MW; Sanchez-Vega, F; Adusumilli, PS; Schultz, N; Jones, DR				Amin, Elianna M.; Liu, Yuan; Deng, Su; Tan, Kay See; Chudgar, Neel; Mayo, Marty W.; Sanchez-Vega, Francisco; Adusumilli, Prasad S.; Schultz, Nikolaus; Jones, David R.			The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK	SCIENCE SIGNALING			English	Article							FOCAL ADHESION KINASE; CELL-MIGRATION; HEPATOCELLULAR-CARCINOMA; UNWINDING ACTIVITY; GENE-EXPRESSION; BINDING DOMAIN; HUMAN CANCER; KAPPA-B; METASTASIS; ADENOSINE	Large-scale, genome-wide studies report that RNA binding proteins are altered in cancers, but it is unclear how these proteins control tumor progression. We found that the RNA-editing protein ADAR (adenosine deaminase acting on double-stranded RNA) acted as a facilitator of lung adenocarcinoma (LUAD) progression through its ability to stabilize transcripts encoding focal adhesion kinase (FAK). In samples from 802 stage I LUAD patients, increased abundance of ADAR at both the mRNA and protein level correlated with tumor recurrence. Knocking down ADAR in LUAD cells suppressed their mesenchymal properties, migration, and invasion in culture. Analysis of gene expression patterns in LUAD cells identified ADAR-associated enrichment of a subset of genes involved in cellmigration pathways; among these, FAK is the most notable gene whose expression was increased in the presence of ADAR. Molecular analyses revealed that ADAR posttranscriptionally increased FAK protein abundance by binding to the FAK transcript and editing a specific intronic site that resulted in the increased stabilization of FAK mRNA. Pharmacological inhibition of FAK blocked ADAR-induced invasiveness of LUAD cells, suggesting a potential therapeutic application for LUAD that has a high abundance of ADAR.	[Amin, Elianna M.; Liu, Yuan; Deng, Su; Chudgar, Neel; Adusumilli, Prasad S.; Jones, David R.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Tan, Kay See; Sanchez-Vega, Francisco; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Mayo, Marty W.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Jones, DR (reprint author), Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA.	jonesd2@mskcc.org		Jones, Drew/0000-0001-8732-9818	NIH/National Cancer Institute Cancer Center [P30 CA008748];  [R01 CA136705];  [R01 CA192399];  [R01 CA132580];  [U54 CA137788]	This work was supported by grants R01 CA136705 (to D.R.J.), R01 CA192399 (to M.W.M.), R01 CA132580 (to M.W.M.), and U54 CA137788 (to P.S.A.). This work was also supported, in part, by NIH/National Cancer Institute Cancer Center Support Grant P30 CA008748.	Anadon C, 2016, ONCOGENE, V35, P4407, DOI 10.1038/onc.2015.469; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437                                                        ; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170                                                       ; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Cheng N, 2013, HEPATOLOGY, V57, P1906, DOI 10.1002/hep.26202; Chung GG, 2001, CLIN CANCER RES, V7, P4013; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Daniel C, 2015, BIOCHIMIE, V117, P22, DOI 10.1016/j.biochi.2015.05.020; Devarakonda SHK, 2014, J CLIN ONCOL, V32; Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Galeano F, 2012, SEMIN CELL DEV BIOL, V23, P244, DOI 10.1016/j.semcdb.2011.09.003; Gerber DE, 2014, J CLIN ONCOL, V32; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Ho BT, 2012, J BIOL CHEM, V287, P18656, DOI 10.1074/jbc.M111.322883; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kadota K, 2015, ONCOTARGET, V6, P27505, DOI 10.18632/oncotarget.4752; Konstantinidou G, 2013, CANCER DISCOV, V3, P444, DOI 10.1158/2159-8290.CD-12-0388; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Lee BY, 2015, PHARMACOL THERAPEUT, V146, P132, DOI 10.1016/j.pharmthera.2014.10.001; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Liu Y, 2015, MOL CELL BIOL, V35, P303, DOI 10.1128/MCB.00869-14; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; O'Shannessy DJ, 2012, ONCOTARGET, V3, P414; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997                                                          ; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shoshan E, 2015, NAT CELL BIOL, V17, P311, DOI 10.1038/ncb3110; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Stein WD, 2004, CANCER RES, V64, P2805, DOI 10.1158/0008-5472.CAN-03-3383; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	59	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1945-0877	1937-9145		SCI SIGNAL	Sci. Signal.	SEP 19	2017	10	497							eaah3941	10.1126/scisignal.aah3941				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FH4PF	WOS:000411137600001					2018-01-05	
J	Huang, YH; Su, JZ; Lei, Y; Brunetti, L; Gundry, MC; Zhang, XT; Jeong, M; Li, W; Goodell, MA				Huang, Yung-Hsin; Su, Jianzhong; Lei, Yong; Brunetti, Lorenzo; Gundry, Michael C.; Zhang, Xiaotian; Jeong, Mira; Li, Wei; Goodell, Margaret A.			DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A	GENOME BIOLOGY			English	Article							ACUTE MYELOID-LEUKEMIA; METHYLTRANSFERASE 3A; GENE-EXPRESSION; METHYLATION; DEMETHYLATION; SYSTEM; GENOME; CELLS; ACTIVATION; DOMAIN	Background: DNA methylation has widespread effects on gene expression during development. However, our ability to assign specific function to regions of DNA methylation is limited by the poor correlation between global patterns of DNA methylation and gene expression. Results: Here, we utilize nuclease-deactivated Cas9 protein fused to repetitive peptide epitopes (SunTag) recruiting multiple copies of antibody-fused de novo DNA methyltransferase 3A (DNMT3A) (dCas9-SunTag-DNMT3A) to amplify the local DNMT3A concentration to methylate genomic sites of interest. We demonstrate that dCas9-SunTag-DNMT3A dramatically increases CpG methylation at the HOXA5 locus in human embryonic kidney (HEK293T) cells. Furthermore, using a single guide RNA, dCas9-SunTag-DNMT3A is able to methylate a 4.5-kb genomic region and repress HOXA5 gene expression. Reduced representation bisulfite sequencing and RNA-seq show that dCas9-SunTag-DNMT3A methylates regions of interest with minimal impact on the global DNA methylome and transcriptome. Conclusions: This effective and precise tool enables site-specific manipulation of DNA methylation and may be used to address the relationship between DNA methylation and gene expression.	[Huang, Yung-Hsin; Goodell, Margaret A.] Baylor Coll Med, Dept Dev Biol, Houston, TX 77030 USA; [Huang, Yung-Hsin; Lei, Yong; Brunetti, Lorenzo; Gundry, Michael C.; Zhang, Xiaotian; Jeong, Mira; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Huang, Yung-Hsin; Lei, Yong; Brunetti, Lorenzo; Gundry, Michael C.; Zhang, Xiaotian; Jeong, Mira; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Su, Jianzhong; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Gundry, Michael C.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Goodell, MA (reprint author), Baylor Coll Med, Dept Dev Biol, Houston, TX 77030 USA.; Goodell, MA (reprint author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.; Goodell, MA (reprint author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.; Li, W (reprint author), Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA.; Goodell, MA (reprint author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	wl1@bcm.edu; goodell@bcm.edu		Zhang, Xiaotian/0000-0002-9533-4761	Cancer Prevention and Research Institute of Texas; Evans Foundation; National Institutes of Health (NIH) [DK092883, DK060445, CA183252, P50CA126752, CA193235, HG007538, CA193466, RP110471, RP150292]; NIH (NCRR grant) [S10RR024574]; NIH (NIAID) [AI036211]; NIH (NCI) [P30CA125123]	This work was supported by the Cancer Prevention and Research Institute of Texas, the Evans Foundation, and the National Institutes of Health (NIH) (DK092883, DK060445, CA183252, P50CA126752, CA193235, HG007538, CA193466, RP110471, and RP150292. Flow cytometry was partially supported by the NIH (NCRR grant S10RR024574, NIAID AI036211, and NCI P30CA125123) for the Baylor College of Medicine (BCM) Cytometry and Cell Sorting Core.	BESTOR TH, 1992, EMBO J, V11, P2611; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r92, 10.1186/gb-2012-13-10-R92]; Choudhury SR, 2016, ONCOTARGET, V7, P46545, DOI 10.18632/oncotarget.10234; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Stepper P, 2017, NUCLEIC ACIDS RES, V45, P1703, DOI 10.1093/nar/gkw1112; Strathdee G, 2007, CARCINOGENESIS, V28, P299, DOI 10.1093/carcin/bgl133; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9                                                   ; Xi Yuanxin, 2009, BMC Bioinformatics, V10, P232, DOI 10.1186/1471-2105-10-232; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	28	0	0	13	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	SEP 18	2017	18								176	10.1186/s13059-017-1306-z				11	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FH2AN	WOS:000410941100001	28923089	gold			2018-01-05	
J	Chen, TC; Liu, YC; Wang, XW; Wu, CH; Huang, CH; Chang, CC				Chen, Ting-Chieh; Liu, Yu-Chang; Wang, Xuewen; Wu, Chi-Hsuan; Huang, Chih-Hao; Chang, Ching-Chun			Whole plastid transcriptomes reveal abundant RNA editing sites and differential editing status in Phalaenopsis aphrodite subsp formosana	BOTANICAL STUDIES			English	Article						Plastids; Plastid gene expression; RNA editing; Moth orchids; Phalaenopsis aphrodite	CYTOPLASMIC MALE-STERILE; CHLOROPLAST DNA MARKERS; PROTEIN-CODING GENES; PLANT-MITOCHONDRIA; GENOME; IDENTIFICATION; ARABIDOPSIS; EVOLUTION; SEQUENCE; EVENTS	Background: RNA editing is a process of post-transcriptional level of gene regulation by nucleotide modification. Previously, the chloroplast DNA of Taiwan endemic moth orchid, P. aphrodite subsp. formosana was determined, and 44 RNA editing sites were identified from 24 plastid protein-coding transcripts of leaf tissue via RT-PCR and then conventional Sanger sequencing. However, the RNA editing status of whole-plastid transcripts in leaf and other distinct tissue types in moth orchids has not been addressed. To sensitively and extensively examine the plastid RNA editing status of moth orchid, RNA-Seq was used to investigate the editing status of whole-plastid transcripts from leaf and floral tissues by mapping the sequence reads to the corresponding cpDNA template. With the threshold of at least 5% C-to-U or U-to-C conversion events observed in sequence reads considered as RNA editing sites. Results: In total, 137 edits with 126 C-to-U and 11 U-to-C conversions, including 93 newly discovered edits, were identified in plastid transcripts, representing an average of 0.09% of the nucleotides examined in moth orchid. Overall, 110 and 106 edits were present in leaf and floral tissues, respectively, with 79 edits in common. As well, 79 edits were involved in protein-coding transcripts, and the 58 nucleotide conversions caused the non-synonymous substitution. At least 32 edits showed significant (>= 20%) differential editing between leaf and floral tissues. Finally, RNA editing in trnM is required for the formation of a standard clover-leaf structure. Conclusions: We identified 137 edits in plastid transcripts of moth orchid, the highest number reported so far in monocots. The consequence of RNA editing in protein-coding transcripts mainly cause the amino acid change and tend to increase the hydrophobicity as well as conservation among plant phylogeny. RNA editing occurred in non-protein-coding transcripts such as tRNA, introns and untranslated regulatory regions could affect the formation and stability of secondary structure, which might play an important role in the regulation of gene expression. Furthermore, some unidentified tissue-specific factors might be required for regulating RNA editing in moth orchid.	[Chen, Ting-Chieh; Liu, Yu-Chang; Wu, Chi-Hsuan; Huang, Chih-Hao; Chang, Ching-Chun] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan; [Chen, Ting-Chieh; Liu, Yu-Chang; Huang, Chih-Hao; Chang, Ching-Chun] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan 701, Taiwan; [Wang, Xuewen] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Chang, CC (reprint author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan.; Chang, CC (reprint author), Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan 701, Taiwan.	chingcc@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan [MOST 104-2321-B-006-001, MOST 105-2313-B-006-001, MOST 106-2313-B-006-003-MY3]	This work was financially supported in part by the Grants (MOST 104-2321-B-006-001, MOST 105-2313-B-006-001 and MOST 106-2313-B-006-003-MY3) to C.-C. Chang from the Ministry of Science and Technology, Taiwan.	Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2011, PLANT PHYSIOL, V155, P1520, DOI 10.1104/pp.110.171231; Bentolila S, 2005, PLANT PHYSIOL, V139, P2006, DOI 10.1104/pp.105.069013; Bentolila S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003584; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; BINDER S, 1994, MOL GEN GENET, V244, P67, DOI 10.1007/BF00280188; Bock R, 2000, BIOCHIMIE, V82, P549, DOI 10.1016/S0300-9084(00)00610-6                                                   ; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Boussardon C, 2014, NEW PHYTOL, V203, P1090, DOI 10.1111/nph.12928; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chateigner-Boutin AL, 2003, NUCLEIC ACIDS RES, V31, P2586, DOI 10.1093/nar/gkg354; Chen HY, 2011, J INTEGR PLANT BIOL, V53, P961, DOI 10.1111/j.1744-7909.2011.01082.x; Christenson EA, 2001, PHALAENOPSIS MONOGRA; Drescher A, 2002, MOL GENET GENOMICS, V267, P262, DOI 10.1007/s00438-002-0662-9; Dressler Robert L., 2006, Selbyana, V27, P154; Farre JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052644; Fiebig A, 2004, NUCLEIC ACIDS RES, V32, P3615, DOI 10.1093/nar/gkh695; Grennan AK, 2011, PLANT PHYSIOL, V156, P453, DOI 10.1104/pp.111.900412; Grimes BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-31; Guo WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117075; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; He P, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0944-8; Hein A, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0589-0; Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144; Howad W, 1997, P NATL ACAD SCI USA, V94, P11090, DOI 10.1073/pnas.94.20.11090; HRUBEC TC, 1985, PLANT PHYSIOL, V77, P1010, DOI 10.1104/pp.77.4.1010; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; JANKE A, 1993, NUCLEIC ACIDS RES, V21, P1523, DOI 10.1093/nar/21.7.1523; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; Jiang Y, 2012, GENET MOL RES, V11, P987, DOI 10.4238/2012.April.19.4; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Kunzmann A, 1998, P NATL ACAD SCI USA, V95, P108, DOI 10.1073/pnas.95.1.108; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092501; Lin BY, 2016, BIOL PLANTARUM, V60, P68, DOI 10.1007/s10535-015-0566-2; Lin CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129396; Lin JY, 2015, SCI HORTIC-AMSTERDAM, V192, P302, DOI 10.1016/j.scienta.2015.06.019; Liu YC, 2016, SCI HORTIC-AMSTERDAM, V203, P86, DOI 10.1016/j.scienta.2016.03.021; MarechalDrouard L, 1996, NUCLEIC ACIDS RES, V24, P3229, DOI 10.1093/nar/24.16.3229                                                          ; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; [Anonymous], NUCL ACIDS RES; Ruf S, 1997, CURR GENET, V32, P19, DOI 10.1007/s002940050242; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Sasaki T, 2003, MOL BIOL EVOL, V20, P1028, DOI 10.1093/molbev/msg098; Sasaki T, 2006, PLANT J, V47, P802, DOI 10.1111/j.1365-313X.2006.02825.x; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SCHWITZGUEBEL JP, 1984, PLANT PHYSIOL, V75, P670, DOI 10.1104/pp.75.3.670; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; Sun T, 2016, TRENDS PLANT SCI, V21, P962, DOI 10.1016/j.tplants.2016.07.005; Sun T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005028; Sun T, 2013, P NATL ACAD SCI USA, V110, pE1169, DOI 10.1073/pnas.1220162110; Suzuki H, 2013, MOL GENET GENOMICS, V288, P445, DOI 10.1007/s00438-013-0764-6; Takenaka M, 2014, MITOCHONDRION, V19, P191, DOI 10.1016/j.mito.2014.04.005; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Tillich M, 2005, PLANT J, V43, P708, DOI 10.1111/j.1365-313X.2005.02484.x; Tseng CC, 2013, PLANT MOL BIOL, V82, P375, DOI 10.1007/s11103-013-0069-5; Tsudzuki T, 2001, J MOL EVOL, V53, P327, DOI 10.1007/s002390010222; Uthaipaisanwong P, 2012, GENE, V500, P172, DOI 10.1016/j.gene.2012.03.061; Vogel J, 1997, J MOL BIOL, V270, P179, DOI 10.1006/jmbi.1997.1115; Wagoner JA, 2015, J BIOL CHEM, V290, P2957, DOI 10.1074/jbc.M114.622084; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wang MX, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010013; Wang MX, 2015, PLANT MOL BIOL REP, V33, P1526, DOI 10.1007/s11105-015-0853-2; Wang ZJ, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0143-4; Wolf PG, 2004, GENE, V339, P89, DOI 10.1016/j.gene.2004.06.018; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; YANG AJ, 1991, MOL CELL BIOL, V11, P4278, DOI 10.1128/MCB.11.8.4278                                                           ; Zeng WH, 2007, PLANT CELL PHYSIOL, V48, P362, DOI 10.1093/pcp/pcl058	72	0	0	5	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1999-3110			BOT STUD	Bot. Stud.	SEP 16	2017	58								38	10.1186/s40529-017-0193-7				14	Plant Sciences	Plant Sciences	FH3IU	WOS:000411041300001	28916985	gold			2018-01-05	
J	Flowers, GP; Sanor, LD; Crews, CM				Flowers, Grant Parker; Sanor, Lucas D.; Crews, Craig M.			Lineage tracing of genome-edited alleles reveals high fidelity axolotl limb regeneration	ELIFE			English	Article							RNA-GUIDED NUCLEASE; MUSCLE REGENERATION; CELLS; DEDIFFERENTIATION; CHOREOGRAPHY; MUTAGENESIS; CARTILAGE; ORIGIN	Salamanders are unparalleled among tetrapods in their ability to regenerate many structures, including entire limbs, and the study of this ability may provide insights into human regenerative therapies. The complex structure of the limb poses challenges to the investigation of the cellular and molecular basis of its regeneration. Using CRISPR/Cas, we genetically labelled unique cell lineages within the developing axolotl embryo and tracked the frequency of each lineage within amputated and fully regenerated limbs. This allowed us, for the first time, to assess the contributions of multiple low frequency cell lineages to the regenerating limb at once. Our comparisons reveal that regenerated limbs are high fidelity replicas of the originals even after repeated amputations.	[Flowers, Grant Parker; Sanor, Lucas D.; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA	Flowers, GP; Crews, CM (reprint author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Crews, CM (reprint author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.; Crews, CM (reprint author), Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.	fowers@yale.edu; craig.crews@yale.edu		Flowers, Grant/0000-0001-7436-3531	Connecticut Innovations Seed Grant [15RMA-YALE-09]; Eunice Kennedy Shriver National Institute of Child Health and Human Development Individual Postdoctoral Fellowship [F32HD086942]; Connecticut Innovations Established Investigator Award [15-RMB-YALE-01]; National Institute of General Medical Sciences Predoctoral Training Fellowship [T32GM007499]	Connecticut Innovations Seed Grant 15RMA-YALE-09 Grant Parker Flowers; Eunice Kennedy Shriver National Institute of Child Health and Human Development Individual Postdoctoral Fellowship F32HD086942 Grant Parker Flowers; Connecticut Innovations Established Investigator Award 15-RMB-YALE-01 Craig M Crews; National Institute of General Medical Sciences Predoctoral Training Fellowship T32GM007499 Lucas D Sanor; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; Currie JD, 2016, DEV CELL, V39, P411, DOI 10.1016/j.devcel.2016.10.013; Flowers GP, 2015, METHODS MOL BIOL, V1290, P279, DOI 10.1007/978-1-4939-2495-0_22; Flowers GP, 2014, DEVELOPMENT, V141, P2165, DOI 10.1242/dev.105072; Francis E. T., 1934, ANATOMY SALAMANDER; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lopez D, 2014, BLOOD, V124, P1232, DOI 10.1182/blood-2013-09-526970; Maden M, 2015, REGENERATION, V2, P137, DOI 10.1002/reg2.35; McCusker CD, 2016, DEV BIOL, V416, P26, DOI 10.1016/j.ydbio.2016.05.032; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Monaghan JR, 2014, REGENERATION, V1, P2, DOI 10.1002/reg2.8; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nacu E, 2013, DEVELOPMENT, V140, P513, DOI 10.1242/dev.081752; NAMENWIRTH M, 1974, DEV BIOL, V41, P42, DOI 10.1016/0012-1606(74)90281-4; Sandoval-Guzman T, 2014, CELL STEM CELL, V14, P174, DOI 10.1016/j.stem.2013.11.007; Seifert AW, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-2; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Tanaka EM, 2016, CELL, V165, P1598, DOI 10.1016/j.cell.2016.05.038; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tanaka HV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11069; Voss SR, 2015, REGENERATION, V2, P120, DOI 10.1002/reg2.37	25	0	0	4	4	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	SEP 16	2017	6								e25726	10.7554/eLife.25726				15	Biology	Life Sciences & Biomedicine - Other Topics	FI6SD	WOS:000412125700001		gold			2018-01-05	
J	Kondo, S; Vedanayagam, J; Mohammed, J; Eizadshenass, S; Kan, LJ; Pang, N; Aradhya, R; Siepel, A; Steinhauer, J; Lai, EC				Kondo, Shu; Vedanayagam, Jeffrey; Mohammed, Jaaved; Eizadshenass, Sogol; Kan, Lijuan; Pang, Nan; Aradhya, Rajaguru; Siepel, Adam; Steinhauer, Josefa; Lai, Eric C.			New genes often acquire male-specific functions but rarely become essential in Drosophila	GENES & DEVELOPMENT			English	Article						Drosophila; gene evolution; spermatogenesis; testis	EVOLUTION; EXPRESSION; SPERMATOGENESIS; ORGANISMS; PATTERNS; PROJECT; ROLES; INDEX	Relatively little is known about the in vivo functions of newly emerging genes, especially in metazoans. Although prior RNAi studies reported prevalent lethality among young gene knockdowns, our phylogenomic analyses reveal that young Drosophila genes are frequently restricted to the nonessential male reproductive system. We performed large-scale CRISPR/Cas9 mutagenesis of "conserved, essential" and "young, RNAi-lethal" genes and broadly confirmed the lethality of the former but the viability of the latter. Nevertheless, certain young gene mutants exhibit defective spermatogenesis and/or male sterility. Moreover, we detected widespread signatures of positive selection on young male-biased genes. Thus, young genes have a preferential impact on male reproductive system function.	[Kondo, Shu] Natl Inst Genet, Invertebrate Genet Lab, Mishima, Shizuoka 4118540, Japan; [Vedanayagam, Jeffrey; Mohammed, Jaaved; Kan, Lijuan; Pang, Nan; Aradhya, Rajaguru; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, New York, NY 10065 USA; [Mohammed, Jaaved] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Mohammed, Jaaved] Triinst Training Program Computat Biol & Med, New York, NY 10021 USA; [Eizadshenass, Sogol; Steinhauer, Josefa] Yeshiva Univ, Dept Biol, New York, NY 10033 USA; [Siepel, Adam] Cold Spring Harbor Lab, Simons Ctr Quantitat Biol, Cold Spring Harbor, NY 11724 USA	Kondo, S (reprint author), Natl Inst Genet, Invertebrate Genet Lab, Mishima, Shizuoka 4118540, Japan.; Lai, EC (reprint author), Sloan Kettering Inst, Dept Dev Biol, New York, NY 10065 USA.	skondo@nig.ac.jp; laie@mskcc.org			Mochida Memorial Foundation for Medical and Pharmaceutical Research; National Institutes of Health (NIH) [R01-GM102192]; NIH [R15-HD080511, R01-NS083833, R01-GM083300]; Memorial Sloan-Kettering Core [P30-CA008748]	We are very grateful to Doris Kretzschmar for sharing unpublished characterization of BACE mutants. We thank Sayani Sen for assistance with fly husbandry, and Mariana Wolfner, the Bloomington Stock Center, and the Developmental Studies Hybridoma Bank for fly stocks and antibodies. S.K. was supported by the Mochida Memorial Foundation for Medical and Pharmaceutical Research. A.S. was supported by National Institutes of Health (NIH) R01-GM102192. Work in J.S.'s laboratory was supported by NIH R15-HD080511. Work in E.C.L.'s group was supported by the NIH (R01-NS083833 and R01-GM083300) and Memorial Sloan-Kettering Core Grant P30-CA008748.	Assis R, 2013, P NATL ACAD SCI USA, V110, P17409, DOI 10.1073/pnas.1313759110; Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Belote JM, 2009, HEREDITY, V103, P23, DOI 10.1038/hdy.2009.23; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Chen SD, 2013, NAT REV GENET, V14, P645, DOI 10.1038/nrg3521; Chen SD, 2012, CELL REPORTS, V1, P118, DOI 10.1016/j.celrep.2011.12.010; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Drost HG, 2016, MOL BIOL EVOL, V33, P1158, DOI 10.1093/molbev/msw039; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9                                                   ; Mohammed J, 2014, RNA, V20, P1195, DOI 10.1261/rna.044644.114; Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Ross BD, 2013, SCIENCE, V340, P1211, DOI 10.1126/science.1234393; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; Wen JY, 2015, MOL CELL, V57, P165, DOI 10.1016/j.molcel.2014.11.025; Wen KJ, 2016, GENOME RES, V26, P1233, DOI 10.1101/gr.199547.115; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zeng XK, 2015, CELL REP, V10, P1226, DOI 10.1016/j.celrep.2015.01.051; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179; Zhang YE, 2010, GENOME RES, V20, P1526, DOI 10.1101/gr.107334.110; Zhao L, 2014, SCIENCE, V343, P769, DOI 10.1126/science.1248286	28	1	1	1	1	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	SEP 15	2017	31	18					1841	1846		10.1101/gad.303131.117				6	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	FK1QD	WOS:000413256000004	29051389				2018-01-05	
J	Newman, CE; Toxopeus, J; Udaka, H; Ahn, S; Martynowicz, DM; Graether, SP; Sinclair, BJ; Percival-Smith, A				Newman, Claire E.; Toxopeus, Jantina; Udaka, Hiroko; Ahn, Soohyun; Martynowicz, David M.; Graether, Steffen P.; Sinclair, Brent J.; Percival-Smith, Anthony			CRISPR-induced null alleles show that Frost protects Drosophila melanogaster reproduction after cold exposure	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Genome editing; CRISPR-Cas9; Cold tolerance; Chill coma; Intrinsically disordered protein; Insect	CHILL-COMA RECOVERY; LEA PROTEINS; TOLERANCE; STRESS; GENE; ACCLIMATION; RESISTANCE; DESICCATION; PLASTICITY; SELECTION	The ability to survive and reproduce after cold exposure is important in all kingdoms of life. However, even in a sophisticated genetic model system like Drosophila melanogaster, few genes have been identified as functioning in cold tolerance. The accumulation of the Frost (Fst) gene transcript increases after cold exposure, making it a good candidate for a gene that has a role in cold tolerance. Despite extensive RNAi knockdown analysis, no role in cold tolerance has been assigned to Fst. CRISPR is an effective technique for completely knocking down genes, and is less likely to produce offtarget effects than GAL4-UAS RNAi systems. We have used CRISPR-mediated homologous recombination to generate Fst-null alleles, and these Fst alleles uncovered a requirement for FST protein in maintaining female fecundity following cold exposure. However, FST does not have a direct role in survival following cold exposure. FST mRNA accumulates in the Malpighian tubules, and the FST protein is a highly disordered protein with a putative signal peptide for export from the cell. Future work is needed to determine whether FST is exported from the Malpighian tubules and directly interacts with female reproductive tissues post-cold exposure, or whether it is required for other repair/recovery functions that indirectly alter energy allocation to reproduction.	[Newman, Claire E.; Toxopeus, Jantina; Udaka, Hiroko; Ahn, Soohyun; Sinclair, Brent J.; Percival-Smith, Anthony] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Martynowicz, David M.; Graether, Steffen P.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Udaka, Hiroko] Kyoto Univ, Dept Zool, Kyoto, Japan; [Ahn, Soohyun] Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic, Australia	Percival-Smith, A (reprint author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	aperciva@uwo.ca		Toxopeus, Jantina/0000-0002-0761-801X	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Canada Graduate Scholarship; Japan Society for the Promotion of Science	This work was supported by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to S.P.G., B.J.S. and A.P.-S.; by an NSERC Canada Graduate Scholarship to J.T.; and by a postdoctoral fellowship from the Japan Society for the Promotion of Science to H.U.	Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bing X, 2012, INSECT MOL BIOL, V21, P31, DOI 10.1111/j.1365-2583.2011.01108.x; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clarke MW, 2015, J BIOL CHEM, V290, P26900, DOI 10.1074/jbc.M115.678219; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; Collinge JE, 2008, HEREDITY, V101, P260, DOI 10.1038/hdy.2008.57; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Dennis AB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13965; Dillon ME, 2007, J EXP BIOL, V210, P2897, DOI 10.1242/jeb.007591; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Gerken AR, 2016, J THERM BIOL, V59, P77, DOI 10.1016/j.jtherbio.2016.04.004; Gerken AR, 2015, P NATL ACAD SCI USA, V112, P4399, DOI 10.1073/pnas.1503456112; Goto SG, 2001, GENE, V270, P259, DOI 10.1016/S0378-1119(01)00465-6                                                   ; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hincha DK, 2012, BIOCHEM SOC T, V40, P1000, DOI 10.1042/BST20120109; Hoffmann AA, 2012, INSECT MOL BIOL, V21, P437, DOI 10.1111/j.1365-2583.2012.01149.x; Hoffmann AA, 2001, EVOLUTION, V55, P1621; Hughes S, 2011, PROTEIN SCI, V20, P42, DOI 10.1002/pro.534; Hughes SL, 2013, PLANT PHYSIOL, V163, P1376, DOI 10.1104/pp.113.226803; Jakobs R, 2015, J INSECT PHYSIOL, V79, P1, DOI 10.1016/j.jinsphys.2015.05.003; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lee Richard E. Jr, 2010, P3, DOI 10.1017/CBO9780511675997.002; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; MacMillan HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28999; MacMillan HA, 2015, SCI REP-UK, V5, DOI 10.1038/srep18607; MacMillan HA, 2015, J EXP BIOL, V218, P423, DOI 10.1242/jeb.115790; Markow T. A., 2005, DROSOPHILA GUIDE SPE; MARSHALL AT, 1973, J INSECT PHYSIOL, V19, P2317, DOI 10.1016/0022-1910(73)90238-2; Marshall KE, 2010, P R SOC B, V277, P963, DOI 10.1098/rspb.2009.1807; Mizianty M. J., 2013, INTRINSICALLY DISORD, V1, DOI DOI 10.4161/IDP.24428; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Nilson TL, 2006, J INSECT PHYSIOL, V52, P1027, DOI 10.1016/j.jinsphys.2006.07.001; Overgaard J, 2017, ANNU REV PHYSIOL, V79, P187, DOI 10.1146/annurev-physiol-022516-034142; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin W, 2005, INSECT MOL BIOL, V14, P607, DOI 10.1111/j.1365-2583.2005.00589.x; Reis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025520; Shreve SM, 2004, J EXP BIOL, V207, P1797, DOI 10.1242/jeb.00951; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; Sinclair BJ, 2015, J THERM BIOL, V53, P180, DOI 10.1016/j.jtherbio.2015.11.003; Sorensen JG, 2017, EVOLUTION, V71, P1627, DOI 10.1111/evo.13243; Storey KB, 2013, COMPR PHYSIOL, V3, P1283, DOI 10.1002/cphy.c130007; Telonis-Scott M, 2009, J INSECT PHYSIOL, V55, P549, DOI 10.1016/j.jinsphys.2009.01.010; Terhzaz S, 2015, P NATL ACAD SCI USA, V112, P2882, DOI 10.1073/pnas.1501518112; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Udaka H, 2013, INSECT MOL BIOL, V22, P541, DOI 10.1111/imb.12044; Udaka H, 2010, J INSECT PHYSIOL, V56, P1889, DOI 10.1016/j.jinsphys.2010.08.008; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x                                                ; Venables W. N., 2002, MODERN APPL STAT S; Watson MJO, 1996, EVOLUTION, V50, P1182, DOI 10.1111/j.1558-5646.1996.tb02359.x; Williams CM, 2014, EVOLUTION, V68, P3505, DOI 10.1111/evo.12541; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289; Zhang J, 2011, J EXP BIOL, V214, P4021, DOI 10.1242/jeb.059535	58	0	0	5	5	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	SEP 15	2017	220	18					3344	3354		10.1242/jeb.160176				11	Biology	Life Sciences & Biomedicine - Other Topics	FH5IT	WOS:000411199600021	28705828				2018-01-05	
J	Wright, AV; Liu, JJ; Knott, GJ; Doxzen, KW; Nogales, E; Doudna, JA				Wright, Addison V.; Liu, Jun-Jie; Knott, Gavin J.; Doxzen, Kevin W.; Nogales, Eva; Doudna, Jennifer A.			Structures of the CRISPR genome integration complex	SCIENCE			English	Article							CAS ADAPTIVE IMMUNITY; SPACER ACQUISITION; ESCHERICHIA-COLI; HOST FACTOR; DNA; ADAPTATION; PROTEIN; ELEMENTS; REPEATS; SYSTEMS	CRISPR-Cas systems depend on the Cas1-Cas2 integrase to capture and integrate short foreign DNA fragments into the CRISPR locus, enabling adaptation to new viruses. We present crystal structures of Cas1-Cas2 bound to both donor and target DNA in intermediate and product integration complexes, as well as a cryo-electron microscopy structure of the full CRISPR locus integration complex, including the accessory protein IHF (integration host factor). The structures show unexpectedly that indirect sequence recognition dictates integration site selection by favoring deformation of the repeat and the flanking sequences. IHF binding bends the DNA sharply, bringing an upstream recognition motif into contact with Cas1 to increase both the specificity and efficiency of integration. These results explain how the Cas1-Cas2 CRISPR integrase recognizes a sequence-dependent DNA structure to ensure site-selective CRISPR array expansion during the initial step of bacterial adaptive immunity.	[Wright, Addison V.; Liu, Jun-Jie; Knott, Gavin J.; Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Liu, Jun-Jie; Nogales, Eva; Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Doxzen, Kevin W.; Doudna, Jennifer A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Nogales, Eva; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA	Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Knott, Gavin J./0000-0002-9007-6273	University of California Office of the President, Multicampus Research Programs and Initiatives grant [MR-15-328599]; Sandler Foundation; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; U.S. DOE, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; U.S. National Science Foundation (NSF) grant [1244557]; National Institute of General Medical Sciences [1P50GM102706-01]; U.S. NSF Graduate Research Fellowship; Howard Hughes Medical Institute	We thank G. Meigs and the staff of the Advanced Light Source 8.3.1 beamline and D. Tzanko, A. Gonzalez, and the staff of the Stanford Synchrotron Radiation Light Source 9-2 beamline for assistance with data collection. Beamline 8.3.1 at the Advanced Light Source is operated by the University of California Office of the President, Multicampus Research Programs and Initiatives (grant MR-15-328599), and the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. Use of the Stanford Synchrotron Radiation Lightsource (SSRL), a directorate of SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-76SF00515. The EM data were collected in the Howard Hughes Medical Institute EM facility located at the University of California, Berkeley. We thank D. B. Toso and P. Grob for expert EM assistance, A. Chintangal for computational support, and members of the Nogales laboratory for helpful discussions about EM data processing. We thank A. East-Seletsky for input on the manuscript. The SSRL Structural Molecular Biology Program is supported by the U.S. DOE, Office of Biological and Environmental Research, and the National Institutes of Health, National Institute of General Medical Sciences (including grant no. P41GM103393). This project was funded by U.S. National Science Foundation (NSF) grant no. 1244557 (to J.A.D.) and National Institute of General Medical Sciences grant no. 1P50GM102706-01 (to J. H. Cate). A.V.W. and K.W.D. are supported by a U.S. NSF Graduate Research Fellowship, and G.J.K. is funded by the Howard Hughes Medical Institute. J. A. D. and E.N. are investigators of the Howard Hughes Medical Institute and members of the Center for RNA Systems Biology. Atomic coordinates and structure factors for the reported crystal structures have been deposited in the Protein Data Bank under accession codes 5VVJ (half-site-bound), 5VVK (pseudo-full-site-bound), and 5VVL (pseudo-full-sitebound with Ni<SUP>2+</SUP>). The cryo-EM structure and map have been deposited in the Protein Data Bank under accession code 5WFE and the Electron Microscopy Data Bank under accession code EMD-8827. A patent has been filed by the University of California for the use of Cas1-Cas2 for integrating DNA into genomes. J.A.D. is a cofounder and Scientific Advisory Board member of Caribou Biosciences and Intellia Therapeutics and a cofounder of Editas Medicine, all of which develop CRISPR-based technologies.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beguin P, 2016, NUCLEIC ACIDS RES, V44, P10367, DOI 10.1093/nar/gkw821; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Fagerlund RD, 2017, P NATL ACAD SCI USA, V114, pE5122, DOI 10.1073/pnas.1618421114; Gardiner EJ, 2003, J MOL BIOL, V332, P1025, DOI 10.1016/j.jmb.2003.08.006; Goren MG, 2016, CELL REP, V16, P2811, DOI 10.1016/j.celrep.2016.08.043; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97; Hickman AB, 2015, NUCLEIC ACIDS RES, V43, P10576, DOI 10.1093/nar/gkv1180; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Laxmikanthan G, 2016, ELIFE, V5, DOI 10.7554/eLife.14313; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Moch C, 2017, NUCLEIC ACIDS RES, V45, P2714, DOI 10.1093/nar/gkw1309; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Nadler DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12266; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163                                                        ; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	34	2	2	14	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2017	357	6356					1113	+		10.1126/science.aao0679				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FG7XX	WOS:000410639800035	28729350				2018-01-05	
J	Schwarzer, S; Spiess, S; Brand, M; Hans, S				Schwarzer, Simone; Spiess, Sandra; Brand, Michael; Hans, Stefan			Dlx3b/4b is required for early-born but not later-forming sensory hair cells during zebrafish inner ear development	BIOLOGY OPEN			English	Article						Inner ear; Neurogenesis; Sensorigenesis; Tether cells; Dlx3b/4b; Foxi1; CRISPR/Cas9; Zebrafish	OTIC PLACODE INDUCTION; TRANSCRIPTION FACTORS; HOMEOBOX GENES; CRANIOFACIAL DEVELOPMENT; DANIO-RERIO; EXPRESSION; FGF8; SPECIFICATION; MOUSE; FATE	Morpholino-mediated knockdown has shown that the homeodomain transcription factors Dlx3b and Dlx4b are essential for proper induction of the otic-epibranchial progenitor domain (OEPD), as well as subsequent formation of sensory hair cells in the developing zebrafish inner ear. However, increasing use of reverse genetic approaches has revealed poor correlation between morpholino-induced and mutant phenotypes. Using CRISPR/Cas9-mediated mutagenesis, we generated a defined deletion eliminating the entire open reading frames of dlx3b and dlx4b (dlx3b/4b) and investigated a potential phenotypic difference between mutants and morpholino-mediated knockdown. Consistent with previous findings obtained by morpholino-mediated knockdown of Dlx3b and Dlx4b, dlx3b/4b mutants display compromised otic induction, the development of smaller otic vesicles and an elimination of all indications of otic specification when combined with loss of foxi1, a second known OEPD competence factor in zebrafish. Furthermore, sensorigenesis is also affected in dlx3b/4b mutants. However, we find that only early-born sensory hair cells (tether cells), that seed and anchor the formation of otoliths, are affected. Later-forming sensory hair cells are present, indicating that two genetically distinct pathways control the development of early-born and later-forming sensory hair cells. Finally, impairment of early-born sensory hair cell formation in dlx3b/4b mutant embryos reverses the common temporal sequence of neuronal and sensory hair cell specification in zebrafish, resembling the order of cell specification in amniotes; Neurog1 expression before Atoh1 expression. We conclude that the Dlx3b/4b-dependent pathway has been either acquired newly in the fish lineage or lost in other vertebrate species during evolution, and that the events during early inner ear development are remarkably similar in fish and amniotes in the absence of this pathway.	[Hans, Stefan] Tech Univ Dresden, Biotechnol Ctr, Tatzberg 47-49, D-01307 Dresden, Germany; Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden Cluster Excel, Tatzberg 47-49, D-01307 Dresden, Germany	Hans, S (reprint author), Tech Univ Dresden, Biotechnol Ctr, Tatzberg 47-49, D-01307 Dresden, Germany.	stefan.hans@biotec.tu-dresden.de	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512	Deutsche Forschungsgemeinschaft [SFB655, HA 6362/1-1]; Technische Universitat Dresden; European Research Council (ERC) under the European Union's Horizon research and innovation program [225094]	Funding was provided by the Deutsche Forschungsgemeinschaft (SFB655 and HA 6362/1-1), Technische Universitat Dresden (Support-the-Best grant to M.B.) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 225094).	Adolf B, 2004, GENE EXPR PATTERNS, V5, P35, DOI 10.1016/j.modgep.2004.06.009; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Barald KF, 2004, DEVELOPMENT, V131, P4119, DOI 10.1242/dev.01339; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Birol O, 2016, DEV BIOL, V409, P139, DOI 10.1016/j.ydbio.2015.09.022; Boer EF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167278; Brand Michael, 2002, P7; Brown ST, 2005, J COMP NEUROL, V483, P48, DOI 10.1002/cne.20418; Chen JC, 2013, HEARING RES, V297, P3, DOI 10.1016/j.heares.2012.11.018; Dee CT, 2008, DEV BIOL, V320, P289, DOI 10.1016/j.ydbio.2008.05.542; DIRKSEN ML, 1993, MECH DEVELOP, V41, P121, DOI 10.1016/0925-4773(93)90042-V; Edlund RK, 2015, CURR TOP DEV BIOL, V111, P461, DOI 10.1016/bs.ctdb.2014.11.014; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; EKKER M, 1992, NEURON, V9, P27, DOI 10.1016/0896-6273(92)90217-2; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189                                                           ; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Fritzsch B, 2010, CELL MOL LIFE SCI, V67, P3089, DOI 10.1007/s00018-010-0403-x; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Haddon C, 1996, J COMP NEUROL, V365, P113, DOI 10.1002/(SICI)1096-9861(19960129)365:1<113::AID-CNE9>3.0.CO;2-6; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Hans S, 2013, DEVELOPMENT, V140, P1936, DOI 10.1242/dev.087718; Hochmann S, 2007, GENE EXPR PATTERNS, V7, P355, DOI 10.1016/j.modgep.2006.07.008; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2                                                   ; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Khatri SB, 2014, DEV BIOL, V391, P158, DOI 10.1016/j.ydbio.2014.04.014; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; Ladher RK, 2017, SEMIN CELL DEV BIOL, V65, P39, DOI 10.1016/j.semcdb.2016.10.006; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Langenau DM, 2002, MECH DEVELOP, V117, P243, DOI 10.1016/S0925-4773(02)00187-9; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X                                                   ; Liu D, 2003, DEVELOPMENT, V130, P2213, DOI 10.1242/dev.00445; Lundberg YW, 2015, DEV DYNAM, V244, P239, DOI 10.1002/dvdy.24195; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Maroon H, 2002, DEVELOPMENT, V129, P2099; Maulding K, 2014, DEV DYNAM, V243, P1275, DOI [10.1002/DVDY.24119, 10.1002/dvdy.24119]; McCarroll MN, 2012, DEVELOPMENT, V139, P2740, DOI 10.1242/dev.076075; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Nissen RM, 2003, DEVELOPMENT, V130, P2543, DOI 10.1242/dev.00455; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; PAPALOPULU N, 1993, DEVELOPMENT, V117, P961; Pfeffer PL, 1998, DEVELOPMENT, V125, P3063; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Radosevic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109860; Raft S, 2015, CELL TISSUE RES, V359, P315, DOI 10.1007/s00441-014-1917-6; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Saint-Germain N, 2004, DEVELOPMENT, V131, P1755, DOI 10.1242/dev.01066; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Solomon KS, 2004, DEV DYNAM, V230, P419, DOI 10.1002/dvdy.20067; Solomon KS, 2003, DEVELOPMENT, V130, P929, DOI 10.1242/dev.00308; Solomon KS, 2002, DEVELOPMENT, V129, P3127; Stooke-Vaughan GA, 2015, DEVELOPMENT, V142, P1137, DOI 10.1242/dev.116632; Stooke-Vaughan GA, 2012, DEVELOPMENT, V139, P1777, DOI 10.1242/dev.079947; Streit A, 2007, INT J DEV BIOL, V51, P447, DOI 10.1387/ijdb.072327as; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Whitfield TT, 2015, CURR OPIN GENET DEV, V32, P112, DOI 10.1016/j.gde.2015.02.006; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev/00555; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yamanishi E, 2012, DEV GROWTH DIFFER, V54, P785, DOI 10.1111/dgd.12007	66	0	0	5	5	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	2046-6390			BIOL OPEN	Biol. Open	SEP 15	2017	6	9					1270	1278		10.1242/bio.026211				9	Biology	Life Sciences & Biomedicine - Other Topics	FH1SH	WOS:000410919200002	28751305	gold			2018-01-05	
J	Braun, SMG; Kirkland, JG; Chory, EJ; Husmann, D; Calarco, JP; Crabtree, GR				Braun, Simon M. G.; Kirkland, Jacob G.; Chory, Emma J.; Husmann, Dylan; Calarco, Joseph P.; Crabtree, Gerald R.			Rapid and reversible epigenome editing by endogenous chromatin regulators	NATURE COMMUNICATIONS			English	Article							TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; HISTONE H3; STEM-CELLS; LYSINE 9; GENOME; COMPLEX; HETEROCHROMATIN; PLURIPOTENT; MODULATION	Understanding the causal link between epigenetic marks and gene regulation remains a central question in chromatin biology. To edit the epigenome we developed the FIRE-Cas9 system for rapid and reversible recruitment of endogenous chromatin regulators to specific genomic loci. We enhanced the dCas9-MS2 anchor for genome targeting with Fkbp/Frb dimerizing fusion proteins to allow chemical-induced proximity of a desired chromatin regulator. We find that mSWI/SNF (BAF) complex recruitment is sufficient to oppose Polycomb within minutes, leading to activation of bivalent gene transcription in mouse embryonic stem cells. Furthermore, Hp1/Suv39h1 heterochromatin complex recruitment to active promoters deposits H3K9me3 domains, resulting in gene silencing that can be reversed upon washout of the chemical dimerizer. This inducible recruitment strategy provides precise kinetic information to model epigenetic memory and plasticity. It is broadly applicable to mechanistic studies of chromatin in mammalian cells and is particularly suited to the analysis of endogenous multi-subunit chromatin regulator complexes.	[Braun, Simon M. G.; Kirkland, Jacob G.; Chory, Emma J.; Husmann, Dylan; Calarco, Joseph P.; Crabtree, Gerald R.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Braun, Simon M. G.; Kirkland, Jacob G.; Chory, Emma J.; Husmann, Dylan; Calarco, Joseph P.; Crabtree, Gerald R.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Chory, Emma J.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Crabtree, Gerald R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Crabtree, GR (reprint author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Crabtree, GR (reprint author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.; Crabtree, GR (reprint author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	crabtree@stanford.edu		Kirkland, Jacob/0000-0001-5617-7065	NIH [5F31CA203228-02]; Swiss National Science Foundation postdoctoral fellowship [SNSF-P300PA164675]; USAMRAA grant [W81XWH-16-1-0083]; National Cancer Institute grant [T32 CA09151]	This manuscript is dedicated to the memory of Joe P. Calarco, a brilliant scientist, dedicated colleague, and true friend. We thank the Crabtree lab, C. Weber, K. Majzoub, R. Kamakaka and J.A. Calarco for helpful discussions and E. Miller for sharing curated GEO data sets. Lentiviral plasmids were a gift from N. Hathaway, C. Kadoch, F. Zhang, and D. Trono (via Addgene). FACS analysis was performed using the Stanford Shared FACS Facility. This work was supported by an NIH grant. G.R.C. is an HHMI Investigator. S.M.G.B. is supported by a Swiss National Science Foundation postdoctoral fellowship (SNSF-P300PA164675). J.G.K. is supported by a USAMRAA grant (W81XWH-16-1-0083) and a National Cancer Institute grant (T32 CA09151). E.J.C. is supported by an NIH grant (5F31CA203228-02).	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Holz A, 2010, DEVELOPMENT, V137, P4249, DOI 10.1242/dev.053819; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller EL, 2017, NAT STRUCT MOL BIOL, V24, P344, DOI 10.1038/nsmb.3384; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F                                                    ; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stanton BZ, 2017, NAT GENET, V49, P282, DOI 10.1038/ng.3735; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	38	0	0	17	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	SEP 15	2017	8								560	10.1038/s41467-017-00644-y				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FH0EM	WOS:000410812200007	28916764	gold			2018-01-05	
J	Czarnek, M; Bereta, J				Czarnek, Maria; Bereta, Joanna			SmartFlares fail to reflect their target transcripts levels	SCIENTIFIC REPORTS			English	Article							MESSENGER-RNA DETECTION; LIVING CELLS; GENE-EXPRESSION; NANO-FLARES; HETEROGENEITY; PROBES	SmartFlare probes have recently emerged as a promising tool for visualisation and quantification of specific RNAs in living cells. They are supposed to overcome the common drawbacks of current methods for RNA analysis: the need of cell fixation or lysis, or the requirements for genetic manipulations. In contrast to the traditional methods, SmartFlare probes are also presumed to provide information on RNA levels in single cells. Disappointingly, the results of our comprehensive study involving probes specific to five different transcripts, HMOX1, IL6, PTGS2, Nrg1, and ERBB4, deny the usefulness of SmartFlare probes for RNA analysis. We report a total lack of correlation between fluorescence intensities of SmartFlare probes and the levels of corresponding RNAs assessed by RT-qPCR. To ensure strong differences in the levels of analysed RNAs, their expression was modified via: (i) HMOX1-knockdown generated by CRISPR-Cas9 genome editing, (ii) hemin-mediated stimulation of HMOX1-and IL1 beta- mediated stimulation of IL6- and PTGS2 transcription, (iii) lentiviral vector-mediated Nrg1 overexpression. Additionally, ERBB4-specific SmartFlare probe failed to distinguish between ERBB4-expressing and non-expressing cell lines. Finally, we demonstrated that fluorescence intensity of HMOX1-specific SmartFlare probe corresponds to the efficacy of its uptake and/or accumulation.	[Czarnek, Maria; Bereta, Joanna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland	Bereta, J (reprint author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland.	joanna.bereta@uj.edu.pl			Grant for Young Researchers - Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow [BMN 1/2015]; Diamentowy Grant - Ministry of Science and Higher Education in Poland [DI2012 013342]; Polish Ministry of Science and Higher Education	This work was supported by the Grant for Young Researchers no. BMN 1/2015 to M.C. funded by the Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow and by the Diamentowy Grant no DI2012 013342 to M.C. funded by Ministry of Science and Higher Education in Poland. Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow is a partner of the Leading National Research Center (KNOW) supported by the Polish Ministry of Science and Higher Education. We thank Dr. Dominik Czaplicki and Tomasz Klaus for critically reading the manuscript.	Amatya VJ, 2016, INT J ONCOL, V48, P1599, DOI 10.3892/ijo.2016.3358; Bereta M, 2007, VACCINE, V25, P4183, DOI 10.1016/j.vaccine.2007.03.008; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Budik S., 2017, REPROD FERT DEVELOP, DOI [10.1071/RD16362, DOI 10.1071/RD16362(2017).]; Chen F, 2016, NAT METHODS, V13, P679, DOI 10.1038/nmeth.3899; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Halo TL, 2014, P NATL ACAD SCI USA, V111, P17104, DOI 10.1073/pnas.1418637111; HAZELTON BJ, 1987, CANCER RES, V47, P4501; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kronig M, 2015, ONCOTARGET, V6, P1302; Lahm H, 2015, STEM CELLS, V33, P392, DOI 10.1002/stem.1872; Lee H., 2014, NAT COMMUN, V5; Li BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26014; Liu ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099175; Mason D., 2016, SCI RES, DOI 10.14293/S2199-1006.1.SOR-CHEM.AZ1MJU.v1; McClellan S, 2015, METHODS, V82, P47, DOI 10.1016/j.ymeth.2015.04.022; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36                                                            ; Prigodich AE, 2009, ACS NANO, V3, P2147, DOI 10.1021/nn9003814; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Seftor EA, 2014, SEMIN ONCOL, V41, P259, DOI 10.1053/j.seminoncol.2014.02.001; Sokol DL, 1998, P NATL ACAD SCI USA, V95, P11538, DOI 10.1073/pnas.95.20.11538                                                        ; Vaidyanathan S., 2014, DETECTION ENUMERATIO; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729                                                              ; Wu XCA, 2014, J AM CHEM SOC, V136, P7726, DOI 10.1021/ja503010a; Yucesoy A., 2014, THESIS	27	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 15	2017	7								11682	10.1038/s41598-017-11067-6				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FH0VT	WOS:000410859400014	28916792	gold			2018-01-05	
J	Grigoraki, L; Puggioli, A; Mavridis, K; Douris, V; Montanari, M; Bellini, R; Vontas, J				Grigoraki, Linda; Puggioli, Arianna; Mavridis, Konstantinos; Douris, Vassilis; Montanari, Mario; Bellini, Romeo; Vontas, John			Striking diflubenzuron resistance in Culex pipiens, the prime vector of West Nile Virus	SCIENTIFIC REPORTS			English	Article							INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; BACILLUS-SPHAERICUS; HUMAN-DISEASE; MOSQUITOS; POPULATION; CULICIDAE; DIPTERA; GAMBIAE; LARVAE	Culex pipiens mosquitoes cause severe nuisance and transmit human diseases including West Nile. Vector control by insecticides is the main tool to prevent these diseases and diflubenzuron is one of the most effective mosquito larvicides used in many places. Here, high levels of resistance were identified in Cx. pipiens from Italy, with a Resistance Ratio of 128 fold. The phenotype was associated with mutations at amino acid I1043 (I1043M and I1043L) of the Chitin synthase gene, which showed significantly higher frequency in bioassay survivors. Both mutations have been introduced in the Drosophila melanogaster chitin synthase gene using the genome editing method CRISPR/Cas9 and validated to confer significant levels of resistance, although at different levels. The I -> M mutation results in a Resistance Ratio > 2,900 fold and the I -> L mutation > 20 fold. Two PCR based diagnostics were developed for monitoring of the resistant mutations in field populations. The findings are of major concern for public health given the importance of diflubenzuron in mosquito control in many places, the intensity of the resistance phenotype and the limited availability of alternative larvicides.	[Grigoraki, Linda; Mavridis, Konstantinos; Douris, Vassilis; Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 73100, Greece; [Grigoraki, Linda] Univ Crete, Dept Biol, Iraklion 70013, Greece; [Puggioli, Arianna; Bellini, Romeo] Ctr Agr Ambiente G Nicoli, Med & Vet Entomol, Bologna, Italy; [Montanari, Mario] Azimut, Ravenna, Italy; [Vontas, John] Agr Univ Athens, Dept Crop Sci, Pesticide Sci Lab, GR-11855 Athens, Greece	Vontas, J (reprint author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 73100, Greece.; Vontas, J (reprint author), Agr Univ Athens, Dept Crop Sci, Pesticide Sci Lab, GR-11855 Athens, Greece.	vontas@imbb.forth.gr		Grigoraki, Linda/0000-0001-8997-0406			Bellinato DF, 2016, BIOMED RES INT, DOI 10.1155/2016/8603263; BENCHEIKH H, 1993, J AM MOSQUITO CONTR, V9, P335; Darboux I, 2007, CELL MICROBIOL, V9, P2022, DOI 10.1111/j.1462-5822.2007.00934.x; Douris V, 2016, P NATL ACAD SCI USA, V113, P14692, DOI 10.1073/pnas.1618258113; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kioulos I, 2014, PEST MANAG SCI, V70, P623, DOI 10.1002/ps.3595; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Navajas M, 1999, EXP APPL ACAROL, V23, P851, DOI 10.1023/A:1006251220052; NielsenLeroux C, 1997, J MED ENTOMOL, V34, P321, DOI 10.1093/jmedent/34.3.321                                                        ; Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; PUSZTAI M, 1991, BIOCHEM J, V273, P43, DOI 10.1042/bj2730043                                                               ; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Scott JG, 2015, PESTIC BIOCHEM PHYS, V120, P68, DOI 10.1016/j.pestbp.2014.12.018; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; Verloop A., 1977, ACS SYM SER, V37, P237; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; Weetman D, 2015, T ROY SOC TROP MED H, V109, P291, DOI 10.1093/trstmh/trv017; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; WHO-World Health Organization, 1981, INSTR DET SUSC RES M; WHO, 2008, GUID DRINK WAT QUAL; World Health Organization, 2016, LYMPH FIL FACT SHEET; Yunta C, 2016, INSECT BIOCHEM MOLEC, V78, P50, DOI 10.1016/j.ibmb.2016.09.001; Zhang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep39425	25	0	0	8	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 15	2017	7								11699	10.1038/s41598-017-12103-1				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FH0VT	WOS:000410859400031	28916816	gold			2018-01-05	
J	Song, KH; Choi, CH; Lee, HJ; Oh, SJ; Woo, SR; Hong, SO; Noh, KH; Cho, H; Chung, EJ; Kim, JH; Chung, JY; Hewitt, SM; Baek, S; Lee, KM; Yee, C; Son, M; Mao, CP; Wu, TC; Kim, TW				Song, Kwon-Ho; Choi, Chel Hun; Lee, Hyo-Jung; Oh, Se Jin; Woo, Seon Rang; Hong, Soon-Oh; Noh, Kyung Hee; Cho, Hanbyoul; Chung, Eun Joo; Kim, Jae-Hoon; Chung, Joon-Yong; Hewitt, Stephen M.; Baek, Seungki; Lee, Kyung-Mi; Yee, Cassian; Son, Minjoo; Mao, Chih-Ping; Wu, T. C.; Kim, Tae Woo			HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells	CANCER RESEARCH			English	Article							LARGE GENE LISTS; DRUG-RESISTANCE; LUNG-CANCER; INHIBITOR; MCL-1; UBIQUITINATION; HETEROGENEITY; ACTIVATION; REPRESSION; PLASTICITY	Cancer immunoediting drives the adaptation of tumor cells to host immune surveillance. Immunoediting driven by antigen (Ag)-specific T cells enriches NANOG expression in tumor cells, resulting in a stem-like phenotype and immune resistance. Here, we identify HDAC1 as a key mediator of the NANOG-associated phenotype. NANOG upregulated HDAC1 through promoter occupancy, thereby decreasing histone H3 acetylation on K14 and K27. NANOG-dependent, HDAC1-driven epigenetic silencing of cell-cycle inhibitors CDKN2D and CDKN1B induced stem-like features. Silencing of TRIM17 and NOXA induced immune and drug resistance in tumor cells by increasing antiapoptotic MCL1. Importantly, HDAC inhibition synergized with Ag-specific adoptive T-cell therapy to control immune refractory cancers. Our results reveal that NANOG influences the epigenetic state of tumor cells via HDAC1, and they encourage a rational application of epigenetic modulators and immunotherapy in treatment of NANOG(+) refractory cancer types. (C) 2017 AACR.	[Song, Kwon-Ho; Lee, Hyo-Jung; Oh, Se Jin; Woo, Seon Rang; Hong, Soon-Oh; Kim, Tae Woo] Korea Univ, Grad Sch Med, Dept Biomed Sci, Lab Tumor Immunol, Seoul, South Korea; [Song, Kwon-Ho; Lee, Hyo-Jung; Oh, Se Jin; Woo, Seon Rang; Hong, Soon-Oh; Baek, Seungki; Lee, Kyung-Mi; Kim, Tae Woo] Korea Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Song, Kwon-Ho; Lee, Hyo-Jung; Oh, Se Jin; Hong, Soon-Oh; Baek, Seungki; Lee, Kyung-Mi; Kim, Tae Woo] Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Choi, Chel Hun] NCI, Expt Pathol Lab, Lab Pathol, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Choi, Chel Hun; Chung, Joon-Yong; Hewitt, Stephen M.] Sungkyunkwan Univ, Dept Obstet & Gynecol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Woo, Seon Rang; Kim, Tae Woo] Korea Univ, Translat Res Inst Incurable Dis, Coll Med, Seoul, South Korea; [Noh, Kyung Hee] Korea Res Inst Biosci & Biotechnol, Gene Therapy Res Unit, Daejeon, South Korea; [Cho, Hanbyoul; Kim, Jae-Hoon] Yonsei Univ, Gangnam Severance Hosp, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Cho, Hanbyoul; Kim, Jae-Hoon] Yonsei Univ, Inst Womens Life Med Sci, Coll Med, Seoul, South Korea; [Chung, Eun Joo] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Yee, Cassian] UT MD Anderson Canc Ctr, Dept Melanoma Med Oncol & Immunol, Houston, TX USA; [Yee, Cassian] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Son, Minjoo] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Mao, Chih-Ping; Wu, T. C.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA	Kim, TW (reprint author), Korea Univ, Lab Tumor Immunol, Coll Med, Room 319,Moonsook Med Hall,73 Inchon Ro, Seoul 02841, South Korea.	twkim0421@korea.ac.kr		Chung, Joon-Yong/0000-0001-5041-5982	National Research Foundation of Korea [NRF-2014R1A2A1A10054205, NRF-2013M3A9D3045881]	This work was funded by the National Research Foundation of Korea (NRF-2014R1A2A1A10054205 and NRF-2013M3A9D3045881).	Bertero A, 2015, GENE DEV, V29, P702, DOI 10.1101/gad.255984.114; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Chen CL, 2016, CELL METAB, V23, P206, DOI 10.1016/j.cmet.2015.12.004; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gomez-Bougie P, 2011, BIOCHEM BIOPH RES CO, V413, P460, DOI 10.1016/j.bbrc.2011.08.118; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Keshelava N, 2007, J NATL CANCER I, V99, P1107, DOI 10.1093/jnci/djm044; Kroesen M, 2014, ONCOTARGET, V5, P6558, DOI 10.18632/oncotarget.2289                                                        ; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee YH, 2015, CLIN CANCER RES, V21, P1438, DOI 10.1158/1078-0432.CCR-14-1979; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin YC, 2008, CANCER RES, V68, P2375, DOI 10.1158/0008-5472.CAN-07-5807; Magiera MM, 2013, CELL DEATH DIFFER, V20, P281, DOI 10.1038/cdd.2012.124; Mao CP, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.947871; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Mattoo AR, 2014, CLIN CANCER RES, V20, P5446, DOI 10.1158/1078-0432.CCR-14-1134; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mojsa Barbara, 2014, Cells, V3, P418, DOI 10.3390/cells3020418; Noh KH, 2014, CANCER RES, V74, P3556, DOI 10.1158/0008-5472.CAN-13-3225; Noh KH, 2012, J CLIN INVEST, V122, P4077, DOI 10.1172/JCI64057; Noh KH, 2012, CANCER RES, V72, P1717, DOI 10.1158/0008-5472.CAN-11-3758; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Sasakawa Y, 2002, BIOCHEM PHARMACOL, V64, P1079, DOI 10.1016/S0006-2952(02)01261-3                                                   ; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Setiadi AF, 2008, CANCER RES, V68, P9601, DOI 10.1158/0008-5472.CAN-07-5270; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Wang L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.328; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	43	0	0	2	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	SEP 15	2017	77	18					5039	5053		10.1158/0008-5472.CAN-17-0072				15	Oncology	Oncology	FH2CG	WOS:000410945700026	28716899				2018-01-05	
J	Sossey-Alaoui, K; Pluskota, E; Bialkowska, K; Szpak, D; Parker, Y; Morrison, CD; Lindner, DJ; Schiemann, WP; Plow, EF				Sossey-Alaoui, Khalid; Pluskota, Elzbieta; Bialkowska, Katarzyna; Szpak, Dorota; Parker, Yvonne; Morrison, Chevaun D.; Lindner, Daniel J.; Schiemann, William P.; Plow, Edward F.			Kindlin-2 Regulates the Growth of Breast Cancer Tumors by Activating CSF-1-Mediated Macrophage Infiltration	CANCER RESEARCH			English	Article							TGF-BETA; INTEGRIN ACTIVATION; CELL-MIGRATION; EXPRESSION; METASTASIS; PROGRESSION; INVASION; MICROENVIRONMENT; ANGIOGENESIS; PROGNOSIS	Interplay between tumor cells and host cells in the tumor microenvironment dictates the development of all cancers. In breast cancer, malignant cells educate host macrophages to adopt a protumorigenic phenotype. In this study, we show how the integrin-regulatory protein kindlin-2 (FERMT2) promotes metastatic progression of breast cancer through the recruitment and subversion of host macrophages. Kindlin-2 expression was elevated in breast cancer biopsy tissues where its levels correlated with reduced patient survival. On the basis of these observations, we used CRISPR/Cas9 technology to ablate Kindlin-2 expression in human MDA-MB- 231 and murine 4T1 breast cancer cells.Kindlin-2 deficiency inhibited invasive and migratory properties in vitro without affecting proliferation rates. However, in vivo tumor outgrowth was inhibited by >80% in a manner associated with reduced macrophage infiltration and secretion of the macrophage attractant and growth factor colony-stimulating factor-1 (CSF-1). The observed loss of CSF-1 appeared to be caused by a more proximal deficiency in TGF beta-dependent signaling in Kindlin-2-deficient cells. Collectively, our results illuminate a Kindlin-2/TGF beta/CSF-1 signaling axis employed by breast cancer cells to capture host macrophage functions that drive tumor progression. (C) 2017 AACR.	[Sossey-Alaoui, Khalid; Pluskota, Elzbieta; Bialkowska, Katarzyna; Szpak, Dorota; Plow, Edward F.] Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH USA; [Sossey-Alaoui, Khalid; Morrison, Chevaun D.; Schiemann, William P.; Plow, Edward F.] Case Comprehens Canc Ctr, Cleveland, OH USA; [Parker, Yvonne; Lindner, Daniel J.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA	Sossey-Alaoui, K; Plow, EF (reprint author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB-50, Cleveland, OH 44195 USA.	sosseyk@ccf.org; plowe@ccf.org			NIH [P01 HL 073311, R01 HL096062]	This work was supported in part by NIH grants P01 HL 073311 and R01 HL096062 to E.F. Plow.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Augoff K, 2011, MOL CANCER RES, V9, P1500, DOI 10.1158/1541-7786.MCR-11-0311; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Gong XW, 2010, CANCER LETT, V299, P54, DOI 10.1016/j.canlet.2010.08.003; Guo BH, 2015, CANCER LETT, V361, P271, DOI 10.1016/j.canlet.2015.03.011; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lokody I, 2014, NAT REV CANCER, V14, DOI 10.1038/nrc3727; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mahawithitwong P, 2013, PANCREAS, V42, P663, DOI 10.1097/MPA.0b013e318279bd66; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Ou YW, 2014, ACTA PHARMACOL SIN, V35, P1199, DOI 10.1038/aps.2014.60; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patsialou A, 2015, ONCOGENE, V34, P2721, DOI 10.1038/onc.2014.226; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Ploplis VA, 1998, BLOOD, V91, P2005; Plow EF, 2009, CURR OPIN HEMATOL, V16, P323, DOI 10.1097/MOH.0b013e32832ea389; Plow E. F., 2016, DISCOVERIES, V4, pe59; Pluskota E, 2013, BLOOD, V122, P2491, DOI 10.1182/blood-2013-04-497669; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Quigley DA, 2015, MOL ONCOL, V9, P2054, DOI 10.1016/j.molonc.2015.10.003; Rognoni E, 2016, J CELL SCI, V129, P17, DOI 10.1242/jcs.161190; Santoni M, 2013, CANCER IMMUNOL IMMUN, V62, P1757, DOI 10.1007/s00262-013-1487-6; Soloviev DA, 2014, J IMMUNOL, V193, P4712, DOI 10.4049/jimmunol.1400202; Sossey-Alaoui K, 2016, MOL CANCER RES, V14, P228, DOI 10.1158/1541-7786.MCR-15-0299; Sossey-Alaoui K, 2014, FASEB J, V28, P2260, DOI 10.1096/fj.13-244004; Taylor MA, 2013, BREAST CANCER RES TR, V142, P341, DOI 10.1007/s10549-013-2753-1; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Taylor MA, 2011, NEOPLASIA, V13, P406, DOI 10.1593/neo.101086; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Wendt MK, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3623; Wu CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8531; Yan Yan, 2016, Onco Targets Ther, V9, P3975, DOI 10.2147/OTT.S103112; Ye F, 2011, CURR OPIN HEMATOL, V18, P356, DOI 10.1097/MOH.0b013e3283497f09; Yu Y, 2013, INT J CANCER, V133, P1368, DOI 10.1002/ijc.28151; Zhao T, 2013, CANCER LETT, V330, P208, DOI 10.1016/j.canlet.2012.11.043	48	0	0	7	7	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	SEP 15	2017	77	18					5129	5141		10.1158/0008-5472.CAN-16-2337				13	Oncology	Oncology	FH2CG	WOS:000410945700033	28687620				2018-01-05	
J	Eribe, ERK; Olsen, I				Eribe, Emenike R. K.; Olsen, Ingar			Leptotrichia species in infections II	JOURNAL OF ORAL MICROBIOLOGY			English	Review						Leptotrichia species; taxonomy; opportunistic pathogens; Crispr-Cas; CSIs	PRIMARY ENDODONTIC INFECTIONS; DNA-DNA HYBRIDIZATION; SALIVARY MICROBIOME; SP-NOV; SUBGINGIVAL MICROBIOTA; BACTERIAL PROFILES; ORAL MICROBIOTA; CARIES-FREE; BACTEREMIA; DIVERSITY	Leptotrichia species are non-motile facultative anaerobic/anaerobic bacteria that are found mostly in the oral cavity and some other parts of the human body, in animals, and even in ocean sediments. Valid species include L. buccalis, L. goodfellowii, L. hofstadii, L. honkongensis, L. shahii, L. trevisanii, and L. wadei. Some species require serum or blood for growth. All species ferment carbohydrates and produce lactic acid that may be involved with tooth decay. Acting as opportunistic pathogens, they are involved in a variety of diseases, and have been isolated from immunocompromised but also immunocompetent individuals. Mucositis, oral lesions, wounds, and abscesses may predispose to Leptotrichia septicemia. Because identification of Leptotrichia species by phenotypic features occasionally lead to misidentification, genetic techniques such as 16S rRNA gene sequencing is recommended. Early diagnosis and treatment of leptotrichia infections is important for positive outcomes. Over the last years, Leptotrichia species have been associated with several changes in taxonomy and new associations with clinical diseases. Such changes are reported in this updated review.	[Eribe, Emenike R. K.; Olsen, Ingar] Univ Oslo, Dept Oral Biol, Fac Dent, Oslo, Norway	Eribe, ERK (reprint author), Univ Oslo, Dept Oral Biol, Fac Dent, Oslo, Norway.	emenike.r.eribe@odont.uio.no			European Commission [FP/HEALTH- 306029]	The authors acknowledge the European Commission (FP/HEALTH- 306029 'TRIGGER') for funding.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adriaens LA, 2009, J PERIODONTOL, V80, P72, DOI [10.1902/jop.2009.080012, 10.1902/jop.2009.080012 ]; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Arvikar S, 2015, ACR ARHP ANN M OCT 2; Asikainen S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013589; Baracaldo R, 2013, J CLIN MICROBIOL, V51, P389, DOI [10.1128/JCM.01156-12, 10.1128/JCM.01154-12]; Belstrom D, 2014, CARIES RES, V48, P368, DOI 10.1159/000357502; BIRKELAND NK, 1985, SCAND J DENT RES, V93, P432; Blairon L, 2006, CLIN MICROBIOL INFEC, V12, P527, DOI 10.1111/j.1469-0691.2006.01407.x; Boot R, 2008, VET MICROBIOL, V128, P395, DOI 10.1016/j.vetmic.2007.10.007; Bouvet P, 2012, MED MALADIES INFECT, V42, P174, DOI 10.1016/j.medmal.2012.02.005; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Card RM, 2015, ANTIMICROB AGENTS CH, V59, P4410, DOI 10.1128/AAC.00068-15; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; Cheung MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054574; Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02067-7; Cho EH, 2017, ANN LAB MED, V37, P272, DOI 10.3343/alm.2017.37.3.272; Coit P, 2016, CLIN IMMUNOL, V169, P28, DOI 10.1016/j.clim.2016.06.002; Cooreman S, 2011, ANAEROBE, V17, P1, DOI 10.1016/j.anaerobe.2010.12.002; Couturier MR, 2012, J CLIN MICROBIOL, V50, P1228, DOI 10.1128/JCM.05926-11; Dareng EO, 2016, EPIDEMIOL INFECT, V144, P123, DOI 10.1017/S0950268815000965; Decroix V, 2013, J MED MICROBIOL, V62, P785, DOI 10.1099/jmm.0.051870-0; Duan XB, 2017, INT J ORAL SCI, V9, P95, DOI 10.1038/ijos.2017.18; Eribe ERK, 2008, ANAEROBE, V14, P131, DOI 10.1016/j.anaerobe.2008.04.004; Eribe ERK, 2011, MOLECULAR DETECTION OF HUMAN BACTERIAL PATHOGENS, P555; Eribe ERK, 2004, INT J SYST EVOL MICR, V54, P583, DOI 10.1099/ijs.0.02819-0; Fan XZ, 2018, GUT, V67, P120, DOI 10.1136/gutjnl-2016-312580; Fernandez Y, 2014, FRONT CELL INFECT MI, V4, P95; Fethers K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030633; Ganesan SM, 2017, ISME J, V11, P2075, DOI 10.1038/ismej.2017.73; Guerrero-Preston R, 2016, ONCOTARGET, V7, P51320, DOI 10.18632/oncotarget.9710; Guiu A, 2012, REV ESP QUIM, V25, P220; Gupta RS, 2014, ANAEROBE, V28, P182, DOI 10.1016/j.anaerobe.2014.06.007; Han CS, 2016, PEERJ, V4, DOI 10.7717/peerj.2660; Harwich MD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S4; He Y, 2017, ORAL DIS, V23, P674, DOI 10.1111/odi.12657; Higurashi Y, 2013, J INFECT CHEMOTHER, V19, P1181, DOI 10.1007/s10156-013-0596-7; HOFSTAD T, 1982, J GEN MICROBIOL, V128, P151; Holgerson PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128534; [胡晓宇 Hu Xiaoyu], 2016, [南方医科大学学报, Journal of Southern Medical University], V36, P1328; Huang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24705; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Ivanova N, 2009, STAND GENOMIC SCI, V1, P126, DOI 10.4056/sigs.1854; Jang JY, 2017, J PERIODONTAL RES, V52, P447, DOI 10.1111/jre.12410; Janus MM, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2016.1270613; Jiang S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121978; Jiang W, 2011, MICROB ECOL, V61, P342, DOI 10.1007/s00248-010-9753-z; Johansson I, 2016, J DENT RES, V95, P80, DOI 10.1177/0022034515609554; Kapferer Ines, 2013, Pediatr Dent, V35, pE23; Kawanami T, 2009, J CLIN MICROBIOL, V47, P496, DOI 10.1128/JCM.01429-08; Krieg NR, 2005, BACTEROIDETES SPIROC, V4, P766; Kumagai J, 2013, INTERNAL MED, V52, P2573, DOI 10.2169/internalmedicine.52.9580; Kumar PS, 2012, J CLIN PERIODONTOL, V39, P425, DOI 10.1111/j.1600-051X.2012.01856.x; Langfeldt D, 2014, FEMS MICROBIOL LETT, V360, P137, DOI 10.1111/1574-6968.12596; Li YH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2891-z; Li YH, 2014, J CLIN MICROBIOL, V52, P1400, DOI 10.1128/JCM.02954-13; Lim YK, 2016, ANN CLIN LAB SCI, V46, P83; Ling ZX, 2013, MICROB ECOL, V65, P487, DOI 10.1007/s00248-012-0123-x; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Liu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24340; Liu SY, 2015, CURR MICROBIOL, V71, P643, DOI 10.1007/s00284-015-0895-6; Lo TS, 2012, INFECT DIS REP, V4, P90, DOI 10.4081/idr.2012.e24; Luo AH, 2012, ORAL DIS, V18, P595, DOI 10.1111/j.1601-0825.2012.01915.x; Martin-Gutierrez G, 2015, JOM, P1, DOI 10.1099/jmmcr.0.000036; Matias WR, 2016, CASE REP INFECT DIS, DOI 10.1155/2016/3051212; Mok SF, 2017, MALAYS J PATHOL, V39, P1; Morou-Bermudez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139315; Murad CF, 2014, J ENDODONT, V40, P899, DOI 10.1016/j.joen.2014.02.010; Muttaiyah Sharmini, 2007, N Z Med J, V120, pU2809; Pepin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025082; Persson GR, 2007, J PERIODONTOL, V78, P1751, DOI 10.1902/jop.2007.070138; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Rashid MU, 2016, ANTIMICROB AGENTS CH, V60, P4244, DOI 10.1128/AAC.00461-16; Ren W, 2016, J MICROBIOL BIOTECHN, V26, P2141, DOI 10.4014/jmb.1605.05012; Ren W, 2016, SCI REP-UK, V6, DOI 10.1038/srep24481; Renvert S, 2017, CLIN ORAL IMPLAN RES, V28, P1127, DOI 10.1111/clr.12927; Robles-Sikisaka R, 2013, ISME J, V7, P1710, DOI 10.1038/ismej.2013.63; Ruviere Denise Belucio, 2007, J Dent Child (Chic), V74, P118; Cabrera CS, 2017, ENFERM INFEC MICR CL, V35, P389, DOI 10.1016/j.eimc.2016.09.010; Saltykova IV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004809; Sandle T., 2016, SCIENCE; Santiago GLD, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1022-6; Sassone L, 2007, ORAL MICROBIOL IMMUN, V22, P390, DOI 10.1111/j.1399-302X.2007.00376.x                                                ; Sassone LM, 2008, INT ENDOD J, V41, P508, DOI 10.1111/j.1365-2591.2008.01397.x; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Schrimsher JM, 2013, EMERG INFECT DIS, V19, P1690, DOI 10.3201/eid1910.121048; Shah HN, 2009, ANAEROBE, V15, P179, DOI 10.1016/j.anaerobe.2009.08.003; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Smid MC, 2015, INFECT DIS REP, V7, P32, DOI 10.4081/idr.2015.5801; Su J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130736; Takeshita T, 2010, APPL ENVIRON MICROB, V76, P2806, DOI 10.1128/AEM.02304-09; Tee W, 2001, EUR J CLIN MICROBIOL, V20, P765, DOI 10.1007/s100960100618                                                           ; Thompson J, 2012, MOL ORAL MICROBIOL, V27, P34, DOI 10.1111/j.2041-1014.2011.00627.x; Torres PJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1373; Verhulst NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028991; von Rosenvinge EC, 2013, ISME J, V7, P1354, DOI 10.1038/ismej.2013.33; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Wolff D, 2013, CARIES RES, V47, P69, DOI 10.1159/000344022; Woo PCY, 2010, J ZHEJIANG UNIV-SC B, V11, P391, DOI 10.1631/jzus.B1000056; Wu J, 2016, ISME J, V10, P2435, DOI 10.1038/ismej.2016.37; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083445; Xiang WL, 2013, WORLD J MICROB BIOT, V29, P559, DOI 10.1007/s11274-012-1210-3; Xiao CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01145; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Yang F, 2013, J DENT RES, V92, P1106, DOI 10.1177/0022034513507065; Yang I, 2016, SCI REP-UK, V6, DOI 10.1038/srep18594; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141310; Zhu X, 2012, WORLD J MICROB BIOT, V28, P2229, DOI 10.1007/s11274-012-1030-5	108	0	0	4	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-2297			J ORAL MICROBIOL	J. Oral Microbiology	SEP 15	2017	9						1	31		10.1080/20002297.2017.1368848				31	Microbiology	Microbiology	FG8BR	WOS:000410651300001		gold			2018-01-05	
J	Fuster-Garcia, C; Garcia-Garcia, G; Gonzalez-Romero, E; Jaijo, T; Sequedo, MD; Ayuso, C; Vazquez-Manrique, RP; Millan, JM; Aller, E				Fuster-Garcia, Carla; Garcia-Garcia, Gema; Gonzalez-Romero, Elisa; Jaijo, Teresa; Sequedo, Maria D.; Ayuso, Carmen; Vazquez-Manrique, Rafael P.; Millan, Jose M.; Aller, Elena			USH2A Gene Editing Using the CRISPR System	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAK; OFF-TARGET ACTIVITY; IN-VIVO; USHER-SYNDROME; HOMOLOGOUS RECOMBINATION; PHOTORECEPTOR PRECURSORS; RETINAL DEGENERATION; MUSCULAR-DYSTROPHY; AMPLICON VECTORS	Usher syndrome (USH) is a rare autosomal recessive disease and the most common inherited form of combined visual and hearing impairment. Up to 13 genes are associated with this disorder, with USH2A being the most prevalent, due partially to the recurrence rate of the c.2299delG mutation. Excluding hearing aids or cochlear implants for hearing impairment, there are no medical solutions available to treat USH patients. The repair of specific mutations by gene editing is, therefore, an interesting strategy that can be explored using the CRISPR/Cas9 system. In this study, this method of gene editing is used to target the c.2299delG mutation on fibroblasts from an USH patient carrying the mutation in homozygosis. Successful in vitro mutation repair was demonstrated using locus-specific RNA-Cas9 ribonucleoproteins with subsequent homologous recombination repair induced by an engineered template supply. Effects on predicted off-target sites in the CRISPR-treated cells were discarded after a targeted deep-sequencing screen. The proven effectiveness and specificity of these correction tools, applied to the c.2299delG pathogenic variant of USH2A, indicates that the CRISPR system should be considered to further explore a potential treatment of USH.	[Fuster-Garcia, Carla; Garcia-Garcia, Gema; Gonzalez-Romero, Elisa; Jaijo, Teresa; Sequedo, Maria D.; Vazquez-Manrique, Rafael P.; Millan, Jose M.; Aller, Elena] IIS La Fe, Grp Invest Biomed Mol Celular & Genom, Valencia, Spain; [Garcia-Garcia, Gema; Jaijo, Teresa; Sequedo, Maria D.; Ayuso, Carmen; Vazquez-Manrique, Rafael P.; Millan, Jose M.; Aller, Elena] CIBERER, Madrid, Spain; [Jaijo, Teresa; Aller, Elena] Hosp Univ & Politecn La Fe, Unidad Genet & Diagnost Prenatal, Valencia, Spain; [Ayuso, Carmen] UAM, IIS FJD, Univ Hosp, Serv Genet,Fdn Jimenez Diaz, Madrid, Spain	Millan, JM (reprint author), IIS La Fe, Grp Invest Biomed Mol Celular & Genom, Valencia 46026, Spain.	millan_jos@gva.es			Institute of Health Carlos III; FEDER funds (ISCIII) [PI13/00638, PI16/00425, PI16/00539, PIE13/00046]; Fundacion ONCE [2015/0398]; XVIII Fundaluce-FARPE; "Telemaraton: Todos Somos Raros, Todos Somos Unicos" grant [IP58]; ISCIII [IFI14/00021]; ISCIII, Madrid, Spain [CP11/00090]; ISCIII - European Regional Development Fund; European Commission [CIG322034]	We thank the patients involved in this study and the patient associations Retina CV and FARPE. We thank the CIBERER biobank (Valencia, Spain) for sharing the skin biopsy-derived HDFs from one of the control patients, and we also thank dermatologist Montserrat Evole for the medical procedure. We also thank Paul E. Gutteridge for the grammatical revision of the English. We acknowledge Sheila Zuniga at the Medical Research Institute Hospital La Fe and Galo A. Goig from the Genomics and Health Unit (Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana [FISABIO]) for help with the bioinformatics analysis. We are grateful to Dr. Juan Bueren (Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas [CIEMAT]) and Dr. Lluis Montoliu (Centro Nacional de Biotecnologia-Centro Superior de Investigaciones Cientificas [CNB-CSIC]) for their technical support. This work was financially supported by the Institute of Health Carlos III and FEDER funds (ISCIII; grants PI13/00638, PI16/00425, PI16/00539, and PIE13/00046), Fundacion ONCE (grant 2015/0398), XVIII Fundaluce-FARPE, and "Telemaraton: Todos Somos Raros, Todos Somos Unicos" (grant IP58). C.F.-G. is a recipient of a fellowship (grant IFI14/00021) from the ISCIII. R.P.V.-M. is a Miguel Servet researcher (grant CP11/00090 funded by ISCIII, Madrid, Spain). The funds from the ISCIII are partially supported by the European Regional Development Fund. R.-P.V.M. is also a Marie Curie fellow (grant CIG322034 from the European Commission).	Aller E, 2004, EUR J HUM GENET, V12, P407, DOI 10.1038/sj.ejhg.5201138; Anderson EM, 2015, J BIOTECHNOL, V211, P56, DOI 10.1016/j.jbiotec.2015.06.427; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barnea-Cramer AO, 2016, SCI REP-UK, V6, DOI 10.1038/srep29784; Barnes DE, 2001, CURR BIOL, V11, pR455, DOI 10.1016/S0960-9822(01)00279-2; Baux D, 2014, HUM MUTAT, V35, P1179, DOI 10.1002/humu.22608; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Burgess DJ, 2013, NAT REV GENET, V14, P80, DOI 10.1038/nrg3409; Cashman SM, 2007, MOL THER, V15, P1640, DOI 10.1038/sj.mt.6300203; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coonrod A, 1997, GENE THER, V4, P1313, DOI 10.1038/sj.gt.3300536; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Dai WJ, 2016, MOL THER-NUCL ACIDS, V5, P349; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fraefel C, 2005, GENE THER, V12, P1283, DOI 10.1038/sj.gt.3302553; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Grobarczyk B, 2015, STEM CELL REV REP, V11, P774, DOI 10.1007/s12015-015-9600-1; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Han C, 2016, STEM CELLS INT, V2016, DOI DOI 10.1155/2016/7653489; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hibbitt OC, 2006, CURR GENE THER, V6, P325, DOI 10.2174/156652306777592054                                                      ; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Homma K, 2013, STEM CELLS, V31, P1149, DOI 10.1002/stem.1372; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang D, 2017, MOL PHARMACEUT, V14, P533, DOI 10.1021/acs.molpharmaceut.6b01029; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kouranova E, 2016, HUM GENE THER, V27, P464, DOI 10.1089/hum.2016.009; Kumar-Singh R, 2008, VISION RES, V48, P1671, DOI 10.1016/j.visres.2008.05.005; Lee J, 2017, MOL PHARMACEUT, V14, P423, DOI 10.1021/acs.molpharmaceut.6b00864; Lenarduzzi S, 2015, HEARING RES, V320, P18, DOI 10.1016/j.heares.2014.12.006; Li HL, 2016, METHODS, V101, P27, DOI 10.1016/j.ymeth.2015.10.015; Li J, 2013, J CONTROL RELEASE, V172, P589, DOI 10.1016/j.jconrel.2013.04.010; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lopes VS, 2013, GENE THER, V20, P824, DOI 10.1038/gt.2013.3; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mathur P, 2015, BBA-MOL BASIS DIS, V1852, P406, DOI 10.1016/j.bbadis.2014.11.020; Melendez ME, 2014, METHODS MOL BIOL, V1144, P81, DOI 10.1007/978-1-4939-0428-0_6; Millan JM, 2011, J OPHTHALMOL, DOI 10.1155/2011/417217; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mishra G. P., 2011, J DRUG DELIV, V2011, DOI DOI 10.1155/2011/863734; Mortensen R., 2007, CURR PROTOC NEUROSCI; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ou ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32463; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Pearson RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13029; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Slijkerman Radulfus Wn, 2016, Mol Ther Nucleic Acids, V5, pe381, DOI 10.1038/mtna.2016.89; Song F, 2017, MOL THER-NUCL ACIDS, V7, P53, DOI 10.1016/j.omtn.2017.02.006; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tucker BA, 2013, ELIFE, V2, DOI 10.7554/eLife.00824; van den Bosch M, 2002, BIOL CHEM, V383, P873; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang YH, 2016, THERANOSTICS, V6, P1514, DOI 10.7150/thno.15230; Wei LZ, 2016, DNA REPAIR, V44, P76, DOI 10.1016/j.dnarep.2016.05.009; Williams DS, 2017, GENE THER, V24, P68, DOI 10.1038/gt.2016.81; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418                                                        ; Zhang K, 2014, INT J MOL SCI, V15, P7409, DOI 10.3390/ijms15057409; Zhao L, 2017, J CONTROL RELEASE, V247, P153, DOI 10.1016/j.jconrel.2016.12.038; Zhu HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep24313	83	0	0	11	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 15	2017	8						529	541		10.1016/j.omtn.2017.08.003				13	Medicine, Research & Experimental	Research & Experimental Medicine	FG6XR	WOS:000410543000003	28918053	gold			2018-01-05	
J	Jeong, HH; Kim, SY; Rousseaux, MWC; Zoghbi, HY; Liu, ZD				Jeong, Hyun-Hwan; Kim, Seon Young; Rousseaux, Maxime W. C.; Zoghbi, Huda Y.; Liu, Zhandong			CRISPRcloud: a secure cloud-based pipeline for CRISPR pooled screen deconvolution	BIOINFORMATICS			English	Article							FUNCTIONAL GENOMICS; HUMAN-CELLS; GENE; ACTIVATION	aSummary: We present a user-friendly, cloud-based, data analysis pipeline for the deconvolution of pooled screening data. This tool, CRISPRcloud, serves a dual purpose of extracting, clustering and analyzing raw next generation sequencing files derived from pooled screening experiments while at the same time presenting them in a user-friendly way on a secure web-based platform. Moreover, CRISPRcloud serves as a useful web-based analysis pipeline for reanalysis of pooled CRISPR screening datasets. Taken together, the framework described in this study is expected to accelerate development of web-based bioinformatics tool for handling all studies which include next generation sequencing data. Availability and implementation: http://crispr.nrihub.org Contact: zhandong.liu@bcm.edu Supplementary information: Supplementary data are available at Bioinformatics online.	[Jeong, Hyun-Hwan; Kim, Seon Young; Rousseaux, Maxime W. C.; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jeong, Hyun-Hwan; Kim, Seon Young; Rousseaux, Maxime W. C.; Zoghbi, Huda Y.; Liu, Zhandong] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.; Liu, Zhandong] Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Liu, ZD (reprint author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Liu, ZD (reprint author), Dept Pediat, Houston, TX 77030 USA.	zhandong.liu@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Jeong, Hyun-Hwan/0000-0001-5090-2422	National Institute of General Medical Sciences [R01-GM120033]; National Science Foundation - Division of Mathematical Sciences [DMS-1263932]; Cancer Prevention Research Institute of Texas [RP170387]; Houston Endowment; Huffington Foundation; Howard Hughes Medical Institute; Canadian Institutes of Health Research Fellowship [201210MFE-290072-173743]	This work has been supported by National Institute of General Medical Sciences R01-GM120033, National Science Foundation - Division of Mathematical Sciences DMS-1263932, Cancer Prevention Research Institute of Texas RP170387, Houston Endowment (Z.L.), Huffington Foundation, Howard Hughes Medical Institute (H.Y.Z.), and Canadian Institutes of Health Research Fellowship 201210MFE-290072-173743 (M.W.C.R.).	Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Miles LA, 2016, FEBS J, V283, P3170, DOI 10.1111/febs.13770; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Peterson KA, 2017, MAMM GENOME, V28, P283, DOI 10.1007/s00335-017-9681-z; Pham TV, 2012, BIOINFORMATICS, V28, pI596, DOI 10.1093/bioinformatics/bts394; Rauscher B, 2017, NUCLEIC ACIDS RES, V45, pD679, DOI 10.1093/nar/gkw997; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Simon MM, 2015, MAMM GENOME, V26, P486, DOI 10.1007/s00335-015-9603-x; Wang J, 2017, AM J HUM GENET, V100, P843, DOI 10.1016/j.ajhg.2017.04.010; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Winter J., 2017, BIORXIV; Winter J, 2016, BIOINFORMATICS, V32, P632, DOI 10.1093/bioinformatics/btv617; Wu ZJ, 2010, GENOME RES, V20, P1730, DOI 10.1101/gr.108217.110	21	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	SEP 15	2017	33	18					2963	2965		10.1093/bioinformatics/btx335				3	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	FG1FW	WOS:000409541400030	28541456				2018-01-05	
J	Protas, ME; Weh, E; Footz, T; Kasberger, J; Baraban, SC; Levin, AV; Katz, LJ; Ritch, R; Walter, MA; Semina, EV; Gould, DB				Protas, Meredith E.; Weh, Eric; Footz, Tim; Kasberger, Jay; Baraban, Scott C.; Levin, Alex V.; Katz, L. Jay; Ritch, Robert; Walter, Michael A.; Semina, Elena V.; Gould, Douglas B.			Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma	HUMAN MOLECULAR GENETICS			English	Article							AXENFELD-RIEGER SYNDROME; ANTERIOR SEGMENT; PROTEIN FUNCTION; HUMAN-DISEASE; GENOME; ZEBRAFISH; READS; SIFT	Mutations in FOXC1 and PITX2 constitute the most common causes of ocular anterior segment dysgenesis (ASD), and confer a high risk for secondary glaucoma. The genetic causes underlying ASD in approximately half of patients remain unknown, despite many of them being screened by whole exome sequencing. Here, we performed whole genome sequencing on DNA from two affected individuals from a family with dominantly inherited ASD and glaucoma to identify a 748-kb deletion in a gene desert that contains conserved putative PITX2 regulatory elements. We used CRISPR/Cas9 to delete the orthologous region in zebrafish in order to test the pathogenicity of this structural variant. Deletion in zebrafish reduced pitx2 expression during development and resulted in shallow anterior chambers. We screened additional patients for copy number variation of the putative regulatory elements and found an overlapping deletion in a second family and in a potentially-ancestrally-related index patient with ASD and glaucoma. These data suggest that mutations affecting conserved non-coding elements of PITX2 may constitute an important class of mutations in patients with ASD for whom the molecular cause of their disease have not yet been identified. Improved functional annotation of the human genome and transition to sequencing of patient genomes instead of exomes will be required before the magnitude of this class of mutations is fully understood.	[Protas, Meredith E.; Gould, Douglas B.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Protas, Meredith E.; Gould, Douglas B.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Protas, Meredith E.; Gould, Douglas B.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Weh, Eric; Semina, Elena V.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Footz, Tim; Walter, Michael A.] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; [Kasberger, Jay] Celgene Quanticel Res, San Francisco, CA 94158 USA; [Baraban, Scott C.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Levin, Alex V.] Thomas Jefferson Univ, Wills Eye Hosp, Pediat Ophthalmol & Ocular Genet, Philadelphia, PA 19107 USA; [Katz, L. Jay] Thomas Jefferson Univ, Wills Eye Hosp, Glaucoma Serv, Philadelphia, PA 19107 USA; [Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY 10003 USA	Gould, DB (reprint author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.; Gould, DB (reprint author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.; Gould, DB (reprint author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.; Semina, EV (reprint author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Walter, MA (reprint author), Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada.	mwalter@ualberta.ca; esemina@mcw.edu; gouldd@vision.ucsf.edu			National Institutes of Health [R01EY019887, R01EY015518]; Bright Focus Foundation; Research to Prevent Blindness; The Foerderer Fund; National Institute of Health [EY02162]; That Man May See; Robison D. Harley, MD Endowed Chair in Pediatric Ophthalmology and Ocular Genetics; Denise B. Evans Endowed Chair in Ophthalmology	National Institutes of Health (R01EY019887 to D.B.G., R01EY015518 to E.V.S.); Bright Focus Foundation (D.B.G.); Research to Prevent Blindness (D.B.G.); That Man May See (D.B.G.) and The Foerderer Fund and Robison D. Harley, MD Endowed Chair in Pediatric Ophthalmology and Ocular Genetics (AVL), Denise B. Evans Endowed Chair in Ophthalmology (DBG). Additional support was provided by a core grant from National Institute of Health (EY02162) and Research to Prevent Blindness unrestricted grants to UCSF Department of Ophthalmology.	Ansari M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153757; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Chang TC, 2012, BRIT J OPHTHALMOL, V96, P318, DOI 10.1136/bjophthalmol-2011-300801; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Gould DB, 2004, INT J DEV BIOL, V48, P1015, DOI 10.1387/ijdb.041865dg; HENKIND P, 1965, ARCH OPHTHALMOL-CHIC, V73, P810; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Idrees F, 2006, SURV OPHTHALMOL, V51, P213, DOI 10.1016/j.survophthal.2006.02.006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030896; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Qu Hongzhu, 2013, [Genomics, Proteomics & Bioinformatics, 基因组蛋白质组与生物信息学报], V11, P135, DOI 10.1016/j.gpb.2013.05.001; Reis LM, 2012, EUR J HUM GENET, V20, P1224, DOI 10.1038/ejhg.2012.80; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Seifi M, 2016, ACTA OPHTHALMOL, V94, pE571, DOI 10.1111/aos.13030; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spielmann M, 2013, BIOESSAYS, V35, P533, DOI 10.1002/bies.201200178; To Chi-ho, 2002, Clin Exp Optom, V85, P335; Volkmann BA, 2011, INVEST OPHTH VIS SCI, V52, P1450, DOI 10.1167/iovs.10-6060; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464	26	0	0	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	SEP 15	2017	26	18					3630	3638		10.1093/hmg/ddx251				9	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	FF6CO	WOS:000409091200015	28911203				2018-01-05	
J	Yang, MJ; Wei, H; Wang, YL; Deng, JJ; Tang, YN; Zhou, LX; Guo, G; Tong, AP				Yang, Meijia; Wei, Heng; Wang, Yuelong; Deng, Jiaojiao; Tang, Yani; Zhou, Liangxue; Guo, Gang; Tong, Aiping			Targeted Disruption of V600E-Mutant BRAFGene by CRISPR-Cpf1	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							HUMAN-CELLS; VEMURAFENIB RESISTANCE; NUCLEASE SPECIFICITY; CAS9 NUCLEASES; LUNG-CANCER; RNA; MUTATIONS; DNA; MELANOMA; CPF1	BRAF-V600E (1799T > A) is one of the most frequently reported driver mutations in multiple types of cancers, and patients with such mutations could benefit from selectively inactivating the mutant allele. Near this mutation site, there are two TTTN and one NGG protospacer-adjacent motifs (PAMs) for Cpf1 and Cas9 CRISPR nucleases, respectively. The 1799T > A substitution also leads to the occurrence of a novel NGNG PAM for the EQR variant of Cas9. We examined the editing efficacy and selectivity of Cpf1, Cas9, and EQR variant to this mutation site. Only Cpf1 demonstrated robust activity to induce specific disruption of only mutant BRAF, not wild-type sequence. Cas9 recognized and cut both normal and mutant alleles, and no obvious gene editing events were observed using EQR variant. Our results support the potential applicability of Cpf1 in precision medicine through highly specific inactivation of many other gain-of-function mutations.	[Yang, Meijia; Tang, Yani; Guo, Gang; Tong, Aiping] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy & Canc Ctr,Collaborat In, Chengdu 610041, Sichuan, Peoples R China; [Wei, Heng] Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Wang, Yuelong; Deng, Jiaojiao; Zhou, Liangxue] Sichuan Univ, West China Med Sch, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China	Guo, G; Tong, AP (reprint author), Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy & Canc Ctr,Collaborat In, Chengdu 610041, Sichuan, Peoples R China.	guogang@scu.edu.cn; aipingtong@scu.edu.cn			National Natural Science Foundation of China [31471286, 31171370]; National Scientific and Technological Special Project for New Drugs Development [2015ZX09102010]	This work was supported by the National Natural Science Foundation of China (grants 31471286 and 31171370) and the National Scientific and Technological Special Project for New Drugs Development (2015ZX09102010).	Arcaini L, 2012, BLOOD, V119, P188, DOI 10.1182/blood-2011-08-368209; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Brastianos PK, 2014, NAT GENET, V46, P161, DOI 10.1038/ng.2868; Carroll D, 2013, NAT BIOTECHNOL, V31, P807, DOI 10.1038/nbt.2684; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766                                                             ; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fu BXH, 2014, NUCLEIC ACIDS RES, V42, P13778, DOI 10.1093/nar/gku1102; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gebler C., 2016, JNCI-J NATL CANCER I, V109; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144970; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Miao BC, 2015, CANCER DISCOV, V5, P274, DOI 10.1158/2159-8290.CD-14-0295; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paraiso KHT, 2012, CLIN CANCER RES, V18, P2502, DOI 10.1158/1078-0432.CCR-11-2612; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shin J. W., 2016, HUM MOL GENET; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wu Xuebing, 2014, Quant Biol, V2, P59; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	40	0	0	22	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 15	2017	8						450	458		10.1016/j.omtn.2017.05.009				9	Medicine, Research & Experimental	Research & Experimental Medicine	FE2PA	WOS:000408057000002	28918044	gold			2018-01-05	
J	Kretova, OV; Fedoseeva, DM; Gorbacheva, MA; Gashnikova, NM; Gashnikova, MP; Melnikova, NV; Chechetkin, VR; Kravatsky, YV; Tchurikov, NA				Kretova, Olga V.; Fedoseeva, Daria M.; Gorbacheva, Maria A.; Gashnikova, Natalya M.; Gashnikova, Maria P.; Melnikova, Nataliya V.; Chechetkin, Vladimir R.; Kravatsky, Yuri V.; Tchurikov, Nickolai A.			Six Highly Conserved Targets of RNAi Revealed in HIV-1-Infected Patients from Russia Are Also Present in Many HIV-1 Strains Worldwide	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							TYPE-1 REVERSE-TRANSCRIPTASE; REDUCED REPLICATION; DRUG-RESISTANCE; INTERFERENCE; INHIBITION; INFECTION; CELLS; MUTATIONS; DESIGN; VECTOR	RNAi has been suggested for use in gene therapy of HIV/AIDS, but the main problem is that HIV-1 is highly variable and could escape attack from the small interfering RNAs (siRNAs) due to even single nucleotide substitutions in the potential targets. To exhaustively check the variability in selected RNA targets of HIV-1, we used ultra-deep sequencing of six regions of HIV-1 from the plasma of two independent cohorts of patients from Russia. Six RNAi targets were found that are invariable in 82%-97% of viruses in both cohorts and are located inside the domains specifying reverse transcriptase (RT), integrase, vpu, gp120, and p17. The analysis of mutation frequencies and their characteristics inside the targets suggests a likely role for APOBEC3G (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G, A3G) in G-to-A mutations and a predominant effect of RT biases in the detected variability of the virus. The lowest frequency of mutations was detected in the central part of all six targets. We also discovered that the identical RNAi targets are present in many HIV-1 strains from many countries and from all continents. The data are important for both the understanding of the patterns of HIV-1 mutability and properties of RT and for the development of gene therapy approaches using RNAi for the treatment of HIV/AIDS.	[Kretova, Olga V.; Fedoseeva, Daria M.; Gorbacheva, Maria A.; Chechetkin, Vladimir R.; Kravatsky, Yuri V.; Tchurikov, Nickolai A.] Engelhardt Inst Mol Biol, Dept Epigenet Mech Gene Express Regulat, Moscow 119334, Russia; [Gashnikova, Natalya M.; Gashnikova, Maria P.] State Res Ctr Virol & Biotechnol Vector, Dept Retroviruses, Koltsov 630559, Russia; [Melnikova, Nataliya V.] Engelhardt Inst Mol Biol, Lab Postgenom Res, Moscow 119334, Russia	Tchurikov, NA (reprint author), Engelhardt Inst Mol Biol, Dept Epigenet Mech Gene Express Regulat, Moscow 119334, Russia.	tchurikov@eimb.ru	Melnikova, Nataliya/E-5894-2014	Melnikova, Nataliya/0000-0001-8083-3018	Russian Science Foundation [15-14-00005]	We thank Dr. A.V. Kudryavtseva and Dr. A.V. Snezhkina for help with sequencing and Y.N. Toropchina and D.S. Vinogradov for technical assistance. This work was supported by a grant from the Russian Science Foundation (Project No. 15-14-00005).	Abram ME, 2014, J VIROL, V88, P7589, DOI 10.1128/JVI.00302-14; Andrews S., 2010, FASTQC QUALITY CONTR; Back NKT, 1996, EMBO J, V15, P4040; Berkhout B, 2004, AIDS, V18, P1861, DOI 10.1097/00002030-200409030-00022                                                ; Bobbin ML, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0174-y; Capodici J, 2002, J IMMUNOL, V169, P5196, DOI 10.4049/jimmunol.169.9.5196                                                     ; Carneiro B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117742; Churikov N A, 2006, Mol Biol (Mosk), V40, P784; Coburn GA, 2002, J VIROL, V76, P9225, DOI 10.1128/JVI.76.18.9225-9231.2002; Cuevas JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002251; Delviks-Frankenberry KA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005646; Garforth SJ, 2014, VIRUSES-BASEL, V6, P4080, DOI 10.3390/v6104080; GU ZX, 1992, J VIROL, V66, P7128; Harris D, 1998, BIOCHEMISTRY-US, V37, P9630, DOI 10.1021/bi980549z                                                               ; Harris RS, 2003, NAT IMMUNOL, V4, P641, DOI 10.1038/ni0703-641; Hu WY, 2002, CURR BIOL, V12, P1301, DOI 10.1016/S0960-9822(02)00975-2; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Johnson N. L., 1977, STAT EXPT DESIGN ENG, V1; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Keulen W, 1997, J VIROL, V71, P3346; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Klemm V, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120119; Kravatsky Y V, 2016, Mol Biol (Mosk), V50, P480, DOI 10.7868/S0026898416020117; Kretova OV, 2017, AIDS RES HUM RETROV, V33, P194, DOI [10.1089/aid.2016.0088, 10.1089/AID.2016.0088]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Leipzig J, 2017, BRIEF BIOINFORM, V18, P530, DOI 10.1093/bib/bbw020; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu YP, 2008, NUCLEIC ACIDS RES, V36, P2811, DOI 10.1093/nar/gkn109; Mangul S, 2014, BIOINFORMATICS, V30, P329, DOI 10.1093/bioinformatics/btu295; Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200; Naito Y, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-80; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Park WS, 2002, NUCLEIC ACIDS RES, V30, P4830, DOI 10.1093/nar/gkf627; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; Pingen M, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0113-9; Posada-Cespedesa S., 2016, VIRUS RES; Pusch O, 2003, NUCLEIC ACIDS RES, V31, P6444, DOI 10.1093/nar/gkg876; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Senserrich J, 2008, VIROLOGY, V372, P421, DOI 10.1016/j.virol.2007.10.045; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; Stevenson M, 2003, NAT REV IMMUNOL, V3, P851, DOI 10.1038/nri1227; Surabhi RM, 2002, J VIROL, V76, P12963, DOI 10.1128/JVI.76.24.12963-12973.2002; Tchurikov NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000476; Tchurikov NA, 2016, GENE, V583, P78, DOI 10.1016/j.gene.2016.03.001; Tchurikov NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021882; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; Wee EG, 2017, MOL THER, V25, P494, DOI 10.1016/j.ymthe.2016.12.004; Weir B.S., 1996, GENETIC DATA ANAL; Wrobel JA, 1998, P NATL ACAD SCI USA, V95, P638, DOI 10.1073/pnas.95.2.638                                                           ; Yamamoto T, 2002, MICROBIOL IMMUNOL, V46, P809, DOI 10.1111/j.1348-0421.2002.tb02768.x                                              	58	0	0	9	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 15	2017	8						330	344		10.1016/j.omtn.2017.07.010				15	Medicine, Research & Experimental	Research & Experimental Medicine	FC0EC	WOS:000406510200007	28918033	gold			2018-01-05	
J	Meca-Cortes, O; Guerra-Rebollo, M; Garrido, C; Borros, S; Rubio, N; Blanco, J				Meca-Cortes, Oscar; Guerra-Rebollo, Marta; Garrido, Cristina; Borros, Salvador; Rubio, Nuria; Blanco, Jeronimo			CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							MESENCHYMAL STEM-CELLS; ADIPOSE-TISSUE; STROMAL CELLS; REPAIR; EXPRESSION	The use of non-viral procedures, together with CRISPR/Cas9 genome-editing technology, allows the insertion of single-copy therapeutic genes at pre-determined genomic sites, overcoming safety limitations resulting from random gene insertions of viral vectors with potential for genome damage. In this study, we demonstrate that combination of non-viral gene delivery and CRISPR/Cas9-mediated knockin via homology-directed repair can replace the use of viral vectors for the generation of genetically modified therapeutic cells. Wecustom-modified humanadipose mesenchymal stem cells (hAMSCs), using electroporation as a transfection method and CRISPR/Cas9-mediated knockin for the introduction and stable expression of a 3 kb DNA fragment including the eGFP (selectable marker) and a variant of the herpes simplex virus 1 thymidine kinase genes (therapeutic gene), under the control of the human elongation factor 1 alpha promoter in exon 5 of the endogenous thymidine kinase 2 gene. Using a U87 gliomamodel in SCID mice, we show that the therapeutic capacity of the new CRISPR/Cas9-engineered hAMSCs is equivalent to that of therapeutic hAMSCs generated by introduction of the same therapeutic gene by transduction with a lentiviral vector previously published by our group. This strategy should be of general use to other applications requiring genetic modification of therapeutic cells.	[Meca-Cortes, Oscar; Guerra-Rebollo, Marta; Garrido, Cristina; Rubio, Nuria; Blanco, Jeronimo] CSIC, Cell Therapy Grp, Catalonian Inst Adv Chem IQAC, Jordi Girona 18-26, ES-08034 Barcelona, Spain; [Meca-Cortes, Oscar; Guerra-Rebollo, Marta; Garrido, Cristina; Borros, Salvador; Rubio, Nuria; Blanco, Jeronimo] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Zaragoza 50018, Spain; [Borros, Salvador] Univ Ramon Llull, Grp Engn Mat GEMAT, Inst Quim Sarria, Via Augusta 390, Barcelona 08017, Spain	Blanco, J (reprint author), CSIC, Catalonian Inst Adv Chem IQAC, Jordi Girona St 18-26, ES-08034 Barcelona, Spain.	jbfnqb@iqac.csic.es			MINECO/FEDER [SAF2015-64927-C2-1-R, SAF2015-64927-C2-2-R]; Instituto de Salud Carlos III (Red Tematica de Investigacion Cooperativa en Terapia Celular-TERCEL)	This work was supported by MINECO/FEDER (grants SAF2015-64927-C2-1-R and SAF2015-64927-C2-2-R) and the Instituto de Salud Carlos III (Red Tematica de Investigacion Cooperativa en Terapia Celular-TERCEL). We would like to thank M.A. Pastor and C. Bestard (flow cytometry) for their excellent technical assistance.	Alieva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035148; Bago JR, 2013, MOL THER, V21, P1758, DOI 10.1038/mt.2013.145; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; Dodson BP, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0190-4; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Jackson HJ, 2016, NAT REV CLIN ONCOL, V13, P370, DOI 10.1038/nrclinonc.2016.36; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Pendleton C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058198; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816                                                   ; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213	20	0	0	53	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 15	2017	8						395	403		10.1016/j.omtn.2017.07.012				9	Medicine, Research & Experimental	Research & Experimental Medicine	FC0EC	WOS:000406510200012	28918039	gold			2018-01-05	
J	Palmer, DJ; Grove, NC; Turner, DL; Ng, P				Palmer, Donna J.; Grove, Nathan C.; Turner, Dustin L.; Ng, Philip			Gene Editing with Helper-Dependent Adenovirus Can Efficiently Introduce Multiple Changes Simultaneously over a Large Genomic Region	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							PLURIPOTENT STEM-CELLS; HOMOLOGOUS RECOMBINATION; CYSTIC-FIBROSIS; VECTOR PRODUCTION; PATIENT IPSCS; INTEGRATION; MUTATIONS; CFTR; DNA; EXPRESSION	Helper-dependent adenoviral vectors (HDAds) possess long homology arms that mediate high-efficiency gene editing. These long homology arms may permit simultaneous introduction of multiple modifications into a large genomic region or may permit a single HDAd to correct many different individual mutations spread widely across a gene. We investigated this important potential using an HDAd bearing 13 genetic markers in the region of homology to the target CFTR locus in human iPSCs and found that all markers can be simultaneously introduced into the target locus, with the two farthest markers being 22.2 kb apart. We found that genetic markers closer to the HDAd's selectable marker are more efficiency introduced into the target locus; a marker located 208 bp from the selectable marker was introduced with 100% efficiency. However, even markers 11 kb from the selectable marker were introduced at a relatively high frequency of 21.7%. Our study also revealed extensive heteroduplex DNA formation of up to 10 kb with no bias toward vector or chromosomal repair. However, mismatches escape repair at a frequency of up to 15%, leading to a genetically mixed colony and emphasizing the need for caution, especially if the donor and target sequences are not 100% homologous.	[Palmer, Donna J.; Grove, Nathan C.; Turner, Dustin L.; Ng, Philip] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA	Ng, P (reprint author), Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA.	png@bcm.edu			internal Baylor College of Medicine funds	This study was supported by internal Baylor College of Medicine funds.	Aizawa E, 2012, MOL THER, V20, P424, DOI 10.1038/mt.2011.266; Aoyama M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni055; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; HASTINGS PJ, 1993, GENETICS, V135, P973; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/nmeth.3075, 10.1038/NMETH.3075]; Kan YN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004251; Langston LD, 2004, P NATL ACAD SCI USA, V101, P15392, DOI 10.1073/pnas.0403748101; Li JL, 2001, MOL CELL BIOL, V21, P501, DOI 10.1128/MCB.21.2.501-510.2001; Li M, 2014, J BIOL CHEM, V289, P4594, DOI 10.1074/jbc.R113.488247; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Liu GH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5330; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Ohbayashi F, 2005, P NATL ACAD SCI USA, V102, P13628, DOI 10.1073/pnas.0506598102; Palmer D, 2003, MOL THER, V8, P846, DOI 10.1016/j.ymthe.2003.08.014; Palmer DJ, 2004, MOL THER, V10, P792, DOI 10.1016/j.ymthe.2004.06.1013; Palmer DJ, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.83; Palmer DJ, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.39; Palmer Donna J., 2008, V433, P33, DOI 10.1007/978-1-59745-237-3_3; Parks RJ, 1997, J VIROL, V71, P3293; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Umeda K, 2013, STEM CELL RES, V10, P179, DOI 10.1016/j.scr.2012.11.003; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yamamoto H, 2016, GENE THER, V23, P205, DOI 10.1038/gt.2015.91; Yoshida T, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-45; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356	29	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 15	2017	8						101	110		10.1016/j.omtn.2017.06.001				10	Medicine, Research & Experimental	Research & Experimental Medicine	EZ0PO	WOS:000404408200002	28918012	gold			2018-01-05	
J	Jubair, L; McMillan, NAJ				Jubair, Luqman; McMillan, Nigel A. J.			The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Review							EPSTEIN-BARR-VIRUS; HUMAN-PAPILLOMAVIRUS E6; CERVICAL-CARCINOMA CELLS; RNA-GUIDED ENDONUCLEASE; IN-VIVO; CRISPR-CAS9 NUCLEASES; CLINICAL RESISTANCE; ANTICANCER THERAPY; MAMMALIAN-CELLS; GENE-EXPRESSION	The field of gene editing is undergoing unprecedented growth. The first ex vivo human clinical trial in China started in 2016, more than 1000 US patents have been filed, and there is exponential growth in publications. The ability to edit genes with high fidelity is promising for the development of new treatments for a range of diseases, particularly inherited conditions, infectious diseases, and cancers. For cancer, a major issue is the identification of driver mutations and oncogenes to target for therapeutic effect, and this requires the development of robust models with which to prove their efficacy. The challenge is that there is rarely a single critical gene. However, virally driven cancers, in which cells are addicted to the expression of a single viral oncogene in some cases, may serve as model systems for CRISPR/Cas therapies, as they did for RNAi. These models and systems offer an excellent opportunity to test both preclinical models and clinical conditions to examine the effectiveness of gene editing, and here we review the options and offer a way forward.	[Jubair, Luqman; McMillan, Nigel A. J.] Griffith Univ, Sch Med Sci, Gold Coast Campus, Gold Coast, Qld 4222, Australia; [McMillan, Nigel A. J.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld 4222, Australia; [McMillan, Nigel A. J.] Univ Queensland, Diamantina Inst, Brisbane St Lucia, Qld 4072, Australia	Jubair, L (reprint author), Griffith Univ, Sch Med Sci, Gold Coast Campus, Gold Coast, Qld 4222, Australia.	luqman.jubair@griffithuni.edu.au			Griffith University; Cancer Council of Queensland; National Health and Medical Research Council of Australia	L.J. is funded by Griffith University. N.A.J.M. has received funding from the Cancer Council of Queensland and the National Health and Medical Research Council of Australia.	Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; Alexander-Sefre F, 2006, GYNECOL ONCOL, V101, P450, DOI 10.1016/j.ygyno.2005.11.007; Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Beerheide W, 1999, J NATL CANCER I, V91, P1211, DOI 10.1093/jnci/91.14.1211                                                         ; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Brunet CL, 1998, CELL DEATH DIFFER, V5, P107, DOI 10.1038/sj.cdd.4400334                                                          ; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879                                                         ; Chapoy-Villanueva H, 2015, J BUON, V20, P1471; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Covens A, 2001, GYNECOL ONCOL, V81, P133, DOI 10.1006/gyno.2001.6158; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; de la Cruz FF, 2015, ANNU REV PHARMACOL, V55, P513, DOI 10.1146/annurev-pharmtox-010814-124511; DeFilippis RA, 2003, J VIROL, V77, P1551, DOI 10.1128/JVI.77.2.1551-1563.2003; Ding YD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00703; Duenas-Gonzalez A, 2014, EXPERT OPIN PHARMACO, V15, P51, DOI 10.1517/14656566.2014.855198; Felsher DW, 2008, CANCER RES, V68, P3081, DOI 10.1158/0008-5472.CAN-07-5832; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gabrielli B, 2015, MOL CANCER THER, V14, P2753, DOI 10.1158/1535-7163.MCT-15-0506; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SV, 2010, FUTURE MICROBIOL, V5, P1493, DOI 10.2217/FMB.10.107; Gu W, 2006, CANCER GENE THER, V13, P1023, DOI 10.1038/sj.cgt.7700971; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guo CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017734; Hamada K, 1996, GYNECOL ONCOL, V60, P373, DOI 10.1006/gyno.1996.0057; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu Z, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/612823; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jung HS, 2015, J CLIN MED, V4, P1126, DOI 10.3390/jcm4051126; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamb A, 2003, MOL BIOL CELL, V14, P2201, DOI 10.1091/mbc.E02-11-0732; Kennedy EM, 2014, J VIROL, V88, P11965, DOI 10.1128/JVI.01879-14; KENNEDY IM, 1991, J VIROL, V65, P2093; Kidd EA, 2008, CLIN CANCER RES, V14, P5236, DOI 10.1158/1078-0432.CCR-07-5252; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Li CX, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0054-1; Lin GG, 2015, INT J MOL SCI, V16, P26077, DOI 10.3390/ijms161125950; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Milligan SG, 2007, VIROLOGY, V360, P172, DOI 10.1016/j.virol.2006.10.012; Nishida H, 2016, J CONTROL RELEASE, V231, P29, DOI 10.1016/j.jconrel.2016.03.016; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x                                          ; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415                                                         ; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Reade CJ, 2013, GYNECOL ONCOL, V131, P222, DOI 10.1016/j.ygyno.2013.07.078; Reardon S, 2016, NATURE; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rose PG, 2002, EUR J CANCER, V38, P270, DOI 10.1016/S0959-8049(01)00352-5; ROWE M, 1992, J VIROL, V66, P122; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schaefer KA, 2017, NAT METHODS, V14, P547, DOI 10.1038/nmeth.4293; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shlomai A, 2014, SCIENCE, V343, P1212, DOI 10.1126/science.1252186; Singhania R, 2016, BBA-GENE REGUL MECH, V1859, P1034, DOI 10.1016/j.bbagrm.2016.06.005; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sontheimer EJ, 2015, HUM GENE THER, V26, P413, DOI 10.1089/hum.2015.091; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; TAN TMC, 1995, CANCER RES, V55, P4599; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Tycko J, 2016, MOL CELL, V63, P355, DOI 10.1016/j.molcel.2016.07.004; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Villanueva R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-218; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Weinstein IB, 2008, CANCER RES, V68, P3086; Weinstein IB, 2000, CARCINOGENESIS, V21, P857, DOI 10.1093/carcin/21.5.857                                                         ; Wen WS, 2016, INT J CANCER, V138, P1328, DOI 10.1002/ijc.29626; White MK, 2015, DISCOV MED, V19, P255; Wu Xuebing, 2014, Quant Biol, V2, P59; Yu L, 2015, ONCOTARGETS THER, V8, P37, DOI 10.2147/OTT.S64092; Yuen KS, 2015, J GEN VIROL, V96, P626, DOI 10.1099/jgv.0.000012; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37; Zhen S, 2014, BIOCHEM BIOPH RES CO, V450, P1422, DOI 10.1016/j.bbrc.2014.07.014; Zheng Y. F., 2002, CASKI DI YI JUN YI D, V22, P496	91	0	0	88	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 15	2017	8						56	63		10.1016/j.omtn.2017.06.006				8	Medicine, Research & Experimental	Research & Experimental Medicine	EY6DS	WOS:000404073300002	28918056	gold			2018-01-05	
J	Li, SL; Zhang, AQ; Xue, HP; Li, DL; Liu, Y				Li, Shenglan; Zhang, Anqi; Xue, Haipeng; Li, Dali; Liu, Ying			One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							MOTOR-NEURON; TRANSCRIPTIONAL ACTIVATION; IN-VIVO; CELLS; RNA; EXPRESSION; SYSTEM; DIFFERENTIATION; COMPLEX; MICE	Neural cell fate is determined by a tightly controlled transcription regulatory network during development. The ability to manipulate the expression of multiple transcription factors simultaneously is required to delineate the complex picture of neural cell development. Because of the limited carrying capacity of the commonly used viral vectors, such as lentiviral or retroviral vectors, it is often challenging to perform perturbation experiments on multiple transcription factors. Here we have developed a piggyBac (PB) transposon-based CRISPR activation (CRISPRa) all-in-one system, which allows for simultaneous and stable endogenous transactivation of multiple transcription factors and long non-coding RNAs. As a proof of principle, we showed that the PB-CRISPRa system could accelerate the differentiation of human induced pluripotent stem cells into neurons and astrocytes by triggering endogenous expression of different sets of transcription factors. The PB-CRISPRa system has the potential to become a convenient and robust tool in neuroscience, which can meet the needs of a variety of in vitro and in vivo gain-of-function applications.	[Li, Shenglan; Zhang, Anqi; Xue, Haipeng; Li, Dali; Liu, Ying] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA; [Li, Shenglan; Zhang, Anqi; Xue, Haipeng; Li, Dali; Liu, Ying] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Ctr Stem Cell & Regenerat Med, Houston, TX 77030 USA; [Zhang, Anqi] Liaocheng Peoples Hosp, Cent Lab, Liaocheng 252000, Shandong, Peoples R China	Liu, Y (reprint author), Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, 1825 Pressler St,SRB 630G, Houston, TX 77030 USA.	ying.liu@uth.tmc.edu			Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Memorial Hermann Foundation-Staman Ogilvie Fund; Bentsen Stroke Center; TIRR Foundation [014-115]; Craig H. Neilsen Foundation [338617]	The authors thank Dr. Joanna S. OLeary for editing the manuscript. This work was supported by the start-up fund from The Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Memorial Hermann Foundation-Staman Ogilvie Fund (to Y.L.), the Bentsen Stroke Center (to Y.L.), the TIRR Foundation through Mission Connect (014-115 to Y.L.), and the Craig H. Neilsen Foundation (338617 to Y.L.).	Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Busskamp V, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145508; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5430; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dixit R, 2014, J NEUROSCI, V34, P539, DOI 10.1523/JNEUROSCI.0614-13.2014; Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hindley C, 2012, DEVELOPMENT, V139, P1718, DOI 10.1242/dev.077552; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003657; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Li MA, 2013, MOL CELL BIOL, V33, P1317, DOI 10.1128/MCB.00670-12; Li SL, 2015, STEM CELLS DEV, V24, P2925, DOI 10.1089/scd.2015.0131; Liu Y, 2011, NAT PROTOC, V6, P640, DOI 10.1038/nprot.2011.310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5                                                   ; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; MacArthur CC, 2012, STEM CELLS DEV, V21, P191, DOI 10.1089/scd.2011.0163; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Perrin FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015914; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Sadahiro T, 2015, CIRC RES, V116, P1378, DOI 10.1161/CIRCRESAHA.116.305374; Saridey SK, 2009, MOL THER, V17, P2115, DOI 10.1038/mt.2009.234; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0                                                   ; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wei S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19648; Woodard LE, 2015, TRENDS BIOTECHNOL, V33, P525, DOI 10.1016/j.tibtech.2015.06.009; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060; Wu S, 2014, P NATL ACAD SCI USA, V111, P10678, DOI 10.1073/pnas.1409933111; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xu CL, 2017, P NATL ACAD SCI USA, V114, P722, DOI 10.1073/pnas.1615735114; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; Yan Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep38970; Yusa K, 2013, NAT PROTOC, V8, P2061, DOI 10.1038/nprot.2013.126; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	64	0	0	48	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	SEP 15	2017	8						64	76		10.1016/j.omtn.2017.06.007				13	Medicine, Research & Experimental	Research & Experimental Medicine	EY6DS	WOS:000404073300003	28918057	gold			2018-01-05	
J	Guk, K; Keem, JO; Hwang, SG; Kim, H; Kang, T; Lim, EK; Jung, J				Guk, Kyeonghye; Keem, Joo Oak; Hwang, Seul Gee; Kim, Hyeran; Kang, Taejoon; Lim, Eun-Kyung; Jung, Juyeon			A facile, rapid and sensitive detection of MRSA using a CRISPR-mediated DNA FISH method, antibody-like dCas9/sgRNA complex	BIOSENSORS & BIOELECTRONICS			English	Article						Diagnostic; Rapid detection; DNA-FISH; Fluorescence	RESISTANT STAPHYLOCOCCUS-AUREUS; CHROMOGENIC MEDIA; PCR ASSAY; IDENTIFICATION; SPECIMENS; BINDING; SYSTEM	Rapid and reliable diagnosis of methicillin-resistant Staphylococcus aureus (MRSA) is crucial for guiding effective patient treatment and preventing the spread of MRSA infections. Nonetheless, further simplification of MRSA detection procedures to shorten detection time and reduce labor relative to that of conventional methods remains a challenge. Here, we have demonstrated a Clustered regularly interspaced palindromic repeats (CRISPR)-mediated DNA-FISH method for the simple, rapid and highly sensitive detection of MRSA; this method uses CRISPR associated protein 9/single-guide RNA (dCas9/sgRNA) complex as a targeting material and SYBR Green I (SG I) as a fluorescent probe. A dCas9/sgRNA-SG I based detection approach has advantages over monoclonal antibody in conventional immunoassay systems due to its ability to interact with the target gene in a sequence-specific manner. The detection limit of MRSA was as low as 10 cfu/ml and was found to be sufficient to effectively detect MRSA. Unlike conventional gene diagnosis methods in which PCR must be accompanied or genes are isolated and analyzed, the target gene can be detected within 30 min with high sensitivity without performing a gene separation step by using cell lysates. We showed that the fluorescence signal of the MRSA cell lysate was more than 10-fold higher than that of methicillin-susceptible S. aureus (MSSA). Importantly, the present approach can be applied to any target other than MRSA by simply changing the single-guide RNA (sgRNA) sequence. Because dCas9/sgRNA-SG I based detection approach has proved to be easy, fast, sensitive, and cost-efficient, it can be applied directly at the point of care to detect various pathogens as well as MRSA in this study.	[Guk, Kyeonghye; Hwang, Seul Gee; Kim, Hyeran; Kang, Taejoon; Lim, Eun-Kyung; Jung, Juyeon] KRIBB, Inst Biosci & Biotechnol, Hazards Monitoring Bionano Res Ctr, 125 Gwahak Ro, Daejeon 305806, South Korea; [Guk, Kyeonghye; Hwang, Seul Gee; Kim, Hyeran; Kang, Taejoon; Lim, Eun-Kyung; Jung, Juyeon] Univ Sci & Technol, Nanobiotechnol Major, Sch Engn, 217 Gajeong Rp, Daejeon 34113, South Korea; [Keem, Joo Oak] BioNano Hlth Guard Res Ctr, 125 Gwahak Ro, Daejeon 305806, South Korea	Jung, J (reprint author), KRIBB, Inst Biosci & Biotechnol, Hazards Monitoring Bionano Res Ctr, 125 Gwahak Ro, Daejeon 305806, South Korea.	jjung@kribb.re.kr			BioNano Health-Guard Research Center; Ministry of Science, ICT & Future Planning (MSIP) of Korea [H-GUARD_2014M3A6B2060507, H-GUARD_2014M3A6B2060489]; KRIBB Initiative Program, Republic of Korea	The authors acknowledge the financial support from BioNano Health-Guard Research Center funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project (H-GUARD_2014M3A6B2060507, H-GUARD_2014M3A6B2060489) and the KRIBB Initiative Program, Republic of Korea.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; CHAMBERS HF, 1985, J CLIN INVEST, V76, P325, DOI 10.1172/JCI111965; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Dickinson DJ, 2016, GENETICS, V202, P885, DOI 10.1534/genetics.115.182162; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Golkar Z, 2014, J INFECT DEV COUNTR, V8, P129, DOI 10.3855/jidc.3573; Hagen RM, 2005, INT J MED MICROBIOL, V295, P77, DOI 10.1016/j.ijmm.2004.12.008; Harrison MM, 2014, GENE DEV, V28, P1859, DOI 10.1101/gad.248252.114; Huang ZG, 2015, PATHOGENS, V4, P199, DOI 10.3390/pathogens4020199; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KOZLOV JV, 1981, J GEN VIROL, V56, P437, DOI 10.1099/0022-1317-56-2-437                                                      ; LaFlamme B., 2014, NAT GENET, V46, P99; Lee S, 2013, ANN LAB MED, V33, P255, DOI 10.3343/alm.2013.33.4.255; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Malhotra-Kumar S, 2010, J CLIN MICROBIOL, V48, P4598, DOI 10.1128/JCM.00004-10; Malhotra-Kumar S, 2010, J CLIN MICROBIOL, V48, P1040, DOI 10.1128/JCM.01745-09; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240; Oh AC, 2013, MOL MED REP, V7, P11, DOI 10.3892/mmr.2012.1121; Pantosti J., 2012, FRONT MICROBIOL, V3, P1; Qin PW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14725; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rossney AS, 2008, J CLIN MICROBIOL, V46, P3285, DOI 10.1128/JCM.02487-07; RYFFEL C, 1992, ANTIMICROB AGENTS CH, V36, P25, DOI 10.1128/AAC.36.1.25                                                             ; Sherlock O, 2010, CLIN MICROBIOL INFEC, V16, P955, DOI 10.1111/j.1469-0691.2009.02948.x; Unniyampurath U, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030291; Wang DO, 2012, RNA, V18, P166, DOI 10.1261/rna.028431.111; Wilkinson Royce, 2014, F1000Prime Rep, V6, P3, DOI 10.12703/P6-3; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	30	0	0	57	74	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	SEP 15	2017	95						67	71		10.1016/j.bios.2017.04.016				5	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	EW0ZM	WOS:000402219700011					2018-01-05	
J	Wei, ZQ; Zhang, YH; Ke, CZ; Chen, HX; Ren, P; He, YL; Hu, P; Ma, DQ; Luo, J; Meng, ZJ				Wei, Zhi-Qiang; Zhang, Yong-Hong; Ke, Chang-Zheng; Chen, Hong-Xia; Ren, Pan; He, Yu-Lin; Hu, Pei; Ma, De-Qiang; Luo, Jie; Meng, Zhong-Ji			Curcumin inhibits hepatitis B virus infection by downregulating cccDNA-bound histone acetylation	WORLD JOURNAL OF GASTROENTEROLOGY			English	Article						Curcumin; Hepatitis B virus; Covalently closed circular DNA; Histone deacetylation	GENE-EXPRESSION; DNA; REPLICATION; TRANSCRIPTION; DEGRADATION; CRISPR/CAS9; NUCLEASES; STRATEGY; CANCER; ANALOG	AIM To investigate the potential effect of curcumin on hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) and the underlying mechanism. METHODS A HepG2.2.15 cell line stably transfected with HBV was treated with curcumin, and HBV surface antigen (HBsAg) and e antigen (HBeAg) expression levels were assessed by ELISA. Intracellular HBV DNA replication intermediates and cccDNA were detected by Southern blot and real-time PCR, respectively. The acetylation levels of histones H3 and H4 were measured by Western blot. H3/H4-bound cccDNA was detected by chromatin immunoprecipitation (ChIP) assays. The deacetylase inhibitors trichostatin A and sodium butyrate were used to study the mechanism of action for curcumin. Additionally, short interfering RNAs (siRNAs) targeting HBV were tested along with curcumin. RESULTS Curcumin treatment led to time-and dose-dependent reductions in HBsAg and HBeAg expression and significant reductions in intracellular HBV DNA replication intermediates and HBV cccDNA. After treatment with 20 mu mol/L curcumin for 2 d, HBsAg and cccDNA levels in HepG2.2.15 cells were reduced by up to 57.7% (P < 0.01) and 75.5% (P < 0.01), respectively, compared with levels in non-treated cells. Meanwhile, time-and dose-dependent reductions in the histone H3 acetylation levels were also detected upon treatment with curcumin, accompanied by reductions in H3- and H4-bound cccDNA. Furthermore, the deacetylase inhibitors trichostatin A and sodium butyrate could block the effects of curcumin. Additionally, transfection of siRNAs targeting HBV enhanced the inhibitory effects of curcumin. CONCLUSION Curcumin inhibits HBV gene replication via downregulation of cccDNA-bound histone acetylation and has the potential to be developed as a cccDNA-targeting antiviral agent for hepatitis B.	[Wei, Zhi-Qiang; Chen, Hong-Xia; He, Yu-Lin; Meng, Zhong-Ji] Hubei Univ Med, Inst Biomed Res, Taihe Hosp, Shiyan 442000, Hubei, Peoples R China; [Wei, Zhi-Qiang; Ke, Chang-Zheng; Ma, De-Qiang; Meng, Zhong-Ji] Hubei Univ Med, Taihe Hosp, Dept Infect Dis, Shiyan 442000, Hubei, Peoples R China; [Zhang, Yong-Hong] Hubei Univ Med, Inst Wudang Chinese Med, Taihe Hosp, Shiyan 442000, Hubei, Peoples R China; [Ren, Pan] Hubei Univ Chinese Med, Wuhan 430000, Hubei, Peoples R China; [Hu, Pei] Wuhan Univ, Dept Pharm, Zhongnan Hosp, Wuhan 430000, Hubei, Peoples R China; [Luo, Jie] Hubei Univ Med, Ctr Evidence Based Med & Clin Res, Taihe Hosp, Shiyan 442000, Hubei, Peoples R China	Meng, ZJ (reprint author), Hubei Univ Med, Med, Taihe Hosp, 32 South Renmin Rd, Shiyan 442000, Hubei, Peoples R China.	zhongji.meng@taihehospital.com			National Natural Science Foundation of China [81541140]; Natural Science Foundation of Hubei Province of China [2014CFB645]; Research and Development Project of the Science and Technology Plan of Hubei Province [2011BCB030]; Foundation for Innovative Research Team of Hubei University of Medicine [2014CXG05]; Taihe Hospital [2016JZ05]	Supported by National Natural Science Foundation of China, No. 81541140; Natural Science Foundation of Hubei Province of China, No. 2014CFB645; Research and Development Project of the Science and Technology Plan of Hubei Province, No. 2011BCB030; Foundation for Innovative Research Team of Hubei University of Medicine, No. 2014CXG05; and Key Program for Precision Medicine of Taihe Hospital, No. 2016JZ05.	Ahsan N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09862; Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27539; Anand P, 2007, MOL PHARM, V4, P807, DOI 10.1021/mp700113r; Anggakusuma, 2014, GUT, V63, P1137, DOI 10.1136/gutjnl-2012-304299; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Bharitkar YP, 2015, ORG LETT, V17, P4440, DOI 10.1021/acs.orglett.5b02085; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Fourati S, 2016, F1000RES, V5; Gogoi B, 2015, ACS APPL MATER INTER, V7, P11195, DOI 10.1021/acsami.5b01102; Guidotti LG, 2015, CURR OPIN IMMUNOL, V36, P61, DOI 10.1016/j.coi.2015.06.016; Hassan MM, 2008, J CLIN ONCOL, V26, P4557, DOI 10.1200/JCO.2008.17.3526; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Kim DH, 2016, WORLD J GASTROENTERO, V22, P7017, DOI 10.3748/wjg.v22.i31.7017; Kim HJ, 2009, J ETHNOPHARMACOL, V124, P189, DOI 10.1016/j.jep.2009.04.046; Kumari N, 2015, DRUG DES DEV THER, V9, P5051, DOI 10.2147/DDDT.S86558; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lee JY, 2003, J LEUKOCYTE BIOL, V73, P862, DOI 10.1189/jlb.1202618; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Meng ZJ, 2008, J VIROL METHODS, V150, P27, DOI 10.1016/j.jviromet.2008.02.008; Meng ZJ, 2009, VIROLOGY, V384, P88, DOI 10.1016/j.virol.2008.11.012; Mishra A, 2015, FUTURE ONCOL, V11, P2487, DOI 10.2217/fon.15.166; Moghadamtousi SZ, 2014, BIOMED RES INT, DOI 10.1155/2014/186864; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Pan Y, 2012, BRIT J PHARMACOL, V166, P1169, DOI 10.1111/j.1476-5381.2012.01854.x; Pecheur EI, 2014, GUT, V63, P1035, DOI 10.1136/gutjnl-2013-305646; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Rechtman MM, 2010, FEBS LETT, V584, P2485, DOI 10.1016/j.febslet.2010.04.067; Riviere L, 2015, J HEPATOL, V63, P1093, DOI 10.1016/j.jhep.2015.06.023; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Taranta A, 2014, J CLIN VIROL, V60, P354, DOI 10.1016/j.jcv.2014.04.015; Tropberger P, 2015, P NATL ACAD SCI USA, V112, pE5715, DOI 10.1073/pnas.1518090112; Wang Y, 2011, J MED CHEM, V54, P3768, DOI 10.1021/jm200017g; Yang XX, 2016, NANOSCALE, V8, P3040, DOI 10.1039/c5nr07918g; You CR, 2014, WORLD J GASTROENTERO, V20, P13293, DOI 10.3748/wjg.v20.i37.13293; Zhu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091303	40	0	0	3	3	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1007-9327	2219-2840		WORLD J GASTROENTERO	World J. Gastroenterol.	SEP 14	2017	23	34					6252	6260		10.3748/wjg.v23.i34.6252				9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FG9IG	WOS:000410751600007	28974891	green_published			2018-01-05	
J	Moelling, K; Broecker, F; Russo, G; Sunagawa, S				Moelling, Karin; Broecker, Felix; Russo, Giancarlo; Sunagawa, Shinichi			RNase H As Gene Modifier, Driver of Evolution and Antiviral Defense	FRONTIERS IN MICROBIOLOGY			English	Review						RNase H; reverse transcriptase; retroviruses; (Retro)-transposons; ribozymes; evolution; antiviral defense; immune systems	LTR RETROTRANSPOSABLE ELEMENTS; DEPENDENT DNA-POLYMERASE; GROUP-II INTRONS; RIBONUCLEASE-H; REVERSE-TRANSCRIPTASE; SUPERINFECTION EXCLUSION; CRYSTAL-STRUCTURE; MAMMALIAN EVOLUTION; STRUCTURAL-ANALYSIS; ZINC-FINGER	Retroviral infections are 'mini-symbiotic' events supplying recipient cells with sequences for viral replication, including the reverse transcriptase (RT) and ribonuclease H (RNase H). These proteins and other viral or cellular sequences can provide novel cellular functions including immune defense mechanisms. Their high error rate renders RT-RNases H drivers of evolutionary innovation. Integrated retroviruses and the related transposable elements (TEs) have existed for at least 150 million years, constitute up to 80% of eukaryotic genomes and are also present in prokaryotes. Endogenous retroviruses regulate host genes, have provided novel genes including the syncytins that mediate maternal-fetal immune tolerance and can be experimentally rendered infectious again. The RT and the RNase H are among the most ancient and abundant protein folds. RNases H may have evolved from ribozymes, related to viroids, early in the RNA world, forming ribosomes, RNA replicases and polymerases. Basic RNA-binding peptides enhance ribozyme catalysis. RT and ribozymes or RNases H are present today in bacterial group II introns, the precedents of TEs. Thousands of unique RTs and RNases H are present in eukaryotes, bacteria, and viruses. These enzymes mediate viral and cellular replication and antiviral defense in eukaryotes and prokaryotes, splicing, R-loop resolvation, DNA repair. RNase H-like activities are also required for the activity of small regulatory RNAs. The retroviral replication components share striking similarities with the RNA-induced silencing complex (RISC), the prokaryotic CRISPR-Cas machinery, eukaryotic V(D)J recombination and interferon systems. Viruses supply antiviral defense tools to cellular organisms. TEs are the evolutionary origin of siRNA and miRNA genes that, through RISC, counteract detrimental activities of TEs and chromosomal instability. Moreover, piRNAs, implicated in transgenerational inheritance, suppress TEs in germ cells. Thus, virtually all known immune defense mechanisms against viruses, phages, TEs, and extracellular pathogens require RNase H-like enzymes. Analogous to the prokaryotic CRISPR-Cas anti-phage defense possibly originating from TEs termed casposons, endogenized retroviruses ERVs and amplified TEs can be regarded as related forms of inheritable immunity in eukaryotes. This survey suggests that RNase H-like activities of retroviruses, TEs, and phages, have built up innate and adaptive immune systems throughout all domains of life.	[Moelling, Karin] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [Moelling, Karin] Max Planck Inst Mol Genet, Berlin, Germany; [Broecker, Felix] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Russo, Giancarlo] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Sunagawa, Shinichi] Swiss Fed Inst Technol, Inst Microbiol, Dept Biol, Zurich, Switzerland	Moelling, K (reprint author), Univ Zurich, Inst Med Microbiol, Zurich, Switzerland.; Moelling, K (reprint author), Max Planck Inst Mol Genet, Berlin, Germany.	moelling@molgen.mpg.de		Sunagawa, Shinichi/0000-0003-3065-0314	German National Academy of Sciences Leopoldina; Helmut Horten Foundation	This work was partially funded by the German National Academy of Sciences Leopoldina to FB. SS is supported by the Helmut Horten Foundation.	Abelson J, 2013, NAT STRUCT MOL BIOL, V20, P645, DOI 10.1038/nsmb.2603; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; ARTYMIUK PJ, 1993, FEBS LETT, V324, P15, DOI 10.1016/0014-5793(93)81523-3; Assis R, 2009, P NATL ACAD SCI USA, V106, P7079, DOI 10.1073/pnas.0900523106; Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0                                                               ; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X                                                   ; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Boesler B, 2014, J BIOL CHEM, V289, P35124, DOI 10.1074/jbc.M114.612663; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Broecker F., 2016, COLD SPRING HARB MOL, V2, DOI [10.1101/mcs.a000448, DOI 10.1101/MCS.A000448]; Broecker Felix, 2017, Gut Microbes, V8, P214, DOI 10.1080/19490976.2016.1265196; Broecker F, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0081-9; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878                                                    ; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Denner J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-108; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Dlakic M, 2011, RNA, V17, P799, DOI 10.1261/rna.2396011; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feiss M, 2012, ADV EXP MED BIOL, V726, P489, DOI 10.1007/978-1-4614-0980-9_22; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Flint J, 2015, PRINCIPLES VIROLOGY; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gosenca D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049341; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Guo H., 2014, MDNA300292014, V2, DOI [10.1128/microbiolspec, DOI 10.1128/MICROBIOLSPEC]; HANSEN J, 1988, EMBO J, V7, P239; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Harrison BR, 2009, BIOCHEM CELL BIOL, V87, P767, DOI 10.1139/O09-043; Hegedus K, 2001, J GEN VIROL, V82, P687, DOI 10.1099/0022-1317-82-3-687                                                      ; Heras SR, 2013, NAT STRUCT MOL BIOL, V20, P1173, DOI 10.1038/nsmb.2658; Hindmarsh P, 1999, MICROBIOL MOL BIOL R, V63, P836; HUTCHISON CA, 1971, J VIROL, V8, P121; Imakawa K, 2015, GENES CELLS, V20, P771, DOI 10.1111/gtc.12278; Inouye K, 2011, MICROBIOL IMMUNOL, V55, P510, DOI 10.1111/j.1348-0421.2011.00342.x; Jiang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27101; Jimenez RM, 2015, TRENDS BIOCHEM SCI, V40, P648, DOI 10.1016/j.tibs.2015.09.001; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Kapitonov VV, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0055-8; KARWAN R, 1986, FEBS LETT, V206, P189, DOI 10.1016/0014-5793(86)80978-4; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-1; Koonin EV, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0177-2; Kovalskaya N, 2014, PLANT SCI, V228, P48, DOI 10.1016/j.plantsci.2014.05.006; Krupovic M, 2017, CURR OPIN MICROBIOL, V38, P36, DOI 10.1016/j.mib.2017.04.004; Kurzynska-Kokorniak A, 2007, J MOL BIOL, V374, P322, DOI 10.1016/j.jmb.2007.09.047; Laliberte JP, 2014, J VIROL, V88, P9751, DOI 10.1128/JVI.00816-14; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600                                          ; Lambowitz A. M., 2015, MDNA300502014, V3, DOI [10.1128/microbiolspec, DOI 10.1128/MICROBIOLSPEC]; Lander ES, 2001, NATURE, V412, P565; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Lescot M, 2016, ISME J, V10, P1134, DOI 10.1038/ismej.2015.192; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Lu Meng-Ji, 1994, Trends in Microbiology, V2, P137, DOI 10.1016/0966-842X(94)90601-7; Ma BG, 2008, BIOCHEM BIOPH RES CO, V366, P607, DOI 10.1016/j.bbrc.2007.12.014; Mack M, 2004, IMMUNOGENETICS, V56, P321, DOI 10.1007/s00251-004-0705-y; Mackenzie KJ, 2016, EMBO J, V35, P831, DOI 10.15252/embj.201593339; Majorek KA, 2014, NUCLEIC ACIDS RES, V42, P4160, DOI 10.1093/nar/gkt1414; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164                                           ; Malik HS, 2001, GENOME RES, V11, P1187, DOI 10.1101/gr.185101                                                               ; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matskevich AA, 2007, J GEN VIROL, V88, P2627, DOI 10.1099/vir.0.83103-0; Maumus F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5268; Mayerle M, 2017, P NATL ACAD SCI USA, V114, P4739, DOI 10.1073/pnas.1701462114; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004                                                     ; Miller JL, 2008, PLOS BIOL, V6, P1195, DOI 10.1371/journal.pbio.0060131; Moelling K, 2006, COLD SPRING HARB SYM, V71, P365, DOI 10.1101/sqb.2006.71.010; Moelling K., 2017, VIRUSES MORE FRIENDS; Moelling K, 2015, ANN NY ACAD SCI, V1341, P126, DOI 10.1111/nyas.12668; Moelling K, 2013, ARCH VIROL, V158, P1833, DOI 10.1007/s00705-013-1679-6; Moelling K, 2012, EMBO REP, V13, P1033, DOI 10.1038/embor.2012.173; MOLLING K, 1971, NATURE-NEW BIOL, V234, P240; MULLER G, 1994, J MOL BIOL, V242, P422, DOI 10.1006/jmbi.1994.1592; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; NIBLETT CL, 1978, VIROLOGY, V91, P198, DOI 10.1016/0042-6822(78)90368-9                                                    ; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Ohtani N, 2004, NUCLEIC ACIDS RES, V32, P5809, DOI 10.1093/nar/gkh917; Oshima J, 2000, BIOESSAYS, V22, P894, DOI 10.1002/1521-1878(200010)22:10<894::AID-BIES4>3.3.CO;2-2; Patel BH, 2015, NAT CHEM, V7, P301, DOI [10.1038/NCHEM.2202, 10.1038/nchem.2202]; Qin CH, 2010, MOL CARCINOGEN, V49, P54, DOI 10.1002/mc.20576; Qin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131365; Rassoulzadegan M, 2015, ANN NY ACAD SCI, V1341, P172, DOI 10.1111/nyas.12694; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Roberts J. T., 2014, MOB GENET ELEMENTS, V4, DOI [DOI 10.4161/MGE.29255, 10.4161/mge.29255]; Salaman RN, 1933, NATURE, V131, P468, DOI 10.1038/131468a0                                                                ; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Sarkies P, 2014, NAT REV MOL CELL BIO, V15, P525, DOI 10.1038/nrm3840; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; Smith D, 2005, GENE DEV, V19, P2477, DOI 10.1101/gad.1345105; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; STEIN H, 1969, SCIENCE, V166, P393, DOI 10.1126/science.166.3903.393; Sulej AA, 2012, NUCLEIC ACIDS RES, V40, P11563, DOI 10.1093/nar/gks885; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/nmeth.2693, 10.1038/NMETH.2693]; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; Taylor JM, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021568; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; tenOever BR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.52; Terry SN, 2017, VIROLOGY, V509, P52, DOI 10.1016/j.virol.2017.06.004; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; TISDALE M, 1991, J GEN VIROL, V72, P59, DOI 10.1099/0022-1317-72-1-59; Ustyantsev K, 2015, MOL BIOL EVOL, V32, P1197, DOI 10.1093/molbev/msv008; Wang LF, 2011, CURR OPIN VIROL, V1, P649, DOI 10.1016/j.coviro.2011.10.013; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wilson WH, 2017, ISME J, V11, P1736, DOI 10.1038/ismej.2017.61; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Yurchenko V, 2003, GENE DEV, V17, P581, DOI 10.1101/gad.1058103; Zimmerly S, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0037-5; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	130	0	0	8	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	SEP 14	2017	8								1745	10.3389/fmicb.2017.01745				20	Microbiology	Microbiology	FG7ZB	WOS:000410643100001	28959243	gold			2018-01-05	
J	Begemann, MB; Gray, BN; January, E; Gordon, GC; He, YH; Liu, HJ; Wu, XR; Brutnell, TP; Mockler, TC; Oufattole, M				Begemann, Matthew B.; Gray, Benjamin N.; January, Emma; Gordon, Gina C.; He, Yonghua; Liu, Haijun; Wu, Xingrong; Brutnell, Thomas P.; Mockler, Todd C.; Oufattole, Mohammed			Precise insertion and guided editing of higher plant genomes using Cpf1 CRISPR nucleases	SCIENTIFIC REPORTS			English	Article							EFFICIENT TARGETED MUTAGENESIS; HUMAN-CELLS; RICE; CAS9; RNA; SPECIFICITIES; ENDONUCLEASES	Precise genome editing of plants has the potential to reshape global agriculture through the targeted engineering of endogenous pathways or the introduction of new traits. To develop a CRISPR nuclease-based platform that would enable higher efficiencies of precise gene insertion or replacement, we screened the Cpf1 nucleases from Francisella novicida and Lachnospiraceae bacterium ND2006 for their capability to induce targeted gene insertion via homology directed repair. Both nucleases, in the presence of a guide RNA and repairing DNA template flanked by homology DNA fragments to the target site, were demonstrated to generate precise gene insertions as well as indel mutations at the target site in the rice genome. The frequency of targeted insertion for these Cpf1 nucleases, up to 8%, is higher than most other genome editing nucleases, indicative of its effective enzymatic chemistry. Further refinements and broad adoption of the Cpf1 genome editing technology have the potential to make a dramatic impact on plant biotechnology.	[Begemann, Matthew B.; Gray, Benjamin N.; January, Emma; Gordon, Gina C.; He, Yonghua; Liu, Haijun; Wu, Xingrong; Brutnell, Thomas P.; Oufattole, Mohammed] Benson Hill Biosyst, 1100 Corp Sq Dr, St Louis, MO 63132 USA; [Brutnell, Thomas P.; Mockler, Todd C.] Donald Danforth Plant Sci Ctr, 975N Warson Rd, St Louis, MO 63132 USA	Begemann, MB (reprint author), Benson Hill Biosyst, 1100 Corp Sq Dr, St Louis, MO 63132 USA.	mbegemann@bensonhillbio.com					Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Belhaj K, 2015, CURR OPIN BIOTECH, V32, P76, DOI 10.1016/j.copbio.2014.11.007; Bothmer A., 2017, LOCUS, V8, P13905; Chen L, 1998, PLANT CELL REP, V18, P25, DOI 10.1007/s002990050526                                                           ; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Egelie KJ, 2016, NAT BIOTECHNOL, V34, P1025, DOI 10.1038/nbt.3692; Endo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38169; Fu C., 2015, PLOS ONE, V9; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Jia H., 2016, PLANT BIOTECHNOLOGY; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Lee S, 2005, PLANT MOL BIOL, V57, P805, DOI 10.1007/s11103-005-2066-9; Li J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.139, 10.1038/nplants.2016.139]; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Mikami M, 2015, PLANT MOL BIOL, V88, P561, DOI 10.1007/s11103-015-0342-x; Moreno- Mateos M. A., 2017, CRISPR CPF1 MEDIATES; Petolino JF, 2016, PLANT BIOTECHNOL J, V14, P435, DOI 10.1111/pbi.12542; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Shi J., 2016, PLANT BIOTECHNOLOGY; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Waltz E, 2016, NAT BIOTECHNOL, V34, P582, DOI 10.1038/nbt0616-582; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Xu R., 2016, PLANT BIOTECHNOLOGY; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zetsche B., 2016, NAT BIOTECH ADV ONLI; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	30	0	0	24	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 14	2017	7								11606	10.1038/s41598-017-11760-6				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FG9DM	WOS:000410739000104	28912524	gold			2018-01-05	
J	Zhao, HY; Choi, K				Zhao, Haiyong; Choi, Kyunghee			A CRISPR screen identifies genes controlling Etv2 threshold expression in murine hemangiogenic fate commitment	NATURE COMMUNICATIONS			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; IN-VITRO; AORTIC ENDOTHELIUM; DEFINITIVE HEMATOPOIESIS; BLOOD DEVELOPMENT; COMMON PRECURSOR; CARDIAC MESODERM; PRIMITIVE STREAK; MOUSE	The ETS transcription factor Etv2 is necessary and sufficient for the generation of hematopoietic and endothelial cells. However, upstream regulators of Etv2 in hemangiogenesis, generation of hematopoietic and endothelial cells, have not been clearly addressed. Here we track the developmental route of hemangiogenic progenitors from mouse embryonic stem cells, perform genome-wide CRISPR screening, and transcriptome analysis of en route cell populations by utilizing Brachyury, Etv2, or Scl reporter embryonic stem cell lines to further understand the mechanisms that control hemangiogenesis. We identify the forkhead transcription factor Foxh1, in part through Eomes, to be critical for the formation of FLK1(+) mesoderm, from which the hemangiogenic fate is specified. Importantly, hemangiogenic fate is specified not simply by the onset of Etv2 expression, but by a threshold-dependent mechanism, in which VEGF-FLK1 signaling plays an instructive role by promoting Etv2 threshold expression. These studies reveal comprehensive cellular and molecular pathways governing the hemangiogenic cell lineage development.	[Zhao, Haiyong; Choi, Kyunghee] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Choi, Kyunghee] Washington Univ, Sch Med, Dev Regenerat & Stem Cell Biol Program, St Louis, MO 63110 USA	Choi, K (reprint author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Choi, K (reprint author), Washington Univ, Sch Med, Dev Regenerat & Stem Cell Biol Program, St Louis, MO 63110 USA.	kchoi@wustl.edu			NIH [R01HL63736, R01HL55337]	We thank the lab members for constructive criticism and helpful discussion. We thank Karen Krchma for help with mouse work, Rong Zhang for help with CRISPR lentivirus library preparation, and Gordon Keller for T/EGFP ES cells. We thank Masa Ema for Flk1GFP/GFP ES cells. We thank the Genome Technology Access Center at Washington University School of Medicine for deep sequencing service. This work was supported by NIH Grants R01HL63736 and R01HL55337 (K.C.).	Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0                                                                ; Casadio A, 2015, EMBO REP, V16, P71, DOI 10.15252/embr.201439183; Chiu WT, 2014, DEVELOPMENT, V141, P4537, DOI 10.1242/dev.107227; Choi EY, 2012, STEM CELLS, V30, P2297, DOI 10.1002/stem.1192; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Choi K, 1998, DEVELOPMENT, V125, P725; Chung YS, 2002, DEVELOPMENT, V129, P5511, DOI 10.1242/dev.00149; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Diaz AA, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1197; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Goode DK, 2016, DEV CELL, V36, P572, DOI 10.1016/j.devcel.2016.01.024; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Koyano-Nakagawa N, 2015, J BIOL CHEM, V290, P28107, DOI 10.1074/jbc.M115.662197; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3                                                   ; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu F, 2015, EMBO REP, V16, P654, DOI 10.15252/embr.201439939; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; Lugus JJ, 2009, BLOOD, V113, P563, DOI 10.1182/blood-2008-06-162750; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Murray PDF, 1932, P R SOC LOND B-CONTA, V111, P497, DOI 10.1098/rspb.1932.0070                                                          ; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Peng GD, 2016, DEV CELL, V36, P681, DOI 10.1016/j.devcel.2016.02.020; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Rasmussen TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050103; Reischauer S, 2016, NATURE, V535, P294, DOI 10.1038/nature18614; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Schuh AC, 1999, P NATL ACAD SCI USA, V96, P2159, DOI 10.1073/pnas.96.5.2159; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi XZ, 2015, J BIOL CHEM, V290, P9614, DOI 10.1074/jbc.M114.614628; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wareing S, 2012, DEV DYNAM, V241, P1454, DOI 10.1002/dvdy.23825; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yoon SJ, 2011, GENE DEV, V25, P1654, DOI 10.1101/gad.16800511; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	64	0	0	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	SEP 14	2017	8								541	10.1038/s41467-017-00667-5				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FG8TO	WOS:000410710600011	28912455	gold			2018-01-05	
J	Williams, P; Li, L; Dong, XL; Wang, YS				Williams, Preston; Li, Lin; Dong, Xiaoli; Wang, Yinsheng			Identification of SLIRP as a G Quadruplex-Binding Protein	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							C-MYC; DNA; PROMOTER; TRANSCRIPTION; MITOCHONDRIA; EXPRESSION; PROTEOMICS; SEQUENCE; COMPLEX; CELLS	The guanine quadruplex (G4) structure in DNA is a secondary structure motif that plays important roles in DNA replication, transcriptional regulation, and maintenance of genomic stability. Here, we employed a quantitative mass spectrometry-based approach to profile the interaction proteomes of three well-defined G4 structures derived from the human telomere and the promoters of cMYC and cKIT genes. We identified SLIRP as a novel G4-interacting protein. We also demonstrated that the protein could bind directly with G4 DNA with Kd values in the low nanomolar range and revealed that the robust binding of the protein toward G4 DNA requires its RRM domain. We further assessed, by using CRISPR-Cas9-introduced affinity tag and ChIP-Seq analysis, the genome-wide occupancy of SLIRP, and showed that the protein binds preferentially to G-rich DNA sequences that can fold into G4 structures. Together, our results uncovered a novel cellular protein that can interact directly with G4 DNA, which underscored the complex regulatory networks involved in G4 biology.	[Williams, Preston; Li, Lin; Dong, Xiaoli; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	Wang, YS (reprint author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu			National Institutes of Health [R01 ES019873]	This work was supported by the National Institutes of Health (R01 ES019873).	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cammas A, 2017, NUCLEIC ACIDS RES, V45, P1584, DOI 10.1093/nar/gkw1280; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Diveshkumar KV, 2016, BIOCHEMISTRY-US, V55, P3571, DOI 10.1021/acs.biochem.6b00120; Du ZF, 2014, J AM CHEM SOC, V136, P2948, DOI 10.1021/ja410678y; Gao J, 2015, CHEM COMMUN, V51, P7242, DOI 10.1039/c5cc00742a; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Gray LT, 2014, NAT CHEM BIOL, V10, P313, DOI [10.1038/NCHEMBIO.1475, 10.1038/nchembio.1475]; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Huang WC, 2015, NUCLEIC ACIDS RES, V43, P10102, DOI 10.1093/nar/gkv1061; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; Lanz RB, 2002, P NATL ACAD SCI USA, V99, P16081, DOI 10.1073/pnas.192571399; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Paramasivam M, 2009, NUCLEIC ACIDS RES, V37, P2841, DOI 10.1093/nar/gkp138; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Soldatenkov VA, 2008, ACS CHEM BIOL, V3, P214, DOI 10.1021/cb700234f; Wang F, 2012, P NATL ACAD SCI USA, V109, P20413, DOI 10.1073/pnas.1200232109	27	0	0	12	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	SEP 13	2017	139	36					12426	12429		10.1021/jacs.7b07563				4	Chemistry, Multidisciplinary	Chemistry	FH3JU	WOS:000411043900024	28859475				2018-01-05	
J	Asad, N; Deodato, D; Lan, X; Widegren, MB; Phillips, DL; Du, LL; Dore, TM				Asad, Naeem; Deodato, Davide; Lan, Xin; Widegren, Magnus B.; Phillips, David Lee; Du, Lili; Dore, Timothy M.			Photochemical Activation of Tertiary Amines for Applications in Studying Cell Physiology	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							PHOTOREMOVABLE PROTECTING GROUP; SENSITIVE QUADRUPOLAR PROBES; PHOTO-CLAISEN REARRANGEMENT; SITE-SPECIFIC RECOMBINATION; C-N BOND; CAGED COMPOUNDS; CAGING GROUPS; AQUEOUS-SOLUTIONS; EXCITED-STATES; BIOLOGICAL PROCESSES	Representative tertiary amines were linked to the 8-cyano-7-hydroxyquinolinyl (CyHQ) photoremovable protecting group (PPG) to create photoactivatable forms suitable for use in studying cell physiology. The photoactivation of tamoxifen and 4-hydroxytamoxifen, which can be used to activate Cre recombinase and CR1SPR-Cas9 gene editing, demonstrated that highly efficient release of bioactive molecules could be achieved through one-and two-photon excitation (WE and 2PE). CyHQ-protected anilines underwent a photoaza-Claisen rearrangement instead of releasing amines. Time-resolved spectroscopic studies revealed that photorelease of the tertiary amines was extremely fast, occurring from a singlet excited state of CyHQ on the 70 Ps time scale.	[Asad, Naeem; Deodato, Davide; Widegren, Magnus B.; Dore, Timothy M.] New York Univ Abu Dhabi, POB 129188, Abu Dhabi, U Arab Emirates; [Lan, Xin; Phillips, David Lee; Du, Lili] Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong 999077, Hong Kong, Peoples R China; [Dore, Timothy M.] Univ Georgia, Dept Chem, Athens, GA 30602 USA	Dore, TM (reprint author), New York Univ Abu Dhabi, POB 129188, Abu Dhabi, U Arab Emirates.; Phillips, DL; Du, LL (reprint author), Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong 999077, Hong Kong, Peoples R China.; Dore, TM (reprint author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.	phillips@hku.hk; justailleen@gmail.com; timothy.dore@nyu.edu		Phillips, David Lee/0000-0002-8606-8780; Dore, Timothy/0000-0002-3876-5012; LAN, XIN/0000-0002-6745-2154	National Science Foundation [CHE-1317760]; New York University Abu Dhabi; Hong Kong Research Grants Council [GRF 17301815, AoE/P-03/08, SEG HKU/07]; University of Hong Kong Development Fund project "New Ultrafast Spectroscopy Experiments for Shared Facilities" [297]	This research was sponsored in part by a grant from the National Science Foundation (CHE-1317760) to T.M.D. and New York University Abu Dhabi. Also acknowledged is partial support from the Hong Kong Research Grants Council grants GRF 17301815, AoE/P-03/08, SEG HKU/07, and The University of Hong Kong Development Fund 2013-2014 297 project "New Ultrafast Spectroscopy Experiments for Shared Facilities" to D.L.P. We thank Cyril Herbivo and Adna Muliawan for technical assistance. Part of the work was carried out using Core Technology Platform resources at New York University Abu Dhabi.	ALBERT A, 1956, J CHEM SOC, P1294, DOI 10.1039/jr9560001294                                                            ; Albright TR, 2015, J AM CHEM SOC, V137, P3402, DOI 10.1021/jacs.5b00707; Ammer J, 2013, J PHYS ORG CHEM, V26, P59, DOI 10.1002/poc.3064; Ammer J, 2010, J PHYS ORG CHEM, V23, P1029, DOI 10.1002/poc.1707; An HY, 2010, J PHYS CHEM A, V114, P2498, DOI [10.1021/jp911143c, 10.1021/jp911143e]; ANDERSON JC, 1963, J CHEM SOC, P1781, DOI 10.1039/jr9630001781                                                            ; BARLTROP JA, 1962, TETRAHEDRON LETT, P697; Binldey R. W., 1984, SYNTHETIC ORGANIC PH, P375; Bochet CG, 2002, J CHEM SOC PERK T 1, P125, DOI 10.1039/b009522m; Bort G, 2013, ANGEW CHEM INT EDIT, V52, P4526, DOI 10.1002/anie.201204203; Bownik I, 2015, J ORG CHEM, V80, P9713, DOI 10.1021/acs.joc.5b01770; Buchanan CM, 2006, J PHARM SCI-US, V95, P2246, DOI 10.1002/jps.20710; Burdzinski G, 2006, J AM CHEM SOC, V128, P13402, DOI 10.1021/ja061520i; CARROLL FA, 1972, J AM CHEM SOC, V94, P7151, DOI 10.1021/ja00775a048                                                             ; Claisen L, 1912, BER DTSCH CHEM GES, V45, P3157, DOI 10.1002/cber.19120450348                                                        ; Corrie JET, 1996, J CHEM SOC PERK T 1, P1583, DOI 10.1039/p19960001583                                                            ; Corrie J. E. T., 1993, BIOORGANIC PHOTOCHEM, P243; Corrie JET, 2008, PHOTOCH PHOTOBIO SCI, V7, P84, DOI 10.1039/b711398f; Davis MJ, 2009, J ORG CHEM, V74, P1721, DOI 10.1021/jo802658a; Dong XQ, 2015, RSC ADV, V5, P53342, DOI 10.1039/c5ra09314g; Du LL, 2015, J ORG CHEM, V80, P7340, DOI 10.1021/acs.joc.5b00086; Dunkel P, 2014, ORG BIOMOL CHEM, V12, P9899, DOI 10.1039/c4ob01551g; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Ellis-Davies GCR, 2013, BEILSTEIN J ORG CHEM, V9, P64, DOI 10.3762/bjoc.9.8; Faal T, 2015, MOL BIOSYST, V11, P783, DOI 10.1039/c4mb00581c; Fedoryak OD, 2002, ORG LETT, V4, P3419, DOI 10.1021/ol026524g; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Furuta T, 2007, ORG LETT, V9, P4717, DOI 10.1021/ol702106t; Ganem B, 1996, ANGEW CHEM INT EDIT, V35, P937; Gillespie DC, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P232; Goppert M, 1929, NATURWISSENSCHAFTEN, V17, P932; Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273; Govan JM, 2012, ACS CHEM BIOL, V7, P1247, DOI 10.1021/cb300161r; Hess GP, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P205; Horbert R, 2015, ACS CHEM BIOL, V10, P2099, DOI 10.1021/acschembio.5b00174; HORNG ML, 1995, J PHYS CHEM-US, V99, P17311, DOI 10.1021/j100048a004                                                             ; Huang JQ, 2017, PHOTOCH PHOTOBIO SCI, V16, P575, DOI 10.1039/c6pp00377j; Immeln D, 2012, J AM CHEM SOC, V134, P12536, DOI 10.1021/ja302121z; Inlay MA, 2013, CHEM COMMUN, V49, P4971, DOI 10.1039/c3cc42179a; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Kamatham N, 2017, ORG LETT, V19, P3588, DOI 10.1021/acs.orglett.7b01572; Kammari L, 2007, PHOTOCH PHOTOBIO SCI, V6, P50, DOI 10.1039/b612233g; KAWAOKA K, 1967, J CHEM PHYS, V46, P1842, DOI 10.1063/1.1840943; KELLY DP, 1966, TETRAHEDRON LETT, P5953; Klan P, 2013, CHEM REV, V113, P119, DOI 10.1021/cr300177k; KOBSA H, 1962, J ORG CHEM, V27, P2293, DOI 10.1021/jo01054a001                                                             ; KOGA G, 1968, B CHEM SOC JPN, V41, P745, DOI 10.1246/bcsj.41.745                                                             ; Kramer R. H., 2011, PHOTOSENSITIVE MOL C; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Kwok WM, 2008, J AM CHEM SOC, V130, P5131, DOI 10.1021/ja077831q; Kwok WM, 2006, J AM CHEM SOC, V128, P11894, DOI 10.1021/ja0622002; Kwok WM, 2009, J PHYS CHEM B, V113, P11527, DOI 10.1021/jp906265c; LEE SI, 1995, J PHYS CHEM-US, V99, P7537, DOI 10.1021/j100019a040                                                             ; Li YM, 2010, J PHOTOCH PHOTOBIO A, V211, P129, DOI 10.1016/j.jphotochem.2010.02.009; Li YM, 2010, TETRAHEDRON LETT, V51, P1609, DOI 10.1016/j.tetlet.2010.01.071; Link KH, 2005, J AM CHEM SOC, V127, P13088, DOI 10.1021/ja0531226; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Lu X, 2012, BIOCONJUGATE CHEM, V23, P1945, DOI 10.1021/bc300319c; Ma JN, 2017, PHYS CHEM CHEM PHYS, V19, P1089, DOI 10.1039/c6cp05499d; Ma JN, 2012, CHEM-EUR J, V18, P6854, DOI 10.1002/chem.201200366; Mayer G, 2006, ANGEW CHEM INT EDIT, V45, P4900, DOI 10.1002/anie.200600387; McLain D. E., 2015, PHOTOCHEM PHOTOBIOL, V14, P2141; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991                                                         ; Morckel AR, 2012, DEVELOPMENT, V139, P437, DOI 10.1242/dev.072165; Nerbonne JM, 1996, CURR OPIN NEUROBIOL, V6, P379, DOI 10.1016/S0959-4388(96)80123-1; Noguchi M, 2008, BIOORGAN MED CHEM, V16, P5389, DOI 10.1016/j.bmc.2008.04.022; Nubbemeyer U, 2005, TOP CURR CHEM, V244, P149, DOI 10.1007/b96891; Ouyang XH, 2009, J AM CHEM SOC, V131, P13255, DOI 10.1021/ja809933h; PADWA A, 1984, J ORG CHEM, V49, P399, DOI 10.1021/jo00177a001                                                             ; PADWA A, 1982, TETRAHEDRON LETT, V23, P915, DOI 10.1016/S0040-4039(00)86982-8                                                   ; PATCHORN.A, 1970, J AM CHEM SOC, V92, P6333, DOI 10.1021/ja00724a041                                                             ; Pelliccioli A. P., 2002, J PHOTOCHEM PHOTOBIO, V1, P441; Peng L, 1997, TETRAHEDRON LETT, V38, P2961, DOI 10.1016/S0040-4039(97)00533-9                                                   ; Petit M, 2012, ORG LETT, V14, P6366, DOI 10.1021/ol3031704; Pettit DL, 2001, METHOD PHARMACOL TOX, P349; PITCHUMANI K, 1992, J PHOTOCH PHOTOBIO A, V69, P201, DOI 10.1016/1010-6030(92)85278-3                                                    ; Rea AC, 2013, CHEM BIOL, V20, P1536, DOI 10.1016/j.chembiol.2013.11.005; Sacker A. M., 1998, J PHYS CHEM A, V102, P5375; Salmi H, 2014, POLYM CHEM-UK, V5, P6577, DOI 10.1039/c4py00927d; Schafer F, 2011, ORG LETT, V13, P1450, DOI 10.1021/ol200141v; Shi YH, 2004, CHEMBIOCHEM, V5, P788, DOI 10.1002/cbic.200300823; SHIMAMURA N, 1971, B CHEM SOC JPN, V44, P281, DOI 10.1246/bcsj.44.281                                                             ; Sinha DK, 2010, CHEMBIOCHEM, V11, P653, DOI 10.1002/cbic.201000008; Specht A, 2009, HFSP J, V3, P255, DOI 10.2976/1.3132954; Suyama K, 2006, J PHOTOPOLYM SCI TEC, V19, P81, DOI 10.2494/photopolymer.19.81                                                      ; Suyama K, 2009, PROG POLYM SCI, V34, P194, DOI 10.1016/j.progpolymsci.2008.08.005; Tran C, 2017, CHEM-EUR J, V23, P1860, DOI 10.1002/chem.201604500; Tran C, 2015, ORG LETT, V17, P402, DOI 10.1021/ol5035035; VOGLER B, 1989, J ORG CHEM, V54, P4165, DOI 10.1021/jo00278a033                                                             ; Wang H, 2003, CHEM PHYS LETT, V367, P599, DOI 10.1016/S0009-2614(02)01741-4; Wang PF, 2016, J ORG CHEM, V81, P6195, DOI 10.1021/acs.joc.6b00508; Wang PF, 2015, ORG LETT, V17, P170, DOI 10.1021/ol503473c; Wong PT, 2017, ACS CHEM BIOL, V12, P1001, DOI 10.1021/acschembio.6b00999; Young DD, 2007, ORG BIOMOL CHEM, V5, P999, DOI 10.1039/b616410m; Zayat L, 2006, INORG CHEM, V45, P1728, DOI 10.1021/ic0512983; Zayat L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0330; Zhang ZP, 2011, CHINESE CHEM LETT, V22, P338, DOI 10.1016/j.cclet.2010.10.007; Zhu Y, 2006, J AM CHEM SOC, V128, P4267, DOI 10.1021/ja0555320; Goeldner M, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P1, DOI 10.1002/3527605592	101	1	1	14	14	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	SEP 13	2017	139	36					12591	12600		10.1021/jacs.7b06363				10	Chemistry, Multidisciplinary	Chemistry	FH3JU	WOS:000411043900045	28806084				2018-01-05	
J	Chihara, K; Kato, Y; Yoshiki, H; Takeuchi, K; Fujieda, S; Sada, K				Chihara, Kazuyasu; Kato, Yuji; Yoshiki, Hatsumi; Takeuchi, Kenji; Fujieda, Shigeharu; Sada, Kiyonao			Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcR gamma-mediated phagocytosis and chemokine expression in U937 cells	SCIENTIFIC REPORTS			English	Article							ADAPTER PROTEIN 3BP2; HUMAN MONONUCLEAR PHAGOCYTES; INHERITED DISEASE CHERUBISM; MURINE MACROPHAGES; SIGNAL-TRANSDUCTION; SH3BP2 CHERUBISM; ANTIGEN RECEPTOR; NFAT ACTIVATION; RBL-2H3 CELLS; HOST-DEFENSE	The adaptor protein c-Abl SH3 domain binding protein-2 (3BP2) is tyrosine phosphorylated by Syk in response to cross-linking of antigen receptors, which in turn activates various immune responses. Recently, a study using the mouse model of cherubism, a dominant inherited disorder caused by mutations in the gene encoding 3BP2, showed that 3BP2 is involved in the regulation of phagocytosis mediated by Fc receptor for IgG (Fc gamma R) in macrophages. However, the molecular mechanisms underlying 3BP2-mediated regulation of phagocytosis and the physiological relevance of 3BP2 tyrosine phosphorylation remains elusive. In this study, we established various gene knockout U937 cell lines using the CRISPR/Cas9 system and found that 3BP2 is rapidly tyrosine phosphorylated by Syk in response to cross-linking of Fc gamma RI. Depletion of 3BP2 caused significant reduction in the Fc receptor. chain (FcR gamma)-mediated phagocytosis in addition to the Fc gamma RI-mediated induction of chemokine mRNA for IL-8, CCL3L3 and CCL4L2. Syk-dependent tyrosine phosphorylation of 3BP2 was required for overcoming these defects. Finally, we found that the PH and SH2 domains play important roles on Fc gamma RI-mediated tyrosine phosphorylation of 3BP2 in HL-60 cells. Taken together, these results indicate that Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcR gamma-mediated phagocytosis and chemokine expression.	[Chihara, Kazuyasu; Kato, Yuji; Yoshiki, Hatsumi; Takeuchi, Kenji; Sada, Kiyonao] Univ Fukui, Fac Med Sci, Dept Genome Sci & Microbiol, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan; [Chihara, Kazuyasu; Takeuchi, Kenji; Sada, Kiyonao] Univ Fukui, Life Sci Innovat Ctr, 3-9-1 Bunkyo, Fukui, Fukui 9108507, Japan; [Kato, Yuji; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan	Sada, K (reprint author), Univ Fukui, Fac Med Sci, Dept Genome Sci & Microbiol, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.; Sada, K (reprint author), Univ Fukui, Life Sci Innovat Ctr, 3-9-1 Bunkyo, Fukui, Fukui 9108507, Japan.	ksada@u-fukui.ac.jp			JSPS KAKENHI Grant [17K08656, 26293368, 17H04344]; Yakult Honsha Co., Ltd; Life Science Innovation Center at University of Fukui	We wish to thank Satomi Yamamoto and the Life Science Research Laboratory of University of Fukui for their assistance. This work was supported by JSPS KAKENHI Grant Number 17K08656 (to K.S.), JSPS KAKENHI Grant Number 26293368 and 17H04344 (to S.F), a grant from Yakult Honsha Co., Ltd (to K.S.) and a grant from the Life Science Innovation Center at University of Fukui (to K.C).	AGARWAL A, 1993, J BIOL CHEM, V268, P15900; Ainsua-Enrich E, 2012, J IMMUNOL, V189, P2727, DOI 10.4049/jimmunol.1200380; Bonilla FA, 2000, P NATL ACAD SCI USA, V97, P1725, DOI 10.1073/pnas.040543597; CELADA A, 1985, J CLIN INVEST, V76, P2196, DOI 10.1172/JCI112228; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chihara K, 2014, EXP CELL RES, V322, P99, DOI 10.1016/j.yexcr.2013.12.026; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dai XL, 2009, BLOOD, V114, P318, DOI 10.1182/blood-2008-10-184457; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Fernandez N, 2002, J IMMUNOL, V169, P3321, DOI 10.4049/jimmunol.169.6.3321                                                     ; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107                                                     ; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Greuber EK, 2012, J IMMUNOL, V189, P5382, DOI 10.4049/jimmunol.1200974; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980                                                               ; Hatani T, 2008, CURR MED CHEM, V15, P549; Honjoh C, 2017, SCI REP-UK, V7, DOI 10.1038/srep46064; Huang ZY, 2011, J BIOL CHEM, V286, P160, DOI 10.1074/jbc.M110.163030; Jevremovic D, 2001, J IMMUNOL, V166, P7219, DOI 10.4049/jimmunol.166.12.7219                                                    ; Kimura Y, 2014, J BIOL CHEM, V289, P31565, DOI 10.1074/jbc.M114.581322; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; Levaot N, 2011, J CLIN INVEST, V121, P3244, DOI 10.1172/JCI45843; LUBECK MD, 1985, J IMMUNOL, V135, P1299; Maeno K, 2003, J BIOL CHEM, V278, P24912, DOI 10.1074/jbc.M301201200; Miah SMS, 2004, GENES CELLS, V9, P993, DOI 10.1111/j.1365-2443.2004.00784.x; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mukai T, 2014, J BONE MINER RES, V29, P2618, DOI 10.1002/jbmr.2295; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872                                                           ; Nakashima K., 2012, PLOS ONE, V7; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ogi K, 2011, GENES CELLS, V16, P951, DOI 10.1111/j.1365-2443.2011.01539.x; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Prod'Homme V, 2015, J CLIN INVEST, V125, P1396, DOI 10.1172/JCI71081; Qu XJ, 2005, BIOCHEMISTRY-US, V44, P3891, DOI 10.1021/bi048353o; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970                                           ; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006                                                        ; Schoenen H, 2014, J IMMUNOL, V193, P3664, DOI 10.4049/jimmunol.1301593; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Strzelecka A, 1997, FEBS LETT, V400, P11, DOI 10.1016/S0014-5793(96)01359-2                                                   ; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Tohyama Y, 2009, J BIOCHEM, V145, P267, DOI 10.1093/jb/mvp001; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199                                                          ; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; WANG AVT, 1994, J EXP MED, V180, P1165, DOI 10.1084/jem.180.3.1165; Yamauchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38336; Yoshitaka T, 2014, CELL REP, V8, P1752, DOI 10.1016/j.celrep.2014.08.023	57	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 13	2017	7								11480	10.1038/s41598-017-11915-5				14	Multidisciplinary Sciences	Science & Technology - Other Topics	FG8GF	WOS:000410666900038	28904407	gold			2018-01-05	
J	Lee, HJ; Lee, KY; Park, YH; Choi, HJ; Yao, YX; Nair, V; Han, JY				Lee, Hong Jo; Lee, Kyung Youn; Park, Young Hyun; Choi, Hee Jung; Yao, Yongxiu; Nair, Venugopal; Han, Jae Yong			Acquisition of resistance to avian leukosis virus subgroup B through mutations on tvb cysteine-rich domains in DF-1 chicken fibroblasts	VETERINARY RESEARCH			English	Article							RECEPTOR GENE; HIV-1 INFECTION; DECREASED SUSCEPTIBILITY; INTRONIC DELETIONS; SARCOMA; SYSTEM; RNA; INTERFERENCE; CRISPR/CAS9; INDIVIDUALS	Avian leukosis virus (ALV) is a retrovirus that causes tumors in avian species, and its vertical and horizontal transmission in poultry flocks results in enormous economic losses. Despite the discovery of specific host receptors, there have been few reports on the modulation of viral susceptibility via genetic modification. We therefore engineered acquired resistance to ALV subgroup B using CRISPR/Cas9-mediated genome editing technology in DF-1 chicken fibroblasts. Using this method, we efficiently modified the tumor virus locus B (tvb) gene, encoding the TVB receptor, which is essential for ALV subgroup B entry into host cells. By expanding individual DF-1 clones, we established that artificially generated premature stop codons in the cysteine-rich domain (CRD) of TVB receptor confer resistance to ALV subgroup B. Furthermore, we found that a cysteine residue (C80) of CRD2 plays a crucial role in ALV subgroup B entry. These results suggest that CRISPR/Cas9-mediated genome editing can be used to efficiently modify avian cells and establish novel chicken cell lines with resistance to viral infection.	[Lee, Hong Jo; Lee, Kyung Youn; Park, Young Hyun; Choi, Hee Jung; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 08826, South Korea; [Lee, Hong Jo; Lee, Kyung Youn; Park, Young Hyun; Choi, Hee Jung; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea; [Yao, Yongxiu; Nair, Venugopal] Pirbright Inst Woking, Pirbright GU24 0NF, Surrey, England; [Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Minamiminowa, Nagano 3994598, Japan	Han, JY (reprint author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 08826, South Korea.; Han, JY (reprint author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea.	jaehan@snu.ac.kr	Nair, Venugopal/D-4447-2016; Institute, Pirbright/K-4476-2014	Nair, Venugopal/0000-0002-8255-516X; 	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2015R1A3A2033826]; Royal Society International Professorships	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2015R1A3A2033826). Authors also acknowledge the funding support from the Royal Society International Professorships.	Adkins HB, 2001, J VIROL, V75, P3520, DOI 10.1128/JVI.75.8.3520-3526.2001; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Burkard C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006206; Chai N, 2006, P NATL ACAD SCI USA, V103, P5531, DOI 10.1073/pnas.0509785103; Chen WG, 2015, SCI REP-UK, V5, DOI 10.1038/srep09900; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Elleder D, 2005, J VIROL, V79, P10408, DOI 10.1128/JVI.79.16.10408-10419.2005; Elleder D, 2004, J VIROL, V78, P13489, DOI 10.1128/JVI.13489-13500.2004; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hughes SH, 2004, FOLIA BIOL-PRAGUE, V50, P107; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Justice J, 2013, CURR OPIN VIROL, V3, P664, DOI 10.1016/j.coviro.2013.08.008; Khalili K, 2017, CELL MOL LIFE SCI, V74, P2439, DOI 10.1007/s00018-017-2479-z; Kinkade A, 2006, TRENDS IMMUNOL, V27, P362, DOI 10.1016/j.it.2006.06.004; Klucking S, 2002, J VIROL, V76, P7918, DOI 10.1128/JVI.76.15.7918-7921.2002; Kucerova D, 2013, J VIROL, V87, P8399, DOI 10.1128/JVI.03180-12; Lee HJ, 2016, FASEB J, V30, P555, DOI 10.1096/fj.15-274712; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995                                                    ; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Reinisova M, 2008, J VIROL, V82, P2097, DOI 10.1128/JVI.02206-07; Reinisova M, 2012, J VIROL, V86, P2021, DOI 10.1128/JVI.05771-11; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Suenaga T, 2014, MICROBIOL IMMUNOL, V58, P513, DOI 10.1111/1348-0421.12180; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2	36	1	1	3	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	0928-4249	1297-9716		VET RES	Vet. Res.	SEP 13	2017	48								48	10.1186/s13567-017-0454-1				10	Veterinary Sciences	Veterinary Sciences	FH0NR	WOS:000410838000002	28903753	gold			2018-01-05	
J	Pyenson, NC; Gayvert, K; Varble, A; Elemento, O; Marraffini, LA				Pyenson, Nora C.; Gayvert, Kaitlyn; Varble, Andrew; Elemento, Olivier; Marraffini, Luciano A.			Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape	CELL HOST & MICROBE			English	Article							DNA CLEAVAGE; NUCLEOTIDE-SEQUENCE; FUNCTIONAL MAP; SEED SEQUENCE; DUAL-RNA; COMPLEX; SYSTEM; INTERFERENCE; RESISTANCE; PROTEIN	CRISPR loci are a cluster of repeats separated by short "spacer" sequences derived from prokaryotic viruses and plasmids that determine the targets of the host's CRISPR-Cas immune response against its invaders. For type I and II CRISPR-Cas systems, single-nucleotide mutations in the seed or proto-spacer adjacent motif (PAM) of the target sequence cause immune failure and allow viral escape. This is overcome by the acquisition of multiple spacers that target the same invader. Here we show that targeting by the Staphylococcus epidermidis type III-A CRISPR-Cas system does not require PAM or seed sequences, and thus prevents viral escape via single-nucleotide substitutions. Instead, viral escapers can only arise through complete target deletion. Our work shows that, as opposed to type I and II systems, the relaxed specificity of type III CRISPR-Cas targeting provides robust immune responses that can lead to viral extinction with a single spacer targeting an essential phage sequence.	[Pyenson, Nora C.; Varble, Andrew; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA; [Gayvert, Kaitlyn; Elemento, Olivier] Cornell Univ, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10021 USA; [Gayvert, Kaitlyn] Triinst Grad Program Computat Biol & Med, New York, NY 10065 USA	Marraffini, LA (reprint author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA.	marraffini@rockefeller.edu			Arnold O. Beckman Postdoctoral Fellowship; Tri-Institutional Training Program in Computational Biology and Medicine (via NIH) [T32GM083937]; PhRMA Foundation Pre-Doctoral Informatics Fellowship; NIH [R01CA194547, U24CA210989]; Rita Allen Scholars Program; Irma T. Hirschl Award; Sinsheimer Foundation Award; Burroughs Wellcome Fund PATH award; NIH Director's New Innovator Award [1DP2AI104556-01]; HHMI-Simons Faculty Scholar Award	We thank Robert Heler for pRH plasmids and Gregory Goldberg for pGG plasmids. We would like to acknowledge the Rockefeller University Genomics Resource Center core facility for performing next-generation sequencing. A.V. is supported by the Arnold O. Beckman Postdoctoral Fellowship. K.G. is supported by the Tri-Institutional Training Program in Computational Biology and Medicine (via NIH training grant T32GM083937) and by the PhRMA Foundation Pre-Doctoral Informatics Fellowship. O.E. is supported by NIH grants R01CA194547 and U24CA210989. L.A.M. is supported by the Rita Allen Scholars Program, an Irma T. Hirschl Award, a Sinsheimer Foundation Award, a Burroughs Wellcome Fund PATH award, an NIH Director's New Innovator Award (1DP2AI104556-01), and an HHMI-Simons Faculty Scholar Award. L.A.M. is a founder of Intellia Therapeutics and a member of its scientific advisory board.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Daniel A, 2007, J BACTERIOL, V189, P2086, DOI 10.1128/JB.01637-06; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Elmore J, 2015, NUCLEIC ACIDS RES, V43, P10353, DOI 10.1093/nar/gkv1140; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Frigols B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005609; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Han WY, 2017, NUCLEIC ACIDS RES, V45, P1983, DOI 10.1093/nar/gkw1274; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; HORINOUCHI S, 1982, J BACTERIOL, V150, P815; HORINOUCHI S, 1982, J BACTERIOL, V150, P804; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0                                                                ; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maniv I, 2016, J BACTERIOL, V198, P941, DOI 10.1128/JB.00897-15; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991                                                 ; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Zebec Z, 2014, NUCLEIC ACIDS RES, V42, P5280, DOI 10.1093/nar/gku161	49	1	1	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1931-3128	1934-6069		CELL HOST MICROBE	Cell Host Microbe	SEP 13	2017	22	3					343	+		10.1016/j.chom.2017.07.016				14	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	FG7CH	WOS:000410565400014	28826839				2018-01-05	
J	Zhou, JP; Deng, KJ; Cheng, Y; Zhong, ZH; Tian, L; Tang, X; Tang, AT; Zheng, XL; Zhang, T; Qi, YP; Zhang, Y				Zhou, Jianping; Deng, Kejun; Cheng, Yan; Zhong, Zhaohui; Tian, Li; Tang, Xu; Tang, Aiting; Zheng, Xuelian; Zhang, Tao; Qi, Yiping; Zhang, Yong			CRISPR-Cas9 Based Genome Editing Reveals New Insights into MicroRNA Function and Regulation in Rice	FRONTIERS IN PLANT SCIENCE			English	Article						microRNAs; CRISPR-Cas9; genome editing; rice; OsMIR408; OsMIR528	ABIOTIC STRESS RESPONSES; TARGETED MUTAGENESIS; EFFECTOR NUCLEASES; PLANT DEVELOPMENT; CROP PLANTS; SMALL RNAS; ARABIDOPSIS; SYSTEM; CRISPR/CAS9; EXPRESSION	MicroRNAs (miRNAs) are small non-coding RNAs that play important roles in plant development and stress responses. Loss-of-function analysis of miRNA genes has been traditionally challenging due to lack of appropriate knockout tools. In this study, single miRNA genes (OsMIR408 and OsMIR528) and miRNA gene families (miR815a/b/c and miR820a/b/c) in rice were targeted by CRISPR-Cas9. We showed single strand conformation polymorphism (SSCP) is a more reliable method than restriction fragment length polymorphism (RFLP) for identifying CRISPR-Cas9 generated mutants. Frequencies of targeted mutagenesis among regenerated TO lines ranged from 48 to 89% at all tested miRNA target sites. In the case of miRNA528, three independent guide RNAs (gRNAs) all generated biallelic mutations among confirmed mutant lines. When targeted by two gRNAs, miRNA genes were readily to be deleted at a frequency up to 60% in TO rice lines. Thus, we demonstrate CRISPR-Cas9 is an effective tool for knocking out plant miRNAs. Single-base pair (bp) insertion/deletion mutations (indels) in mature miRNA regions can lead to the generation of functionally redundant miRNAs. Large deletions at either the mature miRNA or the complementary miRNA* were found to readily abolish miRNA function. Utilizing mutants of OsMIR408 and OsMIR528, we find that knocking out a single miRNA can result in expression profile changes of many other seemingly unrelated miRNAs. In a case study on OsMIR528, we reveal it is a positive regulator in salt stress. Our work not only provides empirical guidelines on targeting miRNAs with CRISPR-Cas9, but also brings new insights into miRNA function and complex cross-regulation in rice.	[Zhou, Jianping; Deng, Kejun; Cheng, Yan; Zhong, Zhaohui; Tian, Li; Tang, Xu; Tang, Aiting; Zheng, Xuelian; Zhang, Yong] Univ Elect Sci & Technol China, Ctr Informat Biol, Sch Life Sci & Technol, Dept Biotechnol, Chengdu, Sichuan, Peoples R China; [Zhang, Tao] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Jiangsu, Peoples R China; [Qi, Yiping] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Qi, Yiping] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA	Zhang, Y (reprint author), Univ Elect Sci & Technol China, Ctr Informat Biol, Sch Life Sci & Technol, Dept Biotechnol, Chengdu, Sichuan, Peoples R China.; Qi, YP (reprint author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.; Qi, YP (reprint author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	yiping@umd.edu; zhangyong916@uestc.edu.cn	Zhang, Tao/L-9336-2013	Zhang, Tao/0000-0002-7897-0205	National Science Foundation of China [31330017, 31371682]; Sichuan Youth Science and Technology Foundation [2017JQ0005]; Fundamental Research Funds for the Central Universities [ZYGX2016J119, ZYGX2016J122]; North Carolina Biotechnology Center; Syngenta Biotechnology [2016-CFG-8003]; University of Maryland-College Park	This work was supported by grants including the National Science Foundation of China (31330017 and 31371682), the Sichuan Youth Science and Technology Foundation (2017JQ0005) and the Fundamental Research Funds for the Central Universities (ZYGX2016J119 and ZYGX2016J122) to YZ and XZ, and a Collaborative Funding Grant from North Carolina Biotechnology Center and Syngenta Biotechnology (2016-CFG-8003) and a startup fund from University of Maryland-College Park to YQ.	Akdogan G, 2016, FUNCT INTEGR GENOMIC, V16, P221, DOI 10.1007/s10142-015-0452-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cheah BH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1851-3; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Demirci Y., 2017, J CELL PHYSL, DOI 10.1002/jcp.25970; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo CK, 2017, PLANT CELL, V29, P1293, DOI 10.1105/tpc.16.00975; Hajyzadeh M, 2015, GENE, V555, P186, DOI 10.1016/j.gene.2014.11.002; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kumar R, 2014, APPL BIOCHEM BIOTECH, V174, P93, DOI 10.1007/s12010-014-0914-2; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma C, 2015, PLANT J, V84, P169, DOI 10.1111/tpj.12999; Ma XL, 2015, MOL PLANT, V8, P1285, DOI 10.1016/j.molp.2015.02.012; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Narayanan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32386; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Paul JW, 2016, PLANT CELL REP, V35, P1417, DOI 10.1007/s00299-016-1985-z; Reichel M, 2015, PLANT BIOTECHNOL J, V13, P915, DOI 10.1111/pbi.12327; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Sharma D, 2015, METALLOMICS, V7, P174, DOI [10.1039/c4mt00264d, 10.1039/C4MT00264D]; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Wang F, 2015, CURR OPIN PLANT BIOL, V27, P118, DOI 10.1016/j.pbi.2015.06.012; Wang FH, 2008, J PLANT PHYSIOL, V165, P324, DOI 10.1016/j.jplph.2006.11.006; Wu JG, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.203; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yan J, 2012, PLANT CELL, V24, P415, DOI 10.1105/tpc.111.094144; Yuan SG, 2015, PLANT PHYSIOL, V169, P576, DOI 10.1104/pp.15.00899; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhao YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23890; Zheng XL, 2016, PLANT CELL REP, V35, P1545, DOI 10.1007/s00299-016-1967-1; Zhu HL, 2013, NAT STRUCT MOL BIOL, V20, P1106, DOI 10.1038/nsmb.2646	53	0	0	34	34	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	SEP 13	2017	8								1598	10.3389/fpls.2017.01598				12	Plant Sciences	Plant Sciences	FG6LR	WOS:000410491500001	28955376	gold			2018-01-05	
J	Feng, WR; Jasin, M				Feng, Weiran; Jasin, Maria			BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination	NATURE COMMUNICATIONS			English	Article							CANCER SUSCEPTIBILITY PROTEIN; DNA-REPLICATION; BREAST-CANCER; GENOME STABILITY; MAMMALIAN-CELLS; DIRECTED REPAIR; FORKS; MITOSIS; ANEMIA; CAS9	Mutations in the tumor suppressor BRCA2 predominantly predispose to breast cancer. Paradoxically, while loss of BRCA2 promotes tumor formation, it also causes cell lethality, although how lethality is triggered is unclear. Here, we generate BRCA2 conditional non-transformed human mammary epithelial cell lines using CRISPR-Cas9. Cells are inviable upon BRCA2 loss, which leads to replication stress associated with under replication, causing mitotic abnormalities, 53BP1 nuclear body formation in the ensuing G1 phase, and G1 arrest. Unexpected from other systems, the role of BRCA2 in homologous recombination, but not in stalled replication fork protection, is primarily associated with supporting human mammary epithelial cell viability, and, moreover, preventing replication stress, a hallmark of precancerous lesions. Thus, we uncover a DNA under replication-53BP1 nuclear body formation-G1 arrest axis as an unanticipated outcome of homologous recombination deficiency, which triggers cell lethality and, we propose, serves as a barrier that must be overcome for tumor formation.	[Feng, Weiran; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA; [Feng, Weiran; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10065 USA	Jasin, M (reprint author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.; Jasin, M (reprint author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10065 USA.	m-jasin@ski.mskcc.org			Olayan Fellowship; MSK Cancer Center Support Grant/Core Grant [P30 CA008748]; Geoffrey Beene Cancer Research Center Grant;  [R01 CA185660]	We thank members of the Jasin lab for discussions and suggestions. We thank Scott Keeney, Prasad Jallepalli, Przemek M. Krawczyk, Mathew Jones, and Qiao Wang for discussions; Paige Arnold for technical assistance; Mathew Jones, Leili Ran, Elissa Wong, Zhen Cao, and Hanzhi Luo for reagents and technical support; Sho Fujisawa (Molecular Cytology core facility, MSKCC) for assistance in automated image quantification. This work was supported by an Olayan Fellowship (W.F.), MSK Cancer Center Support Grant/Core Grant P30 CA008748, a Geoffrey Beene Cancer Research Center Grant, and R01 CA185660 (M.J.).	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033                                                                  ; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bhowmick R, 2016, MOL CELL, V64, P1117, DOI 10.1016/j.molcel.2016.10.037; Biswas K, 2011, BLOOD, V118, P2430, DOI 10.1182/blood-2010-12-324541; Carlos AR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3697; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chaudhuri AR, 2016, NATURE, V535, P382, DOI 10.1038/nature18325; Choi E, 2012, DEV CELL, V22, P295, DOI 10.1016/j.devcel.2012.01.009; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Cuella-Martin R, 2016, MOL CELL, V64, P51, DOI 10.1016/j.molcel.2016.08.002; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Ding X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12425; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Guillemette S, 2015, GENE DEV, V29, P489, DOI 10.1101/gad.256214.114; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098                                                         ; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kass EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13241; Kondrashova O, 2017, CANCER DISCOV, V7, P984, DOI 10.1158/2159-8290.CD-17-0419; Kuznetsov SG, 2008, NAT MED, V14, P875, DOI 10.1038/nm.1719; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Ludwig T, 2001, ONCOGENE, V20, P3937, DOI 10.1038/sj.onc.1204512; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; McAllister KA, 2002, CANCER RES, V62, P990; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Mondal G, 2012, DEV CELL, V23, P137, DOI 10.1016/j.devcel.2012.05.008; Naim V., NAT CELL BIOL, V15; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Nordling M, 1998, CANCER RES, V58, P1372; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Siaud N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002409; SOULE HD, 1990, CANCER RES, V50, P6075; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Vriend LEM, 2014, METHOD ENZYMOL, V546, P175, DOI 10.1016/B978-0-12-801185-0.00009-X; Willis NA, 2014, NATURE, V510, P556, DOI 10.1038/nature13295; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yata K, 2014, CELL REP, V7, P1547, DOI 10.1016/j.celrep.2014.04.023; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zhang Y, 2014, METHODS, V69, P171, DOI 10.1016/j.ymeth.2014.05.003	73	1	1	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	SEP 13	2017	8								525	10.1038/s41467-017-00634-0				15	Multidisciplinary Sciences	Science & Technology - Other Topics	FG8TI	WOS:000410709900001	28904335	gold			2018-01-05	
J	Chen, Q; Ai, N; Liao, J; Shao, X; Liu, YF; Fan, XH				Chen, Qian; Ai, Ni; Liao, Jie; Shao, Xin; Liu, Yufeng; Fan, Xiaohui			Revealing topics and their evolution in biomedical literature using Bio-DTM: a case study of ginseng	CHINESE MEDICINE			English	Article							PANAX-GINSENG; MODELS	Background: Valuable scientific results on biomedicine are very rich, but they are widely scattered in the literature. Topic modeling enables researchers to discover themes from an unstructured collection of documents without any prior annotations or labels. In this paper, taking ginseng as an example, biological dynamic topic model (Bio-DTM) was proposed to conduct a retrospective study and interpret the temporal evolution of the research of ginseng. Methods: The system of Bio-DTM mainly includes four components, documents pre-processing, bio-dictionary construction, dynamic topic models, topics analysis and visualization. Scientific articles pertaining to ginseng were retrieved through text mining from PubMed. The bio-dictionary integrates MedTerms medical dictionary, the second edition of side effect resource, a dictionary of biology and HGNC database of human gene names (HGNC). A dynamic topic model, a text mining technique, was used to emphasize on capturing the development trends of topics in a sequentially collected documents. Besides the contents of topics taken on, the evolution of topics was visualized over time using ThemeRiver. Results: From the topic 9, ginseng was used in dietary supplements and complementary and integrative health practices, and became very popular since the early twentieth century. Topic 6 reminded that the planting of ginseng is a major area of research and symbiosis and allelopathy of ginseng became a research hotspot in 2007. In addition, the Bio-DTM model gave an insight into the main pharmacologic effects of ginseng, such as anti-metabolic disorder effect, cardioprotective effect, anti-cancer effect, hepatoprotective effect, anti-thrombotic effect and neuroprotective effect. Conclusion: The Bio-DTM model not only discovers what ginseng's research involving in but also displays how these topics evolving	[Chen, Qian] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China; [Ai, Ni; Liao, Jie; Shao, Xin; Liu, Yufeng; Fan, Xiaohui] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China	Fan, XH (reprint author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China.	fanxh@zju.edu.cn	Fan, Xiaohui/F-6458-2010	Fan, Xiaohui/0000-0002-6336-3007	National Project for TCM Standardization [ZYBZH-C-ZJ-60]; National Natural Science Foundation of China [81373893]; National youth top-notch talent support program	This work was financially supported by the National Project for TCM Standardization (No. ZYBZH-C-ZJ-60), the National Natural Science Foundation of China (No. 81373893) and the National youth top-notch talent support program.	Allahyari M, 2017, ARXIV170702919; AlSumait L, 2008, IEEE DATA MINING, P3, DOI 10.1109/ICDM.2008.140; Barnes PM, 2002, SEMINARS INTEGRATIVE, P54; Barnes PM, 2008, NATL HLTH STAT REPOR, P1; Bernards MA, 2006, DIS MANAG FRUITS VEG, V2, P157; Bisgin H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S15-S6; Black Lindsey I, 2015, NCHS Data Brief, P1; Blei DM, 2007, ANN APPL STAT, V1, P17, DOI 10.1214/07-AOAS114; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993                                                     ; Blei DM, 2005, ADV NEURAL INFORM PR, P113; Bolelli L, 2009, LECT NOTES COMPUT SC, V5478, P776, DOI 10.1007/978-3-642-00958-7_84; Chang J., 2015, IDA COLLAPSED GIBBS; CHEN C-B, 2006, J JILIN AGR U, V5; Cho KM, 2007, MICROB ECOL, V54, P341, DOI 10.1007/s00248-007-9208-3; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Fleuren WWM, 2015, METHODS, V74, P97, DOI 10.1016/j.ymeth.2015.01.015; Garcia-Alvarez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092265; Grun B, 2011, J STAT SOFTW, V40, P1; Gunnemann Nikou, 2013, Datenbank-Spektrum, V13, P213, DOI 10.1007/s13222-013-0134-x; Guo Y, 2014, COLING, V2014, P76; Havre S, 2000, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2000, P115, DOI 10.1109/INFVIS.2000.885098; Holzinger Andreas, 2014, Interactive Knowledge Discovery and Data Mining in Biomedical Informatics. State-of-the-Art and Future Challenges: LNCS 8401, P271, DOI 10.1007/978-3-662-43968-5_16; Howard Brian E, 2016, Syst Rev, V5, P87, DOI 10.1186/s13643-016-0263-z; Junfei M, 2009, ECOL ECON, V5, P160; Lee MH, 2017, J GINSENG RES, V41, P428, DOI 10.1016/j.jgr.2017.03.003; Lee YS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01048; Liu L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3252-8; Liu SX, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2089094.2089101; Lo YT, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0029-x; Lu Zhiyong, 2011, Database (Oxford), V2011, pbaq036, DOI 10.1093/database/baq036; Mechanick Jeffrey I, 2003, Endocr Pract, V9, P417; Ramage D, 2009, P 2009 C EMP METH NA, V1; Rebholz-Schuhmann D, 2012, NAT REV GENET, V13, P829, DOI 10.1038/nrg3337; Rider AK, 2013, P INT C BIOINF COMP, P333; Rosen-Zvi M., 2004, P 20 C UNC ART INT, P487; Shi W, 2007, FOOD CHEM, V102, P664, DOI 10.1016/j.foodchem.2006.05.053; Song C, 2006, SET CHINESE FORMULAE; Takahashi Yusuke, 2012, Advances in Natural Language Processing. Proceedings 8th International Conference on NLP, JapTAL 2012, P239, DOI 10.1007/978-3-642-33983-7_24; Tang SL, 2013, CHINA COMMUN, V10, P1, DOI 10.1109/CC.2013.6488826; van Altena Allard J., 2016, Journal of Big Data, V3, DOI 10.1186/s40537-016-0057-0; Vendan RT, 2010, J MICROBIOL, V48, P559, DOI 10.1007/s12275-010-0082-1; Wang X., 2006, P 12 ACM SIGKDD INT, P424; Wildgaard LE, 2016, LIBR HI TECH, V34, P669, DOI 10.1108/LHT-06-2016-0066; Xiaoyan Zhang, 2010, Journal of Software, V5, P482; Xie JT, 2005, ACTA PHARMACOL SIN, V26, P1104, DOI 10.1111/j.1745-7254.2005.00156.x; Ye Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162721; Yeganova L, 2014, BIOINFORMATICS, V30, P3240, DOI 10.1093/bioinformatics/btu514; Yin RS, 2005, CHINA ENV SERIES, V6, P17; [Anonymous], 2005, NIH STAT OF THE SCI, P1	49	0	0	9	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1749-8546			CHIN MED-UK	Chin. Med.	SEP 12	2017	12								27	10.1186/s13020-017-0148-7				9	Integrative & Complementary Medicine; Pharmacology & Pharmacy	Integrative & Complementary Medicine; Pharmacology & Pharmacy	FH0TH	WOS:000410853000002	28919923	gold			2018-01-05	
J	Baeumler, TA; Ahmed, AA; Fulga, TA				Baeumler, Toni A.; Ahmed, Ahmed Ashour; Fulga, Tudor A.			Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors	CELL REPORTS			English	Article							PROTEIN-COUPLED RECEPTORS; CAR-T CELLS; TRANSCRIPTIONAL PROGRAMS; NOTCH RECEPTORS; CANCER; COMPLEX; CRISPR-CAS9; CIRCUITS; DESIGN; MODULATION	Synthetic receptors provide a powerful experimental tool for generation of designer cells capable of monitoring the environment, sensing specific input signals, and executing diverse custom response programs. To advance the promise of cellular engineering, we have developed a class of chimeric receptors that integrate a highly programmable and portable nuclease-deficient CRISPR/Cas9 (dCas9) signal transduction module. We demonstrate that the core dCas9 synthetic receptor (dCas9-synR) architecture can be readily adapted to various classes of native ectodomain scaffolds, linking their natural inputs with orthogonal output functions. Importantly, these receptors achieved stringent OFF/ON state transition characteristics, showed agonist-mediated dose-dependent activation, and could be programmed to couple specific disease markers with diverse, therapeutically relevant multi-gene expression circuits. The modular dCas9-synR platform developed here provides a generalizable blueprint for designing next generations of synthetic receptors, which will enable the implementation of highly complex combinatorial functions in cellular engineering.	[Baeumler, Toni A.; Fulga, Tudor A.] Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford OX3 9DS, England; [Ahmed, Ahmed Ashour] Univ Oxford, Ovarian Canc Cell Lab, Weatherall Inst Mol Med, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	Fulga, TA (reprint author), Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Med, Oxford OX3 9DS, England.	tudor.fulga@imm.ox.ac.uk		Fulga, Tudor/0000-0002-1056-0082	Radcliffe Department of Medicine/MRC Scholars Programme Studentship; MRC [G0902418]; Ovarian Cancer Action [HER00070]; Oxford Biomedical Research Centre, the National Institute of Health Research [IS-BRC-0211-10025]; BBSRC [BB/ N006550/1]; Wellcome Trust ISSF [105605/Z/14/Z]	We are especially grateful to Quentin Ferry and Mohammad KaramiNejadRanjbar for providing advice and reagents and to David Knapp for critical feedback and help with data analysis. We would like to thank Kevin Clark and Paul Sopp (WIMM FACS Core Facility) for assistance with single-cell sorting and technical expertise; Christoffer Lagerholm (Wolfson Imaging Centre Oxford), Aron Szabo, and Markus Toegel (Fulga lab) for help with confocal imaging; and David Knapp, Yale Michaels, Quentin Ferry, Qianxin Wu, and Mike Barnkob for providing critical comments on the manuscript. T.A.B. is supported by a Radcliffe Department of Medicine/MRC Scholars Programme Studentship. A.A.A. is supported by the MRC (G0902418), Ovarian Cancer Action (HER00070), and Oxford Biomedical Research Centre, the National Institute of Health Research (IS-BRC-0211-10025). T.A.F. is supported by MRC (G0902418), BBSRC (BB/ N006550/1), and Wellcome Trust ISSF (105605/Z/14/Z). A patent application (United Kingdom Patent Application No. 1711470.3) covering inventions described in this manuscript has been submitted.	Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Burton Elizabeth R, 2009, J Biol, V8, P85, DOI 10.1186/jbiol189; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Farzadfard F, 2013, ACS SYNTH BIOL, V2, P604, DOI 10.1021/sb400081r; Ferry QRV, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14633; Fesnak AD, 2016, NAT REV CANCER, V16, P566, DOI 10.1038/nrc.2016.97; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Gill S, 2015, IMMUNOL REV, V263, P68, DOI 10.1111/imr.12243; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jusiak B, 2016, TRENDS BIOTECHNOL, V34, P535, DOI 10.1016/j.tibtech.2015.12.014; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Lawler P. R., 2012, PERSPECT MED, V2, DOI 10.1101/cshperspect.a00662722553494; Lee D, 2017, NAT METHODS, V14, P495, DOI [10.1038/nmeth.4234, 10.1038/NMETH.4234]; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lienert F, 2014, NAT REV MOL CELL BIO, V15, P95, DOI 10.1038/nrm3738; Lim W., 2014, CELL SIGNALING PRINC; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Maji B, 2017, NAT CHEM BIOL, V13, P9, DOI 10.1038/nchembio.2224; Mauceri HJ, 2002, INT J CANCER, V97, P410, DOI 10.1002/ijc.1629; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Nguyen DP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12009; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Sarabipour S, 2016, ELIFE, V5, DOI 10.7554/eLife.13876; Schwarz KA, 2017, NAT CHEM BIOL, V13, P202, DOI [10.1038/NCHEMBIO.2253, 10.1038/nchembio.2253]; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Srivastava S, 2015, TRENDS IMMUNOL, V36, P494, DOI 10.1016/j.it.2015.06.004; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Wang W, 2017, NAT BIOTECHNOL; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Xie M, 2016, SCIENCE, V354, P1296, DOI 10.1126/science.aaf4006; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	55	0	0	13	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	SEP 12	2017	20	11					2639	2653		10.1016/j.celrep.2017.08.044				15	Cell Biology	Cell Biology	FG5OW	WOS:000410377400011	28903044	gold			2018-01-05	
J	Zhang, QQ; Su, J; Wang, ZW; Qi, H; Ge, ZY; Li, ZJ; Chen, WD; Wang, YD				Zhang, Qiqi; Su, Jia; Wang, Ziwei; Qi, Hui; Ge, Zeyong; Li, Zhijun; Chen, Wei-Dong; Wang, Yan-Dong			MicroRNA-149*suppresses hepatic inflammatory response through antagonizing STAT3 signaling pathway	ONCOTARGET			English	Article						miR-149*; liver inflammation; STAT3; miRNA; CRISPR/CAS9	NF-KAPPA-B; BILE-ACID RECEPTOR; HEPATOCELLULAR-CARCINOMA; MESSENGER-RNAS; CANCER-CELLS; GPBAR1 TGR5; PROLIFERATION; INHIBITION; MICRORNA; DISEASE	Chronic inflammation is increasingly recognized as an important component of tumorigenesis and metabolic diseases. The roles of microRNA149* (miRNA149*) in inflammation remain poorly understood. Here, we demonstrate that miR-149* is a suppressor of STAT3-mediated inflammation. MiR-149*(-/-) mice were generated with CRISPR/CAS9 technique. In a lipopolysaccharide (LPS)-induced inflammation model, miR-149*(-/-) mice show more severe liver injury and inflammation, compared with wildtype (WT) mice. MiR-149*(-/-) mice also displayed elevated messenger RNA (mRNA) levels of interleukin (IL)-6, inducible nitric oxide synthase (iNOS), complement C3 (C3) and IL-4 in response to LPS. Then miR-149* agomir administration is largely able to alleviate the LPS-induced some inflammatory gene expression in WT mouse liver. In vitro, miR-149* mimics inhibited expression of STAT3-meidated inflammatory mediators induced by LPS and suppresses the phosphorylation of STAT3 and its transcription activity in HepG2 cells. These findings identify miR-149* as a negative mediator of inflammation that may serve as an attractive therapeutic tool for immune and inflammatory liver diseases.	[Zhang, Qiqi; Su, Jia; Wang, Ziwei; Wang, Yan-Dong] Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Chem Resource Engn, Beijing, Peoples R China; [Qi, Hui; Ge, Zeyong; Chen, Wei-Dong] Henan Univ, Sch Med, Key Lab Receptors Mediated Gene Regulat & Drug Di, Kaifeng, Henan, Peoples R China; [Li, Zhijun; Chen, Wei-Dong] Inner Mongolia Med Univ, Sch Basic Med Sci, Key Lab Mol Pathol, Hohhot, Inner Mongolia, Peoples R China	Wang, YD (reprint author), Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Chem Resource Engn, Beijing, Peoples R China.; Chen, WD (reprint author), Henan Univ, Sch Med, Key Lab Receptors Mediated Gene Regulat & Drug Di, Kaifeng, Henan, Peoples R China.; Chen, WD (reprint author), Inner Mongolia Med Univ, Sch Basic Med Sci, Key Lab Mol Pathol, Hohhot, Inner Mongolia, Peoples R China.	wdchen666@163.com; ydwangbuct2009@163.com			National Natural Science Foundation of China [81370537, 81672433, 81472232, 81270522, 81260269]; Program for Science & Technology Innovation Talents in Universities of Henan Province (HASTIT) [13HASTIT024]; Plan for Scientific Innovation Talent of Henan Province; Fundamental Research Funds for the Central Universities [YS1407, PT1624]	This work is supported by the National Natural Science Foundation of China (Grant No. 81370537 and Grant No. 81672433) to Y.-D.W., the National Natural Science Foundation of China (Grant No. 81472232 and Grant No. 81270522), Program for Science & Technology Innovation Talents in Universities of Henan Province (HASTIT, Grant No. 13HASTIT024) and Plan for Scientific Innovation Talent of Henan Province to W.-D.C., the Fundamental Research Funds for the Central Universities (Grant No. YS1407 and PT1624) to Y.-D.W, and the National Natural Science Foundation of China (Grant No. 81260269) to Z.L.	Alas S, 2003, CLIN CANCER RES, V9, P316; Bala S, 2016, J HEPATOL, V64, P1378, DOI 10.1016/j.jhep.2016.01.035; Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390; Collins AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069090; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Ding HY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11533; El-Guendy NM, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.33881; Fan SJ, 2016, LEUKEMIA RES, V41, P62, DOI 10.1016/j.leukres.2015.11.016; Fenoglio C, 2013, MULT SCLER J, V19, P1938, DOI 10.1177/1352458513485654; Gavino AC, 2016, ALLERGY, V71, P1684, DOI 10.1111/all.12937; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Giebeler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100522; Guo C, 2015, ONCOTARGET, V6, P34402, DOI 10.18632/oncotarget.5353; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Huan Lin, 2016, [Cancer Biology and Medicine, 癌症生物学与医学], V13, P407, DOI 10.20892/j.issn.2095-3941.2016.0071; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Jiang GS, 2017, MOL CANCER THER, V16, P924, DOI 10.1158/1535-7163.MCT-16-0631; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kumar A, 2012, GENOMICS, V100, P352, DOI 10.1016/j.ygeno.2012.08.006; Li CF, 2016, ONCOTARGET, V7, P17021, DOI 10.18632/oncotarget.7740; Li DQ, 2015, J CLIN INVEST, V125, P3008, DOI 10.1172/JCI79052; Li WC, 2006, CLIN CANCER RES, V12, P7140, DOI 10.1158/1078-0432.CCR-06-0484; Li XY, 2015, ONCOL LETT, V10, P2691, DOI 10.3892/ol.2015.3654; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Liu XM, 2016, ONCOL REP, V36, P1385, DOI 10.3892/or.2016.4971; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Musso A, 2005, INFLAMM BOWEL DIS, V11, P91, DOI 10.1097/00054725-200502000-00001; Mycko MP, 2012, P NATL ACAD SCI USA, V109, pE1248, DOI 10.1073/pnas.1114325109; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Toll A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0537-z; Wang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep41456; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Wang YD, 2015, MOL ENDOCRINOL, V29, P322, DOI 10.1210/me.2014-1225; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Weber SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158819; Xue F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00040; Ye EA, 2017, VISION RES; Yoshida A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26088; Zhang YQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-253; Zhou QY, 2012, INVEST OPHTH VIS SCI, V53, P5665, DOI 10.1167/iovs.12-9832	42	1	1	8	8	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	SEP 12	2017	8	39					65397	65406		10.18632/oncotarget.18541				10	Oncology; Cell Biology	Oncology; Cell Biology	FG4YC	WOS:000410291200058	29029439				2018-01-05	
J	Bagacean, C; Tempescul, A; Le Dantec, C; Bordron, A; Mohr, A; Saad, H; Olivier, V; Zdrenghea, M; Cristea, V; Cartron, PF; Douet-Guilbert, N; Berthou, C; Renaudineau, Y				Bagacean, Cristina; Tempescul, Adrian; Le Dantec, Christelle; Bordron, Anne; Mohr, Audrey; Saad, Hussam; Olivier, Valerie; Zdrenghea, Mihnea; Cristea, Victor; Cartron, Pierre-Francois; Douet-Guilbert, Nathalie; Berthou, Christian; Renaudineau, Yves			Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia	ONCOTARGET			English	Article						chronic lymphocytic leukemia; methylation; hydroxymethylation; TET; SAT1	B-CELL; DISEASE PROGRESSION; EPIGENETIC CHANGES; GENE-EXPRESSION; METHYLATION; CANCER; TET1; 5-HYDROXYMETHYLCYTOSINE; HYPOMETHYLATION; METHYLOME	Cytosine derivative dysregulations represent important epigenetic modifications whose impact on the clinical outcome in chronic lymphocytic leukemia (CLL) is incompletely understood. Hence, global levels of 5-methylcytosine (5-mCyt), 5-hydroxymethylcytosine (5-hmCyt), 5-carboxylcytosine (5-CaCyt) and 5-hydroxymethyluracil were tested in purified B cells from CLL patients (n = 55) and controls (n = 17). The DNA methylation 'writers' (DNA methyltransferases [DNMT1/3A/3B]), ` readers' (methyl-CpG-binding domain [MBD2/4]), 'editors' (ten-eleven translocation [TET1/2/3]) and 'modulators' (SAT1) were also evaluated. Accordingly, patients were stratified into three subgroups. First, a subgroup with a global deficit in cytosine derivatives characterized by hyperlymphocytosis, reduced median progression free survival (PFS = 52 months) and shorter treatment free survival (TFS = 112 months) was identified. In this subgroup, major epigenetic modifications were highlighted including a reduction of 5-mCyt, 5-hmCyt, 5-CaCyt associated with DNMT3A, MBD2/4 and TET1/2 downregulation. Second, the cytosine derivative analysis revealed a subgroup with a partial deficit (PFS = 84, TFS = 120 months), mainly affecting DNA demethylation (5-hmCyt reduction, SAT1 induction). Third, a subgroup epigenetically similar to controls was identified (PFS and TFS > 120 months). The prognostic impact of stratifying CLL patients within three epigenetic subgroups was confirmed in a validation cohort. In conclusion, our results suggest that dysregulations of cytosine derivative regulators represent major events acquired during CLL progression and are independent from IGHV mutational status.	[Bagacean, Cristina; Tempescul, Adrian; Le Dantec, Christelle; Bordron, Anne; Mohr, Audrey; Berthou, Christian; Renaudineau, Yves] Univ Brest, INSERM, Network IC CGO, Labex IGO,Lymphocytes & Autoimmun U1227 B,IBSAM, Brest, France; [Bagacean, Cristina; Tempescul, Adrian; Le Dantec, Christelle; Bordron, Anne; Mohr, Audrey; Berthou, Christian; Renaudineau, Yves] Univ Brest, INSERM, Network REpiCGO Canceropole Grand Ouest, Labex IGO,Lymphocytes & Autoimmun U1227 B,IBSAM, Brest, France; [Bagacean, Cristina; Olivier, Valerie; Renaudineau, Yves] Brest Univ, Med Sch Hosp, Lab Immunol & Immunotherapy, Brest, France; [Bagacean, Cristina; Zdrenghea, Mihnea; Cristea, Victor] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania; [Tempescul, Adrian; Saad, Hussam; Berthou, Christian] Brest Univ, Dept Hematol, Med Sch Hosp, Brest, France; [Zdrenghea, Mihnea] Ion Chiricuta Oncol Inst, Dept Hematol, Cluj Napoca, Romania; [Cartron, Pierre-Francois] INSERM, Epigenet Network Canceropole Grand Ouest, U892, Nantes, France; [Douet-Guilbert, Nathalie] Brest Univ, Lab Cytogenet, Med Sch Hosp, Brest, France	Renaudineau, Y (reprint author), Univ Brest, INSERM, Network IC CGO, Labex IGO,Lymphocytes & Autoimmun U1227 B,IBSAM, Brest, France.; Renaudineau, Y (reprint author), Univ Brest, INSERM, Network REpiCGO Canceropole Grand Ouest, Labex IGO,Lymphocytes & Autoimmun U1227 B,IBSAM, Brest, France.; Renaudineau, Y (reprint author), Brest Univ, Med Sch Hosp, Lab Immunol & Immunotherapy, Brest, France.	yves.renaudineau@univ-brest.fr	Cartron, Pierre Francois/K-9802-2015; Mohr, Audrey/P-2999-2017	Mohr, Audrey/0000-0001-7031-8602; Renaudineau, Yves/0000-0001-5098-5002	Association Laurette Fugain [ALF 2015/03]; Region Bretagne; Canceropole Grand Ouest	This study was supported by research funding from the "Association Laurette Fugain" (ALF 2015/03), the "Region Bretagne" and from the "Canceropole Grand Ouest".	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Arruga F., 2016, LEUKEMIA; Bagacean C, 2016, IMMUNOTHERAPY-UK, V8, P569, DOI 10.2217/imt-2015-0015; Cahill N, 2013, LEUKEMIA, V27, P150, DOI 10.1038/leu.2012.245; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chen E, 2015, BLOOD, V125, P327, DOI 10.1182/blood-2014-04-567024; Chen SS, 2009, P NATL ACAD SCI USA, V106, P13433, DOI 10.1073/pnas.0906455106; Chuang HY, 2012, BLOOD, V120, P2639, DOI 10.1182/blood-2012-03-416461; Cui B, 2014, BLOOD, V124, P546, DOI 10.1182/blood-2014-03-559690; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Eichhorst B, 2015, ANN ONCOL, V26, pV78, DOI 10.1093/annonc/mdv303; Fabris S, 2011, EPIGENETICS-US, V6, P188, DOI 10.4161/epi.6.2.13528; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Ficz G, 2014, GENOMICS, V104, P352, DOI 10.1016/j.ygeno.2014.08.017; Garaud S, 2016, CELL MOL IMMUNOL; Garaud S, 2011, J IMMUNOL, V186, P4835, DOI 10.4049/jimmunol.1003050; Haney SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34222; Haney SL, 2016, CELL REP, V15, P1190, DOI 10.1016/j.celrep.2016.04.004; Harikrishnan KN, 2004, CANCER BIOL THER, V3, P989, DOI 10.4161/cbt.3.10.1137                                                           ; Hernandez-Sanchez M, 2014, BIOMED RES INT, V2014; Hoxha M, 2014, GENE CHROMOSOME CANC, V53, P612, DOI 10.1002/gcc.22171; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Karouzakis E, 2012, ARTHRITIS RHEUM-US, V64, P1809, DOI 10.1002/art.34340; Kipps Thomas J, 2017, Nat Rev Dis Primers, V3, P17008, DOI 10.1038/nrdp.2017.8; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/nchembio.1042, 10.1038/NCHEMBIO.1042]; Nabhan C, 2015, JAMA ONCOL, V1, P988, DOI 10.1001/jamaoncol.2015.2532; Nabhan C, 2015, JAMA ONCOL, V1, P965, DOI 10.1001/jamaoncol.2015.0779; Neidhart M, 2014, ARTHRITIS RHEUMATOL, V66, P1723, DOI 10.1002/art.38574; Oakes CC, 2016, NAT GENET, V48, P253, DOI 10.1038/ng.3488; Oakes CC, 2014, CANCER DISCOV, V4, P348, DOI 10.1158/2159-8290.CD-13-0349; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Palamarchuk A, 2012, P NATL ACAD SCI USA, V109, P2555, DOI 10.1073/pnas.1200003109; Pei LR, 2012, EPIGENETICS-US, V7, P567, DOI 10.4161/epi.20237; Peters SL, 2014, LEUKEMIA, V28, P1138, DOI 10.1038/leu.2013.364; Puiggros A, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/435983; Queiros AC, 2015, LEUKEMIA, V29, P598, DOI 10.1038/leu.2014.252; Renaudineau Y, 2005, BLOOD, V106, P2781, DOI 10.1182/blood-2005-02-0597; Rendeiro AF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11938; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Swerdlow SH, 2008, IARC WHO CLASSIFICAT; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thabet Y, 2013, J AUTOIMMUN, V41, P175, DOI 10.1016/j.jaut.2013.02.002; Upchurch GM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00182; Van Damme M, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0298-y; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wiehle L, 2016, MOL CELL BIOL, V36, P452, DOI 10.1128/MCB.00587-15; Wu JZ, 2016, ONCOTARGET, V7, P40558, DOI 10.18632/oncotarget.9941; Zhang XT, 2016, NAT GENET, V48, P1014, DOI 10.1038/ng.3610; Zhao ZG, 2015, CELL REP, V13, P1692, DOI 10.1016/j.celrep.2015.10.037; Zhao ZK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13765	56	1	1	3	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	SEP 12	2017	8	39					65699	65716		10.18632/oncotarget.20081				18	Oncology; Cell Biology	Oncology; Cell Biology	FG4YC	WOS:000410291200084	29029465	green_published			2018-01-05	
J	Tidball, AM; Dang, LT; Glenn, TW; Kilbane, EG; Klarr, DJ; Margolis, JL; Uhler, MD; Parent, JM				Tidball, Andrew M.; Dang, Louis T.; Glenn, Trevor W.; Kilbane, Emma G.; Klarr, Daniel J.; Margolis, Joshua L.; Uhler, Michael D.; Parent, Jack M.			Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing	STEM CELL REPORTS			English	Article							PLURIPOTENT STEM-CELLS; CRISPR-CAS9; EFFICIENT; CAS9; ENDONUCLEASE; DYNAMICS	Specifically ablating genes in human induced pluripotent stem cells (iPSCs) allows for studies of gene function as well as disease mechanisms in disorders caused by loss-of-function (LOF) mutations. While techniques exist for engineering such lines, we have developed and rigorously validated a method of simultaneous iPSC reprogramming while generating CRISPR/Cas9-dependent insertions/deletions (indels). This approach allows for the efficient and rapid formation of genetic LOF human disease cell models with isogenic controls. The rate of mutagenized lines was strikingly consistent across experiments targeting four different human epileptic encephalopathy genes and a metabolic enzyme-encoding gene, and was more efficient and consistent than using CRISPR gene editing of established iPSC lines. The ability of our streamlined method to reproducibly generate heterozygous and homozygous LOF iPSC lines with passage-matched isogenic controls in a single step provides for the rapid development of LOF disease models with ideal control lines, even in the absence of patient tissue.	[Tidball, Andrew M.; Glenn, Trevor W.; Kilbane, Emma G.; Klarr, Daniel J.; Margolis, Joshua L.; Parent, Jack M.] Univ Michigan, Sch Med, Dept Neurol, 5021 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Dang, Louis T.] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Uhler, Michael D.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Uhler, Michael D.] Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Parent, Jack M.] VA Ann Arbor HealthCare Syst, Ann Arbor, MI 48105 USA	Parent, JM (reprint author), Univ Michigan, Sch Med, Dept Neurol, 5021 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.; Parent, JM (reprint author), VA Ann Arbor HealthCare Syst, Ann Arbor, MI 48105 USA.	parent@umich.edu			NIH [NS090364]; Citizens United for Research in Epilepsy (CURE)	This work was supported by grants from the NIH NS090364 and Citizens United for Research in Epilepsy (CURE) to J.M.P. We thank the Center for Computational and Integrative Biology (CCIB) DNA Core Facility at Massachusetts General Hospital (Cambridge, MA) for providing sequencing services.	Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Bai Q, 2015, STEM CELLS DEV, V24, P653, DOI 10.1089/scd.2014.0292; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Howden SE, 2016, STEM CELL REP, V7, P508, DOI 10.1016/j.stemcr.2016.07.001; Howden SE, 2015, STEM CELL REP, V5, P1109, DOI [10.1016/j.stemer.2015.10.009, 10.1016/j.stemcr.2015.10.009]; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Mallon BS, 2013, STEM CELL RES, V10, P57, DOI 10.1016/j.scr.2012.09.002; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679                                                            ; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Ptak SE, 2002, GENETICS, V162, P1233; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Smith C, 2015, MOL THER, V23, P570, DOI 10.1038/mt.2014.226; Symonds JD, 2017, EPILEPSIA, V58, P565, DOI 10.1111/epi.13669; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	17	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	SEP 12	2017	9	3					725	731		10.1016/j.stemcr.2017.07.003				7	Cell & Tissue Engineering; Cell Biology	Cell Biology	FG4WO	WOS:000410279200001	28781079	gold			2018-01-05	
J	Belyhun, Y; Liebert, UG; Maier, M				Belyhun, Yeshambel; Liebert, Uwe Gerd; Maier, Melanie			Clade homogeneity and low rate of delta virus despite hyperendemicity of hepatitis B virus in Ethiopia	VIROLOGY JOURNAL			English	Article						HDV; Genotype; Clade homogeneity; Ethiopia	GENOTYPE-I; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; INFECTED PATIENTS; MAJOR CLADES; REPLICATION; ANTIGEN; RNA; PHOSPHORYLATION; INDICATE	Background: Although hepatitis B virus (HBV) is hyperendemic and heterogeneous in its genetic diversity in Ethiopia, little is known about hepatitis D virus (HDV) circulating genotypes and molecular diversity. Methods: A total of 321 hepatitis B surface antigen (HBsAg) positives (125 HIV co-infected, 102 liver disease patients and 94 blood donors) were screened for anti-HDV antibody. The anti-HDV positive sera were subjected to Real time PCR for HDV-RNA confirmation. The non coding genome region (spanning from 467 to 834 nucleotides) commonly used for HDV genotyping as well as complete HDV genome were sequenced for genotyping and molecular analysis. Results: The anti-HDV antibody was found to be 3.2% (3) in blood donors, 8.0% (10) in HIV co-infected individuals and 12.7% (13) in liver disease patients. None of the HIV co-infected patients who revealed HBV lamivudine (3TC) resistance at tyrosine-methionine/isoleucine-aspartate-aspartate (YM(I) DD) reverse transcriptase (RT) motif with concomitant vaccine escape gene mutants was positive for anti-HDV antibody. The HDV viremia rate was 33.3%, 30.0% and 23.1% in respect to the above study groups. All the six isolates sequenced were phylogenetically classified as HDV genotype 1 (HDV-1) and grouped into two monophyletic clusters. Amino acid (aa) residues analysis of clathrin heavy chain (CHC) domain and the isoprenylation signal site (Py) at 19 carboxyl (C)-terminal amino acids (aa 196-214) and the HDV RNA binding domain (aa 79-107) were highly conserved and showed a very little nucleotide variations. All the sequenced isolates showed serine at amino acid position 202. The RNA editing targets of the anti-genomic HDV RNA (nt1012) and its corresponding genomic RNA (nt 580) showed nucleotides A and C, respectively. Conclusions: The low seroprevalence and viraemic rates of HDV in particular during HIV-confection might be highly affected by HBV drug resistance selected HBsAg mutant variants in this setting, although HDV-1 sequences analysis revealed clade homogeneity and highly conserved structural and functional domains. Thus, the potential role of HBV drug resistance associated polymerase mutations and concomitant HBsAg protein variability on HDV viral assembly, secretion and infectivity needs further investigation.	[Belyhun, Yeshambel; Liebert, Uwe Gerd; Maier, Melanie] Univ Leipzig, Inst Virol, Med Fac, Johannisallee 30, D-04103 Leipzig, Germany; [Belyhun, Yeshambel] Univ Gondar, Sch Biomed & Lab Sci, Coll Med & Hlth Sci, Gondar, Ethiopia	Belyhun, Y (reprint author), Univ Leipzig, Inst Virol, Med Fac, Johannisallee 30, D-04103 Leipzig, Germany.; Belyhun, Y (reprint author), Univ Gondar, Sch Biomed & Lab Sci, Coll Med & Hlth Sci, Gondar, Ethiopia.	belyhun@gmail.com					Abbas Zaigham, 2013, World J Hepatol, V5, P666, DOI 10.4254/wjh.v5.i12.666; Aghasadeghi MR, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.7481; Andernach IE, 2014, J CLIN MICROBIOL, V52, P1629, DOI 10.1128/JCM.02297-13; Belyhun Yeshambel, 2017, Antivir Ther, V22, P97, DOI 10.3851/IMP3060; Belyhun Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2090-1; Celik I, 2011, ARCH VIROL, V156, P2215, DOI 10.1007/s00705-011-1120-y; De Paschale M, 2014, J MED VIROL, V86, P1281, DOI 10.1002/jmv.23951; Deny P, 2006, CURR TOP MICROBIOL, V307, P151; Hofmann J, 2010, DIAGN MICR INFEC DIS, V67, P172, DOI 10.1016/j.diagmicrobio.2010.02.003; Hong SY, 2010, J VIROL, V84, P1430, DOI 10.1128/JVI.02083-09; Honge BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099971; Huang C, 2007, J VIROL, V81, P5985, DOI 10.1128/JVI.02809-06; Huang CR, 2014, WORLD J GASTROENTERO, V20, P14589, DOI 10.3748/wjg.v20.i40.14589; Huang Chi-Ruei, 2010, Advances in Bioinformatics, P323654, DOI 10.1155/2010/323654; Hundie GB, 2016, J MED VIROL, V88, P1035, DOI 10.1002/jmv.24437; Hung CC, 2014, CLIN INFECT DIS, V58, P1625, DOI 10.1093/cid/ciu127; Ivaniushina V, 2001, J GEN VIROL, V82, P2709, DOI 10.1099/0022-1317-82-11-2709                                                    ; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112                                                          ; Le Gal F, 2012, ARCH VIROL, V157, P647, DOI 10.1007/s00705-011-1212-8; Makuwa M, 2009, J CLIN MICROBIOL, V47, P2265, DOI 10.1128/JCM.02012-08; Mendes-Correa MC, 2011, INT J INFECT DIS, V15, pE828, DOI 10.1016/j.ijid.2011.08.003; Mu JJ, 2004, VIROLOGY, V319, P60, DOI 10.1016/j.virol.2003.10.024; Pascarella S, 2011, LIVER INT, V31, P7, DOI 10.1111/j.1478-3231.2010.02320.x; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; Radjef N, 2004, J VIROL, V78, P2537, DOI 10.1128/JVI.78.5.2537-2544.2004; RAPICETTA M, 1988, EUR J EPIDEMIOL, V4, P185, DOI 10.1007/BF00144749; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Saudy N, 2003, J MED VIROL, V70, P529, DOI 10.1002/jmv.10427; Soriano V, 2011, AIDS, V25, P1987, DOI 10.1097/QAD.0b013e32834babb3; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; Sy BT, 2015, J VIRAL HEPATITIS, V22, P55, DOI 10.1111/jvh.12228; TSEGA E, 1986, AM J EPIDEMIOL, V123, P344, DOI 10.1093/oxfordjournals.aje.a114243                                              ; Vietheer PTK, 2005, J VIROL, V79, P6570, DOI 10.1128/JVI.19.10.6570-6573.2005; Wang YC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-31; Watanabe H, 2003, J GEN VIROL, V84, P3275, DOI 10.1099/vir.0.19499-0; Wedemeyer H, 2007, HEPATOLOGY, V45, P1331, DOI 10.1002/hep.21590; Yeh TS, 1998, VIROLOGY, V249, P12, DOI 10.1006/viro.1998.9310; Zhang YY, 1996, J CLIN MICROBIOL, V34, P3023	38	0	0	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-422X			VIROL J	Virol. J.	SEP 12	2017	14								176	10.1186/s12985-017-0844-z				10	Virology	Virology	FH0DY	WOS:000410810800002	28899424	gold			2018-01-05	
J	Denecke, S; Fusetto, R; Martelli, F; Giang, A; Battlay, P; Fournier-Level, A; O'Hair, RA; Batterham, P				Denecke, Shane; Fusetto, Roberto; Martelli, Felipe; Giang, Alex; Battlay, Paul; Fournier-Level, Alexandre; O'Hair, Richard A.; Batterham, Philip			Multiple P450s and Variation in Neuronal Genes Underpins the Response to the Insecticide Imidacloprid in a Population of Drosophila melanogaster	SCIENTIFIC REPORTS			English	Article							NEONICOTINOID INSECTICIDES; CYTOCHROME-P450 GENES; OVER-EXPRESSION; REFERENCE PANEL; RESISTANCE; METABOLISM; CYP6G1; DETOXIFICATION; THIAMETHOXAM; D-ALPHA-1	Insecticide resistance is an economically important example of evolution in response to intense selection pressure. Here, the genetics of resistance to the neonicotinoid insecticide imidacloprid is explored using the Drosophila Genetic Reference Panel, a collection of inbred Drosophila melanogaster genotypes derived from a single population in North Carolina. Imidacloprid resistance varied substantially among genotypes, and more resistant genotypes tended to show increased capacity to metabolize and excrete imidacloprid. Variation in resistance level was then associated with genomic and transcriptomic variation, implicating several candidate genes involved in central nervous system function and the cytochrome P450s Cyp6g1 and Cyp6g2. CRISPR-Cas9 mediated removal of Cyp6g1 suggested that it contributed to imidacloprid resistance only in backgrounds where it was already highly expressed. Cyp6g2, previously implicated in juvenile hormone synthesis via expression in the ring gland, was shown to be expressed in metabolically relevant tissues of resistant genotypes. Cyp6g2 overexpression was shown to both metabolize imidacloprid and confer resistance. These data collectively suggest that imidacloprid resistance is influenced by a variety of previously known and unknown genetic factors.	[Denecke, Shane; Fusetto, Roberto; Martelli, Felipe; Giang, Alex; Battlay, Paul; Fournier-Level, Alexandre; Batterham, Philip] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Sch Biosci, Parkville, Vic 3010, Australia; [Fusetto, Roberto; O'Hair, Richard A.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Sch Chem, Melbourne, Vic 3010, Australia; [Fusetto, Roberto; O'Hair, Richard A.] Univ Melbourne, ARC Ctr Excellence Free Rad Chem & Biotechnol, Melbourne, Vic 3010, Australia	Batterham, P (reprint author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Sch Biosci, Parkville, Vic 3010, Australia.	p.batterham@unimelb.edu.au		Denecke, Shane/0000-0002-7291-1394	University of Melbourne; Melbourne International Research Scholarship	The authors would like to thank the University of Melbourne for the Writing Up Scholarship and the Melbourne International Research Scholarship that assisted in financing this work. Furthermore, we must acknowledge Hang Nuoc Bao Hang for assisting in larvae picking. Llewellyn Green and Trent Perry also contributed productive discussions on the topic matter. Lastly, we must thank Michael Murray of the University of Melbourne for providing fly facilities during the renovations of our own flyroom.	Abe T, 2015, DEVELOPMENT, V142, P1021, DOI 10.1242/dev.122713; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; BAI DL, 1991, PESTIC SCI, V33, P197, DOI 10.1002/ps.2780330208; Bass C, 2011, INSECT MOL BIOL, V20, P763, DOI 10.1111/j.1365-2583.2011.01105.x; Bass C, 2015, PESTIC BIOCHEM PHYS, V121, P78, DOI 10.1016/j.pestbp.2015.04.004; Battlay P, 2016, G3-GENES GENOM GENET, V6, P2573, DOI [10.1534/g3.116.031054/-/DC1, 10.1534/g3.116.031054]; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Christesen D, 2017, G3-GENES GENOM GENET, V7, P467, DOI 10.1534/g3.116.037333; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Denecke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145051; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507                                                   ; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Ford KA, 2008, J AGR FOOD CHEM, V56, P10168, DOI 10.1021/jf8020909; Ford KA, 2006, CHEM RES TOXICOL, V19, P1549, DOI 10.1021/tx0601859; Fusetto R., 2017, SCI REP, V7; Groeters FR, 2000, J ECON ENTOMOL, V93, P1580, DOI 10.1603/0022-0493-93.6.1580                                                     ; Hoi KK, 2014, ANAL CHEM, V86, P3525, DOI 10.1021/ac404188g; Huang W, 2015, P NATL ACAD SCI USA, V112, pE6010, DOI 10.1073/pnas.1519159112; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Ilias A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2161-5; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Le Goff G, 2017, PEST MANAG SCI, V73, P493, DOI 10.1002/ps.4470; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marzinke MA, 2013, ARCH BIOCHEM BIOPHYS, V540, P94, DOI 10.1016/j.abb.2013.10.012; McCart C, 2008, PEST MANAG SCI, V64, P639, DOI 10.1002/ps.1567; MCKENZIE JA, 1994, TRENDS ECOL EVOL, V9, P166, DOI 10.1016/0169-5347(94)90079-5; Merzendorfer H., 2014, ADV INSECT PHYSL, V46; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Pandey G, 2009, BIOCHEM BIOPH RES CO, V380, P710, DOI 10.1016/j.bbrc.2009.01.156; Perry T, 2008, INSECT BIOCHEM MOLEC, V38, P520, DOI 10.1016/j.ibmb.2007.12,007; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; R Core Team, 2017, R LANG ENV STAT COMP; Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Somers J, 2017, GENETICS, V205, P263, DOI 10.1534/genetics.116.195750; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007	47	1	1	10	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 12	2017	7								11338	10.1038/s41598-017-11092-5				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FG4ZR	WOS:000410297900052	28900129	gold			2018-01-05	
J	Fusetto, R; Denecke, S; Perry, T; O'Hair, RAJ; Batterham, P				Fusetto, Roberto; Denecke, Shane; Perry, Trent; O'Hair, Richard A. J.; Batterham, Philip			Partitioning the roles of CYP6G1 and gut microbes in the metabolism of the insecticide imidacloprid in Drosophila melanogaster	SCIENTIFIC REPORTS			English	Article							BEMISIA-TABACI HEMIPTERA; NEONICOTINOID INSECTICIDES; IN-VIVO; CYTOCHROME-P450 GENES; MASS-SPECTROMETRY; OVER-EXPRESSION; MYZUS-PERSICAE; RESISTANCE; PESTICIDES; NITROREDUCTION	Resistance to insecticides through enhanced metabolism is a worldwide problem. The Cyp6g1 gene of the vinegar fly, Drosophila melanogaster, is a paradigm for the study of metabolic resistance. Constitutive overexpression of this gene confers resistance to several classes of insecticides, including the neonicotinoid imidacloprid (IMI). The metabolism of IMI in this species has been previously shown to yield oxidative and nitro-reduced metabolites. While levels of the oxidative metabolites are correlated with CYP6G1 expression, nitro-reduced metabolites are not, raising the question of how these metabolites are produced. Some IMI metabolites are known to be toxic, making their fate within the insect a second question of interest. These questions have been addressed by coupling the genetic tools of gene overexpression and CRISPR gene knock-out with the mass spectrometric technique, the Twin-Ion Method (TIM). Analysing axenic larvae indicated that microbes living within D. melanogaster are largely responsible for the production of the nitro-reduced metabolites. Knock-out of Cyp6g1 revealed functional redundancy, with some metabolites produced by CYP6G1 still detected. IMI metabolism was shown to produce toxic products that are not further metabolized but readily excreted, even when produced in the Central Nervous System (CNS), highlighting the significance of transport and excretion in metabolic resistance.	[Fusetto, Roberto; O'Hair, Richard A. J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Sch Chem, Melbourne, Vic 3010, Australia; [Fusetto, Roberto; Denecke, Shane; Perry, Trent; Batterham, Philip] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Sch Biosci, Melbourne, Vic 3010, Australia	Batterham, P (reprint author), Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Sch Biosci, Melbourne, Vic 3010, Australia.	p.batterham@unimelb.edu.au		Perry, Trent/0000-0002-8045-0487; Denecke, Shane/0000-0002-7291-1394	University of Melbourne	The authors thank the University of Melbourne for the provision of the postgraduate and writing up scholarships to Roberto Fusetto and Shane Denecke and to all members of the O'Hair and Batterham research groups for their support. We thank Metabolomics Australia and the University of Melbourne Department of Chemistry for access to facilities and Sioe See Volaric for technical assistance with the analytical instrumentation.	Adams AS, 2013, APPL ENVIRON MICROB, V79, P3468, DOI 10.1128/AEM.00068-13; Bass C, 2011, INSECT MOL BIOL, V20, P763, DOI 10.1111/j.1365-2583.2011.01105.x; Bass C, 2015, PESTIC BIOCHEM PHYS, V121, P78, DOI 10.1016/j.pestbp.2015.04.004; Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Ceja-Navarro JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8618; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2012, INSECT BIOCHEM MOLEC, V42, P918, DOI 10.1016/j.ibmb.2012.09.003; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dai YJ, 2006, APPL MICROBIOL BIOT, V71, P927, DOI 10.1007/s00253-005-0223-3; Dai YJ, 2010, J AGR FOOD CHEM, V58, P2419, DOI 10.1021/jf903787s; Denecke S., 2017, SCI REP, V7; Denecke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145051; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Ford KA, 2008, J AGR FOOD CHEM, V56, P10168, DOI 10.1021/jf8020909; Ford KA, 2006, CHEM RES TOXICOL, V19, P944, DOI 10.1021/tx0600696; Fusetto R., 2015, CHEM AUSTR, P18; Good RT, 2014, GENOME BIOL EVOL, V6, P1118, DOI 10.1093/gbe/evu083; Harrop TWR, 2014, G3-GENES GENOM GENET, V4, P2197, DOI 10.1534/g3.114.013870; Hoi KK, 2014, ANAL CHEM, V86, P3525, DOI 10.1021/ac404188g; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Jouen N, 2008, PEST MANAG SCI, V64, P65, DOI DOI 10.1002/PS.1472; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Le Goff G., 2016, PEST MANAG IN PRESS; Lu TQ, 2016, J AGR FOOD CHEM, V64, P4866, DOI 10.1021/acs.jafc.6b01376; Merzendorfer H, 2014, ADV INSECT PHYSIOL, V46, P1, DOI 10.1016/B978-0-12-417010-0.00001-X; Nauen R, 1998, PESTIC SCI, V52, P53, DOI 10.1002/(SICI)1096-9063(199801)52:1<53::AID-PS621>3.0.CO;2-6                    ; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331.abs; Nauen R, 1999, PESTIC SCI, V55, P265, DOI 10.1002/(SICI)1096-9063(199903)55:3<265::AID-PS891>3.3.CO;2-3; Nishiwaki H, 2004, J PESTIC SCI, V29, P110, DOI 10.1584/jpestics.29.110; Pandey G, 2009, BIOCHEM BIOPH RES CO, V380, P710, DOI 10.1016/j.bbrc.2009.01.156; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Schulz-Jander DA, 2002, TOXICOL LETT, V132, P65, DOI 10.1016/S0378-4274(02)00068-1; Scott C, 2008, INDIAN J MICROBIOL, V48, P65, DOI 10.1007/s12088-008-0007-4; Sharma S, 2014, ENVIRON MONIT ASSESS, V186, P7183, DOI 10.1007/s10661-014-3919-y; Stokstad E, 2013, SCIENCE, V340, P674, DOI 10.1126/science.340.6133.674; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Swenson TL, 2013, TOXICOL SCI, V133, P22, DOI 10.1093/toxsci/kft066; Thurman EM, 2013, RAPID COMMUN MASS SP, V27, P1891, DOI 10.1002/rcm.6637; Tomalski M, 2010, ANN ENTOMOL SOC AM, V103, P84, DOI 10.1603/008.103.0111; Tomizawa M, 2011, J AGR FOOD CHEM, V59, P2825, DOI 10.1021/jf1019455; Tomizawa M, 2009, ACCOUNTS CHEM RES, V42, P260, DOI 10.1021/ar800131p; Tsvetkov N, 2017, SCIENCE, V356, P1395, DOI 10.1126/science.aam7470; van den Bosch T. J. M., 2016, MICROBIAL B IN PRESS; Venu I, 2014, J EXP BIOL, V217, P1346, DOI 10.1242/jeb.099648; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Woodcock BA, 2017, SCIENCE, V356, P1393, DOI 10.1126/science.aaa1190; Xia XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068852	60	0	0	11	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 12	2017	7								11339	10.1038/s41598-017-09800-2				12	Multidisciplinary Sciences	Science & Technology - Other Topics	FG4ZR	WOS:000410297900053	28900131	gold			2018-01-05	
J	Yeh, YC; Kinoshita, M; Ng, TH; Chang, YH; Maekawa, S; Chiang, YA; Aoki, T; Wang, HC				Yeh, Ying-Chun; Kinoshita, Masato; Ng, Tze Hann; Chang, Yu-Hsuan; Maekawa, Shun; Chiang, Yi-An; Aoki, Takashi; Wang, Han-Ching			Using CRISPR/Cas9-mediated gene editing to further explore growth and trade-off effects in myostatin-mutated F4 medaka (Oryzias latipes)	SCIENTIFIC REPORTS			English	Article							DOUBLE-MUSCLED PHENOTYPE; SKELETAL-MUSCLE; TARGETED MUTAGENESIS; IN-VIVO; EXPRESSION; FISH; HYPERTROPHY; ZEBRAFISH; SYSTEM; MICE	Myostatin (MSTN) suppresses skeletal muscle development and growth in mammals, but its role in fish is less well understood. Here we used CRISPR/Cas9 to mutate the MSTN gene in medaka (Oryzias latipes) and evaluate subsequent growth performance. We produced mutant F0 fish that carried different frameshifts in the OlMSTN coding sequence and confirmed the heritability of the mutant genotypes to the F1 generation. Two F1 fish with the same heterozygous frame-shifted genomic mutations (a 22 bp insertion in one allele; a 32 bp insertion in the other) were then crossbred to produce subsequent generations (F2 similar to F5). Body length and weight of the MSTN-/- F4 medaka were significantly higher than in the wild type fish, and muscle fiber density in the inner and outer compartments of the epaxial muscles was decreased, suggesting that MSTN null mutation induces muscle hypertrophy. From 3 similar to 4 weeks post hatching (wph), the expression of three major myogenic related factors (MRFs), MyoD, Myf5 and Myogenin, was also significantly upregulated. Some medaka had a spinal deformity, and we also observed a trade-off between growth and immunity in MSTN-/- F4 medaka. Reproduction was unimpaired in the fast-growth phenotypes.	[Yeh, Ying-Chun; Ng, Tze Hann; Chang, Yu-Hsuan; Maekawa, Shun; Chiang, Yi-An; Aoki, Takashi; Wang, Han-Ching] Natl Cheng Kung Univ, Inst Biotechnol, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Kinoshita, Masato] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; [Wang, Han-Ching] Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan	Wang, HC (reprint author), Natl Cheng Kung Univ, Inst Biotechnol, Coll Biosci & Biotechnol, Tainan 701, Taiwan.; Wang, HC (reprint author), Natl Cheng Kung Univ, Dept Biotechnol & Bioind Sci, Tainan, Taiwan.	wanghc@mail.ncku.edu.tw			Ministry of Science and Technology [MOST 105-2633-B-006-004]	This study was supported financially by the Ministry of Science and Technology (MOST 105-2633-B-006-004). We thank Mr. Paul Barlow, National Cheng Kung University, for his helpful criticism of the manuscript.	Acosta J, 2005, J BIOTECHNOL, V119, P324, DOI 10.1016/j.jbiotec.2005.04.023; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Ansai S, 2014, DEV GROWTH DIFFER, V56, P98, DOI 10.1111/dgd.12104; Barber I, 2005, INT J PARASITOL, V35, P137, DOI 10.1016/j.ijpara.2004.11.010; Carnac G, 2007, CURR GENOMICS, V8, P415, DOI 10.2174/138920207783591672; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chiang YA, 2016, FISH SHELLFISH IMMUN, V48, P212, DOI 10.1016/j.fsi.2015.11.016; Chisada S, 2011, DEV BIOL, V359, P82, DOI 10.1016/j.ydbio.2011.08.027; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Du W, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027778; Dunlop ES, 2009, ECOL APPL, V19, P1815, DOI 10.1890/08-1404.1; Elkasrawy MN, 2010, J MUSCULOSKEL NEURON, V10, P56; Folkvord A, 2014, CAN J FISH AQUAT SCI, V71, P1106, DOI 10.1139/cjfas-2013-0600; Foote MR, 2007, J DAIRY SCI, V90, P404, DOI 10.3168/jds.S0022-0302(07)72641-3                                               ; Fuentes EN, 2013, J BIOTECHNOL, V168, P295, DOI 10.1016/j.jbiotec.2013.10.028; Furusawa R, 2006, J GEN VIROL, V87, P2333, DOI [10.1099/vir.0.81761-0, 10.1099/vir.0.01761-0]; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; IWAMATSU T, 1983, J EXP ZOOL, V228, P83, DOI 10.1002/jez.1402280109                                                          ; Johnson PL, 2005, J ANIM SCI, V83, P2729; Jones MV, 2007, BIOTECHNIQUES, V42, P569, DOI 10.2144/000112456; Kinoshita M, 2000, DEV GROWTH DIFFER, V42, P469; Kirchmaier S, 2015, GENETICS, V199, P905, DOI 10.1534/genetics.114.173849; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee CY, 2009, BIOCHEM BIOPH RES CO, V387, P766, DOI 10.1016/j.bbrc.2009.07.110; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098                                                          ; Maccatrozzo L, 2001, MAR BIOTECHNOL, V3, P224, DOI 10.1007/s101260000064; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2                                                   ; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Proudfoot C, 2015, TRANSGENIC RES, V24, P147, DOI 10.1007/s11248-014-9832-x; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roberts SB, 2001, FEBS LETT, V491, P212, DOI 10.1016/S0014-5793(01)02196-2; Rodgers BD, 2001, ENDOCRINOLOGY, V142, P1412, DOI 10.1210/endo.142.4.8097; ROFF DA, 1983, CAN J FISH AQUAT SCI, V40, P1395, DOI 10.1139/f83-161; Sawatari E, 2010, COMP BIOCHEM PHYS A, V155, P183, DOI 10.1016/j.cbpa.2009.10.030; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Terova G, 2013, MOL BIOTECHNOL, V54, P673, DOI 10.1007/s12033-012-9609-5; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; VANROOIJ JM, 1995, MAR ECOL PROG SER, V122, P93, DOI 10.3354/meps122093; Watts R, 2013, OBESITY, V21, P525, DOI 10.1002/oby.20070; Xu C, 2003, J EXP BIOL, V206, P4067, DOI 10.1242/jeb.00635; Zhou FF, 2015, ANIM BIOTECHNOL, V26, P169, DOI 10.1080/10495398.2014.913598; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2                                                   ; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	55	0	0	12	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 12	2017	7								11435	10.1038/s41598-017-09966-9				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FG4ZR	WOS:000410297900149	28900124	gold			2018-01-05	
J	Alvarez, MI; Glover, LC; Luo, P; Wang, LY; Theusch, E; Oehlers, SH; Walton, EM; Tram, TTB; Kuang, YL; Rotter, JI; McClean, CM; Chinh, NT; Medina, MW; Tobin, DM; Dunstan, SJ; Ko, DC				Alvarez, Monica I.; Glover, Luke C.; Luo, Peter; Wang, Liuyang; Theusch, Elizabeth; Oehlers, Stefan H.; Walton, Eric M.; Trinh Thi Bich Tram; Kuang, Yu-Lin; Rotter, Jerome I.; McClean, Colleen M.; Nguyen Tran Chinh; Medina, Marisa W.; Tobin, David M.; Dunstan, Sarah J.; Ko, Dennis C.			Human genetic variation in VAC14 regulates Salmonella invasion and typhoid fever through modulation of cholesterol	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						single nucleotide polymorphism; lymphoblastoid cell line; phosphoinositide; ezetimibe; Salmonella pathogenicity island 1	GENOME-WIDE ASSOCIATION; MEMBRANE CONTACT SITES; INFLAMMATORY CELL-DEATH; ALZHEIMERS-DISEASE; ENTERIC FEVER; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; PHOSPHOINOSITIDE METABOLISM; CRISPR-CAS9 SYSTEM; 5-KINASE ACTIVITY; SECRETION SYSTEM	Risk, severity, and outcome of infection depend on the interplay of pathogen virulence and host susceptibility. Systematic identification of genetic susceptibility to infection is being undertaken through genome-wide association studies, but how to expeditiously move from genetic differences to functional mechanisms is unclear. Here, we use genetic association of molecular, cellular, and human disease traits and experimental validation to demonstrate that genetic variation affects expression of VAC14, a phosphoinositide-regulating protein, to influence susceptibility to Salmonella enterica serovar Typhi (S. Typhi) infection. Decreased VAC14 expression increased plasma membrane cholesterol, facilitating Salmonella docking and invasion. This increased susceptibility at the cellular level manifests as increased susceptibility to typhoid fever in a Vietnamese population. Furthermore, treating zebrafish with a cholesterol-lowering agent, ezetimibe, reduced susceptibility to S. Typhi. Thus, coupling multiple genetic association studies with mechanistic dissection revealed how VAC14 regulates Salmonella invasion and typhoid fever susceptibility and may open doors to new prophylactic/therapeutic approaches.	[Alvarez, Monica I.; Glover, Luke C.; Luo, Peter; Wang, Liuyang; Oehlers, Stefan H.; Walton, Eric M.; Tobin, David M.; Ko, Dennis C.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Theusch, Elizabeth; Kuang, Yu-Lin; Medina, Marisa W.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Oehlers, Stefan H.] Centenary Inst, TB Res Program, Camperdown, NSW 2050, Australia; [Oehlers, Stefan H.] Univ Sydney, Sydney Med Sch, Newtown, NSW 2042, Australia; [Trinh Thi Bich Tram] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Rotter, Jerome I.] Harbor Univ Calif, Inst Translat Genom & Populat Sci, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [McClean, Colleen M.; Tobin, David M.] Duke Univ, Sch Med, Dept Immunol, Durham, NC 27710 USA; [Nguyen Tran Chinh] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Dunstan, Sarah J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic 3010, Australia; [Ko, Dennis C.] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA	Ko, DC (reprint author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Ko, DC (reprint author), Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA.	dennis.ko@duke.edu		Tobin, David/0000-0003-3465-5518; Wang, Liuyang/0000-0001-9556-2361; Oehlers, Stefan/0000-0003-0260-672X	NIH [R01AI118903, K22AI093595, U19 HL069757, P50 GM115318]; Duke University Whitehead Scholarship; Butler Pioneer Award; National Science Foundation Predoctoral Fellowship; Duke Molecular Genetics and Microbiology Summer Undergraduate Research Engagement Fellowship; Australian National Health and Medical Research Council CJ Martin Early Career Fellowship [1053407]; Wellcome Trust Major Overseas Program in Viet Nam [089276/Z/09/Z]; NIH National Center for Advancing Translational Science University of California, Los Angeles Clinical and Translational Science Institute [UL1TR001881]; National Institute of Allergy and Infectious Diseases/NIH [F30 AI126693]; Duke Light Microscopy Core and Flow Cytometry Shared Resource	We thank Samuel I. Miller for early support of this work; T. Y. Chang for thoughtful discussions on cholesterol distribution and trafficking; the clinical staff from the Hospital of Tropical Diseases, Ho Chi Minh City, and Dong Thap Provincial Hospital, Vietnam, who initially diagnosed and studied the patients with typhoid fever; and Dr. Nguyen Thi Hieu from Hung Vuong Obstetric Hospital for the collection of the cord blood controls. M.I.A., L.C.G., P.L., L.W., D.M.T., S.J.D., and D.C.K. were supported by NIH Grants R01AI118903 and K22AI093595. D.C.K. was also supported by a Duke University Whitehead Scholarship and the Butler Pioneer Award. M.I.A. is supported by a National Science Foundation Predoctoral Fellowship. L.C.G. was supported by a Duke Molecular Genetics and Microbiology Summer Undergraduate Research Engagement Fellowship. S.H.O. was supported by an Australian National Health and Medical Research Council CJ Martin Early Career Fellowship, Grant 1053407. S.J.D. and T.T.B.T. were supported by the Wellcome Trust Major Overseas Program in Viet Nam, Grant 089276/Z/09/Z. E.T., Y.-L.K., and M.W.M. were supported by NIH Grants U19 HL069757 and P50 GM115318. J.I.R. was supported by NIH National Center for Advancing Translational Science University of California, Los Angeles Clinical and Translational Science Institute Grant UL1TR001881. C.M.M. was supported by National Institute of Allergy and Infectious Diseases/NIH Grant F30 AI126693. The graphical abstract was generated by itFigures Consulting. Research reported in this publication was supported by the Duke Light Microscopy Core and Flow Cytometry Shared Resource. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding sources.	Ackerman H, 2005, ANN HUM GENET, V69, P559, DOI 10.1111/j.1529-8817.2005.00180.x; Alghamdi TA, 2013, J BIOL CHEM, V288, P9363, DOI 10.1074/jbc.M113.453712; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Baek JS, 2012, CHOLESTEROL, DOI 10.1155/2012/564705; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Balklava Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130485; Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4                                                   ; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X                                                   ; Castro-Eguiluz D, 2009, MICROB PATHOGENESIS, V47, P52, DOI 10.1016/j.micpath.2009.04.005; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; Chinh NT, 2000, ANTIMICROB AGENTS CH, V44, P1855, DOI 10.1128/AAC.44.7.1855-1859.2000                                                 ; Clifton JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012386; Currinn H, 2016, BIOCHEM SOC T, V44, P185, DOI 10.1042/BST20150179; Currinn H, 2016, CELL MOL LIFE SCI, V73, P393, DOI 10.1007/s00018-015-1993-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dougan G, 2014, ANNU REV MICROBIOL, V68, P317, DOI 10.1146/annurev-micro-091313-103739; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Du XM, 2015, CURR OPIN CELL BIOL, V35, P37, DOI 10.1016/j.ceb.2015.04.002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunstan SJ, 2014, NAT GENET, V46, P1333, DOI 10.1038/ng.3143; Ehrbar K, 2002, INT J MED MICROBIOL, V291, P479; ENDO A, 1992, J LIPID RES, V33, P1569; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Galan JE, 1996, MOL MICROBIOL, V20, P263, DOI 10.1111/j.1365-2958.1996.tb02615.x; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; GARCIADELPORTILLO F, 1994, INFECT IMMUN, V62, P4641; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; GIANNELLA RA, 1973, J INFECT DIS, V128, P69, DOI 10.1093/infdis/128.1.69                                                         ; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Gratacap RL, 2013, DIS MODEL MECH, V6, P1260, DOI 10.1242/dmm.012039; Hacke M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8688; Hammond GRV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139957; Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Henne WM, 2016, J STRUCT BIOL, V196, P15, DOI 10.1016/j.jsb.2016.05.003; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188                                                         ; House D, 2002, J INFECT DIS, V186, P240, DOI 10.1086/341298; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howlader DR, 2016, VACCINE, V34, P5099, DOI 10.1016/j.vaccine.2016.08.077; Humphreys D, 2012, CELL HOST MICROBE, V11, P129, DOI 10.1016/j.chom.2012.01.006; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433                                                               ; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Jutras I, 2003, INFECT IMMUN, V71, P260, DOI 10.1128/IAI.71.1.260-266.2003; Karki S, 2013, CLIN INFECT DIS, V57, pE167, DOI 10.1093/cid/cit563; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Ko DC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003424; Ko DC, 2012, P NATL ACAD SCI USA, V109, pE2343, DOI 10.1073/pnas.1206701109; Ko DC, 2009, AM J HUM GENET, V85, P214, DOI 10.1016/j.ajhg.2009.07.012; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lai CH, 2008, INFECT IMMUN, V76, P3293, DOI 10.1128/IAI.00365-08; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Lenk GM, 2016, AM J HUM GENET, V99, P188, DOI 10.1016/j.ajhg.2016.05.008; Lenk GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002104; Li XR, 2013, P NATL ACAD SCI USA, V110, P21165, DOI 10.1073/pnas.1311864110; Luxemburger C, 2001, T ROY SOC TROP MED H, V95, P19, DOI 10.1016/S0035-9203(01)90318-9                                                   ; Mahammad S, 2015, METHODS MOL BIOL, V1232, P91, DOI 10.1007/978-1-4939-1752-5_8; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marineli F, 2013, ANN GASTROENTEROL, V26, P132; Mason WP, 1909, SCIENCE, V30, P117, DOI 10.1126/science.30.760.117-a                                                    ; McGregor AC, 2013, CURR OPIN INFECT DIS, V26, P254, DOI 10.1097/QCO.0b013e32835fb829; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; Misselwitz B, 2011, INFECT IMMUN, V79, P330, DOI 10.1128/IAI.00581-10; MROCZENSKIWILDEY MJ, 1989, MICROB PATHOGENESIS, V6, P143, DOI 10.1016/0882-4010(89)90017-X; Nasstrom E, 2014, ELIFE, V3, DOI 10.7554/eLife.03100; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Purcell S, 2005, AM J HUM GENET, V76, P249, DOI 10.1086/427886                                                                  ; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roppenser B, 2012, METHOD CELL BIOL, V108, P173, DOI 10.1016/B978-0-12-386487-1.00009-2; Rosales-Reyes R, 2012, MICROB PATHOGENESIS, V52, P367, DOI 10.1016/j.micpath.2012.03.007; Salinas RE, 2014, MOL BIOL CELL, V25, P76, DOI 10.1091/mbc.E13-06-0294; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Sewda K, 2016, ONCOTARGET, V7, P17773, DOI 10.18632/oncotarget.7402; Souwer Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050667; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Team R. C., 2016, R LANG ENV STAT COMP; Theusch E, 2017, PHARMACOGENOMICS J, V17, P222, DOI 10.1038/tpj.2016.12; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; Vinh H, 2004, PEDIATR INFECT DIS J, V23, P226, DOI 10.1097/01.inf.0000114905.87426.c2; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Wang L, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602096; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; WATSON PR, 1995, INFECT IMMUN, V63, P2743; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275105	106	2	2	5	5	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 12	2017	114	37					E7746	E7755		10.1073/pnas.1706070114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FG4YP	WOS:000410293400011	28827342				2018-01-05	
J	Liu, HQ; Li, Y; Chen, DP; Qi, ZM; Wang, QH; Wang, JH; Jiang, C; Xu, JR				Liu, Huiquan; Li, Yang; Chen, Daipeng; Qi, Zhaomei; Wang, Qinhu; Wang, Jianhua; Jiang, Cong; Xu, Jin-Rong			A-to-I RNA editing is developmentally regulated and generally adaptive for sexual reproduction in Neurospora crassa	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						Neurospora; RNA editing; perithecia; RNA modification; adaptive evolution	HIGH-THROUGHPUT; TEMPERATURE ADAPTATION; SEQUENCE ALIGNMENTS; FILAMENTOUS FUNGUS; GLOBAL ANALYSIS; PROTEIN-KINASE; K+ CHANNELS; MAP KINASE; GENES; TRANSCRIPTION	Although fungi lack adenosine deaminase acting on RNA (ADAR) enzymes, adenosine to inosine (A-to-I) RNA editing was reported recently in Fusarium graminearum during sexual reproduction. In this study, we profiled the A-to-I editing landscape and characterized its functional and adaptive properties in the model filamentous fungus Neurospora crassa. A total of 40,677 A-to-I editing sites were identified, and approximately half of them displayed stage-specific editing or editing levels at different sexual stages. RNA-sequencing analysis with the Delta stc-1 and Delta sad-1 mutants confirmed A-to-I editing occurred before ascus development but became more prevalent during ascosporogenesis. Besides fungal-specific sequence and secondary structure preference, 63.5% of A-to-I editing sites were in the coding regions and 81.3% of them resulted in nonsynonymous recoding, resulting in a significant increase in the proteome complexity. Many genes involved in RNA silencing, DNA methylation, and histone modifications had extensive recoding, including sad-1, sms-3, qde-1, and dim-2. Fifty pseudogenes harbor premature stop codons that require A-to-I editing to encode full-length proteins. Unlike in humans, nonsynonymous editing events in N. crassa are generally beneficial and favored by positive selection. Almost half of the nonsynonymous editing sites in N. crassa are conserved and edited in Neurospora tetrasperma. Furthermore, hundreds of them are conserved in F. graminearum and had higher editing levels. Two unknown genes with editing sites conserved between Neurospora and Fusarium were experimentally shown to be important for ascosporogenesis. This study comprehensively analyzed A-to-I editing in N. crassa and showed that RNA editing is stage-specific and generally adaptive, and may be functionally related to repeat induced point mutation and meiotic silencing by unpaired DNA.	[Liu, Huiquan; Chen, Daipeng; Qi, Zhaomei; Wang, Qinhu; Jiang, Cong] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Li, Yang; Chen, Daipeng; Wang, Jianhua; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Liu, HQ (reprint author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Xu, JR (reprint author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	liuhuiquan@nwsuaf.edu.cn; jinrong@purdue.edu		Wang, Qinhu/0000-0003-1251-073X; Liu, Huiquan/0000-0002-4723-845X	NIH Program Project grant; National Science Fund for Excellent Young Scholars [31622045]; Purdue University AgSEED; Special Fund for Agro-Scientific Research in the Public Interest [201303016]	We thank Dr. Michael Freitag (Oregon State University) and the FGSC for providing most of the strains used in this study, and an NIH Program Project grant for funding the generation of the Neurospora deletion set. We also thank Dr. ChenfangWang for fruitful discussions. This work was supported by grants from the National Science Fund for Excellent Young Scholars (Grant 31622045), Purdue University AgSEED, and the Special Fund for Agro-Scientific Research in the Public Interest (Grant 201303016).	Alon S, 2015, ELIFE, V4, DOI 10.7554/eLife.05198; Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1                                                   ; Aramayo R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017921; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Benz JP, 2014, MOL MICROBIOL, V91, P275, DOI 10.1111/mmi.12459; Borkovich KA, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P1; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Burt A, 2000, EVOLUTION, V54, P337; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Collopy PD, 2010, METHODS MOL BIOL, V638, P33, DOI 10.1007/978-1-60761-611-5_3; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Duan Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006648; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; Ellison CE, 2011, GENETICS, V189, P55, DOI 10.1534/genetics.111.130690; Garrett S, 2012, SCIENCE, V335, P848, DOI 10.1126/science.1212795; Garrett SC, 2012, PHYSIOLOGY, V27, P362, DOI 10.1152/physiol.00029.2012; Ghosh A, 2014, G3-GENES GENOM GENET, V4, P349, DOI 10.1534/g3.113.008813; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Gommans WM, 2009, BIOESSAYS, V31, P1137, DOI 10.1002/bies.200900045; Grice LF, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0279-3; Hammond TM, 2012, P NATL ACAD SCI USA, V109, P12093, DOI 10.1073/pnas.1203267109; Jin YF, 2009, IUBMB LIFE, V61, P572, DOI 10.1002/iub.207; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kim H, 2012, GENETICS, V190, P1389, DOI 10.1534/genetics.111.136358; KOLTIN Y, 1975, MUTAT RES, V27, P319, DOI 10.1016/0027-5107(75)90288-2; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309                                                        ; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leeder AC, 2013, GENETICS, V195, P883, DOI 10.1534/genetics.113.156984; Lew RR, 2008, EUKARYOT CELL, V7, P647, DOI 10.1128/EC.00411-07; Lewis ZA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001196; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liscovitch-Brauer N, 2017, CELL, V169, P191, DOI 10.1016/j.cell.2017.03.025; Liu HQ, 2016, GENOME RES, V26, P499, DOI 10.1101/gr.199877.115; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; McCluskey K, 2011, G3-GENES GENOM GENET, V1, P303, DOI 10.1534/g3.111.000307; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321                                                           ; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Park G, 2011, METHODS MOL BIOL, V722, P179, DOI 10.1007/978-1-61779-040-9_13; Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9; Picardi E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14941; Picardi E, 2013, BIOINFORMATICS, V29, P1813, DOI 10.1093/bioinformatics/btt287; Poggeler S, 2006, FRUITING BODY DEV AS, P325; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286                                                           ; Raju NB, 2009, J BIOSCIENCES, V34, P139, DOI 10.1007/s12038-009-0015-5                                                       ; Rattray A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004910; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Savva YA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1789; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Seeburg PH, 1996, J NEUROCHEM, V66, P1; SELKER EU, 1987, CELL, V51, P741, DOI 10.1016/0092-8674(87)90097-3                                                    ; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Teichert I, 2017, GENOME BIOL EVOL, V9, P855, DOI 10.1093/gbe/evx052; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wang CF, 2016, RNA BIOL, V13, P940, DOI 10.1080/15476286.2016.1215796; Wang Z, 2014, EUKARYOT CELL, V13, P154, DOI 10.1128/EC.00248-13; Wu C, 2014, G3-GENES GENOM GENET, V4, P1731, DOI 10.1534/g3.114.012617; Xiang QJ, 2002, GENETICS, V160, P169; Xu GX, 2014, P NATL ACAD SCI USA, V111, P3769, DOI 10.1073/pnas.1321745111; Yamashita K, 2008, FUNGAL GENET BIOL, V45, P1562, DOI 10.1016/j.fgb.2008.09.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006191; Zhang R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006563; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	75	0	0	7	7	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 12	2017	114	37					E7756	E7765		10.1073/pnas.1702591114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FG4YP	WOS:000410293400012	28847945				2018-01-05	
J	Zhao, T; Hong, Y; Yin, P; Li, SH; Li, XJ				Zhao, Ting; Hong, Yan; Yin, Peng; Li, Shihua; Li, Xiao-Jiang			Differential HspBP1 expression accounts for the greater vulnerability of neurons than astrocytes to misfolded proteins	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						polyglutamine; Huntington; chaperone; misfolding; neurodegeneration	HUNTINGTONS-DISEASE MICE; UBIQUITIN LIGASE CHIP; NEURODEGENERATIVE DISEASES; PREFERENTIAL ACCUMULATION; STRESS-RESPONSE; GLIAL-CELLS; HEAT-SHOCK; BRAIN; DEGENERATION; DEGRADATION	Although it is well known that astrocytes are less vulnerable than neurons in neurodegenerative diseases, the mechanism behind this differential vulnerability is unclear. Here we report that neurons and astrocytes show markedly different activities in C terminus of Hsp70-interacting protein (CHIP), a cochaperone of Hsp70. In astrocytes, CHIP is more actively monoubiquitinated and binds to mutant huntingtin (mHtt), the Huntington's disease protein, more avidly, facilitating its K48-linked polyubiquitination and degradation. Astrocytes also show the higher level and heat-shock induction of Hsp70 and faster CHIP-mediated degradation of various misfolded proteins than neurons. In contrast to astrocytes, neurons express abundant HspBP1, a CHIP inhibitory protein, resulting in the low activity of CHIP. Silencing HspBP1 expression via CRISPR-Cas9 in neurons ameliorated mHtt aggregation and neuropathology in HD knockin mouse brains. Our findings indicate a critical role of HspBP1 in differential CHIP/Hsp70 activities in neuronal and glial cells and the greater neuronal vulnerability to misfolded proteins in neurodegenerative diseases.	[Zhao, Ting; Hong, Yan; Yin, Peng; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Li, Xiao-Jiang] Jinan Univ, Guangdong Hong Kong Macau Inst CNS Regenerat, Guangzhou 510632, Guangdong, Peoples R China	Li, SH; Li, XJ (reprint author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.; Li, XJ (reprint author), Jinan Univ, Guangdong Hong Kong Macau Inst CNS Regenerat, Guangzhou 510632, Guangdong, Peoples R China.	sli@emory.edu; xli2@emory.edu			NIH [NS101701, NS036232, NS095279, NS095181]; National Natural Science Foundation [91332206]	We thank Marta Gaertig for maintaining HD140Q KI mice, Cheryl Strauss for critical reading of this manuscript, and the Integrated Cellular Imaging Core at Emory University for the use of imaging facilities. This work was supported by NIH Grants [NS101701 and NS036232 (to X.-J.L.) and NS095279 and NS095181 (to S.L.)] and the National Natural Science Foundation (91332206).	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Batulan Z, 2003, J NEUROSCI, V23, P5789; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529                                                            ; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Lee JS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.181; Li H, 2001, J NEUROSCI, V21, P8473; LI Y, 1992, ACTA NEUROPATHOL, V84, P94, DOI 10.1007/BF00427221                                                              ; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marcuccilli CJ, 1996, J NEUROSCI, V16, P478; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162                                                                ; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Paul I, 2013, ONCOGENE, V32, P1284, DOI 10.1038/onc.2012.144; Pimienta G, 2011, MOL PHARMACEUT, V8, P2252, DOI 10.1021/mp200346y; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Tsvetkov AS, 2013, NAT CHEM BIOL, V9, P586, DOI [10.1038/NCHEMBIO.1308, 10.1038/nchembio.1308]; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Valencia A, 2013, J HUNTINGTONS DIS, V2, P459, DOI 10.3233/JHD-130080; Yan S, 2014, HUM MOL GENET, V23, P2678, DOI 10.1093/hmg/ddt662; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhao T, 2016, J NEUROSCI, V36, P8317, DOI 10.1523/JNEUROSCI.0806-16.2016	31	0	0	6	6	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 12	2017	114	37					E7803	E7811		10.1073/pnas.1710549114				9	Multidisciplinary Sciences	Science & Technology - Other Topics	FG4YP	WOS:000410293400017	28847953				2018-01-05	
J	Godfray, HCJ; North, A; Burt, A				Godfray, H. Charles J.; North, Ace; Burt, Austin			How driving endonuclease genes can be used to combat pests and disease vectors	BMC BIOLOGY			English	Review						Gene drive; Gene editing; Endonucleases; CRISPR-Cas9; Vector control; Pest control; Mosquitoes	HOMING ENDONUCLEASE; ANOPHELES-GAMBIAE; SEX-RATIO; NATURAL-POPULATIONS; MALARIA MOSQUITO; AEDES-AEGYPTI; DYNAMICS; SYSTEM; REQUIREMENTS; ELIMINATION	Driving endonuclease genes (DEGs) spread through a population by a non-Mendelian mechanism. In a heterozygote, the protein encoded by a DEG causes a double-strand break in the homologous chromosome opposite to where its gene is inserted and when the break is repaired using the homologue as a template the DEG heterozygote is converted to a homozygote. Some DEGs occur naturally while several classes of endonucleases can be engineered to spread in this way, with CRISPR-Cas9 based systems being particularly flexible. There is great interest in using driving endonuclease genes to impose a genetic load on insects that vector diseases or are economic pests to reduce their population density, or to introduce a beneficial gene such as one that might interrupt disease transmission. This paper reviews both the population genetics and population dynamics of DEGs. It summarises the theory that guides the design of DEG constructs intended to perform different functions. It also reviews the studies that have explored the likelihood of resistance to DEG phenotypes arising, and how this risk may be reduced. The review is intended for a general audience and mathematical details are kept to a minimum.	[Godfray, H. Charles J.; North, Ace] Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3PS, England; [Burt, Austin] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England	Godfray, HCJ (reprint author), Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3PS, England.	charles.godfray@zoo.ox.ac.uk			Bill & Melinda Gates Foundation	We thank Anne Deredec, Philip Eckhoff, Ben Lambert and the members of the Target Malaria Consortium for valuable discussion. The authors are supported by a grant from the Bill & Melinda Gates Foundation.	Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003; Alphey L, 2016, NAT BIOTECHNOL, V34, P149, DOI 10.1038/nbt.3473; Alphey N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1071; Anderson R. M., 1991, INFECT DIS HUMANS; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87                                                             ; Beaghton A, 2017, GENETICS, V205, P1587, DOI 10.1534/genetics.116.197632; Beaghton A, 2016, THEOR POPUL BIOL, V108, P51, DOI 10.1016/j.tpb.2015.11.005; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A., 2006, GENES CONFLICT; Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; CRAIG GB, 1960, SCIENCE, V132, P1887, DOI 10.1126/science.132.3443.1887; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eckhoff PA, 2017, P NATL ACAD SCI USA, V114, pE255, DOI 10.1073/pnas.1611064114; Esvelt K, 2016, NATURE, V534, P153, DOI 10.1038/534153a; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x                                              ; Galizi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31139; Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977; Gantz VM, 2016, BIOESSAYS, V38, P50, DOI 10.1002/bies.201500102; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Hancock PA, 2009, P R SOC B, V276, P71, DOI 10.1098/rspb.2008.0689; HICKEY WA, 1966, GENETICS, V53, P1177; Huang YX, 2007, EVOLUTION, V61, P717, DOI 10.1111/j.1558-5646.2007.00075.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077                                           ; Leftwich PT, 2016, EVOL APPL, V9, P212, DOI 10.1111/eva.12280; LYIMO EO, 1992, PARASITOLOGY, V104, P233, DOI 10.1017/S0031182000061667                                                       ; MACDONALD G, 1957, EPIDEMIOLOGY CONTROL; Marshall JM, 2016, SCI REP UK IN PRESS; May R. M., 1974, STABILITY COMPLEXITY; Molineaux L, 1980, THE GARKI PROJECT; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964; North A, 2013, J APPL ECOL, V50, P1216, DOI 10.1111/1365-2664.12133; Ovaskainen O, 2016, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780198714866.001.0001; Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Tuljapurkar SD, 1990, POPULATION DYNAMICS; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Unckless RL, 2015, GENETICS, V201, P425, DOI 10.1534/genetics.115.177592; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; Wu B, 2016, NAT BIOTECHNOL, V34, P137, DOI 10.1038/nbt.3444; Yajima H, 2013, DNA REPAIR, V12, P936, DOI 10.1016/j.dnarep.2013.08.009	62	0	0	23	23	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1741-7007			BMC BIOL	BMC Biol.	SEP 11	2017	15								81	10.1186/s12915-017-0420-4				12	Biology	Life Sciences & Biomedicine - Other Topics	FG4MV	WOS:000410232800002	28893259	gold			2018-01-05	
J	Liu, ZP; Chen, SL; Jin, X; Wang, QK; Yang, KX; Li, CL; Xiao, QQ; Hou, PP; Liu, S; Wu, SS; Hou, W; Xiong, Y; Kong, CY; Zhao, XX; Wu, L; Li, CM; Sun, GH; Guo, DY				Liu, Zhepeng; Chen, Shuliang; Jin, Xu; Wang, Qiankun; Yang, Kongxiang; Li, Chenlin; Xiao, Qiaoqiao; Hou, Panpan; Liu, Shuai; Wu, Shaoshuai; Hou, Wei; Xiong, Yong; Kong, Chunyan; Zhao, Xixian; Wu, Li; Li, Chunmei; Sun, Guihong; Guo, Deyin			Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4(+) T cells from HIV-1 infection	CELL AND BIOSCIENCE			English	Article						CRISPR-Cas9; CCR5 and CXCR4 simultaneous; HIV-1; AIDS	IMMUNODEFICIENCY-VIRUS-INFECTION; PLURIPOTENT STEM-CELLS; ZINC-FINGER NUCLEASES; ANTIRETROVIRAL THERAPY; PROGENITOR CELLS; RESISTANCE; GENE; STRATEGIES; MECHANISM; MUTATION	Background: The main approach to treat HIV-1 infection is combination antiretroviral therapy (cART). Although cART is effective in reducing HIV-1 viral load and controlling disease progression, it has many side effects, and is expensive for HIV-1 infected patients who must remain on lifetime treatment. HIV-1 gene therapy has drawn much attention as studies of genome editing tools have progressed. For example, zinc finger nucleases (ZFN), transcription activator like effector nucleases (TALEN) and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 have been utilized to successfully disrupt the HIV-1 co-receptors CCR5 or CXCR4, thereby restricting HIV-1 infection. However, the effects of simultaneous genome editing of CXCR4 and CCR5 by CRISPR-Cas9 in blocking HIV-1 infection in primary CD4(+) T cells has been rarely reported. Furthermore, combination of different target sites of CXCR4 and CCR5 for disruption also need investigation. Results: In this report, we designed two different gRNA combinations targeting both CXCR4 and CCR5, in a single vector. The CRISPR-sgRNAs-Cas9 could successfully induce editing of CXCR4 and CCR5 genes in various cell lines and primary CD4(+) T cells. Using HIV-1 challenge assays, we demonstrated that CXCR4-tropic or CCR5-tropic HIV-1 infections were significantly reduced in CXCR4- and CCR5-modified cells, and the modified cells exhibited a selective advantage over unmodified cells during HIV-1 infection. The off-target analysis showed that no non-specific editing was identified in all predicted sites. In addition, apoptosis assays indicated that simultaneous disruption of CXCR4 and CCR5 in primary CD4(+) T cells by CRISPR-Cas9 had no obvious cytotoxic effects on cell viability. Conclusions: Our results suggest that simultaneous genome editing of CXCR4 and CCR5 by CRISPR-Cas9 can potentially provide an effective and safe strategy towards a functional cure for HIV-1 infection.	[Liu, Zhepeng; Chen, Shuliang; Wang, Qiankun; Li, Chenlin; Xiao, Qiaoqiao; Liu, Shuai; Wu, Shaoshuai; Hou, Wei; Kong, Chunyan; Zhao, Xixian; Li, Chunmei; Sun, Guihong; Guo, Deyin] Wuhan Univ, Sch Basic Med Sci, Wuhan 430072, Hubei, Peoples R China; [Chen, Shuliang; Wu, Li] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Jin, Xu] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Yang, Kongxiang; Hou, Panpan] Wuhan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Xiong, Yong] Wuhan Univ, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Li, Chunmei; Guo, Deyin] Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou 510080, Guangdong, Peoples R China	Chen, SL; Guo, DY (reprint author), Wuhan Univ, Sch Basic Med Sci, Wuhan 430072, Hubei, Peoples R China.; Chen, SL (reprint author), Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA.; Guo, DY (reprint author), Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou 510080, Guangdong, Peoples R China.	chen-shuliang@whu.edu.cn; dguo@whu.edu.cn		Wu, Li/0000-0002-5468-2487	China National Special Research Program of Major Infectious Diseases [2014ZX10001003]; Hubei Provincial Science & Technology Innovation Team Grant [2012FFA043]; Hubei Province's Outstanding Medical Academic Leader Program; Natural Science Foundation of China [81401659]; China Postdoctoral Science Foundation [2015T80838, 2014M560622]; China Scholarship Council	This work was funded by the China National Special Research Program of Major Infectious Diseases (2014ZX10001003) and Hubei Provincial Science & Technology Innovation Team Grant (#2012FFA043). DG is supported by the Hubei Province's Outstanding Medical Academic Leader Program. This work was also supported by the Natural Science Foundation of China (81401659) and China Postdoctoral Science Foundation (2015T80838 and 2014M560622) to SC. This work is partially supported by the scholarships from the China Scholarship Council.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Badia R, 2014, J ANTIMICROB CHEMOTH, V69, P1755, DOI 10.1093/jac/dku072; Bayer R, 1983, AIDS Res, V1, P275, DOI 10.1089/aid.1.1983.1.275; Blas-Garcia A, 2011, CURR PHARM DESIGN, V17, P4076, DOI 10.2174/138161211798764951                                                      ; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chung SH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3158; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cunningham AL, 2010, CURR OPIN MICROBIOL, V13, P524, DOI 10.1016/j.mib.2010.06.002; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Didigu CA, BLOOD; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Duan JZ, 2014, CELL RES, V24, P1009, DOI 10.1038/cr.2014.87; Durand CM, 2012, TRENDS IMMUNOL, V33, P554, DOI 10.1016/j.it.2012.07.001; Finzi D, 1999, NAT MED, V5, P512; Gao GZ, 2013, J BIOL CHEM, V288, P14297, DOI 10.1074/jbc.M112.438465; Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hutter G, 2015, VIRUSES-BASEL, V7, P4186, DOI 10.3390/v7082816; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang H, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.42; KIM SY, 1989, J VIROL, V63, P3708; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; Kordelas L, 2014, NEW ENGL J MED, V371, P880, DOI 10.1056/NEJMc1405805; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017                                                ; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; Poveda E, 2015, AIDS REV, V17, P65; Shi BJ, 2017, JAIDS-J ACQ IMM DEF, V74, P229, DOI 10.1097/QAI.0000000000001190; Siliciano JD, 2013, CURR OPIN HIV AIDS, V8, P318, DOI 10.1097/COH.0b013e328361eaca; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Update on acquired immune deficiency syndrome (AIDS)-United States, 1982, MMWR, V31, p[507, 13]; Wang C, 2014, J INFECT DIS, V210, P1838, DOI 10.1093/infdis/jiu338; Wang W, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1016/J.GR.2014.02.002; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Yu S, 2017, HUMAN GENE THERAPY; Yuan JY, 2012, MOL THER, V20, P849, DOI 10.1038/mt.2011.310; Zheng YH, 2005, IMMUNOL LETT, V97, P225, DOI 10.1016/j.imlet.2004.11.026	49	1	1	31	31	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2045-3701			CELL BIOSCI	Cell Biosci.	SEP 9	2017	7								47	10.1186/s13578-017-0174-2				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FG5PL	WOS:000410380900001	28904745	gold			2018-01-05	
J	Bellmaine, SF; Ovchinnikov, DA; Manallack, DT; Cuddy, CE; Elefanty, AG; Stanley, EG; Wolvetang, EJ; Williams, SJ; Pera, M				Bellmaine, Stephanie F.; Ovchinnikov, Dmitry A.; Manallack, David T.; Cuddy, Claire E.; Elefanty, Andrew G.; Stanley, Edouard G.; Wolvetang, Ernst J.; Williams, Spencer J.; Pera, Martin			Inhibition of DYRK1A disrupts neural lineage specificationin human pluripotent stem cells	ELIFE			English	Article							SYNDROMIC INTELLECTUAL DISABILITY; PROTEIN-KINASE DYRK1A; DOWN-SYNDROME; NEURONAL DIFFERENTIATION; ALZHEIMERS-DISEASE; CYCLE EXIT; GENE; PROLIFERATION; FATE; MNB/DYRK1A	Genetic analysis has revealed that the dual specificity protein kinase DYRK1A has multiple roles in the development of the central nervous system. Increased DYRK1A gene dosage, such as occurs in Down syndrome, is known to affect neural progenitor cell differentiation, while haploinsufficiency of DYRK1A is associated with severe microcephaly. Using a set of known and newly synthesized DYRK1A inhibitors, along with CRISPR-mediated gene activation and shRNA knockdown of DYRK1A, we show here that chemical inhibition or genetic knockdown of DYRK1A interferes with neural specification of human pluripotent stem cells, a process equating to the earliest stage of human brain development. Specifically, DYRK1A inhibition insulates the self-renewing subpopulation of human pluripotent stem cells from powerful signals that drive neural induction. Our results suggest a novel mechanism for the disruptive effects of the absence or haploinsufficiency of DYRK1A on early mammalian development, and reveal a requirement for DYRK1A in the acquisition of competence for differentiation in human pluripotent stem cells.	[Bellmaine, Stephanie F.; Williams, Spencer J.] Univ Melbourne, Sch Chem, Melbourne, Vic, Australia; [Bellmaine, Stephanie F.; Cuddy, Claire E.; Pera, Martin] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Bellmaine, Stephanie F.; Williams, Spencer J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Ovchinnikov, Dmitry A.; Wolvetang, Ernst J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Manallack, David T.] Monash Univ, Fac Pharm & Pharmaceut Sci, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Anat & Dev Biol, Melbourne, Vic, Australia; [Pera, Martin] Florey Neurosci & Mental Hlth Inst, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia	Pera, M (reprint author), Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia.; Pera, M (reprint author), Florey Neurosci & Mental Hlth Inst, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.	mpera@unimelb.edu.au		Pera, Martin/0000-0001-6239-0428; Wolvetang, Ernst/0000-0002-2146-6614	Australian Research Council (Special Research Initiative) [SR1101002]; National Health and Medical Research Council; University of Melbourne (Strategic APA)	Australian Research Council Special Research Initiative SR1101002 Dmitry A Ovchinnikov Andrew G Elefanty Edouard G Stanley Ernst J Wolvetang Martin Pera; National Health and Medical Research Council Senior Research Fellowship Andrew G Elefanty Edouard G Stanley; University of Melbourne Strategic APA Stephanie F Bellmaine Spencer J Williams Martin Pera; The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Abbassi R, 2015, PHARMACOL THERAPEUT, V151, P87, DOI 10.1016/j.pharmthera.2015.03.004; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Boward B, 2016, STEM CELLS, V34, P1427, DOI 10.1002/stem.2345; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Bronicki LM, 2015, EUR J HUM GENET, V23, P1482, DOI 10.1038/ejhg.2015.29; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chambers Stuart M, 2016, Methods Mol Biol, V1307, P329, DOI 10.1007/7651_2013_59; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Courcet JB, 2012, J MED GENET, V49, P731, DOI 10.1136/jmedgenet-2012-101251; Coutadeur S, 2015, J NEUROCHEM, V133, P440, DOI 10.1111/jnc.13018; Dang T, 2017, MOL PSYCHIAT; Davis RP, 2008, NAT PROTOC, V3, P1550, DOI 10.1038/nprot.2008.146; Denham M, 2015, STEM CELLS, V33, P1759, DOI 10.1002/stem.1991; Denham M, 2012, STEM CELLS, V30, P2400, DOI 10.1002/stem.1204; Duchon A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00104; Evers JMG, 2017, HUM MOL GENET, V26, P519, DOI 10.1093/hmg/ddw409; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Hasegawa K, 2012, STEM CELL TRANSL MED, V1, P18, DOI 10.5966/sctm.2011-0033; Hough SR, 2014, STEM CELL REP, V2, P881, DOI 10.1016/j.stemcr.2014.04.014; Ji JL, 2015, EUR J HUM GENET, V23, P1473, DOI 10.1038/ejhg.2015.71; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Najas S, 2015, EBIOMEDICINE, V2, P120, DOI 10.1016/j.ebiom.2015.01.010; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Shen WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9372; Smith B, 2012, ACS CHEM NEUROSCI, V3, P857, DOI 10.1021/cn300094k; Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104; Stotani S, 2016, FUTURE MED CHEM, V8, P681, DOI 10.4155/fmc-2016-0013; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; van Bon BWM, 2016, MOL PSYCHIATR, V21, P126, DOI 10.1038/mp.2015.5; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yamamoto T, 2011, AM J MED GENET A, V155A, P113, DOI 10.1002/ajmg.a.33735; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017	38	0	0	2	2	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	SEP 8	2017	6								e24502	10.7554/eLife.24502				20	Biology	Life Sciences & Biomedicine - Other Topics	FK7XN	WOS:000413721200001		gold			2018-01-05	
J	Ma, YT; Leonard, SM; Gordon, N; Anderton, J; James, C; Huen, D; Woodman, CB; Palmer, DH				Ma, Yuk Ting; Leonard, Sarah M.; Gordon, Naheema; Anderton, Jennifer; James, Claire; Huen, David; Woodman, Ciaran B.; Palmer, Daniel H.			Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer	ONCOTARGET			English	Article						haploid genetic screen; biomarkers; epigenetic therapy; pancreatic cancer	HISTONE DEACETYLASE INHIBITOR; REFRACTORY SOLID TUMORS; DEOXYCYTIDINE KINASE; TRICHOSTATIN-A; DOUBLE-BLIND; HUMAN-CELLS; PHASE-II; GEMCITABINE; RESISTANCE; MECHANISMS	The ability to develop a comprehensive panel of treatment predicting factors would significantly improve our ability to stratify patients for cytotoxic or targeted therapies, and prevent patients receiving ineffective treatments. We have investigated if a recently developed genome-wide haploid genetic screen can be used to reveal the critical mediators of response to anticancer therapy. Pancreatic cancer is known to be highly resistant to systemic therapy. Recently epigenetic changes have been shown to be a key determinant in the maintenance of subpopulations of cancer cells with high-level resistance to cytotoxic therapy. We show that in human pancreatic cancer cell lines, treatment with the potent class I histone deacetylase inhibitor, entinostat, synergistically enhances gemcitabine-induced inhibition of cell proliferation and apoptosis. Using a genome-wide haploid genetic screen, we identified deoxycytidine kinase (DCK) as one of the genes with the highest degree of insertional enrichment following treatment with gemcitabine and entinostat; DCK is already known to be the rate-limiting activating enzyme for gemcitabine. Immunoblotting confirmed loss of DCK protein expression in the resistant KBM7 cells. CRISPR/Cas-9 inactivation of DCK in pancreatic cancer cell lines resulted in resistance to gemcitabine alone and in combination with entinostat. We have identified gemcitabine and entinostat as a potential new combination therapy in pancreatic cancer, and in this proof-of-principle study we have demonstrated that a recently developed haploid genetic screen can be used as a novel approach to identify the critical genes that determine treatment response.	[Ma, Yuk Ting; Leonard, Sarah M.; Gordon, Naheema; Anderton, Jennifer; James, Claire; Woodman, Ciaran B.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Huen, David] Wolverhampton Univ, Fac Sci & Engn, Wolverhampton, W Midlands, England; [Palmer, Daniel H.] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England	Ma, YT (reprint author), Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England.	y.t.ma@bham.ac.uk			Cancer Research UK; University of Birmingham (College of Medical and Dental Sciences Innovative Biomedicine Award); Queen Elizabeth Hospital Birmingham Charity	This work was supported by funding from Cancer Research UK, the University of Birmingham (College of Medical and Dental Sciences Innovative Biomedicine Award) and the Queen Elizabeth Hospital Birmingham Charity.	Ammerpohl O, 2007, BRIT J CANCER, V96, P73, DOI 10.1038/sj.bjc.6603511; Arnold NB, 2007, CLIN CANCER RES, V13, P18, DOI 10.1158/1078-0432.CCR-06-0914; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403                                                      ; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4                                                    ; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Donadelli M, 2007, BBA-MOL CELL RES, V1773, P1095, DOI 10.1016/j.bbamcr.2007.05.002; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Gore L, 2008, CLIN CANCER RES, V14, P4517, DOI 10.1158/1078-0432.CCR-07-1461; Heijink AM, 2015, P NATL ACAD SCI USA, V112, P15160, DOI 10.1073/pnas.1505283112; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Kroep JR, 2002, MOL CANCER THER, V1, P371; Lehmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-395; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Ohhashi S, 2008, ANTICANCER RES, V28, P2205; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Piacentini P, 2006, VIRCHOWS ARCH, V448, P797, DOI 10.1007/s00428-006-0173-x; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Richards DA, 2006, ANN ONCOL, V17, P1096, DOI 10.1093/annonc/mdl081; Rosmarin DM, 2012, P NATL ACAD SCI USA, V109, P10059, DOI 10.1073/pnas.1120244109; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Sebastiani V, 2006, CLIN CANCER RES, V12, P2492, DOI 10.1158/1078-0432.CCR-05-2655; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052095; Wijdeven RH, 2015, CANCER RES, V75, P4176, DOI 10.1158/0008-5472.CAN-15-0380; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251	31	0	0	8	8	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	SEP 8	2017	8	38					63635	63645		10.18632/oncotarget.18879				11	Oncology; Cell Biology	Oncology; Cell Biology	FG4XE	WOS:000410284800068	28969017				2018-01-05	
J	Aarnio-Peterson, M; Zhao, P; Yu, SH; Christian, C; Flanagan-Steet, H; Wells, L; Steet, R				Aarnio-Peterson, Megan; Zhao, Peng; Yu, Seok-Ho; Christian, Courtney; Flanagan-Steet, Heather; Wells, Lance; Steet, Richard			Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; PROTEIN-TYROSINE PHOSPHATASES; ALZHEIMERS AMYLOID-BETA; MUCOLIPIDOSIS-II; GAMMA-SUBUNIT; REVERSIBLE OXIDATION; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; SKIN FIBROBLASTS; DISEASE	Acid hydrolases utilize a carbohydrate-dependent mechanism for lysosomal targeting. These hydrolases acquire a mannose 6-phosphate tag by the action of the GlcNAc-1-phospho-transferase enzyme, allowing them to bind receptors and traffic to endosomes. Loss of GlcNAc-1-phosphotransferase results in hydrolase hypersecretion and profound lysosomal storage. Little, however, is known about how these cellular phenotypes affect the trafficking, activity, and localization of surface glycoproteins. To address this question, we profiled the abundance of surface glycoproteins in WT and CRISPR-mediated GNPTAB(-/-) HeLa cells and identified changes in numerous glycoproteins, including the uptake receptor LRP1 and multiple receptor tyrosine kinases. Decreased cell surface LRP1 in GNPTAB(-/-) cells corresponded with a reduction in its steady-state level and less amyloid-beta-40 (A beta 40) peptide uptake. GNPTAB(-/-) cells displayed elevated activation of several kinases including Met receptor. We found increased Met phosphorylation within both the kinase and the docking domains and observed that lower concentrations of pervanadate were needed to cause an increase in phospho-Met in GNPTAB(-/-) cells. Together, these data suggested a decrease in the activity of the receptor and non-receptor protein-tyrosine phosphatases that down-regulate Met phosphorylation. GNPTAB(-/-) cells exhibited elevated levels of reactive oxygen species, known to inactivate cell surface and cytosolic phosphatases by oxidation of active site cysteine residues. Consistent with this mode of action, peroxide treatment of parental HeLa cells elevated phospho-Met levels whereas antioxidant treatment of GNPTAB(-/-) cells reduced phospho-Met levels. Collectively, these findings identify new mechanisms whereby impaired lysosomal targeting can impact the activity and recycling of receptors.	[Aarnio-Peterson, Megan; Zhao, Peng; Yu, Seok-Ho; Christian, Courtney; Flanagan-Steet, Heather; Wells, Lance; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Steet, R (reprint author), 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu			National Institutes of Health [GM086524, GM107012]; Yash Gandhi Foundation	This work was supported by National Institutes of Health Grants GM086524 and GM107012 and the Yash Gandhi Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Boivin B, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975633; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0                                                   ; Clavijo-Cornejo D, 2013, BIOCHIMIE, V95, P1177, DOI 10.1016/j.biochi.2013.01.005; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; De Pace R, 2015, HUM MOL GENET, V24, P6826, DOI 10.1093/hmg/ddv387; De Pace R, 2014, HUM MUTAT, V35, P368, DOI 10.1002/humu.22502; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Dittmer F, 1999, J CELL SCI, V112, P1591; Flanagan-Steet H, 2016, J BONE MINER RES, V31, P535, DOI 10.1002/jbmr.2722; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Godfrey R, 2012, BLOOD, V119, P4499, DOI 10.1182/blood-2011-02-336446; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Gomez-Quiroz LE, 2016, TOXICOLOGY, V361, P39, DOI 10.1016/j.tox.2016.07.004; Gujdar A, 2004, CELL SIGNAL, V16, P505, DOI 10.1016/j.cellsig.2003.09.009; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Liu CC, 2017, J NEUROSCI, V37, P4023, DOI 10.1523/JNEUROSCI.3442-16.2017; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Mana G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13546; Markmann S, 2015, TRAFFIC, V16, P743, DOI 10.1111/tra.12284; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mbua NE, 2013, P NATL ACAD SCI USA, V110, P10207, DOI 10.1073/pnas.1221105110; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8                                                   ; Otomo T, 2011, J BIOL CHEM, V286, P35283, DOI 10.1074/jbc.M111.267930; Otomo T, 2009, MOL GENET METAB, V98, P393, DOI 10.1016/j.ymgme.2009.07.002; Owen JB, 2010, FREE RADICAL BIO MED, V49, P1798, DOI 10.1016/j.freeradbiomed.2010.09.013; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; Pohl S, 2010, AM J MED GENET A, V152A, P124, DOI 10.1002/ajmg.a.33170; Qian Y, 2015, J BIOL CHEM, V290, P3045, DOI 10.1074/jbc.M114.612507; REITMAN ML, 1981, J BIOL CHEM, V256, P1977; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Stewart F, 1996, Rev Reprod, V1, P144, DOI 10.1530/revreprod/1.3.144; Storck SE, 2016, J CLIN INVEST, V126, P123, DOI 10.1172/JCI81108; Sun TT, 2016, J AM CHEM SOC, V138, P11575, DOI 10.1021/jacs.6b04049; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tseng WL, 2017, CELL TRANSPLANT, V26, P513, DOI 10.3727/096368916X694265; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; van Meel E, 2016, J BIOL CHEM, V291, P8295, DOI 10.1074/jbc.M116.714568; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Yang WH, 2015, P NATL ACAD SCI USA, V112, P13657, DOI 10.1073/pnas.1515464112; Yu SH, 2016, J BIOL CHEM, V291, P3982, DOI 10.1074/jbc.M115.700369; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	57	0	0	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15094	15104		10.1074/jbc.M117.790139				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FG2FL	WOS:000409902100031	28724630				2018-01-05	
J	Vella, MR; Gunning, CE; Lloyd, AL; Gould, F				Vella, Michael R.; Gunning, Christian E.; Lloyd, Alun L.; Gould, Fred			Evaluating strategies for reversing CRISPR-Cas9 gene drives	SCIENTIFIC REPORTS			English	Article							ROCK-PAPER-SCISSORS; POPULATIONS; EVOLUTION; ENDONUCLEASE; GAME	A gene drive biases inheritance of a gene so that it increases in frequency within a population even when the gene confers no fitness benefit. There has been renewed interest in environmental releases of engineered gene drives due to recent proof of principle experiments with the CRISPR-Cas9 system as a drive mechanism. Release of modified organisms, however, is controversial, especially when the drive mechanism could theoretically alter all individuals of a species. Thus, it is desirable to have countermeasures to reverse a drive if a problem arises. Several genetic mechanisms for limiting or eliminating gene drives have been proposed and/or developed, including synthetic resistance, reversal drives, and immunizing reversal drives. While predictions about efficacy of these mechanisms have been optimistic, we lack detailed analyses of their expected dynamics. We develop a discrete time model for population genetics of a drive and proposed genetic countermeasures. Efficacy of drive reversal varies between countermeasures. For some parameter values, the model predicts unexpected behavior including polymorphic equilibria and oscillatory dynamics. The timing and number of released individuals containing a genetic countermeasure can substantially impact outcomes. The choice among countermeasures by researchers and regulators will depend on specific goals and population parameters of target populations.	[Vella, Michael R.; Lloyd, Alun L.] North Carolina State Univ, Dept Math, Biomath Grad Program, Raleigh, NC 27695 USA; [Vella, Michael R.; Lloyd, Alun L.; Gould, Fred] North Carolina State Univ, Genet Engn & Soc Ctr, Raleigh, NC 27695 USA; [Gunning, Christian E.; Gould, Fred] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA	Gould, F (reprint author), North Carolina State Univ, Genet Engn & Soc Ctr, Raleigh, NC 27695 USA.; Gould, F (reprint author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.	fred_gould@ncsu.edu			National Institutes of Health (NIH) [R01-A1091980]; W.M. Keck Foundation; National Science Foundation [RTG/DMS - 1246991, NSF-IGERT - 1068676]	This research was funded by the National Institutes of Health (NIH) grant R01-A1091980, the W.M. Keck Foundation, and the National Science Foundation (RTG/DMS - 1246991 and NSF-IGERT - 1068676). We thank Brandon Hollingsworth, Jaye Sudweeks, Sumit Dhole, Jennifer Baltzegar, Kevin Esvelt, Ethan Bier, Anthony James, and Valentino Gantz for helpful discussion.	BULL JJ, 2017, EVOL MED PUBLIC HLTH, V2017, P1, DOI DOI 10.1093/EMPH/E0W030; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Cameron DD, 2009, J ECOL, V97, P1311, DOI 10.1111/j.1365-2745.2009.01568.x; Champer J., 2017, BIORXIV; Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292                                                          ; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Gantz VM, 2016, BIOESSAYS, V38, P50, DOI 10.1002/bies.201500102; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hartl DL, 2007, PRINCIPLES POPULATIO; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Marshall J. M., 2017, SCI REPORTS, V7; National Academies of Sciences Engineering and Medicine (NASEM), 2016, GEN DRIV HOR ADV SCI; Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964; Okamoto KW, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002827; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Unckless R. L., 2015, GENETICS, V115; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Wu B, 2016, NAT BIOTECHNOL, V34, P137, DOI 10.1038/nbt.3444; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	24	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 8	2017	7								11038	10.1038/s41598-017-10633-2				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FG1VI	WOS:000409841100100	28887462	gold			2018-01-05	
J	Moller, AG; Liang, C				Moller, Abraham G.; Liang, Chun			MetaCRAST: reference-guided extraction of CRISPR spacers from unassembled metagenomes	PEERJ			English	Article						Metagenomics; Repetitive sequences; CRISPR; Microbial ecology; Virus-host interactions	SIMULATION; ALGORITHM; BACTERIA; PROGRAM; ARCHAEA; TOOL	Clustered regularly interspaced short palindromic repeat (CRISPR) systems are the adaptive immune systems of bacteria and archaea against viral infection. While CRISPRs have been exploited as a tool for genetic engineering, their spacer sequences can also provide valuable insights into microbial ecology by linking environmental viruses to their microbial hosts. Despite this importance, metagenomic CRISPR detection remains a major challenge. Here we present a reference-guided CRISPR spacer detection tool (Metagenomic CRISPR Reference-Aided Search Tool-MetaCRAST) that constrains searches based on user-specified direct repeats (DRs). These DRs could be expected from assembly or taxonomic profiles of metagenomes. We compared the performance of MetaCRAST to those of two existing metagenomic CRISPR detection tools-Crass and MinCED-using both real and simulated acid mine drainage (AMD) and enhanced biological phosphorus removal (EBPR) metagenomes. Our evaluation shows MetaCRAST improves CRISPR spacer detection in real metagenomes compared to the de novo CRISPR detection methods Crass and MinCED. Evaluation on simulated metagenomes show it performs better than de novo tools for Illumina metagenomes and comparably for 454 metagenomes. It also has comparable performance dependence on read length and community composition, run time, and accuracy to these tools. MetaCRAST is implemented in Perl, parallelizable through the Many Core Engine (MCE), and takes metagenomic sequence reads and direct repeat queries (FASTA or FASTQ) as input. It is freely available for download at https://github.com/molleraj/MetaCRAST.	[Moller, Abraham G.; Liang, Chun] Miami Univ, Dept Biol, Oxford, OH 45056 USA	Liang, C (reprint author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	liangc@miamioh.edu			Committee on Faculty Research (CFR) program; Office for the Advancement of Research & Scholarship (OARS); Academic Challenge grant from the Department of Biology (Miami University)	The project was funded by the Committee on Faculty Research (CFR) program, the Office for the Advancement of Research & Scholarship (OARS), and by an Academic Challenge grant from the Department of Biology (Miami University). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RE, 2011, FEMS MICROBIOL ECOL, V77, P120, DOI 10.1111/j.1574-6941.2011.01090.x; Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hurwitz B., 2014, PLANT AN GEN 22 C SA; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S4; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; MOLLER AG, 2017, PEERJ, V5, DOI DOI 10.7717/PEERJ.2844; Rho M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002441; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Sanguino L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv046; [Anonymous], 2016, MINCED MINING CRISPR; Skennerton CT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt183; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; WANG K, 2017, PEERJ, V5, DOI DOI 10.7717/PEERJ.3219.; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17; WU S, 1995, J ALGORITHM, V19, P346, DOI 10.1006/jagm.1995.1041                                                          ; Zhang Q, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1512-4	30	0	0	0	0	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	SEP 7	2017	5								e3788	10.7717/peerj.3788				17	Multidisciplinary Sciences	Science & Technology - Other Topics	FI4QV	WOS:000411958900004	28894651	gold			2018-01-05	
J	Forrest, MP; Zhang, HW; Moy, W; McGowan, H; Leites, C; Dionisio, LE; Xu, ZH; Shi, JX; Sanders, AR; Greenleaf, WJ; Cowan, CA; Pang, ZP; Gejman, PV; Penzes, P; Duan, JB				Forrest, Marc P.; Zhang, Hanwen; Moy, Winton; McGowan, Heather; Leites, Catherine; Dionisio, Leonardo E.; Xu, Zihui; Shi, Jianxin; Sanders, Alan R.; Greenleaf, William J.; Cowan, Chad A.; Pang, Zhiping P.; Gejman, Pablo V.; Penzes, Peter; Duan, Jubao			Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; BIPOLAR DISORDER; TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; SEQUENCE VARIATION; GENE-EXPRESSION; HUMAN GENOME; SCHIZOPHRENIA; MIR-137; BRAIN	Most disease variants lie within noncoding genomic regions, making their functional interpretation challenging. Because chromatin openness strongly influences transcriptional activity, we hypothesized that cell-type-specific open chromatin regions (OCRs) might highlight disease-relevant noncoding sequences. To investigate, we mapped global OCRs in neurons differentiating from hiPSCs, a cellular model for studying neurodevelopmental disorders such as schizophrenia (SZ). We found that the OCRs are highly dynamic and can stratify GWAS-implicated SZ risk variants. Of the more than 3,500 SZ-associated variants analyzed, we prioritized similar to 100 putatively functional ones located in neuronal OCRs, including rs1198588, at a leading risk locus flanking MIR137. Excitatory neurons derived from hiPSCs with CRISPR/Cas9-edited rs1198588 or a rare proximally located SZ risk variant showed altered MIR137 expression, dendrite arborization, and synapse maturation. Our study shows that noncoding disease variants in OCRs can affect neurodevelopment, and that analysis of open chromatin regions can help prioritize functionally relevant noncoding variants identified by GWAS.	[Forrest, Marc P.; Dionisio, Leonardo E.; Penzes, Peter] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Zhang, Hanwen; Moy, Winton; Leites, Catherine; Sanders, Alan R.; Gejman, Pablo V.; Duan, Jubao] NorthShore Univ HealthSyst, Ctr Psychiat Genet, Evanston, IL 60201 USA; [McGowan, Heather; Xu, Zihui; Pang, Zhiping P.] Rutgers State Univ, Dept Neurosci & Cell Biol, New Brunswick, NJ 08901 USA; [McGowan, Heather; Xu, Zihui; Pang, Zhiping P.] Rutgers State Univ, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Shi, Jianxin] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Sanders, Alan R.; Gejman, Pablo V.; Duan, Jubao] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Greenleaf, William J.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Penzes, P (reprint author), Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA.; Duan, JB (reprint author), NorthShore Univ HealthSyst, Ctr Psychiat Genet, Evanston, IL 60201 USA.; Duan, JB (reprint author), Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.	p-penzes@northwestern.edu; jduan@uchicago.edu		Forrest, Marc/0000-0002-9280-7850	Swiss National Science Foundation early postdoctoral mobility fellowship; NIH [F31NS084551]; Robert Wood Johnson Foundation;  [R21MH102685];  [R01MH106575];  [R01MH097216]	This work was supported by R21MH102685 and R01MH106575 (to J.D.), R01MH097216 (to P.P.), a Swiss National Science Foundation early postdoctoral mobility fellowship (to M.P.F.), and NIH grant F31NS084551 (to H.M.). Research in the Pang Laboratory was supported in part by the Robert Wood Johnson Foundation.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang YS, 2016, CELL, V167, P1734, DOI 10.1016/j.cell.2016.11.033; Bavamian S, 2015, MOL PSYCHIATR, V20, P573, DOI 10.1038/mp.2014.176; Blizinsky KD, 2016, P NATL ACAD SCI USA, V113, P8520, DOI 10.1073/pnas.1607014113; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Corvin A, 2016, SCHIZOPHRENIA BULL, V42, P538, DOI 10.1093/schbul/sbw014; Cotter D, 2000, SCHIZOPHR RES, V41, P313, DOI 10.1016/S0920-9964(99)00068-7; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Duan JB, 2014, AM J HUM GENET, V95, P744, DOI 10.1016/j.ajhg.2014.11.001; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Guella I, 2013, J PSYCHIATR RES, V47, P1215, DOI 10.1016/j.jpsychires.2013.05.021; Handel AE, 2017, HUM MOL GENET, V26, P79, DOI 10.1093/hmg/ddw369; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Konopaske GT, 2014, JAMA PSYCHIAT, V71, P1323, DOI 10.1001/jamapsychiatry.2014.1582; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li JC, 2016, MOL PSYCHIATR, V21, P290, DOI 10.1038/mp.2015.40; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Loohuis NFMO, 2015, CELL REP, V11, P1876, DOI 10.1016/j.celrep.2015.05.040; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Panchision DM, 2016, STEM CELLS, V34, P523, DOI 10.1002/stem.2295; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Patzke C, 2016, J EXP MED, V213, P499, DOI 10.1084/jem.20150951; Paul DS, 2014, BIOESSAYS, V36, P191, DOI 10.1002/bies.201300126; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rigamonti A, 2016, STEM CELL REP, V6, P993, DOI 10.1016/j.stemcr.2016.05.010; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roberts RC, 2008, SYNAPSE, V62, P616, DOI 10.1002/syn.20534; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seshadri M, 2017, ASIAN J PSYCHIATR, V25, P46, DOI 10.1016/j.ajp.2016.10.015; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi S, 2014, J BIOL CHEM, V289, P13434, DOI 10.1074/jbc.M113.535203; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Siegert S, 2015, NAT NEUROSCI, V18, P1008, DOI 10.1038/nn.4023; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Topol A, 2016, CELL REP, V15, P1024, DOI 10.1016/j.celrep.2016.03.090; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Volk L, 2015, ANNU REV NEUROSCI, V38, P127, DOI 10.1146/annurev-neuro-071714-033821; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wen ZX, 2016, CURR OPIN NEUROBIOL, V36, P118, DOI 10.1016/j.conb.2015.11.003; Wright Carrie, 2013, Frontiers in Genetics, V4, P58, DOI 10.3389/fgene.2013.00058; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	60	0	0	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 7	2017	21	3					305	+		10.1016/j.stem.2017.07.008				22	Cell & Tissue Engineering; Cell Biology	Cell Biology	FG1BN	WOS:000409527700009	28803920				2018-01-05	
J	Xu, T; Li, YC; He, ZL; van Nostrand, JD; Zhou, JZ				Xu, Tao; Li, Yongchao; He, Zhili; van Nostrand, Joy D.; Zhou, Jizhong			Cas9 Nickase-Assisted RNA Repression Enables Stable and Efficient Manipulation of Essential Metabolic Genes in Clostridium cellulolyticum	FRONTIERS IN MICROBIOLOGY			English	Article						essential genes; genome editing; gene repression; metabolic engineering; consolidated bioprocessing; Clostridium cellulolyticum	PLASMID COPY NUMBER; ANTISENSE RNA; ETHANOL; ACETOBUTYLICUM; THERMOCELLUM; EXPRESSION; CELLULOSE; CRISPR; FERMENTATION; STABILITY	Essential gene functions remain largely underexplored in bacteria. Clostridium cellulolyticum is a promising candidate for consolidated bioprocessing; however, its genetic manipulation to reduce the formation of less-valuable acetate is technically challenging due to the essentiality of acetate-producing genes. Here we developed a Cas9 nickase-assisted chromosome-based RNA repression to stably manipulate essential genes in C. cellulolyticum. Our plasmid-based expression of antisense RNA (asRNA) molecules targeting the phosphotransacetylase (pta) gene successfully reduced the enzymatic activity by 35% in cellobiose-grown cells, metabolically decreased the acetate titer by 15 and 52% in wildtype transformants on cellulose and xylan, respectively. To control both acetate and lactate simultaneously, we transformed the repression plasmid into lactate production-deficient mutant and found the plasmid delivery reduced acetate titer by more than 33%, concomitant with negligible lactate formation. The strains with pta gene repression generally diverted more carbon into ethanol. However, further testing on chromosomal integrants that were created by double-crossover recombination exhibited only very weak repression because DNA integration dramatically lessened gene dosage. With the design of a tandem repetitive promoter-driven asRNA module and the use of a new Cas9 nickase genome editing tool, a chromosomal integrant (LM3P) was generated in a single step and successfully enhanced RNA repression, with a 27% decrease in acetate titer on cellulose in antibioticfree medium. These results indicate the effectiveness of tandem promoter-driven RNA repression modules in promoting gene repression in chromosomal integrants. Our combinatorial method using a Cas9 nickase genome editing tool to integrate the gene repression module demonstrates easy-to-use and high-efficiency advantages, paving the way for stably manipulating genes, even essential ones, for functional characterization and microbial engineering.	[Xu, Tao; Li, Yongchao; He, Zhili; van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Xu, Tao; Li, Yongchao; He, Zhili; van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Lawrence Berkeley Natl Lab, Earth Sci Div, Berkeley, CA 94720 USA; [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing, Peoples R China	Zhou, JZ (reprint author), Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.; Zhou, JZ (reprint author), Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.; Zhou, JZ (reprint author), Lawrence Berkeley Natl Lab, Earth Sci Div, Berkeley, CA 94720 USA.; Zhou, JZ (reprint author), Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing, Peoples R China.	jzhou@ou.edu			NSF EPSCoR Program [EPS 0814361]	This work was supported by the NSF EPSCoR Program through the award EPS 0814361.	ANDERSCH W, 1983, EUR J APPL MICROBIOL, V18, P327, DOI 10.1007/BF00504740                                                              ; Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Barrangou R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0816-9; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Brown SD, 2011, P NATL ACAD SCI USA, V108, P13752, DOI 10.1073/pnas.1102444108; Cheung JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005849; Desai RP, 1999, APPL ENVIRON MICROB, V65, P936; Desvaux M, 2005, FEMS MICROBIOL REV, V29, P741, DOI 10.1016/j.femsre.2004.11.003; Desvaux M, 2000, APPL ENVIRON MICROB, V66, P2461, DOI 10.1128/AEM.66.6.2461-2470.2000; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Gao F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021683; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guedon E, 2002, APPL ENVIRON MICROB, V68, P53, DOI 10.1128/AEM.68.1.53-58.2002; Heap JT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1321; Hemme CL, 2011, APPL ENVIRON MICROB, V77, P7998, DOI 10.1128/AEM.05677-11; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Ji YD, 1999, J BACTERIOL, V181, P6585; Juhas M, 2012, TRENDS BIOTECHNOL, V30, P601, DOI 10.1016/j.tibtech.2012.08.002; Kung SH, 2013, APPL ENVIRON MICROB, V79, P1712, DOI 10.1128/AEM.03525-12; Lee JH, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-2; LEE SY, 1993, FEMS MICROBIOL LETT, V108, P319, DOI 10.1016/0378-1097(93)90562-G; Levine E, 2008, PLOS BIOL, V6, P191, DOI 10.1371/journal.pbio.0060005; Li YC, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-25; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-2; Lin PP, 2015, METAB ENG, V31, P44, DOI 10.1016/j.ymben.2015.07.001; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Man SA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr034; Martinez-Alonso M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-64; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Papanek B, 2015, METAB ENG, V32, P49, DOI 10.1016/j.ymben.2015.09.002; Perret S, 2004, MOL MICROBIOL, V51, P599, DOI 10.1046/j.1365-2958.2003.03860.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; ROSE IA, 1955, METHOD ENZYMOL, V1, P591, DOI 10.1016/0076-6879(55)01102-6; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Wang B, 2005, INFECT IMMUN, V73, P3568, DOI 10.1128/IAI.73.6.3568-3576.2005; Xu T, 2015, APPL ENVIRON MICROB, V81, P4423, DOI 10.1128/AEM.00873-15; Xu T, 2014, APPL ENVIRON MICROB, V80, P1544, DOI 10.1128/AEM.03786-13; Zhu Y, 2005, BIOTECHNOL BIOENG, V90, P154, DOI 10.1002/bit.20354	43	0	0	6	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	SEP 7	2017	8								1744	10.3389/fmicb.2017.01744				11	Microbiology	Microbiology	FF9YY	WOS:000409376800001	28936208	gold			2018-01-05	
J	Harrington, LB; Doxzen, KW; Ma, E; Liu, JJ; Knott, GJ; Edraki, A; Garcia, B; Amrani, N; Chen, JS; Cofsky, JC; Kranzusch, PJ; Sontheimer, EJ; Davidson, AR; Maxwell, KL; Doudna, JA				Harrington, Lucas B.; Doxzen, Kevin W.; Ma, Enbo; Liu, Jun-Jie; Knott, Gavin J.; Edraki, Alireza; Garcia, Bianca; Amrani, Nadia; Chen, Janice S.; Cofsky, Joshua C.; Kranzusch, Philip J.; Sontheimer, Erik J.; Davidson, Alan R.; Maxwell, Karen L.; Doudna, Jennifer A.			A Broad-Spectrum Inhibitor of CRISPR-Cas9	CELL			English	Article							SMALL-ANGLE SCATTERING; BACTERIAL IMMUNE-SYSTEM; QUORUM SENSING CONTROLS; CAS SYSTEMS; ADAPTIVE IMMUNITY; DNA CLEAVAGE; NEISSERIA-MENINGITIDIS; PROGRAM PACKAGE; DUAL-RNA; COMPLEX	CRISPR-Cas9 proteins function within bacterial immune systems to target and destroy invasive DNA and have been harnessed as a robust technology for genome editing. Small bacteriophage-encoded anti-CRISPR proteins (Acrs) can inactivate Cas9, providing an efficient off switch for Cas9-based applications. Here, we show that two Acrs, AcrIIC1 and AcrIIC3, inhibit Cas9 by distinct strategies. AcrIIC1 is a broad-spectrum Cas9 inhibitor that prevents DNA cutting by multiple divergent Cas9 orthologs through direct binding to the conserved HNH catalytic domain of Cas9. A crystal structure of an AcrIIC1-Cas9 HNH domain complex shows how AcrIIC1 traps Cas9 in a DNA-bound but catalytically inactive state. By contrast, AcrIIC3 blocks activity of a single Cas9 ortholog and induces Cas9 dimerization while preventing binding to the target DNA. These two orthogonal mechanisms allow for separate control of Cas9 target binding and cleavage and suggest applications to allow DNA binding while preventing DNA cutting by Cas9.	[Harrington, Lucas B.; Ma, Enbo; Liu, Jun-Jie; Knott, Gavin J.; Chen, Janice S.; Cofsky, Joshua C.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Doxzen, Kevin W.; Doudna, Jennifer A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Liu, Jun-Jie; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Edraki, Alireza; Amrani, Nadia; Sontheimer, Erik J.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Program Mol Med, Worcester, MA 01605 USA; [Garcia, Bianca; Davidson, Alan R.; Maxwell, Karen L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kranzusch, Philip J.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Kranzusch, Philip J.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA	Doudna, JA (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (reprint author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu			UC Office of the President, Multicampus Research Programs and Initiatives [MR-15-328599]; Sandler Foundation; Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; National Science Foundation [MCB-1244557]; NIH [GM115911]; Canadian Institutes of Health Research [MOP-130482, MOP-136845]; US National Science Foundation	We thank G. Meigs and the 8.3.1 beamline staff at the Advanced Light Source for assistance with data collection and members of the Doudna laboratory for comments and discussions. The 8.3.1 beamline is supported by UC Office of the President, Multicampus Research Programs and Initiatives grant MR-15-328599 and Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. J.A.D. is an Investigator of the Howard Hughes Medical Institute. This research was supported in part by the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group, the National Science Foundation (MCB-1244557 to J.A.D.), the NIH (GM115911 to E.J.S.), and the Canadian Institutes of Health Research (MOP-130482 to A.R.D. and MOP-136845 to K.L.M.). L.B.H., K.W.D., and J.S.C. are supported by US National Science Foundation graduate research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Dagdas Y., 2017, BIORXIV; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Franzosa EA, 2011, P NATL ACAD SCI USA, V108, P10538, DOI 10.1073/pnas.1101440108; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Harrington L., 2017, BIORXIV; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM E, 2017, NAT COMMUN, V8; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mekler V, 2017, P NATL ACAD SCI USA, V114, P5443, DOI 10.1073/pnas.1619926114; Morgan G. J., 2002, BACTERIO PHAGE MU GE; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Patterson AG, 2017, CURR OPIN MICROBIOL, V37, P1, DOI 10.1016/j.mib.2017.02.004; Patterson AG, 2016, MOL CELL, V64, P1102, DOI 10.1016/j.molcel.2016.11.012; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shin J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701620; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033                                                       ; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Yamada M, 2017, MOL CELL, V65, P1109, DOI 10.1016/j.molcel.2017.02.007; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020	58	2	2	42	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1224	1233		10.1016/j.cell.2017.07.037				10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FG1ED	WOS:000409536000018	28844692				2018-01-05	
J	Burr, ML; Sparbier, CE; Chan, YC; Williamson, JC; Woods, K; Beavis, PA; Lam, EYN; Henderson, MA; Bell, CC; Stolzenburg, S; Gilan, O; Bloor, S; Noori, T; Morgens, DW; Bassik, MC; Neeson, PJ; Behren, A; Darcy, PK; Dawson, SJ; Voskoboinik, I; Trapani, JA; Cebon, J; Lehner, PJ; Dawson, MA				Burr, Marian L.; Sparbier, Christina E.; Chan, Yih-Chih; Williamson, James C.; Woods, Katherine; Beavis, Paul A.; Lam, Enid Y. N.; Henderson, Melissa A.; Bell, Charles C.; Stolzenburg, Sabine; Gilan, Omer; Bloor, Stuart; Noori, Tahereh; Morgens, David W.; Bassik, Michael C.; Neeson, Paul J.; Behren, Andreas; Darcy, Phillip K.; Dawson, Sarah-Jane; Voskoboinik, Ilia; Trapani, Joseph A.; Cebon, Jonathan; Lehner, Paul J.; Dawson, Mark A.			CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity	NATURE			English	Article							INFECTION; MEMBRANE	Cancer cells exploit the expression of the programmed death-1 (PD-1) ligand 1 (PD-L1) to subvert T-cell-mediated immunosurveillance(1,2). The success of therapies that disrupt PD-L1-mediated tumour tolerance has highlighted the need to understand the molecular regulation of PD-L1 expression(1). Here we identify the uncharacterized protein CMTM6 as a critical regulator of PD-L1 in a broad range of cancer cells, by using a genome-wide CRISPR-Cas9 screen. CMTM6 is a ubiquitously expressed protein that binds PD-L1 and maintains its cell surface expression. CMTM6 is not required for PD-L1 maturation but co-localizes with PD-L1 at the plasma membrane and in recycling endosomes, where it prevents PD-L1 from being targeted for lysosome-mediated degradation. Using a quantitative approach to profile the entire plasma membrane proteome, we find that CMTM6 displays specificity for PD-L1. Notably, CMTM6 depletion decreases PD-L1 without compromising cell surface expression of MHC class I. CMTM6 depletion, via the reduction of PD-L1, significantly alleviates the suppression of tumour-specific T cell activity in vitro and in vivo. These findings provide insights into the biology of PD-L1 regulation, identify a previously unrecognized master regulator of this critical immune checkpoint and highlight a potential therapeutic target to overcome immune evasion by tumour cells.	[Burr, Marian L.; Sparbier, Christina E.; Chan, Yih-Chih; Beavis, Paul A.; Lam, Enid Y. N.; Henderson, Melissa A.; Bell, Charles C.; Stolzenburg, Sabine; Gilan, Omer; Noori, Tahereh; Neeson, Paul J.; Darcy, Phillip K.; Dawson, Sarah-Jane; Voskoboinik, Ilia; Trapani, Joseph A.; Dawson, Mark A.] Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic 3000, Australia; [Burr, Marian L.; Beavis, Paul A.; Lam, Enid Y. N.; Henderson, Melissa A.; Bell, Charles C.; Gilan, Omer; Neeson, Paul J.; Darcy, Phillip K.; Dawson, Sarah-Jane; Voskoboinik, Ilia; Trapani, Joseph A.; Dawson, Mark A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Burr, Marian L.; Williamson, James C.; Bloor, Stuart; Lehner, Paul J.] Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England; [Woods, Katherine; Behren, Andreas; Cebon, Jonathan] La Trobe Univ, Sch Canc Med, Melbourne, Vic 3086, Australia; [Woods, Katherine; Behren, Andreas; Cebon, Jonathan] Olivia Newton John Canc Res Inst, Heidelberg, Vic 3084, Australia; [Morgens, David W.; Bassik, Michael C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Dawson, Sarah-Jane; Dawson, Mark A.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [Dawson, Mark A.] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia	Dawson, MA (reprint author), Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic 3000, Australia.; Dawson, MA (reprint author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia.; Lehner, PJ (reprint author), Cambridge Inst Med Res, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.; Dawson, MA (reprint author), Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.; Dawson, MA (reprint author), Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia.	marian.burr@petermac.org; pjl30@cam.ac.uk; mark.dawson@petermac.org		Dawson, Mark A./0000-0002-5464-5029; Trapani, Joseph/0000-0003-0983-1532; Lam, Enid Yi Ni/0000-0001-5843-7836; Burr, Marian/0000-0002-8995-3398; Sparbier, Christina/0000-0002-7482-0672; Neeson, Paul/0000-0002-2729-5887; , Ilia/0000-0002-6410-009X; Darcy, Phillip/0000-0002-5303-9561; Bell, Charles/0000-0003-2194-8311	Cancer Research UK Fellowship; Addenbrooke's Charitable Trust award; NIHR fellowship; Senior Leukaemia Foundation Australia Fellowship; NHMRC [1085015, 1106444, 1106447]; Cancer Council Victoria; Leukaemia Foundation Australia; Wellcome Trust PRF [101835/Z/13/Z]; NHSBT; NIHR Cambridge BRC; Wellcome Trust Strategic Award; Addenbrooke's Charitable Trust	M.L.B. is supported by a Cancer Research UK Fellowship, Addenbrooke's Charitable Trust award and NIHR fellowship. M.A.D. is supported by a Senior Leukaemia Foundation Australia Fellowship and work in the Dawson laboratory is supported by the NHMRC (Grants 1085015, 1106444 and 1106447) Cancer Council Victoria and Leukaemia Foundation Australia. P.J.L. is supported by a Wellcome Trust PRF (101835/Z/13/Z) and work in the Lehner laboratory is supported by NHSBT, NIHR Cambridge BRC, a Wellcome Trust Strategic Award to CIMR, and the Addenbrooke's Charitable Trust.	Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Behren A, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12097; Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Han WL, 2003, GENOMICS, V81, P609, DOI 10.1016/S0888-7543(03)00095-8; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Li CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12574; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Matheson NJ, 2015, CELL HOST MICROBE, V18, P409, DOI 10.1016/j.chom.2015.09.003; Moreno BH, 2015, SEMIN ONCOL, V42, P466, DOI 10.1053/j.seminoncol.2015.02.008; Morgens DW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15178; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Woods K, 2013, CLIN CANCER RES, V19, P4021, DOI 10.1158/1078-0432.CCR-13-1349	19	3	3	22	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					101	105		10.1038/nature23643				5	Multidisciplinary Sciences	Science & Technology - Other Topics	FG0DH	WOS:000409388700041	28813417				2018-01-05	
J	Simeonov, DR; Gowen, BG; Boontanrart, M; Roth, TL; Gagnon, JD; Mumbach, MR; Satpathy, AT; Lee, YJ; Bray, NL; Chan, AY; Lituiev, DS; Nguyen, ML; Gate, RE; Subramaniam, M; Li, ZM; Woo, JM; Mitros, T; Ray, GJ; Curie, GL; Naddaf, N; Chu, JS; Ma, H; Boyer, E; Van Gool, F; Huang, HL; Liu, RZ; Tobin, VR; Schumann, K; Daly, MJ; Farh, KK; Ansel, KM; Ye, CJ; Greenleaf, WJ; Anderson, MS; Bluestone, JA; Chang, HY; Corn, JE; Marson, A				Simeonov, Dimitre R.; Gowen, Benjamin G.; Boontanrart, Mandy; Roth, Theodore L.; Gagnon, John D.; Mumbach, Maxwell R.; Satpathy, Ansuman T.; Lee, Youjin; Bray, Nicolas L.; Chan, Alice Y.; Lituiev, Dmytro S.; Nguyen, Michelle L.; Gate, Rachel E.; Subramaniam, Meena; Li, Zhongmei; Woo, Jonathan M.; Mitros, Therese; Ray, Graham J.; Curie, Gemma L.; Naddaf, Nicki; Chu, Julia S.; Ma, Hong; Boyer, Eric; Van Gool, Frederic; Huang, Hailiang; Liu, Ruize; Tobin, Victoria R.; Schumann, Kathrin; Daly, Mark J.; Farh, Kyle K.; Ansel, K. Mark; Ye, Chun J.; Greenleaf, William J.; Anderson, Mark S.; Bluestone, Jeffrey A.; Chang, Howard Y.; Corn, Jacob E.; Marson, Alexander			Discovery of stimulation-responsive immune enhancers with CRISPR activation	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUPER-ENHANCERS; REGULATORY DNA; INTERLEUKIN-2; GENE; AUTOIMMUNITY; EXPRESSION; GENERATION; ANTIBODIES; VARIANTS	The majority of genetic variants associated with common human diseases map to enhancers, non-coding elements that shape cell-type-specific transcriptional programs and responses to extracellular cues(1-3). Systematic mapping of functional enhancers and their biological contexts is required to understand the mechanisms by which variation in non-coding genetic sequences contributes to disease. Functional enhancers can be mapped by genomic sequence disruption(4-6), but this approach is limited to the subset of enhancers that are necessary in the particular cellular context being studied. We hypothesized that recruitment of a strong transcriptional activator to an enhancer would be sufficient to drive target gene expression, even if that enhancer was not currently active in the assayed cells. Here we describe a discovery platform that can identify stimulus-responsive enhancers for a target gene independent of stimulus exposure. We used tiled CRISPR activation (CRISPRa)(7) to synthetically recruit a transcriptional activator to sites across large genomic regions (more than 100 kilobases) surrounding two key autoimmunity risk loci, CD69 and IL2RA. We identified several CRISPRa-responsive elements with chromatin features of stimulus-responsive enhancers, including an IL2RA enhancer that harbours an autoimmunity risk variant. Using engineered mouse models, we found that sequence perturbation of the disease-associated Il2ra enhancer did not entirely block Il2ra expression, but rather delayed the timing of gene activation in response to specific extracellular signals. Enhancer deletion skewed polarization of naive T cells towards a pro-inflammatory T helper (T(H)17) cell state and away from a regulatory T cell state. This integrated approach identifies functional enhancers and reveals how non-coding variation associated with human immune dysfunction alters context-specific gene programs.	[Simeonov, Dimitre R.; Roth, Theodore L.; Gagnon, John D.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Simeonov, Dimitre R.; Roth, Theodore L.; Gagnon, John D.; Lee, Youjin; Nguyen, Michelle L.; Li, Zhongmei; Woo, Jonathan M.; Tobin, Victoria R.; Schumann, Kathrin; Ansel, K. Mark; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Simeonov, Dimitre R.; Roth, Theodore L.; Lee, Youjin; Chan, Alice Y.; Nguyen, Michelle L.; Li, Zhongmei; Woo, Jonathan M.; Boyer, Eric; Van Gool, Frederic; Tobin, Victoria R.; Schumann, Kathrin; Anderson, Mark S.; Bluestone, Jeffrey A.; Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Simeonov, Dimitre R.; Gowen, Benjamin G.; Boontanrart, Mandy; Roth, Theodore L.; Lee, Youjin; Bray, Nicolas L.; Nguyen, Michelle L.; Li, Zhongmei; Woo, Jonathan M.; Mitros, Therese; Ray, Graham J.; Curie, Gemma L.; Naddaf, Nicki; Chu, Julia S.; Ma, Hong; Boyer, Eric; Tobin, Victoria R.; Schumann, Kathrin; Corn, Jacob E.; Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Gowen, Benjamin G.; Boontanrart, Mandy; Bray, Nicolas L.; Mitros, Therese; Ray, Graham J.; Curie, Gemma L.; Naddaf, Nicki; Chu, Julia S.; Ma, Hong; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Gagnon, John D.; Ansel, K. Mark] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Mumbach, Maxwell R.; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Mumbach, Maxwell R.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Mumbach, Maxwell R.; Satpathy, Ansuman T.; Greenleaf, William J.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Chan, Alice Y.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Lituiev, Dmytro S.; Gate, Rachel E.; Subramaniam, Meena; Ye, Chun J.] Univ Calif San Francisco, IHG, Dept Bioengn & Therapeut Sci, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Gate, Rachel E.; Subramaniam, Meena] Univ Calif San Francisco, Biol & Med Informat Grad Program, San Francisco, CA 94158 USA; [Huang, Hailiang; Liu, Ruize; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Huang, Hailiang; Liu, Ruize; Daly, Mark J.] Harvard Med Sch, Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Farh, Kyle K.] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94025 USA; [Greenleaf, William J.; Marson, Alexander] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Anderson, Mark S.; Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	Marson, A (reprint author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Marson, A (reprint author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Corn, JE; Marson, A (reprint author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Corn, JE (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Marson, A (reprint author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Marson, A (reprint author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Marson, A (reprint author), Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	jcorn@berkeley.edu; alexander.marson@ucsf.edu		Roth, Theodore/0000-0002-3970-9573; Satpathy, Ansuman/0000-0002-5167-537X	NIH [DP3DK111914-01, R01HG0081410-01, R01HL109102, P50-HG007735]; Scleroderma Research Foundation; UCSF Sandler Fellowship; National Multiple Sclerosis Society grant [CA 1074-A-21]; Marcus Program in Precision Medicine Innovation; Career Award for Medical Scientists from the Burroughs Wellcome Fund; Li Ka Shing Foundation; IGI-AstraZeneca Postdoctoral Fellowship; DFG Postdoctoral Fellowship; NIH S10 Instrumentation Grants [S10RR029668, S10RR027303]; Diabetes Research Center [NIH P30 DK063720]	We thank members of Marson and Corn laboratories, as well as A. Abbas, S. Qi, L. Gilbert, J. Hiatt, M. Lee, V. Nguyen, J. Weissman, J. Roose, M. Gavin and W. Leonard for suggestions and technical assistance. This research was supported by NIH grants DP3DK111914-01 (A. M., M. S. A., C.Y.), R01HG0081410-01 (A. M, W.G.), R01HL109102 (K.M.A., A. M.), P50-HG007735 (H.Y.C., W.J.G.), Scleroderma Research Foundation (H.Y.C.), the UCSF Sandler Fellowship (A. M.), a gift from Jake Aronov (A. M.), a National Multiple Sclerosis Society grant (A. M.; CA 1074-A-21), and the Marcus Program in Precision Medicine Innovation (A. M.). A. M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is a Chan Zuckerberg Biohub Investigator. J.E.C. is supported by the Li Ka Shing Foundation. B.G.G. is supported by the IGI-AstraZeneca Postdoctoral Fellowship. K.M.A. is a Leukemia & Lymphoma Society Scholar. J.D.G. is a National Science Foundation Predoctoral Fellow. K.S. is supported by a DFG Postdoctoral Fellowship. We thank Jackson Laboratories for generating the SNP and EDEL mice and Agilent for generating oligo pools for cloning of the CRISPRa gRNA library. We thank UC Berkeley High Throughput Screening Facility and Flow Cytometry Facility. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants S10RR029668 and S10RR027303. We also relied on the Flow Cytometry Core at UCSF, supported by the Diabetes Research Center grant NIH P30 DK063720.	Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Goudy K, 2013, CLIN IMMUNOL, V146, P248, DOI 10.1016/j.clim.2013.01.004; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Horlbeck M. A., 2016, ELIFE, V5, P2767; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kuhn C, 2016, IMMUNOTHERAPY-UK, V8, P889, DOI 10.2217/imt-2016-0049; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Laguna T, 2015, MOL IMMUNOL, V66, P171, DOI 10.1016/j.molimm.2015.02.031; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LEONARD WJ, 1985, P NATL ACAD SCI USA, V82, P6281, DOI 10.1073/pnas.82.18.6281; Martin M, 2011, EMBNET J, V17, P1, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI [10.1038/NMTH.3999, 10.1038/nmeth.3999]; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Pimentel H. J., 2016, PREPRINT; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Sinha R., 2017, PREPRINT; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502                                                         	38	4	4	20	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					111	+		10.1038/nature23875				18	Multidisciplinary Sciences	Science & Technology - Other Topics	FG0DH	WOS:000409388700043	28854172				2018-01-05	
J	Fan, YL; Liu, J; Lyu, SH; Wang, Q; Yang, SM; Zhu, HY				Fan, Yinglun; Liu, Jinge; Lyu, Shanhua; Wang, Qi; Yang, Shengming; Zhu, Hongyan			The Soybean Rfg1 Gene Restricts Nodulation by Sinorhizobium fredii USDA193	FRONTIERS IN PLANT SCIENCE			English	Article						soybean; nodulation; nitrogen fixation; rhizobial symbiosis; symbiosis specificity	III SECRETION SYSTEM; HOST-SPECIFICITY; RHIZOBIUM-LEGUMINOSARUM; BRADYRHIZOBIUM-ELKANII; EXTRACELLULAR PROTEINS; STRAIN USDA-205; LEGUME; SYMBIOSIS; INCOMPATIBILITY; PLANTS	Sinorhizobium fredii is a fast-growing rhizobial species that can establish a nitrogen-fixing symbiosis with a wide range of legume species including soybeans (Glycine max). In soybeans, this interaction shows a high level of specificity such that particular S. fredii strains nodulate only a limited set of plant genotypes. Here we report the identification of a dominant gene in soybeans that restricts nodulation with S. fredii USDA193. Genetic mapping in an F2 population revealed co-segregation of the underlying locus with the previously cloned Rfg1 gene. The Rfg1 allele encodes a member of the Toll-interleukin receptor/nucleotide-binding site/leucine-rich repeat class of plant resistance proteins that restricts nodulation by S. fredii strains USDA257 and USDA205, and an allelic variant of this gene also restricts nodulation by Bradyrhizobium japonicum USDA122. By means of complementation tests and CRISPR/Cas9-mediated gene knockouts, we demonstrate that the Rfg1 allele also is responsible for resistance to nodulation by S. fredii USDA193. Therefore, the Rfg1 allele likely provides broad-spectrum resistance to nodulation by many S. fredii and B. japonicum strains in soybeans.	[Fan, Yinglun; Lyu, Shanhua] Liaocheng Univ, Coll Agr, Liaocheng, Peoples R China; [Fan, Yinglun; Liu, Jinge; Lyu, Shanhua; Wang, Qi; Yang, Shengming; Zhu, Hongyan] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA	Zhu, HY (reprint author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.	hzhu4@uky.edu		Wang, Qi/0000-0002-2379-4814	Kentucky Soybean Promotion Board; National Natural Science Foundation of China [31271751]; Shandong Provincial Education Association of China	This work was supported by the Kentucky Soybean Promotion Board to HZ and by the National Natural Science Foundation of China (grant number 31271751) to SL and YF. YF and SL received support from the Shandong Provincial Education Association of China to study at University of Kentucky.	BALATTI PA, 1992, CAN J PLANT SCI, V72, P49, DOI 10.4141/cjps92-006                                                              ; Bras CP, 2000, MOL PLANT MICROBE IN, V13, P475, DOI 10.1094/MPMI.2000.13.4.475; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; CALDWELL BE, 1966, CROP SCI, V6, P427, DOI 10.2135/cropsci1966.0011183X000600050010x                                       ; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009                                                       ; Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; DEVINE TE, 1985, CROP SCI, V25, P354, DOI 10.2135/cropsci1985.0011183X002500020037x                                       ; DEVINE TE, 1994, PLANT SOIL, V158, P47, DOI 10.1007/BF00007916; Devine T. E., 1981, FREQUENCIES NODULATI; Dodds PN, 2001, PLANT CELL, V13, P163, DOI 10.1105/tpc.13.1.163; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Faruque OM, 2015, APPL ENVIRON MICROB, V81, P6710, DOI 10.1128/AEM.01942-15; Fauvart M, 2008, FEMS MICROBIOL LETT, V285, P1, DOI 10.1111/j.1574-6968.2008.01254.x; Geurts R, 1997, PLANT PHYSIOL, V115, P351, DOI 10.1104/pp.115.2.351                                                            ; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Kereszt A, 2007, NAT PROTOC, V2, P948, DOI 10.1038/nprot.2007.141; KEYSER HH, 1992, PLANT SOIL, V141, P119, DOI 10.1007/BF00011313; KEYSER HH, 1982, SCIENCE, V215, P1631, DOI 10.1126/science.215.4540.1631; Kiers ET, 2007, P ROY SOC B-BIOL SCI, V274, P3119, DOI 10.1098/rspb.2007.1187; Kim DH, 2014, J BIOSCIENCES, V39, P513, DOI 10.1007/s12038-014-9429-9; Krishnan HB, 2003, MOL PLANT MICROBE IN, V16, P617, DOI 10.1094/MPMI.2003.16.7.617; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0                                                                ; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Liu JG, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-167; Marek L. F., 1996, Soybean Genetics Newsletter, V23, P126; Mondragon-Palomino M, 2002, GENOME RES, V12, P1305, DOI 10.1101/gr.159402; Mutch LA, 2004, MOL ECOL, V13, P2435, DOI 10.1111/j.1365-294X.2004.02259.x; Nakano Y, 1997, SOIL SCI PLANT NUTR, V43, P929, DOI 10.1080/00380768.1997.10414659                                                  ; Okazaki S, 2009, FEMS MICROBIOL LETT, V295, P88, DOI 10.1111/j.1574-6968.2009.01593.x; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; SADOWSKY MJ, 1990, PLANT SOIL, V129, P53, DOI 10.1007/BF00011691                                                              ; Soto MJ, 2009, CELL MICROBIOL, V11, P381, DOI [10.1111/j.1462-5822.2009.01282.x, 10.1111/j.1462-5822.2008.01282.x]; Tang F, 2016, PLANT PHYSIOL, V170, P26, DOI 10.1104/pp.15.01661; TRESE AT, 1995, EUPHYTICA, V81, P279, DOI 10.1007/BF00025618                                                              ; Tsukui T, 2013, APPL ENVIRON MICROB, V79, P1048, DOI 10.1128/AEM.03297-12; Tsurumaru H, 2015, APPL ENVIRON MICROB, V81, P5812, DOI 10.1128/AEM.00823-15; Wang D, 2012, CELL MICROBIOL, V14, P334, DOI 10.1111/j.1462-5822.2011.01736.x; Wang Q, 2017, P NATL ACAD SCI USA, V114, P6854, DOI 10.1073/pnas.1700715114; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yang SM, 2017, P NATL ACAD SCI USA, V114, P6848, DOI 10.1073/pnas.1700460114; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Yasuda M, 2016, PLANT CELL PHYSIOL, V57, P1791, DOI 10.1093/pcp/pcw104	50	0	0	9	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-462X			FRONT PLANT SCI	Front. Plant Sci.	SEP 7	2017	8								1548	10.3389/fpls.2017.01548				9	Plant Sciences	Plant Sciences	FG1CH	WOS:000409529700002	28936222	gold			2018-01-05	
J	Burnight, ER; Gupta, M; Wiley, LA; Anfinson, KR; Tran, A; Triboulet, R; Hoffmann, JM; Klaahsen, DL; Andorf, JL; Jiao, CH; Sohn, EH; Adur, MK; Ross, JW; Mullins, RF; Daley, GQ; Schlaeger, TM; Stone, EM; Tucker, BA				Burnight, Erin R.; Gupta, Manav; Wiley, Luke A.; Anfinson, Kristin R.; Tran, Audrey; Triboulet, Robinson; Hoffmann, Jeremy M.; Klaahsen, Darcey L.; Andorf, Jeaneen L.; Jiao, Chunhua; Sohn, Elliott H.; Adur, Malavika K.; Ross, Jason W.; Mullins, Robert F.; Daley, George Q.; Schlaeger, Thorsten M.; Stone, Edwin M.; Tucker, Budd A.			Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration	MOLECULAR THERAPY			English	Article							LEBER CONGENITAL AMAUROSIS; PLURIPOTENT STEM-CELLS; STAPHYLOCOCCUS-AUREUS CAS9; OFF-TARGET CLEAVAGE; RETINITIS-PIGMENTOSA; PROGENITOR CELLS; PHOTORECEPTOR PRECURSORS; TRANSPLANTATION; BLINDNESS; THERAPY	Patient-derived induced pluripotent stem cells (iPSCs) hold great promise for autologous cell replacement. However, for many inherited diseases, treatment will likely require genetic repair pre-transplantation. Genome editing technologies are useful for this application. The purpose of this study was to develop CRISPR-Cas9-mediated genome editing strategies to target and correct the three most common types of disease causing variants in patient-derived iPSCs: (1) exonic, (2) deep intronic, and (3) dominant gain of function. We developed a homology-directed repair strategy targeting a homozygous Mu insertion in exon 9 of male germ cell-associated kinase (MAK) and demonstrated restoration of the retinal transcript and protein in patient cells. We generated a CRISPR-Cas9-mediated non-homologous end joining (NHEJ) approach to excise a major contributor to Leber congenital amaurosis, the IVS26 cryptic-splice mutation in CEP290, and demonstrated correction of the transcript and protein in patient iPSCs. Lastly, we designed allele-specific CRISPR guides that selectively target the mutant Pro23His rhodopsin (RHO) allele, which, following delivery to both patient iPSCs in vitro and pig retina in vivo, created a frameshift and premature stop that would prevent transcription of the disease-causing variant. The strategies developed in this study will prove useful for correcting a wide range of genetic variants in genes that cause inherited retinal degeneration.	[Burnight, Erin R.; Wiley, Luke A.; Anfinson, Kristin R.; Hoffmann, Jeremy M.; Klaahsen, Darcey L.; Andorf, Jeaneen L.; Jiao, Chunhua; Sohn, Elliott H.; Mullins, Robert F.; Stone, Edwin M.; Tucker, Budd A.] Univ Iowa, Carver Coll Med, Stephen A Wynn Inst Vis Res, Iowa City, IA 52241 USA; [Burnight, Erin R.; Wiley, Luke A.; Anfinson, Kristin R.; Hoffmann, Jeremy M.; Klaahsen, Darcey L.; Andorf, Jeaneen L.; Jiao, Chunhua; Sohn, Elliott H.; Mullins, Robert F.; Stone, Edwin M.; Tucker, Budd A.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52241 USA; [Gupta, Manav; Tran, Audrey; Triboulet, Robinson; Daley, George Q.; Schlaeger, Thorsten M.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 01451 USA; [Gupta, Manav; Tran, Audrey; Triboulet, Robinson; Daley, George Q.; Schlaeger, Thorsten M.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 01451 USA; [Gupta, Manav; Tran, Audrey; Triboulet, Robinson; Daley, George Q.; Schlaeger, Thorsten M.] Harvard Med Sch, Harvard Stem Cell Inst, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 01451 USA; [Adur, Malavika K.; Ross, Jason W.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Tucker, BA (reprint author), Univ Iowa, Carver Coll Med, Stephen A Wynn Inst Vis Res, 375 Newton Rd, Iowa City, IA 52242 USA.; Tucker, BA (reprint author), Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, 375 Newton Rd, Iowa City, IA 52242 USA.	budd-tucker@uiowa.edu			Stephen A. Wynn Foundation; National Eye Institute [R01EY024588, R01EY026008]; Grousbeck Family Foundation	The authors are appreciative of reagents and helpful discussions from Dr. Feng Zhang and Dr. Patrick Hsu. The authors would like to thank the NSRRC for providing the Pro23His transgenic sperm that was used to re-derive the Pro23His pig model of retinal degenerative blindness. This work was supported by the Stephen A. Wynn Foundation (to R.F.M., E.M.S., and B.A.T.), the National Eye Institute (R01EY024588 to R.F.M., E.M.S., and B.A.T.; R01EY026008 to E.M.S. and B.A.T.), and the Grousbeck Family Foundation to (G.Q.D., R.F.M., E.M.S., and B.A.T.).	Braun TA, 2013, HUM MOL GENET, V22, P5136, DOI 10.1093/hmg/ddt367; Burnight ER, 2014, GENE THER, V21, P662, DOI 10.1038/gt.2014.39; BUSH RA, 1995, INVEST OPHTH VIS SCI, V36, P2054; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Courtney DG, 2016, GENE THER, V23, P108, DOI 10.1038/gt.2015.82; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Diniz B, 2013, INVEST OPHTH VIS SCI, V54, P5087, DOI 10.1167/iovs.12-11239; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gamm DM, 2010, REGEN MED, V5, P315, DOI [10.2217/rme.10.28, 10.2217/RME.10.28]; Gilbert C, 2001, BRIT J OPHTHALMOL, V85, P1025, DOI 10.1136/bjo.85.9.1025; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Gregory-Evans K, 1998, TRENDS GENET, V14, P103, DOI 10.1016/S0168-9525(98)01402-4; Gust J, 2011, INVEST OPHTH VIS SCI, V52, P5266, DOI 10.1167/iovs.10-6329; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hartong DT, 2009, MOL VIS, V15, P592; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Inglehearn CF, 1998, J MED GENET, V35, P1, DOI 10.1136/jmg.35.1.1                                                              ; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Johnston JC, 1999, J VIROL, V73, P4991; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kundu J, 2014, DEV OPHTHALMOL, V53, P143, DOI 10.1159/000357369; Lakowski J, 2015, STEM CELLS, V33, P2469, DOI 10.1002/stem.2051; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Light JG, 2014, EXP EYE RES, V128, P34, DOI 10.1016/j.exer.2014.09.004; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Luo J, 2014, J BIOL CHEM, V289, P6362, DOI 10.1074/jbc.M113.513713; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mullins RF, 2012, INVEST OPHTH VIS SCI, V53, P1883, DOI 10.1167/iovs.12-9477; Osborn MJ, 2016, MOL THER, V24, P570, DOI 10.1038/mt.2015.197; Parfitt DA, 2016, CELL STEM CELL, V18, P769, DOI 10.1016/j.stem.2016.03.021; Pasadhika S, 2010, INVEST OPHTH VIS SCI, V51, P2608, DOI 10.1167/iovs.09-3734; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Saliba RS, 2002, J CELL SCI, V115, P2907; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011                                            ; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Seo S, 2013, INVEST OPHTH VIS SCI, V54, P6118, DOI 10.1167/iovs.13-11673; Shirai H, 2016, P NATL ACAD SCI USA, V113, pE81, DOI 10.1073/pnas.1512590113; Small KW, 2016, OPHTHALMOLOGY, V123, P9, DOI 10.1016/j.ophtha.2015.10.006; Sun N, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200038; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tomita M, 2006, STEM CELLS, V24, P2270, DOI 10.1634/stemcells.2005-0507; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tucker BA, 2014, HUM MOL GENET, V23, pR9, DOI 10.1093/hmg/ddu124; Tucker BA, 2013, ELIFE, V2, DOI 10.7554/eLife.00824; Tucker BA, 2013, STEM CELL TRANSL MED, V2, P16, DOI 10.5966/sctm.2012-0040; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093575; Wiley LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30742; Wilson JH, 2003, MOL NEUROBIOL, V28, P149, DOI 10.1385/MN:28:2:149; Worthington KS, 2017, ACTA BIOMATER, V55, P385, DOI 10.1016/j.actbio.2017.03.039; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Yao J, 2015, TISSUE ENG PT A, V21, P1247, DOI [10.1089/ten.tea.2013.0720, 10.1089/ten.TEA.2013.0720]; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yoshimi K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10431; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Zhao TB, 2015, CELL STEM CELL, V17, P353, DOI 10.1016/j.stem.2015.07.021; Zhou PY, 2015, J CELL SCI, V128, P2169, DOI 10.1242/jcs.169086	73	0	0	18	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	SEP 6	2017	25	9					1999	2013		10.1016/j.ymthe.2017.05.015				15	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FG6DZ	WOS:000410462600005	28619647				2018-01-05	
J	Stover, JD; Farhang, N; Berrett, KC; Gertz, J; Lawrence, B; Bowles, RD				Stover, Joshua D.; Farhang, Niloofar; Berrett, Kristofer C.; Gertz, Jason; Lawrence, Brandon; Bowles, Robby D.			CRISPR Epigenome Editing of AKAP150 in DRG Neurons Abolishes Degenerative IVD-Induced Neuronal Activation	MOLECULAR THERAPY			English	Article							HUMAN INTERVERTEBRAL DISC; ROOT GANGLION NEURONS; GENE-RELATED PEPTIDE; LOW-BACK-PAIN; THERMAL HYPERALGESIA; PROINFLAMMATORY MEDIATORS; CYTOKINE EXPRESSION; SYSTEMATIC ANALYSIS; LENTIVIRAL VECTOR; SENSORY NEURONS	Back pain is a major contributor to disability and has significant socioeconomic impacts worldwide. The degenerative intervertebral disc (IVD) has been hypothesized to contribute to back pain, but a better understanding of the interactions between the degenerative IVD and nociceptive neurons innervating the disc and treatment strategies that directly target these interactions is needed to improve our understanding and treatment of back pain. We investigated degenerative IVD-induced changes to dorsal root ganglion (DRG) neuron activity and utilized CRISPR epigenome editing as a neuromodulation strategy. By exposing DRG neurons to degenerative IVD-conditioned media under both normal and pathological IVD pH levels, we demonstrate that degenerative IVDs trigger interleukin (IL)-6-induced increases in neuron activity to thermal stimuli, which is directly mediated by AKAP and enhanced by acidic pH. Utilizing this novel information on AKAP-mediated increases in nociceptive neuron activity, we developed lentiviral CRISPR epigenome editing vectors that modulate endogenous expression of AKAP150 by targeted promoter histone methylation. When delivered to DRG neurons, these epigenome-modifying vectors abolished degenerative IVD-induced DRG-elevated neuron activity while preserving non pathologic neuron activity. This work elucidates the potential for CRISPR epigenome editing as a targeted gene-based pain neuromodulation strategy.	[Stover, Joshua D.; Farhang, Niloofar; Bowles, Robby D.] Univ Utah, Dept Bioengn, 20 S 2030 E,Room 108, Salt Lake City, UT 84112 USA; [Lawrence, Brandon; Bowles, Robby D.] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Berrett, Kristofer C.; Gertz, Jason] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Berrett, Kristofer C.; Gertz, Jason] Univ Utah, Hunstman Canc Inst, Salt Lake City, UT 84112 USA	Bowles, RD (reprint author), Univ Utah, Dept Bioengn, 20 S 2030 E,Room 108, Salt Lake City, UT 84112 USA.	robert.bowles@utah.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH [R03AR068777]	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH under award R03AR068777. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors thank Elena Budko for her expertise in DRG neuron harvesting and cell culture.	Andratsch M, 2009, J NEUROSCI, V29, P13473, DOI 10.1523/JNEUROSCI.1822-09.2009; Aoki Y, 2005, SPINE, V30, P1496, DOI 10.1097/01.brs.0000167532.96540.31; Aoki Y, 2004, SPINE, V29, P1077, DOI 10.1097/00007632-200405150-00005; ASHTON IK, 1994, J ORTHOPAED RES, V12, P186, DOI 10.1002/jor.1100120206; Banik RK, 2009, PAIN, V141, P41, DOI 10.1016/j.pain.2008.10.004; Bowles RD, 2016, EUR J PAIN, V20, P365, DOI 10.1002/ejp.732; Brandao KE, 2012, J COMP NEUROL, V520, P81, DOI 10.1002/cne.22692; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/nmeth.2926, 10.1038/NMETH.2926]; Brown MF, 1997, J BONE JOINT SURG BR, V79B, P147, DOI 10.1302/0301-620X.79B1.6814; Btesh J, 2013, J NEUROSCI, V33, P9184, DOI 10.1523/JNEUROSCI.4991-12.2013; Burke JG, 2003, SPINE, V28, P2685, DOI 10.1097/01.BRS.0000103341.45133.F3; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511                                                    ; Caterina MJ, 1997, NATURE, V389, P816; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COPPES MH, 1990, LANCET, V336, P189, DOI 10.1016/0140-6736(90)91723-N; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; DIAMANT B, 1968, EXPERIENTIA, V24, P1195, DOI 10.1007/BF02146615; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fang D, 2015, PAIN, V156, P1124, DOI 10.1097/j.pain.0000000000000158; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Garcia-Cosamalon J, 2010, J ANAT, V217, P1, DOI 10.1111/j.1469-7580.2010.01227.x; Greffrath W, 2001, NEUROSCIENCE, V104, P539, DOI 10.1016/S0306-4522(01)00088-4; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Jeske NA, 2009, PAIN, V146, P301, DOI 10.1016/j.pain.2009.08.002; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson WEB, 2001, SPINE, V26, P2550, DOI 10.1097/00007632-200112010-00007                                                ; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kestell GR, 2015, J COMP NEUROL, V523, P2555, DOI 10.1002/cne.23804; KITANO T, 1993, CLIN ORTHOP RELAT R, P372; Kokubo Y, 2008, J NEUROSURG-SPINE, V9, P285, DOI 10.3171/SPI/2008/9/9/285; Kordower JH, 1999, EXP NEUROL, V160, P1, DOI 10.1006/exnr.1999.7178; Krebs CJ, 2012, MOL CELL BIOL, V32, P3732, DOI 10.1128/MCB.00615-12; Krock E, 2014, J CELL MOL MED, V18, P1213, DOI 10.1111/jcmm.12268; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652                                                              ; Le Maitre Christine Lyn, 2007, Arthritis Res Ther, V9, pR77; Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862; Lotz JC, 2006, J BONE JOINT SURG AM, V88A, P76, DOI 10.2106/JBJS.E.01448; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Melrose J, 2002, SPINE, V27, P1278, DOI 10.1097/00007632-200206150-00007; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Obreja O, 2005, BRAIN, V128, P1634, DOI 10.1093/brain/awh490; Obreja O, 2002, PAIN, V96, P57, DOI 10.1016/S0304-3959(01)00420-1; Ohtori S, 2002, ANN ANAT, V184, P235, DOI 10.1016/S0940-9602(02)80113-3; Oka Y, 2007, NEUROSCIENCE, V145, P530, DOI 10.1016/j.neuroscience.2006.10.055; Opree A, 2000, J NEUROSCI, V20, P6289; Rathee PK, 2002, J NEUROSCI, V22, P4740; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Salmon P., 2006, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0421S37; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Specchia N, 2002, EUR SPINE J, V11, P145, DOI 10.1007/s00586-001-0361-y; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Suthar P, 2015, J CLIN DIAGN RES, V9, pTC4, DOI 10.7860/JCDR/2015/11927.5761; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Vernon-Roberts B, 2007, SPINE, V32, P2797, DOI 10.1097/BRS.0b013e31815b64d2; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Watson DJ, 2002, MOL THER, V5, P528, DOI 10.1006/mthe.2001.0584; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	72	0	0	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	SEP 6	2017	25	9					2014	2027		10.1016/j.ymthe.2017.06.010				14	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FG6DZ	WOS:000410462600006	28676344				2018-01-05	
J	Liu, T; Liu, ZZ; Ye, Q; Pan, SF; Wang, XD; Li, YJ; Peng, WF; Liang, YX; She, QX; Peng, N				Liu, Tao; Liu, Zhenzhen; Ye, Qing; Pan, Saifu; Wang, Xiaodi; Li, Yingjun; Peng, Wenfang; Liang, Yunxiang; She, Qunxin; Peng, Nan			Coupling transcriptional activation of CRISPR-Cas system and DNA repair genes by Csa3a in Sulfolobus islandicus	NUCLEIC ACIDS RESEARCH			English	Article							ADAPTIVE IMMUNE-SYSTEMS; ESCHERICHIA-COLI; SPACER ACQUISITION; ANTIVIRAL DEFENSE; FOREIGN DNA; H-NS; ADAPTATION; ARCHAEAL; RNA; INTERFERENCE	CRISPR-Cas system provides the adaptive immunity against invading genetic elements in prokaryotes. Recently, we demonstrated that Csa3a regulator mediates spacer acquisition in Sulfolobus is-landicus by activating the expression of Type I-A adaptation cas genes. However, links between the activation of spacer adaptation and CRISPR transcription/processing, and the requirement for DNA repair genes during spacer acquisition remained poorly understood. Here, we demonstrated that de novo spacer acquisition required Csa1, Cas1, Cas2 and Cas4 proteins of the Sulfolobus Type I-A system. Disruption of genes implicated in crRNA maturation or DNA interference led to a significant accumulation of acquired spacers, mainly derived from host genomic DNA. Transcriptome and proteome analyses showed that Csa3a activated expression of adaptation cas genes, CRISPR RNAs, and DNA repair genes, including herA helicase, nurA nuclease and DNA polymerase II genes. Importantly, Csa3a specifically bound the promoters of the above DNA repair genes, suggesting that they were directly activated by Csa3a for adaptation. The Csa3a regulator also specifically bound to the leader sequence to activate CRISPR transcription in vivo. Our data indicated that the Csa3a regulator couples transcriptional activation of the CRISPR-Cas system and DNA repair genes for spacer adaptation and efficient interference of invading genetic elements.	[Liu, Tao; Liu, Zhenzhen; Ye, Qing; Pan, Saifu; Wang, Xiaodi; Li, Yingjun; Liang, Yunxiang; Peng, Nan] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Li, Yingjun; Peng, Wenfang; She, Qunxin] Univ Copenhagen, Dept Biol, Archaeal Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark	Peng, N (reprint author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.	nanp@mail.hzau.edu.cn	Peng, Wenfang/D-1894-2014	Peng, Wenfang/0000-0001-9073-1509	National Natural Science Foundation of China [3167080536]; Fundamental Research Funds for the Central Universities [2662015PX199, 2662015PY038]; Danish Council for Independent Research [DFF-4181-00274, DFF-1323-00330]	National Natural Science Foundation of China [3167080536 to N.P.]; Fundamental Research Funds for the Central Universities [2662015PX199, 2662015PY038 to N.P.]; Danish Council for Independent Research [DFF-4181-00274, DFF-1323-00330 to Q.S.]. Funding for open access charge: National Natural Science Foundation of China [3167080536].	Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; Alkhnbashi OS, 2016, BIOINFORMATICS, V32, P576, DOI 10.1093/bioinformatics/btw454; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Blackwood JK, 2012, NUCLEIC ACIDS RES, V40, P3183, DOI 10.1093/nar/gkr1157; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Choi JY, 2011, J BIOL CHEM, V286, P31180, DOI 10.1074/jbc.M111.258038; Constantinesco F, 2004, NUCLEIC ACIDS RES, V32, P1439, DOI 10.1093/nar/gkh283; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dwarakanath S, 2015, NUCLEIC ACIDS RES, V43, P8913, DOI 10.1093/nar/gkv882; Erdmann S, 2014, MOL MICROBIOL, V91, P900, DOI 10.1111/mmi.12503; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Garrett Roger A., 2015, Life-Basel, V5, P783, DOI 10.3390/life5010783; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; He F, 2017, NUCLEIC ACIDS RES, V45, P1902, DOI 10.1093/nar/gkw1265; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Herrmann U, 2002, MOL MICROBIOL, V46, P395, DOI 10.1046/j.1365-2958.2002.03181.x                                                ; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Koonin EV, 2013, RNA BIOL, V10, P679, DOI 10.4161/rna.24022; Leon-Sobrino C, 2016, MOL MICROBIOL, V99, P719, DOI 10.1111/mmi.13263; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Li YJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1044; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Liu T, 2015, NUCLEIC ACIDS RES, V43, P1044, DOI 10.1093/nar/gku1383; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Patterson AG, 2015, NUCLEIC ACIDS RES, V43, P6038, DOI 10.1093/nar/gkv517; Paytubi S, 2009, MOL MICROBIOL, V72, P1487, DOI 10.1111/j.1365-2958.2009.06737.x; Peng N, 2017, SCI CHINA LIFE SCI, V60, P370, DOI 10.1007/s11427-016-0355-8; Peng N, 2012, APPL ENVIRON MICROB, V78, P5630, DOI 10.1128/AEM.00855-12; Peng N, 2009, MOL MICROBIOL, V74, P928, DOI 10.1111/j.1365-2958.2009.06908.x; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Peng WF, 2013, RNA BIOL, V10, P738, DOI 10.4161/rna.23798; Perez-Rodriguez R, 2011, MOL MICROBIOL, V79, P584, DOI 10.1111/j.1365-2958.2010.07482.x; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Rollie C, 2015, ELIFE, V4, DOI 10.7554/eLife.08716.001; Song ZD, 2014, MOL CELL PROTEOMICS, V13, P3519, DOI 10.1074/mcp.M113.035675; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Yang CD, 2014, MOL MICROBIOL, V92, P1072, DOI 10.1111/mmi.12614; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhang CY, 2010, MICROBIOL-SGM, V156, P3386, DOI 10.1099/mic.0.042523-0; Zhang ST, 2008, DNA REPAIR, V7, P380, DOI 10.1016/j.dnarep.2007.10.010	66	1	1	6	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-1048	1362-4962		NUCLEIC ACIDS RES	Nucleic Acids Res.	SEP 6	2017	45	15					8978	8992		10.1093/nar/gkx612				15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FG0AH	WOS:000409380900033	28911114	gold			2018-01-05	
J	Delannoy, S; Mariani-Kurkdjian, P; Webb, HE; Bonacorsi, S; Fach, P				Delannoy, Sabine; Mariani-Kurkdjian, Patricia; Webb, Hattie E.; Bonacorsi, Stephane; Fach, Patrick			The Mobilome; A Major Contributor to Escherichia coli stx2-Positive O26:H11 Strains Intra-Serotype Diversity	FRONTIERS IN MICROBIOLOGY			English	Article						Escherichia coli; E. coli; STEC; stx2; Shiga toxin-producing E. coli; mobile genetic elements; comparative genomics; phylogenetic relationship	ENTEROHEMORRHAGIC ESCHERICHIA-COLI; HEMOLYTIC-UREMIC SYNDROME; VIRULENCE GENE PROFILES; NUCLEOTIDE POLYMORPHISMS; COMPARATIVE GENOMICS; DAIRY-PRODUCTS; UNITED-STATES; CAS SYSTEMS; SEQUENCE; CRISPR	Shiga toxin-producing Escherichia coli of serotype O26:H11/ H-constitute a diverse group of strains and several clones with distinct genetic characteristics have been identified and characterized. Whole genome sequencing was performed using Illumina and PacBio technologies on eight stx2-positive O26:H11 strains circulating in France. Comparative analyses of the whole genome of the stx2-positive O26:H11 strains indicate that several clones of EHEC O26:H11 are co-circulating in France. Phylogenetic analysis of the French strains together with stx2-positive and stx-negative E. coli O26:H11 genomes obtained from Genbank indicates the existence of four clonal complexes (SNP-CCs) separated in two distinct lineages, one of which comprises the "new French clone" (SNP-CC1) that appears genetically closely related to stx-negative attaching and effacing E. coli (AEEC) strains. Interestingly, the whole genome SNP (wgSNP) phylogeny is summarized in the cas gene phylogeny, and a simple qPCR assay targeting the CRISPR array specific to SNP-CC1 (SP_O26-E) can distinguish between the two main lineages. The PacBio sequencing allowed a detailed analysis of the mobile genetic elements (MGEs) of the strains. Numerous MGEs were identified in each strain, including a large number of prophages and up to four large plasmids, representing overall 8.7-19.8% of the total genome size. Analysis of the prophage pool of the strains shows a considerable diversity with a complex history of recombination. Each clonal complex (SNP-CC) is characterized by a unique set of plasmids and phages, including stx-prophages, suggesting evolution through separate acquisition events. Overall, the MGEs appear to play a major role in O26:H11 intra-serotype clonal diversification.	[Delannoy, Sabine; Fach, Patrick] Univ Paris Est, ANSES, Food Safety Lab, Platform IdentyPath, Maisons Alfort, France; [Mariani-Kurkdjian, Patricia; Bonacorsi, Stephane] Hop Robert Debre, AP HP, Microbiol Serv, CNR Associe Escherichia Coli, Paris, France; [Mariani-Kurkdjian, Patricia; Bonacorsi, Stephane] INSERM, UMR 1137, Infect, Antimicrobials,Modelling,Evolut, Paris, France; [Mariani-Kurkdjian, Patricia; Bonacorsi, Stephane] Univ Paris Diderot, Sorbonne Paris Cite, UMR 1137, Infect,Antimicrobials,Modelling,Evolut, Paris, France; [Webb, Hattie E.] Texas Tech Univ, Dept Anim & Food Sci, Lubbock, TX 79409 USA	Delannoy, S (reprint author), Univ Paris Est, ANSES, Food Safety Lab, Platform IdentyPath, Maisons Alfort, France.	sabine.delannoy@anses.fr					Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; Beutin L, 2012, J VIROL, V86, P10444, DOI 10.1128/JVI.00986-12; Bielaszewska M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/cid/cit055; Bletz S, 2013, GENOME BIOL EVOL, V5, P1807, DOI 10.1093/gbe/evt136; Bobay LM, 2013, MOL BIOL EVOL, V30, P737, DOI 10.1093/molbev/mss279; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536                                                                  ; Bugarel M, 2011, APPL ENVIRON MICROB, V77, P2275, DOI 10.1128/AEM.02832-10; Byrne L, 2014, J MED MICROBIOL, V63, P1181, DOI 10.1099/jmm.0.075895-0; Campbell A, 2002, GENE, V300, P13, DOI 10.1016/S0378-1119(02)00846-6; Campilongo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106589; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Cooper KK, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00482-14, DOI 10.1128/GENOMEA.00482-14]; Delannoy S., 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.00852-15, DOI 10.1128/GENOMEA.00852-15]; Delannoy S, 2015, J CLIN MICROBIOL, V53, P486, DOI 10.1128/JCM.02290-14; Delannoy S, 2012, J CLIN MICROBIOL, V50, P4035, DOI 10.1128/JCM.02097-12; Douellou T, 2017, INT J FOOD MICROBIOL, V253, P59, DOI 10.1016/j.ijfoodmicro.2017.04.010; Douellou T, 2016, INT J FOOD MICROBIOL, V232, P52, DOI 10.1016/j.ijfoodmicro.2016.04.032; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3590, 10.2903/j.efsa.2014.3547]; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Germinario C, 2016, EUROSURVEILLANCE, V21, P52, DOI [10.2807/1560-7917.ES.2016.21.38.303432, 10.2807/1560-7917.ES.2016.21.38.30343]; Gilmour MW, 2007, J CLIN MICROBIOL, V45, P3771, DOI 10.1128/JCM.01125-07; Gonzalez-Escalona N, 2016, APPL ENVIRON MICROB, V82, P3900, DOI 10.1128/AEM.00498-16; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Haugum K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111788; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11                                                           ; Hazen TH, 2012, J BACTERIOL, V194, P3026, DOI 10.1128/JB.00426-12; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ishijima N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43136; Ison SA, 2016, APPL ENVIRON MICROB, V82, P640, DOI 10.1128/AEM.03182-15; Ison SA, 2015, APPL ENVIRON MICROB, V81, P3671, DOI 10.1128/AEM.00397-15; Januszkiewicz A, 2015, LETT APPL MICROBIOL, V60, P605, DOI 10.1111/lam.12413; Jost C, 2016, J ANTIMICROB CHEMOTH, V71, P1183, DOI 10.1093/jac/dkv477; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Kiro R, 2013, BIOCHEM SOC T, V41, P1412, DOI 10.1042/BST20130109; Kruger A, 2015, MICROBIOL-SGM, V161, P451, DOI 10.1099/mic.0.000003; L'Abee-Lund TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031413; Laing CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037362; LeJeune JT, 2004, EMERG INFECT DIS, V10, P1482, DOI 10.3201/eid1008.030784                                                          ; Leomil L, 2005, FEMS MICROBIOL LETT, V249, P335, DOI 10.1016/j.femsle.2005.06.030; Mai-Prochnow A, 2015, FEMS MICROBIOL REV, V39, P465, DOI 10.1093/femsre/fuu007; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marejkova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073927; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Miko A, 2010, FEMS MICROBIOL LETT, V303, P137, DOI 10.1111/j.1574-6968.2009.01874.x; Norman KN, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00021; Norman KN, 2012, APPL ENVIRON MICROB, V78, P6689, DOI 10.1128/AEM.01259-12; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4; Pusz P, 2014, ACTA BIOCHIM POL, V61, P389; Richter C, 2012, VIRUSES-BASEL, V4, P2291, DOI 10.3390/v4102291; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Rusconi B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00985; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944                                                ; Scaletsky ICA, 2005, INFECT IMMUN, V73, P4753, DOI 10.1128/IAI.73.8.4753-4765.2005; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Scott L, 2009, VET MICROBIOL, V134, P288, DOI 10.1016/j.vetmic.2008.08.008; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Smith DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-311; Steyert SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00133; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Trees E., 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00718-14, DOI 10.1128/GENOMEA.00718-14]; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; Vally H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-63; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yin Shuang, 2013, Appl Environ Microbiol, V79, P5710, DOI 10.1128/AEM.00950-13; Zhang WL, 2000, J CLIN MICROBIOL, V38, P2134; Zweifel C, 2013, APPL ENVIRON MICROB, V79, P5411, DOI 10.1128/AEM.01728-13	78	0	0	4	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	SEP 6	2017	8								1625	10.3389/fmicb.2017.01625				17	Microbiology	Microbiology	FF9WP	WOS:000409369500001	28932209	gold			2018-01-05	
J	Li, XM; Yang, TY; He, XS; Wang, JR; Gan, WJ; Zhang, S; Li, JM; Wu, H				Li, Xiu-Ming; Yang, Tian-Yu; He, Xiao-Shun; Wang, Jing-Ru; Gan, Wen-Juan; Zhang, Shen; Li, Jian-Ming; Wu, Hua			Orphan nuclear receptor Nur77 inhibits poly (I:C)-triggered acute liver inflammation by inducing the ubiquitin-editing enzyme A20	ONCOTARGET			English	Article						Nur77; liver inflammation; NF-kappa B; A20; mouse model	NF-KAPPA-B; THERAPEUTIC TARGET; CANCER-CELLS; EXPRESSION; DISEASES; MACROPHAGES; HOMEOSTASIS; ACTIVATION; MECHANISMS; PATHWAY	Inflammation is a key contributor to various types of acute and chronic liver disease. We recently reported that lack of Nur77, an orphan nuclear receptor, contributes to the pathogenesis of inflammatory diseases including inflammatory bowel disease and sepsis. However, whether Nur77 plays a critical role in liver inflammation remains to be fully understood. Employing in vivo acute liver inflammation model in wild-type (Nur77(+/+)) and Nur77(-/-) mice, we here found that Nur77 deficiency dramatically increased the production of pro-inflammatory cytokines and accelerated liver injury induced by poly (I:C)/D-GalN in Nur77(-/-) mice. Mechanistically, Nur77 acts as a negative regulator of NF-kappa B signaling by inducing the expression of ubiquitin-editing enzyme A20, a novel target gene of Nur77. Notably, in inflammatory cells, overexpression of A20 enhanced, whereas knockdown of A20 by siRNA approach impaired, the inhibitory effect of Nur77 on poly (I:C)-triggered inflammation. Collectively, our data suggest that the orphan nuclear receptor Nur77 plays a protective role in poly (I:C)-triggered liver inflammation by inducing A20, thus making it a promising target for the prevention and treatment of liver inflammation.	[Li, Xiu-Ming; Yang, Tian-Yu; Wang, Jing-Ru; Zhang, Shen; Li, Jian-Ming; Wu, Hua] Soochow Univ, Pathol Ctr, Suzhou 215123, Peoples R China; [Li, Xiu-Ming; Yang, Tian-Yu; Wang, Jing-Ru; Zhang, Shen; Li, Jian-Ming; Wu, Hua] Soochow Univ, Dept Pathol, Suzhou 215123, Peoples R China; [He, Xiao-Shun; Gan, Wen-Juan] Soochow Univ, Affiliated Hosp 1, Dept Pathol, Suzhou 215006, Peoples R China	Li, JM; Wu, H (reprint author), Soochow Univ, Pathol Ctr, Suzhou 215123, Peoples R China.	jianmingli@suda.edu.cn; wuhua@suda.edu.cn			National Natural Science Foundation of China [81372574, 31300630, 31540036, 81272300, 31570753, 81525020, 81401942]; Natural Science Foundation of Jiangsu Province [BK20130337, BE2016666, BK20161206]; Natural Science Foundation of Suzhou [SYS201536]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (81372574, 31300630, 31540036 to H.W., 81272300, 31570753, 81525020 to J-M.L. and 81401942 to W-J.G), Natural Science Foundation of Jiangsu Province (BK20130337 to H.W., BE2016666 to J-M.L. and BK20161206 to W-J G), and Natural Science Foundation of Suzhou (SYS201536 to W-J G). This work was also supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Baranova IN, 2016, J IMMUNOL, V196, P3135, DOI 10.4049/jimmunol.1501709; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Curran C L, 2001, Expert Opin Ther Targets, V5, P197, DOI 10.1517/14728222.5.2.197; Guo PD, 2016, CANCER RES, V76, P3813, DOI 10.1158/0008-5472.CAN-15-2882; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Higuchi H, 2003, CURR MOL MED, V3, P483, DOI 10.2174/1566524033479528; Kurakula K, 2015, J IMMUNOL, V195, P1388, DOI 10.4049/jimmunol.1401714; Lee SO, 2012, ONCOGENE, V31, P3265, DOI 10.1038/onc.2011.504; Lee SO, 2011, EXPERT OPIN THER TAR, V15, P195, DOI 10.1517/14728222.2011.547481; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; Li XB, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0115-y; Li XM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171347; Lin TH, 2017, ADV PROTEIN CHEM STR, V107, P117, DOI 10.1016/bs.apcsb.2016.11.002; Liu JJ, 2010, CANCER RES, V70, P3628, DOI 10.1158/0008-5472.CAN-09-3160; Murakawa Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8367; Nakamoto Y, 2003, CURR MOL MED, V3, P537, DOI 10.2174/1566524033479591; O'Dea E, 2009, WIRES SYST BIOL MED, V1, P107, DOI [10.1002/wsbm.030, 10.1002/wsbm.30]; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Shaked I, 2015, NAT IMMUNOL, V16, P1228, DOI 10.1038/ni.3321; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; To SKY, 2012, EXPERT OPIN THER TAR, V16, P573, DOI 10.1517/14728222.2012.680958; Wang J., 2014, J NANOMATER, V2014, P1, DOI DOI 10.1088/1748-9326/9/9/094002; Wu H, 2016, J PATHOL, V238, P457, DOI 10.1002/path.4670; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yan TD, 2010, CANCER RES, V70, P2285, DOI 10.1158/0008-5472.CAN-09-2968; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Yuk JM, 2015, IMMUNITY, V43, P80, DOI 10.1016/j.immuni.2015.07.003; Zhan YY, 2013, CANCER LETT, V329, P37, DOI 10.1016/j.canlet.2012.09.022; Zhang XK, 2007, EXPERT OPIN THER TAR, V11, P69, DOI 10.1517/14728222.11.1.69; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	32	0	0	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	SEP 5	2017	8	37					61025	61035		10.18632/oncotarget.17731				11	Oncology; Cell Biology	Oncology; Cell Biology	FF8GI	WOS:000409254200023	28977843	green_published			2018-01-05	
J	Cao, QY; Ma, J; Chen, CH; Xu, H; Chen, Z; Li, W; Liu, XS				Cao, Qingyi; Ma, Jian; Chen, Chen-Hao; Xu, Han; Chen, Zhi; Li, Wei; Liu, X. Shirley			CRISPR-FOCUS: A web server for designing focused CRISPR screening experiments	PLOS ONE			English	Article							PRIMARY IMMUNE CELLS; GENETIC SCREENS; HUMAN GENOME; GUIDE RNA; ELEMENTS; IDENTIFICATION; SPECIFICITY; NUCLEASES; LIBRARY; TARGETS	The recently developed CRISPR screen technology, based on the CRISPR/Cas9 genome editing system, enables genome-wide interrogation of gene functions in an efficient and costeffective manner. Although many computational algorithms and web servers have been developed to design single-guide RNAs (sgRNAs) with high specificity and efficiency, algorithms specifically designed for conducting CRISPR screens are still lacking. Here we present CRISPR-FOCUS, a web-based platform to search and prioritize sgRNAs for CRISPR screen experiments. With official gene symbols or RefSeq IDs as the only mandatory input, CRISPRFOCUS filters and prioritizes sgRNAs based on multiple criteria, including efficiency, specificity, sequence conservation, isoform structure, as well as genomic variations including Single Nucleotide Polymorphisms and cancer somatic mutations. CRISPR-FOCUS also provides pre-defined positive and negative control sgRNAs, as well as other necessary sequences in the construct (e.g., U6 promoters to drive sgRNA transcription and RNA scaffolds of the CRISPR/Cas9). These features allow users to synthesize oligonucleotides directly based on the output of CRISPR-FOCUS. Overall, CRISPR-FOCUS provides a rational and highthroughput approach for sgRNA library design that enables users to efficiently conduct a focused screen experiment targeting up to thousands of genes.	[Cao, Qingyi; Chen, Zhi] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Coll Med,State Key Lab Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Ma, Jian] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai, Peoples R China; [Chen, Chen-Hao; Xu, Han; Li, Wei; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Chen, Chen-Hao; Xu, Han; Li, Wei; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Chen, Chen-Hao; Xu, Han; Li, Wei; Liu, X. Shirley] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Chen, Chen-Hao; Xu, Han; Li, Wei; Liu, X. Shirley] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA	Chen, Z (reprint author), Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Coll Med,State Key Lab Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Li, W; Liu, XS (reprint author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.; Li, W; Liu, XS (reprint author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Li, W; Liu, XS (reprint author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Li, W; Liu, XS (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	chenzhi@zju.edu.cn; wli@jimmy.harvard.edu; xsliu@jimmy.harvard.edu			National Natural Science Foundation of China [31401104, 31329003]; NIH of US [R01 HG008927]	This study was supported by National Natural Science Foundation of China, No. 31401104 (QC), National Natural Science Foundation of China Grant 31329003 and NIH R01 HG008927 of US (to XSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chen C, 2017, GENOME RES; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; DIAKOULAKI D, 1995, COMPUT OPER RES, V22, P763, DOI 10.1016/0305-0548(94)00059-H; Diao YR, 2016, GENOME RES, V26, P397, DOI 10.1101/gr.197152.115; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Heigwer F, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0915-2; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Liu HL, 2015, BIOINFORMATICS, V31, P3676, DOI 10.1093/bioinformatics/btv423; Ma J, 2016, BIOINFORMATICS, V32, P3336, DOI 10.1093/bioinformatics/btw476; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Panda SK, 2017, BIOINFORMATICS, V33, P1099, DOI 10.1093/bioinformatics/btw739; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhang F, OPTIMIZED CRISPR DES; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	41	0	0	13	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2017	12	9							e0184281	10.1371/journal.pone.0184281				8	Multidisciplinary Sciences	Science & Technology - Other Topics	FF8QL	WOS:000409282800068	28873439	gold			2018-01-05	
J	Zimmermann, S; Pfannkuch, L; Al-Zeer, MA; Bartfeld, S; Koch, M; Liu, JP; Rechner, C; Soerensen, M; Sokolova, O; Zamyatina, A; Kosma, P; Maurer, AP; Glowinski, F; Pleissner, KP; Schmid, M; Brinkmann, V; Karlas, A; Naumann, M; Rother, M; Machuy, N; Meyer, TF				Zimmermann, Stephanie; Pfannkuch, Lennart; Al-Zeer, Munir A.; Bartfeld, Sina; Koch, Manuel; Liu, Jianping; Rechner, Cindy; Soerensen, Meike; Sokolova, Olga; Zamyatina, Alla; Kosma, Paul; Maeurer, Andre P.; Glowinski, Frithjof; Pleissner, Klaus-Peter; Schmid, Monika; Brinkmann, Volker; Karlas, Alexander; Naumann, Michael; Rother, Marion; Machuy, Nikolaus; Meyer, Thomas F.			ALPK1-and TIFA-Dependent Innate Immune Response Triggered by the Helicobacter pylori Type IV Secretion System	CELL REPORTS			English	Article							NF-KAPPA-B; WIDE SIRNA SCREEN; SIGNALING PATHWAYS; GENE-EXPRESSION; PROTEIN; INFLAMMATION; INFECTION; COMPLEX; METHYLTRANSFERASE; RECOGNITION	Activation of transcription factor NF-kappa B is a hallmark of infection with the gastric pathogen Helicobacter pylori, associated with inflammation and carcinogenesis. Genome-wide RNAi screening revealed numerous host factors involved in H. pylori-, but not IL-1 beta- and TNF-alpha-dependent NF-kappa B regulation. Pathway analysis including CRISPR/Cas9-knockout and recombinant protein technology, immunofluorescence microscopy, immunoblotting, mass spectrometry, and mutant H. pylori strains identified the H. pylori metabolite D-glycero-beta-D-manno-heptose 1,7-bisphosphate (bHBP) as a cagPAI type IV secretion system (T4SS)-dependent effector of NF-kappa B activation in infected cells. Upon pathogen-host cell contact, TIFA forms large complexes (TIFAsomes) including interacting host factors, such as TRAF2. NF-kappa B activation, TIFA phosphorylation, and TIFAsome formation depend on a functional ALPK1 kinase, highlighting the ALPK1-TIFA axis as a core innate immune pathway. ALPK1-TIFA-mediated NF-kappa B activation was independent of CagA protein translocation, indicating that CagA translocation and HBP delivery to host cells are distinct features of the pathogen's T4SS.	[Zimmermann, Stephanie; Pfannkuch, Lennart; Al-Zeer, Munir A.; Bartfeld, Sina; Koch, Manuel; Liu, Jianping; Rechner, Cindy; Soerensen, Meike; Maeurer, Andre P.; Glowinski, Frithjof; Pleissner, Klaus-Peter; Schmid, Monika; Brinkmann, Volker; Karlas, Alexander; Machuy, Nikolaus; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Sokolova, Olga; Naumann, Michael] Otto von Guericke Univ, Inst Expt Internal Med, D-39120 Magdeburg, Germany; [Zamyatina, Alla; Kosma, Paul] Univ Nat Resources & Life Sci Vienna, Dept Chem, A-1190 Vienna, Austria; [Rother, Marion; Meyer, Thomas F.] Steinbeis Innovat, Ctr Syst Biomed, D-14612 Berlin, Germany; [Bartfeld, Sina] Univ Wurzburg, Inst Mol Infect Biol, Res Ctr Infect Dis, ZINF, D-97080 Wurzburg, Germany	Meyer, TF (reprint author), Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany.; Meyer, TF (reprint author), Steinbeis Innovat, Ctr Syst Biomed, D-14612 Berlin, Germany.	meyer@mpiib-berlin.mpg.de	Naumann, Michael/B-5285-2011; Brinkmann, Volker/A-6015-2009; Zamyatina, Alla/N-8411-2014	Naumann, Michael/0000-0002-8060-2313; Zamyatina, Alla/0000-0002-4001-3522; Meyer, Thomas F./0000-0002-6120-8679; Kosma, Paul/0000-0001-5342-7161	EU [LSHC-CT-2005-018704]	We thank Jorg Angermann, Elke Ziska, Jan-David Manntz, Kathrin Lattig, and Isabella Gravenstein for technical assistance, Rike Zietlow for editing the manuscript, and Diane Schad for help with graphics. We are grateful to Ralf Jacob and Katharina Cramm-Behrens for the ALPK1 expression construct. This work was supported in part by funding under the 6th Research Framework Programme of the EU Project INCA (LSHC-CT-2005-018704) to T.F.M.	Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x                                                ; Backert S, 2016, HELICOBACTER, V21, P19, DOI 10.1111/hel.12335; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Bartfeld S., 2009, THESIS; Bartfeld S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-21; Bielig H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004351; BLASER MJ, 1995, CANCER RES, V55, P2111; Bleich A, 2010, INFLAMM BOWEL DIS, V16, P765, DOI 10.1002/ibd.21146; CRABTREE JE, 1991, LANCET, V338, P332, DOI 10.1016/0140-6736(91)90477-7                                                    ; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Gaudet RG, 2017, CELL REP, V19, P1418, DOI 10.1016/j.celrep.2017.04.063; Gaudet RG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005807; Gaudet RG, 2015, SCIENCE, V348, P1251, DOI 10.1126/science.aaa4921; Gewurz BE, 2012, P NATL ACAD SCI USA, V109, P2467, DOI 10.1073/pnas.1120542109; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Heine M, 2005, J BIOL CHEM, V280, P25637, DOI 10.1074/jbc.M502265200; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x                                                ; Huang CCF, 2012, MOL CELL BIOL, V32, P2664, DOI 10.1128/MCB.00438-12; Jung H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.558; Kanamori M, 2002, BIOCHEM BIOPH RES CO, V290, P1108, DOI 10.1006/bbrc.2001.6315; Koch M, 2016, CELL MICROBIOL, V18, P137, DOI 10.1111/cmi.12492; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Lee CP, 2016, SCI REP-UK, V6, DOI 10.1038/srep25740; Lin TY, 2016, P NATL ACAD SCI USA, V113, P15078, DOI 10.1073/pnas.1618773114; Lipinski S, 2012, P NATL ACAD SCI USA, V109, P21426, DOI 10.1073/pnas.1209673109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milivojevic M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006224; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Quante M, 2008, PHYSIOLOGY, V23, P350, DOI 10.1152/physiol.00031.2008; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Schlaermann P, 2016, GUT, V65, P202, DOI 10.1136/gutjnl-2014-307949; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Valvano MA, 2002, MICROBIOL-SGM, V148, P1979, DOI 10.1099/00221287-148-7-1979                                                     ; Velin D, 2016, HELICOBACTER, V21, P26, DOI 10.1111/hel.12336; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang SJ, 2011, J MOL MED, V89, P1241, DOI 10.1007/s00109-011-0796-5; Warner N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003305; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	50	0	0	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2211-1247			CELL REP	Cell Reports	SEP 5	2017	20	10					2384	2395		10.1016/j.celrep.2017.08.039				12	Cell Biology	Cell Biology	FF8EL	WOS:000409248000010	28877472	gold			2018-01-05	
J	Westrick, RJ; Tomberg, K; Siebert, AE; Zhu, GJ; Winn, ME; Dobies, SL; Manning, SL; Brake, MA; Cleuren, AC; Hobbs, LM; Mishack, LM; Johnston, AJ; Kotnik, E; Siemieniak, DR; Xu, JS; Li, JZ; Saunders, TL; Ginsburg, D				Westrick, Randal J.; Tomberg, Kart; Siebert, Amy E.; Zhu, Guojing; Winn, Mary E.; Dobies, Sarah L.; Manning, Sara L.; Brake, Marisa A.; Cleuren, Audrey C.; Hobbs, Linzi M.; Mishack, Lena M.; Johnston, Alexander J.; Kotnik, Emilee; Siemieniak, David R.; Xu, Jishu; Li, Jun Z.; Saunders, Thomas L.; Ginsburg, David			Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						venous thromboembolism; Factor V Leiden; ENU mutagenesis|; tissue factor pathway inhibitor; genetic screen	VENOUS THROMBOSIS; ARP2/3 COMPLEX; TARGETED DISRUPTION; SEQUENCING DATA; MOUSE; RISK; THROMBOEMBOLISM; GENERATION; GENETICS; FAMILIES	Factor V Leiden (F5(L)) is a common genetic risk factor for venous thromboembolism in humans. We conducted a sensitized N-ethyl-N-nitrosourea (ENU) mutagenesis screen for dominant thrombosuppressor genes based on perinatal lethal thrombosis in mice homozygous for F5(L) (F5(L/L)) and haploinsufficient for tissue factor pathway inhibitor (Tfpi(+/-)). F8 deficiency enhanced the survival of F5(L/L) Tfpi(+/-) mice, demonstrating that F5(L/L) Tfpi(+/-) lethality is genetically suppressible. ENU-mutagenized F5(L/L) males and F5(L/+) Tfpi(+/-) females were crossed to generate 6,729 progeny, with 98 F5(L/L) Tfpi(+/-) offspring surviving until weaning. Sixteen lines, referred to as "modifier of Factor 5 Leiden (MF5L1-16)," exhibited transmission of a putative thrombosuppressor to subsequent generations. Linkage analysis in MF5L6 identified a chromosome 3 locus containing the tissue factor gene (F3). Although no ENU-induced F3 mutation was identified, haploinsufficiency for F3 (F3(+/-)) suppressed F5(L/L) Tfpi(+/)- lethality. Whole-exome sequencing in MF5L12 identified an Actr2 gene point mutation (p.R258G) as the sole candidate. Inheritance of this variant is associated with suppression of F5(L/L) Tfpi(+/-) lethality (P = 1.7 x 10(-6)), suggesting that Actr2(p.R258G) is thrombosuppressive. CRISPR/Cas9 experiments to generate an independent Actr2 knockin/knockout demonstrated that Actr2 haploinsufficiency is lethal, supporting a hypomorphic or gain-of-function mechanism of action for Actr2(p.R258G). Our findings identify F8 and the Tfpi/F3 axis as key regulators in determining thrombosis balance in the setting of F5L and also suggest a role for Actr2 in this process.	[Westrick, Randal J.; Siebert, Amy E.; Brake, Marisa A.; Hobbs, Linzi M.; Mishack, Lena M.; Johnston, Alexander J.] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA; [Westrick, Randal J.] Oakland Univ, Ctr Data Sci & Big Data Anal, Rochester, MI 48309 USA; [Westrick, Randal J.; Tomberg, Kart; Zhu, Guojing; Dobies, Sarah L.; Manning, Sara L.; Cleuren, Audrey C.; Kotnik, Emilee; Ginsburg, David] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Tomberg, Kart; Xu, Jishu; Li, Jun Z.; Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Winn, Mary E.] Van Andel Res Inst, Bioinformat & Biostat Core, Grand Rapids, MI 49503 USA; [Siemieniak, David R.; Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Transgen Anim Model Core, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA	Westrick, RJ (reprint author), Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA.; Westrick, RJ (reprint author), Oakland Univ, Ctr Data Sci & Big Data Anal, Rochester, MI 48309 USA.; Westrick, RJ; Ginsburg, D (reprint author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.; Ginsburg, D (reprint author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Ginsburg, D (reprint author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.; Ginsburg, D (reprint author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Ginsburg, D (reprint author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	rjwestrick@oakland.edu; ginsburg@umich.edu		Tomberg, Kart/0000-0002-6144-3601	National Cancer Institute of the NIH [P30CA046592]; NIH [P01-HL057346, R15-HL133907, R01-HL135035]; Oakland University Research Excellence Fund; Aniara Diagnostica Coagulation Research Grant; American Heart Association (AHA) Predoctoral Fellowship; AHA Innovative Research and Scientist Development Grants; AHA Predoctoral Fellowship; AHA Undergraduate Fellowships	We thank the expertise of the Transgenic Animal Model Core staff of the University of Michigan's Biomedical Research Core Facilities for their assistance with this study. Research reported in this publication was supported by the National Cancer Institute of the NIH under Award P30CA046592 by the use of the following Cancer Center Shared Resources: Transgenic Animal Models. This research was supported by NIH Grants P01-HL057346 (to D.G.) and R15-HL133907 and R01-HL135035 (to R.J.W.). R.J.W. was supported by the Oakland University Research Excellence Fund, an Aniara Diagnostica Coagulation Research Grant, an American Heart Association (AHA) Predoctoral Fellowship, and AHA Innovative Research and Scientist Development Grants. K.T. was an International Fulbright Science and Technology Fellow and the recipient of an AHA Predoctoral Fellowship. M.A.B. and A.J.J. were recipients of AHA Undergraduate Fellowships. D.G. is a member of the University of Michigan Cancer Center and is an Investigator of the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bank I, 2005, J THROMB HAEMOST, V3, P79, DOI 10.1111/j.1538-7836.2004.01033.x                                                ; Berg AO, 2011, GENET MED, V13, P67, DOI 10.1097/GIM.0b013e3181fbe46f; Beutler B, 2017, MUTAGENETIX; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Bull KR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003219; Carpinelli MR, 2004, P NATL ACAD SCI USA, V101, P6553, DOI 10.1073/pnas.0401496101; Clark JSC, 2013, J APPL GENET, V54, P441, DOI 10.1007/s13353-013-0166-9; Cordes SP, 2005, MICROBIOL MOL BIOL R, V69, P426, DOI 10.1128/MMBR.69.3.426-439.2005; Cui JS, 2000, BLOOD, V96, P4222; Dahlback B, 2008, BLOOD, V112, P19, DOI 10.1182/blood-2008-01-077909; Davis AP, 1998, GENETICS, V148, P7; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; Dentali F, 2012, SEMIN THROMB HEMOST, V38, P535, DOI 10.1055/s-0032-1315758; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eitzman DT, 2002, CIRCULATION, V105, P2139, DOI 10.1161/01.CIR.0000017361.39256.82; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Germain M, 2015, AM J HUM GENET, V96, P532, DOI 10.1016/j.ajhg.2015.01.019; Huang ZF, 1997, BLOOD, V90, P944; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Justice MJ, 2000, MAMM GENOME, V11, P484, DOI 10.1007/s003350010094; Koseoglu S, 2015, BLOOD, V126, P651, DOI 10.1182/blood-2014-12-618744; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959                                                            ; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lange K, 2013, BIOINFORMATICS, V29, P1568, DOI 10.1093/bioinformatics/btt187; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2002, BLOOD, V99, P4466, DOI 10.1182/blood.V99.12.4466; Lijfering WM, 2010, BRIT J HAEMATOL, V149, P824, DOI 10.1111/j.1365-2141.2010.08206.x; Lusis AJ, 2012, TRENDS GENET, V28, P267, DOI 10.1016/j.tig.2012.03.001; Matera I, 2008, HUM MOL GENET, V17, P2118, DOI 10.1093/hmg/ddn110; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Moresco EMY, 2013, AM J PATHOL, V182, P1462, DOI 10.1016/j.ajpath.2013.02.002; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Roach REJ, 2015, J THROMB HAEMOST, V13, P1815, DOI 10.1111/jth.13116; Rosendaal FR, 2009, J THROMB HAEMOST, V7, P301, DOI 10.1111/j.1538-7836.2009.03394.x; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Sakurai T, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-69; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Souto JC, 2000, CIRCULATION, V101, P1546; Tchekneva EE, 2007, J AM SOC NEPHROL, V18, P103, DOI 10.1681/ASN.2006020164; Therneau TM, 2000, MODELING SURVIVAL DA, p[xiv, 350]; Tomberg K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150852; Toomey JR, 1996, BLOOD, V88, P1583; Tregouet DA, 2016, J THROMB HAEMOST, V14, P1798, DOI 10.1111/jth.13392; vanBoven HH, 1996, THROMB HAEMOSTASIS, V75, P417; Vandenbroucke JP, 2001, NEW ENGL J MED, V344, P1527, DOI 10.1056/NEJM200105173442007                                                     ; Vauti F, 2007, FEBS LETT, V581, P5691, DOI 10.1016/j.febslet.2007.11.031; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westrick RJ, 2009, J THROMB HAEMOST, V7, P132, DOI 10.1111/j.1538-7836.2009.03362.x; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yoo YJ, 2008, ANN HUM GENET, V72, P566, DOI 10.1111/j.1469-1809.2008.00442.x	61	0	0	5	5	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 5	2017	114	36					9659	9664		10.1073/pnas.1705762114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FF7FP	WOS:000409182200059	28827327				2018-01-05	
J	Hashwah, H; Schmid, CA; Kasser, S; Bertram, K; Stelling, A; Manz, MG; Muller, A				Hashwah, Hind; Schmid, Corina A.; Kasser, Sabrina; Bertram, Katrin; Stelling, Anna; Manz, Markus G.; Mueller, Anne			Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						epigenetic modifiers; DLBCL pathogenesis; xenotransplantation models; tumor suppressor	MUTATIONS; LYMPHOMA	The genes encoding the histone acetyl-transferases (HATs) CREB binding protein (CREBBP) and EP300 are recurrently mutated in the activated B cell-like and germinal center (GC) B cell-like subtypes of diffuse large B cell lymphoma (DLBCL). Here, we introduced a patientmutation into a human DLBCL cell line using CRISPR and deleted Crebbp and Ep300 in the GC B cell compartment of mice. CREBBPmutant DLBCL clones exhibited reduced histone H3 acetylation, expressed significantly less MHCII, and grew faster than wild-type clones in s.c. and orthotopic xenograft models. Mice lacking Crebbp in GC B cells exhibited hyperproliferation of their GC compartment upon immunization, had reduced MHCII surface expression on GC cells, and developed accelerated MYC-driven lymphomas. Ep300 inactivation reproduced some, but not all, consequences of Crebbp inactivation. MHCII deficiency phenocopied the effects of CREBBP loss in spontaneous and serial transplantation models of MYC-driven lymphomagenesis, supporting the idea that the mutational inactivation of CREBBP promotes immune evasion. Indeed, the depletion of CD4(+) T cells greatly facilitated the engraftment of lymphoma cells in serial transplantation models. In summary, we provide evidence that both HATs are bona fide tumor suppressors that control MHCII expression and promote tumor immune control; mutational inactivation of CREBBP, but not of EP300, has additional cell-intrinsic engraftment and growth-promoting effects.	[Hashwah, Hind; Schmid, Corina A.; Kasser, Sabrina; Bertram, Katrin; Stelling, Anna; Mueller, Anne] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Manz, Markus G.] Univ Zurich, Dept Hematol, CH-8091 Zurich, Switzerland; [Schmid, Corina A.] Roche Innovat Ctr Zurich, CH-8952 Schlieren, Switzerland	Muller, A (reprint author), Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland.	mueller@imcr.uzh.ch			Zurich Cantonal League; Swiss Cancer League; Clinical Research Priority Program "Human Hemato-lymphatic Diseases" of the University of Zurich	We thank Alexandar Tzankov and Darius Juskevicius for helpful discussions and comments on the manuscript. This study was funded by grants from the Zurich Cantonal and Swiss Cancer Leagues (to A.M.), and additional support was provided by the Clinical Research Priority Program "Human Hemato-lymphatic Diseases" of the University of Zurich.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Andersen Christen Lykkegaard, 2012, Leuk Res Rep, V2, P1, DOI 10.1016/j.lrr.2012.10.002; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bosch R, 2012, CLIN EXP METASTAS, V29, P339, DOI 10.1007/s10585-012-9454-8; Chambwe N, 2014, BLOOD, V123, P1699, DOI 10.1182/blood-2013-07-509885; Chandra V, 2015, TRENDS IMMUNOL, V36, P527, DOI 10.1016/j.it.2015.07.003; De S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003137; Green MR, 2015, P NATL ACAD SCI USA, V112, pE1116, DOI 10.1073/pnas.1501199112; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Jiang YW, 2016, CURR OPIN HEMATOL, V23, P377, DOI 10.1097/MOH.0000000000000249; Juskevicius D, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0438-7; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Pan H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7921; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Santoro R, 2014, METHODS MOL BIOL, V1094, P319, DOI 10.1007/978-1-62703-706-8_25; Zhang JY, 2017, CANCER DISCOV, V7, P322, DOI 10.1158/2159-8290.CD-16-1417; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940	19	0	0	1	1	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 5	2017	114	36					9701	9706		10.1073/pnas.1619555114				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FF7FP	WOS:000409182200066	28831000				2018-01-05	
J	Zhang, Y; Markert, MJ; Groves, SC; Hardin, PE; Merlin, C				Zhang, Ying; Markert, Matthew J.; Groves, Shayna C.; Hardin, Paul E.; Merlin, Christine			Vertebrate-like CRYPTOCHROME 2 from monarch regulates circadian transcription via independent repression of CLOCK and BMAL1 activity	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						circadian clock; CRYPTOCHROME 2; BMAL1 C terminus; CLOCK; CRISPR	FEEDBACK LOOP; BUTTERFLY MIGRATION; LIMITING AMOUNTS; C-TERMINUS; DROSOPHILA; COMPLEX; PERIOD; CLOCK-BMAL1; MECHANISM; RHYTHMS	Grcadian repression of CLOCK-BMAL1 by PERIOD and CRYPTOCHROME (CRY) in mammals lies at the core of the circadian timekeeping mechanism. CRY repression of CLOCK-BMAL1 and regulation of circadian period are proposed to rely primarily on competition for binding with coactivators on an a-helix located within the transactivation domain (TAD) of the BMAL1 C terminus. This model has, however, not been tested in vivo. Here, we applied CRISPR/Cas9-mediated mutagenesis in the monarch butterfly (Danaus plexippus), which possesses a vertebrate-like CRY (dpCRY2) and an ortholog of BMAL1, to show that insect CRY2 regulates circadian repression through TAD alpha-helix-dependent and -independent mechanisms. Monarch mutants lacking the BMAL1 C terminus including the TAD exhibited arrhythmic eclosion behavior. In contrast, mutants lacking the TAD alpha-helix but retaining the most distal C-terminal residues exhibited robust rhythms during the first day of constant darkness (DD1), albeit with a delayed peak of eclosion. Phase delay in this mutant on DD1 was exacerbated in the presence of a single functional allele of dpCry2, and rhythmicity was abolished in the absence of dpCRY2. Reporter assays in Drosophila 52 cells further revealed that dpCRY2 represses through two distinct mechanisms: a TAD dependent mechanism that involves the dpBMAL1 TAD alpha-helix and dpCLK W328 and a TAD-independent mechanism involving dpCLK E333. Together, our results provide evidence for independent mechanisms of vertebrate-like CRY circadian regulation on the BMAL1 C terminus and the CLK PAS-B domain and demonstrate the importance of a BMAL1 TAD-independent mechanism for generating circadian rhythms in vivo.	[Zhang, Ying; Markert, Matthew J.; Groves, Shayna C.; Hardin, Paul E.; Merlin, Christine] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Zhang, Ying; Markert, Matthew J.; Groves, Shayna C.; Hardin, Paul E.; Merlin, Christine] Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX 77843 USA	Merlin, C (reprint author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.; Merlin, C (reprint author), Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX 77843 USA.	cmerlin@bio.tamu.edu		Hardin, Paul/0000-0002-3370-9011	Texas AM University; National Science Foundation [10S-1456985]; NIH [N5052854]	We thank Steve Reppert for the generous gift of the anti-dpCRY2 R42 and anti-dpCRY2 GP51 antibodies and for providing the pAC plasmids containing dpClk, dpBmal1, and dpCry2; Michael Rosbash for providing the pAC-Renilla-Luc- and VP16-containing plasmids and for discussions; Courtney Caster for information that neither CRY2 nor the BMAL1 C terminus is present in the genome of flies belonging to the Brachyceran lineage and for help in generating Fig. 5A; Justin Vann, Sarah Kenny, and Kendall Bowen for help with monarch husbandry; Aldrin Lugena and Samantha liams for help with the generation of a construct used in the study; Jerome Menet for discussions and suggestions; and Deborah Bell-Pedersen for comments on the manuscript. This work was supported by startup funds from Texas A&M University and by National Science Foundation Grant 10S-1456985 (to C.M.) and NIH Grant N5052854 (to P.E.H.).	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3                                                   ; Bae K, 2000, J NEUROSCI, V20, P1746; Chang DC, 2003, CURR BIOL, V13, P758, DOI 10.1016/S0960-9822(03)00286-0; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564                                                   ; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Gustafson CL, 2017, MOL CELL, V66, P447, DOI 10.1016/j.molcel.2017.04.011; Hosoda H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-34; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Hung HC, 2007, J BIOL CHEM, V282, P31349, DOI 10.1074/jbc.M702319200; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Khan SK, 2012, J BIOL CHEM, V287, P25917, DOI 10.1074/jbc.M112.368001; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lande-Diner L, 2013, P NATL ACAD SCI USA, V110, P16021, DOI 10.1073/pnas.1305980110; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Markert MJ, 2016, G3-GENES GENOM GENET, V6, P905, DOI 10.1534/g3.116.027029; McDonald MJ, 2001, MOL CELL BIOL, V21, P1207, DOI 10.1128/MCB.21.4.1207-1217.2001; Merlin C, 2013, GENOME RES, V23, P159, DOI 10.1101/gr.145599.112; Michael AK, 2017, P NATL ACAD SCI USA, V114, P1560, DOI 10.1073/pnas.1615310114; Nangle SN, 2014, ELIFE, V3, DOI 10.7554/eLife.03674; Park N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138661; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reppert SM, 2016, ANNU REV ENTOMOL, V61, P25, DOI 10.1146/annurev-ento-010814-020855; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; van der Horst GTJ, 1999, NATURE, V398, P627; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Xu HY, 2015, NAT STRUCT MOL BIOL, V22, P476, DOI 10.1038/nsmb.3018; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576                                                                ; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhao WN, 2007, NAT CELL BIOL, V9, P268, DOI 10.1038/ncb1539; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030                                                       	47	0	0	10	10	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 5	2017	114	36					E7516	E7525		10.1073/pnas.1702014114				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FF7FP	WOS:000409182200013	28831003				2018-01-05	
J	Wu, J; Vilarino, M; Suzuki, K; Okamura, D; Bogliotti, YS; Park, I; Rowe, J; McNabb, B; Ross, PJ; Belmonte, JCI				Wu, Jun; Vilarino, Marcela; Suzuki, Keiichiro; Okamura, Daiji; Bogliotti, Yanina Soledad; Park, Insung; Rowe, Joan; McNabb, Bret; Ross, Pablo Juan; Belmonte, Juan Carlos Izpisua			CRISPR-Cas9 mediated one-step disabling of pancreatogenesis in pigs	SCIENTIFIC REPORTS			English	Article							PANCREAS; SYSTEM; CELLS; GENERATION; INJECTION; MOUSE	Genome editing using programmable nucleases has revolutionized biomedical research. CRISPR-Cas9 mediated zygote genome editing enables high efficient production of knockout animals suitable for studying development and relevant human diseases. Here we report efficient disabling pancreatogenesis in pig embryos via zygotic co-delivery of Cas9 mRNA and dual sgRNAs targeting the PDX1 gene, which when combined with chimeric-competent human pluriopotent stem cells may serve as a suitable platform for the xeno-generation of human tissues and organs in pigs.	[Wu, Jun; Suzuki, Keiichiro; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Wu, Jun; Okamura, Daiji] Univ Catolica San Antonio Murcia, Campus Jeronimos 135, Guadalupe 30107, Spain; [Vilarino, Marcela; Bogliotti, Yanina Soledad; Park, Insung; Ross, Pablo Juan] Univ Calif Davis, Dept Anim Sci, One Shields Ave, Davis, CA 95616 USA; [Okamura, Daiji] Kindai Univ, Grad Sch Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan; [Rowe, Joan; McNabb, Bret] Univ Calif Davis, Sch Vet Med, One Shields Ave, Davis, CA 95616 USA	Belmonte, JCI (reprint author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Ross, PJ (reprint author), Univ Calif Davis, Dept Anim Sci, One Shields Ave, Davis, CA 95616 USA.	pross@ucdavis.edu; belmonte@salk.edu			UC Davis Academic Senate New Research Grant; UCAM; G. Harold and Leila Y. Mathers Charitable Foundation; Moxie Foundation	We thank Aaron Prinz, Kent Parker, and their crews for excellent assistance with embryo transfers and pig care at UC Davis. We would like to thank M. Schwarz, and P. Schwarz for administrative help. P.J.R. was supported by UC Davis Academic Senate New Research Grant. Work in the laboratory of JCIB was supported by the UCAM, G. Harold and Leila Y. Mathers Charitable Foundation and The Moxie Foundation.	Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Offield MF, 1996, DEVELOPMENT, V122, P983; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171                                                     ; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Wu J, 2016, NATURE, V540, P51, DOI 10.1038/nature20573; Yoshioka K, 2012, ANIM REPROD SCI, V131, P23, DOI 10.1016/j.anireprosci.2012.01.018; Zhou JK, 2014, FEBS J, V281, P1717, DOI 10.1111/febs.12735	15	1	1	22	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 5	2017	7								10487	10.1038/s41598-017-08596-5				6	Multidisciplinary Sciences	Science & Technology - Other Topics	FF9AN	WOS:000409309300075	28874671	gold			2018-01-05	
J	Heraud-Farlow, JE; Chalk, AM; Linder, SE; Li, Q; Taylor, S; White, JM; Pang, L; Liddicoat, BJ; Gupte, A; Li, JB; Walkley, CR				Heraud-Farlow, Jacki E.; Chalk, Alistair M.; Linder, Sandra E.; Li, Qin; Taylor, Scott; White, Joshua M.; Pang, Lokman; Liddicoat, Brian J.; Gupte, Ankita; Li, Jin Billy; Walkley, Carl R.			Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis	GENOME BIOLOGY			English	Article						ADAR1; RNA editing; MDA5; Development; dsRNA; Innate immunity; Epitranscriptome	AICARDI-GOUTIERES SYNDROME; ADENOSINE-DEAMINASE; ENZYME ADAR1; NONCODING RNA; IN-VIVO; GENE; DSRNA; MICE; EXPRESSION; RESPONSES	Background: Adenosine-to-inosine (A-to-I) editing of dsRNA by ADAR proteins is a pervasive epitranscriptome feature. Tens of thousands of A-to-I editing events are defined in the mouse, yet the functional impact of most is unknown. Editing causing protein recoding is the essential function of ADAR2, but an essential role for recoding by ADAR1 has not been demonstrated. ADAR1 has been proposed to have editing-dependent and editing-independent functions. The relative contribution of these in vivo has not been clearly defined. A critical function of ADAR1 is editing of endogenous RNA to prevent activation of the dsRNA sensor MDA5 (Ifih1). Outside of this, how ADAR1 editing contributes to normal development and homeostasis is uncertain. Results: We describe the consequences of ADAR1 editing deficiency on murine homeostasis. Adar1(E861A/E861A)Ifih1(-/-) mice are strikingly normal, including their lifespan. There is a mild, non-pathogenic innate immune activation signature in the Adar1(E861A/E861A)Ifih1(-/-) mice. Assessing A-to-I editing across adult tissues demonstrates that outside of the brain, ADAR1 performs the majority of editing and that ADAR2 cannot compensate in its absence. Direct comparison of the Adar1(-/-) and Adar1(E861A/E861A) alleles demonstrates a high degree of concordance on both Ifih1(+/+) and Ifih1(-/-) backgrounds, suggesting no substantial contribution from ADAR1 editing-independent functions. Conclusions: These analyses demonstrate that the lifetime absence of ADAR1-editing is well tolerated in the absence of MDA5. We conclude that protein recoding arising from ADAR1-mediated editing is not essential for organismal homeostasis. Additionally, the phenotypes associated with loss of ADAR1 are the result of RNA editing and MDA5-dependent functions.	[Heraud-Farlow, Jacki E.; Chalk, Alistair M.; Taylor, Scott; White, Joshua M.; Pang, Lokman; Liddicoat, Brian J.; Gupte, Ankita; Walkley, Carl R.] St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia; [Heraud-Farlow, Jacki E.; Chalk, Alistair M.; White, Joshua M.; Liddicoat, Brian J.; Walkley, Carl R.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Linder, Sandra E.; Li, Qin; Li, Jin Billy] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Walkley, CR (reprint author), St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia.; Walkley, CR (reprint author), Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.	cwalkley@svi.edu.au		Walkley, Carl/0000-0002-4784-9031; Chalk, Alistair/0000-0002-9630-6236	NHMRC [APP1102006]; Angior Foundation Grant; SVI Women in Research Award; NIH [R01GM102484]; Ellison Medical Foundation; Stanford University Department of Genetics; Victorian State Government OIS; Victorian Cancer Agency Mid- Career Fellowship [MCRF15015]	This work was supported by grants an NHMRC (APP1102006; CW and JBL), Angior Foundation Grant (CW), SVI Women in Research Award (JHF), NIH R01GM102484 (JBL), Ellison Medical Foundation (JBL), Stanford University Department of Genetics (JBL); in part by the Victorian State Government OIS (to St. Vincent's Institute); Victorian Cancer Agency Mid- Career Fellowship (MCRF15015; CW).	Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen T, 2015, CELL RES, V25, P459, DOI 10.1038/cr.2015.24; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Daniel C, 2015, BIOCHIMIE, V117, P22, DOI 10.1016/j.biochi.2015.05.020; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Feng S, 2011, NAT STRUCT MOL BIOL, V18, P169, DOI 10.1038/nsmb.1962; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hardwick SA, 2016, NAT METHODS, V13, P792, DOI [10.1038/NMETH.3958, 10.1038/nmeth.3958]; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heraud-Farlow JE, 2016, J MOL MED, V94, P1095, DOI 10.1007/s00109-016-1416-1; Higuchi M, 2000, NATURE, V406, P78; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Huntley MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2291-9; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157                                                         ; Levanon EY, 2015, BIOESSAYS, V37, P175, DOI 10.1002/bies.201400163; Li YZ, 2017, ELIFE, V6, DOI 10.7554/eLife.25687; Liddicoat BJ, 2016, EXP HEMATOL, V44, P947, DOI 10.1016/j.exphem.2016.06.250; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419                                                          ; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Ng AJM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005160; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; O'Connell MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005687; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Rice GI, 2017, NEUROPEDIATRICS, V48, P166, DOI 10.1055/s-0037-1601449; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Schoft VK, 2007, NUCLEIC ACIDS RES, V35, P3723, DOI 10.1093/nar/gkm314; Smeets MF, 2014, J CLIN INVEST, V124, P3551, DOI 10.1172/JCI75334; Snyder EM, 2017, BIOL REPROD, V96, P244, DOI 10.1095/biolreprod.116.145151; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404                                                         ; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang Qiong, 2013, RNA, V19, P1525, DOI 10.1261/rna.041533.113; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Washburn MC, 2014, CELL REP, V6, P599, DOI 10.1016/j.celrep.2014.01.011; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; XuFeng R, 2009, P NATL ACAD SCI USA, V106, P17763, DOI 10.1073/pnas.0903324106; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yao H, 2015, MOL CELL, V58, P541, DOI 10.1016/j.molcel.2015.03.014; Yu SB, 2013, GENE, V513, P101, DOI 10.1016/j.gene.2012.10.068; Zhang R, 2014, NAT METHODS, V11, P51, DOI 10.1038/nmeth.2736; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	69	2	2	6	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1474-760X			GENOME BIOL	Genome Biol.	SEP 5	2017	18								66	10.1186/s13059-017-1301-4				18	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FF8KK	WOS:000409266900001	28874170	gold			2018-01-05	
J	Deng, HX; Gao, RJ; Liao, XR; Cai, YJ				Deng, Huaxiang; Gao, Ruijie; Liao, Xiangru; Cai, Yujie			CRISPR system in filamentous fungi: Current achievements and future directions	GENE			English	Review						CRISPR/Cas9 system; Filamentous fungi; Drug discovery; Genome editing; Transcriptional regulation; Synthetic gene circuit	BIOSYNTHETIC GENE CLUSTERS; OFF-TARGET CLEAVAGE; ASPERGILLUS-NIDULANS; HUMAN-CELLS; POLYKETIDE SYNTHASES; CAS9 NUCLEASES; EFFECTOR GENE; GENOME; DNA; SPECIFICITY	As eukaryotes, filamentous fungi share many features with humans, and they produce numerous active metabolites, some of which are toxic. Traditional genetic approaches are generally inefficient, but the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system that has been widely used for basic research on bacteria, mammals and plants offers a simple, fast, versatile technology for systemic research on filamentous fungi. In this review, we summarized the current knowledge on Cas9 and its variants, various selective markers used to screen positive clones, different ways used to detect off-target mutations, and different approaches used to express and transform the CRISPR complex. We also highlight several methods that improve the nuclease specificity and efficiency, and discuss current and potential applications of CRISPR/Cas9 system in filamentous fungi for pathogenesis decoding, confirmation of the gene and pathway, bioenergy process, drug discovery, and chromatin dynamics. We also describe how the synthetic gene circuit of CRISPR/Cas9 systems has been used in the response to various complex environmental signals to redirect metabolite flux and ensure continuous metabolite biosynthesis.	[Deng, Huaxiang; Gao, Ruijie; Liao, Xiangru; Cai, Yujie] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China	Liao, XR; Cai, YJ (reprint author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China.	xrliao@jiangnan.edu.cn; yjcai@jiangnan.edu.cn			National Science Foundation of China [21275066]; Six-talent peak program [SWYY-126]; Fundamental Research of Doctor of Philosophy [2050205, 205020502]	This study was financially supported by the National Science Foundation of China (Grant No. 21275066), Six-talent peak program at 2016 (Grant No. SWYY-126), the Fundamental Research of Doctor of Philosophy at 2014 (Grant No. 2050205), the Fundamental Research of Doctor of Philosophy at 2015 (Grant No. 205020502).	Ahuja M, 2012, J AM CHEM SOC, V134, P8212, DOI 10.1021/ja3016395; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barrios-Gonzalez J, 2010, APPL MICROBIOL BIOT, V85, P869, DOI 10.1007/s00253-009-2239-6; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/nmeth.2926, 10.1038/NMETH.2926]; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Chen B., 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKV1533; Chen Jingjing, 2017, Sci Rep, V8, P45763, DOI 10.1038/srep45763; Chiang YM, 2013, J AM CHEM SOC, V135, P7720, DOI 10.1021/ja401945a; Chiang YM, 2009, J AM CHEM SOC, V131, P2965, DOI 10.1021/ja8088185; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Deng H., 2017, RES MICROBIOL; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fang YF, 2016, MOL PLANT PATHOL, V17, P127, DOI 10.1111/mpp.12318; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Grundy SM, 2016, NAT REV CARDIOL, V13, P73, DOI 10.1038/nrcardio.2015.208; Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hirashima K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj011; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Jakociunas T, 2016, METAB ENG, V34, P44, DOI 10.1016/j.ymben.2015.12.003; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang HS, 2016, ACS SYNTH BIOL, V5, P1002, DOI 10.1021/acssynbio.6b00080; Katayama T, 2016, BIOTECHNOL LETT, V38, P637, DOI 10.1007/s10529-015-2015-x; Keller NP, 2015, NAT CHEM BIOL, V11, P671, DOI [10.1038/NCHEMBIO.1897, 10.1038/nchembio.1897]; Khrunyk Y, 2010, NEW PHYTOL, V187, P957, DOI 10.1111/j.1469-8137.2010.03413.x; Kiely DE, 2000, J POLYM SCI POL CHEM, V38, P594, DOI 10.1002/(SICI)1099-0518(20000201)38:3<594::AID-POLA24>3.0.CO;2-#                ; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kim JS, 2016, NAT PROTOC, V11, P1573, DOI 10.1038/nprot.2016.104; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kuivanen J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00225; Kuivanen J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0613-5; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Liu Q, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0693-9; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Ma H., 2016, NAT BIOTECHNOL, V34; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Mehtio T, 2016, CRIT REV BIOTECHNOL, V36, P904, DOI 10.3109/07388551.2015.1060189; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Nielsen ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169712; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Oliveros JC, 2016, NUCLEIC ACIDS RES, V44, pW267, DOI 10.1093/nar/gkw407; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin H, 2017, PROCESS BIOCHEM, V56, P57, DOI 10.1016/j.procbio.2017.02.012; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sarkari P., 2017, BIORESOUR TECHNOL; Schuster M, 2017, FUNGAL GENET BIOL; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smanski MJ, 2016, NAT REV MICROBIOL, V14, P135, DOI 10.1038/nrmicro.2015.24; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Sugano SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00883-5; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Weber J, 2017, ACS SYNTH BIOL, V6, P62, DOI 10.1021/acssynbio.6b00203; Wenderoth M, 2017, FUNGAL GENET BIOL, V101, P55, DOI 10.1016/j.fgb.2017.03.001; Weyda I, 2017, J MICROBIOL METH, V135, P26, DOI 10.1016/j.mimet.2017.01.015; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Woloshuk CP, 2013, FEMS MICROBIOL REV, V37, P94, DOI 10.1111/1574-6976.12009; Yeh HH, 2016, ACS CHEM BIOL, V11, P2275, DOI 10.1021/acschembio.6b00213; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007; Zhang L, 2016, WORLD J PSYCHIATR, V6, P1, DOI 10.5498/wjp.v6.i1.1; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	95	1	1	42	42	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	SEP 5	2017	627						212	221		10.1016/j.gene.2017.06.019				10	Genetics & Heredity	Genetics & Heredity	FD6SK	WOS:000407658000028	28625564				2018-01-05	
J	Huang, WC; Daboussi, F				Huang, Weichao; Daboussi, Fayza			Genetic and metabolic engineering in diatoms	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES			English	Review						genetic engineering; metabolic engineering; biotechnology	POLYUNSATURATED FATTY-ACIDS; PHAEODACTYLUM-TRICORNUTUM BACILLARIOPHYCEAE; MARINE DIATOM; NUCLEAR TRANSFORMATION; DIACYLGLYCEROL ACYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; EFFICIENT TRANSFORMATION; THALASSIOSIRA-PSEUDONANA; HOMOLOGOUS RECOMBINATION; CARBONIC ANHYDRASE	Diatoms have attracted considerable attention due to their success in diverse environmental conditions, which probably is a consequence of their complex origins. Studies of their metabolism will provide insight into their adaptation capacity and are a prerequisite for metabolic engineering. Several years of investigation have led to the development of the genome engineering tools required for such studies, and a profusion of appropriate tools is now available for exploring and exploiting the metabolism of these organisms. Diatoms are highly prized in industrial biotechnology, due to both their richness in natural lipids and carotenoids and their ability to produce recombinant proteins, of considerable value in diverse markets. This review provides an overview of recent advances in genetic engineering methods for diatoms, from the development of gene expression cassettes and gene delivery methods, to cutting-edge genome-editing technologies. It also highlights the contributions of these rapid developments to both basic and applied research: they have improved our understanding of key physiological processes; and they have made it possible to modify the natural metabolism to favour the production of specific compounds or to produce new compounds for green chemistry and pharmaceutical applications. This article is part of the themed issue 'The peculiar carbon metabolism in diatoms'.	[Huang, Weichao; Daboussi, Fayza] Univ Toulouse, LISBP, CNRS, INRA,INSA LISBP INSA Toulouse, 135 Ave Rangueil, F-31077 Toulouse, France	Daboussi, F (reprint author), Univ Toulouse, LISBP, CNRS, INRA,INSA LISBP INSA Toulouse, 135 Ave Rangueil, F-31077 Toulouse, France.	fayza.daboussi@insa-toulouse.fr			Region Midi-Pyrenees [15058490]	The postdoctoral grant for Weichao Huang was funded by the Region Midi-Pyrenees 15058490. This work was supported by the grant 15058490 from Region Midi-Pyrenees (financial support for 'Accueil d'Equipes d'Excellence').	Ankeny RA, 2011, STUD HIST PHILOS SCI, V42, P313, DOI 10.1016/j.shpsa.2010.11.039; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Apt KE, 2002, J CELL SCI, V115, P4061, DOI 10.1242/jcs.00092; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Barka F, 2016, BBA-MOL CELL BIOL L, V1861, P239, DOI 10.1016/j.bbalip.2015.12.023; Barra L, 2014, MAR DRUGS, V12, P1641, DOI 10.3390/md12031641; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Bogorad L, 2000, TRENDS BIOTECHNOL, V18, P257, DOI 10.1016/S0167-7799(00)01444-X; Bozarth A, 2009, APPL MICROBIOL BIOT, V82, P195, DOI 10.1007/s00253-008-1804-8; Cho C, 2015, BIOTECHNOL ADV, V33, P1455, DOI 10.1016/j.biotechadv.2014.11.006; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Chu LL, 2016, PEERJ, V4, DOI 10.7717/peerj.2344; Daboussi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4831; Dambek M, 2012, J EXP BOT, V63, P5607, DOI 10.1093/jxb/ers211; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Delalat B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9791; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dolch LJ, 2015, MAR DRUGS, V13, P1317, DOI 10.3390/md13031317; Dunahay TG, 1995, J PHYCOL, V31, P1004, DOI 10.1111/j.0022-3646.1995.01004.x; Eilers U, 2016, J PLANT PHYSIOL, V192, P64, DOI 10.1016/j.jplph.2016.01.006; Eilers U, 2016, J APPL PHYCOL, V28, P123, DOI 10.1007/s10811-015-0583-8; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773                                                              ; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fortunato AE, 2016, PLANT CELL, V28, P616, DOI 10.1105/tpc.15.00928; Gong YM, 2013, FEBS LETT, V587, P481, DOI 10.1016/j.febslet.2013.01.015; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Guiheneuf F, 2011, FEBS J, V278, P3651, DOI 10.1111/j.1742-4658.2011.08284.x; Haimovich-Dayan M, 2013, NEW PHYTOL, V197, P177, DOI 10.1111/j.1469-8137.2012.04375.x; Hamilton ML, 2016, MAR DRUGS, V14, DOI 10.3390/md14030053; Hamilton ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144054; Hamilton ML, 2014, METAB ENG, V22, P3, DOI 10.1016/j.ymben.2013.12.003; Harada H, 2005, PLANT PHYSIOL, V139, P1041, DOI 10.1104/pp.105.065185; Hempel F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-126; Hempel F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028424; Hempel F, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-81; Hildebrand M, 2012, BIOFUELS-UK, V3, P221, DOI 10.4155/bfs.11.157; Hopes A, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0148-0; Hopkinson BM, 2016, CURR OPIN PLANT BIOL, V31, P51, DOI 10.1016/j.pbi.2016.03.013; Costa BHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065057; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang WC, 2016, J EUKARYOT MICROBIOL, V63, P536, DOI 10.1111/jeu.12298; Huysman MJJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0469-6; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Ifuku K, 2015, PHOTOSYNTH RES, V123, P203, DOI 10.1007/s11120-014-0048-y; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kadono T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18708; Kadono T, 2015, MAR DRUGS, V13, P5334, DOI 10.3390/md13085334; Karas BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7925; Kaur S, 2015, MAR BIOTECHNOL, V17, P1, DOI 10.1007/s10126-014-9593-9; Kikutani S, 2016, P NATL ACAD SCI USA, V113, P9828, DOI 10.1073/pnas.1603112113; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Kroth P, 2007, ADV EXP MED BIOL, V616, P23; Kung Y, 2012, ACS SYNTH BIOL, V1, P498, DOI 10.1021/sb300074k; Lavaud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036806; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Levitan O, 2015, PLANT J, V84, P963, DOI 10.1111/tpj.13052; Liu XJ, 2016, ALGAL RES, V20, P249, DOI 10.1016/j.algal.2016.10.018; Materna AC, 2009, J PHYCOL, V45, P838, DOI 10.1111/j.1529-8817.2009.00711.x; Mathieu-Rivet E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00359; Miyahara M, 2013, BIOSCI BIOTECH BIOCH, V77, P874, DOI 10.1271/bbb.120936; Muto M, 2013, MAR BIOTECHNOL, V15, P48, DOI 10.1007/s10126-012-9457-0; Niu Y. F., 2012, BIOTECHNIQUES, V52, P1, DOI [10.2144/000113881, DOI 10.2144/000113881]; Niu YF, 2013, MAR DRUGS, V11, P4558, DOI 10.3390/md11114558; Nymark M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24951; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Peng KT, 2014, J AGR FOOD CHEM, V62, P8773, DOI 10.1021/jf5031086; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Purton S, 2013, RUSS J PLANT PHYSL+, V60, P491, DOI 10.1134/S1021443713040146; Radakovits R, 2011, METAB ENG, V13, P89, DOI 10.1016/j.ymben.2010.10.003; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; Sabatino V, 2015, MAR BIOTECHNOL, V17, P452, DOI 10.1007/s10126-015-9633-0; Sakaue K, 2008, PHYSIOL PLANTARUM, V133, P59, DOI 10.1111/j.1399-3054.2008.01089.x; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; Seo S, 2015, ALGAL RES, V11, P50, DOI 10.1016/j.algal.2015.05.012; John Sheehan TDJ., 1998, TECHNICAL REPORT; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Taddei L, 2016, J EXP BOT, V67, P3939, DOI 10.1093/jxb/erw198; Takaichi S, 2011, MAR DRUGS, V9, P1101, DOI 10.3390/md9061101; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Vanier G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139282; Weyman PD, 2015, PLANT BIOTECHNOL J, V13, P460, DOI 10.1111/pbi.12254; Wilhelm C, 2014, MAR GENOM, V16, P5, DOI 10.1016/j.margen.2013.12.003; Xie WH, 2014, MAR BIOTECHNOL, V16, P538, DOI 10.1007/s10126-014-9570-3; Xue J, 2015, METAB ENG, V27, P1, DOI 10.1016/j.ymben.2014.10.002; Yoshinaga R, 2014, MAR GENOM, V16, P55, DOI 10.1016/j.margen.2014.01.005; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; Zhang CY, 2014, MAR GENOM, V16, P63, DOI 10.1016/j.margen.2013.10.003; Zhu BH, 2016, NEW BIOTECHNOL, V33, P237, DOI 10.1016/j.nbt.2015.06.003; Duchateau P, 2014, Patent, Patent No. [WO2014207043, 2014207043]; Duchateau P, 2013, Patent, Patent No. [WO2014076571, 2014076571]	98	1	1	36	36	ROYAL SOC	LONDON	6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	0962-8436	1471-2970		PHILOS T R SOC B	Philos. Trans. R. Soc. B-Biol. Sci.	SEP 5	2017	372	1728							20160411	10.1098/rstb.2016.0411				10	Biology	Life Sciences & Biomedicine - Other Topics	FA8DK	WOS:000405676200016					2018-01-05	
J	Liu, L; Zhang, Z; Shao, CL; Wang, CY				Liu, Lu; Zhang, Zheng; Shao, Chang-Lun; Wang, Chang-Yun			Analysis of the Sequences, Structures, and Functions of Product-Releasing Enzyme Domains in Fungal Polyketide Synthases	FRONTIERS IN MICROBIOLOGY			English	Article						fungal polyketide synthase; product-releasing enzyme; sequence; structure; function	CROSS-COUPLING ACTIVITY; FATTY-ACID SYNTHASE; THIOESTERASE DOMAIN; BIOSYNTHETIC-PATHWAY; ASPERGILLUS-NIDULANS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CLAISEN CYCLASE; GENE-CLUSTER; REVEALS	Product-releasing enzyme (PRE) domains in fungal non-reducing polyketide synthases (NR-PKSs) play a crucial role in catalysis and editing during polyketide biosynthesis, especially accelerating final biosynthetic reactions accompanied with product offloading. However, up to date, the systematic knowledge about PRE domains is deficient. In the present study, the relationships between sequences, structures, and functions of PRE domains were analyzed with 574 NR-PKSs of eight groups (I-VIII). It was found that the PRE domains in NR-PKSs could be mainly classified into three types, thioesterase (TE), reductase (R), and metallo-beta-lactamase-type TE (M beta L-TE). The widely distributed TE or TE-like domains were involved in NR-PKSs of groups I-IV, VI, and VIII. The R domains appeared in NR-PKSs of groups IV and VII, while the physically discrete M beta L-TE domains were employed by most NR-PKSs of group V. The changes of catalytic sites and structural characteristics resulted in PRE functional differentiations. The phylogeny revealed that the evolution of TE domains was accompanied by complex functional divergence. The diverse sequence lengths of TE lid-loops affected substrate specificity with different chain lengths. The volume diversification of TE catalytic pockets contributed to catalytic mechanisms with functional differentiations. The above findings may help to understand the crucial catalysis of fungal aromatic polyketide biosyntheses and govern recombination of NR-PKSs to obtain unnatural target products.	[Liu, Lu; Shao, Chang-Lun; Wang, Chang-Yun] Ocean Univ China, Key Lab Marine Drugs, Minist Educ China, Sch Med & Pharm, Qingdao, Peoples R China; [Liu, Lu; Shao, Chang-Lun; Wang, Chang-Yun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Bioprod, Qingdao, Peoples R China; [Zhang, Zheng] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China; [Wang, Chang-Yun] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China	Wang, CY (reprint author), Ocean Univ China, Key Lab Marine Drugs, Minist Educ China, Sch Med & Pharm, Qingdao, Peoples R China.; Wang, CY (reprint author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Bioprod, Qingdao, Peoples R China.; Zhang, Z (reprint author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China.; Wang, CY (reprint author), Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China.	zhzhang.sdu@gmail.com; changyun@ouc.edu.cn			Taishan Scholars Program, China; National Natural Science Foundation of China [81673350, 41376145]; Fundamental Research Funds for the Central Universities of China [201762017]; Open Research Fund Program of State Key Laboratory of Microbial Metabolism (Shanghai Jiao Tong University), China [MMLKF1609]; Postdoctoral Personnel Applied Research Funds of Qingdao, China [2015066]	This work was supported by the Taishan Scholars Program, China; the National Natural Science Foundation of China (Nos. 81673350; 41376145); the Fundamental Research Funds for the Central Universities of China (No. 201762017); the Open Research Fund Program of State Key Laboratory of Microbial Metabolism (Shanghai Jiao Tong University), China (MMLKF1609); and Postdoctoral Personnel Applied Research Funds of Qingdao, China (No. 2015066).	ASHKENAZY H, 2010, NUCLEIC ACIDS RES, V2010, P38, DOI DOI 10.1093/NAR/GKQ399; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bailey AM, 2007, CHEM COMMUN, P4053, DOI 10.1039/b708614h; Barajas JF, 2015, CHEM BIOL, V22, P1018, DOI 10.1016/j.chembiol.2015.06.022; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5                                                   ; Chakravarty B, 2004, P NATL ACAD SCI USA, V101, P15567, DOI 10.1073/pnas.0406901101; Chen B, 2009, BIOCHEMISTRY-US, V48, P11496, DOI 10.1021/bi9014727; Cheng Q, 2004, BIOORG CHEM, V32, P92, DOI 10.1016/j.bioorg.2003.10.001; Chooi YH, 2012, J ORG CHEM, V77, P9933, DOI 10.1021/jo301592k; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2010, NAT REV MICROBIOL, V8, P879, DOI 10.1038/nrmicro2465; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Giraldes JW, 2006, NAT CHEM BIOL, V2, P531, DOI 10.1038/nchembio822; Gressler M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00184; Heberlig GW, 2014, ORG LETT, V16, P5858, DOI 10.1021/ol502747t; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5                                                    ; Humphrey W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Korman TP, 2010, P NATL ACAD SCI USA, V107, P6246, DOI 10.1073/pnas.0913531107; Lackner G, 2013, CHEM BIOL, V20, P1101, DOI [10.1016/j.chembio1.2013.07.009, 10.1016/j.chembiol.2013.07.009]; Lackner G, 2012, FUNGAL GENET BIOL, V49, P996, DOI 10.1016/j.fgb.2012.09.009; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944                                                       ; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201; Li YR, 2011, J AM CHEM SOC, V133, P15773, DOI 10.1021/ja206906d; Lim FY, 2012, APPL ENVIRON MICROB, V78, P4117, DOI 10.1128/AEM.07710-11; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10463; Lo HC, 2012, J AM CHEM SOC, V134, P4709, DOI 10.1021/ja209809t; Manavalan B, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-1; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Newman AG, 2014, J AM CHEM SOC, V136, P7348, DOI 10.1021/ja5007299; Newman AG, 2012, CHEM COMMUN, V48, P11772, DOI 10.1039/c2cc36010a; Pavelka A, 2016, IEEE ACM T COMPUT BI, V13, P505, DOI 10.1109/TCBB.2015.2459680; Pemble CW, 2007, NAT STRUCT MOL BIOL, V14, P704, DOI 10.1038/nsmb1265; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177; Vagstad AL, 2012, CHEM BIOL, V19, P1525, DOI 10.1016/j.chembiol.2012.10.002; Vagstad AL, 2012, J AM CHEM SOC, V134, P6865, DOI 10.1021/ja3016389; Wang M, 2009, BIOCHEMISTRY-US, V48, P6288, DOI 10.1021/bi9009049; Xu YQ, 2013, J AM CHEM SOC, V135, P10783, DOI 10.1021/ja4041362; Xu YQ, 2013, APPL ENVIRON MICROB, V79, P2038, DOI 10.1128/AEM.03334-12; Yang JY, 2016, J MOL BIOL, V428, P693, DOI 10.1016/j.jmb.2015.09.024; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yeh HH, 2013, ORG LETT, V15, P756, DOI 10.1021/ol303328t; Yu PW, 2016, J NAT PROD, V79, P1485, DOI 10.1021/acs.jnatprod.5b00798; Zabala AO, 2012, CHEM BIOL, V19, P1049, DOI 10.1016/j.chembiol.2012.07.004; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zhou H, 2010, J BIOL CHEM, V285, P41412, DOI 10.1074/jbc.M110.183574	59	0	0	12	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-302X			FRONT MICROBIOL	Front. Microbiol.	SEP 4	2017	8								1685	10.3389/fmicb.2017.01685				13	Microbiology	Microbiology	FF9OE	WOS:000409345100001	28928723	gold			2018-01-05	
J	Tang, Q; Lou, CB; Liu, SJ				Tang, Qiang; Lou, Chunbo; Liu, Shuang-Jiang			Construction of an easy-to-use CRISPR-Cas9 system by patching a newly designed EXIT circuit	JOURNAL OF BIOLOGICAL ENGINEERING			English	Article						EXIT circuit; I-SceI; Plasmid elimination; One-step; CRISPR-Cas9; Easy-to-use; Genome editing; Atrazine-degradation; Escherichia coli	ORAL VACCINE CANDIDATE; ESCHERICHIA-COLI K-12; LARGE-DNA-FRAGMENT; LOW-COPY-NUMBER; HOMING ENDONUCLEASES; MOBILIZABLE VECTORS; EXPRESSION VECTORS; DELIVERY-SYSTEM; PLASMID; GENE	Background: Plasmid-borne genetic editing tools, including the widely used CRISPR-Cas9 system, have greatly facilitated bacterial programming to obtain novel functionalities. However, the lack of effective post-editing plasmid elimination methods impedes follow-up genetic manipulation or application. Conventional strategies including exposure to physical and chemical treatments, or exploiting temperature-sensitive replication origins have several drawbacks (e.g., they are limited for efficiency and are time-consuming). Therefore, the demand is apparent for easy and rapid elimination of the tool plasmids from their bacterial hosts after genetic manipulation. Results: To bridge this gap, we designed a novel EXIT circuit with the homing endonuclease, which can be exploited for rapid and efficient elimination of various plasmids with diverse replication origins. As a proof of concept, we validated the EXIT circuit in Escherichia coli by harnessing homing endonuclease I-SceI and its cleavage site. When integrated into multiple plasmids with different origins, the EXIT circuit allowed them to be eliminated from the host cells, simultaneously. By combining the widely used plasmid-borne CRISPR-Cas9 system and the EXIT circuit, we constructed an easy-to-use CRISPR-Cas9 system that eliminated the Cas9- and the single-guide RNA (sgRNA)-encoding plasmids in one-step. Within 3 days, we successfully constructed an atrazine-degrading E. coli strain, thus further demonstrating the advantage of this new CRISPR-Cas9 system for bacterial genome editing. Conclusions: Our novel EXIT circuit, which exploits the homing endonuclease I-SceI, enables plasmid(s) with different replication origins to be eliminated from their host cells rapidly and efficiently. We also developed an easy-to-use CRISPR-Cas9 system with the EXIT circuit, and this new system can be widely applied to bacterial genome editing.	[Tang, Qiang; Liu, Shuang-Jiang] Chinese Acad Sci, Res Ctr, State Key Lab Microbial Resources & Environm Micr, Beijing 100101, Peoples R China; [Tang, Qiang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lou, Chunbo] Chinese Acad Sci, CAS Key Lab Microbial Physiol & Metab Engn, Beijing 100101, Peoples R China; [Lou, Chunbo; Liu, Shuang-Jiang] Chinese Acad Sci, Inst Microbiol, Beichen Xilu 1, Beijing 100101, Peoples R China	Liu, SJ (reprint author), Chinese Acad Sci, Res Ctr, State Key Lab Microbial Resources & Environm Micr, Beijing 100101, Peoples R China.; Lou, CB (reprint author), Chinese Acad Sci, CAS Key Lab Microbial Physiol & Metab Engn, Beijing 100101, Peoples R China.; Lou, CB; Liu, SJ (reprint author), Chinese Acad Sci, Inst Microbiol, Beichen Xilu 1, Beijing 100101, Peoples R China.	louchunbo@im.ac.cn; liusj@im.ac.cn			CAS/SAFEA; Ministry of Science and Technology, China [2012CB7211-04]	This work was supported by the CAS/SAFEA international partnership program and the 973 Project from the Ministry of Science and Technology, China (No. 2012CB7211-04).	Bassalo MC, 2016, ACS SYNTH BIOL, V5, P561, DOI 10.1021/acssynbio.5b00187; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Belfort M, 2014, METHODS MOL BIOL, V1123, P1, DOI 10.1007/978-1-62703-968-0_1; Berzin V, 2013, ARCH MICROBIOL, V195, P181, DOI 10.1007/s00203-012-0862-6; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; BRANA H, 1983, FOLIA MICROBIOL, V28, P441, DOI 10.1007/BF02879679; Brzoska AJ, 2013, APPL ENVIRON MICROB, V79, P3133, DOI 10.1128/AEM.00144-13; Casini A, 2014, ACS SYNTH BIOL, V3, P525, DOI 10.1021/sb4001323; Chakravartty V, 2015, PLASMID, V81, P21, DOI 10.1016/j.plasmid.2015.03.001; Chen ZQ, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw231; Chou HH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3595; Chung ME, 2017, BIOTECHNOL BIOENG, V114, P172, DOI 10.1002/bit.26056; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Copley SD, 2009, NAT CHEM BIOL, V5, P560, DOI 10.1038/nchembio.197; Cui GZ, 2014, APPL MICROBIOL BIOT, V98, P313, DOI 10.1007/s00253-013-5330-y; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Moraes MH, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0139-y; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DESOUZA ML, 1995, APPL ENVIRON MICROB, V61, P3373; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Enyeart PJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.41; FAIRHEAD C, 1993, MOL GEN GENET, V240, P170, DOI 10.1007/BF00277054; Freudenau Inga, 2015, Front Bioeng Biotechnol, V3, P127, DOI 10.3389/fbioe.2015.00127; Furukawa K, 2003, TRENDS BIOTECHNOL, V21, P187, DOI 10.1016/S0167-7799(03)00054-4; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; Hu SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep29087; Jiang WY, NAT BIOTECHNOL; Kurumbang NP, 2014, ACS SYNTH BIOL, V3, P172, DOI 10.1021/sb400147n; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Liu WX, 2015, APPL MICROBIOL BIOT, V99, P4005, DOI 10.1007/s00253-014-6332-0; Liu WX, 2015, APPL MICROBIOL BIOT, V99, P855, DOI 10.1007/s00253-014-6099-3; Miyazaki R, 2013, APPL ENVIRON MICROB, V79, P4440, DOI 10.1128/AEM.00711-13; Molitor B, 2016, SCI REP-UK, V6, DOI 10.1038/srep31518; Moore SJ, 2016, ACS SYNTH BIOL, V5, P1059, DOI 10.1021/acssynbio.6b00031; Nallapareddy SR, 2006, APPL ENVIRON MICROB, V72, P334, DOI 10.1128/AEM.72.1.334-345.2006; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; PARKE D, 1990, GENE, V93, P135, DOI 10.1016/0378-1119(90)90147-J; Portnoy VA, 2011, CURR OPIN BIOTECH, V22, P590, DOI 10.1016/j.copbio.2011.03.007; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reisch CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15096; Ronda C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19452; ROSE RE, 1988, NUCLEIC ACIDS RES, V16, P355, DOI 10.1093/nar/16.1.355; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064                                                         ; SEEGERS JFML, 1995, MOL GEN GENET, V249, P43, DOI 10.1007/BF00290234; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Skowronek K, 2002, ANAL BIOCHEM, V300, P185, DOI 10.1006/abio.2001.5456; UHLIN BE, 1975, J BACTERIOL, V124, P641; Vail AW, 2015, TRANSGENIC RES, V24, P475, DOI 10.1007/s11248-014-9851-7; Wang Y, 2016, ACS SYNTH BIOL, V5, P721, DOI 10.1021/acssynbio.6b00060; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9                                                   ; WATABE K, 1987, J BACTERIOL, V169, P4141, DOI 10.1128/jb.169.9.4141-4146.1987                                                 ; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	55	0	0	9	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1754-1611			J BIOL ENG	J. Biol. Eng.	SEP 4	2017	11								32	10.1186/s13036-017-0072-5				11	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	FF6NA	WOS:000409127500001	28878819	gold			2018-01-05	
J	Mettananda, S; Fisher, CA; Hay, D; Badat, M; Quek, L; Clark, K; Hublitz, P; Downes, D; Kerry, J; Gosden, M; Telenius, J; Sloane-Stanley, JA; Faustino, P; Coelho, A; Doondeea, J; Usukhbayar, B; Sopp, P; Sharpe, JA; Hughes, JR; Vyas, P; Gibbons, RJ; Higgs, DR				Mettananda, Sachith; Fisher, Chris A.; Hay, Deborah; Badat, Mohsin; Quek, Lynn; Clark, Kevin; Hublitz, Philip; Downes, Damien; Kerry, Jon; Gosden, Matthew; Telenius, Jelena; Sloane-Stanley, Jackie A.; Faustino, Paula; Coelho, Andreia; Doondeea, Jessica; Usukhbayar, Batchimeg; Sopp, Paul; Sharpe, Jacqueline A.; Hughes, Jim R.; Vyas, Paresh; Gibbons, Richard J.; Higgs, Douglas R.			Editing an alpha-globin enhancer in primary human hematopoietic stem cells as a treatment for beta-thalassemia	NATURE COMMUNICATIONS			English	Article							UNEXPECTEDLY MILD PHENOTYPE; HUMAN GENE-THERAPY; FETAL-HEMOGLOBIN; GENOME; EXPRESSION; INTERMEDIA; DELETION; DISEASE; TARGET	beta-Thalassemia is one of the most common inherited anemias, with no effective cure for most patients. The pathophysiology reflects an imbalance between alpha- and beta-globin chains with an excess of free alpha-globin chains causing ineffective erythropoiesis and hemolysis. When alpha-thalassemia is co-inherited with beta-thalassemia, excess free alpha-globin chains are reduced significantly ameliorating the clinical severity. Here we demonstrate the use of CRISPR/Cas9 genome editing of primary human hematopoietic stem/progenitor (CD34+) cells to emulate a natural mutation, which deletes the MCS-R2 alpha-globin enhancer and causes a-thalassemia. When edited CD34+ cells are differentiated into erythroid cells, we observe the expected reduction in alpha-globin expression and a correction of the pathologic globin chain imbalance in cells from patients with beta-thalassemia. Xenograft assays show that a proportion of the edited CD34+ cells are long-term repopulating hematopoietic stem cells, demonstrating the potential of this approach for translation into a therapy for beta-thalassemia.	[Mettananda, Sachith; Fisher, Chris A.; Hay, Deborah; Badat, Mohsin; Quek, Lynn; Downes, Damien; Kerry, Jon; Gosden, Matthew; Telenius, Jelena; Sloane-Stanley, Jackie A.; Doondeea, Jessica; Usukhbayar, Batchimeg; Sharpe, Jacqueline A.; Hughes, Jim R.; Vyas, Paresh; Gibbons, Richard J.; Higgs, Douglas R.] Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Hematol Unit, Oxford OX3 9DS, England; [Mettananda, Sachith] Univ Kelaniya, Fac Med, Dept Paediat, Ragama 11010, Sri Lanka; [Clark, Kevin; Hublitz, Philip; Sopp, Paul] Univ Oxford, MRC, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Faustino, Paula; Coelho, Andreia] Natl Inst Hlth Dr Ricardo Jorge, Human Genet Dept, Av Padre Cruz, P-1649016 Lisbon, Portugal; [Faustino, Paula] Univ Lisbon, Fac Med, Inst Environm Hlth, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal; [Vyas, Paresh; Higgs, Douglas R.] Oxford Univ Hosp, Hlth Res Biomed Res Ctr, Oxford Natl Inst, Blood Theme, Oxford OX3 9DU, England	Higgs, DR (reprint author), Univ Oxford, Weatherall Inst Mol Med, MRC, Mol Hematol Unit, Oxford OX3 9DS, England.; Higgs, DR (reprint author), Oxford Univ Hosp, Hlth Res Biomed Res Ctr, Oxford Natl Inst, Blood Theme, Oxford OX3 9DU, England.	doug.higgs@imm.ox.ac.uk		Mettananda, Sachith/0000-0002-0760-0418; Vyas, Paresh/0000-0003-3931-0914	UK Medical Research Council [MC_UU_12025/ unit programme MC_UU_12009/4]; NIHR Oxford Biomedical Research Center; UK government; Helmut Horten Foundation	This work was supported by grants to D.R.H. by the UK Medical Research Council (grant number MC_UU_12025/ unit programme MC_UU_12009/4) and the NIHR Oxford Biomedical Research Center. S.M. is a Commonwealth Scholar, funded by the UK government. We also acknowledge funding from Helmut Horten Foundation. We thank Anuja Premawardana of University of Kelaniya, Sri Lanka for providing samples from beta-thalassemia patients and Gathsaurie Neelika Malavige of University of Sri Jayawardenapura, Sri Lanka for providing facilities for some of the tissue culture work. We thank Yale Michaels for advice using Droplet Digital PCR. Addgene plasmid 48138 (pSpCas9(BB)-2A-GFP (PX458)) was a gift from Feng Zhang. We thank family (C) for their kind collaboration. We also thank Dr Joao Lavinha for critically reading the paper and Dr Tudor Fulga for helpful discussion.	Angelucci E, 2014, HAEMATOLOGICA, V99, P811, DOI 10.3324/haematol.2013.099747; Anguita E, 2002, BLOOD, V100, P3450, DOI 10.1182/blood-2002-05-1409                                                      ; Arumugam P, 2010, HEMATOL-AM SOC HEMAT, P445, DOI 10.1182/asheducation-2010.1.445; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Canver MC, 2016, BLOOD, V127, P2536, DOI 10.1182/blood-2016-01-678128; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Coelho A, 2010, BLOOD CELL MOL DIS, V45, P147, DOI 10.1016/j.bcmd.2010.05.010; Davies JOJ, 2016, NAT METHODS, V13, P74, DOI [10.1038/NMETH.3664, 10.1038/nmeth.3664]; De Gobbi M, 2007, BLOOD, V110, P4503, DOI 10.1182/blood-2007-06-097964; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; FIBACH E, 1989, BLOOD, V73, P100; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Higgs DR, 2008, CURR OPIN HEMATOL, V15, P176, DOI 10.1097/MOH.0b013e3282f734c4; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ludwig LS, 2016, AM J MED GENET C, V172, P332, DOI 10.1002/ajmg.c.31529; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; Meissner TB, 2014, METHOD ENZYMOL, V546, P273, DOI 10.1016/B978-0-12-801185-0.00013-1; Mettananda S, 2017, HAEMATOLOGICA, V102, pE80, DOI 10.3324/haematol.2016.155655; Mettananda S, 2016, ANN NY ACAD SCI, V1368, P16, DOI 10.1111/nyas.12988; Mettananda S, 2015, BLOOD, V125, P3694, DOI 10.1182/blood-2015-03-633594; Persons DA, 2001, BLOOD, V97, P3275, DOI 10.1182/blood.V97.10.3275; Premawardhena A, 2005, BLOOD, V106, P3251, DOI 10.1182/blood-2005-02-0593; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rugless MJ, 2008, HUM MOL GENET, V17, P3084, DOI 10.1093/hmg/ddn205; Sankaran VG, 2015, NAT MED, V21, P221, DOI 10.1038/nm.3814; SHARPE JA, 1992, EMBO J, V11, P4565; Shi LH, 2013, NAT MED, V19, P291, DOI 10.1038/nm.3101; Sollaino MC, 2009, HAEMATOL-HEMATOL J, V94, P1445, DOI 10.3324/haematol.2009.005728; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Weatherall DJ, 2001, THALASSAEMIA SYNDROM	35	0	0	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	SEP 4	2017	8								424	10.1038/s41467-017-00479-7				11	Multidisciplinary Sciences	Science & Technology - Other Topics	FG0FI	WOS:000409394000007	28871148	gold			2018-01-05	
J	Wazir, U; Mokbel, K; Carmichael, A; Mokbel, K				Wazir, Umar; Mokbel, Kinan; Carmichael, Amtul; Mokbel, Kefah			Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?	CELLULAR & MOLECULAR BIOLOGY LETTERS			English	Review						Breast cancer; Molecular biotechnology; Genomic assay; Prognosis; Gene expression regulation	SEER-MEDICARE DATA; PROGNOSTIC MODEL; RECURRENCE SCORE; ADJUVANT THERAPY; DISTANT RECURRENCE; ENDOCRINE THERAPY; REGISTRATION DATA; COMPUTER-PROGRAM; DECISION AID; PAM50 RISK	Background: Clinicians use clinical and pathological parameters, such as tumour size, grade and nodal status, to make decisions on adjuvant treatments for breast cancer. However, therapeutic decisions based on these features tend to vary due to their subjectivity. Computational and mathematical algorithms were developed using clinical outcome data from breast cancer registries, such as Adjuvant! Online and NHS PREDICT. More recently, assessments of molecular profiles have been applied in the development of better prognostic tools. Methods: Based on the available literature on online registry-based tools and genomic assays, we evaluated whether these online tools could be valid and accurate alternatives to genomic and molecular profiling of the individual breast tumour in aiding therapeutic decisions, particularly in patients with early ER-positive breast cancer. Results and conclusions: Early breast cancer is currently considered a systemic disease and a complex ecosystem with behaviour determined by the complex genetic and molecular signatures of the tumour cells, mammary stem cells, microenvironment and host immune system. We anticipate that molecular profiling will continue to evolve, expanding beyond the primary tumour to include the tumour microenvironment, cancer stem cells and host immune system. This should further refine therapeutic decisions and optimise clinical outcome. This article was specially invited by the editors and represents work by leading researchers.	[Wazir, Umar; Mokbel, Kinan; Carmichael, Amtul; Mokbel, Kefah] Princess Grace Hosp, London Breast Inst, 45 Nottingham Pl, London W1U 5NY, England	Wazir, U (reprint author), Princess Grace Hosp, London Breast Inst, 45 Nottingham Pl, London W1U 5NY, England.	umar.wazir@rcsed.ac.uk		Wazir, Umar/0000-0001-8979-692X	Breast Cancer Hope Foundation (UK)	This study was supported by funding from the Breast Cancer Hope Foundation (UK).	AALTOMAA S, 1992, J CANCER RES CLIN, V118, P75, DOI 10.1007/BF01192316; BREWSTER D, 1994, BRIT J CANCER, V70, P954, DOI 10.1038/bjc.1994.428                                                            ; BREWSTER D, 1995, J ROY SOC MED, V88, P268; Bueno-de-Mesquita JM, 2009, BREAST CANCER RES TR, V117, P483, DOI 10.1007/s10549-008-0191-2; Buus R, 2016, J NATL CANC I, V108; Campbell HE, 2009, BRIT J CANCER, V101, P1074, DOI 10.1038/sj.bjc.6605283; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; de Glas NA, 2014, LANCET ONCOL, V15, P722, DOI 10.1016/S1470-2045(14)70200-1; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Dubsky P, 2013, ANN ONCOL, V24, P640, DOI 10.1093/annonc/mds334; Gnant M, 2014, ANN ONCOL, V25, P339, DOI 10.1093/annonc/mdt494; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Harowicz MR, 2017, BREAST CANC RES TREA; Harris LN, 2016, J CLIN ONCOL, V34, P1134, DOI 10.1200/JCO.2015.65.2289; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hosseini H, 2016, NATURE; Joishy S K, 1989, J Cancer Educ, V4, P17; Loprinzi CL, 2001, J CLIN ONCOL, V19, P972, DOI 10.1200/JCO.2001.19.4.972                                                       ; Mook S, 2009, LANCET ONCOL, V10, P1070, DOI 10.1016/S1470-2045(09)70254-2; [Anonymous], 2013, 10 NICE; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Peele PB, 2005, MED DECIS MAKING, V25, P301, DOI 10.1177/0272989X05276851; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980                                                       ; Ravdin PM, 1996, SEMIN ONCOL, V23, P43; Reed SD, 2013, GENET MED, V15, P203, DOI 10.1038/gim.2012.119; Shachar SS, 2016, NPJ BREAST CANCER, V2, P1, DOI 10.1038/npjbcancer.2016.11; Siminoff LA, 2006, PSYCHO-ONCOL, V15, P1001, DOI 10.1002/pon.1040; Tsai M. L., 2016, J CLIN ONCOL; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, MED CARE, V40, P55; Wazir Umar, 2014, World J Clin Oncol, V5, P795, DOI 10.5306/wjco.v5.i5.795; Whitworth P, 2014, ANN SURG ONCOL, V21, P3261, DOI 10.1245/s10434-014-3908-y; Wishart GC, 2012, BRIT J CANCER, V107, P800, DOI 10.1038/bjc.2012.338; Wishart GC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2464; Wong HS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000593	36	0	0	2	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1425-8153	1689-1392		CELL MOL BIOL LETT	Cell. Mol. Biol. Lett.	SEP 4	2017	22								20	10.1186/s11658-017-0049-x				7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FF8VX	WOS:000409297000002	28878809	green_published			2018-01-05	
J	Amlinger, L; Hoekzema, M; Wagner, EGH; Koskiniemi, S; Lundgren, M				Amlinger, Lina; Hoekzema, Mirthe; Wagner, E. Gerhart H.; Koskiniemi, Sanna; Lundgren, Magnus			Fluorescent CRISPR Adaptation Reporter for rapid quantification of spacer acquisition	SCIENTIFIC REPORTS			English	Article							QUORUM SENSING CONTROLS; ESCHERICHIA-COLI; CAS ADAPTATION; IMMUNE-SYSTEM; HOST FACTOR; DNA; RESISTANCE; ELEMENTS; REPEATS; BACTERIOPHAGE	CRISPR-Cas systems are adaptive prokaryotic immune systems protecting against horizontally transferred DNA or RNA such as viruses and other mobile genetic elements. Memory of past invaders is stored as spacers in CRISPR loci in a process called adaptation. Here we developed a novel assay where spacer integration results in fluorescence, enabling detection of memory formation in single cells and quantification of as few as 0.05% cells with expanded CRISPR arrays in a bacterial population. Using this fluorescent CRISPR Adaptation Reporter (f-CAR), we quantified adaptation of the two CRISPR arrays of the type I-E CRISPR-Cas system in Escherichia coli, and confirmed that more integration events are targeted to CRISPR-II than to CRISPR-I. The f-CAR conveniently analyzes and compares many samples, allowing new insights into adaptation. For instance, we show that in an E. coli culture the majority of acquisition events occur in late exponential phase.	[Amlinger, Lina; Hoekzema, Mirthe; Wagner, E. Gerhart H.; Koskiniemi, Sanna; Lundgren, Magnus] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden	Lundgren, M (reprint author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	magnus.lundgren@icm.uu.ses		Lundgren, Magnus/0000-0002-1122-3352	Swedish Research Council; Wenner-Gren Foundations; Royal Swedish Academy of Sciences; Uppsala RNA Research Center; RFI/VR; Science for Life Laboratory, Sweden	We thank Erik Gullberg for generously sharing strains. We also thank Martin Larsson, Tim Blokker and Jonas Kjellin for their contributions to the project. This work was supported by the Swedish Research Council (M.L., E.G.H.W.), the Wenner-Gren Foundations, the Royal Swedish Academy of Sciences and the Uppsala RNA Research Center (M.L.). We acknowledge the National Genomics Infrastructure (NGI) Uppsala Genome Center (UGC) and UPPMAX for providing assistance in massive parallel sequencing and computational infrastructure, and Moritz Buck at National Bioinformatics Infrastructure Sweden (NBIS) for assistance with sequence analysis. Work performed at NGI UGC has been funded by RFI/VR and Science for Life Laboratory, Sweden.	Azam TA, 1999, J BACTERIOL, V181, P6361; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Diez-Villasenor C, 2010, MICROBIOL-SGM, V156, P1351, DOI 10.1099/mic.0.036046-0; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gullberg E, 2014, MBIO, V5, DOI 10.1128/mBio.01918-14; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Patterson AG, 2016, MOL CELL, V64, P1102, DOI 10.1016/j.molcel.2016.11.012; Patterson AG, 2015, NUCLEIC ACIDS RES, V43, P6038, DOI 10.1093/nar/gkv517; Pietsch F, 2017, J ANTIMICROB CHEMOTH, V72, P75, DOI 10.1093/jac/dkw364; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Savitskaya E, 2013, RNA BIOL, V10, P716, DOI 10.4161/rna.24325; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	34	0	0	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 4	2017	7								10392	10.1038/s41598-017-10876-z				10	Multidisciplinary Sciences	Science & Technology - Other Topics	FF5EC	WOS:000408997700091	28871175	gold			2018-01-05	
J	Potenza, MN				Potenza, Marc N.			Clinical neuropsychiatric considerations regarding nonsubstance or behavioral addictions	DIALOGUES IN CLINICAL NEUROSCIENCE			English	Article						anxiety behavioral addiction; DSM; ICD-11; nonsubstance addiction	INTERNET-GAMING DISORDER; PLACEBO-CONTROLLED TRIAL; COMPULSIVE SEXUAL-BEHAVIOR; GENOME-WIDE ASSOCIATION; COCAINE-USE DISORDER; RECEPTOR 2 GENE; N-ACETYLCYSTEINE; PATHOLOGICAL GAMBLERS; DECISION-MAKING; ENVIRONMENTAL-INFLUENCES	Over the past several decades, non-substance-use behaviors like gambling, gaming, and sex have received greater consideration as possible foci of addictions. In this article, I will review the recent history and current status of nonsubstance or behavioral addictions. A main focus will involve gambling and gambling disorder, given that the latter is currently the sole nonsubstance addictive disorder described in the main text of the current (fifth) edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Internet gaming disorder, currently in the DSM-5 section addressing conditions that may need additional research, will also be considered, as will the concept of Internet addiction. Compulsive sexual behaviors (including problematic pornography use) will be considered, particularly with respect to how behavioral addictions may be considered in the forthcoming 11th edition of the International Classification of Diseases (ICD-11). (C) 2017, AICH - Servier Research Group	[Potenza, Marc N.] Yale Univ, Sch Med, Natl Ctr Addict & Subst Abuse, Child Study Ctr,Dept Psychiat, New Haven, CT 06520 USA; [Potenza, Marc N.] Connecticut Mental Hlth Ctr, Room S-104,34 Pk St, New Haven, CT 06519 USA	Potenza, MN (reprint author), Connecticut Mental Hlth Ctr, Room S-104,34 Pk St, New Haven, CT 06519 USA.	marc.potenza@yale.edu			Mohegan Sun Casino; National Center for Responsible Gaming; Pfizer; National Center for Responsible Gaming Center of Excellence grant; National Center on Addiction and Substance Abuse	Dr Potenza declares no conflicts of interest. Dr Potenza has consulted for and advised INSYS, Shire, RiverMend Health, Opiant/Lakelight Therapeutics, and Jazz Pharmaceuticals; has received research support from the Mohegan Sun Casino, the National Center for Responsible Gaming, and Pfizer; has participated in surveys, mailings, or telephone consultations related to drug addiction, impulse-control disorders, or other health topics; has consulted for gambling and legal entities on issues related to impulse-control and addictive disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has edited journals or journal sections; has given academic lectures in grand rounds, CME events, and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. Dr Potenza's involvement was supported through the National Center for Responsible Gaming Center of Excellence grant and from the National Center on Addiction and Substance Abuse. The content of the manuscript does not necessarily reflect the views of any of the funding agencies.	Aarseth E, 2017, J BEHAV ADDICT, V6, P267, DOI 10.1556/2006.5.2016.088; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Balodis IM, 2015, BIOL PSYCHIAT, V77, P434, DOI 10.1016/j.biopsych.2014.08.020; Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; Banca P, 2016, J PSYCHIATR RES, V72, P91, DOI 10.1016/j.jpsychires.2015.10.017; Banz Barbara C, 2016, Prog Brain Res, V223, P311, DOI 10.1016/bs.pbr.2015.08.003; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Beveridge TJR, 2008, PHILOS T R SOC B, V363, P3257, DOI 10.1098/rstb.2008.0102; Boileau I, 2013, ADDICTION, V108, P953, DOI 10.1111/add.12066; Boileau I, 2012, J NEUROSCI, V32, P1353, DOI 10.1523/JNEUROSCI.4371-11.2012; Brand M, 2016, NEUROSCI BIOBEHAV R, V71, P252, DOI 10.1016/j.neubiorev.2016.08.033; Carroll KM, 2004, ARCH GEN PSYCHIAT, V61, P264, DOI 10.1001/archpsyc.61.3.264; Choi JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041654; Comings DE, 1998, CNS SPECTRUMS, V3, P20; Dong GH, 2015, PROG NEURO-PSYCHOPH, V57, P76, DOI 10.1016/j.pnpbp.2014.10.012; Dong GH, 2014, J PSYCHIATR RES, V58, P7, DOI 10.1016/j.jpsychires.2014.07.005; Dowling NA, 2016, ADDICT BEHAV, V58, P21, DOI 10.1016/j.addbeh.2016.02.012; Esterlis I, 2016, NICOTINE TOB RES, V18, P1845, DOI 10.1093/ntr/ntw081; Fauth-Buhler M, 2017, ADDICT BEHAV, V64, P349, DOI 10.1016/j.addbeh.2015.11.004; Fauth-Buhler M, 2017, ADDICT BIOL, V22, P885, DOI 10.1111/adb.12378; Fauth-Buhler M, 2014, NEUROIMAGE-CLIN, V6, P243, DOI 10.1016/j.nicl.2014.09.008; Froeliger B, 2015, DRUG ALCOHOL DEPEN, V156, P234, DOI 10.1016/j.drugalcdep.2015.09.021; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Gola M, 2017, NEUROPSYCHOPHARMACOL, V42, P2021, DOI 10.1038/npp.2017.78; Grant JE, 2002, COMPR PSYCHIAT, V43, P56, DOI 10.1053/comp.2002.29857; Grant JE, J CLIN PSYC IN PRESS; Grant JE, 2008, PSYCHOPHARMACOLOGY, V200, P521, DOI 10.1007/s00213-008-1235-3; Grant JE, 2007, BIOL PSYCHIAT, V62, P652, DOI 10.1016/j.biopsych.2006.11.021; Grant JE, 2014, J CLIN PSYCHIAT, V75, P39, DOI 10.4088/JCP.13m08411; Grant JE, 2013, EUR NEUROPSYCHOPHARM, V23, P1587, DOI 10.1016/j.euroneuro.2013.07.008; Grant JE, 2012, J NERV MENT DIS, V200, P996, DOI 10.1097/NMD.0b013e3182718a4d; Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884; Guillot CR, 2015, J GAMBL STUD, V31, P513, DOI 10.1007/s10899-013-9434-1; Harper Douglas, ONLINE ETYMOLOGY DIC; Hillemacher T, 2016, PSYCHIAT RES, V239, P154, DOI 10.1016/j.psychres.2016.03.021; Hillemacher T, 2015, PROG NEURO-PSYCHOPH, V63, P30, DOI 10.1016/j.pnpbp.2015.05.013; Holden C, 2001, SCIENCE, V294, P980, DOI 10.1126/science.294.5544.980                                                    ; Holden C, 2010, SCIENCE, V327, P935, DOI 10.1126/science.327.5968.935; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403                                                     ; Kober H, 2016, NEUROPSYCHOPHARMACOL, V41, P628, DOI 10.1038/npp.2015.193; Kor A, 2013, SEX ADDICT COMPULSIV, V20, P27, DOI DOI 10.1080/10720162.2013.768132; Kovanen L, 2016, EUR ADDICT RES, V22, P70, DOI 10.1159/000435876; Kraus SW, 2016, ADDICTION, V111, P2097, DOI 10.1111/add.13297; Kraus SW, 2016, NEUROPSYCHOPHARMACOL, V41, P385, DOI 10.1038/npp.2015.300; Kraus SW, 2015, AM J PSYCHIAT, V172, P1260, DOI 10.1176/appi.ajp.2015.15060843; Krueger RB, 2016, ADDICTION, V111, P2110, DOI 10.1111/add.13366; Lang M, 2016, EUR PSYCHIAT, V36, P38, DOI 10.1016/j.eurpsy.2016.04.001; LaRowe SD, 2006, AM J ADDICTION, V15, P105, DOI 10.1080/10550490500419169; LaRowe SD, 2007, AM J PSYCHIAT, V164, P1115, DOI 10.1176/appi.ajp.164.7.1115; Lawrence AJ, 2009, ADDICTION, V104, P1006, DOI 10.1111/j.1360-0443.2009.02533.x; Leeman RF, 2013, CAN J PSYCHIAT, V58, P260, DOI 10.1177/070674371305800503                                                      ; Leeman RF, 2012, PSYCHOPHARMACOLOGY, V219, P469, DOI 10.1007/s00213-011-2550-7; Limbrick-Oldfield EH, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.256; Lind PA, 2013, ADDICT BIOL, V18, P511, DOI 10.1111/j.1369-1600.2012.00463.x; Liu L, 2017, NEUROIMAGE-CLIN, V14, P741, DOI 10.1016/j.nicl.2017.03.010; Maisel NC, 2013, ADDICTION, V108, P275, DOI 10.1111/j.1360-0443.2012.04054.x; Matuskey D, 2014, DRUG ALCOHOL DEPEN, V139, P100, DOI 10.1016/j.drugalcdep.2014.03.013; Mechelmans DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105476; Mick I, 2017, ADDICT BIOL, V22, P1601, DOI 10.1111/adb.12457; Mick I, 2016, NEUROPSYCHOPHARMACOL, V41, P1742, DOI 10.1038/npp.2015.340; Echevarria MA, 2017, PSYCHIAT RES, V251, P197, DOI 10.1016/j.psychres.2017.02.024; Nutt DJ, 2015, NAT REV NEUROSCI, V16, P305, DOI 10.1038/nrn3939; O'Brien CP, 2006, AM J PSYCHIAT, V163, P764, DOI 10.1176/appi.ajp.163.5.764; Oslin DW, 2003, NEUROPSYCHOPHARMACOL, V28, P1546, DOI 10.1038/sj.npp.1300219; Payer DE, 2014, NEUROPSYCHOPHARMACOL, V39, P311, DOI 10.1038/npp.2013.192; Petry NM, 2006, ADDICTION, V101, P152, DOI 10.1111/j.1360-0443.2006.01593.x                                                ; Petry NM, 2013, ADDICTION, V108, P1186, DOI 10.1111/add.12162; Petry NM, 2005, PSYCHOL ADDICT BEHAV, V19, P226, DOI 10.1037/0893-164X.19.2.226; Potenza M, 2015, NATURE, V522, pS62, DOI 10.1038/522S62a; Potenza MN, 2008, PHILOS T R SOC B, V363, P3181, DOI 10.1098/rstb.2008.0100; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x                                                ; Potenza MN, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00206; Potenza MN, 2009, PSYCHIAT RES, V170, P22, DOI 10.1016/j.psychres.2008.06.036; Potenza MN, 2003, ARCH GEN PSYCHIAT, V60, P828, DOI 10.1001/archpsyc.60.8.828; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990                                                    ; Potenza MN, 2001, AM J PSYCHIAT, V158, P1500, DOI 10.1176/appi.ajp.158.9.1500; Potenza MN, 2002, NEUROPSYCHOPHARMACOL; Randall CL, 1999, J STUD ALCOHOL, V60, P252, DOI 10.15288/jsa.1999.60.252                                                        ; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Richmond-Rakerd LS, 2014, ADDICTION, V109, P323, DOI 10.1111/add.12310; Saunders JB, J BEHAV ADD IN PRESS; Scherrer JF, 2007, J NERV MENT DIS, V195, P72, DOI 10.1097/01.nmd.0000252384.20382.e9; Slutske WS, 2015, J ABNORM PSYCHOL, V124, P606, DOI 10.1037/abn0000071; Slutske WS, 2015, ADDICTION, V110, P144, DOI 10.1111/add.12717; Slutske WS, 2013, TWIN RES HUM GENET, V16, P525, DOI 10.1017/thg.2013.11; Slutske WS, 2010, ARCH GEN PSYCHIAT, V67, P624, DOI 10.1001/archgenpsychiatry.2010.51; Slutske WS, 2000, ARCH GEN PSYCHIAT, V57, P666, DOI 10.1001/archpsyc.57.7.666; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tavares H, 2001, J Gambl Stud, V17, P151, DOI 10.1023/A:1016620513381; Voon V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102419; Wolfling K, 2014, BIOMED RES INT, V2014; Worhunsky PD, 2017, DRUG ALCOHOL DEPEN, V178, P363, DOI 10.1016/j.drugalcdep.2017.05.025; Worhunsky PD, 2017, NEUROIMAGE, V148, P343, DOI 10.1016/j.neuroimage.2017.01.045; Worhunsky PD, 2014, DRUG ALCOHOL DEPEN, V145, P77, DOI 10.1016/j.drugalcdep.2014.09.013; Xian H, 2014, ADDICTION, V109, P635, DOI 10.1111/add.12407; Yang BZ, 2007, HUM MOL GENET, V16, P2844, DOI 10.1093/hmg/ddm240; Yang BZ, 2016, J BEHAV ADDICT, V5, P282, DOI 10.1556/2006.5.2016.026; Yip Sarah W, 2017, Biol Psychiatry Cogn Neurosci Neuroimaging, V2, P188, DOI 10.1016/j.bpsc.2016.03.001; Yip Sarah W, 2014, Curr Treat Options Psychiatry, V1, P189; Yip SW, 2017, ADDICT BIOL, DOI [10.1111/adb.12492, DOI 10.1111/ADB.12492]; Yip SW, 2016, CLIN PSYCHOL REV, DOI [10.1016/j.cpr.2016.11.003, DOI 10.1016/J.CPR.2016.11.003]; Young KS, 1996, PSYCHOL REP, V79, P899, DOI 10.2466/pr0.1996.79.3.899                                                       ; Zhang JT, 2016, NEUROIMAGE-CLIN, V12, P591, DOI 10.1016/j.nicl.2016.09.004; Zhang JT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28109	106	0	0	0	0	INST CONFERENCE HIPPOCRATE	SURESNESS-CEDEX	50 RUE CARNOT, SURESNESS-CEDEX, 92284, FRANCE	1294-8322	1958-5969		DIALOGUES CLIN NEURO	Dialogues Clin. Neurosci.	SEP	2017	19	3					281	+						12	Neurosciences	Neurosciences & Neurology	FQ0CD	WOS:000418016500008					2018-01-05	
J	Cobb, DW; Florentin, A; Fierro, MA; Krakowiak, M; Moore, JM; Muralidharan, V				Cobb, David W.; Florentin, Anat; Fierro, Manuel A.; Krakowiak, Michelle; Moore, Julie M.; Muralidharan, Vasant			The Exported Chaperone PfHsp70x Is Dispensable for the Plasmodium falciparum Intraerythrocytic Life Cycle	MSPHERE			English	Article						Plasmodium falciparum; Hsp70; malaria; protein export	FOOD VACUOLE PLASMEPSINS; RED-BLOOD-CELLS; HOST ERYTHROCYTE; INFECTED ERYTHROCYTES; MALARIA PARASITES; PROTEIN EXPORT; PTEX COMPONENT; VIRULENCE; MEMBRANE; TRAFFICKING	Export of parasite proteins into the host erythrocyte is essential for survival of Plasmodium falciparum during its asexual life cycle. While several studies described key factors within the parasite that are involved in protein export, the mechanisms employed to traffic exported proteins within the host cell are currently unknown. Members of the Hsp70 family of chaperones, together with their Hsp40 cochaperones, facilitate protein trafficking in other organisms, and are thus likely used by P. falciparum in the trafficking of its exported proteins. A large group of Hsp40 proteins is encoded by the parasite and exported to the host cell, but only one Hsp70, P. falciparum Hsp70x (PfHsp70x), is exported with them. PfHsp70x is absent in most Plasmodium species and is found only in P. falciparum and closely related species that infect apes. Herein, we have utilized clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 genome editing in P. falciparum to investigate the essentiality of PfHsp70x. We show that parasitic growth was unaffected by knockdown of PfHsp70x using both the dihydrofolate reductase (DHFR)-based destabilization domain and the glmS ribozyme system. Similarly, a complete gene knockout of PfHsp70x did not affect the ability of P. falciparum to proceed through its intraerythrocytic life cycle. The effect of PfHsp70x knockdown/knockout on the export of proteins to the host red blood cell (RBC), including the critical virulence factor P. falciparum erythrocyte membrane protein 1 (PfEMP1), was tested, and we found that this process was unaffected. These data show that although PfHsp70x is the sole exported Hsp70, it is not essential for the asexual development of P. falciparum. IMPORTANCE Half of the world's population lives at risk for malaria. The intraerythrocytic life cycle of Plasmodium spp. is responsible for clinical manifestations of malaria; therefore, knowledge of the parasite's ability to survive within the erythrocyte is needed to combat the deadliest agent of malaria, P. falciparum. An outstanding question in the field is how P. falciparum undertakes the essential process of trafficking its proteins within the host cell. In most organisms, chaperones such as Hsp70 are employed in protein trafficking. Of the Plasmodium species causing human disease, the chaperone PfHsp70x is unique to P. falciparum, and it is the only parasite protein of its kind exported to the host (S. Kulzer et al., Cell Microbiol 14: 1784 - 1795, 2012). This has placed PfHsp70x as an ideal target to inhibit protein trafficking and kill the parasite. However, we show that PfHsp70x is not required for export of parasite effectors and it is not essential for parasite survival inside the RBC.	[Cobb, David W.; Florentin, Anat; Fierro, Manuel A.; Krakowiak, Michelle; Muralidharan, Vasant] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Florentin, Anat; Moore, Julie M.; Muralidharan, Vasant] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Moore, Julie M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	Muralidharan, V (reprint author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.; Muralidharan, V (reprint author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	vasant@uga.edu			March of Dimes Foundation (Basil O'Connor Starter Scholar Research Award); ARCS Foundation Award; U.S. National Institutes of Health [R00AI099156, R01AI050240, T32 AI060546]	This work was supported by a grant from the March of Dimes Foundation (Basil O'Connor Starter Scholar Research Award to V.M.), ARCS Foundation Award to D.W.C., and by grants from the U.S. National Institutes of Health (R00AI099156 to V.M., R01AI050240 to J.M.M., and T32 AI060546 to M.A.F.).	Avery JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031090; Banumathy G, 2002, J BIOL CHEM, V277, P3902, DOI 10.1074/jbc.M110513200; Batinovic S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16044; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Charnaud SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181656; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Desai SA, 2014, TRENDS PARASITOL, V30, P151, DOI 10.1016/j.pt.2014.01.003; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Egan ES, 2015, SCIENCE, V348, P711, DOI 10.1126/science.aaa3526; Elsworth B, 2016, CELL MICROBIOL, V18, P1551, DOI 10.1111/cmi.12596; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hodder AN, 2015, NAT STRUCT MOL BIOL, V22, P590, DOI 10.1038/nsmb.3061; Kats LM, 2014, INT J PARASITOL, V44, P319, DOI 10.1016/j.ijpara.2014.01.003; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mesen-Ramirez P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005618; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nacer A, 2015, CELL MICROBIOL, V17, P1205, DOI 10.1111/cmi.12430; Nilsson SK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004871; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pei Y, 2013, CELL MICROBIOL, V15, P1508, DOI 10.1111/cmi.12124; Perrault SD, 2009, AM J TROP MED HYG, V80, P119; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Rhiel M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36174; Riglar DT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2449; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Watermeyer JM, 2016, BLOOD, V127, P343, DOI 10.1182/blood-2015-10-674002; World Health Organization (WHO), 2016, WORLD MALARIA REPORT	45	1	1	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2379-5042			MSPHERE	mSphere	SEP-OCT	2017	2	5							e00363-17	10.1128/mSphere.00363-17				15	Microbiology	Microbiology	FO6TH	WOS:000416998800020		gold			2018-01-05	
J	Karlgren, M; Simoff, I; Backlund, M; Wegler, C; Keiser, M; Handin, N; Muller, J; Lundquist, P; Jareborg, AC; Oswald, S; Artursson, P				Karlgren, Maria; Simoff, Ivailo; Backlund, Maria; Wegler, Christine; Keiser, Markus; Handin, Niklas; Mueller, Janett; Lundquist, Patrik; Jareborg, Anne-Christine; Oswald, Stefan; Artursson, Per			A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						MDCK cells; ABC transporters; efflux pumps; P-glycoprotein; permeability; membrane transporter; drug transport; genomics; proteomics; multidrug resistance transporters	BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; TRANSPORT; PERMEABILITY; KNOCKOUT	Madin-Darby canine kidney (MDCK) II cells stably transfected with transport proteins are commonly used models for drug transport studies. However, endogenous expression of especially canine MDR1 (cMDR1) confounds the interpretation of such studies. Here we have established an MDCK cell line stably overexpressing the human MDR1 transporter (hMDR1; P-glycoprotein), and used CRISPR-Cas9 gene editing to knockout the endogenous cMDR1. Genomic screening revealed the generation of a clonal cell line homozygous for a 4-nucleotide deletion in the canine ABCB1 gene leading to a frameshift and a premature stop codon. Knockout of cMDR1 expression was verified by quantitative protein analysis and functional studies showing retained activity of the human MDR1 transporter. Application of this cell line allowed unbiased reclassification of drugs previously defined as both substrates and non-substrates in different studies using commonly used MDCK-MDR1 clones. Our new MDCK-hMDR1 cell line, together with a previously developed control cell line, both with identical deletions in the canine ABCB1 gene and lack of cMDR1 expression represent excellent in vitro tools for use in drug discovery. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.	[Karlgren, Maria; Simoff, Ivailo; Backlund, Maria; Wegler, Christine; Handin, Niklas; Lundquist, Patrik; Artursson, Per] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Karlgren, Maria; Backlund, Maria; Artursson, Per] Uppsala Univ, Drug Optimizat & Pharmaceut Profiling Platform, Sci Life Lab, Uppsala, Sweden; [Wegler, Christine] AstraZeneca R&D, Cardiovasc Metab Dis DMPK, Molndal, Sweden; [Keiser, Markus; Mueller, Janett; Oswald, Stefan] Univ Med Greifswald, Dept Clin Pharmacol, Ctr Drug Absorpt & Transport, Greifswald, Germany; [Jareborg, Anne-Christine] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden	Karlgren, M (reprint author), Uppsala Univ, Dept Pharm, Uppsala, Sweden.; Karlgren, M (reprint author), Uppsala Univ, Drug Optimizat & Pharmaceut Profiling Platform, Sci Life Lab, Uppsala, Sweden.	maria.karlgren@farmaci.uu.se		Keiser, Markus/0000-0003-4842-6273	Swedish Fund for Research without Animal Experiments; Ake Wiberg Foundation [M15-0100]; Magnus Bergvall Foundation [2015-01250]; Swedish Research Council [5715, 2822]; German Federal Ministry of Education and Research (BMBF, InnoProfile-Transfer) [03IPT612X]	We are grateful to Maria Mastej and Elin Khan for assistance with clonal expansion of the cells and Maria Mastej for cell culturing. We acknowledge the staff at the BioVis platform, Science for Life Laboratory, Uppsala University, for assistance with fluorescence-activated cell sorting, microscopy, and imaging. This work was supported by the Swedish Fund for Research without Animal Experiments, the Ake Wiberg Foundation (grant number M15-0100), the Magnus Bergvall Foundation (grant number 2015-01250), the Swedish Research Council (approval numbers 5715 and 2822), and the German Federal Ministry of Education and Research (BMBF, InnoProfile-Transfer, grant number 03IPT612X).	Artursson P, 2014, TRANSPORTERS DRUG DE; Boulton DW, 2002, LIFE SCI, V71, P163, DOI 10.1016/S0024-3205(02)01680-6                                                   ; Broccatelli F, 2012, ADV DRUG DELIVER REV, V64, P95, DOI 10.1016/j.addr.2011.12.008; Celius T, 2004, BIOCHEM BIOPH RES CO, V324, P365, DOI 10.1016/j.bbrc.2004.09.061; Cui YH, 2001, MOL PHARMACOL, V60, P934; Di L, 2011, J PHARM SCI-US, V100, P4974, DOI 10.1002/jps.22674; Dukes JD, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-43; European Medicines Agency, 2013, GUID INV DRUG INT; Gartzke D, 2015, PHARM RES-DORDR, V32, P2060, DOI 10.1007/s11095-014-1599-5; Gartzke D, 2014, J PHARM SCI-US, V103, P1298, DOI 10.1002/jps.23901; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hammerle SP, 2000, EUR J PHARM SCI, V12, P69, DOI 10.1016/S0928-0987(00)00142-1; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kalvass JC, 2007, PHARM RES, V24, P265, DOI 10.1007/s11095-006-9135-x; Konig J, 2011, BRIT J PHARMACOL, V163, P546, DOI 10.1111/j.1476-5381.2010.01052.x; Kuteykin-Teplyakov K, 2010, BRIT J PHARMACOL, V160, P1453, DOI 10.1111/j.1476-5381.2010.00801.x; Li JB, 2013, J PHARM SCI-US, V102, P3436, DOI 10.1002/jps.23523; Nagasaka Y, 2012, BIOPHARM DRUG DISPOS, V33, P304, DOI 10.1002/bdd.1801; PASTAN I, 1988, P NATL ACAD SCI USA, V85, P4486, DOI 10.1073/pnas.85.12.4486; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Sasaki M, 2002, J BIOL CHEM, V277, P6497, DOI 10.1074/jbc.M109081200; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Siegmund W, 2015, BRIT J CLIN PHARMACO, V79, P501, DOI 10.1111/bcp.12522; Simoff I, 2016, J PHARM SCI-US, V105, P1017, DOI 10.1016/S0022-3549(15)00171-9; Tweedie D, 2013, CLIN PHARMACOL THER, V94, P113, DOI 10.1038/clpt.2013.77; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research., 2012, GUID IND DRUG INT ST; Wager TT, 2010, ACS CHEM NEUROSCI, V1, P420, DOI 10.1021/cn100007x; Wang JS, 2006, PSYCHOPHARMACOLOGY, V187, P415, DOI 10.1007/s00213-006-0437-9; Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007; Xiao Y, 2016, AAPS ANN M EXP; Yang Y, 2016, AM J TRANSL RES, V8, P3986	32	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	SEP	2017	106	9					2909	2913		10.1016/j.xphs.2017.04.018				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	FP0ZU	WOS:000417339900089	28450237				2018-01-05	
J	Li, WR; Liu, CX; Zhang, XM; Chen, L; Peng, XR; He, SG; Lin, JP; Han, B; Wang, LQ; Huang, JC; Liu, MJ				Li, Wen-Rong; Liu, Chen-Xi; Zhang, Xue-Mei; Chen, Lei; Peng, Xin-Rong; He, San-Gang; Lin, Jia-Peng; Han, Bin; Wang, Li-Qin; Huang, Jun-Cheng; Liu, Ming-Jun			CRISPR/Cas9-mediated loss of FGF5 function increases wool staple length in sheep	FEBS JOURNAL			English	Article						FGF5; loss-of-function; Merino sheep; staple length; wool	INHIBITS HAIR-GROWTH; MESSENGER-RNA; EXPRESSION; GENE; GENERATION; SYSTEM; CYCLE; LONG; MUTATIONS; FOLLICLE	Fibroblast growth factor 5 (FGF5) regulates hair length in humans and a variety of other animals. To investigate whether FGF5 has similar effects in sheep, we used clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated 9 (Cas9) to generate loss-of-function mutations with the FGF5 gene in Chinese Merino sheep. A total of 16 lambs were identified with genetic mutations within the targeting locus: 13 lambs had biallelic modifications and three lambs had monoallelic modifications. Characterization of the modifications revealed that 13 were frameshift mutations that led to premature termination, whereas the other three were in-frame deletions. Thus, CRISPR/Cas9 efficiently generated loss-of-function mutations in the sheep FGF5 gene. We then investigated the effect of loss of FGF5 function on wool traits in 12 lambs and found that wool staple length and stretched length of genetically modified (GM) yearling sheep were significantly longer compared with that of wild-type (WT) control animals. The greasy fleece weight of GM yearling sheep was also significantly greater compared with that of WT sheep. Moreover, the mean fiber diameter in GM sheep showed no significant difference compared with WT sheep, suggesting that the increase in greasy fleece weight was likely attributed to the increase in wool length. The results of this study suggest that CRISPR/Cas9-mediated loss of FGF5 activity could promote wool growth and, consequently, increase wool length and yield.	[Li, Wen-Rong] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Peoples R China; [Li, Wen-Rong; Liu, Chen-Xi; Zhang, Xue-Mei; Chen, Lei; Peng, Xin-Rong; He, San-Gang; Lin, Jia-Peng; Han, Bin; Wang, Li-Qin; Huang, Jun-Cheng; Liu, Ming-Jun] Minist Agr, Key Lab Genet Breeding & Reprod Grass Feeding Liv, Urumqi 830000, Peoples R China; [Li, Wen-Rong; Liu, Chen-Xi; Zhang, Xue-Mei; Chen, Lei; Peng, Xin-Rong; He, San-Gang; Lin, Jia-Peng; Han, Bin; Wang, Li-Qin; Huang, Jun-Cheng; Liu, Ming-Jun] Xinjiang Acad Anim Sci, Xinjiang Inst Anim Biotechnol, Key Lab Anim Biotechnol, Urumqi, Peoples R China	Liu, MJ (reprint author), Minist Agr, Key Lab Genet Breeding & Reprod Grass Feeding Liv, Urumqi 830000, Peoples R China.	xjlmj@hotmail.com			China Agriculture Ministry genetically modified organisms project [2016ZX08008001-002-001]; China National Natural Science Foundation [U1303284]; China National High Technology Research Development Program (863 Program) [2013AA102506]; Key Laboratory Research Grant of Xinjiang Province [2014KL007]	This study was funded by grant 2016ZX08008001-002-001 from the China Agriculture Ministry genetically modified organisms project. It was also partly supported by grant U1303284 from the China National Natural Science Foundation, a subcontract of grant 2013AA102506 from the China National High Technology Research Development Program (863 Program) and the Key Laboratory Research Grant of Xinjiang Province (2014KL007).	Bao WL, 2015, GENET MOL RES, V14, P11154, DOI 10.4238/2015.September.22.9; Cho YM, 2003, J INVEST DERMATOL, V120, P715, DOI 10.1046/j.1523-1747.2003.12147.x; Dierks C, 2013, ANIM GENET, V44, P425, DOI 10.1111/age.12010; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Greenwood PL, 2010, MANAGING THE PRENATAL ENVIRONMENT TO ENHANCE LIVESTOCK PRODUCTIVITY, P1, DOI 10.1007/978-90-481-3135-8; Hattori Y, 1996, BBA-GENE STRUCT EXPR, V1306, P31, DOI 10.1016/0167-4781(19)60001-1; He XL, 2016, GENE, V575, P393, DOI 10.1016/j.gene.2015.09.034; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Higgins CA, 2014, P NATL ACAD SCI USA, V111, P10648, DOI 10.1073/pnas.1402862111; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; Hu R, 2017, J ANIM SCI, V95, P2019, DOI [10.2527/jas2017.1503, 10.2527/jas.2017.1503]; Ito C, 2003, J CELL PHYSIOL, V197, P272, DOI 10.1002/jcp.10369; Kawano M, 2005, J INVEST DERMATOL, V124, P877, DOI 10.1111/j.0022-202X.2005.23693.x; Legrand R, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0065-5; Liu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054614; Mizuno S, 2011, EXP ANIM TOKYO, V60, P161, DOI 10.1538/expanim.60.161                                                          ; Ota Y, 2002, BIOCHEM BIOPH RES CO, V290, P169, DOI 10.1006/bbrc.2001.6140; Ozawa K, 1998, J BIOL CHEM, V273, P29262, DOI 10.1074/jbc.273.44.29262; Pena JC, 1999, EMBO J, V18, P3596, DOI 10.1093/emboj/18.13.3596; Powell BC, 1997, FORMATION STRUCTURE, V78, P59; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rosenquist TA, 1996, DEV DYNAM, V205, P379, DOI 10.1002/(SICI)1097-0177(199604)205:4<379::AID-AJA2>3.0.CO;2-F                   ; Wang LQ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/161372; Wang XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164640; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; Yoshizawa Y, 2016, MAMM GENOME, V27, P98, DOI 10.1007/s00335-015-9617-4; Zhang LH, 2015, GENE, V555, P95, DOI 10.1016/j.gene.2014.10.036; Zhang XM, 2017, THERIOGENOLOGY, V91, P163, DOI 10.1016/j.theriogenology.2016.10.025; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	29	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	SEP	2017	284	17					2764	2773		10.1111/febs.14144				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FO8QD	WOS:000417151300006	28631368	gold			2018-01-05	
J	Horimizu, R; Ogawa, R; Watanabe, Y; Tatsukawa, H; Kinoshita, M; Hashimoto, H; Hitomi, K				Horimizu, Rima; Ogawa, Ryota; Watanabe, Yuko; Tatsukawa, Hideki; Kinoshita, Masato; Hashimoto, Hisashi; Hitomi, Kiyotaka			Biochemical characterization of a medaka (Oryzias latipes) orthologue for mammalian Factor XIII and establishment of a gene-edited mutant	FEBS JOURNAL			English	Article						coagulation; gene-editing; medaka; transglutaminase	COAGULATION-FACTOR-XIII; TARGETED MUTAGENESIS; DEFICIENT MICE; TRANSGLUTAMINASE; BONE; IDENTIFICATION; EXPRESSION; SYSTEM	In the final process of blood coagulation, fibrin molecules are stabilized via a catalytic reaction by Factor XIIIA (FXIIIA), a member of the transglutaminase (TGase) family that catalyzes protein cross-linking reactions. In this study, we characterized the orthologue of this enzyme in medaka (Oryzias latipes), an established model fish in which a coagulation system is also preserved. The recombinant protein of this orthologue enzyme was produced in baculovirus-infected insect cells and used for analysis of its biochemical properties including activation by thrombin proteolysis and calcium dependence of the TGase enzymatic activity. Immunostaining and immunoblotting revealed that medaka FXIIIA is expressed in the kidney, bone, and esophagus in addition to blood cells. Furthermore, a gene-mutant fish was established using the CRISPR/Cas9 system. The loss of FXIIIA expression was validated in the mutants, and phenotypes, such as absence of fibrin cross-linking, were investigated in the established mutant fish.	[Horimizu, Rima; Ogawa, Ryota; Watanabe, Yuko; Tatsukawa, Hideki; Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Kinoshita, Masato] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Hashimoto, Hisashi] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi, Japan	Hitomi, K (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan.	hitomi@ps.nagoya-u.ac.jp			JSPS, KAKENHI, Japan [26292192, 26860500]	OK-Cab strain medaka and the plasmid vector encoding OlTGT cDNA was provided by National BioResources Project (NBRP) Medaka, Okazaki, Japan. We thank K. Naruse and Y. Kamei (NBRP) for kind discussions. The technical assistance for medaka tissue sections was kindly supported by Mr T. Nishimaki and H. Oota (Kitasato Univ.). We also thank for M. Souri (Yamagata Univ.) for technical advice. This work was supported by Grant-in-Aid for Scientific Research (B) (No. 26292192 to KH) and also Grant-in-Aid for Young Scientists Research (No. 26860500 to HT) (JSPS, KAKENHI, Japan).	Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Ansai S, 2014, DEV GROWTH DIFFER, V56, P98, DOI 10.1111/dgd.12104; Bouchareb A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40241; Cordell PA, 2015, MATRIX BIOL, V43, P85, DOI 10.1016/j.matbio.2015.02.001; Dorgalaleh A, 2016, BLOOD REV, V30, P461, DOI 10.1016/j.blre.2016.06.002; Druval C, 2016, MATRIX BIOL MATRIX B, V60-61, P8; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Hitomi K, 2015, TRANSGLUTAMINASES MU; Inbal A, 2005, THROMB HAEMOSTASIS, V94, P432, DOI 10.1160/TH05-04-0291; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Johnson KA, 2008, J CELL SCI, V121, P2256, DOI 10.1242/jcs.011262; Keillor JW, 2015, TRENDS PHARMACOL SCI, V36, P32, DOI 10.1016/j.tips.2014.10.014; Kikuta A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144194; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Kirchmaier S, 2015, GENETICS, V199, P905, DOI 10.1534/genetics.114.173849; Kohler HP, 2011, J THROMB HAEMOST, V9, P1404, DOI 10.1111/j.1538-7836.2011.04315.x; Kohler HP, 2013, BLOOD, V121, P1931, DOI 10.1182/blood-2013-01-479055; Lauer P, 2002, THROMB HAEMOSTASIS, V88, P967; Lin CY, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0236-5; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Myneni VD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35574; Nakano Y, 2007, J HISTOCHEM CYTOCHEM, V55, P675, DOI 10.1369/jhc.6A7091.2007; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Piercy-Kotb SA, 2012, J CELL PHYSIOL, V227, P2936, DOI 10.1002/jcp.23040; Raghu H, 2015, BLOOD, V125, P427, DOI 10.1182/blood-2014-08-594754; Schartl M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143057; Souri M, 2008, THROMB HAEMOSTASIS, V99, P401, DOI 10.1160/TH07-10-0599; Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003; Stieler M, 2013, ANGEW CHEM INT EDIT, V52, P11930, DOI 10.1002/anie.201305133; Takada Y, 2017, BIOSCI BIOTECH BIOCH, V81, P469, DOI 10.1080/09168451.2016.1256757; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yu TS, 2017, DEVELOPMENT, V144, P265, DOI 10.1242/dev.139550	33	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	SEP	2017	284	17					2843	2855		10.1111/febs.14153				13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FO8QD	WOS:000417151300011	28653811				2018-01-05	
J	Beriain, ID				De Miguel Beriain, Inigo			Legal issues regarding gene editing at the beginning of life: an EU perspective	REGENERATIVE MEDICINE			English	Article						bioethics; biolaw; ethical; eugenics; gene editing; germline; human embryos; legal/regulatory; regulation	PLURIPOTENT STEM-CELLS; GENOME; EMBRYOS; CRISPR/CAS9; TECHNOLOGY; BIOETHICS; GERMLINE; POSITION; MUTATION	The development of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas genemodification technologies has opened impressive possibilities for the biomedical sciences. However, their application to human embryos and early fetuses has raised huge ethical and legal discussions because it affects the human germline. This paper provides a critical and in-depth analysis of the current legal framework on this topic in the EU context and at the national level in the member states. It also offers an alternative interpretation of the regulation, so as to help researchers, practitioners, policy makers and society as a whole to find efficient responses to challenges that cannot wait for a legally updated answer. As a final result, this paper will show that eugenic uses of CRISP-Cas and any kind of modification intended to alter the human germ line are generally banned in the EU context, while basic research on human embryos is mostly permitted. The legal status of therapeutic applications of CRISPR-Cas on early fetuses, however, has not been adequately addressed by the EU zone regulation.	[De Miguel Beriain, Inigo] Univ Basque Country, UPV EHU, Catedra Derecho & Genoma Humano, Bilbao, Spain	Beriain, ID (reprint author), Univ Basque Country, UPV EHU, Catedra Derecho & Genoma Humano, Bilbao, Spain.	Inigo.demiguelb@ehu.eus			Instituto de Salud Carlos III (Spanish Government) [PMP15/00007]; European Regional Development Fund; Government of the Basque Country Baque [IT-1066-16]	Supported by a grant for the project 'Functional and Clinical Impact of Genomic Analysis in CLL' (PMP15/00007) from the Instituto de Salud Carlos III (Spanish Government) and the European Regional Development Fund and a grant for research groups provided by the Government of the Basque Country Baque (IT-1066-16). The author has no other relevant affiliation or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter discussed in the manuscript.	Andorno R., 2005, J INT BIOTECHNOL LAW, V2, P133; Angelos MG, 2015, CURR OPIN ORGAN TRAN, V20, P663, DOI 10.1097/MOT.0000000000000244; Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Bostrom Nick, 2008, NEW WAVES APPL ETHIC, P120; Braun M, 2016, EMBO REP, V17, P279, DOI 10.15252/embr.201541935; Callaway E., 2016, NATURE; Callaway E, 2016, NATURE, V532, P289, DOI 10.1038/532289a; Capella V. Bellver, 2016, CUADERNOS BIOETICA, V2016, P223; Steering Committee on Bioethics (CDBI), 2000, CONV HUM RIGHTS BIOM, V62; Chan Sarah, 2016, ETHICS MED PUB HLTH, V2, P426; Chen KY, 2016, REGEN MED, V11, P801, DOI 10.2217/rme-2016-0107; Comfort N., 2015, CAN WE CURE GENETIC; Committee on Social Affairs Health and Sustainable Development, 2017, US NEW GEN TECHN HUM; Council of Europe, CHART SIGN RAT TREAT; Davies JL, 2016, REGULATION GENE EDIT; Beriain ID, 2016, ACTA BIOETH, V22, P203; de Miguel-Beriain I, 2015, ADV DRUG DELIVER REV, V82-83, P176, DOI 10.1016/j.addr.2014.11.011; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; European Academies. Science Advisory Council, 2017, 31 EASAC; Foht BP, 2016, NEW ATLANTIS, V48, P3; Friedmann T, 2015, MOL THER, V23, P1282, DOI 10.1038/mt.2015.118; Gillet Jean-Pierre, 2009, V542, P5, DOI 10.1007/978-1-59745-561-9_1; Hamzelou J., 2016, NEW SCI; Hennette-Vauchez S., 2015, J CON, V9, P32; The Hinxton Group, 2015, STAT GEN ED RECHN HU; Hirsch F, 2017, NATURE, V541, P30, DOI 10.1038/541030c; Hitchcock J., 2016, REFLECTIONS LAW GENE; Huang XS, 2015, STEM CELLS, V33, P1470, DOI 10.1002/stem.1969; Isasi R, 2016, SCIENCE, V351, P337, DOI 10.1126/science.aad6778; Isasi R., 2017, FOCUS GENOMEDITIERUN, P43; Isasi R, 2015, NAT BIOTECHNOL, V33, P454, DOI 10.1038/nbt.3231; Isasi Rosario M, 2006, Rev Derecho Genoma Hum, P13; Ishii T, 2017, BRIEF FUNCT GENOMICS, V16, P46, DOI 10.1093/bfgp/elv053; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jordan A, 2004, PRECAUTIONARY PRINCI, P31; Kang XJ, 2016, J ASSIST REPROD GEN, V33, P581, DOI 10.1007/s10815-016-0710-8; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kipling J., 2016, EUROPEAN LANDSCAPE H; Kohn DB, 2016, BLOOD, V127, P2553, DOI 10.1182/blood-2016-01-678136; Kure J., 2009, EMBRYONIC STEM CELL; LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Mertes H, 2015, AM J BIOETHICS, V15, P52, DOI 10.1080/15265161.2015.1103813; Mulvihill JJ, 2017, BRIT MED BULL, V122, P17, DOI 10.1093/bmb/ldx002; Clairborne A, 2016, MIT REPL TECHN ETH S; National Academies of sciences engineering and medicine, 2017, HUM GEN ED SCI ETH G; The National Academies of Sciences Engineering and Medicine, 2016, AC CONS STUD HUM GEN; Nuffield Council on Bioethics, 2016, GEN ED ETH REV; Palacios-Gonzalez C, 2017, MED HEALTH CARE PHIL, V20, P503, DOI 10.1007/s11019-017-9772-3; Palacios-Gonzalez C, 2017, J LAW BIOSCI, V4, P50, DOI 10.1093/jlb/lsw065; Parens Erik, 2003, Hastings Cent Rep, V33, pS1, DOI 10.2307/3528384; Romeo-Casabona CM, 2002, GENES SUS LEYES DERE, P273; Santalo J, 2016, DOCUMENT BIOETHICS G; Savulescu J, 2015, PROTEIN CELL, V6, P476, DOI 10.1007/s13238-015-0184-y; Scully JL, 2009, GENET SOC, P367; Simons C., COMMENTS MADE G PENN; Skerrett P., 2015, STAT; Thomson C., 2015, IMPACT ETHICS; [International bioethics committee UNESCO], 2015, SHSYESIBC22152REV2 U; Vassena R, 2016, HUM REPROD UPDATE, V22, P411, DOI 10.1093/humupd/dmw005; Wang HF, 2016, ANNU REV BIOCHEM, V85, P227, DOI 10.1146/annurev-biochem-060815-014607; Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111; Zaret A, 2016, HASTINGS LAW J, V67, P1805; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2	67	0	0	3	3	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1746-0751	1746-076X		REGEN MED	Regen. Med.	SEP	2017	12	6					669	679		10.2217/rme-2017-0033				11	Cell & Tissue Engineering; Engineering, Biomedical	Cell Biology; Engineering	FO7GL	WOS:000417040900011	28976851				2018-01-05	
J	Bansal, A; Molina-Cruz, A; Brzostowski, J; Mu, JB; Miller, LH				Bansal, Abhisheka; Molina-Cruz, Alvaro; Brzostowski, Joseph; Mu, Jianbing; Miller, Louis H.			Plasmodium falciparum Calcium-Dependent Protein Kinase 2 Is Critical for Male Gametocyte Exflagellation but Not Essential for Asexual Proliferation	MBIO			English	Article						PfCDPK2; exflagellation; female gametocyte; male gametocyte; mosquito	HUMAN MALARIA PARASITE; GENE-EXPRESSION; IN-VITRO; GAMETE DEVELOPMENT; CULTURE; TRANSMISSION; MEMBRANE; EGRESS; ERYTHROCYTE; INHIBITORS	Drug development efforts have focused mostly on the asexual blood stages of the malaria parasite Plasmodium falciparum. Except for primaquine, which has its own limitations, there are no available drugs that target the transmission of the parasite to mosquitoes. Therefore, there is a need to validate new parasite proteins that can be targeted for blocking transmission. P. falciparum calcium-dependent protein kinases (PfCDPKs) play critical roles at various stages of the parasite life cycle and, importantly, are absent in the human host. These features mark them as attractive drug targets. In this study, using CRISPR/Cas9 we successfully knocked out PfCDPK2 from blood-stage parasites, which was previously thought to be an indispensable protein. The growth rate of the PfCDPK2 knockout (KO) parasites was similar to that of wild-type parasites, confirming that PfCDPK2 function is not essential for the asexual proliferation of the parasite in vitro. The mature male and female gametocytes of PfCDPK2 KO parasites become round after induction. However, they fail to infect female Anopheles stephensi mosquitoes due to a defect(s) in male gametocyte exflagellation and possibly in female gametes. IMPORTANCE Despite reductions in the number of deaths it causes, malaria continues to be a leading infectious disease of the developing world. For effective control and elimination of malaria, multiple stages of the parasite need to be targeted. One such stage includes the transmission of the parasite to mosquitoes. Here, we demonstrate the successful knockout of PfCDPK2, which was previously thought to be indispensable for parasite growth in red blood cells. The PfCDPK2 KO parasites are incapable of establishing an infection in mosquitoes. Therefore, our study suggests that targeting PfCDPK2 may be a good strategy to control malaria transmission in countries with high transmission. Moreover, molecular understanding of the signaling pathway of PfCDPK2 may provide additional targets for malaria control.	[Bansal, Abhisheka; Molina-Cruz, Alvaro; Mu, Jianbing; Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Brzostowski, Joseph] NIAID, LIG Imaging Facil, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Bansal, A; Miller, LH (reprint author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bansal.abhisheka@gmail.com; lmiller@niaid.nih.gov			Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA.	ATHERTON E, 1981, J CHEM SOC PERK T 1, P538, DOI 10.1039/p19810000538; Azevedo MF, 2013, BIOCHEM J, V452, P433, DOI 10.1042/BJ20130124; Bansal A, 2016, MBIO, V7, DOI [10.1128/mBio.02011-16, 10.1128/mbio.02011-16]; Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Brochet M, 2016, MOL MICROBIOL, V100, P397, DOI 10.1111/mmi.13324; Bunnik EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r128; Carter R, 1979, B WHO S1, V57, P37; CARTER R, 1977, SCIENCE, V195, P407, DOI 10.1126/science.12566; CARTER R, 1977, NATURE, V270, P240, DOI 10.1038/270240a0                                                                ; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Eksi S, 2008, MOL BIOCHEM PARASIT, V160, P148, DOI 10.1016/j.molbiopara.2008.04.005; Eksi S, 2011, EUKARYOT CELL, V10, P744, DOI 10.1128/EC.00008-11; Fang HW, 2017, ELIFE, V6, DOI 10.7554/eLife.26524; Farber PM, 1997, MOL BIOCHEM PARASIT, V87, P211, DOI 10.1016/S0166-6851(97)00052-2; Fernandez-Becerra C, 2003, EXP PARASITOL, V103, P88, DOI 10.1016/S0014-4894(03)00065-1; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Guerreiro A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0493-0; Gupta AP, 2017, INT J PARASITOL, V47, P399, DOI 10.1016/j.ijpara.2016.10.008; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; KAWAMOTO F, 1990, MOL BIOCHEM PARASIT, V42, P101, DOI 10.1016/0166-6851(90)90117-5; Kirchner S, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0343-7; Kumar S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00053-1; Lasonder E, 2016, NUCLEIC ACIDS RES, V44, P6087, DOI 10.1093/nar/gkw536; Lauciello L, 2013, PROTEIN EXPRES PURIF, V90, P170, DOI 10.1016/j.pep.2013.06.006; Laveran CLA., 1880, B ACAD NATL MED, V9, P1235; Miao J, 2013, EXP PARASITOL, V135, P541, DOI 10.1016/j.exppara.2013.09.010; NIJHOUT MM, 1978, PARASITOLOGY, V76, P39, DOI 10.1017/S0031182000047375                                                       ; OGWANG RA, 1993, AM J TROP MED HYG, V49, P25, DOI 10.4269/ajtmh.1993.49.25                                                        ; Ojo KK, 2014, J INFECT DIS, V209, P275, DOI 10.1093/infdis/jit522; Ojo KK, 2012, J CLIN INVEST, V122, P2301, DOI 10.1172/JCI61822; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X                                                       ; QUAKYI IA, 1989, INFECT IMMUN, V57, P833; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Riu ER, 2007, MOL THER, V15, P1348, DOI 10.1038/sj.mt.6300177; SINDEN RE, 1978, PROC R SOC SER B-BIO, V201, P375, DOI 10.1098/rspb.1978.0051; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Sologub L, 2011, CELL MICROBIOL, V13, P897, DOI 10.1111/j.1462-5822.2011.01588.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Team R. C., 2016, R LANG ENV STAT COMP; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vembar SS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0771-5; Voss TS, 2014, CURR OPIN MICROBIOL, V20, P88, DOI 10.1016/j.mib.2014.05.007; Wirth CC, 2014, CELL MICROBIOL, V16, P709, DOI 10.1111/cmi.12288	51	0	0	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	SEP-OCT	2017	8	5							e01656-17	10.1128/mBio.01656-17				17	Microbiology	Microbiology	FN8JS	WOS:000416271100096		gold			2018-01-05	
J	Das, A; Hirai-Yuki, A; Gonzalez-Lopez, O; Rhein, B; Moller-Tank, S; Brouillette, R; Hensley, L; Misumi, I; Lovell, W; Cullen, JM; Whitmire, JK; Maury, W; Lemon, SM				Das, Anshuman; Hirai-Yuki, Asuka; Gonzalez-Lopez, Olga; Rhein, Bethany; Moller-Tank, Sven; Brouillette, Rachel; Hensley, Lucinda; Misumi, Ichiro; Lovell, William; Cullen, John M.; Whitmire, Jason K.; Maury, Wendy; Lemon, Stanley M.			TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions	MBIO			English	Article						hepatitis A virus; hepatovirus; phosphatidylserine; picornavirus; receptor; viral attachment	PHOSPHATIDYLSERINE RECEPTORS; VIRUS ENTRY; CELLS	Receptor molecules play key roles in the cellular entry of picornaviruses, and TIM1 (HAVCR1) is widely accepted to be the receptor for hepatitis A virus (HAV), an unusual, hepatotropic human picornavirus. However, its identification as the hepatovirus receptor predated the discovery that hepatoviruses undergo nonlytic release from infected cells as membrane-cloaked, quasi-enveloped HAV (eHAV) virions that enter cells via a pathway distinct from naked, nonenveloped virions. We thus revisited the role of TIM1 in hepatovirus entry, examining both adherence and infection/replication in cells with clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-engineered TIM1 knockout. Cell culture-derived, gradient-purified eHAV bound Huh-7.5 human hepatoma cells less efficiently than naked HAV at 4 degrees C, but eliminating TIM1 expression caused no difference in adherence of either form of HAV, nor any impact on infection and replication in these cells. In contrast, TIM1-deficient Vero cells showed a modest reduction in quasi-enveloped eHAV (but not naked HAV) attachment and replication. Thus, TIM1 facilitates quasi-enveloped eHAV entry in Vero cells, most likely by binding phosphatidylserine (PtdSer) residues on the eHAV membrane. Both Tim1(-/-) Ifnar1(-/-) and Tim4(-/-) Ifnar1(-/-) double-knockout mice were susceptible to infection upon intravenous challenge with infected liver homogenate, with fecal HAV shedding and serum alanine aminotransferase (ALT) elevations similar to those in Ifnar1(-/-) mice. However, intrahepatic HAV RNA and ALT elevations were modestly reduced in Tim1(-/-) Ifnar1(-/-) mice compared to Ifnar1(-/-) mice challenged with a lower titer of gradient-purified HAV or eHAV. We conclude that TIM1 is not an essential hepatovirus entry factor, although its PtdSer-binding activity may contribute to the spread of quasi-enveloped virus and liver injury in mice. IMPORTANCE T cell immunoglobulin and mucin-containing domain protein 1 (TIM1) was reported more than 2 decades ago to be an essential cellular receptor for hepatitis A virus (HAV), a picornavirus in the Hepatovirus genus, resulting in its designation as "hepatitis A virus cellular receptor 1" (HAVCR1) by the Human Genome Organization Gene Nomenclature Committee. However, recent studies have shown that HAV exists in nature as both naked, nonenveloped (HAV) virions and membrane-cloaked, quasi-enveloped infectious virus (eHAV), prompting us to revisit the role of TIM1 in viral entry. We show here that TIM1 (HAVCR1) is not an essential cellular receptor for HAV entry into cultured cells or required for viral replication and pathogenesis in permissive strains of mice, although it may facilitate early stages of infection by binding phosphatidylserine on the eHAV surface. This work thus corrects the published record and sets the stage for future efforts to identify specific hepatovirus entry factors.	[Das, Anshuman; Hirai-Yuki, Asuka; Gonzalez-Lopez, Olga; Hensley, Lucinda; Misumi, Ichiro; Lovell, William; Whitmire, Jason K.; Lemon, Stanley M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Rhein, Bethany; Moller-Tank, Sven; Brouillette, Rachel; Maury, Wendy] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Cullen, John M.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Whitmire, Jason K.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Misumi, Ichiro; Whitmire, Jason K.; Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Hirai-Yuki, Asuka] Natl Inst Infect Dis, Div Expt Anim Res, Tokyo, Japan; [Rhein, Bethany] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Moller-Tank, Sven] Regeneron, Tarrytown, NY USA	Lemon, SM (reprint author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Lemon, SM (reprint author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Lemon, SM (reprint author), Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA.	smlemon@med.unc.edu			National Institute of Allergy and Infectious Diseases [R01-AI103083, R01-AI131685, U19-AI109965, R01-AI077519, U54-AI057160]	This work was supported in part by grants from the National Institute of Allergy and Infectious Diseases (R01-AI103083, R01-AI131685, and U19-AI109965 to S.M.L., and R01-AI077519 and U54-AI057160 to W.M.).	Agrawal H, 2009, J IMMUNOL, V183, P6021, DOI 10.4049/jimmunol.0803872; Balasubramanian S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003200; Bergelson JM, 2013, ADV EXP MED BIOL, V790, P24, DOI 10.1007/978-1-4614-7651-1_2; BINN LN, 1984, J CLIN MICROBIOL, V20, P28; Counihan NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21855; Dotauer A, 2005, J GEN VIROL, V86, P2747, DOI 10.1099/vir.0.81157-0; Drexler JF, 2015, P NATL ACAD SCI USA, V112, P15190, DOI 10.1073/pnas.1516992112; Feigelstock D, 1998, J VIROL, V72, P6621; Feng ZD, 2014, ANNU REV VIROL, V1, P539, DOI 10.1146/annurev-virology-031413-085359; Feng ZD, 2015, J CLIN INVEST, V125, P169, DOI 10.1172/JCI77527; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Hirai-Yuki A, 2016, MBIO, V7, DOI 10.1128/mBio.01998-16; Hirai-Yuki A, 2016, SCIENCE, V353, P1541, DOI 10.1126/science.aaf8325; JANSEN RW, 1988, VIROLOGY, V163, P299, DOI 10.1016/0042-6822(88)90270-X; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; Kaplan G, 1996, EMBO J, V15, P4282; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; McKnight KL, 2017, P NATL ACAD SCI USA, V114, P6587, DOI 10.1073/pnas.1619519114; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; MIDTHUN K, 1991, J INFECT DIS, V163, P735, DOI 10.1093/infdis/163.4.735                                                        ; Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009; Moller-Tank S, 2014, J VIROL, V88, P6702, DOI 10.1128/JVI.00300-14; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221                                                         ; Osada N, 2014, DNA RES, V21, P673, DOI 10.1093/dnares/dsu029; Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107; Silberstein E, 2001, J VIROL, V75, P717, DOI 10.1128/JVI.75.2.717-725.2001                                                   ; Strauss M, 2015, J VIROL, V89, P4143, DOI 10.1128/JVI.03101-14; Sumpter Rhea Jr, 2005, Journal of Virology, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Wang XX, 2017, P NATL ACAD SCI USA, V114, P770, DOI 10.1073/pnas.1616502114; Wang XX, 2015, NATURE, V517, P85, DOI 10.1038/nature13806; Yin X, 2016, J VIROL, V90, P4232, DOI 10.1128/JVI.02804-15	35	0	0	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	SEP-OCT	2017	8	5							e00969-17	10.1128/mBio.00969-17				14	Microbiology	Microbiology	FN8JS	WOS:000416271100016		gold			2018-01-05	
J	Shmakov, SA; Sitnik, V; Makarova, KS; Wolf, YI; Severinov, KV; Koonin, EV				Shmakov, Sergey A.; Sitnik, Vassilii; Makarova, Kira S.; Wolf, Yuri I.; Severinov, Konstantin V.; Koonin, Eugene V.			The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes	MBIO			English	Article						CRISPR-Cas; bacteriophages; mobilome; oligonucleotide composition; spacer acquisition	BACTERIAL PAN-GENOME; CAS SYSTEMS; ADAPTIVE IMMUNITY; ACQUIRED-RESISTANCE; TARGET RECOGNITION; GENETIC ELEMENTS; RNA; DNA; ADAPTATION; EVOLUTIONARY	Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein (CRISPR-Cas) systems store the memory of past encounters with foreign DNA in unique spacers that are inserted between direct repeats in CRISPR arrays. For only a small fraction of the spacers, homologous sequences, called proto-spacers, are detectable in viral, plasmid, and microbial genomes. The rest of the spacers remain the CRISPR "dark matter." We performed a comprehensive analysis of the spacers from all CRISPR-cas loci identified in bacterial and archaeal genomes, and we found that, depending on the CRISPR-Cas subtype and the prokaryotic phylum, protospacers were detectable for 1% to about 19% of the spacers (similar to 7% global average). Among the detected protospacers, the majority, typically 80 to 90%, originated from viral genomes, including proviruses, and among the rest, the most common source was genes that are integrated into microbial chromosomes but are involved in plasmid conjugation or replication. Thus, almost all spacers with identifiable protospacers target mobile genetic elements (MGE). The GC content, as well as dinucleotide and tetranucleotide compositions, of microbial genomes, their spacer complements, and the cognate viral genomes showed a nearly perfect correlation and were almost identical. Given the near absence of self-targeting spacers, these findings are most compatible with the possibility that the spacers, including the dark matter, are derived almost completely from the species-specific microbial mobilomes. IMPORTANCE The principal function of CRISPR-Cas systems is thought to be protection of bacteria and archaea against viruses and other parasitic genetic elements. The CRISPR defense function is mediated by sequences from parasitic elements, known as spacers, that are inserted into CRISPR arrays and then transcribed and employed as guides to identify and inactivate the cognate parasitic genomes. However, only a small fraction of the CRISPR spacers match any sequences in the current databases, and of these, only a minority correspond to known parasitic elements. We show that nearly all spacers with matches originate from viral or plasmid genomes that are either free or have been integrated into the host genome. We further demonstrate that spacers with no matches have the same properties as those of identifiable origins, strongly suggesting that all spacers originate from mobile elements.	[Shmakov, Sergey A.; Sitnik, Vassilii; Severinov, Konstantin V.] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Shmakov, Sergey A.; Makarova, Kira S.; Wolf, Yuri I.; Koonin, Eugene V.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Severinov, Konstantin V.] State Univ New Jersey, Waksman Inst Microbiol Rutgers, Piscataway, NJ USA; [Severinov, Konstantin V.] Russian Acad Sci, Inst Mol Genet, Moscow, Russia	Koonin, EV (reprint author), Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	koonin@ncbi.nlm.nih.gov			SkolTech-MIT Next Generation Program Grant; NIH [RO1 GM10407]	S.A.S. and K.V.S. are partially supported by SkolTech-MIT Next Generation Program Grant. K.V.S. was supported by grant NIH RO1 GM10407.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406; Almendros C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.81, 10.1038/nmicrobiol.2016.81]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389                                                          ; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2013, WIRES RNA, V4, P267, DOI 10.1002/wrna.1159; Biswas A, 2014, BIOINFORMATICS, V30, P1805, DOI 10.1093/bioinformatics/btu114; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Childs LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101710; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Daubin V, 2004, CURR OPIN GENET DEV, V14, P616, DOI 10.1016/j.gde.2004.09.004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Edgar RC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-18; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; England WE, 2013, BIOCHEM SOC T, V41, P1431, DOI 10.1042/BST20130243; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Goldberg GW, 2015, NAT REV IMMUNOL, V15, P717, DOI 10.1038/nri3910; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Han WY, 2017, NUCLEIC ACIDS RES, V45, P1983, DOI 10.1093/nar/gkw1274; Heussler GE, 2016, J BACTERIOL, V198, P1481, DOI 10.1128/JB.00086-16; Hooton SPT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00355; Hooton Steven P T, 2014, Front Microbiol, V5, P744, DOI 10.3389/fmicb.2014.00744; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Iranzo J, 2013, J BACTERIOL, V195, P3834, DOI 10.1128/JB.00412-13; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Manica A, 2013, NUCLEIC ACIDS RES, V41, P10509, DOI 10.1093/nar/gkt767; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281                                                            ; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mortimer James R, 2003, Appl Bioinformatics, V2, P47; NCBIResourceCoordinators, 2017, Nucleic Acids Res, V45, pD12, DOI 10.1093/nar/gkw1071; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Plagens A, 2015, FEMS MICROBIOL REV, V39, P442, DOI 10.1093/femsre/fuv019; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Savitskaya E, 2017, MOL ECOL, V26, P2019, DOI 10.1111/mec.13961; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Stoll B, 2013, BIOCHEM SOC T, V41, P1444, DOI 10.1042/BST20130098; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Houte S, 2016, MICROBIOL MOL BIOL R, V80, P745, DOI 10.1128/MMBR.00011-16; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Westra ER, 2012, MOL MICROBIOL, V85, P1021, DOI 10.1111/j.1365-2958.2012.08170.x; Wolf Yuri I, 2016, Nat Microbiol, V2, P16208, DOI 10.1038/nmicrobiol.2016.208; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Zhang MG, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1473-7; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	87	1	1	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	SEP-OCT	2017	8	5							e01397-17	10.1128/mBio.01397-17				18	Microbiology	Microbiology	FN8JS	WOS:000416271100059		gold			2018-01-05	
J	Tanouchi, Y; Covert, MW				Tanouchi, Yu; Covert, Markus W.			Combining Comprehensive Analysis of Off-Site Lambda Phage Integration with a CRISPR-Based Means of Characterizing Downstream Physiology	MBIO			English	Article						CRISPR/Cas 9; DNA sequencing; phage lambda	SECONDARY ATTACHMENT SITES; ESCHERICHIA-COLI; BACTERIAL PATHOGENS; CYSTIC-FIBROSIS; SPECIFICITY; ADAPTATION; RESISTANCE; EVOLUTION; VIRULENCE; INSERTION	During its lysogenic life cycle, the phage genome is integrated into the host chromosome by site-specific recombination. In this report, we analyze lambda phage integration into noncanonical sites using next-generation sequencing and show that it generates significant genetic diversity by targeting over 300 unique sites in the host Escherichia coli genome. Moreover, these integration events can have important phenotypic consequences for the host, including changes in cell motility and increased antibiotic resistance. Importantly, the new technologies that we developed to enable this study-sequencing secondary sites using next-generation sequencing and then selecting relevant lysogens using clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-based selection-are broadly applicable to other phage-bacterium systems. IMPORTANCE Bacteriophages play an important role in bacterial evolution through lysogeny, where the phage genome is integrated into the host chromosome. While phage integration generally occurs at a specific site in the host chromosome, it is also known to occur at other, so-called secondary sites. In this study, we developed a new experimental technology to comprehensively study secondary integration sites and discovered that phage can integrate into over 300 unique sites in the host genome, resulting in significant genetic diversity in bacteria. We further developed an assay to examine the phenotypic consequence of such diverse integration events and found that phage integration can cause changes in evolutionarily relevant traits such as bacterial motility and increases in antibiotic resistance. Importantly, our method is readily applicable to other phage-bacterium systems.	[Tanouchi, Yu; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Covert, MW (reprint author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mcovert@stanford.edu			Paul Allen Family Foundation; NIH Pioneer award [5DP1LM01150-05]; Systems Biology Center grant [P50 GM107615]	We gratefully acknowledge funding from several sources, including a Distinguished Investigator award and a Discovery Center grant from the Paul Allen Family Foundation, as well as an NIH Pioneer award (5DP1LM01150-05) to M.W.C. and a Systems Biology Center grant (P50 GM107615).	Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Bobay LM, 2013, MOL BIOL EVOL, V30, P737, DOI 10.1093/molbev/mss279; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Busby B, 2013, ENVIRON MICROBIOL, V15, P307, DOI 10.1111/j.1462-2920.2012.02886.x; CAMPBELL AM, 1992, J BACTERIOL, V174, P7495; Davies EV, 2016, P NATL ACAD SCI USA, V113, P8266, DOI 10.1073/pnas.1520056113; Feiner R, 2015, NAT REV MICROBIOL, V13, P641, DOI 10.1038/nrmicro3527; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Hendrix RW., 1983, LAMBDA; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; PARKINSON JS, 1982, J BACTERIOL, V151, P106; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Rabinovich L, 2012, CELL, V150, P792, DOI 10.1016/j.cell.2012.06.036; ROSS W, 1983, CELL, V33, P261, DOI 10.1016/0092-8674(83)90355-0                                                    ; Rutkai E, 2003, J MOL BIOL, V329, P983, DOI 10.1016/S0022-2836(03)00442-X; SHIMADA K, 1972, J MOL BIOL, V63, P483, DOI 10.1016/0022-2836(72)90443-3; Tal A, 2014, P NATL ACAD SCI USA, V111, P7308, DOI 10.1073/pnas.1324066111; THANASSI DG, 1995, J BACTERIOL, V177, P998, DOI 10.1128/jb.177.4.998-1007.1995                                                  ; Trinh JT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14341; Winstanley C, 2016, TRENDS MICROBIOL, V24, P327, DOI 10.1016/j.tim.2016.01.008; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	26	0	0	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	SEP-OCT	2017	8	5							e01038-17	10.1128/mBio.01038-17				9	Microbiology	Microbiology	FN8JS	WOS:000416271100021		gold			2018-01-05	
J	Yang, GH; Billings, G; Hubbard, TP; Park, JS; Leung, KY; Liu, Q; Davis, BM; Zhang, YX; Wang, QY; Waldor, MK				Yang, Guanhua; Billings, Gabriel; Hubbard, Troy P.; Park, Joseph S.; Leung, Ka Yin; Liu, Qin; Davis, Brigid M.; Zhang, Yuanxing; Wang, Qiyao; Waldor, Matthew K.			Time-Resolved Transposon Insertion Sequencing Reveals Genome-Wide Fitness Dynamics during Infection	MBIO			English	Article						Edwardsiella piscicida; live attenuated vaccine; pattern analysis of conditional essentiality (PACE); transposon insertion sequencing; fitness dynamics and profiles	LIVE ATTENUATED VACCINE; III SECRETION SYSTEM; EDWARDSIELLA-TARDA; ESRB MUTANT; DETERMINANTS; ANNOTATION; PATHOGEN; TURBOT; GENE	Transposon insertion sequencing (TIS) is a powerful high-throughput genetic technique that is transforming functional genomics in prokaryotes, because it enables genome-wide mapping of the determinants of fitness. However, current approaches for analyzing TIS data assume that selective pressures are constant over time and thus do not yield information regarding changes in the genetic requirements for growth in dynamic environments (e.g., during infection). Here, we describe structured analysis of TIS data collected as a time series, termed pattern analysis of conditional essentiality (PACE). From a temporal series of TIS data, PACE derives a quantitative assessment of each mutant's fitness over the course of an experiment and identifies mutants with related fitness profiles. In so doing, PACE circumvents major limitations of existing methodologies, specifically the need for artificial effect size thresholds and enumeration of bacterial population expansion. We used PACE to analyze TIS samples of Edwardsiella piscicida (a fish pathogen) collected over a 2-week infection period from a natural host (the flatfish turbot). PACE uncovered more genes that affect E. piscicida's fitness in vivo than were detected using a cutoff at a terminal sampling point, and it identified subpopulations of mutants with distinct fitness profiles, one of which informed the design of new live vaccine candidates. Overall, PACE enables efficient mining of time series TIS data and enhances the power and sensitivity of TIS-based analyses. IMPORTANCE Transposon insertion sequencing (TIS) enables genome-wide mapping of the genetic determinants of fitness, typically based on observations at a single sampling point. Here, we move beyond analysis of endpoint TIS data to create a framework for analysis of time series TIS data, termed pattern analysis of conditional essentiality (PACE). We applied PACE to identify genes that contribute to colonization of a natural host by the fish pathogen Edwardsiella piscicida. PACE uncovered more genes that affect E. piscicida's fitness in vivo than were detected using a terminal sampling point, and its clustering of mutants with related fitness profiles informed design of new live vaccine candidates. PACE yields insights into patterns of fitness dynamics and circumvents major limitations of existing methodologies. Finally, the PACE method should be applicable to additional "omic" time series data, including screens based on clustered regularly interspaced short palindromic repeats with Cas9 (CRISPR/Cas9).	[Yang, Guanhua; Leung, Ka Yin; Liu, Qin; Zhang, Yuanxing; Wang, Qiyao; Waldor, Matthew K.] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China; [Liu, Qin; Wang, Qiyao] Qingdao Natl Lab Marine Sci & Technol, Qingdao, Peoples R China; [Billings, Gabriel; Hubbard, Troy P.; Park, Joseph S.; Davis, Brigid M.; Waldor, Matthew K.] Dept Microbiol & Immunobiol, Boston, MA USA; [Billings, Gabriel; Hubbard, Troy P.; Park, Joseph S.; Davis, Brigid M.; Waldor, Matthew K.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Billings, Gabriel; Hubbard, Troy P.; Park, Joseph S.; Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Leung, Ka Yin] Trinity Western Univ, Dept Biol, Langley, BC, Canada	Wang, QY (reprint author), East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai, Peoples R China.; Wang, QY (reprint author), Qingdao Natl Lab Marine Sci & Technol, Qingdao, Peoples R China.	oaiwqiyao@ecust.edu.cn			National Natural Science Foundation of China [31430090]; Ministry of Agriculture of China [CRAS-47]; Shanghai Pujiang Program [16PJD018]; Howard Hughes Medical Institute (HHMI) [063101]; National Institutes of Health [AI R37-042347, F31 AI-120 665]; Natural Sciences and Engineering Research Council of Canada (NSERC) [06385-2014]	This study was supported by National Natural Science Foundation of China grant no. 31430090 (Y.X.Z.), Ministry of Agriculture of China grant no. CRAS-47 (Q.Y.W.), and Shanghai Pujiang Program grant no. 16PJD018 (Q.Y.W.). The Waldor lab is supported by Howard Hughes Medical Institute (HHMI) grant no. 063101 and National Institutes of Health grants AI R37-042347 (M.K.W.) and F31 AI-120 665 (T.P.H.). K.Y.L. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (06385-2014).	Abayneh T, 2013, J APPL MICROBIOL, V114, P644, DOI 10.1111/jam.12080; Abel S, 2015, NAT METHODS, V12, P223, DOI [10.1038/NMETH.3253, 10.1038/nmeth.3253]; Barquist L, 2013, RNA BIOL, V10, P1161, DOI 10.4161/rna.24765; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Carter R, 2014, CELL HOST MICROBE, V15, P587, DOI 10.1016/j.chom.2014.04.005; Chao MC, 2016, NAT REV MICROBIOL, V14, P119, DOI 10.1038/nrmicro.2015.7; Chao MC, 2013, NUCLEIC ACIDS RES, V41, P9033, DOI 10.1093/nar/gkt654; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hartenian E, 2015, FEBS J, V282, P1383, DOI 10.1111/febs.13248; Kamp HD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003800; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9                                                   ; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Lan MZ, 2007, FISH SHELLFISH IMMUN, V23, P521, DOI 10.1016/j.fsi.2006.11.002; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Leung KY, 2012, MICROBES INFECT, V14, P26, DOI 10.1016/j.micinf.2011.08.005; Li J, 2014, INT J MECH MATER DES, V10, P43, DOI 10.1007/s10999-013-9229-7; Lv YZ, 2012, VET MICROBIOL, V157, P190, DOI 10.1016/j.vetmic.2011.12.018; Park SB, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-67; Pritchard JR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004782; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Straube J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134540; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; van Opijnen T, 2012, GENOME RES, V22, P2541, DOI 10.1101/gr.137430.112; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; Wang YF, 2013, APPL MICROBIOL BIOT, V97, P7015, DOI 10.1007/s00253-012-4430-4; Xiao JF, 2013, FISH SHELLFISH IMMUN, V35, P632, DOI 10.1016/j.fsi.2013.05.022; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie HX, 2010, INFECT IMMUN, V78, P5011, DOI 10.1128/IAI.00152-10; Xu LL, 2010, ARCH MICROBIOL, V192, P1039, DOI 10.1007/s00203-010-0635-z; Yang WZ, 2015, APPL MICROBIOL BIOT, V99, P1765, DOI 10.1007/s00253-014-6214-5; Zheng J, 2005, INFECT IMMUN, V73, P4127, DOI 10.1128/IAI.73.7.4127-4137.2005; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng JY, 2011, J ANHUI AGR SCI, V39, P17944	36	0	0	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	SEP-OCT	2017	8	5							e01581-17	10.1128/mBio.01581-17				13	Microbiology	Microbiology	FN8JS	WOS:000416271100082		gold			2018-01-05	
J	Zhu, P; Duan, AQ; Deng, TX; Lu, XR; Ma, XY; Liang, SS; Pang, CY; Liang, XW				Zhu, Peng; Duan, An-Qin; Deng, Ting-Xian; Lu, Xing-Rong; Ma, Xiao-Ya; Liang, Sha-Sha; Pang, Chun-Ying; Liang, Xian-Wei			Generation of buffalo mammary epithelial cells with targeted knockout of 18s rDNA by a CRISPR/Cas9 adenovirus system	BIOTECHNOLOGY AND BIOPROCESS ENGINEERING			English	Article						CRISPR/Cas9; multiple-locus gene targeting; 18s rDNA; buffalo; adenovirus	EMBRYONIC STEM-CELLS; GENE FAMILY; GUIDE RNA; LOCUS; CAS9; DNA; IDENTIFICATION; VECTORS; NICKASE; CLONING	In recent years, CRISPR/Cas9 has rapidly become one of the most promising genome editing tools because it is simple and easy to use and cost effective. However, the large size of Cas9 sequences limits its application in clinically promising vectors and it also impacts non-viral transfection. In this study, CRISPR/Cas9 adenovirus vectors that target the buffalo 18s rDNA gene were constructed, transfected into 293 cells for adenovirus packaging, and the adenovirus was used to knockout the 18s rDNA gene in buffalo mammary epithelial cells. The results demonstrated that the CRISPR/Cas9 adenovirus vectors for the buffalo 18s rDNA gene could efficiently target the sites as revealed by the fluorescence reporter system. After amplification, the adenovirus titer of Sn458-18s1 and Sn458-18s2 reached 1.03 x 10(9)PFU/mL and 1.05 x 10(9) PFU/mL, respectively. For buffalo mammary epithelial cell infection, the efficiency was 100% when the multiplicity of infection (MOI) ae<yen> 100 PFU/mL. There were 9 mutational clones found in the 20 clones, and the gene mutagenesis rate reached 45%. Of these, 2 clones were 35-bp deleted and 7 clones were 12-bp deleted. These results suggested that the adenovirus system overcame the low transfection efficiency of the buffalo mammary epithelial cells associated with using lipid-based methods or electroporation. Moreover, we preliminary developed an efficient technique for multiple-locus gene targeting at repeated sequences of the buffalo genome.	[Zhu, Peng; Duan, An-Qin; Deng, Ting-Xian; Lu, Xing-Rong; Ma, Xiao-Ya; Liang, Sha-Sha; Pang, Chun-Ying; Liang, Xian-Wei] Chinese Acad Agr Sci, Guangxi Buffalo Res Inst, Guangxi Key Lab Buffalo Genet Breeding & Reprod, Nanning, Peoples R China; [Zhu, Peng] Qinzhou Univ, Guangxi Key Lab Beibu Gulf Marine Biodivers Conse, Coll Ocean, Qinzhou, Guangxi, Peoples R China	Pang, CY; Liang, XW (reprint author), Chinese Acad Agr Sci, Guangxi Buffalo Res Inst, Guangxi Key Lab Buffalo Genet Breeding & Reprod, Nanning, Peoples R China.	pangcy800@163.com; liangbri@126.com			China Transgenic Project [2014ZX0801012B]; Natural Science Foundation of Guangxi, China [2016jjb130252]	This work was supported by the China Transgenic Project (2014ZX0801012B) and the Natural Science Foundation of Guangxi, China (2016jjb130252).	Cheng YY, 2017, ANIM BIOTECHNOL, V28, P168, DOI 10.1080/10495398.2016.1244068; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Liu X., 2012, PLOS ONE, V7, P410; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pang CY, 2012, GENET MOL RES, V11, P2878, DOI 10.4238/2012.July.10.3; Pang JL, 2016, BIOCHEM BIOPH RES CO, V472, P144, DOI 10.1016/j.bbrc.2016.02.083; Ramachandra CJA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr409; Rottman JB, 1997, AM J PATHOL, V151, P1341; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; SAKAI K, 1995, GENOMICS, V26, P521, DOI 10.1016/0888-7543(95)80170-Q; Shang JH, 2013, BUFFALO BULL, V32, P436; STEINBACH P, 1983, HUM GENET, V65, P155, DOI 10.1007/BF00286654; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Su YH, 2015, ANIM BIOTECHNOL, V26, P279, DOI 10.1080/10495398.2015.1027774; Tang D, 2006, CZECH J ANIM SCI, V51, P425; Terao M, 2016, EXP ANIM TOKYO, V65, P275, DOI 10.1538/expanim.15-0116; Ui-Tei K, 2017, GENOME, V60, P537, DOI 10.1139/gen-2016-0127; Uusi-Kerttula H, 2016, ONCOTARGET, V7, P27926, DOI 10.18632/oncotarget.8545; Uusi-Kerttula H., 2015, HUMAN GENE THERAPY, V26; Wu Y, 2014, BIOCHEM BIOPH RES CO, V446, P261, DOI 10.1016/j.bbrc.2014.02.099; Yang BZ, 2013, BUFFALO BULL, V32, P111; Zhang JH, 2016, BIOENGINEERED, V7, P166, DOI 10.1080/21655979.2016.1189039; Zhang Y, 2016, MOL ECOL, V25, P1530, DOI 10.1111/mec.13518	30	0	0	0	0	KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING	SEOUL	KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	1226-8372	1976-3816		BIOTECHNOL BIOPROC E	Biotechnol. Bioprocess Eng.	SEP	2017	22	5					569	576		10.1007/s12257-017-0094-3				8	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FN3IY	WOS:000415893100010					2018-01-05	
J	Cui, M; Lin, CY; Su, YH				Cui, Miao; Lin, Che-Yi; Su, Yi-Hsien			Recent advances in functional perturbation and genome editing techniques in studying sea urchin development	BRIEFINGS IN FUNCTIONAL GENOMICS			English	Article						morpholino; genome editing; CRISPR/Cas9; sea urchin	ZINC-FINGER NUCLEASES; DNA-BINDING SPECIFICITY; GENE REGULATORY NETWORK; TRANSCRIPTION FACTORS; TARGETED MUTAGENESIS; CRISPR/CAS SYSTEM; III EFFECTORS; CLONED DNA; EMBRYO; EXPRESSION	Studies on the gene regulatory networks (GRNs) of sea urchin embryos have provided a basic understanding of the molecular mechanisms controlling animal development. The causal links in GRNs have been verified experimentally through perturbation of gene functions. Microinjection of antisense morpholino oligonucleotides (MOs) into the egg is the most widely used approach for gene knockdown in sea urchin embryos. The modification of MOs into a membrane-permeable form (vivo-MOs) has allowed gene knockdown at later developmental stages. Recent advances in genome editing tools, such as zinc-finger nucleases, transcription activator-like effector-based nucleases and the clustered regularly interspaced short palindromic repeat/clustered regularly interspaced short palindromic repeat-associated protein 9 (CRISPR/Cas9) system, have provided methods for gene knockout in sea urchins. Here, we review the use of vivo-MOs and genome editing tools in sea urchin studies since the publication of its genome in 2006. Various applications of the CRISPR/Cas9 system and their potential in studying sea urchin development are also discussed. These new tools will provide more sophisticated experimental methods for studying sea urchin development.	[Lin, Che-Yi; Su, Yi-Hsien] Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan; [Cui, Miao] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	Su, YH (reprint author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	yhsu@gate.sinica.edu.tw			Ministry of Science and Technology, Taiwan [103-2311-B-001 -030 -MY3, 104-2627-B-001-001, 105-2321-B-001-035]	Y.-H.S. is supported by the Ministry of Science and Technology, Taiwan (grant numbers 103-2311-B-001 -030 -MY3, 104-2627-B-001-001 and 105-2321-B-001-035).	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Adomako-Ankomah A, 2011, DEV BIOL, V353, P81, DOI 10.1016/j.ydbio.2011.02.021; Akasaka K, 1999, CELL MOL BIOL, V45, P555; Andrikou C, 2015, ELIFE, V4, DOI 10.7554/eLife.07343; Angerer LM, 2004, METHOD CELL BIOL, V74, P699; Annunziata R, 2014, DEVELOPMENT, V141, P2462, DOI 10.1242/dev.105775; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Calestani C, 2010, DEV BIOL, V340, P249, DOI 10.1016/j.ydbio.2010.01.026; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cheers MS, 2005, DEV BIOL, V283, P384, DOI 10.1016/j.ydbio.2005.02.037; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Core AB, 2012, P NATL ACAD SCI USA, V109, P5334, DOI 10.1073/pnas.1117846109; Cui M, 2014, P NATL ACAD SCI USA, V111, pE5029, DOI 10.1073/pnas.1419141111; Davidson EH, 2009, CURR OPIN GENET DEV, V19, P535, DOI 10.1016/j.gde.2009.10.007; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Ernst SG, 1997, AM ZOOL, V37, P250; FRANKS RR, 1988, DEVELOPMENT, V102, P287; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heyland A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113866; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hosoi S, 2014, DEV GROWTH DIFFER, V56, P92, DOI 10.1111/dgd.12099; HOUGHEVANS BR, 1988, DEV BIOL, V129, P198, DOI 10.1016/0012-1606(88)90174-1; Juillerat A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08150; Juliano CE, 2010, DEV BIOL, V337, P220, DOI 10.1016/j.ydbio.2009.10.030; Kim S, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7a; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kurokawa D, 1999, MECH DEVELOP, V80, P41, DOI 10.1016/S0925-4773(98)00192-0; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lepage T, 2004, METHOD CELL BIOL, V74, P677; Lin CY, 2016, DEV BIOL, V409, P420, DOI 10.1016/j.ydbio.2015.11.018; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525                                                         ; Luo YJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001402; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/nmeth.2598, 10.1038/NMETH.2598]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martik ML, 2015, ELIFE, V4, DOI 10.7554/eLife.08827; Materna SC, 2013, DEVELOPMENT, V140, P1796, DOI 10.1242/dev.091157; Materna SC, 2012, DEV BIOL, V364, P77, DOI 10.1016/j.ydbio.2012.01.017; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nam JM, 2010, P NATL ACAD SCI USA, V107, P3930, DOI 10.1073/pnas.1000147107; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Nelles DA, 2015, BIOESSAYS, V37, P732, DOI 10.1002/bies.201500001; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Ochiai H, 2008, DEV DYNAM, V237, P2475, DOI 10.1002/dvdy.21690; Ochiai H, 2012, P NATL ACAD SCI USA, V109, P10915, DOI 10.1073/pnas.1202768109; Ochiai H, 2010, GENES CELLS, V15, P875, DOI 10.1111/j.1365-2443.2010.01425.x; Oliveri P, 2002, DEV BIOL, V246, P209, DOI 10.1006/dbio.2002.0627; Oulhen N, 2017, DEVELOPMENT, V144, P1201, DOI 10.1242/dev.144170; Oulhen N, 2016, MOL REPROD DEV, V83, P1046, DOI 10.1002/mrd.22757; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313                                                ; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Range RC, 2016, DEVELOPMENT, V143, P1523, DOI 10.1242/dev.128165; Ransick A, 2006, DEV BIOL, V297, P587, DOI 10.1016/j.ydbio.2006.05.037; Revilla-I-Domingo R, 2007, P NATL ACAD SCI USA, V104, P12383, DOI 10.1073/pnas.0705324104; Rottinger E, 2008, DEVELOPMENT, V135, P353, DOI 10.1242/dev.014282; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sasakura Y, 2010, ZOOL SCI, V27, P256, DOI 10.2108/zsj.27.256; Saudemont A, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1001259, DOI 10.1371/J0URNAL.PGEN.1001259]; Saunders LR, 2014, DEVELOPMENT, V141, P1503, DOI 10.1242/dev.101436; Su YH, 2009, DEV BIOL, V329, P410, DOI 10.1016/j.ydbio.2009.02.029; Summerton JE, 2005, ANN NY ACAD SCI, V1058, P62, DOI 10.1196/annals.1359.012; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tallafuss A, 2012, DEVELOPMENT, V139, P1691, DOI 10.1242/dev.072702; Walton KD, 2009, DEV BIOL, V331, P26, DOI 10.1016/j.ydbio.2009.04.018; Yaguchi S, 2006, DEVELOPMENT, V133, P2337, DOI 10.1242/dev.02396; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	82	0	0	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2041-2649	2041-2657		BRIEF FUNCT GENOMICS	Brief. Funct. Genomics	SEP	2017	16	5					309	318		10.1093/bfgp/elx011				10	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	FM9II	WOS:000415579800006	28605407				2018-01-05	
J	Zhao, J; Zhao, JJ; Xu, GJ; Wang, ZJ; Gao, J; Cui, S; Liu, JL				Zhao, Jie; Zhao, Jianjun; Xu, Guojin; Wang, Zhijuan; Gao, Jie; Cui, Sheng; Liu, Jiali			Deletion of Spata2 by CRISPR/Cas9n causes increased inhibin alpha expression and attenuated fertility in male mice	BIOLOGY OF REPRODUCTION			English	Article						spermatogenesis associated protein 2; Sertoli cell; gene knockout; inhibin-alpha; male fertility	FOLLICLE-STIMULATING-HORMONE; SPERMATOGENESIS-ASSOCIATED PROTEIN-2; SERTOLI-CELLS; GRANULOSA-CELLS; KNOCKOUT MICE; SUBUNIT GENE; LEYDIG-CELLS; MOUSE; RECEPTOR; TESTIS	As somatic cells in the testis seminiferous tubule, Sertoli cells provide the medium for spermatogenesis. One of the important functions of Sertoli cells is synthesizing and secreting cell factors to affect the production of sperm; however, much of those molecular regulation mechanisms remain unknown. Here, we confirm the localization of protein SPATA2 (spermatogenesis-associated protein 2), which had previously been shown to be highly expressed in Sertoli cells of the adult mouse testis. To further conduct a functional study, we generated SPATA2 global knockout mice via use of the CRISPR/Cas9n gene editing technology. The 120-day-old knockout mice testes showed almost a 40% decrease in size and weight and variations in the histomorphology of the seminiferous epithelium, with a 40% decrease in sperm count. Further examination revealed that the proliferation of germ cells in the seminiferous tubules was attenuated by 28%. In addition, we found that SPATA2 deletion led to an approximately 70% increase in the inhibin alpha-subunit mRNA and protein level in the testes compared to that of wild-type mice. Our data revealed the impact of SPATA2 on male fertility and suggested that SPATA2 ensures the normal secretory function of Sertoli cells. Summary Sentence The deficiency of spermatogenesis-associated protein 2, a protein which is highly expressed in Sertoli cells, causes attenuated reproduction ability inmales and increased in hibin alpha expression in testis.	[Zhao, Jie; Zhao, Jianjun; Xu, Guojin; Wang, Zhijuan; Gao, Jie; Cui, Sheng; Liu, Jiali] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	Liu, JL (reprint author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	liujiali@cau.edu.cn			National Basic Research Program of China [2014CB138505]; National Natural Science Foundation of China [31372393]	This work was supported by grants from the National Basic Research Program of China (2014CB138505) and the National Natural Science Foundation of China (31372393).	Andersen JM, 2016, HUM REPROD, V31, P1662, DOI 10.1093/humrep/dew121; Bai MZ, 2016, J GENET GENOMICS, V43, P289, DOI 10.1016/j.jgg.2016.02.003; Bao JQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004825; Burns KH, 2003, MOL ENDOCRINOL, V17, P2053, DOI 10.1210/me.2003-0038; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Chen SR, 2015, REPRODUCTION, V149, pR159, DOI 10.1530/REP-14-0481; Cho BN, 2001, ENDOCRINOLOGY, V142, P4994, DOI 10.1210/endo.142.11.8481; Dovere L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059431; Draper LB, 1998, J BIOL CHEM, V273, P398, DOI 10.1074/jbc.273.1.398                                                           ; Elliott PR, 2016, MOL CELL, V63, P990, DOI 10.1016/j.molcel.2016.08.001; Feltham R, 2016, EMBO J, V35, P1848, DOI 10.15252/embj.201695061; Gerber J, 2016, REPRODUCTION, V151, pR15, DOI 10.1530/REP-15-0366; Graziotto R, 1999, EXP CELL RES, V248, P620, DOI 10.1006/excr.1999.4449                                                          ; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; Hu XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12982; Iliadou PK, 2015, HORM-INT J ENDOCRINO, V14, P504, DOI 10.14310/horm.2002.1648; Kumar TR, 2009, ENDOCRINE, V36, P1, DOI 10.1007/s12020-009-9199-6; Kupka S, 2016, CELL REP, V16, P2271, DOI 10.1016/j.celrep.2016.07.086; Layman LC, 2000, MOL CELL ENDOCRINOL, V161, P9, DOI 10.1016/S0303-7207(99)00217-8; Lee AYF, 2014, FEBS OPEN BIO, V4, P637, DOI 10.1016/j.fob.2014.06.007; LI CH, 1987, ANNU REV PHARMACOL, V27, P1; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033861; Maqdasy S, 2015, ENDOCRINOLOGY, V156, P4545, DOI 10.1210/en.2015-1382; Maran C, 2009, CURR GENOMICS, V10, P361, DOI 10.2174/138920209788920976; MATSUMOTO AM, 1986, J CLIN ENDOCR METAB, V62, P1184, DOI 10.1210/jcem-62-6-1184                                                          ; Maurizio O, 2001, BIOCHEM BIOPH RES CO, V283, P86, DOI 10.1006/bbrc.2001.4754; MEANS AR, 1980, ANNU REV PHYSIOL, V42, P59, DOI 10.1146/annurev.ph.42.030180.000423; MECCARIELLO R, 2014, FRONT ENDOCRINOL, V5; Meduri G, 2008, MOL CELL ENDOCRINOL, V282, P130, DOI 10.1016/j.mce.2007.11.027; Morales V, 2006, ENDOCRINOLOGY, V147, P5932, DOI 10.1210/en.2006-0635; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; Onisto M, 2000, J ENDOCRINOL INVEST, V23, P605, DOI 10.1007/BF03343783                                                              ; Osuru HP, 2014, MOL REPROD DEV, V81, P896, DOI 10.1002/mrd.22358; Ozaki Y, 2011, GENE EXPR PATTERNS, V11, P309, DOI 10.1016/j.gep.2011.03.002; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; ROBERTS V, 1989, ENDOCRINOLOGY, V125, P2350, DOI 10.1210/endo-125-5-2350                                                         ; Schlicher L, 2017, CELL CYCLE, V16, P11, DOI 10.1080/15384101.2016.1232090; Schlicher L, 2016, EMBO REP, V17, P1485, DOI 10.15252/embr.201642592; Seok OS, 2004, MOL CELLS, V17, P67; Shupe J, 2011, MOL ENDOCRINOL, V25, P238, DOI 10.1210/me.2010-0030; Slongo ML, 2003, BBA-GENE STRUCT EXPR, V1625, P192, DOI 10.1016/S0167-4781(02)00594-8; Wang JQ, 2016, BIOCHEM BIOPH RES CO, V469, P836, DOI 10.1016/j.bbrc.2015.12.018; Wang X, 2016, BIOCHEM PHARMACOL, V105, P80, DOI 10.1016/j.bcp.2016.03.001; Weck J, 2006, MOL ENDOCRINOL, V20, P1090, DOI 10.1210/me.2005-0199; WOODRUFF TK, 1990, ANNU REV PHYSIOL, V52, P807; WOODRUFF TK, 1995, ANNU REV PHYSIOL, V57, P219; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Young SAM, 2015, ASIAN J ANDROL, V17, P623, DOI 10.4103/1008-682X.153851	49	0	0	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	SEP	2017	97	3					497	513		10.1093/biolre/iox093				17	Reproductive Biology	Reproductive Biology	FL9NZ	WOS:000414584000015	29025062				2018-01-05	
J	Bauer, DE; Brendel, C; Fitzhugh, CD				Bauer, Daniel E.; Brendel, Christian; Fitzhugh, Courtney D.			Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies	BLOOD CELLS MOLECULES AND DISEASES			English	Review							CORD BLOOD TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; BETA-GLOBIN GENE; LOCUS-CONTROL REGION; SEVERE COMBINED IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; EX-VIVO EXPANSION; FETAL-HEMOGLOBIN; LENTIVIRAL VECTOR	Despite sickle cell disease (SCD) first being reported > 100 years ago and molecularly characterized > 50 years ago, patients continue to experience severe morbidity and early mortality. Although there have been substantial clinical advances with immunizations, penicillin prophylaxis, hydroxyurea treatment, and transfusion therapy, the only cure that can be offered is hematopoietic stem cell transplantation (HSCT). In this work, we summarize the various allogeneic curative approaches reported to date and discuss open and upcoming clinical research protocols. Then we consider gene therapy and gene editing strategies that may enable cure based on autologous HSCs.	[Bauer, Daniel E.] Harvard Med Sch, Boston Childrens Hosp, Dana Farber Canc Inst, Div Hematol Oncol,Dept Pediat Oncol, Boston, MA 02115 USA; [Brendel, Christian] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Gene Therapy Program, Boston, MA 02115 USA; [Fitzhugh, Courtney D.] NHLBI, Sickle Cell Branch, Bldg 10, Bethesda, MD 20892 USA; [Bauer, Daniel E.] Harvard Med Sch, Harvard Stem Cell Inst, Dept Pediat, Boston, MA 02115 USA	Bauer, DE (reprint author), Harvard Med Sch, Boston Childrens Hosp, Dana Farber Canc Inst, Div Hematol Oncol,Dept Pediat Oncol, Boston, MA 02115 USA.; Fitzhugh, CD (reprint author), NHLBI, Sickle Cell Branch, Bldg 10, Bethesda, MD 20892 USA.	daniel.bauer@childrens.harvard.edu; courtney.fitzhugh@nih.gov			NIDDK [K08DK093705, R03DK109232]; NHLBI [DP2OD022716]; Burroughs Wellcome Fund [1014696]; American Society of Hematology; Harvard Stem Cell Institute; Doris Duke Charitable Foundation [2015134]; Charles H. Hood Foundation; Cooley's Anemia Foundation; NIH [HL117720-03]; National Heart, Lung, and Blood Institute, NIH	D.E.B. was supported by NIDDK (K08DK093705, R03DK109232), NHLBI (DP2OD022716), Burroughs Wellcome Fund (1014696), American Society of Hematology, Harvard Stem Cell Institute, and the Doris Duke Charitable Foundation (2015134), Charles H. Hood Foundation, and Cooley's Anemia Foundation. C.B. was supported by NIH grant HL117720-03. C.D.F. was supported by the intramural program of the National Heart, Lung, and Blood Institute, NIH.	Adamkiewicz TV, 2007, PEDIATR TRANSPLANT, V11, P641, DOI 10.1111/j.1399-3046.2007.00725.x; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102                                                     ; Agarwal M B, 2006, J Assoc Physicians India, V54, P143; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Altrock PM, 2016, AM J HEMATOL, V91, P931, DOI 10.1002/ajh.24449; Arumugam PI, 2009, MOL THER, V17, P1929, DOI 10.1038/mt.2009.183; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Basak A, 2015, J CLIN INVEST, V125, P2363, DOI 10.1172/JCI81163; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Bhatia M, 2014, BONE MARROW TRANSPL, V49, P913, DOI 10.1038/bmt.2014.84; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Bolanos-Meade J, 2012, BLOOD, V120, P4285, DOI 10.1182/blood-2012-07-438408; Boncimino A, 2010, TRANSFUS APHER SCI, V42, P277, DOI 10.1016/j.transci.2010.03.006; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Bradley MB, 2005, HUM IMMUNOL, V66, P431, DOI 10.1016/j.humimm.2005.01.010; Braun C.J., 2014, SCI TRANS MED, V6, DOI DOI 10.1126/SCITRANSLMED.3007280; Breda L, 2016, BLOOD, V128, P1139, DOI 10.1182/blood-2016-01-691089; Brendel C, 2016, J CLIN INVEST, V126, P3868, DOI 10.1172/JCI87885; Brichard B, 1996, J PEDIATR-US, V128, P241, DOI 10.1016/S0022-3476(96)70398-0; BROXMEYER HE, 1992, P NATL ACAD SCI USA, V89, P4109, DOI 10.1073/pnas.89.9.4109; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana M, 2015, BLOOD, V126; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dallas MH, 2013, BIOL BLOOD MARROW TR, V19, P820, DOI 10.1016/j.bbmt.2013.02.010; de Sio FRS, 2006, BLOOD, V107, P4257; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Dias C, 2016, AM J HUM GENET, V99, P253, DOI 10.1016/j.ajhg.2016.05.030; Fitzhugh CD, 2009, CYTOTHERAPY, V11, P464, DOI 10.1080/14653240902849788; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159                                                         ; Funnell APW, 2015, BLOOD, V126, P89, DOI 10.1182/blood-2015-04-638528; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707                                                     ; Gluckman E, 2017, BLOOD, V129, P1548, DOI 10.1182/blood-2016-10-745711; Gore L, 2000, J PEDIAT HEMATOL ONC, V22, P437, DOI 10.1097/00043426-200009000-00010                                                ; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Guda S, 2015, MOL THER, V23, P1465, DOI 10.1038/mt.2015.113; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616                                                            ; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314                                                     ; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JC135700; Hargrove PW, 2008, MOL THER, V16, P525, DOI 10.1038/sj.mt.6300394; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hsieh M., 2007, AM SOC HEM ANN M; Hsieh MM, 2014, JAMA-J AM MED ASSOC, V312, P48, DOI 10.1001/jama.2014.7192; Iannone R, 2003, BIOL BLOOD MARROW TR, V9, P519, DOI 10.1016/S1083-8791(03)00192-7; JOHNSON FL, 1984, NEW ENGL J MED, V311, P780, DOI 10.1056/NEJM198409203111207; Kamani NR, 2012, BIOL BLOOD MARROW TR, V18, P1265, DOI 10.1016/j.bbmt.2012.01.019; Kanathezhath B, 2010, HEMATOL ONCOL CLIN N, V24, P1165, DOI 10.1016/j.hoc.2010.08.006; Kanter J., 2016, ASH 58 ANN M; Kanter J., 2015, BLOOD, V126, P3233; Kharbanda S, 2014, BIOL BLOOD MARROW TR, V20, P581, DOI 10.1016/j.bbmt.2013.12.564; Kim AG, 2016, BLOOD, V128, P2457, DOI 10.1182/blood-2016-06-723981; King AA, 2015, AM J HEMATOL, V90, P1093, DOI 10.1002/ajh.24183; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Krishnamurti L, 2003, BONE MARROW TRANSPL, V31, P547, DOI 10.1038/sj.bmt.1703887; Krishnamurti L, 2008, BIOL BLOOD MARROW TR, V14, P1270, DOI 10.1016/j.bbmt.2008.08.016; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Le PQ, 2015, PEDIATR BLOOD CANCER, V62, P1956, DOI 10.1002/pbc.25608; LEBOULCH P, 1994, EMBO J, V13, P3065; Leboulch P, 2015, BLOOD, V126; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Lettre G, 2016, LANCET, V387, P2554, DOI 10.1016/S0140-6736(15)01341-0; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; Lin S., 2014, ELIFE, P3; Locatelli F, 2003, BLOOD, V101, P2137, DOI 10.1182/blood-2002-07-2090; Locatelli F, 2013, BLOOD, V122, P1072, DOI 10.1182/blood-2013-03-489112; Luc S, 2016, CELL REP, V16, P3181, DOI 10.1016/j.celrep.2016.08.064; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; MAGRAM J, 1985, NATURE, V315, P338, DOI 10.1038/315338a0; Malik P, 2016, MOL THER, V24, P668, DOI 10.1038/mt.2016.57; Maruggi G, 2009, MOL THER, V17, P851, DOI 10.1038/mt.2009.51; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; Matthes-Martin S, 2013, EUR J HAEMATOL, V90, P308, DOI 10.1111/ejh.12082; May C, 2000, NATURE, V406, P82; Mayani H, 1998, STEM CELLS, V16, P153, DOI 10.1002/stem.160153                                                             ; Mazur M, 2006, J PEDIAT HEMATOL ONC, V28, P840, DOI 10.1097/MPH.0b013e31802d3e53; MCCUNE SL, 1994, P NATL ACAD SCI USA, V91, P9852, DOI 10.1073/pnas.91.21.9852; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Miccio A, 2008, P NATL ACAD SCI USA, V105, P10547, DOI 10.1073/pnas.0711666105; Miniero R, 1998, BONE MARROW TRANSPL, V22, pS78; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt.1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Munchel AT, 2011, BEST PRACT RES CL HA, V24, P359, DOI 10.1016/j.beha.2011.05.001; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; Negre O, 2015, CURR GENE THER, V15, P64; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Palchaudhuri R, 2016, NAT BIOTECHNOL, V34, P738, DOI 10.1038/nbt.3584; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806                                                         ; Perkins A, 2016, BLOOD, V127, P1856, DOI 10.1182/blood-2016-01-694331; Perumbeti A, 2009, BLOOD, V114, P1174, DOI 10.1182/blood-2009-01-201863; Pinto FO, 2008, BRIT J HAEMATOL, V141, P309, DOI 10.1111/j.1365-2141.2008.07016.x; Psatha N, 2016, EXP HEMATOL, V44, P528, DOI 10.1016/j.exphem.2016.04.007; Quinn CT, 2010, BLOOD, V115, P3447, DOI 10.1182/blood-2009-07-233700; Radhakrishnan K, 2013, BIOL BLOOD MARROW TR, V19, P676, DOI 10.1016/j.bbmt.2013.02.002; Raj A, 2004, J PEDIAT HEMATOL ONC, V26, P312, DOI 10.1097/00043426-200405000-00011                                                ; Ramezani A, 2008, STEM CELLS, V26, P3257, DOI 10.1634/stemcells.2008-0258; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Romero Z, 2013, J CLIN INVEST, V123, P3317, DOI 10.1172/JCI67930; Rosler ES, 2000, BLOOD, V96, P3414; Ruggeri A, 2011, BIOL BLOOD MARROW TR, V17, P1375, DOI 10.1016/j.bbmt.2011.01.012; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Saraf S, 2015, BIOL BLOOD MARROW TR, V21, pS44, DOI 10.1016/j.bbmt.2014.11.038                                                      ; Sauter C, 2010, BONE MARROW TRANSPL, V45, P1252, DOI 10.1038/bmt.2009.317; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; Shenoy S, 2016, BLOOD, V128, P2561, DOI 10.1182/blood-2016-05-715870; Shenoy S, 2013, STEM CELL TRANSL MED, V2, P337, DOI 10.5966/sctm.2012-0180; Smith EC, 2016, BLOOD, V128, P2338, DOI 10.1182/blood-2016-08-736249; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Strocchio L, 2015, BRIT J HAEMATOL, V169, P726, DOI 10.1111/bjh.13352; SUNSHINE HR, 1978, NATURE, V275, P238, DOI 10.1038/275238a0; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tewari R, 1996, DEVELOPMENT, V122, P3991; Thompson LM, 2012, AM J HEALTH-SYST PH, V69, P1295, DOI 10.2146/ajhp110308; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Tsang JCH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0739-5; Urbinati F, 2015, EXP HEMATOL, V43, P346, DOI 10.1016/j.exphem.2015.01.009; Varas F, 1998, EXP HEMATOL, V26, P100; Walters M C, 1996, Biol Blood Marrow Transplant, V2, P100; Walters MC, 2016, BIOL BLOOD MARROW TR, V22, P207, DOI 10.1016/j.bbmt.2015.10.017; Walters MC, 2005, ANN NY ACAD SCI, V1054, P206, DOI 10.1196/annals.1345.025; Walters MC, 2001, BIOL BLOOD MARROW TR, V7, P665, DOI 10.1053/bbmt.2001.v7.pm11787529                                                 ; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Williams DA, 2014, STEM CELL TRANSL MED, V3, P636, DOI 10.5966/sctm.2013-0206; Williams DA, 2013, CELL STEM CELL, V13, P263, DOI 10.1016/j.stem.2013.08.006; Wu CJ, 2007, BRIT J HAEMATOL, V139, P504, DOI 10.1111/j.1365-2141.2007.06803.x; Wu CJ, 2005, BLOOD, V106, P3639, DOI 10.1182/blood-2005-04-1376; Xu RL, 2001, TRANSFUSION, V41, P213, DOI 10.1046/j.1537-2995.2001.41020213.x                                             ; Yamamoto Y, 2015, G3-GENES GENOM GENET, V5, P1843, DOI 10.1534/g3.115.019901; Yannaki E, 2010, ANN NY ACAD SCI, V1202, P59, DOI 10.1111/j.1749-6632.2010.05576.x; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	146	0	0	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1079-9796	1096-0961		BLOOD CELL MOL DIS	Blood Cells Mol. Dis.	SEP	2017	67				SI		155	168		10.1016/j.bcmd.2017.08.014				14	Hematology	Hematology	FL6GC	WOS:000414342200026	28893518				2018-01-05	
J	Ahmed, HH; El-Abhar, HS; Hassanin, EAK; Abdelkader, NF; Shalaby, MB				Ahmed, Hanaa H.; El-Abhar, Hanan S.; Hassanin, Elsayed Abdul Khalik; Abdelkader, Noha F.; Shalaby, Mohamed B.			Punica granatum suppresses colon cancer through downregulation of Wnt/beta-Catenin in rat model	REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY			English	Article						Colon cancer; Pomegranate; Wnt/beta-Catenin; Inflammation; Proliferation; Apoptosis	THYMIDYLATE SYNTHASE EXPRESSION; GENE-EXPRESSION; ELLAGIC ACID; CELLS; 5-FLUOROURACIL; PROLIFERATION; COMBINATION; PATHWAY; FRUIT	This study aims to elucidate the beneficial effect of Punica granatum L., Lythraceae (pomegranate) peel extract in the management of colon cancer induced intrarectally with N-methylnitrosourea. Adult male Sprague-Dawley rats were administered N-methylnitrosourea (2 mg in 0.5 ml water/rat) intrarectally three times/week for five weeks to induce colorectal cancer, followed by treatment with either 5-fluorouracil (12.5 mg/kg, i.p.) or Punica peel extract (2.25 or 4.5 g/kg, p.o.). Developed tumor elevated plasma TGF-beta, and Bcl2, serum epidermal growth factor, carcinoembryonic antigen, colon cancer specific antigens, and matrix metalloproteinase-7. Besides, immune-histochemical studies revealed an increase in COX-2, cyclin D1 and survivin content, as well as upregulation of the expression of colonic beta-Catenin, K-ras and C-myc genes. These results were further supported by the histological findings. Punica peel extract-treated rats, particularly those treated with a high dose, exhibited a marked reduction in the aforementioned parameters and improved the histological organization of the colon tissue. These alterations were consistent with those mediated through 5-fluorouracil. The present study encourages the use of P. granatum L. against colon cancer. Because Punica peel extract promotes apoptosis, mitigates inflammation and suppresses tumor cell proliferation in vivo, the potential mechanism underlying these activities might depend on the inhibition of the Wnt/beta-Catenin signaling pathway. (C) 2017 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Farmacognosia.	[Ahmed, Hanaa H.] Natl Res Ctr, Med Res Div, Dept Hormones, Cairo, Egypt; [El-Abhar, Hanan S.; Abdelkader, Noha F.] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt; [Hassanin, Elsayed Abdul Khalik; Shalaby, Mohamed B.] Minist Hlth Cairo, Gen Org Teaching Hosp & Inst, Natl Nutr Inst, Cairo, Egypt	Shalaby, MB (reprint author), Minist Hlth Cairo, Gen Org Teaching Hosp & Inst, Natl Nutr Inst, Cairo, Egypt.	mohamed.shalaby@std.pharma.cu.edu.eg					Ahmed HH, 2013, INT J PHARM PHARM SC, V5, P379; Ashihara E, 2015, CANCER SCI, V106, P665, DOI 10.1111/cas.12655; Austinat M., 2008, MOL CANC; Bhatia D., 2013, EVID BASED COMPLEMEN; Chen H., 2013, SCI WORLD J; El-Toumy SAA, 2002, PHYTOCHEMISTRY, V61, P971, DOI 10.1016/S0031-9422(02)00435-1; Ghaly I. S., 2010, J AM SCI, V6, P175, DOI DOI 10.7537/MARSJAS060410.2; Fuentes-Calvo I., 2010, PLOS ONE, V14, pe8703; Gonzalez-Sarrias A, 2009, MOL NUTR FOOD RES, V53, P686, DOI 10.1002/mnfr.200800150; Herbst A., 2014, BMC GENOMICS; Kikuchi M, 2009, BRIT J CANCER, V101, P116, DOI 10.1038/sj.bjc.6605105; Kundu JK, 2006, BBA-REV CANCER, V1765, P14, DOI 10.1016/j.bbcan.2005.08.006; Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d; Longley DB, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00119-2; Middha S.K., 2013, EVID BASED COMPLEMEN; Narisawa T, 2003, DIS COLON RECTUM, V46, P900, DOI 10.1097/01.DCR.0000074730.30361.30; Orgil O, 2014, LWT-FOOD SCI TECHNOL, V58, P571, DOI 10.1016/j.lwt.2014.03.030; Patel R, 2008, TOXICOL APPL PHARM, V227, P136, DOI 10.1016/j.taap.2007.10.009; REEVES PG, 1993, J NUTR, V123, P1939; Refaat B, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0187-9; Sharma M, 2010, J AGR FOOD CHEM, V58, P3965, DOI 10.1021/jf902857v; Shin Jang-Woo, 2010, [Journal of Korean Medicine, 대한한의학회지], V31, P1; Shirode AB, 2014, MOL CARCINOGEN, V53, P458, DOI 10.1002/mc.21995; Srimuangwong K, 2012, WORLD J GASTROENTERO, V18, P6951, DOI 10.3748/wjg.v18.i47.6951; Tang JM, 2016, INT J GYNECOL CANCER, V26, P1557, DOI 10.1097/IGC.0000000000000805; Tao LH, 2002, CARCINOGENESIS, V23, P1447, DOI 10.1093/carcin/23.9.1447; Vijay M, 2016, BRATISL MED J, V117, P171, DOI 10.4149/BLL_2016_033; Watson SA, 1998, INT J CANCER, V75, P873, DOI 10.1002/(SICI)1097-0215(19980316)75:6<873::AID-IJC9>3.0.CO;2-S; Wen W, 2010, CANCER RES, V70, P2010, DOI 10.1158/0008-5472.CAN-08-4910; Zhao YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087938	30	1	1	1	1	SOC BRASILEIRA FARMACOGNOSIA	CURITIBA-PR	C/O PROF CID AIMBIRE DE MORAES SANTOS, UFPR-LAB FARM, RUA PREF LOTHARIO MEISSNER, 632-JD BOTANICO, CURITIBA-PR, 80210-170, BRAZIL	0102-695X			REV BRAS FARMACOGN	Rev. Bras. Farmacogn.-Braz. J. Pharmacogn.	SEP-OCT	2017	27	5					627	635		10.1016/j.bjp.2017.05.010				9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	FL9ZG	WOS:000414617800014		gold			2018-01-05	
J	Jiang, WZ; Weeks, DP				Jiang, Wen Zhi; Weeks, Donald P.			A gene-within-a-gene Cas9/sgRNA hybrid construct enables gene editing and gene replacement strategies in Chlamydomonas reinhardtii	ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS			English	Article						CRISPR/Cas9; Chlamydomonas reinhardtii; Gene editing; Gene replacement; Tobacco; Gene-within-a-gene	CHIMERIC RNA/DNA OLIGONUCLEOTIDES; RNA-DNA OLIGONUCLEOTIDE; TRANSGENIC PLANTS; GUIDE RNA; EXPRESSION; MARKER; RICE; CAS9; TRANSFORMATION; RECOMBINATION	Previous studies demonstrated highly inefficient gene editing in C. reinhardtii using conventional Cas9 and sgRNA genes (only 1 editing event using > 1.5 x 10(9) initial cells). Design and testing of a hybrid gene-within-agene construct (composed of a Cas9 gene containing an artificial intron with an inserted sgRNA gene) demonstrated that such constructs were functional both in tobacco cells and C. reinhardtii cells. In tests with C. reinhardtii, approximately one in every similar to 3 x 10(7) initial cells contained an edited version of the targeted FKB12 gene (i.e., an average of similar to 3 colonies with an edited FKB12 gene per electroporation using 10(8) initial cells). Lack of an intact Cas9/intron-sgRNA gene in cells carrying either of two different edited genes strongly suggested that editing was due to transient expression of the Cas9/intron-sgRNA gene and the likely toxicity of long-term expression of Cas9 in C. reinhardtii cells. Co-transformation of the arginine-requiring mutant, arg7-8, with Cas9/intron-sgRNA constructs and appropriately designed synthetic, 80 nucleotide ssDNAs complementary to the argininosuccinate lyase (ARG) gene led to successful homologous recombination or nucleotide replacement and production of arginine prototrophs. As a practical application, a similar ssDNA oligonucleotide targeting the acetolactate synthase (ALS) gene and an appropriate Cas9/intron-sgRNA construct was used to create cells resistant to the herbicide, sulfometuron methyl.	[Jiang, Wen Zhi; Weeks, Donald P.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Jiang, Wen Zhi] Harvard Med Sch, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA	Weeks, DP (reprint author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	dweeks1@unl.edu			U.S. National Science Foundation [MCB-0952533, EPSCoR-1004094]; U.S. Department of Energy [DOE DE-EE0001052, DOE CAB-COMM DOE DE-EE0003373]	We thank Dr. Martin Spalding and Dr. David Wright for their helpful comments on the manuscript and Aaron Duthoy and Andrew Blazek for technical assistance. This work was supported by the U.S. National Science Foundation (MCB-0952533 and EPSCoR-1004094) and the U.S. Department of Energy (DOE DE-EE0001052 and DOE CAB-COMM DOE DE-EE0003373).	Alexeev V, 1998, NAT BIOTECHNOL, V16, P1343; Baek K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30620; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dong CM, 2006, PLANT CELL REP, V25, P457, DOI 10.1007/s00299-005-0098-x; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gao H, 2015, PLANT J, V82, P1, DOI 10.1111/tpj.12788; Gao H, 2014, ALGAL RES, V5, P52, DOI 10.1016/j.algal.2014.05.003; Jiang W, 2013, NUCLEIC ACIDS RES, V41, pe188, DOI DOI 10.1093/NAR/GKT780; Jiang W., 2015, ANN REV MICROBIOL; Jiang WZ, 2014, EUKARYOT CELL, V13, P1465, DOI 10.1128/EC.00213-14; Jiang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099225; Kovar JL, 2002, PLANT J, V29, P109, DOI 10.1046/j.1365-313x.2002.01193.x                                                ; Kren BT, 1998, NAT MED, V4, P285, DOI 10.1038/nm0398-285                                                              ; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Mages W, 2007, PROTIST, V158, P435, DOI 10.1016/j.protis.2007.05.001; Maiti IB, 1998, BIOCHEM BIOPH RES CO, V244, P440, DOI 10.1006/bbrc.1998.8287; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Okuzaki A, 2004, PLANT CELL REP, V22, P509, DOI 10.1007/s00299-003-0698-2; Pang SZ, 1996, PLANT PHYSIOL, V112, P893, DOI 10.1104/pp.112.3.893; Plucinak TM, 2015, PLANT J, V82, P717, DOI 10.1111/tpj.12844; Shin SE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27810; Sizova I, 2013, PLANT J, V73, P873, DOI 10.1111/tpj.12066; Svitashev S., 2015, PLANT PHYSIOL; TAM LW, 1993, GENETICS, V135, P375; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; VANCANNEYT G, 1990, MOL GEN GENET, V220, P245; Weeks D.P., 2015, PLANT BIOTECHNOL J; Yoon K, 1996, P NATL ACAD SCI USA, V93, P2071, DOI 10.1073/pnas.93.5.2071; Zhang R, 2014, PLANT CELL, V26, P1398, DOI 10.1105/tpc.114.124099; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu T, 1999, P NATL ACAD SCI USA, V96, P8768, DOI 10.1073/pnas.96.15.8768; Zhu T, 2000, NAT BIOTECHNOL, V18, P555	35	1	1	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2211-9264			ALGAL RES	Algal Res.	SEP	2017	26						474	480		10.1016/j.algal.2017.04.001				7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FI1YC	WOS:000411731800053					2018-01-05	
J	Munera, JMV; Rios, AMO; Urrego, DM; Quiceno, JNJ				Vanegas Munera, Johanna Marcela; Ocampo Rios, Ana Maria; Montoya Urrego, Daniela; Jimenez Quiceno, Judy Natalia			&ITIn vitro&IT susceptibility of methicillin-resistant &ITStaphylococcus aureus&IT isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						MRSA; Skin and soft tissues infections; Tedizolid; Linezolid; Vancomycin; Daptomycin	ACUTE BACTERIAL SKIN; STAPHYLOCOCCUS-AUREUS; POPULATION PHARMACOKINETICS; MULTIPLEX PCR; OXAZOLIDINONE; PATHOGENESIS; ENTEROCOCCI; HOSPITALS; GENES; IDENTIFICATION	Introduction: Treatment of multidrug-resistant Gram-positive infections caused by Staphylococcus aureus remains as a clinical challenge due to emergence of new resistance mechanisms. Tedizolid is a next-generation oxazolidinone, recently approved for skin and soft tissues infections. We conducted a study to determine in vitro susceptibility to vancomycin, daptomycin, linezolid and tedizolid in MRSA clinical isolates from adult patients with skin and soft tissue infections.& para;& para;Material and methods: Methicillin-resistant S. aureus isolates were collected in three tertiary-care hospitals of Medellin, Colombia, from February 2008 to June 2010 as part of a previous study. Clinical characteristics were assessed by medical records and MIC values were determined by Epsilometer test. Genotypic analysis included spa typing, MLST, and SCCmec typing.& para;& para;Results: A total of 150 MRSA isolates were evaluated and tedizolid MIC values obtained showed higher in vitro activity than other antimicrobials, with MIC values ranging from 0.13 mu g/mL to 0.75 mu g/mL and lower values of MIC50 and MIC90 (0.38 mu g/mL and 0.5 mu g/mL). In contrast, vancomycin and linezolid had higher MIC values, which ranged from 0.5 mu g/mL to 2.0 mu g/mL and from 0.38 mu g/mL to 4.0 mu g/mL, respectively. Tedizolid MICs were 2- to 5-fold lower than those of linezolid. Clinical characteristics showed high previous antimicrobial use and hospitalization history. The majority of the strains belong to the CC8 harboring the SCCmec IVc and were associated with the spa tl610 (29.33%, n = 44).& para;& para;Conclusion: In vitro effectiveness of tedizolid was superior for isolates from skin and soft tissue infections in comparison with the other antibiotics evaluated. The above added to its less toxicity, good bioavailability, daily dose and unnecessity of dosage adjustment, make tedizolid in a promising alternative for the treatment of infections caused by MRSA. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[Vanegas Munera, Johanna Marcela; Ocampo Rios, Ana Maria; Montoya Urrego, Daniela; Jimenez Quiceno, Judy Natalia] Univ Antioquia, Escuela Microbiol, Grp Microbiol Basica & Aplicada, Medellin, Colombia	Quiceno, JNJ (reprint author), Univ Antioquia, Escuela Microbiol, Grp Microbiol Basica & Aplicada, Medellin, Colombia.	jnatalia.jimenez@udea.edu.co			BAYER S.A.	This work was supported by BAYER S.A.	Barber KE, 2016, J ANTIMICROB CHEMOTH, V71, P152, DOI 10.1093/jac/dkv302; Barrero LI, 2014, BIOMEDICA, V34, P345, DOI [10.7705/biomedica.v34i3.1692, 10.1590/S0120-41572014000300005]; BRAKSTAD OG, 1995, APMIS, V103, P209, DOI 10.1111/j.1699-0463.1995.tb01097.x                                              ; Chan LC, 2015, ANTIMICROB AGENTS CH; Chopra Ian, 2003, Expert Rev Anti Infect Ther, V1, P45, DOI 10.1586/14787210.1.1.45; Conly John M, 2002, Can J Infect Dis, V13, P282; Caballero JD, 2016, ANTIMICROB AGENTS CH, V60, P1878, DOI 10.1128/AAC.02067-15; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Durkin MJ, 2015, THER CLIN RISK MANAG, V11, P857, DOI 10.2147/TCRM.S64553; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008; Flanagan S, 2014, ANTIMICROB AGENTS CH, V58, P6462, DOI 10.1128/AAC.03423-14; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Gould IM, 2012, INT J ANTIMICROB AG, V39, P96, DOI 10.1016/j.ijantimicag.2011.09.028; Hall RG, 2015, INFECT DRUG RESIST, V8, P75, DOI 10.2147/IDR.S56691; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kisgen JJ, 2014, AM J HEALTH-SYST PH, V71, P621, DOI 10.2146/ajhp130482; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Lee Y, 2015, ANN LAB MED, V35, P523, DOI 10.3343/alm.2015.35.5.523; Locke JB, 2014, CLIN INFECT DIS, V58, pS35, DOI 10.1093/cid/cit616; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Mariem BJJ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-2; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032; Moise PA, 2009, LANCET INFECT DIS, V9, P617, DOI 10.1016/S1473-3099(09)70200-2; Moran GJ, 2014, LANCET INFECT DIS, V14, P696, DOI 10.1016/S1473-3099(14)70737-6; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Jimenez JN, 2013, INT J MED MICROBIOL, V303, P76, DOI 10.1016/j.ijmm.2012.12.003; Jimenez JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038576; Jimenez JN, 2011, MEM I OSWALDO CRUZ, V106, P980, DOI 10.1590/S0074-02762011000800013; Ortiz-Covarrubias A, 2016, BRAZ J INFECT DIS, V20, P184, DOI 10.1016/j.bjid.2015.12.007; Villalobos AP, 2014, BIOMEDICA, V34, P67, DOI [10.1590/S0120-41572014000500009, 10.7705/biomedica.v34i0.1698]; Riedel S, 2014, J CLIN MICROBIOL, V52, P2216, DOI 10.1128/JCM.00957-14; Rodvold KA, 2014, CLIN INFECT DIS, V58, pS20, DOI 10.1093/cid/cit614; Ruef C, 2004, INFECTION, V32, P315, DOI 10.1007/s15010-004-4224-7; Rybak JM, 2015, INFECT DIS THER; Schaadt R, 2009, ANTIMICROB AGENTS CH, V53, P3236, DOI 10.1128/AAC.00228-09; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556; Shorr AF, 2015, ANTIMICROB AGENTS CH, V59, P864, DOI 10.1128/AAC.03688-14; Silva-Del Toro SL, 2016, DIAGN MICR INFEC DIS, V85, P102, DOI 10.1016/j.diagmicrobio.2016.02.008; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; Yum JH, 2010, ANTIMICROB AGENTS CH, V54, P5381, DOI 10.1128/AAC.00728-10; Zhanel GG, 2015, DRUGS, V75, P253, DOI 10.1007/s40265-015-0352-7	43	0	0	2	2	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	SEP-OCT	2017	21	5					493	499		10.1016/j.bjid.2017.03.010				7	Infectious Diseases	Infectious Diseases	FL5KS	WOS:000414276300001	28432878	gold			2018-01-05	
J	Rusak, LA; Junqueira, RM; Hofer, E; Vallim, DC; Asensi, MD				Rusak, Leonardo Alves; Junqueira, Ricardo Magrani; Hofer, Ernesto; Vallim, Deyse Christina; Asensi, Marise Dutra			Next-generation sequencing virulome analysis of a &ITYersinia enterocolitica&IT subsp.&IT palearctica&IT bioserotype 4/O:3 ST18 isolated from human blood in Brazil	BRAZILIAN JOURNAL OF INFECTIOUS DISEASES			English	Article						Yersinia enterocolitica; Virulence; Brazil; Next-generation sequencing	YERSINIA-ENTEROCOLITICA; GENOMES	Yersinia enterocolitica is a widespread Gram-negative bacterium that causes gastrointestinal disease and other clinical manifestations in humans. Potentially pathogenic Y. enterocolitica has been isolated in Brazil, from human, environmental, food, and animal sources. Herein we report a genome sequence of Y. enterocolitica subsp. palearctica strain YE 19, serotype O:3, biotype 4, sequence type 18, with virulence determinants isolated from human blood in Rio de Janeiro in 2005. The results corroborate other findings that this strain harbors a set of virulence determinants that could play a role in host pathoadaptation and may also justify the successful dissemination of bioserotype 4/O:3 in Brazil. The presence of strains harboring all of these virulence genes in Brazil is a potential threat to young children and immunocompromised individuals, for whom yersiniosis are a significant source of morbidity and mortality. The results of a genomic data analysis will help understand the virulence of Brazilian strains and provide data for Y. enterocolitica studies worldwide. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.	[Rusak, Leonardo Alves; Asensi, Marise Dutra] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Infeccao Hosp, Rio De Janeiro, RJ, Brazil; [Junqueira, Ricardo Magrani] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Computac & Sistemas, Rio De Janeiro, RJ, Brazil; [Hofer, Ernesto; Vallim, Deyse Christina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Zoonoses Bacterianas, Setor Listeria, Rio De Janeiro, RJ, Brazil	Rusak, LA (reprint author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Infeccao Hosp, Rio De Janeiro, RJ, Brazil.	rusak@ioc.fiocruz.br			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)	We thank Fundacao de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for financial support.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Batzilla J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-348; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Fabrega A, 2012, ENFERM INFEC MICR CL, V30, P24, DOI 10.1016/j.eimc.2011.07.017; Falcao J. P., 2006, Revista de Ciencias Farmaceuticas Basica e Aplicada, V27, P9; Fuchs TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-168; Galindo CL, 2011, J PATHOG, DOI 10.4061/2011/182051; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Kapatral V, 2004, MICROBIOL-SGM, V150, P2289, DOI 10.1099/mic.0.26814-0                                                           ; Kim TJ, 2008, APPL ENVIRON MICROB, V74, P5466, DOI 10.1128/AEM.00222-08; Kolmogorov M, 2014, BIOINFORMATICS, V30, P302, DOI 10.1093/bioinformatics/btu280; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mikula KM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00169; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Rusak LA, 2014, J INFECT DEV COUNTR, V8, P1533, DOI [10.3855/jidc.4533, 10.3855/jidc.4553]; Sabina Y, 2011, J PATHOG, V2011, P1; STOJILJKOVIC I, 1992, EMBO J, V11, P4359; von Tils D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00160; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963	20	0	0	0	0	ELSEVIER BRAZIL	RIO DE JANEIRO	R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL	1413-8670	1678-4391		BRAZ J INFECT DIS	Braz. J. Infect. Dis.	SEP-OCT	2017	21	5					550	553		10.1016/j.bjid.2017.04.005				4	Infectious Diseases	Infectious Diseases	FL5KS	WOS:000414276300011	28571687	gold			2018-01-05	
J	Kalajdzic, P; Schetelig, MF				Kalajdzic, Predrag; Schetelig, Marc F.			CRISPR/Cas-mediated gene editing using purified protein in Drosophila suzukii	ENTOMOLOGIA EXPERIMENTALIS ET APPLICATA			English	Article						spotted wing drosophila; recombinant Cas9 protein; genome editing; Diptera; Drosophilidae; sterile insect technique; SIT	STERILE INSECT TECHNIQUE; SPOTTED WING DROSOPHILA; SITE-SPECIFIC RECOMBINATION; GERM-LINE TRANSFORMATION; INVASIVE PEST; WHITE LOCUS; TRANSGENIC MOSQUITOS; DIPTERA TEPHRITIDAE; PIGGYBAC TRANSPOSON; ANASTREPHA-SUSPENSA	The spotted wing drosophila, Drosophila suzukii (Matsumura) (Diptera: Drosophilidae), is an invasive pest of stone fruits and berries currently without effective control management. The sterile insect technique (SIT) is an environmentally friendly and effective pest control method that releases sterile males to mate with wild females resulting in the suppression or eradication of targeted pest populations. New molecular technologies and genome editing methods are paving the way to bring this technology to invasive species like D.suzukii. The CRISPR/Cas technology is emerging as a versatile option for efficient tailored gene manipulation. Components of this system, the guide RNA (gRNA) and Cas9 protein, can be delivered into the organism in the form of DNA, RNA, or protein. We report CRISPR/Cas-mediated site-specific white gene editing using purified Cas9 protein delivered directly into D.suzukii embryos. Mutant flies with 13, 3, and 1nt deletions within the cutting site of the Cas9 protein were retrieved. Moreover, the two independent G(1) deletion events (13 and 3nt) derived from the same G(0) female. Our results show that the recombinant Cas9 protein could be a method of choice for generating heritable gene modifications in D.suzukii.	[Kalajdzic, Predrag; Schetelig, Marc F.] Justus Liebig Univ Giessen, Inst Insect Biotechnol, Dept Insect Biotechnol Plant Protect, Winchesterstr 2, D-35394 Giessen, Hesse, Germany; [Schetelig, Marc F.] Fraunhofer Inst Mol Biol & Appl Ecol IME, Giessen, Germany	Schetelig, MF (reprint author), Justus Liebig Univ Giessen, Inst Insect Biotechnol, Dept Insect Biotechnol Plant Protect, Winchesterstr 2, D-35394 Giessen, Hesse, Germany.; Kalajdzic, P (reprint author), Childrens Med Res Inst, Vector & Genome Engn Facil, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia.	pkalajdzic@cmri.org.au; marc.schetelig@uni-giessen.de			Fraunhofer Attract program of the Fraunhofer Society; Emmy Noether program of the German Research Foundation [SCHE 1833/1-1]	This project was funded by the Fraunhofer Attract program of the Fraunhofer Society (MFS) and the Emmy Noether program of the German Research Foundation SCHE 1833/1-1 (MFS). The authors thank Derya Arslan, Abhishek Shrestha, and Subhadra Chakrabarty for technical support, and Ying Yan for comments and suggestions on the manuscript.	Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Atkinson PW, 2002, GENESIS, V32, P42, DOI 10.1002/gene.10026; Bachmann Andre, 2008, V420, P61, DOI 10.1007/978-1-59745-583-1_4; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Benito NP, 2016, PESQUI AGROPECU BRAS, V51, P571, DOI 10.1590/S0100-204X2016000500018; Beumer KJ, 2014, METHODS, V68, P29, DOI 10.1016/j.ymeth.2013.12.002; Bolda M. P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; Borycz J, 2008, NEUROPSYCHOPHARMACOL, V33, P619, DOI 10.1038/sj.npp.1301445; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Chiu JC, 2013, G3-GENES GENOM GENET, V3, P2257, DOI 10.1534/g3.113.008185; Cossentine J, 2016, J ECON ENTOMOL, V109, P1071, DOI 10.1093/jee/tow062; De Ros G, 2015, J BERRY RES, V5, P89, DOI 10.3233/JBR-150092; Demerec M, 1937, GENETICS, V22, P469; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; DYCK V.A, 2005, STERILE INSECT TECHN; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Gurr Geoff M, 2015, Front Plant Sci, V6, P1255, DOI 10.3389/fpls.2015.01255; Hacker I, 2017, SCI REP-UK, V7, DOI 10.1038/srep43883; Haghighat-Khah RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121097; Handler AM, 2002, GENETICA, V116, P137, DOI 10.1023/A:1020924028450; Handler AM, 2002, INSECT BIOCHEM MOLEC, V32, P1211, DOI 10.1016/S0965-1748(02)00084-X; HE XJ, 2016, NUCL ACIDS RES, V44; Heinrich JC, 2002, INSECT MOL BIOL, V11, P1, DOI 10.1046/j.0962-1075.2001.00301.x; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Inbar O, 2000, J BIOL CHEM, V275, P30833, DOI 10.1074/jbc.C000133200; INOUE YH, 1987, MOL GEN GENET, V209, P94, DOI 10.1007/BF00329842; INOUE YH, 1988, GENETICS, V119, P903; Judd BH, 1964, DROS INFORM SERV, V39, P59; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947                                                          ; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459                                                            ; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; LEVIS R, 1982, P NATL ACAD SCI-BIOL, V79, P564, DOI 10.1073/pnas.79.2.564; Li F, 2016, BIOCHEM BIOPH RES CO, V469, P911, DOI 10.1016/j.bbrc.2015.12.081; Lu ZH, 2003, BLOOD, V102, P1531, DOI 10.1182/blood-2003-03-0708; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4                                                   ; Maik W, 2015, Tsitol Genet, V49, P73; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; MEREDITH SEO, 1990, ANN PARASIT HUM COMP, V65, P113, DOI 10.1051/parasite/1990651113                                                     ; MIYASHITA N, 1988, GENETICS, V120, P199; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Murphy KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22587; Ogaugwu CE, 2013, INSECT BIOCHEM MOLEC, V43, P1, DOI 10.1016/j.ibmb.2012.10.010; Pavlopoulos A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S2; Renkema JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21432; Robinson AS, 2004, INSECT BIOCHEM MOLEC, V34, P113, DOI 10.1016/j.ibmb.2003.10.004; Schetelig MF, 2016, INSECT MOL BIOL, V25, P500, DOI 10.1111/imb.12238; Schetelig MF, 2013, GENETICA, V141, P189, DOI 10.1007/s10709-013-9717-6; Schetelig MF, 2011, BIOL INSPIR SYST, V2, P169, DOI 10.1007/978-90-481-9641-8_9; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P790, DOI 10.1016/j.ibmb.2012.07.007; Schetelig MF, 2012, P NATL ACAD SCI USA, V109, P9348, DOI 10.1073/pnas.1203352109; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Smirle MJ, 2017, PEST MANAG SCI, V73, P130, DOI 10.1002/ps.4310; Ul Ain Q, 2015, J CONTROL RELEASE, V205, P120, DOI 10.1016/j.jconrel.2014.12.036; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Venken KJT, 2014, METHODS, V68, P15, DOI 10.1016/j.ymeth.2014.02.025; Wimmer EA, 2005, NAT METHODS, V2, P580, DOI 10.1038/nmeth0805-580                                                           	67	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-8703	1570-7458		ENTOMOL EXP APPL	Entomol. Exp. Appl.	SEP	2017	164	3			SI		350	362		10.1111/eea.12599				13	Entomology	Entomology	FK3RL	WOS:000413403700017					2018-01-05	
J	Jang, L; Hu, G; Chen, FF; Du, XY; Liu, B; Liu, C				Jang, L.; Hu, G.; Chen, F. -F.; Du, X. -Y.; Liu, B.; Liu, C.			CSR1 suppresses tumor growth and metastasis of human hepatocellular carcinoma via inhition of HPIP	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Cellular stress response 1; Human hepatocellular carcinoma; CRISPR; HPIP	OVARIAN-CANCER; CELL-DEATH; PATHWAY; PROLIFERATION; ACTIVATION; TRANSITION; RESISTANCE; INVASION	OBJECTIVE: Cellular stress response 1 (CSR1) is a tumor suppressor gene that was frequently down-regulated in prostate cancer. CSR1 has critical roles in the regulation of cell apoptosis via inactivation of CPSF3 or preventing the interaction of XIAP with caspases. However, whether CSR1 plays a role in human hepatocellular carcinoma (HCC) is completely unknown. PATIENTS AND METHODS: The expression of CSR1 in HCC clinic samples and cell lines was detected by Real-time PCR and Western blot. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 system was used to knockout CSR1 gene in HepG2 cells. The proliferation of HCC cells was measured by MTT assay. The migration and invasion abilities of HepG2 cells were determined by in vitro scratch wounding and matrigel invasion assays. Co-immunoprecipitation assay was used to determine the interaction between CSR1 and hematopoietic PBX interacting protein (HPIP). RESULTS: The mRNA and protein levels of CSR1 were down-regulated in human HCC cell lines and clinic HCC tissues. Over-expression of CSR1 inhibited cell proliferation, migration and invasion in human HCC cell lines. Knockout of CSR1 gene by CRISPR-Cas9 in HepG2 cells achieved the opposite effects. At the molecular level, we found that CSR1 associated with HPIP and inhibited the activation PI3K/AKT pathway. CONCLUSIONS: For the first time we demonstrated that CSR1 inhibited HCC cell proliferation, migration and invasion through inactivation of HPIP and its downstream PI3K/AKT signaling pathway and suggested CSR1 as a potential therapy target for HCC treatment.	[Jang, L.; Chen, F. -F.; Du, X. -Y.; Liu, C.] Bengbu Med Coll, Affiliated Hosp 1, Dept Gen Surg, Bengbu, Anhui, Peoples R China; [Hu, G.; Liu, B.] Hubei Polytech Univ, Sch Med, Huangshi Cent Hosp,Edong Healthcare Grp, Hubei Key Lab Kidney Dis Pathogenesis & Intervent, Huangshi, Hubei, Peoples R China	Liu, C (reprint author), Bengbu Med Coll, Affiliated Hosp 1, Dept Gen Surg, Bengbu, Anhui, Peoples R China.; Liu, B (reprint author), Hubei Polytech Univ, Sch Med, Huangshi Cent Hosp,Edong Healthcare Grp, Hubei Key Lab Kidney Dis Pathogenesis & Intervent, Huangshi, Hubei, Peoples R China.	Liubin3575630@163.com; Chengliu76@163.com			Natural Science Foundation of Hubei Province [2016CF13517]; Research Foundation of Hubei Polytechnic University for Talented Scholars [16xjz01R]	This study is supported by grants from the Natural Science Foundation of Hubei Province (2016CF13517) and Research Foundation of Hubei Polytechnic University for Talented Scholars (16xjz01R).	Brown CO, 2013, LEUKEMIA RES, V37, P963, DOI 10.1016/j.leukres.2013.03.004; Bugide S, 2017, CELL ONCOL, V40, P133, DOI 10.1007/s13402-016-0308-2; Cao F, 2016, EUR REV MED PHARMACO, V20, P3392; Chen B, 2016, ONCOL REP, V36, P3664, DOI 10.3892/or.2016.5157; Chen YJ, 2016, ONCOL RES, V24, P153, DOI 10.3727/096504016X14612603423476; Ciresa M, 2015, EUR REV MED PHARMACO, V19, P2786; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Liu B, 2012, J PROTEOME RES, V11, P1773, DOI 10.1021/pr2010204; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030938; Mai H, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.44; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Ursino S, 2012, EUR REV MED PHARMACO, V16, P1599; Wang Y, 2017, HUM PATHOL, V60, P114, DOI 10.1016/j.humpath.2016.10.015; Wang YP, 2017, ONCOTARGETS THER, V10, P95, DOI 10.2147/OTT.S114884; Xu XJ, 2013, IUBMB LIFE, V65, P873, DOI 10.1002/iub.1202; Yu GY, 2006, AM J PATHOL, V168, P597, DOI 10.2353/ajpath.2006.050620; Zheng ZL, 2012, AM J PATHOL, V181, P463, DOI 10.1016/j.ajpath.2012.04.016; Zhu ZH, 2009, ONCOGENE, V28, P41, DOI 10.1038/onc.2008.359	20	0	0	0	0	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	SEP	2017	21	17					3813	3820						8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FJ1LV	WOS:000412479300011					2018-01-05	
J	Anantharaman, A; Gholamalamdari, O; Khan, A; Yoon, JH; Jantsch, MF; Hartner, JC; Gorospe, M; Prasanth, SG; Prasanth, KV				Anantharaman, Aparna; Gholamalamdari, Omid; Khan, Abid; Yoon, Je-Hyun; Jantsch, Michael F.; Hartner, Jochen C.; Gorospe, Myriam; Prasanth, Supriya G.; Prasanth, Kannanganattu V.			RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA	FEBS LETTERS			English	Article						ADAR; breast cancer; Ctn RNA; HuR; mRNA stability; RNA editing	DOUBLE-STRANDED-RNA; BREAST-CANCER; ADENOSINE DEAMINASES; HUMAN TRANSCRIPTOME; GENE-EXPRESSION; NONCODING RNA; REPRODUCIBLE CHANGES; NUCLEAR RETENTION; DOWN-REGULATION; SEQ DATA	Adenosine deaminases acting on RNA (ADARs) are proteins that catalyse widespread A-to-I editing within RNA sequences. We recently reported that ADAR2 edits and stabilizes nuclear-retained Cat2 transcribed nuclear RNA (Ctn RNA). Here, we report that ADAR1 coordinates with ADAR2 to regulate editing and stability of Ctn RNA. We observe an RNA-dependent interaction between ADAR1 and ADAR2. Furthermore, ADAR1 negatively regulates interaction of Ctn RNA with RNA-destabilizing proteins. We also show that breast cancer (BC) cells display elevated ADAR1 but not ADAR2 levels, compared to nontumourigenic cells. Additionally, BC patients with elevated levels of ADAR1 show low survival. Our findings provide insights into overlapping substrate preferences of ADARs and potential involvement of ADAR1 in BC.	[Anantharaman, Aparna; Gholamalamdari, Omid; Khan, Abid; Prasanth, Supriya G.; Prasanth, Kannanganattu V.] Univ Illinois, Dept Cell & Dev Biol, C426,Chem & Life Sci Bldg,601 S Goodwin Ave, Urbana, IL 61801 USA; [Yoon, Je-Hyun; Gorospe, Myriam] NIA, Lab Genet & Genom, Intramural Res Program, NIH, Baltimore, MD USA; [Jantsch, Michael F.] Med Univ Vienna, Dept Med Biochem, Ctr Anat & Cell Biol, Vienna, Austria; [Hartner, Jochen C.] Horizon Discovery, Cambridge, England; [Yoon, Je-Hyun] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Prasanth, KV (reprint author), Univ Illinois, Dept Cell & Dev Biol, C426,Chem & Life Sci Bldg,601 S Goodwin Ave, Urbana, IL 61801 USA.	kumarp@life.illinois.edu			National Institute of Health [1RO1GM088252, 1RO1GM099669]; American Cancer Society [RSG-11-174-01-RMC]; National Science Foundation [1243372]; EAGER; National Institute on Aging-Intramural Research Program; National Institutes of Health [Z01AG000511]	This work was supported by grants from the National Institute of Health (1RO1GM088252 to KVP, 1RO1GM099669 to SGP); the American Cancer Society (RSG-11-174-01-RMC to KVP); the National Science Foundation (career, 1243372 to SGP and EAGER to KVP); and the National Institute on Aging-Intramural Research Program, National Institutes of Health (Z01AG000511 to JHY and MG). The funders had no role in study design, data collection and analysis.	Anantharaman A, 2017, NUCLEIC ACIDS RES, V45, P4189, DOI 10.1093/nar/gkw1304; Bahn JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7355; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, NUCLEIC ACIDS RES, V42, P6876, DOI 10.1093/nar/gku414; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Ben-Shoshan SO, 2017, RNA BIOL, V14, P587, DOI 10.1080/15476286.2016.1203501; Capshew CR, 2012, NUCLEIC ACIDS RES, V40, P8637, DOI 10.1093/nar/gks590; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chen LL, 2012, CURR TOP MICROBIOL, V353, P111, DOI 10.1007/82_2011_149; Chilibeck KA, 2006, J BIOL CHEM, V281, P16530, DOI 10.1074/jbc.M511831200; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Conrad NK, 2006, MOL CELL, V24, P943, DOI 10.1016/j.molcel.2006.10.029; Daniel C, 2012, NUCLEIC ACIDS RES, V40, P9876, DOI 10.1093/nar/gks691; Dawson PJ, 1996, AM J PATHOL, V148, P313; Elbarbary RA, 2013, GENE DEV, V27, P1495, DOI 10.1101/gad.220962.113; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Galeano F, 2013, ONCOGENE, V32, P998, DOI 10.1038/onc.2012.125; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; Goodman RA, 2012, CURR TOP MICROBIOL, V353, P1, DOI 10.1007/82_2011_144; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hayashi M, 2013, J DERMATOL, V40, P336, DOI 10.1111/j.1346-8138.2012.01661.x; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Higuchi M, 2000, NATURE, V406, P78; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Iizasa H, 2009, NAT IMMUNOL, V10, P16, DOI 10.1038/ni0109-16; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Jadaliha M, 2016, ONCOTARGET, V7, P40418, DOI 10.18632/oncotarget.9622; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.285504; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Mallela A, 2012, CRIT REV BIOCHEM MOL, V47, P493, DOI 10.3109/10409238.2012.714350; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marcu-Malina V, 2016, ONCOTARGET, V7, P54370, DOI 10.18632/oncotarget.11029; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795                                                        ; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Nakano M, 2017, J BIOL CHEM, V292, P4873, DOI 10.1074/jbc.M117.775684; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Orecchini E, 2017, NUCLEIC ACIDS RES, V45, P155, DOI 10.1093/nar/gkw834; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Poulsen H, 2006, RNA, V12, P1350, DOI 10.1261/rna.2314406; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Rayon-Estrada Violeta, 2015, Trends Cancer, V1, P211; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992                                                                   ; Sakurai M, 2017, NAT STRUCT MOL BIOL, V24, P534, DOI 10.1038/nsmb.3403; Salameh A, 2015, P NATL ACAD SCI USA, V112, P8403, DOI 10.1073/pnas.1507882112; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schnitt SJ, 2010, MODERN PATHOL, V23, pS60, DOI 10.1038/modpathol.2010.33; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shtrichman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041576; Song C, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120129; Stellos K, 2016, NAT MED, V22, P1140, DOI 10.1038/nm.4172; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ulbricht RJ, 2014, BIOESSAYS, V36, P730, DOI 10.1002/bies.201400055; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Vesely C, 2014, NUCLEIC ACIDS RES, V42, P12155, DOI 10.1093/nar/gku844; Vesely C, 2012, GENOME RES, V22, P1468, DOI 10.1101/gr.133025.111; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Washburn MC, 2014, CELL REP, V6, P599, DOI 10.1016/j.celrep.2014.01.011	82	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1873-3468			FEBS LETT	FEBS Lett.	SEP	2017	591	18					2890	2904		10.1002/1873-3468.12795				15	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FI2CL	WOS:000411744200018	28833069				2018-01-05	
J	Berterame, NM; Bertagnoli, S; Codazzi, V; Porro, D; Branduardi, P				Berterame, Nadia Maria; Bertagnoli, Stefano; Codazzi, Vera; Porro, Danilo; Branduardi, Paola			Temperature-induced lipocalin (TIL): a shield against stress-inducing environmental shocks in Saccharomyces cerevisiae	FEMS YEAST RESEARCH			English	Article						TIL; Saccharomyces cerevisiae; temperature stress; organic acid stress; oxidative stress; robustness	ACID STRESS; OXIDATIVE STRESS; SALT STRESS; CELL-DEATH; WILD-TYPE; YEAST; TOLERANCE; STRAINS; PROTEIN; ARABIDOPSIS	The yeast Saccharomyces cerevisiae is a well-established workhorse, either for recombinant or natural products, thanks to its natural traits and easily editable metabolism. However, during a bio-based industrial process it meets multiple stresses generated by operative conditions such as non-optimal temperature, pH, oxygenation and product accumulation. The development of tolerant strains is therefore indispensable for the improvement of production, yield and productivity of fermentative processes. In this regard, plants as resilient organisms are a generous source for fishing genes and/or metabolites that can help the cell factory to counteract environmental constraints. Plants possess proteins named temperature-induced lipocalins, TIL, whose levels in the cells correlates with the tolerance to sudden temperature changes and with the scavenging of reactive oxygen species. In this work, the gene encoding for the Arabidopsis thaliana TIL protein was for the first time expressed in S. cerevisiae. The recombinant strain was compared and analysed against the parental counterpart under heat shock, freezing, exposure to organic acid and oxidative agents. In all the tested conditions, TIL expression conferred a higher tolerance to the stress imposed, making this strain a promising candidate for the development of robust cell factories able to overtake the major impairments of industrial processes.	[Berterame, Nadia Maria; Bertagnoli, Stefano; Codazzi, Vera; Porro, Danilo; Branduardi, Paola] Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy; [Codazzi, Vera] Assobiomedica, Area Innovaz, Via Marostica 1, I-20146 Milan, Italy	Branduardi, P (reprint author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	paola.branduardi@unimib.it			FA (Fondo di Ateneo) of the University of Milano Bicocca	This work was supported by FA (Fondo di Ateneo) of the University of Milano Bicocca to PB and DP.	Abo-Ogiala A, 2014, J PLANT PHYSIOL, V171, P250, DOI 10.1016/j.jplph.2013.08.003; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; Berterame NM, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0438-2; Boca S, 2014, PLANT CELL ENVIRON, V37, P368, DOI 10.1111/pce.12159; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Charron JBF, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-86; Chi WT, 2009, PLANT CELL ENVIRON, V32, P917, DOI 10.1111/j.1365-3040.2009.01972.x; Chmurzynska A, 2006, J APPL GENETICS, V47, P39, DOI 10.1007/BF03194597                                                              ; di Masi A, 2016, J CONTROL RELEASE, V228, P191, DOI 10.1016/j.jconrel.2016.02.049; Du L, 2008, FEMS YEAST RES, V8, P531, DOI 10.1111/j.1567-1364.2008.00375.x; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fossati T, 2011, METAB ENG, V13, P177, DOI 10.1016/j.ymben.2010.12.007; Giannattasio S, 2005, GENE, V354, P93, DOI 10.1016/j.gene.2005.03.030; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; He XY, 2015, PLANT MOL BIOL, V87, P645, DOI 10.1007/s11103-015-0304-3; Hernandez-Gras F, 2015, PLANT MOL BIOL, V88, P301, DOI 10.1007/s11103-015-0326-x; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Levesque-Tremblay G, 2009, PLANT J, V60, P691, DOI 10.1111/j.1365-313X.2009.03991.x; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Martani F, 2013, YEAST, V30, P365, DOI 10.1002/yea.2969; Martorell P, 2007, INT J FOOD MICROBIOL, V114, P234, DOI 10.1016/j.ijfoodmicro.2006.09.014; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Pandey GK, 2016, FRONT PLANT SCI, V7, P681; Piper P, 2001, MICROBIOL-SGM, V147, P2635, DOI 10.1099/00221287-147-10-2635                                                    ; Porro D, 2014, CURR OPIN BIOTECH, V30, P101, DOI 10.1016/j.copbio.2014.06.009; Porro D, 2011, APPL MICROBIOL BIOT, V89, P939, DOI 10.1007/s00253-010-3019-z; Porro D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-51; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Schiefner A, 2015, ACCOUNTS CHEM RES, V48, P976, DOI 10.1021/ar5003973; SCHULTE D, 1995, J CELL SCI, V108, P1381; STEELS EL, 1994, MICROBIOL-UK, V140, P569, DOI 10.1099/00221287-140-3-569                                                      ; Teixeira MC, 2011, CURR OPIN BIOTECH, V22, P150, DOI 10.1016/j.copbio.2010.10.011; Van Dien S, 2013, CURR OPIN BIOTECH, V24, P1061, DOI 10.1016/j.copbio.2013.03.002; Wendisch VF, 2016, J BIOTECHNOL, V234, P139, DOI 10.1016/j.jbiotec.2016.07.022	39	1	1	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	SEP	2017	17	6							fox056	10.1093/femsyr/fox056				9	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	FJ6BN	WOS:000412838700003					2018-01-05	
J	Arbuthnot, P; Maepa, MB; Ely, A; Pepper, MS				Arbuthnot, P.; Maepa, M. B.; Ely, A.; Pepper, M. S.			The state of gene therapy research in Africa, its significance and implications for the future	GENE THERAPY			English	Review							HEPATITIS-B-VIRUS; HEMATOPOIETIC STEM-CELLS; DNA-BASED IMMUNIZATION; ZINC-FINGER NUCLEASES; SHORT HAIRPIN RNAS; IN-VIVO; PROGENITOR CELLS; HUMANIZED MICE; OF-CONCEPT; EFFECTOR NUCLEASES	Gene therapy has made impressive recent progress and has potential for treating a wide range of diseases, many of which are important to Africa. However, as a result of lack of direct public funding and skilled personnel, direct research on gene therapy in Africa is currently limited and resources to support the endeavor are modest. A strength of the technology is that it is based on principles of rational design, and the tools of gene therapy are now highly versatile. For example gene silencing and gene editing may be used to disable viral genes for therapeutic purposes. Gene therapy may thus lead to cure from infections with HIV-1, hepatitis B virus and Ebola virus, which are of significant public health importance in Africa. Although enthusiasm for gene therapy is justified, significant challenges to implementing the technology remain. These include ensuring efficient delivery of therapeutic nucleic acids to target cells, limiting unintended effects, cost and complexity of treatment regimens. In addition, implementation of effective legislation that will govern gene therapy research will be a challenge. Nevertheless, it is an exciting prospect that gene therapy should soon reach the mainstream of medical management. Participation of African researchers in the exciting developments is currently limited, but their involvement is important to address health problems, develop capacity and enhance economic progress of the continent.	[Arbuthnot, P.; Maepa, M. B.; Ely, A.] Univ Witwatersrand, Wits SAMRC Antiviral Gene Therapy Res Unit, Dept Mol Med & Haematol, Sch Pathol,Fac Hlth Sci, 7 York Rd, ZA-2193 Johannesburg, Gauteng, South Africa; [Pepper, M. S.] Univ Pretoria, SAMRC Extramural Unit Stem Cell Res & Therapy, Prinshof Campus, Pretoria, South Africa; [Pepper, M. S.] Univ Pretoria, Inst Cellular & Mol Med, Dept Immunol, Prinshof Campus, Pretoria, South Africa	Arbuthnot, P (reprint author), Univ Witwatersrand, Wits SAMRC Antiviral Gene Therapy Res Unit, Dept Mol Med & Haematol, Sch Pathol,Fac Hlth Sci, 7 York Rd, ZA-2193 Johannesburg, Gauteng, South Africa.	Patrick.Arbuthnot@wits.ac.za			South African National Research Foundation (NRF) [81768, 81692, 68339, 85981, 77954, 61508]; South African Medical Research Council; Swiss-South African Joint Research Program; Johnson & Johnson Innovation; South African Poliomyelitis Research Foundation [PRF-15/27]	Financial assistance for work carried out in the authors' laboratories, which was received from the South African National Research Foundation (NRF, GUNs 81768, 81692, 68339, 85981, 77954 and 61508), the South African Medical Research Council, the Swiss-South African Joint Research Program, Johnson & Johnson Innovation and the South African Poliomyelitis Research Foundation ( PRF-15/27) is gratefully acknowledged.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Arbuthnot P., 2015, GENE THERAPY VIRAL I; Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670; Balazs AB, 2014, NAT MED, V20, P296, DOI 10.1038/nm.3471; Barmania F, 2013, APPL TRANSL GENOM, V2, P3, DOI 10.1016/j.atg.2013.05.004; Barouch DH, 2014, NAT REV MICROBIOL, V12, P765, DOI 10.1038/nrmicro3360; Beasley DWC, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.13; Berkhout B, 2009, EXPERT OPIN BIOL TH, V9, P161, DOI [10.1517/14712590802653619, 10.1517/14712590802653619 ]; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; Brennan TA, 2014, NAT BIOTECHNOL, V32, P874, DOI 10.1038/nbt.3003; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burnett JC, 2012, CURR OPIN IMMUNOL, V24, P625, DOI 10.1016/j.coi.2012.08.013; Cannon P, 2011, CURR OPIN HIV AIDS, V6, P74, DOI 10.1097/COH.0b013e32834122d7; Carmona S, 2006, MOL THER, V13, P411, DOI 10.1016/j.ymthe.2005.10.013; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Collins M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3003; Cooper C, 2013, QJM-INT J MED, V106, P153, DOI 10.1093/qjmed/hcs214; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Davis HL, 1996, VACCINE, V14, P910, DOI 10.1016/0264-410X(95)00255-Y                                                    ; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Ely A, 2008, MOL THER, V16, P1105, DOI 10.1038/mt.2008.82; Ely A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp446; Frenk J, 2017, LANCET, V389, P667, DOI 10.1016/S0140-6736(16)30181-7; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949                                                    ; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Gish RG, 2015, ANTIVIR RES, V121, P97, DOI 10.1016/j.antiviral.2015.06.019; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hofer U, 2013, J INFECT DIS, V208, pS160, DOI 10.1093/infdis/jit382; Hossain MA, 2017, MOL THER, V25, P561, DOI 10.1016/j.ymthe.2017.02.003; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hutter G, 2011, AIDS, V25, P273, DOI 10.1097/QAD.0b013e328340fe28; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS GEN EV; Ivacik D, 2011, REV MED VIROL, V21, P383, DOI 10.1002/rmv.705; Jablonka S, 2017, GENE THER, V24, P506, DOI 10.1038/gt.2017.46; Jackson CS, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt204; Janes HE, 2017, J INFECT DIS, V215, P1376, DOI 10.1093/infdis/jix086; Johnson SW, 2016, J CLIN PHARM THER, V41, P727, DOI 10.1111/jcpt.12455; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Lowe M, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.237.9402; Mancini M, 1996, J BIOTECHNOL, V44, P47, DOI 10.1016/0168-1656(95)00098-4; Mancini M, 1998, J IMMUNOL, V161, P5564; Marimani MD, 2015, J CONTROL RELEASE, V209, P198, DOI 10.1016/j.jconrel.2015.04.042; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Michler T., 2016, RNA, V8, P1082; Montuclard C, 2015, J HEPATOL, V62, P1265, DOI 10.1016/j.jhep.2015.01.020; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Morrissey DV, 2005, HEPATOLOGY, V41, P1349, DOI 10.1002/hep.20702; Myburgh R, 2015, J VIROL, V89, P6761, DOI 10.1128/JVI.00277-15; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Obed A, 2016, AM J CASE REP, V17, DOI 10.12659/AJCR.898594; Olejniczak M, 2016, BBA-GENE REGUL MECH, V1859, P306, DOI 10.1016/j.bbagrm.2015.11.005; Parvez MK, 2016, CURR PHARM DESIGN, V22, P286, DOI 10.2174/1381612822666151112152733; Pearson S, 2004, NAT BIOTECHNOL, V22, P3, DOI 10.1038/nbt0104-3; Pepper MS, 2015, S AFR J BIOETH LAW, V8, P23, DOI 10.7196/SAJBL.8402; Pol J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1115641; Scott T, 2012, ANTIVIR THER, V17, P643, DOI 10.3851/IMP2073; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1; Snoy PJ, 2010, VET PATHOL, V47, P774, DOI 10.1177/0300985810372506; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Thi EP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009706; Touchot N, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020078; Touchot N, 2015, NAT BIOTECHNOL, V33, P902, DOI 10.1038/nbt.3332; Ursic-Bedoya R, 2014, J INFECT DIS, V209, P562, DOI 10.1093/infdis/jit465; van der Loo JCM, 2016, HUM MOL GENET, V25, pR42, DOI 10.1093/hmg/ddv451; Wang J, 2015, WORLD J GASTROENTERO, V21, P9554, DOI 10.3748/wjg.v21.i32.9554; Weber ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097579; Weinberg MS, 2007, MOL THER, V15, P534, DOI 10.1038/sj.mt.6300077; Yang NH, 2016, HEPATOL INT, V10, P277, DOI 10.1007/s12072-015-9661-x; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Zeisel MB, 2015, GUT, V64, P1314, DOI 10.1136/gutjnl-2014-308943; Zhen S, 2015, GENE THER, V22, P404, DOI 10.1038/gt.2015.2; Zimmerman KA, 2008, J VIROL, V82, P8013, DOI 10.1128/JVI.00366-08	85	0	0	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	SEP	2017	24	9					581	589		10.1038/gt.2017.57				9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	FI5FA	WOS:000412006500021	28692018				2018-01-05	
J	Xie, LQ; Torigoe, SE; Xiao, JF; Mai, DH; Li, L; Davis, FP; Dong, P; Marie-Nelly, H; Grimm, J; Lavis, L; Darzacq, X; Cattoglio, C; Liu, Z; Tjian, R				Xie, Liangqi; Torigoe, Sharon E.; Xiao, Jifang; Mai, Daniel H.; Li, Li; Davis, Fred P.; Dong, Peng; Marie-Nelly, Herve; Grimm, Jonathan; Lavis, Luke; Darzacq, Xavier; Cattoglio, Claudia; Liu, Zhe; Tjian, Robert			A dynamic interplay of enhancer elements regulates Klf4 expression in naive pluripotency	GENES & DEVELOPMENT			English	Article						dynamics; enhancer; CRISPR; naive pluripotency	EMBRYONIC STEM-CELLS; GROUND-STATE PLURIPOTENCY; ESRRB; CHROMATIN; BINDING; TARGET	Transcription factor (TF)-directed enhanceosome assembly constitutes a fundamental regulatory mechanism driving spatiotemporal gene expression programs during animal development. Despite decades of study, we know little about the dynamics or order of events animating TF assembly at cis-regulatory elements in living cells and the long-range molecular "dialog" between enhancers and promoters. Here, combining genetic, genomic, and imaging approaches, we characterize a complex long-range enhancer cluster governing Kruppel-like factor 4 (Klf4) expression in naive pluripotency. Genome editing by CRISPR/Cas9 revealed that OCT4 and SOX2 safeguard an accessible chromatin neighborhood to assist the binding of other TFs/cofactors to the enhancer. Single-molecule live-cell imaging uncovered that two naive pluripotency TFs, STAT3 and ESRRB, interrogate chromatin in a highly dynamic manner, in which SOX2 promotes ESRRB target search and chromatin-binding dynamics through a direct protein-tethering mechanism. Together, our results support a highly dynamic yet intrinsically ordered enhanceosome assembly to maintain the finely balanced transcription program underlying naive pluripotency.	[Xie, Liangqi; Torigoe, Sharon E.; Darzacq, Xavier; Cattoglio, Claudia; Tjian, Robert] Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Xiao, Jifang; Mai, Daniel H.; Marie-Nelly, Herve; Tjian, Robert] Univ Calif Berkeley, Calif Inst Regenerat Med Ctr Excellence, Li Ka Shing Ctr Biomed & Hlth Sci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Li, Li; Dong, Peng; Grimm, Jonathan; Lavis, Luke; Liu, Zhe] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Davis, Fred P.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Torigoe, Sharon E.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA	Xie, LQ (reprint author), Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Liu, Z (reprint author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	jmlim@berkeley.edu; liuz11@janelia.hhmi.org			California Institute of Regenerative Medicine [LA1-08013]; Janelia visitor program; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; Howard Hughes Medical Institute	We thank Dirk Hockemeyer and members of the Tjian laboratory for critical discussion and proofreading the manuscript. We thank Anders Sejr Hansen for providing the Matlab code to analyze the displacement data. We also thank K. Heydari for assistance with flow cytometry (Li Ka Shing Flow Cytometry Facility, University of California at Berkeley). This work was supported by California Institute of Regenerative Medicine grant LA1-08013 (to X.D. and R.T.), the Janelia visitor program (L.X.), the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (F.P.D.), and the Howard Hughes Medical Institute (R.T.).	Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/nmeth.2688, 10.1038/NMETH.2688]; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Hou T, 2008, J BIOL CHEM, V283, P30725, DOI 10.1074/jbc.M805941200; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kalkan T, 2017, DEVELOPMENT, V5, P733; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li L, 2016, ELIFE, V5, DOI 10.7554/eLife.17056; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609                                                         ; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mascetti VL, 2014, NAT BIOTECHNOL, V32, P68, DOI 10.1038/nbt.2789; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rossant J, 2017, CELL STEM CELL, V20, P18, DOI 10.1016/j.stem.2016.12.004; Swinstead EE, 2016, CELL, V165, P593, DOI 10.1016/j.cell.2016.02.067; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024                                                      ; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994	33	0	0	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	0890-9369	1549-5477		GENE DEV	Genes Dev.	SEP 1	2017	31	17					1795	1808		10.1101/gad.303321.117				14	Cell Biology; Developmental Biology; Genetics & Heredity	Cell Biology; Developmental Biology; Genetics & Heredity	FI8TR	WOS:000412275500008	28982762				2018-01-05	
J	Zhigalova, NA; Zhenilo, SV; Artemov, AV; Prokhortchouk, EB				Zhigalova, N. A.; Zhenilo, S. V.; Artemov, A. V.; Prokhortchouk, E. B.			CRISPR/Cas9-editing-based modeling of hypoxia in renal cancer cells	MOLECULAR BIOLOGY			English	Article						VHL; hypoxia; DNA methylation; HIF1 alpha; CRISPR/Cas9	HIPPEL-LINDAU-DISEASE; MUTATIONS; MECHANISM; PROTEIN; ALPHA	Uncontrolled growth in the cell mass of malignant tumors induces intensive angiogenesis. However, the demands of the cancer cells for nutrients and oxygen remain only partially met. Hypoxia is a process that accompanies malignant transformation and evokes changes in the DNA methylation profile in solid tumors. To a certain extent, these changes, including the hypermethylation of tumor suppressor gene promoters, are related to the decrease in the activity of Tet proteins under the conditions of oxygen and free radical deficit. Stabilization, accumulation, and nuclear translocation of the transcription factor HIF1 alpha are the key molecular events in hypoxia. We modified the clear-cell renal cancer cell line Caki1 to stabilize the HIF1 alpha protein and characterized a model cell line that will enable the studies of the mechanisms of changes of the DNA methylation level at a constant activity of Tet proteins and a gene transcription profile characteristic of hypoxia. The CRISPR/Cas9 DNA editing system was used to edit the VHL gene. The mutant VHL protein contained a disrupted alpha-helix at the C-terminus and could not participate in the molecular pathway of proteasomal degradation of the HIF1 alpha factor; therefore, the latter accumulated in the nucleus and activated the specific target genes. An analysis of gene transcription revealed the induction of hypoxia-associated genes in the modified cell line. The developed D<inverted exclamation>aki-1/VHLmut model can be used to discriminate between the effects evoked by oxygen-suppressed hydroxylases of the Tet family and other hypoxia-associated mechanisms of DNA methylation/demethylation.	[Zhigalova, N. A.; Zhenilo, S. V.; Artemov, A. V.; Prokhortchouk, E. B.] Russian Acad Sci, Inst Bioengn, Fed Res Ctr Fundamental Studies Biotechnol, Moscow 117312, Russia	Prokhortchouk, EB (reprint author), Russian Acad Sci, Inst Bioengn, Fed Res Ctr Fundamental Studies Biotechnol, Moscow 117312, Russia.	prokhortchouk@gmail.com			Russian Science Foundation [14-14-01202]	Financial support for the present work was provided by the Russian Science Foundation (14-14-01202).	Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Eustace A, 2013, CLIN CANCER RES, V19, P4879, DOI 10.1158/1078-0432.CCR-13-0542; Kopera E, 2004, CHEM RES TOXICOL, V17, P1452, DOI 10.1021/tx049842s; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938                                                          ; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001                                                ; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430                                                   ; Rechsteiner MP, 2011, CANCER RES, V71, P5500, DOI 10.1158/0008-5472.CAN-11-0757; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zhigalova Nadezhda, 2015, F1000Res, V4, P1518, DOI 10.12688/f1000research.7571.1	12	0	0	2	2	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0026-8933	1608-3245		MOL BIOL+	Mol. Biol.	SEP	2017	51	5					728	732		10.1134/S0026893317050235				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FJ6YI	WOS:000412903500011					2018-01-05	
J	Lizio, M; Deviatiiarov, R; Nagai, H; Galan, L; Arner, E; Itoh, M; Lassmann, T; Kasukawa, T; Hasegawa, A; Ros, MA; Hayashizaki, Y; Carninci, P; Forrest, ARR; Kawaji, H; Gusev, O; Sheng, GJ				Lizio, Marina; Deviatiiarov, Ruslan; Nagai, Hiroki; Galan, Laura; Arner, Erik; Itoh, Masayoshi; Lassmann, Timo; Kasukawa, Takeya; Hasegawa, Akira; Ros, Marian A.; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.; Kawaji, Hideya; Gusev, Oleg; Sheng, Guojun			Systematic analysis of transcription start sites in avian development	PLOS BIOLOGY			English	Article							MAMMALIAN EXPRESSION ATLAS; GENE-EXPRESSION; RNA-SEQ; CHICKEN GENOME; CAP-ANALYSIS; REGULATORY ELEMENTS; STEM-CELLS; ACTIVATION; ENHANCERS; EPIBLAST	Cap Analysis of Gene Expression (CAGE) in combination with single-molecule sequencing technology allows precision mapping of transcription start sites (TSSs) and genome-wide capture of promoter activities in differentiated and steady state cell populations. Much less is known about whether TSS profiling can characterize diverse and non-steady state cell populations, such as the approximately 400 transitory and heterogeneous cell types that arise during ontogeny of vertebrate animals. To gain such insight, we used the chick model and performed CAGE-based TSS analysis on embryonic samples covering the full 3-week developmental period. In total, 31,863 robust TSS peaks (> 1 tag per million [TPM]) were mapped to the latest chicken genome assembly, of which 34% to 46% were active in any given developmental stage. ZENBU, a web-based, open-source platform, was used for interactive data exploration. TSSs of genes critical for lineage differentiation could be precisely mapped and their activities tracked throughout development, suggesting that non-steady state and heterogeneous cell populations are amenable to CAGE-based transcriptional analysis. Our study also uncovered a large set of extremely stable housekeeping TSSs and many novel stage-specific ones. We furthermore demonstrated that TSS mapping could expedite motif-based promoter analysis for regulatory modules associated with stage-specific and housekeeping genes. Finally, using Brachyury as an example, we provide evidence that precise TSS mapping in combination with Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-on technology enables us, for the first time, to efficiently target endogenous avian genes for transcriptional activation. Taken together, our results represent the first report of genome-wide TSS mapping in birds and the first systematic developmental TSS analysis in any amniote species (birds and mammals). By facilitating promoter-based molecular analysis and genetic manipulation, our work also underscores the value of avian models in unravelling the complex regulatory mechanism of cell lineage specification during amniote development.	[Lizio, Marina; Arner, Erik; Itoh, Masayoshi; Lassmann, Timo; Kasukawa, Takeya; Hasegawa, Akira; Carninci, Piero; Forrest, Alistair R. R.; Kawaji, Hideya] RIKEN Ctr Life Sci Technol CLST, Div Genom Technol, Yokohama, Kanagawa, Japan; [Lizio, Marina; Arner, Erik; Itoh, Masayoshi; Lassmann, Timo; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.; Kawaji, Hideya] RIKEN Omics Sci Ctr OSC, Yokohama, Kanagawa, Japan; [Deviatiiarov, Ruslan; Gusev, Oleg] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Nagai, Hiroki; Sheng, Guojun] Kumamoto Univ, IRCMS, Kumamoto, Japan; [Nagai, Hiroki; Sheng, Guojun] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan; [Galan, Laura; Ros, Marian A.] Univ Cantabria, CSIC, SODERCAN, Inst Biomed & Biotecnol Cantabria, Santander, Spain; [Itoh, Masayoshi; Hayashizaki, Yoshihide; Kawaji, Hideya; Gusev, Oleg] RIKEN Prevent Med & Diag Innovat Program, Yokohama, Kanagawa, Japan; [Forrest, Alistair R. R.] QEII Med Ctr, Harry Perkins Inst Med Res, Nedlands, WA, Australia; [Forrest, Alistair R. R.] Univ Western Australia, Med Res Ctr, Nedlands, WA, Australia; [Gusev, Oleg] RIKEN Innovat Ctr, Wako, Saitama, Japan	Kawaji, H (reprint author), RIKEN Ctr Life Sci Technol CLST, Div Genom Technol, Yokohama, Kanagawa, Japan.; Kawaji, H (reprint author), RIKEN Omics Sci Ctr OSC, Yokohama, Kanagawa, Japan.; Gusev, O (reprint author), Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.; Sheng, GJ (reprint author), Kumamoto Univ, IRCMS, Kumamoto, Japan.; Sheng, GJ (reprint author), RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan.; Kawaji, H; Gusev, O (reprint author), RIKEN Prevent Med & Diag Innovat Program, Yokohama, Kanagawa, Japan.; Gusev, O (reprint author), RIKEN Innovat Ctr, Wako, Saitama, Japan.	kawaji@gsc.riken.jp; oleg.gusev@riken.jp; sheng@kumamoto-u.ac.jp	Gusev, Oleg/D-9383-2011; Itoh, Masayoshi/N-5363-2015	Gusev, Oleg/0000-0002-6203-9758; Itoh, Masayoshi/0000-0002-1772-318X; carninci, piero/0000-0001-7202-7243; Forrest, Alistair/0000-0003-4543-1675; Kawaji, Hideya/0000-0002-0575-0308	Ministry of Education, Culture, Sports, Science and Technology, Japan; Russian Science Foundation [14-44-00022]; Russian Government Program of Competitive Growth of Kazan Federal University; Takeda Science Foundation; Kumamoto University IRCMS; RIKEN Center for Developmental Biology	Ministry of Education, Culture, Sports, Science and Technology, Japan http://www.mext.go.jp/en/ Innovative Cell Biology by Innovative Technology (Cell Innovation Program) to Yoshihide Hayashizaki. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ministry of Education, Culture, Sports, Science and Technology, Japan http://www.mext.go.jp/en/ to RIKEN Preventive Medicine and Diagnosis Innovation Program (Yoshihide Hayashizaki). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ministry of Education, Culture, Sports, Science and Technology, Japan http:/www.mext.go.jp/en/ to RIKEN Omics Science Center (Yoshihide Hayashizaki). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ministry of Education, Culture, Sports, Science and Technology, Japan trap:http://wwwmext.go.jp/en/ to RIKEN Center for Life Science Technologies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Russian Science Foundation grant for international groups (grant number 14-44-00022) to Oleg Gusev. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Russian Government Program of Competitive Growth of Kazan Federal University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Takeda Science Foundation http://www.takeda-scior.jp/ to Guojun Sheng. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kumamoto University IRCMS http://irmskumamoto-u.ac.jp/ to Guojun Sheng. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RIKEN Center for Developmental Biology http://www.cdb/riken.jp/ to Guojun Sheng. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-900; Abu-Bonsrah KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34524; Alev C, 2013, METHODS MOL BIOL, V1074, P151, DOI 10.1007/978-1-62703-628-3_12; Alev C, 2010, DEVELOPMENT, V137, P2863, DOI 10.1242/dev.053462; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Burt DW, 2005, GENOME RES, V15, P1692, DOI 10.1101/gr.414805; Chen JC, 2017, DEVELOPMENT, V144, P1531, DOI 10.1242/dev.148494; Chen W, 2013, POULTRY SCI, V92, P2754, DOI 10.3382/ps.2013-03099; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Dreos R, 2017, NUCLEIC ACIDS RES, V45, pD51, DOI 10.1093/nar/gkw1069; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gong T, 2013, BIOINFORMATICS, V29, P1083, DOI 10.1093/bioinformatics/btt090; Haberle V, 2014, NATURE, V507, P381, DOI 10.1038/nature12974; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Innocenti N, 2015, RNA, V21, P1018, DOI 10.1261/rna.048470.114; Itoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030809; Jean C, 2013, DEV GROWTH DIFFER, V55, P41, DOI 10.1111/dgd.12021; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Kawaji H, 2014, GENOME RES, V24, P708, DOI 10.1101/gr.156232.113; Khan MAF, 2013, GENESIS, V51, P311, DOI 10.1002/dvg.22375; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Lever M, 2014, BRAIN STRUCT FUNCT, V219, P1009, DOI 10.1007/s00429-013-0550-6; Li AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124003; Li Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S11; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Lowe CB, 2015, MOL BIOL EVOL, V32, P23, DOI 10.1093/molbev/msu309; Muret K, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-016-0275-0; Nepal C, 2013, GENOME RES, V23, P1938, DOI 10.1101/gr.153692.112; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Poulain S, 2017, METHODS MOL BIOL, V1543, P57, DOI 10.1007/978-1-4939-6716-2_4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roellig D, 2017, ELIFE, V6, DOI 10.7554/eLife.21620; Schmid M, 2015, CYTOGENET GENOME RES, V145, P78, DOI 10.1159/000430927; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Seki R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14229; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; Sharma CM, 2014, CURR OPIN MICROBIOL, V19, P97, DOI 10.1016/j.mib.2014.06.010; Sheng GJ, 2015, DEV BIOL, V401, P17, DOI 10.1016/j.ydbio.2014.10.003; Shin M, 2011, MECH DEVELOP, V128, P268, DOI 10.1016/j.mod.2011.03.001; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Warren WC, 2017, G3-GENES GENOM GENET, V7, P109, DOI 10.1534/g3.116.035923; Weng W, 2014, STEM CELL REP, V2, P262, DOI 10.1016/j.stemcr.2014.01.019; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	61	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1545-7885			PLOS BIOL	PLoS. Biol.	SEP	2017	15	9							e2002887	10.1371/journal.pbio.2002887				23	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	FI4WB	WOS:000411978200010	28873399	gold			2018-01-05	
J	Escobar-Aguirre, M; Zhang, H; Jamieson-Lucy, A; Mullins, MC				Escobar-Aguirre, Matias; Zhang, Hong; Jamieson-Lucy, Allison; Mullins, Mary C.			Microtubule-actin crosslinking factor 1 (Macf1) domain function in Balbiani body dissociation and nuclear positioning	PLOS GENETICS			English	Article							XENOPUS-LAEVIS OOCYTES; SHORT-STOP; CAENORHABDITIS-ELEGANS; AXON EXTENSION; VEGETAL CORTEX; LINC COMPLEX; MOUSE ACF7; F-ACTIN; ZEBRAFISH; ORGANIZATION	Animal-vegetal (AV) polarity of most vertebrate eggs is established during early oogenesis through the formation and disassembly of the Balbiani Body (Bb). The Bb is a structure conserved from insects to humans that appears as a large granule, similar to a mRNP granule composed of mRNA and proteins, that in addition contains mitochondria, ER and Golgi. The components of the Bb, which have amyloid-like properties, include germ cell and axis determinants of the embryo that are anchored to the vegetal cortex upon Bb disassembly. Our lab discovered in zebrafish the only gene known to function in Bb disassembly, microtubule-actin crosslinking factor 1a (macf1a). Macf1 is a conserved, giant multi-domain cytoskeletal linker protein that can interact with microtubules (MTs), actin filaments (AF), and intermediate filaments (IF). In macf1a mutant oocytes the Bb fails to dissociate, the nucleus is acentric, and AV polarity of the oocyte and egg fails to form. The cytoskeleton-dependent mechanism by which Macf1a regulates Bb mRNP granule dissociation was unknown. We found that disruption of AFs phenocopies the macf1a mutant phenotype, while MT disruption does not. We determined that cytokeratins (CK), a type of IF, are enriched in the Bb. We found that Macf1a localizes to the Bb, indicating a direct function in regulating its dissociation. We thus tested if Macf1a functions via its actin binding domain (ABD) and plectin repeat domain (PRD) to integrate cortical actin and Bb CK, respectively, to mediate Bb dissociation at the oocyte cortex. We developed a CRISPR/Cas9 approach to delete the exons encoding these domains from the macf1a endogenous locus, while maintaining the open reading frame. Our analysis shows that Macf1a functions via its ABD to mediate Bb granule dissociation and nuclear positioning, while the PRD is dispensable. We propose that Macf1a does not function via its canonical mechanism of linking two cytoskeletal systems together in dissociating the Bb. Instead our results suggest that Macf1a functions by linking one cytoskeletal system, cortical actin, to another structure, the Bb, where Macf1a is localized. Through this novel linking process, it dissociates the Bb at the oocyte cortex, thus specifying the AV axis of the oocyte and future egg. To our knowledge, this is also the first study to use genome editing to unravel the module-dependent function of a cytoskeletal linker.	[Escobar-Aguirre, Matias; Zhang, Hong; Jamieson-Lucy, Allison; Mullins, Mary C.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, 1152 BRBII-III,421 Curie Blvd, Philadelphia, PA 19104 USA	Mullins, MC (reprint author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, 1152 BRBII-III,421 Curie Blvd, Philadelphia, PA 19104 USA.	mullins@mail.med.upenn.edu			National Institute of Health [R01GM117981, T32GM008216, 1F31GM115066]; Becas Chile	This study was funded by grants from the National Institute of Health (http://www.nih.gov/), R01GM117981 to MCM, and T32GM008216 and 1F31GM115066 to AJL. MEA also received funding from the Becas Chile (http://www.conicyt.cl/becasc onicyt/2016/01/becas-doctorado-en-el-extranjerob ch-2016/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2012, J NEUROSCI, V32, P9143, DOI 10.1523/JNEUROSCI.0416-12.2012; Anger M, 2005, BIOL REPROD, V72, P188, DOI 10.1095/biolreprod.104.035451; Antonellis PJ, 2014, J NEUROSCI, V34, P305, DOI 10.1523/JNEUROSCI.1880-13.2014; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bernier G, 1996, GENOMICS, V38, P19, DOI 10.1006/geno.1996.0587                                                          ; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Bontems F, 2009, CURR BIOL, V19, P414, DOI 10.1016/j.cub.2009.01.038; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; Bottenberg W, 2009, MECH DEVELOP, V126, P489, DOI 10.1016/j.mod.2009.04.004; Bouameur JE, 2014, J INVEST DERMATOL, V134, P885, DOI 10.1038/jid.2013.498; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brosig M, 2010, INT J BIOCHEM CELL B, V42, P1717, DOI 10.1016/j.biocel.2010.07.001; Chang P, 2004, MOL BIOL CELL, V15, P4669, DOI 10.1091/mbc.E04-03-0265; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Elkouby YM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002335; Escobar-Aguirre M, 2016, VERTEBRATE DEV MATER, P173; Fernandez J, 2013, DEV DYNAM, V242, P503, DOI 10.1002/dvdy.23943; Gard DL, 1997, DEV BIOL, V184, P95, DOI 10.1006/dbio.1997.8508; GARD DL, 1991, DEV BIOL, V143, P346, DOI 10.1016/0012-1606(91)90085-H; GARD DL, 1995, DEV BIOL, V168, P189, DOI 10.1006/dbio.1995.1071; Ge XY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004422; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Gupta T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001073; Heim AE, 2014, DEVELOPMENT, V141, P842, DOI 10.1242/dev.090449; Jorgensen LH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05180; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kim HS, 2011, DEVELOPMENT, V138, P4013, DOI 10.1242/dev.059568; KLOC M, 1995, DEVELOPMENT, V121, P287; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4                                                   ; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Laporte C, 2003, PLANT CELL, V15, P2058, DOI 10.1105/tpc.013896; Lee S, 2000, J NEUROSCI, V20, P1096; Lee S, 2002, DEVELOPMENT, V129, P1195; Lee S, 2002, DEVELOPMENT, V129, P1509; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Lin CM, 2005, J CELL SCI, V118, P3727, DOI 10.1242/jcs.02510; Link J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004099; Lombardi ML, 2011, BIOCHEM SOC T, V39, P1729, DOI 10.1042/BST20110686; Tran LD, 2012, DEVELOPMENT, V139, P3644, DOI 10.1242/dev.082362; Marlow FL, 2008, DEV BIOL, V321, P40, DOI 10.1016/j.ydbio.2008.05.557; Meinke P, 2011, BIOCHEM SOC T, V39, P1693, DOI 10.1042/BST20110658; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Nashchekin D, 2016, DEV CELL, V38, P61, DOI 10.1016/j.devcel.2016.06.010; Roper K, 2004, CURR BIOL, V14, P99, DOI 10.1016/j.cub.2003.12.056; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Smith SM, 2015, METHODS MOL BIOL, V1245, P243, DOI 10.1007/978-1-4939-1966-6_18; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wuhr M, 2011, METHOD CELL BIOL, V101, P1, DOI 10.1016/B978-0-12-387036-0.00001-3; Wuhr M, 2015, CURR BIOL, V25, P2663, DOI 10.1016/j.cub.2015.08.047	58	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7404			PLOS GENET	PLoS Genet.	SEP	2017	13	9							e1006983	10.1371/journal.pgen.1006983				29	Genetics & Heredity	Genetics & Heredity	FI4VJ	WOS:000411976100014	28880872	gold			2018-01-05	
J	Deng, HX; Gao, RJ; Liao, XR; Cai, YJ				Deng, Huaxiang; Gao, Ruijie; Liao, Xiangru; Cai, Yujie			Characterization of a major facilitator superfamily transporter in Shiraia bambusicola	RESEARCH IN MICROBIOLOGY			English	Article						MSF transporter; Hypocrellin resistance; CRISPR/Cas9 system; Shiraia bambusicola; Reactive oxygen species	CERCOSPORA-NICOTIANAE; ASPERGILLUS-FUMIGATUS; CRISPR-CAS9 SYSTEM; FUNGAL VIRULENCE; MFS TRANSPORTER; GENE; HYPOCRELLIN; RESISTANCE; CRISPR/CAS9; TOXIN	Reactive oxygen species (ROS) generated by photo-activated hypocrellin from Shiraia bambusicola are detrimental to cellular macromolecules. However, S. bambusicola can still maintain excellent morphology during continuous hypocrellin production, indicating an extraordinary autoresistance system that protects against the harmful ROS. In this study, a major facilitator superfamily transporter (MFS) was isolated from S. bambusicola and deleted using the clustered regularly interspaced short palindromic repeat sequences (CRISPR)/Cas9 system. The Delta MFS mutant abolished hypocrellin production and was slightly sensitive to 40-mu M hypocrellin, while the Delta MFS compliment strain restored hypocrellin production and resistance. Hypocrellin treatment also enhanced the relative expression of MFS in wild-type S. bambusicola. Subsequent pathogenicity assays showed that MFS deletion reduced damage to bamboo leaves. By contrast, restoration of hypocrellin production in the MFS compliment strain generated similar necrotic lesions on bamboo leaves to those observed with the wild-type strain. These results revealed that the identified MFS is involved in efflux of hypocrellin from cells, which reduces the hypocrellin toxicity. Furthermore, hypocrellin contributed to the virulence of S. bambusicola on bamboo leaves. These findings could help to reduce plant loss by disrupting hypocrellin biosynthesis in S. bambusicola, or overexpressing the associated resistance gene in transgenic plants. (C) 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.	[Deng, Huaxiang; Gao, Ruijie; Liao, Xiangru; Cai, Yujie] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China	Liao, XR; Cai, YJ (reprint author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, 1800 Lihu Rd, Wuxi 214122, Jiangsu, Peoples R China.	xrliao@jiangnan.edu.cn; yjcai@jiangnan.edu.cn			National Science Foundation of China [21275066]; Six Talent Peak Program [SWYY-126]; Fundamental Research of Doctor of Philosophy [2050205, 205020502]	This study was financially supported by the National Science Foundation of China (Grant No. 21275066), the Six Talent Peak Program at 2016 (Grant No. SWYY-126), the Fundamental Research of Doctor of Philosophy at 2014 (Grant No. 2050205) and the Fundamental Research of Doctor of Philosophy at 2015 (Grant No. 205020502).	Amnuaykanjanasin A, 2009, FUNGAL GENET BIOL, V46, P146, DOI 10.1016/j.fgb.2008.11.007; Arazoe T, 2015, BIOTECHNOL BIOENG, V112, P2543, DOI 10.1002/bit.25662; Beseli A, 2015, CURR GENET, V61, P601, DOI 10.1007/s00294-015-0486-x; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Cai YJ, 2011, NEW BIOTECHNOL, V28, P588, DOI 10.1016/j.nbt.2011.02.001; CHEN WS, 1981, LIEBIGS ANN CHEM, P1880; Cheng TF, 2004, J BASIC MICROB, V44, P339, DOI 10.1002/jobm.200410434; Choquer M, 2005, MOL PLANT MICROBE IN, V18, P468, DOI 10.1094/MPMI-18-0468; Choquer M, 2007, FEBS LETT, V581, P489, DOI 10.1016/j.febslet.2007.01.011; Chung KR, 2003, BIOCHEM BIOPH RES CO, V302, P302, DOI 10.1016/S0006-291X(03)00171-2; Crutcher FK, 2015, MICROBIOL-SGM, V161, P875, DOI 10.1099/mic.0.000043; Daub ME, 2013, ANTIOXID REDOX SIGN, V19, P970, DOI 10.1089/ars.2012.5080; Deng HX, 2016, MOLECULES, V21, DOI 10.3390/molecules21091118; Deng HX, 2016, PROCESS BIOCHEM, V51, P1357, DOI 10.1016/j.procbio.2016.07.013; Deng HX, 2016, GENE, V580, P67, DOI 10.1016/j.gene.2016.01.019; Fang YF, 2016, MOL PLANT PATHOL, V17, P127, DOI 10.1111/mpp.12318; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gao L, 2012, ACS NANO, V6, P8030, DOI 10.1021/nn302634m; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Jin S, 2013, NANOSCALE, V5, P11910, DOI 10.1039/c3nr03515h; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; LU SW, 1994, P NATL ACAD SCI USA, V91, P12649, DOI 10.1073/pnas.91.26.12649; Ma H, 2016, NAT BIOTECHNOL, P34; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Matsu-Ura Toru, 2015, Fungal Biol Biotechnol, V2, P4, DOI 10.1186/s40694-015-0015-1; Mousa JJ, 2016, NAT PROD REP, V33, P1255, DOI 10.1039/c6np00006a; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pohl C, 2016, ACS SYNTH BIOL, V5, P754, DOI 10.1021/acssynbio.6b00082; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schuster M, 2016, FUNGAL GENET BIOL, V89, P3, DOI 10.1016/j.fgb.2015.09.001; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Weber J, 2017, ACS SYNTH BIOL, V6, P62, DOI 10.1021/acssynbio.6b00203; Wu Z, 2016, BIOTECHNOL LETT, V38, P1349, DOI 10.1007/s10529-016-2113-4; Yang H, 2014, GENOME ANNOUNC, V2, P11, DOI DOI 10.1128/GENOMEA.00011-14; Yang YC, 2013, PROCESS BIOCHEM, V48, P351, DOI 10.1016/j.procbio.2012.12.011; Zhang C, 2016, FUNGAL GENET BIOL, V86, P47, DOI 10.1016/j.fgb.2015.12.007	44	0	0	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0923-2508	1769-7123		RES MICROBIOL	Res. Microbiol.	SEP	2017	168	7					664	672		10.1016/j.resmic.2017.05.002				9	Microbiology	Microbiology	FJ9WT	WOS:000413132900006	28549739				2018-01-05	
J	Ka, D; Hong, S; Jeong, U; Jeong, M; Suh, N; Suh, JY; Bae, E				Ka, Donghyun; Hong, Suji; Jeong, Ugeene; Jeong, Migyeong; Suh, Nayoung; Suh, Jeong-Yong; Bae, Euiyoung			Structural and dynamic insights into the role of conformational switching in the nuclease activity of the Xanthomonas albilineans Cas2 in CRISPR-mediated adaptive immunity	STRUCTURAL DYNAMICS			English	Article							SHORT PALINDROMIC REPEATS; SPACER ACQUISITION; MECHANISTIC BASIS; HOST FACTOR; SYSTEMS; PROTEIN; BACTERIA; ARCHAEA; ADAPTATION; DNA	Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins constitute a microbial, adaptive immune system countering invading nucleic acids. Cas2 is a universal Cas protein found in all types of CRISPR-Cas systems, and its role is implicated in new spacer acquisition into CRISPR loci. In subtype I-C CRISPR-Cas systems, Cas2 proteins are metaldependent double-stranded DNA (dsDNA) nucleases, and a pH-dependent conformational transition has been proposed as a prerequisite for catalytic action. Here, we report the crystal structure of Xanthomonas albilineans Cas2 (XaCas2) and provide experimental evidence of a pH-dependent conformational change during functional activation. XaCas2 crystallized at an acidic pH represented a catalytically inactive conformational state in which two Asp8 residues were too far apart to coordinate a single catalytic metal ion. Consistently, XaCas2 exhibited dsDNA nuclease activity only under neutral and basic conditions. Despite the overall structural similarity of the two protomers, significant conformational heterogeneity was evident in the putative hinge regions, suggesting that XaCas2 engages in hinge-bending conformational switching. The presence of a Trp residue in the hinge region enabled the investigation of hinge dynamics by fluorescence spectroscopy. The pH dependence of the fluorescence intensity overlapped precisely with that of nuclease activity. Mutational analyses further suggested that conformational activation proceeded via a rigid-body hinge-bending motion as both D8E and hinge mutations significantly reduced nuclease activity. Together, our results reveal strong correlations between the conformational states, catalytic activity, and hinge dynamics of XaCas2, and provide structural and dynamic insights into the conformational activation of the nuclease function of Cas2. (C) 2017 Author(s).	[Ka, Donghyun; Hong, Suji; Jeong, Ugeene; Jeong, Migyeong; Suh, Jeong-Yong; Bae, Euiyoung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea; [Suh, Nayoung] Soon Chun Hyang Univ, Dept Pharmaceut Engn, Asan 31538, South Korea; [Suh, Jeong-Yong; Bae, Euiyoung] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea; [Bae, Euiyoung] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 08826, South Korea	Bae, E (reprint author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.; Bae, E (reprint author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea.; Bae, E (reprint author), Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 08826, South Korea.	bae@snu.ac.kr			Cooperative Research Program for Agricultural Science and Technology Development - Rural Development Administration [PJ01111201]	We thank the staff of the beamline 7A of the Pohang Accelerator Laboratory for their support with data collection and Tae-kyu Lee for help in fluorescence spectroscopy. This work was supported by the Cooperative Research Program for Agricultural Science and Technology Development funded by Rural Development Administration (PJ01111201).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghisaidoobe ABT, 2014, INT J MOL SCI, V15, P22518, DOI 10.3390/ijms151222518; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jackson SA, 2017, SCIENCE, V356, P40, DOI 10.1126/science.aal5056; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jung TY, 2016, PROTEIN SCI, V25, P1890, DOI 10.1002/pro.2981; Ka D, 2014, BIOCHEM BIOPH RES CO, V451, P152, DOI 10.1016/j.bbrc.2014.07.087; Kwon AR, 2012, NUCLEIC ACIDS RES, V40, P4216, DOI 10.1093/nar/gkr1305; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nam KH, 2012, J BIOL CHEM, V287, P35943, DOI 10.1074/jbc.M112.382598; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Rollins M. F., P NATL AC SCI US; Samai P, 2010, ACTA CRYSTALLOGR F, V66, P1552, DOI 10.1107/S1744309110039801; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151	46	0	0	2	2	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	2329-7778			STRUCT DYNAM-US	Struct. Dyn.-US	SEP	2017	4	5							054701	10.1063/1.4984052				14	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	FL4CW	WOS:000414175400014	28612041	gold			2018-01-05	
J	Yu, ZQ; Tong, W; Zheng, H; Li, LW; Li, GX; Gao, F; Wang, T; Liang, C; Ye, C; Wu, JQ; Huang, QF; Tong, GZ				Yu, Zhi-qing; Tong, Wu; Zheng, Hao; Li, Li-wei; Li, Guo-xin; Gao, Fei; Wang, Tao; Liang, Chao; Ye, Chao; Wu, Ji-qiang; Huang, Qinfeng; Tong, Guang-zhi			Variations in glycoprotein B contribute to immunogenic difference between PRV variant JS-2012 and Bartha-K61	VETERINARY MICROBIOLOGY			English	Article						Glycoprotein B; Pseudorabies virus variant; Antigenic variation	PSEUDORABIES VIRUS VARIANT; HERPES-SIMPLEX-VIRUS; AUJESZKYS-DISEASE VIRUS; MONOCLONAL-ANTIBODIES; GENOMIC CHARACTERIZATION; DNA VACCINE; PIGS; GII; CHINA; SWINE	A newly emerged pseudorabies virus (PRV) variant has been identified in many Bartha-K61-vaccinated pig farms. This variant has caused great economic losses to the swine industry in China since 2011. Sequence analysis demonstrated that the gB gene of the emerging PRV variant JS-2012 had multiple variations compared with the vaccine strain Bartha-K61. In the study, a specific CRISPR/Cas9 system combined with homologous recombination was used to construct two recombinant viruses, BJB (Bartha-K61 + JS-2012gB) and JBJ (JS-2012-Delta gE/gI + Bartha-K61gB), by interchanging the full-length gB genes between Bartha-K61 and JS-2012-AgE/gI. The two recombinant viruses showed similar characteristics in growth kinetics in vitro and similar pathogenicity in mice, as compared to their parental strains. Immunization of mice with inactivated BJB or JBJ followed by challenge of JS-2012 showed that BJB could increase protective efficacy to 80%, compared to only 40% protection by the parental Bartha-K61 strain. JBJ had a decreased protective efficacy of 65%, as compared to 90% protection by its parental JS-2012-Delta gE/gI strain. Exchange of the gB gene markedly altered the immunogenicity of the recombinant PRV. These data suggest that variations in gB might play an important role in the virulence of the reemergent PRV variant in China. Our results demonstrate the importance of gB in protective immunity and suggest that the recombinant virus BJB could be a promising vaccine candidate for eradication of the PRV variant.	[Yu, Zhi-qing; Tong, Wu; Zheng, Hao; Li, Li-wei; Li, Guo-xin; Gao, Fei; Wang, Tao; Liang, Chao; Ye, Chao; Wu, Ji-qiang; Huang, Qinfeng; Tong, Guang-zhi] Chinese Acad Agr Sci, Shanghai Vet Res Inst, 518 Ziyue Rd, Shanghai 200241, Peoples R China; [Tong, Wu; Zheng, Hao; Li, Li-wei; Li, Guo-xin; Gao, Fei; Huang, Qinfeng; Tong, Guang-zhi] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China	Huang, QF; Tong, GZ (reprint author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, 518 Ziyue Rd, Shanghai 200241, Peoples R China.	qhuang@shvri.ac.cn; gztong@shvri.ac.cn			National Key Research and Development Program of China [2016YFD0500100]; China Agriculture Research System [NYCYTX-009]; Shanghai Municipal Agriculture Science and Technology Key Project [2015, 1-7, 2016, 4-2]	This work was supported by the National Key Research and Development Program of China (2016YFD0500100), China Agriculture Research System (NYCYTX-009) and Shanghai Municipal Agriculture Science and Technology Key Project (2015, 1-7 and 2016, 4-2)	An TQ, 2013, EMERG INFECT DIS, V19, P1749, DOI 10.3201/eid1911.130177; Bender FC, 2005, J VIROL, V79, P11588, DOI 10.1128/JVI.79.18.11588-11597.2005; Bender FC, 2007, J VIROL, V81, P3827, DOI 10.1128/JVI.02710-06; Brittle EE, 2004, J VIROL, V78, P12951, DOI 10.1128/JVI.78.23.12951-12963.2004; Cairns TM, 2014, J VIROL, V88, P2677, DOI 10.1128/JVI.03200-13; Cong X, 2016, VET MICROBIOL, V182, P170, DOI 10.1016/j.vetmic.2015.11.022; Gu ZQ, 2015, VIRUS RES, V195, P57, DOI 10.1016/j.virusres.2014.09.003; HAMPL H, 1984, J VIROL, V52, P583; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hu RM, 2015, VACCINE, V33, P5733, DOI 10.1016/j.vaccine.2015.09.066; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; LUKACS N, 1985, J VIROL, V53, P166; Luo YZ, 2014, VET MICROBIOL, V174, P107, DOI 10.1016/j.vetmic.2014.09.003; MARCHIOLI C, 1988, AM J VET RES, V49, P860; MORENKOV OS, 1994, VOP VIRUSOL+, V39, P174; MUKAMOTO M, 1991, VET MICROBIOL, V29, P109, DOI 10.1016/0378-1135(91)90119-Z; NAKAMURA T, 1993, VET MICROBIOL, V36, P83, DOI 10.1016/0378-1135(93)90130-Y; Ober BT, 2000, J VIROL, V74, P1752, DOI 10.1128/JVI.74.4.1752-1760.2000; PEETERS B, 1992, J VIROL, V66, P894; RAUH I, 1991, J VIROL, V65, P5348; REED L. J., 1938, AMER JOUR HYG, V27, P493; RIVIERE M, 1992, J VIROL, V66, P3424; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith GA, 1999, J VIROL, V73, P6405; Szpara ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002282; Tong G.Z., 1999, CHIN J VET SCI, V19, P2; Tong W., 2013, CHIN J ANIM INFECT D, V21, P1; Tong W, 2016, ANTIVIR RES, V130, P110, DOI 10.1016/j.antiviral.2016.03.002; Tong W, 2015, VET MICROBIOL, V181, P236, DOI 10.1016/j.vetmic.2015.09.021; van Rooij EMA, 2000, VET IMMUNOL IMMUNOP, V74, P121, DOI 10.1016/S0165-2427(00)00170-7; VANOIRSCHOT JT, 1987, RES VET SCI, V42, P12; WATHEN LMK, 1985, VIRUS RES, V4, P19, DOI 10.1016/0168-1702(85)90017-6; WHEALY ME, 1990, J VIROL, V64, P1946; WOLFER U, 1990, J VIROL, V64, P3122; Ye C, 2015, VIROLOGY, V483, P32, DOI 10.1016/j.virol.2015.04.013; Yoon HA, 2006, IMMUNOL CELL BIOL, V84, P502, DOI 10.1111/j.1440-1711.2006.01463.x; Yu XL, 2014, EMERG INFECT DIS, V20, P102, DOI 10.3201/eid2001.130531; Zaripov M. M., 2001, Voprosy Virusologii, V46, P41; Zaripov MM, 1999, J GEN VIROL, V80, P537, DOI 10.1099/0022-1317-80-3-537                                                      ; Zaripov MM, 1998, RES VIROLOGY, V149, P29, DOI 10.1016/S0923-2516(97)86898-7	42	0	0	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1135	1873-2542		VET MICROBIOL	Vet. Microbiol.	SEP	2017	208						97	105		10.1016/j.vetmic.2017.07.019				9	Microbiology; Veterinary Sciences	Microbiology; Veterinary Sciences	FJ3FN	WOS:000412616000016	28888658				2018-01-05	
J	Pineda, M; Moghadam, F; Ebrahimkhani, MR; Kiani, S				Pineda, Michael; Moghadam, Farzaneh; Ebrahimkhani, Mo R.; Kiani, Samira			Engineered CRISPR Systems for Next Generation Gene Therapies	ACS SYNTHETIC BIOLOGY			English	Review						gene therapy; controllable CRISPR; clustered regularly interspaced short palindromic repeats; safe CRISPR; CRISPR; Cas9; synthetic biology; gene editing; gene modulation; gRNA	DUCHENNE MUSCULAR-DYSTROPHY; HOMOLOGY-DIRECTED REPAIR; ONE-STEP GENERATION; RNA-GUIDED ENDONUCLEASE; IN-VIVO; HUMAN-CELLS; MAMMALIAN-CELLS; CAS9 NUCLEASE; MOUSE MODEL; TARGETED INTEGRATION	An ideal in vivo gene therapy platform provides safe, reprogrammable, and precise strategies which modulate cell and tissue gene regulatory networks with a high temporal and spatial resolution. Clustered regularly interspaced short palindromic repeats (CRISPR), a bacterial adoptive immune system, and its CRISPR-associated protein 9 (Cas9), have gained attention for the ability to target and modify DNA sequences on demand with unprecedented flexibility and precision. The precision and programmability of Cas9 is derived from its complexation with a guide-RNA (gRNA) that is complementary to a desired genomic sequence. CRISPR systems open-up widespread applications including genetic disease modeling, functional screens, and synthetic gene regulation. The plausibility of in vivo genetic engineering using CRISPR has garnered significant traction as a next generation in vivo therapeutic. However, there are hurdles that need to be addressed before CRISPR-based strategies are fully implemented. Some key issues center on the controllability of the CRISPR platform, including minimizing genomic-off target effects and maximizing in vivo gene editing efficiency, in vivo cellular delivery, and spatial-temporal regulation. The modifiable components of CRISPR systems: Cas9 protein, gRNA, delivery platform, and the form of CRISPR system delivered (DNA, RNA, or ribonucleoprotein) have recently been engineered independently to design a better genome engineering toolbox. This review focuses on evaluating CRISPR potential as a next generation in vivo gene therapy platform and discusses bioengineering advancements that can address challenges associated with clinical translation of this emerging technology.	[Pineda, Michael; Moghadam, Farzaneh; Ebrahimkhani, Mo R.; Kiani, Samira] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA; [Ebrahimkhani, Mo R.] Mayo Clin, Ctr Regenerat Med, Phoenix, AZ 85054 USA	Kiani, S (reprint author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	samira.kiani@asu.edu			 [D16AP00047-DARPA]	Authors would like to thank Garret G. Gosse for his input on the initial version of manuscript. This work was supported by D16AP00047-DARPA Young Faculty Award.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Agne M, 2014, ACS SYNTH BIOL, V3, P986, DOI 10.1021/sb500035y; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Bisht K, 2017, ANAL BIOCHEM, V530, P40, DOI 10.1016/j.ab.2017.05.001; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Braun CJ, 2016, P NATL ACAD SCI USA, V113, pE3892, DOI 10.1073/pnas.1600582113; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Cao Jian, 2016, Nucleic Acids Res, V44, pe149; Chavez A, 2016, NAT METHODS, V13, P563, DOI [10.1038/nmeth.3871, 10.1038/NMETH.3871]; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cyranoski D, 2015, NATURE, V519, P272, DOI 10.1038/519272a; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; de Solis CA, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00070; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Didovyk A, 2016, CURR OPIN BIOTECH, V40, P177, DOI 10.1016/j.copbio.2016.06.003; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gao YC, 2016, NAT METHODS, V13, P1043, DOI [10.1038/NMETH.4042, 10.1038/nmeth.4042]; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gimenez CA, 2016, GENE THER, V23, P543, DOI 10.1038/gt.2016.28; Gomez EJ, 2016, ACS NANO, V10, P225, DOI 10.1021/acsnano.5b05558; Guan YT, 2016, EMBO MOL MED, V8, P477, DOI 10.15252/emmm.201506039; Guo JY, 2017, PROTEIN CELL, V8, P379, DOI 10.1007/s13238-016-0360-8; Gutschner T, 2016, CELL REP, V14, P1555, DOI 10.1016/j.celrep.2016.01.019; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hemphill J, 2015, J AM CHEM SOC, V137, P5642, DOI 10.1021/ja512664v; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kalebic N, 2016, EMBO REP, V17, P338, DOI 10.15252/embr.201541715; Kaminski R, 2016, GENE THER, V23, P690, DOI 10.1038/gt.2016.41; Kapahnke M, 2016, CELLS, V5, P45; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/NMETH.2969, 10.1038/nmeth.2969]; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim HK, 2017, NAT METHODS, V14, P153, DOI [10.1038/NMETH.4104, 10.1038/nmeth.4104]; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lundstrom K, 2015, VIRUSES-BASEL, V7, P2321, DOI 10.3390/v7052321; Maji B, 2017, NAT CHEM BIOL, V13, P9, DOI 10.1038/nchembio.2224; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; McDonald JI, 2016, BIOL OPEN, V5, P866, DOI 10.1242/bio.019067; Mekler V, 2016, NUCLEIC ACIDS RES, V44, P2837, DOI 10.1093/nar/gkw138; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murlidharan G, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.49; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27857; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Nielsen AA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145735; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Nowak CM, 2016, NUCLEIC ACIDS RES, V44, P9555, DOI 10.1093/nar/gkw908; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Paglialunga L, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2015-000022; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Ruan GX, 2017, MOL THER, V25, P331, DOI 10.1016/j.ymthe.2016.12.006; Ruan JX, 2015, SCI REP, V5, P14253; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sim X., 2014, METHOD MOL BIOL, V1353, P13; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Toth E, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0147-0; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Wang X., 2016, SCI REP, V6, P20620; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Wei YD, 2016, MOL THER, V24, P1889, DOI 10.1038/mt.2016.192; Wright AV, 2015, P NATL ACAD SCI USA, V112, P2984, DOI 10.1073/pnas.1501698112; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Wyvekens N, 2015, HUM GENE THER, V26, P425, DOI 10.1089/hum.2015.084; Xu L, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1048; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Yu WH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14716; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	136	1	1	17	17	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	SEP	2017	6	9					1614	1626		10.1021/acssynbio.7b00011				13	Biochemical Research Methods	Biochemistry & Molecular Biology	FH6RY	WOS:000411305600002					2018-01-05	
J	Vogel, P; Hanswillemenke, A; Stafforste, T				Vogel, Paul; Hanswillemenke, Alfred; Stafforst, Thorsten			Switching Protein Localization by Site-Directed RNA Editing under Control of Light	ACS SYNTHETIC BIOLOGY			English	Article						RNA editing photocontrol; photocaging; protein localization; optogenetics; epitranscriptomics; gene regulation	MAMMALIAN-CELLS; TRANSLATION; DEAMINASES; TRANSCRIPTION; RECOMBINASE; INITIATION; MUTATIONS; TOOL	Site directed RNA editing is an engineered tool for the posttranscriptional manipulation of RNA and proteins. Here, we demonstrate the inclusion of additional N-and C-terminal protein domains in an RNA editing-dependent manner to switch between protein isoforms in mammalian cell culture. By inclusion of localization signals, a switch of the subcellular protein localization was achieved. This included the shift from the cytoplasm to the outer-membrane, which typically is inaccessible at the protein-level. Furthermore, the strategy allows to implement photocaging to achieve spatiotemporal control of isoform switching. The strategy does not require substantial genetic engineering, and might well complement current optogenetic and optochemical approaches.	[Vogel, Paul; Hanswillemenke, Alfred; Stafforst, Thorsten] Univ Tubingen, Interfac Inst Biochem, Morgenstelle 15, D-72076 Tubingen, Germany	Stafforste, T (reprint author), Univ Tubingen, Interfac Inst Biochem, Morgenstelle 15, D-72076 Tubingen, Germany.	thorsten.stafforst@uni-tuebingen.de			University of Tubingen; Deutsche Forschungsgemeinschaft [STA1053/3-2, STA1053/4-1, STA1053/7-1]; European Research Council (ERC) under the European Union's Horizon research and innovation program [647328]	We gratefully acknowledge support from the University of Tubingen and the Deutsche Forschungsgemeinschaft (STA1053/3-2; STA1053/4-1; STA1053/7-1). This work has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No 647328).	Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; Edwards WF, 2009, ACS CHEM BIOL, V4, P441, DOI 10.1021/cb900041s; Engelke H, 2014, ACS SYNTH BIOL, V3, P731, DOI 10.1021/sb400192a; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Hanswillemenke A, 2015, J AM CHEM SOC, V137, P15875, DOI 10.1021/jacs.5b10216; Inlay MA, 2013, CHEM COMMUN, V49, P4971, DOI 10.1039/c3cc42179a; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073                                                           ; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kuttan A, 2012, P NATL ACAD SCI USA, V109, pE3295, DOI 10.1073/pnas.1212548109; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Montiel-Gonzalez MF, 2013, P NATL ACAD SCI USA, V110, P18285, DOI 10.1073/pnas.1306243110; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Reid DW, 2015, NAT REV MOL CELL BIO, V16, P221, DOI 10.1038/nrm3958; Schneider MF, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku272; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stafforst T, 2012, ANGEW CHEM INT EDIT, V51, P11166, DOI 10.1002/anie.201206489; Van Der Kelen K, 2009, CRIT REV BIOCHEM MOL, V44, P143, DOI 10.1080/10409230902882090; Vogel P, 2014, CHEMMEDCHEM, V9, P2021, DOI 10.1002/cmdc.201402139; Vogel P, 2014, ANGEW CHEM INT EDIT, V53, P6267, DOI 10.1002/anie.201402634; Wettengel J, 2017, NUCLEIC ACIDS RES, V45, P2797, DOI 10.1093/nar/gkw911	29	0	0	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	SEP	2017	6	9					1642	1649		10.1021/acssynbio.7b00113				8	Biochemical Research Methods	Biochemistry & Molecular Biology	FH6RY	WOS:000411305600005	28562030	gold			2018-01-05	
J	Dalia, TN; Hayes, CA; Stolyar, S; Marx, CJ; McKinlay, JB; Dalia, AB				Dalia, Triana N.; Hayes, Chelsea A.; Stolyar, Sergey; Marx, Christopher J.; McKinlay, James B.; Dalia, Ankur B.			Multiplex Genome Editing by Natural Transformation (MuGENT) for Synthetic Biology in Vibrio natriegens	ACS SYNTHETIC BIOLOGY			English	Article							POLY-BETA-HYDROXYBUTYRATE; ESCHERICHIA-COLI; CHOLERAE; ENVIRONMENT; COMPETENCE; CLONING; HOST	Vibrio natriegens has recently emerged as an alternative to Escherichia coli for molecular biology and biotechnology, but low-efficiency genetic tools hamper its development. Here, we uncover how to induce natural competence in V. natriegens and describe methods for multiplex genome editing by natural transformation (Mu GENT). MuGENT promotes integration of multiple genome edits at high-efficiency on unprecedented time scales. Also, this method allows for generating highly complex mutant populations, which can be exploited for metabolic engineering efforts. As a proof-of-concept, we attempted to enhance production of the value added chemical poly-beta-hydroxybutyrate (PHB) in V. natriegens by targeting the expression of nine genes involved in PHB biosynthesis via MuGENT. Within 1 week, we isolated edited strains that produced similar to 100 times more PI-LB than the parent isolate and times more than a rationally designed strain. Thus, the methods described here should extend the utility of this species for diverse academic and industrial applications.	[Dalia, Triana N.; Hayes, Chelsea A.; McKinlay, James B.; Dalia, Ankur B.] Indiana Univ, Dept Biol, Bloomington, IN 47401 USA; [Stolyar, Sergey; Marx, Christopher J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	Dalia, AB (reprint author), Indiana Univ, Dept Biol, Bloomington, IN 47401 USA.	ankdalia@indiana.edu			US National Institutes of Health Grant [AI118863]; Indiana University College of Arts and Sciences	We would like to thank Tufts TUCF Genomics and the Indiana University CGB for assistance with whole genome sequencing of strains. This work was supported by US National Institutes of Health Grant AI118863 to ABD. JBM and ABD were also supported by the Indiana University College of Arts and Sciences.	Bik EM, 1996, MOL MICROBIOL, V20, P799, DOI 10.1111/j.1365-2958.1996.tb02518.x; Centeno-Leija S, 2014, ANTON LEEUW INT J G, V105, P687, DOI 10.1007/s10482-014-0124-5; Chen YS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-274; Chien CC, 2007, J BIOTECHNOL, V132, P259, DOI 10.1016/jjbiotee.2007.03.002; Csorgo B, 2016, CURR OPIN MICROBIOL, V33, P113, DOI 10.1016/j.mib.2016.07.005; Dalia AB, 2014, P NATL ACAD SCI USA, V111, P8937, DOI 10.1073/pnas.1406478111; Dalia AB, 2014, MBIO, V5, DOI 10.1128/mBio.01028-13; Dalia AB, 2013, J BACTERIOL, V195, P2389, DOI 10.1128/JB.02112-12; EAGON RG, 1962, J BACTERIOL, V83, P736; ERICKSON RJ, 1973, GENETICS, V73, P13; Gulig PA, 2009, APPL ENVIRON MICROB, V75, P4936, DOI 10.1128/AEM.02564-08; Hayes CA, 2017, MOL MICROBIOL, V104, P568, DOI 10.1111/mmi.13646; KARR DB, 1983, APPL ENVIRON MICROB, V46, P1339; KIDWELL J, 1995, APPL ENVIRON MICROB, V61, P1391; Lazinski DW, 2013, BIOTECHNIQUES, V54, P25, DOI 10.2144/000113981; Lee HH, 2016, BIORXIV, DOI [10.1101/058487, DOI 10.1101/058487]; LORENZ MG, 1994, MICROBIOL REV, V58, P563; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Mercaldi MP, 2008, BIOMACROMOLECULES, V9, P1988, DOI 10.1021/bm800239p; PAYNE WJ, 1961, ANTON VAN LEE J M S, V27, P121, DOI 10.1007/BF02538432; Pollack-Berti A, 2010, ENVIRON MICROBIOL, V12, P2302, DOI 10.1111/j.1462-2920.2010.02250.x; Seed KD, 2014, ELIFE, V3, DOI 10.7554/eLife.03497; Spiekermann P, 1999, ARCH MICROBIOL, V171, P73, DOI 10.1007/s002030050681; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Weinstock MT, 2016, NAT METHODS, V13, P849, DOI 10.1038/nmeth.3970; Yamamoto S, 2014, MOL MICROBIOL, V91, P326, DOI 10.1111/mmi.12462	26	0	0	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-5063			ACS SYNTH BIOL	ACS Synth. Biol.	SEP	2017	6	9					1650	1655		10.1021/acssynbio.7b00116				6	Biochemical Research Methods	Biochemistry & Molecular Biology	FH6RY	WOS:000411305600006	28571309				2018-01-05	
J	Zhao, D; Xu, YZ; Li, JT; Fu, SE; Xiao, FF; Song, XW; Xie, ZB; Jiang, M; He, Y; Liu, CW; Wen, QX; Yang, XL				Zhao, Dong; Xu, Yanzhen; Li, Jiatong; Fu, Shien; Xiao, Feifan; Song, Xiaowei; Xie, Zhibin; Jiang, Min; He, Yan; Liu, Chengwu; Wen, Qiongxian; Yang, Xiaoli			Association between F508 deletion in CFTR and chronic pancreatitis risk	DIGESTIVE AND LIVER DISEASE			English	Review						CFTR; Chronic pancreatitis; F508 deletion; Idiopathic chronic pancreatitis; Meta-analysis	IDIOPATHIC CHRONIC-PANCREATITIS; GENOTYPE-PHENOTYPE CORRELATION; GENE-MUTATIONS; VARIANTS; SPINK1; DIAGNOSIS; CTRC; METAANALYSIS; RECURRENT; SPECTRUM	Background: The cystic fibrosis transmembrane conductance regulator (CFTR) has been reported to influence individual susceptibility to chronic pancreatitis (CP), but the results of previous studies are controversial. Aims: We performed a study to demonstrate the relationship between CFTR and CP. Methods: We searched PubMed, Scopus, and Embase for studies of patients with CP. Seven studies from 1995 to 2016 were identified, and included 64,832 patients. Pooled prevalence and 95% confidence intervals (CIs) were calculated. Results: F508 deletion in CFTR was significantly positively associated with CP risk in the overall analysis (odds ratio [OR] = 3.20, 95% CI: 2.30-4.44, I-2 = 31.7%). In subgroup analysis stratified by ethnicity, F508 deletion was significantly associated with CP risk in Indian populations, using a fixed effects model (ORs = 5.45, 95% CI: 2.52-11.79, I-2 = 0.0%), and in non-Indian populations, using a random effects model (ORs = 3.59, 95% CI: 1.73-7.48, I-2 = 60.9%). At the same time, we found that Indians with F508 deletion had much higher CP prevalence than non-Indians. Interestingly, F508 deletion was also associated with CP and idiopathic CP risk in subgroup analysis stratified by aeitiology, using the fixed effects model. Conclusions: Based on current evidence, F508 deletion is a risk factor for CP, and Indians with F508 deletion have much higher CP morbidity. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.	[Zhao, Dong; Xu, Yanzhen; Li, Jiatong; Fu, Shien; Xiao, Feifan; Song, Xiaowei; Xie, Zhibin; Jiang, Min; Yang, Xiaoli] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi, Peoples R China; [Xu, Yanzhen; Li, Jiatong; Liu, Chengwu] Guangxi Med Univ, Dept Pathophysiol, Nanning, Guangxi, Peoples R China; [Song, Xiaowei] Guangxi Med Univ, Affiliated Hosp 1, Dept Gastrointestinal & Gland Surg, Nanning, Guangxi, Peoples R China; [Xie, Zhibin] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol, Nanning, Guangxi, Peoples R China; [He, Yan] Guangxi Med Univ, Affiliated Hosp 1, Dept Geriatr Cardiol, Nanning, Guangxi, Peoples R China; [Wen, Qiongxian] Guilin Med Univ, Affiliated Hosp 2, Sch Nursing, Guilin, Guangxi, Peoples R China	Yang, XL (reprint author), Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi, Peoples R China.	cncsyxl@126.com			National Natural Science Foundations of China [21505025, 81560130]; Guangxi Nature Science Foundation [2016GXNSFDA380010]; Guangxi medical and healthcare technology research and development project [S201303_06]	This work was supported by the National Natural Science Foundations of China (Grant numbers: 21505025, 81560130), Guangxi Nature Science Foundation (Grant number: 2016GXNSFDA380010) and Guangxi medical and healthcare technology research and development project (Grant number: S201303_06).	Bernardino Andrea L Ferreira, 2003, JOP, V4, P169; Capurso G, 2016, UNITED EUR GASTROENT, V4, P697, DOI 10.1177/2050640616630117; Chang MC, 2007, CLIN GENET, V71, P530, DOI 10.1111/j.1399-0004.2007.00813.x; Cho SM, 2016, ANN LAB MED, V36, P555, DOI 10.3343/alm.2016.36.6.555; de Cid R, 2010, PANCREAS, V39, P209, DOI 10.1097/MPA.0b013e3181bab679; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Fujiki K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014456; Garg Pramod Kumar, 2012, Curr Gastroenterol Rep, V14, P118, DOI 10.1007/s11894-012-0241-0; Garg PK, 2009, J CLIN GASTROENTEROL, V43, P848, DOI 10.1097/MCG.0b013e3181a4e772; Gelrud A, 2004, AM J GASTROENTEROL, V99, P1557, DOI 10.1111/j.1572-0241.2004.30834.x; Giri AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147345; Gurusamy KS, 2016, COCHRANE DB SYST REV, V2; Hu CH, 2017, ONCOTARGET, V8, P30888, DOI 10.18632/oncotarget.15737; Issa Y, 2014, NAT REV GASTRO HEPAT, V11, P556, DOI 10.1038/nrgastro.2014.74; Jawad ZA, HPB, V18, P121; Kleeff J, 2016, DTSCH ARZTEBL INT, V113, P489, DOI 10.3238/arztebl.2016.0489; Kondo S, 2015, AM J PHYSIOL-GASTR L, V309, pG260, DOI 10.1152/ajpgi.00015.2014; Lan A, ONCOTARGET, V8, P41487; Mantovani V, 2007, CLIN CHEM, V53, P531, DOI 10.1373/clinchem.2006.074807; Martinez B, 2014, J HUM GENET, V59, P206, DOI 10.1038/jhg.2014.2; Midha S, 2010, GUT, V59, P800, DOI 10.1136/gut.2009.191239; Muthuswamy S, 2014, GENE, V539, P125, DOI 10.1016/j.gene.2014.01.022; Niederberger C, 2015, J UROLOGY, V193, P1607, DOI 10.1016/j.juro.2015.02.033; Nishima S, 1989, Arerugi, V38, P1295; Palermo JJ, 2016, PANCREAS, V45, P1347, DOI 10.1097/MPA.0000000000000655; RAJAKUMAR R, 1987, GENITOURIN MED, V63, P192; Rosendahl J, 2013, GUT, V62, P582, DOI [10.1136/gutjnl-2012-303192, 10.1136/gutjnl-2011-300645]; Schneider A, 2011, GASTROENTEROLOGY, V140, P162, DOI 10.1053/j.gastro.2010.10.045; Singh S, 2014, SCI WORLD J, DOI 10.1155/2014/763195; Sofia VM, 2016, MOL MED, V22, P300, DOI 10.2119/molmed.2016.00010; Terlizzi V, 2017, J MED GENET, V54, P224, DOI 10.1136/jmedgenet-2016-103985; Tomaiuolo AC, 2015, J MOL DIAGN, V17, P171, DOI 10.1016/j.jmoldx.2014.11.007; Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462; Wang W, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003150; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Xiao F, 2017, ONCOTARGET; Zoller H, 2007, WIEN KLIN WOCHENSCHR, V119, P527, DOI 10.1007/s00508-007-0849-5	37	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	SEP	2017	49	9					967	972		10.1016/j.dld.2017.06.013				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	FH0MK	WOS:000410834400003	28780053				2018-01-05	
J	Macias, VM; Ohm, JR; Rasgon, JL				Macias, Vanessa M.; Ohm, Johanna R.; Rasgon, Jason L.			Gene Drive for Mosquito Control: Where Did It Come from and Where Are We Headed?	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Review						CRISPR/Cas9; gene editing; vector control	YELLOW-FEVER MOSQUITO; INDUCED CYTOPLASMIC INCOMPATIBILITY; PLASMODIUM-FALCIPARUM DEVELOPMENT; DROSOPHILA GENOME PROJECT; POST-INTEGRATION BEHAVIOR; VECTOR ANOPHELES-GAMBIAE; MUTAGENIC CHAIN-REACTION; STERILE INSECT TECHNIQUE; TAL EFFECTOR NUCLEASES; P-ELEMENT INSERTIONS	Mosquito-borne pathogens place an enormous burden on human health. The existing toolkit is insufficient to support ongoing vector-control efforts towards meeting disease elimination and eradication goals. The perspective that genetic approaches can potentially add a significant set of tools toward mosquito control is not new, but the recent improvements in site-specific gene editing with CRISPR/Cas9 systems have enhanced our ability to both study mosquito biology using reverse genetics and produce genetics-based tools. Cas9-mediated gene-editing is an efficient and adaptable platform for gene drive strategies, which have advantages over innundative release strategies for introgressing desirable suppression and pathogen-blocking genotypes into wild mosquito populations; until recently, an effective gene drive has been largely out of reach. Many considerations will inform the effective use of new genetic tools, including gene drives. Here we review the lengthy history of genetic advances in mosquito biology and discuss both the impact of efficient site-specific gene editing on vector biology and the resulting potential to deploy new genetic tools for the abatement of mosquito-borne disease.	[Macias, Vanessa M.; Rasgon, Jason L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Ohm, Johanna R.; Rasgon, Jason L.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Macias, VM (reprint author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	vzm10@psu.edu; jo.ohm@psu.edu; jlr54@psu.edu			USDA NIFA [2017-67012-26101]; USDA [2014-10320]; NIH [R01AI128201, R01AI116636]; NSF [1645331]; Bill and Melinda Gates Grand Challenges [OP 1140117]	We acknowledge the manifold authors that have contributed work to this field over the last century or so and apologize for any omission of specific credit on our part. We thank Daryl Branford for assistance with Figure 1. Funding: USDA NIFA fellowship 2017-67012-26101, USDA grant 2014-10320, NIH grants R01AI128201 and R01AI116636, and NSF grant 1645331, Bill and Melinda Gates Grand Challenges Grant OP 1140117.	Adelman ZN, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P1; Adelman ZN, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P139; Afrane Y.A., 2016, CURR TOP MALAR; Ageep T.B., 2014, MALAR J, V13; Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742; Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059; Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Arca B, 1997, GENETICS, V145, P267; Arensburger P, 2005, GENETICS, V169, P697, DOI 10.1534/genetics.104.036145; Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082; Aryan A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01603; Ashworth J., 2006, NATURE; Ashworth J., 2010, NUCL ACIDS RES; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Awata H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15885; Barreaux P., 2017, TRENDS PARASITOL; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Beaty B.J., 2009, PLOS NEGL TROP DIS, V3; Beeman R., 1992, SCIENCE, V256; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Belfort Marlene, 2002, P761; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Benelli Giovanni, 2016, Insects, V7, DOI 10.3390/insects7040052; Bernardini F, 2014, P NATL ACAD SCI USA, V111, P7600, DOI 10.1073/pnas.1404996111; Bhatt S., 2015, NATURE; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boivin A, 2003, GENETICS, V164, P195; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2006, GENES CONFLICT BIOL; Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; Carson R., 1962, SILENT SPRING; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Champer J, 2017, BIORXIV; Chang HT, 2017, CURR BIOL, V27, P1610, DOI 10.1016/j.cub.2017.04.035; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595; Chen Lei, 2016, [Zoological Research, 动物学研究], V37, P220, DOI 10.13918/j.issn.2095-8137.2016.4.220; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748                                                          ; Coen D, 1970, Symp. Soc. exp. Biol., V24, P449; COLLINS FH, 1995, ANNU REV ENTOMOL, V40, P195, DOI 10.1146/annurev.ento.40.1.195; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Collins F. H., 1996, SCI MED, V3, P52; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001003; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; CURTIS CF, 1985, BIOL J LINN SOC, V26, P359, DOI 10.1111/j.1095-8312.1985.tb02047.x; CURTIS CF, 1976, B WORLD HEALTH ORGAN, V53, P107; CURTIS CF, 1974, B WORLD HEALTH ORGAN, V51, P249; CURTIS CF, 1988, J TROP MED HYG, V91, P43; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; Davis S, 2001, J THEOR BIOL, V212, P83, DOI 10.1006/jtbi.2001.2357; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Eckhoff PA, 2017, P NATL ACAD SCI USA, V114, pE255, DOI 10.1073/pnas.1611064114; Engels WR, 1997, GENETICS, V145, P11; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fenn K., 2006, PLOS PATHOG; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; FITZEARLE M, 1973, GENETICS, V74, P461; Fitzpatrick B., 1986, GENET RES; Foster J., 2005, PLOS BIOL; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869                                                            ; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Ghosh AK, 2011, P NATL ACAD SCI USA, V108, P17153, DOI 10.1073/pnas.1103657108; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Grassi G.B, RAPPORTI TRA MALARIA; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; GRAVES PM, 1982, J MED ENTOMOL, V19, P127, DOI 10.1093/jmedent/19.2.127                                                        ; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Grubaugh ND, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003628; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452                                                    ; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hammond A., 2015, NAT BIOTECHNOL; Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; Hauck ES, 2013, MICROBES INFECT, V15, P775, DOI 10.1016/j.micinf.2013.05.006; Heinze Svenia D, 2017, Sci Rep, V7, P4582, DOI 10.1038/s41598-017-04686-6; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hotopp J.C.D, 2011, TRENDS GENET; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hsu P., 2013, NATURE; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987                                                ; Ishizu H, 2015, CELL REP, V12, P429, DOI 10.1016/j.celrep.2015.06.035; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Iyer V., 2015, NAT METHODS; James AA, 2000, INSECT TRANSGENESIS, P319, DOI 10.1201/9781420039399.ch18; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; JAMES AA, 1989, GENE, V75, P73, DOI 10.1016/0378-1119(89)90384-3; Jarjour J., 2009, NUCL ACIDS RES; Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084; Kawaoka S, 2012, RNA, V18, P265, DOI 10.1261/rna.029777.111; Kidwell M., 1992, PARASITOL TODAY; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Klasson L., 2009, BMC GENOM; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; KNIPLING EF, 1968, B WORLD HEALTH ORGAN, V38, P421; Knipling E. F., 1955, J ECON ENTOMOL, V48, P902; Kohno H, 2016, ZOOL SCI, V33, P505, DOI 10.2108/zs160043; Kondo N., 2002, P NATL ACAD SCI US; Kouri G, 1986, Bull Pan Am Health Organ, V20, P24; Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607; Krishnamurthy B.S., 1962, INDIAN J MALARIOL, V4, P365; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Labbe GMC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001724; Labbe GMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000788; Lambrechts L, 2008, TRENDS PARASITOL, V24, P4, DOI 10.1016/j.pt.2007.09.009; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391; Le Thomas A., 2014, GENES, V28, P1167; Li M., 2017, BIORXIV; Li Y, 2016, INSECT BIOCHEM MOLEC, V79, P27, DOI 10.1016/j.ibmb.2016.10.003; Liesch J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002486; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525                                                         ; Luckhart S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003180; Lyman RF, 1996, GENETICS, V143, P277; MACDONALD G, 1957, EPIDEMIOLOGY CONTROL; Macias V., 2014, INSECT MOL BIOL; Macias V.M., 2017, INSECT BIOCH MOL BIO; Mackay T, 1986, GENET RES; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manson P., 1897, British Medical Journal, Vii, P1786; Manson P., 1878, J LINN SOC ZOOL, V14, P304, DOI DOI 10.1111/J.1096-3642.1878.TB01837.X; Marinotti O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-142; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Marshall JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02744-7; Marshall JM, 2009, J THEOR BIOL, V258, P250, DOI 10.1016/j.jtbi.2009.01.031; Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x; McClintock B, 1987, DISCOVERY CHARACTERI; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; McNaughton D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001785; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; MEREDITH SEO, 1990, ANN PARASIT HUM COMP, V65, P113, DOI 10.1051/parasite/1990651113                                                     ; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; MILLER LH, 1987, SCIENCE, V237, P779, DOI 10.1126/science.3039658; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; MORLAN HARVEY B., 1962, MOSQUITO NEWS, V22, P295; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mukundarajan H., 2017, BIORXIV; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; Munhenga G., 2014, MALAR J, V13; Nakajima K., 2016, SCI REP; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; *NIOSH, DHHS NIOSH PUBL; Noble C, 2016, BIORXIV; Noble C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601964; Nolan T., 2002, J BIOL; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Oliveros JC, 2016, NUCLEIC ACIDS RES, V44, pW267, DOI 10.1093/nar/gkw407; Olovnikov I., 2013, NUCLEIC ACIDS RES, P1; Olson KE, 2002, INSECT BIOCHEM MOLEC, V32, P1333, DOI 10.1016/S0965-1748(02)00096-6; Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066; Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; PATTERSON RS, 1970, SCIENCE, V168, P1368, DOI 10.1126/science.168.3937.1368                                                   ; Perera OP, 2002, INSECT MOL BIOL, V11, P291, DOI 10.1046/j.1365-2583.2002.00336.x; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Pigott D.M., 2014, ENHANCING INFECT DIS; Pike A, 2014, INSECT BIOCHEM MOLEC, V52, P82, DOI 10.1016/j.ibmb.2014.06.005; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Puggioli A, 2016, ACTA TROP, V164, P473, DOI 10.1016/j.actatropica.2016.10.014; Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Rasgon JL, 2005, INSECT MOL BIOL, V14, P493, DOI 10.1111/j.1365-2583.2005.00580.x; Rasgon JL, 2004, J MED ENTOMOL, V41, P385, DOI 10.1603/0022-2585-41.3.385; Reed W, 1901, J AMER MED ASSOC, V36, P431; Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Riehle MM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-87; Robert MA, 2014, EVOL APPL, V7, P1238, DOI 10.1111/eva.12219; RODICIO MR, 1982, J BACTERIOL, V151, P1078; Rodrigues F., 2006, MEM I O CRUZ; Roman J, 1998, P NATL ACAD SCI USA, V95, P2134, DOI 10.1073/pnas.95.5.2134; RONSSERAY S, 1991, GENETICS, V129, P501; Scali C, 2007, MOL GENET GENOMICS, V278, P575, DOI 10.1007/s00438-007-0274-5; Schaefer K.A., 2016, NAT METHODS; Sebo ZL, 2014, FLY, V8, P52, DOI 10.4161/fly.26828; Sellem CH, 1997, MOL BIOL EVOL, V14, P518, DOI 10.1093/oxfordjournals.molbev.a025788                                           ; Serebrovskii A.S., 1940, ZOOL ZH, V19, P618; Service Mike W., 2002, P59; Sethuraman N, 2007, INSECT BIOCHEM MOLEC, V37, P941, DOI 10.1016/j.ibmb.2007.05.004; Shenoy RK, 2009, ANN TROP MED PARASIT, V103, P235, DOI 10.1179/136485909X398249; Shpiz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004138; Sinkins SP, 1997, INFLUENTIAL PASSENGERS, P155; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smidler AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074511; Smith RC, 2015, P NATL ACAD SCI USA, V112, pE3412, DOI 10.1073/pnas.1420078112; Smith RC, 2011, GENETICA, V139, P7, DOI 10.1007/s10709-010-9459-7; SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7                                                             ; SOPER FL, 1943, ANOPHELES GAMBIAE BR; SPIELMAN A, 1993, J MED ENTOMOL, V30, P6, DOI 10.1093/jmedent/30.1.6                                                          ; SPIELMAN A, 1994, PARASITOL TODAY, V10, P374, DOI 10.1016/0169-4758(94)90223-2                                                    ; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435                                                         ; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Takeuchi R, 2014, P NATL ACAD SCI USA, V111, P4061, DOI 10.1073/pnas.1321030111; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Thomas MB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001262; Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x; Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285; Unckless RL, 2015, GENETICS, V201, P425, DOI 10.1534/genetics.115.177592; Vanderplank F. L., 1947, Transactions of the Royal Entomological Society of London, V98, P1; VANDERPLANK FL, 1948, ANN TROP MED PARASIT, V42, P131, DOI 10.1080/00034983.1948.11685357                                                  ; Vanderplank FL, 1944, NATURE, V154, P607, DOI 10.1038/154607a0                                                                ; WADE MJ, 1994, GENETICS, V138, P1309; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Warren A., 1990, MOL INSECT SCI, P339; WEIDHAAS DONALD E., 1962, MOSQUITO NEWS, V22, P283; Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; WHO Scientific Group on the Genetics of Vectors and Insecticide Resistance, WHO TECHN REP SER, V268; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wilson R, 2003, INSECT BIOCHEM MOLEC, V33, P853, DOI 10.1016/S0965-1748(03)00044-4; Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; WOOD RJ, 1978, J MED ENTOMOL, V14, P461; Wu B, 2016, NAT BIOTECHNOL, V34, P137, DOI 10.1038/nbt.3444; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yan WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15058; Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894; YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Yoshioka S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18341; Yu R, 2006, TOXICOL SCI, V93, P82, DOI 10.1093/toxsci/kfl047; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; [Anonymous], 2014, WHO GLOBAL PROGRAMME	274	0	0	22	22	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	SEP	2017	14	9							1006	10.3390/ijerph14091006				30	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	FH9YO	WOS:000411574400058		gold			2018-01-05	
J	Mayor-Ruiz, C; Dominguez, O; Fernandez-Capetillo, O				Mayor-Ruiz, Cristina; Dominguez, Orlando; Fernandez-Capetillo, Oscar			Trap (seq): An RNA Sequencing-Based Pipeline for the Identification of Gene-Trap Insertions in Mammalian Cells	JOURNAL OF MOLECULAR BIOLOGY			English	Article						Gene trap; piggyBac transposon; RNAseq; haploid mammalian cells; genetic screenings	EMBRYONIC STEM-CELLS; DNA-DAMAGE; ATR INHIBITORS; GENOME-WIDE; PIGGYBAC TRANSPOSON; HOST FACTORS; ES CELLS; SCREENS; CRISPR; DIFFERENTIATION	The development of haploid mammalian cell lines, coupled to next-generation sequencing, has recently facilitated forward genetic screenings in mammals. For mutagenesis, retrovirus- or transposon-based gene traps are frequently used. Current methods to map gene-trap insertions are based on inverse or splinkerette PCR, which despite their efficacy are prone to artifacts and do not provide information on expression of the targeted gene. Here, we describe a new RNA sequencing-based method (Trap(seq)) to map gene-trap insertions. By recognizing chimeric mRNAs containing gene-trap sequences spliced to an exon, our method identifies insertions that lead to productive trapping. When applied to individual mutant clones, our method provides a fast and cost-effective way that not only identifies the insertion site but also reveals its impact on the expression of the trapped gene. As proof of principle, we conducted two independent screenings for resistance against 6-thioguanine and an ATR inhibitor, which identified mutations known to provide resistance to these reagents and revealed ECT2 as a novel determinant for the sensitivity to ATR inhibition. (C) 2017 Elsevier Ltd. All rights reserved.	[Mayor-Ruiz, Cristina; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr, Genom Instabil Grp, Madrid 28029, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr, Genom Unit, Madrid 28029, Spain; [Fernandez-Capetillo, Oscar] Karolinska Inst, Div Genome Biol, Dept Med Biochem & Biophys, Sci Life Lab, S-17121 Stockholm, Sweden	Fernandez-Capetillo, O (reprint author), Spanish Natl Canc Res Ctr, Genom Instabil Grp, Madrid 28029, Spain.	ofernandez@cnio.es			Spanish Ministry of Economy and Competitivenes [SAF2014-59498-R, SAF2014-57791-REDC]; Fundacion Botin, Banco Santander, through its Santander Universities Global Division; Fundacio La Marato de TV3; Howard Hughes Medical Institute; European Research Council [ERC-617840]; La Caixa Foundation	The authors would like to thank the Flow Cytometry Unit of the CNIO for their help in work with human HAP1 cells, Sergio Ruiz for his help with the plasmids to generate the HAP1 <SUP>Cas9</SUP> line, and Jose Maria Fernandez from the Spanish National Bioinformatics Institute for his advice. Research was funded by Fundacion Botin, Banco Santander, through its Santander Universities Global Division; by grants from the Spanish Ministry of Economy and Competitivenes (SAF2014-59498-R, SAF2014-57791-REDC), Fundacio La Marato de TV3, Howard Hughes Medical Institute, and the European Research Council (ERC-617840) to O.F.; and by a PhD fellowship from La Caixa Foundation to C.M.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cottini F, 2015, CANCER DISCOV, V5, P972, DOI 10.1158/2159-8290.CD-14-0943; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Flynn RL, 2015, SCIENCE, V347, P273, DOI 10.1126/science.1257216; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46                                                     ; He D, 2016, SCI REP-UK, V6, DOI 10.1038/srep24504; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Krajewska M, 2015, ONCOGENE, V34, P3474, DOI 10.1038/onc.2014.276; Kwok M, 2016, BLOOD, V127, P582, DOI 10.1182/blood-2015-05-644872; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MA, 2010, METHOD ENZYMOL, V477, P217, DOI 10.1016/S0076-6879(10)77012-9; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Morgado-Palacin I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8243; Nieto-Soler M, 2016, ONCOTARGET, V7, P58759, DOI 10.18632/oncotarget.11643; OCHMAN H, 1988, GENETICS, V120, P621; Otto SP, 2001, SCIENCE, V292, P2441, DOI 10.1126/science.1062890; Pettitt SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061520; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ruiz S, 2016, MOL CELL, V62, P307, DOI 10.1016/j.molcel.2016.03.006; Sagi I, 2016, NATURE, V532, P107, DOI 10.1038/nature17408; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921                                                           ; Timms RT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11786; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2009, GENOME RES, V19, P667, DOI 10.1101/gr.085621.108; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	43	0	0	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2836	1089-8638		J MOL BIOL	J. Mol. Biol.	SEP 1	2017	429	18					2780	2789		10.1016/j.jmb.2017.07.020				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FH9LL	WOS:000411532900006	28782559				2018-01-05	
J	Kajiura, K; Takizawa, H; Morimoto, Y; Masuda, K; Tsuboi, M; Kishibuchi, R; Wusiman, N; Sawada, T; Kawakita, N; Toba, H; Yoshida, M; Kawakami, Y; Naruto, T; Imoto, I; Tangoku, A; Kondo, K				Kajiura, Koichiro; Takizawa, Hiromitsu; Morimoto, Yuki; Masuda, Kiyoshi; Tsuboi, Mitsuhiro; Kishibuchi, Reina; Wusiman, Nuliamina; Sawada, Toru; Kawakita, Naoya; Toba, Hiroaki; Yoshida, Mitsuteru; Kawakami, Yukikiyo; Naruto, Takuya; Imoto, Issei; Tangoku, Akira; Kondo, Kazuya			Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours	LUNG CANCER			English	Article						RASSFIA; Thymic neuroendocrine tumour; DNA methylation	FORTHCOMING 8TH EDITION; STAGING PROJECT PROPOSALS; CELL LUNG CANCERS; EPITHELIAL TUMORS; TNM CLASSIFICATION; MALIGNANT-TUMORS; METASTASIS; SUPPRESSOR; ASSOCIATION; CARCINOMAS	Objectives: Aberrant methylation of promoter CpG islands (CGIs) of tumour suppressor genes is a common epigenetic mechanism underlying cancer pathogenesis. The methylation patterns of thymic tumours have not been studied in detail since such tumours are rare. Herein, we sought to identify genes that could serve as epigenetic targets for thymic neuroendocrine tumour (NET) therapy. Materials and methods: Genome-wide screening for aberrantly methylated CGIs was performed in three NET samples, seven thymic carcinoma (TC) samples, and eight type-B3 thymoma samples. The methylation status of thymic epithelial tumours (TETs) samples was validated by pyrosequencing in a larger cohort. The expression status was analysed by quantitative polymerase chain reaction (PCR) and immunohistochemistry. Results: We identified a CGI on a novel gene, RASSFIA, which was strongly hypermethylated in NET, but not in thymic carcinoma or B3 thymoma. RASSFIA was identified as a candidate gene statistically and bibliographically, as it showed frequent CGI hypermethylation in NET by genome-wide screening. Pyrosequencing confirmed significant hypermethylation of a RASSFIA CGI in NET. Low-grade NET tissue was more strongly methylated than high-grade NET. Quantitative PCR and immunohistochemical staining revealed that RASSF1A mRNA and protein expression levels were negatively regulated by DNA methylation. Conclusions: RASSFIA is a tumour suppressor gene epigenetically dysregulated in NET. Aberrant methylation of RASSF1A has been reported in various tumours, but this is the first report of RASSFIA hypermethylation in TETs. RASSF1A may represent an epigenetic therapeutic target in thymic NET.	[Kajiura, Koichiro; Takizawa, Hiromitsu; Tsuboi, Mitsuhiro; Sawada, Toru; Kawakita, Naoya; Toba, Hiroaki; Yoshida, Mitsuteru; Kawakami, Yukikiyo; Tangoku, Akira] Tokushima Univ, Grad Sch, Grad Sch Biomed Sci, Dept Thorac Endocrine & Ontol Surg, Tokushima 7708503, Japan; [Morimoto, Yuki; Kishibuchi, Reina; Wusiman, Nuliamina; Kondo, Kazuya] Tokushima Univ, Grad Sch, Grad Sch Biomed Sci, Dept Ontol Med Serv, Tokushima 7708503, Japan; [Kajiura, Koichiro; Masuda, Kiyoshi; Naruto, Takuya; Imoto, Issei] Tokushima Univ, Grad Sch, Grad Sch Biomed Sci, Dept Human Genet, Tokushima 7708503, Japan	Takizawa, H (reprint author), Tokushima Univ, Grad Sch, Grad Sch Biomed Sci, Dept Thorac Endocrine & Ontol Surg, Tokushima 7708503, Japan.	kkajiura7@ybb.ne.jp; h-takizawa@mbf.ocn.ne.jp; morimoto.yuuki@tokushima-u.ac.jp; kiyoshim@tokushima-u.ac.jp; tsuboi.mitsuhiro@tokushima-u.ac.jp; x6911xlth1@gmail.com; uyghur.amina@gmail.com; sawada.tooru@tokushima-u.ac.jp; kawakita.naoya@tokushima-u.ac.jp; ht1109@tokushima-u.ac.jp; mitsuteru@tokushima-u.ac.jp; y-kawakami@tokushima-u.ac.jp; naruto.takuya@tokushima-u.ac.jp; issehgen@tokushima-u.ac.jp; tangoku@tokushima-u.ac.jp; kzykondo@tokusima-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25861245, 26462145]	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI[grant numbers 25861245 (K.K.), 26462145 (Y.N.)].	Abate F, 2017, P NATL ACAD SCI USA, V114, P764, DOI 10.1073/pnas.1608839114; Bhora FY, 2014, J THORAC ONCOL, V9, pS88, DOI 10.1097/JTO.0000000000000293; Bultmann I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065614; Detterbeck FC, 2014, J THORAC ONCOL, V9, pS65, DOI 10.1097/JTO.0000000000000290; Detterbeck FC, 2011, J THORAC ONCOL, V6, pS1710, DOI 10.1097/JTO.0b013e31821e8cff; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Filosso PL, 2016, EUR J CARDIO-THORAC, V50, P766, DOI 10.1093/ejcts/ezw107; Hattori N, 2011, CANCER SCI, V102, P1337, DOI 10.1111/j.1349-7006.2011.01955.x; Honjo A, 2013, RESPIR INVESTIG, V51, P241, DOI 10.1016/j.resinv.2013.04.007; Imoto I, 2006, CANCER RES, V66, P4617, DOI 10.1158/0008-5472.CAN-05-4437; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Kajiura K, 2017, ONCOTARGET, V8, P2890, DOI 10.18632/oncotarget.13761; Karpathakis A, 2013, ENDOCR-RELAT CANCER, V20, pR65, DOI 10.1530/ERC-12-0338; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; Kondo K, 2014, J THORAC ONCOL, V9, pS81, DOI 10.1097/JTO.0000000000000291; Liu LX, 2005, MODERN PATHOL, V18, P1632, DOI 10.1038/modpathol.3800490; Mapelli P., 2014, ONCOGENE, P1; Marx A, 2015, J THORAC ONCOL, V10, P1383, DOI 10.1097/JTO.0000000000000654; Marx A, 2014, J THORAC ONCOL, V9, P596, DOI 10.1097/JTO.0000000000000154; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Nicholson AG, 2014, J THORAC ONCOL, V9, pS73, DOI 10.1097/JTO.0000000000000303; Pelosi G, 2010, ANTICANCER RES, V30, P4269; Sille FCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029632; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Xu D, 2014, J CELL MOL MED, V18, P1655, DOI 10.1111/jcmm.12352; Yadav R, 2016, J MOL BIOL, V428, P4031, DOI 10.1016/j.jmb.2016.07.018; Yang HP, 2015, ONCOL REP, V34, P87, DOI 10.3892/or.2015.3961; Zhang HY, 2006, ENDOCRINE, V30, P299, DOI 10.1007/s12020-006-0008-1; Zhou HY, 2016, INT J ONCOL, V49, P2442, DOI 10.3892/ijo.2016.3718	29	0	0	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	SEP	2017	111						116	123		10.1016/j.lungcan.2017.05.019				8	Oncology; Respiratory System	Oncology; Respiratory System	FH6QX	WOS:000411302900021	28838380				2018-01-05	
J	Reuss, DR; Commichau, FM; Stulke, J				Reuss, Daniel R.; Commichau, Fabian M.; Stuelke, Joerg			The contribution of bacterial genome engineering to sustainable development	MICROBIAL BIOTECHNOLOGY			English	Article							CRISPR-CAS SYSTEMS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; SYNTHETIC BIOLOGY; REDUCED-GENOME; GENE DELETION; DNA FRAGMENTS; IN-VITRO; CELL	The United Nations' Sustainable Development Goals define important challenges for the prosperous development of mankind. To reach several of these goals, among them the production of value-added compounds, improved economic and ecologic balance of production processes, prevention of climate change and protection of ecosystems, the use of engineered bacteria can make valuable contributions. We discuss the strategies for genome engineering and how they can be applied to meet the United Nations' goals for sustainable development.	[Reuss, Daniel R.; Commichau, Fabian M.; Stuelke, Joerg] Georg August Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany	Stulke, J (reprint author), Georg August Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.	jstuelk@gwdg.de		Commichau, Fabian/0000-0003-0323-7479	EU Horizon 2020 grant [720776]	EU Horizon 2020 grant 720776.	Arevalo-Rodriguez M, 2004, EUKARYOT CELL, V3, P1287, DOI 10.1128/EC.3.5.1287-1296.2004; Commichau FM, 2015, METAB ENG, V29, P196, DOI 10.1016/j.ymben.2015.03.007; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; de Kok S, 2014, ACS SYNTH BIOL, V3, P97, DOI 10.1021/sb4001992; de Oliveira RR, 2016, APPL MICROBIOL BIOT, V100, P719, DOI 10.1007/s00253-015-7030-2; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Erb TJ, 2016, CURR OPIN CHEM BIOL, V34, P72, DOI 10.1016/j.cbpa.2016.06.026; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Greenberg M., 1999, TOXICOLOGICAL REV AC; Guiziou S, 2016, NUCLEIC ACIDS RES, V44, P7495, DOI 10.1093/nar/gkw624; Hirokawa Y, 2013, J BIOSCI BIOENG, V116, P52, DOI 10.1016/j.jbiosc.2013.01.010; Hong SH, 2002, APPL MICROBIOL BIOT, V58, P286, DOI 10.1007/s00253-001-0899-y; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karas BJ, 2012, ACS SYNTH BIOL, V1, P22, DOI 10.1021/sb200013j; Kokura S, 1999, CIRC RES, V84, P516; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Lee JH, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-2; Leprince A, 2012, ENVIRON MICROBIOL, V14, P1444, DOI 10.1111/j.1462-2920.2012.02730.x; Li CY, 2016, CHEMOSPHERE, V161, P224, DOI 10.1016/j.chemosphere.2016.07.019; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; [李勇鹏 Li Yongpeng], 2016, [东北林业大学学报, Journal of North-East Forestry University], V44, P34; Liu L, 2013, APPL MICROBIOL BIOT, V97, P6113, DOI 10.1007/s00253-013-4960-4; Manabe K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-18; Manabe K, 2011, APPL ENVIRON MICROB, V77, P8370, DOI 10.1128/AEM.06136-11; McGary KL, 2013, P NATL ACAD SCI USA, V110, P11481, DOI 10.1073/pnas.1304461110; Mizoguchi H, 2008, DNA RES, V15, P277, DOI 10.1093/dnares/dsn019; Morimoto T, 2008, DNA RES, V15, P73, DOI 10.1093/dnares/dsn002; Morimoto T, 2009, GENES GENET SYST, V84, P315, DOI 10.1266/ggs.84.315                                                              ; Noskov VN, 2012, ACS SYNTH BIOL, V1, P267, DOI 10.1021/sb3000194; Portnoy VA, 2011, CURR OPIN BIOTECH, V22, P590, DOI 10.1016/j.copbio.2011.03.007; Qi H, 2015, BIOTECHNOL ADV, V33, P1412, DOI 10.1016/j.biotechadv.2015.04.002; Reuss DR, 2017, GENOME RES, V27, P289, DOI 10.1101/gr.215293.116; Revuelta JL, 2016, MICROB BIOTECHNOL, V9, P564, DOI 10.1111/1751-7915.12379; Robles H., 2014, ENCY TOXICOLOGY, P40; Romero S, 2007, APPL ENVIRON MICROB, V73, P5190, DOI 10.1128/AEM.00625-07; Rosenberg J, 2017, BIOTECHNOL ADV, V35, P31, DOI 10.1016/j.biotechadv.2016.11.004; Schwander T, 2016, SCIENCE, V354, P900, DOI 10.1126/science.aah5237; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Trinh CT, 2008, APPL ENVIRON MICROB, V74, P3634, DOI 10.1128/AEM.02708-07; Unthan S, 2015, BIOTECHNOL J, V10, P290, DOI 10.1002/biot.201400041; Wenda S, 2011, GREEN CHEM, V13, P3007, DOI 10.1039/c1gc15579b; Wenzel M, 2015, MICROBIOL-SGM, V161, P1942, DOI 10.1099/mic.0.000150; Zheng QP, 2014, BIOTECHNIQUES, V57, P115, DOI 10.2144/000114196; ZHU XD, 1995, J BIOL CHEM, V270, P23044, DOI 10.1074/jbc.270.39.23044                                                        	50	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-7915			MICROB BIOTECHNOL	Microb. Biotechnol.	SEP	2017	10	5			SI		1259	1263		10.1111/1751-7915.12784				5	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	FH8YJ	WOS:000411491300053	28772004	gold			2018-01-05	
J	Duncan, SM; Jones, NG; Mottram, JC				Duncan, Samuel M.; Jones, Nathaniel G.; Mottram, Jeremy C.			Recent advances in Leishmania reverse genetics: Manipulating a manipulative parasite	MOLECULAR AND BIOCHEMICAL PARASITOLOGY			English	Review						Leishmania; Leishmaniasis; Essential genes; Genome engineering; Drug targets	CONDITIONAL NULL MUTANT; CRE RECOMBINASE; EXPRESSION; MEXICANA; GALACTOSE; DONOVANI; SYSTEM; GENOME; IDENTIFICATION; AMASTIGOTES	In this review we describe the expanding repertoire of molecular tools with which to study gene function in Leishmania. Specifically we review the tools available for studying functions of essential genes, such as plasmid shuffle and DiCre, as well as the rapidly expanding portfolio of available CRISPR/Cas9 approaches for large scale gene knockout and endogenous tagging. We include detail on approaches that allow the direct manipulation of RNA using RNAi and protein levels via Tet or DiCre induced overexpression and destabilization domain mediated degradation. The utilisation of current methods and the development of more advanced molecular tools will lead to greater understanding of the role of essential genes in the parasite and thereby more robust drug target validation, thereby paving the way for the development of novel therapeutics to treat this important disease.	[Duncan, Samuel M.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Wellcome Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; [Jones, Nathaniel G.; Mottram, Jeremy C.] Univ York, Dept Biol, Ctr Immunol & Infect, Wentworth Way, York YO10 5DD, N Yorkshire, England	Mottram, JC (reprint author), Univ York, Dept Biol, Ctr Immunol & Infect, Wentworth Way, York YO10 5DD, N Yorkshire, England.	jeremy.mottram@york.ac.uk			Wellcome Trust [200807/Z/16/Z]; Medical Research Council [MR/K019384/1]; MRC	Research in the JCM laboratory is funded by a Wellcome Trust Investigator Award (200807/Z/16/Z) and by the Medical Research Council (MR/K019384/1). SMD was funded by an MRC studentship.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barrett MP, 1999, TRENDS MICROBIOL, V7, P82, DOI 10.1016/S0966-842X(98)01433-4                                                   ; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Beverley SM, 2003, NAT REV GENET, V4, P11, DOI 10.1038/nrg980; Beverley SM, 1998, TRENDS MICROBIOL, V6, P35, DOI 10.1016/S0966-842X(97)01180-3; Boltz J. M., 2017, INFECT IMMUN, V8, P5; de Paiva RMC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005296; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Dacher M, 2014, MOL MICROBIOL, V93, P146, DOI 10.1111/mmi.12648; Damerow S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004205; Damerow S, 2015, INT J PARASITOL, V45, P783, DOI 10.1016/j.ijpara.2015.06.004; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Duncan SM, 2016, MOL MICROBIOL, V100, P931, DOI 10.1111/mmi.13375; Faria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26937; Gazanion E, 2016, P NATL ACAD SCI USA, V113, pE3012, DOI 10.1073/pnas.1520693113; GueirosFilho FJ, 1996, MOL CELL BIOL, V16, P5655; Hassan P, 2001, MOL BIOCHEM PARASIT, V113, P189, DOI 10.1016/S0166-6851(01)00220-1; Ishemgulova A, 2016, FOLIA PARASIT, V63, DOI 10.14411/fp.2016.016; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Jullien N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001355; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; Kraeva N, 2014, MOL BIOCHEM PARASIT, V198, P11, DOI 10.1016/j.molbiopara.2014.11.002; Laffitte MCN, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006117; Lamerz AC, 2010, GLYCOBIOLOGY, V20, P872, DOI 10.1093/glycob/cwq045; Leprohon P, 2015, INT J PARASITOL-DRUG, V5, P26, DOI 10.1016/j.ijpddr.2014.09.005; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Madeira da Silva Luciana, 2010, Proc Natl Acad Sci U S A, V107, P11965, DOI 10.1073/pnas.1004599107; McCall LI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003588; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107; Mottram JC, 1996, MOL MICROBIOL, V22, P573, DOI 10.1046/j.1365-2958.1996.00136.x                                                ; Murta SMF, 2009, MOL MICROBIOL, V71, P1386, DOI 10.1111/j.1365-2958.2009.06610.x; Nguyen DP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12009; Passos-Silva DG, 2010, J NUCL ACIDS, V2010, DOI DOI 10.4061/2010/840768; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Peng D., 2015, MICROB GENOM, V1, DOI DOI 10.1099/MGEN.0.000033; Podesvova L, 2017, MOL BIOCHEM PARASIT, V214, P62, DOI 10.1016/j.molbiopara.2017.03.008; Price HP, 2013, MOL MICROBIOL, V90, P597, DOI 10.1111/mmi.12383; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Santos R. E. R. S., 2017, MOL BIOCH PARASITOL; Schindler SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13627; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P1168, DOI 10.1128/AAC.45.4.1168-1173.2001; Sollelis L, 2015, CELL MICROBIOL, V17, P1405, DOI 10.1111/cmi.12456; Soysa R, 2015, MOL BIOCHEM PARASIT, V204, P89, DOI 10.1016/j.molbiopara.2016.01.008; Spath GF, 2016, MOL MICROBIOL, V100, P923, DOI 10.1111/mmi.13374; Sterkers Y, 2014, TRENDS PARASITOL, V30, P429, DOI 10.1016/j.pt.2014.07.002; Tetaud E, 2002, MOL BIOCHEM PARASIT, V120, P195, DOI 10.1016/S0166-6851(02)00002-6; Urbaniak MD, 2006, EUKARYOT CELL, V5, P1906, DOI 10.1128/EC.00156-06; Wang Qiong, 2005, Kinetoplastid Biol Dis, V4, P6, DOI 10.1186/1475-9292-4-6; Wheeler RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9964; Wyllie S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005971; Yan SF, 2001, MOL BIOCHEM PARASIT, V112, P61, DOI 10.1016/S0166-6851(00)00345-5; Zhang WW, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00340-16, 10.1128/msphere.00340-16]; Zhang WW, 2015, MBIO, V6, DOI 10.1128/mBio.00861-15	60	1	1	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-6851	1872-9428		MOL BIOCHEM PARASIT	Mol. Biochem. Parasitol.	SEP	2017	216						30	38		10.1016/j.molbiopara.2017.06.005				9	Biochemistry & Molecular Biology; Parasitology	Biochemistry & Molecular Biology; Parasitology	FI2LT	WOS:000411771100005	28629934	gold			2018-01-05	
J	Patel, S; Ashwanikumar, N; Robinson, E; DuRoss, A; Sun, C; Murphy-Benenato, KE; Mihai, C; Almarsson, O; Sahay, G				Patel, Siddharth; Ashwanikumar, N.; Robinson, Emily; DuRoss, Allison; Sun, Conroy; Murphy-Benenato, Kerry E.; Mihai, Cosmin; Almarsson, Orn; Sahay, Gaurav			Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA	NANO LETTERS			English	Article						Intracellular delivery; mRNA; lipid nanoparticles; endosome escape; bioactive lipids; mTOR	SIRNA DELIVERY; IN-VITRO; THERAPEUTICS; LYSOSOME; VACCINES; MTORC1; DRUGS; CELLS; OLIGONUCLEOTIDES; TRAFFICKING	Intracellular delivery of mRNA holds great potential for vaccine(1-3) and therapeutic(4) discovery and development. Despite increasing recognition of the utility of lipid-based nanoparticles (LNPs) for intracellular delivery of mRNA, particle engineering is hindered by insufficient understanding of endosomal escape, which is believed to be a main limiter of cytosolic availability and activity of the nucleic acid inside the cell. Using a series of CRISPR-based genetic perturbations of the lysosomal pathway, we have identified that late endosome/lysosome (LE/Ly) formation is essential for functional delivery of exogenously presented mRNA. Lysosomes provide a spatiotemporal hub to orchestrate mTOR signaling and are known to control cell proliferation, nutrient sensing, ribosomal biogenesis, and mRNA translation. Through modulation of the mTOR pathway we were able to enhance or inhibit LNP-mediated mRNA delivery. To further boost intracellular delivery of mRNA, we screened 212 bioactive lipid-like molecules that are either enriched in vesicular compartments or modulate cell signaling. Surprisingly, we have discovered that leukotriene-antagonists, clinically approved for treatment of asthma and other lung diseases, enhance intracellular mRNA delivery in vitro (over 3-fold, p < 0.005) and in vivo (over 2-fold, p < 0.005). Understanding LNP-mediated intracellular delivery will inspire the next generation of RNA therapeutics that have high potency and limited toxicity.	[Patel, Siddharth; Ashwanikumar, N.; Robinson, Emily; DuRoss, Allison; Sun, Conroy; Sahay, Gaurav] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Collaborat Life Sci Bldg,2730 SW Moody Ave, Portland, OR 97201 USA; [Sahay, Gaurav] Oregon Hlth & Sci Univ, Dept Biomed Engn, Collaborat Life Sci Bldg,2730 SW Moody Ave, Portland, OR 97201 USA; [Murphy-Benenato, Kerry E.; Mihai, Cosmin; Almarsson, Orn] Moderna Therapeut, 200 Technol Sq, Cambridge, MA 02139 USA; [Sun, Conroy] Oregon Hlth & Sci Univ, Sch Med, Dept Radiat Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Sahay, G (reprint author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Collaborat Life Sci Bldg,2730 SW Moody Ave, Portland, OR 97201 USA.; Sahay, G (reprint author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Collaborat Life Sci Bldg,2730 SW Moody Ave, Portland, OR 97201 USA.	sahay@ohsu.edu		Patel, Siddhart/0000-0002-9543-3233	Moderna Therapeutics; OSU College of Pharmacy; National Institute of Biomedical Imaging and Bioengineering [1R15EB021581-01]; National Institute of General Medical Sciences (NIGMS) [1R35GM119839-01]; Cystic Fibrosis Foundation	This project was supported through funding from Moderna Therapeutics (G.S.), OSU College of Pharmacy startup funding (G.S.), National Institute of Biomedical Imaging and Bioengineering 1R15EB021581-01 (G.S.), National Institute of General Medical Sciences (NIGMS) 1R35GM119839-01 (C.S.), and Cystic Fibrosis Foundation (G.S.). We thank Dr. D. J. Kwiatkowski and Dr. Sovan Sarkar for TSC2<SUP>-/-</SUP> MEFs and Dr. Adam Alani for access to Malvern Zetasizer. Electron microscopy was performed at the Multiscale Microscopy Core (MMC) with technical support from the Oregon Health and Science University (OHSU) FEI Living Lab and the OHSU Center for Spatial Systems Biomedicine (OCSSB). We would like to thank Mr. Fabian Wieghardt (University of Wurzburg) for technical assistance. We thank Dr. John Joyal and Dr. Luis Brito (Moderna Therapeutics) for insightful comments.	Akinc A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016980; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035; Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013; Behr JP, 1997, CHIMIA, V51, P34; Bissig C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016816; Bissig C, 2012, METHOD CELL BIOL, V108, P19, DOI 10.1016/B978-0-12-386487-1.00002-X; Castellano BM, 2017, SCIENCE, V355, P1306, DOI 10.1126/science.aag1417; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Chen HY, 2016, ACS MED CHEM LETT, V7, P335, DOI 10.1021/acsmedchemlett.5b00482; Crooke ST, 2017, NAT BIOTECHNOL, V35, P230, DOI 10.1038/nbt.3779; Cullis PR, 2017, MOL THER, V25, P1467, DOI 10.1016/j.ymthe.2017.03.013; DeRosa F, 2016, GENE THER, V23, P699, DOI 10.1038/gt.2016.46; Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111; Dowdy SF, 2017, NAT BIOTECHNOL, V35, P222, DOI 10.1038/nbt.3802; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fenton O.S., 2017, ADV MATER; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gilleron J, 2015, NUCLEIC ACIDS RES, V43, P7984, DOI 10.1093/nar/gkv762; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Kaczmarek JC, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0450-0; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; Kim HJ, 2015, ACS NANO, V9, P10214, DOI 10.1021/acsnano.5b03902; Lim CY, 2016, J CELL BIOL, V214, P653, DOI 10.1083/jcb.201607005; Liu YC, 1998, BRIT J PHARMACOL, V124, P563, DOI 10.1038/sj.bjp.0701886                                                          ; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Peterson BG, 2017, PHARMACOL RES, V119, P313, DOI 10.1016/j.phrs.2017.02.024; Raiborg C, 2015, EMBO J, V34, P1848, DOI 10.15252/embj.201591481; Rauch S, 2017, METHODS MOL BIOL, V1499, P89, DOI 10.1007/978-1-4939-6481-9_5; Riccioni G, 2007, CURR MED CHEM, V14, P1966; Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278; Seiffert M, 2007, LEUKEMIA, V21, P1977, DOI 10.1038/sj.leu.2404863; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; Stewart MP, 2016, WIRES NANOMED NANOBI, V8, P465, DOI 10.1002/wnan.1377; Suh J, 2005, ADV DRUG DELIVER REV, V57, P63, DOI 10.1016/j.addr.2004.06.001; Turnbull IC, 2016, MOL THER, V24, P66, DOI 10.1038/mt.2015.193; Uchida Satoshi, 2015, Pharmaceutics, V7, P137, DOI 10.3390/pharmaceutics7030137; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Wang YH, 2013, NAT BIOTECHNOL, V31, P610, DOI 10.1038/nbt.2634; Wittrup A, 2015, NAT BIOTECHNOL, V33, P870, DOI 10.1038/nbt.3298; Yang B, 2015, NUCLEIC ACIDS RES, V43, P1987, DOI 10.1093/nar/gkv060; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Youn H, 2015, EXPERT OPIN BIOL TH, V15, P1337, DOI 10.1517/14712598.2015.1057563; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055                                                                ; Zou S, 2010, INT J PHARMACEUT, V389, P232, DOI 10.1016/j.ijpharm.2010.01.019	56	0	0	33	33	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1530-6984	1530-6992		NANO LETT	Nano Lett.	SEP	2017	17	9					5711	5718		10.1021/acs.nanolett.7b02664				8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	FH3JQ	WOS:000411043500079	28836442				2018-01-05	
J	Kenny, J; Forsythe, E; Beales, P; Bacchelli, C				Kenny, Joanna; Forsythe, Elizabeth; Beales, Philip; Bacchelli, Chiara			Toward personalized medicine in Bardet-Biedl syndrome	PERSONALIZED MEDICINE			English	Review						Bardet-Biedl syndrome; deep phenotyping; exon skipping; gene editing; gene therapy; next-generation sequencing; personalized medicine; pharmacogenomics; read-through therapy; targeted drug therapy	LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; GENE-THERAPY; CLINICAL-TRIAL; MOUSE MODEL; NONSENSE MUTATIONS; GENOME; CILIOPATHIES; CRISPR/CAS9; EFFICACY	Personalized medicine is becoming routine in the treatment of common diseases such as cancer, but has lagged behind in the field of rare diseases. It is currently in the early stages for the treatment of Bardet-Biedl syndrome. Advances in the understanding of ciliary biology and diagnostic techniques have opened up the prospect of treating BBS in a patient-specific manner. Owing to their structure and function, cilia provide an attractive therapeutic target and genetic therapies are being explored in ciliopathy treatment. Promising avenues include gene therapy, gene editing techniques and splice-correcting and read-through therapies. Targeted drug design has been successful in the treatment of genetic disease and research is underway in the discovery of known and novel drugs to treat Bardet-Biedl syndrome.	[Kenny, Joanna; Forsythe, Elizabeth; Beales, Philip; Bacchelli, Chiara] UCL Great Ormond St Inst Child Hlth, Biomed Res Ctr, NIHR Great Ormond St Hosp, 30 Guildford St, London WC1N 1EH, England	Beales, P (reprint author), UCL Great Ormond St Inst Child Hlth, Biomed Res Ctr, NIHR Great Ormond St Hosp, 30 Guildford St, London WC1N 1EH, England.	p.beales@ucl.ac.uk			Innovate UK; Medical Research Council; NIHR Great Ormond Street Hospital Biomedical Research Centre (GOSH BRC)	J Kenny is funded in part by Innovate UK. E Forsythe is funded by the Medical Research Council. P Beales is an NIHR Senior Investigator. This work was supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre (GOSH BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Akiyama M, 2014, ACTA OPHTHALMOL, V92, pE229, DOI 10.1111/aos.12293; Alagoz O, 2016, PHARMACOGENOMICS J, V16, P129, DOI 10.1038/tpj.2015.39; American Associantion of Ophthalmologists, 2016, GEN THER X LINK RET; Aslam AA, 2017, COCHRANE, V1; Bacchi N, 2014, INVEST OPHTH VIS SCI, V55, P3285, DOI 10.1167/iovs.14-14544; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178                                                                  ; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Bennett Lunawati L, 2015, Drug Des Devel Ther, V9, P4639, DOI 10.2147/DDDT.S77760; Berson EL, 2010, ARCH OPHTHALMOL-CHIC, V128, P403, DOI 10.1001/archophthalmol.2010.32; Castro-Sanchez S, 2015, J MED GENET, V52, P503, DOI 10.1136/jmedgenet-2015-103099; Clancy JP, 2014, CLIN PHARMACOL THER, V95, P592, DOI 10.1038/clpt.2014.54; Collin RWJ, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.3; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; Daniels AB, 2012, ARCH OPHTHALMOL-CHIC, V130, P901, DOI 10.1001/archophthalmol.2012.89; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Eichers ER, 2004, ANN MED, V36, P262, DOI 10.1080/07853890410026214; [Anonymous], 2016, EU HOR 2020 WORK PRO; Falsini B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0750-3; FARAG TI, 1989, CLIN GENET, V36, P463; Forsythe E, 1993, GENEREVIEWS; Forsythe E, 2017, J AM SOC NEPHROL, V28, P963, DOI 10.1681/ASN.2015091029; Friesen WJ, 2017, RNA, V23, P567, DOI 10.1261/rna.060236.116; Gerhardt Christoph, 2016, Cilia, V5, P14, DOI 10.1186/s13630-016-0035-3; Heon E, 2016, HUM MOL GENET, V25, P2283, DOI 10.1093/hmg/ddw096; Hjortshoj TD, 2009, BRIT J OPHTHALMOL, V93, P409, DOI 10.1136/bjo.2007.131110; Hoffman DR, 2014, JAMA OPHTHALMOL, V132, P866, DOI 10.1001/jamaophthalmol.2014.1634; Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034; Hulleman JD, 2016, MOL VIS, V22, P73; Irfanullah, 2016, AM J MED GENET A, V170, P3289, DOI 10.1002/ajmg.a.37934; Kammermeier J, 2014, J MED GENET, V51, P748, DOI 10.1136/jmedgenet-2014-102624; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khan DA, 2016, J ALLERGY CLIN IMMUN, V138, P943, DOI 10.1016/j.jaci.2016.08.002; Khan NA, 2016, ONCOTARGET, V7, P9975, DOI 10.18632/oncotarget.7198; Khan SA, 2016, CLIN GENET, V90, P3, DOI 10.1111/cge.12737; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Knopp C, 2015, MOL CELL PROBE, V29, P299, DOI 10.1016/j.mcp.2015.05.008; Kumar A, 2014, J OCUL PHARMACOL TH, V30, P580, DOI 10.1089/jop.2013.0166; Latorre-Rey LJ, 2017, J THROMB HAEMOST, V15, P341, DOI 10.1111/jth.13582; Lee HLR, 2012, PHARMACOL THERAPEUT, V136, P227, DOI 10.1016/j.pharmthera.2012.07.007; Lipinski DM, 2015, MOL THER, V23, P1308, DOI 10.1038/mt.2015.68; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Mookherjee S, 2015, HUM MOL GENET, V24, P6446, DOI 10.1093/hmg/ddv354; Moore SJ, 2005, AM J MED GENET A, V132A, P352, DOI 10.1002/ajmg.a.30406; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakamura K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05635; Nakazawa M, 2013, BIOMED RES INT, DOI 10.1155/2013/585729; Onoufriadis A, 2014, HUM MOL GENET, V23, P3362, DOI 10.1093/hmg/ddu046; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Quon BS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i859; Reardon S., 2016, NATURE, DOI [10.1038/nature.2016.20137, DOI 10.1038/NATURE.2016.20137]; Reinig AM, 2017, PHARMACOTHERAPY, V37, P492, DOI 10.1002/phar.1909; Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080; Rotenstreich Y, 2013, JAMA OPHTHALMOL, V131, P985, DOI 10.1001/jamaophthalmol.2013.147; Roy B, 2015, P NATL ACAD SCI USA, V112, P3038, DOI 10.1073/pnas.1424127112; Salsman J, 2017, BIOCHEM CELL BIOL, V95, P187, DOI 10.1139/bcb-2016-0137; Scacheri CA, 2015, CURR OPIN PEDIATR, V27, P659, DOI 10.1097/MOP.0000000000000283; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Schaefer E, 2016, J HUM GENET, V61, P447, DOI 10.1038/jhg.2015.162; Schmid F, 2011, HUM MUTAT, V32, P815, DOI 10.1002/humu.21509; Scholl HPN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143846; Seo S, 2013, INVEST OPHTH VIS SCI, V54, P6118, DOI 10.1167/iovs.13-11673; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Simons DL, 2011, P NATL ACAD SCI USA, V108, P6276, DOI 10.1073/pnas.1019222108; Stagno F, 2016, EXPERT REV ANTICANC, V16, P273, DOI 10.1586/14737140.2016.1151356; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tarantal AF, 2017, HUM GENE THER, V28, P385, DOI 10.1089/hum.2016.130; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wert KJ, 2014, HUM MOL GENET, V23, P514, DOI 10.1093/hmg/ddt452; Wrighton KH, 2015, NAT REV MOL CELL BIO, V16, P577, DOI 10.1038/nrm4064; Zaki MS, 2011, AM J MED GENET A, V155A, P3042, DOI 10.1002/ajmg.a.34173; Zhong H, 2015, GENE THER, V22, P619, DOI 10.1038/gt.2015.42	81	0	0	3	3	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1741-0541	1744-828X		PERS MED	Pers. Med.	SEP	2017	14	5					447	456		10.2217/pme-2017-0019				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FH8WE	WOS:000411484800010					2018-01-05	
J	Ramesh, SV; Sahu, PP; Prasad, M; Praveen, S; Pappu, HR				Ramesh, Shunmugiah V.; Sahu, Pranav P.; Prasad, Manoj; Praveen, Shelly; Pappu, Hanu R.			Geminiviruses and Plant Hosts: A Closer Examination of the Molecular Arms Race	VIRUSES-BASEL			English	Review						geminivirus; plant-virus interactions; cellular reprogramming; small non-coding RNAs; viral suppressors	LEAF-CURL-VIRUS; GOLDEN-MOSAIC-VIRUS; NUCLEAR SHUTTLE PROTEIN; NEW-DELHI-VIRUS; SILENCING SUPPRESSOR ACTIVITY; INTERFERING RNA ACCUMULATION; YELLOW VEIN DISEASE; ARABIDOPSIS-THALIANA; DNA-REPLICATION; L2 PROTEINS	Geminiviruses are plant-infecting viruses characterized by a single-stranded DNA (ssDNA) genome. Geminivirus-derived proteins are multifunctional and effective regulators in modulating the host cellular processes resulting in successful infection. Virus-host interactions result in changes in host gene expression patterns, reprogram plant signaling controls, disrupt central cellular metabolic pathways, impair plant's defense system, and effectively evade RNA silencing response leading to host susceptibility. This review summarizes what is known about the cellular processes in the continuing tug of war between geminiviruses and their plant hosts at the molecular level. In addition, implications for engineered resistance to geminivirus infection in the context of a greater understanding of the molecular processes are also discussed. Finally, the prospect of employing geminivirus-based vectors in plant genome engineering and the emergence of powerful genome editing tools to confer geminivirus resistance are highlighted to complete the perspective on geminivirus-plant molecular interactions.	[Ramesh, Shunmugiah V.] Indian Council Agr Res, ICAR Indian Inst Soybean Res, Indore 452001, Madhya Pradesh, India; [Ramesh, Shunmugiah V.; Pappu, Hanu R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99163 USA; [Sahu, Pranav P.; Prasad, Manoj] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India; [Praveen, Shelly] ICAR Indian Agr Res Inst IARI, Div Plant Pathol, Adv Ctr Plant Virol, New Delhi 110012, India	Pappu, HR (reprint author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99163 USA.	ramesh.sv@icar.gov.in; prnv_pankaj@yahoo.co.in; manoj_prasad@nipgr.ac.in; shellypraveen@hotmail.com; hrp@wsu.edu					ACCOTTO GP, 1993, VIROLOGY, V195, P257, DOI 10.1006/viro.1993.1369; Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Ali Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep26912; Ali Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0799-6; Amin I, 2011, MOL PLANT MICROBE IN, V24, P973, DOI 10.1094/MPMI-01-11-0001; Amin I, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-143; Aregger M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002941; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Bagewadi B, 2004, J VIROL, V78, P11890, DOI 10.1128/JVI.78.21.11890-11903.2004; Baliji S, 2007, MOL PLANT MICROBE IN, V20, P194, DOI 10.1094/MPMI-20-2-0194; Baltes NJ, 2015, NAT PLANTS, V1, DOI 10.1038/NPLANTS.2015.145; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Bar-Ziv A, 2012, PLANT SIGNAL BEHAV, V7, P983, DOI 10.4161/psb.20935; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Bisaro DM, 2006, VIROLOGY, V344, P158, DOI 10.1016/j.virol.2005.09.041; BISARO DM, 1982, NUCLEIC ACIDS RES, V10, P4913, DOI 10.1093/nar/10.16.4913; Bisaro D.M., 1996, DNA REPLICATION EUKA, P833; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Briddon RW, 2004, VIROLOGY, V324, P462, DOI 10.1016/j.virol.2004.03.041; Briddon RW, 2000, VIRUS RES, V71, P151, DOI 10.1016/S0168-1702(00)00195-7; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Briddon R.W., 2000, BMC EVOL BIOL, V10, P97; BROUGH CL, 1992, PLANT MOL BIOL, V18, P703, DOI 10.1007/BF00020012; Brown JK, 2012, 9 INT COMM TAX VIR, P351; Bruce G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-561; Buchmann RC, 2009, J VIROL, V83, P5005, DOI 10.1128/JVI.01771-08; Carrillo-Tripp J, 2007, PHYTOPATHOLOGY, V97, P51, DOI 10.1094/PHYTO-97-0051; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Carvalho CM, 2008, PLANT J, V55, P869, DOI 10.1111/j.1365-313X.2008.03556.x; Castillo AG, 2003, VIROLOGY, V312, P381, DOI [10.1016/S0042-6822(03)00234-4, 10.1016/S0042-6822(03)0023-4]; Castillo AG, 2004, J VIROL, V78, P2758, DOI 10.1128/JVI.78.6.2758-2769.2004; Chellappan P, 2005, PLANT PHYSIOL, V138, P1828, DOI 10.1104/pp.105.066563; CHOI IR, 1995, VIROLOGY, V206, P904, DOI 10.1006/viro.1995.1013; Cui XF, 2005, J VIROL, V79, P10764, DOI 10.1128/JVI.79.16.10764-10775.2005; Czosnek H, 2013, VIRUSES-BASEL, V5, P998, DOI 10.3390/v5030998; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dong XL, 2003, J VIROL, V77, P7026, DOI 10.1128/JVI.77.12.7026-7033.2003; Egelkrout EM, 2001, PLANT CELL, V13, P1437, DOI 10.1105/tpc.13.6.1437; Eini O, 2009, MOL PLANT MICROBE IN, V22, P737, DOI 10.1094/MPMI-22-6-0737; Florentino LH, 2006, J VIROL, V80, P6648, DOI 10.1128/JVI.00173-06; Fondong VN, 2007, MOL PLANT MICROBE IN, V20, P380, DOI 10.1094/MPMI-20-4-0380; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Fregene M, 2004, PLANT MOL BIOL, V56, P563, DOI 10.1007/s11103-004-3477-8; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Gopal P, 2007, VIRUS RES, V123, P9, DOI 10.1016/j.virusres.2006.07.014; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Hagen C, 2008, PHYTOPATHOLOGY, V98, P1029, DOI 10.1094/PHYTO-98-9-1029; Hanley-Bowdoin L, 2000, CRIT REV BIOCHEM MOL, V35, P105; Hanley-Bowdoin L, 2004, MOL PLANT PATHOL, V5, P149, DOI 10.1111/J.1364-3703.2004.00214.X; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Hao LH, 2003, PLANT CELL, V15, P1034, DOI 10.1105/tpc.009530; Harrison BD, 1999, ANNU REV PHYTOPATHOL, V37, P369, DOI 10.1146/annurev.phyto.37.1.369; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Huang CJ, 2013, VIRUSES-BASEL, V5, P2116, DOI 10.3390/v5092116; Jackel JN, 2015, J VIROL, V89, P3176, DOI 10.1128/JVI.02625-14; Ji X, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.144, 10.1038/nplants.2015.144]; Kaur H, 2015, J PLANT BIOCHEM BIOT, V24, P347, DOI 10.1007/s13562-014-0280-8; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156                                                          ; Kon T, 2007, ARCH VIROL, V152, P1273, DOI 10.1007/s00705-007-0957-6; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Lewis JD, 2010, P NATL ACAD SCI USA, V107, P2491, DOI 10.1073/pnas.0909080107; Li F., 2014, SCI WORLD J, V2014, P6, DOI DOI 10.1155/2014/763108; Li FF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006213; Li FF, 2015, NEW PHYTOL, V208, P555, DOI 10.1111/nph.13473; Lozano-Duran R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022383; Maghuly F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098263; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Martin DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002203; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mills-Lujan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122356; Miozzi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089951; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Moffat AS, 1999, SCIENCE, V286, P1835, DOI 10.1126/science.286.5446.1835                                                   ; Mor TS, 2003, BIOTECHNOL BIOENG, V81, P430, DOI 10.1002/bit.10483; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; Naqvi AR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-281; Nawaz-ul-Rehman MS, 2010, VIROLOGY, V405, P300, DOI 10.1016/j.virol.2010.06.024; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pandey P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-152; Paprotka T, 2011, J VIROL, V85, P12001, DOI 10.1128/JVI.05567-11; Perez-Quintero AL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-138; PILARTZ M, 1992, VIROLOGY, V189, P800, DOI 10.1016/0042-6822(92)90610-2; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Pooggin M, 2003, NAT BIOTECHNOL, V21, P131, DOI 10.1038/nbt0203-131b; Praveen S, 2010, TRANSGENIC RES, V19, P45, DOI 10.1007/s11248-009-9291-y; Priyadarshini CGP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026929; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Raja P, 2014, J VIROL, V88, P2611, DOI 10.1128/JVI.02305-13; Ramesh SV, 2007, OLIGONUCLEOTIDES, V17, P251, DOI 10.1089/oli.2006.0063; Ramesh SV, 2017, PHYSIOL MOL PLANT P, V100, P13, DOI 10.1016/j.pmpp.2017.05.001; Ramesh SV, 2014, VIRUS GENES, V48, P1, DOI 10.1007/s11262-014-1038-z; Regnard GL, 2010, PLANT BIOTECHNOL J, V8, P38, DOI 10.1111/j.1467-7652.2009.00462.x; Reyes MI, 2013, J VIROL, V87, P9691, DOI 10.1128/JVI.01095-13; Rodriguez-Negrete EA, 2009, J VIROL, V83, P1332, DOI 10.1128/JVI.01474-08; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Rubio-Somoza I, 2009, CURR OPIN PLANT BIOL, V12, P622, DOI 10.1016/j.pbi.2009.07.003; Sahu PP, 2014, PLANT MOL BIOL REP, V32, P1015, DOI 10.1007/s11105-014-0708-2; Sahu PP, 2014, FUNCT INTEGR GENOMIC, V14, P47, DOI 10.1007/s10142-013-0346-z; Sahu PP, 2012, MOL BIOTECHNOL, V52, P140, DOI 10.1007/s12033-011-9481-8; Sahu PP, 2010, MOL PLANT PATHOL, V11, P531, DOI [10.1111/J.1364-3703.2010.00630.X, 10.1111/j.1364-3703.2010.00630.x]; Sansregret R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003435; Saunders K, 2001, VIROLOGY, V282, P38, DOI 10.1006/viro.2000.0832; Saunders K, 2000, P NATL ACAD SCI USA, V97, P6890, DOI 10.1073/pnas.97.12.6890; Schoelz JE, 2011, MOL PLANT, V4, P813, DOI 10.1093/mp/ssr070; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Seemanpillai M, 2003, MOL PLANT MICROBE IN, V16, P429, DOI 10.1094/MPMI.2003.16.5.429; Settlage SB, 2005, J VIROL, V79, P9885, DOI 10.1128/JVI.79.15.9885-9895.2005; Shepherd DN, 2010, MOL PLANT PATHOL, V11, P1, DOI [10.1111/j.1364-3703.2009.00568.x, 10.1111/j.1364-3703.2009.00568.X]; Shivaprasad PV, 2005, J VIROL, V79, P8149, DOI 10.1128/JVI.79.13.8149-8163.2005; Shukla R., 2013, J BIOSCIENCE, V38, P1; Singh A, 2015, MOL PLANT PATHOL, V16, P724, DOI 10.1111/mpp.12229; Singh DK, 2007, NUCLEIC ACIDS RES, V35, P755, DOI 10.1093/nar/gkl1088; Sunter G, 2001, VIROLOGY, V285, P59, DOI 10.1006/viro.2001.0950; Suyal G, 2014, VIRUS GENES, V48, P486, DOI 10.1007/s11262-013-1028-6; Tao XR, 2008, J GEN VIROL, V89, P306, DOI 10.1099/vir.0.83388-0; Thresh JM, 2005, PLANT PATHOL, V54, P587, DOI 10.1111/j.1365-3059.2005.01282.x; Tousi N, 2017, AUSTRALAS PLANT PATH, V46, P379, DOI 10.1007/s13313-017-0500-5; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; van Wezel R, 2002, MOL PLANT MICROBE IN, V15, P203, DOI 10.1094/MPMI.2002.15.3.203; Vanderschuren H, 2007, PLANT MOL BIOL, V64, P549, DOI 10.1007/s11103-007-9175-6; Vanderschuren H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045277; Vanitharani R, 2005, TRENDS PLANT SCI, V10, P144, DOI 10.1016/j.tplants.2005.01.005; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Varsani A, 2017, ARCH VIROL, V162, P1819, DOI 10.1007/s00705-017-3268-6; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Verlaan MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003399; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang H, 2005, J VIROL, V79, P7410, DOI 10.1128/JVI.79.12.7410-7418.2005; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Wang MG, 2017, MOL PLANT, V10, P1007, DOI 10.1016/j.molp.2017.03.002; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wang YQ, 2014, J GEN VIROL, V95, P2082, DOI 10.1099/vir.0.064246-0; Yadav RK, 2011, MOL PLANT MICROBE IN, V24, P1189, DOI 10.1094/MPMI-03-11-0075; Yang XL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002329; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016928; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang J, 2012, VIRUS RES, V163, P51, DOI 10.1016/j.virusres.2011.08.009; Zhang ZH, 2011, PLANT CELL, V23, P273, DOI 10.1105/tpc.110.081695; Zrachya A, 2007, VIROLOGY, V358, P159, DOI 10.1016/j.virol.2006.08.016	147	0	0	12	12	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	SEP	2017	9	9							256	10.3390/v9090256				21	Virology	Virology	FH8YM	WOS:000411491600026		gold			2018-01-05	
J	Filipuzzi, I; Thomas, JR; Pries, V; Estoppey, D; Salcius, M; Studer, C; Schirle, M; Hoepfner, D				Filipuzzi, Ireos; Thomas, Jason Ray; Pries, Verena; Estoppey, David; Salcius, Michael; Studer, Christian; Schirle, Markus; Hoepfner, Dominic			Direct Interaction of Chivosazole F with Actin Elicits Cell Responses Similar to Latrunculin A but Distinct from Chondramide	ACS CHEMICAL BIOLOGY			English	Article							MYXOBACTERIA; CYTOSKELETON; PROTEIN; IDENTIFICATION; INHIBITION; FILAMENTS; MUTANTS; TARGETS	The microbial metabolite Chivosazole F has been described to affect the cytoskeleton and to inhibit actin polymerization in vitro. Applying orthogonal genomic and proteomics approaches, we now show for the first time that Chivosazole F exerts,its effect by directly interacting with actin and demonstrate the cellular impact of Chivosazole F in an unbiased, genome-wide context in yeast and in mammalian cells. Furthermore, mutation-based resistance mapping identifies two SNPs located in the putative Chivosazole F binding site of actin. Comparing chemogenomic profiles and responses to the Chivosazole F-resistant SNPs shows a partially conserved mechanism of action for Chivosazole F and Latrunculin A, but clear divergence from Chondramide. In addition, Cl4orf80 is an evolutionarily highly conserved ORF, lacking any functional annotation. As editing of Cl4orf80 leads to Chivosazole F hyper-resistance, we propose a function for this gene product in counteracting perturbation of actin filaments.	[Filipuzzi, Ireos; Pries, Verena; Estoppey, David; Studer, Christian; Hoepfner, Dominic] Novartis Pharma AG, Novartis Inst BioMed Res, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland; [Thomas, Jason Ray; Salcius, Michael; Schirle, Markus] Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	Hoepfner, D (reprint author), Novartis Pharma AG, Novartis Inst BioMed Res, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland.; Schirle, M (reprint author), Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	markus.schirle@novartis.com; dominic.hoepfner@novartis.com					ALBERTS B, 2002, MOL BIOL CELL; Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Davidson AJ, 2016, TRENDS CELL BIOL, V26, P569, DOI 10.1016/j.tcb.2016.04.001; Diestel R, 2009, CHEMBIOCHEM, V10, P2900, DOI 10.1002/cbic.200900562; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Eira J, 2016, PROG NEUROBIOL, V141, P61, DOI 10.1016/j.pneurobio.2016.04.007; ESTOPPEY D, 2017, SCI REP, V7; Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071; Filipuzzi I, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006374; Gunning PW, 2015, J CELL SCI, V128, P2009, DOI 10.1242/jcs.165563; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; IRSCHIK H, 1995, J ANTIBIOT, V48, P962, DOI 10.7164/antibiotics.48.962                                                      ; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; Kiuchi T, 2011, J CELL BIOL, V193, P365, DOI 10.1083/jcb.201101035; Krastel P, 2015, ANGEW CHEM INT EDIT, V54, P10149, DOI 10.1002/anie.201505069; Melak M, 2017, J CELL SCI, V130, P525, DOI 10.1242/jcs.189068; Mulholland J, 1997, MOL BIOL CELL, V8, P1481; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Pries V, 2016, J BIOMOL SCREEN, V21, P306, DOI 10.1177/1087057115610488; Salcius M, 2014, J BIOMOL SCREEN, V19, P917, DOI 10.1177/1087057114522691; Schmitt EK, 2016, J IND MICROBIOL BIOT, V43, P249, DOI 10.1007/s10295-015-1691-9; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Takayama H, 2012, METHODS MOL BIOL, V800, P75, DOI 10.1007/978-1-61779-349-3_6; Xu JY, 1999, CELL MOTIL CYTOSKEL, V42, P73, DOI 10.1002/(SICI)1097-0169(1999)42:1<73::AID-CM7>3.3.CO;2-Q; Yarmola EG, 2000, J BIOL CHEM, V275, P28120	27	0	0	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	SEP	2017	12	9					2264	2269		10.1021/acschembio.7b00385				6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FH6RK	WOS:000411304200006	28796488				2018-01-05	
J	Felden, B; Paillard, L				Felden, Brice; Paillard, Luc			When eukaryotes and prokaryotes look alike: the case of regulatory RNAs	FEMS MICROBIOLOGY REVIEWS			English	Review						regulatory RNA; RNA-mediated adaptive immunity; gene regulation; RNA function; RNA mechanism; RNA biogenesis; epigenetic control	AMEBA DICTYOSTELIUM-DISCOIDEUM; PAIRING SMALL RNAS; MESSENGER-RNA; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; GENE-REGULATION; ANTISENSE RNA; SOLUBLE-RNA; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS	The discovery that all living entities express many RNAs beyond mRNAs, tRNAs and rRNAs has been a surprise in the past two decades. In fact, regulatory RNAs (regRNAs) are plentiful, and we report stunning parallels between their mechanisms and functions in prokaryotes and eukaryotes. For instance, prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats) defense systems are functional analogs to eukaryotic RNA interference processes that preserve the cell against foreign nucleic acid elements. Regulatory RNAs shape the genome in many ways: by controlling mobile element transposition in both domains, via regulation of plasmid counts in prokaryotes, or by directing epigenetic modifications of DNA and associated proteins in eukaryotes. RegRNAs control gene expression extensively at transcriptional and post-transcriptional levels, with crucial roles in fine-tuning cell environmental responses, including intercellular interactions. Although the lengths, structures and outcomes of the regRNAs in all life kingdoms are disparate, they act through similar patterns: by guiding effectors to target molecules or by sequestering macromolecules to hamper their functions. In addition, their biogenesis processes have a lot in common. This unifying vision of regRNAs in all living cells from bacteria to humans points to the possibility of fruitful exchanges between fundamental and applied research in both domains.	[Felden, Brice] Univ Rennes 1, INSERM, Biochim Pharmaceut U1230, F-35043 Rennes, France; [Felden, Brice; Paillard, Luc] Univ Rennes 1, Biosit, F-35043 Rennes, France; [Paillard, Luc] CNRS, Inst Genet & Dev Rennes, UMR 6290, F-35043 Rennes, France	Paillard, L (reprint author), Univ Rennes 1, Biosit, F-35043 Rennes, France.; Paillard, L (reprint author), CNRS, Inst Genet & Dev Rennes, UMR 6290, F-35043 Rennes, France.; Felden, B (reprint author), Univ Rennes 1, U1230, 2 Ave Prof Leon Bernard, F-35043 Rennes, France.	brice.felden@univ-rennes1.fr; luc.paillard@univ-rennes1.fra			Institut National de la Sante et de la Recherche Medicale; University of Rennes 1; Centre National de la Recherche Scientifique; French National Research Agency (sRNA-FIT)	Institut National de la Sante et de la Recherche Medicale, University of Rennes 1, Centre National de la Recherche Scientifique and The French National Research Agency (sRNA-FIT to BF).	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Avesson L, 2012, RNA, V18, P1771, DOI 10.1261/rna.033175.112; Avesson L, 2011, RNA BIOL, V8, P1094, DOI 10.4161/rna.8.6.17214; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Bai YH, 2015, FUNGAL GENET BIOL, V81, P113, DOI 10.1016/j.fgb.2015.03.004; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Benjamin JAM, 2010, CAN J PHYSIOL PHARM, V88, P264, DOI 10.1139/Y10-014; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110                                                                ; Berulava T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118438; Bhan A, 2015, BBA-REV CANCER, V1856, P151, DOI 10.1016/j.bbcan.2015.07.001; Bhatt S, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00105; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bohn C, 2010, NUCLEIC ACIDS RES, V38, P6620, DOI 10.1093/nar/gkq462; Bonnin RA, 2015, INT J GENOMICS, DOI 10.1155/2015/395753; Bossi L, 2016, NAT REV MICROBIOL, V14, P775, DOI 10.1038/nrmicro.2016.129; Brantl S, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0001-2013; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Cahova H, 2015, NATURE, V519, P374, DOI 10.1038/nature14020; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Chao YJ, 2017, MOL CELL, V65, P39, DOI 10.1016/j.molcel.2016.11.002; Montes RAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4722; Chen YW, 2014, DEV CELL, V31, P784, DOI 10.1016/j.devcel.2014.11.029; Cibois M, 2010, RNA, V16, P10, DOI 10.1261/rna.1742610; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Court DL, 2013, ANNU REV GENET, V47, P405, DOI 10.1146/annurev-genet-110711-155618; Crowley JJ, 2015, BIOL PSYCHIAT, V77, pE5, DOI 10.1016/j.biopsych.2014.05.022; Cushing L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005238; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Ellis MJ, 2016, WIRES RNA, V7, P382, DOI 10.1002/wrna.1341; Ellis MJ, 2015, NUCLEIC ACIDS RES, V43, P6511, DOI 10.1093/nar/gkv584; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Felden B, 1998, EMBO J, V17, P3188, DOI 10.1093/emboj/17.11.3188; Felden B, 2017, RNA, V23, P131, DOI 10.1261/rna.058891.116; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Fellmann C, 2017, NAT REV DRUG DISCOV, V16, P89, DOI 10.1038/nrd.2016.238; Feng LH, 2015, CELL, V160, P228, DOI 10.1016/j.cell.2014.11.051; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Filippov V, 2000, GENE, V245, P213, DOI 10.1016/S0378-1119(99)00571-5; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; GERDES K, 1986, EMBO J, V5, P2023; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Giudice E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00113; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Hardy S, 2010, BIOL CELL, V102, P561, DOI 10.1042/BC20100038; Harms A, 2016, SCIENCE, P354; Hoe CH, 2013, INT J MED MICROBIOL, V303, P217, DOI 10.1016/j.ijmm.2013.04.002; HUTTENHOFER A, 1994, EMBO J, V13, P3892; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jorjani H, 2016, NUCLEIC ACIDS RES, V44, P5068, DOI 10.1093/nar/gkw386; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lalaouna D, 2015, MOL CELL, V58, P393, DOI 10.1016/j.molcel.2015.03.013; Le Pabic H, 2015, NUCLEIC ACIDS RES, V43, P9232, DOI 10.1093/nar/gkv783; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Libis VK, 2014, ACS SYNTH BIOL, V3, P1003, DOI 10.1021/sb500033d; Liu Y, 2010, FEBS LETT, V584, P4325, DOI 10.1016/j.febslet.2010.09.024; MA C, 1990, EMBO J, V9, P1267; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Marbaniang CN, 2016, CURR OPIN MICROBIOL, V30, P50, DOI 10.1016/j.mib.2016.01.001; Mauro T, 2016, NUCLEIC ACIDS RES, V44, P10186, DOI 10.1093/nar/gkw777; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Meyer MM, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1370; Mika F, 2013, INT J MOL SCI, V14, P4560, DOI 10.3390/ijms14034560; Mira-Bontenbal H, 2016, CURR BIOL, V26, pR338, DOI 10.1016/j.cub.2016.03.022; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Miyakoshi M, 2015, EMBO J, V34, P1478, DOI 10.15252/embj.201490546; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mohanty BK, 2016, ANNU REV MICROBIOL, V70, P25, DOI 10.1146/annurev-micro-091014-104515; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; NOVICK RP, 1989, CELL, V59, P395, DOI 10.1016/0092-8674(89)90300-0; NOVICK RP, 1993, EMBO J, V12, P3967; O'Callaghan J, 2011, MICROBIOL-SGM, V157, P3417, DOI 10.1099/mic.0.052050-0; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Powers JT, 2016, NATURE, V535, P246, DOI 10.1038/nature18632; Pulvermacher SC, 2009, J BACTERIOL, V191, P238, DOI 10.1128/JB.00915-08; Qu F, 2010, WIRES RNA, V1, P22, DOI 10.1002/wrna.7; Qu SB, 2017, RNA BIOL, V14, P992, DOI 10.1080/15476286.2016.1220473; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Ross JA, 2013, RNA, V19, P670, DOI 10.1261/rna.037747.112; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Schultze T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01199; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shen LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148532; Shimura H, 2011, BBA-GENE REGUL MECH, V1809, P601, DOI 10.1016/j.bbagrm.2011.04.005; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4                                                    ; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; STOUGAARD P, 1981, P NATL ACAD SCI-BIOL, V78, P6008, DOI 10.1073/pnas.78.10.6008; Sun Y, 2013, J BACTERIOL, V195, P4804, DOI 10.1128/JB.00722-13; Svensson SL, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0028-2015; TOMIZAWA J, 1981, P NATL ACAD SCI-BIOL, V78, P1421, DOI 10.1073/pnas.78.3.1421; TOMIZAWA JI, 1981, P NATL ACAD SCI-BIOL, V78, P6096, DOI 10.1073/pnas.78.10.6096; Updegrove TB, 2016, CURR OPIN MICROBIOL, V30, P133, DOI 10.1016/j.mib.2016.02.003; Updegrove TB, 2015, FEMS MICROBIOL REV, V39, P379, DOI 10.1093/femsre/fuv014; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291                                                             ; Vanderpool CK, 2011, BIOCHIMIE, V93, P1943, DOI 10.1016/j.biochi.2011.07.016; Verma P, 2015, ELIFE, V4, DOI 10.7554/eLife.07389; Verma SC, 2013, INT J MOL SCI, V14, P16386, DOI 10.3390/ijms140816386; Vestergaard G, 2014, RNA BIOL, V11, P156, DOI 10.4161/rna.27990; Grosso-Becera MV, 2015, TRENDS MICROBIOL, V23, P509, DOI 10.1016/j.tim.2015.04.004; Vitsios DM, 2017, NUCLEIC ACIDS RES, V45, P1079, DOI 10.1093/nar/gkw1031; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003659; Voigt K, 2014, ISME J, V8, P2056, DOI 10.1038/ismej.2014.57; Wagner EGH, 2015, ADV GENET, V90, P133, DOI 10.1016/bs.adgen.2015.05.001; Wang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1770; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Weng RF, 2015, DEVELOPMENT, V142, P3713, DOI 10.1242/dev.127209; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Willbanks A, 2016, GENET EPIGENETICS, V8, P25, DOI 10.4137/GEG.S31863; Xhemalce B, 2012, CELL, V151, P278, DOI 10.1016/j.cell.2012.08.041; Xie RY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002713; Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012; Yang L, 2016, GENE DEV, V30, P1747, DOI 10.1101/gad.281162.116; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zhao XA, 2013, MOL MICROBIOL, V89, P989, DOI 10.1111/mmi.12325	134	1	1	10	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0168-6445	1574-6976		FEMS MICROBIOL REV	Fems Microbiol. Rev.	SEP	2017	41	5					624	639		10.1093/femsre/fux038				16	Microbiology	Microbiology	FI5HX	WOS:000412014200003	28981746				2018-01-05	
J	Gil, MA; Martinez, CA; Nohalez, A; Parrilla, I; Roca, J; Wu, J; Ross, PJ; Cuello, C; Izpisua, JC; Martinez, EA				Gil, Maria A.; Martinez, Cristina A.; Nohalez, Alicia; Parrilla, Inmaculada; Roca, Jordi; Wu, Jun; Ross, Pablo J.; Cuello, Cristina; Izpisua, Juan C.; Martinez, Emilio A.			Developmental competence of porcine genome-edited zygotes	MOLECULAR REPRODUCTION AND DEVELOPMENT			English	Review						CRISPR; Cas9; cytoplasmic microinjection; in vitro-produced zygotes; in vivo-derived zygotes; TALEN; ZFN	CHEMICALLY-DEFINED MEDIUM; IN-VITRO PRODUCTION; GENE-MODIFIED PIGS; EFFICIENT GENERATION; EMBRYO DEVELOPMENT; KNOCKOUT PIGS; CYTOPLASMIC MICROINJECTION; INJECTION; RNA; SUPEROVULATION	Genome editing in pigs has tremendous practical applications for biomedicine. The advent of genome editing technology, with its use of site-specific nucleasesincluding ZFNs, TALENs, and the CRISPR/Cas9 systemhas popularized targeted zygote genome editing via one-step microinjection in several mammalian species. Here, we review methods to optimize the developmental competence of genome-edited porcine embryos and strategies to improve the zygote genome-editing efficiency in pigs.	[Gil, Maria A.; Martinez, Cristina A.; Nohalez, Alicia; Parrilla, Inmaculada; Roca, Jordi; Cuello, Cristina; Martinez, Emilio A.] Univ Murcia, Dept Anim Med & Surg, E-30100 Murcia, Spain; [Wu, Jun; Izpisua, Juan C.] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ross, Pablo J.] Univ Calif Davis, Dept Anim Sci, Davis, CA USA	Gil, MA (reprint author), Univ Murcia, Dept Anim Med & Surg, E-30100 Murcia, Spain.	mariagil@um.es			Fundacion Seneca [GERM 19892/GERM/15]; MINECO [BES-2013-064087, BES-2013-064069]	Fundacion Seneca, Grant number: GERM 19892/GERM/15; MINECO, Grant numbers: BES-2013-064087, BES-2013-064069	Alminana C, 2010, ANIM REPROD SCI, V121, P145, DOI 10.1016/j.anireprosci.2010.05.004; Angel MA, 2014, THERIOGENOLOGY, V81, P832, DOI 10.1016/j.theriogenology.2013.12.017; Bogliotti Y. S., 2016, JOVE-J VIS EXP, V5, P116; Britt J H, 1985, J Reprod Fertil Suppl, V33, P37; Cameron RDA, 2004, THERIOGENOLOGY, V61, P1533, DOI 10.1016/j.theriogenology.2003.09.003; Carter D. Bart, 2002, Cloning and Stem Cells, V4, P131, DOI 10.1089/153623002320253319; Cuello C, 2016, SCI REP-UK, V6, DOI 10.1038/srep33915; De Rensis F, 2016, THERIOGENOLOGY, V86, P1460, DOI 10.1016/j.theriogenology.2016.04.089; Gil MA, 2008, THERIOGENOLOGY, V70, P1260, DOI 10.1016/j.theriogenology.2008.06.004; Gil MA, 2013, THERIOGENOLOGY, V79, P392, DOI 10.1016/j.theriogenology.2012.10.012; Gil MA, 2010, REPROD DOMEST ANIM, V45, P40, DOI 10.1111/j.1439-0531.2010.01623.x; Gomis J, 2013, REPROD FERT DEVELOP, V25, P798, DOI 10.1071/RD12179; Grupen CG, 2014, THERIOGENOLOGY, V81, P24, DOI 10.1016/j.theriogenology.2013.09.022; Guthrie HD, 1997, J ANIM SCI, V75, P3246; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Han YM, 1999, BIOL REPROD, V60, P1110, DOI 10.1095/biolreprod60.5.1110; Han YM, 1999, BIOL REPROD, V61, P1340, DOI 10.1095/biolreprod61.5.1340                                                     ; Hazeleger W, 2000, THERIOGENOLOGY, V53, P1063, DOI 10.1016/S0093-691X(00)00252-1; Hisamatsu S, 2015, ANIM SCI J, V86, P132, DOI 10.1111/asj.12259; HUNTER RHF, 1974, ANAT REC, V178, P169, DOI 10.1002/ar.1091780203; Kikuchi K, 2004, J REPROD DEVELOP, V50, P21, DOI 10.1262/jrd.50.21; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Lee K, 2013, ANIM FRONT, V3, P56; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Liu S, 2016, IN VITRO CELL DEV-AN, V52, P713, DOI 10.1007/s11626-016-0025-1; Lutz AJ, 2013, XENOTRANSPLANTATION, V20, P27, DOI 10.1111/xen.12019; MARTINEZ E, 2015, SCI REP UK, V5; Martinez E. A., 2014, PLOS ONE, V13; Martinez EA, 2016, THERIOGENOLOGY, V85, P152, DOI 10.1016/j.theriogenology.2015.06.002; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40176; Peng J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16705; Petersen B, 2016, XENOTRANSPLANTATION, V23, P338, DOI 10.1111/xen.12258; PETTERS RM, 1993, J REPROD FERTIL, P61; Reyes LM, 2014, J IMMUNOL, V193, P5751, DOI 10.4049/jimmunol.1402059; Sato M, 2015, INT J MOL SCI, V16, P17838, DOI 10.3390/ijms160817838; Somfai T, 2008, ANIM REPROD SCI, V107, P131, DOI 10.1016/j.anireprosci.2007.06.025; Spate LD, 2015, MOL REPROD DEV, V82, P315, DOI 10.1002/mrd.22474; WALL RJ, 1985, BIOL REPROD, V32, P645, DOI 10.1095/biolreprod32.3.645; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep38854; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08256; Whitelaw CBA, 2016, J PATHOL, V238, P247, DOI 10.1002/path.4648; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Xin JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084250; Yamanaka K, 2009, J REPROD DEVELOP, V55, P299, DOI 10.1262/jrd.20174; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Yu HH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101668; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zhou XY, 2016, HUM MUTAT, V37, P110, DOI 10.1002/humu.22913; Ziecik AJ, 2005, J REPROD DEVELOP, V51, P379, DOI 10.1262/jrd.17008	54	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1040-452X	1098-2795		MOL REPROD DEV	Mol. Reprod. Dev.	SEP	2017	84	9					814	821		10.1002/mrd.22829				8	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	FH2CC	WOS:000410945300007	28471514				2018-01-05	
J	Whitworth, KM; Prather, RS				Whitworth, Kristin M.; Prather, Randall S.			Gene editing as applied to prevention of reproductive porcine reproductive and respiratory syndrome	MOLECULAR REPRODUCTION AND DEVELOPMENT			English	Review						CD163; CRISPR; Cas9; genetic engineering; zygote injection	SYNDROME VIRUS-INFECTION; SCAVENGER RECEPTOR; NUCLEAR TRANSFER; PRRS VIRUS; IN-VITRO; CD163; ENTRY; PIGS; REPLICATION; APOPTOSIS	Porcine Reproductive and Respiratory Syndrome (PRRS) causes severe reproductive failure in sows as well as transplacental transfer of PRRS virus (PRRSV) to late-gestation fetuses, resulting in abortions, early farrowing, increased number of stillborn piglets, and weak neonatal piglets. PRRSV-infected boars present with anorexia and lethargy, and have decreased sperm quality. The gene for the cellular receptor that the PRRSV uses, Cluster of differentiation 163 (CD163), was edited using Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 gene-editing technology to create biallelic DNA edits to the CD163 gene in 100% of the offspring. CD163-null pigs challenged with virus were completely resistant to both Type 1 and Type 2 PRRSV isolates, as measured by clinical signs, viremia, antibody response, and lung histopathology. In vitro studies showed that CD163-null alveolar macrophages were also not permissive to infection by a panel of six Type 1 and nine Type 2 viral isolates. Thus, DNA editing of the CD163 gene prevented PRRSV infection and reproductive losses associated with infection.	[Whitworth, Kristin M.; Prather, Randall S.] Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA	Prather, RS (reprint author), Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA.	pratherr@missouri.edu		Prather, Randall/0000-0002-6012-4035	Genus plc, DeForest, WI	Genus plc, DeForest, WI	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bazer FW, 2014, DIFFERENTIATION, V87, P52, DOI 10.1016/j.diff.2013.11.005; Benson JE, 2001, THERIOGENOLOGY, V56, P777, DOI 10.1016/S0093-691X(01)00607-0; Brar MS, 2015, J GEN VIROL, V96, P1570, DOI 10.1099/vir.0.000104; Burkard C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006206; Calvert JG, 2007, J VIROL, V81, P7371, DOI 10.1128/JVI.00513-07; Cheon DS, 2001, J COMP PATHOL, V124, P231, DOI 10.1053/jcpa.2000.0457; Christopher-Hennings J, 1998, VET PATHOL, V35, P260, DOI 10.1177/030098589803500404                                                      ; Enders AC, 1999, ADV DRUG DELIVER REV, V38, P3, DOI 10.1016/S0169-409X(99)00003-4                                                   ; Forsberg R, 2002, VIROLOGY, V299, P38, DOI 10.1006/viro.2002.1450; Gleissner CA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00001; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Han K, 2013, VET RES COMMUN, V37, P155, DOI 10.1007/s11259-013-9558-x; Han K, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-156; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; HOPPER SA, 1992, VET REC, V131, P140, DOI 10.1136/vr.131.7.140                                                            ; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Karniychuk UU, 2009, PLACENTA, V30, P497, DOI 10.1016/j.placenta.2009.03.016; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; Keffaber KK, 1989, AM ASS SWINE PRACT N, V1, P1; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785                                                              ; Kranker S, 1998, VET MICROBIOL, V61, P21, DOI 10.1016/S0378-1135(98)00176-X                                                   ; Kreutz LC, 1996, VIRUS RES, V42, P137, DOI 10.1016/0168-1702(96)01313-5                                                    ; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Ladinig A, 2015, VIRUS RES, V203, P24, DOI 10.1016/j.virusres.2015.03.005; Ladinig A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096104; Lager KM, 1996, J VET DIAGN INVEST, V8, P275, DOI 10.1177/104063879600800301                                                      ; Li H, 2015, INT J CLIN EXP MED, V8, P15373; Li SF, 2016, ONCOTARGET, V7, P56002, DOI 10.18632/oncotarget.10817; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MENGELING WL, 1994, AM J VET RES, V55, P1391; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Nauwynck HJ, 1999, J GEN VIROL, V80, P297, DOI 10.1099/0022-1317-80-2-297                                                      ; Novakovic P, 2016, VET RES, V47, DOI 10.1186/s13567-016-0364-7; Onofre Gabriela, 2009, Acta Medica (Hradec Kralove), V52, P57, DOI 10.14712/18059694.2016.105; Prather RS, 2013, J VIROL, V87, P9538, DOI 10.1128/JVI.00177-13; Prieto C, 2003, THERIOGENOLOGY, V60, P1505, DOI 10.1016/S0093-691X(03)00129-8; Prieto C, 1996, VET REC, V138, P536, DOI 10.1136/vr.138.22.536                                                           ; Redman M, 2016, ARCH DIS CHILDHOOD-E, V101, P213, DOI 10.1136/archdischild-2016-310459; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rowland RRR, 2010, VIRUS RES, V154, P114, DOI 10.1016/j.virusres.2010.09.001; Rowland RRR, 2003, VET MICROBIOL, V96, P219, DOI 10.1016/j.vetmic.2003.07.006; Schulze M, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-16; Shi CX, 2015, ARCH MICROBIOL, V197, P503, DOI 10.1007/s00203-015-1088-1; Shi M, 2010, VIRUS RES, V154, P7, DOI 10.1016/j.virusres.2010.18.014; Sirinarumitr T, 1998, J GEN VIROL, V79, P2989, DOI 10.1099/0022-1317-79-12-2989                                                    ; Stadejek T, 2013, VET MICROBIOL, V165, P21, DOI 10.1016/j.vetmic.2013.02.029; Sur JH, 1997, J VIROL, V71, P9170; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Van Breedam W, 2010, J GEN VIROL, V91, P1659, DOI 10.1099/vir.0.020503-0; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Van Gorp H, 2010, J VIROL, V84, P3101, DOI 10.1128/JVI.02093-09; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wang X., 2016, SCI REP, V6, P20620; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348; Welch SKW, 2010, VIRUS RES, V154, P98, DOI 10.1016/j.virusres.2010.07.018; Wells K. D., 2016, J VIROLOGY, V91; Whitworth KM, 2017, TRANSGENIC RES, V26, P97, DOI 10.1007/s11248-016-9989-6; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whitworth KM, 2015, CELL REPROGRAM, V17, P243, DOI 10.1089/cell.2015.0022; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wilkinson JM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2720-4; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yuan SZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156518; Zhang QZ, 2015, VET MICROBIOL, V177, P229, DOI 10.1016/j.vetmic.2015.04.002; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	69	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1040-452X	1098-2795		MOL REPROD DEV	Mol. Reprod. Dev.	SEP	2017	84	9					926	933		10.1002/mrd.22811				8	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	FH2CC	WOS:000410945300017	28390179				2018-01-05	
J	Wells, KD; Prather, RS				Wells, Kevin D.; Prather, Randall S.			Genome-editing technologies to improve research, reproduction, and production in pigs	MOLECULAR REPRODUCTION AND DEVELOPMENT			English	Review						CRISPR; Cas9; homologous recombination; non-homologous end joining; translational research	NUCLEAR TRANSFER; PROTEIN-SYNTHESIS; MOUSE EMBRYOS; KNOCKOUT PIGS; GENE; DISRUPTION; GENERATION; VIRUS; MICROINJECTION; EXPRESSION	The ability to directly manipulate the pig genome through genetic engineering has been available to the research community for over three decades. This technology has progressed from the random insertion of foreign DNA, via a variety of techniques (pronuclear microinjection, sperm mediated gene transfer, and integration of mobile genetic elements), to manipulation of endogenous genes, via homologous recombination in somatic cells followed by somatic cell nuclear transfer. Over the last few years, designer nucleases facilitated the development of techniques that provide efficient ways to introduce foreign DNA or to modify endogenous genes in eggs, zygotes, or somatic cells. Together, these genome-editing technologies have essentially removed the obstacles to gene manipulation in swine. Although the regulatory environment is still unclear for agricultural applications, genetic engineering of pigs will continue to advance biomedicine and biology. In addition, genetic engineering is now sufficiently simple and efficient that agricultural research can now ask basic and applied questions that are not hampered by limited funding.	[Wells, Kevin D.; Prather, Randall S.] Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA	Prather, RS (reprint author), Univ Missouri, Div Anim Sci, 920 East Campus Dr, Columbia, MO 65211 USA.	ratherr@missouri.edu		Prather, Randall/0000-0002-6012-4035	NIH Office of the Director [U42 OD011140]	NIH Office of the Director, Grant number: U42 OD011140; Food for the 21st Century	BISHOP JO, 1989, MOL BIOL MED, V6, P283; Brauer VM, 2016, GENE, V587, P137, DOI 10.1016/j.gene.2016.04.052; Burkard C., 2017, PLOS PATHOG, V13; Cabot RA, 2001, ANIM BIOTECHNOL, V12, P205, DOI 10.1081/ABIO-100108347; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Carlson DF, 2011, TRANSGENIC RES, V20, P1125, DOI 10.1007/s11248-010-9481-7; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Desauliners A. T., 2016, USE GENETICALLY ENG; Desaulniers AT, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128082; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0                                                                ; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; FREI RE, 1989, J REPROD FERTIL, V86, P637; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380                                                         ; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; JARRELL VL, 1991, BIOL REPROD, V44, P62, DOI 10.1095/biolreprod44.1.62; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kostic C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071363; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lavitrano M, 1997, TRANSPLANT P, V29, P3508, DOI 10.1016/S0041-1345(97)00998-6                                                   ; LEVEY IL, 1978, DEV BIOL, V64, P140, DOI 10.1016/0012-1606(78)90066-0; LEVEY IL, 1978, J EXP ZOOL, V203, P351, DOI 10.1002/jez.1402030303; Lillico SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21645; Lillico SG, 2013, SCI REP-UK, V3, DOI 10.1038/srep02847; Lorson MA, 2011, TRANSGENIC RES, V20, P1293, DOI 10.1007/s11248-011-9496-8; Mathew DJ, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126128; Mendicino M, 2011, TRANSGENIC RES, V20, P625, DOI 10.1007/s11248-010-9444-z; Miles EL, 2013, P NATL ACAD SCI USA, V110, P6334, DOI 10.1073/pnas.1220910110; Mordhorst B. R., 2017, ANIMAL MODELS HUMAN, P213; Nowak-Imialek M, 2011, STEM CELLS DEV, V20, P1564, DOI 10.1089/scd.2010.0399; Park KE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40176; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Prather RS, 2013, NAT BIOTECHNOL, V31, P122, DOI 10.1038/nbt.2490; Ramsoondar J, 2011, TRANSGENIC RES, V20, P643, DOI 10.1007/s11248-010-9445-y; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; WALL RJ, 1992, THERIOGENOLOGY, V38, P337, DOI 10.1016/0093-691X(92)90239-N; Wells K. D., 2017, J VIROLOGY; Whitelaw CBA, 2004, FEBS LETT, V571, P233, DOI 10.1016/j.febslet.2004.06.076; Whitworth K. M., 2017, MOL REPROD DEV, V9999, P1; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Whyte JJ, 2011, MOL REPROD DEV, V78, P2, DOI 10.1002/mrd.21271; Yao J, 2016, HUM GENET, V135, P1093, DOI 10.1007/s00439-016-1710-6	46	3	3	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1040-452X	1098-2795		MOL REPROD DEV	Mol. Reprod. Dev.	SEP	2017	84	9					1012	1017		10.1002/mrd.22812				6	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	FH2CC	WOS:000410945300026	28394093				2018-01-05	
J	Webb, S				Webb, Sarah			PLANTS IN THE CRISPR	BIOTECHNIQUES			English	Article																Jia HG, 2017, PLANT BIOTECHNOL J, V15, P817, DOI 10.1111/pbi.12677; Ledford H, 2016, NATURE, V532, P158, DOI 10.1038/532158a; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Svitashev S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13274	5	0	0	5	5	BIOTECHNIQUES OFFICE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	0736-6205	1940-9818		BIOTECHNIQUES	Biotechniques	SEP	2017	63	3					96	101		10.2144/000114583				4	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FG7YV	WOS:000410642400002	28911311				2018-01-05	
J	Gomaa, F; Garcia, PA; Delaney, J; Girguis, PR; Buie, CR; Edgcomb, VP				Gomaa, Fatma; Garcia, Paulo A.; Delaney, Jennifer; Girguis, Peter R.; Buie, Cullen R.; Edgcomb, Virginia P.			Toward establishing model organisms for marine protists: Successful transfection protocols for Parabodo caudatus (Kinetoplastida: Excavata)	ENVIRONMENTAL MICROBIOLOGY			English	Article							PHAEODACTYLUM-TRICORNUTUM; ELECTROPORATION; RNA; GENE; FLAGELLATE; PROTEINS; MARKER; DNA	We developed protocols for, and demonstrated successful transfection of, the free-living kinetoplastid flagellate Parabodo caudatus with three plasmids carrying a fluorescence reporter gene (pEF-GFP with the EF1 alpha promoter, pUB-GFP with Ubiquitin C promoter, and pEYFP-Mitotrap with CMV promoter). We evaluated three electroporation approaches: (1) a square-wave electroporator designed for eukaryotes, (2) a novel microfluidic transfection system employing hydrodynamically-controlled electric field waveforms, and (3) a traditional exponential decay electroporator. We found the microfluidic device provides a simple and efficient platform to quickly test a wide range of electric field parameters to find the optimal set of conditions for electroporation of target species. It also allows for processing large sample volumes (>10 ml) within minutes, increasing throughput 100 times over cuvettes. Fluorescence signal from the reporter gene was detected a few hours after transfection and persisted for 3 days in cells transfected by pEF-GFP and pUB-GFP plasmids and for at least 5 days post-transfection for cells transfected with pEYFP-Mitotrap. Expression of the reporter genes (GFP and YFP) was also confirmed using reverse transcription-PCR (RT-PCR). This work opens the door for further efforts with this taxon and close relatives toward establishing model systems for genome editing.	[Gomaa, Fatma; Edgcomb, Virginia P.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Garcia, Paulo A.; Buie, Cullen R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Gomaa, Fatma; Delaney, Jennifer; Girguis, Peter R.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Edgcomb, VP (reprint author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	vedgcomb@whoi.edu			Gordon and Betty Moore Foundation [GBMF4963]; National Science Foundation (NSF) [I-Corps 1562925, PFI: AIR - TT 1640678]	The authors have no conflict of interest to declare. This project was funded by the Gordon and Betty Moore Foundation through Grant GBMF4963 to V. Edgcomb, P. Girguis, and C. Buie. This work was also funded by the National Science Foundation (NSF) I-Corps 1562925 and NSF PFI: AIR - TT 1640678.	Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Clark MB, 2013, ESSAYS BIOCHEM, V54, P1, DOI [10.1042/BSE0540001, 10.1042/bse0540001]; Cold ER, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155015; Corovic S, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-37; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Fernandez-Robledo JA, 2008, MOL BIOCHEM PARASIT, V157, P44, DOI 10.1016/j.molbiopara.2007.09.007; Garcia PA, 2017, LAB CHIP, V17, P490, DOI 10.1039/c6lc01309k; Garcia PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21238; Gong WD, 2017, ISME J, V11, P439, DOI 10.1038/ismej.2016.129; Hoffmeyer TT, 2016, CURR OPIN GENET DEV, V39, P42, DOI 10.1016/j.gde.2016.05.016; Hopes A, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0148-0; Jackson AP, 2016, CURR BIOL, V26, P161, DOI 10.1016/j.cub.2015.11.055; Jackson AP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-594; Jones KL, 2007, BIOTECHNIQUES, V43, P675, DOI 10.2144/000112593; Josenhans C, 1998, FEMS MICROBIOL LETT, V161, P263, DOI 10.1111/j.1574-6968.1998.tb12957.x; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Kim TK, 2010, ANAL BIOANAL CHEM, V397, P3173, DOI 10.1007/s00216-010-3821-6; KNIGHT DE, 1986, BIOCHEM J, V234, P497, DOI 10.1042/bj2340497                                                               ; KOPYLOV AI, 1980, OKEANOLOGIYA+, V20, P1073; Kotnik T, 2015, TRENDS BIOTECHNOL, V33, P480, DOI 10.1016/j.tibtech.2015.06.002; Lander N, 2016, J BIOL CHEM, V291, P25505, DOI 10.1074/jbc.M116.749655; Lander N, 2016, J EUKARYOT MICROBIOL, V63, P679, DOI 10.1111/jeu.12338; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Liang XQ, 2017, J BIOTECHNOL, V241, P136, DOI 10.1016/j.jbiotec.2016.11.011; Liu XJ, 2016, ALGAL RES, V20, P249, DOI 10.1016/j.algal.2016.10.018; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Miyahara M, 2013, BIOSCI BIOTECH BIOCH, V77, P874, DOI 10.1271/bbb.120936; NEUMANN E, 1982, EMBO J, V1, P841; Opperdoes FR, 2016, J EUKARYOT MICROBIOL, V63, P657, DOI 10.1111/jeu.12315; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; TEISSIE J, 1981, BIOCHEMISTRY-US, V20, P1548, DOI 10.1021/bi00509a022; ten Lohuis MR, 1998, PLANT J, V13, P427; Tikhonenkov DV, 2016, J EUKARYOT MICROBIOL, V63, P220, DOI 10.1111/jeu.12271; van Ooijen G, 2012, JOVE-J VIS EXP, DOI 10.3791/4074; von der Heyden S, 2004, J EUKARYOT MICROBIOL, V51, P402; Weaver JC, 2012, BIOELECTROCHEMISTRY, V87, P236, DOI 10.1016/j.bioelechem.2012.02.007; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335                                                  ; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594	40	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-2912	1462-2920		ENVIRON MICROBIOL	Environ. Microbiol.	SEP	2017	19	9					3487	3499		10.1111/1462-2920.13830				13	Microbiology	Microbiology	FG8EG	WOS:000410660900008	28631386				2018-01-05	
J	Aushev, M; Koller, U; Mussolino, C; Cathomen, T; Reichelt, J				Aushev, Magomet; Koller, Ulrich; Mussolino, Claudio; Cathomen, Toni; Reichelt, Julia			Traceless Targeting and Isolation of Gene- Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients	MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT			English	Article							EPIDERMAL STEM-CELLS; INTERMEDIATE-FILAMENTS; HUMAN KERATIN-14; CLONAL ANALYSIS; GENOME; MUTATIONS; INHIBITION; KNOCKOUT; SIRNA; SHOCK	Epidermolysis bullosa simplex (EBS) is a blistering skin disease caused by dominant-negative mutations in either KRT5 or KRT14, resulting in impairment of keratin filament structure and epidermal fragility. Currently, nearly 200 mutations distributed across the entire length of these genes are known to cause EBS. Genome editing using programmable nucleases enables the development of ex vivo gene therapies for dominant-negative genetic diseases. A clinically feasible strategy involves the disruption of the mutant allele while leaving the wild-type allele unaffected. Our aim was to develop a traceless approach to efficiently disrupt KRT5 alleles using TALENs displaying unbiased monoallelic disruption events and devise a strategy that allows for subsequent screening and isolation of correctly modified keratinocyte clones without the need for selection markers. Here we report on TALENs that efficiently disrupt the KRT5 locus in immortalized patient-derived EBS keratinocytes. Inactivation of the mutant allele using a TALEN working at sub-optimal levels resulted in restoration of intermediate filament architecture. This approach can be used for the functional inactivation of any mutant keratin allele regardless of the position of the mutation within the gene and is furthermore applicable to the treatment of other inherited skin disorders.	[Aushev, Magomet] Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Ctr Life, Biomed West Wing,Times Sq, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Koller, Ulrich; Reichelt, Julia] Paracelsus Med Univ Salzburg, Res Program Mol Therapy Genodermatoses, Univ Hosp, EB House Austria, A-5020 Salzburg, Austria; [Koller, Ulrich; Reichelt, Julia] Paracelsus Med Univ Salzburg, Univ Hosp, Dept Dermatol, A-5020 Salzburg, Austria; [Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Inst Transfus Med & Gene Therapy, Med Ctr, Hugstetter Str 55, D-79106 Freiburg, Germany; [Mussolino, Claudio; Cathomen, Toni] Univ Freiburg, Ctr Chron Immunodeficiency, Med Ctr, Breisacher Str 115, D-79106 Freiburg, Germany; [Cathomen, Toni] Univ Freiburg, Fac Med, D-79106 Freiburg, Germany	Reichelt, J (reprint author), Paracelsus Med Univ Salzburg, Res Program Mol Therapy Genodermatoses, Univ Hosp, EB House Austria, A-5020 Salzburg, Austria.; Reichelt, J (reprint author), Paracelsus Med Univ Salzburg, Univ Hosp, Dept Dermatol, A-5020 Salzburg, Austria.	j.reichelt@salk.at		Cathomen, Toni/0000-0002-7757-4630	DEBRA Austria; German Federal Ministry of Education and Research [BMBF 01EO0803]	This work was part of a self-funded studentship (to M.A.) and financially supported by DEBRA Austria (to U.K and J.R.) and grants from the German Federal Ministry of Education and Research (BMBF 01EO0803 to C.M. and T.C.). We are grateful to Thomas Lahaye for kindly allowing us to use his TALEN Golden Gate cloning platform, Christien Bednarski for technical assistance in generating the TALENs, Hans Torma for providing the immortalized keratinocyte lines, Ingo Haase for providing 3T3-J2 feeder cells, and Nick Reynolds and the Urology Department of the Freeman Hospital NHS Foundation Trust for providing primary keratinocytes. We thank Andrew Fuller and David McDonald from the Newcastle University Flow Cytometry Core Facility for help with flow cytometry. We also thank Alex Laude from the Newcastle University Bio-Imaging Unit for help with developing the live-cell imaging assay and Thorsten Hoher for constructing the GFP-K10 plasmid. We also thank Jelena Mann for providing feedback and suggestions for the manuscript.	Atkinson SD, 2011, J INVEST DERMATOL, V131, P2079, DOI 10.1038/jid.2011.169; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; Barrandon Y, 2012, SEMIN CELL DEV BIOL, V23, P937, DOI 10.1016/j.semcdb.2012.09.011; Bauer JW, 2017, J INVEST DERMATOL, V137, P778, DOI 10.1016/j.jid.2016.10.038; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chamcheu JC, 2011, BRIT J DERMATOL, V164, P263, DOI 10.1111/j.1365-2133.2010.10092.x; Chamcheu JC, 2010, BRIT J DERMATOL, V162, P980, DOI 10.1111/j.1365-2133.2009.09615.x; Chamcheu JC, 2011, J INVEST DERMATOL, V131, P1684, DOI 10.1038/jid.2011.93; Chamcheu JC, 2009, J DERMATOL SCI, V53, P198, DOI 10.1016/j.jdermsci.2008.11.003; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; Chen SJ, 2013, NUCLEIC ACIDS RES, V41, P2769, DOI 10.1093/nar/gks1356; Coluccio A, 2013, MOL THER, V21, P1695, DOI 10.1038/mt.2013.143; Cornu TI, 2017, NAT MED, V23, P415, DOI 10.1038/nm.4313; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; De Rosa L, 2014, STEM CELL REP, V2, P1, DOI 10.1016/j.stemcr.2013.11.001; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cellbio.11.1.123; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706                                                     ; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hickerson RP, 2008, J INVEST DERMATOL, V128, P594, DOI 10.1038/sj.jid.5701060; Hickerson RP, 2006, ANN NY ACAD SCI, V1082, P56, DOI 10.1196/annals.1348.059; Hoher T, 2012, STEM CELL REV REP, V8, P426, DOI 10.1007/s12015-011-9313-z; ISHIDAYAMAMOTO A, 1991, J INVEST DERMATOL, V97, P959, DOI 10.1111/1523-1747.ep12491885; Kaspar BK, 2005, J GENE MED, V7, P316, DOI 10.1002/jgm.665; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; KITAJIMA Y, 1989, ARCH DERMATOL RES, V281, P5, DOI 10.1007/BF00424265                                                              ; Lathion SDG, 2015, EMBO MOL MED, V7, P380; Leachman SA, 2010, MOL THER, V18, P442, DOI 10.1038/mt.2009.273; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; March O. P., 2017, EXP PHYSL; Mathor MB, 1996, P NATL ACAD SCI USA, V93, P10371, DOI 10.1073/pnas.93.19.10371; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Mou HM, 2016, CELL STEM CELL, V19, P217, DOI 10.1016/j.stem.2016.05.012; Muller FB, 2006, HUM MOL GENET, V15, P1133, DOI 10.1093/hmg/ddl028; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2                                                    ; Rochat A., 2013, HDB STEM CELLS, P766; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009                                                ; Roshan A, 2016, NAT CELL BIOL, V18, P145, DOI 10.1038/ncb3282; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096                                                          ; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Sorensen CB, 1999, J INVEST DERMATOL, V112, P184, DOI 10.1046/j.1523-1747.1999.00495.x; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139	56	1	1	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2329-0501			MOL THER-METH CLIN D	Mol.Ther.-Methods Clin. Dev.	SEP	2017	6						112	123		10.1016/j.omtm.2017.06.008				12	Medicine, Research & Experimental	Research & Experimental Medicine	FG8EE	WOS:000410660600013	28765827	gold			2018-01-05	
J	Nitta, K; Matsuzaki, Y; Konno, A; Hirai, H				Nitta, Keisuke; Matsuzaki, Yasunori; Konno, Ayumu; Hirai, Hirokazu			Minimal Purkinje Cell-Specific PCP2/L7 Promoter Virally Available for Rodents and Non-human Primates	MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT			English	Article							LONG-TERM DEPRESSION; GREEN FLUORESCENT PROTEIN; ROR NUCLEAR RECEPTORS; KINASE-C INHIBITOR; CEREBELLAR PURKINJE; RESPONSE ELEMENT; TRANSGENIC MICE; VESTIBULOOCULAR REFLEX; METABOTROPIC GLUTAMATE; SYNAPSE ELIMINATION	Cell-type-specific promoters in combination with viral vectors and gene-editing technology permit efficient gene manipulation in specific cell populations. Cerebellar Purkinje cells play a pivotal role in cerebellar functions. Although the Purkinje cell-specific L7 promoter is widely used for the generation of transgenic mice, it remains unsuitable for viral vectors because of its large size (3 kb) and exceedingly weak promoter activity. Here, we found that the 0.8-kb region (named here as L7-6) upstream of the transcription initiation codon in the first exon was alone sufficient as a Purkinje cell-specific promoter, presenting a far stronger promoter activity over the original 3-kb L7 promoter with a sustained significant specificity to Purkinje cells. Intravenous injection of adeno-associated virus vectors that are highly permeable to the blood-brain barrier confirmed the Purkinje cell specificity of the L7-6 in the CNS. The features of the L7-6 were also preserved in the marmoset, a non-human primate. The high sequence homology of the L7-6 among mouse, marmoset, and human suggests the preservation of the promoter strength and Purkinje cell specificity features also in humans. These findings suggest that L7-6 will facilitate the cerebellar research targeting the pathophysiology and gene therapy of cerebellar disorders.	[Nitta, Keisuke; Matsuzaki, Yasunori; Konno, Ayumu; Hirai, Hirokazu] Gunma Univ, Dept Neurophysiol & Neural Repair, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan; [Nitta, Keisuke] Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Hirai, Hirokazu] Gunma Univ, Div Endocrinol Metab & Signal Res, Res Program Neural Signalling, Initiat Adv Res, Maebashi, Gunma 3718511, Japan	Hirai, H (reprint author), Gunma Univ, Dept Neurophysiol & Neural Repair, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	hirai@gunma-u.ac.jp		Hirai, Hirokazu/0000-0002-0721-4293	Ministry of Education, Culture, and Sports Science (MEXT); Japan Agency for Medical Research and Development (AMED); Gunma University Initiative for Advanced Research (GIAR)	The authors thank Asako Ohnishi, Junko Sugiyama, Motoko Uchiyama, and Minako Noguchi for the AAV9 vector production, mice genotyping, and raising the marmoset. This study was partially supported by the program for Brain Mapping by Integrated Neuro-technologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, and Sports Science (MEXT), Japan Agency for Medical Research and Development (AMED), and Gunma University Initiative for Advanced Research (GIAR) (to H.H.).	AIBA A, 1994, CELL, V79, P377; Anderson GW, 1998, J BIOL CHEM, V273, P16391, DOI 10.1074/jbc.273.26.16391; Barski JJ, 2014, CEREBELLUM, V13, P207, DOI 10.1007/s12311-013-0529-0; Bellebaum C, 2007, CEREBELLUM, V6, P184, DOI 10.1080/14734220601169707; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Burkart JM, 2015, NEUROSCI RES, V93, P8, DOI 10.1016/j.neures.2014.09.003; Collinson SL, 2006, NEUROCASE, V12, P350, DOI 10.1080/13554790601076697; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Gebhart AL, 2002, ANN NY ACAD SCI, V978, P318, DOI 10.1111/j.1749-6632.2002.tb07577.x; Goossens J, 2001, J NEUROSCI, V21, P5813; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hagen SG, 1996, J MOL NEUROSCI, V7, P245, DOI 10.1007/BF02737062                                                              ; Hirai H, 2005, EMBO REP, V6, P90, DOI 10.1038/sj.embor.7400312; Hirai H, 2000, J NEUROSCI, V20, P5217; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832                                                   ; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Janssen G, 1998, KLIN PADIATR, V210, P243, DOI 10.1055/s-2008-1043886                                                          ; Jetten AM, 2006, AD DEV BIOL, V16, P313, DOI 10.1016/S1574-3349(06)16010-X; Kakizawa S, 2007, EMBO J, V26, P1924, DOI 10.1038/sj.emboj.7601639; Kina S, 2007, EUR J NEUROSCI, V26, P2269, DOI 10.1111/j.1460-9568.2007.05829.x; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Konno A, 2014, CEREBELLUM, V13, P29, DOI 10.1007/s12311-013-0516-5; Korhonen L, 2008, NEUROSCIENCE, V156, P515, DOI 10.1016/j.neuroscience.2008.08.005; Leggio MG, 2000, J NEUROL NEUROSUR PS, V69, P102, DOI 10.1136/jnnp.69.1.102                                                           ; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0                                                   ; Matsuzaki Y, 2014, J NEUROSCI METH, V223, P133, DOI 10.1016/j.jneumeth.2013.12.004; Miki T, 2013, J NEUROSCI, V33, P18755, DOI 10.1523/JNEUROSCI.3161-13.2013; Mitchell JF, 2015, NEUROSCI RES, V93, P20, DOI 10.1016/j.neures.2015.01.008; NORDQUIST DT, 1988, J NEUROSCI, V8, P4780; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Okano H, 2015, NEUROSCI RES, V93, P3, DOI 10.1016/j.neures.2014.08.014; Oue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051015; Peterburs J, 2016, CURR OPIN NEUROBIOL, V40, P38, DOI 10.1016/j.conb.2016.06.011; Sawada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27758; Sawada Y, 2010, CEREBELLUM, V9, P291, DOI 10.1007/s12311-010-0161-1; Serinagaoglu Y, 2007, MOL CELL NEUROSCI, V34, P324, DOI 10.1016/j.mcn.2006.11.013; Shinohara Y., 2017, CEREBELLUM; Shinohara Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162023; Sierk ML, 2001, BIOCHEMISTRY-US, V40, P12833, DOI 10.1021/bi011086r; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Tanaka S, 2013, J NEUROSCI, V 33, P17209, DOI 10.1523/JNEUROSCI.0793-13.2013; Tomomura M, 2001, EUR J NEUROSCI, V14, P57, DOI 10.1046/j.0953-816x.2001.01624.x; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Uesaka N, 2014, SCIENCE, V344, P1020, DOI 10.1126/science.1252514; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Wu ZJ, 2010, MOL THER, V18, P80, DOI 10.1038/mt.2009.255; Xu Y, 2008, J NEUROSCI, V28, P8873, DOI 10.1523/JNEUROSCI.0812-08.2008; Zhang X, 2001, HISTOCHEM CELL BIOL, V115, P455; Zhang XL, 2002, MOL BRAIN RES, V105, P1, DOI 10.1016/S0169-328X(02)00379-0; ZOU LL, 1994, J BIOL CHEM, V269, P13346; Hirai H., 2007, Purkinje cell-tropic viral vector. U. S. Patent, Patent No. [8912315 B2, 8912315]	59	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2329-0501			MOL THER-METH CLIN D	Mol.Ther.-Methods Clin. Dev.	SEP	2017	6						159	170		10.1016/j.omtm.2017.07.006				12	Medicine, Research & Experimental	Research & Experimental Medicine	FG8EE	WOS:000410660600017	28828391	gold			2018-01-05	
J	Stamm, S; Gruber, SB; Rabchevsky, AG; Emeson, RB				Stamm, Stefan; Gruber, Samuel B.; Rabchevsky, Alexander G.; Emeson, Ronald B.			The activity of the serotonin receptor 2C is regulated by alternative splicing	HUMAN GENETICS			English	Review							SPINAL-CORD-INJURY; PRE-MESSENGER-RNA; 5-HT2C RECEPTORS; CONSTITUTIVE ACTIVITY; PERSISTENT SODIUM; PREFRONTAL CORTEX; CALCIUM CURRENTS; SUICIDE VICTIMS; SNORNA MBII-52; MOUSE MODEL	The central nervous system-specific serotonin receptor 2C (5HT2C) controls key physiological functions, such as food intake, anxiety, and motoneuron activity. Its deregulation is involved in depression, suicidal behavior, and spasticity, making it the target for antipsychotic drugs, appetite controlling substances, and possibly anti-spasm agents. Through alternative pre-mRNA splicing and RNA editing, the 5HT2C gene generates at least 33 mRNA isoforms encoding 25 proteins. The 5HT2C is a G-protein coupled receptor that signals through phospholipase C, influencing the expression of immediate/early genes like c-fos. Most 5HT2C isoforms show constitutive activity, i.e., signal without ligand binding. The constitutive activity of 5HT2C is decreased by pre-mRNA editing as well as alternative pre-mRNA splicing, which generates a truncated isoform that switches off 5HT2C receptor activity through heterodimerization; showing that RNA processing regulates the constitutive activity of the 5HT2C system. RNA processing events influencing the constitutive activity target exon Vb that forms a stable double stranded RNA structure with its downstream intron. This structure can be targeted by small molecules and oligonucleotides that change exon Vb alternative splicing and influence 5HT2C signaling in mouse models, leading to a reduction in food intake. Thus, the 5HT2C system is a candidate for RNA therapy in multiple models of CNS disorders.	[Stamm, Stefan; Gruber, Samuel B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Rabchevsky, Alexander G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Emeson, Ronald B.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA	Stamm, S (reprint author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	stefan@stamms-lab.net		Emeson, Ronald/0000-0002-4585-1648	NIH [R21NS098186]; Foundation for Prader-Willi Research	The work was supported by the NIH (R21NS098186) and the Foundation for Prader-Willi Research.	Barbon A, 2011, NEUROPSYCHOBIOLOGY, V63, P160, DOI 10.1159/000321593; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Bennett DJ, 1999, J NEUROTRAUM, V16, P69, DOI 10.1089/neu.1999.16.69; Berg KA, 2001, BRIT J PHARMACOL, V134, P386, DOI 10.1038/sj.bjp.0704255; Berg KA, 1998, MOL PHARMACOL, V54, P94; Berglund ED, 2014, J CLIN INVEST, V124, P1868, DOI 10.1172/JCI75669; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Carlin KP, 2000, EUR J NEUROSCI, V12, P1624, DOI 10.1046/j.1460-9568.2000.00050.x; CARLSSON A, 1963, EXPERIENTIA, V19, P359, DOI 10.1007/BF02152316; Carmel L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002663; Castensson A, 2005, AM J MED GENET B, V134B, P84, DOI 10.1002/ajmg.b.30151; Castensson A, 2003, BIOL PSYCHIAT, V54, P1212, DOI 10.1016/S0006-3223(03)00526-2; Cavaille J, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1417; Chagraoui A., 2016, BIOL PSYCHIAT, V66, P120; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Di Narzo AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12615; Di Narzo AF, 2014, HUM MOL GENET, V23, P4801, DOI 10.1093/hmg/ddu195; Dracheva S, 2008, NEUROREPORT, V19, P379, DOI 10.1097/WNR.0b013e3282f556d2; Driscoll DJ, 1993, GENEREVIEWS R; Du YZ, 2007, GENE, V391, P186, DOI 10.1016/j.gene.2006.12.023; Falaleeva M, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600264; Flomen R, 2004, NUCLEIC ACIDS RES, V32, P2113, DOI 10.1093/nar/gkh536; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Fukuda M, 2015, GENES CELLS, V20, P834, DOI 10.1111/gtc.12272; Garfield AS, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0277-4; Gorassini MA, 2004, BRAIN, V127, P2247, DOI 10.1093/brain/awh243; Greenway FL, 2016, CLIN OBES, V6, P285, DOI 10.1111/cob.12159; Gurevich I, 2002, J NEUROSCI, V22, P10529; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1141, DOI 10.1152/jn.00335.2005; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Herrick-Davis K, 2004, BIOCHEMISTRY-US, V43, P13963, DOI 10.1021/bi048398p; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Herrick-Davis K, 2013, EXP BRAIN RES, V230, P375, DOI 10.1007/s00221-013-3622-1; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336                                                  ; HUMPHREY PPA, 1993, TRENDS PHARMACOL SCI, V14, P233, DOI 10.1016/0165-6147(93)90016-D; Jacobs BL, 2002, BRAIN RES REV, V40, P45, DOI 10.1016/S0165-0173(02)00187-X; Jorjani H, 2016, NUCLEIC ACIDS RES, V44, P5068, DOI 10.1093/nar/gkw386; Karanovic J, 2015, WORLD J BIOL PSYCHIA, V16, P261, DOI 10.3109/15622975.2014.1000374; Kim D, 2001, EXP NEUROL, V169, P496, DOI 10.1006/exnr.2001.7660; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Li X, 2007, J NEUROPHYSIOL, V97, P1236, DOI 10.1152/jn.00995.2006; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Martin CBP, 2013, MOL PSYCHIATR, V18, P656, DOI 10.1038/mp.2012.171; Martin CBP, 2014, NEUROSCI BIOBEHAV R, V42, P208, DOI 10.1016/j.neubiorev.2014.03.001; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; Mickey BJ, 2012, J NEUROSCI, V32, P9344, DOI 10.1523/JNEUROSCI.1260-12.2012; Mongeau R, 2010, J NEUROCHEM, V115, P438, DOI 10.1111/j.1471-4159.2010.06932.x; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nakae A, 2013, NEUROSCI LETT, V532, P49, DOI 10.1016/j.neulet.2012.10.034; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Navarrett S, 2012, NEUROSCI LETT, V506, P74, DOI 10.1016/j.neulet.2011.10.052; Nielsen JB, 2007, ACTA PHYSIOL, V189, P171, DOI 10.1111/j.1748-1716.206.01652.x; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Ottesen EW, 2017, TRANSL NEUROSCI, V8, P1, DOI 10.1515/tnsci-2017-0001; Perrier JF, 2005, J NEUROSCI, V25, P7993, DOI 10.1523/JNEUROSCI.1957-05.2005; Rabchevsky AG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00329; Rabchevsky AG, 2011, NEUROTHERAPEUTICS, V8, P274, DOI 10.1007/s13311-011-0025-5; Rekling JC, 2000, PHYSIOL REV, V80, P767; Ren LQ, 2013, NEUROSCIENCE, V236, P31, DOI 10.1016/j.neuroscience.2012.12.063; Rodriguez EM, 2010, PEPTIDES, V31, P757, DOI 10.1016/j.peptides.2010.01.003; Schellekens H, 2015, ACS CHEM NEUROSCI, V6, P1186, DOI 10.1021/cn500318q; Schellekens H, 2013, J BIOL CHEM, V288, P181, DOI 10.1074/jbc.M112.382473; Schellekens H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032266; Schirle NT, 2010, ORG BIOMOL CHEM, V8, P4898, DOI 10.1039/c0ob00309c; Schmauss C, 2010, RNA, V16, P1779, DOI 10.1261/rna.2188110; Schmidt BJ, 2000, BRAIN RES BULL, V53, P689, DOI 10.1016/S0361-9230(00)00402-0                                                   ; Serra MJ, 2004, NUCLEIC ACIDS RES, V32, P1824, DOI 10.1093/nar/gkh501; Shams TA, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0473-9; Shen JHQ, 2014, J PSYCHIATR RES, V53, P14, DOI 10.1016/j.jpsychires.2014.02.012; Shen ML, 2013, NUCLEIC ACIDS RES, V41, P3819, DOI 10.1093/nar/gkt063; Shen ML, 2011, NUCLEIC ACIDS RES, V39, P9720, DOI 10.1093/nar/gkr684; Shukla AP, 2015, EXPERT OPIN PHARMACO, V16, P2531, DOI 10.1517/14656566.2015.1096345; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Soeno Y, 2010, RNA, V16, P1293, DOI 10.1261/rna.2109710; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Uchida H, 2017, FASEB J, V31, P1847, DOI 10.1096/fj.201600950R; Videtic A, 2009, GENES BRAIN BEHAV, V8, P541, DOI 10.1111/j.1601-183X.2009.00505.x; Walstab J, 2011, PHARMACOL REP, V63, P45, DOI 10.1016/S1734-1140(11)70397-8                                                   ; Walter JS, 2002, J REHABIL RES DEV, V39, P53; Wang QD, 2000, J NEUROCHEM, V74, P1290; Watanabe Y, 2014, INT J NEUROPSYCHOPH, V17, P739, DOI 10.1017/S1461145713001545; Weissmann D, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.121; Yang WD, 2004, MOL BRAIN RES, V124, P70, DOI 10.1016/j.molbrainres.2004.02.010; Zhang J, 2008, PROG NEURO-PSYCHOPH, V32, P467, DOI 10.1016/j.pnpbp.2007.09.019; Zhang Z, 2016, EMBO MOL MED, V8, P878, DOI 10.15252/emmm.201506030; Zhang ZY, 2013, EXP BRAIN RES, V230, P387, DOI 10.1007/s00221-013-3458-8	97	0	0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6717	1432-1203		HUM GENET	Hum. Genet.	SEP	2017	136	9			SI		1079	1091		10.1007/s00439-017-1826-3				13	Genetics & Heredity	Genetics & Heredity	FG9KE	WOS:000410757000005	28664341				2018-01-05	
J	Renuka, P; Madhav, MS; Padmakumari, AP; Barbadikar, KM; Mangrauthia, SK; Rao, KVS; Marla, SS; Babu, VR				Renuka, Pichili; Madhav, Maganti S.; Padmakumari, Ayyagari Phani; Barbadikar, Kalyani M.; Mangrauthia, Satendra K.; Rao, Kola Vijaya Sudhakara; Marla, Soma S.; Babu, Vemuri Ravindra			RNA-seq of Rice Yellow Stem Borer Scirpophaga incertulas Reveals Molecular Insights During Four Larval Developmental Stages	G3-GENES GENOMES GENETICS			English	Article						insect; Scirpophaga incertulas; de novo transcriptome; RNAi; growth and development; detoxification mechanism	BEETLE TRIBOLIUM-CASTANEUM; ZINC-FINGER PROTEINS; LOOP-HELIX FACTORS; INSECTICIDE-RESISTANCE; NILAPARVATA-LUGENS; BROWN PLANTHOPPER; DIFFERENTIAL EXPRESSION; DROSOPHILA-MELANOGASTER; ANTENNAL TRANSCRIPTOME; SPODOPTERA-LITURA	The yellow stem borer (YSB), Scirpophaga incertulas, is a prominent pest in rice cultivation causing serious yield losses. The larval stage is an important stage in YSB, responsible for maximum infestation. However, limited knowledge exists on the biology and mechanisms underlying the growth and differentiation of YSB. To understand and identify the genes involved in YSB development and infestation, so as to design pest control strategies, we performed de novo transcriptome analysis at the first, third, fifth, and seventh larval developmental stages employing Illumina Hi-seq. High-quality reads (HQR) of similar to 229 Mb were assembled into 24,775 transcripts with an average size of 1485 bp. Genes associated with various metabolic processes, i.e., detoxification mechanism [CYP450, GSTs, and carboxylesterases (CarEs)], RNA interference (RNAi) machinery (Dcr-1, Dcr-2, Ago-1, Ago-2, Sid-1, Sid-2, Sid-3, and Sid-1-related gene), chemoreception (CSPs, GRs, OBPs, and ORs), and regulators [transcription factors (TFs) and hormones] were differentially regulated during the developmental stages. Identification of stage-specific transcripts made it possible to determine the essential processes of larval development. Comparative transcriptome analysis revealed that YSB has not evolved much with respect to the detoxification mechanism, but showed the presence of distinct RNAi machinery. The presence of strong specific visual recognition coupled with chemosensory mechanisms supports the monophagous nature of YSB. Designed expressed sequenced tags-simple-sequence repeats (EST-SSRs) will facilitate accurate estimation of the genetic diversity of YSB. This is the first report on characterization of the YSB transcriptome and the identification of genes involved in key processes, which will help researchers and industry to devise novel pest control strategies. This study also opens up a new avenue to develop next-generation resistant rice using RNAi or genome editing approaches.	[Renuka, Pichili; Madhav, Maganti S.; Barbadikar, Kalyani M.; Mangrauthia, Satendra K.; Rao, Kola Vijaya Sudhakara] ICAR Indian Inst Rice Res, Dept Biotechnol, Hyderabad 500030, Telangana, India; [Padmakumari, Ayyagari Phani] ICAR Indian Inst Rice Res, Dept Entomol, Hyderabad 500030, Telangana, India; [Babu, Vemuri Ravindra] ICAR Indian Inst Rice Res, Dept Plant Breeding, Hyderabad 500030, Telangana, India; [Babu, Vemuri Ravindra] ICAR Natl Bur Plant Genom Resources, Div Genom Resources, New Delhi, India	Madhav, MS (reprint author), ICAR Indian Inst Rice Res, Dept Biotechnol, Crop Improvement Sect, Hyderabad 500030, Telangana, India.	sheshu24@gmail.com			Department of Biotechnology, Government of India [BT/PR2468/AGR/36/701/2011]	Authors are highly thankful to the Director of the Indian Council of Agricultural Research-Indian Institute of Rice Research for providing the research facilities for the experiments. P. Renuka acknowledges the Department of Genetics, Osmania University, Hyderabad for Ph.D. doctoral Programme. M.S.M has received funding for RNA-seq from the Department of Biotechnology, Government of India under grant BT/PR2468/AGR/36/701/2011 dt 23.05.2012.	ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Arias RS, 2011, ANN ENTOMOL SOC AM, V104, P576, DOI 10.1603/AN10135; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307                                                  ; Banerjee S. N., 1967, LEPIDOPTEROUS STALK, P103; Bauer M, 2006, PHYSIOL GENOMICS, V25, P393, DOI 10.1152/physiolgenomics.00009.2006.; Beermann A, 2004, DEVELOPMENT, V131, P733, DOI 10.1242/dev.00974; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Camargo RD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1841-5; Chelliah A., 1989, APPROACHES, V26, P12; CHIPPENDALE GM, 1977, ANNU REV ENTOMOL, V22, P121, DOI 10.1146/annurev.en.22.010177.001005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feuda R, 2016, GENOME BIOL EVOL, V8, P579, DOI 10.1093/gbe/evw015; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gong L, 2015, INT J AGRIC BIOL, V17, P937, DOI 10.17957/IJAB/15.0005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Hamarsheh O, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-189; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023                                                         ; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Huvenne H., 2012, J INSECT PHYSL, V56, P227; Jia XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29067; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kobayashi I, 2012, INSECT BIOCHEM MOLEC, V42, P148, DOI 10.1016/j.ibmb.2011.11.007; Kola VSR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00020; Kola VSR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00119; Kulkarni KS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00847; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Li LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073911; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Listinger J. A., 1979, INT RICE RES NEWSL, V4, P14; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Ma WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038151; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Metzgar D, 2000, GENOME RES, V10, P72; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897                                                          ; Muralidharan K, 2006, CROP PROT, V25, P409, DOI 10.1016/j.cropro.2005.06.007; Ningshen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079468; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Ota A, 2002, COMP BIOCHEM PHYS B, V133, P371, DOI 10.1016/S1096-4959(02)00153-7; Ou J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-820; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Padmakumari A. P., 2013, ORYZA, V50, P259; Parekh MJ, 2016, IND CROP PROD, V83, P620, DOI 10.1016/j.indcrop.2015.12.061; Park Y, 2003, J BIOL CHEM, V278, P17710, DOI 10.1074/jbc.M301119200; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pathak M D, 1994, INSECT PESTS RICE; Patnaik BB, 2016, INT J GENOMICS, DOI 10.1155/2016/4169587; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Posnien N., 2009, COLD SPRING HARB PRO, V8, P5256; Prentice K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115336; Pridgeon JW, 2003, GENE, V314, P157, DOI 10.1016/S0378-1119(03)00725-X; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rath P. C., 2001, Journal of Applied Zoological Researches, V12, P191; Raymond-Delpech Valerie, 2005, Invert Neurosci, V5, P119; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers BT, 2002, EVOL DEV, V4, P96, DOI 10.1046/j.1525-142X.2002.01065.x                                                ; Saeed AI, 2003, BIOTECHNIQUES, V34, P374; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schliesky S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00220; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott Jeffrey G., 2008, P117; Shao YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-324; SMITH BH, 1994, ANNU REV ENTOMOL, V39, P351, DOI 10.1146/annurev.en.39.010194.002031                                             ; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; Stolle E, 2013, GENOME BIOL EVOL, V5, P151, DOI 10.1093/gbe/evs133; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2014, PEPTIDES, V53, P125, DOI 10.1016/j.peptides.2013.07.027; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Wang P, 2005, INSECT BIOCHEM MOLEC, V35, P611, DOI 10.1016/j.ibmb.2005.02.002; Wang RL, 2015, INT J MOL SCI, V16, P22606, DOI 10.3390/ijms160922606; Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495; Wolf JBW, 2013, MOL ECOL RESOUR, V13, P559, DOI 10.1111/1755-0998.12109; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183                                                ; Xu HJ, 2013, INSECT MOL BIOL, V22, P635, DOI 10.1111/imb.12051; Xue J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0521-0; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Yan SG, 2009, PROTEIN PEPTIDE LETT, V16, P1181; Yan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111683; Yang XM, 2012, INT J MOL SCI, V13, P2863, DOI 10.3390/ijms13032863; Yin CL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau065; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Yu R, 2014, INT J BIOL SCI, V10, P1171, DOI 10.7150/ijbs.9598; Zhang YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087800; Zhao W, 2016, INSECT BIOCHEM MOLEC, V70, P60, DOI 10.1016/j.ibmb.2015.11.009; Zhao X. M., 2014, BIOINFORMATICS, P1, DOI DOI 10.1007/S00245-013-9234-0; Zhou XJ, 2010, PESTIC BIOCHEM PHYS, V97, P209, DOI 10.1016/j.pestbp.2010.02.003; Zhu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038572	105	0	0	6	6	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	SEP	2017	7	9					3031	3045		10.1534/g3.117.043737				15	Genetics & Heredity	Genetics & Heredity	FG1CF	WOS:000409529500014	28717048	gold			2018-01-05	
J	Hart, JC; Miller, CT				Hart, James C.; Miller, Craig T.			Sequence-Based Mapping and Genome Editing Reveal Mutations in Stickleback Hps5 Cause Oculocutaneous Albinism and the casper Phenotype	G3-GENES GENOMES GENETICS			English	Article						genome editing; stickleback; pigmentation; albinism; Hermansky-Pudlak; syndrome	PUDLAK-SYNDROME TYPE-5; HUMAN HERMANSKY-PUDLAK-SYNDROME-5 HPS5; CO-CRISPR STRATEGY; BLACK-AND-WHITE; THREESPINE STICKLEBACKS; ZEBRAFISH; EFFICIENT; EVOLUTION; VERTEBRATES; IDENTIFICATION	Here, we present and characterize the spontaneous X-linked recessive mutation casper, which causes oculocutaneous albinism in threespine sticklebacks (Gasterosteus aculeatus). In humans, Hermansky-Pudlak syndrome results in pigmentation defects due to disrupted formation of the melanin-containing lysosomal-related organelle (LRO), the melanosome. casper mutants display not only reduced pigmentation of melanosomes in melanophores, but also reductions in the iridescent silver color from iridophores, while the yellow pigmentation from xanthophores appears unaffected. We mapped casper using high-throughput sequencing of genomic DNA from bulked casper mutants to a region of the stickleback X chromosome (chromosome 19) near the stickleback ortholog of Hermansky-Pudlak syndrome 5 (Hps5). casper mutants have an insertion of a single nucleotide in the sixth exon of Hps5, predicted to generate an early frameshift. Genome editing using CRISPR/Cas9 induced lesions in Hps5 and phenocopied the casper mutation. Injecting single or paired Hps5 guide RNAs revealed higher incidences of genomic deletions from paired guide RNAs compared to single gRNAs. Stickleback Hps5 provides a genetic system where a hemizygous locus in XY males and a diploid locus in XX females can be used to generate an easily scored visible phenotype, facilitating quantitative studies of different genome editing approaches. Lastly, we show the ability to better visualize patterns of fluorescent transgenic reporters in Hps5 mutant fish. Thus, Hps5 mutations present an opportunity to study pigmented LROs in the emerging stickleback model system, as well as a tool to aid in assaying genome editing and visualizing enhancer activity in transgenic fish.	[Hart, James C.; Miller, Craig T.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	Miller, CT (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ctmiller@berkeley.edu		Hart, James/0000-0002-6245-0459	National Institutes of Health (NIH) S10 Instrumentation Grants [S10RR029668, S10RR027303]; NIH [R01DE021475]; NIH genomics training grant [5T32HG000047-15]	We thank Anthony Lee for first noticing the original casper male. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC-Berkeley, supported by National Institutes of Health (NIH) S10 Instrumentation Grants S10RR029668 and S10RR027303. This work was funded by NIH R01DE021475 (to C.T.M.), and NIH genomics training grant 5T32HG000047-15 (to J.C.H.)	Bowen ME, 2012, GENETICS, V190, P1017, DOI 10.1534/genetics.111.136069; Burger A, 2016, DEVELOPMENT, V143, P2025, DOI 10.1242/dev.134809; COOPER KM, 1990, CELL TISSUE RES, V259, P15, DOI 10.1007/BF00571425; Cuperus JT, 2010, P NATL ACAD SCI USA, V107, P466, DOI 10.1073/pnas.0913203107; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Daly CMS, 2013, GENETICS, V195, P481, DOI 10.1534/genetics.113.154898; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265                                                           ; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doitsidou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015435; Erickson P. A., 2016, J VIS EXP, V111; Erickson PA, 2015, DEV BIOL, V401, P310, DOI 10.1016/j.ydbio.2015.02.006; Falcon-Perez JM, 2007, TRAFFIC, V8, P154, DOI 10.1111/j.1600-0854.2006.00514.x; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Fujii T, 2012, GENETICA, V140, P463, DOI 10.1007/s10709-012-9694-1; Gibson G, 2005, SCIENCE, V307, P1890, DOI 10.1126/science.1109835; Glazer AM, 2015, G3-GENES GENOM GENET, V5, P1463, DOI 10.1534/g3.115.017905; Glazer AM, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-19; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Helip-Wooley A, 2007, J INVEST DERMATOL, V127, P1471, DOI 10.1038/sj.jid.5700737; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Huizing M, 2004, TRAFFIC, V5, P711, DOI 10.1111/j.1600-0854.2004.00208.x; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Irion U, 2016, CURR TOP DEV BIOL, V117, P141, DOI 10.1016/bs.ctdb.2015.12.012; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jamann TM, 2015, METHODS MOL BIOL, V1284, P257, DOI 10.1007/978-1-4939-2444-8_13; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kane NS, 2017, G3-GENES GENOM GENET, V7, P87, DOI 10.1534/g3.116.036723; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Kelsh RN, 2004, PIGM CELL RES, V17, P326, DOI 10.1111/j.1600-0749.2004.00174.x; Kelsh RN, 2009, SEMIN CELL DEV BIOL, V20, P90, DOI 10.1016/j.semcdb.2008.10.001; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Martin A, 2016, CURR BIOL, V26, P14, DOI 10.1016/j.cub.2015.11.021; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Nakayama T, 2017, DEV BIOL, V426, P472, DOI 10.1016/j.ydbio.2016.08.020; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; Obholzer N, 2012, DEVELOPMENT, V139, P4280, DOI 10.1242/dev.083931; Oshima N, 2001, PIGM CELL RES, V14, P312, DOI 10.1034/j.1600-0749.2001.140502.x                                               ; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Rozen S, 2000, Methods Mol Biol, V132, P365; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Schraermeyer U, 1999, PIGM CELL RES, V12, P219, DOI 10.1111/j.1600-0749.1999.tb00755.x; SHOUP JR, 1966, J CELL BIOL, V29, P223, DOI 10.1083/jcb.29.2.223; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Square T, 2015, DEVELOPMENT, V142, P4180, DOI 10.1242/dev.125609; Syrzycka M, 2007, GENOME, V50, P548, DOI 10.1139/G07-032; Talbot JC, 2014, ZEBRAFISH, V11, P583, DOI 10.1089/zeb.2014.1047; Van der Auwera GA, 2013, CURR PROTOC BIOINFOR, V43, P11, DOI DOI 10.1002/0471250953.BI1110S43; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Wedekind C, 1998, J CHEM ECOL, V24, P787, DOI 10.1023/A:1022365315836                                                         ; Wei AH, 2013, J DERMATOL, V40, P325, DOI 10.1111/1346-8138.12025; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087; Ziegler I, 2003, PIGM CELL RES, V16, P172, DOI 10.1034/j.1600-0749.2003.00044.x                                                ; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	66	0	0	6	6	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	2160-1836			G3-GENES GENOM GENET	G3-Genes Genomes Genet.	SEP	2017	7	9					3123	3131		10.1534/g3.117.1125				9	Genetics & Heredity	Genetics & Heredity	FG1CF	WOS:000409529500022	28739598	gold			2018-01-05	
J	Xie, YY; Niu, BX; Long, YM; Li, GS; Tang, JT; Zhang, YL; Ren, D; Liu, YG; Chen, LT				Xie, Yongyao; Niu, Baixiao; Long, Yunming; Li, Gousi; Tang, Jintao; Zhang, Yaling; Ren, Ding; Liu, Yao-Guang; Chen, Letian			Suppression or knockout of SaF/SaM overcomes the Sa-mediated hybrid male sterility in rice	JOURNAL OF INTEGRATIVE PLANT BIOLOGY			English	Article							ORYZA-SATIVA L.; REPRODUCTIVE ISOLATION; LINKED GENES; BARRIER; SYSTEM; MUTATIONS; PLANTS; LOCUS; LINES; F-1	Hybrids between the indica and japonica subspecies of rice (Oryza sativa) are usually sterile, which hinders utilization of heterosis in the inter-subspecific hybrid breeding. The complex locus Sa comprises two adjacently located genes, SaF and SaM, which interact to cause abortion of pollen grains carrying the japonica allele in japonica-indica hybrids. Here we showed that silencing of SaF or SaM by RNA interference restored male fertility in indica-japonica hybrids with heterozygous Sa. We further used clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-based genome editing to knockout the SaF and SaM alleles, respectively, of an indica rice line to create hybrid-compatible lines. The resultant artificial neutral alleles did not affect pollen viability and other agricultural traits, but did break down the reproductive barrier in the hybrids. We found that some rice lines have natural neutral allele Sa-n, which was compatible with the typical japonica or indica Sa alleles in hybrids. Our results demonstrate that SaF and SaM are required for hybrid male sterility, but are not essential for pollen development. This study provides effective approaches for the generation of hybrid-compatible lines by knocking out the Sa locus or using the natural Sa-n allele to overcome hybrid male sterility in rice breeding. (c) 2017 The Authors. Bioelectromagnetics published by Wiley Periodicals, Inc.	[Xie, Yongyao; Li, Gousi; Tang, Jintao; Zhang, Yaling; Liu, Yao-Guang; Chen, Letian] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China; [Xie, Yongyao; Li, Gousi; Tang, Jintao; Zhang, Yaling; Liu, Yao-Guang; Chen, Letian] South China Agr Univ, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 510642, Guangdong, Peoples R China; [Xie, Yongyao; Niu, Baixiao; Long, Yunming; Li, Gousi; Tang, Jintao; Zhang, Yaling; Ren, Ding; Liu, Yao-Guang; Chen, Letian] South China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China; [Liu, Yao-Guang; Chen, Letian] South China Agr Univ, Key Lab Plant Funct Genom & Biotechnol, Guangdong Prov Higher Educ Inst, Guangzhou 510642, Guangdong, Peoples R China; [Niu, Baixiao] Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou 225009, Jiangsu, Peoples R China; [Long, Yunming] North Dakota State Univ, Dept Plant Sci, Fargo, ND 58108 USA; [Ren, Ding] Fudan Univ, Inst Plant Biol, Inst Biomed Sci, Sch Life Sci,State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Ren, Ding] Fudan Univ, Inst Plant Biol, Inst Biomed Sci, Collaborat Innovat Ctr Genet & Dev,Sch Life Sci, Shanghai 200438, Peoples R China	Chen, LT (reprint author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China.; Chen, LT (reprint author), South China Agr Univ, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 510642, Guangdong, Peoples R China.; Chen, LT (reprint author), South China Agr Univ, Coll Life Sci, Guangzhou 510642, Guangdong, Peoples R China.; Chen, LT (reprint author), South China Agr Univ, Key Lab Plant Funct Genom & Biotechnol, Guangdong Prov Higher Educ Inst, Guangzhou 510642, Guangdong, Peoples R China.	lotichen@scau.edu.cn	Chen, Letian/B-1263-2015	Chen, Letian/0000-0001-6413-636X	National Key Research and Development Program of China [2016YFD0100804]; National Natural Science Foundation of China [31471564]	We are grateful to Professor Xiangdong Liu at SCAU for providing the japonica-compatible indica seeds. This work was supported by grants from the National Key Research and Development Program of China (2016YFD0100804), and the National Natural Science Foundation of China (31471564).	Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Craig SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086647; Dan ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093122; Guo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26878; [胡旭霞 Hu Xuxia], 2006, [分子植物育种, Molecular Plant Breeding], V4, P621; Huang JZ, 2014, RICE, V7, DOI 10.1186/s12284-014-0013-6; Kubo T, 2016, G3-GENES GENOM GENET, V6, P1459, DOI 10.1534/g3.116.027573; Kubo T, 2016, MOL PLANT, V9, P221, DOI 10.1016/j.molp.2015.09.014; Kubo T, 2011, GENETICS, V189, P1083, DOI 10.1534/genetics.111.132035; Kubo T, 2008, GENES GENET SYST, V83, P443, DOI 10.1266/ggs.83.443; Li DT, 2007, THEOR APPL GENET, V114, P515, DOI 10.1007/s00122-006-0450-8; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Ma XL, 2015, MOL PLANT, V8, P1285, DOI 10.1016/j.molp.2015.02.012; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; OKA HI, 1974, GENETICS, V77, P521; Ouyang YD, 2013, ANNU REV PLANT BIOL, V64, P111, DOI 10.1146/annurev-arplant-050312-120205; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Sakata M, 2014, BREEDING SCI, V64, P309, DOI 10.1270/jsbbs.64.309; Wang Y, 2010, PLANTA, V231, P559, DOI 10.1007/s00425-009-1063-7; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Yamagata Y, 2010, P NATL ACAD SCI USA, V107, P1494, DOI 10.1073/pnas.0908283107; Yang JY, 2012, SCIENCE, V337, P1336, DOI 10.1126/science.1223702; Yu Y, 2016, GENETICS, V203, P1439, DOI 10.1534/genetics.115.183848; Yuan LP, 2014, RICE SCI, V21, P1, DOI 10.1016/S1672-6308(13)60167-5; Zhang Guiquan, 1993, Acta Genetica Sinica, V20, P541; Zuo JR, 2014, NATL SCI REV, V1, P253, DOI 10.1093/nsr/nwt004	30	3	3	23	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1672-9072	1744-7909		J INTEGR PLANT BIOL	J. Integr. Plant Biol.	SEP	2017	59	9			SI		669	679		10.1111/jipb.12564				11	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	FG2EA	WOS:000409894300009	28636095				2018-01-05	
J	Peng, RX; Zhang, R; Lin, GG; Yang, X; Li, ZY; Zhang, K; Zhang, JW; Li, JM				Peng, Rongxue; Zhang, Rui; Lin, Guigao; Yang, Xin; Li, Ziyang; Zhang, Kuo; Zhang, Jiawei; Li, Jinming			CRISPR/Cas9 Technology-Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing	JOURNAL OF MOLECULAR DIAGNOSTICS			English	Article							CELL LUNG-CANCER; ALK GENE REARRANGEMENT; QUALITY-CONTROL; CRIZOTINIB; INHIBITORS; ADENOCARCINOMAS; CHEMOTHERAPY	The echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase (ALK) receptor tyrosine kinase (EML4-ALK) rearrangement is an important biomarker that plays a pivotal role in therapeutic decision making for non small-cell lung cancer (NSCLC) patients. Ensuring accuracy and reproducibility of EML4-ALK testing by fluorescence in situ hybridization, immunohistochemistry, RT-PCR, and next generation sequencing requires reliable reference materials for monitoring assay sensitivity and specificity. Herein, we developed novel reference materials for various kinds of EML4-ALK testing. CRISPR/Cas9 was used to edit various NSCLC cell lines containing EML4-ALK rearrangement variants 1, 2, and 3a/b. After s.c. inoculation, the formalin-fixed, paraffin-embedded (FFPE) samples from xenografts were prepared and tested for suitability as candidate reference materials by fluorescence in situ hybridization, immunohistochemistry, RT-PCR, and next-generation sequencing. Sample validation and commutability assessments showed that all types of FFPE samples derived from xenograft tumors have typical histological structures, and EML4-ALK testing results were similar to the clinical ALK-positive NSCLC specimens. Among the four methods for EML4-ALK detection, the validation test showed 100% concordance. Furthermore, these novel FFPE reference materials showed good stability and homogeneity. Without limitations on varianttypes and production, our novel FFPE samples based on CRISPR/Cas9 editing and xenografts are suitable as candidate reference materials for the validation, verification, internal quality control, and proficiency testing of EML4-ALK detection.	[Peng, Rongxue; Zhang, Rui; Lin, Guigao; Yang, Xin; Li, Ziyang; Zhang, Kuo; Zhang, Jiawei; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Natl Ctr Gerontol, Beijing, Peoples R China; [Peng, Rongxue; Yang, Xin; Li, Ziyang; Zhang, Jiawei; Li, Jinming] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China; [Peng, Rongxue; Zhang, Rui; Lin, Guigao; Yang, Xin; Li, Ziyang; Zhang, Kuo; Zhang, Jiawei; Li, Jinming] Beijing Hosp, Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China	Li, JM (reprint author), Beijing Hosp, Natl Ctr Clin Labs, 1 Dahua Rd, Beijing 100730, Peoples R China.	jmli@nccl.org.cn			Beijing Natural Science Foundation [7164295, 7174345]; National Nature Science Foundation of China [81601841, 81601848]; Special Fund for Health Scientific Research in the Public Interest from National Population and Family Planning Commission of the People's Republic of China [201402018]	Supported by the Beijing Natural Science Foundation 7164295 (G.L.) and 7174345 (R.Z.), the National Nature Science Foundation of China 81601841 (G.L.) and 81601848 (R.Z.), and the Special Fund for Health Scientific Research in the Public Interest from National Population and Family Planning Commission of the People's Republic of China 201402018 (J.L.).	Akamatsu H, 2014, J THORAC ONCOL, V9, P1048, DOI 10.1097/JTO.0000000000000203; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arbour KC, 2017, HEMATOL ONCOL CLIN N, V31, P101, DOI 10.1016/j.hoc.2016.08.012; Cha YJ, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1061-z; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cruz-Rico G, 2015, AM J CLIN ONCOL-CANC, DOI 10.1097/COC.0000000000000213; Cui SH, 2017, ONCOTARGET, V8, P2771, DOI 10.18632/oncotarget.13741; Hargrave E, 2014, PHARMACOGENOMICS, V15, P260; Jang JS, 2016, J THORAC ONCOL, V11, P1891, DOI 10.1016/j.jtho.2016.06.001; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Laffert MV, 2013, LUNG CANCER, V81, P200, DOI 10.1016/j.lungcan.2013.04.015; Lam DCL, 2015, ONCOTARGETS THER, V8, P195, DOI 10.2147/OTT.S71242; Lantuejoul S, 2015, EUR RESPIR J, V46, P207, DOI 10.1183/09031936.00119914; Li YL, 2016, J THORAC ONCOL, V11, P924, DOI 10.1016/j.jtho.2016.03.004; [刘畅 Liu Chang], 2016, [中国肺癌杂志, Chinese Journal of Lung Cancer], V19, P38; Liu JR, 2017, CURR MED CHEM, V24, P590, DOI 10.2174/0929867323666161029223823; Mattsson JSM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2646-x; Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586; Rekhtman N, 2015, J ONCOL PRACT, V11, P135, DOI 10.1200/JOP.2014.002303; Roskoski R, 2017, PHARMACOL RES, V117, P343, DOI 10.1016/j.phrs.2017.01.007; Sabour Siamak, 2016, J Thorac Oncol, V11, pe92, DOI 10.1016/j.jtho.2016.04.022; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2016, J CLIN ONCOL, V34, P2858, DOI 10.1200/JCO.2015.63.5888; Teixido C, 2014, TRANSL LUNG CANCER R, V3, P70, DOI 10.3978/j.issn.2218-6751.2014.02.02; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; von Laffert M, 2017, LUNG CANCER, V103, P1, DOI 10.1016/j.lungcan.2016.11.008; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xiao Y, 2009, CLIN CHEM, V55, P1307, DOI 10.1373/clinchem.2008.120576; Zhang R, 2017, CLIN CHEM, V63, P1465, DOI 10.1373/clinchem.2017.272559; Zhang SR, 2016, ONCOTARGET, V7, P50477, DOI 10.18632/oncotarget.10464	32	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1525-1578	1943-7811		J MOL DIAGN	J. Mol. Diagn.	SEP	2017	19	5					766	775		10.1016/j.jmoldx.2017.06.003				10	Pathology	Pathology	FG6ET	WOS:000410464600013	28732214				2018-01-05	
J	Zhu, XN; Zhao, DD; Qiu, HN; Fan, FY; Man, SL; Bi, CH; Zhang, XL				Zhu, Xinna; Zhao, Dongdong; Qiu, Huanna; Fan, Feiyu; Man, Shuli; Bi, Changhao; Zhang, Xueli			The CRISPR/Cas9-facilitated multiplex pathway optimization (CFPO) technique and its application to improve the Escherichia coli xylose utilization pathway	METABOLIC ENGINEERING			English	Article						CRISPR/Cas9; Genome editing; Combinatorial metabolic engineering; CRISPR/Cas9-facilitated multiplex pathway optimization (CFPO)	GENE-EXPRESSION; CATABOLITE REPRESSION; SUCCINATE PRODUCTION; METABOLIC EVOLUTION; ETHANOL-PRODUCTION; CHROMOSOMAL GENES; GLYCOLYTIC FLUX; STRAINS; FERMENTATION; GROWTH	One of the most important research subjects of metabolic engineering is the pursuit of balanced metabolic pathways, which requires the modulation of expression of many genes. However, simultaneously modulating multiple genes on the chromosome remains challenging in prokaryotic organisms, including the industrial workhorse - Escherichia coli. In this work, the CRISPR/Cas9-facilitated multiplex pathway optimization (CFPO) technique was developed to simultaneously modulate the expression of multiple genes on the chromosome. To implement it, two plasmids were employed to target Cas9 to regulatory sequences of pathway genes, and a donor DNA plasmid library was constructed containing a regulator pool to modulate the expression of these genes. A modularized plasmid construction strategy was used to enable the assembly of a complex donor DNA plasmid library. After genome editing using this technique, a combinatorial library was obtained with variably expressed pathway genes. As a demonstration, the CFPO technique was applied to the xylose metabolic pathway genes in E. coli to improve xylose utilization. Three transcriptional units containing a total of four genes were modulated simultaneously with 70% efficiency, and improved strains were selected from the resulting combinatorial library by growth enrichment. The best strain, HQ304, displayed a 3-fold increase of the xylose-utilization rate. Finally, the xylose-utilization pathway of HQ304 was analyzed enzymologically to determine the optimal combination of enzyme activities.	[Zhu, Xinna; Zhao, Dongdong; Qiu, Huanna; Fan, Feiyu; Bi, Changhao; Zhang, Xueli] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China; [Zhu, Xinna; Zhao, Dongdong; Qiu, Huanna; Fan, Feiyu; Bi, Changhao; Zhang, Xueli] Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Qiu, Huanna; Man, Shuli] Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin 300457, Peoples R China	Bi, CH; Zhang, XL (reprint author), 32 XiQidao,Tianjin Airport Econ Pk, Tianjin 300308, Peoples R China.	bi_ch@tib.cas.cn; zhang_xl@tib.cas.cn			Chinese Academy of Sciences [ZDRW-ZS-2016-3]; National High Technology Research and Development Program of China [2014AA021205, 2015AA020202]; National Natural the Science Foundation of China [31522002, 31100089]; Tianjin Key Technology R & D program of Tianjin Municipal Science and Technology Commission [13ZCZDSY05300, 14ZCZDSY00067]	This research was supported by grants from the key deployment project of the Chinese Academy of Sciences (ZDRW-ZS-2016-3), the National High Technology Research and Development Program of China (2014AA021205 and 2015AA020202), the National Natural the Science Foundation of China (31522002 and 31100089), and Tianjin Key Technology R & D program of Tianjin Municipal Science and Technology Commission (13ZCZDSY05300 and 14ZCZDSY00067).	Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Cueva-Mendez G, 2007, EMBO REP, V8, P458, DOI 10.1038/sj.embor.7400957; Desai TA, 2010, APPL ENVIRON MICROB, V76, P1524, DOI 10.1128/AEM.01970-09; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Gawand P, 2013, METAB ENG, V20, P63, DOI 10.1016/j.ymben.2013.08.003; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GLICK BR, 1995, BIOTECHNOL ADV, V13, P247, DOI 10.1016/0734-9750(95)00004-A; Gonzalez R, 2002, BIOTECHNOL PROGR, V18, P6, DOI 10.1021/bp010121i; Hasona A, 2004, J BACTERIOL, V186, P7593, DOI 10.1128/JB.186.22.7593-7600.2204; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Jantama K, 2008, BIOTECHNOL BIOENG, V101, P881, DOI 10.1002/bit.22005; Jantama K, 2008, BIOTECHNOL BIOENG, V99, P1140, DOI 10.1002/bit.21694; Jeffries T W, 1983, Adv Biochem Eng Biotechnol, V27, P1; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Kim S. M., 2015, ESCHERICHIA COLI MET, V32, P141; Lee JY, 2008, BIOTECHNOL LETT, V30, P899, DOI 10.1007/s10529-007-9616-y; Lee ME, 2013, NUCLEIC ACIDS RES, V41, P10668, DOI 10.1093/nar/gkt809; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Lu J, 2012, APPL MICROBIOL BIOT, V93, P2455, DOI 10.1007/s00253-011-3752-y; Maehara T, 2013, FUNGAL BIOL-UK, V117, P776, DOI 10.1016/j.funbio.2013.09.005; Martinez A, 2007, BIOTECHNOL LETT, V29, P397, DOI 10.1007/s10529-006-9252-y; Meynial-Salles I, 2005, APPL ENVIRON MICROB, V71, P2140, DOI 10.1128/AEM.71.4.2140-2144.2005; Neidhardt F. C., 1996, ESCHERICHIA COLI SAL, P206; Ng CY, 2015, METAB ENG, V29, P86, DOI 10.1016/j.ymben.2015.03.001; Nichols NN, 2001, APPL MICROBIOL BIOT, V56, P120, DOI 10.1007/s002530100628; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Shi AQ, 2013, METAB ENG, V16, P1, DOI 10.1016/j.ymben.2012.11.008; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; SPRENGER GA, 1995, J BACTERIOL, V177, P5930, DOI 10.1128/jb.177.20.5930-5936.1995                                                ; SUMIYA M, 1995, RECEPTOR CHANNEL, V3, P117; Tan ZG, 2013, APPL ENVIRON MICROB, V79, P4838, DOI 10.1128/AEM.00826-13; Tao H, 2001, J BACTERIOL, V183, P2979, DOI 10.1128/JB.183.10.2979-2988.2001; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Yin LH, 2014, BIOTECHNOL BIOPROC E, V19, P132, DOI 10.1007/s12257-013-0416-z; Yomano LP, 2009, BIOTECHNOL LETT, V31, P1389, DOI 10.1007/s10529-009-0011-8; Zelcbuch L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt151; Zhang X, 2007, APPL MICROBIOL BIOT, V77, P355, DOI 10.1007/s00253-007-1170-y; Zhang XL, 2009, P NATL ACAD SCI USA, V106, P20180, DOI 10.1073/pnas.0905396106; Zhao D., 2016, MICROB CELL FACT, V15; Zhao J, 2013, METAB ENG, V17, P42, DOI 10.1016/j.ymben.2013.02.002	44	0	0	26	26	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7176	1096-7184		METAB ENG	Metab. Eng.	SEP	2017	43		A				37	45		10.1016/j.ymben.2017.08.003				9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FG6IV	WOS:000410479600005	28800965				2018-01-05	
J	de Rie, D; Abugessaisa, I; Alam, T; Arner, E; Arner, P; Ashoor, H; Astrom, G; Babina, M; Bertin, N; Burroughs, AM; Carlisle, AJ; Daub, CO; Detmar, M; Deviatiiarov, R; Fort, A; Gebhard, C; Goldowitz, D; Guhl, S; Ha, TJ; Harshbarger, J; Hasegawa, A; Hashimoto, K; Herlyn, M; Heutink, P; Hitchens, KJ; Hon, CC; Huang, E; Ishizu, Y; Kai, C; Kasukawa, T; Klinken, P; Lassmann, T; Lecellier, CH; Lee, W; Lizio, M; Makeev, V; Mathelier, A; Medvedeva, YA; Mejhert, N; Mungall, CJ; Noma, S; Ohshima, M; Okada-Hatakeyama, M; Persson, H; Rizzu, P; Roudnicky, F; Saetrom, P; Sato, H; Severin, J; Shin, JW; Swoboda, RK; Tarui, H; Toyoda, H; Vitting-Seerup, K; Winteringham, L; Yamaguchi, Y; Yasuzawa, K; Yoneda, M; Yumoto, N; Zabierowski, S; Zhang, PG; Wells, CA; Summers, KM; Kawaji, H; Sandelin, A; Rehli, M; Hayashizaki, Y; Carninci, P; Forrest, ARR; de Hoon, MJL				de Rie, Derek; Abugessaisa, Imad; Alam, Tanvir; Arner, Erik; Arner, Peter; Ashoor, Haitham; Astrom, Gaby; Babina, Magda; Bertin, Nicolas; Burroughs, A. Maxwell; Carlisle, Ailsa J.; Daub, Carsten O.; Detmar, Michael; Deviatiiarov, Ruslan; Fort, Alexandre; Gebhard, Claudia; Goldowitz, Daniel; Guhl, Sven; Ha, Thomas J.; Harshbarger, Jayson; Hasegawa, Akira; Hashimoto, Kosuke; Herlyn, Meenhard; Heutink, Peter; Hitchens, Kelly J.; Hon, Chung Chau; Huang, Edward; Ishizu, Yuri; Kai, Chieko; Kasukawa, Takeya; Klinken, Peter; Lassmann, Timo; Lecellier, Charles-Henri; Lee, Weonju; Lizio, Marina; Makeev, Vsevolod; Mathelier, Anthony; Medvedeva, Yulia A.; Mejhert, Niklas; Mungall, Christopher J.; Noma, Shohei; Ohshima, Mitsuhiro; Okada-Hatakeyama, Mariko; Persson, Helena; Rizzu, Patrizia; Roudnicky, Filip; Saetrom, Pal; Sato, Hiroki; Severin, Jessica; Shin, Jay W.; Swoboda, Rolf K.; Tarui, Hiroshi; Toyoda, Hiroo; Vitting-Seerup, Kristoffer; Winteringham, Louise; Yamaguchi, Yoko; Yasuzawa, Kayoko; Yoneda, Misako; Yumoto, Noriko; Zabierowski, Susan; Zhang, Peter G.; Wells, Christine A.; Summers, Kim M.; Kawaji, Hideya; Sandelin, Albin; Rehli, Michael; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.; de Hoon, Michiel J. L.		FANTOM Consortium	An integrated expression atlas of miRNAs and their promoters in human and mouse	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; MICRORNA BIOGENESIS; SEQUENCING DATA; REGULATORY SITES; NONCODING RNAS; CAP-ANALYSIS; START SITES; TRANSCRIPTION; GENOME; CANCER	MicroRNAs (miRNAs) are short non-coding RNAs with key roles in cellular regulation. As part of the fifth edition of the Functional Annotation of Mammalian Genome (FANTOM5) project, we created an integrated expression atlas of miRNAs and their promoters by deep-sequencing 492 short RNA (sRNA) libraries, with matching Cap Analysis Gene Expression (CAGE) data, from 396 human and 47 mouse RNA samples. Promoters were identified for 1,357 human and 804 mouse miRNAs and showed strong sequence conservation between species. We also found that primary and mature miRNA expression levels were correlated, allowing us to use the primary miRNA measurements as a proxy for mature miRNA levels in a total of 1,829 human and 1,029 mouse CAGE libraries. We thus provide a broad atlas of miRNA expression and promoters in primary mammalian cells, establishing a foundation for detailed analysis of miRNA expression patterns and transcriptional control regions.	[de Rie, Derek; Abugessaisa, Imad; Arner, Erik; Bertin, Nicolas; Burroughs, A. Maxwell; Daub, Carsten O.; Deviatiiarov, Ruslan; Fort, Alexandre; Harshbarger, Jayson; Hasegawa, Akira; Hashimoto, Kosuke; Hon, Chung Chau; Ishizu, Yuri; Kasukawa, Takeya; Lassmann, Timo; Lizio, Marina; Noma, Shohei; Severin, Jessica; Shin, Jay W.; Tarui, Hiroshi; Yasuzawa, Kayoko; Kawaji, Hideya; Carninci, Piero; Forrest, Alistair R. R.; de Hoon, Michiel J. L.] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [de Rie, Derek] Vrije Univ Amsterdam, Ctr Integrat Bioinformat IBIVU, Amsterdam, Netherlands; [Alam, Tanvir; Ashoor, Haitham] KAUST, Computat Biosci Res Ctr, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia; [Arner, Erik; Bertin, Nicolas; Burroughs, A. Maxwell; Daub, Carsten O.; Fort, Alexandre; Harshbarger, Jayson; Hasegawa, Akira; Hashimoto, Kosuke; Ishizu, Yuri; Lassmann, Timo; Lizio, Marina; Noma, Shohei; Severin, Jessica; Shin, Jay W.; Tarui, Hiroshi; Kawaji, Hideya; Hayashizaki, Yoshihide; Carninci, Piero; Forrest, Alistair R. R.; de Hoon, Michiel J. L.] RIKEN Om Sci Ctr OSC, Yokohama, Kanagawa, Japan; [Arner, Peter; Astrom, Gaby; Mejhert, Niklas] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden; [Babina, Magda; Guhl, Sven] Univ Med Berlin, Dept Dermatol & Allergy, Charite Campus Mitte, Berlin, Germany; [Bertin, Nicolas] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Burroughs, A. Maxwell] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Carlisle, Ailsa J.; Summers, Kim M.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Carlisle, Ailsa J.; Summers, Kim M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Detmar, Michael; Roudnicky, Filip] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Deviatiiarov, Ruslan] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Gebhard, Claudia; Rehli, Michael] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany; [Gebhard, Claudia; Rehli, Michael] Regensburg Ctr Intervent Immunol RCI, Regensburg, Germany; [Goldowitz, Daniel; Ha, Thomas J.; Lecellier, Charles-Henri; Mathelier, Anthony; Zhang, Peter G.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC, Canada; [Herlyn, Meenhard; Swoboda, Rolf K.] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA; [Heutink, Peter; Rizzu, Patrizia] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Hitchens, Kelly J.] Univ Queensland, Australian Infect Dis Res Ctr AID, Brisbane, Qld, Australia; [Huang, Edward; Wells, Christine A.] Univ Melbourne, Sch Biomed Sci, Ctr Stem Cell Syst, Melbourne, Vic, Australia; [Huang, Edward; Wells, Christine A.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Kai, Chieko; Sato, Hiroki; Yoneda, Misako] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo, Japan; [Klinken, Peter; Winteringham, Louise; Forrest, Alistair R. R.] Univ Western Australia, QEII Med Ctr, Harry Perkins Inst Med Res, Perth, WA, Australia; [Klinken, Peter; Winteringham, Louise; Forrest, Alistair R. R.] Univ Western Australia, QEII Med Ctr, Med Res Ctr, Perth, WA, Australia; [Lassmann, Timo] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia; [Lecellier, Charles-Henri] Inst Mol Genet Montpellier, Montpellier, France; [Lee, Weonju] Kyungpook Natl Univ, Sch Med, Dept Dermatol, Daegu, South Korea; [Makeev, Vsevolod; Medvedeva, Yulia A.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Makeev, Vsevolod] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Makeev, Vsevolod] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Medvedeva, Yulia A.] Inst Predict & Personalized Med Canc, IMPPC, Ctra Can Ruti, Badalona, Spain; [Medvedeva, Yulia A.] Biotechnol Res Ctr, Inst Bioengn, Moscow, Russia; [Mungall, Christopher J.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA USA; [Ohshima, Mitsuhiro] Ohu Univ, Sch Pharmaceut Sci, Dept Biochem, Koriyama, Fukushima, Japan; [Okada-Hatakeyama, Mariko] Osaka Univ, Inst Prot Res, Lab Cell Syst, Osaka, Japan; [Okada-Hatakeyama, Mariko; Yumoto, Noriko] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Persson, Helena] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, Trondheim, Norway; [Toyoda, Hiroo] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Mol Genet, Tokyo, Japan; [Vitting-Seerup, Kristoffer; Sandelin, Albin] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Vitting-Seerup, Kristoffer; Sandelin, Albin] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Yamaguchi, Yoko] Nihon Univ, Sch Dent, Dept Biochem, Tokyo, Japan; [Zabierowski, Susan] Sloan Kettering Inst, SKI Stem Cell Res Facil, Ctr Stem Cell Biol, New York, NY USA; [Zabierowski, Susan] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Summers, Kim M.] Univ Queensland, Translat Res Inst, Mater Res Inst, Brisbane, Qld, Australia; [Kawaji, Hideya; Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program, Wako, Saitama, Japan	Forrest, ARR; de Hoon, MJL (reprint author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.; Forrest, ARR; de Hoon, MJL (reprint author), RIKEN Om Sci Ctr OSC, Yokohama, Kanagawa, Japan.; Forrest, ARR (reprint author), Univ Western Australia, QEII Med Ctr, Harry Perkins Inst Med Res, Perth, WA, Australia.; Forrest, ARR (reprint author), Univ Western Australia, QEII Med Ctr, Med Res Ctr, Perth, WA, Australia.	alistair.forrest@gmail.com; michiel.dehoon@riken.jp	Makeev, Vsevolod/E-8015-2013	Makeev, Vsevolod/0000-0001-9405-9748; Medvedeva, Yulia/0000-0002-7587-1666; Bertin, Nicolas/0000-0002-9835-9606; Kawaji, Hideya/0000-0002-0575-0308; Babina, Magda/0000-0002-4500-7615; Sandelin, Albin/0000-0002-7109-7378; carninci, piero/0000-0001-7202-7243; Persson, Helena/0000-0002-5187-6446; Forrest, Alistair/0000-0003-4543-1675; Abugessaisa, Imad/0000-0001-7458-801X	Research Grant for RIKEN Omics Science Center from MEXT; Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT; MEXT; Lundbeck Foundation; Novo Nordisk Foundation; Cancer Research Trust; MACA Ride to Conquer Cancer; Australian Research Council's Discovery Projects funding scheme [DP160101960]; Russian Science Foundation [15-14-30002, 14-44-00022]	FANTOM5 was made possible by the following grants: Research Grant for RIKEN Omics Science Center from MEXT to Y.H.; Grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT to Y.H.; Research Grant from MEXT to the RIKEN Center for Life Science Technologies; Research Grant to RIKEN Preventive Medicine and Diagnosis Innovation Program from MEXT to Y.H. K.V.-S. and A.S. were supported by the Lundbeck and Novo Nordisk Foundations. A.R.R.F. is supported by a Senior Cancer Research Fellowship from the Cancer Research Trust, funds raised by the MACA Ride to Conquer Cancer, and the Australian Research Council's Discovery Projects funding scheme (DP160101960). Y.A.M. was supported by the Russian Science Foundation, grant 15-14-30002. R.D. was supported by the Russian Science Foundation, grant 14-44-00022. We would like to thank L. Schwarzfischer for technical assistance and N. Eichner and G. Meister for sequencing RACE products. We would also like to thank GeNAS for data production.	Abugessaisa I., 2016, DATABASE, V2016; Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5                                                   ; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Brown GR, 2015, NUCLEIC ACIDS RES, V43, pD36, DOI 10.1093/nar/gku1055; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chang TC, 2015, GENOME RES, V25, P1401, DOI 10.1101/gr.193607.115; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Ding J, 2015, NAT GENET, V47, P776, DOI 10.1038/ng.3324; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023; Georgakilas G, 2016, NUCLEIC ACIDS RES, V44, pD190, DOI 10.1093/nar/gkv1254; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Jimenez VC, 2014, GENOM DATA, V2, P181, DOI 10.1016/j.gdata.2014.06.019; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2015, NAT STRUCT MOL BIOL, V22, P2, DOI 10.1038/nsmb.2946; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Londin E, 2015, P NATL ACAD SCI USA, V112, pE1106, DOI 10.1073/pnas.1420955112; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Moon HG, 2014, J IMMUNOL, V193, P4558, DOI 10.4049/jimmunol.1401372; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Nepal C, 2016, NUCLEIC ACIDS RES, V44, P3070, DOI 10.1093/nar/gkv1354; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pachkov M, 2013, NUCLEIC ACIDS RES, V41, pD214, DOI 10.1093/nar/gks1145; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Srivastava SK, 2015, BRIT J CANCER, V113, P660, DOI 10.1038/bjc.2015.252; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Takahashi H, 2012, NAT PROTOC, V7, P542, DOI 10.1038/nprot.2012.005; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Vijayan D, 2012, IMMUNOL CELL BIOL, V90, P889, DOI 10.1038/icb.2012.24; Vinod M, 2014, BBA-MOL CELL BIOL L, V1841, P827, DOI 10.1016/j.bbalip.2014.02.006; Westholm JO, 2011, BIOCHIMIE, V93, P1897, DOI 10.1016/j.biochi.2011.06.017; Zhang L, 2013, CANCER RES, V73, P6435, DOI 10.1158/0008-5472.CAN-12-3308	67	1	1	13	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2017	35	9					872	+		10.1038/nbt.3947				11	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FG5NR	WOS:000410371600022	28829439				2018-01-05	
J	Holme, IB; Wendt, T; Gil-Humanes, J; Deleuran, LC; Starker, CG; Voytas, DF; Brinch-Pedersen, H				Holme, Inger B.; Wendt, Toni; Gil-Humanes, Javier; Deleuran, Lise C.; Starker, Colby G.; Voytas, Daniel F.; Brinch-Pedersen, Henrik			Evaluation of the mature grain phytase candidate HvPAPhy_a gene in barley (Hordeum vulgare L.) using CRISPR/Cas9 and TALENs	PLANT MOLECULAR BIOLOGY			English	Article						Barley; CRISPR/Cas9; GCN4/Skn1/RY motif; HvPAPhy_a; Mature grain phytase activity; TALENs	TRITICUM-AESTIVUM L.; RICE GLUTELIN GENE; TARGETED MUTAGENESIS; PLANT GENOME; RY REPEAT; PROMOTER; EXPRESSION; ENDOSPERM; WHEAT; NUCLEASES	In the present study, we utilized TALEN- and CRISPR/Cas9-induced mutations to analyze the promoter of the barley phytase gene HvPAPhy_a. The purpose of the study was dual, validation of the PAPhy_a enzyme as the main contributor of the mature grain phytase activity (MGPA), as well as validating the importance of a specific promoter region of the PAPhy_a gene which contains three overlapping cis-acting regulatory elements (GCN4, Skn1 and the RY-element) known to be involved in gene expression during grain filling. The results confirm that the barley PAPhy_a enzyme is the main contributor to the MGPA as grains of knock-out lines show very low MGPA. Additionally, the analysis of the HvPAPhy_a promoter region containing the GCN4/Skn1/RY motif highlights its importance for HvPAPhy_a expression as the MGPA in grains of plant lines with mutations within this motif is significantly reduced. Interestingly, lines with deletions located downstream of the motif show even lower MGPA levels, indicating that the GCN4/SKn1/RY motif is not the only element responsible for the level of PAPhy_a expression during grain maturation. Mutant grains with very low MPGA showed delayed germination as compared to grains of wild type barley. As grains with high levels of preformed phytases would provide more readily available phosphorous needed for a fast germination, this indicates that faster germination may be implicated in the positive selection of the ancient PAPhy gene duplication that lead to the creation of the PAPhy_a gene.	[Holme, Inger B.; Wendt, Toni; Brinch-Pedersen, Henrik] Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark; [Gil-Humanes, Javier; Starker, Colby G.; Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Gil-Humanes, Javier; Starker, Colby G.; Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA; [Gil-Humanes, Javier] Calyxt Inc, New Brighton, MN USA; [Deleuran, Lise C.] Aarhus Univ, Res Ctr Flakkebjerg, Dept Agroecol, Slagelse, Denmark	Holme, IB (reprint author), Aarhus Univ, Res Ctr Flakkebjerg, Dept Mol Biol & Genet, Slagelse, Denmark.	inger.holme@mbg.au.dk			Danish Ministry of Food, Agriculture and Fisheries [3304-FVFP-09-B-006]; Brd. Hartmann's foundation [A27246]; National Science Foundation [IOS-1444511, IOS-1339209]; Fundacion Alfonso Martin Escudero	The authors thank Rikke B Jacobsen, Lis B Holte and Ole B Hansen for skilful technical assistance. The research was funded by a grant to IBH from the Danish Ministry of Food, Agriculture and Fisheries (3304-FVFP-09-B-006), a Grant to IBH from Brd. Hartmann's foundation (A27246) and Grants to DFV from the National Science Foundation (IOS-1444511 and IOS-1339209). Javier Gil-Humanes acknowledges the Fundacion Alfonso Martin Escudero for his post-doctoral fellowship.	BAUMLEIN H, 1992, PLANT J, V2, P233; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bradford KJ, 2013, SEED SCI TECHNOL, V41, P420, DOI 10.15258/sst.2013.41.3.09                                                       ; Brinch-Pedersen H, 2000, MOL BREEDING, V6, P195, DOI 10.1023/A:1009690730620; Brinch-Pedersen H, 2002, TRENDS PLANT SCI, V7, P118, DOI 10.1016/S1360-1385(01)02222-1; Brinch-Pedersen H, 2014, J CEREAL SCI, V59, P373, DOI 10.1016/j.jcs.2013.10.003; Char SN, 2015, PLANT BIOTECHNOL J, V13, P1002, DOI 10.1111/pbi.12344; Christian ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045383; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; Dionisio G, 2007, PLANT BIOTECHNOL J, V5, P325, DOI 10.1111/j.1467-7652.2007.00244.x; Dionisio G, 2011, PLANT PHYSIOL, V156, P1087, DOI 10.1104/pp.110.164756; Duan YB, 2016, PLANT MOL BIOL, V90, P49, DOI 10.1007/s11103-015-0393-z; ENGELEN AJ, 1994, J AOAC INT, V77, P760; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Erlang-Nielsen M, 2014, THESIS; Fauteux F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-126; FORSTER C, 1994, PLANT MOL BIOL, V26, P235, DOI 10.1007/BF00039535; FUJIWARA T, 1994, PLANT MOL BIOL, V24, P261, DOI 10.1007/BF00020166; Grant CA, 2001, CAN J PLANT SCI, V81, P211, DOI 10.4141/P00-093                                                                 ; Greiner R, 2000, J CEREAL SCI, V31, P127, DOI 10.1006/jcrs.1999.0254; Gurushidze M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092046; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Holme IB, 2012, PLANT BIOTECHNOL J, V10, P237, DOI 10.1111/j.1467-7652.2011.00660.x; Jia HG, 2016, PLANT BIOTECHNOL J, V14, P1291, DOI 10.1111/pbi.12495; Jiang WZ, 2017, PLANT BIOTECHNOL J, V15, P648, DOI 10.1111/pbi.12663; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Juhasz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029501; Kapusi E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00540; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Madsen CK, 2013, J EXP BOT, V64, P3111, DOI 10.1093/jxb/ert116; Mann DGJ, 2012, PLANT BIOTECHNOL J, V10, P226, DOI 10.1111/j.1467-7652.2011.00658.x; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; NAKANO T, 1999, FOOD SCI TECHNOL RES, V5, P18; Onate L, 1999, J BIOL CHEM, V274, P9175, DOI 10.1074/jbc.274.14.9175                                                         ; Ranford JC, 2002, J EXP BOT, V53, P147, DOI 10.1093/jexbot/53.366.147; Reidt W, 2000, PLANT J, V21, P401, DOI 10.1046/j.1365-313x.2000.00686.x; Robinson WD, 2012, NEW PHYTOL, V196, P1024, DOI 10.1111/nph.12006; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Vain P, 2003, THEOR APPL GENET, V107, P210, DOI 10.1007/s00122-003-1255-7; Voytas DF, 2016, J GENET GENOMICS, V43, P229, DOI 10.1016/j.jgg.2016.03.004; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; White PJ, 2012, PLANT SOIL, V357, P1, DOI 10.1007/s11104-012-1128-4; Wu CY, 1998, PLANT J, V14, P673, DOI 10.1046/j.1365-313x.1998.00167.x                                                ; Wu CY, 2000, PLANT J, V23, P415, DOI 10.1046/j.1365-313x.2000.00797.x; Zhang DD, 2016, J GENET GENOMICS, V43, P251, DOI 10.1016/j.jgg.2016.03.001; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179	54	0	0	18	18	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4412	1573-5028		PLANT MOL BIOL	Plant Mol.Biol.	SEP	2017	95	1-2					111	121		10.1007/s11103-017-0640-6				11	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	FG6HZ	WOS:000410475500008	28755320				2018-01-05	
J	Maina, PK; Shao, P; Jia, XF; Liu, Q; Umesalma, S; Marin, M; Long, D; Concepcion-Roman, S; Qi, HH				Maina, Peterson Kariuki; Shao, Peng; Jia, Xiongfei; Liu, Qi; Umesalma, Shaikamjad; Marin, Maximo; Long, Donald, Jr.; Concepcion-Roman, Samantha; Qi, Hank Heng			Histone demethylase PHF8 regulates hypoxia signaling through HIF1 alpha and H3K4me3	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						PHF8; HIF1 alpha; KDM3A; H3K4me3; Hypoxia; Prostate cancer	PROSTATE-CANCER CELLS; DEPENDENT GENE-EXPRESSION; INDUCIBLE FACTOR; PROGRESSION; BINDING; METHYLATION; REST; HIF; TRANSCRIPTION; HIF-1-ALPHA	Hypoxia through transcription factor HIF1 alpha plays a critical role in cancer development. In prostate cancer, HIF1 alpha interplays with androgen receptor (AR) to contribute to the progression of this disease to its lethal form castration-resistant prostate cancer (CRPC). Hypoxia upregulates several epigenetic factors including histone demethylase KDM3A which is a critical co-factor of HIF1 alpha. However, how histone demethylases regulate hypoxia signaling is not fully understood. Here, we report that histone demethylase PHF8 plays an essential role in hypoxia signaling. Knockdown or knockout of PHF8 by RNAi or CRISPR-Cas9 system reduced the activation of HIF1a and the induction of HIF1 alpha target genes including KDM3A. Mechanistically, PHF8 regulates hypoxia inducible genes mainly through sustaining the level of trimethylated histone 3 lysine 4 (H3K4me3), an active mark in transcriptional regulation. The positive role of PHF8 in hypoxia signaling extended to hypoxia-induced neuroendocrine differentiation (NED), wherein PHF8 cooperates with KDM3A to regulate the expression of NED genes. Moreover, we discovered that the role of PHF8 in hypoxia signaling is associated with the presence of full-length AR in CRPC cells. Collectively, our study identified PHF8 as a novel epigenetic factor in hypoxia signaling, and the underlying regulatory mechanisms likely apply to general cancer development involving HIF1a. Therefore, targeting PHF8 can potentially be a novel therapeutic strategy in cancer therapy.	[Maina, Peterson Kariuki; Shao, Peng; Jia, Xiongfei; Liu, Qi; Qi, Hank Heng] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Umesalma, Shaikamjad] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Marin, Maximo] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Long, Donald, Jr.] Southern Utah Univ, Dept Biol, Cedar City, UT 84720 USA; [Concepcion-Roman, Samantha] Univ Med & Hlth Sci, Basseterre KN0101, St Kitts & Nevi; [Shao, Peng] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Jia, Xiongfei] Kunming Gen Hosp, Dept Lab Med, Kunming 650032, Yunnan, Peoples R China	Qi, HH (reprint author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	hank-qi@uiowa.edu			Department of Anatomy and Cell Biology of the Carver College of Medicine at the University of Iowa; Roy. J. Carver Charitable Trust [01-224]; Oberley Seed Grant from Holden Comprehensive Cancer Center (HCCC) (NIH) [P30 CA086862]; ACS-IRG seed grant from the American Cancer Society [IRG-77-004-34]; Institute for Clinical and Translational Science (ICTS); University of Iowa (NIH and CTSA) [UL1RR024979]; Genomics and Flow Cytometry core facilities (NIH) at the University of Iowa [P30 CA086862]; UI SROP (Summer Research Opportunity Program) at the University of Iowa	We thank Dr. Brad Amendt, Dr. Weizhou Zhang, and Dr. Michael Henry for valuable discussions; and Dr. Zoran Cullig, Dr. Michael Henry and Dr. Frederick Domann for sharing the LNCaP-Abl, 22Rv1, DU145 and PC3 cell lines. We also thank Dr. Yi Zhang for sharing KDM3A plasmids. This work was supported by Dr. Qi's laboratory start-up funds from the Department of Anatomy and Cell Biology of the Carver College of Medicine at the University of Iowa, and the following research grants to Dr. Qi: a Carver Trust Young Investigator Award (Grant # 01-224) from the Roy. J. Carver Charitable Trust; an Oberley Seed Grant from Holden Comprehensive Cancer Center (HCCC) (NIH Grant P30 CA086862); an ACS-IRG seed grant (Grant IRG-77-004-34) from the American Cancer Society administered through HCCC, the University of Iowa; and a pilot grant from the Institute for Clinical and Translational Science (ICTS), the University of Iowa (NIH and CTSA grant UL1RR024979). This work was also supported by the Genomics and Flow Cytometry core facilities (NIH Grant P30 CA086862) at the University of Iowa. DL was supported through UI SROP (Summer Research Opportunity Program) at the University of Iowa. We also thank Drs. Christine Blaumueller and Marie Gaine for editorial consultation.	Abe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8052; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Butterworth KT, 2008, INT J CANCER, V123, P760, DOI 10.1002/ijc.23418; Cavadas MAS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17851; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Danilovskyi S V, 2014, Ukr Biochem J, V86, P90; Danza G, 2012, MOL CANCER RES, V10, P230, DOI 10.1158/1541-7786.MCR-11-0296; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hancock R. L., 2015, EPIGENOMICS, P1; Horii K, 2007, MOL CANCER RES, V5, P383, DOI 10.1158/1541-7786.MCR-06-0226; Jeong JY, 2014, BMB REP, V47, P411, DOI 10.5483/BMBRep.2014.47.7.104; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Lee HY, 2013, CARCINOGENESIS, V34, P2706, DOI 10.1093/carcin/bgt256; Liang HZ, 2014, EXP CELL RES, V320, P188, DOI 10.1016/j.yexcr.2013.09.020; Lin TP, 2016, ONCOTARGET, V7, P26137, DOI 10.18632/oncotarget.8433; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Maina PK, 2016, ONCOTARGET, V7, P75585, DOI 10.18632/oncotarget.12310; Marignol L, 2008, CANCER TREAT REV, V34, P313, DOI 10.1016/j.ctrv.2008.01.006; McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002; Milosevic M, 2012, CLIN CANCER RES, V18, P2108, DOI 10.1158/1078-0432.CCR-11-2711; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Mitani T, 2012, J BIOL CHEM, V287, P33594, DOI 10.1074/jbc.M112.388298; Mitani T, 2011, J STEROID BIOCHEM, V123, P58, DOI 10.1016/j.jsbmb.2010.10.009; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Ramadoss S, 2017, ONCOGENE, V36, P47, DOI 10.1038/onc.2016.174; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shao P, 2017, NUCLEIC ACIDS RES, V45, P1687, DOI 10.1093/nar/gkw1093; Stewart GD, 2010, BJU INT, V105, P8, DOI 10.1111/j.1464-410X.2009.08921.x; Sun XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077353; Svensson C, 2014, NUCLEIC ACIDS RES, V42, P999, DOI 10.1093/nar/gkt921; Tao L, 2016, MOL CANCER THER, V15, P1943, DOI 10.1158/1535-7163.MCT-15-0306; Tong D, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.74; Wang Q, 2016, J CLIN INVEST, V126, P2205, DOI 10.1172/JCI85747; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701                                                             ; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu HT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13644; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Zhong H, 2000, CANCER RES, V60, P1541; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942	49	0	0	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	SEP	2017	1860	9					1002	1012		10.1016/j.bbagrm.2017.07.005				11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FG3CM	WOS:000410014400009	28734980	gold			2018-01-05	
J	Drean, A; Williamson, CT; Brough, R; Brandsma, I; Menon, M; Konde, A; Garcia-Murillas, I; Pemberton, HN; Frankum, J; Rafiq, R; Badham, N; Campbell, J; Gulati, A; Turner, NC; Pettitt, SJ; Ashworth, A; Lord, CJ				Drean, Amy; Williamson, Chris T.; Brough, Rachel; Brandsma, Inger; Menon, Malini; Konde, Asha; Garcia-Murillas, Isaac; Pemberton, Helen N.; Frankum, Jessica; Rafiq, Rumana; Badham, Nicholas; Campbell, James; Gulati, Aditi; Turner, Nicholas C.; Pettitt, Stephen J.; Ashworth, Alan; Lord, Christopher J.			Modeling Therapy Resistance in BRCA1/2-Mutant Cancers	MOLECULAR CANCER THERAPEUTICS			English	Article							DOUBLE-STRAND BREAKS; OLAPARIB MAINTENANCE THERAPY; DNA-DAMAGE CHECKPOINT; HOMOLOGOUS RECOMBINATION; SOMATIC MUTATIONS; PARP INHIBITOR; OVARIAN-CANCER; WEE1 KINASE; CELL-LINES; BRCA2	Although PARP inhibitors target BRCA1- or BRCA2-mutant tumor cells, drug resistance is a problem. PARP inhibitor resistance is sometimes associated with the presence of secondary or "revertant" mutations in BRCA1 or BRCA2. Whether secondary mutant tumor cells are selected for in a Darwinian fashion by treatment is unclear. Furthermore, how PARP inhibitor resistance might be therapeutically targeted is also poorly understood. Using CRISPR mutagenesis, we generated isogenic tumor cell models with secondary BRCA1 or BRCA2 mutations. Using these in heterogeneous in vitro culture or in vivo xenograft experiments in which the clonal composition of tumor cell populations in response to therapy was monitored, we established that PARP inhibitor or platinum salt exposure selects for secondary mutant clones in a Darwinian fashion, with the periodicity of PARP inhibitor administration and the pretreatment frequency of secondary mutant tumor cells influencing the eventual clonal composition of the tumor cell population. In xenograft studies, the presence of secondary mutant cells in tumors impaired the therapeutic effect of a clinical PARP inhibitor. However, we found that both PARP inhibitor-sensitive and PARP inhibitor-resistant BRCA2 mutant tumor cells were sensitive to AZD-1775, a WEE1 kinase inhibitor. In mice carrying heterogeneous tumors, AZD-1775 delivered a greater therapeutic benefit than olaparib treatment. This suggests that despite the restoration of some BRCA1 or BRCA2 gene function in "revertant" tumor cells, vulnerabilities still exist that could be therapeutically exploited. (C) 2017 AACR.	[Drean, Amy; Williamson, Chris T.; Brough, Rachel; Brandsma, Inger; Menon, Malini; Konde, Asha; Pemberton, Helen N.; Frankum, Jessica; Rafiq, Rumana; Badham, Nicholas; Campbell, James; Gulati, Aditi; Pettitt, Stephen J.; Ashworth, Alan; Lord, Christopher J.] Inst Canc Res, CRUK Gene Funct Lab, London, England; [Drean, Amy; Williamson, Chris T.; Brough, Rachel; Brandsma, Inger; Menon, Malini; Konde, Asha; Pemberton, Helen N.; Frankum, Jessica; Rafiq, Rumana; Badham, Nicholas; Campbell, James; Gulati, Aditi; Pettitt, Stephen J.; Ashworth, Alan; Lord, Christopher J.] Inst Canc Res, Breast Canc Now Toby Robins Breast Canc Res Ctr, London, England; [Garcia-Murillas, Isaac; Turner, Nicholas C.] Inst Canc Res, Breast Canc Now Toby Robins Breast Canc Res Ctr, Mol Oncol Lab, London, England; [Ashworth, Alan] UCSF Helen Diller Family Comprehens Canc Ctr, 1450 Third St, San Francisco, CA 94158 USA	Ashworth, A (reprint author), UCSF Helen Diller Family Comprehens Canc Ctr, 1450 Third St, San Francisco, CA 94158 USA.; Lord, CJ (reprint author), Inst Canc Res, 237 Fulham Rd, London SW3 6JB, England.	Alan.Ashworth@ucsf.edu; Chris.Lord@icr.ac.uk		Brandsma, Inger/0000-0003-3257-2540	Breast Cancer Now [CTR-Q4-Y2]; Cancer Research UK [CRUK/A14276]	This work was supported by Breast Cancer Now (CTR-Q4-Y2; to C.J. Lord) and Cancer Research UK (CRUK/A14276; to C.J. Lord).	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331 , 10.1517/13543780802291760]; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Barber LJ, 2013, J PATHOL, V229, P422, DOI 10.1002/path.4140; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Ter Brugge P, 2016, JNCI-J NATL CANCER I, V108; Campbell J, 2016, CELL REP, V14, P2490, DOI 10.1016/j.celrep.2016.02.023; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Do K, 2013, CELL CYCLE, V12, P3159, DOI 10.4161/cc.26062; Domchek SM, 2006, NAT CLIN PRACT ONCOL, V3, P2, DOI 10.1038/ncponc0384; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5,172.CAN-05-2853; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Goggins M, 1996, CANCER RES, V56, P5360; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hall AB, 2014, ONCOTARGET, V5, P5674, DOI 10.18632/oncotarget.2158                                                        ; Hill SJ, 2014, MOL CELL BIOL, V34, P3828, DOI 10.1128/MCB.01646-13; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Hucl T, 2008, CANCER RES, V68, P5023, DOI 10.1158/0008-5472.CAN-07-6189; Issaeva N, 2010, CANCER RES, V70, P6268, DOI 10.1158/0008-5472.CAN-09-3416; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43932; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Liu QH, 2000, GENE DEV, V14, P1448; Lord CJ, 2015, ANNU REV MED, V66, P455, DOI 10.1146/annurev-med-050913-022545; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Miller RE, 2016, MOL CANCER THER, V15, P1472, DOI 10.1158/1535-7163.MCT-15-0554; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Pender A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139074; Pfister SX, 2015, CANCER CELL, V28, P557, DOI 10.1016/j.ccell.2015.09.015; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704                                                        ; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Zimmer J, 2016, MOL CELL, V61, P449, DOI 10.1016/j.molcel.2015.12.004	41	0	0	8	8	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	SEP 1	2017	16	9					2022	2034		10.1158/1535-7163.MCT-17-0098				13	Oncology	Oncology	FG1IZ	WOS:000409550300026	28619759				2018-01-05	
J	Homann, S; Hofmann, C; Gorin, AM; Nguyen, HCX; Huynh, D; Hamid, P; Maithel, N; Yacoubian, V; Mu, WL; Kossyvakis, A; Sen Roy, S; Yang, OO; Kelesidis, T				Homann, Stefanie; Hofmann, Christian; Gorin, Aleksandr M.; Huy Cong Xuan Nguyen; Diana Huynh; Hamid, Phillip; Maithel, Neil; Yacoubian, Vahe; Mu, Wenli; Kossyvakis, Athanasios; Sen Roy, Shubhendu; Yang, Otto Orlean; Kelesidis, Theodoros			A novel rapid and reproducible flow cytometric method for optimization of transfection efficiency in cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CRISPR-CAS SYSTEM; GENE DELIVERY; HIGHLY EFFICIENT; T-LYMPHOCYTES; PLASMID DNA; EXPRESSION; ACTIVATION; PROTAMINE; REAGENTS	Transfection is one of the most frequently used techniques in molecular biology that is also applicable for gene therapy studies in humans. One of the biggest challenges to investigate the protein function and interaction in gene therapy studies is to have reliable monospecific detection reagents, particularly antibodies, for all human gene products. Thus, a reliable method that can optimize transfection efficiency based on not only expression of the target protein of interest but also the uptake of the nucleic acid plasmid, can be an important tool in molecular biology. Here, we present a simple, rapid and robust flow cytometric method that can be used as a tool to optimize transfection efficiency at the single cell level while overcoming limitations of prior established methods that quantify transfection efficiency. By using optimized ratios of transfection reagent and a nucleic acid (DNA or RNA) vector directly labeled with a fluorochrome, this method can be used as a tool to simultaneously quantify cellular toxicity of different transfection reagents, the amount of nucleic acid plasmid that cells have taken up during transfection as well as the amount of the encoded expressed protein. Finally, we demonstrate that this method is reproducible, can be standardized and can reliably and rapidly quantify transfection efficiency, reducing assay costs and increasing throughput while increasing data robustness.	[Homann, Stefanie; Hofmann, Christian; Gorin, Aleksandr M.; Huy Cong Xuan Nguyen; Diana Huynh; Hamid, Phillip; Maithel, Neil; Yacoubian, Vahe; Mu, Wenli; Kossyvakis, Athanasios; Sen Roy, Shubhendu; Yang, Otto Orlean; Kelesidis, Theodoros] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Kelesidis, T (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	tkelesidis@mednet.ucla.edu			NIH grants NIH/NCATS [UL1TR000124, NIH K08AI08272]; UCLA AIDS Institute/UCLA Center for AIDS Research (CFAR) [NIH/NIAID AI028697]; National Institutes of Health [UCLA Center for AIDS Research (CFAR)] [NIH/NIAID 5P30 AI028697]; UCLA AIDS Institute; UCLA Council of Bioscience Resources	This research was supported by NIH grants NIH/NCATS grant # UL1TR000124, NIH K08AI08272 and by grant from the UCLA AIDS Institute/UCLA Center for AIDS Research (CFAR) (NIH/NIAID AI028697). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Center for AIDS Research Virology Core Lab and the Gene and Cellular Therapy Core that are supported by the National Institutes of Health [UCLA Center for AIDS Research (CFAR) NIH/NIAID 5P30 AI028697] and by the UCLA AIDS Institute and the UCLA Council of Bioscience Resources.	ADACHI A, 1986, J VIROL, V59, P284; Anderson MT, 1996, P NATL ACAD SCI USA, V93, P8508, DOI 10.1073/pnas.93.16.8508; ARRIO B, 1970, BIOCHEM BIOPH RES CO, V39, P589, DOI 10.1016/0006-291X(70)90244-5                                                    ; Bell MP, 2001, NAT MED, V7, P1155, DOI 10.1038/nm1001-1155; BERGERON D, 1995, CELL MOL BIOL RES, V41, P155; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ducrest AL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf064; Ebert O, 1997, GENE THER, V4, P296, DOI 10.1038/sj.gt.3300394                                                           ; FARR A, 1992, NUCLEIC ACIDS RES, V20, P920, DOI 10.1093/nar/20.4.920; Fegan A, 2008, CHEM COMMUN, P2004, DOI 10.1039/b801629a; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Hackett PB, 2005, ADV GENET, V54, P189, DOI 10.1016/S0065-2660(05)54009-4; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Hwang SY, 2013, J IMMUNOL, V190, P1192, DOI 10.4049/jimmunol.1202326; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang LZ, 2016, NAT PROTOC, V11, P655, DOI 10.1038/nprot.2016.028; Kapoor V, 2009, J IMMUNOL METHODS, V344, P6, DOI 10.1016/j.jim.2009.02.004; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim TK, 2010, ANAL BIOANAL CHEM, V397, P3173, DOI 10.1007/s00216-010-3821-6; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li J, 2014, BIOMATERIALS, V35, P5572, DOI 10.1016/j.biomaterials.2014.03.047; Li XQ, 1999, J BIOL CHEM, V274, P21244, DOI 10.1074/jbc.274.30.21244; Liu YF, 2015, MECH SCI, V6, P15, DOI 10.5194/ms-6-15-2015; Maess MB, 2014, JOVE-J VIS EXP; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Masotti A, 2009, COLLOID SURFACE B, V68, P136, DOI 10.1016/j.colsurfb.2008.09.017; Masuda T, 2005, FEBS LETT, V579, P2143, DOI 10.1016/j.febslet.2005.02.071; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Morachis JM, 2012, J DRUG DELIV, V2012; Nickells RW, 2015, EXP EYE RES, V141, P99, DOI 10.1016/j.exer.2015.05.009; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Nybo K, 2012, BIOTECHNIQUES, V52, P351, DOI 10.2144/000113870; OMAHONEY JV, 1994, DNA CELL BIOL, V13, P1227, DOI 10.1089/dna.1994.13.1227                                                        ; Ouyang SD, 2009, ZEBRAFISH, V6, P245, DOI 10.1089/zeb.2009.0589; Ritter SC, 2011, BIOMED OPT EXPRESS, V2, P2012, DOI 10.1364/BOE.2.002012; Romoren K, 2004, BBA-BIOMEMBRANES, V1663, P127, DOI 10.1016/j.bbamem.2004.02.007; Saito G, 2003, GENE THER, V10, P72, DOI 10.1038/sj.gt.3301859; Sandbichler AM, 2013, BIORESEARCH OPEN ACC, V2, P20, DOI 10.1089/biores.2012.0287; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Stoll SM, 2002, CURR OPIN MOL THER, V4, P299; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; Teif VB, 2011, PROG BIOPHYS MOL BIO, V105, P208, DOI 10.1016/j.pbiomolbio.2010.07.002; van der Aa MAEM, 2007, PHARM RES, V24, P1590, DOI 10.1007/s11095-007-9287-3; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Wang LT, 2007, BIOTECHNOL LETT, V29, P1691, DOI 10.1007/s10529-007-9448-9; WEISS A, 1984, J IMMUNOL, V133, P123; Wilson SM, 2012, NAT PROTOC, V7, P1716, DOI 10.1038/nprot.2012.096; Xie ZL, 2011, CELL BIOL INT, V35, P187, DOI 10.1042/CBI20100470; Zhou ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22824	55	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0182941	10.1371/journal.pone.0182941				22	Multidisciplinary Sciences	Science & Technology - Other Topics	FF3ON	WOS:000408816900003	28863132	gold			2018-01-05	
J	Sanz, DJ; Hollywood, JA; Scallan, MF; Harrison, PT				Sanz, David J.; Hollywood, Jennifer A.; Scallan, Martina F.; Harrison, Patrick T.			Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA	PLOS ONE			English	Article							CONDUCTANCE REGULATOR GENE; PULMONARY-DISEASE; EPITHELIAL-CELLS; DELTA-F508 CFTR; CAS9 PROTEIN; DOUBLE-BLIND; 3849+10 KB; DNA; IVACAFTOR; VARIANTS	Cystic Fibrosis is an autosomal recessive disorder caused by mutations in the CFTR gene. CRISPR mediated, template-dependent homology-directed gene editing has been used to correct the most common mutation, c.1521_1523delCTT / p.Phe508del (F508del) which affects similar to 70% of individuals, but the efficiency was relatively low. Here, we describe a high efficiency strategy for editing of three different rare CFTR mutations which together account for about 3% of individuals with Cystic Fibrosis. The mutations cause aberrant splicing of CFTR mRNA due to the creation of cryptic splice signals that result in the formation of pseudoexons containing premature stop codons c.1679+1634A>G (1811+1.6kbA>G) and c.3718-2477C>T (3849+10kbC>T), or an out-of-frame 5' extension to an existing exon c.3140-26A>G (3272-26A>G). We designed pairs of Cas9 guide RNAs to create targeted double-stranded breaks in CFTR either side of each mutation which resulted in high efficiency excision of the target genomic regions via non-homologous end-joining repair. When evaluated in a mini-gene splicing assay, we showed that targeted excision restored normal splicing for all three mutations. This approach could be used to correct aberrant splicing signals or remove disruptive transcription regulatory motifs caused by deep-intronic mutations in a range of other genetic disorders.	[Sanz, David J.; Hollywood, Jennifer A.; Harrison, Patrick T.] Univ Coll Cork, BioSci Inst, Dept Physiol, Cork, Ireland; [Hollywood, Jennifer A.; Scallan, Martina F.] Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Hollywood, Jennifer A.] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand	Harrison, PT (reprint author), Univ Coll Cork, BioSci Inst, Dept Physiol, Cork, Ireland.	p.harrison@ucc.ie			Cystic Fibrosis Foundation Therapeutics [HARRIS14XX0]; Cystic Fibrosis Trust [VIA011]; Cystic Fibrosis Foundation (Bethesda, MD, USA); Cystic Fibrosis Trust (London, UK)	This work was supported by the Cystic Fibrosis Foundation Therapeutics, HARRIS14XX0 (https://mw.cftorg/Research/Researcher-Resources/Cystic-Fibrosis-Foundation-Therapeutics/) to PTH and the Cystic Fibrosis Trust, VIA011 (https://www.cysticfibrosis.org.uk) to PTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dieter Gruenert (Department of Otolaryngology-Head and Neck Surgery, UCSF, San Francisco, CA) for the CFTE cell line, and Feng Zhang (Broad Institute, Boston, MA) for the plasmid pSpCas9(BB)-2a-GFP (Addgene PX458). This work was supported by Cystic Fibrosis Foundation (Bethesda, MD, USA) and Cystic Fibrosis Trust (London, UK). The authors would like to thank Ken Martin and Grzegorz Jasionek for excellent technical support.	Alton EWFW, 2017, THORAX, V72, P137, DOI 10.1136/thoraxjnl-2016-208406; Alton EWFW, 2016, PEDIATR PULM, V51, pS5, DOI 10.1002/ppul.23543; Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; ANGLANI F, 1990, AM J HUM GENET, V47, P169; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Beck S, 1999, HUM MUTAT, V14, P133, DOI 10.1002/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.3.CO;2-K; Bednarski C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161072; Castellani C, 2013, PAEDIATR RESPIR REV, V14, P2, DOI 10.1016/j.prrv.2013.01.006; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Chiba-Falek O, 1998, GENOMICS, V53, P276, DOI 10.1006/geno.1998.5517; CHILLON M, 1995, AM J HUM GENET, V56, P623; Choi JG, 2016, GENE THER, V23, P627, DOI 10.1038/gt.2016.27; Cooney AL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88730; Costantino L, 2013, AM J RESP CELL MOL, V48, P619, DOI 10.1165/rcmb.2012-0371OC; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379                                                             ; Friedman KJ, 1999, J BIOL CHEM, V274, P36193, DOI 10.1074/jbc.274.51.36193                                                        ; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Goncz KK, 1998, HUM MOL GENET, V7, P1913, DOI 10.1093/hmg/7.12.1913                                                           ; Goncz KK, 2001, GENE THER, V8, P961, DOI 10.1038/sj.gt.3301476; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Harrison PT, 2016, HUM GENET, V135, P983, DOI 10.1007/s00439-016-1693-3; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503                                                     ; Hollywood JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32230; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522                                                          ; Kunzelmann K, 1996, GENE THER, V3, P859; Lee CM, 2012, BIORESEARCH OPEN ACC, V1, P99, DOI 10.1089/biores.2012.0218; Lee M, 2017, AM J HUM GENET, V100, P751, DOI 10.1016/j.ajhg.2017.04.001; McNeer NA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7952; Moss RB, 2015, LANCET RESP MED, V3, P524, DOI 10.1016/S2213-2600(15)00201-5; Mutyam V, 2017, J CYST FIBROS, V16, P24, DOI 10.1016/j.jcf.2016.09.005; Nissim-Rafinia M, 2000, HUM MOL GENET, V9, P1771, DOI 10.1093/hmg/9.12.1771; Nissim-Rafinia M, 2004, EMBO REP, V5, P1071, DOI 10.1038/sj.embor.7400273; OHMAN K, 1993, VIROLOGY, V194, P50, DOI 10.1006/viro.1993.1234; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riordan JR, 1989, SCIENCE, P245; Sanz DJ, 2010, CLIN CANCER RES, V16, P1957, DOI 10.1158/1078-0432.CCR-09-2564; Sharma N, 2014, HUM MUTAT, V35, P1249, DOI 10.1002/humu.22624; Steines B, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88728; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J                                                    ; STERN RC, 1995, LANCET, V346, P274, DOI 10.1016/S0140-6736(95)92165-6; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Vaz-Drago R., 2017, HUM GENET; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Zhang L.J., 2009, ETHYLENE IND, V25, P7	55	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184009	10.1371/journal.pone.0184009				13	Multidisciplinary Sciences	Science & Technology - Other Topics	FF3ON	WOS:000408816900016	28863137	gold			2018-01-05	
J	Lappas, M				Lappas, Martha			A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes	MOLECULAR HUMAN REPRODUCTION			English	Article						A20; myometrium; foetal membranes; pro-labour mediators; inflammation; preterm birth	NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; PRO-LABOR MEDIATORS; SMOOTH-MUSCLE-CELLS; TOLL-LIKE RECEPTOR; PRETERM LABOR; EPITHELIAL-CELLS; TERM LABOR; IN-VITRO; EXPRESSION	STUDY QUESTION: Does A20 regulate mediators involved in the terminal processes of human labour in primary myometrial and amnion cells? SUMMARY ANSWER: A20 is a nuclear factor-kappa B (NF-kappa B) responsive gene that acts as a negative regulator of NF-kappa B-induced expression of pro-labour mediators. WHAT IS KNOWN ALREADY: Inflammation is commonly implicated in spontaneous preterm birth and the processes involved in rupture of foetal membranes and uterine contractions. In myometrium and foetal membranes, the pro-inflammatory transcription factor NF-kappa B regulates the transcription of pro-labour mediators in response to inflammatory stimuli. In non-gestational tissues, A20 is widely recognised as an anti-inflammatory protein that inhibits inflammation-induced NF-kappa B signalling. STUDY DESIGN, SIZE, DURATION: Primary human amnion and myometrial cells were used to determine the effect of pro-inflammatory mediators on A20 expression and the effect of A20 siRNA on the expression and secretion of pro-labour mediators. The expression of A20 was assessed in myometrium and foetal membranes from non-labouring and labouring women at preterm and or term (n = 8 or nine samples per group). PARTICIPANTS/MATERIALS, SETTING, METHODS: The effects of pro-inflammatory mediators and of A20 siRNA in cell cultures were determined by quantitative RT-PCR (qRT-PCR), western blots, immunoassays, gelatin zymography and luciferase assays. A20 expression in tissue samples was assessed by qRT-PCR. Statistical significance was ascribed to a P value < 0.05. MAIN RESULTS AND THE ROLE OF CHANCE: In primary cells isolated from myometrium and or amnion, the pro-inflammatory cytokines IL1B and TNF, the bacterial products flagellin and fsl-1, and the viral double stranded RNA analogue poly(I: C) significantly increased A20 mRNA expression via NF-kappa B. A20 siRNA studies in primary myometrial and amnion cells demonstrated an augmentation of inflammation-induced expression and or secretion of pro-inflammatory cytokines (IL1A, IL6), chemokines (CXCL1, CXCL8, CCL2), adhesion molecules (ICAM1, VCAM1), contraction-associated proteins (PTGS2, PTGFR, PGF(2 alpha)) and the extracellular matrix degrading enzyme MMP9, as well as NF-kappa B activation. Inhibition of NF-kappa B activity significant attenuated inflammation-induced expression of pro-labour mediators in A20 siRNA transfected cells. Finally, A20 mRNA expression was decreased in myometrium and foetal membranes with labour, and in foetal membranes with chorioamnionitis. LARGE SCALE DATA: Not applicable. LIMITATIONS, REASONS FOR CAUTION: The conclusions of this study are solely reliant on the data from in vitro experiments using cells isolated from myometrium and amnion. WIDER IMPLICATIONS OF THE FINDINGS: The results of this study raise the possibility that targeting A20 may be a therapeutic approach to reduce inflammation associated with spontaneous preterm birth.	[Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Melbourne, Vic, Australia; [Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	Lappas, M (reprint author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Level 4-163 Studley Rd, Heidelberg, Vic 3084, Australia.	mlappas@unimelb.edu.au			Career Development Fellowship from the National Health and Medical Research Council (NHMRC) [1047025]; NHMRC [1058786]; Mercy Research Foundation; Norman Beischer Medical Research Foundation	Associate Professor Martha Lappas is supported by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC; grant no. 1047025). Funding for this study was provided by the NHMRC (grant no. 1058786), Norman Beischer Medical Research Foundation and the Mercy Research Foundation.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; Bates JS, 2009, GENES IMMUN, V10, P470, DOI 10.1038/gene.2009.31; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4                                                   ; Bollapragada S, 2009, AM J OBSTET GYNECOL, V200, P104, DOI DOI 10.1016/J.AJ0G.2008.08.032); Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289; Catrysse L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.154; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chevillard G, 2007, REPRODUCTION, V134, P811, DOI 10.1530/REP-07-0289; Choi SJ, 2007, EUR J OBSTET GYN R B, V132, P182, DOI 10.1016/j.ejogrb.2006.07.024; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068                                                        ; De Silva D, 2010, BRIT J PHARMACOL, V160, P1808, DOI 10.1111/j.1476-5381.2010.00839.x; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Fortier MA, 2008, J PHYSIOL PHARMACOL, V59, P65; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007                                                     ; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Grey ST, 2003, J IMMUNOL, V170, P6250, DOI 10.4049/jimmunol.170.12.6250                                                    ; Guedes RP, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-122; Hah YS, 2010, ARTHRITIS RHEUM-US, V62, P2313, DOI 10.1002/art.27545; Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428; Kang NI, 2009, J IMMUNOL, V183, P1488, DOI 10.4049/jimmunol.0900163; Keelan JA, 2009, J IMMUNOL, V183, P5270, DOI 10.4049/jimmunol.0802660; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lappas M, 2007, PLACENTA, V28, P543, DOI 10.1016/j.placenta.2006.05.011; Lappas M, 2006, PLACENTA, V27, P568, DOI 10.1016/j.placenta.2005.06.003; Lappas M, 2005, ENDOCRINOLOGY, V146, P1491, DOI 10.1210/en.2004-0809; Lappas M, 2009, PLACENTA, V30, pS90, DOI 10.1016/j.placenta.2008.10.005; Lappas M, 2015, REPRODUCTION, V149, P413, DOI 10.1530/REP-14-0597; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Ledingham MA, 2001, OBSTET GYNECOL, V97, P235, DOI 10.1016/S0029-7844(00)01126-1                                                   ; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lim R, 2015, PLACENTA, V36, P454, DOI 10.1016/j.placenta.2015.01.007; Lim R, 2015, PLACENTA, V36, P7, DOI 10.1016/j.placenta.2014.11.004; Lim R, 2013, BIOL REPROD, V88, P156; Lim R, 2017, MOL HUM REPROD, V23, P428, DOI 10.1093/molehr/gax013; Lim R, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142372; Lim R, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134726; Lim R, 2014, AM J REPROD IMMUNOL, V71, P401, DOI 10.1111/aji.12229; Lim R, 2014, REPROD SCI, V21, P562, DOI 10.1177/1933719113503406; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Longo CR, 2005, HEPATOLOGY, V42, P156, DOI 10.1002/hep.20741; Luo HW, 2015, MATH PROBL ENG, DOI 10.1155/2015/917259; Malcomson B, 2016, P NATL ACAD SCI USA, V113, pE3725, DOI 10.1073/pnas.1520289113; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Mussalli GM, 1999, J SOC GYNECOL INVEST, V6, P188, DOI 10.1016/S1071-5576(99)00013-1; OBrien WF, 1995, CLIN PERINATOL, V22, P973; Onose A, 2006, EUR J PHARMACOL, V541, P198, DOI 10.1016/j.ejphar.2006.03.073; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/humrep/gag001; Poljak M, 2014, REPROD SCI, V21, P804, DOI 10.1177/1933719113518990; Reihill JA, 2016, BRIT J PHARMACOL, V173, P778, DOI 10.1111/bph.13200; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Roh CR, 2000, MOL HUM REPROD, V6, P96, DOI 10.1093/molehr/6.1.96                                                           ; ROMERO R, 1994, ANN NY ACAD SCI, V734, P414, DOI 10.1111/j.1749-6632.1994.tb21771.x; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Stjernholm-Vladic Ylva, 2004, Reprod Biol Endocrinol, V2, P74, DOI 10.1186/1477-7827-2-74; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Vereecke L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6103; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Vora S, 2008, REPROD SCI, V15, p187A; Weiner CP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.034; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yoshimura K, 2005, J SOC GYNECOL INVEST, V12, P533, DOI 10.1016/j.jsgi.2005.06.006; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	70	0	0	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1360-9947	1460-2407		MOL HUM REPROD	Mol. Hum. Reprod.	SEP	2017	23	9					628	645		10.1093/molehr/gax041				18	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	FG1VC	WOS:000409836400005	28911210				2018-01-05	
J	Scott, DA; Zhang, F				Scott, David A.; Zhang, Feng			Implications of human genetic variation in CRISPR-based therapeutic genome editing	NATURE MEDICINE			English	Article							HUMAN-CELLS; CAS9 NUCLEASES; DNA CLEAVAGE; TARGET DNA; SPECIFICITY; SYSTEMS; CPF1; SEQ; BREAKS	CRISPR-Cas genome-editing methods hold immense potential as therapeutic tools to fix disease-causing mutations at the level of DNA. In contrast to typical drug development strategies aimed at targets that are highly conserved among individual patients, treatment at the genomic level must contend with substantial inter-individual natural genetic variation. Here we analyze the recently released ExAC and 1000 Genomes data sets to determine how human genetic variation impacts target choice for Cas endonucleases in the context of therapeutic genome editing. We find that this genetic variation confounds the target sites of certain Cas endonucleases more than others, and we provide a compendium of guide RNAs predicted to have high efficacy in diverse patient populations. For further analysis, we focus on 12 therapeutically relevant genes and consider how genetic variation affects off-target candidates for these loci. Our analysis suggests that, in large populations of individuals, most candidate off-target sites will be rare, underscoring the need for prescreening of patients through whole-genome sequencing to ensure safety. This information can be integrated with empirical methods for guide RNA selection into a framework for designing CRISPR-based therapeutics that maximizes efficacy and safety across patient populations.	[Scott, David A.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Scott, David A.; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Scott, David A.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Scott, David A.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Zhang, F (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Zhang, F (reprint author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Zhang, F (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org			US National Institutes of Health through the National Institute of Mental Health [5DP1-MH100706, 1R01-MH110049]; National Science Foundation; New York Stem Cell Foundation; Howard Hughes Medical Institute; Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation; Skoltech-MIT Next-Generation Program; James and Patricia Poitras; Robert Metcalfe	We would like to thank R. Macrae, L. Francioli, S. Jones, J. Strecker, D. Cox, I. Slaymaker, and W. Yan for helpful discussions and insights. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the US National Institutes of Health through the National Institute of Mental Health (5DP1-MH100706 and 1R01-MH110049); the National Science Foundation; the New York Stem Cell Foundation; the Howard Hughes Medical Institute; the Simons Foundation; the Paul G. Allen Family Foundation; the Vallee Foundation; the Skoltech-MIT Next-Generation Program; James and Patricia Poitras; Robert Metcalfe; and David Cheng. The computer code and resources related to this work are available through the Zhang laboratory website (http://www.genome-engineering.org/) and GitHub (http://github.com/fengzhanglab).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Cameron P., 2017, PROTOCOL EXCHANGE; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Lu YF, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a008581; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Yan WX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15058; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	29	2	2	18	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2017	23	9					1095	+		10.1038/nm.4377				10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	FG2XO	WOS:000409996200017	28759051				2018-01-05	
J	Liu, Q; Jiang, Y; Shao, L; Yang, P; Sun, BB; Yang, S; Chen, DJ				Liu, Qi; Jiang, Yu; Shao, Lei; Yang, Ping; Sun, Bingbing; Yang, Sheng; Chen, Daijie			CRISPR/Cas9-based efficient genome editing in Staphylococcus aureus	ACTA BIOCHIMICA ET BIOPHYSICA SINICA			English	Article						Staphylococci; plasmid; molecular genetics; genotyping; gene	ALLELIC-REPLACEMENT; RNA-POLYMERASE; SYSTEM; CRISPR-CAS9; GENE; EXPRESSION; RESISTANCE; VECTORS; DESIGN; SIGMA	Staphylococcus aureus is an important pathogenic bacterium prevalent in nosocomial infections and associated with high morbidity and mortality rates, which arise from the significant pathogenicity and multi-drug resistance. However, the typical genetic manipulation tools used to explore the relevant molecular mechanisms of S. aureus have multiple limitations: leaving a scar in the genome, comparatively low gene-editing efficiency, and prolonged experimental period. Here, we present a single-plasmid based on the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system which allows rapid and efficient chromosomal manipulation in S. aureus. The plasmid carries the cas9 gene under the control of the constitutive promoter P-xyl/tet, a single guide RNA-encoding sequence transcribed via a strong promoter Pspac, and donor DNA used to repair the double strand breaks. The function of the CRISPR/Cas9 vector was demonstrated by deleting the tgt gene and the rocA gene, and by inserting the erm R cassette in S. aureus. This research establishes a CRISPR/Cas9 genome editing tool in S. aureus, which enables marker-free, scarless and rapid genetic manipulation, thus accelerating the study of gene function in S. aureus.	[Liu, Qi; Yang, Ping] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Liu, Qi; Shao, Lei; Yang, Ping; Sun, Bingbing; Chen, Daijie] Shanghai Inst Pharmaceut Ind, Shanghai 201203, Peoples R China; [Jiang, Yu; Yang, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Jiang, Yu; Yang, Sheng] Shanghai Res & Dev Ctr Ind Biotechnol, Shanghai 201206, Peoples R China; [Sun, Bingbing; Chen, Daijie] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China	Chen, DJ (reprint author), Shanghai Inst Pharmaceut Ind, Shanghai 201203, Peoples R China.; Yang, S (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Synthet Biol, Shanghai 200032, Peoples R China.; Yang, S (reprint author), Shanghai Res & Dev Ctr Ind Biotechnol, Shanghai 201206, Peoples R China.; Chen, DJ (reprint author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.	syang@sibs.ac.cn; hccb001@163.com			National Natural Science Foundation of China [81573329]; National Basic Research Program of China [2014CB745101]	This work was supported by the grants from the National Natural Science Foundation of China (No. 81573329) and the National Basic Research Program of China (No. 2014CB745101).	Altenbuchner J, 2016, APPL ENVIRON MICROB, V82, P5421, DOI 10.1128/AEM.01453-16; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; Borukhov S, 2002, RES MICROBIOL, V153, P557, DOI 10.1016/S0923-2508(02)01368-2; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen WH, 2017, J AM CHEM SOC, V139, P3790, DOI 10.1021/jacs.6b13317; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Espedido Bjorn A, 2012, Front Biosci (Schol Ed), V4, P900; Fan F, 2001, PLASMID, V46, P71, DOI 10.1006/plas.2001.1526; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hryhorowicz M, 2017, ARCH IMMUNOL THER EX, V65, P233, DOI 10.1007/s00005-016-0427-5; Huang H, 2016, ACS SYNTH BIOL, V5, P1355, DOI 10.1021/acssynbio.6b00044; Huang He, 2015, Acta Biochim Biophys Sin (Shanghai), V47, P231, DOI 10.1093/abbs/gmv007; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kato F, 2011, J MICROBIOL METH, V87, P76, DOI 10.1016/j.mimet.2011.07.010; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626                                                                  ; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Leibig M, 2008, APPL ENVIRON MICROB, V74, P1316, DOI 10.1128/AEM.02424-07; Li Q, 2016, BIOTECHNOL J, V11, P961, DOI 10.1002/biot.201600053; MacPherson CR, 2015, NAT BIOTECHNOL, V33, P805, DOI 10.1038/nbt.3291; Monk IR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00049; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; Prax M, 2013, MICROBIOL-SGM, V159, P421, DOI 10.1099/mic.0.061705-0; Pyne ME, 2016, SCI REP, V6; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Tong YJ, 2015, ACS SYNTH BIOL, V4, P1020, DOI 10.1021/acssynbio.5b00038; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Yan MY, 2009, PLASMID, V61, P188, DOI 10.1016/j.plasmid.2009.02.001; Yi Jiang, 2015, ICIC Express Letters, V9, P81; Zeng H, 2015, APPL MICROBIOL BIOT, V99, P10575, DOI 10.1007/s00253-015-6931-4; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27943	37	0	0	15	15	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1672-9145	1745-7270		ACTA BIOCH BIOPH SIN	Acta Biochim. Biophys. Sin.	SEP	2017	49	9					764	770		10.1093/abbs/gmx074				7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	FF8EA	WOS:000409246700002	28910979				2018-01-05	
J	Molinski, SV; Ahmadi, S; Ip, W; Ouyang, H; Villella, A; Miller, JP; Lee, PS; Kulleperuma, K; Du, K; Di Paola, M; Eckford, PDW; Laselva, O; Huan, LJ; Wellhauser, L; Li, E; Ray, PN; Pomes, R; Moraes, TJ; Gonska, T; Ratjen, F; Bear, CE				Molinski, Steven V.; Ahmadi, Saumel; Ip, Wan; Ouyang, Hong; Villella, Adriana; Miller, John P.; Lee, Po-Shun; Kulleperuma, Kethika; Du, Kai; Di Paola, Michelle; Eckford, Paul D. W.; Laselva, Onofrio; Huan, Ling Jun; Wellhauser, Leigh; Li, Ellen; Ray, Peter N.; Pomes, Regis; Moraes, Theo J.; Gonska, Tanja; Ratjen, Felix; Bear, Christine E.			Orkambi (R) and amplifier co-therapy improves function from a rare CFTR mutation in gene-edited cells and patient tissue	EMBO MOLECULAR MEDICINE			English	Article						amplifier; c.3700 A > G; CFTR; CRISPR/Cas9; cystic fibrosis	TRANSMEMBRANE CONDUCTANCE REGULATOR; ACTIVATED CHLORIDE CHANNEL; MULTIDRUG ABC TRANSPORTER; MEMBRANE-SPANNING DOMAIN; CYSTIC-FIBROSIS; MOLECULAR-DYNAMICS; INTESTINAL ORGANOIDS; PHE508DEL CFTR; IN-VITRO; PROTEIN	The combination therapy of lumacaftor and ivacaftor (Orkambi (R)) is approved for patients bearing the major cystic fibrosis (CF) mutation: DF508. It has been predicted that Orkambi (R) could treat patients with rarer mutations of similar "theratype"; however, a standardized approach confirming efficacy in these cohorts has not been reported. Here, we demonstrate that patients bearing the rare mutation: c.3700 A>G, causing protein misprocessing and altered channel function-similar to DF508-CFTR, are unlikely to yield a robust Orkambi (R) response. While in silico and biochemical studies confirmed that this mutation could be corrected and potentiated by lumacaftor and ivacaftor, respectively, this combination led to a minor in vitro response in patient-derived tissue. A CRISPR/Cas9-edited bronchial epithelial cell line bearing this mutation enabled studies showing that an "amplifier" compound, effective in increasing the levels of immature CFTR protein, augmented the Orkambi (R) response. Importantly, this "amplifier" effect was recapitulated in patient-derived nasal culturesproviding the first evidence for its efficacy in augmenting Orkambi (R) in tissues harboring a rare CF-causing mutation. We propose that this multi-disciplinary approach, including creation of CRISPR/Cas9-edited cells to profile modulators together with validation using primary tissue, will facilitate therapy development for patients with rare CF mutations.	[Molinski, Steven V.; Kulleperuma, Kethika; Di Paola, Michelle; Pomes, Regis; Bear, Christine E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Molinski, Steven V.; Ahmadi, Saumel; Kulleperuma, Kethika; Du, Kai; Di Paola, Michelle; Eckford, Paul D. W.; Laselva, Onofrio; Huan, Ling Jun; Wellhauser, Leigh; Li, Ellen; Pomes, Regis; Bear, Christine E.] Hosp Sick Children, Res Inst, Programme Mol Med, Toronto, ON, Canada; [Ahmadi, Saumel; Bear, Christine E.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ip, Wan; Ouyang, Hong; Moraes, Theo J.; Gonska, Tanja] Hosp Sick Children, Res Inst, Programme Translat Med, Toronto, ON, Canada; [Villella, Adriana; Miller, John P.; Lee, Po-Shun] Proteostasis Therapeut, Cambridge, MA USA; [Ray, Peter N.] Hosp Sick Children, Div Mol Genet, Toronto, ON, Canada; [Moraes, Theo J.; Gonska, Tanja] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Ratjen, Felix] Hosp Sick Children, Div Resp Med, Toronto, ON, Canada	Bear, CE (reprint author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.; Bear, CE (reprint author), Hosp Sick Children, Res Inst, Programme Mol Med, Toronto, ON, Canada.; Bear, CE (reprint author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	bear@sickkids.ca		Ratjen, Felix/0000-0003-4057-6592	Cystic Fibrosis Canada; SickKids Hospital Foundation; Canadian Institutes of Health Research [CIHR MOP-97954, CIHR GPG-102171, CIHR MOP-130461]; Sick Kids Foundation; Peterborough K.M. Hunter and Ontario Graduate Studentships; H.W.C. Clayton Paediatric Research Studentship; Dr. Albert and Dorris Award for Cardiovascular Physiology; Canada Foundation for Innovation under Compute Canada; Government of Ontario; Ontario Research Fund Research Excellence; University of Toronto; Al Qamra Holding Group	We thank the family of study participants for their contributions. The Research Ethics Board of SickKids Hospital (Toronto, Canada) approved the study, and informed consent was obtained to generate airway cultures from nasal brushings for the purpose of functional testing. The electrophysiological measurements obtained from nasal cultures generated from the individuals homozygous for Delta F508 were provided through the Program in Individualized Cystic Fibrosis Therapy (CFIT), supported by Cystic Fibrosis Canada and SickKids Hospital Foundation. The authors also thank Dr. Luis Galietta (U.O.C. Genetica Medica, Istituto Giannina Gaslini, Genova, Italy) for helpful comments regarding the TMEM16A studies, as well as Drs. Johanna Rommens and Roman Melnyk for helpful commentary on the manuscript. We thank Jennifer Curran for technical support. These studies were supported by Operating Grants to C.E.B. from the Canadian Institutes of Health Research (CIHR MOP-97954, CIHR GPG-102171) and Cystic Fibrosis Canada; New Investigator grant to T.G. from the Canadian Institutes of Health Research and Sick Kids Foundation; New Investigator grant to T.J.M. from the Canadian Institutes of Health Research and Sick Kids Foundation; Operating Grants to R.P. from the Canadian Institutes of Health Research (CIHR MOP-130461). S.V.M. was supported by Peterborough K.M. Hunter and Ontario Graduate Studentships. S.A. was supported by the H.W.C. Clayton Paediatric Research Studentship and Dr. Albert and Dorris Award for Cardiovascular Physiology. Computations were performed on the GPC super-computer at the SciNet HPC Consortium. SciNet is funded by the Canada Foundation for Innovation under the auspices of Compute Canada; the Government of Ontario; Ontario Research Fund Research Excellence; and the University of Toronto. These studies were also partially funded by the Al Qamra Holding Group, located in Qatar, where c.3700A>G affects most CF patients.	Awatade NT, 2015, EBIOMEDICINE, V2, P147, DOI 10.1016/j.ebiom.2014.12.005; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dekkers R, 2015, J CYST FIBROS, V14, P178, DOI 10.1016/j.jcf.2014.10.007; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117                                                                ; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Haggie PM, 2017, J BIOL CHEM, V292, P771, DOI 10.1074/jbc.M116.764720; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Howell LD, 2004, BIOCHEM J, V378, P151, DOI 10.1042/BJ20021428; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5                                                    ; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760                                                               ; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869                                                                ; Kopeikin Z, 2014, J CYST FIBROS, V13, P508, DOI 10.1016/j.jcf.2014.04.003; Kulleperuma K, 2013, J GEN PHYSIOL, V141, P445, DOI 10.1085/jgp.201210856; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Laselva O, 2016, BIOCHEM PHARMACOL, V119, P85, DOI 10.1016/j.bcp.2016.09.005; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Maitra R, 2013, J BIOMOL SCREEN, V18, P1132, DOI 10.1177/1087057113488420; Mansoura MK, 1999, HUM GENE THER, V10, P861, DOI 10.1089/10430349950018274; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; Miller JP, 2016, AM J RESP CRIT CARE, V193; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Molinski SV, 2015, J BIOMOL SCREEN, V20, P1204, DOI 10.1177/1087057115605834; Molinski SV, 2014, GENET MED, V16, P625, DOI 10.1038/gim.2014.4; Moyer BD, 1999, AM J PHYSIOL-RENAL, V277, pF271; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334                                                                ; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196                                                     ; Pasyk S, 2015, PROTEOMICS, V15, P447, DOI 10.1002/pmic.201400218; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rajagopal M, 2011, AM J PHYSIOL-RENAL, V301, pF544, DOI 10.1152/ajprenal.00709.2010; Ramalho AS, 2016, J CYST FIBROS, V15, P21, DOI 10.1016/j.jcf.2015.02.002; Rapino D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119796; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184                                                            ; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788                                                               ; Sabusap CM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86581; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yeh HI, 2015, J GEN PHYSIOL, V145, P47, DOI 10.1085/jgp.201411272; Yu W, 2011, J BIOL CHEM, V286, P24714, DOI 10.1074/jbc.M111.239699	68	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1757-4676	1757-4684		EMBO MOL MED	EMBO Mol. Med.	SEP	2017	9	9					1224	1243		10.15252/emmm.201607137				20	Medicine, Research & Experimental	Research & Experimental Medicine	FF6JA	WOS:000409112900005	28667089	gold			2018-01-05	
J	van de Weijer, ML; Schuren, ABC; van den Boomen, DJH; Mulder, A; Claas, FHJ; Lehner, PJ; Lebbink, RJ; Wiertz, EJHJ				van de Weijer, Michael L.; Schuren, Anouk B. C.; van den Boomen, Dick J. H.; Mulder, Arend; Claas, Frans H. J.; Lehner, Paul J.; Lebbink, Robert Jan; Wiertz, Emmanuel J. H. J.			Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation	JOURNAL OF CELL SCIENCE			English	Article						ERAD; ER-associated protein degradation; E2; Ubiquitin; US2; Cytomegalovirus	MHC CLASS-I; RETICULUM-ASSOCIATED DEGRADATION; HMG-COA REDUCTASE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; HEAVY-CHAINS; PEPTIDE TRANSLOCATION; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; IMMUNE EVASION	Misfolded endoplasmic reticulum (ER) proteins are dislocated towards the cytosol and degraded by the ubiquitin-proteasome system in a process called ER-associated protein degradation (ERAD). During infection with human cytomegalovirus (HCMV), the viral US2 protein targets HLA class I molecules (HLA-I) for degradation via ERAD to avoid elimination by the immune system. US2-mediated degradation of HLA-I serves as a paradigm of ERAD and has facilitated the identification of TRC8 (also known as RNF139) as an E3 ubiquitin ligase. No specific E2 enzymes had previously been described for cooperation with TRC8. In this study, we used a lentiviral CRISPR/Cas9 library targeting all known human E2 enzymes to assess their involvement in US2-mediated HLA-I downregulation. We identified multiple E2 enzymes involved in this process, of which UBE2G2 was crucial for the degradation of various immunoreceptors. UBE2J2, on the other hand, counteracted US2induced ERAD by downregulating TRC8 expression. These findings indicate the complexity of cellular quality control mechanisms, which are elegantly exploited by HCMV to elude the immune system.	[van de Weijer, Michael L.; Schuren, Anouk B. C.; Lebbink, Robert Jan; Wiertz, Emmanuel J. H. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [van den Boomen, Dick J. H.; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Mulder, Arend; Claas, Frans H. J.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, NL-2333 ZA Leiden, Netherlands; [van de Weijer, Michael L.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Wiertz, EJHJ (reprint author), Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands.	E.Wiertz@umcutrecht.nl			Graduate Programme of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research; NWO) [022.004.018]; Wellcome Trust PRF (Principal Research Fellowship) [101835/Z/13/Z]	A.B.C.S. is funded by the Graduate Programme of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research; NWO) (project number 022.004.018), and by a Wellcome Trust PRF (Principal Research Fellowship) to P.J.L. with grant no. 101835/Z/13/Z. Deposited in PMC for release after 6 months.	Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Duncan LM, 2010, J IMMUNOL, V184, P6978, DOI 10.4049/jimmunol.0904154; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241                                                              ; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hewitt EW, 2001, EMBO J, V20, P387, DOI 10.1093/emboj/20.3.387; Hsu JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004811; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu WX, 2014, EMBO J, V33, P46, DOI 10.1002/embj.201385315; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Miao HH, 2010, ACTA BIOCH BIOPH SIN, V42, P303, DOI 10.1093/abbs/gmq022; Mocarski ES, 2002, TRENDS MICROBIOL, V10, P332, DOI 10.1016/S0966-842X(02)02393-4; Noriega V, 2012, IMMUNOL RES, V54, P140, DOI 10.1007/s12026-012-8304-8; Noriega VM, 2012, MOL IMMUNOL, V51, P245, DOI 10.1016/j.molimm.2012.03.024; Olzmann JA, 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A013185; Oresic K, 2009, J BIOL CHEM, V284, P5905, DOI 10.1074/jbc.M807568200; Park B, 2010, J EXP MED, V207, P2033, DOI 10.1084/jem.20091793; Park BY, 2004, IMMUNITY, V20, P71, DOI 10.1016/S1074-7613(03)00355-8; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Schuren ABC, 2016, CURR OPIN IMMUNOL, V40, P43, DOI 10.1016/j.coi.2016.02.007; Soetandyo N, 2010, J BIOL CHEM, V285, P32352, DOI 10.1074/jbc.M110.131649; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; van de Weijer ML, 2015, SEMIN IMMUNOL, V27, P125, DOI 10.1016/j.smim.2015.03.010; van den Boomen DJH, 2015, MOL IMMUNOL, V68, P106, DOI 10.1016/j.molimm.2015.07.005; van den Boomen DJH, 2014, P NATL ACAD SCI USA, V111, P11425, DOI 10.1073/pnas.1409099111; van de Weijer M. L., 2014, NAT COMMUN, V5, P3832, DOI [DOI 10.1038/NC0MMS4832, 10.1038/ncomms4832]; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5                                                   ; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0                                                                ; Yan L, 2014, J CELL SCI, V127, P1417, DOI 10.1242/jcs.135293; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	51	0	0	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	SEP 1	2017	130	17					2883	2892		10.1242/jcs.206839				10	Cell Biology	Cell Biology	FF4IF	WOS:000408902000015	28743740				2018-01-05	
J	Zheng, Y; Jongejan, A; Mulder, CL; Mastenbroek, S; Repping, S; Wang, YH; Li, JS; Hamer, G				Zheng, Yi; Jongejan, Aldo; Mulder, Callista L.; Mastenbroek, Sebastiaan; Repping, Sjoerd; Wang, Yinghua; Li, Jinsong; Hamer, Geert			Trivial role for NSMCE2 during in vitro proliferation and differentiation of male germline stem cells	REPRODUCTION			English	Article							SUMO LIGASE ACTIVITY; FEEDER-FREE CULTURE; LONG-TERM CULTURE; ACID GENE-8 STRA8; SMC5/6 COMPLEX; RETINOIC ACID; DNA-REPAIR; SMC5-SMC6 COMPLEX; SELF-RENEWAL; MOUSE	Spermatogenesis, starting with spermatogonial differentiation, is characterized by ongoing and dramatic alterations in composition and function of chromatin. Failure to maintain proper chromatin dynamics during spermatogenesis may lead to mutations, chromosomal aberrations or aneuploidies. When transmitted to the offspring, these can cause infertility or congenital malformations. The structural maintenance of chromosomes (SMC) 5/6 protein complex has recently been described to function in chromatin modeling and genomic integrity maintenance during spermatogonial differentiation and meiosis. Among the subunits of the SMC5/6 complex, non-SMC element 2 (NSMCE2) is an important small ubiquitin-related modifier (SUMO) ligase. NSMCE2 has been reported to be essential for mouse development, prevention of cancer and aging in adult mice and topological stress relief in human somatic cells. By using in vitro cultured primary mouse spermatogonial stem cells (SSCs), referred to as male germline stem (GS) cells, we investigated the function of NSMCE2 during spermatogonial proliferation and differentiation. We first optimized a protocol to generate genetically modified GS cell lines using CRISPR-Cas9 and generated an Nsmce2(-/-) GS cell line. Using this Nsmce2(-/-) GS cell line, we found that NSMCE2 was dispensable for proliferation, differentiation and topological stress relief in mouse GS cells. Moreover, RNA sequencing analysis demonstrated that the transcriptome was only minimally affected by the absence of NSMCE2. Only differential expression of Sgsm1 appeared highly significant, but with SGSM1 protein levels being unaffected without NSMCE2. Hence, despite the essential roles of NSMCE2 in somatic cells, chromatin integrity maintenance seems differentially regulated in the germline.	[Zheng, Yi; Mulder, Callista L.; Mastenbroek, Sebastiaan; Repping, Sjoerd; Hamer, Geert] Univ Amsterdam, Acad Med Ctr, Amsterdam Res Inst Reprod & Dev, Ctr Reprod Med, Amsterdam, Netherlands; [Jongejan, Aldo] Acad Med Ctr, Amsterdam Publ Hlth Res Inst, Bioinformat Lab, Dept Clin Epidemiol Biostat & Bioinform, Amsterdam, Netherlands; [Wang, Yinghua; Li, Jinsong] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab C, CAS Ctr Excellence Mol Cell Sci,Shanghai Key Lab, Shanghai, Peoples R China	Hamer, G (reprint author), Univ Amsterdam, Acad Med Ctr, Amsterdam Res Inst Reprod & Dev, Ctr Reprod Med, Amsterdam, Netherlands.	g.hamer@amc.uva.nl		Mastenbroek, Sebastiaan/0000-0002-7550-2924; Hamer, Geert/0000-0002-9583-6796	AMC; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme [CIG 293765]; China Scholarship Counsel (CSC) [201306300081]	This study has been supported by an AMC Fellowship, the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (CIG 293765) to Geert Hamer and the China Scholarship Counsel (CSC) number 201306300081 to Yi Zheng.	Agostinho A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003591; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bickel JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001028; Carter SD, 2012, CRIT REV BIOCHEM MOL, V47, P1, DOI 10.3109/10409238.2011.614593; Chapman KM, 2015, CELL REP, V10, P1828, DOI 10.1016/j.celrep.2015.02.040; Chen J, 2017, NUCLEIC ACIDS RES, V45, P4142, DOI 10.1093/nar/gkw1287; Copsey A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004071; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; de Rooij DG, 2003, CYTOGENET GENOME RES, V103, P267, DOI 10.1159/000076812; Fanslow DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112652; Farmer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020948; Fernandez-Capetillo O, 2016, CELL CYCLE, V15, P775, DOI 10.1080/15384101.2015.1137713; Gomez R, 2013, J CELL SCI, V126, P4239, DOI 10.1242/jcs.130195; Guo Y, 2014, J CELL PHYSIOL, V229, P407, DOI 10.1002/jcp.24471; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7                                                   ; Hong Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005872; Hwang G, 2017, DEVELOPMENT, V144, P1648, DOI 10.1242/dev.145607; Jacome A, 2015, EMBO J, V34, P2604, DOI 10.15252/embj.201591829; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Jeppsson K., 2012, NAT REV, V15, P601; Ju LM, 2013, DNA REPAIR, V12, P356, DOI 10.1016/j.dnarep.2013.02.006; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P236, DOI 10.1095/biolreprod.104.035659; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI [10.1095/biolreprod.103.017012, 10.1095/biloreprod.103.017012]; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122317; Kanatsu-Shinohara M, 2011, BIOL REPROD, V84, P97, DOI 10.1095/biolreprod.110.086462; Kanatsu-Shinohara M, 2010, METHOD ENZYMOL, V477, P17, DOI 10.1016/S0076-6879(10)77002-6; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/nmeth.3317, 10.1038/NMETH.3317]; Kliszczak M, 2012, DNA REPAIR, V11, P799, DOI 10.1016/j.dnarep.2012.06.010; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Langston RE, 2015, MOL CELL, V60, P832, DOI 10.1016/j.molcel.2015.12.006; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lilienthal I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003898; Manku G, 2015, REPRODUCTION, V149, pR139, DOI 10.1530/REP-14-0431; Marjault HB, 2016, MUTAT RES-REV MUTAT, V770, P340, DOI 10.1016/j.mrrev.2016.07.004; McDonald WH, 2003, J BIOL CHEM, V278, P45460, DOI 10.1074/jbc.M308828200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulder CL, 2016, HUM REPROD UPDATE, V22, P561, DOI 10.1093/humupd/dmw017; Ni HJ, 2012, BBA-GEN SUBJECTS, V1820, P1893, DOI 10.1016/j.bbagen.2012.08.002; O'Neil NJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003582; Payne F, 2014, J CLIN INVEST, V124, P4028, DOI 10.1172/JCI73264; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Potts PR, 2009, DNA REPAIR, V8, P499, DOI 10.1016/j.dnarep.2009.01.009; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Pryzhkova MV, 2016, J CELL SCI, V129, P1619, DOI 10.1242/jcs.179036; Rai R, 2011, J BIOL CHEM, V286, P14516, DOI 10.1074/jbc.M110.157149; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sato T, 2015, STEM CELL REP, V5, P75, DOI 10.1016/j.stemcr.2015.05.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Tseng YT, 2015, REPRODUCTION, V150, pR77, DOI 10.1530/REP-14-0679; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Verver DE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.269; Verver DE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111782; Verver DE, 2016, CHROMOSOMA, V125, P15, DOI 10.1007/s00412-015-0518-9; Verver DE, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118596; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223                                             ; Wang S, 2016, STEM CELL REP, V7, P80, DOI 10.1016/j.stemcr.2016.05.013; Wehrkamp-Richter S, 2012, NUCLEIC ACIDS RES, V40, P9633, DOI 10.1093/nar/gks713; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Wu YX, 2015, CELL RES, V25, P67, DOI 10.1038/cr.2014.160; Xaver M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004067; Yang H, 2007, GENOMICS, V90, P249, DOI 10.1016/j.ygeno.2007.03.013; Zeng W, 2012, MOL REPROD DEV, V79, P255, DOI 10.1002/mrd.22014; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zheng Y, 2014, REPRODUCTION, V147, pR65, DOI 10.1530/REP-13-0466; Zhou Q, 2008, BIOL REPROD, V79, P35, DOI 10.1095/biolreprod.107.066795; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	74	1	1	8	8	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	1470-1626			REPRODUCTION	Reproduction	SEP	2017	154	3					181	195		10.1530/REP-17-0173				15	Developmental Biology; Reproductive Biology	Developmental Biology; Reproductive Biology	FF7QF	WOS:000409210300002	28576919				2018-01-05	
J	Albert, M; Kalebic, N; Florio, M; Lakshmanaperumal, N; Haffner, C; Brandl, H; Henry, I; Huttner, WB				Albert, Mareike; Kalebic, Nereo; Florio, Marta; Lakshmanaperumal, Naharajan; Haffner, Christiane; Brandl, Holger; Henry, Ian; Huttner, Wieland B.			Epigenome profiling and editing of neocortical progenitor cells during development	EMBO JOURNAL			English	Article						Cas9; epigenome; histone methylation; neocortical development; neural progenitor cell	NEURAL STEM-CELLS; GENOME-WIDE MAPS; GENE-EXPRESSION; IN-VIVO; DNA METHYLATION; CEREBRAL-CORTEX; CHIP-SEQ; HISTONE METHYLTRANSFERASE; CHROMATIN STATE; PRECURSOR CELLS	The generation of neocortical neurons from neural progenitor cells (NPCs) is primarily controlled by transcription factors binding to DNA in the context of chromatin. To understand the complex layer of regulation that orchestrates different NPC types from the same DNA sequence, epigenome maps with cell type resolution are required. Here, we present genomewide histone methylation maps for distinct neural cell populations in the developing mouse neocortex. Using different chromatin features, we identify potential novel regulators of cortical NPCs. Moreover, we identify extensive H3K27me3 changes between NPC subtypes coinciding with major developmental and cell biological transitions. Interestingly, we detect dynamic H3K27me3 changes on promoters of several crucial transcription factors, including the basal progenitor regulator Eomes. We use catalytically inactive Cas9 fused with the histone methyltransferase Ezh2 to edit H3K27me3 at the Eomes locus in vivo, which results in reduced Tbr2 expression and lower basal progenitor abundance, underscoring the relevance of dynamic H3K27me3 changes during neocortex development. Taken together, we provide a rich resource of neocortical histone methylation data and outline an approach to investigate its contribution to the regulation of selected genes during neocortical development.	[Albert, Mareike; Kalebic, Nereo; Florio, Marta; Lakshmanaperumal, Naharajan; Haffner, Christiane; Brandl, Holger; Henry, Ian; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Florio, Marta] Harvard Med Sch, Dept Genet, Boston, MA USA	Albert, M; Huttner, WB (reprint author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	albert@mpi-cbg.de; huttner@mpi-cbg.de		Henry, Ian/0000-0002-7134-3110; Albert, Mareike/0000-0001-9855-9344	Christiane Nusslein-Volhard Foundation; EMBO longterm fellowship [ALTF 861-2013]; DFG [SFB 655]; ERC [250197]; DFG; Fonds der Chemischen Industrie	We are grateful to the Services and Facilities of the MPI-CBG for the outstanding support provided, notably J. Helppi and his team of the Biomedical Services Facility, M. Sarov and D. Olbert of the Genome Engineering Facility, J. Peychl and his team of the Light Microscopy Facility, and I. Nuesslein, J. Jarrells, E. Guhr, and A. Eugster Oegema for support with FACS. NGS work was performed by the Deep Sequencing Group of the SFB 655 at the Biotechnology Center of the Technische Universitat Dresden. We thank all members of the Huttner laboratory for help and discussion, and K. Long, M. Krause, and N.L. Vastenhouw for critical reading of the manuscript. M. A. acknowledges support from the Christiane Nusslein-Volhard Foundation. N. K. was supported by an EMBO longterm fellowship (ALTF 861-2013). W.B.H. was supported by grants from the DFG (SFB 655, A2) and the ERC (250197), by the DFG-funded Center for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie.	Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Aprea J, 2013, EMBO J, V32, P3145, DOI 10.1038/emboj.2013.245; Arcila ML, 2014, NEURON, V81, P1255, DOI 10.1016/j.neuron.2014.01.017; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borrell V, 2012, DEV NEUROBIOL, V72, P955, DOI 10.1002/dneu.22013; Burney MJ, 2013, STEM CELLS, V31, P1868, DOI 10.1002/stem.1431; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Egan CM, 2013, DEV CELL, V26, P223, DOI 10.1016/j.devcel.2013.07.008; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fleiss J. L., 1981, STAT METHODS RATES P; Florio M, 2017, CURR OPIN NEUROBIOL, V42, P33, DOI 10.1016/j.conb.2016.11.004; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hatada I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003189; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kalebic N, 2016, EMBO REP, V17, P338, DOI 10.15252/embr.201541715; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kinkley S, 2016, NAT; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lorzadeh A, 2016, CELL REP, V17, P2112, DOI 10.1016/j.celrep.2016.10.055; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mastrototaro G, 2017, J MOL NEUROSCI, V61, P590, DOI 10.1007/s12031-017-0900-6; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Morimoto-Suzki N, 2014, DEVELOPMENT, V141, P4343, DOI 10.1242/dev.112276; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Park DH, 2014, CELL REP, V8, P1290, DOI 10.1016/j.celrep.2014.07.060; Pataskar A, 2016, EMBO J, V35, P24, DOI 10.15252/embj.201591206; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Silver DL, 2016, BIOESSAYS, V38, P162, DOI 10.1002/bies.201500108; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Taverna E, 2014, ANNU REV CELL DEV BI, V30, P465, DOI 10.1146/annurev-cellbio-101011-155801; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/NMETH.3733, 10.1038/nmeth.3733]; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Weiner A, 2016, NAT BIOTECHNOL, V34, P953, DOI 10.1038/nbt.3652; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	61	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0261-4189	1460-2075		EMBO J	Embo J.	SEP 1	2017	36	17					2642	2658		10.15252/embj.201796764				17	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FF3QJ	WOS:000408828500014	28765163				2018-01-05	
J	Brophy, PD; Rasmussen, M; Parida, M; Bonde, G; Darbro, BW; Hong, XJ; Clarke, JC; Peterson, KA; Denegre, J; Schneider, M; Sussman, CR; Sunde, L; Lildballe, DL; Hertz, JM; Cornell, RA; Murray, SA; Manak, JR				Brophy, Patrick D.; Rasmussen, Maria; Parida, Mrutyunjaya; Bonde, Greg; Darbro, Benjamin W.; Hong, Xiaojing; Clarke, Jason C.; Peterson, Kevin A.; Denegre, James; Schneider, Michael; Sussman, Caroline R.; Sunde, Lone; Lildballe, Dorte L.; Hertz, Jens Michael; Cornell, Robert A.; Murray, Stephen A.; Manak, J. Robert			A Gene Implicated in Activation of Retinoic Acid Receptor Targets Is a Novel Renal Agenesis Gene in Humans	GENETICS			English	Article						GREB1L; retinoic acid; renal agenesis; CAKUT; whole exome sequencing	COPY NUMBER VARIATION; ZEBRAFISH KIDNEY DEVELOPMENT; HUMAN GENOME; CONGENITAL-ANOMALIES; URETERAL BUD; BRANCHING MORPHOGENESIS; TRANSCRIPTION FACTOR; CANCER GROWTH; URINARY-TRACT; BREAST-CANCER	Renal agenesis (RA) is one of the more extreme examples of congenital anomalies of the kidney and urinary tract (CAKUT). Bilateral renal agenesis is almost invariably fatal at birth, and unilateral renal agenesis can lead to future health issues including end-stage renal disease. Genetic investigations have identified several gene variants that cause RA, including EYA1, LHX1, and WT1. However, whereas compound null mutations of genes encoding alpha and gamma retinoic acid receptors (RARs) cause RA in mice, to date there have been no reports of variants in RAR genes causing RA in humans. In this study, we carried out whole exome sequence analysis of two families showing inheritance of an RA phenotype, and in both identified a single candidate gene, GREB1L. Analysis of a zebrafish greb1l loss-of-function mutant revealed defects in the pronephric kidney just prior to death, and F0 CRISPR/Cas9 mutagenesis of Greb1l in the mouse revealed kidney agenesis phenotypes, implicating Greb1l in this disorder. GREB1L resides in a chromatin complex with RAR members, and our data implicate GREB1L as a coactivator for RARs. This study is the first to associate a component of the RAR pathway with renal agenesis in humans.	[Brophy, Patrick D.; Darbro, Benjamin W.; Clarke, Jason C.; Manak, J. Robert] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Parida, Mrutyunjaya; Hong, Xiaojing; Manak, J. Robert] Univ Iowa, Dept Biol, 459 Biol Bldg,129 E Jefferson St, Iowa City, IA 52242 USA; [Bonde, Greg; Cornell, Robert A.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Rasmussen, Maria; Sunde, Lone; Lildballe, Dorte L.] Aarhus Univ Hosp, Dept Clin Genet, DK-8200 Skejby, Denmark; [Peterson, Kevin A.; Denegre, James; Murray, Stephen A.] Jackson Lab, Genet & Genom, Bar Harbor, ME 04609 USA; [Schneider, Michael] Carle Fdn Hosp & Phys Grp, Med Genet, Urbana, IL 61801 USA; [Sussman, Caroline R.] Mayo Clin, Dept Hypertens & Nephrol, Rochester, MN 55905 USA; [Hertz, Jens Michael] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark	Manak, JR (reprint author), Univ Iowa, Dept Biol, 459 Biol Bldg,129 E Jefferson St, Iowa City, IA 52242 USA.	john-manak@uiowa.edu		Sunde, Lone/0000-0002-8479-165X	National Institutes of Health [R01 DE021071, RC4 DK090937, UM1 OD023222]; Haderslevs Foundation	The authors thank Senuri Jayatilleka for initial work on the greb1l morpholino and zebrafish in situ assays, and Caleb Heffner for assistance with mouse embryo processing. This work was funded in part by the National Institutes of Health grant R01 DE021071 (J.R.M.) as well as by the National Institutes of Health grant RC4 DK090937 (P.D.B. and J.R.M.), a National Institutes of Health grant UM1 OD023222 (S.A.M.), and a Maria Dorthea and Holger From, Haderslevs Foundation grant (M.R.).	Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Berry R, 2011, HUM MOL GENET, V20, P917, DOI 10.1093/hmg/ddq530; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Bouchard M, 2004, DIFFERENTIATION, V72, P295, DOI 10.1111/j.1432-0436.2004.07207001.x; Brophy PD, 2013, HUM GENET, V132, P1339, DOI 10.1007/s00439-013-1338-8; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Carroll T, 1999, CURR TOP DEV BIOL, V44, P67; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; CARTER CO, 1979, J MED GENET, V16, P176, DOI 10.1136/jmg.16.3.176; Cartry J, 2006, DEV BIOL, V299, P35, DOI 10.1016/j.ydbio.2006.06.047; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Cheng CN, 2015, DEV BIOL, V399, P100, DOI 10.1016/j.ydbio.2014.12.020; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarke JC, 2006, HUM MOL GENET, V15, P3420, DOI 10.1093/hmg/ddl418; Costantini F, 2010, ORGANOGENESIS, V6, P252, DOI 10.4161/org6.4.12680; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Diep CQ, 2015, GENESIS, V53, P257, DOI 10.1002/dvg.22846; Donovan MJ, 1999, DEV GENET, V24, P252, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<252::AID-DVG8>3.0.CO;2-K; Drummond IA, 2016, METHOD CELL BIOL, V134, P391, DOI 10.1016/bs.mcb.2016.03.041; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Ghosh MG, 2000, CANCER RES, V60, P6367; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Guimier A, 2015, NAT GENET, V47, P1260, DOI 10.1038/ng.3376; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Harewood L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012375; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Humbert C, 2014, AM J HUM GENET, V94, P288, DOI 10.1016/j.ajhg.2013.12.017; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Iyer LM, 2013, NUCLEIC ACIDS RES, V41, P7635, DOI 10.1093/nar/gkt573; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776                                                          ; Kerecuk L, 2008, NAT CLIN PRACT NEPHR, V4, P312, DOI 10.1038/ncpneph0807; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302                                                          ; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81                                                               ; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Lee SJ, 2010, MECH DEVELOP, V127, P49, DOI 10.1016/j.mod.2009.11.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2014, DEV BIOL, V386, P111, DOI 10.1016/j.ydbio.2013.11.021; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Marra AN, 2016, DEV BIOL, V411, P231, DOI 10.1016/j.ydbio.2016.01.035; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Meeus L, 2004, J CLIN ENDOCR METAB, V89, P4285, DOI 10.1210/jc.2004-0166; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Natarajan G, 2013, CLIN KIDNEY J, V6, P144, DOI 10.1093/ckj/sfs186; Norwood V. F., 2003, RENAL DEV DISORDERS; Osafune K, 2002, DEV GROWTH DIFFER, V44, P161; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0                                                                ; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Piscione TD, 2002, DIFFERENTIATION, V70, P227, DOI 10.1046/j.1432-0436.2002.700602.x; POTTER EL, 1946, AM J OBSTET GYNECOL, V51, P885, DOI 10.1016/S0002-9378(16)39968-9                                                   ; POTTER EL, 1965, OBSTET GYNECOL, V25, P3; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rae JM, 2006, PROSTATE, V66, P886, DOI 10.1002/pros.20403; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; ROODHOOFT M, 1984, NEW ENGL J MED, V310, P1341; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241                                                              ; Schreuder MF, 2008, J PAEDIATR CHILD H, V44, P363, DOI 10.1111/j.1440-1754.2008.01315.x; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Shim GJ, 2004, P NATL ACAD SCI USA, V101, P1720, DOI 10.1073/pnas.0307915100; Sinnott R, 2014, CANCER RES, V74, P3857, DOI 10.1158/0008-5472.CAN-13-3398; Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008; Talbot JC, 2014, ZEBRAFISH, V11, P583, DOI 10.1089/zeb.2014.1047; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Toka HR, 2010, SEMIN NEPHROL, V30, P374, DOI 10.1016/j.semnephrol.2010.06.004; Torres M, 1995, DEVELOPMENT, V121, P4057; Trueba SS, 2005, J CLIN ENDOCR METAB, V90, P455, DOI 10.1210/jc.2004-1358; Uetani N, 2009, CLIN GENET, V75, P307, DOI 10.1111/j.1399-0004.2009.01175.x; [Anonymous], 1999, AM J KIDNEY DIS, V34, pS1; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088                                                                ; Vasilyev A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039992; Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009; Vilar J, 1996, KIDNEY INT, V49, P1478, DOI 10.1038/ki.1996.208                                                             ; Vivante A, 2017, J AM SOC NEPHROL, V28, P69, DOI 10.1681/ASN.2015080962; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168                                                                  ; WESTERFIELD M, 2000, ZEBRAFISH BOOK GUIDE; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Yalavarthy Rajesh, 2003, Saudi J Kidney Dis Transpl, V14, P336; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871	101	2	2	10	10	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	SEP	2017	207	1					215	228		10.1534/genetics.117.1125				14	Genetics & Heredity	Genetics & Heredity	FF7ER	WOS:000409179800017	28739660				2018-01-05	
J	Highfill, CA; Tran, JH; Nguyen, SKT; Moldenhauer, TR; Wang, XF; Macdonald, SJ				Highfill, Chad A.; Tran, Jonathan H.; Nguyen, Samantha K. T.; Moldenhauer, Taylor R.; Wang, Xiaofei; Macdonald, Stuart J.			Naturally Segregating Variation at Ugt86Dd Contributes to Nicotine Resistance in Drosophila melanogaster	GENETICS			English	Article						xenobiotics; CRISPR; functional validation; QTL mapping; RNAi	QUANTITATIVE TRAIT LOCI; SYNTHETIC POPULATION RESOURCE; GENETIC REFERENCE PANEL; COPY-NUMBER VARIATION; COMPLEX TRAITS; TRANSGENIC RNAI; INSECTICIDE RESISTANCE; BRISTLE NUMBER; GENOME; EXPRESSION	Identifying the sequence polymorphisms underlying complex trait variation is a key goal of genetics research, since knowing the precise causative molecular events allows insight into the pathways governing trait variation. Genetic analysis of complex traits in model systems regularly starts by constructing QTL maps, but generally fails to identify causative sequence polymorphisms. Previously we mapped a series of QTL contributing to resistance to nicotine in a Drosophila melanogaster multiparental mapping resource and here use a battery of functional tests to resolve QTL to the molecular level. One large-effect QTL resided over a cluster of UDP-glucuronosyltransferases, and quantitative complementation tests using deficiencies eliminating subsets of these detoxification genes revealed allelic variation impacting resistance. RNAseq showed that Ugt86Dd had significantly higher expression in genotypes that are more resistant to nicotine, and anterior midgut-specific RNA interference (RNAi) of this gene reduced resistance. We discovered a segregating 22-bp frameshift deletion in Ugt86Dd, and accounting for the InDel during mapping largely eliminates the QTL, implying the event explains the bulk of the effect of the mapped locus. CRISPR/Cas9 editing of a relatively resistant genotype to generate lesions in Ugt86Dd that recapitulate the naturally occurring putative loss-of-function allele, leads to a large reduction in resistance. Despite this major effect of the deletion, the allele appears to be very rare in wild-caught populations and likely explains only a small fraction of the natural variation for the trait. Nonetheless, this putatively causative coding InDel can be a launchpad for future mechanistic exploration of xenobiotic detoxification.	[Highfill, Chad A.; Tran, Jonathan H.; Nguyen, Samantha K. T.; Moldenhauer, Taylor R.; Wang, Xiaofei; Macdonald, Stuart J.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66047 USA; [Macdonald, Stuart J.] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66047 USA	Macdonald, SJ (reprint author), Univ Kansas, Dept Mol Biosci, 4043 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.	sjmac@ku.edu		Macdonald, Stuart/0000-0002-9421-002X	Kansas IdeA Networks of Biomedical Research Excellence project [NIH P20-GM103418]; NIH Centers of Biomedical Research Excellence [P20-GM103638]; NIH [R01-OD010974]	We thank Tony Long for suggesting the in silico InDel frequency estimation approach, Emily Pfeifer for technical assistance, and Rob Unckless for comments on a previous version of this manuscript. We thank the TRiP [National Institutes of Health (NIH) R01-GM084947] and the Vienna Drosophila Resource Center for providing transgenic RNAi fly stocks used in this study. Various additional fly stocks, including the DGRP strains, were obtained from the Bloomington Drosophila Stock Center (NIH P40-OD018537). We also thank Julian Dow and Shireen Davies (University of Glasgow) for providing malpighian tubule Gal4 strains, and Nicolas Buchon (Cornell University) for donating a tissue-specific gut Gal4 driver (flygut.epfl.ch). Finally, we thank Johannes Bischof for donating the pUASg.attB vector used for the overexpression experiment (flyorf.ch). X.W.'s work on this project was supported via the Kansas IdeA Networks of Biomedical Research Excellence project (NIH P20-GM103418), and the University of Kansas Genome Sequencing Core is supported by an NIH Centers of Biomedical Research Excellence (P20-GM103638). This project was supported by NIH grant R01-OD010974 to S.J.M. and Anthony D. Long (University of California Irvine).	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bergland AO, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004775; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; Blumenstiel JP, 2009, GENETICS, V182, P25, DOI 10.1534/genetics.109.101998; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Chakraborty M., 2017, BIORXIV IN PRESS; Chandler CH, 2013, TRENDS GENET, V29, P358, DOI 10.1016/j.tig.2013.01.009; Chari S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003661; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; CHURCHILL GA, 1994, GENETICS, V138, P963; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Cook DE, 2016, GENETICS, V204, P371, DOI 10.1534/genetics.116.191148; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Cornforth TW, 2003, GENET RES, V82, P139, DOI 10.1017/S0016672303006396; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Dutta D, 2015, CELL REP, V12, P346, DOI 10.1016/j.celrep.2015.06.009; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Environmental Protection Agency, 2009, FED REGISTER, V74, P26695; FALCONER DS, 1996, INTRO QUANTITATIVE G; Forsberg SKG, 2017, NAT GENET, V49, P497, DOI 10.1038/ng.3800; Geiger-Thornsberry GL, 2004, MECH AGEING DEV, V125, P179, DOI 10.1016/j.mad.2003.12.008; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Glendinning JI, 2002, ENTOMOL EXP APPL, V104, P15, DOI 10.1023/A:1021271717409; Good RT, 2014, GENOME BIOL EVOL, V6, P1118, DOI 10.1093/gbe/evu083; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Harrop TWR, 2014, G3-GENES GENOM GENET, V4, P2197, DOI 10.1534/g3.114.013870; He BZ, 2014, GENETICS, V196, P557, DOI 10.1534/genetics.113.157800; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; King EG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004322; King EG, 2012, GENOME RES, V22, P1558, DOI 10.1101/gr.134031.111; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; LANDER ES, 1989, GENETICS, V121, P185; Li XC, 2012, GENE, V502, P1, DOI 10.1016/j.gene.2012.04.031; Linder RA, 2016, MOL BIOL CELL, V27, P209, DOI 10.1091/mbc.E15-06-0408; Long AD, 2000, GENETICS, V154, P1255; Long AD, 1996, GENETICS, V144, P1497; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marriage TN, 2014, GENETICS, V198, P45, DOI 10.1534/genetics.114.162107; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Metcalf R. L., 1955, ORGANIC INSECTICIDES; Monnahan PJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005201; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Pasyukova EG, 2000, GENETICS, V156, P1129; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rosay P, 1997, J CELL SCI, V110, P1683; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Schrider DR, 2016, MOL BIOL EVOL, V33, P1308, DOI 10.1093/molbev/msw014; Shepard H. H., 1951, CHEM ACTION INSECTIO; Sittig LJ, 2016, NEURON, V91, P1253, DOI 10.1016/j.neuron.2016.08.013; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; Stam LF, 1996, GENETICS, V144, P1559; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Terhzaz S, 2010, CELL SIGNAL, V22, P737, DOI 10.1016/j.cellsig.2009.12.009; Threadgill DW, 2012, G3-GENES GENOM GENET, V2, P153, DOI 10.1534/g3.111.001891; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Zhou J, 2011, GENOME BIOL EVOL, V3, P1014, DOI 10.1093/gbe/evr023	91	0	0	6	6	GENETICS SOCIETY AMERICA	BETHESDA	9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA	0016-6731	1943-2631		GENETICS	Genetics	SEP	2017	207	1					311	325		10.1534/genetics.117.300058				15	Genetics & Heredity	Genetics & Heredity	FF7ER	WOS:000409179800024	28743761	green_published			2018-01-05	
J	Arruga, F; Gizdic, B; Bologna, C; Cignetto, S; Buonincontri, R; Serra, S; Vaisitti, T; Gizzi, K; Vitale, N; Garaffo, G; Mereu, E; Diop, F; Neri, F; Incarnato, D; Coscia, M; Allan, J; Piva, R; Oliviero, S; Furman, RR; Rossi, D; Gaidano, G; Deaglio, S				Arruga, F.; Gizdic, B.; Bologna, C.; Cignetto, S.; Buonincontri, R.; Serra, S.; Vaisitti, T.; Gizzi, K.; Vitale, N.; Garaffo, G.; Mereu, E.; Diop, F.; Neri, F.; Incarnato, D.; Coscia, M.; Allan, J.; Piva, R.; Oliviero, S.; Furman, R. R.; Rossi, D.; Gaidano, G.; Deaglio, S.			Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22	LEUKEMIA			English	Article							RICHTER SYNDROME; CLL; EXPRESSION; DISEASE; CANCER; IMPACT; TRANSFORMATION; PROGRESSION; ACTIVATION; SUBGROUPS	Even if NOTCH1 is commonly mutated in chronic lymphocytic leukemia (CLL), its functional impact in the disease remains unclear. Using CRISPR/Cas9-generated Mec-1 cell line models, we show that NOTCH1 regulates growth and homing of CLL cells by dictating expression levels of the tumor suppressor gene DUSP22. Specifically, NOTCH1 affects the methylation of DUSP22 promoter by modulating a nuclear complex, which tunes the activity of DNA methyltransferase 3A (DNMT3A). These effects are enhanced by PEST-domain mutations, which stabilize the molecule and prolong signaling. CLL patients with a NOTCH1-mutated clone showed low levels of DUSP22 and active chemotaxis to CCL19. Lastly, in xenograft models, NOTCH1-mutated cells displayed a unique homing behavior, localizing preferentially to the spleen and brain. These findings connect NOTCH1, DUSP22, and CCL19-driven chemotaxis within a single functional network, suggesting that modulation of the homing process may provide a relevant contribution to the unfavorable prognosis associated with NOTCH1 mutations in CLL.	[Arruga, F.; Gizdic, B.; Bologna, C.; Cignetto, S.; Buonincontri, R.; Serra, S.; Vaisitti, T.; Gizzi, K.; Neri, F.; Incarnato, D.; Oliviero, S.; Deaglio, S.] Human Genet Fdn, Turin, Italy; [Arruga, F.; Gizdic, B.; Bologna, C.; Cignetto, S.; Buonincontri, R.; Serra, S.; Vaisitti, T.; Deaglio, S.] Univ Turin, Dept Med Sci, Turin, Italy; [Vitale, N.; Garaffo, G.; Mereu, E.; Coscia, M.; Piva, R.] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Diop, F.; Rossi, D.; Gaidano, G.] Univ Piemonte Orientale, Dept Translat Med, Div Hematol, Novara, Italy; [Allan, J.; Furman, R. R.] Weill Cornell Med, Dept Hematol, New York, NY USA; [Oliviero, S.] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	Arruga, F; Deaglio, S (reprint author), Univ Turin, Dept Med Sci, Sch Med, Via Nizza 52, I-10126 Turin, Italy.; Arruga, F; Deaglio, S (reprint author), Univ Turin, Human Genet Fdn, Via Nizza 52, I-10126 Turin, Italy.	francesca.arruga@hugef-torino.org; silvia.deaglio@unito.it			Associazione Italiana per la Ricerca sul Cancro AIRC [IG-17314, IG-15217]; Human Genetics Foundation Institutional funds; Italian Ministry of Education [RBFR12D1CB]; Italian Ministry of University [RBFR12D1CB]; Italian Ministry of Research [RBFR12D1CB]; Italian Ministry of Health (Bando Giovani Ricercatori) [GR-2011-02346826]; Italian Ministry of Health (Bando Ricerca Finalizzata) [RF-2011-02349712]; Fondazione Cariplo [2012-0689]	Supported by the Associazione Italiana per la Ricerca sul Cancro AIRC (IG-17314 to SD, IG-15217 to SO and 5x1000 #100007 to GG), by the Human Genetics Foundation Institutional funds, by the Italian Ministries of Education, University and Research (Futuro in Ricerca 2012 # RBFR12D1CB), the Italian Ministry of Health (Bando Giovani Ricercatori GR-2011-02346826 and Bando Ricerca Finalizzata RF-2011-02349712), the Fondazione Cariplo, grant #2012-0689 and local university funds (ex-60%).	Arruga F, 2014, LEUKEMIA, V28, P1060, DOI 10.1038/leu.2013.319; Baliakas P, 2015, LEUKEMIA, V29, P329, DOI 10.1038/leu.2014.196; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Cuesta-Mateos C, 2010, EXP HEMATOL, V38, P756, DOI 10.1016/j.exphem.2010.05.003; Del Giudice I, 2012, HAEMATOL-HEMATOL J, V97, P437, DOI 10.3324/haematol.2011.060129; Fabbri G, 2013, J EXP MED, V210, P2273, DOI 10.1084/jem.20131448; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Jiang K, 2009, PLACENTA, V30, P806, DOI 10.1016/j.placenta.2009.06.006; Jung YW, 2016, P NATL ACAD SCI USA, V113, P8278, DOI 10.1073/pnas.1602899113; Khan DH, 2013, J BIOL CHEM, V288, P16518, DOI 10.1074/jbc.M112.440446; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lewintre EJ, 2009, LEUKEMIA LYMPHOMA, V50, P68, DOI 10.1080/10428190802541807; Li JP, 2010, J BIOL CHEM, V285, P5472, DOI 10.1074/jbc.M109.060186; Liu DB, 2012, BIOCHEMISTRY-MOSCOW+, V77, P934, DOI 10.1134/S0006297912080159; Malet-Engra G, 2013, CANCER RES, V73, P3412, DOI 10.1158/0008-5472.CAN-12-3564; Morabito F, 2013, CLIN CANCER RES, V19, P5890, DOI 10.1158/1078-0432.CCR-13-0622; Nadeu F, 2016, BLOOD, V127, P2122, DOI 10.1182/blood-2015-07-659144; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Ojha J, 2014, LEUKEMIA, V28, P2395, DOI 10.1038/leu.2014.226; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Pozzo F, 2016, LEUKEMIA, V30, P182, DOI 10.1038/leu.2015.182; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; Rossi D, 2016, SEMIN ONCOL, V43, P311, DOI 10.1053/j.seminoncol.2016.02.012; Rossi D, 2013, BLOOD, V121, P1403, DOI 10.1182/blood-2012-09-458265; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Secchiero P, 2009, BLOOD, V113, P4300, DOI 10.1182/blood-2008-11-187708; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Strati P, 2016, HAEMATOLOGICA, V101, P458, DOI 10.3324/haematol.2015.136556; Sutton LA, 2015, HAEMATOLOGICA, V100, P7, DOI 10.3324/haematol.2014.115923; Vaisitti T, 2015, LEUKEMIA, V29, P356, DOI 10.1038/leu.2014.207; Sanchez-Mut JV, 2014, HIPPOCAMPUS, V24, P363, DOI 10.1002/hipo.22245; Villamor N, 2013, LEUKEMIA, V27, P1100, DOI 10.1038/leu.2012.357; Weissmann S, 2013, LEUKEMIA, V27, P2393, DOI 10.1038/leu.2013.218; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895; Yu D, 2015, TUMOR BIOL, V36, P8531, DOI 10.1007/s13277-015-3588-7	39	3	3	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	SEP	2017	31	9					1882	1893		10.1038/leu.2016.383				12	Oncology; Hematology	Oncology; Hematology	FF7YJ	WOS:000409232000006	28017968				2018-01-05	
J	Jin, K; Pandey, NB; Popel, AS				Jin, Kideok; Pandey, Niranjan B.; Popel, Aleksander S.			Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis	ONCOTARGET			English	Article						IL-8; TNBC; CXCR1/2; breast cancer; tumor microenvironment	CHEMOKINE RECEPTORS CXCR1; BREAST-CANCER; STEM-CELLS; MYELOID CELLS; LYMPH-NODES; MICROENVIRONMENT; RESISTANCE; EXPRESSION; LYMPHANGIOGENESIS; MACROPHAGES	Triple negative breast cancer (TNBC) as a metastatic disease is currently incurable. Reliable and reproducible methods for testing drugs against metastasis are not available. Stromal cells may play a critical role in tumor progression and metastasis. In this study, we determined that fibroblasts and macrophages secreted IL-8 upon induction by tumor cell-conditioned media (TCM) from MDA-MB-231 cancer cells. Our data showed that the proliferation of MDA-MB-231 cells co-cultured with fibroblasts or macrophages was enhanced compared to the monoculture. Furthermore, TNBC cell migration, a key step in tumor metastasis, was promoted by conditioned media (CM) from TCM-induced fibroblasts or macrophages. Knockdown of the IL-8 receptor CXCR2 by CRISPR-Cas9 reduces MDA-MB-231 cell proliferation and migration compared to wild type. In a mouse xenograft tumor model, the growth of MDA-MB-231-CXCR2(-/-) tumor was significantly decreased compared to the growth of tumors from wild-type cells. In addition, the incidence of thoracic metastasis of MDA-MB-231-CXCR2(-/-) tumors was reduced compared to wild type. We found that the auto-and paracrine loop exists between TNBC cells and stroma, which results in enhanced IL-8 secretion from the stromal components. Significantly, inhibition of the IL-8 signaling pathway by reparixin, an inhibitor of the IL-8 receptor, CXCR1/2, reduced MDA-MB-231 tumor growth and metastasis. Taken together, these findings implicate IL-8 signaling as a critical event in TNBC tumor growth and metastasis via crosstalk with stromal components.	[Jin, Kideok; Pandey, Niranjan B.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Jin, K (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	Kjin2@jhmi.edu			National Institutes of Health [R01 CA138264]	We thank ACEA Biosciences and Dr. Yama Abassi for technical advice for using RTCA system. This work was supported by the National Institutes of Health grant R01 CA138264.	Baghdadi M, 2016, CANCER RES, V76, P6030, DOI 10.1158/0008-5472.CAN-16-1170; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bertini R, 2004, P NATL ACAD SCI USA, V101, P11791, DOI 10.1073/pnas.0402090101; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Brandolini L, 2015, ONCOTARGET, V6, P43375, DOI 10.18632/oncotarget.6234; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; Sousa LFD, 2013, CLINICS, V68, P391, DOI 10.6061/clinics/2013(03)OA17; Dore-Savard L, 2016, SCI REP-UK, V6, DOI 10.1038/srep39460; Duong T, 2012, J ONCOL, V2012, P1; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Gangadhara S, 2012, FUTURE ONCOL, V8, P1427, DOI [10.2217/FON.12.134, 10.2217/fon.12.134]; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI [10.1172/JCI39397, 10.1172/JC139397]; Gorio A, 2007, J PHARMACOL EXP THER, V322, P973, DOI 10.1124/jpet.107.123679; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Jin K, 2015, CANCER DISCOV, V5, P944, DOI 10.1158/2159-8290.CD-15-0090; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kim HY, 2011, BIOL PHARM BULL, V34, P120, DOI 10.1248/bpb.34.120; Lee E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5715; Lee E, 2014, CLIN EXP METASTAS, V31, P67, DOI 10.1007/s10585-013-9610-9; Lee E, 2013, NEOPLASIA, V15, P112, DOI 10.1593/neo.121638; Lee E, 2011, INT J BIOCHEM CELL B, V43, P1812, DOI 10.1016/j.biocel.2011.08.020; Long XX, 2016, INT J ONCOL, V48, P5, DOI 10.3892/ijo.2015.3234; Malorni L, 2012, BREAST CANCER RES TR, V136, P795, DOI 10.1007/s10549-012-2315-y; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Marusyk A, 2016, CANCER RES, V76, P6495, DOI 10.1158/0008-5472.CAN-16-1457; Mazumdar J, 2009, J CELL MOL MED, V13, P4319, DOI 10.1111/j.1582-4934.2009.00963.x; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Moriconi A, 2007, J MED CHEM, V50, P3984, DOI 10.1021/jm061469t; Mumprecht V, 2009, J CELL MOL MED, V13, P1405, DOI 10.1111/j.1582-4934.2009.00834.x; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Paraiso KHT, 2013, BIOCHEM PHARMACOL, V85, P1033, DOI 10.1016/j.bcp.2013.01.018; Place AE, 2011, BREAST CANC RES, V13, P227; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Schaaij-Visser TBM, 2013, BBA-PROTEINS PROTEOM, V1834, P2242, DOI 10.1016/j.bbapap.2013.01.029; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Techasen A, 2012, ASIAN PAC J CANCER P, V13, P115, DOI 10.7314/APJCP.2012.13.KKSuppl.115; Turley SJ, 2015, NAT REV IMMUNOL, V15, P669, DOI 10.1038/nri3902; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; Wuyts A, 1997, BIOCHEMISTRY-US, V36, P2716, DOI 10.1021/bi961999z; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	47	0	0	6	6	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1949-2553			ONCOTARGET	Oncotarget	SEP 1	2017	8	36					60210	60222		10.18632/oncotarget.19417				13	Oncology; Cell Biology	Oncology; Cell Biology	FF4RQ	WOS:000408944300016	28947965	green_published			2018-01-05	
J	Yang, YF; Zhang, XQ; Ma, XH; Zhao, TL; Sun, QS; Huan, Q; Wu, SH; Du, Z; Qian, WF				Yang, Yu-Fei; Zhang, Xiaoqing; Ma, Xuehua; Zhao, Taolan; Sun, Qiushi; Huan, Qing; Wu, Shaohuan; Du, Zhuo; Qian, Wenfeng			Trans-splicing enhances translational efficiency in C. elegans	GENOME RESEARCH			English	Article							SYNONYMOUS CODON USAGE; GENOME-WIDE ANALYSIS; IN-VIVO TRANSLATION; CAENORHABDITIS-ELEGANS; PROTEIN EXPRESSION; GENE-EXPRESSION; MESSENGER-RNAS; SECONDARY STRUCTURE; FUNCTIONAL-ANALYSIS; GLOBAL ANALYSIS	Translational efficiency is subject to extensive regulation. However, the factors influencing such regulation are poorly understood. In Caenorhabditis elegans, 62% of genes are trans-spliced to a specific spliced leader (SLI), which replaces part of the native 5' untranslated region (5' UTR). Given the pivotal role the 5' UTR plays in the regulation of translational efficiency, we hypothesized that SLI trans-splicing functions to regulate translational efficiency. With genome-wide analysis on Ribo-seq data, polysome profiling experiments, and CRISPR-Cas9-based genetic manipulation of trans-splicing sites, we found four lines of evidence in support of this hypothesis. First, SLI trans-spliced genes have higher translational efficiencies than non trans-spliced genes. Second, SLI trans-spliced genes have higher translational efficiencies than non-trans-spliced orthologous genes in other nematode species. Third, an SLI trans-spliced isoform has higher translational efficiency than the non-trans spliced isoform of the same gene. Fourth, deletion of trans-splicing sites of endogenous genes leads to reduced translational efficiency. Importantly, we demonstrated that SLI trans-splicing plays a key role in enhancing translational efficiencies of essential genes. We further discovered that SLI trans-splicing likely enhances translational efficiency by shortening the native 5' UTRs, hence reducing the presence of upstream start codons (uAUG) and weakening mRNA secondary structures. Taken together, our study elucidates the global function of trans-splicing in enhancing translational efficiency in nematodes, paving the way for further understanding the genomic mechanisms of translational regulation.	[Yang, Yu-Fei; Zhang, Xiaoqing; Zhao, Taolan; Sun, Qiushi; Huan, Qing; Wu, Shaohuan; Qian, Wenfeng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Yang, Yu-Fei; Zhang, Xiaoqing; Ma, Xuehua; Zhao, Taolan; Sun, Qiushi; Huan, Qing; Wu, Shaohuan; Qian, Wenfeng] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Genet Network Biol, Beijing 100101, Peoples R China; [Yang, Yu-Fei; Zhang, Xiaoqing; Wu, Shaohuan; Qian, Wenfeng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Ma, Xuehua; Du, Zhuo] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100701, Peoples R China; [Sun, Qiushi] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing Key Lab Traff Data Anal & Min, Beijing 100044, Peoples R China	Qian, WF (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.; Qian, WF (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Genet Network Biol, Beijing 100101, Peoples R China.; Qian, WF (reprint author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Du, Z (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100701, Peoples R China.	zdu@genetics.ac.cn; wfqian@genetics.ac.cn			National Natural Science Foundation of China [31571308, 91331112, 31601061, 31571535]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDB19000000]; NIH Office of Research Infrastructure Programs [P40 OD010440]	The authors thank Qiwen Gan, Youli Ran, and Chonglin Yang for their help on worm experiments; Shiqin Jia from the core facility of the State Key Laboratory of Plant Genomics for her help on poly some profiling experiments; Yi Liu and Xiaofeng Cao for valuable discussions; and Bryan Moyers and John R. Speakman for critical reading of the manuscript. This work was supported by grants from the National Natural Science Foundation of China to W.Q. (31571308, 91331112), Y.-F.Y. (31601061), and Z.D. (31571535), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences to Z.D. (XDB19000000). Three worm strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Artieri CG, 2014, GENOME RES, V24, P411, DOI 10.1101/gr.165522.113; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Bao Z, 2011, COLD SPRING HARB PRO, V2011; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Blumenthal T., 2005, WORMBOOK; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; BULMER M, 1991, GENETICS, V129, P897; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P18077, DOI 10.1073/pnas.0608212103; Cheng GF, 2007, MOL BIOCHEM PARASIT, V153, P95, DOI 10.1016/j.molbiopara.2007.02.003; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; CONRAD R, 1993, NUCLEIC ACIDS RES, V21, P913, DOI 10.1093/nar/21.4.913; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Dvir S, 2013, P NATL ACAD SCI USA, V110, pE2792, DOI 10.1073/pnas.1222534110; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; Harris TW, 2014, NUCLEIC ACIDS RES, V42, pD789, DOI 10.1093/nar/gkt1063; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C., 1997, ENV FACTORS GENE ACT; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lall S, 2004, J BIOL CHEM, V279, P45573, DOI 10.1074/jbc.M407475200; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; MARONEY PA, 1995, RNA, V1, P714; McManus CJ, 2014, GENOME RES, V24, P422, DOI 10.1101/gr.164996.113; Nimmo R, 2002, BIOESSAYS, V24, P983, DOI 10.1002/bies.10181; Paek KY, 2015, P NATL ACAD SCI USA, V112, P1041, DOI 10.1073/pnas.1416883112; Paix A, 2014, GENETICS, V198, P1347, DOI 10.1534/genetics.114.170423; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Qian WF, 2008, GENOME RES, V18, P412, DOI 10.1101/gr.7112608; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Quax TEF, 2013, CELL REP, V4, P938, DOI 10.1016/j.celrep.2013.07.049; Saito TL, 2013, GENOME RES, V23, P1348, DOI 10.1101/gr.151571.112; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097                                                          ; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sen ND, 2015, GENOME RES, V25, P1196, DOI 10.1101/gr.191601.115; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Spike CA, 2008, DEVELOPMENT, V135, P983, DOI 10.1242/dev.015552; Stadler M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003739; Stadler M, 2011, RNA, V17, P2063, DOI 10.1261/rna.02890211; Staley CA, 2012, GENE, V496, P118, DOI [10.1016/j.gene.2012.01.006, 10.1016/j.gene.2012.01.008]; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Wallace A, 2010, MOL CELL BIOL, V30, P1958, DOI 10.1128/MCB.01437-09; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Zaslaver A, 2011, CELL, V145, P981, DOI 10.1016/j.cell.2011.05.013; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	74	0	0	4	4	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	SEP	2017	27	9					1525	1535		10.1101/gr.202150.115				11	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	FF3JF	WOS:000408790600006	28684554				2018-01-05	
J	Reimer, J; Knoss, S; Labuhn, M; Charpentier, EM; Gohring, G; Schlegelberger, B; Klusmann, JH; Heckl, D				Reimer, Jana; Knoess, Sabine; Labuhn, Maurice; Charpentier, Emmanuelle M.; Goehring, Gudrun; Schlegelberger, Brigitte; Klusmann, Jan-Henning; Heckl, Dirk			CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo	HAEMATOLOGICA			English	Article							STEM-CELLS; MYELOID-LEUKEMIA; HIGH-FREQUENCY; CRISPR/CAS9; GENERATION; NUCLEASES; MICE; TRANSFORMATION; EXPRESSION; GENES	Chromosomal translocations that generate oncogenic fusion proteins are causative for most pediatric leukemias and frequently affect the MLL/ KMT2A gene. In vivo modeling of bona fide chromosomal translocations in human hematopoietic stem and progenitor cells is challenging but essential to determine their actual leukemogenic potential. We therefore developed an advanced lentiviral CRISPR-Cas9 vector that efficiently transduced human CD34(+) hematopoietic stem and progenitor cells and induced the t(11; 19)/MLL-ENL translocation. Leveraging this system, we could demonstrate that hematopoietic stem and progenitor cells harboring the translocation showed only a transient clonal growth advantage in vitro. In contrast, t(11; 19)/MLL-ENL-harboring CD34(+) hematopoietic stem and progenitor cells not only showed longterm engraftment in primary immunodeficient recipients, but t(11; 19)/ MLL-ENL also served as a first hit to initiate a monocytic leukemia-like disease. Interestingly, secondary recipients developed acute lymphoblastic leukemia with incomplete penetrance. These findings indicate that environmental cues not only contribute to the disease phenotype, but also to t(11; 19)/ MLL-ENL-mediated oncogenic transformation itself. Thus, by investigating the true chromosomal t(11; 19) rearrangement in its natural genomic context, our study emphasizes the importance of environmental cues for the pathogenesis of pediatric leukemias, opening an avenue for novel treatment options.	[Reimer, Jana; Knoess, Sabine; Labuhn, Maurice; Klusmann, Jan-Henning; Heckl, Dirk] Hannover Med Sch, Pediat Hematol & Oncol, Hannover, Germany; [Charpentier, Emmanuelle M.] Max Planck Inst Infect Biol, Berlin, Germany; [Charpentier, Emmanuelle M.] Umea Univ, Lab Mol Infect Med Sweden, Umea, Sweden; [Goehring, Gudrun; Schlegelberger, Brigitte] Hannover Med Sch, Human Genet, Hannover, Germany	Heckl, D (reprint author), Hannover Med Sch, Pediat Hematol & Oncol, Hannover, Germany.	Heckl.Dirk@mh-hannover.de			German Cancer Aid [111743]; DFG [HE-7482/1-1, KL-2374/2-1, KL-2374/1-3, EXC 62/3]; Hannover Biomedical Research School	We thank Dr. Dr. A. Schambach and Michelle Ng for discussions and D. Trono of EPFL, Lausanne, Switzerland, for kindly providing both pMD2. G (Addgene plasmid 12259) and psPAX2 (Addgene plasmid 12260). DH is supported by the German Cancer Aid (111743). JHK is a fellow of the Emmy Noether-Programme from the DFG (KL-2374/2-1). This work was supported by grants to DH and JHK from the DFG (HE-7482/1-1, KL-2374/2-1; KL-2374/1-3) and to GG and BS for the Cluster of Excellence REBIRTH (DFG, EXC 62/3). JR and ML were supported by the Hannover Biomedical Research School.	Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Arai S, 2011, BLOOD, V117, P6304, DOI 10.1182/blood-2009-07-234310; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bindels EMJ, 2012, BLOOD, V119, P5838, DOI 10.1182/blood-2011-11-393827; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Breese EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136644; Buechele C, 2015, BLOOD, V126, P1683, DOI 10.1182/blood-2015-05-646398; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Creutzig U, 2012, BLOOD, V120, P3187, DOI 10.1182/blood-2012-03-362608; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Horton SJ, 2013, LEUKEMIA, V27, P1116, DOI 10.1038/leu.2012.343; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mandal PK, 2014, CELL STEM CELL, V15, P643, DOI 10.1016/j.stem.2014.10.004; Mejstrikova E, 2005, LEUKEMIA, V19, P1092, DOI 10.1038/sj.leu.2403737; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Rehe K, 2013, EMBO MOL MED, V5, P38, DOI 10.1002/emmm.201201703; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Stavropoulou V, 2016, CANCER CELL, V30, P43, DOI 10.1016/j.ccell.2016.05.011; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Suggs JL, 2007, EXP MOL PATHOL, V83, P471, DOI 10.1016/j.yexmp.2007.08.012; Takacova S, 2012, CANCER CELL, V21, P517, DOI 10.1016/j.ccr.2012.01.021; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Ugale A, 2014, CELL REP, V9, P1246, DOI 10.1016/j.celrep.2014.10.036; Vanden Bempt M, 2016, LEUKEMIA, V30, P1913, DOI 10.1038/leu.2016.62; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158	35	0	0	6	6	FERRATA STORTI FOUNDATION	PAVIA	VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY	0390-6078			HAEMATOLOGICA	Haematologica	SEP	2017	102	9					1558	1566		10.3324/haematol.2017.164046				9	Hematology	Hematology	FF2RA	WOS:000408743300024	28572162	gold			2018-01-05	
J	van der Krogt, JA; Vanden Bempt, M; Ferreiro, JF; Mentens, N; Jacobs, K; Pluys, U; Doms, K; Geerdens, E; Uyttebroeck, A; Pierre, P; Michaux, L; Devos, T; Vandenberghe, P; Tousseyn, T; Cools, J; Wlodarska, I				van der Krogt, Jo-Anne; Vanden Bempt, Marlies; Ferreiro, Julio Finalet; Mentens, Nicole; Jacobs, Kris; Pluys, Ursula; Doms, Kathleen; Geerdens, Ellen; Uyttebroeck, Anne; Pierre, Pascal; Michaux, Lucienne; Devos, Timothy; Vandenberghe, Peter; Tousseyn, Thomas; Cools, Jan; Wlodarska, Iwona			Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene	HAEMATOLOGICA			English	Article							GAMMA-RELATED SEQUENCE; IN-SITU HYBRIDIZATION; NON-HODGKINS-LYMPHOMA; NPM-ALK; TYROSINE KINASE; TRANSGENIC MICE; TRANSLOCATION; CANCER; IDENTIFICATION; INV(2)(P23Q35)	Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma is characterized by 2p23/ALK aberrations, including the classic t(2; 5)(p23; q35)/NPM1-ALK rearrangement present in similar to 80% of cases and several variant t(2p23/ALK) occurring in the remaining cases. The ALK fusion partners play a key role in the constitutive activation of the chimeric protein and its subcellular localization. Using various molecular technologies, we have characterized ALK fusions in eight recently diagnosed anaplastic large cell lymphoma cases with cytoplasmic- only ALK expression. The identified partner genes included EEF1G (one case), RNF213/ALO17 (one case), ATIC (four cases) and TPM3 (two cases). Notably, all cases showed copy number gain of the rearranged ALK gene, which is never observed in NPM1-ALK-positive lymphomas. We hypothesized that this could be due to lower expression levels and/or lower oncogenic potential of the variant ALK fusions. Indeed, all partner genes, except EEF1G, showed lower expression in normal and malignant T cells, in comparison with NPM1. In addition, we investigated the transformation potential of endogenous Npm1-Alk and Atic-Alk fusions generated by clustered regularly interspaced short palindromic repeats/Cas9 genome editing in Ba/F3 cells. We found that Npm1-Alk has a stronger transformation potential than Atic-Alk, and we observed a subclonal gain of Atic-Alk after a longer culture period, which was not observed for Npm1-Alk. Taken together, our data illustrate that lymphomas driven by the variant ATIC-ALK fusion (and likely by RNF213ALK and TPM3-ALK), but not the classic NPM1-ALK, require an increased dosage of the ALK hybrid gene to compensate for the relatively low and insufficient expression and signaling properties of the chimeric gene.	[van der Krogt, Jo-Anne; Vanden Bempt, Marlies; Ferreiro, Julio Finalet; Mentens, Nicole; Jacobs, Kris; Pluys, Ursula; Doms, Kathleen; Geerdens, Ellen; Michaux, Lucienne; Vandenberghe, Peter; Cools, Jan; Wlodarska, Iwona] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Vanden Bempt, Marlies; Mentens, Nicole; Jacobs, Kris; Geerdens, Ellen; Cools, Jan] VIB, Ctr Canc Biol, Leuven, Belgium; [Uyttebroeck, Anne] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium; [Pierre, Pascal] Clin Sud Luxembourg, Dept Hematol, Arlon, Belgium; [Devos, Timothy; Vandenberghe, Peter] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium; [Tousseyn, Thomas] Katholieke Univ Leuven, Translat Cell & Tissue Res, Leuven, Belgium; [Tousseyn, Thomas] Univ Hosp Leuven, Dept Pathol, Leuven, Belgium	Wlodarska, I (reprint author), Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium.	iwona.wlodarska@uzleuven.be		Cools, Jan/0000-0001-6626-5843; Vanden Bempt, Marlies/0000-0003-0111-0263	concerted action grant from the KU Leuven [3M040406]; FWO Vlaanderen [G081411N]; "Stichting tegen Kanker"; Research Foundation-Flanders; Mandate for Fundamental and Translational Research from the "Stichting tegen Kanker" [2014-083]	This study was supported by the concerted action grant from the KU Leuven no. 3M040406 (JAvdK, PV, TT, JC and IW), research grants from the FWO Vlaanderen (G081411N to TT) and "Stichting tegen Kanker" (PV). MVDB holds a SB Fellowship of the Research Foundation-Flanders. PV is a senior clinical investigator of the FWO-Vlaanderen. TT holds a Mandate for Fundamental and Translational Research from the "Stichting tegen Kanker" (2014-083).	Abate F, 2014, LEUKEMIA, P1; Achilonu I, 2014, PROTEIN EXPRES PURIF, V99, P70, DOI 10.1016/j.pep.2014.04.003; Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Atak ZK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003997; Boi M, 2015, BRIT J HAEMATOL, V168, P771, DOI 10.1111/bjh.13265; Boi M, 2013, BLOOD, V122, P2683, DOI 10.1182/blood-2013-04-497933; Cataldo KA, 1999, AM J SURG PATHOL, V23, P1386, DOI 10.1097/00000478-199911000-00009                                                ; CHI KF, 1992, GASTROENTEROLOGY, V103, P98, DOI 10.1016/0016-5085(92)91101-9                                                    ; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Colleoni GWB, 2000, AM J PATHOL, V156, P781, DOI 10.1016/S0002-9440(10)64945-0                                                   ; Cools J, 2002, GENE CHROMOSOME CANC, V34, P354, DOI 10.1002/gcc.10033; Drexler HG, 2000, LEUKEMIA, V14, P1533, DOI 10.1038/sj.leu.2401878; ENDER B, 1993, MOL CARCINOGEN, V7, P18, DOI 10.1002/mc.2940070104; Falini B, 1999, BLOOD, V93, P2697; Ferreiro JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102977; Gambacorti PC, 2014, JNCI-J NATL CANCER I, V106; Giuriato S, 2010, BLOOD, V115, P4061, DOI 10.1182/blood-2008-06-163386; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hernandez L, 2002, AM J PATHOL, V160, P1487, DOI 10.1016/S0002-9440(10)62574-6                                                   ; Hoshino A, 2015, INT J HEMATOL, V101, P198, DOI 10.1007/s12185-014-1701-0; Kuefer MU, 1997, BLOOD, V90, P2901; KUMABE T, 1992, NUCLEIC ACIDS RES, V20, P2598, DOI 10.1093/nar/20.10.2598; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lamant L, 1999, BLOOD, V93, P3088; Lange K, 2003, ONCOGENE, V22, P517, DOI 10.1038/sj.onc.1206076; LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350; LEW Y, 1992, PANCREAS, V7, P144, DOI 10.1097/00006676-199203000-00003; Liang XY, 2013, J PEDIAT HEMATOL ONC, V35, pE209, DOI 10.1097/MPH.0b013e3182815046; Liang XY, 2004, AM J CLIN PATHOL, V121, P496, DOI 10.1309/TLE8FN6EYF0NJGP7; Ma ZG, 2000, BLOOD, V95, P2144; Mathew P, 1997, BLOOD, V89, P1678; Meech SJ, 2001, BLOOD, V98, P1209, DOI 10.1182/blood.V98.4.1209; Mimori K, 1996, GUT, V38, P66, DOI 10.1136/gut.38.1.66; Mologni L, 2012, EXPERT OPIN INV DRUG, V21, P985, DOI 10.1517/13543784.2012.690031; Monaco S, 2007, AM J HEMATOL, V82, P59, DOI 10.1002/ajh.20758; Moritake H, 2011, AM J HEMATOL, V86, P75, DOI 10.1002/ajh.21887; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Palacios G, 2017, LEUKEMIA, V31, P743, DOI 10.1038/leu.2016.331; Pall G, 2015, CURR OPIN ONCOL, V27, P118, DOI 10.1097/CCO.0000000000000165; Perkins SL, 2005, BRIT J HAEMATOL, V131, P624, DOI 10.1111/j.1365-2141.2005.05808.x; Ries S, 2010, DIAGN CYTOPATHOL, V38, P141, DOI 10.1002/dc.21170; Sakamoto K, 2016, INT J HEMATOL, V103, P399, DOI 10.1007/s12185-016-1934-1; Siebert R, 1999, BLOOD, V94, P3614; Stein H, 2000, BLOOD, V96, P3681; Swerdlow SH, 2008, WHO CLASSIFICATION T; Takeoka K, 2014, J CLIN EXP HEMATOP, V54, P225, DOI 10.3960/jslrt.54.225                                                            ; Van Roosbroeck K, 2009, EUROPEAN HAEMATOLOGY, V3, P50; Wlodarska I, 1998, BLOOD, V92, P2688	48	1	1	3	3	FERRATA STORTI FOUNDATION	PAVIA	VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY	0390-6078			HAEMATOLOGICA	Haematologica	SEP	2017	102	9					1605	1616		10.3324/haematol.2016.146571				12	Hematology	Hematology	FF2RA	WOS:000408743300029	28659337				2018-01-05	
J	Shay, AE; Diwakar, BT; Guan, BJ; Narayan, V; Urban, JF; Prabhu, KS				Shay, Ashley E.; Diwakar, Bastihalli T.; Guan, Bo-Jhih; Narayan, Vivek; Urban, Joseph F., Jr.; Prabhu, K. Sandeep			IL-4 up-regulates cyclooxygenase-1 expression in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONIC MYOFIBROBLAST MIGRATION; FES PROTOONCOGENE PRODUCT; RECEPTOR PPAR-GAMMA; ALTERNATIVE ACTIVATION; LIPID MEDIATORS; GENE-EXPRESSION; DENDRITIC CELLS; PROTEIN-KINASE; CANCER CELLS; INFLAMMATION	Macrophages use various cell-surface receptors to sense their environment and undergo polarized responses. The cytokines, interleukin (IL)-4 and IL-13, released from T-helper type 2 (Th2) cells, drive macrophage polarization toward an alternatively activated phenotype (M2). This phenotype is associated with the expression of potent pro-resolving mediators, such as the prostaglandin (PG) D2-derived cyclopentenone metabolite, 15d-PGJ2, produced by the cyclooxygenase (Ptgs; Cox) pathway. Interestingly, IL-4 treatment of bone marrow-derived macrophages (BMDMs) significantly down-regulates Cox-2 protein expression, whereas Cox-1 levels are significantly increased. This phenomenon not only challenges the dogma that Cox-1 is only developmentally regulated, but also demonstrates a novel mechanism in which IL-4-dependent regulation of Cox-1 involves the activation of the mechanistic target of rapamycin complex (mTORC). Using specific chemical inhibitors, we demonstrate here that IL-4-dependent Cox-1 up-regulation occurs at the post-transcriptional level via the Fes-Akt-mTORC axis. Activation of AMP-activated protein kinase (AMPK) by metformin, inhibition of mTORC by torin 1, or CRISPR/Cas9-mediated genetic knock-out of tuberous sclerosis complex-2 (Tsc2) blocked the IL-4-dependent expression of Cox-1 and the ability of macrophages to polarize to M2. However, use of 15d-PGJ2 partially rescued the effects of AMPK activation, suggesting the importance of Cox-1 in macrophage polarization as also observed in a model of gastrointestinal helminth clearance. In summary, these findings suggest a new paradigm where IL-4-dependent up-regulation of Cox-1 expression may play a key role in tissue homeostasis and wound healing during Th2-mediated immune responses, such as parasitic infections.	[Shay, Ashley E.; Diwakar, Bastihalli T.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Shay, Ashley E.; Diwakar, Bastihalli T.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Guan, Bo-Jhih] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Narayan, Vivek] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Urban, Joseph F., Jr.] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA	Prabhu, KS (reprint author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.; Prabhu, KS (reprint author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.	ksprabhu@psu.edu			United States Public Health Service National Institutes of Health and Office of Dietary Supplements Grant [R01DK077152]; USDA Hatch Funds [4605]; National Institutes of Health [5T32AI074551-05]	This work was funded in part by the United States Public Health Service National Institutes of Health and Office of Dietary Supplements Grant R01DK077152, and by USDA Hatch Funds Grant 4605 (to K. S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health T32 Training Grant 5T32AI074551-05.	Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Camberis M., 2003, CURR PROTOC IMMUNOL, P12, DOI DOI 10.1002/0471142735.IM1912S55; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831                                                     ; Cho W, 2011, MOL IMMUNOL, V48, P966, DOI 10.1016/j.molimm.2011.01.007; Chu E, 2017, J SURG RES, V209, P191, DOI 10.1016/j.jss.2016.10.014; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Ding L, 2015, ONCOTARGET, V6, P36441, DOI 10.18632/oncotarget.5541; Erices R, 2013, REPROD SCI, V20, P1433, DOI 10.1177/1933719113488441; Fagone P, 2012, INFLAMM RES, V61, P1131, DOI 10.1007/s00011-012-0506-y; Fitzpatrick FA, 2004, CURR PHARM DESIGN, V10, P577, DOI 10.2174/1381612043453144                                                        ; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guan BJ, 2014, J BIOL CHEM, V289, P12593, DOI 10.1074/jbc.M113.543215; Harrington LS, 2008, FASEB J, V22, P4005, DOI 10.1096/fj.08-107979; Huang JT, 1999, NATURE, V400, P378; Incio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141392; Izuhara K, 1996, BLOOD, V88, P3910; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Jiang H, 2001, J IMMUNOL, V166, P2627, DOI 10.4049/jimmunol.166.4.2627                                                     ; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943                                                                   ; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kihara Y, 2014, BIOPHYS J, V106, P966, DOI 10.1016/j.bpj.2014.01.015; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356                                                 ; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6                                                   ; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303                                                    ; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Miller-Graziano Carol L, 2008, Novartis Found Symp, V291, P196; Mohammadi A, 2016, INFLAMMATION, V39, P1116, DOI 10.1007/s10753-016-0343-1; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Nelson SM, 2016, J BIOL CHEM, V291, P2787, DOI 10.1074/jbc.M115.684738; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oeser K, 2015, MUCOSAL IMMUNOL, V8, P672, DOI 10.1038/mi.2014.101; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Peebles RS, 2002, AM J RESP CRIT CARE, V165, P1154, DOI 10.1164/rccm.2106025; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06; Saini S, 2016, J SURG RES, V204, P145, DOI 10.1016/j.jss.2016.04.034; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200                                                          ; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Williams CS, 1999, ONCOGENE, V18, P7908; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	53	0	0	5	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 1	2017	292	35					14544	14555		10.1074/jbc.M117.785014				12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FF2SQ	WOS:000408747500020	28684424				2018-01-05	
J	Javidfar, B; Park, R; Kassim, BS; Bicks, LK; Akbarian, S				Javidfar, Behnam; Park, Royce; Kassim, Bibi S.; Bicks, Lucy K.; Akbarian, Schahram			The epigenomics of schizophrenia, in the mouse	AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS			English	Review							HISTONE DEACETYLASE INHIBITORS; DNA-METHYLATION CHANGES; OF-FUNCTION VARIANTS; GENE-EXPRESSION; PREFRONTAL CORTEX; TRANSCRIPTION FACTOR; SYNAPTIC PLASTICITY; BIPOLAR DISORDER; HUMAN BRAIN; VOCAL COMMUNICATION	Large-scale consortia including the Psychiatric Genomics Consortium, the Common Minds Consortium, BrainSeq and PsychENCODE, and many other studies taken together provide increasingly detailed insights into the genetic and epigenetic risk architectures of schizophrenia (SCZ) and offer vast amounts of molecular information, but with largely unexplored therapeutic potential. Here we discuss how epigenomic studies in human brain could guide animal work to test the impact of disease-associated alterations in chromatin structure and function on cognition and behavior. For example, transcription factors such as MYOCYTE-SPECIFIC ENHANCER FACTOR 2C (MEF2C), or multiple regulators of the open chromatin mark, methyl-histone H3-lysine 4, are associated with the genetic risk architectures of common psychiatric disease and alterations in chromatin structure and function in diseased brain tissue. Importantly, these molecules also affect cognition and behavior in genetically engineered mice, including virus-mediated expression changes in prefrontal cortex (PFC) and other key nodes in the circuitry underlying psychosis. Therefore, preclinical and small laboratory animal work could target genomic sequences affected by chromatin alterations in SCZ. To this end, in vivo editing of enhancer and other regulatory non-coding DNA by RNA-guided nucleases including CRISPR-Cas, and designer transcription factors, could be expected to deliver pipelines for novel therapeutic approaches aimed at improving cognitive dysfunction and other core symptoms of SCZ.	[Javidfar, Behnam; Park, Royce; Kassim, Bibi S.; Bicks, Lucy K.; Akbarian, Schahram] Icahn Sch Med Mt Sinai, Dept Psychiat, Friedman Brain Inst, New York, NY 10029 USA	Akbarian, S (reprint author), Icahn Sch Med Mt Sinai, Dept Psychiat, Friedman Brain Inst, New York, NY 10029 USA.	schahram.akbarian@mssm.edu		Akbarian, Schahram/0000-0001-7700-0891	National Institutes of Health [R01MH104341, R01MH106056]; Brain Research Foundation	National Institutes of Health, Grant numbers: R01MH104341, R01MH106056; Brain Research Foundation	Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Adachi M, 2016, BIOL PSYCHIAT, V80, P140, DOI 10.1016/j.biopsych.2015.09.018; Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156                                                                 ; Andreassen OA, 2014, SCHIZOPHRENIA BULL, V40, P13, DOI 10.1093/schbul/sbt168; Arion D, 2015, MOL PSYCHIATR, V20, P1397, DOI 10.1038/mp.2014.171; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Arnsten AFT, 2017, BIOL PSYCHIAT, V81, P67, DOI 10.1016/j.biopsych.2015.12.028; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Baumann K, 2015, NAT REV MOL CELL BIO, V16, P265, DOI 10.1038/nrm3992; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Benito E, 2015, J CLIN INVEST, V125, P3572, DOI 10.1172/JCI79942; Bernstein HG, 2014, SCHIZOPHRENIA BULL, V40, P499, DOI 10.1093/schbul/sbt237; Bertran-Gonzalez J, 2009, NEUROPSYCHOPHARMACOL, V34, P1710, DOI 10.1038/npp.2008.228; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Bharadwaj R, 2013, J NEUROSCI, V33, P11839, DOI 10.1523/JNEUROSCI.1252-13.2013; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Breen G, 2016, NAT NEUROSCI, V19, P1392, DOI 10.1038/nn.4411; Brennand KJ, 2014, BIOL PSYCHIAT, V75, P936, DOI 10.1016/j.biopsych.2013.10.025; Brown JB, 2015, ANNU REV GENOM HUM G, V16, P31, DOI 10.1146/annurev-genom-090413-025448; Catts VS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00060; Chen YC, 2016, NAT NEUROSCI, V19, P1513, DOI 10.1038/nn.4380; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dincer A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.169; Doan RN, 2016, CELL, V167, P341, DOI 10.1016/j.cell.2016.08.071; Dorph-Petersen KA, 2011, BIOL PSYCHIAT, V69, P113, DOI 10.1016/j.biopsych.2010.04.030; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Green MF, 2016, J CLIN PSYCHIAT, V77, P8, DOI 10.4088/JCP.14074su1c.02; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Hasan A, 2013, EUR ARCH PSY CLIN N, V263, P273, DOI 10.1007/s00406-013-0395-2; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Hess JL, 2015, AM J MED GENET B, V168, P14, DOI 10.1002/ajmg.b.32284; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hinna KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132456; Horvath S, 2015, BIOL PSYCHIAT, V77, P22, DOI 10.1016/j.biopsych.2014.01.001; Huang HS, 2007, J NEUROSCI, V27, P11254, DOI 10.1523/JNEUROSCI.3272-07.2007; Huang JL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0740-z; Ibrahim HM, 2011, ANNU REV PHARMACOL, V51, P189, DOI 10.1146/annurev.pharmtox.010909.105851; Iwamoto K, 2005, J NEUROSCI, V25, P5376, DOI 10.1523/JNEUROSCI.0766-05.2005; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jakovcevski M, 2015, J NEUROSCI, V35, P5097, DOI 10.1523/JNEUROSCI.3004-14.2015; Jakovcevski M, 2013, BIOL PSYCHIAT, V74, P696, DOI 10.1016/j.biopsych.2013.03.020; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Kano S, 2013, MOL PSYCHIATR, V18, P740, DOI 10.1038/mp.2012.120; Kennedy AJ, 2016, CELL REP, V16, P2666, DOI 10.1016/j.celrep.2016.08.004; Kerimoglu C, 2013, J NEUROSCI, V33, P3452, DOI 10.1523/JNEUROSCI.3356-12.2013; Kim DH, 2010, CURR TOP BEHAV NEURO, V4, P123, DOI 10.1007/7854_2010_47; Kim S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.42; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Konopka G, 2016, CELL, V164, P1269, DOI 10.1016/j.cell.2016.02.039; Kurita M, 2012, NAT NEUROSCI, V15, P1245, DOI 10.1038/nn.3181; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; LEIFER D, 1994, NEUROSCIENCE, V63, P1067, DOI 10.1016/0306-4522(94)90573-8; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lencz T, 2015, MOL PSYCHIATR, V20, P820, DOI 10.1038/mp.2015.28; Lewandowski KE, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00100; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688                                                            ; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lo SB, 2016, SCHIZOPHR RES, V175, P79, DOI 10.1016/j.schres.2016.03.013; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Lundberg SM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0925-0; McKinney B, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.297; Middleton FA, 2002, J NEUROSCI, V22, P2718; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mitchell A. C., 2017, MOL PSYCHIAT; Ohi K, 2016, SCHIZOPHR RES, V174, P35, DOI 10.1016/j.schres.2016.03.032; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Rannals MD, 2016, NEURON, V90, P43, DOI 10.1016/j.neuron.2016.02.021; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Ruderfer DM, 2016, NAT GENET, V48, P1107, DOI 10.1038/ng.3638; Ruzicka WB, 2015, JAMA PSYCHIAT, V72, P541, DOI 10.1001/jamapsychiatry.2015.49; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Sandner Guy, 2011, Front Psychiatry, V1, P153, DOI 10.3389/fpsyt.2010.00153; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Schroeder FA, 2017, ACS CHEM NEUROSCI, V8, P662, DOI 10.1021/acschemneuro.6b00372; Schubert CR, 2015, NEURON, V88, P1078, DOI 10.1016/j.neuron.2015.10.047; Sharma RP, 2008, SCHIZOPHR RES, V98, P111, DOI 10.1016/j.schres.2007.09.020; Shen EY, 2016, NEUROPSYCHOPHARMACOL, V41, P3103, DOI 10.1038/npp.2016.144; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Swartz MS, 2007, AM J PSYCHIAT, V164, P428, DOI 10.1176/appi.ajp.164.3.428; Taher L, 2011, GENOME RES, V21, P1139, DOI 10.1101/gr.119016.110; Takata A, 2016, NEURON, V89, P940, DOI 10.1016/j.neuron.2016.02.024; Takata A, 2014, NEURON, V82, P773, DOI 10.1016/j.neuron.2014.04.043; Taly A, 2013, EXPERT OPIN DRUG DIS, V8, P1285, DOI 10.1517/17460441.2013.821108; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Vallianatos CN, 2015, EPIGENOMICS-UK, V7, P503, DOI 10.2217/epi.15.1; Vawter MP, 2004, NEUROCHEM RES, V29, P1245, DOI 10.1023/B:NERE.0000023611.99452.47; Vernimmen D, 2015, TRENDS GENET, V31, P696, DOI 10.1016/j.tig.2015.10.004; Volk DW, 2015, AM J PSYCHIAT, V172, P1112, DOI 10.1176/appi.ajp.2015.15010019; Whittle N, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.231; Wockner LF, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.111; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Xiao S, 2012, CELL, V149, P1381, DOI 10.1016/j.cell.2012.04.029; Xiao X., 2016, MOL NEUROBIOLOGY; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zhao Z, 2015, MOL PSYCHIATR, V20, P563, DOI 10.1038/mp.2014.82; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	114	0	0	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4841	1552-485X		AM J MED GENET B	Am. J. Med. Genet. B	SEP	2017	174	6			SI		631	640		10.1002/ajmg.b.32566				10	Genetics & Heredity; Psychiatry	Genetics & Heredity; Psychiatry	FD9DA	WOS:000407821800005	28699694				2018-01-05	
J	Klima, C; Cameron, A; Javed, MA; Alexander, T; Zaheer, R; Munns, K; McAllister, TA				Klima, Cassidy; Cameron, Andrew; Javed, Muhammad Afzal; Alexander, Trevor; Zaheer, Rahat; Munns, Krysty; McAllister, Tim A.			Genomic approaches to characterizing and reducing antimicrobial resistance in beef cattle production systems	CANADIAN JOURNAL OF ANIMAL SCIENCE			English	Review						antimicrobial resistance; genomics; cattle; beef; metagenomics; CRISPR-Cas	ESCHERICHIA-COLI O157; SEQUENCE-SPECIFIC ANTIMICROBIALS; YEAST SACCHAROMYCES-CEREVISIAE; GROUP-B STREPTOCOCCUS; DIRECT-FED MICROBIALS; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; DRUG TARGETS; FUNCTIONAL METAGENOMICS; BIOFILM FORMATION	Antimicrobial resistance (AMR) is a global health threat, and a standstill in the discovery and design of new antibiotics has been linked to the growing number of human deaths attributed to AMR infections. Intensive beef production utilizes antimicrobials to promote health and growth efficiency. To understand the magnitude and risk of AMR in beef production, it is important to assess the prevalence and diversity of antimicrobial resistant genes (ARGs) within microbial populations. Antimicrobial resistant bacteria are traditionally identified by isolation and growth in the presence of selective antibiotics. Whole-genome, metagenomic, and RNA sequencing provide new avenues to detect and identify novel ARGs in both culturable and unculturable bacterial communities. Some of these approaches place ARGs within the context of mobile genetic elements, gauging their likelihood of transfer across genomes. Genomics can also mitigate AMR, contributing to rational drug design or the development of alternatives to antimicrobials such as vaccines and probiotics. RNA-seq-based transcriptomics and Tn-seq may provide new ways to examine mechanisms that promote or prevent AMR. Finally, clustered regularly interspaced short palindromic repeats (CRISPR) - Cas gene editing could directly reduce AMR by killing AMR-resistant bacteria without harming beneficial bacteria. Together, these technologies may provide new opportunities to identify, quantify, and mitigate AMR while developing alternatives to antimicrobials for beef production.	[Klima, Cassidy; Cameron, Andrew; Alexander, Trevor; Zaheer, Rahat; Munns, Krysty; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB T1J 4B1, Canada; [Klima, Cassidy; Javed, Muhammad Afzal] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada	McAllister, TA (reprint author), Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB T1J 4B1, Canada.	Tim.McAllister@agr.gc.ca			Beef Cattle Research Council - Agriculture and Agri-Food Canada Beef Cluster AMR	We acknowledge the financial support of the Beef Cattle Research Council - Agriculture and Agri-Food Canada Beef Cluster AMR program that enabled the preparation of this review.	Agga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132586; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; Atterbury RJ, 2007, APPL ENVIRON MICROB, V73, P4543, DOI 10.1128/AEM.00049-07; Barquist L, 2013, RNA BIOL, V10, P1161, DOI 10.4161/rna.24765; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bhagwat AA, 2008, FOODBORNE PATHOG DIS, V5, P487, DOI [10.1089/fpd.2008.0117, 10.1089/fpd.08.0117]; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Blainey PC, 2013, FEMS MICROBIOL REV, V37, P407, DOI 10.1111/1574-6976.12015; Bloemendaal ALA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011841; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Brandt C, 2016, FUTURE MICROBIOL, V11, P617, DOI 10.2217/fmb.16.13; Brashears MM, 2003, J FOOD PROTECT, V66, P748, DOI 10.4315/0362-028X-66.5.748                                                      ; Butt AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043080; Callaway T. R., 2008, Animal Health Research Reviews, V9, P217, DOI 10.1017/S1466252308001540; Chalker AF, 2002, PHARMACOL THERAPEUT, V95, P1, DOI 10.1016/S0163-7258(02)00222-X                                                   ; Chambers L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133764; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Chaucheyras-Durand F, 2008, ANIM FEED SCI TECH, V145, P5, DOI 10.1016/j.anifeedsci.2007.04.019; Chaucheyras-Durand F, 2006, APPL ENVIRON MICROB, V72, P4136, DOI 10.1128/AEM.02600-05; Chaucheyras-Durand F, 2010, BENEF MICROBES, V1, P3, DOI 10.3920/BM2008.1002; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Chawley P, 2014, GENOMICS, V103, P83, DOI 10.1016/j.ygeno.2013.12.002; Chen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158882; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Cornelissen A, 2012, VIROLOGY, V434, P251, DOI 10.1016/j.virol.2012.09.030; Craig JW, 2010, APPL ENVIRON MICROB, V76, P1633, DOI 10.1128/AEM.02169-09; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Davis MA, 2011, APPL ENVIRON MICROB, V77, P3293, DOI 10.1128/AEM.02588-10; Dean SN, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-114; DiGiandomenico A, 2012, J EXP MED, V209, P1273, DOI 10.1084/jem.20120033; Drulis-Kawa Z, 2012, CURR PROTEIN PEPT SC, V13, P699, DOI 10.2174/138920312804871193                                                      ; Durso LM, 2011, J MICROBIOL METH, V84, P278, DOI 10.1016/j.mimet.2010.12.008; Dutta Anirban, 2006, In Silico Biology, V6, P43; Eckert SE, 2011, J BACTERIOL, V193, P1771, DOI 10.1128/JB.01292-10; Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x; Edgar R, 2012, APPL ENVIRON MICROB, V78, P744, DOI 10.1128/AEM.05741-11; Ekkers DM, 2012, APPL MICROBIOL BIOT, V93, P1005, DOI 10.1007/s00253-011-3804-3; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Falconer SB, 2009, CURR OPIN MICROBIOL, V12, P497, DOI 10.1016/j.mib.2009.07.001; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Fouhy F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00172; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Gabrani R., 2015, FREE RADICALS HUMAN, P369, DOI 10.1007/978-81-322-2035-0_23; Galvez A, 2008, CRIT REV BIOTECHNOL, V28, P125, DOI 10.1080/07388550802107202 ; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Gokcen A, 2014, VIRULENCE, V5, P378, DOI 10.4161/viru.27919; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Gordon NC, 2014, J CLIN MICROBIOL, V52, P1182, DOI 10.1128/JCM.03117-13; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Hao Haihong, 2014, Front Microbiol, V5, P288, DOI 10.3389/fmicb.2014.00288; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hayek N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00041; Hegstad K, 2010, CLIN MICROBIOL INFEC, V16, P541, DOI 10.1111/j.1469-0691.2010.03226.x; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; HUTTNER A, 2013, ANTIMICROB RESIST IN, V2; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Iqbal HA, 2014, FEMS MICROBIOL LETT, V354, P19, DOI 10.1111/1574-6968.12431; Javed MA, 2015, VIRUSES-BASEL, V7, P6661, DOI 10.3390/v7122964; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johnson R. P., 2008, Animal Health Research Reviews, V9, P201, DOI 10.1017/S1466252308001576; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Jones DS, 2012, NEW ENGL J MED, V366, P2333, DOI 10.1056/NEJMp1113569; Karimi M, 2016, ADV DRUG DELIVER REV, V106, P45, DOI 10.1016/j.addr.2016.03.003; Khairnar K, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-264; Kjos M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005422; Klima CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149520; Koser CU, 2014, TRENDS GENET, V30, P401, DOI 10.1016/j.tig.2014.07.003; Kos VN, 2015, ANTIMICROB AGENTS CH, V59, P427, DOI 10.1128/AAC.03954-14; Kullen M J, 2000, Curr Issues Mol Biol, V2, P41; Lakin SM, 2017, NUCLEIC ACIDS RES, V45, pD574, DOI 10.1093/nar/gkw1009; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08; Lesmeister KE, 2004, J DAIRY SCI, V87, P1832, DOI 10.3168/jds.S0022-0302(04)73340-8                                               ; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Li L, 2016, P NATL ACAD SCI USA, V113, P1648, DOI 10.1073/pnas.1520300113; Linnarsson S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0960-x; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Loc CC, 2005, APPL ENVIRON MICROB, V71, P6554, DOI [10.1128/AEM.71.11.6554-6563.2005, DOI 10.1128/AEM.71.11.6554-6563.2005]; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lood R, 2015, ANTIMICROB AGENTS CH, V59, P1983, DOI 10.1128/AAC.04641-14; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Losada L, 2016, PLASMID, V83, P8, DOI 10.1016/j.plasmid.2015.12.001; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Ma LP, 2016, ENVIRON SCI TECHNOL, V50, P420, DOI 10.1021/acs.est.5b03522; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; McPhillie MJ, 2015, CHEM BIOL DRUG DES, V85, P22, DOI 10.1111/cbdd.12385; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mobegi FM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-958; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Musa HH, 2009, J ANIM VET ADV, V8, P313; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Newbold CJ, 1996, BRIT J NUTR, V76, P249, DOI 10.1079/BJN19960029; Noyes NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24645; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Panjkovich A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-36; Perron GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0069533; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pires DP, 2015, J VIROL, V89, P7449, DOI 10.1128/JVI.00385-15; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816                                                   ; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Punina NV, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0037-z; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Roemer T, 2013, NAT CHEM BIOL, V9, P222, DOI [10.1038/nchembio.1205, 10.1038/NCHEMBIO.1205]; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219                                                         ; Schmelcher M, 2016, CURR OPIN BIOTECH, V37, P76, DOI 10.1016/j.copbio.2015.10.005; Scholl D, 2008, ANTIMICROB AGENTS CH, V52, P1647, DOI 10.1128/AAC.01479-07; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Seib KL, 2012, CLIN MICROBIOL INFEC, V18, P109, DOI 10.1111/j.1469-0691.2012.03939.x; Shan Y, 2015, MBIO, V6, DOI 10.1128/mBio.00078-15; Singh KM, 2012, GENE, V507, P146, DOI 10.1016/j.gene.2012.07.037; Smith D.R., 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.EHEC-0006-2013, DOI 10.1128/MICROBIOLSPEC]; Stephens TP, 2007, J FOOD PROTECT, V70, P2386, DOI 10.4315/0362-028X-70.10.2386                                                    ; Stoesser N, 2013, J ANTIMICROB CHEMOTH, V68, P2234, DOI 10.1093/jac/dkt180; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; Taha-Abdelaziz K, 2013, VET IMMUNOL IMMUNOP, V152, P289, DOI 10.1016/j.vetimm.2012.12.016; Takemura-Uchiyama I, 2014, MICROBES INFECT, V16, P512, DOI 10.1016/j.micinf.2014.02.011; Thanassi JA, 2002, NUCLEIC ACIDS RES, V30, P3152, DOI 10.1093/nar/gkf418; Troeschel SC, 2012, J BIOTECHNOL, V161, P71, DOI 10.1016/j.jbiotec.2012.02.020; Turner MS, 2007, SYST APPL MICROBIOL, V30, P58, DOI 10.1016/j.syapm.2006.01.013; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wallner G, 1997, APPL ENVIRON MICROB, V63, P4223; Waseh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013904; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Westwater C, 2003, ANTIMICROB AGENTS CH, V47, P1301, DOI 10.1128/AAC.47.4.1301-1307.2003; White RA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00045-16; White TA, 2004, COMP FUNCT GENOM, V5, P304, DOI 10.1002/cfg.411; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001                                                 ; Yankson KK, 2009, APPL ENVIRON MICROB, V75, P6017, DOI 10.1128/AEM.00211-09; Yarus S, 1996, P NATL ACAD SCI USA, V93, P14118, DOI 10.1073/pnas.93.24.14118; Younts-Dahl SM, 2005, J FOOD PROTECT, V68, P6, DOI 10.4315/0362-028X-68.1.6                                                        ; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	154	0	0	23	23	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-3984	1918-1825		CAN J ANIM SCI	Can. J. Anim. Sci.	SEP	2017	97	3					347	364		10.1139/cjas-2016-0208				18	Agriculture, Dairy & Animal Science	Agriculture	FE9PT	WOS:000408536300002					2018-01-05	
J	Yong, L; Thet, Z; Zhu, Y				Yong, Lengxob; Thet, Zayer; Zhu, Yong			Genetic editing of the androgen receptor contributes to impaired male courtship behavior in zebrafish	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Behavioral variation; Hormones; Gene knockout; Behavioral genetics; TALENs; Danio rerio	ELABORATE MALE COURTSHIP; MALE SEXUAL-BEHAVIOR; REPRODUCTIVE-BEHAVIOR; NATURAL-HISTORY; FEMALE CHOICE; DANIO-RERIO; BRAIN; EVOLUTION; TESTOSTERONE; SENSITIVITY	Elucidating the genes that contribute to behavioral variation has become an important endeavor in behavioral studies. While advances in genomics have narrowed down the list of candidate genes, functional validation of them has lagged behind, partly because of challenges associated with rapid gene manipulations. Consequently, few studies have demonstrated causal genetic changes linked to behaviors. The 'gene editing revolution' has offered unprecedented opportunities to investigate candidate genes responsible for critical behaviors. Here, we edited the androgen receptor gene (AR), which is associated with male reproductive behavior in zebrafish, using TAL effector nucleases (TALENs), and tested whether modifications at the AR impacted courtship during mating trials. We reveal that males lacking AR courted females significantly less, showing reduced levels of stereotypic behaviors. Consistent with previous studies, disrupting androgen mechanisms can lead to behavioral changes with potential fitness consequences. Our study highlights the possibility of genetically altering a reproductive behavior, further solidifying the link between genotype and behavior.	[Yong, Lengxob; Thet, Zayer; Zhu, Yong] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Yong, Lengxob] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Cornwall EX4 4QJ, England	Yong, L (reprint author), East Carolina Univ, Dept Biol, Greenville, NC 27858 USA.; Yong, L (reprint author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Cornwall EX4 4QJ, England.	l.l.yong@exeter.ac.uk			North Carolina Biotechnology Center [2012-BRG-1210]; National Institutes of Health [GM100461]	Funding was provided by the North Carolina Biotechnology Center (Biotechnology Research Grant no. 2012-BRG-1210) and National Institutes of Health (grant GM100461) to Y.Z. Deposited in PMC for release after 12 months.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Andersson M. B., 1994, SEXUAL SELECTION; ARNOLD AP, 1985, HORM BEHAV, V19, P469, DOI 10.1016/0018-506X(85)90042-X; Ball GF, 2004, PHYSIOL BEHAV, V83, P329, DOI 10.1016/j.physbeh.2004.08.020; Blazina AR, 2013, ZEBRAFISH, V10, P480, DOI 10.1089/zeb.2012.0860; BORGIA G, 1995, ANIM BEHAV, V49, P1291, DOI 10.1006/anbe.1995.0161; Chen L, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-24; Conradsen C, 2015, J FISH BIOL, V87, P1219, DOI 10.1111/jfb.12784; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Foster S., 1994, EVOLUTIONARY BIOL TH, P391; Fusani L, 2014, NEUROSCI BIOBEHAV R, V46, P534, DOI 10.1016/j.neubiorev.2014.07.017; Fuxjager MJ, 2013, ENDOCRINOLOGY, V154, P3168, DOI 10.1210/en.2013-1302; Gorelick DA, 2008, DEV DYNAM, V237, P2987, DOI 10.1002/dvdy.21700; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Juntti SA, 2016, CURR BIOL, V26, P943, DOI 10.1016/j.cub.2016.01.067; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Oliveira RF, 2016, P NATL ACAD SCI USA, V113, pE654, DOI 10.1073/pnas.1514292113; Parichy DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05635; Partecke J, 2008, DEV NEUROBIOL, V68, P1538, DOI 10.1002/dneu.20676; Phelps SM, 1998, HORM BEHAV, V34, P294, DOI 10.1006/hbeh.1998.1485                                                          ; REGNIER M, 1993, J NEUROBIOL, V24, P1215, DOI 10.1002/neu.480240908; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; Rittschof CC, 2014, P NATL ACAD SCI USA, V111, P17929, DOI 10.1073/pnas.1420369111; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Rosvall KA, 2012, P ROY SOC B-BIOL SCI, V279, P3547, DOI 10.1098/rspb.2012.0442; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schlinger BA, 2008, GEN COMP ENDOCR, V157, P254, DOI 10.1016/j.ygcen.2008.05.015; Teles MC, 2016, HORM BEHAV, V78, P8, DOI 10.1016/j.yhbeh.2015.10.009; van Breukelen NA, 2013, HORM BEHAV, V63, P527, DOI 10.1016/j.yhbeh.2013.01.008; Yabuki Y, 2016, NAT NEUROSCI, V19, P897, DOI 10.1038/nn.4314; Zhu Y, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00037; Zuk M, 2014, BEHAV ECOL, V25, P1277, DOI 10.1093/beheco/aru172	39	0	0	16	16	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	SEP	2017	220	17					3017	3021		10.1242/jeb.161596				5	Biology	Life Sciences & Biomedicine - Other Topics	FF1AI	WOS:000408631800010	28620015				2018-01-05	
J	Mzoughi, S; Zhang, JX; Hequet, D; Teo, SX; Fang, HT; Xing, QR; Bezzi, M; Seah, MKY; Ong, SLM; Shin, EM; Wollmann, H; Wong, ESM; Al-Haddawi, M; Stewart, CL; Tergaonkar, V; Loh, YH; Dunn, NR; Messerschmidt, DM; Guccione, E				Mzoughi, Slim; Zhang, Jingxian; Hequet, Delphine; Teo, Shun Xie; Fang, Haitong; Xing, Qiao Rui; Bezzi, Marco; Seah, Michelle Kay Yi; Ong, Sheena L. M.; Shin, Eun Myoung; Wollmann, Heike; Wong, Esther S. M.; Al-Haddawi, Muthafar; Stewart, Colin L.; Tergaonkar, Vinay; Loh, Yuin-Han; Dunn, N. Ray; Messerschmidt, Daniel M.; Guccione, Ernesto			PRDM15 safeguards naive pluripotency by transcriptionally regulating WNT and MAPK-ERK signaling	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; GERMLINE DEVELOPMENT; GENOME-WIDE; DNA; DIFFERENTIATION; ACTIVATION; EXPRESSION; PATHWAYS; NETWORK	The transcriptional network acting downstream of LIF, WNT and MAPK-ERK to stabilize mouse embryonic stem cells (ESCs) in their naive state has been extensively characterized. However, the upstream factors regulating these three signaling pathways remain largely uncharted. PR-domain-containing proteins (PRDMs) are zinc-finger sequence-specific chromatin factors that have essential roles in embryonic development and cell fate decisions. Here we characterize the transcriptional regulator PRDM15, which acts independently of PRDM14 to regulate the naive state of mouse ESCs. Mechanistically, PRDM15 modulates WNT and MAPK-ERK signaling by directly promoting the expression of Rspo1 (R-spondin1) and Spry1 (Sprouty1). Consistent with these findings, CRISPR-Cas9-mediated disruption of PRDM15-binding sites in the Rspo1 and Spry1 promoters recapitulates PRDM15 depletion, both in terms of local chromatin organization and the transcriptional modulation of these genes. Collectively, our findings uncover an essential role for PRDM15 as a chromatin factor that modulates the transcription of upstream regulators of WNT and MAPK-ERK signaling to safeguard naive pluripotency.	[Mzoughi, Slim; Zhang, Jingxian; Hequet, Delphine; Teo, Shun Xie; Bezzi, Marco; Guccione, Ernesto] ASTAR, Inst Mol & Cell Biol, Methyltransferases Dev & Dis Grp, Singapore, Singapore; [Mzoughi, Slim; Bezzi, Marco; Tergaonkar, Vinay; Messerschmidt, Daniel M.; Guccione, Ernesto] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Fang, Haitong; Xing, Qiao Rui; Loh, Yuin-Han] ASTAR, Inst Mol & Cell Biol, Epigenet & Cell Fates Grp, Singapore, Singapore; [Xing, Qiao Rui] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Seah, Michelle Kay Yi; Messerschmidt, Daniel M.] ASTAR, Inst Mol & Cell Biol, Dev Epigenet & Dis Grp, Singapore, Singapore; [Ong, Sheena L. M.; Wong, Esther S. M.; Stewart, Colin L.; Dunn, N. Ray] ASTAR, IBM, Singapore, Singapore; [Shin, Eun Myoung; Guccione, Ernesto] Natl Univ Singapore, Canc Sci Inst Singapore CSI, Singapore, Singapore; [Shin, Eun Myoung] ASTAR, Inst Mol & Cell Biol, NF kB Signaling Human Ailments, Singapore, Singapore; [Wollmann, Heike] ASTAR, Inst Mol & Cell Biol, DNA Sequencing Facil NGS Unit, Singapore, Singapore; [Al-Haddawi, Muthafar] IMCB, Adv Mol Pathol Lab, Singapore, Singapore; [Tergaonkar, Vinay; Guccione, Ernesto] Nat Canc Ctr Singapore, Singapore, Singapore; [Tergaonkar, Vinay] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Tergaonkar, Vinay] SA Pathol, Adelaide, SA, Australia; [Loh, Yuin-Han] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Guccione, Ernesto] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tisch Canc Inst, New York, NY 10029 USA	Guccione, E (reprint author), ASTAR, Inst Mol & Cell Biol, Methyltransferases Dev & Dis Grp, Singapore, Singapore.; Guccione, E (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Guccione, E (reprint author), Natl Univ Singapore, Canc Sci Inst Singapore CSI, Singapore, Singapore.; Guccione, E (reprint author), Nat Canc Ctr Singapore, Singapore, Singapore.; Guccione, E (reprint author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tisch Canc Inst, New York, NY 10029 USA.	eguccione@imcb.a-star.edu.sg		Hequet, Delphine/0000-0001-8926-5651	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore; AGA-SINGA (Singapore Graduate Award) fellowship; French College of Gynecology and Obstetrics; NRF fellowship;  [NMRC/OFIRG/0032/2017]	We thank F. Aguilo, M. Walsh and W.W. Tee for helpful discussions and critically reading the manuscript, H.-H. Ng (GIS/Singapore) for the kind gift of antibodies, and T. Teng and BRC Shared facilities for technical support. We acknowledge the technical expertise provided by the Advanced Molecular Pathology Laboratory (AMPL) at IMCB, and in particular we thank C.B. Ong. This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. We acknowledge support from NMRC/OFIRG/0032/2017, an AGA-SINGA (Singapore Graduate Award) fellowship to S.M. and M.B., the French College of Gynecology and Obstetrics to D.H. and an NRF fellowship to D.M.M.	Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan YS, 2013, STEM CELLS, V31, P682, DOI 10.1002/stem.1307; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.3.CO;2-#; del Valle I, 2013, DEVELOPMENT, V140, P1684, DOI 10.1242/dev.088690; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung JE, 2012, STEM CELLS DEV, V21, P554, DOI 10.1089/scd.2011.0110; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kranc KR, 2015, STEM CELLS, V33, P699, DOI 10.1002/stem.1889; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-11-r134, 10.1186/gb-2009-10-3-r25]; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mzoughi S, 2016, CURR OPIN GENET DEV, V36, P83, DOI 10.1016/j.gde.2016.03.009; Nady N, 2015, ELIFE, V4, DOI 10.7554/eLife.10150; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048                                                          ; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Persikov AV, 2014, NUCLEIC ACIDS RES, V42, P97, DOI 10.1093/nar/gkt890; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shin EM, 2014, J CLIN INVEST, V124, P3807, DOI 10.1172/JCI73451; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tu S, 2016, NATURE, V534, P387, DOI 10.1038/nature18004; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Ye T., 2011, NUCL ACIDS RES, V39; Zhang Y, 2008, GENOME BIOL, V9, pR137, DOI DOI 10.1186/GB-2008-9-9-R137; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	46	0	0	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2017	49	9					1354	+		10.1038/ng.3922				13	Genetics & Heredity	Genetics & Heredity	FF1PS	WOS:000408672000014	28740264				2018-01-05	
J	Rose, JC; Stephany, JJ; Valente, WJ; Trevillian, BM; Dang, HV; Bielas, JH; Maly, DJ; Fowler, DM				Rose, John C.; Stephany, Jason J.; Valente, William J.; Trevillian, Bridget M.; Dang, Ha V.; Bielas, Jason H.; Maly, Dustin J.; Fowler, Douglas M.			Rapidly inducible Cas9 and DSB-ddPCR to probe editing kinetics	NATURE METHODS			English	Article							DOUBLE-STRAND BREAKS; X-L INHIBITOR; IN-VIVO; FAMILY PROTEINS; DNA-DAMAGE; CRISPR-CAS9; BCL-2; NUCLEASES; QUANTIFICATION; INTERROGATION	We developed a chemically inducible Cas9 (ciCas9) and a droplet digital PCR assay for double-strand breaks (DSB-ddPCR) to investigate the kinetics of Cas9-mediated generation and repair of DSBs in cells. ciCas9 is a rapidly activated, single-component Cas9 variant engineered by replacing the protein's REC2 domain with the BCLCL-xL protein and fusing an interacting BH3 peptide to the C terminus. ciCas9 can be tunably activated by a compound that disrupts the BCLCL-xL-BH3 interaction within minutes. DSB-ddPCR demonstrates time-resolved, highly quantitative, and targeted measurement of DSDSBs. Combining these tools facilitated an unprecedented exploration of the kinetics of Cas9-mediated DNA cleavage and repair. We find that sgRNAs targeting different sites generally induce cleavage within minutes and repair within 1 or 2 h. However, we observe distinct kinetic profiles, even for proximal sites, and this suggests that target sequence and chromatin state modulate cleavage and repair kinetics.	[Rose, John C.; Trevillian, Bridget M.; Maly, Dustin J.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Stephany, Jason J.; Fowler, Douglas M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Valente, William J.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Dang, Ha V.; Maly, Dustin J.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Fowler, Douglas M.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	Maly, DJ (reprint author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.; Fowler, DM (reprint author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Maly, DJ (reprint author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Fowler, DM (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	djmaly@uw.edu; dfowler@uw.edu		Rose, John/0000-0003-1810-4337	NIH [R01GM086858, R01GM109110, F30CA189793]; NSF [0954242]	We thank M. Dickinson for assistance generating reagents. This work was supported by the NIH (R01GM086858 (D.J.M.), R01GM109110 (D.M.F.), and F30CA189793 (J.C.R.)), and by the NSF (0954242 (D.J.M.)).	Ashkenazi A, 2017, NAT REV DRUG DISCOV, V16, P273, DOI 10.1038/nrd.2016.253; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Feng J, 2015, ELIFE, V4, DOI 10.7554/eLife.10606; Furda Amy M, 2012, Methods Mol Biol, V920, P111, DOI 10.1007/978-1-61779-998-3_9; Geisinger JM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1542; Goreshnik I, 2010, J AM CHEM SOC, V132, P938, DOI 10.1021/ja907886v; Gregoire MC, 2016, DNA REPAIR, V48, P63, DOI 10.1016/j.dnarep.2016.10.005; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lensing SV, 2016, NAT METHODS, V13, P855, DOI 10.1038/nmeth.3960; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liang ZB, 2016, NUCLEIC ACIDS RES, V44, P2769, DOI 10.1093/nar/gkw013; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu KI, 2016, NAT CHEM BIOL, V12, P980, DOI 10.1038/nchembio.2179; Maji B, 2017, NAT CHEM BIOL, V13, P9, DOI 10.1038/nchembio.2224; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Nguyen DP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12009; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Oakes BL, 2016, NAT BIOTECHNOL, V34, P646, DOI 10.1038/nbt.3528; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rose J. C., 2017, PROTOCOL EXCHANGE; Rose JC, 2017, NAT CHEM BIOL, V13, P119, DOI [10.1038/NCHEMBIO.2244, 10.1038/nchembio.2244]; Senturk S, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14370; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wendt MD, 2006, J MED CHEM, V49, P1165, DOI 10.1021/jm050754u; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI [10.1016/S1470-2045(10)70261-8, 10.1016/S1470.2045(10)70261.8]; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	53	2	2	12	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	SEP	2017	14	9					891	+		10.1038/NMETH.4368				9	Biochemical Research Methods	Biochemistry & Molecular Biology	FF3DT	WOS:000408776400018	28737741				2018-01-05	
J	Cody, WB; Scholthof, HB; Mirkov, TE				Cody, Will B.; Scholthof, Herman B.; Mirkov, T. Erik			Multiplexed Gene Editing and Protein Overexpression Using a Tobacco mosaic virus Viral Vector	PLANT PHYSIOLOGY			English	Article							SEQUENCE-SPECIFIC CONTROL; RNA-GUIDED ENDONUCLEASE; NICOTIANA-BENTHAMIANA; CRISPR; PLANTS; SYSTEM; CAS9; EXPRESSION; INTERFERENCE; ARABIDOPSIS	Development of CRISPR/Cas9 transient gene editing screening tools in plant biology has been hindered by difficulty of delivering high quantities of biologically active single guide RNAs (sgRNAs). Furthermore, it has been largely accepted that in vivo generated sgRNAs need to be devoid of extraneous nucleotides, which has limited sgRNA expression by delivery vectors. Here, we increased cellular concentrations of sgRNA by transiently delivering sgRNAs using a Tobacco mosaic virus-derived vector (TRBO) designed with 5' and 3' sgRNA proximal nucleotide-processing capabilities. To demonstrate proof-of-principle, we used the TRBO-sgRNA delivery platform to target GFP in Nicotiana benthamiana (16c) plants, and gene editing was accompanied by loss of GFP expression. Surprisingly, indel (insertions and deletions) percentages averaged nearly 70% within 7 d postinoculation using the TRBO-sgRNA constructs, which retained 5' nucleotide overhangs. In contrast, and in accordance with current models, in vitro Cas9 cleavage assays only edited DNA when 5' sgRNA nucleotide overhangs were removed, suggesting a novel processing mechanism is occurring in planta. Since the Cas9/TRBO-sgRNA platform demonstrated sgRNA flexibility, we targeted the N. benthamiana NbAGO1 paralogs with one sgRNA and also multiplexed two sgRNAs using a single TRBO construct, resulting in indels in three genes. TRBO-mediated expression of an RNA transcript consisting of an sgRNA adjoining a GFP protein coding region produced indels and viral-based GFP overexpression. In conclusion, multiplexed delivery of sgRNAs using the TRBO system offers flexibility for gene expression and editing and uncovered novel aspects of CRISPR/Cas9 biology.	[Cody, Will B.; Scholthof, Herman B.; Mirkov, T. Erik] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77840 USA; [Mirkov, T. Erik] Texas A&M AgriLife, Weslaco, TX 78596 USA	Mirkov, TE (reprint author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77840 USA.; Mirkov, TE (reprint author), Texas A&M AgriLife, Weslaco, TX 78596 USA.	herscho@tamu.edu; erik.mirkov@ag.tamu.edu			USDA National Institute of Food and Agriculture [2017-67011-26026]; USDA National Institute of Food and Agriculture AFRI [2015-67013-22916]; Texas A&M University AFS Development Leave	W.B.C. is a recipient of USDA National Institute of Food and Agriculture Predoctoral Fellowship Award 2017-67011-26026. H.B. S. was funded by USDA National Institute of Food and Agriculture AFRI award 2015-67013-22916 and was also supported by the Texas A&M University AFS Development Leave Program.	Ali Z, 2015, MOL PLANT, V8, P1288, DOI 10.1016/j.molp.2015.02.011; Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barrangou R, 2015, NUCLEIC ACIDS RES, V43, P3407, DOI 10.1093/nar/gkv226; Basak J, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fnhum.2015.01001, 10.3389/fpls.2015.01001]; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Buck KW, 1999, PHILOS T ROY SOC B, V354, P613, DOI 10.1098/rstb.1999.0413; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; CERMAK T, 2011, NUCLEIC ACIDS RES, V39, DOI DOI 10.1093/NAR/GKR218; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CULVER JN, 1993, P NATL ACAD SCI USA, V90, P2055, DOI 10.1073/pnas.90.5.2055                                                          ; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; DAWSON WO, 1989, VIROLOGY, V172, P285, DOI 10.1016/0042-6822(89)90130-X; Dong CM, 2006, PLANT CELL REP, V25, P457, DOI 10.1007/s00299-005-0098-x; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Everett AL, 2010, VIROLOGY, V396, P37, DOI 10.1016/j.virol.2009.10.006; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066046; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gursinsky T, 2015, PLANT PHYSIOL, V168, P938, DOI 10.1104/pp.15.00070; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones L, 2006, PLANT PHYSIOL, V141, P598, DOI 10.1104/pp.105.076109; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandadi KK, 2013, PLANT CELL, V25, P1489, DOI 10.1105/tpc.113.111658; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; National Academies of Science, 2016, GEN ENG CROPS EXP PR; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Odokonyero D, 2015, VIROLOGY, V486, P209, DOI [10.1016/j.virol.2015.09.008, 10.1016/j.viro1.2015.09.008]; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; RESTREPO MA, 1990, PLANT CELL, V2, P987; Ruiz MT, 1998, PLANT CELL, V10, P937; Schiml S, 2014, PLANT J, V80, P1139, DOI 10.1111/tpj.12704; Scholthof HB, 1996, ANNU REV PHYTOPATHOL, V34, P299, DOI 10.1146/annurev.phyto.34.1.299; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; Scholthof KBG, 2002, GENET ENG P, V24, P67; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090528; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Yin KQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14926; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470	57	2	2	26	26	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	SEP	2017	175	1					23	35		10.1104/pp.17.00411				13	Plant Sciences	Plant Sciences	FF3JV	WOS:000408792200004	28663331				2018-01-05	
J	Chadwick, AC; Wang, X; Musunuru, K				Chadwick, Alexandra C.; Wang, Xiao; Musunuru, Kiran			In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						gene therapy; lipids and lipoprotein metabolism; molecular biology; nucleotides; PCSK9	OF-FUNCTION MUTATIONS; MAMMALIAN-CELLS; DISEASE; SPECIFICITIES; PROTECTION; ENABLES; MICE	Objective-High-efficiency genome editing to disrupt therapeutic target genes, such as PCSK9 (proprotein convertase subtilisin/kexin type 9), has been demonstrated in preclinical animal models, but there are safety concerns because of the unpredictable nature of cellular repair of double-strand breaks, as well as off-target mutagenesis. Moreover, precise knock-in of specific nucleotide changes-whether to introduce or to correct gene mutations-has proven to be inefficient in nonproliferating cells in vivo. Base editors comprising CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats [CRISPR]-CRISPR-associated 9) fused to a cytosine deaminase domain can effect the alteration of cytosine bases to thymine bases in genomic DNA in a sequence-specific fashion, without the need for double-strand DNA breaks. The efficacy of base editing has not been established in vivo. The goal of this study was to assess whether in vivo base editing could be used to modify the mouse Pcsk9 gene in a sequence-specific fashion in the liver in adult mice. Approach and Results-We screened base editors for activity in cultured cells, including human-induced pluripotent stem cells. We then delivered a base editor into the livers of adult mice to assess whether it could introduce site-specific nonsense mutations into the Pcsk9 gene. In adult mice, this resulted in substantially reduced plasma PCSK9 protein levels (>50%), as well as reduced plasma cholesterol levels (approximate to 30%). There was no evidence of off-target mutagenesis, either cytosine-to-thynine edits or indels. Conclusions-These results demonstrate the ability to precisely introduce therapeutically relevant nucleotide variants into the genome in somatic tissues in adult mammals, as well as highlighting a potentially safer alternative to therapeutic genome editing. Visual Overview-An online visual overview is available for this article.	Univ Penn, Perelman Sch Med, Dept Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Musunuru, K (reprint author), Univ Penn, Perelman Sch Med, Smilow Ctr Translat Res 11 104, 3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	kiranmusunuru@gmail.com			United States National Institutes of Health (NIH) [T32-HL007843, R01-HL118744, R0-GM104464, R0-DK099571, R0I-HL126875]; NIH [ULI-TR001878]; Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics; American Heart Association Postdoctoral Fellowship; University of Pennsylvania	This work was supported by grants T32-HL007843 (A.C. Chadwick) and R01-HL118744, R0-GM104464, R0-DK099571, and R0I-HL126875 (K. Musunum) from the United States National Institutes of Health (NIH); grant ULI-TR001878 from the NIH and the Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics (K. Musunuru); an American Heart Association Postdoctoral Fellowship (X. Wang); and funds from the University of Pennsylvania.	Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nishida K, 2016, SCIENCE, V353, P8729; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Stitziel NO, 2017, J AM COLL CARDIOL, V69, P2054, DOI 10.1016/j.jacc.2017.02.030; Strong A, 2017, NAT REV CARDIOL, V14, P11, DOI 10.1038/nrcardio.2016.139; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI DOI 10.1056/NEJM0A1307095; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488                                                                  	22	5	5	11	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	SEP	2017	37	9					1741	+		10.1161/ATVBAHA.117.309881				11	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	FE4QE	WOS:000408197600026	28751571				2018-01-05	
J	Zhang, R; Peng, RX; Li, ZY; Gao, P; Jia, SY; Yang, X; Ding, JS; Han, YX; Xie, JH; Li, JM				Zhang, Rui; Peng, Rongxue; Li, Ziyang; Gao, Peng; Jia, Shiyu; Yang, Xin; Ding, Jiansheng; Han, Yanxi; Xie, Jiehong; Li, Jinming			Synthetic Circulating Cell-free DNA as Quality Control Materials for Somatic Mutation Detection in Liquid Biopsy for Cancer	CLINICAL CHEMISTRY			English	Article							TUMOR DNA; GENETIC-VARIATION; QUANTIFICATION; BLOOD; ORIGIN; SIZE	BACKGROUND: Detection of somatic genomic alterations in tumor-derived cell-free DNA (cfDNA) in the plasma is challenging owing to the low concentrations of cfDNA, variable detection methods, and complex workflows. Moreover, no proper quality control materials are available currently. METHODS: We developed a set of synthetic cfDNA quality control materials (SCQCMs) containing spike-in cfDNA on the basis of micrococcal nuclease digestion carrying somatic mutations as simulated cfDNA and matched genomic DNA as genetic background to emulate paired tumor-normal samples in real clinical tests. Site-directed mutagenesis DNA that contained 15002000 bases with single-nucleotide variants or indels and genomic DNA from CRISPR/Cas9 edited cells with EML4-ALK rearrangements was fragmented, quantified, and added into micrococcal nuclease-digested DNA derived from HEK293T cells. To prove their suitability, the SCQCMs were compared with patient-derived plasma samples and validated in a collaborative study that encompassed 11 laboratories. RESULTS: The results of SCQCM analysis by next-generation sequencing showed strong agreement with those of patient-derived plasma samples, including the size profile of cfDNA and the quality control metrics of the sequencing data. More than 95% of laboratories correctly detected the SCQCMs with EGFR T790M, L858R, KRAS G12D, and a deletion in exon 19, as well as with EML4-ALK variant 2. CONCLUSIONS: The SCQCMs were successfully applied in a broad range of settings, methodologies, and informatics techniques. We conclude that SCQCMs can be used as optimal quality controls in test performance assessments for circulating tumor DNA somatic mutation detection. (C) 2017 American Association for Clinical Chemistry	[Zhang, Rui; Peng, Rongxue; Li, Ziyang; Gao, Peng; Jia, Shiyu; Yang, Xin; Ding, Jiansheng; Han, Yanxi; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Natl Ctr Gerontol, Beijing, Peoples R China; [Peng, Rongxue; Li, Ziyang; Gao, Peng; Yang, Xin; Ding, Jiansheng; Li, Jinming] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Rui; Peng, Rongxue; Li, Ziyang; Gao, Peng; Jia, Shiyu; Yang, Xin; Ding, Jiansheng; Han, Yanxi; Xie, Jiehong; Li, Jinming] Beijing Hosp, Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China; [Jia, Shiyu] Peking Univ, Sch Clin Med 5, Beijing, Peoples R China	Li, JM (reprint author), Beijing Hosp, Natl Ctr Clin Labs, 1 Dahua Rd, Beijing 100730, Peoples R China.	jmli@nccl.org.cn			Beijing Natural Science Foundation [7174345]; National Natural Science Foundation of China [81601848]; Special Fund for Health Scientific Research in the Public Interest from National Population and Family Planning Commission of the People's Republic of China [201402018]	R. Zhang, Beijing Natural Science Foundation (Grant 7174345) to Beijing Hospital and National Natural Science Foundation of China (Grant 81601848) to Beijing Hospital; J. Li, the Special Fund for Health Scientific Research in the Public Interest from National Population and Family Planning Commission of the People's Republic of China (No. 201402018) to Beijing Hospital.	Alix-Panabieres C, 2016, CANCER DISCOV, V6, P479, DOI 10.1158/2159-8290.CD-15-1483; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aung KL, 2014, J MOL DIAGN, V16, P343, DOI 10.1016/j.jmoldx.2013.12.004; Brychta N, 2016, CLIN CHEM, V62, P1482, DOI 10.1373/clinchem.2016.257469; Chan KCA, 2005, CLIN CHEM, V51, P781, DOI 10.1373/clinchem.2004.046219; Cole HA, 2016, NUCLEIC ACIDS RES, V44, P573, DOI 10.1093/nar/gkv943; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Devonshire AS, 2014, ANAL BIOANAL CHEM, V406, P6499, DOI 10.1007/s00216-014-7835-3; Diaz IM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166354; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Garcia-Olmo DC, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-8; GARCIAMURILLAS I, 2015, SCI TRANSL MED, V7; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Guo Y, 2014, BRIEF BIOINFORM, V15, P879, DOI 10.1093/bib/bbt069; HARKINS SB, 2016, CANCER RES S14, V76; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Jiang PY, 2016, TRENDS GENET, V32, P360, DOI 10.1016/j.tig.2016.03.009; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Kuderer NM, 2017, JAMA ONCOL, V3, P996, DOI 10.1001/jamaoncol.2016.4983; Kwiatkowski DJ, 2016, PLOS GENET, V12; Liu YC, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0300-5; Malentacchi F, 2015, CLIN CHEM LAB MED, V53, P1935, DOI 10.1515/cclm-2014-1161; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Mu WB, 2016, J MOL DIAGN, V18, P923, DOI 10.1016/j.jmoldx.2016.07.006; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Volik S, 2016, MOL CANCER RES, V14, P898, DOI 10.1158/1541-7786.MCR-16-0044; Yang X, 2016, ONCOTARGET, V7, P20810, DOI 10.18632/oncotarget.8021; Zhang R, 2016, ONCOTARGET, V7, P58500, DOI 10.18632/oncotarget.11306	38	3	3	7	7	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA	0009-9147	1530-8561		CLIN CHEM	Clin. Chem.	SEP	2017	63	9					1465	1475		10.1373/clinchem.2017.272559				11	Medical Laboratory Technology	Medical Laboratory Technology	FE7XW	WOS:000408421200010	28720677				2018-01-05	
J	Liu, P; Wang, W; Wei, DZ				Liu, Pei; Wang, Wei; Wei, Dongzhi			Use of transcription activator-like effector for efficient gene modification and transcription in the filamentous fungus Trichoderma reesei	JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY			English	Article						Genome editing; TALEN; TALE-TF; Filamentous fungus; Trichoderma reesei; Genome-manipulating tool	DOUBLE-STRAND BREAKS; TAL EFFECTORS; MUTAGENESIS; GENOME; CONSTRUCTION; EXPRESSION; KNOCKOUT	Filamentous fungi have wide applications in the field of biotechnology. The use of transcription activator-like effectors (TALEs) is a powerful genome-engineering tool, which can facilitate genome editing and transcriptional modulation, and has been used for genetic modification in a variety of organisms. However, a transcription activator-like effectors nuclease (TALEN) approach has not been used in filamentous fungi so far. Here, we aimed to establish the shortest TALEN and TALE-transcription factor (TALE-TF) proteins for use in gene modification and transcription in the filamentous fungus Trichoderma reesei. The alternative tandem repeat unit of the TALEs was first established by the ligation of two isocaudamers: XbaI and SpeI, instead of the natural unit. In addition, we adopted T. reesei expression assays to monitor the activities of the TALENs and TALE-TF in vivo in T. reesei. Our results showed that TALEs are a powerful genome-manipulating tool for use in T. reesei and other filamentous fungal species and that their use might facilitate studies on functional genomics and strain improvement in these filamentous fungi.	[Liu, Pei; Wang, Wei; Wei, Dongzhi] East China Univ Sci & Technol, New World Inst Biotechnol, State Key Lab Bioreactor Engn, POB 311,130 Meilong Rd, Shanghai 200237, Peoples R China	Wang, W (reprint author), East China Univ Sci & Technol, New World Inst Biotechnol, State Key Lab Bioreactor Engn, POB 311,130 Meilong Rd, Shanghai 200237, Peoples R China.	wadexp@ecust.edu.cn			National Natural Science Foundation of China [C010302-31500066]; Fundamental Research Funds for the Central Universities [222201714053]	This research was supported by the National Natural Science Foundation of China (No. C010302-31500066), and the Fundamental Research Funds for the Central Universities (No. 222201714053).	Briggs AW, 2012, NUCLEIC ACIDS RES, V40, P283; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gerlach J., 2012, ENDOPLASMIC RETICULU, P23; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hwang WY, 2014, METHODS, V69, P76, DOI 10.1016/j.ymeth.2014.04.009; Jiang DW, 2013, BIOTECHNOL ADV, V31, P1562, DOI 10.1016/j.biotechadv.2013.08.005; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Liu R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.7; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Peterson R, 2012, MICROBIOL-SGM, V158, P58, DOI 10.1099/mic.0.054031-0; Reyon D, 2012, ENG DESIGNER TRANSCR, P15; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; SUOMINEN PL, 1993, MOL GEN GENET, V241, P523, DOI 10.1007/BF00279894; Taleei R, 2013, RADIAT RES, V179, P530, DOI 10.1667/RR3123.1; Wang S, 2016, GENES IMMUN, V17, P165, DOI 10.1038/gene.2016.4; Wang W, 2014, J IND MICROBIOL BIOT, V41, P1709, DOI 10.1007/s10295-014-1508-2; Wang W, 2014, J MICROBIOL METH, V103, P37, DOI 10.1016/j.mimet.2014.05.017; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang L, 2016, WORLD J PSYCHIATR, V6, P1, DOI 10.5498/wjp.v6.i1.1; Zhong YH, 2012, BIORESOURCE TECHNOL, V110, P572, DOI 10.1016/j.biortech.2012.01.129	24	1	1	12	12	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1367-5435	1476-5535		J IND MICROBIOL BIOT	J. Ind. Microbiol. Biotechnol.	SEP	2017	44	9					1367	1373		10.1007/s10295-017-1963-7				7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	FE7IV	WOS:000408381700010	28674932				2018-01-05	
J	Wu, ZQ; Sloan, DB; Brown, CW; Rosenblueth, O; Palmer, JD; Ong, HC				Wu, Zhiqiang; Sloan, Daniel B.; Brown, Colin W.; Rosenblueth, Monica; Palmer, Jeffrey D.; Ong, Han Chuan			Mitochondrial Retroprocessing Promoted Functional Transfers of rpl5 to the Nucleus in Grasses	MOLECULAR BIOLOGY AND EVOLUTION			English	Article						endosymbiotic gene transfer; intracellular gene transfer; mtDNA; pseudogene; reverse transcription	ENDOSYMBIOTIC GENE-TRANSFER; RNA-MEDIATED TRANSFER; PLANT MITOCHONDRIAL; FLOWERING PLANTS; RIBOSOMAL-PROTEIN; INTRON LOSS; ARABIDOPSIS-THALIANA; HORIZONTAL TRANSFER; EDITING SITES; MAXIMUM-LIKELIHOOD	Functional gene transfers from the mitochondrion to the nucleus are ongoing in angiosperms and have occurred repeatedly for all 15 ribosomal protein genes, but it is not clear why some of these genes are transferred more often than others nor what the balance is between DNA-and RNA-mediated transfers. Although direct insertion of mitochondrial DNA into the nucleus occurs frequently in angiosperms, case studies of functional mitochondrial gene transfer have implicated an RNA-mediated mechanism that eliminates introns and RNA editing sites, which would otherwise impede proper expression of mitochondrial genes in the nucleus. To elucidate the mechanisms that facilitate functional gene transfers and the evolutionary dynamics of the coexisting nuclear and mitochondrial gene copies that are established during these transfers, we have analyzed rpl5 genes from90 grasses (Poaceae) and related monocots. Multiple lines of evidence indicate that rpl5 has been functionally transferred to the nucleus at least three separate times in the grass family and that at least seven species have intact and transcribed (but not necessarily functional) copies in both the mitochondrion and nucleus. In two grasses, likely functional nuclear copies of rpl5 have been subject to recent gene conversion events via secondarily transferred mitochondrial copies in what we believe are the first described cases of mitochondrial-to-nuclear gene conversion. We show that rpl5 underwent a retroprocessing event within the mitochondrial genome early in the evolution of the grass family, which we argue predisposed the gene towards successful, DNA-mediated functional transfer by generating a "pre-edited" sequence.	[Wu, Zhiqiang; Sloan, Daniel B.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Brown, Colin W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Rosenblueth, Monica] UNAM, Ctr Genom Sci, Cuernavaca, Morelos, Mexico; [Palmer, Jeffrey D.] Indiana Univ, Dept Biol, Bloomington, IN 47401 USA; [Ong, Han Chuan] King Univ, Dept Biol, Bristol, TN 37620 USA	Ong, HC (reprint author), King Univ, Dept Biol, Bristol, TN 37620 USA.	hanchuanong@king.edu			NIH [GM-35087, GM-70612]; NSF [MCB-1412260]; Colorado State University	We thank E. Kellogg, L. Clark, and K. Clay for generously contributing DNA samples and/or plant materials; Gane Ka-Shu Wong and the 1KP consortium for providing access to the 1 KP data set; M.P. Simmons for helpful discussion about phylogenetic analysis; and two anonymous reviewers and the lab groups of DBS and Rachel Mueller for comments on an earlier version of this manuscript. This research was supported by NIH GM-35087 and GM-70612 to JDP and by NSF MCB-1412260 and start-up funds from Colorado State University to DBS.	Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, PLANT CELL, V14, P931, DOI 10.1105/tpc.010483; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; Atluri S, 2015, MOL GENET GENOMICS, V290, P2325, DOI 10.1007/s00438-015-1087-6; AUBERT D, 1992, PLANT MOL BIOL, V20, P1169, DOI 10.1007/BF00028903; Barkman TJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-248; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x                                                ; Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; BLANCHARD JL, 1995, J MOL EVOL, V41, P397, DOI 10.1007/BF00160310                                                              ; Bonen L, 2006, MOL BIOL EVOL, V23, P701, DOI 10.1093/molbev/msj080; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; BRANDT P, 1993, CURR GENET, V24, P330, DOI 10.1007/BF00336785; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Byrne SL, 2015, PLANT J, V84, P816, DOI 10.1111/tpj.13037; Choi C, 2006, NEW PHYTOL, V172, P429, DOI 10.1111/j.1469-8137.2006.01821.x; Christin PA, 2014, SYST BIOL, V63, P153, DOI 10.1093/sysbio/syt072; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Cotton JL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0563-9; COVELLO PS, 1992, EMBO J, V11, P3815; Cuenca A, 2016, GENOME BIOL EVOL, V8, P2176, DOI 10.1093/gbe/evw148; Cuenca A, 2012, J MOL EVOL, V74, P158, DOI 10.1007/s00239-012-9496-1; Cuenca A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-349; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doyle JJ, 1987, PHYTOCHEMISTRY B, V19, P11; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Figueroa P, 1999, PLANT J, V18, P601, DOI 10.1046/j.1365-313x.1999.00485.x; Fuentes I, 2012, CURR BIOL, V22, P763, DOI 10.1016/j.cub.2012.03.005; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gaut BS, 1998, EVOL BIOL, V30, P93; GEISS KT, 1994, MOL GEN GENET, V243, P97, DOI 10.1007/BF00283881; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grewe F, 2016, GENOME BIOL EVOL, V8, P3193, DOI 10.1093/gbe/evw233; Grewe F, 2014, MITOCHONDRION, V19, P135, DOI 10.1016/j.mito.2014.05.008; Grimes BT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-31; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo WH, 2017, NEW PHYTOL, V213, P391, DOI 10.1111/nph.14135; Hammani K, 2014, TRENDS PLANT SCI, V19, P380, DOI 10.1016/j.tplants.2013.12.008; Hao Weilong, 2011, Mob Genet Elements, V1, P256; Hao WL, 2010, P NATL ACAD SCI USA, V107, P21576, DOI 10.1073/pnas.1016295107; Hao WL, 2009, P NATL ACAD SCI USA, V106, P16728, DOI 10.1073/pnas.0908766106; Havird JC, 2016, MOL BIOL EVOL, V33, P3042, DOI 10.1093/molbev/msw185; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hazle T, 2007, GENE, V405, P108, DOI 10.1016/j.gene.2007.09.019; Henze K, 2001, TRENDS GENET, V17, P383, DOI 10.1016/S0168-9525(01)02312-5; Hepburn NJ, 2012, MOL BIOL EVOL, V29, P3111, DOI 10.1093/molbev/mss130; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Itchoda N, 2002, THEOR APPL GENET, V104, P209, DOI 10.1007/s001220100744; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KNOOP V, 1995, CURR GENET, V27, P559, DOI 10.1007/BF00314448; KRISHNASAMY S, 1994, PLANT MOL BIOL, V24, P129, DOI 10.1007/BF00040580; Kubo N, 1999, P NATL ACAD SCI USA, V96, P9207, DOI 10.1073/pnas.96.16.9207; LAMATTINA L, 1991, NUCLEIC ACIDS RES, V19, P3275, DOI 10.1093/nar/19.12.3275                                                          ; Lavrov DV, 2016, CURR BIOL, V26, P86, DOI 10.1016/j.cub.2015.11.043; Liu SL, 2009, MOL BIOL EVOL, V26, P875, DOI 10.1093/molbev/msp011; Long MY, 1996, P NATL ACAD SCI USA, V93, P7727, DOI 10.1073/pnas.93.15.7727; Lopez L, 2007, BIOCHIMIE, V89, P159, DOI 10.1016/j.biochi.2006.09.011; Lough AN, 2008, GENETICS, V178, P47, DOI 10.1534/genetics.107.079624; Lu MZ, 1998, PLANT MOL BIOL, V37, P225, DOI 10.1023/A:1005972513322; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Michalovova M, 2013, HEREDITY, V111, P314, DOI 10.1038/hdy.2013.51; Mower JP, 2006, MOL GENET GENOMICS, V276, P285, DOI 10.1007/s00438-006-0139-3; Mower JP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-150; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Mower JP, 2012, PLANT GENOME DIVERSI, V1, P123, DOI DOI 10.1007/978-3-7091-1130-7_; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Noutsos C, 2005, GENOME RES, V15, P616, DOI 10.1101/gr.9788705; NUGENT JM, 1991, CELL, V66, P473, DOI 10.1016/0092-8674(81)90011-8; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Park S, 2015, NEW PHYTOL, V208, P570, DOI 10.1111/nph.13467; Parkinson CL, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-73; Petersen G, 2006, TAXON, V55, P871, DOI 10.2307/25065682                                                                ; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; Qiu Y, 2014, CURRENT PLANT BIOL, V1, P68, DOI 10.1016/j.cpb.2014.08.002; Ran JH, 2010, MOL PHYLOGENET EVOL, V54, P136, DOI 10.1016/j.ympev.2009.09.011; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sandoval P, 2004, GENE, V324, P139, DOI 10.1016/j.gene.2003.09.027; Schuster W, 1993, NUCLEIC ACIDS RES, V19, P6923; Sheppard AE, 2011, PLANT MOL BIOL, V76, P299, DOI 10.1007/s11103-011-9764-2; Sloan DB, 2012, NEW PHYTOL, V196, P1228, DOI 10.1111/j.1469-8137.2012.04340.x; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Sloan DB, 2010, GENETICS, V185, P1369, DOI 10.1534/genetics.110.118000; Stegemann S, 2003, P NATL ACAD SCI USA, V100, P8828, DOI 10.1073/pnas.1430924100; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; Subramanian S, 2006, GENOME, V49, P275, DOI 10.1139/G05-098; SUTTON CA, 1993, CURR GENET, V23, P472, DOI 10.1007/BF00312637; Timmis JN, 2012, CURR BIOL, V22, pR296, DOI 10.1016/j.cub.2012.03.043; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; WISCHMANN C, 1995, FEBS LETT, V374, P152, DOI 10.1016/0014-5793(95)01100-S; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Wu ZQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2155-3; Wysocki WP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0321-5; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186	107	1	1	16	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0737-4038	1537-1719		MOL BIOL EVOL	Mol. Biol. Evol.	SEP	2017	34	9					2340	2354		10.1093/molbev/msx170				15	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	FE6GG	WOS:000408307400016	28541477				2018-01-05	
J	Yan, MY; Yan, HQ; Ren, GX; Zhao, JP; Guo, XP; Sun, YC				Yan, Mei-Yi; Yan, Hai-Qin; Ren, Gai-Xian; Zhao, Ju-Ping; Guo, Xiao-Peng; Sun, Yi-Cheng			CRISPR-Cas12a-Assisted Recombineering in Bacteria	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article						Cas12a; recombineering; Mycobacterium smegmatis; Yersinia pestis	CRISPR-CAS SYSTEMS; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; YERSINIA-PESTIS; GENOME; DNA; GENE; GENERATION	Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas12a (Cpf1) has emerged as an effective genome editing tool in many organisms. Here, we developed and optimized a CRISPR-Cas12a-assisted recombineering system to facilitate genetic manipulation in bacteria. Using this system, point mutations, deletions, insertions, and gene replacements can be easily generated on the chromosome or native plasmids in Escherichia coli, Yersinia pestis, and Mycobacterium smegmatis. Because CRISPR-Cas12a-assisted recombineering does not require introduction of an antibiotic resistance gene into the chromosome to select for recombinants, it is an efficient approach for generating markerless and scarless mutations in bacteria. IMPORTANCE The CRISPR-Cas9 system has been widely used to facilitate genome editing in many bacteria. CRISPR-Cas12a (Cpf1), a new type of CRISPR-Cas system, allows efficient genome editing in bacteria when combined with recombineering. Cas12a and Cas9 recognize different target sites, which allows for more precise selection of the cleavage target and introduction of the desired mutation. In addition, CRISPR-Cas12a-assisted recombineering can be used for genetic manipulation of plasmids and plasmid curing. Finally, Cas12a-assisted recombineering in the generation of point mutations, deletions, insertions, and replacements in bacteria has been systematically analyzed. Taken together, our findings will guide efficient Cas12amediated genome editing in bacteria.	[Yan, Mei-Yi; Ren, Gai-Xian; Zhao, Ju-Ping; Guo, Xiao-Peng; Sun, Yi-Cheng] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China; [Yan, Mei-Yi; Ren, Gai-Xian; Zhao, Ju-Ping; Guo, Xiao-Peng; Sun, Yi-Cheng] Chinese Acad Med Sci, Ctr TB Res, Beijing, Peoples R China; [Yan, Mei-Yi; Ren, Gai-Xian; Zhao, Ju-Ping; Guo, Xiao-Peng; Sun, Yi-Cheng] Peking Union Med Coll, Beijing, Peoples R China; [Yan, Hai-Qin] Bengbu Med Coll, Dept Histol & Embryol, Bengbu, Anhui, Peoples R China	Sun, YC (reprint author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China.; Sun, YC (reprint author), Chinese Acad Med Sci, Ctr TB Res, Beijing, Peoples R China.; Sun, YC (reprint author), Peking Union Med Coll, Beijing, Peoples R China.	sunyc@ipbcams.ac.cn			National Natural Science Foundation of China [31670139]; National Basic Research Program of China (973 Program) [2015CB554200]; National Major Research & Development Program of China [2016YFC1202600]; CAMS Initiative for Innovative Medicine [2016-I2M-1-013]	This work was supported by the National Natural Science Foundation of China (31670139), the National Basic Research Program of China (973 Program; 2015CB554200), the National Major Research & Development Program of China (2016YFC1202600), and CAMS Initiative for Innovative Medicine (2016-I2M-1-013).	Agudelo D, 2017, NAT METHODS, V14, P615, DOI [10.1038/nmeth.4265, 10.1038/NMETH.4265]; Attar Naomi, 2016, Nat Rev Microbiol, V14, P335, DOI [10.1038/nrmicro.2016.71, 10.1038/nrmicro.2016.70, 10.1038/nrmicro.2016.69]; Balasubramanian V, 1996, J BACTERIOL, V178, P273, DOI 10.1128/jb.178.1.273-279.1996                                                   ; Barrangou R, 2016, CURR OPIN BIOTECH, V37, P61, DOI 10.1016/j.copbio.2015.10.003; Chen FQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14958; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Cui L, 2016, NUCLEIC ACIDS RES, V44, P4243, DOI 10.1093/nar/gkw223; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gavigan JA, 1997, J BACTERIOL, V179, P4115, DOI 10.1128/jb.179.13.4115-4122.1997                                                ; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286                                                          ; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15179; Jiang Y, 2015, APPL ENVIRON MICROB, V81, P2506, DOI 10.1128/AEM.04023-14; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kim H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14406; Kim JH, 2011, NUCLEIC ACIDS RES, V39, P2210, DOI 10.1093/nar/gkq1149; Kim Y, 2016, NAT BIOTECHNOL, V34, P808, DOI 10.1038/nbt.3614; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Lemay M-L, 2017, ACS SYNTH B IN PRESS; Luo ML, 2016, BIOTECHNOL BIOENG, V113, P930, DOI 10.1002/bit.25851; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; MANEN D, 1991, MOL MICROBIOL, V5, P233, DOI 10.1111/j.1365-2958.1991.tb02103.x; Mao XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22922; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mougiakos I, 2016, TRENDS BIOTECHNOL, V34, P575, DOI 10.1016/j.tibtech.2016.02.004; Nayak DD, 2017, P NATL ACAD SCI USA, V114, P2976, DOI 10.1073/pnas.1618596114; Oh JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku623; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; Rock JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.274; Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112; SELZER G, 1983, CELL, V32, P119, DOI 10.1016/0092-8674(83)90502-0                                                    ; Shenkerman Y, 2014, GENE, V533, P374, DOI 10.1016/j.gene.2013.09.082; Singh AK, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw625; Song HH, 2007, GENE, V399, P112, DOI 10.1016/j.gene.2007.05.005; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Tang X, 2017, NAT PLANTS, V3, DOI [10.1038/nplants.2017.56, 10.1038/nplants.2017.18]; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; [武晓林 Wu Xiaolin], 2012, [微生物学报, Acta Microbiologica Sinica], V52, P1151; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	56	1	1	23	23	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	SEP	2017	83	17							UNSP e00947	10.1128/AEM.00947-17				13	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	FE5NU	WOS:000408259000011					2018-01-05	
J	Paclikova, P; Bernatik, O; Radaszkiewicz, TW; Bryja, V				Paclikova, Petra; Bernatik, Ondrej; Radaszkiewicz, Tomasz Witold; Bryja, Vitezslav			The N-Terminal Part of the Dishevelled DEP Domain Is Required for Wnt/beta-Catenin Signaling in Mammalian Cells	MOLECULAR AND CELLULAR BIOLOGY			English	Article						CRISPR/Cas; DEP domain; Dishevelled; Wnt/beta-catenin signaling; Wnt3a	BETA-CATENIN; TUMOR-SUPPRESSOR; PLANAR POLARITY; WNT; PHOSPHORYLATION; PROTEIN; MECHANISMS; FAMILY; AXIN; DROSOPHILA	Dishevelled (DVL) proteins are key mediators of the Wnt/beta-catenin signaling pathway. All DVL proteins contain three conserved domains: DIX, PDZ, and DEP. There is a consensus in the field that the DIX domain is critical for Wnt/beta-catenin signaling, but contradictory evidence regarding the function of the DEP domain exists. It has been difficult, until recently, to test the importance of the DEP domain rigorously because of the interference with endogenous DVL, expressed in all Wnt-responsive cell lines. In this study, we took advantage of DVL knockout (DVL1/DVL2/DVL3 triple knockout) cells fully deficient in Wnt3a-induced signaling events and performed a series of rescue experiments. Using these complementation assays, we analyzed the role of individual DVL isoforms. Further domain mapping of DVL1 showed that both the DVL1 DEP domain and especially its N-terminal region are required and sufficient for Wnt3a-induced phosphorylation of LRP6 and TopFlash reporter activation. On the contrary, multiple DEP domain mutants deficient in the planar cell polarity (PCP) pathway could fully rescue the Wnt3a response. This study provides conclusive evidence that the DVL DEP domain is essential for Wnt/beta-catenin signaling in mammalian cells and establishes an experimental system suitable for further functional testing of DVL.	[Paclikova, Petra; Bernatik, Ondrej; Radaszkiewicz, Tomasz Witold; Bryja, Vitezslav] Masaryk Univ, Dept Expt Biol, Fac Sci, Brno, Czech Republic; [Bryja, Vitezslav] Czech Acad Sci, Inst Biophys, Brno, Czech Republic	Bryja, V (reprint author), Masaryk Univ, Dept Expt Biol, Fac Sci, Brno, Czech Republic.; Bryja, V (reprint author), Czech Acad Sci, Inst Biophys, Brno, Czech Republic.	bryja@sci.muni.cz			Czech Science Foundation [15-21789S, GA17-16680S]; Masaryk University [MUNI/G/1100/2016]; Marie Curie ITN WntsApp [608180]; municipality of the city of Brno, Czech Republic	This study was supported by the Czech Science Foundation (15-21789S, GA17-16680S), by Masaryk University (MUNI/G/1100/2016), and by Marie Curie ITN WntsApp (grant no. 608180). Petra Paclikova is the holder of a Brno Ph.D. talent scholarship, which is funded by the municipality of the city of Brno, Czech Republic.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X                                                   ; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Capelluto DGS, 2014, BIOPHYS J, V106, P1101, DOI 10.1016/j.bpj.2014.01.032; Cervenka I, 2016, P NATL ACAD SCI USA, V113, P9304, DOI 10.1073/pnas.1608783113; Collu GM, 2015, CURR BIOL, V25, pR372, DOI 10.1016/j.cub.2015.03.011; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gammons MV, 2016, MOL CELL, V64, P92, DOI 10.1016/j.molcel.2016.08.026; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784                                                   ; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Ma Li, 2010, J Mol Signal, V5, P19, DOI 10.1186/1750-2187-5-19; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mlodzik M, 2016, CURR TOP DEV BIOL, V117, P75, DOI 10.1016/bs.ctdb.2015.11.027; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Penton A, 2002, GENETICS, V161, P747; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Singh J, 2010, GENE DEV, V24, P2157, DOI 10.1101/gad.1961010; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1                                                   ; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wynshaw-Boris A, 2012, CURR TOP DEV BIOL, V101, P213, DOI 10.1016/B978-0-12-394592-1.00007-7; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443                                                          ; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	38	1	1	2	2	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	SEP	2017	37	18							UNSP e00145-17	10.1128/MCB.00145-17				16	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	FE7ZL	WOS:000408425300005		green_published			2018-01-05	
J	Najem, A; Krayem, M; Sales, F; Hussein, N; Badran, B; Robert, C; Awada, A; Journe, F; Ghanem, GE				Najem, Ahmad; Krayem, Mohammad; Sales, Francois; Hussein, Nader; Badran, Bassam; Robert, Caroline; Awada, Ahmad; Journe, Fabrice; Ghanem, Ghanem E.			P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition	EUROPEAN JOURNAL OF CANCER			English	Article						(Q61)NRAS; MEK inhibition; p53 activation; Bcl-2 inhibition; Drug resistance; Melanoma	METASTATIC MELANOMA; CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; SIGNALING PATHWAY; CELL-LINES; OPEN-LABEL; IN-VIVO; BCL-XL; CANCER; APOPTOSIS	Activating mutations in Neuroblastoma RAS viral oncogene homolog (NRAS) are found in 15-30% of melanomas and are associated with a poor prognosis. Although MAP kinase kinase (MEK) inhibitors used as single agents showed a limited clinical benefit in patients with NRAS-mutant melanoma due to their rather cytostatic effect and high toxicity, their combination with other inhibitors of pathways known to cooperate with MEK inhibition may maximise their antitumour activity. Similarly, in a context where p53 is largely inactivated in melanoma, hyperexpression of Microphthalmia associated transcription factor (MITF) and its downstream anti-apoptotic targets may be the cause of the restraint cytotoxic effects of MEK inhibitors. Indeed, drug combinations targeting both mutant BRAF and MITF or one of its important targets Bcl-2 were effective in mutant BRAF melanoma but had no effect on acquired resistance. Therefore, we aimed to further investigate the downstream MITF targets that can explain this anti-apoptotic effect and to evaluate in parallel the effect of p53 reactivation on the promotion of apoptosis under MEK inhibition in a panel of Q61 NRAS-mutant melanoma cells. First, we showed that MEK inhibition (pimasertib) led to a significant inhibition of cell proliferation but with a limited effect on apoptosis that could be explained by the systematic MITF upregulation. Mimicking the MITF effect via cyclic adenosine monophosphate activation conferred resistance to MEK inhibition and upregulated Bcl-2 expression. In addition, acquired resistance to MEK inhibition was associated with a strong activation of the anti-apoptotic signalling MITF/Bcl-2. More importantly, selective Bcl-2 inhibition by ABT-199 or Bcl-2 knockout using CRISPR/Cas9 system annihilated the acquired resistance and restored the sensitivity of NRAS-mutant melanoma cells to MEK inhibition. Strikingly and similarly, direct p53 reactivation (PRIMA-1(Met), APR-246) also broke resistance and synergised with MEK inhibition to induce massive apoptosis in NRAS-mutant melanoma cells with wild-type or mutant p53. Hence, our data identify MITF/Bcl-2 as a key mechanism underlying resistance of NRAS-mutant melanoma cells to apoptosis by MEK inhibitors and paves the way for a promising drug combination that could prevent or reverse anti-MEK resistance in this group of patients. (C) 2017 Elsevier Ltd. All rights reserved.	[Najem, Ahmad; Krayem, Mohammad; Sales, Francois; Journe, Fabrice; Ghanem, Ghanem E.] Univ Libre Bruxelles, Inst Jules Bordet, Lab Oncol & Expt Surg, Brussels, Belgium; [Sales, Francois] Univ Libre Bruxelles, Inst Jules Bordet, Dept Surg, Brussels, Belgium; [Hussein, Nader; Badran, Bassam] Lebanese Univ, Dept Biochem, Beirut, Lebanon; [Robert, Caroline] Gustave Roussy Canc Campus Grand Paris, Villejuif, France; [Awada, Ahmad] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, Brussels, Belgium; [Journe, Fabrice] Univ Mons, Serv Anat Humaine & Oncol Expt, Mons, Belgium	Ghanem, GE (reprint author), Inst Jules Bordet, LOCE, 1 Rue Heger Bordet, B-1000 Brussels, Belgium.	gghanem@ulb.ac.be			BRIC (Universite Libre de Bruxelles); Lebanese University; MEDIC Foundation; Fondation contre le cancer; Amis de l'institut Bordet'	A. Najem is a recipient of a grant from BRIC (Universite Libre de Bruxelles) and from the Lebanese University. The work has been supported by grants from the MEDIC Foundation, 'Fondation contre le cancer' and 'Amis de l'institut Bordet'.	Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Bao WJ, 2011, CELL CYCLE, V10, P301, DOI 10.4161/cc.10.2.14538; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Bedikian AY, 2014, MELANOMA RES, V24, P237, DOI 10.1097/CMR.0000000000000056; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Ciuffreda L, 2012, J MOL MED, V90, P667, DOI 10.1007/s00109-011-0844-1; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092                                                            ; Dar AA, 2016, P NATL ACAD SCI USA, V113, P6254, DOI 10.1073/pnas.1606027113; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766                                                             ; Deben C, 2016, CANCER LETT, V375, P313, DOI 10.1016/j.canlet.2016.03.017; Delord J, 2010, J CLIN ONCOL S, V28, p15s; Devitt B, 2011, PIGM CELL MELANOMA R, V24, P666, DOI 10.1111/j.1755-148X.2011.00873.x; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Drosten M, 2014, P NATL ACAD SCI USA, V111, P15155, DOI 10.1073/pnas.1417549111; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Fedorenko IV, 2013, ONCOGENE, V32, P3009, DOI 10.1038/onc.2012.453; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; Hartman ML, 2015, J INVEST DERMATOL, V135, P352, DOI 10.1038/jid.2014.319; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Houede N, 2011, ASCO M S15, V29, P3019; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Krayem M, 2014, EUR J CANCER, V50, P1310, DOI 10.1016/j.ejca.2014.01.021; Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Posch C, 2015, J INVEST DERMATOL, V135, P2475, DOI 10.1038/jid.2015.198; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Serasinghe MN, 2015, ONCOGENE, V34, P857, DOI 10.1038/onc.2014.21; Siroy AE, 2015, J INVEST DERMATOL, V135, P508, DOI 10.1038/jid.2014.366; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smith MP, 2016, CANCER CELL, V29, P270, DOI 10.1016/j.ccell.2016.02.003; Smith MP, 2013, JNCI-J NATL CANCER I, V105, P33, DOI 10.1093/jnci/djs471; Synnott NC, 2017, INT J CANCER, V140, P234, DOI 10.1002/ijc.30425; Uustalu M, 2015, CELL DEATH DIS, V6, pe1794; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Wroblewski D, 2013, CARCINOGENESIS, V34, P237, DOI 10.1093/carcin/bgs330; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	43	0	0	7	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0959-8049	1879-0852		EUR J CANCER	Eur. J. Cancer	SEP	2017	83						154	165		10.1016/j.ejca.2017.06.033				12	Oncology	Oncology	FE5TJ	WOS:000408273800019	28738256				2018-01-05	
J	Iacoangeli, A; Lui, A; Haines, A; Ohta, Y; Flajnik, M; Hsu, E				Iacoangeli, Anna; Lui, Anita; Haines, Ashley; Ohta, Yuko; Flajnik, Martin; Hsu, Ellen			Evidence for Ig Light Chain Isotype Exclusion in Shark B Lymphocytes Suggests Ordered Mechanisms	JOURNAL OF IMMUNOLOGY			English	Article							ANTIGEN RECEPTOR; LYMPHOID-TISSUES; NURSE SHARK; VERTEBRATE PHYLOGENY; IMMUNOGLOBULIN GENES; GENOMIC ORGANIZATION; CELL DEVELOPMENT; KAPPA-CHAIN; BONE-MARROW; EVOLUTION	Unlike most vertebrates, the shark IgL gene organization precludes secondary rearrangements that delete self-reactive VJ rearranged genes. Nurse sharks express four L chain isotypes, kappa, lambda, sigma, and sigma-2, encoded by 35 functional minigenes or clusters. The sequence of gene activation/expression and receptor editing of these isotypes have not been studied. We therefore investigated the extent of isotypic exclusion in separated B cell subpopulations. Surface Ig (sIg)kappa-expressing cells, isolated with mAb LK14 that recognizes C kappa, carry predominantly nonproductive rearrangements of other L chain isotypes. Conversely, after depletion with LK14, sIgM(+) cells contained largely nonproductive kappa and enrichment for in-frame VJ of the others. Because some isotypic inclusion was observed at the mRNA level, expression in the BCR was examined. Functional lambda mRNA was obtained, as expected, from the LK14-depleted population, but was also in sIg kappa(+) splenocytes. Whereas lambda somatic mutants from the depleted sample displayed evidence of positive selection, the lambda genes in sIg kappa(+) cells accumulated bystander mutations indicating a failure to express their products at the cell surface in association with the BCR H chain. In conclusion, a shark B cell expresses one L chain isotype at the surface and other isotypes as nonproductive VJ, sterile transcripts, or in-frame VJ whose products may not associate with the H chain. Based on the mRNA content found in the B cell subpopulations, an order of L chain gene activation is suggested as: sigma-2 followed by kappa, then sigma and lambda.	[Iacoangeli, Anna] Tisch Multiple Sclerosis Res Ctr New York, New York, NY 10019 USA; [Lui, Anita] SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Haines, Ashley; Ohta, Yuko; Flajnik, Martin] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Hsu, E (reprint author), SUNY Hlth Sci Ctr, 450 Clarkson Ave,Box 31, Brooklyn, NY 11203 USA.	hsue@hscbklyn.edu			National Institutes of Health [R01 GM068095, R01 DO0549-25]	This work was supported in part by funding from National Institutes of Health Grants R01 GM068095 (to E.H.) and R01 DO0549-25 (to M.F.).	Abarrategui I, 2009, ADV EXP MED BIOL, V650, P93; Bannish G, 2001, J EXP MED, V194, P1583, DOI 10.1084/jem.194.11.1583                                                         ; Beck K, 2009, J EXP MED, V206, P2271, DOI 10.1084/jem.20090756; Bengten E, 2000, IMMUNOGENETICS, V51, P647, DOI 10.1007/s002510000176; Bengten E, 2015, RESULTS PROBL CELL D, V57, P193, DOI 10.1007/978-3-319-20819-0_9; BURNET MF, 1959, CLONAL SELECTION THE; Casellas R, 2007, J EXP MED, V204, P153, DOI 10.1084/jem.20061918; Chemin G, 2010, J IMMUNOL, V184, P5009, DOI 10.4049/jimmunol.0902949; Chen H, 2009, P NATL ACAD SCI USA, V106, P8591, DOI 10.1073/pnas.0811283106; CHEN JZ, 1993, EMBO J, V12, P821; Criscitiello MF, 2007, EUR J IMMUNOL, V37, P2683, DOI 10.1002/eji.200737263; Criscitiello MF, 2015, IMMUNOBIOLOGY OF THE SHARK, P221; Criscitiello MF, 2010, J IMMUNOL, V184, P6950, DOI 10.4049/jimmunol.0902774; Derudder E, 2009, NAT IMMUNOL, V10, P647, DOI 10.1038/ni.1732; Diaz M, 1999, INT IMMUNOL, V11, P825, DOI 10.1093/intimm/11.5.825; Eason DD, 2004, EUR J IMMUNOL, V34, P2551, DOI 10.1002/eji.200425224; Fleurant M, 2004, J IMMUNOL, V173, P5574, DOI 10.4049/jimmunol.173.9.5574                                                     ; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GIACHINO C, 1995, J EXP MED, V181, P1245, DOI 10.1084/jem.181.3.1245; Greenberg A. S., 1994, THESIS; Hsu E, 2006, J IMMUNOL, V177, P2452, DOI 10.4049/jimmunol.177.4.2452                                                     ; Iacoangeli A, 2015, J IMMUNOL, V195, P3992, DOI 10.4049/jimmunol.1501426; Ji YR, 1999, MOL IMMUNOL, V36, P1159, DOI 10.1016/S0161-5890(99)00123-6                                                   ; Kalinina O, 2011, P NATL ACAD SCI USA, V108, P7125, DOI 10.1073/pnas.1019389108; KORSMEYER SJ, 1982, J EXP MED, V156, P975, DOI 10.1084/jem.156.4.975; Lee SS, 2002, IMMUNITY, V16, P571, DOI 10.1016/S1074-7613(02)00300-X                                                   ; Lee SS, 2000, CURR TOP MICROBIOL, V248, P285; Lee SS, 2000, J EXP MED, V191, P1637, DOI 10.1084/jem.191.10.1637                                                         ; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109                                                ; Liu X, 2000, J Immunol, V165, P7058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malecek K, 2008, PLOS BIOL, V6, P1226, DOI 10.1371/journal.pbio.0060157; Miracle AL, 2001, INT IMMUNOL, V13, P567, DOI 10.1093/intimm/13.4.567; MOORE MW, 1985, P NATL ACAD SCI USA, V82, P6211, DOI 10.1073/pnas.82.18.6211; NADEL B, 1990, EMBO J, V9, P435; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2                                                    ; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; Qin T, 2008, DEV COMP IMMUNOL, V32, P156, DOI 10.1016/j.dci.2007.05.007; RAST JP, 1994, IMMUNOGENETICS, V40, P83; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; Rezanka LJ, 2005, CELL IMMUNOL, V238, P38, DOI 10.1016/j.cellimm.2005.12.004; Rumfelt LL, 2002, SCAND J IMMUNOL, V56, P130, DOI 10.1046/j.1365-3083.2002.01116.x; Rumfelt LL, 2001, P NATL ACAD SCI USA, V98, P1775, DOI 10.1073/pnas.98.4.1775; SHAMBLOTT MJ, 1989, EMBO J, V8, P3733; SIMINOVITCH KA, 1985, NATURE, V316, P260, DOI 10.1038/316260a0; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009                                                          ; Tze LE, 2005, PLOS BIOL, V3, P463, DOI 10.1371/journal.pbio.0030082; Velez MG, 2007, J IMMUNOL, V179, P1049, DOI 10.4049/jimmunol.179.2.1049                                                     ; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Zhu C, 2011, J IMMUNOL, V187, P2492, DOI 10.4049/jimmunol.1101671	50	0	0	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	SEP 1	2017	199	5					1875	1885		10.4049/jimmunol.1700762				11	Immunology	Immunology	FE1VH	WOS:000408005200035	28760881	green_published			2018-01-05	
J	Huang, XB; Zhuang, CL; Zhuang, CS; Xiong, TF; Li, YW; Gui, YT				Huang, Xinbo; Zhuang, Chengle; Zhuang, Changshui; Xiong, Tiefu; Li, Yawen; Gui, Yaoting			An enhanced hTERT promoter-driven CRISPR/Cas9 system selectively inhibits the progression of bladder cancer cells	MOLECULAR BIOSYSTEMS			English	Article							HRAS MUTATION; UROTHELIAL CANCER; GAL4-UAS SYSTEM; EXPRESSION; DNA; REACTIVATION; GENERATION; SIGNAL; NEVUS	The current therapies for treating tumors are lacking in efficacy and specificity. Synthetic biology principles may bring some new possible methods for curing cancer. Here we present a synthetic logic circuit based on the CRISPR/Cas9 system. The CRISPR/Cas9 technology has been applied in many biological fields, including cancer research. In this study, the expression of Cas9 nuclease was controlled indirectly by an enhanced hTERT promoter using the GAL4/upstream activating sequence (UAS) binding system. Cas9 was driven by 5XUAS, single guide RNA (sgRNA) was used to target mutant or wild-type HRAS, and the fusion gene GAL4-P65 was driven by the enhanced hTERT promoter. The system was tested in bladder cancer cells (T24 and 5637) and the results showed that the enhanced hTERT promoter could drive the expression of GAL4-P65 in these bladder cancer cell lines. Then all these devices were packed into lentivirus and the results of quantitative real-time PCR showed that the mRNA expression level of HRAS was selectively inhibited in the T24 and 5637 cells. The results of functional experiments suggested that the proliferation, cell migration and invasion were selectively suppressed, and that the apoptosis rate was increased in bladder cancer cells but not in human foreskin fibroblasts (HFF). In conclusion, we successfully constructed an enhanced hTERT promoter-driven CRISPR/Cas9 system and data showed that it could selectively suppress the progression of bladder cancer cells.	[Huang, Xinbo; Li, Yawen; Gui, Yaoting] Anhui Med Univ, Grad Sch, Hefei 230032, Anhui, Peoples R China; [Huang, Xinbo; Zhuang, Chengle; Zhuang, Changshui; Xiong, Tiefu; Gui, Yaoting] Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen Hosp, Shenzhen 518000, Peoples R China	Gui, YT (reprint author), Anhui Med Univ, Grad Sch, Hefei 230032, Anhui, Peoples R China.; Gui, YT (reprint author), Peking Univ, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen Hosp, Shenzhen 518000, Peoples R China.	guiyaoting2007@aliyun.com			Shenzhen Project of Science and Technology [JCYJ20170307111748761, 201506042]	The authors thank the donors whose names are not included in the author list but who participated in this program. This work was supported by grants from the Shenzhen Project of Science and Technology (JCYJ20170307111748761 and 201506042).	Biagioni A, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0550-0; Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cheng L, 2017, EUR UROL, V71, P497, DOI 10.1016/j.eururo.2016.12.008; Cheng L, 2014, CRIT REV ONCOL HEMAT, V89, P73, DOI 10.1016/j.critrevonc.2013.08.008; Eremeeva E., 2017, CHEMISTRY, DOI [10.1002/chem.201700679, DOI 10.1002/CHEM.201700679]; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Hafner C, 2011, NEW ENGL J MED, V365, P1940, DOI 10.1056/NEJMc1109381; Harms PW, 2016, HUM PATHOL, V51, P25, DOI 10.1016/j.humpath.2015.12.015; Hartley KO, 2002, P NATL ACAD SCI USA, V99, P1377, DOI 10.1073/pnas.022646899; Heidenreich B, 2017, MUTAT RES-REV MUTAT, V771, P15, DOI 10.1016/j.mrrev.2016.11.002; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]; Ji HYY, 2016, MOL THER, V24, P508, DOI 10.1038/mt.2016.7; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lei AQ, 2011, EXPERT REV ANTICANC, V11, P1851, DOI [10.1586/era.11.181, 10.1586/ERA.11.181]; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu BH, 2006, MOL THER, V14, P872, DOI 10.1016/j.ymthe.2006.05.020; Liu YC, 2016, NAT METHODS, V13, P938, DOI [10.1038/NMETH.3994, 10.1038/nmeth.3994]; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Marta GN, 2012, INT BRAZ J UROL, V38, P144, DOI 10.1590/S1677-55382012000200002; Miglietta G, 2015, ACS MED CHEM LETT, V6, P1179, DOI 10.1021/acsmedchemlett.5b00315; Pang SC, 2015, MAR BIOTECHNOL, V17, P593, DOI 10.1007/s10126-015-9641-0; Park MY, 2017, ONCOTARGET, V8, P36331, DOI 10.18632/oncotarget.16752; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Racioppi M, 2012, UROL INT, V88, P249, DOI 10.1159/000335556; Radoeva T, 2016, PLANT PHYSIOL, V171, P1169, DOI 10.1104/pp.16.00213; Saraggi D, 2017, PATHOL RES PRACT, V213, P860, DOI 10.1016/j.prp.2017.03.012; Shay JW, 2003, CLIN CANCER RES, V9, P3521; Stenman A, 2016, GENE CHROMOSOME CANC, V55, P452, DOI 10.1002/gcc.22347; Wang H, 2017, NAT METHODS, V14, P145, DOI [10.1038/nmeth.4109, 10.1038/NMETH.4109]; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Wu S, 2014, EUR UROL, V65, P274, DOI 10.1016/j.eururo.2013.10.038; Ye Haifeng, 2017, Nat Biomed Eng, V1, P0005, DOI 10.1038/s41551-016-0005	37	0	0	17	17	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1742-206X	1742-2051		MOL BIOSYST	Mol. Biosyst.	SEP 1	2017	13	9					1713	1721		10.1039/c7mb00354d				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE4WP	WOS:000408214300005	28702647				2018-01-05	
J	Du, ZH; Uversky, VN				Du, Zhihua; Uversky, Vladimir N.			Functional roles of intrinsic disorder in CRISPR-associated protein Cas9	MOLECULAR BIOSYSTEMS			English	Article							RNA-BINDING CHAMELEON; UNSTRUCTURED PROTEINS; CRYSTAL-STRUCTURE; TARGET DNA; RECOGNITION; SEQUENCE; ENDONUCLEASE; IMMUNITY; SYSTEMS; COMPLEX	Protein intrinsic disorder is an important characteristic commonly detected in multifunctional or RNA-and DNA-binding proteins. Due to their high conformational flexibility and solvent accessibility, intrinsically disordered proteins (IDPs) and IDP regions (IDPRs) execute diverse functions including interaction with multiple partners, and are frequently subjected to various post-translational modifications. Recent studies on the components comprising the CRISPR (clustered regularly interspaced short palindromic repeats) system have elucidated the crystal structure of Cas9 proteins and the mechanism by which the Cas9-sgRNA complex recognizes and cleaves its target DNA. Yet the extent and functional implications of intrinsic disorder in the Cas9 protein have never been fully assessed. Here, we present a comprehensive computational analysis based on both sequence and structural data in an attempt to investigate the roles of IDPRs in the functioning of Cas9 proteins of different origin. We conclude that among the functional roles of IDPRs in Cas9 proteins are recognition of the target DNA and mediation of nucleic acid and protein binding.	[Du, Zhihua; Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC07, Tampa, FL USA; [Du, Zhihua] Shenzhen Univ, Shenzhen, Guangdong, Peoples R China; [Uversky, Vladimir N.] Univ S Florida, USF Hlth Byrd Alzheimers Res Inst, Morsani Coll Med, 12901 Bruce B Downs Blvd MDC07, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Lab New Methods Biol, Inst Biol Instrumentat, Inst Skaya Str 7, Pushchino 142290, Moscow Region, Russia	Du, ZH; Uversky, VN (reprint author), Univ S Florida, Dept Mol Med, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC07, Tampa, FL USA.; Du, ZH (reprint author), Shenzhen Univ, Shenzhen, Guangdong, Peoples R China.; Uversky, VN (reprint author), Univ S Florida, USF Hlth Byrd Alzheimers Res Inst, Morsani Coll Med, 12901 Bruce B Downs Blvd MDC07, Tampa, FL USA.; Uversky, VN (reprint author), Russian Acad Sci, Lab New Methods Biol, Inst Biol Instrumentat, Inst Skaya Str 7, Pushchino 142290, Moscow Region, Russia.	duzh@szu.edu.cn; vuversky@health.usf.edu					Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Borg M, 2007, P NATL ACAD SCI USA, V104, P9650, DOI 10.1073/pnas.0702580104; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeForte S, 2016, PROTEIN SCI, V25, P676, DOI 10.1002/pro.2864; Di Domenico T, 2012, BIOINFORMATICS, V28, P2080, DOI 10.1093/bioinformatics/bts327; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hrabe T, 2016, NUCLEIC ACIDS RES, V44, pD423, DOI 10.1093/nar/gkv1316; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Khan WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054024; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Li X, 1999, GENOME INFORMATICS, V10, P30; Malhis N, 2016, NUCLEIC ACIDS RES, V44, pW488, DOI 10.1093/nar/gkw409; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Peng Z, 2012, PAC S BIOCOMPUT, V2012, P176; Peng ZL, 2012, CURR PROTEIN PEPT SC, V13, P6, DOI 10.2174/138920312799277938                                                      ; Peng ZL, 2014, CELL MOL LIFE SCI, V71, P1477, DOI 10.1007/s00018-013-1446-6; Potenza E, 2015, NUCLEIC ACIDS RES, V43, pD315, DOI 10.1093/nar/gku982; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Redman M, 2016, ARCH DIS CHILDHOOD-E, V101, P213, DOI 10.1136/archdischild-2016-310459; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero P, 1997, GENOME INFORMATICS, V8, P110; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Schrodinger LLC, UNPUB; Smith CA, 2000, MOL CELL, V6, P1067, DOI 10.1016/S1097-2765(00)00105-2; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Van Roey K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003345; Walsh I, 2015, BIOINFORMATICS, V31, P201, DOI 10.1093/bioinformatics/btu625; Wang S, 2016, BIOINFORMATICS, V32, P672, DOI 10.1093/bioinformatics/btw446; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xie B, 2004, J VIROL, V78, P1456, DOI 10.1128/JVI.78.3.1456-1463.2004; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Ye XM, 1999, CHEM BIOL, V6, P657, DOI 10.1016/S1074-5521(99)80117-3	59	0	0	13	13	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1742-206X	1742-2051		MOL BIOSYST	Mol. Biosyst.	SEP 1	2017	13	9					1770	1780		10.1039/c7mb00279c				11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	FE4WP	WOS:000408214300010	28692085				2018-01-05	
J	Parveen, S; Reddy, M				Parveen, Sadiya; Reddy, Manjula			Identification of YfiH (PgeF) as a factor contributing to the maintenance of bacterial peptidoglycan composition	MOLECULAR MICROBIOLOGY			English	Article							ESCHERICHIA-COLI K-12; L-ALANINE LIGASE; CELL-WALL SYNTHESIS; D-AMINO ACIDS; L-SERINE; STAPHYLOCOCCUS-AUREUS; SUSCEPTIBILITY LOCI; CHROMOSOMAL GENES; MUREIN; BIOSYNTHESIS	Peptidoglycan (PG) is an essential, envelope-fortifying macromolecule of eubacterial cell walls. It is a large polymer with multiple glycan strands interconnected by short peptide chains forming a sac-like structure around cytoplasmic membrane. In most bacteria, the composition of the peptide chain is well-conserved and distinctive; in E. coli, the peptide chain length varies from two to five amino acids with a tetrapeptide consisting of L-alanine - D-glutamic acid - meso-diaminopimelic acid - D-alanine. However, it is not known how bacteria conserve the composition and sequence of peptide chains of PG. Here, we find that a conserved open reading frame of unknown function, YfiH (renamed PgeF) contributes to the maintenance of peptide composition in E. coli. Using genetic, biochemical and mass spectrometrical analyses we demonstrate that absence of yfiH results in incorporation of non-canonical amino acids, L-serine or glycine in place of L-alanine in PG sacculi leading to -lactam - sensitivity, lethality in mutants defective in PG remodelling or recycling pathways, altered cell morphology and reduced PG synthesis. yfiH orthologs from other Gram-positive genera were able to compensate the absence of yfiH in E. coli indicating a conserved pathway in bacterial kingdom. Our results suggest editing/quality control mechanisms exist to maintain composition and integrity of bacterial peptidoglycan.	[Parveen, Sadiya; Reddy, Manjula] CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Telangana, India	Reddy, M (reprint author), CSIR Ctr Cellular & Mol Biol, Hyderabad 500007, Telangana, India.	manjula@ccmb.res.in			Council of Scientific and Industrial Research [BSC0104]; Department of Biotechnology (COE on Microbial Biology), Government of India; University Grants Commission of India	We thank NBRP (Japan): E. coli and NBRP (Japan): B. subtilis for Keio mutant collection and Bacillus mutants respectively. We would also like to thank Waldemar Vollmer for help with mass spectrometry; RN Amrutha for construction of plasmid pSA20; C Subbalakshmi, V Krishna Kumari for HPLC analysis; and Y Kameshwari for MALDI analysis. This work is supported by funds from Council of Scientific and Industrial Research (BSC0104) and Department of Biotechnology (COE on Microbial Biology), Government of India. SP acknowledges financial support from University Grants Commission of India. The authors declare that they have no conflict of interest.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; GSCHAEDLER A, 1994, J BIOTECHNOL, V37, P235, DOI 10.1016/0168-1656(94)90131-7; Gubler M, 1996, J BACTERIOL, V178, P906, DOI 10.1128/jb.178.3.906-910.1996                                                   ; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995                                                ; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; HISHINUMA F, 1969, AGR BIOL CHEM TOKYO, V33, P1577, DOI 10.1080/00021369.1969.10859511                                                  ; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Kim Y, 2006, PROTEINS, V63, P1097, DOI 10.1002/prot.20589; LIGER D, 1995, EUR J BIOCHEM, V230, P80, DOI 10.1111/j.1432-1033.1995.tb20536.x; LIGER D, 1991, FEMS MICROBIOL LETT, V80, P111; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Liu H, 2015, NAT GENET, V47, P267, DOI 10.1038/ng.3212; Mahapatra S, 2000, J BACTERIOL, V182, P6827, DOI 10.1128/JB.182.23.6827-6830.2000; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; MILLER I, 1966, BIOCHEM BIOPH RES CO, V25, P415, DOI 10.1016/0006-291X(66)90221-X; Miller J.H., 1992, SHORT COURSE BACTERI; NEWMAN EB, 1982, J BACTERIOL, V151, P777; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PARK JT, 1958, BIOCHEM J, V70, pP2; Park J. T., 1996, ESCHERICHIA COLI SAL, V2, P48; Patin D, 2010, BIOCHIMIE, V92, P1793, DOI 10.1016/j.biochi.2010.07.009; Sambrook J, 1989, MOL CLONING LAB MANU; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407; SHAO ZQ, 1994, EUR J BIOCHEM, V222, P901, DOI 10.1111/j.1432-1033.1994.tb18938.x; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; STROMING.JL, 1965, J BACTERIOL, V89, P1124; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2007, J BACTERIOL, V189, P5634, DOI 10.1128/JB.00446-07; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wakil SM, 2015, ARTHRITIS RHEUMATOL, V67, P288, DOI 10.1002/art.38877; WIENTJES FB, 1985, J BACTERIOL, V164, P331; Zhang X, 2008, MOL MICROBIOL, V69, P870, DOI 10.1111/j.1365-2958.2008.06315.x; Zhang XA, 2010, J BACTERIOL, V192, P5515, DOI 10.1128/JB.00748-10	46	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	SEP	2017	105	5					705	720		10.1111/mmi.13730				16	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	FE6HC	WOS:000408309600004	28612943				2018-01-05	
J	Wang, M; Cao, SN; Du, NL; Fu, JW; Li, ZR; Jia, HL; Song, MX				Wang, Ming; Cao, Shinuo; Du, Nali; Fu, Jiawen; Li, Zhaoran; Jia, Honglin; Song, Mingxin			The moving junction protein RON4, although not critical, facilitates host cell invasion and stabilizes MJ members	PARASITOLOGY			English	Article						TgRON4; Toxoplasma gondii; knockout; MJ complex	GONDII ANTIBODY-TITERS; TOXOPLASMA-GONDII; SUICIDE ATTEMPTS; AMINOPEPTIDASE; PARASITE; HISTORY; ROLES	Toxoplasma gondii is an obligate intracellular parasite of phylum Apicomplexa. To facilitate high-efficiency invasion of host cells, T. gondii secretes various proteins related to the moving junction (MJ) complex from rhoptries and micronemes into the interface between the parasite and host. AMA1/RON2/4/5/8 is an important MJ complex, but its mechanism of assembly remains unclear. In this study, we used the CRISPR-Cas9 system to generate a derivative of T. gondii strain RH with a null mutation in TgRON4, thought to be an essential MJ component. Deficiency of TgRON4 moderately decreased invasion ability relative to that of the wild-type parasite. In addition, expression of the endogenous N-terminal fragment of RON5 decreased in the mutant. Together, the results improve our understanding of the assembly mechanism of the MJ complex of T. gondii and raise the possibility of developing new therapeutic drugs that target this complex.	[Wang, Ming; Song, Mingxin] Northeast Agr Univ, Coll Vet Med, Mucai St 59, Harbin 150001, Heilongjiang, Peoples R China; [Wang, Ming; Cao, Shinuo; Du, Nali; Fu, Jiawen; Li, Zhaoran; Jia, Honglin] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Haping Rd 678, Harbin 150001, Heilongjiang, Peoples R China	Song, MX (reprint author), Northeast Agr Univ, Coll Vet Med, Mucai St 59, Harbin 150001, Heilongjiang, Peoples R China.; Jia, HL (reprint author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Haping Rd 678, Harbin 150001, Heilongjiang, Peoples R China.	jiahonglin@caas.cn; songmx@neau.edu.cn			State Key Laboratory of Veterinary Biotechnology [SKLVBF201601]	This work was supported in part by a grant from the State Key Laboratory of Veterinary Biotechnology (no. SKLVBF201601).	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; Beck JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004025; Besteiro S., 2009, PLOS PATHOG, V2; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Ling VJ, 2011, J NERV MENT DIS, V199, P440, DOI 10.1097/NMD.0b013e318221416e; Okusaga O, 2011, SCHIZOPHR RES, V133, P150, DOI 10.1016/j.schres.2011.08.006; Parker ML, 2016, P NATL ACAD SCI USA, V113, P398, DOI 10.1073/pnas.1515898113; Poukchanski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070637; Rashid I, 2011, VACCINE, V29, P8838, DOI 10.1016/j.vaccine.2011.09.099; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Straub KW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002007; Takemae H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03199; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; Zheng J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34448; Zheng J, 2015, INT J PARASITOL, V45, P141, DOI 10.1016/j.ijpara.2014.09.003	22	2	2	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0031-1820	1469-8161		PARASITOLOGY	Parasitology	SEP	2017	144	11					1490	1497		10.1017/S0031182017000968				8	Parasitology	Parasitology	FE5TA	WOS:000408272800009	28662729				2018-01-05	
J	Ibrahim, M; Subramanian, A; Anishetty, S				Ibrahim, Maziya; Subramanian, Ahalyaa; Anishetty, Sharmila			Comparative pan genome analysis of oral Prevotella species implicated in periodontitis	FUNCTIONAL & INTEGRATIVE GENOMICS			English	Article						Prevotella; Periodontitis; Pan genome; T6SS; CRISPR; PorSS	CRISPR-CAS SYSTEMS; SHORT PALINDROMIC REPEATS; POR SECRETION SYSTEM; PORPHYROMONAS-GINGIVALIS; GLIDING MOTILITY; DRUG TARGETS; PROTEINS; PATHWAY; CLASSIFICATION; BIOSYNTHESIS	Prevotella is part of the oral bacterial community implicated in periodontitis. Pan genome analyses of eight oral Prevotella species, P. dentalis, P. enoeca, P. fusca, P. melaninogenica, P. denticola, P. intermedia 17, P. intermedia 17-2 and P. sp. oral taxon 299 are presented in this study. Analysis of the Prevotella pan genome revealed features such as secretion systems, resistance to oxidative stress and clustered regularly interspaced short palindromic repeat (CRISPR)-Cas systems that enable the bacteria to adapt to the oral environment. We identified the presence of type VI secretion system (T6SS) in P. fusca and P. intermedia strains. For some VgrG and Hcp proteins which were not part of the core T6SS loci, we used gene neighborhood analysis and identified putative effector proteins and putative polyimmunity loci in P. fusca and polymorphic toxin systems in P. intermedia strains. Earlier studies have identified the presence of Por secretion system (PorSS) in P. gingivalis, P. melaninogenica and P. intermedia. We noted the presence of their homologs in six other oral Prevotella studied here. We suggest that in Prevotella, PorSS is used to secrete cysteine proteases such as interpain and C-terminal domain containing proteins with a "Por_secre_tail" domain. We identified subtype I-B CRISPR-Cas system in P. enoeca. Putative CRISPR-Cas system subtypes for 37 oral Prevotella and 30 non-oral Prevotella species were also predicted. Further, we performed a BLASTp search of the Prevotella proteins which are also conserved in the red-complex pathogens, against the human proteome to identify potential broad-spectrum drug targets. In summary, the use of a pan genome approach enabled identification of secretion systems and defense mechanisms in Prevotella that confer adaptation to the oral cavity.	[Ibrahim, Maziya; Subramanian, Ahalyaa; Anishetty, Sharmila] Anna Univ, Ctr Biotechnol, Madras 600025, Tamil Nadu, India	Anishetty, S (reprint author), Anna Univ, Ctr Biotechnol, Madras 600025, Tamil Nadu, India.	sharmi.anishetty@gmail.com			Council of Scientific and Industrial Research (CSIR), India	I. Maziya acknowledges support through Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR), India.	Anishetty S, 2005, COMPUT BIOL CHEM, V29, P368, DOI 10.1016/j.compbiolchem.2005.07.001; Arora Nupur, 2014, J Indian Soc Periodontol, V18, P9, DOI 10.4103/0972-124X.128192; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Boyd ES, 2014, BIOCHEMISTRY-US, V53, P5834, DOI 10.1021/bi500488r; Byrne Dominic P, 2009, Biochem J, V425, P257, DOI 10.1042/BJ20090343; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Cooper VS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000732; Coyne MJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2377-z; Dhillon BK, 2013, NUCLEIC ACIDS RES, V41, pW129, DOI 10.1093/nar/gkt394; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gupta VK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1350-6; Hamamoto H, 2015, NAT CHEM BIOL, V11, P127, DOI [10.1038/NCHEMBIO.1710, 10.1038/nchembio.1710]; He JZ, 2015, FOLIA MICROBIOL, V60, P69, DOI 10.1007/s12223-014-0342-2; Henry LG, 2014, J ORAL BIOSCI, V56, P63, DOI 10.1016/j.job.2014.03.001; Heuston S, 2012, MICROBIOL-SGM, V158, P1389, DOI 10.1099/mic.0.051599-0; Huynen MA, 1999, TRENDS MICROBIOL, V7, P281, DOI 10.1016/S0966-842X(99)01539-5; Jamet A, 2015, MBIO, V6, DOI 10.1128/mBio.00285-15; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2015, KEGG REFERENCE RESOU; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kempf F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147954; Kjos M, 2010, J BACTERIOL, V192, P2068, DOI 10.1128/JB.01553-09; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Kurosu M, 2010, MOLECULES, V15, P1531, DOI 10.3390/molecules15031531; Li J, 2015, ENVIRON MICROBIOL, V17, P2196, DOI 10.1111/1462-2920.12794; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McBride MJ, 2015, CURR OPIN MICROBIOL, V28, P72, DOI 10.1016/j.mib.2015.07.016; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; McNab R, 2003, J BACTERIOL, V185, P274, DOI 10.1128/JB.185.1.274-284.2003; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Monachese M, 2012, APPL ENVIRON MICROB, V78, P6397, DOI 10.1128/AEM.01665-12; Naito M, 2015, COMPLETE GENOME SEQU; Parashar A, 2015, ORAL SCI INT, V12, P37, DOI 10.1016/S1348-8643(15)00016-6; Pleckaityte M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-301; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Romano S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00387; Ruan YF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1272-3; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028; Scannapieco F. A., 2013, Clinical Microbiology Newsletter, V35, P163, DOI 10.1016/j.clinmicnews.2013.09.003; Scheres N, 2015, ANAEROBE, V35, P3, DOI 10.1016/j.anaerobe.2014.11.011; Song CX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2289-3; TAMURA M, 1992, INFECT IMMUN, V60, P4932; Tang YXP, 1999, MOL MICROBIOL, V32, P139, DOI 10.1046/j.1365-2958.1999.01337.x; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Teughels W, 2014, PERIODONTOL 2000, V65, P107, DOI 10.1111/prd.12020; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120; Viennot S, 2005, EUR J ORAL SCI, V113, P90, DOI 10.1111/j.1600-0722.2005.00190.x; Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yost S, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0153-3; Zakham Fathiah, 2012, Microb Inform Exp, V2, P7, DOI 10.1186/2042-5783-2-7; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	61	3	3	10	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1438-793X	1438-7948		FUNCT INTEGR GENOMIC	Funct. Integr. Genomics	SEP	2017	17	5					513	536		10.1007/s10142-017-0550-3				24	Genetics & Heredity	Genetics & Heredity	FE0TX	WOS:000407933700003	28236274				2018-01-05	
J	Chen, YG; Satpathy, AT; Chang, HY				Chen, Y. Grace; Satpathy, Ansuman T.; Chang, Howard Y.			Gene regulation in the immune system by long noncoding RNAs	NATURE IMMUNOLOGY			English	Review							CENTRAL-NERVOUS-SYSTEM; EDITING ENZYME ADAR1; MESSENGER-RNA; THEILERS-VIRUS; CIRCULAR RNAS; CELL-DIFFERENTIATION; TRANSCRIPTION FACTOR; X-CHROMOSOME; CANCER METASTASIS; CANDIDATE GENE	Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression in the immune system. Studies have shown that lncRNAs are expressed in a highly lineage-specific manner and control the differentiation and function of innate and adaptive cell types. In this Review, we focus on mechanisms used by lncRNAs to regulate genes encoding products involved in the immune response, including direct interactions with chromatin, RNA and proteins. In addition, we address new areas of lncRNA biology, such as the functions of enhancer RNAs, circular RNAs and chemical modifications to RNA in cellular processes. We emphasize critical gaps in knowledge and future prospects for the roles of lncRNAs in the immune system and autoimmune disease.	[Chen, Y. Grace; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Chen, Y. Grace; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Chang, HY (reprint author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Chang, HY (reprint author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu		Satpathy, Ansuman/0000-0002-5167-537X	US National Institutes of Health [P50HG007735]; Parker Institute for Cancer Immunotherapy; Scleroderma Research Foundation; Cancer Research Institute (Irvington Fellowship)	We thank members of the Chang laboratory for discussions, and J. Tumey for figure artwork. Supported by the US National Institutes of Health (P50HG007735), the Parker Institute for Cancer Immunotherapy, the Scleroderma Research Foundation (H.Y.C.) and the Cancer Research Institute (Irvington Fellowship to A.T.S.).	Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Bass BL, 1997, RNA, V3, P947; Batista P. J., 2014, RNA BIOL, V15, P707, DOI DOI 10.1016/J.STEM.2014.09.019; Bihl F, 1999, GENETICS, V152, P385; Blanco S, 2014, CURR OPIN CELL BIOL, V31, P1, DOI 10.1016/j.ceb.2014.06.006; Bokar JA, 1997, RNA, V3, P1233; BOKAR JA, 1994, J BIOL CHEM, V269, P17697; Bonafe L, 2005, PLOS GENET, V1, P444, DOI 10.1371/journal.pgen.0010047; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BUREAU JF, 1993, NAT GENET, V5, P87, DOI 10.1038/ng0993-87; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cao GC, 2016, OPEN BIOL, V6, DOI [10.1098/rsob.16.0003, 10.1098/rsob.160003]; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castellanos-Rubio A, 2016, SCIENCE, V352, P91, DOI 10.1126/science.aad0467; Chen YG, 2017, MOL CELL, V67, P228, DOI 10.1016/j.molcel.2017.05.022; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Collier SP, 2014, J IMMUNOL, V193, P3959, DOI 10.4049/jimmunol.1401099; Collier SP, 2012, J IMMUNOL, V189, P2084, DOI 10.4049/jimmunol.1200774; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371                                                               ; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dijkstra Johannes M, 2014, F1000Res, V3, P160, DOI 10.12688/f1000research.4711.2; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dou YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37982; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Eckmann CR, 2001, MOL BIOL CELL, V12, P1911, DOI 10.1091/mbc.12.7.1911                                                           ; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Fumagalli D., 2015, NAT IMMUNOL, V13, P277; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gallo A, 2012, BIOL REV, V87, P95, DOI 10.1111/j.1469-185X.2011.00186.x; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Goldstein B, 2017, GENOME RES, V27, P462, DOI 10.1101/gr.211169.116; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gong J, 2017, NUCLEIC ACIDS RES, V45, pD79, DOI 10.1093/nar/gkw835; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Higuchi M, 2000, NATURE, V406, P78; Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2015, SCIENCE, V350, P455, DOI 10.1126/science.aac7442; Ivanov A, 2015, CELL REP, V10, P170, DOI 10.1016/j.celrep.2014.12.019; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Klungland A, 2014, CURR OPIN GENET DEV, V26, P47, DOI 10.1016/j.gde.2014.05.006; Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346; Krawczyk M, 2014, ELIFE, V3, DOI 10.7554/eLife.01776; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levillayer F, 2007, GENETICS, V176, P1835, DOI 10.1534/genetics.107.073536; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Li Y, 2016, CELL CHEM BIOL, V23, P1325, DOI 10.1016/j.chembiol.2016.09.011; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Luo M, 2015, CELL STEM CELL, V16, P426, DOI 10.1016/j.stem.2015.02.002; Makitie O, 1998, EUR J PEDIATR, V157, P816, DOI 10.1007/s004310050943                                                           ; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marcu-Malina V, 2016, ONCOTARGET, V7, P54370, DOI 10.18632/oncotarget.11029; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Monnier P, 2013, P NATL ACAD SCI USA, V110, P20693, DOI 10.1073/pnas.1310201110; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Ng WL, 2016, RNA BIOL, V13, P861, DOI 10.1080/15476286.2016.1207036; Nie YZ, 2004, J BIOL CHEM, V279, P13249, DOI 10.1074/jbc.M312753200; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Paz-Yaacov N., 2015, NUCLEIC ACIDS RES, V13, P267; Peschansky VJ, 2014, EPIGENETICS-US, V9, P3, DOI 10.4161/epi.27473; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Picardi E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14941; Picardi Ernesto, 2014, Front Bioeng Biotechnol, V2, P64, DOI 10.3389/fbioe.2014.00064; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/nmeth.1982, 10.1038/NMETH.1982]; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Salameh A, 2015, P NATL ACAD SCI USA, V112, P8403, DOI 10.1073/pnas.1507882112; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Silberberg G, 2012, HUM MOL GENET, V21, P311, DOI 10.1093/hmg/ddr461; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145                                                ; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Spurlock CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7932; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Vigneau S, 2003, J VIROL, V77, P5632, DOI 10.1128/JVI.77.10.5632-5638.2003; Vigneau S, 2001, GENOMICS, V78, P206, DOI 10.1006/geno.2001.6656; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765                                                   ; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2015, P NATL ACAD SCI USA, V112, pE3883, DOI 10.1073/pnas.1501662112; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Washietl S, 2014, GENOME RES, V24, P616, DOI 10.1101/gr.165035.113; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wilusz Jeremy E, 2015, Mob Genet Elements, V5, P1; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Zhao BXS, 2017, NATURE, V542, P475, DOI 10.1038/nature21355; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	153	2	2	23	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					962	972		10.1038/ni.3771				11	Immunology	Immunology	FE3TD	WOS:000408137700006	28829444				2018-01-05	
